,DrugBank ID,Drug Name,Drug Type,UniProt ID,Protein Names,Gene Symbol,Length
0,DB00001,Lepirudin,BiotechDrug,P00734,Prothrombin,F2,622.0
1,DB00002,Cetuximab,BiotechDrug,P00533,Epidermal growth factor receptor,EGFR,1210.0
2,DB00002,Cetuximab,BiotechDrug,O75015,Low affinity immunoglobulin gamma Fc region receptor III-B,FCGR3B,233.0
3,DB00002,Cetuximab,BiotechDrug,P00736,Complement C1r subcomponent,C1R,705.0
4,DB00002,Cetuximab,BiotechDrug,P02745,Complement C1q subcomponent subunit A,C1QA,245.0
5,DB00002,Cetuximab,BiotechDrug,P02746,Complement C1q subcomponent subunit B,C1QB,253.0
6,DB00002,Cetuximab,BiotechDrug,P02747,Complement C1q subcomponent subunit C,C1QC,245.0
7,DB00002,Cetuximab,BiotechDrug,P08637,Low affinity immunoglobulin gamma Fc region receptor III-A,FCGR3A,254.0
8,DB00002,Cetuximab,BiotechDrug,P09871,Complement C1s subcomponent,C1S,688.0
9,DB00002,Cetuximab,BiotechDrug,P12314,High affinity immunoglobulin gamma Fc receptor I,FCGR1A,374.0
10,DB00002,Cetuximab,BiotechDrug,P12318,Low affinity immunoglobulin gamma Fc region receptor II-a,FCGR2A,317.0
11,DB00002,Cetuximab,BiotechDrug,P31994,Low affinity immunoglobulin gamma Fc region receptor II-b,FCGR2B,310.0
12,DB00002,Cetuximab,BiotechDrug,P31995,Low affinity immunoglobulin gamma Fc region receptor II-c,FCGR2C,323.0
13,DB00004,Denileukin diftitox,BiotechDrug,P01589,Interleukin-2 receptor subunit alpha,IL2RA,272.0
14,DB00004,Denileukin diftitox,BiotechDrug,P14784,Interleukin-2 receptor subunit beta,IL2RB,551.0
15,DB00004,Denileukin diftitox,BiotechDrug,P31785,Cytokine receptor common subunit gamma,IL2RG,369.0
16,DB00005,Etanercept,BiotechDrug,P01375,Tumor necrosis factor,TNF,233.0
17,DB00005,Etanercept,BiotechDrug,P20333,Tumor necrosis factor receptor superfamily member 1B,TNFRSF1B,461.0
18,DB00005,Etanercept,BiotechDrug,P12314,High affinity immunoglobulin gamma Fc receptor I,FCGR1A,374.0
19,DB00005,Etanercept,BiotechDrug,P08637,Low affinity immunoglobulin gamma Fc region receptor III-A,FCGR3A,254.0
20,DB00005,Etanercept,BiotechDrug,P12318,Low affinity immunoglobulin gamma Fc region receptor II-a,FCGR2A,317.0
21,DB00005,Etanercept,BiotechDrug,P31994,Low affinity immunoglobulin gamma Fc region receptor II-b,FCGR2B,310.0
22,DB00005,Etanercept,BiotechDrug,P31995,Low affinity immunoglobulin gamma Fc region receptor II-c,FCGR2C,323.0
23,DB00005,Etanercept,BiotechDrug,P01374,Lymphotoxin-alpha,LTA,205.0
24,DB00005,Etanercept,BiotechDrug,O75015,Low affinity immunoglobulin gamma Fc region receptor III-B,FCGR3B,233.0
25,DB00005,Etanercept,BiotechDrug,P09871,Complement C1s subcomponent,C1S,688.0
26,DB00005,Etanercept,BiotechDrug,P00736,Complement C1r subcomponent,C1R,705.0
27,DB00005,Etanercept,BiotechDrug,P02745,Complement C1q subcomponent subunit A,C1QA,245.0
28,DB00005,Etanercept,BiotechDrug,P02746,Complement C1q subcomponent subunit B,C1QB,253.0
29,DB00005,Etanercept,BiotechDrug,P02747,Complement C1q subcomponent subunit C,C1QC,245.0
30,DB00006,Bivalirudin,SmallMoleculeDrug,P00734,Prothrombin,F2,622.0
31,DB00007,Leuprolide,BiotechDrug,P30968,Gonadotropin-releasing hormone receptor,GNRHR,328.0
32,DB00008,Peginterferon alfa-2a,BiotechDrug,P48551,Interferon alpha/beta receptor 2,IFNAR2,515.0
33,DB00008,Peginterferon alfa-2a,BiotechDrug,P17181,Interferon alpha/beta receptor 1,IFNAR1,557.0
34,DB00009,Alteplase,BiotechDrug,P00747,Plasminogen,PLG,810.0
35,DB00009,Alteplase,BiotechDrug,P02671,Fibrinogen alpha chain,FGA,866.0
36,DB00009,Alteplase,BiotechDrug,Q03405,Urokinase plasminogen activator surface receptor,PLAUR,335.0
37,DB00009,Alteplase,BiotechDrug,P05121,Plasminogen activator inhibitor 1,SERPINE1,402.0
38,DB00010,Sermorelin,BiotechDrug,Q02643,Growth hormone-releasing hormone receptor,GHRHR,423.0
39,DB00011,Interferon alfa-n1,BiotechDrug,P48551,Interferon alpha/beta receptor 2,IFNAR2,515.0
40,DB00011,Interferon alfa-n1,BiotechDrug,P17181,Interferon alpha/beta receptor 1,IFNAR1,557.0
41,DB00012,Darbepoetin alfa,BiotechDrug,P19235,Erythropoietin receptor,EPOR,508.0
42,DB00013,Urokinase,BiotechDrug,P00747,Plasminogen,PLG,810.0
43,DB00013,Urokinase,BiotechDrug,Q03405,Urokinase plasminogen activator surface receptor,PLAUR,335.0
44,DB00013,Urokinase,BiotechDrug,P00749,Urokinase-type plasminogen activator,PLAU,431.0
45,DB00013,Urokinase,BiotechDrug,P00750,Tissue-type plasminogen activator,PLAT,562.0
46,DB00013,Urokinase,BiotechDrug,P05121,Plasminogen activator inhibitor 1,SERPINE1,402.0
47,DB00013,Urokinase,BiotechDrug,P05120,Plasminogen activator inhibitor 2,SERPINB2,415.0
48,DB00013,Urokinase,BiotechDrug,P05154,Plasma serine protease inhibitor,SERPINA5,406.0
49,DB00013,Urokinase,BiotechDrug,P98164,Low-density lipoprotein receptor-related protein 2,LRP2,4655.0
50,DB00013,Urokinase,BiotechDrug,Q9Y5Y6,Suppressor of tumorigenicity 14 protein,ST14,855.0
51,DB00013,Urokinase,BiotechDrug,P14543,Nidogen-1,NID1,1247.0
52,DB00014,Goserelin,SmallMoleculeDrug,P22888,Lutropin-choriogonadotropic hormone receptor,LHCGR,699.0
53,DB00014,Goserelin,SmallMoleculeDrug,P30968,Gonadotropin-releasing hormone receptor,GNRHR,328.0
54,DB00015,Reteplase,BiotechDrug,P00747,Plasminogen,PLG,810.0
55,DB00015,Reteplase,BiotechDrug,P02671,Fibrinogen alpha chain,FGA,866.0
56,DB00015,Reteplase,BiotechDrug,Q03405,Urokinase plasminogen activator surface receptor,PLAUR,335.0
57,DB00015,Reteplase,BiotechDrug,P05121,Plasminogen activator inhibitor 1,SERPINE1,402.0
58,DB00016,Erythropoietin,BiotechDrug,P19235,Erythropoietin receptor,EPOR,508.0
59,DB00017,Salmon Calcitonin,BiotechDrug,P30988,Calcitonin receptor,CALCR,508.0
60,DB00018,Interferon alfa-n3,BiotechDrug,P17181,Interferon alpha/beta receptor 1,IFNAR1,557.0
61,DB00018,Interferon alfa-n3,BiotechDrug,P48551,Interferon alpha/beta receptor 2,IFNAR2,515.0
62,DB00019,Pegfilgrastim,BiotechDrug,Q99062,Granulocyte colony-stimulating factor receptor,CSF3R,836.0
63,DB00019,Pegfilgrastim,BiotechDrug,P08246,Neutrophil elastase,ELANE,267.0
64,DB00020,Sargramostim,BiotechDrug,P15509,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,CSF2RA,400.0
65,DB00020,Sargramostim,BiotechDrug,P26951,Interleukin-3 receptor subunit alpha,IL3RA,378.0
66,DB00020,Sargramostim,BiotechDrug,P32927,Cytokine receptor common subunit beta,CSF2RB,897.0
67,DB00020,Sargramostim,BiotechDrug,P34741,Syndecan-2,SDC2,201.0
68,DB00020,Sargramostim,BiotechDrug,P13727,Bone marrow proteoglycan,PRG2,222.0
69,DB00021,Secretin,BiotechDrug,P47872,Secretin receptor,SCTR,440.0
70,DB00022,Peginterferon alfa-2b,BiotechDrug,P17181,Interferon alpha/beta receptor 1,IFNAR1,557.0
71,DB00022,Peginterferon alfa-2b,BiotechDrug,P48551,Interferon alpha/beta receptor 2,IFNAR2,515.0
72,DB00024,Thyrotropin Alfa,BiotechDrug,P16473,Thyrotropin receptor,TSHR,764.0
73,DB00025,Antihemophilic Factor (Recombinant),BiotechDrug,P00742,Coagulation factor X,F10,488.0
74,DB00025,Antihemophilic Factor (Recombinant),BiotechDrug,P00740,Coagulation factor IX,F9,461.0
75,DB00025,Antihemophilic Factor (Recombinant),BiotechDrug,P04275,von Willebrand factor,VWF,2813.0
76,DB00025,Antihemophilic Factor (Recombinant),BiotechDrug,O14832,"Phytanoyl-CoA dioxygenase, peroxisomal",PHYH,338.0
77,DB00025,Antihemophilic Factor (Recombinant),BiotechDrug,P07307,Asialoglycoprotein receptor 2,ASGR2,311.0
78,DB00025,Antihemophilic Factor (Recombinant),BiotechDrug,P11021,78 kDa glucose-regulated protein,HSPA5,654.0
79,DB00025,Antihemophilic Factor (Recombinant),BiotechDrug,P27797,Calreticulin,CALR,417.0
80,DB00025,Antihemophilic Factor (Recombinant),BiotechDrug,P27824,Calnexin,CANX,592.0
81,DB00025,Antihemophilic Factor (Recombinant),BiotechDrug,P49257,Protein ERGIC-53,LMAN1,510.0
82,DB00025,Antihemophilic Factor (Recombinant),BiotechDrug,Q07954,Prolow-density lipoprotein receptor-related protein 1,LRP1,4544.0
83,DB00025,Antihemophilic Factor (Recombinant),BiotechDrug,Q8NI22,Multiple coagulation factor deficiency protein 2,MCFD2,146.0
84,DB00026,Anakinra,BiotechDrug,P14778,Interleukin-1 receptor type 1,IL1R1,569.0
85,DB00028,Immune Globulin Human,BiotechDrug,P12314,High affinity immunoglobulin gamma Fc receptor I,FCGR1A,374.0
86,DB00028,Immune Globulin Human,BiotechDrug,Q92637,High affinity immunoglobulin gamma Fc receptor IB,FCGR1B,280.0
87,DB00028,Immune Globulin Human,BiotechDrug,P12318,Low affinity immunoglobulin gamma Fc region receptor II-a,FCGR2A,317.0
88,DB00028,Immune Globulin Human,BiotechDrug,P31994,Low affinity immunoglobulin gamma Fc region receptor II-b,FCGR2B,310.0
89,DB00028,Immune Globulin Human,BiotechDrug,P31995,Low affinity immunoglobulin gamma Fc region receptor II-c,FCGR2C,323.0
90,DB00028,Immune Globulin Human,BiotechDrug,P08637,Low affinity immunoglobulin gamma Fc region receptor III-A,FCGR3A,254.0
91,DB00028,Immune Globulin Human,BiotechDrug,O75015,Low affinity immunoglobulin gamma Fc region receptor III-B,FCGR3B,233.0
92,DB00028,Immune Globulin Human,BiotechDrug,P01024,Complement C3,C3,1663.0
93,DB00028,Immune Globulin Human,BiotechDrug,P0C0L4,Complement C4-A,C4A,1744.0
94,DB00028,Immune Globulin Human,BiotechDrug,P0C0L5,Complement C4-B,C4B,1744.0
95,DB00028,Immune Globulin Human,BiotechDrug,P01031,Complement C5,C5,1676.0
96,DB00029,Anistreplase,BiotechDrug,P00747,Plasminogen,PLG,810.0
97,DB00029,Anistreplase,BiotechDrug,P02671,Fibrinogen alpha chain,FGA,866.0
98,DB00029,Anistreplase,BiotechDrug,Q03405,Urokinase plasminogen activator surface receptor,PLAUR,335.0
99,DB00029,Anistreplase,BiotechDrug,P05121,Plasminogen activator inhibitor 1,SERPINE1,402.0
100,DB00030,Insulin Human,BiotechDrug,P06213,Insulin receptor,INSR,1382.0
101,DB00030,Insulin Human,BiotechDrug,P08069,Insulin-like growth factor 1 receptor,IGF1R,1367.0
102,DB00030,Insulin Human,BiotechDrug,P06400,Retinoblastoma-associated protein,RB1,928.0
103,DB00030,Insulin Human,BiotechDrug,P07339,Cathepsin D,CTSD,412.0
104,DB00030,Insulin Human,BiotechDrug,P14735,Insulin-degrading enzyme,IDE,1019.0
105,DB00030,Insulin Human,BiotechDrug,P16519,Neuroendocrine convertase 2,PCSK2,638.0
106,DB00030,Insulin Human,BiotechDrug,P16870,Carboxypeptidase E,CPE,476.0
107,DB00030,Insulin Human,BiotechDrug,P29120,Neuroendocrine convertase 1,PCSK1,753.0
108,DB00030,Insulin Human,BiotechDrug,P48745,Protein NOV homolog,NOV,357.0
109,DB00030,Insulin Human,BiotechDrug,P98164,Low-density lipoprotein receptor-related protein 2,LRP2,4655.0
110,DB00030,Insulin Human,BiotechDrug,Q16270,Insulin-like growth factor-binding protein 7,IGFBP7,282.0
111,DB00030,Insulin Human,BiotechDrug,Q96C24,Synaptotagmin-like protein 4,SYTL4,671.0
112,DB00031,Tenecteplase,BiotechDrug,P00747,Plasminogen,PLG,810.0
113,DB00031,Tenecteplase,BiotechDrug,P02671,Fibrinogen alpha chain,FGA,866.0
114,DB00031,Tenecteplase,BiotechDrug,Q03405,Urokinase plasminogen activator surface receptor,PLAUR,335.0
115,DB00031,Tenecteplase,BiotechDrug,P05121,Plasminogen activator inhibitor 1,SERPINE1,402.0
116,DB00031,Tenecteplase,BiotechDrug,P05120,Plasminogen activator inhibitor 2,SERPINB2,415.0
117,DB00031,Tenecteplase,BiotechDrug,P05452,Tetranectin,CLEC3B,202.0
118,DB00031,Tenecteplase,BiotechDrug,P05787,"Keratin, type II cytoskeletal 8",KRT8,483.0
119,DB00031,Tenecteplase,BiotechDrug,P07355,Annexin A2,ANXA2,339.0
120,DB00031,Tenecteplase,BiotechDrug,P27797,Calreticulin,CALR,417.0
121,DB00031,Tenecteplase,BiotechDrug,P27824,Calnexin,CANX,592.0
122,DB00031,Tenecteplase,BiotechDrug,Q07954,Prolow-density lipoprotein receptor-related protein 1,LRP1,4544.0
123,DB00032,Menotropins,BiotechDrug,P23945,Follicle-stimulating hormone receptor,FSHR,695.0
124,DB00032,Menotropins,BiotechDrug,P22888,Lutropin-choriogonadotropic hormone receptor,LHCGR,699.0
125,DB00033,Interferon gamma-1b,BiotechDrug,P15260,Interferon gamma receptor 1,IFNGR1,489.0
126,DB00033,Interferon gamma-1b,BiotechDrug,P38484,Interferon gamma receptor 2,IFNGR2,337.0
127,DB00034,"Interferon Alfa-2a, Recombinant",BiotechDrug,P17181,Interferon alpha/beta receptor 1,IFNAR1,557.0
128,DB00034,"Interferon Alfa-2a, Recombinant",BiotechDrug,P48551,Interferon alpha/beta receptor 2,IFNAR2,515.0
129,DB00035,Desmopressin,SmallMoleculeDrug,P30518,Vasopressin V2 receptor,AVPR2,371.0
130,DB00035,Desmopressin,SmallMoleculeDrug,P37288,Vasopressin V1a receptor,AVPR1A,418.0
131,DB00035,Desmopressin,SmallMoleculeDrug,P47901,Vasopressin V1b receptor,AVPR1B,424.0
132,DB00036,Coagulation factor VIIa Recombinant Human,BiotechDrug,P00742,Coagulation factor X,F10,488.0
133,DB00036,Coagulation factor VIIa Recombinant Human,BiotechDrug,P05981,Serine protease hepsin,HPN,417.0
134,DB00036,Coagulation factor VIIa Recombinant Human,BiotechDrug,P10646,Tissue factor pathway inhibitor,TFPI,304.0
135,DB00036,Coagulation factor VIIa Recombinant Human,BiotechDrug,P38435,Vitamin K-dependent gamma-carboxylase,GGCX,758.0
136,DB00036,Coagulation factor VIIa Recombinant Human,BiotechDrug,P08709,Coagulation factor VII,F7,466.0
137,DB00036,Coagulation factor VIIa Recombinant Human,BiotechDrug,P13726,Tissue factor,F3,295.0
138,DB00038,Oprelvekin,BiotechDrug,Q14626,Interleukin-11 receptor subunit alpha,IL11RA,422.0
139,DB00039,Palifermin,BiotechDrug,P21802,Fibroblast growth factor receptor 2,FGFR2,821.0
140,DB00039,Palifermin,BiotechDrug,O14786,Neuropilin-1,NRP1,923.0
141,DB00039,Palifermin,BiotechDrug,P11362,Fibroblast growth factor receptor 1,FGFR1,822.0
142,DB00039,Palifermin,BiotechDrug,P22455,Fibroblast growth factor receptor 4,FGFR4,802.0
143,DB00039,Palifermin,BiotechDrug,P22607,Fibroblast growth factor receptor 3,FGFR3,806.0
144,DB00039,Palifermin,BiotechDrug,P98160,Basement membrane-specific heparan sulfate proteoglycan core protein,HSPG2,4391.0
145,DB00040,Glucagon recombinant,BiotechDrug,P47871,Glucagon receptor,GCGR,477.0
146,DB00040,Glucagon recombinant,BiotechDrug,O95838,Glucagon-like peptide 2 receptor,GLP2R,553.0
147,DB00040,Glucagon recombinant,BiotechDrug,P43220,Glucagon-like peptide 1 receptor,GLP1R,463.0
148,DB00041,Aldesleukin,BiotechDrug,P14784,Interleukin-2 receptor subunit beta,IL2RB,551.0
149,DB00041,Aldesleukin,BiotechDrug,P01589,Interleukin-2 receptor subunit alpha,IL2RA,272.0
150,DB00041,Aldesleukin,BiotechDrug,P31785,Cytokine receptor common subunit gamma,IL2RG,369.0
151,DB00042,Botulinum Toxin Type B,BiotechDrug,P63027,Vesicle-associated membrane protein 2,VAMP2,116.0
152,DB00042,Botulinum Toxin Type B,BiotechDrug,P23763,Vesicle-associated membrane protein 1,VAMP1,118.0
153,DB00042,Botulinum Toxin Type B,BiotechDrug,Q8N9I0,Synaptotagmin-2,SYT2,419.0
154,DB00043,Omalizumab,BiotechDrug,P12319,High affinity immunoglobulin epsilon receptor subunit alpha,FCER1A,257.0
155,DB00043,Omalizumab,BiotechDrug,Q01362,High affinity immunoglobulin epsilon receptor subunit beta,MS4A2,244.0
156,DB00044,Lutropin alfa,BiotechDrug,P22888,Lutropin-choriogonadotropic hormone receptor,LHCGR,699.0
157,DB00045,OspA lipoprotein,BiotechDrug,O60603,Toll-like receptor 2,TLR2,784.0
158,DB00046,Insulin Lispro,BiotechDrug,P06213,Insulin receptor,INSR,1382.0
159,DB00046,Insulin Lispro,BiotechDrug,P08069,Insulin-like growth factor 1 receptor,IGF1R,1367.0
160,DB00047,Insulin Glargine,BiotechDrug,P06213,Insulin receptor,INSR,1382.0
161,DB00047,Insulin Glargine,BiotechDrug,P08069,Insulin-like growth factor 1 receptor,IGF1R,1367.0
162,DB00048,Collagenase clostridium histolyticum,BiotechDrug,P02452,Collagen alpha-1(I) chain,COL1A1,1464.0
163,DB00048,Collagenase clostridium histolyticum,BiotechDrug,P02458,Collagen alpha-1(II) chain,COL2A1,1487.0
164,DB00048,Collagenase clostridium histolyticum,BiotechDrug,P02461,Collagen alpha-1(III) chain,COL3A1,1466.0
165,DB00048,Collagenase clostridium histolyticum,BiotechDrug,P08123,Collagen alpha-2(I) chain,COL1A2,1366.0
166,DB00050,Cetrorelix,SmallMoleculeDrug,P30968,Gonadotropin-releasing hormone receptor,GNRHR,328.0
167,DB00050,Cetrorelix,SmallMoleculeDrug,P22888,Lutropin-choriogonadotropic hormone receptor,LHCGR,699.0
168,DB00051,Adalimumab,BiotechDrug,P01375,Tumor necrosis factor,TNF,233.0
169,DB00051,Adalimumab,BiotechDrug,O75015,Low affinity immunoglobulin gamma Fc region receptor III-B,FCGR3B,233.0
170,DB00051,Adalimumab,BiotechDrug,P00736,Complement C1r subcomponent,C1R,705.0
171,DB00051,Adalimumab,BiotechDrug,P02745,Complement C1q subcomponent subunit A,C1QA,245.0
172,DB00051,Adalimumab,BiotechDrug,P02746,Complement C1q subcomponent subunit B,C1QB,253.0
173,DB00051,Adalimumab,BiotechDrug,P02747,Complement C1q subcomponent subunit C,C1QC,245.0
174,DB00051,Adalimumab,BiotechDrug,P08637,Low affinity immunoglobulin gamma Fc region receptor III-A,FCGR3A,254.0
175,DB00051,Adalimumab,BiotechDrug,P09871,Complement C1s subcomponent,C1S,688.0
176,DB00051,Adalimumab,BiotechDrug,P12314,High affinity immunoglobulin gamma Fc receptor I,FCGR1A,374.0
177,DB00051,Adalimumab,BiotechDrug,P12318,Low affinity immunoglobulin gamma Fc region receptor II-a,FCGR2A,317.0
178,DB00051,Adalimumab,BiotechDrug,P31994,Low affinity immunoglobulin gamma Fc region receptor II-b,FCGR2B,310.0
179,DB00051,Adalimumab,BiotechDrug,P31995,Low affinity immunoglobulin gamma Fc region receptor II-c,FCGR2C,323.0
180,DB00052,Somatropin recombinant,BiotechDrug,P10912,Growth hormone receptor,GHR,638.0
181,DB00052,Somatropin recombinant,BiotechDrug,P16471,Prolactin receptor,PRLR,622.0
182,DB00054,Abciximab,BiotechDrug,P05106,Integrin beta-3,ITGB3,788.0
183,DB00054,Abciximab,BiotechDrug,P08514,Integrin alpha-IIb,ITGA2B,1039.0
184,DB00054,Abciximab,BiotechDrug,O75015,Low affinity immunoglobulin gamma Fc region receptor III-B,FCGR3B,233.0
185,DB00054,Abciximab,BiotechDrug,P00736,Complement C1r subcomponent,C1R,705.0
186,DB00054,Abciximab,BiotechDrug,P02745,Complement C1q subcomponent subunit A,C1QA,245.0
187,DB00054,Abciximab,BiotechDrug,P02746,Complement C1q subcomponent subunit B,C1QB,253.0
188,DB00054,Abciximab,BiotechDrug,P02747,Complement C1q subcomponent subunit C,C1QC,245.0
189,DB00054,Abciximab,BiotechDrug,P08637,Low affinity immunoglobulin gamma Fc region receptor III-A,FCGR3A,254.0
190,DB00054,Abciximab,BiotechDrug,P09871,Complement C1s subcomponent,C1S,688.0
191,DB00054,Abciximab,BiotechDrug,P12314,High affinity immunoglobulin gamma Fc receptor I,FCGR1A,374.0
192,DB00054,Abciximab,BiotechDrug,P12318,Low affinity immunoglobulin gamma Fc region receptor II-a,FCGR2A,317.0
193,DB00054,Abciximab,BiotechDrug,P31994,Low affinity immunoglobulin gamma Fc region receptor II-b,FCGR2B,310.0
194,DB00054,Abciximab,BiotechDrug,P31995,Low affinity immunoglobulin gamma Fc region receptor II-c,FCGR2C,323.0
195,DB00054,Abciximab,BiotechDrug,P04004,Vitronectin,VTN,478.0
196,DB00055,Drotrecogin alfa,BiotechDrug,P00451,Coagulation factor VIII,F8,2351.0
197,DB00055,Drotrecogin alfa,BiotechDrug,P12259,Coagulation factor V,F5,2224.0
198,DB00055,Drotrecogin alfa,BiotechDrug,P05121,Plasminogen activator inhibitor 1,SERPINE1,402.0
199,DB00055,Drotrecogin alfa,BiotechDrug,P07204,Thrombomodulin,THBD,575.0
200,DB00055,Drotrecogin alfa,BiotechDrug,P07225,Vitamin K-dependent protein S,PROS1,676.0
201,DB00055,Drotrecogin alfa,BiotechDrug,P00450,Ceruloplasmin,CP,1065.0
202,DB00055,Drotrecogin alfa,BiotechDrug,P00734,Prothrombin,F2,622.0
203,DB00055,Drotrecogin alfa,BiotechDrug,P02776,Platelet factor 4,PF4,101.0
204,DB00055,Drotrecogin alfa,BiotechDrug,P05154,Plasma serine protease inhibitor,SERPINA5,406.0
205,DB00055,Drotrecogin alfa,BiotechDrug,P35237,Serpin B6,SERPINB6,376.0
206,DB00055,Drotrecogin alfa,BiotechDrug,P38435,Vitamin K-dependent gamma-carboxylase,GGCX,758.0
207,DB00055,Drotrecogin alfa,BiotechDrug,Q9UNN8,Endothelial protein C receptor,PROCR,238.0
208,DB00056,Gemtuzumab ozogamicin,BiotechDrug,P20138,Myeloid cell surface antigen CD33,CD33,364.0
209,DB00056,Gemtuzumab ozogamicin,BiotechDrug,O75015,Low affinity immunoglobulin gamma Fc region receptor III-B,FCGR3B,233.0
210,DB00056,Gemtuzumab ozogamicin,BiotechDrug,P00736,Complement C1r subcomponent,C1R,705.0
211,DB00056,Gemtuzumab ozogamicin,BiotechDrug,P02745,Complement C1q subcomponent subunit A,C1QA,245.0
212,DB00056,Gemtuzumab ozogamicin,BiotechDrug,P02746,Complement C1q subcomponent subunit B,C1QB,253.0
213,DB00056,Gemtuzumab ozogamicin,BiotechDrug,P02747,Complement C1q subcomponent subunit C,C1QC,245.0
214,DB00056,Gemtuzumab ozogamicin,BiotechDrug,P08637,Low affinity immunoglobulin gamma Fc region receptor III-A,FCGR3A,254.0
215,DB00056,Gemtuzumab ozogamicin,BiotechDrug,P09871,Complement C1s subcomponent,C1S,688.0
216,DB00056,Gemtuzumab ozogamicin,BiotechDrug,P12314,High affinity immunoglobulin gamma Fc receptor I,FCGR1A,374.0
217,DB00056,Gemtuzumab ozogamicin,BiotechDrug,P12318,Low affinity immunoglobulin gamma Fc region receptor II-a,FCGR2A,317.0
218,DB00056,Gemtuzumab ozogamicin,BiotechDrug,P31994,Low affinity immunoglobulin gamma Fc region receptor II-b,FCGR2B,310.0
219,DB00056,Gemtuzumab ozogamicin,BiotechDrug,P31995,Low affinity immunoglobulin gamma Fc region receptor II-c,FCGR2C,323.0
220,DB00058,Alpha-1-proteinase inhibitor,BiotechDrug,P08246,Neutrophil elastase,ELANE,267.0
221,DB00060,Interferon beta-1a,BiotechDrug,P17181,Interferon alpha/beta receptor 1,IFNAR1,557.0
222,DB00060,Interferon beta-1a,BiotechDrug,P48551,Interferon alpha/beta receptor 2,IFNAR2,515.0
223,DB00061,Pegademase bovine,BiotechDrug,P62993,Growth factor receptor-bound protein 2,GRB2,217.0
224,DB00062,Human Serum Albumin,BiotechDrug,P02649,Apolipoprotein E,APOE,317.0
225,DB00062,Human Serum Albumin,BiotechDrug,P0DJI8,Serum amyloid A-1 protein,SAA1,122.0
226,DB00062,Human Serum Albumin,BiotechDrug,P02760,Protein AMBP,AMBP,352.0
227,DB00063,Eptifibatide,BiotechDrug,P05106,Integrin beta-3,ITGB3,788.0
228,DB00064,Serum albumin iodonated,BiotechDrug,P02649,Apolipoprotein E,APOE,317.0
229,DB00064,Serum albumin iodonated,BiotechDrug,P0DJI8,Serum amyloid A-1 protein,SAA1,122.0
230,DB00064,Serum albumin iodonated,BiotechDrug,P02760,Protein AMBP,AMBP,352.0
231,DB00065,Infliximab,BiotechDrug,P01375,Tumor necrosis factor,TNF,233.0
232,DB00066,Follitropin beta,BiotechDrug,P23945,Follicle-stimulating hormone receptor,FSHR,695.0
233,DB00067,Vasopressin,BiotechDrug,P30518,Vasopressin V2 receptor,AVPR2,371.0
234,DB00067,Vasopressin,BiotechDrug,P37288,Vasopressin V1a receptor,AVPR1A,418.0
235,DB00067,Vasopressin,BiotechDrug,P47901,Vasopressin V1b receptor,AVPR1B,424.0
236,DB00068,Interferon beta-1b,BiotechDrug,P17181,Interferon alpha/beta receptor 1,IFNAR1,557.0
237,DB00068,Interferon beta-1b,BiotechDrug,P48551,Interferon alpha/beta receptor 2,IFNAR2,515.0
238,DB00069,Interferon alfacon-1,BiotechDrug,P17181,Interferon alpha/beta receptor 1,IFNAR1,557.0
239,DB00069,Interferon alfacon-1,BiotechDrug,P48551,Interferon alpha/beta receptor 2,IFNAR2,515.0
240,DB00070,Hyaluronidase,BiotechDrug,P01137,Transforming growth factor beta-1,TGFB1,390.0
241,DB00071,Insulin Pork,BiotechDrug,P06213,Insulin receptor,INSR,1382.0
242,DB00071,Insulin Pork,BiotechDrug,P08069,Insulin-like growth factor 1 receptor,IGF1R,1367.0
243,DB00071,Insulin Pork,BiotechDrug,P14735,Insulin-degrading enzyme,IDE,1019.0
244,DB00071,Insulin Pork,BiotechDrug,P01906,"HLA class II histocompatibility antigen, DQ alpha 2 chain",HLA-DQA2,255.0
245,DB00071,Insulin Pork,BiotechDrug,P01920,"HLA class II histocompatibility antigen, DQ beta 1 chain",HLA-DQB1,261.0
246,DB00071,Insulin Pork,BiotechDrug,P06400,Retinoblastoma-associated protein,RB1,928.0
247,DB00071,Insulin Pork,BiotechDrug,P07339,Cathepsin D,CTSD,412.0
248,DB00071,Insulin Pork,BiotechDrug,P16870,Carboxypeptidase E,CPE,476.0
249,DB00071,Insulin Pork,BiotechDrug,P16519,Neuroendocrine convertase 2,PCSK2,638.0
250,DB00071,Insulin Pork,BiotechDrug,P29120,Neuroendocrine convertase 1,PCSK1,753.0
251,DB00071,Insulin Pork,BiotechDrug,P48745,Protein NOV homolog,NOV,357.0
252,DB00071,Insulin Pork,BiotechDrug,P98164,Low-density lipoprotein receptor-related protein 2,LRP2,4655.0
253,DB00071,Insulin Pork,BiotechDrug,Q16270,Insulin-like growth factor-binding protein 7,IGFBP7,282.0
254,DB00071,Insulin Pork,BiotechDrug,Q96C24,Synaptotagmin-like protein 4,SYTL4,671.0
255,DB00072,Trastuzumab,BiotechDrug,P04626,Receptor tyrosine-protein kinase erbB-2,ERBB2,1255.0
256,DB00072,Trastuzumab,BiotechDrug,P00533,Epidermal growth factor receptor,EGFR,1210.0
257,DB00072,Trastuzumab,BiotechDrug,P00736,Complement C1r subcomponent,C1R,705.0
258,DB00072,Trastuzumab,BiotechDrug,P02745,Complement C1q subcomponent subunit A,C1QA,245.0
259,DB00072,Trastuzumab,BiotechDrug,P02746,Complement C1q subcomponent subunit B,C1QB,253.0
260,DB00072,Trastuzumab,BiotechDrug,P02747,Complement C1q subcomponent subunit C,C1QC,245.0
261,DB00072,Trastuzumab,BiotechDrug,P09871,Complement C1s subcomponent,C1S,688.0
262,DB00072,Trastuzumab,BiotechDrug,P12314,High affinity immunoglobulin gamma Fc receptor I,FCGR1A,374.0
263,DB00072,Trastuzumab,BiotechDrug,P12318,Low affinity immunoglobulin gamma Fc region receptor II-a,FCGR2A,317.0
264,DB00072,Trastuzumab,BiotechDrug,P31994,Low affinity immunoglobulin gamma Fc region receptor II-b,FCGR2B,310.0
265,DB00072,Trastuzumab,BiotechDrug,P31995,Low affinity immunoglobulin gamma Fc region receptor II-c,FCGR2C,323.0
266,DB00072,Trastuzumab,BiotechDrug,O75015,Low affinity immunoglobulin gamma Fc region receptor III-B,FCGR3B,233.0
267,DB00072,Trastuzumab,BiotechDrug,P08637,Low affinity immunoglobulin gamma Fc region receptor III-A,FCGR3A,254.0
268,DB00073,Rituximab,BiotechDrug,P11836,B-lymphocyte antigen CD20,MS4A1,297.0
269,DB00073,Rituximab,BiotechDrug,O75015,Low affinity immunoglobulin gamma Fc region receptor III-B,FCGR3B,233.0
270,DB00073,Rituximab,BiotechDrug,P00736,Complement C1r subcomponent,C1R,705.0
271,DB00073,Rituximab,BiotechDrug,P02745,Complement C1q subcomponent subunit A,C1QA,245.0
272,DB00073,Rituximab,BiotechDrug,P02746,Complement C1q subcomponent subunit B,C1QB,253.0
273,DB00073,Rituximab,BiotechDrug,P02747,Complement C1q subcomponent subunit C,C1QC,245.0
274,DB00073,Rituximab,BiotechDrug,P08637,Low affinity immunoglobulin gamma Fc region receptor III-A,FCGR3A,254.0
275,DB00073,Rituximab,BiotechDrug,P09871,Complement C1s subcomponent,C1S,688.0
276,DB00073,Rituximab,BiotechDrug,P12314,High affinity immunoglobulin gamma Fc receptor I,FCGR1A,374.0
277,DB00073,Rituximab,BiotechDrug,P12318,Low affinity immunoglobulin gamma Fc region receptor II-a,FCGR2A,317.0
278,DB00073,Rituximab,BiotechDrug,P31994,Low affinity immunoglobulin gamma Fc region receptor II-b,FCGR2B,310.0
279,DB00073,Rituximab,BiotechDrug,P31995,Low affinity immunoglobulin gamma Fc region receptor II-c,FCGR2C,323.0
280,DB00074,Basiliximab,BiotechDrug,P01589,Interleukin-2 receptor subunit alpha,IL2RA,272.0
281,DB00074,Basiliximab,BiotechDrug,P14784,Interleukin-2 receptor subunit beta,IL2RB,551.0
282,DB00074,Basiliximab,BiotechDrug,P12314,High affinity immunoglobulin gamma Fc receptor I,FCGR1A,374.0
283,DB00074,Basiliximab,BiotechDrug,P08637,Low affinity immunoglobulin gamma Fc region receptor III-A,FCGR3A,254.0
284,DB00074,Basiliximab,BiotechDrug,P12318,Low affinity immunoglobulin gamma Fc region receptor II-a,FCGR2A,317.0
285,DB00074,Basiliximab,BiotechDrug,P31994,Low affinity immunoglobulin gamma Fc region receptor II-b,FCGR2B,310.0
286,DB00074,Basiliximab,BiotechDrug,P31995,Low affinity immunoglobulin gamma Fc region receptor II-c,FCGR2C,323.0
287,DB00074,Basiliximab,BiotechDrug,O75015,Low affinity immunoglobulin gamma Fc region receptor III-B,FCGR3B,233.0
288,DB00074,Basiliximab,BiotechDrug,P09871,Complement C1s subcomponent,C1S,688.0
289,DB00074,Basiliximab,BiotechDrug,P00736,Complement C1r subcomponent,C1R,705.0
290,DB00074,Basiliximab,BiotechDrug,P02745,Complement C1q subcomponent subunit A,C1QA,245.0
291,DB00074,Basiliximab,BiotechDrug,P02746,Complement C1q subcomponent subunit B,C1QB,253.0
292,DB00074,Basiliximab,BiotechDrug,P02747,Complement C1q subcomponent subunit C,C1QC,245.0
293,DB00075,Muromonab,BiotechDrug,P04234,T-cell surface glycoprotein CD3 delta chain,CD3D,171.0
294,DB00075,Muromonab,BiotechDrug,P07766,T-cell surface glycoprotein CD3 epsilon chain,CD3E,207.0
295,DB00075,Muromonab,BiotechDrug,P09693,T-cell surface glycoprotein CD3 gamma chain,CD3G,182.0
296,DB00075,Muromonab,BiotechDrug,P20963,T-cell surface glycoprotein CD3 zeta chain,CD247,164.0
297,DB00075,Muromonab,BiotechDrug,O75015,Low affinity immunoglobulin gamma Fc region receptor III-B,FCGR3B,233.0
298,DB00075,Muromonab,BiotechDrug,P00736,Complement C1r subcomponent,C1R,705.0
299,DB00075,Muromonab,BiotechDrug,P02745,Complement C1q subcomponent subunit A,C1QA,245.0
300,DB00075,Muromonab,BiotechDrug,P02746,Complement C1q subcomponent subunit B,C1QB,253.0
301,DB00075,Muromonab,BiotechDrug,P02747,Complement C1q subcomponent subunit C,C1QC,245.0
302,DB00075,Muromonab,BiotechDrug,P08637,Low affinity immunoglobulin gamma Fc region receptor III-A,FCGR3A,254.0
303,DB00075,Muromonab,BiotechDrug,P09871,Complement C1s subcomponent,C1S,688.0
304,DB00075,Muromonab,BiotechDrug,P12314,High affinity immunoglobulin gamma Fc receptor I,FCGR1A,374.0
305,DB00075,Muromonab,BiotechDrug,P12318,Low affinity immunoglobulin gamma Fc region receptor II-a,FCGR2A,317.0
306,DB00075,Muromonab,BiotechDrug,P31994,Low affinity immunoglobulin gamma Fc region receptor II-b,FCGR2B,310.0
307,DB00075,Muromonab,BiotechDrug,P31995,Low affinity immunoglobulin gamma Fc region receptor II-c,FCGR2C,323.0
308,DB00078,Ibritumomab tiuxetan,BiotechDrug,P11836,B-lymphocyte antigen CD20,MS4A1,297.0
309,DB00078,Ibritumomab tiuxetan,BiotechDrug,O75015,Low affinity immunoglobulin gamma Fc region receptor III-B,FCGR3B,233.0
310,DB00078,Ibritumomab tiuxetan,BiotechDrug,P00736,Complement C1r subcomponent,C1R,705.0
311,DB00078,Ibritumomab tiuxetan,BiotechDrug,P02745,Complement C1q subcomponent subunit A,C1QA,245.0
312,DB00078,Ibritumomab tiuxetan,BiotechDrug,P02746,Complement C1q subcomponent subunit B,C1QB,253.0
313,DB00078,Ibritumomab tiuxetan,BiotechDrug,P02747,Complement C1q subcomponent subunit C,C1QC,245.0
314,DB00078,Ibritumomab tiuxetan,BiotechDrug,P08637,Low affinity immunoglobulin gamma Fc region receptor III-A,FCGR3A,254.0
315,DB00078,Ibritumomab tiuxetan,BiotechDrug,P09871,Complement C1s subcomponent,C1S,688.0
316,DB00078,Ibritumomab tiuxetan,BiotechDrug,P12314,High affinity immunoglobulin gamma Fc receptor I,FCGR1A,374.0
317,DB00078,Ibritumomab tiuxetan,BiotechDrug,P12318,Low affinity immunoglobulin gamma Fc region receptor II-a,FCGR2A,317.0
318,DB00078,Ibritumomab tiuxetan,BiotechDrug,P31994,Low affinity immunoglobulin gamma Fc region receptor II-b,FCGR2B,310.0
319,DB00078,Ibritumomab tiuxetan,BiotechDrug,P31995,Low affinity immunoglobulin gamma Fc region receptor II-c,FCGR2C,323.0
320,DB00081,Tositumomab,BiotechDrug,P11836,B-lymphocyte antigen CD20,MS4A1,297.0
321,DB00081,Tositumomab,BiotechDrug,O75015,Low affinity immunoglobulin gamma Fc region receptor III-B,FCGR3B,233.0
322,DB00081,Tositumomab,BiotechDrug,P00736,Complement C1r subcomponent,C1R,705.0
323,DB00081,Tositumomab,BiotechDrug,P02745,Complement C1q subcomponent subunit A,C1QA,245.0
324,DB00081,Tositumomab,BiotechDrug,P02746,Complement C1q subcomponent subunit B,C1QB,253.0
325,DB00081,Tositumomab,BiotechDrug,P02747,Complement C1q subcomponent subunit C,C1QC,245.0
326,DB00081,Tositumomab,BiotechDrug,P08637,Low affinity immunoglobulin gamma Fc region receptor III-A,FCGR3A,254.0
327,DB00081,Tositumomab,BiotechDrug,P12314,High affinity immunoglobulin gamma Fc receptor I,FCGR1A,374.0
328,DB00081,Tositumomab,BiotechDrug,P12318,Low affinity immunoglobulin gamma Fc region receptor II-a,FCGR2A,317.0
329,DB00081,Tositumomab,BiotechDrug,P31994,Low affinity immunoglobulin gamma Fc region receptor II-b,FCGR2B,310.0
330,DB00081,Tositumomab,BiotechDrug,P31995,Low affinity immunoglobulin gamma Fc region receptor II-c,FCGR2C,323.0
331,DB00082,Pegvisomant,BiotechDrug,P10912,Growth hormone receptor,GHR,638.0
332,DB00083,Botulinum Toxin Type A,BiotechDrug,P60880,Synaptosomal-associated protein 25,SNAP25,206.0
333,DB00083,Botulinum Toxin Type A,BiotechDrug,P62745,Rho-related GTP-binding protein RhoB,RHOB,196.0
334,DB00086,Streptokinase,BiotechDrug,P00747,Plasminogen,PLG,810.0
335,DB00086,Streptokinase,BiotechDrug,P25116,Proteinase-activated receptor 1,F2R,425.0
336,DB00087,Alemtuzumab,BiotechDrug,P31358,CAMPATH-1 antigen,CD52,61.0
337,DB00087,Alemtuzumab,BiotechDrug,O75015,Low affinity immunoglobulin gamma Fc region receptor III-B,FCGR3B,233.0
338,DB00087,Alemtuzumab,BiotechDrug,P00736,Complement C1r subcomponent,C1R,705.0
339,DB00087,Alemtuzumab,BiotechDrug,P02745,Complement C1q subcomponent subunit A,C1QA,245.0
340,DB00087,Alemtuzumab,BiotechDrug,P02746,Complement C1q subcomponent subunit B,C1QB,253.0
341,DB00087,Alemtuzumab,BiotechDrug,P02747,Complement C1q subcomponent subunit C,C1QC,245.0
342,DB00087,Alemtuzumab,BiotechDrug,P08637,Low affinity immunoglobulin gamma Fc region receptor III-A,FCGR3A,254.0
343,DB00087,Alemtuzumab,BiotechDrug,P12314,High affinity immunoglobulin gamma Fc receptor I,FCGR1A,374.0
344,DB00087,Alemtuzumab,BiotechDrug,P12318,Low affinity immunoglobulin gamma Fc region receptor II-a,FCGR2A,317.0
345,DB00087,Alemtuzumab,BiotechDrug,P31994,Low affinity immunoglobulin gamma Fc region receptor II-b,FCGR2B,310.0
346,DB00087,Alemtuzumab,BiotechDrug,P31995,Low affinity immunoglobulin gamma Fc region receptor II-c,FCGR2C,323.0
347,DB00089,Capromab,BiotechDrug,Q04609,Glutamate carboxypeptidase 2,FOLH1,750.0
348,DB00091,Cyclosporine,SmallMoleculeDrug,P49069,Calcium signal-modulating cyclophilin ligand,CAMLG,296.0
349,DB00091,Cyclosporine,SmallMoleculeDrug,Q96LZ3,Calcineurin subunit B type 2,PPP3R2,170.0
350,DB00091,Cyclosporine,SmallMoleculeDrug,P62937,Peptidyl-prolyl cis-trans isomerase A,PPIA,165.0
351,DB00091,Cyclosporine,SmallMoleculeDrug,P30405,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",PPIF,207.0
352,DB00092,Alefacept,BiotechDrug,P06729,T-cell surface antigen CD2,CD2,351.0
353,DB00092,Alefacept,BiotechDrug,P00736,Complement C1r subcomponent,C1R,705.0
354,DB00092,Alefacept,BiotechDrug,P02745,Complement C1q subcomponent subunit A,C1QA,245.0
355,DB00092,Alefacept,BiotechDrug,P02746,Complement C1q subcomponent subunit B,C1QB,253.0
356,DB00092,Alefacept,BiotechDrug,P02747,Complement C1q subcomponent subunit C,C1QC,245.0
357,DB00092,Alefacept,BiotechDrug,P08637,Low affinity immunoglobulin gamma Fc region receptor III-A,FCGR3A,254.0
358,DB00092,Alefacept,BiotechDrug,P12314,High affinity immunoglobulin gamma Fc receptor I,FCGR1A,374.0
359,DB00092,Alefacept,BiotechDrug,P12318,Low affinity immunoglobulin gamma Fc region receptor II-a,FCGR2A,317.0
360,DB00092,Alefacept,BiotechDrug,P31994,Low affinity immunoglobulin gamma Fc region receptor II-b,FCGR2B,310.0
361,DB00092,Alefacept,BiotechDrug,P31995,Low affinity immunoglobulin gamma Fc region receptor II-c,FCGR2C,323.0
362,DB00092,Alefacept,BiotechDrug,O75015,Low affinity immunoglobulin gamma Fc region receptor III-B,FCGR3B,233.0
363,DB00093,Felypressin,SmallMoleculeDrug,P37288,Vasopressin V1a receptor,AVPR1A,418.0
364,DB00094,Urofollitropin,BiotechDrug,P23945,Follicle-stimulating hormone receptor,FSHR,695.0
365,DB00095,Efalizumab,BiotechDrug,P20701,Integrin alpha-L,ITGAL,1170.0
366,DB00095,Efalizumab,BiotechDrug,O75015,Low affinity immunoglobulin gamma Fc region receptor III-B,FCGR3B,233.0
367,DB00095,Efalizumab,BiotechDrug,P00736,Complement C1r subcomponent,C1R,705.0
368,DB00095,Efalizumab,BiotechDrug,P02745,Complement C1q subcomponent subunit A,C1QA,245.0
369,DB00095,Efalizumab,BiotechDrug,P02746,Complement C1q subcomponent subunit B,C1QB,253.0
370,DB00095,Efalizumab,BiotechDrug,P02747,Complement C1q subcomponent subunit C,C1QC,245.0
371,DB00095,Efalizumab,BiotechDrug,P08637,Low affinity immunoglobulin gamma Fc region receptor III-A,FCGR3A,254.0
372,DB00095,Efalizumab,BiotechDrug,P12314,High affinity immunoglobulin gamma Fc receptor I,FCGR1A,374.0
373,DB00095,Efalizumab,BiotechDrug,P12318,Low affinity immunoglobulin gamma Fc region receptor II-a,FCGR2A,317.0
374,DB00095,Efalizumab,BiotechDrug,P31994,Low affinity immunoglobulin gamma Fc region receptor II-b,FCGR2B,310.0
375,DB00095,Efalizumab,BiotechDrug,P31995,Low affinity immunoglobulin gamma Fc region receptor II-c,FCGR2C,323.0
376,DB00097,Chorionic Gonadotropin (Recombinant),BiotechDrug,P22888,Lutropin-choriogonadotropic hormone receptor,LHCGR,699.0
377,DB00097,Chorionic Gonadotropin (Recombinant),BiotechDrug,P23945,Follicle-stimulating hormone receptor,FSHR,695.0
378,DB00098,Anti-thymocyte Globulin (Rabbit),BiotechDrug,P06126,T-cell surface glycoprotein CD1a,CD1A,327.0
379,DB00098,Anti-thymocyte Globulin (Rabbit),BiotechDrug,Q95460,Major histocompatibility complex class I-related gene protein,MR1,341.0
380,DB00098,Anti-thymocyte Globulin (Rabbit),BiotechDrug,P20701,Integrin alpha-L,ITGAL,1170.0
381,DB00098,Anti-thymocyte Globulin (Rabbit),BiotechDrug,P42081,T-lymphocyte activation antigen CD86,CD86,329.0
382,DB00098,Anti-thymocyte Globulin (Rabbit),BiotechDrug,P31994,Low affinity immunoglobulin gamma Fc region receptor II-b,FCGR2B,310.0
383,DB00098,Anti-thymocyte Globulin (Rabbit),BiotechDrug,P01730,T-cell surface glycoprotein CD4,CD4,458.0
384,DB00098,Anti-thymocyte Globulin (Rabbit),BiotechDrug,P05556,Integrin beta-1,ITGB1,798.0
385,DB00098,Anti-thymocyte Globulin (Rabbit),BiotechDrug,P06756,Integrin alpha-V,ITGAV,1048.0
386,DB00098,Anti-thymocyte Globulin (Rabbit),BiotechDrug,P05106,Integrin beta-3,ITGB3,788.0
387,DB00099,Filgrastim,BiotechDrug,Q99062,Granulocyte colony-stimulating factor receptor,CSF3R,836.0
388,DB00099,Filgrastim,BiotechDrug,P08246,Neutrophil elastase,ELANE,267.0
389,DB00100,Coagulation Factor IX (Recombinant),BiotechDrug,P00742,Coagulation factor X,F10,488.0
390,DB00100,Coagulation Factor IX (Recombinant),BiotechDrug,P03951,Coagulation factor XI,F11,625.0
391,DB00100,Coagulation Factor IX (Recombinant),BiotechDrug,P08709,Coagulation factor VII,F7,466.0
392,DB00100,Coagulation Factor IX (Recombinant),BiotechDrug,P00451,Coagulation factor VIII,F8,2351.0
393,DB00100,Coagulation Factor IX (Recombinant),BiotechDrug,P00734,Prothrombin,F2,622.0
394,DB00100,Coagulation Factor IX (Recombinant),BiotechDrug,Q07954,Prolow-density lipoprotein receptor-related protein 1,LRP1,4544.0
395,DB00100,Coagulation Factor IX (Recombinant),BiotechDrug,P38435,Vitamin K-dependent gamma-carboxylase,GGCX,758.0
396,DB00102,Becaplermin,BiotechDrug,P09619,Platelet-derived growth factor receptor beta,PDGFRB,1106.0
397,DB00102,Becaplermin,BiotechDrug,P16234,Platelet-derived growth factor receptor alpha,PDGFRA,1089.0
398,DB00102,Becaplermin,BiotechDrug,P01023,Alpha-2-macroglobulin,A2M,1474.0
399,DB00104,Octreotide,SmallMoleculeDrug,P30872,Somatostatin receptor type 1,SSTR1,391.0
400,DB00104,Octreotide,SmallMoleculeDrug,P35346,Somatostatin receptor type 5,SSTR5,364.0
401,DB00104,Octreotide,SmallMoleculeDrug,P30874,Somatostatin receptor type 2,SSTR2,369.0
402,DB00105,"Interferon Alfa-2b, Recombinant",BiotechDrug,P48551,Interferon alpha/beta receptor 2,IFNAR2,515.0
403,DB00105,"Interferon Alfa-2b, Recombinant",BiotechDrug,P17181,Interferon alpha/beta receptor 1,IFNAR1,557.0
404,DB00106,Abarelix,BiotechDrug,P30968,Gonadotropin-releasing hormone receptor,GNRHR,328.0
405,DB00107,Oxytocin,BiotechDrug,P30559,Oxytocin receptor,OXTR,389.0
406,DB00107,Oxytocin,BiotechDrug,P01178,Oxytocin-neurophysin 1,OXT,125.0
407,DB00108,Natalizumab,BiotechDrug,P13612,Integrin alpha-4,ITGA4,1032.0
408,DB00108,Natalizumab,BiotechDrug,O75015,Low affinity immunoglobulin gamma Fc region receptor III-B,FCGR3B,233.0
409,DB00108,Natalizumab,BiotechDrug,P00736,Complement C1r subcomponent,C1R,705.0
410,DB00108,Natalizumab,BiotechDrug,P02745,Complement C1q subcomponent subunit A,C1QA,245.0
411,DB00108,Natalizumab,BiotechDrug,P02746,Complement C1q subcomponent subunit B,C1QB,253.0
412,DB00108,Natalizumab,BiotechDrug,P02747,Complement C1q subcomponent subunit C,C1QC,245.0
413,DB00108,Natalizumab,BiotechDrug,P08637,Low affinity immunoglobulin gamma Fc region receptor III-A,FCGR3A,254.0
414,DB00108,Natalizumab,BiotechDrug,P12314,High affinity immunoglobulin gamma Fc receptor I,FCGR1A,374.0
415,DB00108,Natalizumab,BiotechDrug,P12318,Low affinity immunoglobulin gamma Fc region receptor II-a,FCGR2A,317.0
416,DB00108,Natalizumab,BiotechDrug,P31994,Low affinity immunoglobulin gamma Fc region receptor II-b,FCGR2B,310.0
417,DB00108,Natalizumab,BiotechDrug,P31995,Low affinity immunoglobulin gamma Fc region receptor II-c,FCGR2C,323.0
418,DB00108,Natalizumab,BiotechDrug,P05362,Intercellular adhesion molecule 1,ICAM1,532.0
421,DB00110,Palivizumab,BiotechDrug,O75015,Low affinity immunoglobulin gamma Fc region receptor III-B,FCGR3B,233.0
422,DB00110,Palivizumab,BiotechDrug,P00736,Complement C1r subcomponent,C1R,705.0
423,DB00110,Palivizumab,BiotechDrug,P02745,Complement C1q subcomponent subunit A,C1QA,245.0
424,DB00110,Palivizumab,BiotechDrug,P02746,Complement C1q subcomponent subunit B,C1QB,253.0
425,DB00110,Palivizumab,BiotechDrug,P02747,Complement C1q subcomponent subunit C,C1QC,245.0
426,DB00110,Palivizumab,BiotechDrug,P08637,Low affinity immunoglobulin gamma Fc region receptor III-A,FCGR3A,254.0
427,DB00110,Palivizumab,BiotechDrug,P12314,High affinity immunoglobulin gamma Fc receptor I,FCGR1A,374.0
428,DB00110,Palivizumab,BiotechDrug,P12318,Low affinity immunoglobulin gamma Fc region receptor II-a,FCGR2A,317.0
429,DB00110,Palivizumab,BiotechDrug,P31994,Low affinity immunoglobulin gamma Fc region receptor II-b,FCGR2B,310.0
430,DB00110,Palivizumab,BiotechDrug,P31995,Low affinity immunoglobulin gamma Fc region receptor II-c,FCGR2C,323.0
431,DB00111,Daclizumab,BiotechDrug,P01589,Interleukin-2 receptor subunit alpha,IL2RA,272.0
432,DB00111,Daclizumab,BiotechDrug,P14784,Interleukin-2 receptor subunit beta,IL2RB,551.0
433,DB00111,Daclizumab,BiotechDrug,O75015,Low affinity immunoglobulin gamma Fc region receptor III-B,FCGR3B,233.0
434,DB00111,Daclizumab,BiotechDrug,P00736,Complement C1r subcomponent,C1R,705.0
435,DB00111,Daclizumab,BiotechDrug,P02745,Complement C1q subcomponent subunit A,C1QA,245.0
436,DB00111,Daclizumab,BiotechDrug,P02746,Complement C1q subcomponent subunit B,C1QB,253.0
437,DB00111,Daclizumab,BiotechDrug,P02747,Complement C1q subcomponent subunit C,C1QC,245.0
438,DB00111,Daclizumab,BiotechDrug,P08637,Low affinity immunoglobulin gamma Fc region receptor III-A,FCGR3A,254.0
439,DB00111,Daclizumab,BiotechDrug,P12314,High affinity immunoglobulin gamma Fc receptor I,FCGR1A,374.0
440,DB00111,Daclizumab,BiotechDrug,P12318,Low affinity immunoglobulin gamma Fc region receptor II-a,FCGR2A,317.0
441,DB00111,Daclizumab,BiotechDrug,P31994,Low affinity immunoglobulin gamma Fc region receptor II-b,FCGR2B,310.0
442,DB00111,Daclizumab,BiotechDrug,P31995,Low affinity immunoglobulin gamma Fc region receptor II-c,FCGR2C,323.0
443,DB00112,Bevacizumab,BiotechDrug,P15692,Vascular endothelial growth factor A,VEGFA,232.0
444,DB00112,Bevacizumab,BiotechDrug,O75015,Low affinity immunoglobulin gamma Fc region receptor III-B,FCGR3B,233.0
445,DB00112,Bevacizumab,BiotechDrug,P00736,Complement C1r subcomponent,C1R,705.0
446,DB00112,Bevacizumab,BiotechDrug,P02745,Complement C1q subcomponent subunit A,C1QA,245.0
447,DB00112,Bevacizumab,BiotechDrug,P02746,Complement C1q subcomponent subunit B,C1QB,253.0
448,DB00112,Bevacizumab,BiotechDrug,P02747,Complement C1q subcomponent subunit C,C1QC,245.0
449,DB00112,Bevacizumab,BiotechDrug,P08637,Low affinity immunoglobulin gamma Fc region receptor III-A,FCGR3A,254.0
450,DB00112,Bevacizumab,BiotechDrug,P12314,High affinity immunoglobulin gamma Fc receptor I,FCGR1A,374.0
451,DB00112,Bevacizumab,BiotechDrug,P12318,Low affinity immunoglobulin gamma Fc region receptor II-a,FCGR2A,317.0
452,DB00112,Bevacizumab,BiotechDrug,P31994,Low affinity immunoglobulin gamma Fc region receptor II-b,FCGR2B,310.0
453,DB00112,Bevacizumab,BiotechDrug,P31995,Low affinity immunoglobulin gamma Fc region receptor II-c,FCGR2C,323.0
454,DB00113,Arcitumomab,BiotechDrug,P13688,Carcinoembryonic antigen-related cell adhesion molecule 1,CEACAM1,526.0
455,DB00114,Pyridoxal Phosphate,SmallMoleculeDrug,Q9BYV1,"Alanine--glyoxylate aminotransferase 2, mitochondrial",AGXT2,514.0
456,DB00114,Pyridoxal Phosphate,SmallMoleculeDrug,Q99259,Glutamate decarboxylase 1,GAD1,594.0
457,DB00114,Pyridoxal Phosphate,SmallMoleculeDrug,P35520,Cystathionine beta-synthase,CBS,551.0
458,DB00114,Pyridoxal Phosphate,SmallMoleculeDrug,Q16719,Kynureninase,KYNU,465.0
459,DB00114,Pyridoxal Phosphate,SmallMoleculeDrug,P34896,"Serine hydroxymethyltransferase, cytosolic",SHMT1,483.0
460,DB00114,Pyridoxal Phosphate,SmallMoleculeDrug,Q9Y697,"Cysteine desulfurase, mitochondrial",NFS1,457.0
461,DB00114,Pyridoxal Phosphate,SmallMoleculeDrug,P17174,"Aspartate aminotransferase, cytoplasmic",GOT1,413.0
462,DB00114,Pyridoxal Phosphate,SmallMoleculeDrug,P04181,"Ornithine aminotransferase, mitochondrial",OAT,439.0
463,DB00114,Pyridoxal Phosphate,SmallMoleculeDrug,P11926,Ornithine decarboxylase,ODC1,461.0
464,DB00114,Pyridoxal Phosphate,SmallMoleculeDrug,Q8N5Z0,"Kynurenine/alpha-aminoadipate aminotransferase, mitochondrial",AADAT,425.0
465,DB00114,Pyridoxal Phosphate,SmallMoleculeDrug,P80404,"4-aminobutyrate aminotransferase, mitochondrial",ABAT,500.0
466,DB00114,Pyridoxal Phosphate,SmallMoleculeDrug,Q9NVS9,Pyridoxine-5'-phosphate oxidase,PNPO,261.0
467,DB00114,Pyridoxal Phosphate,SmallMoleculeDrug,O95470,Sphingosine-1-phosphate lyase 1,SGPL1,568.0
468,DB00114,Pyridoxal Phosphate,SmallMoleculeDrug,P17735,Tyrosine aminotransferase,TAT,454.0
469,DB00114,Pyridoxal Phosphate,SmallMoleculeDrug,Q16773,Kynurenine--oxoglutarate transaminase 1,KYAT1,422.0
470,DB00114,Pyridoxal Phosphate,SmallMoleculeDrug,Q8IYQ7,Threonine synthase-like 1,THNSL1,743.0
471,DB00114,Pyridoxal Phosphate,SmallMoleculeDrug,P06737,"Glycogen phosphorylase, liver form",PYGL,847.0
472,DB00114,Pyridoxal Phosphate,SmallMoleculeDrug,O15270,Serine palmitoyltransferase 2,SPTLC2,562.0
473,DB00114,Pyridoxal Phosphate,SmallMoleculeDrug,Q9Y600,Cysteine sulfinic acid decarboxylase,CSAD,493.0
474,DB00114,Pyridoxal Phosphate,SmallMoleculeDrug,P19113,Histidine decarboxylase,HDC,662.0
475,DB00114,Pyridoxal Phosphate,SmallMoleculeDrug,Q96A70,Antizyme inhibitor 2,AZIN2,460.0
476,DB00114,Pyridoxal Phosphate,SmallMoleculeDrug,P20132,L-serine dehydratase/L-threonine deaminase,SDS,328.0
477,DB00114,Pyridoxal Phosphate,SmallMoleculeDrug,O75600,"2-amino-3-ketobutyrate coenzyme A ligase, mitochondrial",GCAT,419.0
478,DB00114,Pyridoxal Phosphate,SmallMoleculeDrug,P23378,"Glycine dehydrogenase (decarboxylating), mitochondrial",GLDC,1020.0
479,DB00114,Pyridoxal Phosphate,SmallMoleculeDrug,P24298,Alanine aminotransferase 1,GPT,496.0
480,DB00114,Pyridoxal Phosphate,SmallMoleculeDrug,Q9Y617,Phosphoserine aminotransferase,PSAT1,370.0
481,DB00114,Pyridoxal Phosphate,SmallMoleculeDrug,P13196,"5-aminolevulinate synthase, nonspecific, mitochondrial",ALAS1,640.0
482,DB00114,Pyridoxal Phosphate,SmallMoleculeDrug,P21549,Serine--pyruvate aminotransferase,AGXT,392.0
483,DB00114,Pyridoxal Phosphate,SmallMoleculeDrug,Q96GD0,Pyridoxal phosphate phosphatase,PDXP,296.0
484,DB00114,Pyridoxal Phosphate,SmallMoleculeDrug,O15269,Serine palmitoyltransferase 1,SPTLC1,473.0
485,DB00114,Pyridoxal Phosphate,SmallMoleculeDrug,P32929,Cystathionine gamma-lyase,CTH,405.0
486,DB00114,Pyridoxal Phosphate,SmallMoleculeDrug,P54687,"Branched-chain-amino-acid aminotransferase, cytosolic",BCAT1,386.0
487,DB00114,Pyridoxal Phosphate,SmallMoleculeDrug,O15382,"Branched-chain-amino-acid aminotransferase, mitochondrial",BCAT2,392.0
488,DB00114,Pyridoxal Phosphate,SmallMoleculeDrug,O94903,Proline synthase co-transcribed bacterial homolog protein,PROSC,275.0
489,DB00114,Pyridoxal Phosphate,SmallMoleculeDrug,O95954,Formimidoyltransferase-cyclodeaminase,FTCD,541.0
490,DB00114,Pyridoxal Phosphate,SmallMoleculeDrug,P00505,"Aspartate aminotransferase, mitochondrial",GOT2,430.0
491,DB00114,Pyridoxal Phosphate,SmallMoleculeDrug,P11216,"Glycogen phosphorylase, brain form",PYGB,843.0
492,DB00114,Pyridoxal Phosphate,SmallMoleculeDrug,P11217,"Glycogen phosphorylase, muscle form",PYGM,842.0
493,DB00114,Pyridoxal Phosphate,SmallMoleculeDrug,P20711,Aromatic-L-amino-acid decarboxylase,DDC,480.0
494,DB00114,Pyridoxal Phosphate,SmallMoleculeDrug,Q2TU84,Aspartate aminotransferase,GIG18,413.0
496,DB00114,Pyridoxal Phosphate,SmallMoleculeDrug,Q53ET4,Serine hydroxymethyltransferase,nan,504.0
497,DB00114,Pyridoxal Phosphate,SmallMoleculeDrug,Q59FK2,Selenocysteine lyase variant,nan,235.0
498,DB00114,Pyridoxal Phosphate,SmallMoleculeDrug,Q59GM9,"Alpha-1,4 glucan phosphorylase",nan,865.0
499,DB00114,Pyridoxal Phosphate,SmallMoleculeDrug,Q59HE2,Ornithine aminotransferase variant,nan,281.0
500,DB00114,Pyridoxal Phosphate,SmallMoleculeDrug,Q5JAM2,5-aminolevulinate synthase,ALAS1,640.0
501,DB00114,Pyridoxal Phosphate,SmallMoleculeDrug,Q5VZ30,"Glutamate decarboxylase 2 (Pancreatic islets and brain, 65kDa)",GAD2,585.0
502,DB00114,Pyridoxal Phosphate,SmallMoleculeDrug,Q6IBS8,DDC protein,DDC,480.0
503,DB00114,Pyridoxal Phosphate,SmallMoleculeDrug,Q6P996,Pyridoxal-dependent decarboxylase domain-containing protein 1,PDXDC1,788.0
504,DB00114,Pyridoxal Phosphate,SmallMoleculeDrug,Q6YP21,Kynurenine--oxoglutarate transaminase 3,KYAT3,454.0
505,DB00114,Pyridoxal Phosphate,SmallMoleculeDrug,Q6ZQY3,Acidic amino acid decarboxylase GADL1,GADL1,521.0
506,DB00114,Pyridoxal Phosphate,SmallMoleculeDrug,Q96I15,Selenocysteine lyase,SCLY,445.0
507,DB00114,Pyridoxal Phosphate,SmallMoleculeDrug,Q6WRI0,Immunoglobulin superfamily member 10,IGSF10,2623.0
508,DB00114,Pyridoxal Phosphate,SmallMoleculeDrug,Q8IUZ5,5-phosphohydroxy-L-lysine phospho-lyase,PHYKPL,450.0
509,DB00114,Pyridoxal Phosphate,SmallMoleculeDrug,Q8IVA8,"Glutamate decarboxylase 1 (Brain, 67kDa)",GAD1,594.0
510,DB00114,Pyridoxal Phosphate,SmallMoleculeDrug,P34897,"Serine hydroxymethyltransferase, mitochondrial",SHMT2,504.0
511,DB00114,Pyridoxal Phosphate,SmallMoleculeDrug,P22557,"5-aminolevulinate synthase, erythroid-specific, mitochondrial",ALAS2,587.0
512,DB00114,Pyridoxal Phosphate,SmallMoleculeDrug,Q8TD30,Alanine aminotransferase 2,GPT2,523.0
513,DB00114,Pyridoxal Phosphate,SmallMoleculeDrug,Q96EN8,Molybdenum cofactor sulfurase,MOCOS,888.0
514,DB00114,Pyridoxal Phosphate,SmallMoleculeDrug,Q96GA7,Serine dehydratase-like,SDSL,329.0
515,DB00114,Pyridoxal Phosphate,SmallMoleculeDrug,Q96JQ3,P-selectin cytoplasmic tail-associated protein (PCAP),pcap,260.0
516,DB00114,Pyridoxal Phosphate,SmallMoleculeDrug,Q9BXA1,Hepatic peroxysomal alanine:glyoxylate aminotransferase,nan,361.0
517,DB00114,Pyridoxal Phosphate,SmallMoleculeDrug,Q9GZT4,Serine racemase,SRR,340.0
518,DB00114,Pyridoxal Phosphate,SmallMoleculeDrug,Q9HD40,O-phosphoseryl-tRNA(Sec) selenium transferase,SEPSECS,501.0
519,DB00114,Pyridoxal Phosphate,SmallMoleculeDrug,Q9NUV7,Serine palmitoyltransferase 3,SPTLC3,552.0
520,DB00114,Pyridoxal Phosphate,SmallMoleculeDrug,Q9UGI5,Glutamic acid decarboxylase,GAD65,419.0
521,DB00114,Pyridoxal Phosphate,SmallMoleculeDrug,Q9UJX1,Alanine-glyoxylate aminotransferase homolog,TLH6,270.0
522,DB00115,Cyanocobalamin,SmallMoleculeDrug,Q99707,Methionine synthase,MTR,1265.0
523,DB00115,Cyanocobalamin,SmallMoleculeDrug,P22033,"Methylmalonyl-CoA mutase, mitochondrial",MUT,750.0
524,DB00115,Cyanocobalamin,SmallMoleculeDrug,Q9UBK8,Methionine synthase reductase,MTRR,725.0
525,DB00115,Cyanocobalamin,SmallMoleculeDrug,Q8IVH4,"Methylmalonic aciduria type A protein, mitochondrial",MMAA,418.0
526,DB00115,Cyanocobalamin,SmallMoleculeDrug,Q9Y4U1,Methylmalonic aciduria and homocystinuria type C protein,MMACHC,282.0
527,DB00115,Cyanocobalamin,SmallMoleculeDrug,P42898,Methylenetetrahydrofolate reductase,MTHFR,656.0
528,DB00116,Tetrahydrofolic acid,SmallMoleculeDrug,P11586,"C-1-tetrahydrofolate synthase, cytoplasmic",MTHFD1,935.0
529,DB00116,Tetrahydrofolic acid,SmallMoleculeDrug,P13995,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",MTHFD2,350.0
530,DB00116,Tetrahydrofolic acid,SmallMoleculeDrug,P48728,"Aminomethyltransferase, mitochondrial",AMT,403.0
531,DB00116,Tetrahydrofolic acid,SmallMoleculeDrug,O75891,Cytosolic 10-formyltetrahydrofolate dehydrogenase,ALDH1L1,902.0
532,DB00116,Tetrahydrofolic acid,SmallMoleculeDrug,Q99707,Methionine synthase,MTR,1265.0
533,DB00116,Tetrahydrofolic acid,SmallMoleculeDrug,O95954,Formimidoyltransferase-cyclodeaminase,FTCD,541.0
534,DB00116,Tetrahydrofolic acid,SmallMoleculeDrug,P31939,Bifunctional purine biosynthesis protein PURH,ATIC,592.0
535,DB00116,Tetrahydrofolic acid,SmallMoleculeDrug,P34896,"Serine hydroxymethyltransferase, cytosolic",SHMT1,483.0
536,DB00116,Tetrahydrofolic acid,SmallMoleculeDrug,P34897,"Serine hydroxymethyltransferase, mitochondrial",SHMT2,504.0
537,DB00116,Tetrahydrofolic acid,SmallMoleculeDrug,P42898,Methylenetetrahydrofolate reductase,MTHFR,656.0
538,DB00116,Tetrahydrofolic acid,SmallMoleculeDrug,Q53ET4,Serine hydroxymethyltransferase,nan,504.0
539,DB00116,Tetrahydrofolic acid,SmallMoleculeDrug,Q96DP5,"Methionyl-tRNA formyltransferase, mitochondrial",MTFMT,389.0
540,DB00117,L-Histidine,SmallMoleculeDrug,P19113,Histidine decarboxylase,HDC,662.0
541,DB00117,L-Histidine,SmallMoleculeDrug,P12081,"Histidine--tRNA ligase, cytoplasmic",HARS,509.0
542,DB00117,L-Histidine,SmallMoleculeDrug,Q99624,Sodium-coupled neutral amino acid transporter 3,SLC38A3,504.0
543,DB00117,L-Histidine,SmallMoleculeDrug,P42357,Histidine ammonia-lyase,HAL,657.0
544,DB00118,S-Adenosylmethionine,SmallMoleculeDrug,Q14749,Glycine N-methyltransferase,GNMT,295.0
545,DB00118,S-Adenosylmethionine,SmallMoleculeDrug,P17707,S-adenosylmethionine decarboxylase proenzyme,AMD1,334.0
546,DB00118,S-Adenosylmethionine,SmallMoleculeDrug,P31153,S-adenosylmethionine synthase isoform type-2,MAT2A,395.0
547,DB00118,S-Adenosylmethionine,SmallMoleculeDrug,P35520,Cystathionine beta-synthase,CBS,551.0
548,DB00118,S-Adenosylmethionine,SmallMoleculeDrug,Q00266,S-adenosylmethionine synthase isoform type-1,MAT1A,395.0
549,DB00118,S-Adenosylmethionine,SmallMoleculeDrug,P21964,Catechol O-methyltransferase,COMT,271.0
550,DB00119,Pyruvic acid,SmallMoleculeDrug,O15427,Monocarboxylate transporter 4,SLC16A3,465.0
551,DB00119,Pyruvic acid,SmallMoleculeDrug,P36021,Monocarboxylate transporter 8,SLC16A2,539.0
552,DB00119,Pyruvic acid,SmallMoleculeDrug,Q9BYV1,"Alanine--glyoxylate aminotransferase 2, mitochondrial",AGXT2,514.0
553,DB00119,Pyruvic acid,SmallMoleculeDrug,O15375,Monocarboxylate transporter 6,SLC16A5,505.0
554,DB00119,Pyruvic acid,SmallMoleculeDrug,P30613,Pyruvate kinase PKLR,PKLR,574.0
555,DB00119,Pyruvic acid,SmallMoleculeDrug,O15403,Monocarboxylate transporter 7,SLC16A6,523.0
556,DB00119,Pyruvic acid,SmallMoleculeDrug,O60669,Monocarboxylate transporter 2,SLC16A7,478.0
557,DB00119,Pyruvic acid,SmallMoleculeDrug,P11177,"Pyruvate dehydrogenase E1 component subunit beta, mitochondrial",PDHB,359.0
558,DB00119,Pyruvic acid,SmallMoleculeDrug,P14618,Pyruvate kinase PKM,PKM,531.0
559,DB00119,Pyruvic acid,SmallMoleculeDrug,P80404,"4-aminobutyrate aminotransferase, mitochondrial",ABAT,500.0
560,DB00119,Pyruvic acid,SmallMoleculeDrug,O15374,Monocarboxylate transporter 5,SLC16A4,487.0
561,DB00119,Pyruvic acid,SmallMoleculeDrug,O95907,Monocarboxylate transporter 3,SLC16A8,504.0
562,DB00119,Pyruvic acid,SmallMoleculeDrug,P53985,Monocarboxylate transporter 1,SLC16A1,500.0
563,DB00119,Pyruvic acid,SmallMoleculeDrug,P11498,"Pyruvate carboxylase, mitochondrial",PC,1178.0
564,DB00120,L-Phenylalanine,SmallMoleculeDrug,P17735,Tyrosine aminotransferase,TAT,454.0
565,DB00120,L-Phenylalanine,SmallMoleculeDrug,Q9UHI5,Large neutral amino acids transporter small subunit 2,SLC7A8,535.0
566,DB00120,L-Phenylalanine,SmallMoleculeDrug,Q9Y285,Phenylalanine--tRNA ligase alpha subunit,FARSA,508.0
567,DB00120,L-Phenylalanine,SmallMoleculeDrug,P00439,Phenylalanine-4-hydroxylase,PAH,452.0
568,DB00120,L-Phenylalanine,SmallMoleculeDrug,O95363,"Phenylalanine--tRNA ligase, mitochondrial",FARS2,451.0
569,DB00120,L-Phenylalanine,SmallMoleculeDrug,Q9NSD9,Phenylalanine--tRNA ligase beta subunit,FARSB,589.0
570,DB00120,L-Phenylalanine,SmallMoleculeDrug,P07101,Tyrosine 3-monooxygenase,TH,528.0
571,DB00121,Biotin,SmallMoleculeDrug,P05166,"Propionyl-CoA carboxylase beta chain, mitochondrial",PCCB,539.0
572,DB00121,Biotin,SmallMoleculeDrug,P50747,Biotin--protein ligase,HLCS,726.0
573,DB00121,Biotin,SmallMoleculeDrug,Q9Y289,Sodium-dependent multivitamin transporter,SLC5A6,635.0
574,DB00121,Biotin,SmallMoleculeDrug,Q9HCC0,"Methylcrotonoyl-CoA carboxylase beta chain, mitochondrial",MCCC2,563.0
575,DB00121,Biotin,SmallMoleculeDrug,O00763,Acetyl-CoA carboxylase 2,ACACB,2458.0
576,DB00121,Biotin,SmallMoleculeDrug,Q96RQ3,"Methylcrotonoyl-CoA carboxylase subunit alpha, mitochondrial",MCCC1,725.0
577,DB00121,Biotin,SmallMoleculeDrug,P11498,"Pyruvate carboxylase, mitochondrial",PC,1178.0
578,DB00121,Biotin,SmallMoleculeDrug,P05165,"Propionyl-CoA carboxylase alpha chain, mitochondrial",PCCA,728.0
579,DB00121,Biotin,SmallMoleculeDrug,Q13085,Acetyl-CoA carboxylase 1,ACACA,2346.0
580,DB00122,Choline,SmallMoleculeDrug,Q9Y5K3,Choline-phosphate cytidylyltransferase B,PCYT1B,369.0
581,DB00122,Choline,SmallMoleculeDrug,P22303,Acetylcholinesterase,ACHE,614.0
582,DB00122,Choline,SmallMoleculeDrug,P49585,Choline-phosphate cytidylyltransferase A,PCYT1A,367.0
583,DB00122,Choline,SmallMoleculeDrug,O14939,Phospholipase D2,PLD2,933.0
584,DB00122,Choline,SmallMoleculeDrug,P06276,Cholinesterase,BCHE,602.0
585,DB00122,Choline,SmallMoleculeDrug,Q13393,Phospholipase D1,PLD1,1074.0
586,DB00122,Choline,SmallMoleculeDrug,Q8TCT1,Phosphoethanolamine/phosphocholine phosphatase,PHOSPHO1,267.0
587,DB00123,L-Lysine,SmallMoleculeDrug,P30825,High affinity cationic amino acid transporter 1,SLC7A1,629.0
588,DB00123,L-Lysine,SmallMoleculeDrug,O43246,Cationic amino acid transporter 4,SLC7A4,635.0
589,DB00123,L-Lysine,SmallMoleculeDrug,Q8WY07,Cationic amino acid transporter 3,SLC7A3,619.0
590,DB00123,L-Lysine,SmallMoleculeDrug,P52569,Cationic amino acid transporter 2,SLC7A2,658.0
591,DB00123,L-Lysine,SmallMoleculeDrug,Q15046,Lysine--tRNA ligase,KARS,597.0
592,DB00125,L-Arginine,SmallMoleculeDrug,P29474,"Nitric oxide synthase, endothelial",NOS3,1203.0
593,DB00125,L-Arginine,SmallMoleculeDrug,Q8WY07,Cationic amino acid transporter 3,SLC7A3,619.0
594,DB00125,L-Arginine,SmallMoleculeDrug,Q96A70,Antizyme inhibitor 2,AZIN2,460.0
595,DB00125,L-Arginine,SmallMoleculeDrug,P04424,Argininosuccinate lyase,ASL,464.0
596,DB00125,L-Arginine,SmallMoleculeDrug,P35228,"Nitric oxide synthase, inducible",NOS2,1153.0
597,DB00125,L-Arginine,SmallMoleculeDrug,P30825,High affinity cationic amino acid transporter 1,SLC7A1,629.0
598,DB00125,L-Arginine,SmallMoleculeDrug,P78540,"Arginase-2, mitochondrial",ARG2,354.0
599,DB00125,L-Arginine,SmallMoleculeDrug,O43246,Cationic amino acid transporter 4,SLC7A4,635.0
600,DB00125,L-Arginine,SmallMoleculeDrug,P00966,Argininosuccinate synthase,ASS1,412.0
601,DB00126,Vitamin C,SmallMoleculeDrug,P09848,Lactase-phlorizin hydrolase,LCT,1927.0
604,DB00126,Vitamin C,SmallMoleculeDrug,O00469,"Procollagen-lysine,2-oxoglutarate 5-dioxygenase 2",PLOD2,737.0
605,DB00126,Vitamin C,SmallMoleculeDrug,O14832,"Phytanoyl-CoA dioxygenase, peroxisomal",PHYH,338.0
606,DB00126,Vitamin C,SmallMoleculeDrug,O60568,"Procollagen-lysine,2-oxoglutarate 5-dioxygenase 3",PLOD3,738.0
607,DB00126,Vitamin C,SmallMoleculeDrug,O75936,Gamma-butyrobetaine dioxygenase,BBOX1,387.0
608,DB00126,Vitamin C,SmallMoleculeDrug,P09172,Dopamine beta-hydroxylase,DBH,617.0
609,DB00126,Vitamin C,SmallMoleculeDrug,P19021,Peptidyl-glycine alpha-amidating monooxygenase,PAM,973.0
610,DB00126,Vitamin C,SmallMoleculeDrug,P13674,Prolyl 4-hydroxylase subunit alpha-1,P4HA1,534.0
611,DB00126,Vitamin C,SmallMoleculeDrug,Q32P28,Prolyl 3-hydroxylase 1,P3H1,736.0
612,DB00126,Vitamin C,SmallMoleculeDrug,Q6N063,2-oxoglutarate and iron-dependent oxygenase domain-containing protein 2,OGFOD2,350.0
613,DB00126,Vitamin C,SmallMoleculeDrug,Q6NS38,DNA oxidative demethylase ALKBH2,ALKBH2,261.0
614,DB00126,Vitamin C,SmallMoleculeDrug,Q8IVL5,Prolyl 3-hydroxylase 2,P3H2,708.0
615,DB00126,Vitamin C,SmallMoleculeDrug,Q8IVL6,Prolyl 3-hydroxylase 3,P3H3,736.0
616,DB00126,Vitamin C,SmallMoleculeDrug,Q8N543,Prolyl 3-hydroxylase OGFOD1,OGFOD1,542.0
617,DB00126,Vitamin C,SmallMoleculeDrug,Q96KS0,Egl nine homolog 2,EGLN2,407.0
618,DB00126,Vitamin C,SmallMoleculeDrug,Q96Q83,Alpha-ketoglutarate-dependent dioxygenase alkB homolog 3,ALKBH3,286.0
619,DB00126,Vitamin C,SmallMoleculeDrug,Q9BY66,Lysine-specific demethylase 5D,KDM5D,1539.0
620,DB00126,Vitamin C,SmallMoleculeDrug,Q9GZT9,Egl nine homolog 1,EGLN1,426.0
621,DB00126,Vitamin C,SmallMoleculeDrug,Q9UHI7,Solute carrier family 23 member 1,SLC23A1,598.0
622,DB00126,Vitamin C,SmallMoleculeDrug,Q02809,"Procollagen-lysine,2-oxoglutarate 5-dioxygenase 1",PLOD1,727.0
623,DB00126,Vitamin C,SmallMoleculeDrug,Q9H6Z9,Egl nine homolog 3,EGLN3,239.0
624,DB00126,Vitamin C,SmallMoleculeDrug,Q9NVH6,"Trimethyllysine dioxygenase, mitochondrial",TMLHE,421.0
625,DB00126,Vitamin C,SmallMoleculeDrug,Q9NXG6,Transmembrane prolyl 4-hydroxylase,P4HTM,502.0
626,DB00127,Spermine,SmallMoleculeDrug,P52788,Spermine synthase,SMS,366.0
627,DB00127,Spermine,SmallMoleculeDrug,Q9NWM0,Spermine oxidase,SMOX,555.0
628,DB00127,Spermine,SmallMoleculeDrug,P11926,Ornithine decarboxylase,ODC1,461.0
629,DB00128,L-Aspartic Acid,SmallMoleculeDrug,P07998,Ribonuclease pancreatic,RNASE1,156.0
630,DB00128,L-Aspartic Acid,SmallMoleculeDrug,P61626,Lysozyme C,LYZ,148.0
631,DB00128,L-Aspartic Acid,SmallMoleculeDrug,Q9UJS0,Calcium-binding mitochondrial carrier protein Aralar2,SLC25A13,675.0
632,DB00128,L-Aspartic Acid,SmallMoleculeDrug,P17174,"Aspartate aminotransferase, cytoplasmic",GOT1,413.0
633,DB00128,L-Aspartic Acid,SmallMoleculeDrug,P45381,Aspartoacylase,ASPA,313.0
634,DB00128,L-Aspartic Acid,SmallMoleculeDrug,P08243,Asparagine synthetase [glutamine-hydrolyzing],ASNS,561.0
635,DB00128,L-Aspartic Acid,SmallMoleculeDrug,P00966,Argininosuccinate synthase,ASS1,412.0
636,DB00128,L-Aspartic Acid,SmallMoleculeDrug,Q03154,Aminoacylase-1,ACY1,408.0
637,DB00128,L-Aspartic Acid,SmallMoleculeDrug,P00505,"Aspartate aminotransferase, mitochondrial",GOT2,430.0
638,DB00128,L-Aspartic Acid,SmallMoleculeDrug,P14868,"Aspartate--tRNA ligase, cytoplasmic",DARS,501.0
639,DB00128,L-Aspartic Acid,SmallMoleculeDrug,O75746,Calcium-binding mitochondrial carrier protein Aralar1,SLC25A12,678.0
640,DB00128,L-Aspartic Acid,SmallMoleculeDrug,Q12797,Aspartyl/asparaginyl beta-hydroxylase,ASPH,758.0
641,DB00128,L-Aspartic Acid,SmallMoleculeDrug,P22234,Multifunctional protein ADE2,PAICS,425.0
642,DB00128,L-Aspartic Acid,SmallMoleculeDrug,P27708,CAD protein,CAD,2225.0
643,DB00128,L-Aspartic Acid,SmallMoleculeDrug,P30520,Adenylosuccinate synthetase isozyme 2,ADSS,456.0
644,DB00128,L-Aspartic Acid,SmallMoleculeDrug,P43005,Excitatory amino acid transporter 3,SLC1A1,524.0
645,DB00128,L-Aspartic Acid,SmallMoleculeDrug,Q2TU84,Aspartate aminotransferase,GIG18,413.0
646,DB00128,L-Aspartic Acid,SmallMoleculeDrug,Q5T6L4,"Argininosuccinate synthetase, isoform CRA_a",ASS,412.0
647,DB00128,L-Aspartic Acid,SmallMoleculeDrug,Q6PI48,"Aspartate--tRNA ligase, mitochondrial",DARS2,645.0
648,DB00128,L-Aspartic Acid,SmallMoleculeDrug,Q7L266,Isoaspartyl peptidase/L-asparaginase,ASRGL1,308.0
649,DB00128,L-Aspartic Acid,SmallMoleculeDrug,Q8N142,Adenylosuccinate synthetase isozyme 1,ADSSL1,457.0
650,DB00128,L-Aspartic Acid,SmallMoleculeDrug,Q96HD9,N-acyl-aromatic-L-amino acid amidohydrolase (carboxylate-forming),ACY3,319.0
651,DB00129,L-Ornithine,SmallMoleculeDrug,P04181,"Ornithine aminotransferase, mitochondrial",OAT,439.0
652,DB00129,L-Ornithine,SmallMoleculeDrug,P00480,"Ornithine carbamoyltransferase, mitochondrial",OTC,354.0
653,DB00129,L-Ornithine,SmallMoleculeDrug,P05089,Arginase-1,ARG1,322.0
654,DB00129,L-Ornithine,SmallMoleculeDrug,P54368,Ornithine decarboxylase antizyme 1,OAZ1,228.0
655,DB00129,L-Ornithine,SmallMoleculeDrug,P52569,Cationic amino acid transporter 2,SLC7A2,658.0
656,DB00129,L-Ornithine,SmallMoleculeDrug,Q9BXI2,Mitochondrial ornithine transporter 2,SLC25A2,301.0
657,DB00129,L-Ornithine,SmallMoleculeDrug,O43246,Cationic amino acid transporter 4,SLC7A4,635.0
658,DB00129,L-Ornithine,SmallMoleculeDrug,P30825,High affinity cationic amino acid transporter 1,SLC7A1,629.0
659,DB00129,L-Ornithine,SmallMoleculeDrug,P78540,"Arginase-2, mitochondrial",ARG2,354.0
660,DB00129,L-Ornithine,SmallMoleculeDrug,Q9Y619,Mitochondrial ornithine transporter 1,SLC25A15,301.0
661,DB00129,L-Ornithine,SmallMoleculeDrug,Q8WY07,Cationic amino acid transporter 3,SLC7A3,619.0
662,DB00129,L-Ornithine,SmallMoleculeDrug,O95190,Ornithine decarboxylase antizyme 2,OAZ2,189.0
663,DB00129,L-Ornithine,SmallMoleculeDrug,P50440,"Glycine amidinotransferase, mitochondrial",GATM,423.0
664,DB00129,L-Ornithine,SmallMoleculeDrug,Q9UMX2,Ornithine decarboxylase antizyme 3,OAZ3,235.0
665,DB00130,L-Glutamine,SmallMoleculeDrug,P17812,CTP synthase 1,CTPS1,591.0
666,DB00130,L-Glutamine,SmallMoleculeDrug,Q06203,Amidophosphoribosyltransferase,PPAT,517.0
667,DB00130,L-Glutamine,SmallMoleculeDrug,P15104,Glutamine synthetase,GLUL,373.0
668,DB00131,Adenosine monophosphate,SmallMoleculeDrug,P16220,Cyclic AMP-responsive element-binding protein 1,CREB1,341.0
669,DB00131,Adenosine monophosphate,SmallMoleculeDrug,P11309,Serine/threonine-protein kinase pim-1,PIM1,404.0
670,DB00131,Adenosine monophosphate,SmallMoleculeDrug,Q07343,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B",PDE4B,736.0
671,DB00131,Adenosine monophosphate,SmallMoleculeDrug,P06737,"Glycogen phosphorylase, liver form",PYGL,847.0
672,DB00131,Adenosine monophosphate,SmallMoleculeDrug,Q9Y478,5'-AMP-activated protein kinase subunit beta-1,PRKAB1,270.0
673,DB00131,Adenosine monophosphate,SmallMoleculeDrug,P49773,Histidine triad nucleotide-binding protein 1,HINT1,126.0
674,DB00131,Adenosine monophosphate,SmallMoleculeDrug,Q08499,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",PDE4D,809.0
675,DB00131,Adenosine monophosphate,SmallMoleculeDrug,Q9NUB1,"Acetyl-coenzyme A synthetase 2-like, mitochondrial",ACSS1,689.0
676,DB00131,Adenosine monophosphate,SmallMoleculeDrug,Q9NR19,"Acetyl-coenzyme A synthetase, cytoplasmic",ACSS2,701.0
677,DB00131,Adenosine monophosphate,SmallMoleculeDrug,Q13131,5'-AMP-activated protein kinase catalytic subunit alpha-1,PRKAA1,559.0
678,DB00131,Adenosine monophosphate,SmallMoleculeDrug,O43741,5'-AMP-activated protein kinase subunit beta-2,PRKAB2,272.0
679,DB00131,Adenosine monophosphate,SmallMoleculeDrug,Q08828,Adenylate cyclase type 1,ADCY1,1119.0
680,DB00131,Adenosine monophosphate,SmallMoleculeDrug,P33121,Long-chain-fatty-acid--CoA ligase 1,ACSL1,698.0
681,DB00131,Adenosine monophosphate,SmallMoleculeDrug,P09467,"Fructose-1,6-bisphosphatase 1",FBP1,338.0
682,DB00131,Adenosine monophosphate,SmallMoleculeDrug,P55263,Adenosine kinase,ADK,362.0
683,DB00132,Alpha-Linolenic Acid,SmallMoleculeDrug,O60427,Fatty acid desaturase 1,FADS1,444.0
684,DB00132,Alpha-Linolenic Acid,SmallMoleculeDrug,O95864,Fatty acid desaturase 2,FADS2,444.0
685,DB00132,Alpha-Linolenic Acid,SmallMoleculeDrug,P32418,Sodium/calcium exchanger 1,SLC8A1,973.0
686,DB00132,Alpha-Linolenic Acid,SmallMoleculeDrug,Q8NER1,Transient receptor potential cation channel subfamily V member 1,TRPV1,839.0
687,DB00132,Alpha-Linolenic Acid,SmallMoleculeDrug,Q9GZR5,Elongation of very long chain fatty acids protein 4,ELOVL4,314.0
688,DB00133,L-Serine,SmallMoleculeDrug,P35520,Cystathionine beta-synthase,CBS,551.0
689,DB00133,L-Serine,SmallMoleculeDrug,P20132,L-serine dehydratase/L-threonine deaminase,SDS,328.0
690,DB00133,L-Serine,SmallMoleculeDrug,Q9GZT4,Serine racemase,SRR,340.0
691,DB00133,L-Serine,SmallMoleculeDrug,O15270,Serine palmitoyltransferase 2,SPTLC2,562.0
692,DB00133,L-Serine,SmallMoleculeDrug,O15269,Serine palmitoyltransferase 1,SPTLC1,473.0
693,DB00133,L-Serine,SmallMoleculeDrug,P49591,"Serine--tRNA ligase, cytoplasmic",SARS,514.0
694,DB00133,L-Serine,SmallMoleculeDrug,P21549,Serine--pyruvate aminotransferase,AGXT,392.0
695,DB00134,L-Methionine,SmallMoleculeDrug,Q9UBK8,Methionine synthase reductase,MTRR,725.0
696,DB00134,L-Methionine,SmallMoleculeDrug,Q99707,Methionine synthase,MTR,1265.0
697,DB00134,L-Methionine,SmallMoleculeDrug,P50579,Methionine aminopeptidase 2,METAP2,478.0
698,DB00134,L-Methionine,SmallMoleculeDrug,Q93088,Betaine--homocysteine S-methyltransferase 1,BHMT,406.0
699,DB00134,L-Methionine,SmallMoleculeDrug,Q9H2M3,S-methylmethionine--homocysteine S-methyltransferase BHMT2,BHMT2,363.0
700,DB00135,L-Tyrosine,SmallMoleculeDrug,P07101,Tyrosine 3-monooxygenase,TH,528.0
701,DB00135,L-Tyrosine,SmallMoleculeDrug,Q9Y2Z4,"Tyrosine--tRNA ligase, mitochondrial",YARS2,477.0
702,DB00135,L-Tyrosine,SmallMoleculeDrug,P54577,"Tyrosine--tRNA ligase, cytoplasmic",YARS,528.0
703,DB00135,L-Tyrosine,SmallMoleculeDrug,P17735,Tyrosine aminotransferase,TAT,454.0
704,DB00136,Calcitriol,SmallMoleculeDrug,P11473,Vitamin D3 receptor,VDR,427.0
705,DB00138,L-Cystine,SmallMoleculeDrug,Q9UPY5,Cystine/glutamate transporter,SLC7A11,501.0
706,DB00138,L-Cystine,SmallMoleculeDrug,O60931,Cystinosin,CTNS,367.0
707,DB00138,L-Cystine,SmallMoleculeDrug,P82251,"b(0,+)-type amino acid transporter 1",SLC7A9,487.0
708,DB00138,L-Cystine,SmallMoleculeDrug,Q07837,Neutral and basic amino acid transport protein rBAT,SLC3A1,685.0
709,DB00139,Succinic acid,SmallMoleculeDrug,Q99643,"Succinate dehydrogenase cytochrome b560 subunit, mitochondrial",SDHC,169.0
710,DB00139,Succinic acid,SmallMoleculeDrug,Q9BXA5,Succinate receptor 1,SUCNR1,334.0
711,DB00139,Succinic acid,SmallMoleculeDrug,Q9BYC2,"Succinyl-CoA:3-ketoacid coenzyme A transferase 2, mitochondrial",OXCT2,517.0
712,DB00139,Succinic acid,SmallMoleculeDrug,Q9NVH6,"Trimethyllysine dioxygenase, mitochondrial",TMLHE,421.0
713,DB00139,Succinic acid,SmallMoleculeDrug,Q9P2R7,"Succinyl-CoA ligase [ADP-forming] subunit beta, mitochondrial",SUCLA2,463.0
714,DB00139,Succinic acid,SmallMoleculeDrug,Q9UBX3,Mitochondrial dicarboxylate carrier,SLC25A10,287.0
715,DB00139,Succinic acid,SmallMoleculeDrug,P31040,"Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial",SDHA,664.0
716,DB00139,Succinic acid,SmallMoleculeDrug,O14756,17-beta-hydroxysteroid dehydrogenase type 6,HSD17B6,317.0
717,DB00139,Succinic acid,SmallMoleculeDrug,Q8WWT9,Solute carrier family 13 member 3,SLC13A3,602.0
718,DB00139,Succinic acid,SmallMoleculeDrug,Q13183,Solute carrier family 13 member 2,SLC13A2,592.0
719,DB00139,Succinic acid,SmallMoleculeDrug,Q9BZW2,Solute carrier family 13 member 1,SLC13A1,595.0
720,DB00139,Succinic acid,SmallMoleculeDrug,Q96I99,"Succinyl-CoA ligase [GDP-forming] subunit beta, mitochondrial",SUCLG2,432.0
721,DB00139,Succinic acid,SmallMoleculeDrug,O14521,"Succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial",SDHD,159.0
722,DB00139,Succinic acid,SmallMoleculeDrug,O15460,Prolyl 4-hydroxylase subunit alpha-2,P4HA2,535.0
723,DB00139,Succinic acid,SmallMoleculeDrug,O60568,"Procollagen-lysine,2-oxoglutarate 5-dioxygenase 3",PLOD3,738.0
724,DB00139,Succinic acid,SmallMoleculeDrug,O75936,Gamma-butyrobetaine dioxygenase,BBOX1,387.0
725,DB00139,Succinic acid,SmallMoleculeDrug,P13674,Prolyl 4-hydroxylase subunit alpha-1,P4HA1,534.0
726,DB00139,Succinic acid,SmallMoleculeDrug,P21912,"Succinate dehydrogenase [ubiquinone] iron-sulfur subunit, mitochondrial",SDHB,280.0
727,DB00139,Succinic acid,SmallMoleculeDrug,P51649,"Succinate-semialdehyde dehydrogenase, mitochondrial",ALDH5A1,535.0
728,DB00139,Succinic acid,SmallMoleculeDrug,P53597,"Succinyl-CoA ligase [ADP/GDP-forming] subunit alpha, mitochondrial",SUCLG1,346.0
729,DB00139,Succinic acid,SmallMoleculeDrug,P55809,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",OXCT1,520.0
730,DB00139,Succinic acid,SmallMoleculeDrug,Q02809,"Procollagen-lysine,2-oxoglutarate 5-dioxygenase 1",PLOD1,727.0
731,DB00139,Succinic acid,SmallMoleculeDrug,Q12797,Aspartyl/asparaginyl beta-hydroxylase,ASPH,758.0
732,DB00139,Succinic acid,SmallMoleculeDrug,Q32P28,Prolyl 3-hydroxylase 1,P3H1,736.0
733,DB00139,Succinic acid,SmallMoleculeDrug,Q8IVL5,Prolyl 3-hydroxylase 2,P3H2,708.0
734,DB00139,Succinic acid,SmallMoleculeDrug,Q8IVL6,Prolyl 3-hydroxylase 3,P3H3,736.0
735,DB00140,Riboflavin,SmallMoleculeDrug,Q969G6,Riboflavin kinase,RFK,155.0
737,DB00140,Riboflavin,SmallMoleculeDrug,P30043,Flavin reductase (NADPH),BLVRB,206.0
738,DB00141,N-Acetyl-D-glucosamine,SmallMoleculeDrug,O60512,"Beta-1,4-galactosyltransferase 3",B4GALT3,393.0
739,DB00141,N-Acetyl-D-glucosamine,SmallMoleculeDrug,O60513,"Beta-1,4-galactosyltransferase 4",B4GALT4,344.0
740,DB00141,N-Acetyl-D-glucosamine,SmallMoleculeDrug,O60909,"Beta-1,4-galactosyltransferase 2",B4GALT2,372.0
741,DB00141,N-Acetyl-D-glucosamine,SmallMoleculeDrug,Q9UJ70,N-acetyl-D-glucosamine kinase,NAGK,344.0
742,DB00141,N-Acetyl-D-glucosamine,SmallMoleculeDrug,Q9UK23,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,NAGPA,515.0
743,DB00141,N-Acetyl-D-glucosamine,SmallMoleculeDrug,P54802,Alpha-N-acetylglucosaminidase,NAGLU,743.0
744,DB00141,N-Acetyl-D-glucosamine,SmallMoleculeDrug,P51606,N-acylglucosamine 2-epimerase,RENBP,427.0
745,DB00141,N-Acetyl-D-glucosamine,SmallMoleculeDrug,P15291,"Beta-1,4-galactosyltransferase 1",B4GALT1,398.0
746,DB00142,L-Glutamic Acid,SmallMoleculeDrug,Q13255,Metabotropic glutamate receptor 1,GRM1,1194.0
747,DB00142,L-Glutamic Acid,SmallMoleculeDrug,Q14833,Metabotropic glutamate receptor 4,GRM4,912.0
748,DB00142,L-Glutamic Acid,SmallMoleculeDrug,Q16099,"Glutamate receptor ionotropic, kainate 4",GRIK4,956.0
749,DB00142,L-Glutamic Acid,SmallMoleculeDrug,Q16478,"Glutamate receptor ionotropic, kainate 5",GRIK5,980.0
750,DB00142,L-Glutamic Acid,SmallMoleculeDrug,Q14831,Metabotropic glutamate receptor 7,GRM7,915.0
751,DB00142,L-Glutamic Acid,SmallMoleculeDrug,O00222,Metabotropic glutamate receptor 8,GRM8,908.0
752,DB00142,L-Glutamic Acid,SmallMoleculeDrug,O00341,Excitatory amino acid transporter 5,SLC1A7,560.0
753,DB00142,L-Glutamic Acid,SmallMoleculeDrug,O14841,5-oxoprolinase,OPLAH,1288.0
754,DB00142,L-Glutamic Acid,SmallMoleculeDrug,O15067,Phosphoribosylformylglycinamidine synthase,PFAS,1338.0
755,DB00142,L-Glutamic Acid,SmallMoleculeDrug,O15382,"Branched-chain-amino-acid aminotransferase, mitochondrial",BCAT2,392.0
756,DB00142,L-Glutamic Acid,SmallMoleculeDrug,O15399,"Glutamate receptor ionotropic, NMDA 2D",GRIN2D,1336.0
757,DB00142,L-Glutamic Acid,SmallMoleculeDrug,O43424,"Glutamate receptor ionotropic, delta-2",GRID2,1007.0
758,DB00142,L-Glutamic Acid,SmallMoleculeDrug,O60391,"Glutamate receptor ionotropic, NMDA 3B",GRIN3B,1043.0
759,DB00142,L-Glutamic Acid,SmallMoleculeDrug,O75879,"Glutamyl-tRNA(Gln) amidotransferase subunit B, mitochondrial",GATB,557.0
760,DB00142,L-Glutamic Acid,SmallMoleculeDrug,O94925,"Glutaminase kidney isoform, mitochondrial",GLS,669.0
761,DB00142,L-Glutamic Acid,SmallMoleculeDrug,P00505,"Aspartate aminotransferase, mitochondrial",GOT2,430.0
762,DB00142,L-Glutamic Acid,SmallMoleculeDrug,P07814,Bifunctional glutamate/proline--tRNA ligase,EPRS,1512.0
763,DB00142,L-Glutamic Acid,SmallMoleculeDrug,P08243,Asparagine synthetase [glutamine-hydrolyzing],ASNS,561.0
764,DB00142,L-Glutamic Acid,SmallMoleculeDrug,P15104,Glutamine synthetase,GLUL,373.0
765,DB00142,L-Glutamic Acid,SmallMoleculeDrug,P17174,"Aspartate aminotransferase, cytoplasmic",GOT1,413.0
766,DB00142,L-Glutamic Acid,SmallMoleculeDrug,P17735,Tyrosine aminotransferase,TAT,454.0
767,DB00142,L-Glutamic Acid,SmallMoleculeDrug,P24298,Alanine aminotransferase 1,GPT,496.0
768,DB00142,L-Glutamic Acid,SmallMoleculeDrug,P38435,Vitamin K-dependent gamma-carboxylase,GGCX,758.0
769,DB00142,L-Glutamic Acid,SmallMoleculeDrug,P43003,Excitatory amino acid transporter 1,SLC1A3,542.0
770,DB00142,L-Glutamic Acid,SmallMoleculeDrug,P43004,Excitatory amino acid transporter 2,SLC1A2,574.0
771,DB00142,L-Glutamic Acid,SmallMoleculeDrug,P43005,Excitatory amino acid transporter 3,SLC1A1,524.0
772,DB00142,L-Glutamic Acid,SmallMoleculeDrug,P48506,Glutamate--cysteine ligase catalytic subunit,GCLC,637.0
773,DB00142,L-Glutamic Acid,SmallMoleculeDrug,P48664,Excitatory amino acid transporter 4,SLC1A6,564.0
774,DB00142,L-Glutamic Acid,SmallMoleculeDrug,P49448,"Glutamate dehydrogenase 2, mitochondrial",GLUD2,558.0
775,DB00142,L-Glutamic Acid,SmallMoleculeDrug,P49915,GMP synthase [glutamine-hydrolyzing],GMPS,693.0
776,DB00142,L-Glutamic Acid,SmallMoleculeDrug,P54687,"Branched-chain-amino-acid aminotransferase, cytosolic",BCAT1,386.0
777,DB00142,L-Glutamic Acid,SmallMoleculeDrug,P80404,"4-aminobutyrate aminotransferase, mitochondrial",ABAT,500.0
778,DB00142,L-Glutamic Acid,SmallMoleculeDrug,Q05586,"Glutamate receptor ionotropic, NMDA 1",GRIN1,938.0
779,DB00142,L-Glutamic Acid,SmallMoleculeDrug,Q05932,"Folylpolyglutamate synthase, mitochondrial",FPGS,587.0
780,DB00142,L-Glutamic Acid,SmallMoleculeDrug,Q07075,Glutamyl aminopeptidase,ENPEP,957.0
781,DB00142,L-Glutamic Acid,SmallMoleculeDrug,Q12879,"Glutamate receptor ionotropic, NMDA 2A",GRIN2A,1464.0
782,DB00142,L-Glutamic Acid,SmallMoleculeDrug,Q13224,"Glutamate receptor ionotropic, NMDA 2B",GRIN2B,1484.0
783,DB00142,L-Glutamic Acid,SmallMoleculeDrug,Q14957,"Glutamate receptor ionotropic, NMDA 2C",GRIN2C,1233.0
784,DB00142,L-Glutamic Acid,SmallMoleculeDrug,Q2TU84,Aspartate aminotransferase,GIG18,413.0
785,DB00142,L-Glutamic Acid,SmallMoleculeDrug,Q5JPH6,"Probable glutamate--tRNA ligase, mitochondrial",EARS2,523.0
786,DB00142,L-Glutamic Acid,SmallMoleculeDrug,Q5TDP6,Lengsin,LGSN,509.0
787,DB00142,L-Glutamic Acid,SmallMoleculeDrug,Q6IA69,Glutamine-dependent NAD(+) synthetase,NADSYN1,706.0
788,DB00142,L-Glutamic Acid,SmallMoleculeDrug,Q6YP21,Kynurenine--oxoglutarate transaminase 3,KYAT3,454.0
789,DB00142,L-Glutamic Acid,SmallMoleculeDrug,Q8N159,"N-acetylglutamate synthase, mitochondrial",NAGS,534.0
790,DB00142,L-Glutamic Acid,SmallMoleculeDrug,Q8N5Z0,"Kynurenine/alpha-aminoadipate aminotransferase, mitochondrial",AADAT,425.0
791,DB00142,L-Glutamic Acid,SmallMoleculeDrug,Q8TCU5,"Glutamate receptor ionotropic, NMDA 3A",GRIN3A,1115.0
792,DB00142,L-Glutamic Acid,SmallMoleculeDrug,Q8TD30,Alanine aminotransferase 2,GPT2,523.0
793,DB00142,L-Glutamic Acid,SmallMoleculeDrug,Q9H1K4,Mitochondrial glutamate carrier 2,SLC25A18,315.0
794,DB00142,L-Glutamic Acid,SmallMoleculeDrug,Q9H936,Mitochondrial glutamate carrier 1,SLC25A22,323.0
795,DB00142,L-Glutamic Acid,SmallMoleculeDrug,Q9UDR5,"Alpha-aminoadipic semialdehyde synthase, mitochondrial",AASS,926.0
796,DB00142,L-Glutamic Acid,SmallMoleculeDrug,Q9UI32,"Glutaminase liver isoform, mitochondrial",GLS2,602.0
797,DB00142,L-Glutamic Acid,SmallMoleculeDrug,Q9ULA0,Aspartyl aminopeptidase,DNPEP,475.0
798,DB00142,L-Glutamic Acid,SmallMoleculeDrug,Q9ULK0,"Glutamate receptor ionotropic, delta-1",GRID1,1009.0
799,DB00142,L-Glutamic Acid,SmallMoleculeDrug,Q9UPY5,Cystine/glutamate transporter,SLC7A11,501.0
800,DB00142,L-Glutamic Acid,SmallMoleculeDrug,Q9Y646,Carboxypeptidase Q,CPQ,472.0
801,DB00142,L-Glutamic Acid,SmallMoleculeDrug,Q9Y617,Phosphoserine aminotransferase,PSAT1,370.0
802,DB00142,L-Glutamic Acid,SmallMoleculeDrug,P00367,"Glutamate dehydrogenase 1, mitochondrial",GLUD1,558.0
803,DB00142,L-Glutamic Acid,SmallMoleculeDrug,P39086,"Glutamate receptor ionotropic, kainate 1",GRIK1,918.0
804,DB00142,L-Glutamic Acid,SmallMoleculeDrug,P42261,Glutamate receptor 1,GRIA1,906.0
805,DB00142,L-Glutamic Acid,SmallMoleculeDrug,P48507,Glutamate--cysteine ligase regulatory subunit,GCLM,274.0
806,DB00142,L-Glutamic Acid,SmallMoleculeDrug,Q04609,Glutamate carboxypeptidase 2,FOLH1,750.0
807,DB00142,L-Glutamic Acid,SmallMoleculeDrug,Q05329,Glutamate decarboxylase 2,GAD2,585.0
808,DB00142,L-Glutamic Acid,SmallMoleculeDrug,Q99259,Glutamate decarboxylase 1,GAD1,594.0
809,DB00142,L-Glutamic Acid,SmallMoleculeDrug,O95954,Formimidoyltransferase-cyclodeaminase,FTCD,541.0
810,DB00142,L-Glutamic Acid,SmallMoleculeDrug,P42262,Glutamate receptor 2,GRIA2,883.0
811,DB00142,L-Glutamic Acid,SmallMoleculeDrug,P42263,Glutamate receptor 3,GRIA3,894.0
812,DB00142,L-Glutamic Acid,SmallMoleculeDrug,P48058,Glutamate receptor 4,GRIA4,902.0
813,DB00142,L-Glutamic Acid,SmallMoleculeDrug,P54886,Delta-1-pyrroline-5-carboxylate synthase,ALDH18A1,795.0
814,DB00142,L-Glutamic Acid,SmallMoleculeDrug,Q13002,"Glutamate receptor ionotropic, kainate 2",GRIK2,908.0
815,DB00142,L-Glutamic Acid,SmallMoleculeDrug,Q13003,"Glutamate receptor ionotropic, kainate 3",GRIK3,919.0
816,DB00143,Glutathione,SmallMoleculeDrug,O14880,Microsomal glutathione S-transferase 3,MGST3,152.0
817,DB00143,Glutathione,SmallMoleculeDrug,O60760,Hematopoietic prostaglandin D synthase,HPGDS,199.0
818,DB00143,Glutathione,SmallMoleculeDrug,O95881,Thioredoxin domain-containing protein 12,TXNDC12,172.0
819,DB00143,Glutathione,SmallMoleculeDrug,P08263,Glutathione S-transferase A1,GSTA1,222.0
820,DB00143,Glutathione,SmallMoleculeDrug,P09210,Glutathione S-transferase A2,GSTA2,222.0
821,DB00143,Glutathione,SmallMoleculeDrug,P10620,Microsomal glutathione S-transferase 1,MGST1,155.0
822,DB00143,Glutathione,SmallMoleculeDrug,P10768,S-formylglutathione hydrolase,ESD,282.0
823,DB00143,Glutathione,SmallMoleculeDrug,P19440,Gamma-glutamyltranspeptidase 1,GGT1,569.0
824,DB00143,Glutathione,SmallMoleculeDrug,P28161,Glutathione S-transferase Mu 2,GSTM2,218.0
825,DB00143,Glutathione,SmallMoleculeDrug,P35754,Glutaredoxin-1,GLRX,106.0
826,DB00143,Glutathione,SmallMoleculeDrug,P36969,"Phospholipid hydroperoxide glutathione peroxidase, mitochondrial",GPX4,197.0
827,DB00143,Glutathione,SmallMoleculeDrug,P46439,Glutathione S-transferase Mu 5,GSTM5,218.0
828,DB00143,Glutathione,SmallMoleculeDrug,P59796,Glutathione peroxidase 6,GPX6,221.0
829,DB00143,Glutathione,SmallMoleculeDrug,Q16775,"Hydroxyacylglutathione hydrolase, mitochondrial",HAGH,308.0
830,DB00143,Glutathione,SmallMoleculeDrug,Q6NSD4,Glutathione peroxidase,GPX1,145.0
831,DB00143,Glutathione,SmallMoleculeDrug,Q8TED1,Probable glutathione peroxidase 8,GPX8,209.0
832,DB00143,Glutathione,SmallMoleculeDrug,Q96SL4,Glutathione peroxidase 7,GPX7,187.0
833,DB00143,Glutathione,SmallMoleculeDrug,Q99735,Microsomal glutathione S-transferase 2,MGST2,147.0
834,DB00143,Glutathione,SmallMoleculeDrug,Q9H4Y5,Glutathione S-transferase omega-2,GSTO2,243.0
835,DB00143,Glutathione,SmallMoleculeDrug,Q9NS18,"Glutaredoxin-2, mitochondrial",GLRX2,164.0
836,DB00143,Glutathione,SmallMoleculeDrug,Q04760,Lactoylglutathione lyase,GLO1,184.0
837,DB00143,Glutathione,SmallMoleculeDrug,Q16873,Leukotriene C4 synthase,LTC4S,150.0
838,DB00143,Glutathione,SmallMoleculeDrug,P00390,"Glutathione reductase, mitochondrial",GSR,522.0
839,DB00143,Glutathione,SmallMoleculeDrug,P48637,Glutathione synthetase,GSS,474.0
840,DB00143,Glutathione,SmallMoleculeDrug,P09488,Glutathione S-transferase Mu 1,GSTM1,218.0
841,DB00143,Glutathione,SmallMoleculeDrug,Q9Y2Q3,Glutathione S-transferase kappa 1,GSTK1,226.0
842,DB00143,Glutathione,SmallMoleculeDrug,Q16772,Glutathione S-transferase A3,GSTA3,222.0
843,DB00143,Glutathione,SmallMoleculeDrug,P21266,Glutathione S-transferase Mu 3,GSTM3,225.0
844,DB00143,Glutathione,SmallMoleculeDrug,O15217,Glutathione S-transferase A4,GSTA4,222.0
845,DB00143,Glutathione,SmallMoleculeDrug,Q03013,Glutathione S-transferase Mu 4,GSTM4,218.0
846,DB00143,Glutathione,SmallMoleculeDrug,Q7RTV2,Glutathione S-transferase A5,GSTA5,222.0
847,DB00143,Glutathione,SmallMoleculeDrug,P09211,Glutathione S-transferase P,GSTP1,210.0
848,DB00143,Glutathione,SmallMoleculeDrug,P78417,Glutathione S-transferase omega-1,GSTO1,241.0
849,DB00143,Glutathione,SmallMoleculeDrug,P07203,Glutathione peroxidase 1,GPX1,203.0
850,DB00143,Glutathione,SmallMoleculeDrug,P18283,Glutathione peroxidase 2,GPX2,190.0
851,DB00143,Glutathione,SmallMoleculeDrug,P30711,Glutathione S-transferase theta-1,GSTT1,240.0
852,DB00143,Glutathione,SmallMoleculeDrug,O43708,Maleylacetoacetate isomerase,GSTZ1,216.0
853,DB00143,Glutathione,SmallMoleculeDrug,O75715,Epididymal secretory glutathione peroxidase,GPX5,221.0
854,DB00143,Glutathione,SmallMoleculeDrug,P22352,Glutathione peroxidase 3,GPX3,226.0
855,DB00144,Phosphatidyl serine,SmallMoleculeDrug,P49619,Diacylglycerol kinase gamma,DGKG,791.0
856,DB00144,Phosphatidyl serine,SmallMoleculeDrug,Q16760,Diacylglycerol kinase delta,DGKD,1214.0
857,DB00144,Phosphatidyl serine,SmallMoleculeDrug,Q9BVG9,Phosphatidylserine synthase 2,PTDSS2,487.0
858,DB00144,Phosphatidyl serine,SmallMoleculeDrug,Q9NXE4,Sphingomyelin phosphodiesterase 4,SMPD4,827.0
859,DB00144,Phosphatidyl serine,SmallMoleculeDrug,Q9NY59,Sphingomyelin phosphodiesterase 3,SMPD3,655.0
860,DB00144,Phosphatidyl serine,SmallMoleculeDrug,Q9Y2Q0,Phospholipid-transporting ATPase IA,ATP8A1,1164.0
861,DB00144,Phosphatidyl serine,SmallMoleculeDrug,P17252,Protein kinase C alpha type,PRKCA,672.0
862,DB00144,Phosphatidyl serine,SmallMoleculeDrug,P48651,Phosphatidylserine synthase 1,PTDSS1,473.0
863,DB00144,Phosphatidyl serine,SmallMoleculeDrug,Q9UG56,Phosphatidylserine decarboxylase proenzyme,PISD,409.0
864,DB00144,Phosphatidyl serine,SmallMoleculeDrug,Q8WTV0,Scavenger receptor class B member 1,SCARB1,552.0
865,DB00145,Glycine,SmallMoleculeDrug,O75600,"2-amino-3-ketobutyrate coenzyme A ligase, mitochondrial",GCAT,419.0
866,DB00145,Glycine,SmallMoleculeDrug,P13196,"5-aminolevulinate synthase, nonspecific, mitochondrial",ALAS1,640.0
867,DB00145,Glycine,SmallMoleculeDrug,P22557,"5-aminolevulinate synthase, erythroid-specific, mitochondrial",ALAS2,587.0
868,DB00145,Glycine,SmallMoleculeDrug,P23434,"Glycine cleavage system H protein, mitochondrial",GCSH,173.0
869,DB00145,Glycine,SmallMoleculeDrug,P41250,Glycine--tRNA ligase,GARS,739.0
870,DB00145,Glycine,SmallMoleculeDrug,Q12879,"Glutamate receptor ionotropic, NMDA 2A",GRIN2A,1464.0
871,DB00145,Glycine,SmallMoleculeDrug,Q14032,Bile acid-CoA:amino acid N-acyltransferase,BAAT,418.0
872,DB00145,Glycine,SmallMoleculeDrug,Q14330,N-arachidonyl glycine receptor,GPR18,331.0
873,DB00145,Glycine,SmallMoleculeDrug,P48637,Glutathione synthetase,GSS,474.0
874,DB00145,Glycine,SmallMoleculeDrug,Q14957,"Glutamate receptor ionotropic, NMDA 2C",GRIN2C,1233.0
875,DB00145,Glycine,SmallMoleculeDrug,Q53ET4,Serine hydroxymethyltransferase,nan,504.0
876,DB00145,Glycine,SmallMoleculeDrug,Q6IB77,Glycine N-acyltransferase,GLYAT,296.0
877,DB00145,Glycine,SmallMoleculeDrug,Q7Z2H8,Proton-coupled amino acid transporter 1,SLC36A1,476.0
878,DB00145,Glycine,SmallMoleculeDrug,P34897,"Serine hydroxymethyltransferase, mitochondrial",SHMT2,504.0
879,DB00145,Glycine,SmallMoleculeDrug,Q8WU03,Glycine N-acyltransferase-like protein 2,GLYATL2,294.0
880,DB00145,Glycine,SmallMoleculeDrug,Q969I3,Glycine N-acyltransferase-like protein 1,GLYATL1,302.0
881,DB00145,Glycine,SmallMoleculeDrug,Q9BYV1,"Alanine--glyoxylate aminotransferase 2, mitochondrial",AGXT2,514.0
882,DB00145,Glycine,SmallMoleculeDrug,Q9H598,Vesicular inhibitory amino acid transporter,SLC32A1,525.0
883,DB00145,Glycine,SmallMoleculeDrug,Q9P0Z9,Peroxisomal sarcosine oxidase,PIPOX,390.0
884,DB00145,Glycine,SmallMoleculeDrug,Q9Y345,Sodium- and chloride-dependent glycine transporter 2,SLC6A5,797.0
885,DB00145,Glycine,SmallMoleculeDrug,O60391,"Glutamate receptor ionotropic, NMDA 3B",GRIN3B,1043.0
886,DB00145,Glycine,SmallMoleculeDrug,P23378,"Glycine dehydrogenase (decarboxylating), mitochondrial",GLDC,1020.0
887,DB00145,Glycine,SmallMoleculeDrug,P48067,Sodium- and chloride-dependent glycine transporter 1,SLC6A9,706.0
888,DB00145,Glycine,SmallMoleculeDrug,P23415,Glycine receptor subunit alpha-1,GLRA1,457.0
889,DB00145,Glycine,SmallMoleculeDrug,P21549,Serine--pyruvate aminotransferase,AGXT,392.0
890,DB00145,Glycine,SmallMoleculeDrug,P48167,Glycine receptor subunit beta,GLRB,497.0
891,DB00145,Glycine,SmallMoleculeDrug,P34896,"Serine hydroxymethyltransferase, cytosolic",SHMT1,483.0
892,DB00145,Glycine,SmallMoleculeDrug,O75311,Glycine receptor subunit alpha-3,GLRA3,464.0
893,DB00145,Glycine,SmallMoleculeDrug,P23416,Glycine receptor subunit alpha-2,GLRA2,452.0
894,DB00145,Glycine,SmallMoleculeDrug,Q14749,Glycine N-methyltransferase,GNMT,295.0
895,DB00145,Glycine,SmallMoleculeDrug,P50440,"Glycine amidinotransferase, mitochondrial",GATM,423.0
896,DB00146,Calcidiol,SmallMoleculeDrug,P11473,Vitamin D3 receptor,VDR,427.0
897,DB00147,Pyridoxal,SmallMoleculeDrug,O00764,Pyridoxal kinase,PDXK,312.0
898,DB00148,Creatine,SmallMoleculeDrug,P06732,Creatine kinase M-type,CKM,381.0
899,DB00148,Creatine,SmallMoleculeDrug,P12532,"Creatine kinase U-type, mitochondrial",CKMT1A,417.0
900,DB00148,Creatine,SmallMoleculeDrug,P12277,Creatine kinase B-type,CKB,381.0
901,DB00148,Creatine,SmallMoleculeDrug,P17540,"Creatine kinase S-type, mitochondrial",CKMT2,419.0
902,DB00148,Creatine,SmallMoleculeDrug,P48029,Sodium- and chloride-dependent creatine transporter 1,SLC6A8,635.0
903,DB00148,Creatine,SmallMoleculeDrug,Q14353,Guanidinoacetate N-methyltransferase,GAMT,236.0
904,DB00149,L-Leucine,SmallMoleculeDrug,Q15031,"Probable leucine--tRNA ligase, mitochondrial",LARS2,903.0
905,DB00149,L-Leucine,SmallMoleculeDrug,O15382,"Branched-chain-amino-acid aminotransferase, mitochondrial",BCAT2,392.0
906,DB00149,L-Leucine,SmallMoleculeDrug,P54687,"Branched-chain-amino-acid aminotransferase, cytosolic",BCAT1,386.0
907,DB00149,L-Leucine,SmallMoleculeDrug,O60294,tRNA wybutosine-synthesizing protein 4,LCMT2,686.0
908,DB00149,L-Leucine,SmallMoleculeDrug,Q9UIC8,Leucine carboxyl methyltransferase 1,LCMT1,334.0
909,DB00149,L-Leucine,SmallMoleculeDrug,Q9P2J5,"Leucine--tRNA ligase, cytoplasmic",LARS,1176.0
910,DB00150,L-Tryptophan,SmallMoleculeDrug,Q9UGM6,"Tryptophan--tRNA ligase, mitochondrial",WARS2,360.0
912,DB00150,L-Tryptophan,SmallMoleculeDrug,P23381,"Tryptophan--tRNA ligase, cytoplasmic",WARS,471.0
913,DB00151,L-Cysteine,SmallMoleculeDrug,P48507,Glutamate--cysteine ligase regulatory subunit,GCLM,274.0
914,DB00151,L-Cysteine,SmallMoleculeDrug,P48506,Glutamate--cysteine ligase catalytic subunit,GCLC,637.0
916,DB00151,L-Cysteine,SmallMoleculeDrug,P17174,"Aspartate aminotransferase, cytoplasmic",GOT1,413.0
917,DB00151,L-Cysteine,SmallMoleculeDrug,P32929,Cystathionine gamma-lyase,CTH,405.0
918,DB00151,L-Cysteine,SmallMoleculeDrug,P35520,Cystathionine beta-synthase,CBS,551.0
919,DB00151,L-Cysteine,SmallMoleculeDrug,P49589,"Cysteine--tRNA ligase, cytoplasmic",CARS,748.0
920,DB00151,L-Cysteine,SmallMoleculeDrug,P16455,Methylated-DNA--protein-cysteine methyltransferase,MGMT,207.0
921,DB00151,L-Cysteine,SmallMoleculeDrug,P48637,Glutathione synthetase,GSS,474.0
922,DB00151,L-Cysteine,SmallMoleculeDrug,Q9BZV2,Thiamine transporter 2,SLC19A3,496.0
923,DB00151,L-Cysteine,SmallMoleculeDrug,Q9HA77,"Probable cysteine--tRNA ligase, mitochondrial",CARS2,564.0
924,DB00151,L-Cysteine,SmallMoleculeDrug,Q9Y600,Cysteine sulfinic acid decarboxylase,CSAD,493.0
925,DB00151,L-Cysteine,SmallMoleculeDrug,Q9Y697,"Cysteine desulfurase, mitochondrial",NFS1,457.0
926,DB00151,L-Cysteine,SmallMoleculeDrug,Q16878,Cysteine dioxygenase type 1,CDO1,200.0
927,DB00152,Thiamine,SmallMoleculeDrug,Q9H3S4,Thiamin pyrophosphokinase 1,TPK1,243.0
928,DB00152,Thiamine,SmallMoleculeDrug,O60779,Thiamine transporter 1,SLC19A2,497.0
929,DB00153,Ergocalciferol,SmallMoleculeDrug,P11473,Vitamin D3 receptor,VDR,427.0
930,DB00154,Dihomo-gamma-linolenic acid,SmallMoleculeDrug,P23219,Prostaglandin G/H synthase 1,PTGS1,599.0
931,DB00154,Dihomo-gamma-linolenic acid,SmallMoleculeDrug,P35354,Prostaglandin G/H synthase 2,PTGS2,604.0
932,DB00155,L-Citrulline,SmallMoleculeDrug,P00966,Argininosuccinate synthase,ASS1,412.0
933,DB00155,L-Citrulline,SmallMoleculeDrug,O95865,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 2",DDAH2,285.0
934,DB00155,L-Citrulline,SmallMoleculeDrug,Q5T6L4,"Argininosuccinate synthetase, isoform CRA_a",ASS,412.0
935,DB00155,L-Citrulline,SmallMoleculeDrug,O94760,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",DDAH1,285.0
936,DB00155,L-Citrulline,SmallMoleculeDrug,P00480,"Ornithine carbamoyltransferase, mitochondrial",OTC,354.0
937,DB00155,L-Citrulline,SmallMoleculeDrug,P29475,"Nitric oxide synthase, brain",NOS1,1434.0
938,DB00155,L-Citrulline,SmallMoleculeDrug,P35228,"Nitric oxide synthase, inducible",NOS2,1153.0
939,DB00155,L-Citrulline,SmallMoleculeDrug,P29474,"Nitric oxide synthase, endothelial",NOS3,1203.0
940,DB00155,L-Citrulline,SmallMoleculeDrug,Q6TGC4,Protein-arginine deiminase type-6,PADI6,694.0
941,DB00155,L-Citrulline,SmallMoleculeDrug,Q9ULC6,Protein-arginine deiminase type-1,PADI1,663.0
942,DB00155,L-Citrulline,SmallMoleculeDrug,Q9ULW8,Protein-arginine deiminase type-3,PADI3,664.0
943,DB00155,L-Citrulline,SmallMoleculeDrug,Q9Y2J8,Protein-arginine deiminase type-2,PADI2,665.0
944,DB00155,L-Citrulline,SmallMoleculeDrug,Q9UM07,Protein-arginine deiminase type-4,PADI4,663.0
945,DB00156,L-Threonine,SmallMoleculeDrug,Q8IYQ7,Threonine synthase-like 1,THNSL1,743.0
946,DB00156,L-Threonine,SmallMoleculeDrug,P26639,"Threonine--tRNA ligase, cytoplasmic",TARS,723.0
947,DB00156,L-Threonine,SmallMoleculeDrug,Q9BW92,"Threonine--tRNA ligase, mitochondrial",TARS2,718.0
948,DB00157,NADH,SmallMoleculeDrug,O60701,UDP-glucose 6-dehydrogenase,UGDH,494.0
949,DB00157,NADH,SmallMoleculeDrug,P07327,Alcohol dehydrogenase 1A,ADH1A,375.0
950,DB00157,NADH,SmallMoleculeDrug,Q00796,Sorbitol dehydrogenase,SORD,357.0
951,DB00157,NADH,SmallMoleculeDrug,P08319,Alcohol dehydrogenase 4,ADH4,380.0
952,DB00157,NADH,SmallMoleculeDrug,P00326,Alcohol dehydrogenase 1C,ADH1C,375.0
953,DB00157,NADH,SmallMoleculeDrug,P00325,Alcohol dehydrogenase 1B,ADH1B,375.0
954,DB00157,NADH,SmallMoleculeDrug,P40394,Alcohol dehydrogenase class 4 mu/sigma chain,ADH7,386.0
955,DB00157,NADH,SmallMoleculeDrug,P21695,"Glycerol-3-phosphate dehydrogenase [NAD(+)], cytoplasmic",GPD1,349.0
956,DB00157,NADH,SmallMoleculeDrug,Q6ZMR3,L-lactate dehydrogenase A-like 6A,LDHAL6A,332.0
957,DB00157,NADH,SmallMoleculeDrug,P11766,Alcohol dehydrogenase class-3,ADH5,374.0
958,DB00157,NADH,SmallMoleculeDrug,P15121,Aldose reductase,AKR1B1,316.0
959,DB00157,NADH,SmallMoleculeDrug,Q99714,3-hydroxyacyl-CoA dehydrogenase type-2,HSD17B10,261.0
960,DB00157,NADH,SmallMoleculeDrug,P40926,"Malate dehydrogenase, mitochondrial",MDH2,338.0
961,DB00157,NADH,SmallMoleculeDrug,P00338,L-lactate dehydrogenase A chain,LDHA,332.0
962,DB00157,NADH,SmallMoleculeDrug,P23368,"NAD-dependent malic enzyme, mitochondrial",ME2,584.0
963,DB00157,NADH,SmallMoleculeDrug,P51659,Peroxisomal multifunctional enzyme type 2,HSD17B4,736.0
964,DB00157,NADH,SmallMoleculeDrug,Q9BYZ2,L-lactate dehydrogenase A-like 6B,LDHAL6B,381.0
965,DB00157,NADH,SmallMoleculeDrug,P07864,L-lactate dehydrogenase C chain,LDHC,332.0
966,DB00157,NADH,SmallMoleculeDrug,P07195,L-lactate dehydrogenase B chain,LDHB,334.0
967,DB00157,NADH,SmallMoleculeDrug,Q08426,Peroxisomal bifunctional enzyme,EHHADH,723.0
968,DB00157,NADH,SmallMoleculeDrug,Q16836,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",HADH,314.0
969,DB00157,NADH,SmallMoleculeDrug,Q16798,"NADP-dependent malic enzyme, mitochondrial",ME3,604.0
970,DB00157,NADH,SmallMoleculeDrug,Q02338,"D-beta-hydroxybutyrate dehydrogenase, mitochondrial",BDH1,343.0
971,DB00157,NADH,SmallMoleculeDrug,P40925,"Malate dehydrogenase, cytoplasmic",MDH1,334.0
972,DB00157,NADH,SmallMoleculeDrug,P31937,"3-hydroxyisobutyrate dehydrogenase, mitochondrial",HIBADH,336.0
973,DB00157,NADH,SmallMoleculeDrug,P37058,Testosterone 17-beta-dehydrogenase 3,HSD17B3,310.0
974,DB00157,NADH,SmallMoleculeDrug,P04035,3-hydroxy-3-methylglutaryl-coenzyme A reductase,HMGCR,888.0
975,DB00157,NADH,SmallMoleculeDrug,P48163,NADP-dependent malic enzyme,ME1,572.0
976,DB00157,NADH,SmallMoleculeDrug,O43175,D-3-phosphoglycerate dehydrogenase,PHGDH,533.0
977,DB00157,NADH,SmallMoleculeDrug,P56937,3-keto-steroid reductase,HSD17B7,341.0
978,DB00157,NADH,SmallMoleculeDrug,P51553,"Isocitrate dehydrogenase [NAD] subunit gamma, mitochondrial",IDH3G,393.0
979,DB00157,NADH,SmallMoleculeDrug,O43837,"Isocitrate dehydrogenase [NAD] subunit beta, mitochondrial",IDH3B,385.0
980,DB00157,NADH,SmallMoleculeDrug,P50213,"Isocitrate dehydrogenase [NAD] subunit alpha, mitochondrial",IDH3A,366.0
981,DB00157,NADH,SmallMoleculeDrug,P14061,Estradiol 17-beta-dehydrogenase 1,HSD17B1,328.0
982,DB00157,NADH,SmallMoleculeDrug,P37059,Estradiol 17-beta-dehydrogenase 2,HSD17B2,387.0
983,DB00157,NADH,SmallMoleculeDrug,Q92781,11-cis retinol dehydrogenase,RDH5,318.0
984,DB00157,NADH,SmallMoleculeDrug,O95479,GDH/6PGL endoplasmic bifunctional protein,H6PD,791.0
985,DB00157,NADH,SmallMoleculeDrug,Q92506,Estradiol 17-beta-dehydrogenase 8,HSD17B8,261.0
986,DB00157,NADH,SmallMoleculeDrug,P17516,Aldo-keto reductase family 1 member C4,AKR1C4,323.0
987,DB00157,NADH,SmallMoleculeDrug,P12268,Inosine-5'-monophosphate dehydrogenase 2,IMPDH2,514.0
988,DB00157,NADH,SmallMoleculeDrug,P42330,Aldo-keto reductase family 1 member C3,AKR1C3,323.0
989,DB00157,NADH,SmallMoleculeDrug,P15428,15-hydroxyprostaglandin dehydrogenase [NAD(+)],HPGD,266.0
990,DB00157,NADH,SmallMoleculeDrug,Q13630,GDP-L-fucose synthase,TSTA3,321.0
991,DB00157,NADH,SmallMoleculeDrug,Q04828,Aldo-keto reductase family 1 member C1,AKR1C1,323.0
992,DB00157,NADH,SmallMoleculeDrug,P28845,Corticosteroid 11-beta-dehydrogenase isozyme 1,HSD11B1,292.0
993,DB00157,NADH,SmallMoleculeDrug,P26439,3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 2,HSD3B2,372.0
994,DB00157,NADH,SmallMoleculeDrug,P14060,3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 1,HSD3B1,373.0
995,DB00157,NADH,SmallMoleculeDrug,P20839,Inosine-5'-monophosphate dehydrogenase 1,IMPDH1,514.0
996,DB00157,NADH,SmallMoleculeDrug,P40939,"Trifunctional enzyme subunit alpha, mitochondrial",HADHA,763.0
997,DB00157,NADH,SmallMoleculeDrug,P05091,"Aldehyde dehydrogenase, mitochondrial",ALDH2,517.0
998,DB00157,NADH,SmallMoleculeDrug,P80365,Corticosteroid 11-beta-dehydrogenase isozyme 2,HSD11B2,405.0
999,DB00157,NADH,SmallMoleculeDrug,P52895,Aldo-keto reductase family 1 member C2,AKR1C2,323.0
1000,DB00157,NADH,SmallMoleculeDrug,Q15738,"Sterol-4-alpha-carboxylate 3-dehydrogenase, decarboxylating",NSDHL,373.0
1001,DB00157,NADH,SmallMoleculeDrug,P48448,Aldehyde dehydrogenase family 3 member B2,ALDH3B2,385.0
1002,DB00157,NADH,SmallMoleculeDrug,Q02252,"Methylmalonate-semialdehyde dehydrogenase [acylating], mitochondrial",ALDH6A1,535.0
1003,DB00157,NADH,SmallMoleculeDrug,P30838,"Aldehyde dehydrogenase, dimeric NADP-preferring",ALDH3A1,453.0
1004,DB00157,NADH,SmallMoleculeDrug,P00352,Retinal dehydrogenase 1,ALDH1A1,501.0
1005,DB00157,NADH,SmallMoleculeDrug,O14556,"Glyceraldehyde-3-phosphate dehydrogenase, testis-specific",GAPDHS,408.0
1006,DB00157,NADH,SmallMoleculeDrug,P49189,4-trimethylaminobutyraldehyde dehydrogenase,ALDH9A1,494.0
1007,DB00157,NADH,SmallMoleculeDrug,P47895,Aldehyde dehydrogenase family 1 member A3,ALDH1A3,512.0
1008,DB00157,NADH,SmallMoleculeDrug,P30837,"Aldehyde dehydrogenase X, mitochondrial",ALDH1B1,517.0
1009,DB00157,NADH,SmallMoleculeDrug,P43353,Aldehyde dehydrogenase family 3 member B1,ALDH3B1,468.0
1010,DB00157,NADH,SmallMoleculeDrug,P04406,Glyceraldehyde-3-phosphate dehydrogenase,GAPDH,335.0
1011,DB00157,NADH,SmallMoleculeDrug,O94788,Retinal dehydrogenase 2,ALDH1A2,518.0
1012,DB00157,NADH,SmallMoleculeDrug,P51648,Fatty aldehyde dehydrogenase,ALDH3A2,485.0
1013,DB00157,NADH,SmallMoleculeDrug,P51649,"Succinate-semialdehyde dehydrogenase, mitochondrial",ALDH5A1,535.0
1014,DB00157,NADH,SmallMoleculeDrug,P49419,Alpha-aminoadipic semialdehyde dehydrogenase,ALDH7A1,539.0
1015,DB00157,NADH,SmallMoleculeDrug,P30043,Flavin reductase (NADPH),BLVRB,206.0
1016,DB00157,NADH,SmallMoleculeDrug,Q96C36,Pyrroline-5-carboxylate reductase 2,PYCR2,320.0
1017,DB00157,NADH,SmallMoleculeDrug,P32322,"Pyrroline-5-carboxylate reductase 1, mitochondrial",PYCR1,319.0
1018,DB00157,NADH,SmallMoleculeDrug,P00367,"Glutamate dehydrogenase 1, mitochondrial",GLUD1,558.0
1019,DB00157,NADH,SmallMoleculeDrug,P11177,"Pyruvate dehydrogenase E1 component subunit beta, mitochondrial",PDHB,359.0
1020,DB00157,NADH,SmallMoleculeDrug,P29803,"Pyruvate dehydrogenase E1 component subunit alpha, testis-specific form, mitochondrial",PDHA2,388.0
1021,DB00157,NADH,SmallMoleculeDrug,P08559,"Pyruvate dehydrogenase E1 component subunit alpha, somatic form, mitochondrial",PDHA1,390.0
1022,DB00157,NADH,SmallMoleculeDrug,P53004,Biliverdin reductase A,BLVRA,296.0
1023,DB00157,NADH,SmallMoleculeDrug,P16219,"Short-chain specific acyl-CoA dehydrogenase, mitochondrial",ACADS,412.0
1024,DB00157,NADH,SmallMoleculeDrug,P00374,Dihydrofolate reductase,DHFR,187.0
1025,DB00157,NADH,SmallMoleculeDrug,Q02218,"2-oxoglutarate dehydrogenase, mitochondrial",OGDH,1023.0
1026,DB00157,NADH,SmallMoleculeDrug,P49448,"Glutamate dehydrogenase 2, mitochondrial",GLUD2,558.0
1027,DB00157,NADH,SmallMoleculeDrug,Q9UBM7,7-dehydrocholesterol reductase,DHCR7,475.0
1028,DB00157,NADH,SmallMoleculeDrug,P16083,Ribosyldihydronicotinamide dehydrogenase [quinone],NQO2,231.0
1029,DB00157,NADH,SmallMoleculeDrug,P03891,NADH-ubiquinone oxidoreductase chain 2,MT-ND2,347.0
1030,DB00157,NADH,SmallMoleculeDrug,Q9UDR5,"Alpha-aminoadipic semialdehyde synthase, mitochondrial",AASS,926.0
1031,DB00157,NADH,SmallMoleculeDrug,P03897,NADH-ubiquinone oxidoreductase chain 3,MT-ND3,115.0
1032,DB00157,NADH,SmallMoleculeDrug,O75251,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 7, mitochondrial",NDUFS7,213.0
1033,DB00157,NADH,SmallMoleculeDrug,P11586,"C-1-tetrahydrofolate synthase, cytoplasmic",MTHFD1,935.0
1034,DB00157,NADH,SmallMoleculeDrug,P13995,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",MTHFD2,350.0
1035,DB00157,NADH,SmallMoleculeDrug,P30038,"Delta-1-pyrroline-5-carboxylate dehydrogenase, mitochondrial",ALDH4A1,563.0
1036,DB00157,NADH,SmallMoleculeDrug,P00387,NADH-cytochrome b5 reductase 3,CYB5R3,301.0
1037,DB00157,NADH,SmallMoleculeDrug,Q86Y39,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 11,NDUFA11,141.0
1038,DB00157,NADH,SmallMoleculeDrug,P03905,NADH-ubiquinone oxidoreductase chain 4,MT-ND4,459.0
1039,DB00157,NADH,SmallMoleculeDrug,P09417,Dihydropteridine reductase,QDPR,244.0
1040,DB00157,NADH,SmallMoleculeDrug,P03886,NADH-ubiquinone oxidoreductase chain 1,MT-ND1,318.0
1041,DB00157,NADH,SmallMoleculeDrug,Q13423,"NAD(P) transhydrogenase, mitochondrial",NNT,1086.0
1042,DB00157,NADH,SmallMoleculeDrug,Q16718,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,NDUFA5,116.0
1043,DB00157,NADH,SmallMoleculeDrug,Q16795,"NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 9, mitochondrial",NDUFA9,377.0
1044,DB00157,NADH,SmallMoleculeDrug,P03901,NADH-ubiquinone oxidoreductase chain 4L,MT-ND4L,98.0
1045,DB00157,NADH,SmallMoleculeDrug,O95299,"NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 10, mitochondrial",NDUFA10,355.0
1046,DB00157,NADH,SmallMoleculeDrug,O95182,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 7,NDUFA7,113.0
1047,DB00157,NADH,SmallMoleculeDrug,O15239,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 1,NDUFA1,70.0
1048,DB00157,NADH,SmallMoleculeDrug,P03923,NADH-ubiquinone oxidoreductase chain 6,MT-ND6,174.0
1049,DB00157,NADH,SmallMoleculeDrug,P03915,NADH-ubiquinone oxidoreductase chain 5,MT-ND5,603.0
1050,DB00157,NADH,SmallMoleculeDrug,O00483,Cytochrome c oxidase subunit NDUFA4,NDUFA4,81.0
1051,DB00157,NADH,SmallMoleculeDrug,P56556,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 6,NDUFA6,154.0
1052,DB00157,NADH,SmallMoleculeDrug,O14561,"Acyl carrier protein, mitochondrial",NDUFAB1,156.0
1053,DB00157,NADH,SmallMoleculeDrug,O43678,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 2,NDUFA2,99.0
1054,DB00157,NADH,SmallMoleculeDrug,P51970,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 8,NDUFA8,172.0
1055,DB00157,NADH,SmallMoleculeDrug,O95167,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 3,NDUFA3,84.0
1056,DB00157,NADH,SmallMoleculeDrug,O95169,"NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 8, mitochondrial",NDUFB8,186.0
1057,DB00157,NADH,SmallMoleculeDrug,O95298,NADH dehydrogenase [ubiquinone] 1 subunit C2,NDUFC2,119.0
1058,DB00157,NADH,SmallMoleculeDrug,O75438,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 1,NDUFB1,58.0
1059,DB00157,NADH,SmallMoleculeDrug,P28331,"NADH-ubiquinone oxidoreductase 75 kDa subunit, mitochondrial",NDUFS1,727.0
1060,DB00157,NADH,SmallMoleculeDrug,O96000,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 10,NDUFB10,172.0
1061,DB00157,NADH,SmallMoleculeDrug,O95168,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 4,NDUFB4,129.0
1062,DB00157,NADH,SmallMoleculeDrug,O43676,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 3,NDUFB3,98.0
1063,DB00157,NADH,SmallMoleculeDrug,O95178,"NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 2, mitochondrial",NDUFB2,105.0
1064,DB00157,NADH,SmallMoleculeDrug,P17568,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,NDUFB7,137.0
1065,DB00157,NADH,SmallMoleculeDrug,Q9Y6M9,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 9,NDUFB9,179.0
1066,DB00157,NADH,SmallMoleculeDrug,O75306,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial",NDUFS2,463.0
1067,DB00157,NADH,SmallMoleculeDrug,O43674,"NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 5, mitochondrial",NDUFB5,189.0
1068,DB00157,NADH,SmallMoleculeDrug,O43677,"NADH dehydrogenase [ubiquinone] 1 subunit C1, mitochondrial",NDUFC1,76.0
1069,DB00157,NADH,SmallMoleculeDrug,O95139,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 6,NDUFB6,128.0
1070,DB00157,NADH,SmallMoleculeDrug,P56181,"NADH dehydrogenase [ubiquinone] flavoprotein 3, mitochondrial",NDUFV3,108.0
1071,DB00157,NADH,SmallMoleculeDrug,P09622,"Dihydrolipoyl dehydrogenase, mitochondrial",DLD,509.0
1072,DB00157,NADH,SmallMoleculeDrug,O75489,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 3, mitochondrial",NDUFS3,264.0
1073,DB00157,NADH,SmallMoleculeDrug,P00390,"Glutathione reductase, mitochondrial",GSR,522.0
1074,DB00157,NADH,SmallMoleculeDrug,Q9UI09,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 12,NDUFA12,145.0
1075,DB00157,NADH,SmallMoleculeDrug,O43920,NADH dehydrogenase [ubiquinone] iron-sulfur protein 5,NDUFS5,106.0
1076,DB00157,NADH,SmallMoleculeDrug,O43181,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 4, mitochondrial",NDUFS4,175.0
1077,DB00157,NADH,SmallMoleculeDrug,P49821,"NADH dehydrogenase [ubiquinone] flavoprotein 1, mitochondrial",NDUFV1,464.0
1078,DB00157,NADH,SmallMoleculeDrug,P19404,"NADH dehydrogenase [ubiquinone] flavoprotein 2, mitochondrial",NDUFV2,249.0
1079,DB00157,NADH,SmallMoleculeDrug,Q9P0J0,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 13,NDUFA13,144.0
1080,DB00157,NADH,SmallMoleculeDrug,Q16878,Cysteine dioxygenase type 1,CDO1,200.0
1081,DB00157,NADH,SmallMoleculeDrug,O75380,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",NDUFS6,124.0
1082,DB00157,NADH,SmallMoleculeDrug,Q9NRX3,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 4-like 2,NDUFA4L2,87.0
1083,DB00157,NADH,SmallMoleculeDrug,O00217,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 8, mitochondrial",NDUFS8,210.0
1084,DB00157,NADH,SmallMoleculeDrug,Q02928,Cytochrome P450 4A11,CYP4A11,519.0
1085,DB00157,NADH,SmallMoleculeDrug,P10515,"Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex, mitochondrial",DLAT,647.0
1086,DB00157,NADH,SmallMoleculeDrug,P48728,"Aminomethyltransferase, mitochondrial",AMT,403.0
1087,DB00157,NADH,SmallMoleculeDrug,Q15800,Methylsterol monooxygenase 1,MSMO1,293.0
1088,DB00157,NADH,SmallMoleculeDrug,P09601,Heme oxygenase 1,HMOX1,288.0
1089,DB00157,NADH,SmallMoleculeDrug,P30519,Heme oxygenase 2,HMOX2,316.0
1090,DB00157,NADH,SmallMoleculeDrug,P05093,"Steroid 17-alpha-hydroxylase/17,20 lyase",CYP17A1,508.0
1091,DB00157,NADH,SmallMoleculeDrug,P14679,Tyrosinase,TYR,529.0
1092,DB00158,Folic Acid,SmallMoleculeDrug,P14207,Folate receptor beta,FOLR2,255.0
1093,DB00158,Folic Acid,SmallMoleculeDrug,P41439,Folate receptor gamma,FOLR3,243.0
1094,DB00159,Icosapent,SmallMoleculeDrug,P35354,Prostaglandin G/H synthase 2,PTGS2,604.0
1095,DB00159,Icosapent,SmallMoleculeDrug,P23219,Prostaglandin G/H synthase 1,PTGS1,599.0
1096,DB00159,Icosapent,SmallMoleculeDrug,P37231,Peroxisome proliferator-activated receptor gamma,PPARG,505.0
1097,DB00159,Icosapent,SmallMoleculeDrug,Q03181,Peroxisome proliferator-activated receptor delta,PPARD,441.0
1098,DB00159,Icosapent,SmallMoleculeDrug,O60427,Fatty acid desaturase 1,FADS1,444.0
1099,DB00159,Icosapent,SmallMoleculeDrug,O60488,Long-chain-fatty-acid--CoA ligase 4,ACSL4,711.0
1100,DB00159,Icosapent,SmallMoleculeDrug,O95573,Long-chain-fatty-acid--CoA ligase 3,ACSL3,720.0
1101,DB00159,Icosapent,SmallMoleculeDrug,O14842,Free fatty acid receptor 1,FFAR1,300.0
1102,DB00159,Icosapent,SmallMoleculeDrug,P32418,Sodium/calcium exchanger 1,SLC8A1,973.0
1103,DB00159,Icosapent,SmallMoleculeDrug,Q8NER1,Transient receptor potential cation channel subfamily V member 1,TRPV1,839.0
1104,DB00160,L-Alanine,SmallMoleculeDrug,P21549,Serine--pyruvate aminotransferase,AGXT,392.0
1105,DB00160,L-Alanine,SmallMoleculeDrug,P80404,"4-aminobutyrate aminotransferase, mitochondrial",ABAT,500.0
1106,DB00160,L-Alanine,SmallMoleculeDrug,Q16719,Kynureninase,KYNU,465.0
1107,DB00160,L-Alanine,SmallMoleculeDrug,Q5JTZ9,"Alanine--tRNA ligase, mitochondrial",AARS2,985.0
1108,DB00160,L-Alanine,SmallMoleculeDrug,Q8IUZ5,5-phosphohydroxy-L-lysine phospho-lyase,PHYKPL,450.0
1109,DB00160,L-Alanine,SmallMoleculeDrug,Q8TD30,Alanine aminotransferase 2,GPT2,523.0
1110,DB00160,L-Alanine,SmallMoleculeDrug,P24298,Alanine aminotransferase 1,GPT,496.0
1111,DB00160,L-Alanine,SmallMoleculeDrug,Q9Y697,"Cysteine desulfurase, mitochondrial",NFS1,457.0
1112,DB00160,L-Alanine,SmallMoleculeDrug,Q7Z2H8,Proton-coupled amino acid transporter 1,SLC36A1,476.0
1113,DB00160,L-Alanine,SmallMoleculeDrug,Q9UHI5,Large neutral amino acids transporter small subunit 2,SLC7A8,535.0
1114,DB00160,L-Alanine,SmallMoleculeDrug,Q9BYV1,"Alanine--glyoxylate aminotransferase 2, mitochondrial",AGXT2,514.0
1115,DB00160,L-Alanine,SmallMoleculeDrug,P49588,"Alanine--tRNA ligase, cytoplasmic",AARS,968.0
1116,DB00160,L-Alanine,SmallMoleculeDrug,P43007,Neutral amino acid transporter A,SLC1A4,532.0
1117,DB00161,L-Valine,SmallMoleculeDrug,P05166,"Propionyl-CoA carboxylase beta chain, mitochondrial",PCCB,539.0
1118,DB00161,L-Valine,SmallMoleculeDrug,P54687,"Branched-chain-amino-acid aminotransferase, cytosolic",BCAT1,386.0
1119,DB00161,L-Valine,SmallMoleculeDrug,P26640,Valine--tRNA ligase,VARS,1264.0
1120,DB00162,Vitamin A,SmallMoleculeDrug,Q96NR8,Retinol dehydrogenase 12,RDH12,316.0
1121,DB00162,Vitamin A,SmallMoleculeDrug,O75911,Short-chain dehydrogenase/reductase 3,DHRS3,302.0
1122,DB00162,Vitamin A,SmallMoleculeDrug,P47895,Aldehyde dehydrogenase family 1 member A3,ALDH1A3,512.0
1123,DB00162,Vitamin A,SmallMoleculeDrug,Q6NUM9,"All-trans-retinol 13,14-reductase",RETSAT,610.0
1124,DB00162,Vitamin A,SmallMoleculeDrug,Q8TC12,Retinol dehydrogenase 11,RDH11,318.0
1125,DB00162,Vitamin A,SmallMoleculeDrug,Q9BTZ2,Dehydrogenase/reductase SDR family member 4,DHRS4,278.0
1126,DB00162,Vitamin A,SmallMoleculeDrug,Q9HBH5,Retinol dehydrogenase 14,RDH14,336.0
1127,DB00162,Vitamin A,SmallMoleculeDrug,Q9NYR8,Retinol dehydrogenase 8,RDH8,311.0
1128,DB00162,Vitamin A,SmallMoleculeDrug,O95237,Lecithin retinol acyltransferase,LRAT,230.0
1129,DB00162,Vitamin A,SmallMoleculeDrug,P09455,Retinol-binding protein 1,RBP1,135.0
1130,DB00162,Vitamin A,SmallMoleculeDrug,Q92781,11-cis retinol dehydrogenase,RDH5,318.0
1131,DB00162,Vitamin A,SmallMoleculeDrug,Q8NBN7,Retinol dehydrogenase 13,RDH13,331.0
1132,DB00162,Vitamin A,SmallMoleculeDrug,P10745,Retinol-binding protein 3,RBP3,1247.0
1133,DB00162,Vitamin A,SmallMoleculeDrug,O94788,Retinal dehydrogenase 2,ALDH1A2,518.0
1134,DB00162,Vitamin A,SmallMoleculeDrug,P00352,Retinal dehydrogenase 1,ALDH1A1,501.0
1135,DB00162,Vitamin A,SmallMoleculeDrug,P12271,Retinaldehyde-binding protein 1,RLBP1,317.0
1136,DB00163,Vitamin E,SmallMoleculeDrug,O75469,Nuclear receptor subfamily 1 group I member 2,NR1I2,434.0
1137,DB00163,Vitamin E,SmallMoleculeDrug,P05771,Protein kinase C beta type,PRKCB,671.0
1138,DB00163,Vitamin E,SmallMoleculeDrug,P09917,Arachidonate 5-lipoxygenase,ALOX5,674.0
1139,DB00163,Vitamin E,SmallMoleculeDrug,P17252,Protein kinase C alpha type,PRKCA,672.0
1140,DB00163,Vitamin E,SmallMoleculeDrug,P23743,Diacylglycerol kinase alpha,DGKA,735.0
1141,DB00163,Vitamin E,SmallMoleculeDrug,P62714,Serine/threonine-protein phosphatase 2A catalytic subunit beta isoform,PPP2CB,309.0
1142,DB00163,Vitamin E,SmallMoleculeDrug,P67775,Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform,PPP2CA,309.0
1143,DB00163,Vitamin E,SmallMoleculeDrug,Q9UDX3,SEC14-like protein 4,SEC14L4,406.0
1144,DB00163,Vitamin E,SmallMoleculeDrug,Q9UDX4,SEC14-like protein 3,SEC14L3,400.0
1145,DB00163,Vitamin E,SmallMoleculeDrug,O76054,SEC14-like protein 2,SEC14L2,403.0
1146,DB00165,Pyridoxine,SmallMoleculeDrug,O00764,Pyridoxal kinase,PDXK,312.0
1147,DB00166,Lipoic Acid,SmallMoleculeDrug,Q9Y234,"Lipoyltransferase 1, mitochondrial",LIPT1,373.0
1148,DB00166,Lipoic Acid,SmallMoleculeDrug,O43766,"Lipoyl synthase, mitochondrial",LIAS,372.0
1149,DB00166,Lipoic Acid,SmallMoleculeDrug,Q9Y289,Sodium-dependent multivitamin transporter,SLC5A6,635.0
1150,DB00167,L-Isoleucine,SmallMoleculeDrug,Q9NSE4,"Isoleucine--tRNA ligase, mitochondrial",IARS2,1012.0
1151,DB00167,L-Isoleucine,SmallMoleculeDrug,P45954,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",ACADSB,432.0
1152,DB00167,L-Isoleucine,SmallMoleculeDrug,P54687,"Branched-chain-amino-acid aminotransferase, cytosolic",BCAT1,386.0
1153,DB00167,L-Isoleucine,SmallMoleculeDrug,O15382,"Branched-chain-amino-acid aminotransferase, mitochondrial",BCAT2,392.0
1154,DB00167,L-Isoleucine,SmallMoleculeDrug,P41252,"Isoleucine--tRNA ligase, cytoplasmic",IARS,1262.0
1155,DB00168,Aspartame,SmallMoleculeDrug,Q8NER1,Transient receptor potential cation channel subfamily V member 1,TRPV1,839.0
1156,DB00168,Aspartame,SmallMoleculeDrug,Q8TE23,Taste receptor type 1 member 2,TAS1R2,839.0
1157,DB00169,Cholecalciferol,SmallMoleculeDrug,P11473,Vitamin D3 receptor,VDR,427.0
1158,DB00170,Menadione,SmallMoleculeDrug,P38435,Vitamin K-dependent gamma-carboxylase,GGCX,758.0
1159,DB00170,Menadione,SmallMoleculeDrug,Q9BQB6,Vitamin K epoxide reductase complex subunit 1,VKORC1,163.0
1160,DB00170,Menadione,SmallMoleculeDrug,Q8N0U8,Vitamin K epoxide reductase complex subunit 1-like protein 1,VKORC1L1,176.0
1161,DB00170,Menadione,SmallMoleculeDrug,P00734,Prothrombin,F2,622.0
1162,DB00170,Menadione,SmallMoleculeDrug,P08709,Coagulation factor VII,F7,466.0
1163,DB00170,Menadione,SmallMoleculeDrug,P00740,Coagulation factor IX,F9,461.0
1164,DB00170,Menadione,SmallMoleculeDrug,P00742,Coagulation factor X,F10,488.0
1165,DB00170,Menadione,SmallMoleculeDrug,P04070,Vitamin K-dependent protein C,PROC,461.0
1166,DB00170,Menadione,SmallMoleculeDrug,P07225,Vitamin K-dependent protein S,PROS1,676.0
1167,DB00170,Menadione,SmallMoleculeDrug,P22891,Vitamin K-dependent protein Z,PROZ,400.0
1168,DB00170,Menadione,SmallMoleculeDrug,P16083,Ribosyldihydronicotinamide dehydrogenase [quinone],NQO2,231.0
1169,DB00170,Menadione,SmallMoleculeDrug,P15559,NAD(P)H dehydrogenase [quinone] 1,NQO1,274.0
1170,DB00170,Menadione,SmallMoleculeDrug,P02818,Osteocalcin,BGLAP,100.0
1171,DB00171,Adenosine triphosphate,SmallMoleculeDrug,P42684,Abelson tyrosine-protein kinase 2,ABL2,1182.0
1172,DB00171,Adenosine triphosphate,SmallMoleculeDrug,P08183,Multidrug resistance protein 1,ABCB1,1280.0
1173,DB00171,Adenosine triphosphate,SmallMoleculeDrug,P45844,ATP-binding cassette sub-family G member 1,ABCG1,678.0
1174,DB00171,Adenosine triphosphate,SmallMoleculeDrug,Q92887,Canalicular multispecific organic anion transporter 1,ABCC2,1545.0
1175,DB00171,Adenosine triphosphate,SmallMoleculeDrug,O95477,ATP-binding cassette sub-family A member 1,ABCA1,2261.0
1176,DB00171,Adenosine triphosphate,SmallMoleculeDrug,Q9NR19,"Acetyl-coenzyme A synthetase, cytoplasmic",ACSS2,701.0
1177,DB00171,Adenosine triphosphate,SmallMoleculeDrug,Q9UM73,ALK tyrosine kinase receptor,ALK,1620.0
1178,DB00171,Adenosine triphosphate,SmallMoleculeDrug,Q13564,NEDD8-activating enzyme E1 regulatory subunit,NAE1,534.0
1179,DB00171,Adenosine triphosphate,SmallMoleculeDrug,Q13131,5'-AMP-activated protein kinase catalytic subunit alpha-1,PRKAA1,559.0
1180,DB00171,Adenosine triphosphate,SmallMoleculeDrug,P10398,Serine/threonine-protein kinase A-Raf,ARAF,606.0
1181,DB00171,Adenosine triphosphate,SmallMoleculeDrug,P37023,Serine/threonine-protein kinase receptor R3,ACVRL1,503.0
1182,DB00171,Adenosine triphosphate,SmallMoleculeDrug,P33121,Long-chain-fatty-acid--CoA ligase 1,ACSL1,698.0
1183,DB00171,Adenosine triphosphate,SmallMoleculeDrug,P49902,Cytosolic purine 5'-nucleotidase,NT5C2,561.0
1184,DB00171,Adenosine triphosphate,SmallMoleculeDrug,O43681,ATPase ASNA1,ASNA1,348.0
1185,DB00171,Adenosine triphosphate,SmallMoleculeDrug,O60706,ATP-binding cassette sub-family C member 9,ABCC9,1549.0
1186,DB00171,Adenosine triphosphate,SmallMoleculeDrug,P31749,RAC-alpha serine/threonine-protein kinase,AKT1,480.0
1187,DB00171,Adenosine triphosphate,SmallMoleculeDrug,P25098,Beta-adrenergic receptor kinase 1,GRK2,689.0
1188,DB00171,Adenosine triphosphate,SmallMoleculeDrug,O14727,Apoptotic protease-activating factor 1,APAF1,1248.0
1189,DB00171,Adenosine triphosphate,SmallMoleculeDrug,Q9NUB1,"Acetyl-coenzyme A synthetase 2-like, mitochondrial",ACSS1,689.0
1190,DB00171,Adenosine triphosphate,SmallMoleculeDrug,P36896,Activin receptor type-1B,ACVR1B,505.0
1191,DB00171,Adenosine triphosphate,SmallMoleculeDrug,Q04771,Activin receptor type-1,ACVR1,509.0
1192,DB00171,Adenosine triphosphate,SmallMoleculeDrug,O95342,Bile salt export pump,ABCB11,1321.0
1193,DB00171,Adenosine triphosphate,SmallMoleculeDrug,P08243,Asparagine synthetase [glutamine-hydrolyzing],ASNS,561.0
1194,DB00171,Adenosine triphosphate,SmallMoleculeDrug,Q96Q40,Cyclin-dependent kinase 15,CDK15,435.0
1195,DB00171,Adenosine triphosphate,SmallMoleculeDrug,P12235,ADP/ATP translocase 1,SLC25A4,298.0
1196,DB00171,Adenosine triphosphate,SmallMoleculeDrug,Q09428,ATP-binding cassette sub-family C member 8,ABCC8,1581.0
1197,DB00171,Adenosine triphosphate,SmallMoleculeDrug,P00966,Argininosuccinate synthase,ASS1,412.0
1198,DB00171,Adenosine triphosphate,SmallMoleculeDrug,Q9Y4W6,AFG3-like protein 2,AFG3L2,797.0
1199,DB00171,Adenosine triphosphate,SmallMoleculeDrug,P35626,Beta-adrenergic receptor kinase 2,GRK3,688.0
1200,DB00171,Adenosine triphosphate,SmallMoleculeDrug,Q16671,Anti-Muellerian hormone type-2 receptor,AMHR2,573.0
1201,DB00171,Adenosine triphosphate,SmallMoleculeDrug,Q07912,Activated CDC42 kinase 1,TNK2,1038.0
1202,DB00171,Adenosine triphosphate,SmallMoleculeDrug,P00519,Tyrosine-protein kinase ABL1,ABL1,1130.0
1203,DB00171,Adenosine triphosphate,SmallMoleculeDrug,Q08828,Adenylate cyclase type 1,ADCY1,1119.0
1204,DB00172,L-Proline,SmallMoleculeDrug,O15460,Prolyl 4-hydroxylase subunit alpha-2,P4HA2,535.0
1205,DB00172,L-Proline,SmallMoleculeDrug,O43272,"Proline dehydrogenase 1, mitochondrial",PRODH,600.0
1206,DB00172,L-Proline,SmallMoleculeDrug,O43447,Peptidyl-prolyl cis-trans isomerase H,PPIH,177.0
1207,DB00172,L-Proline,SmallMoleculeDrug,O94903,Proline synthase co-transcribed bacterial homolog protein,PROSC,275.0
1208,DB00172,L-Proline,SmallMoleculeDrug,P13674,Prolyl 4-hydroxylase subunit alpha-1,P4HA1,534.0
1209,DB00172,L-Proline,SmallMoleculeDrug,P23284,Peptidyl-prolyl cis-trans isomerase B,PPIB,216.0
1210,DB00172,L-Proline,SmallMoleculeDrug,P30405,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",PPIF,207.0
1211,DB00172,L-Proline,SmallMoleculeDrug,P45877,Peptidyl-prolyl cis-trans isomerase C,PPIC,212.0
1212,DB00172,L-Proline,SmallMoleculeDrug,P62937,Peptidyl-prolyl cis-trans isomerase A,PPIA,165.0
1213,DB00172,L-Proline,SmallMoleculeDrug,Q13427,Peptidyl-prolyl cis-trans isomerase G,PPIG,754.0
1214,DB00172,L-Proline,SmallMoleculeDrug,Q32P28,Prolyl 3-hydroxylase 1,P3H1,736.0
1215,DB00172,L-Proline,SmallMoleculeDrug,Q4W8W1,Pyrroline-5-carboxylate reductase,P5CR2,319.0
1216,DB00172,L-Proline,SmallMoleculeDrug,Q7L3T8,"Probable proline--tRNA ligase, mitochondrial",PARS2,475.0
1217,DB00172,L-Proline,SmallMoleculeDrug,Q8IVL5,Prolyl 3-hydroxylase 2,P3H2,708.0
1218,DB00172,L-Proline,SmallMoleculeDrug,Q8IVL6,Prolyl 3-hydroxylase 3,P3H3,736.0
1219,DB00172,L-Proline,SmallMoleculeDrug,Q53H96,Pyrroline-5-carboxylate reductase 3,PYCR3,274.0
1220,DB00172,L-Proline,SmallMoleculeDrug,Q96EM0,Trans-3-hydroxy-L-proline dehydratase,L3HYPDH,354.0
1221,DB00172,L-Proline,SmallMoleculeDrug,P32322,"Pyrroline-5-carboxylate reductase 1, mitochondrial",PYCR1,319.0
1222,DB00172,L-Proline,SmallMoleculeDrug,P07814,Bifunctional glutamate/proline--tRNA ligase,EPRS,1512.0
1223,DB00172,L-Proline,SmallMoleculeDrug,Q9UN76,Sodium- and chloride-dependent neutral and basic amino acid transporter B(0+),SLC6A14,642.0
1224,DB00172,L-Proline,SmallMoleculeDrug,Q99884,Sodium-dependent proline transporter,SLC6A7,636.0
1225,DB00172,L-Proline,SmallMoleculeDrug,Q96C36,Pyrroline-5-carboxylate reductase 2,PYCR2,320.0
1226,DB00173,Adenine,SmallMoleculeDrug,P07741,Adenine phosphoribosyltransferase,APRT,180.0
1228,DB00173,Adenine,SmallMoleculeDrug,O00763,Acetyl-CoA carboxylase 2,ACACB,2458.0
1229,DB00173,Adenine,SmallMoleculeDrug,P24666,Low molecular weight phosphotyrosine protein phosphatase,ACP1,158.0
1230,DB00173,Adenine,SmallMoleculeDrug,Q9BY49,Peroxisomal trans-2-enoyl-CoA reductase,PECR,303.0
1233,DB00173,Adenine,SmallMoleculeDrug,P78362,SRSF protein kinase 2,SRPK2,688.0
1235,DB00173,Adenine,SmallMoleculeDrug,Q13126,S-methyl-5'-thioadenosine phosphorylase,MTAP,283.0
1237,DB00174,L-Asparagine,SmallMoleculeDrug,Q15758,Neutral amino acid transporter B(0),SLC1A5,541.0
1238,DB00174,L-Asparagine,SmallMoleculeDrug,Q7L266,Isoaspartyl peptidase/L-asparaginase,ASRGL1,308.0
1239,DB00174,L-Asparagine,SmallMoleculeDrug,Q96I59,"Probable asparagine--tRNA ligase, mitochondrial",NARS2,477.0
1240,DB00174,L-Asparagine,SmallMoleculeDrug,Q99624,Sodium-coupled neutral amino acid transporter 3,SLC38A3,504.0
1241,DB00174,L-Asparagine,SmallMoleculeDrug,P08243,Asparagine synthetase [glutamine-hydrolyzing],ASNS,561.0
1242,DB00174,L-Asparagine,SmallMoleculeDrug,O43776,"Asparagine--tRNA ligase, cytoplasmic",NARS,548.0
1243,DB00175,Pravastatin,SmallMoleculeDrug,P04035,3-hydroxy-3-methylglutaryl-coenzyme A reductase,HMGCR,888.0
1244,DB00176,Fluvoxamine,SmallMoleculeDrug,P31645,Sodium-dependent serotonin transporter,SLC6A4,630.0
1245,DB00177,Valsartan,SmallMoleculeDrug,P30556,Type-1 angiotensin II receptor,AGTR1,359.0
1246,DB00178,Ramipril,SmallMoleculeDrug,P12821,Angiotensin-converting enzyme,ACE,1306.0
1247,DB00179,Masoprocol,SmallMoleculeDrug,P09917,Arachidonate 5-lipoxygenase,ALOX5,674.0
1248,DB00180,Flunisolide,SmallMoleculeDrug,P04150,Glucocorticoid receptor,NR3C1,777.0
1249,DB00181,Baclofen,SmallMoleculeDrug,Q9UBS5,Gamma-aminobutyric acid type B receptor subunit 1,GABBR1,961.0
1250,DB00181,Baclofen,SmallMoleculeDrug,O75899,Gamma-aminobutyric acid type B receptor subunit 2,GABBR2,941.0
1251,DB00182,Amphetamine,SmallMoleculeDrug,Q05940,Synaptic vesicular amine transporter,SLC18A2,514.0
1252,DB00182,Amphetamine,SmallMoleculeDrug,Q01959,Sodium-dependent dopamine transporter,SLC6A3,620.0
1253,DB00182,Amphetamine,SmallMoleculeDrug,Q16568,Cocaine- and amphetamine-regulated transcript protein,CARTPT,116.0
1254,DB00182,Amphetamine,SmallMoleculeDrug,Q96RJ0,Trace amine-associated receptor 1,TAAR1,339.0
1255,DB00182,Amphetamine,SmallMoleculeDrug,P23975,Sodium-dependent noradrenaline transporter,SLC6A2,617.0
1256,DB00182,Amphetamine,SmallMoleculeDrug,P35348,Alpha-1A adrenergic receptor,ADRA1A,466.0
1257,DB00182,Amphetamine,SmallMoleculeDrug,P35368,Alpha-1B adrenergic receptor,ADRA1B,520.0
1258,DB00182,Amphetamine,SmallMoleculeDrug,P25100,Alpha-1D adrenergic receptor,ADRA1D,572.0
1259,DB00182,Amphetamine,SmallMoleculeDrug,P08913,Alpha-2A adrenergic receptor,ADRA2A,450.0
1260,DB00182,Amphetamine,SmallMoleculeDrug,P18089,Alpha-2B adrenergic receptor,ADRA2B,450.0
1261,DB00182,Amphetamine,SmallMoleculeDrug,P18825,Alpha-2C adrenergic receptor,ADRA2C,462.0
1262,DB00182,Amphetamine,SmallMoleculeDrug,P08588,Beta-1 adrenergic receptor,ADRB1,477.0
1263,DB00182,Amphetamine,SmallMoleculeDrug,P07550,Beta-2 adrenergic receptor,ADRB2,413.0
1264,DB00182,Amphetamine,SmallMoleculeDrug,P13945,Beta-3 adrenergic receptor,ADRB3,408.0
1265,DB00182,Amphetamine,SmallMoleculeDrug,P14416,D(2) dopamine receptor,DRD2,443.0
1266,DB00182,Amphetamine,SmallMoleculeDrug,P27338,Amine oxidase [flavin-containing] B,MAOB,520.0
1267,DB00182,Amphetamine,SmallMoleculeDrug,P31645,Sodium-dependent serotonin transporter,SLC6A4,630.0
1268,DB00182,Amphetamine,SmallMoleculeDrug,P21397,Amine oxidase [flavin-containing] A,MAOA,527.0
1269,DB00182,Amphetamine,SmallMoleculeDrug,P27338,Amine oxidase [flavin-containing] B,MAOB,520.0
1270,DB00182,Amphetamine,SmallMoleculeDrug,Q99870,vesicular monoamine transporter 2 (VMAT2),VMAT2,160.0
1271,DB00183,Pentagastrin,SmallMoleculeDrug,P32239,Gastrin/cholecystokinin type B receptor,CCKBR,447.0
1272,DB00184,Nicotine,SmallMoleculeDrug,P43681,Neuronal acetylcholine receptor subunit alpha-4,CHRNA4,627.0
1273,DB00184,Nicotine,SmallMoleculeDrug,P36544,Neuronal acetylcholine receptor subunit alpha-7,CHRNA7,502.0
1274,DB00184,Nicotine,SmallMoleculeDrug,P17787,Neuronal acetylcholine receptor subunit beta-2,CHRNB2,502.0
1275,DB00184,Nicotine,SmallMoleculeDrug,Q15822,Neuronal acetylcholine receptor subunit alpha-2,CHRNA2,529.0
1276,DB00184,Nicotine,SmallMoleculeDrug,P32297,Neuronal acetylcholine receptor subunit alpha-3,CHRNA3,505.0
1277,DB00184,Nicotine,SmallMoleculeDrug,P30532,Neuronal acetylcholine receptor subunit alpha-5,CHRNA5,468.0
1278,DB00184,Nicotine,SmallMoleculeDrug,Q15825,Neuronal acetylcholine receptor subunit alpha-6,CHRNA6,494.0
1279,DB00184,Nicotine,SmallMoleculeDrug,Q9UGM1,Neuronal acetylcholine receptor subunit alpha-9,CHRNA9,479.0
1280,DB00184,Nicotine,SmallMoleculeDrug,Q9GZZ6,Neuronal acetylcholine receptor subunit alpha-10,CHRNA10,450.0
1281,DB00184,Nicotine,SmallMoleculeDrug,Q05901,Neuronal acetylcholine receptor subunit beta-3,CHRNB3,458.0
1282,DB00184,Nicotine,SmallMoleculeDrug,P30926,Neuronal acetylcholine receptor subunit beta-4,CHRNB4,498.0
1283,DB00184,Nicotine,SmallMoleculeDrug,P11511,Aromatase,CYP19A1,503.0
1284,DB00184,Nicotine,SmallMoleculeDrug,P28329,Choline O-acetyltransferase,CHAT,748.0
1285,DB00185,Cevimeline,SmallMoleculeDrug,P20309,Muscarinic acetylcholine receptor M3,CHRM3,590.0
1286,DB00185,Cevimeline,SmallMoleculeDrug,P11229,Muscarinic acetylcholine receptor M1,CHRM1,460.0
1287,DB00186,Lorazepam,SmallMoleculeDrug,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,456.0
1288,DB00186,Lorazepam,SmallMoleculeDrug,P47869,Gamma-aminobutyric acid receptor subunit alpha-2,GABRA2,451.0
1289,DB00186,Lorazepam,SmallMoleculeDrug,P34903,Gamma-aminobutyric acid receptor subunit alpha-3,GABRA3,492.0
1290,DB00186,Lorazepam,SmallMoleculeDrug,P48169,Gamma-aminobutyric acid receptor subunit alpha-4,GABRA4,554.0
1291,DB00186,Lorazepam,SmallMoleculeDrug,P31644,Gamma-aminobutyric acid receptor subunit alpha-5,GABRA5,462.0
1292,DB00186,Lorazepam,SmallMoleculeDrug,Q16445,Gamma-aminobutyric acid receptor subunit alpha-6,GABRA6,453.0
1293,DB00186,Lorazepam,SmallMoleculeDrug,P18505,Gamma-aminobutyric acid receptor subunit beta-1,GABRB1,474.0
1294,DB00186,Lorazepam,SmallMoleculeDrug,P47870,Gamma-aminobutyric acid receptor subunit beta-2,GABRB2,512.0
1295,DB00186,Lorazepam,SmallMoleculeDrug,P28472,Gamma-aminobutyric acid receptor subunit beta-3,GABRB3,473.0
1296,DB00186,Lorazepam,SmallMoleculeDrug,O14764,Gamma-aminobutyric acid receptor subunit delta,GABRD,452.0
1297,DB00186,Lorazepam,SmallMoleculeDrug,P78334,Gamma-aminobutyric acid receptor subunit epsilon,GABRE,506.0
1298,DB00186,Lorazepam,SmallMoleculeDrug,Q8N1C3,Gamma-aminobutyric acid receptor subunit gamma-1,GABRG1,465.0
1299,DB00186,Lorazepam,SmallMoleculeDrug,P18507,Gamma-aminobutyric acid receptor subunit gamma-2,GABRG2,467.0
1300,DB00186,Lorazepam,SmallMoleculeDrug,Q99928,Gamma-aminobutyric acid receptor subunit gamma-3,GABRG3,467.0
1301,DB00186,Lorazepam,SmallMoleculeDrug,O00591,Gamma-aminobutyric acid receptor subunit pi,GABRP,440.0
1302,DB00186,Lorazepam,SmallMoleculeDrug,Q9UN88,Gamma-aminobutyric acid receptor subunit theta,GABRQ,632.0
1303,DB00186,Lorazepam,SmallMoleculeDrug,P30536,Translocator protein,TSPO,169.0
1304,DB00187,Esmolol,SmallMoleculeDrug,P08588,Beta-1 adrenergic receptor,ADRB1,477.0
1305,DB00188,Bortezomib,SmallMoleculeDrug,P28074,Proteasome subunit beta type-5,PSMB5,263.0
1306,DB00188,Bortezomib,SmallMoleculeDrug,P20618,Proteasome subunit beta type-1,PSMB1,241.0
1307,DB00189,Ethchlorvynol,SmallMoleculeDrug,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,456.0
1308,DB00189,Ethchlorvynol,SmallMoleculeDrug,P47869,Gamma-aminobutyric acid receptor subunit alpha-2,GABRA2,451.0
1309,DB00189,Ethchlorvynol,SmallMoleculeDrug,P34903,Gamma-aminobutyric acid receptor subunit alpha-3,GABRA3,492.0
1310,DB00189,Ethchlorvynol,SmallMoleculeDrug,P48169,Gamma-aminobutyric acid receptor subunit alpha-4,GABRA4,554.0
1311,DB00189,Ethchlorvynol,SmallMoleculeDrug,P31644,Gamma-aminobutyric acid receptor subunit alpha-5,GABRA5,462.0
1312,DB00189,Ethchlorvynol,SmallMoleculeDrug,Q16445,Gamma-aminobutyric acid receptor subunit alpha-6,GABRA6,453.0
1313,DB00189,Ethchlorvynol,SmallMoleculeDrug,P18505,Gamma-aminobutyric acid receptor subunit beta-1,GABRB1,474.0
1314,DB00189,Ethchlorvynol,SmallMoleculeDrug,P47870,Gamma-aminobutyric acid receptor subunit beta-2,GABRB2,512.0
1315,DB00189,Ethchlorvynol,SmallMoleculeDrug,P28472,Gamma-aminobutyric acid receptor subunit beta-3,GABRB3,473.0
1316,DB00189,Ethchlorvynol,SmallMoleculeDrug,O14764,Gamma-aminobutyric acid receptor subunit delta,GABRD,452.0
1317,DB00189,Ethchlorvynol,SmallMoleculeDrug,P78334,Gamma-aminobutyric acid receptor subunit epsilon,GABRE,506.0
1318,DB00189,Ethchlorvynol,SmallMoleculeDrug,Q8N1C3,Gamma-aminobutyric acid receptor subunit gamma-1,GABRG1,465.0
1319,DB00189,Ethchlorvynol,SmallMoleculeDrug,P18507,Gamma-aminobutyric acid receptor subunit gamma-2,GABRG2,467.0
1320,DB00189,Ethchlorvynol,SmallMoleculeDrug,Q99928,Gamma-aminobutyric acid receptor subunit gamma-3,GABRG3,467.0
1321,DB00189,Ethchlorvynol,SmallMoleculeDrug,O00591,Gamma-aminobutyric acid receptor subunit pi,GABRP,440.0
1322,DB00189,Ethchlorvynol,SmallMoleculeDrug,Q9UN88,Gamma-aminobutyric acid receptor subunit theta,GABRQ,632.0
1323,DB00190,Carbidopa,SmallMoleculeDrug,P20711,Aromatic-L-amino-acid decarboxylase,DDC,480.0
1324,DB00191,Phentermine,SmallMoleculeDrug,P23975,Sodium-dependent noradrenaline transporter,SLC6A2,617.0
1325,DB00191,Phentermine,SmallMoleculeDrug,P31645,Sodium-dependent serotonin transporter,SLC6A4,630.0
1326,DB00191,Phentermine,SmallMoleculeDrug,Q01959,Sodium-dependent dopamine transporter,SLC6A3,620.0
1327,DB00191,Phentermine,SmallMoleculeDrug,P21397,Amine oxidase [flavin-containing] A,MAOA,527.0
1328,DB00191,Phentermine,SmallMoleculeDrug,P27338,Amine oxidase [flavin-containing] B,MAOB,520.0
1329,DB00192,Indecainide,SmallMoleculeDrug,Q14524,Sodium channel protein type 5 subunit alpha,SCN5A,2016.0
1330,DB00193,Tramadol,SmallMoleculeDrug,P35372,Mu-type opioid receptor,OPRM1,400.0
1331,DB00193,Tramadol,SmallMoleculeDrug,P23975,Sodium-dependent noradrenaline transporter,SLC6A2,617.0
1332,DB00193,Tramadol,SmallMoleculeDrug,P31645,Sodium-dependent serotonin transporter,SLC6A4,630.0
1333,DB00193,Tramadol,SmallMoleculeDrug,P28335,5-hydroxytryptamine receptor 2C,HTR2C,458.0
1334,DB00193,Tramadol,SmallMoleculeDrug,P41145,Kappa-type opioid receptor,OPRK1,380.0
1335,DB00193,Tramadol,SmallMoleculeDrug,P41143,Delta-type opioid receptor,OPRD1,372.0
1336,DB00193,Tramadol,SmallMoleculeDrug,Q8TCU5,"Glutamate receptor ionotropic, NMDA 3A",GRIN3A,1115.0
1337,DB00193,Tramadol,SmallMoleculeDrug,Q693P7,Alpha-7 nicotinic cholinergic receptor subunit,CHRNA7,28.0
1338,DB00193,Tramadol,SmallMoleculeDrug,P20309,Muscarinic acetylcholine receptor M3,CHRM3,590.0
1342,DB00195,Betaxolol,SmallMoleculeDrug,P08588,Beta-1 adrenergic receptor,ADRB1,477.0
1343,DB00195,Betaxolol,SmallMoleculeDrug,P07550,Beta-2 adrenergic receptor,ADRB2,413.0
1345,DB00197,Troglitazone,SmallMoleculeDrug,P37231,Peroxisome proliferator-activated receptor gamma,PPARG,505.0
1346,DB00197,Troglitazone,SmallMoleculeDrug,O60488,Long-chain-fatty-acid--CoA ligase 4,ACSL4,711.0
1347,DB00197,Troglitazone,SmallMoleculeDrug,P05121,Plasminogen activator inhibitor 1,SERPINE1,402.0
1348,DB00197,Troglitazone,SmallMoleculeDrug,Q99808,Equilibrative nucleoside transporter 1,SLC29A1,456.0
1349,DB00197,Troglitazone,SmallMoleculeDrug,P62508,Estrogen-related receptor gamma,ESRRG,458.0
1350,DB00197,Troglitazone,SmallMoleculeDrug,P11474,Steroid hormone receptor ERR1,ESRRA,423.0
1352,DB00198,Oseltamivir,SmallMoleculeDrug,P23141,Liver carboxylesterase 1,CES1,567.0
1353,DB00198,Oseltamivir,SmallMoleculeDrug,Q99519,Sialidase-1,NEU1,415.0
1354,DB00198,Oseltamivir,SmallMoleculeDrug,Q9Y3R4,Sialidase-2,NEU2,380.0
1355,DB00199,Erythromycin,SmallMoleculeDrug,O43193,Motilin receptor,MLNR,412.0
1356,DB00199,Erythromycin,SmallMoleculeDrug,Q12809,Potassium voltage-gated channel subfamily H member 2,KCNH2,1159.0
1357,DB00199,Erythromycin,SmallMoleculeDrug,P02768,Serum albumin,ALB,609.0
1358,DB00200,Hydroxocobalamin,SmallMoleculeDrug,Q99707,Methionine synthase,MTR,1265.0
1359,DB00200,Hydroxocobalamin,SmallMoleculeDrug,P22033,"Methylmalonyl-CoA mutase, mitochondrial",MUT,750.0
1360,DB00200,Hydroxocobalamin,SmallMoleculeDrug,Q9UBK8,Methionine synthase reductase,MTRR,725.0
1361,DB00200,Hydroxocobalamin,SmallMoleculeDrug,Q8IVH4,"Methylmalonic aciduria type A protein, mitochondrial",MMAA,418.0
1362,DB00200,Hydroxocobalamin,SmallMoleculeDrug,P20061,Transcobalamin-1,TCN1,433.0
1363,DB00200,Hydroxocobalamin,SmallMoleculeDrug,Q9BXJ7,Protein amnionless,AMN,453.0
1364,DB00200,Hydroxocobalamin,SmallMoleculeDrug,O60494,Cubilin,CUBN,3623.0
1365,DB00200,Hydroxocobalamin,SmallMoleculeDrug,Q96EY8,"Cob(I)yrinic acid a,c-diamide adenosyltransferase, mitochondrial",MMAB,250.0
1366,DB00200,Hydroxocobalamin,SmallMoleculeDrug,Q9Y4U1,Methylmalonic aciduria and homocystinuria type C protein,MMACHC,282.0
1367,DB00201,Caffeine,SmallMoleculeDrug,P30542,Adenosine receptor A1,ADORA1,326.0
1368,DB00201,Caffeine,SmallMoleculeDrug,P29274,Adenosine receptor A2a,ADORA2A,412.0
1369,DB00201,Caffeine,SmallMoleculeDrug,Q07343,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B",PDE4B,736.0
1370,DB00201,Caffeine,SmallMoleculeDrug,P21817,Ryanodine receptor 1,RYR1,5038.0
1371,DB00201,Caffeine,SmallMoleculeDrug,P54750,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A",PDE1A,535.0
1372,DB00201,Caffeine,SmallMoleculeDrug,Q01064,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B",PDE1B,536.0
1373,DB00201,Caffeine,SmallMoleculeDrug,Q14123,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",PDE1C,709.0
1374,DB00201,Caffeine,SmallMoleculeDrug,Q9Y233,"cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A",PDE10A,779.0
1375,DB00201,Caffeine,SmallMoleculeDrug,P27815,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A",PDE4A,886.0
1376,DB00201,Caffeine,SmallMoleculeDrug,Q07343,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B",PDE4B,736.0
1377,DB00201,Caffeine,SmallMoleculeDrug,Q08493,"cAMP-specific 3',5'-cyclic phosphodiesterase 4C",PDE4C,712.0
1378,DB00201,Caffeine,SmallMoleculeDrug,Q08499,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",PDE4D,809.0
1379,DB00201,Caffeine,SmallMoleculeDrug,Q9NP56,"cAMP-specific 3',5'-cyclic phosphodiesterase 7B",PDE7B,450.0
1380,DB00201,Caffeine,SmallMoleculeDrug,O00408,"cGMP-dependent 3',5'-cyclic phosphodiesterase",PDE2A,941.0
1381,DB00201,Caffeine,SmallMoleculeDrug,Q14432,"cGMP-inhibited 3',5'-cyclic phosphodiesterase A",PDE3A,1141.0
1382,DB00201,Caffeine,SmallMoleculeDrug,Q13370,"cGMP-inhibited 3',5'-cyclic phosphodiesterase B",PDE3B,1112.0
1383,DB00201,Caffeine,SmallMoleculeDrug,O76074,"cGMP-specific 3',5'-cyclic phosphodiesterase",PDE5A,875.0
1384,DB00201,Caffeine,SmallMoleculeDrug,P51160,"Cone cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha'",PDE6C,858.0
1385,DB00201,Caffeine,SmallMoleculeDrug,Q9HCR9,"Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A",PDE11A,933.0
1386,DB00201,Caffeine,SmallMoleculeDrug,Q13946,"High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A",PDE7A,482.0
1387,DB00201,Caffeine,SmallMoleculeDrug,O60658,"High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A",PDE8A,829.0
1388,DB00201,Caffeine,SmallMoleculeDrug,O95263,"High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8B",PDE8B,885.0
1389,DB00201,Caffeine,SmallMoleculeDrug,O76083,"High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A",PDE9A,593.0
1390,DB00201,Caffeine,SmallMoleculeDrug,P16499,"Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha",PDE6A,860.0
1391,DB00201,Caffeine,SmallMoleculeDrug,P35913,"Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit beta",PDE6B,854.0
1392,DB00201,Caffeine,SmallMoleculeDrug,P78527,DNA-dependent protein kinase catalytic subunit,PRKDC,4128.0
1393,DB00201,Caffeine,SmallMoleculeDrug,O00329,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform",PIK3CD,1044.0
1394,DB00201,Caffeine,SmallMoleculeDrug,P42336,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform",PIK3CA,1068.0
1395,DB00201,Caffeine,SmallMoleculeDrug,P42338,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform",PIK3CB,1070.0
1396,DB00201,Caffeine,SmallMoleculeDrug,Q14643,"Inositol 1,4,5-trisphosphate receptor type 1",ITPR1,2758.0
1397,DB00201,Caffeine,SmallMoleculeDrug,Q14571,"Inositol 1,4,5-trisphosphate receptor type 2",ITPR2,2701.0
1398,DB00201,Caffeine,SmallMoleculeDrug,Q14573,"Inositol 1,4,5-trisphosphate receptor type 3",ITPR3,2671.0
1399,DB00201,Caffeine,SmallMoleculeDrug,Q13315,Serine-protein kinase ATM,ATM,3056.0
1400,DB00202,Succinylcholine,SmallMoleculeDrug,Q9GZZ6,Neuronal acetylcholine receptor subunit alpha-10,CHRNA10,450.0
1401,DB00202,Succinylcholine,SmallMoleculeDrug,Q693P7,Alpha-7 nicotinic cholinergic receptor subunit,CHRNA7,28.0
1402,DB00202,Succinylcholine,SmallMoleculeDrug,P11229,Muscarinic acetylcholine receptor M1,CHRM1,460.0
1403,DB00202,Succinylcholine,SmallMoleculeDrug,P08172,Muscarinic acetylcholine receptor M2,CHRM2,466.0
1404,DB00202,Succinylcholine,SmallMoleculeDrug,P20309,Muscarinic acetylcholine receptor M3,CHRM3,590.0
1405,DB00203,Sildenafil,SmallMoleculeDrug,O76074,"cGMP-specific 3',5'-cyclic phosphodiesterase",PDE5A,875.0
1406,DB00203,Sildenafil,SmallMoleculeDrug,P18545,"Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma",PDE6G,87.0
1407,DB00203,Sildenafil,SmallMoleculeDrug,Q13956,"Retinal cone rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma",PDE6H,83.0
1408,DB00204,Dofetilide,SmallMoleculeDrug,Q12809,Potassium voltage-gated channel subfamily H member 2,KCNH2,1159.0
1409,DB00204,Dofetilide,SmallMoleculeDrug,O95069,Potassium channel subfamily K member 2,KCNK2,426.0
1410,DB00204,Dofetilide,SmallMoleculeDrug,Q14500,ATP-sensitive inward rectifier potassium channel 12,KCNJ12,433.0
1411,DB00205,Pyrimethamine,SmallMoleculeDrug,P00374,Dihydrofolate reductase,DHFR,187.0
1413,DB00206,Reserpine,SmallMoleculeDrug,Q05940,Synaptic vesicular amine transporter,SLC18A2,514.0
1414,DB00206,Reserpine,SmallMoleculeDrug,P54219,Chromaffin granule amine transporter,SLC18A1,525.0
1417,DB00207,Azithromycin,SmallMoleculeDrug,Q9UM07,Protein-arginine deiminase type-4,PADI4,663.0
1418,DB00208,Ticlopidine,SmallMoleculeDrug,Q9H244,P2Y purinoceptor 12,P2RY12,342.0
1419,DB00209,Trospium,SmallMoleculeDrug,P11229,Muscarinic acetylcholine receptor M1,CHRM1,460.0
1420,DB00210,Adapalene,SmallMoleculeDrug,P13631,Retinoic acid receptor gamma,RARG,454.0
1421,DB00210,Adapalene,SmallMoleculeDrug,P10826,Retinoic acid receptor beta,RARB,455.0
1422,DB00210,Adapalene,SmallMoleculeDrug,P48443,Retinoic acid receptor RXR-gamma,RXRG,463.0
1423,DB00210,Adapalene,SmallMoleculeDrug,P28702,Retinoic acid receptor RXR-beta,RXRB,533.0
1424,DB00210,Adapalene,SmallMoleculeDrug,P10276,Retinoic acid receptor alpha,RARA,462.0
1425,DB00210,Adapalene,SmallMoleculeDrug,P19793,Retinoic acid receptor RXR-alpha,RXRA,462.0
1426,DB00211,Midodrine,SmallMoleculeDrug,P35348,Alpha-1A adrenergic receptor,ADRA1A,466.0
1427,DB00211,Midodrine,SmallMoleculeDrug,P35368,Alpha-1B adrenergic receptor,ADRA1B,520.0
1428,DB00211,Midodrine,SmallMoleculeDrug,P25100,Alpha-1D adrenergic receptor,ADRA1D,572.0
1429,DB00212,Remikiren,SmallMoleculeDrug,P00797,Renin,REN,406.0
1430,DB00213,Pantoprazole,SmallMoleculeDrug,P20648,Potassium-transporting ATPase alpha chain 1,ATP4A,1035.0
1431,DB00214,Torasemide,SmallMoleculeDrug,Q13621,Solute carrier family 12 member 1,SLC12A1,1099.0
1432,DB00215,Citalopram,SmallMoleculeDrug,P31645,Sodium-dependent serotonin transporter,SLC6A4,630.0
1433,DB00215,Citalopram,SmallMoleculeDrug,P35367,Histamine H1 receptor,HRH1,487.0
1434,DB00215,Citalopram,SmallMoleculeDrug,P35348,Alpha-1A adrenergic receptor,ADRA1A,466.0
1435,DB00215,Citalopram,SmallMoleculeDrug,P11229,Muscarinic acetylcholine receptor M1,CHRM1,460.0
1436,DB00216,Eletriptan,SmallMoleculeDrug,P28221,5-hydroxytryptamine receptor 1D,HTR1D,377.0
1437,DB00216,Eletriptan,SmallMoleculeDrug,P28222,5-hydroxytryptamine receptor 1B,HTR1B,390.0
1438,DB00216,Eletriptan,SmallMoleculeDrug,P30939,5-hydroxytryptamine receptor 1F,HTR1F,366.0
1439,DB00216,Eletriptan,SmallMoleculeDrug,P08908,5-hydroxytryptamine receptor 1A,HTR1A,422.0
1440,DB00216,Eletriptan,SmallMoleculeDrug,P28566,5-hydroxytryptamine receptor 1E,HTR1E,365.0
1441,DB00216,Eletriptan,SmallMoleculeDrug,P41595,5-hydroxytryptamine receptor 2B,HTR2B,481.0
1442,DB00216,Eletriptan,SmallMoleculeDrug,P34969,5-hydroxytryptamine receptor 7,HTR7,479.0
1443,DB00217,Bethanidine,SmallMoleculeDrug,P08913,Alpha-2A adrenergic receptor,ADRA2A,450.0
1444,DB00217,Bethanidine,SmallMoleculeDrug,P18089,Alpha-2B adrenergic receptor,ADRA2B,450.0
1445,DB00217,Bethanidine,SmallMoleculeDrug,P18825,Alpha-2C adrenergic receptor,ADRA2C,462.0
1446,DB00217,Bethanidine,SmallMoleculeDrug,P48048,ATP-sensitive inward rectifier potassium channel 1,KCNJ1,391.0
1447,DB00217,Bethanidine,SmallMoleculeDrug,P08588,Beta-1 adrenergic receptor,ADRB1,477.0
1448,DB00217,Bethanidine,SmallMoleculeDrug,P07550,Beta-2 adrenergic receptor,ADRB2,413.0
1449,DB00217,Bethanidine,SmallMoleculeDrug,P13945,Beta-3 adrenergic receptor,ADRB3,408.0
1452,DB00218,Moxifloxacin,SmallMoleculeDrug,P11388,DNA topoisomerase 2-alpha,TOP2A,1531.0
1453,DB00219,Oxyphenonium,SmallMoleculeDrug,P11229,Muscarinic acetylcholine receptor M1,CHRM1,460.0
1455,DB00221,Isoetarine,SmallMoleculeDrug,P08588,Beta-1 adrenergic receptor,ADRB1,477.0
1456,DB00221,Isoetarine,SmallMoleculeDrug,P07550,Beta-2 adrenergic receptor,ADRB2,413.0
1457,DB00222,Glimepiride,SmallMoleculeDrug,Q14654,ATP-sensitive inward rectifier potassium channel 11,KCNJ11,390.0
1458,DB00222,Glimepiride,SmallMoleculeDrug,P48048,ATP-sensitive inward rectifier potassium channel 1,KCNJ1,391.0
1459,DB00222,Glimepiride,SmallMoleculeDrug,Q09428,ATP-binding cassette sub-family C member 8,ABCC8,1581.0
1460,DB00223,Diflorasone,SmallMoleculeDrug,P04150,Glucocorticoid receptor,NR3C1,777.0
1462,DB00226,Guanadrel,SmallMoleculeDrug,P23975,Sodium-dependent noradrenaline transporter,SLC6A2,617.0
1463,DB00227,Lovastatin,SmallMoleculeDrug,P04035,3-hydroxy-3-methylglutaryl-coenzyme A reductase,HMGCR,888.0
1464,DB00227,Lovastatin,SmallMoleculeDrug,P20701,Integrin alpha-L,ITGAL,1170.0
1465,DB00227,Lovastatin,SmallMoleculeDrug,Q92769,Histone deacetylase 2,HDAC2,488.0
1466,DB00228,Enflurane,SmallMoleculeDrug,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,456.0
1467,DB00228,Enflurane,SmallMoleculeDrug,P47869,Gamma-aminobutyric acid receptor subunit alpha-2,GABRA2,451.0
1468,DB00228,Enflurane,SmallMoleculeDrug,P34903,Gamma-aminobutyric acid receptor subunit alpha-3,GABRA3,492.0
1469,DB00228,Enflurane,SmallMoleculeDrug,P48169,Gamma-aminobutyric acid receptor subunit alpha-4,GABRA4,554.0
1470,DB00228,Enflurane,SmallMoleculeDrug,P31644,Gamma-aminobutyric acid receptor subunit alpha-5,GABRA5,462.0
1471,DB00228,Enflurane,SmallMoleculeDrug,Q16445,Gamma-aminobutyric acid receptor subunit alpha-6,GABRA6,453.0
1472,DB00228,Enflurane,SmallMoleculeDrug,P18505,Gamma-aminobutyric acid receptor subunit beta-1,GABRB1,474.0
1473,DB00228,Enflurane,SmallMoleculeDrug,P47870,Gamma-aminobutyric acid receptor subunit beta-2,GABRB2,512.0
1474,DB00228,Enflurane,SmallMoleculeDrug,P28472,Gamma-aminobutyric acid receptor subunit beta-3,GABRB3,473.0
1475,DB00228,Enflurane,SmallMoleculeDrug,O14764,Gamma-aminobutyric acid receptor subunit delta,GABRD,452.0
1476,DB00228,Enflurane,SmallMoleculeDrug,P78334,Gamma-aminobutyric acid receptor subunit epsilon,GABRE,506.0
1477,DB00228,Enflurane,SmallMoleculeDrug,Q8N1C3,Gamma-aminobutyric acid receptor subunit gamma-1,GABRG1,465.0
1478,DB00228,Enflurane,SmallMoleculeDrug,P18507,Gamma-aminobutyric acid receptor subunit gamma-2,GABRG2,467.0
1479,DB00228,Enflurane,SmallMoleculeDrug,Q99928,Gamma-aminobutyric acid receptor subunit gamma-3,GABRG3,467.0
1480,DB00228,Enflurane,SmallMoleculeDrug,O00591,Gamma-aminobutyric acid receptor subunit pi,GABRP,440.0
1481,DB00228,Enflurane,SmallMoleculeDrug,Q9UN88,Gamma-aminobutyric acid receptor subunit theta,GABRQ,632.0
1482,DB00228,Enflurane,SmallMoleculeDrug,P23415,Glycine receptor subunit alpha-1,GLRA1,457.0
1483,DB00228,Enflurane,SmallMoleculeDrug,P48167,Glycine receptor subunit beta,GLRB,497.0
1484,DB00228,Enflurane,SmallMoleculeDrug,O15554,Intermediate conductance calcium-activated potassium channel protein 4,KCNN4,427.0
1485,DB00228,Enflurane,SmallMoleculeDrug,Q09470,Potassium voltage-gated channel subfamily A member 1,KCNA1,495.0
1486,DB00228,Enflurane,SmallMoleculeDrug,P98194,Calcium-transporting ATPase type 2C member 1,ATP2C1,919.0
1487,DB00228,Enflurane,SmallMoleculeDrug,P42261,Glutamate receptor 1,GRIA1,906.0
1488,DB00228,Enflurane,SmallMoleculeDrug,P30049,"ATP synthase subunit delta, mitochondrial",ATP5D,168.0
1490,DB00230,Pregabalin,SmallMoleculeDrug,O00555,Voltage-dependent P/Q-type calcium channel subunit alpha-1A,CACNA1A,2505.0
1491,DB00231,Temazepam,SmallMoleculeDrug,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,456.0
1492,DB00231,Temazepam,SmallMoleculeDrug,P47869,Gamma-aminobutyric acid receptor subunit alpha-2,GABRA2,451.0
1493,DB00231,Temazepam,SmallMoleculeDrug,P34903,Gamma-aminobutyric acid receptor subunit alpha-3,GABRA3,492.0
1494,DB00231,Temazepam,SmallMoleculeDrug,P48169,Gamma-aminobutyric acid receptor subunit alpha-4,GABRA4,554.0
1495,DB00231,Temazepam,SmallMoleculeDrug,P31644,Gamma-aminobutyric acid receptor subunit alpha-5,GABRA5,462.0
1496,DB00231,Temazepam,SmallMoleculeDrug,Q16445,Gamma-aminobutyric acid receptor subunit alpha-6,GABRA6,453.0
1497,DB00231,Temazepam,SmallMoleculeDrug,P18505,Gamma-aminobutyric acid receptor subunit beta-1,GABRB1,474.0
1498,DB00231,Temazepam,SmallMoleculeDrug,P47870,Gamma-aminobutyric acid receptor subunit beta-2,GABRB2,512.0
1499,DB00231,Temazepam,SmallMoleculeDrug,P28472,Gamma-aminobutyric acid receptor subunit beta-3,GABRB3,473.0
1500,DB00231,Temazepam,SmallMoleculeDrug,Q8N1C3,Gamma-aminobutyric acid receptor subunit gamma-1,GABRG1,465.0
1501,DB00231,Temazepam,SmallMoleculeDrug,P18507,Gamma-aminobutyric acid receptor subunit gamma-2,GABRG2,467.0
1502,DB00231,Temazepam,SmallMoleculeDrug,Q99928,Gamma-aminobutyric acid receptor subunit gamma-3,GABRG3,467.0
1503,DB00231,Temazepam,SmallMoleculeDrug,O14764,Gamma-aminobutyric acid receptor subunit delta,GABRD,452.0
1504,DB00231,Temazepam,SmallMoleculeDrug,P78334,Gamma-aminobutyric acid receptor subunit epsilon,GABRE,506.0
1505,DB00231,Temazepam,SmallMoleculeDrug,O00591,Gamma-aminobutyric acid receptor subunit pi,GABRP,440.0
1506,DB00231,Temazepam,SmallMoleculeDrug,P24046,Gamma-aminobutyric acid receptor subunit rho-1,GABRR1,479.0
1507,DB00231,Temazepam,SmallMoleculeDrug,P28476,Gamma-aminobutyric acid receptor subunit rho-2,GABRR2,465.0
1508,DB00231,Temazepam,SmallMoleculeDrug,A8MPY1,Gamma-aminobutyric acid receptor subunit rho-3,GABRR3,467.0
1509,DB00231,Temazepam,SmallMoleculeDrug,Q9UN88,Gamma-aminobutyric acid receptor subunit theta,GABRQ,632.0
1510,DB00231,Temazepam,SmallMoleculeDrug,P30536,Translocator protein,TSPO,169.0
1511,DB00231,Temazepam,SmallMoleculeDrug,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,456.0
1512,DB00231,Temazepam,SmallMoleculeDrug,P47869,Gamma-aminobutyric acid receptor subunit alpha-2,GABRA2,451.0
1513,DB00231,Temazepam,SmallMoleculeDrug,P34903,Gamma-aminobutyric acid receptor subunit alpha-3,GABRA3,492.0
1514,DB00231,Temazepam,SmallMoleculeDrug,P48169,Gamma-aminobutyric acid receptor subunit alpha-4,GABRA4,554.0
1515,DB00231,Temazepam,SmallMoleculeDrug,P31644,Gamma-aminobutyric acid receptor subunit alpha-5,GABRA5,462.0
1516,DB00231,Temazepam,SmallMoleculeDrug,Q16445,Gamma-aminobutyric acid receptor subunit alpha-6,GABRA6,453.0
1517,DB00231,Temazepam,SmallMoleculeDrug,P18505,Gamma-aminobutyric acid receptor subunit beta-1,GABRB1,474.0
1518,DB00231,Temazepam,SmallMoleculeDrug,P47870,Gamma-aminobutyric acid receptor subunit beta-2,GABRB2,512.0
1519,DB00231,Temazepam,SmallMoleculeDrug,P28472,Gamma-aminobutyric acid receptor subunit beta-3,GABRB3,473.0
1520,DB00231,Temazepam,SmallMoleculeDrug,O14764,Gamma-aminobutyric acid receptor subunit delta,GABRD,452.0
1521,DB00231,Temazepam,SmallMoleculeDrug,P78334,Gamma-aminobutyric acid receptor subunit epsilon,GABRE,506.0
1522,DB00231,Temazepam,SmallMoleculeDrug,Q8N1C3,Gamma-aminobutyric acid receptor subunit gamma-1,GABRG1,465.0
1523,DB00231,Temazepam,SmallMoleculeDrug,P18507,Gamma-aminobutyric acid receptor subunit gamma-2,GABRG2,467.0
1524,DB00231,Temazepam,SmallMoleculeDrug,Q99928,Gamma-aminobutyric acid receptor subunit gamma-3,GABRG3,467.0
1525,DB00231,Temazepam,SmallMoleculeDrug,O00591,Gamma-aminobutyric acid receptor subunit pi,GABRP,440.0
1526,DB00231,Temazepam,SmallMoleculeDrug,Q9UN88,Gamma-aminobutyric acid receptor subunit theta,GABRQ,632.0
1527,DB00232,Methyclothiazide,SmallMoleculeDrug,Q13621,Solute carrier family 12 member 1,SLC12A1,1099.0
1528,DB00232,Methyclothiazide,SmallMoleculeDrug,P00915,Carbonic anhydrase 1,CA1,261.0
1529,DB00232,Methyclothiazide,SmallMoleculeDrug,P00918,Carbonic anhydrase 2,CA2,260.0
1530,DB00232,Methyclothiazide,SmallMoleculeDrug,P22748,Carbonic anhydrase 4,CA4,312.0
1531,DB00233,Aminosalicylic Acid,SmallMoleculeDrug,P35354,Prostaglandin G/H synthase 2,PTGS2,604.0
1532,DB00233,Aminosalicylic Acid,SmallMoleculeDrug,O15111,Inhibitor of nuclear factor kappa-B kinase subunit alpha,CHUK,745.0
1533,DB00233,Aminosalicylic Acid,SmallMoleculeDrug,P09917,Arachidonate 5-lipoxygenase,ALOX5,674.0
1534,DB00233,Aminosalicylic Acid,SmallMoleculeDrug,Q9NZK7,Group IIE secretory phospholipase A2,PLA2G2E,142.0
1536,DB00234,Reboxetine,SmallMoleculeDrug,P23975,Sodium-dependent noradrenaline transporter,SLC6A2,617.0
1537,DB00235,Milrinone,SmallMoleculeDrug,Q14432,"cGMP-inhibited 3',5'-cyclic phosphodiesterase A",PDE3A,1141.0
1538,DB00237,Butabarbital,SmallMoleculeDrug,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,456.0
1539,DB00237,Butabarbital,SmallMoleculeDrug,P47869,Gamma-aminobutyric acid receptor subunit alpha-2,GABRA2,451.0
1540,DB00237,Butabarbital,SmallMoleculeDrug,P34903,Gamma-aminobutyric acid receptor subunit alpha-3,GABRA3,492.0
1541,DB00237,Butabarbital,SmallMoleculeDrug,P48169,Gamma-aminobutyric acid receptor subunit alpha-4,GABRA4,554.0
1542,DB00237,Butabarbital,SmallMoleculeDrug,P31644,Gamma-aminobutyric acid receptor subunit alpha-5,GABRA5,462.0
1543,DB00237,Butabarbital,SmallMoleculeDrug,Q16445,Gamma-aminobutyric acid receptor subunit alpha-6,GABRA6,453.0
1544,DB00237,Butabarbital,SmallMoleculeDrug,P18505,Gamma-aminobutyric acid receptor subunit beta-1,GABRB1,474.0
1545,DB00237,Butabarbital,SmallMoleculeDrug,P47870,Gamma-aminobutyric acid receptor subunit beta-2,GABRB2,512.0
1546,DB00237,Butabarbital,SmallMoleculeDrug,P28472,Gamma-aminobutyric acid receptor subunit beta-3,GABRB3,473.0
1547,DB00237,Butabarbital,SmallMoleculeDrug,O14764,Gamma-aminobutyric acid receptor subunit delta,GABRD,452.0
1548,DB00237,Butabarbital,SmallMoleculeDrug,P78334,Gamma-aminobutyric acid receptor subunit epsilon,GABRE,506.0
1549,DB00237,Butabarbital,SmallMoleculeDrug,Q8N1C3,Gamma-aminobutyric acid receptor subunit gamma-1,GABRG1,465.0
1550,DB00237,Butabarbital,SmallMoleculeDrug,P18507,Gamma-aminobutyric acid receptor subunit gamma-2,GABRG2,467.0
1551,DB00237,Butabarbital,SmallMoleculeDrug,Q99928,Gamma-aminobutyric acid receptor subunit gamma-3,GABRG3,467.0
1552,DB00237,Butabarbital,SmallMoleculeDrug,O00591,Gamma-aminobutyric acid receptor subunit pi,GABRP,440.0
1553,DB00237,Butabarbital,SmallMoleculeDrug,Q9UN88,Gamma-aminobutyric acid receptor subunit theta,GABRQ,632.0
1554,DB00237,Butabarbital,SmallMoleculeDrug,P43681,Neuronal acetylcholine receptor subunit alpha-4,CHRNA4,627.0
1555,DB00237,Butabarbital,SmallMoleculeDrug,P36544,Neuronal acetylcholine receptor subunit alpha-7,CHRNA7,502.0
1556,DB00237,Butabarbital,SmallMoleculeDrug,P42262,Glutamate receptor 2,GRIA2,883.0
1557,DB00237,Butabarbital,SmallMoleculeDrug,Q13002,"Glutamate receptor ionotropic, kainate 2",GRIK2,908.0
1561,DB00240,Alclometasone,SmallMoleculeDrug,P04150,Glucocorticoid receptor,NR3C1,777.0
1562,DB00241,Butalbital,SmallMoleculeDrug,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,456.0
1563,DB00241,Butalbital,SmallMoleculeDrug,P47869,Gamma-aminobutyric acid receptor subunit alpha-2,GABRA2,451.0
1564,DB00241,Butalbital,SmallMoleculeDrug,P34903,Gamma-aminobutyric acid receptor subunit alpha-3,GABRA3,492.0
1565,DB00241,Butalbital,SmallMoleculeDrug,P48169,Gamma-aminobutyric acid receptor subunit alpha-4,GABRA4,554.0
1566,DB00241,Butalbital,SmallMoleculeDrug,P31644,Gamma-aminobutyric acid receptor subunit alpha-5,GABRA5,462.0
1567,DB00241,Butalbital,SmallMoleculeDrug,Q16445,Gamma-aminobutyric acid receptor subunit alpha-6,GABRA6,453.0
1568,DB00241,Butalbital,SmallMoleculeDrug,P43681,Neuronal acetylcholine receptor subunit alpha-4,CHRNA4,627.0
1569,DB00241,Butalbital,SmallMoleculeDrug,P36544,Neuronal acetylcholine receptor subunit alpha-7,CHRNA7,502.0
1570,DB00241,Butalbital,SmallMoleculeDrug,P42262,Glutamate receptor 2,GRIA2,883.0
1571,DB00241,Butalbital,SmallMoleculeDrug,Q13002,"Glutamate receptor ionotropic, kainate 2",GRIK2,908.0
1572,DB00241,Butalbital,SmallMoleculeDrug,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,456.0
1573,DB00241,Butalbital,SmallMoleculeDrug,P47869,Gamma-aminobutyric acid receptor subunit alpha-2,GABRA2,451.0
1574,DB00241,Butalbital,SmallMoleculeDrug,P34903,Gamma-aminobutyric acid receptor subunit alpha-3,GABRA3,492.0
1575,DB00241,Butalbital,SmallMoleculeDrug,P48169,Gamma-aminobutyric acid receptor subunit alpha-4,GABRA4,554.0
1576,DB00241,Butalbital,SmallMoleculeDrug,P31644,Gamma-aminobutyric acid receptor subunit alpha-5,GABRA5,462.0
1577,DB00241,Butalbital,SmallMoleculeDrug,Q16445,Gamma-aminobutyric acid receptor subunit alpha-6,GABRA6,453.0
1578,DB00241,Butalbital,SmallMoleculeDrug,P18505,Gamma-aminobutyric acid receptor subunit beta-1,GABRB1,474.0
1579,DB00241,Butalbital,SmallMoleculeDrug,P47870,Gamma-aminobutyric acid receptor subunit beta-2,GABRB2,512.0
1580,DB00241,Butalbital,SmallMoleculeDrug,P28472,Gamma-aminobutyric acid receptor subunit beta-3,GABRB3,473.0
1581,DB00241,Butalbital,SmallMoleculeDrug,O14764,Gamma-aminobutyric acid receptor subunit delta,GABRD,452.0
1582,DB00241,Butalbital,SmallMoleculeDrug,P78334,Gamma-aminobutyric acid receptor subunit epsilon,GABRE,506.0
1583,DB00241,Butalbital,SmallMoleculeDrug,Q8N1C3,Gamma-aminobutyric acid receptor subunit gamma-1,GABRG1,465.0
1584,DB00241,Butalbital,SmallMoleculeDrug,P18507,Gamma-aminobutyric acid receptor subunit gamma-2,GABRG2,467.0
1585,DB00241,Butalbital,SmallMoleculeDrug,Q99928,Gamma-aminobutyric acid receptor subunit gamma-3,GABRG3,467.0
1586,DB00241,Butalbital,SmallMoleculeDrug,O00591,Gamma-aminobutyric acid receptor subunit pi,GABRP,440.0
1587,DB00241,Butalbital,SmallMoleculeDrug,Q9UN88,Gamma-aminobutyric acid receptor subunit theta,GABRQ,632.0
1588,DB00242,Cladribine,SmallMoleculeDrug,P23921,Ribonucleoside-diphosphate reductase large subunit,RRM1,792.0
1589,DB00242,Cladribine,SmallMoleculeDrug,P31350,Ribonucleoside-diphosphate reductase subunit M2,RRM2,389.0
1590,DB00242,Cladribine,SmallMoleculeDrug,Q7LG56,Ribonucleoside-diphosphate reductase subunit M2 B,RRM2B,351.0
1591,DB00242,Cladribine,SmallMoleculeDrug,P09884,DNA polymerase alpha catalytic subunit,POLA1,1462.0
1592,DB00242,Cladribine,SmallMoleculeDrug,Q07864,DNA polymerase epsilon catalytic subunit A,POLE,2286.0
1593,DB00242,Cladribine,SmallMoleculeDrug,P56282,DNA polymerase epsilon subunit 2,POLE2,527.0
1594,DB00242,Cladribine,SmallMoleculeDrug,Q9NRF9,DNA polymerase epsilon subunit 3,POLE3,147.0
1595,DB00242,Cladribine,SmallMoleculeDrug,Q9NR33,DNA polymerase epsilon subunit 4,POLE4,117.0
1596,DB00242,Cladribine,SmallMoleculeDrug,P00491,Purine nucleoside phosphorylase,PNP,289.0
1597,DB00243,Ranolazine,SmallMoleculeDrug,Q14524,Sodium channel protein type 5 subunit alpha,SCN5A,2016.0
1598,DB00243,Ranolazine,SmallMoleculeDrug,Q15858,Sodium channel protein type 9 subunit alpha,SCN9A,1988.0
1599,DB00244,Mesalazine,SmallMoleculeDrug,P35354,Prostaglandin G/H synthase 2,PTGS2,604.0
1600,DB00244,Mesalazine,SmallMoleculeDrug,P23219,Prostaglandin G/H synthase 1,PTGS1,599.0
1601,DB00244,Mesalazine,SmallMoleculeDrug,P09917,Arachidonate 5-lipoxygenase,ALOX5,674.0
1602,DB00244,Mesalazine,SmallMoleculeDrug,P37231,Peroxisome proliferator-activated receptor gamma,PPARG,505.0
1603,DB00244,Mesalazine,SmallMoleculeDrug,O15111,Inhibitor of nuclear factor kappa-B kinase subunit alpha,CHUK,745.0
1604,DB00244,Mesalazine,SmallMoleculeDrug,O14920,Inhibitor of nuclear factor kappa-B kinase subunit beta,IKBKB,756.0
1605,DB00244,Mesalazine,SmallMoleculeDrug,P05164,Myeloperoxidase,MPO,745.0
1607,DB00245,Benzatropine,SmallMoleculeDrug,P11229,Muscarinic acetylcholine receptor M1,CHRM1,460.0
1608,DB00245,Benzatropine,SmallMoleculeDrug,Q01959,Sodium-dependent dopamine transporter,SLC6A3,620.0
1609,DB00245,Benzatropine,SmallMoleculeDrug,P35367,Histamine H1 receptor,HRH1,487.0
1610,DB00246,Ziprasidone,SmallMoleculeDrug,P14416,D(2) dopamine receptor,DRD2,443.0
1611,DB00246,Ziprasidone,SmallMoleculeDrug,P28223,5-hydroxytryptamine receptor 2A,HTR2A,471.0
1612,DB00246,Ziprasidone,SmallMoleculeDrug,P21728,D(1A) dopamine receptor,DRD1,446.0
1613,DB00246,Ziprasidone,SmallMoleculeDrug,P21918,D(1B) dopamine receptor,DRD5,477.0
1614,DB00246,Ziprasidone,SmallMoleculeDrug,P35462,D(3) dopamine receptor,DRD3,400.0
1615,DB00246,Ziprasidone,SmallMoleculeDrug,P21917,D(4) dopamine receptor,DRD4,467.0
1616,DB00246,Ziprasidone,SmallMoleculeDrug,P08908,5-hydroxytryptamine receptor 1A,HTR1A,422.0
1617,DB00246,Ziprasidone,SmallMoleculeDrug,P28222,5-hydroxytryptamine receptor 1B,HTR1B,390.0
1618,DB00246,Ziprasidone,SmallMoleculeDrug,P28221,5-hydroxytryptamine receptor 1D,HTR1D,377.0
1619,DB00246,Ziprasidone,SmallMoleculeDrug,P28566,5-hydroxytryptamine receptor 1E,HTR1E,365.0
1620,DB00246,Ziprasidone,SmallMoleculeDrug,P28335,5-hydroxytryptamine receptor 2C,HTR2C,458.0
1621,DB00246,Ziprasidone,SmallMoleculeDrug,P46098,5-hydroxytryptamine receptor 3A,HTR3A,478.0
1622,DB00246,Ziprasidone,SmallMoleculeDrug,P50406,5-hydroxytryptamine receptor 6,HTR6,440.0
1623,DB00246,Ziprasidone,SmallMoleculeDrug,P34969,5-hydroxytryptamine receptor 7,HTR7,479.0
1624,DB00246,Ziprasidone,SmallMoleculeDrug,P35367,Histamine H1 receptor,HRH1,487.0
1625,DB00246,Ziprasidone,SmallMoleculeDrug,P35348,Alpha-1A adrenergic receptor,ADRA1A,466.0
1626,DB00246,Ziprasidone,SmallMoleculeDrug,P35368,Alpha-1B adrenergic receptor,ADRA1B,520.0
1627,DB00246,Ziprasidone,SmallMoleculeDrug,P08913,Alpha-2A adrenergic receptor,ADRA2A,450.0
1628,DB00246,Ziprasidone,SmallMoleculeDrug,P18089,Alpha-2B adrenergic receptor,ADRA2B,450.0
1629,DB00246,Ziprasidone,SmallMoleculeDrug,P18825,Alpha-2C adrenergic receptor,ADRA2C,462.0
1630,DB00246,Ziprasidone,SmallMoleculeDrug,P11229,Muscarinic acetylcholine receptor M1,CHRM1,460.0
1631,DB00246,Ziprasidone,SmallMoleculeDrug,P08172,Muscarinic acetylcholine receptor M2,CHRM2,466.0
1632,DB00246,Ziprasidone,SmallMoleculeDrug,P20309,Muscarinic acetylcholine receptor M3,CHRM3,590.0
1633,DB00246,Ziprasidone,SmallMoleculeDrug,P08173,Muscarinic acetylcholine receptor M4,CHRM4,479.0
1634,DB00246,Ziprasidone,SmallMoleculeDrug,P08912,Muscarinic acetylcholine receptor M5,CHRM5,532.0
1635,DB00247,Methysergide,SmallMoleculeDrug,P41595,5-hydroxytryptamine receptor 2B,HTR2B,481.0
1636,DB00247,Methysergide,SmallMoleculeDrug,P28335,5-hydroxytryptamine receptor 2C,HTR2C,458.0
1637,DB00247,Methysergide,SmallMoleculeDrug,P28223,5-hydroxytryptamine receptor 2A,HTR2A,471.0
1638,DB00247,Methysergide,SmallMoleculeDrug,P08908,5-hydroxytryptamine receptor 1A,HTR1A,422.0
1639,DB00247,Methysergide,SmallMoleculeDrug,P34969,5-hydroxytryptamine receptor 7,HTR7,479.0
1640,DB00247,Methysergide,SmallMoleculeDrug,P28222,5-hydroxytryptamine receptor 1B,HTR1B,390.0
1641,DB00247,Methysergide,SmallMoleculeDrug,P30939,5-hydroxytryptamine receptor 1F,HTR1F,366.0
1642,DB00247,Methysergide,SmallMoleculeDrug,P28566,5-hydroxytryptamine receptor 1E,HTR1E,365.0
1643,DB00248,Cabergoline,SmallMoleculeDrug,P14416,D(2) dopamine receptor,DRD2,443.0
1644,DB00248,Cabergoline,SmallMoleculeDrug,P41595,5-hydroxytryptamine receptor 2B,HTR2B,481.0
1645,DB00248,Cabergoline,SmallMoleculeDrug,P35462,D(3) dopamine receptor,DRD3,400.0
1646,DB00248,Cabergoline,SmallMoleculeDrug,P28223,5-hydroxytryptamine receptor 2A,HTR2A,471.0
1647,DB00248,Cabergoline,SmallMoleculeDrug,P18089,Alpha-2B adrenergic receptor,ADRA2B,450.0
1648,DB00248,Cabergoline,SmallMoleculeDrug,P28221,5-hydroxytryptamine receptor 1D,HTR1D,377.0
1649,DB00248,Cabergoline,SmallMoleculeDrug,P21917,D(4) dopamine receptor,DRD4,467.0
1650,DB00248,Cabergoline,SmallMoleculeDrug,P08913,Alpha-2A adrenergic receptor,ADRA2A,450.0
1651,DB00248,Cabergoline,SmallMoleculeDrug,P08908,5-hydroxytryptamine receptor 1A,HTR1A,422.0
1652,DB00248,Cabergoline,SmallMoleculeDrug,P18825,Alpha-2C adrenergic receptor,ADRA2C,462.0
1653,DB00248,Cabergoline,SmallMoleculeDrug,P21918,D(1B) dopamine receptor,DRD5,477.0
1654,DB00248,Cabergoline,SmallMoleculeDrug,P21728,D(1A) dopamine receptor,DRD1,446.0
1655,DB00248,Cabergoline,SmallMoleculeDrug,P28222,5-hydroxytryptamine receptor 1B,HTR1B,390.0
1656,DB00248,Cabergoline,SmallMoleculeDrug,P28335,5-hydroxytryptamine receptor 2C,HTR2C,458.0
1657,DB00248,Cabergoline,SmallMoleculeDrug,P34969,5-hydroxytryptamine receptor 7,HTR7,479.0
1658,DB00248,Cabergoline,SmallMoleculeDrug,P35348,Alpha-1A adrenergic receptor,ADRA1A,466.0
1659,DB00248,Cabergoline,SmallMoleculeDrug,P35368,Alpha-1B adrenergic receptor,ADRA1B,520.0
1660,DB00248,Cabergoline,SmallMoleculeDrug,P25100,Alpha-1D adrenergic receptor,ADRA1D,572.0
1661,DB00248,Cabergoline,SmallMoleculeDrug,P08588,Beta-1 adrenergic receptor,ADRB1,477.0
1662,DB00248,Cabergoline,SmallMoleculeDrug,P07550,Beta-2 adrenergic receptor,ADRB2,413.0
1663,DB00248,Cabergoline,SmallMoleculeDrug,P21728,D(1A) dopamine receptor,DRD1,446.0
1664,DB00248,Cabergoline,SmallMoleculeDrug,P21918,D(1B) dopamine receptor,DRD5,477.0
1669,DB00252,Phenytoin,SmallMoleculeDrug,Q14524,Sodium channel protein type 5 subunit alpha,SCN5A,2016.0
1670,DB00252,Phenytoin,SmallMoleculeDrug,P35498,Sodium channel protein type 1 subunit alpha,SCN1A,2009.0
1671,DB00253,Medrysone,SmallMoleculeDrug,P04150,Glucocorticoid receptor,NR3C1,777.0
1674,DB00254,Doxycycline,SmallMoleculeDrug,Q9UM07,Protein-arginine deiminase type-4,PADI4,663.0
1675,DB00254,Doxycycline,SmallMoleculeDrug,P61769,Beta-2-microglobulin,B2M,119.0
1676,DB00255,Diethylstilbestrol,SmallMoleculeDrug,P03372,Estrogen receptor,ESR1,595.0
1677,DB00255,Diethylstilbestrol,SmallMoleculeDrug,P62508,Estrogen-related receptor gamma,ESRRG,458.0
1678,DB00255,Diethylstilbestrol,SmallMoleculeDrug,Q92731,Estrogen receptor beta,ESR2,530.0
1682,DB00257,Clotrimazole,SmallMoleculeDrug,O15554,Intermediate conductance calcium-activated potassium channel protein 4,KCNN4,427.0
1686,DB00261,Anagrelide,SmallMoleculeDrug,Q14432,"cGMP-inhibited 3',5'-cyclic phosphodiesterase A",PDE3A,1141.0
1687,DB00262,Carmustine,SmallMoleculeDrug,P00390,"Glutathione reductase, mitochondrial",GSR,522.0
1689,DB00264,Metoprolol,SmallMoleculeDrug,P08588,Beta-1 adrenergic receptor,ADRB1,477.0
1690,DB00264,Metoprolol,SmallMoleculeDrug,P07550,Beta-2 adrenergic receptor,ADRB2,413.0
1691,DB00266,Dicoumarol,SmallMoleculeDrug,Q9BQB6,Vitamin K epoxide reductase complex subunit 1,VKORC1,163.0
1692,DB00266,Dicoumarol,SmallMoleculeDrug,P15559,NAD(P)H dehydrogenase [quinone] 1,NQO1,274.0
1693,DB00266,Dicoumarol,SmallMoleculeDrug,Q08257,Quinone oxidoreductase,CRYZ,329.0
1696,DB00268,Ropinirole,SmallMoleculeDrug,P35462,D(3) dopamine receptor,DRD3,400.0
1697,DB00268,Ropinirole,SmallMoleculeDrug,P14416,D(2) dopamine receptor,DRD2,443.0
1698,DB00268,Ropinirole,SmallMoleculeDrug,P21917,D(4) dopamine receptor,DRD4,467.0
1699,DB00268,Ropinirole,SmallMoleculeDrug,P08908,5-hydroxytryptamine receptor 1A,HTR1A,422.0
1700,DB00268,Ropinirole,SmallMoleculeDrug,P28221,5-hydroxytryptamine receptor 1D,HTR1D,377.0
1701,DB00268,Ropinirole,SmallMoleculeDrug,P41595,5-hydroxytryptamine receptor 2B,HTR2B,481.0
1702,DB00268,Ropinirole,SmallMoleculeDrug,P21728,D(1A) dopamine receptor,DRD1,446.0
1703,DB00268,Ropinirole,SmallMoleculeDrug,P21918,D(1B) dopamine receptor,DRD5,477.0
1704,DB00268,Ropinirole,SmallMoleculeDrug,P28222,5-hydroxytryptamine receptor 1B,HTR1B,390.0
1705,DB00268,Ropinirole,SmallMoleculeDrug,P28223,5-hydroxytryptamine receptor 2A,HTR2A,471.0
1706,DB00268,Ropinirole,SmallMoleculeDrug,P28335,5-hydroxytryptamine receptor 2C,HTR2C,458.0
1707,DB00268,Ropinirole,SmallMoleculeDrug,P08913,Alpha-2A adrenergic receptor,ADRA2A,450.0
1708,DB00268,Ropinirole,SmallMoleculeDrug,P18089,Alpha-2B adrenergic receptor,ADRA2B,450.0
1709,DB00268,Ropinirole,SmallMoleculeDrug,P18825,Alpha-2C adrenergic receptor,ADRA2C,462.0
1710,DB00269,Chlorotrianisene,SmallMoleculeDrug,P03372,Estrogen receptor,ESR1,595.0
1711,DB00270,Isradipine,SmallMoleculeDrug,Q13936,Voltage-dependent L-type calcium channel subunit alpha-1C,CACNA1C,2221.0
1712,DB00270,Isradipine,SmallMoleculeDrug,P54289,Voltage-dependent calcium channel subunit alpha-2/delta-1,CACNA2D1,1103.0
1713,DB00270,Isradipine,SmallMoleculeDrug,Q08289,Voltage-dependent L-type calcium channel subunit beta-2,CACNB2,660.0
1714,DB00270,Isradipine,SmallMoleculeDrug,O95180,Voltage-dependent T-type calcium channel subunit alpha-1H,CACNA1H,2353.0
1715,DB00270,Isradipine,SmallMoleculeDrug,Q9NY47,Voltage-dependent calcium channel subunit alpha-2/delta-2,CACNA2D2,1150.0
1716,DB00270,Isradipine,SmallMoleculeDrug,Q01668,Voltage-dependent L-type calcium channel subunit alpha-1D,CACNA1D,2161.0
1717,DB00270,Isradipine,SmallMoleculeDrug,Q13698,Voltage-dependent L-type calcium channel subunit alpha-1S,CACNA1S,1873.0
1718,DB00272,Betazole,SmallMoleculeDrug,P25021,Histamine H2 receptor,HRH2,359.0
1719,DB00273,Topiramate,SmallMoleculeDrug,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,456.0
1720,DB00273,Topiramate,SmallMoleculeDrug,P35498,Sodium channel protein type 1 subunit alpha,SCN1A,2009.0
1721,DB00273,Topiramate,SmallMoleculeDrug,P39086,"Glutamate receptor ionotropic, kainate 1",GRIK1,918.0
1722,DB00273,Topiramate,SmallMoleculeDrug,P00918,Carbonic anhydrase 2,CA2,260.0
1723,DB00273,Topiramate,SmallMoleculeDrug,P22748,Carbonic anhydrase 4,CA4,312.0
1724,DB00273,Topiramate,SmallMoleculeDrug,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,456.0
1725,DB00273,Topiramate,SmallMoleculeDrug,P47869,Gamma-aminobutyric acid receptor subunit alpha-2,GABRA2,451.0
1726,DB00273,Topiramate,SmallMoleculeDrug,P34903,Gamma-aminobutyric acid receptor subunit alpha-3,GABRA3,492.0
1727,DB00273,Topiramate,SmallMoleculeDrug,P48169,Gamma-aminobutyric acid receptor subunit alpha-4,GABRA4,554.0
1728,DB00273,Topiramate,SmallMoleculeDrug,P31644,Gamma-aminobutyric acid receptor subunit alpha-5,GABRA5,462.0
1729,DB00273,Topiramate,SmallMoleculeDrug,Q16445,Gamma-aminobutyric acid receptor subunit alpha-6,GABRA6,453.0
1730,DB00273,Topiramate,SmallMoleculeDrug,P18505,Gamma-aminobutyric acid receptor subunit beta-1,GABRB1,474.0
1731,DB00273,Topiramate,SmallMoleculeDrug,P47870,Gamma-aminobutyric acid receptor subunit beta-2,GABRB2,512.0
1732,DB00273,Topiramate,SmallMoleculeDrug,P28472,Gamma-aminobutyric acid receptor subunit beta-3,GABRB3,473.0
1733,DB00273,Topiramate,SmallMoleculeDrug,O14764,Gamma-aminobutyric acid receptor subunit delta,GABRD,452.0
1734,DB00273,Topiramate,SmallMoleculeDrug,P78334,Gamma-aminobutyric acid receptor subunit epsilon,GABRE,506.0
1735,DB00273,Topiramate,SmallMoleculeDrug,Q8N1C3,Gamma-aminobutyric acid receptor subunit gamma-1,GABRG1,465.0
1736,DB00273,Topiramate,SmallMoleculeDrug,P18507,Gamma-aminobutyric acid receptor subunit gamma-2,GABRG2,467.0
1737,DB00273,Topiramate,SmallMoleculeDrug,Q99928,Gamma-aminobutyric acid receptor subunit gamma-3,GABRG3,467.0
1738,DB00273,Topiramate,SmallMoleculeDrug,O00591,Gamma-aminobutyric acid receptor subunit pi,GABRP,440.0
1739,DB00273,Topiramate,SmallMoleculeDrug,Q9UN88,Gamma-aminobutyric acid receptor subunit theta,GABRQ,632.0
1746,DB00275,Olmesartan,SmallMoleculeDrug,P30556,Type-1 angiotensin II receptor,AGTR1,359.0
1747,DB00276,Amsacrine,SmallMoleculeDrug,P11388,DNA topoisomerase 2-alpha,TOP2A,1531.0
1748,DB00276,Amsacrine,SmallMoleculeDrug,Q12809,Potassium voltage-gated channel subfamily H member 2,KCNH2,1159.0
1749,DB00277,Theophylline,SmallMoleculeDrug,P30542,Adenosine receptor A1,ADORA1,326.0
1750,DB00277,Theophylline,SmallMoleculeDrug,P29274,Adenosine receptor A2a,ADORA2A,412.0
1751,DB00277,Theophylline,SmallMoleculeDrug,P29275,Adenosine receptor A2b,ADORA2B,332.0
1752,DB00277,Theophylline,SmallMoleculeDrug,Q07343,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B",PDE4B,736.0
1753,DB00277,Theophylline,SmallMoleculeDrug,O76074,"cGMP-specific 3',5'-cyclic phosphodiesterase",PDE5A,875.0
1754,DB00277,Theophylline,SmallMoleculeDrug,P27815,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A",PDE4A,886.0
1755,DB00277,Theophylline,SmallMoleculeDrug,Q14432,"cGMP-inhibited 3',5'-cyclic phosphodiesterase A",PDE3A,1141.0
1756,DB00277,Theophylline,SmallMoleculeDrug,Q92769,Histone deacetylase 2,HDAC2,488.0
1757,DB00278,Argatroban,SmallMoleculeDrug,P00734,Prothrombin,F2,622.0
1758,DB00279,Liothyronine,SmallMoleculeDrug,P10827,Thyroid hormone receptor alpha,THRA,490.0
1759,DB00279,Liothyronine,SmallMoleculeDrug,P10828,Thyroid hormone receptor beta,THRB,461.0
1760,DB00280,Disopyramide,SmallMoleculeDrug,Q14524,Sodium channel protein type 5 subunit alpha,SCN5A,2016.0
1761,DB00280,Disopyramide,SmallMoleculeDrug,P11229,Muscarinic acetylcholine receptor M1,CHRM1,460.0
1762,DB00280,Disopyramide,SmallMoleculeDrug,P08172,Muscarinic acetylcholine receptor M2,CHRM2,466.0
1763,DB00280,Disopyramide,SmallMoleculeDrug,P20309,Muscarinic acetylcholine receptor M3,CHRM3,590.0
1764,DB00280,Disopyramide,SmallMoleculeDrug,Q9NZV8,Potassium voltage-gated channel subfamily D member 2,KCND2,630.0
1765,DB00280,Disopyramide,SmallMoleculeDrug,Q9UK17,Potassium voltage-gated channel subfamily D member 3,KCND3,655.0
1766,DB00281,Lidocaine,SmallMoleculeDrug,Q9Y5Y9,Sodium channel protein type 10 subunit alpha,SCN10A,1956.0
1767,DB00281,Lidocaine,SmallMoleculeDrug,Q15858,Sodium channel protein type 9 subunit alpha,SCN9A,1988.0
1768,DB00281,Lidocaine,SmallMoleculeDrug,Q14524,Sodium channel protein type 5 subunit alpha,SCN5A,2016.0
1769,DB00281,Lidocaine,SmallMoleculeDrug,P00533,Epidermal growth factor receptor,EGFR,1210.0
1770,DB00282,Pamidronate,SmallMoleculeDrug,P14324,Farnesyl pyrophosphate synthase,FDPS,419.0
1771,DB00283,Clemastine,SmallMoleculeDrug,P35367,Histamine H1 receptor,HRH1,487.0
1772,DB00284,Acarbose,SmallMoleculeDrug,O43451,"Maltase-glucoamylase, intestinal",MGAM,1857.0
1773,DB00284,Acarbose,SmallMoleculeDrug,P04746,Pancreatic alpha-amylase,AMY2A,511.0
1774,DB00284,Acarbose,SmallMoleculeDrug,P10253,Lysosomal alpha-glucosidase,GAA,952.0
1775,DB00284,Acarbose,SmallMoleculeDrug,P14410,"Sucrase-isomaltase, intestinal",SI,1827.0
1776,DB00285,Venlafaxine,SmallMoleculeDrug,P31645,Sodium-dependent serotonin transporter,SLC6A4,630.0
1777,DB00285,Venlafaxine,SmallMoleculeDrug,P23975,Sodium-dependent noradrenaline transporter,SLC6A2,617.0
1778,DB00285,Venlafaxine,SmallMoleculeDrug,Q01959,Sodium-dependent dopamine transporter,SLC6A3,620.0
1779,DB00286,Conjugated Equine Estrogens,SmallMoleculeDrug,P03372,Estrogen receptor,ESR1,595.0
1780,DB00287,Travoprost,SmallMoleculeDrug,P43088,Prostaglandin F2-alpha receptor,PTGFR,359.0
1781,DB00288,Amcinonide,SmallMoleculeDrug,P04150,Glucocorticoid receptor,NR3C1,777.0
1782,DB00288,Amcinonide,SmallMoleculeDrug,P04083,Annexin A1,ANXA1,346.0
1783,DB00289,Atomoxetine,SmallMoleculeDrug,P23975,Sodium-dependent noradrenaline transporter,SLC6A2,617.0
1784,DB00289,Atomoxetine,SmallMoleculeDrug,P31645,Sodium-dependent serotonin transporter,SLC6A4,630.0
1785,DB00289,Atomoxetine,SmallMoleculeDrug,Q01959,Sodium-dependent dopamine transporter,SLC6A3,620.0
1786,DB00289,Atomoxetine,SmallMoleculeDrug,Q05586,"Glutamate receptor ionotropic, NMDA 1",GRIN1,938.0
1787,DB00289,Atomoxetine,SmallMoleculeDrug,Q12879,"Glutamate receptor ionotropic, NMDA 2A",GRIN2A,1464.0
1788,DB00289,Atomoxetine,SmallMoleculeDrug,Q13224,"Glutamate receptor ionotropic, NMDA 2B",GRIN2B,1484.0
1789,DB00289,Atomoxetine,SmallMoleculeDrug,Q14957,"Glutamate receptor ionotropic, NMDA 2C",GRIN2C,1233.0
1790,DB00289,Atomoxetine,SmallMoleculeDrug,O15399,"Glutamate receptor ionotropic, NMDA 2D",GRIN2D,1336.0
1791,DB00289,Atomoxetine,SmallMoleculeDrug,Q8TCU5,"Glutamate receptor ionotropic, NMDA 3A",GRIN3A,1115.0
1792,DB00289,Atomoxetine,SmallMoleculeDrug,O60391,"Glutamate receptor ionotropic, NMDA 3B",GRIN3B,1043.0
1793,DB00290,Bleomycin,SmallMoleculeDrug,P18858,DNA ligase 1,LIG1,919.0
1794,DB00290,Bleomycin,SmallMoleculeDrug,P49916,DNA ligase 3,LIG3,1009.0
1795,DB00292,Etomidate,SmallMoleculeDrug,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,456.0
1796,DB00292,Etomidate,SmallMoleculeDrug,P18089,Alpha-2B adrenergic receptor,ADRA2B,450.0
1797,DB00292,Etomidate,SmallMoleculeDrug,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,456.0
1798,DB00292,Etomidate,SmallMoleculeDrug,P47869,Gamma-aminobutyric acid receptor subunit alpha-2,GABRA2,451.0
1799,DB00292,Etomidate,SmallMoleculeDrug,P34903,Gamma-aminobutyric acid receptor subunit alpha-3,GABRA3,492.0
1800,DB00292,Etomidate,SmallMoleculeDrug,P48169,Gamma-aminobutyric acid receptor subunit alpha-4,GABRA4,554.0
1801,DB00292,Etomidate,SmallMoleculeDrug,P31644,Gamma-aminobutyric acid receptor subunit alpha-5,GABRA5,462.0
1802,DB00292,Etomidate,SmallMoleculeDrug,Q16445,Gamma-aminobutyric acid receptor subunit alpha-6,GABRA6,453.0
1803,DB00292,Etomidate,SmallMoleculeDrug,P18505,Gamma-aminobutyric acid receptor subunit beta-1,GABRB1,474.0
1804,DB00292,Etomidate,SmallMoleculeDrug,P47870,Gamma-aminobutyric acid receptor subunit beta-2,GABRB2,512.0
1805,DB00292,Etomidate,SmallMoleculeDrug,P28472,Gamma-aminobutyric acid receptor subunit beta-3,GABRB3,473.0
1806,DB00292,Etomidate,SmallMoleculeDrug,O14764,Gamma-aminobutyric acid receptor subunit delta,GABRD,452.0
1807,DB00292,Etomidate,SmallMoleculeDrug,P78334,Gamma-aminobutyric acid receptor subunit epsilon,GABRE,506.0
1808,DB00292,Etomidate,SmallMoleculeDrug,Q8N1C3,Gamma-aminobutyric acid receptor subunit gamma-1,GABRG1,465.0
1809,DB00292,Etomidate,SmallMoleculeDrug,P18507,Gamma-aminobutyric acid receptor subunit gamma-2,GABRG2,467.0
1810,DB00292,Etomidate,SmallMoleculeDrug,Q99928,Gamma-aminobutyric acid receptor subunit gamma-3,GABRG3,467.0
1811,DB00292,Etomidate,SmallMoleculeDrug,O00591,Gamma-aminobutyric acid receptor subunit pi,GABRP,440.0
1812,DB00292,Etomidate,SmallMoleculeDrug,Q9UN88,Gamma-aminobutyric acid receptor subunit theta,GABRQ,632.0
1813,DB00293,Raltitrexed,SmallMoleculeDrug,P04818,Thymidylate synthase,TYMS,313.0
1814,DB00293,Raltitrexed,SmallMoleculeDrug,Q05932,"Folylpolyglutamate synthase, mitochondrial",FPGS,587.0
1815,DB00294,Etonogestrel,SmallMoleculeDrug,P06401,Progesterone receptor,PGR,933.0
1816,DB00294,Etonogestrel,SmallMoleculeDrug,P03372,Estrogen receptor,ESR1,595.0
1817,DB00295,Morphine,SmallMoleculeDrug,P35372,Mu-type opioid receptor,OPRM1,400.0
1818,DB00295,Morphine,SmallMoleculeDrug,P41145,Kappa-type opioid receptor,OPRK1,380.0
1819,DB00295,Morphine,SmallMoleculeDrug,P41143,Delta-type opioid receptor,OPRD1,372.0
1820,DB00296,Ropivacaine,SmallMoleculeDrug,Q9Y5Y9,Sodium channel protein type 10 subunit alpha,SCN10A,1956.0
1821,DB00297,Bupivacaine,SmallMoleculeDrug,Q9Y5Y9,Sodium channel protein type 10 subunit alpha,SCN10A,1956.0
1822,DB00297,Bupivacaine,SmallMoleculeDrug,P34995,Prostaglandin E2 receptor EP1 subtype,PTGER1,402.0
1823,DB00298,Dapiprazole,SmallMoleculeDrug,P35348,Alpha-1A adrenergic receptor,ADRA1A,466.0
1824,DB00298,Dapiprazole,SmallMoleculeDrug,P25100,Alpha-1D adrenergic receptor,ADRA1D,572.0
1825,DB00298,Dapiprazole,SmallMoleculeDrug,P35368,Alpha-1B adrenergic receptor,ADRA1B,520.0
1830,DB00302,Tranexamic Acid,SmallMoleculeDrug,P00747,Plasminogen,PLG,810.0
1839,DB00304,Desogestrel,SmallMoleculeDrug,P06401,Progesterone receptor,PGR,933.0
1840,DB00304,Desogestrel,SmallMoleculeDrug,P03372,Estrogen receptor,ESR1,595.0
1841,DB00306,Talbutal,SmallMoleculeDrug,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,456.0
1842,DB00306,Talbutal,SmallMoleculeDrug,P47869,Gamma-aminobutyric acid receptor subunit alpha-2,GABRA2,451.0
1843,DB00306,Talbutal,SmallMoleculeDrug,P34903,Gamma-aminobutyric acid receptor subunit alpha-3,GABRA3,492.0
1844,DB00306,Talbutal,SmallMoleculeDrug,P48169,Gamma-aminobutyric acid receptor subunit alpha-4,GABRA4,554.0
1845,DB00306,Talbutal,SmallMoleculeDrug,P31644,Gamma-aminobutyric acid receptor subunit alpha-5,GABRA5,462.0
1846,DB00306,Talbutal,SmallMoleculeDrug,Q16445,Gamma-aminobutyric acid receptor subunit alpha-6,GABRA6,453.0
1847,DB00306,Talbutal,SmallMoleculeDrug,P43681,Neuronal acetylcholine receptor subunit alpha-4,CHRNA4,627.0
1848,DB00306,Talbutal,SmallMoleculeDrug,P36544,Neuronal acetylcholine receptor subunit alpha-7,CHRNA7,502.0
1849,DB00306,Talbutal,SmallMoleculeDrug,P42262,Glutamate receptor 2,GRIA2,883.0
1850,DB00306,Talbutal,SmallMoleculeDrug,Q13002,"Glutamate receptor ionotropic, kainate 2",GRIK2,908.0
1851,DB00306,Talbutal,SmallMoleculeDrug,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,456.0
1852,DB00306,Talbutal,SmallMoleculeDrug,P47869,Gamma-aminobutyric acid receptor subunit alpha-2,GABRA2,451.0
1853,DB00306,Talbutal,SmallMoleculeDrug,P34903,Gamma-aminobutyric acid receptor subunit alpha-3,GABRA3,492.0
1854,DB00306,Talbutal,SmallMoleculeDrug,P48169,Gamma-aminobutyric acid receptor subunit alpha-4,GABRA4,554.0
1855,DB00306,Talbutal,SmallMoleculeDrug,P31644,Gamma-aminobutyric acid receptor subunit alpha-5,GABRA5,462.0
1856,DB00306,Talbutal,SmallMoleculeDrug,Q16445,Gamma-aminobutyric acid receptor subunit alpha-6,GABRA6,453.0
1857,DB00306,Talbutal,SmallMoleculeDrug,P18505,Gamma-aminobutyric acid receptor subunit beta-1,GABRB1,474.0
1858,DB00306,Talbutal,SmallMoleculeDrug,P47870,Gamma-aminobutyric acid receptor subunit beta-2,GABRB2,512.0
1859,DB00306,Talbutal,SmallMoleculeDrug,P28472,Gamma-aminobutyric acid receptor subunit beta-3,GABRB3,473.0
1860,DB00306,Talbutal,SmallMoleculeDrug,O14764,Gamma-aminobutyric acid receptor subunit delta,GABRD,452.0
1861,DB00306,Talbutal,SmallMoleculeDrug,P78334,Gamma-aminobutyric acid receptor subunit epsilon,GABRE,506.0
1862,DB00306,Talbutal,SmallMoleculeDrug,Q8N1C3,Gamma-aminobutyric acid receptor subunit gamma-1,GABRG1,465.0
1863,DB00306,Talbutal,SmallMoleculeDrug,P18507,Gamma-aminobutyric acid receptor subunit gamma-2,GABRG2,467.0
1864,DB00306,Talbutal,SmallMoleculeDrug,Q99928,Gamma-aminobutyric acid receptor subunit gamma-3,GABRG3,467.0
1865,DB00306,Talbutal,SmallMoleculeDrug,O00591,Gamma-aminobutyric acid receptor subunit pi,GABRP,440.0
1866,DB00306,Talbutal,SmallMoleculeDrug,Q9UN88,Gamma-aminobutyric acid receptor subunit theta,GABRQ,632.0
1867,DB00307,Bexarotene,SmallMoleculeDrug,P19793,Retinoic acid receptor RXR-alpha,RXRA,462.0
1868,DB00307,Bexarotene,SmallMoleculeDrug,P28702,Retinoic acid receptor RXR-beta,RXRB,533.0
1869,DB00307,Bexarotene,SmallMoleculeDrug,P48443,Retinoic acid receptor RXR-gamma,RXRG,463.0
1870,DB00308,Ibutilide,SmallMoleculeDrug,Q13936,Voltage-dependent L-type calcium channel subunit alpha-1C,CACNA1C,2221.0
1871,DB00308,Ibutilide,SmallMoleculeDrug,Q02641,Voltage-dependent L-type calcium channel subunit beta-1,CACNB1,598.0
1872,DB00308,Ibutilide,SmallMoleculeDrug,Q12809,Potassium voltage-gated channel subfamily H member 2,KCNH2,1159.0
1873,DB00308,Ibutilide,SmallMoleculeDrug,P54289,Voltage-dependent calcium channel subunit alpha-2/delta-1,CACNA2D1,1103.0
1874,DB00308,Ibutilide,SmallMoleculeDrug,Q06432,Voltage-dependent calcium channel gamma-1 subunit,CACNG1,222.0
1875,DB00308,Ibutilide,SmallMoleculeDrug,O00180,Potassium channel subfamily K member 1,KCNK1,336.0
1876,DB00308,Ibutilide,SmallMoleculeDrug,Q9Y257,Potassium channel subfamily K member 6,KCNK6,313.0
1877,DB00308,Ibutilide,SmallMoleculeDrug,Q9H252,Potassium voltage-gated channel subfamily H member 6,KCNH6,994.0
1878,DB00308,Ibutilide,SmallMoleculeDrug,Q9NS40,Potassium voltage-gated channel subfamily H member 7,KCNH7,1196.0
1879,DB00308,Ibutilide,SmallMoleculeDrug,Q14654,ATP-sensitive inward rectifier potassium channel 11,KCNJ11,390.0
1880,DB00309,Vindesine,SmallMoleculeDrug,Q9H4B7,Tubulin beta-1 chain,TUBB1,451.0
1881,DB00310,Chlorthalidone,SmallMoleculeDrug,Q13621,Solute carrier family 12 member 1,SLC12A1,1099.0
1882,DB00311,Ethoxzolamide,SmallMoleculeDrug,P00915,Carbonic anhydrase 1,CA1,261.0
1883,DB00311,Ethoxzolamide,SmallMoleculeDrug,P00918,Carbonic anhydrase 2,CA2,260.0
1884,DB00311,Ethoxzolamide,SmallMoleculeDrug,P22748,Carbonic anhydrase 4,CA4,312.0
1885,DB00311,Ethoxzolamide,SmallMoleculeDrug,P43166,Carbonic anhydrase 7,CA7,264.0
1886,DB00312,Pentobarbital,SmallMoleculeDrug,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,456.0
1887,DB00312,Pentobarbital,SmallMoleculeDrug,P47869,Gamma-aminobutyric acid receptor subunit alpha-2,GABRA2,451.0
1888,DB00312,Pentobarbital,SmallMoleculeDrug,P34903,Gamma-aminobutyric acid receptor subunit alpha-3,GABRA3,492.0
1889,DB00312,Pentobarbital,SmallMoleculeDrug,P48169,Gamma-aminobutyric acid receptor subunit alpha-4,GABRA4,554.0
1890,DB00312,Pentobarbital,SmallMoleculeDrug,P31644,Gamma-aminobutyric acid receptor subunit alpha-5,GABRA5,462.0
1891,DB00312,Pentobarbital,SmallMoleculeDrug,Q16445,Gamma-aminobutyric acid receptor subunit alpha-6,GABRA6,453.0
1892,DB00312,Pentobarbital,SmallMoleculeDrug,P43681,Neuronal acetylcholine receptor subunit alpha-4,CHRNA4,627.0
1893,DB00312,Pentobarbital,SmallMoleculeDrug,P36544,Neuronal acetylcholine receptor subunit alpha-7,CHRNA7,502.0
1894,DB00312,Pentobarbital,SmallMoleculeDrug,P42262,Glutamate receptor 2,GRIA2,883.0
1895,DB00312,Pentobarbital,SmallMoleculeDrug,Q13002,"Glutamate receptor ionotropic, kainate 2",GRIK2,908.0
1896,DB00312,Pentobarbital,SmallMoleculeDrug,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,456.0
1897,DB00312,Pentobarbital,SmallMoleculeDrug,P47869,Gamma-aminobutyric acid receptor subunit alpha-2,GABRA2,451.0
1898,DB00312,Pentobarbital,SmallMoleculeDrug,P34903,Gamma-aminobutyric acid receptor subunit alpha-3,GABRA3,492.0
1899,DB00312,Pentobarbital,SmallMoleculeDrug,P48169,Gamma-aminobutyric acid receptor subunit alpha-4,GABRA4,554.0
1900,DB00312,Pentobarbital,SmallMoleculeDrug,P31644,Gamma-aminobutyric acid receptor subunit alpha-5,GABRA5,462.0
1901,DB00312,Pentobarbital,SmallMoleculeDrug,Q16445,Gamma-aminobutyric acid receptor subunit alpha-6,GABRA6,453.0
1902,DB00312,Pentobarbital,SmallMoleculeDrug,P18505,Gamma-aminobutyric acid receptor subunit beta-1,GABRB1,474.0
1903,DB00312,Pentobarbital,SmallMoleculeDrug,P47870,Gamma-aminobutyric acid receptor subunit beta-2,GABRB2,512.0
1904,DB00312,Pentobarbital,SmallMoleculeDrug,P28472,Gamma-aminobutyric acid receptor subunit beta-3,GABRB3,473.0
1905,DB00312,Pentobarbital,SmallMoleculeDrug,O14764,Gamma-aminobutyric acid receptor subunit delta,GABRD,452.0
1906,DB00312,Pentobarbital,SmallMoleculeDrug,P78334,Gamma-aminobutyric acid receptor subunit epsilon,GABRE,506.0
1907,DB00312,Pentobarbital,SmallMoleculeDrug,Q8N1C3,Gamma-aminobutyric acid receptor subunit gamma-1,GABRG1,465.0
1908,DB00312,Pentobarbital,SmallMoleculeDrug,P18507,Gamma-aminobutyric acid receptor subunit gamma-2,GABRG2,467.0
1909,DB00312,Pentobarbital,SmallMoleculeDrug,Q99928,Gamma-aminobutyric acid receptor subunit gamma-3,GABRG3,467.0
1910,DB00312,Pentobarbital,SmallMoleculeDrug,O00591,Gamma-aminobutyric acid receptor subunit pi,GABRP,440.0
1911,DB00312,Pentobarbital,SmallMoleculeDrug,Q9UN88,Gamma-aminobutyric acid receptor subunit theta,GABRQ,632.0
1912,DB00312,Pentobarbital,SmallMoleculeDrug,Q05586,"Glutamate receptor ionotropic, NMDA 1",GRIN1,938.0
1913,DB00312,Pentobarbital,SmallMoleculeDrug,Q12879,"Glutamate receptor ionotropic, NMDA 2A",GRIN2A,1464.0
1914,DB00312,Pentobarbital,SmallMoleculeDrug,Q13224,"Glutamate receptor ionotropic, NMDA 2B",GRIN2B,1484.0
1915,DB00312,Pentobarbital,SmallMoleculeDrug,Q14957,"Glutamate receptor ionotropic, NMDA 2C",GRIN2C,1233.0
1916,DB00312,Pentobarbital,SmallMoleculeDrug,O15399,"Glutamate receptor ionotropic, NMDA 2D",GRIN2D,1336.0
1917,DB00312,Pentobarbital,SmallMoleculeDrug,Q8TCU5,"Glutamate receptor ionotropic, NMDA 3A",GRIN3A,1115.0
1918,DB00312,Pentobarbital,SmallMoleculeDrug,O60391,"Glutamate receptor ionotropic, NMDA 3B",GRIN3B,1043.0
1919,DB00313,Valproic Acid,SmallMoleculeDrug,Q9UKV0,Histone deacetylase 9,HDAC9,1011.0
1920,DB00313,Valproic Acid,SmallMoleculeDrug,P80404,"4-aminobutyrate aminotransferase, mitochondrial",ABAT,500.0
1921,DB00313,Valproic Acid,SmallMoleculeDrug,P45954,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",ACADSB,432.0
1922,DB00313,Valproic Acid,SmallMoleculeDrug,Q02218,"2-oxoglutarate dehydrogenase, mitochondrial",OGDH,1023.0
1923,DB00313,Valproic Acid,SmallMoleculeDrug,P51649,"Succinate-semialdehyde dehydrogenase, mitochondrial",ALDH5A1,535.0
1924,DB00313,Valproic Acid,SmallMoleculeDrug,P35498,Sodium channel protein type 1 subunit alpha,SCN1A,2009.0
1925,DB00313,Valproic Acid,SmallMoleculeDrug,Q9Y5Y9,Sodium channel protein type 10 subunit alpha,SCN10A,1956.0
1926,DB00313,Valproic Acid,SmallMoleculeDrug,Q9UI33,Sodium channel protein type 11 subunit alpha,SCN11A,1791.0
1927,DB00313,Valproic Acid,SmallMoleculeDrug,Q99250,Sodium channel protein type 2 subunit alpha,SCN2A,2005.0
1928,DB00313,Valproic Acid,SmallMoleculeDrug,Q9NY46,Sodium channel protein type 3 subunit alpha,SCN3A,2000.0
1929,DB00313,Valproic Acid,SmallMoleculeDrug,P35499,Sodium channel protein type 4 subunit alpha,SCN4A,1836.0
1930,DB00313,Valproic Acid,SmallMoleculeDrug,Q14524,Sodium channel protein type 5 subunit alpha,SCN5A,2016.0
1931,DB00313,Valproic Acid,SmallMoleculeDrug,Q01118,Sodium channel protein type 7 subunit alpha,SCN7A,1682.0
1932,DB00313,Valproic Acid,SmallMoleculeDrug,Q9UQD0,Sodium channel protein type 8 subunit alpha,SCN8A,1980.0
1933,DB00313,Valproic Acid,SmallMoleculeDrug,Q15858,Sodium channel protein type 9 subunit alpha,SCN9A,1988.0
1934,DB00313,Valproic Acid,SmallMoleculeDrug,Q07699,Sodium channel subunit beta-1,SCN1B,218.0
1935,DB00313,Valproic Acid,SmallMoleculeDrug,O60939,Sodium channel subunit beta-2,SCN2B,215.0
1936,DB00313,Valproic Acid,SmallMoleculeDrug,Q9NY72,Sodium channel subunit beta-3,SCN3B,215.0
1937,DB00313,Valproic Acid,SmallMoleculeDrug,Q8IWT1,Sodium channel subunit beta-4,SCN4B,228.0
1938,DB00313,Valproic Acid,SmallMoleculeDrug,Q92769,Histone deacetylase 2,HDAC2,488.0
1939,DB00315,Zolmitriptan,SmallMoleculeDrug,P28222,5-hydroxytryptamine receptor 1B,HTR1B,390.0
1940,DB00315,Zolmitriptan,SmallMoleculeDrug,P28221,5-hydroxytryptamine receptor 1D,HTR1D,377.0
1941,DB00315,Zolmitriptan,SmallMoleculeDrug,P30939,5-hydroxytryptamine receptor 1F,HTR1F,366.0
1942,DB00315,Zolmitriptan,SmallMoleculeDrug,P08908,5-hydroxytryptamine receptor 1A,HTR1A,422.0
1943,DB00316,Acetaminophen,SmallMoleculeDrug,P23219,Prostaglandin G/H synthase 1,PTGS1,599.0
1944,DB00316,Acetaminophen,SmallMoleculeDrug,P35354,Prostaglandin G/H synthase 2,PTGS2,604.0
1945,DB00316,Acetaminophen,SmallMoleculeDrug,O00519,Fatty-acid amide hydrolase 1,FAAH,579.0
1946,DB00316,Acetaminophen,SmallMoleculeDrug,Q8NER1,Transient receptor potential cation channel subfamily V member 1,TRPV1,839.0
1947,DB00317,Gefitinib,SmallMoleculeDrug,P00533,Epidermal growth factor receptor,EGFR,1210.0
1948,DB00318,Codeine,SmallMoleculeDrug,P35372,Mu-type opioid receptor,OPRM1,400.0
1949,DB00318,Codeine,SmallMoleculeDrug,P41145,Kappa-type opioid receptor,OPRK1,380.0
1950,DB00318,Codeine,SmallMoleculeDrug,P41143,Delta-type opioid receptor,OPRD1,372.0
1955,DB00320,Dihydroergotamine,SmallMoleculeDrug,P28221,5-hydroxytryptamine receptor 1D,HTR1D,377.0
1956,DB00320,Dihydroergotamine,SmallMoleculeDrug,P28222,5-hydroxytryptamine receptor 1B,HTR1B,390.0
1957,DB00320,Dihydroergotamine,SmallMoleculeDrug,P08913,Alpha-2A adrenergic receptor,ADRA2A,450.0
1958,DB00320,Dihydroergotamine,SmallMoleculeDrug,P41595,5-hydroxytryptamine receptor 2B,HTR2B,481.0
1959,DB00321,Amitriptyline,SmallMoleculeDrug,P23975,Sodium-dependent noradrenaline transporter,SLC6A2,617.0
1960,DB00321,Amitriptyline,SmallMoleculeDrug,P31645,Sodium-dependent serotonin transporter,SLC6A4,630.0
1961,DB00321,Amitriptyline,SmallMoleculeDrug,P28223,5-hydroxytryptamine receptor 2A,HTR2A,471.0
1962,DB00321,Amitriptyline,SmallMoleculeDrug,P08908,5-hydroxytryptamine receptor 1A,HTR1A,422.0
1963,DB00321,Amitriptyline,SmallMoleculeDrug,P41143,Delta-type opioid receptor,OPRD1,372.0
1964,DB00321,Amitriptyline,SmallMoleculeDrug,P41145,Kappa-type opioid receptor,OPRK1,380.0
1965,DB00321,Amitriptyline,SmallMoleculeDrug,P04629,High affinity nerve growth factor receptor,NTRK1,796.0
1966,DB00321,Amitriptyline,SmallMoleculeDrug,Q16620,BDNF/NT-3 growth factors receptor,NTRK2,822.0
1967,DB00321,Amitriptyline,SmallMoleculeDrug,P35348,Alpha-1A adrenergic receptor,ADRA1A,466.0
1968,DB00321,Amitriptyline,SmallMoleculeDrug,P25100,Alpha-1D adrenergic receptor,ADRA1D,572.0
1969,DB00321,Amitriptyline,SmallMoleculeDrug,P08913,Alpha-2A adrenergic receptor,ADRA2A,450.0
1970,DB00321,Amitriptyline,SmallMoleculeDrug,P35367,Histamine H1 receptor,HRH1,487.0
1971,DB00321,Amitriptyline,SmallMoleculeDrug,P11229,Muscarinic acetylcholine receptor M1,CHRM1,460.0
1972,DB00321,Amitriptyline,SmallMoleculeDrug,P08172,Muscarinic acetylcholine receptor M2,CHRM2,466.0
1973,DB00321,Amitriptyline,SmallMoleculeDrug,P20309,Muscarinic acetylcholine receptor M3,CHRM3,590.0
1974,DB00321,Amitriptyline,SmallMoleculeDrug,P08173,Muscarinic acetylcholine receptor M4,CHRM4,479.0
1975,DB00321,Amitriptyline,SmallMoleculeDrug,P08912,Muscarinic acetylcholine receptor M5,CHRM5,532.0
1976,DB00321,Amitriptyline,SmallMoleculeDrug,O43526,Potassium voltage-gated channel subfamily KQT member 2,KCNQ2,872.0
1977,DB00321,Amitriptyline,SmallMoleculeDrug,Q09470,Potassium voltage-gated channel subfamily A member 1,KCNA1,495.0
1978,DB00321,Amitriptyline,SmallMoleculeDrug,Q9NZV8,Potassium voltage-gated channel subfamily D member 2,KCND2,630.0
1979,DB00321,Amitriptyline,SmallMoleculeDrug,Q9UK17,Potassium voltage-gated channel subfamily D member 3,KCND3,655.0
1980,DB00321,Amitriptyline,SmallMoleculeDrug,P25021,Histamine H2 receptor,HRH2,359.0
1981,DB00321,Amitriptyline,SmallMoleculeDrug,Q9H3N8,Histamine H4 receptor,HRH4,390.0
1982,DB00321,Amitriptyline,SmallMoleculeDrug,Q99720,Sigma non-opioid intracellular receptor 1,SIGMAR1,223.0
1983,DB00321,Amitriptyline,SmallMoleculeDrug,P28335,5-hydroxytryptamine receptor 2C,HTR2C,458.0
1984,DB00321,Amitriptyline,SmallMoleculeDrug,P35368,Alpha-1B adrenergic receptor,ADRA1B,520.0
1985,DB00321,Amitriptyline,SmallMoleculeDrug,P34969,5-hydroxytryptamine receptor 7,HTR7,479.0
1986,DB00321,Amitriptyline,SmallMoleculeDrug,P28221,5-hydroxytryptamine receptor 1D,HTR1D,377.0
1987,DB00321,Amitriptyline,SmallMoleculeDrug,P35372,Mu-type opioid receptor,OPRM1,400.0
1988,DB00321,Amitriptyline,SmallMoleculeDrug,P28222,5-hydroxytryptamine receptor 1B,HTR1B,390.0
1989,DB00321,Amitriptyline,SmallMoleculeDrug,P50406,5-hydroxytryptamine receptor 6,HTR6,440.0
1990,DB00321,Amitriptyline,SmallMoleculeDrug,O43525,Potassium voltage-gated channel subfamily KQT member 3,KCNQ3,872.0
1991,DB00321,Amitriptyline,SmallMoleculeDrug,P08588,Beta-1 adrenergic receptor,ADRB1,477.0
1992,DB00321,Amitriptyline,SmallMoleculeDrug,P07550,Beta-2 adrenergic receptor,ADRB2,413.0
1993,DB00321,Amitriptyline,SmallMoleculeDrug,P13945,Beta-3 adrenergic receptor,ADRB3,408.0
1994,DB00322,Floxuridine,SmallMoleculeDrug,P04818,Thymidylate synthase,TYMS,313.0
1995,DB00323,Tolcapone,SmallMoleculeDrug,P21964,Catechol O-methyltransferase,COMT,271.0
1996,DB00324,Fluorometholone,SmallMoleculeDrug,P04150,Glucocorticoid receptor,NR3C1,777.0
1997,DB00325,Nitroprusside,SmallMoleculeDrug,P16066,Atrial natriuretic peptide receptor 1,NPR1,1061.0
1998,DB00327,Hydromorphone,SmallMoleculeDrug,P35372,Mu-type opioid receptor,OPRM1,400.0
1999,DB00327,Hydromorphone,SmallMoleculeDrug,P41143,Delta-type opioid receptor,OPRD1,372.0
2000,DB00327,Hydromorphone,SmallMoleculeDrug,P41145,Kappa-type opioid receptor,OPRK1,380.0
2001,DB00328,Indomethacin,SmallMoleculeDrug,P23219,Prostaglandin G/H synthase 1,PTGS1,599.0
2002,DB00328,Indomethacin,SmallMoleculeDrug,P35354,Prostaglandin G/H synthase 2,PTGS2,604.0
2003,DB00328,Indomethacin,SmallMoleculeDrug,P14555,"Phospholipase A2, membrane associated",PLA2G2A,144.0
2004,DB00328,Indomethacin,SmallMoleculeDrug,Q8N8N7,Prostaglandin reductase 2,PTGR2,351.0
2005,DB00328,Indomethacin,SmallMoleculeDrug,P37231,Peroxisome proliferator-activated receptor gamma,PPARG,505.0
2006,DB00328,Indomethacin,SmallMoleculeDrug,Q04760,Lactoylglutathione lyase,GLO1,184.0
2007,DB00328,Indomethacin,SmallMoleculeDrug,Q9Y5Y4,Prostaglandin D2 receptor 2,PTGDR2,395.0
2008,DB00328,Indomethacin,SmallMoleculeDrug,Q07869,Peroxisome proliferator-activated receptor alpha,PPARA,468.0
2012,DB00331,Metformin,SmallMoleculeDrug,Q9Y478,5'-AMP-activated protein kinase subunit beta-1,PRKAB1,270.0
2013,DB00332,Ipratropium bromide,SmallMoleculeDrug,P11229,Muscarinic acetylcholine receptor M1,CHRM1,460.0
2014,DB00332,Ipratropium bromide,SmallMoleculeDrug,P08172,Muscarinic acetylcholine receptor M2,CHRM2,466.0
2015,DB00332,Ipratropium bromide,SmallMoleculeDrug,P20309,Muscarinic acetylcholine receptor M3,CHRM3,590.0
2016,DB00333,Methadone,SmallMoleculeDrug,P35372,Mu-type opioid receptor,OPRM1,400.0
2017,DB00333,Methadone,SmallMoleculeDrug,Q8TCU5,"Glutamate receptor ionotropic, NMDA 3A",GRIN3A,1115.0
2018,DB00333,Methadone,SmallMoleculeDrug,Q9GZZ6,Neuronal acetylcholine receptor subunit alpha-10,CHRNA10,450.0
2019,DB00333,Methadone,SmallMoleculeDrug,P41143,Delta-type opioid receptor,OPRD1,372.0
2020,DB00333,Methadone,SmallMoleculeDrug,P46098,5-hydroxytryptamine receptor 3A,HTR3A,478.0
2021,DB00334,Olanzapine,SmallMoleculeDrug,P28223,5-hydroxytryptamine receptor 2A,HTR2A,471.0
2022,DB00334,Olanzapine,SmallMoleculeDrug,P14416,D(2) dopamine receptor,DRD2,443.0
2023,DB00334,Olanzapine,SmallMoleculeDrug,P21728,D(1A) dopamine receptor,DRD1,446.0
2024,DB00334,Olanzapine,SmallMoleculeDrug,P21918,D(1B) dopamine receptor,DRD5,477.0
2025,DB00334,Olanzapine,SmallMoleculeDrug,P35462,D(3) dopamine receptor,DRD3,400.0
2026,DB00334,Olanzapine,SmallMoleculeDrug,P21917,D(4) dopamine receptor,DRD4,467.0
2027,DB00334,Olanzapine,SmallMoleculeDrug,P08908,5-hydroxytryptamine receptor 1A,HTR1A,422.0
2028,DB00334,Olanzapine,SmallMoleculeDrug,P28222,5-hydroxytryptamine receptor 1B,HTR1B,390.0
2029,DB00334,Olanzapine,SmallMoleculeDrug,P28221,5-hydroxytryptamine receptor 1D,HTR1D,377.0
2030,DB00334,Olanzapine,SmallMoleculeDrug,P28566,5-hydroxytryptamine receptor 1E,HTR1E,365.0
2031,DB00334,Olanzapine,SmallMoleculeDrug,P28335,5-hydroxytryptamine receptor 2C,HTR2C,458.0
2032,DB00334,Olanzapine,SmallMoleculeDrug,P46098,5-hydroxytryptamine receptor 3A,HTR3A,478.0
2033,DB00334,Olanzapine,SmallMoleculeDrug,P50406,5-hydroxytryptamine receptor 6,HTR6,440.0
2034,DB00334,Olanzapine,SmallMoleculeDrug,P34969,5-hydroxytryptamine receptor 7,HTR7,479.0
2035,DB00334,Olanzapine,SmallMoleculeDrug,P35367,Histamine H1 receptor,HRH1,487.0
2036,DB00334,Olanzapine,SmallMoleculeDrug,P35348,Alpha-1A adrenergic receptor,ADRA1A,466.0
2037,DB00334,Olanzapine,SmallMoleculeDrug,P35368,Alpha-1B adrenergic receptor,ADRA1B,520.0
2038,DB00334,Olanzapine,SmallMoleculeDrug,P08913,Alpha-2A adrenergic receptor,ADRA2A,450.0
2039,DB00334,Olanzapine,SmallMoleculeDrug,P18089,Alpha-2B adrenergic receptor,ADRA2B,450.0
2040,DB00334,Olanzapine,SmallMoleculeDrug,P18825,Alpha-2C adrenergic receptor,ADRA2C,462.0
2041,DB00334,Olanzapine,SmallMoleculeDrug,P11229,Muscarinic acetylcholine receptor M1,CHRM1,460.0
2042,DB00334,Olanzapine,SmallMoleculeDrug,P08172,Muscarinic acetylcholine receptor M2,CHRM2,466.0
2043,DB00334,Olanzapine,SmallMoleculeDrug,P20309,Muscarinic acetylcholine receptor M3,CHRM3,590.0
2044,DB00334,Olanzapine,SmallMoleculeDrug,P08173,Muscarinic acetylcholine receptor M4,CHRM4,479.0
2045,DB00334,Olanzapine,SmallMoleculeDrug,P08912,Muscarinic acetylcholine receptor M5,CHRM5,532.0
2046,DB00334,Olanzapine,SmallMoleculeDrug,P41595,5-hydroxytryptamine receptor 2B,HTR2B,481.0
2047,DB00334,Olanzapine,SmallMoleculeDrug,P47898,5-hydroxytryptamine receptor 5A,HTR5A,357.0
2048,DB00334,Olanzapine,SmallMoleculeDrug,P21728,D(1A) dopamine receptor,DRD1,446.0
2049,DB00334,Olanzapine,SmallMoleculeDrug,P21918,D(1B) dopamine receptor,DRD5,477.0
2050,DB00334,Olanzapine,SmallMoleculeDrug,P25021,Histamine H2 receptor,HRH2,359.0
2051,DB00334,Olanzapine,SmallMoleculeDrug,Q9H3N8,Histamine H4 receptor,HRH4,390.0
2052,DB00334,Olanzapine,SmallMoleculeDrug,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,456.0
2053,DB00334,Olanzapine,SmallMoleculeDrug,P47869,Gamma-aminobutyric acid receptor subunit alpha-2,GABRA2,451.0
2054,DB00334,Olanzapine,SmallMoleculeDrug,P34903,Gamma-aminobutyric acid receptor subunit alpha-3,GABRA3,492.0
2055,DB00334,Olanzapine,SmallMoleculeDrug,P48169,Gamma-aminobutyric acid receptor subunit alpha-4,GABRA4,554.0
2056,DB00334,Olanzapine,SmallMoleculeDrug,P31644,Gamma-aminobutyric acid receptor subunit alpha-5,GABRA5,462.0
2057,DB00334,Olanzapine,SmallMoleculeDrug,Q16445,Gamma-aminobutyric acid receptor subunit alpha-6,GABRA6,453.0
2058,DB00334,Olanzapine,SmallMoleculeDrug,P18505,Gamma-aminobutyric acid receptor subunit beta-1,GABRB1,474.0
2059,DB00334,Olanzapine,SmallMoleculeDrug,P47870,Gamma-aminobutyric acid receptor subunit beta-2,GABRB2,512.0
2060,DB00334,Olanzapine,SmallMoleculeDrug,P28472,Gamma-aminobutyric acid receptor subunit beta-3,GABRB3,473.0
2061,DB00334,Olanzapine,SmallMoleculeDrug,O14764,Gamma-aminobutyric acid receptor subunit delta,GABRD,452.0
2062,DB00334,Olanzapine,SmallMoleculeDrug,P78334,Gamma-aminobutyric acid receptor subunit epsilon,GABRE,506.0
2063,DB00334,Olanzapine,SmallMoleculeDrug,Q8N1C3,Gamma-aminobutyric acid receptor subunit gamma-1,GABRG1,465.0
2064,DB00334,Olanzapine,SmallMoleculeDrug,P18507,Gamma-aminobutyric acid receptor subunit gamma-2,GABRG2,467.0
2065,DB00334,Olanzapine,SmallMoleculeDrug,Q99928,Gamma-aminobutyric acid receptor subunit gamma-3,GABRG3,467.0
2066,DB00334,Olanzapine,SmallMoleculeDrug,O00591,Gamma-aminobutyric acid receptor subunit pi,GABRP,440.0
2067,DB00334,Olanzapine,SmallMoleculeDrug,Q9UN88,Gamma-aminobutyric acid receptor subunit theta,GABRQ,632.0
2068,DB00334,Olanzapine,SmallMoleculeDrug,P08588,Beta-1 adrenergic receptor,ADRB1,477.0
2069,DB00334,Olanzapine,SmallMoleculeDrug,P07550,Beta-2 adrenergic receptor,ADRB2,413.0
2070,DB00334,Olanzapine,SmallMoleculeDrug,P13945,Beta-3 adrenergic receptor,ADRB3,408.0
2071,DB00335,Atenolol,SmallMoleculeDrug,P08588,Beta-1 adrenergic receptor,ADRB1,477.0
2072,DB00335,Atenolol,SmallMoleculeDrug,P07550,Beta-2 adrenergic receptor,ADRB2,413.0
2077,DB00337,Pimecrolimus,SmallMoleculeDrug,P42345,Serine/threonine-protein kinase mTOR,MTOR,2549.0
2078,DB00337,Pimecrolimus,SmallMoleculeDrug,P62942,Peptidyl-prolyl cis-trans isomerase FKBP1A,FKBP1A,108.0
2079,DB00338,Omeprazole,SmallMoleculeDrug,P20648,Potassium-transporting ATPase alpha chain 1,ATP4A,1035.0
2080,DB00340,Metixene,SmallMoleculeDrug,P11229,Muscarinic acetylcholine receptor M1,CHRM1,460.0
2081,DB00340,Metixene,SmallMoleculeDrug,P08173,Muscarinic acetylcholine receptor M4,CHRM4,479.0
2082,DB00340,Metixene,SmallMoleculeDrug,P08912,Muscarinic acetylcholine receptor M5,CHRM5,532.0
2083,DB00340,Metixene,SmallMoleculeDrug,P08172,Muscarinic acetylcholine receptor M2,CHRM2,466.0
2084,DB00340,Metixene,SmallMoleculeDrug,P20309,Muscarinic acetylcholine receptor M3,CHRM3,590.0
2085,DB00341,Cetirizine,SmallMoleculeDrug,P35367,Histamine H1 receptor,HRH1,487.0
2086,DB00342,Terfenadine,SmallMoleculeDrug,P35367,Histamine H1 receptor,HRH1,487.0
2087,DB00342,Terfenadine,SmallMoleculeDrug,Q12809,Potassium voltage-gated channel subfamily H member 2,KCNH2,1159.0
2088,DB00342,Terfenadine,SmallMoleculeDrug,P20309,Muscarinic acetylcholine receptor M3,CHRM3,590.0
2089,DB00342,Terfenadine,SmallMoleculeDrug,P11229,Muscarinic acetylcholine receptor M1,CHRM1,460.0
2090,DB00342,Terfenadine,SmallMoleculeDrug,P08912,Muscarinic acetylcholine receptor M5,CHRM5,532.0
2091,DB00342,Terfenadine,SmallMoleculeDrug,P08173,Muscarinic acetylcholine receptor M4,CHRM4,479.0
2092,DB00342,Terfenadine,SmallMoleculeDrug,P08172,Muscarinic acetylcholine receptor M2,CHRM2,466.0
2093,DB00343,Diltiazem,SmallMoleculeDrug,Q06432,Voltage-dependent calcium channel gamma-1 subunit,CACNG1,222.0
2094,DB00344,Protriptyline,SmallMoleculeDrug,P23975,Sodium-dependent noradrenaline transporter,SLC6A2,617.0
2095,DB00344,Protriptyline,SmallMoleculeDrug,P31645,Sodium-dependent serotonin transporter,SLC6A4,630.0
2096,DB00346,Alfuzosin,SmallMoleculeDrug,P35348,Alpha-1A adrenergic receptor,ADRA1A,466.0
2097,DB00346,Alfuzosin,SmallMoleculeDrug,P35368,Alpha-1B adrenergic receptor,ADRA1B,520.0
2098,DB00346,Alfuzosin,SmallMoleculeDrug,P25100,Alpha-1D adrenergic receptor,ADRA1D,572.0
2099,DB00346,Alfuzosin,SmallMoleculeDrug,Q12809,Potassium voltage-gated channel subfamily H member 2,KCNH2,1159.0
2100,DB00347,Trimethadione,SmallMoleculeDrug,O43497,Voltage-dependent T-type calcium channel subunit alpha-1G,CACNA1G,2377.0
2101,DB00348,Nitisinone,SmallMoleculeDrug,P32754,4-hydroxyphenylpyruvate dioxygenase,HPD,393.0
2102,DB00349,Clobazam,SmallMoleculeDrug,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,456.0
2103,DB00349,Clobazam,SmallMoleculeDrug,P47869,Gamma-aminobutyric acid receptor subunit alpha-2,GABRA2,451.0
2104,DB00349,Clobazam,SmallMoleculeDrug,P34903,Gamma-aminobutyric acid receptor subunit alpha-3,GABRA3,492.0
2105,DB00349,Clobazam,SmallMoleculeDrug,P48169,Gamma-aminobutyric acid receptor subunit alpha-4,GABRA4,554.0
2106,DB00349,Clobazam,SmallMoleculeDrug,P31644,Gamma-aminobutyric acid receptor subunit alpha-5,GABRA5,462.0
2107,DB00349,Clobazam,SmallMoleculeDrug,Q16445,Gamma-aminobutyric acid receptor subunit alpha-6,GABRA6,453.0
2108,DB00349,Clobazam,SmallMoleculeDrug,P18505,Gamma-aminobutyric acid receptor subunit beta-1,GABRB1,474.0
2109,DB00349,Clobazam,SmallMoleculeDrug,P47870,Gamma-aminobutyric acid receptor subunit beta-2,GABRB2,512.0
2110,DB00349,Clobazam,SmallMoleculeDrug,P28472,Gamma-aminobutyric acid receptor subunit beta-3,GABRB3,473.0
2111,DB00349,Clobazam,SmallMoleculeDrug,O14764,Gamma-aminobutyric acid receptor subunit delta,GABRD,452.0
2112,DB00349,Clobazam,SmallMoleculeDrug,P78334,Gamma-aminobutyric acid receptor subunit epsilon,GABRE,506.0
2113,DB00349,Clobazam,SmallMoleculeDrug,Q8N1C3,Gamma-aminobutyric acid receptor subunit gamma-1,GABRG1,465.0
2114,DB00349,Clobazam,SmallMoleculeDrug,P18507,Gamma-aminobutyric acid receptor subunit gamma-2,GABRG2,467.0
2115,DB00349,Clobazam,SmallMoleculeDrug,Q99928,Gamma-aminobutyric acid receptor subunit gamma-3,GABRG3,467.0
2116,DB00349,Clobazam,SmallMoleculeDrug,O00591,Gamma-aminobutyric acid receptor subunit pi,GABRP,440.0
2117,DB00349,Clobazam,SmallMoleculeDrug,Q9UN88,Gamma-aminobutyric acid receptor subunit theta,GABRQ,632.0
2118,DB00350,Minoxidil,SmallMoleculeDrug,P48048,ATP-sensitive inward rectifier potassium channel 1,KCNJ1,391.0
2119,DB00350,Minoxidil,SmallMoleculeDrug,P23219,Prostaglandin G/H synthase 1,PTGS1,599.0
2120,DB00351,Megestrol acetate,SmallMoleculeDrug,P06401,Progesterone receptor,PGR,933.0
2121,DB00351,Megestrol acetate,SmallMoleculeDrug,P04150,Glucocorticoid receptor,NR3C1,777.0
2122,DB00353,Methylergometrine,SmallMoleculeDrug,P21728,D(1A) dopamine receptor,DRD1,446.0
2123,DB00354,Buclizine,SmallMoleculeDrug,P35367,Histamine H1 receptor,HRH1,487.0
2124,DB00354,Buclizine,SmallMoleculeDrug,P11229,Muscarinic acetylcholine receptor M1,CHRM1,460.0
2127,DB00356,Chlorzoxazone,SmallMoleculeDrug,Q12791,Calcium-activated potassium channel subunit alpha-1,KCNMA1,1236.0
2128,DB00357,Aminoglutethimide,SmallMoleculeDrug,P11511,Aromatase,CYP19A1,503.0
2129,DB00357,Aminoglutethimide,SmallMoleculeDrug,P05108,"Cholesterol side-chain cleavage enzyme, mitochondrial",CYP11A1,521.0
2130,DB00358,Mefloquine,SmallMoleculeDrug,P69905,Hemoglobin subunit alpha,HBA1;,142.0
2131,DB00358,Mefloquine,SmallMoleculeDrug,P29274,Adenosine receptor A2a,ADORA2A,412.0
2133,DB00360,Sapropterin,SmallMoleculeDrug,P29474,"Nitric oxide synthase, endothelial",NOS3,1203.0
2134,DB00360,Sapropterin,SmallMoleculeDrug,P00439,Phenylalanine-4-hydroxylase,PAH,452.0
2135,DB00360,Sapropterin,SmallMoleculeDrug,P07101,Tyrosine 3-monooxygenase,TH,528.0
2136,DB00360,Sapropterin,SmallMoleculeDrug,P17752,Tryptophan 5-hydroxylase 1,TPH1,444.0
2137,DB00361,Vinorelbine,SmallMoleculeDrug,P07437,Tubulin beta chain,TUBB,444.0
2139,DB00363,Clozapine,SmallMoleculeDrug,P14416,D(2) dopamine receptor,DRD2,443.0
2140,DB00363,Clozapine,SmallMoleculeDrug,P28223,5-hydroxytryptamine receptor 2A,HTR2A,471.0
2141,DB00363,Clozapine,SmallMoleculeDrug,P21728,D(1A) dopamine receptor,DRD1,446.0
2142,DB00363,Clozapine,SmallMoleculeDrug,P35462,D(3) dopamine receptor,DRD3,400.0
2143,DB00363,Clozapine,SmallMoleculeDrug,P21917,D(4) dopamine receptor,DRD4,467.0
2144,DB00363,Clozapine,SmallMoleculeDrug,P08908,5-hydroxytryptamine receptor 1A,HTR1A,422.0
2145,DB00363,Clozapine,SmallMoleculeDrug,P28222,5-hydroxytryptamine receptor 1B,HTR1B,390.0
2146,DB00363,Clozapine,SmallMoleculeDrug,P28221,5-hydroxytryptamine receptor 1D,HTR1D,377.0
2147,DB00363,Clozapine,SmallMoleculeDrug,P28566,5-hydroxytryptamine receptor 1E,HTR1E,365.0
2148,DB00363,Clozapine,SmallMoleculeDrug,P28335,5-hydroxytryptamine receptor 2C,HTR2C,458.0
2149,DB00363,Clozapine,SmallMoleculeDrug,P46098,5-hydroxytryptamine receptor 3A,HTR3A,478.0
2150,DB00363,Clozapine,SmallMoleculeDrug,P50406,5-hydroxytryptamine receptor 6,HTR6,440.0
2151,DB00363,Clozapine,SmallMoleculeDrug,P34969,5-hydroxytryptamine receptor 7,HTR7,479.0
2152,DB00363,Clozapine,SmallMoleculeDrug,P35367,Histamine H1 receptor,HRH1,487.0
2153,DB00363,Clozapine,SmallMoleculeDrug,Q9H3N8,Histamine H4 receptor,HRH4,390.0
2154,DB00363,Clozapine,SmallMoleculeDrug,P35348,Alpha-1A adrenergic receptor,ADRA1A,466.0
2155,DB00363,Clozapine,SmallMoleculeDrug,P35368,Alpha-1B adrenergic receptor,ADRA1B,520.0
2156,DB00363,Clozapine,SmallMoleculeDrug,P08913,Alpha-2A adrenergic receptor,ADRA2A,450.0
2157,DB00363,Clozapine,SmallMoleculeDrug,P18089,Alpha-2B adrenergic receptor,ADRA2B,450.0
2158,DB00363,Clozapine,SmallMoleculeDrug,P18825,Alpha-2C adrenergic receptor,ADRA2C,462.0
2159,DB00363,Clozapine,SmallMoleculeDrug,P11229,Muscarinic acetylcholine receptor M1,CHRM1,460.0
2160,DB00363,Clozapine,SmallMoleculeDrug,P08172,Muscarinic acetylcholine receptor M2,CHRM2,466.0
2161,DB00363,Clozapine,SmallMoleculeDrug,P20309,Muscarinic acetylcholine receptor M3,CHRM3,590.0
2162,DB00363,Clozapine,SmallMoleculeDrug,P08173,Muscarinic acetylcholine receptor M4,CHRM4,479.0
2163,DB00363,Clozapine,SmallMoleculeDrug,P08912,Muscarinic acetylcholine receptor M5,CHRM5,532.0
2164,DB00363,Clozapine,SmallMoleculeDrug,Q9NYX4,Neuron-specific vesicular protein calcyon,CALY,217.0
2165,DB00364,Sucralfate,SmallMoleculeDrug,P09038,Fibroblast growth factor 2,FGF2,288.0
2166,DB00364,Sucralfate,SmallMoleculeDrug,P01133,Pro-epidermal growth factor,EGF,1207.0
2167,DB00364,Sucralfate,SmallMoleculeDrug,P02671,Fibrinogen alpha chain,FGA,866.0
2168,DB00364,Sucralfate,SmallMoleculeDrug,P02675,Fibrinogen beta chain,FGB,491.0
2169,DB00364,Sucralfate,SmallMoleculeDrug,P02679,Fibrinogen gamma chain,FGG,453.0
2172,DB00366,Doxylamine,SmallMoleculeDrug,P35367,Histamine H1 receptor,HRH1,487.0
2173,DB00366,Doxylamine,SmallMoleculeDrug,P11229,Muscarinic acetylcholine receptor M1,CHRM1,460.0
2174,DB00367,Levonorgestrel,SmallMoleculeDrug,P06401,Progesterone receptor,PGR,933.0
2175,DB00367,Levonorgestrel,SmallMoleculeDrug,P18405,3-oxo-5-alpha-steroid 4-dehydrogenase 1,SRD5A1,259.0
2176,DB00367,Levonorgestrel,SmallMoleculeDrug,P03372,Estrogen receptor,ESR1,595.0
2177,DB00367,Levonorgestrel,SmallMoleculeDrug,P10275,Androgen receptor,AR,920.0
2178,DB00368,Norepinephrine,SmallMoleculeDrug,P35348,Alpha-1A adrenergic receptor,ADRA1A,466.0
2179,DB00368,Norepinephrine,SmallMoleculeDrug,P35368,Alpha-1B adrenergic receptor,ADRA1B,520.0
2180,DB00368,Norepinephrine,SmallMoleculeDrug,P25100,Alpha-1D adrenergic receptor,ADRA1D,572.0
2181,DB00368,Norepinephrine,SmallMoleculeDrug,P08913,Alpha-2A adrenergic receptor,ADRA2A,450.0
2182,DB00368,Norepinephrine,SmallMoleculeDrug,P18089,Alpha-2B adrenergic receptor,ADRA2B,450.0
2183,DB00368,Norepinephrine,SmallMoleculeDrug,P18825,Alpha-2C adrenergic receptor,ADRA2C,462.0
2184,DB00368,Norepinephrine,SmallMoleculeDrug,P08588,Beta-1 adrenergic receptor,ADRB1,477.0
2185,DB00368,Norepinephrine,SmallMoleculeDrug,P07550,Beta-2 adrenergic receptor,ADRB2,413.0
2186,DB00368,Norepinephrine,SmallMoleculeDrug,P13945,Beta-3 adrenergic receptor,ADRB3,408.0
2187,DB00368,Norepinephrine,SmallMoleculeDrug,P00439,Phenylalanine-4-hydroxylase,PAH,452.0
2188,DB00368,Norepinephrine,SmallMoleculeDrug,Q05940,Synaptic vesicular amine transporter,SLC18A2,514.0
2189,DB00368,Norepinephrine,SmallMoleculeDrug,P54219,Chromaffin granule amine transporter,SLC18A1,525.0
2191,DB00370,Mirtazapine,SmallMoleculeDrug,P28223,5-hydroxytryptamine receptor 2A,HTR2A,471.0
2192,DB00370,Mirtazapine,SmallMoleculeDrug,P46098,5-hydroxytryptamine receptor 3A,HTR3A,478.0
2193,DB00370,Mirtazapine,SmallMoleculeDrug,P08913,Alpha-2A adrenergic receptor,ADRA2A,450.0
2194,DB00370,Mirtazapine,SmallMoleculeDrug,P28335,5-hydroxytryptamine receptor 2C,HTR2C,458.0
2195,DB00370,Mirtazapine,SmallMoleculeDrug,P41145,Kappa-type opioid receptor,OPRK1,380.0
2196,DB00370,Mirtazapine,SmallMoleculeDrug,P35367,Histamine H1 receptor,HRH1,487.0
2197,DB00370,Mirtazapine,SmallMoleculeDrug,P18825,Alpha-2C adrenergic receptor,ADRA2C,462.0
2198,DB00370,Mirtazapine,SmallMoleculeDrug,P34969,5-hydroxytryptamine receptor 7,HTR7,479.0
2199,DB00370,Mirtazapine,SmallMoleculeDrug,P35348,Alpha-1A adrenergic receptor,ADRA1A,466.0
2200,DB00370,Mirtazapine,SmallMoleculeDrug,P35368,Alpha-1B adrenergic receptor,ADRA1B,520.0
2201,DB00370,Mirtazapine,SmallMoleculeDrug,P25100,Alpha-1D adrenergic receptor,ADRA1D,572.0
2202,DB00370,Mirtazapine,SmallMoleculeDrug,P14416,D(2) dopamine receptor,DRD2,443.0
2203,DB00370,Mirtazapine,SmallMoleculeDrug,P35462,D(3) dopamine receptor,DRD3,400.0
2204,DB00370,Mirtazapine,SmallMoleculeDrug,P23975,Sodium-dependent noradrenaline transporter,SLC6A2,617.0
2205,DB00370,Mirtazapine,SmallMoleculeDrug,P31645,Sodium-dependent serotonin transporter,SLC6A4,630.0
2206,DB00370,Mirtazapine,SmallMoleculeDrug,Q01959,Sodium-dependent dopamine transporter,SLC6A3,620.0
2207,DB00370,Mirtazapine,SmallMoleculeDrug,P41595,5-hydroxytryptamine receptor 2B,HTR2B,481.0
2208,DB00370,Mirtazapine,SmallMoleculeDrug,P21728,D(1A) dopamine receptor,DRD1,446.0
2209,DB00370,Mirtazapine,SmallMoleculeDrug,P21918,D(1B) dopamine receptor,DRD5,477.0
2210,DB00370,Mirtazapine,SmallMoleculeDrug,Q9Y5N1,Histamine H3 receptor,HRH3,445.0
2211,DB00370,Mirtazapine,SmallMoleculeDrug,P35348,Alpha-1A adrenergic receptor,ADRA1A,466.0
2212,DB00370,Mirtazapine,SmallMoleculeDrug,P08588,Beta-1 adrenergic receptor,ADRB1,477.0
2213,DB00370,Mirtazapine,SmallMoleculeDrug,P07550,Beta-2 adrenergic receptor,ADRB2,413.0
2214,DB00371,Meprobamate,SmallMoleculeDrug,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,456.0
2215,DB00371,Meprobamate,SmallMoleculeDrug,P47869,Gamma-aminobutyric acid receptor subunit alpha-2,GABRA2,451.0
2216,DB00371,Meprobamate,SmallMoleculeDrug,P34903,Gamma-aminobutyric acid receptor subunit alpha-3,GABRA3,492.0
2217,DB00371,Meprobamate,SmallMoleculeDrug,P48169,Gamma-aminobutyric acid receptor subunit alpha-4,GABRA4,554.0
2218,DB00371,Meprobamate,SmallMoleculeDrug,P31644,Gamma-aminobutyric acid receptor subunit alpha-5,GABRA5,462.0
2219,DB00371,Meprobamate,SmallMoleculeDrug,Q16445,Gamma-aminobutyric acid receptor subunit alpha-6,GABRA6,453.0
2220,DB00371,Meprobamate,SmallMoleculeDrug,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,456.0
2221,DB00371,Meprobamate,SmallMoleculeDrug,P47869,Gamma-aminobutyric acid receptor subunit alpha-2,GABRA2,451.0
2222,DB00371,Meprobamate,SmallMoleculeDrug,P34903,Gamma-aminobutyric acid receptor subunit alpha-3,GABRA3,492.0
2223,DB00371,Meprobamate,SmallMoleculeDrug,P48169,Gamma-aminobutyric acid receptor subunit alpha-4,GABRA4,554.0
2224,DB00371,Meprobamate,SmallMoleculeDrug,P31644,Gamma-aminobutyric acid receptor subunit alpha-5,GABRA5,462.0
2225,DB00371,Meprobamate,SmallMoleculeDrug,Q16445,Gamma-aminobutyric acid receptor subunit alpha-6,GABRA6,453.0
2226,DB00371,Meprobamate,SmallMoleculeDrug,P18505,Gamma-aminobutyric acid receptor subunit beta-1,GABRB1,474.0
2227,DB00371,Meprobamate,SmallMoleculeDrug,P47870,Gamma-aminobutyric acid receptor subunit beta-2,GABRB2,512.0
2228,DB00371,Meprobamate,SmallMoleculeDrug,P28472,Gamma-aminobutyric acid receptor subunit beta-3,GABRB3,473.0
2229,DB00371,Meprobamate,SmallMoleculeDrug,O14764,Gamma-aminobutyric acid receptor subunit delta,GABRD,452.0
2230,DB00371,Meprobamate,SmallMoleculeDrug,P78334,Gamma-aminobutyric acid receptor subunit epsilon,GABRE,506.0
2231,DB00371,Meprobamate,SmallMoleculeDrug,Q8N1C3,Gamma-aminobutyric acid receptor subunit gamma-1,GABRG1,465.0
2232,DB00371,Meprobamate,SmallMoleculeDrug,P18507,Gamma-aminobutyric acid receptor subunit gamma-2,GABRG2,467.0
2233,DB00371,Meprobamate,SmallMoleculeDrug,Q99928,Gamma-aminobutyric acid receptor subunit gamma-3,GABRG3,467.0
2234,DB00371,Meprobamate,SmallMoleculeDrug,O00591,Gamma-aminobutyric acid receptor subunit pi,GABRP,440.0
2235,DB00371,Meprobamate,SmallMoleculeDrug,Q9UN88,Gamma-aminobutyric acid receptor subunit theta,GABRQ,632.0
2236,DB00372,Thiethylperazine,SmallMoleculeDrug,P14416,D(2) dopamine receptor,DRD2,443.0
2237,DB00372,Thiethylperazine,SmallMoleculeDrug,P21728,D(1A) dopamine receptor,DRD1,446.0
2238,DB00372,Thiethylperazine,SmallMoleculeDrug,P21917,D(4) dopamine receptor,DRD4,467.0
2239,DB00373,Timolol,SmallMoleculeDrug,P08588,Beta-1 adrenergic receptor,ADRB1,477.0
2240,DB00373,Timolol,SmallMoleculeDrug,P07550,Beta-2 adrenergic receptor,ADRB2,413.0
2242,DB00374,Treprostinil,SmallMoleculeDrug,P43119,Prostacyclin receptor,PTGIR,386.0
2243,DB00374,Treprostinil,SmallMoleculeDrug,Q03181,Peroxisome proliferator-activated receptor delta,PPARD,441.0
2244,DB00374,Treprostinil,SmallMoleculeDrug,Q9H244,P2Y purinoceptor 12,P2RY12,342.0
2245,DB00376,Trihexyphenidyl,SmallMoleculeDrug,P11229,Muscarinic acetylcholine receptor M1,CHRM1,460.0
2246,DB00376,Trihexyphenidyl,SmallMoleculeDrug,P08172,Muscarinic acetylcholine receptor M2,CHRM2,466.0
2247,DB00376,Trihexyphenidyl,SmallMoleculeDrug,P20309,Muscarinic acetylcholine receptor M3,CHRM3,590.0
2248,DB00376,Trihexyphenidyl,SmallMoleculeDrug,P08173,Muscarinic acetylcholine receptor M4,CHRM4,479.0
2249,DB00376,Trihexyphenidyl,SmallMoleculeDrug,P08912,Muscarinic acetylcholine receptor M5,CHRM5,532.0
2250,DB00377,Palonosetron,SmallMoleculeDrug,P46098,5-hydroxytryptamine receptor 3A,HTR3A,478.0
2251,DB00378,Dydrogesterone,SmallMoleculeDrug,P06401,Progesterone receptor,PGR,933.0
2252,DB00379,Mexiletine,SmallMoleculeDrug,Q14524,Sodium channel protein type 5 subunit alpha,SCN5A,2016.0
2253,DB00379,Mexiletine,SmallMoleculeDrug,P35869,Aryl hydrocarbon receptor,AHR,848.0
2254,DB00380,Dexrazoxane,SmallMoleculeDrug,P11388,DNA topoisomerase 2-alpha,TOP2A,1531.0
2255,DB00380,Dexrazoxane,SmallMoleculeDrug,Q02880,DNA topoisomerase 2-beta,TOP2B,1626.0
2256,DB00381,Amlodipine,SmallMoleculeDrug,Q13936,Voltage-dependent L-type calcium channel subunit alpha-1C,CACNA1C,2221.0
2257,DB00381,Amlodipine,SmallMoleculeDrug,P54289,Voltage-dependent calcium channel subunit alpha-2/delta-1,CACNA2D1,1103.0
2258,DB00381,Amlodipine,SmallMoleculeDrug,Q08289,Voltage-dependent L-type calcium channel subunit beta-2,CACNB2,660.0
2259,DB00381,Amlodipine,SmallMoleculeDrug,Q01668,Voltage-dependent L-type calcium channel subunit alpha-1D,CACNA1D,2161.0
2260,DB00381,Amlodipine,SmallMoleculeDrug,Q13698,Voltage-dependent L-type calcium channel subunit alpha-1S,CACNA1S,1873.0
2261,DB00381,Amlodipine,SmallMoleculeDrug,Q00975,Voltage-dependent N-type calcium channel subunit alpha-1B,CACNA1B,2339.0
2262,DB00381,Amlodipine,SmallMoleculeDrug,Q8IZS8,Voltage-dependent calcium channel subunit alpha-2/delta-3,CACNA2D3,1091.0
2263,DB00381,Amlodipine,SmallMoleculeDrug,Q6TME4,Voltage-dependent L-type calcium channel subunit beta-1,CACNB1,216.0
2264,DB00381,Amlodipine,SmallMoleculeDrug,P00915,Carbonic anhydrase 1,CA1,261.0
2265,DB00381,Amlodipine,SmallMoleculeDrug,P17405,Sphingomyelin phosphodiesterase,SMPD1,629.0
2266,DB00382,Tacrine,SmallMoleculeDrug,P22303,Acetylcholinesterase,ACHE,614.0
2267,DB00382,Tacrine,SmallMoleculeDrug,P06276,Cholinesterase,BCHE,602.0
2268,DB00383,Oxyphencyclimine,SmallMoleculeDrug,P20309,Muscarinic acetylcholine receptor M3,CHRM3,590.0
2269,DB00383,Oxyphencyclimine,SmallMoleculeDrug,P11229,Muscarinic acetylcholine receptor M1,CHRM1,460.0
2270,DB00383,Oxyphencyclimine,SmallMoleculeDrug,P08172,Muscarinic acetylcholine receptor M2,CHRM2,466.0
2271,DB00384,Triamterene,SmallMoleculeDrug,P51170,Amiloride-sensitive sodium channel subunit gamma,SCNN1G,649.0
2272,DB00384,Triamterene,SmallMoleculeDrug,P37088,Amiloride-sensitive sodium channel subunit alpha,SCNN1A,669.0
2273,DB00384,Triamterene,SmallMoleculeDrug,P51168,Amiloride-sensitive sodium channel subunit beta,SCNN1B,640.0
2274,DB00384,Triamterene,SmallMoleculeDrug,P51172,Amiloride-sensitive sodium channel subunit delta,SCNN1D,638.0
2275,DB00385,Valrubicin,SmallMoleculeDrug,P11388,DNA topoisomerase 2-alpha,TOP2A,1531.0
2276,DB00386,Alseroxylon,SmallMoleculeDrug,Q05940,Synaptic vesicular amine transporter,SLC18A2,514.0
2277,DB00387,Procyclidine,SmallMoleculeDrug,P11229,Muscarinic acetylcholine receptor M1,CHRM1,460.0
2278,DB00387,Procyclidine,SmallMoleculeDrug,P08172,Muscarinic acetylcholine receptor M2,CHRM2,466.0
2279,DB00387,Procyclidine,SmallMoleculeDrug,P08173,Muscarinic acetylcholine receptor M4,CHRM4,479.0
2280,DB00387,Procyclidine,SmallMoleculeDrug,P20309,Muscarinic acetylcholine receptor M3,CHRM3,590.0
2281,DB00388,Phenylephrine,SmallMoleculeDrug,P35348,Alpha-1A adrenergic receptor,ADRA1A,466.0
2282,DB00388,Phenylephrine,SmallMoleculeDrug,P35368,Alpha-1B adrenergic receptor,ADRA1B,520.0
2283,DB00388,Phenylephrine,SmallMoleculeDrug,P25100,Alpha-1D adrenergic receptor,ADRA1D,572.0
2284,DB00389,Carbimazole,SmallMoleculeDrug,P07202,Thyroid peroxidase,TPO,933.0
2285,DB00390,Digoxin,SmallMoleculeDrug,P05023,Sodium/potassium-transporting ATPase subunit alpha-1,ATP1A1,1023.0
2286,DB00391,Sulpiride,SmallMoleculeDrug,P14416,D(2) dopamine receptor,DRD2,443.0
2287,DB00391,Sulpiride,SmallMoleculeDrug,P35462,D(3) dopamine receptor,DRD3,400.0
2288,DB00392,Ethopropazine,SmallMoleculeDrug,P11229,Muscarinic acetylcholine receptor M1,CHRM1,460.0
2289,DB00392,Ethopropazine,SmallMoleculeDrug,Q8TCU5,"Glutamate receptor ionotropic, NMDA 3A",GRIN3A,1115.0
2290,DB00392,Ethopropazine,SmallMoleculeDrug,P08172,Muscarinic acetylcholine receptor M2,CHRM2,466.0
2291,DB00393,Nimodipine,SmallMoleculeDrug,Q13936,Voltage-dependent L-type calcium channel subunit alpha-1C,CACNA1C,2221.0
2292,DB00393,Nimodipine,SmallMoleculeDrug,Q01668,Voltage-dependent L-type calcium channel subunit alpha-1D,CACNA1D,2161.0
2293,DB00393,Nimodipine,SmallMoleculeDrug,O60840,Voltage-dependent L-type calcium channel subunit alpha-1F,CACNA1F,1977.0
2294,DB00393,Nimodipine,SmallMoleculeDrug,Q13698,Voltage-dependent L-type calcium channel subunit alpha-1S,CACNA1S,1873.0
2295,DB00393,Nimodipine,SmallMoleculeDrug,Q02641,Voltage-dependent L-type calcium channel subunit beta-1,CACNB1,598.0
2296,DB00393,Nimodipine,SmallMoleculeDrug,Q08289,Voltage-dependent L-type calcium channel subunit beta-2,CACNB2,660.0
2297,DB00393,Nimodipine,SmallMoleculeDrug,P54284,Voltage-dependent L-type calcium channel subunit beta-3,CACNB3,484.0
2298,DB00393,Nimodipine,SmallMoleculeDrug,O00305,Voltage-dependent L-type calcium channel subunit beta-4,CACNB4,520.0
2299,DB00393,Nimodipine,SmallMoleculeDrug,P08235,Mineralocorticoid receptor,NR3C2,984.0
2300,DB00393,Nimodipine,SmallMoleculeDrug,P35869,Aryl hydrocarbon receptor,AHR,848.0
2301,DB00394,Beclomethasone dipropionate,SmallMoleculeDrug,P04150,Glucocorticoid receptor,NR3C1,777.0
2302,DB00396,Progesterone,SmallMoleculeDrug,P06401,Progesterone receptor,PGR,933.0
2303,DB00396,Progesterone,SmallMoleculeDrug,P03372,Estrogen receptor,ESR1,595.0
2304,DB00396,Progesterone,SmallMoleculeDrug,P08235,Mineralocorticoid receptor,NR3C2,984.0
2305,DB00396,Progesterone,SmallMoleculeDrug,P05093,"Steroid 17-alpha-hydroxylase/17,20 lyase",CYP17A1,508.0
2306,DB00396,Progesterone,SmallMoleculeDrug,P41145,Kappa-type opioid receptor,OPRK1,380.0
2307,DB00397,Phenylpropanolamine,SmallMoleculeDrug,P35348,Alpha-1A adrenergic receptor,ADRA1A,466.0
2308,DB00397,Phenylpropanolamine,SmallMoleculeDrug,P08913,Alpha-2A adrenergic receptor,ADRA2A,450.0
2309,DB00397,Phenylpropanolamine,SmallMoleculeDrug,P21728,D(1A) dopamine receptor,DRD1,446.0
2310,DB00397,Phenylpropanolamine,SmallMoleculeDrug,P08588,Beta-1 adrenergic receptor,ADRB1,477.0
2311,DB00397,Phenylpropanolamine,SmallMoleculeDrug,P07550,Beta-2 adrenergic receptor,ADRB2,413.0
2312,DB00398,Sorafenib,SmallMoleculeDrug,P15056,Serine/threonine-protein kinase B-raf,BRAF,766.0
2313,DB00398,Sorafenib,SmallMoleculeDrug,P04049,RAF proto-oncogene serine/threonine-protein kinase,RAF1,648.0
2314,DB00398,Sorafenib,SmallMoleculeDrug,P35916,Vascular endothelial growth factor receptor 3,FLT4,1363.0
2315,DB00398,Sorafenib,SmallMoleculeDrug,P35968,Vascular endothelial growth factor receptor 2,KDR,1356.0
2316,DB00398,Sorafenib,SmallMoleculeDrug,P36888,Receptor-type tyrosine-protein kinase FLT3,FLT3,993.0
2317,DB00398,Sorafenib,SmallMoleculeDrug,P09619,Platelet-derived growth factor receptor beta,PDGFRB,1106.0
2318,DB00398,Sorafenib,SmallMoleculeDrug,P10721,Mast/stem cell growth factor receptor Kit,KIT,976.0
2319,DB00398,Sorafenib,SmallMoleculeDrug,P11362,Fibroblast growth factor receptor 1,FGFR1,822.0
2320,DB00398,Sorafenib,SmallMoleculeDrug,P07949,Proto-oncogene tyrosine-protein kinase receptor Ret,RET,1114.0
2321,DB00398,Sorafenib,SmallMoleculeDrug,P17948,Vascular endothelial growth factor receptor 1,FLT1,1338.0
2322,DB00399,Zoledronic acid,SmallMoleculeDrug,P14324,Farnesyl pyrophosphate synthase,FDPS,419.0
2323,DB00399,Zoledronic acid,SmallMoleculeDrug,O95749,Geranylgeranyl pyrophosphate synthase,GGPS1,300.0
2326,DB00400,Griseofulvin,SmallMoleculeDrug,Q99456,"Keratin, type I cytoskeletal 12",KRT12,494.0
2327,DB00401,Nisoldipine,SmallMoleculeDrug,Q13936,Voltage-dependent L-type calcium channel subunit alpha-1C,CACNA1C,2221.0
2328,DB00401,Nisoldipine,SmallMoleculeDrug,P54289,Voltage-dependent calcium channel subunit alpha-2/delta-1,CACNA2D1,1103.0
2329,DB00401,Nisoldipine,SmallMoleculeDrug,Q08289,Voltage-dependent L-type calcium channel subunit beta-2,CACNB2,660.0
2330,DB00401,Nisoldipine,SmallMoleculeDrug,Q01668,Voltage-dependent L-type calcium channel subunit alpha-1D,CACNA1D,2161.0
2331,DB00401,Nisoldipine,SmallMoleculeDrug,Q13698,Voltage-dependent L-type calcium channel subunit alpha-1S,CACNA1S,1873.0
2332,DB00402,Eszopiclone,SmallMoleculeDrug,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,456.0
2333,DB00402,Eszopiclone,SmallMoleculeDrug,P47869,Gamma-aminobutyric acid receptor subunit alpha-2,GABRA2,451.0
2334,DB00402,Eszopiclone,SmallMoleculeDrug,P34903,Gamma-aminobutyric acid receptor subunit alpha-3,GABRA3,492.0
2335,DB00402,Eszopiclone,SmallMoleculeDrug,P31644,Gamma-aminobutyric acid receptor subunit alpha-5,GABRA5,462.0
2336,DB00402,Eszopiclone,SmallMoleculeDrug,P30536,Translocator protein,TSPO,169.0
2337,DB00402,Eszopiclone,SmallMoleculeDrug,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,456.0
2338,DB00402,Eszopiclone,SmallMoleculeDrug,P47869,Gamma-aminobutyric acid receptor subunit alpha-2,GABRA2,451.0
2339,DB00402,Eszopiclone,SmallMoleculeDrug,P34903,Gamma-aminobutyric acid receptor subunit alpha-3,GABRA3,492.0
2340,DB00402,Eszopiclone,SmallMoleculeDrug,P48169,Gamma-aminobutyric acid receptor subunit alpha-4,GABRA4,554.0
2341,DB00402,Eszopiclone,SmallMoleculeDrug,P31644,Gamma-aminobutyric acid receptor subunit alpha-5,GABRA5,462.0
2342,DB00402,Eszopiclone,SmallMoleculeDrug,Q16445,Gamma-aminobutyric acid receptor subunit alpha-6,GABRA6,453.0
2343,DB00402,Eszopiclone,SmallMoleculeDrug,P18505,Gamma-aminobutyric acid receptor subunit beta-1,GABRB1,474.0
2344,DB00402,Eszopiclone,SmallMoleculeDrug,P47870,Gamma-aminobutyric acid receptor subunit beta-2,GABRB2,512.0
2345,DB00402,Eszopiclone,SmallMoleculeDrug,P28472,Gamma-aminobutyric acid receptor subunit beta-3,GABRB3,473.0
2346,DB00402,Eszopiclone,SmallMoleculeDrug,O14764,Gamma-aminobutyric acid receptor subunit delta,GABRD,452.0
2347,DB00402,Eszopiclone,SmallMoleculeDrug,P78334,Gamma-aminobutyric acid receptor subunit epsilon,GABRE,506.0
2348,DB00402,Eszopiclone,SmallMoleculeDrug,Q8N1C3,Gamma-aminobutyric acid receptor subunit gamma-1,GABRG1,465.0
2349,DB00402,Eszopiclone,SmallMoleculeDrug,P18507,Gamma-aminobutyric acid receptor subunit gamma-2,GABRG2,467.0
2350,DB00402,Eszopiclone,SmallMoleculeDrug,Q99928,Gamma-aminobutyric acid receptor subunit gamma-3,GABRG3,467.0
2351,DB00402,Eszopiclone,SmallMoleculeDrug,O00591,Gamma-aminobutyric acid receptor subunit pi,GABRP,440.0
2352,DB00402,Eszopiclone,SmallMoleculeDrug,Q9UN88,Gamma-aminobutyric acid receptor subunit theta,GABRQ,632.0
2353,DB00403,Ceruletide,SmallMoleculeDrug,P32238,Cholecystokinin receptor type A,CCKAR,428.0
2354,DB00404,Alprazolam,SmallMoleculeDrug,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,456.0
2355,DB00404,Alprazolam,SmallMoleculeDrug,P47869,Gamma-aminobutyric acid receptor subunit alpha-2,GABRA2,451.0
2356,DB00404,Alprazolam,SmallMoleculeDrug,P34903,Gamma-aminobutyric acid receptor subunit alpha-3,GABRA3,492.0
2357,DB00404,Alprazolam,SmallMoleculeDrug,P48169,Gamma-aminobutyric acid receptor subunit alpha-4,GABRA4,554.0
2358,DB00404,Alprazolam,SmallMoleculeDrug,P31644,Gamma-aminobutyric acid receptor subunit alpha-5,GABRA5,462.0
2359,DB00404,Alprazolam,SmallMoleculeDrug,Q16445,Gamma-aminobutyric acid receptor subunit alpha-6,GABRA6,453.0
2360,DB00404,Alprazolam,SmallMoleculeDrug,P18505,Gamma-aminobutyric acid receptor subunit beta-1,GABRB1,474.0
2361,DB00404,Alprazolam,SmallMoleculeDrug,P47870,Gamma-aminobutyric acid receptor subunit beta-2,GABRB2,512.0
2362,DB00404,Alprazolam,SmallMoleculeDrug,P28472,Gamma-aminobutyric acid receptor subunit beta-3,GABRB3,473.0
2363,DB00404,Alprazolam,SmallMoleculeDrug,O14764,Gamma-aminobutyric acid receptor subunit delta,GABRD,452.0
2364,DB00404,Alprazolam,SmallMoleculeDrug,P78334,Gamma-aminobutyric acid receptor subunit epsilon,GABRE,506.0
2365,DB00404,Alprazolam,SmallMoleculeDrug,Q8N1C3,Gamma-aminobutyric acid receptor subunit gamma-1,GABRG1,465.0
2366,DB00404,Alprazolam,SmallMoleculeDrug,P18507,Gamma-aminobutyric acid receptor subunit gamma-2,GABRG2,467.0
2367,DB00404,Alprazolam,SmallMoleculeDrug,Q99928,Gamma-aminobutyric acid receptor subunit gamma-3,GABRG3,467.0
2368,DB00404,Alprazolam,SmallMoleculeDrug,O00591,Gamma-aminobutyric acid receptor subunit pi,GABRP,440.0
2369,DB00404,Alprazolam,SmallMoleculeDrug,Q9UN88,Gamma-aminobutyric acid receptor subunit theta,GABRQ,632.0
2370,DB00405,Dexbrompheniramine,SmallMoleculeDrug,P35367,Histamine H1 receptor,HRH1,487.0
2371,DB00407,Ardeparin,SmallMoleculeDrug,P01008,Antithrombin-III,SERPINC1,464.0
2372,DB00407,Ardeparin,SmallMoleculeDrug,P05546,Heparin cofactor 2,SERPIND1,499.0
2373,DB00408,Loxapine,SmallMoleculeDrug,P14416,D(2) dopamine receptor,DRD2,443.0
2374,DB00408,Loxapine,SmallMoleculeDrug,P21728,D(1A) dopamine receptor,DRD1,446.0
2375,DB00408,Loxapine,SmallMoleculeDrug,P28223,5-hydroxytryptamine receptor 2A,HTR2A,471.0
2376,DB00408,Loxapine,SmallMoleculeDrug,P28335,5-hydroxytryptamine receptor 2C,HTR2C,458.0
2377,DB00408,Loxapine,SmallMoleculeDrug,P08908,5-hydroxytryptamine receptor 1A,HTR1A,422.0
2378,DB00408,Loxapine,SmallMoleculeDrug,P28222,5-hydroxytryptamine receptor 1B,HTR1B,390.0
2379,DB00408,Loxapine,SmallMoleculeDrug,P28221,5-hydroxytryptamine receptor 1D,HTR1D,377.0
2380,DB00408,Loxapine,SmallMoleculeDrug,P28566,5-hydroxytryptamine receptor 1E,HTR1E,365.0
2381,DB00408,Loxapine,SmallMoleculeDrug,P46098,5-hydroxytryptamine receptor 3A,HTR3A,478.0
2382,DB00408,Loxapine,SmallMoleculeDrug,P47898,5-hydroxytryptamine receptor 5A,HTR5A,357.0
2383,DB00408,Loxapine,SmallMoleculeDrug,P50406,5-hydroxytryptamine receptor 6,HTR6,440.0
2384,DB00408,Loxapine,SmallMoleculeDrug,P34969,5-hydroxytryptamine receptor 7,HTR7,479.0
2385,DB00408,Loxapine,SmallMoleculeDrug,P35348,Alpha-1A adrenergic receptor,ADRA1A,466.0
2386,DB00408,Loxapine,SmallMoleculeDrug,P35368,Alpha-1B adrenergic receptor,ADRA1B,520.0
2387,DB00408,Loxapine,SmallMoleculeDrug,P08913,Alpha-2A adrenergic receptor,ADRA2A,450.0
2388,DB00408,Loxapine,SmallMoleculeDrug,P18089,Alpha-2B adrenergic receptor,ADRA2B,450.0
2389,DB00408,Loxapine,SmallMoleculeDrug,P18825,Alpha-2C adrenergic receptor,ADRA2C,462.0
2390,DB00408,Loxapine,SmallMoleculeDrug,P08588,Beta-1 adrenergic receptor,ADRB1,477.0
2391,DB00408,Loxapine,SmallMoleculeDrug,P11229,Muscarinic acetylcholine receptor M1,CHRM1,460.0
2392,DB00408,Loxapine,SmallMoleculeDrug,P08172,Muscarinic acetylcholine receptor M2,CHRM2,466.0
2393,DB00408,Loxapine,SmallMoleculeDrug,P20309,Muscarinic acetylcholine receptor M3,CHRM3,590.0
2394,DB00408,Loxapine,SmallMoleculeDrug,P08173,Muscarinic acetylcholine receptor M4,CHRM4,479.0
2395,DB00408,Loxapine,SmallMoleculeDrug,P08912,Muscarinic acetylcholine receptor M5,CHRM5,532.0
2396,DB00408,Loxapine,SmallMoleculeDrug,P21728,D(1A) dopamine receptor,DRD1,446.0
2397,DB00408,Loxapine,SmallMoleculeDrug,P21918,D(1B) dopamine receptor,DRD5,477.0
2398,DB00408,Loxapine,SmallMoleculeDrug,P35462,D(3) dopamine receptor,DRD3,400.0
2399,DB00408,Loxapine,SmallMoleculeDrug,P21917,D(4) dopamine receptor,DRD4,467.0
2400,DB00408,Loxapine,SmallMoleculeDrug,P21918,D(1B) dopamine receptor,DRD5,477.0
2401,DB00408,Loxapine,SmallMoleculeDrug,P35367,Histamine H1 receptor,HRH1,487.0
2402,DB00408,Loxapine,SmallMoleculeDrug,P25021,Histamine H2 receptor,HRH2,359.0
2403,DB00408,Loxapine,SmallMoleculeDrug,Q9H3N8,Histamine H4 receptor,HRH4,390.0
2404,DB00408,Loxapine,SmallMoleculeDrug,P31645,Sodium-dependent serotonin transporter,SLC6A4,630.0
2405,DB00408,Loxapine,SmallMoleculeDrug,P23975,Sodium-dependent noradrenaline transporter,SLC6A2,617.0
2406,DB00408,Loxapine,SmallMoleculeDrug,Q01959,Sodium-dependent dopamine transporter,SLC6A3,620.0
2407,DB00409,Remoxipride,SmallMoleculeDrug,P14416,D(2) dopamine receptor,DRD2,443.0
2408,DB00409,Remoxipride,SmallMoleculeDrug,P21917,D(4) dopamine receptor,DRD4,467.0
2409,DB00409,Remoxipride,SmallMoleculeDrug,P35462,D(3) dopamine receptor,DRD3,400.0
2410,DB00409,Remoxipride,SmallMoleculeDrug,P28223,5-hydroxytryptamine receptor 2A,HTR2A,471.0
2411,DB00409,Remoxipride,SmallMoleculeDrug,Q99720,Sigma non-opioid intracellular receptor 1,SIGMAR1,223.0
2413,DB00411,Carbachol,SmallMoleculeDrug,P11229,Muscarinic acetylcholine receptor M1,CHRM1,460.0
2414,DB00411,Carbachol,SmallMoleculeDrug,P08172,Muscarinic acetylcholine receptor M2,CHRM2,466.0
2415,DB00411,Carbachol,SmallMoleculeDrug,Q15822,Neuronal acetylcholine receptor subunit alpha-2,CHRNA2,529.0
2416,DB00412,Rosiglitazone,SmallMoleculeDrug,P37231,Peroxisome proliferator-activated receptor gamma,PPARG,505.0
2417,DB00412,Rosiglitazone,SmallMoleculeDrug,O60488,Long-chain-fatty-acid--CoA ligase 4,ACSL4,711.0
2418,DB00413,Pramipexole,SmallMoleculeDrug,P35462,D(3) dopamine receptor,DRD3,400.0
2419,DB00413,Pramipexole,SmallMoleculeDrug,P14416,D(2) dopamine receptor,DRD2,443.0
2420,DB00413,Pramipexole,SmallMoleculeDrug,P21917,D(4) dopamine receptor,DRD4,467.0
2421,DB00413,Pramipexole,SmallMoleculeDrug,P18089,Alpha-2B adrenergic receptor,ADRA2B,450.0
2422,DB00413,Pramipexole,SmallMoleculeDrug,P08908,5-hydroxytryptamine receptor 1A,HTR1A,422.0
2423,DB00413,Pramipexole,SmallMoleculeDrug,P28221,5-hydroxytryptamine receptor 1D,HTR1D,377.0
2424,DB00413,Pramipexole,SmallMoleculeDrug,P08913,Alpha-2A adrenergic receptor,ADRA2A,450.0
2425,DB00413,Pramipexole,SmallMoleculeDrug,P28222,5-hydroxytryptamine receptor 1B,HTR1B,390.0
2426,DB00413,Pramipexole,SmallMoleculeDrug,P28223,5-hydroxytryptamine receptor 2A,HTR2A,471.0
2427,DB00413,Pramipexole,SmallMoleculeDrug,P41595,5-hydroxytryptamine receptor 2B,HTR2B,481.0
2428,DB00413,Pramipexole,SmallMoleculeDrug,P28335,5-hydroxytryptamine receptor 2C,HTR2C,458.0
2429,DB00413,Pramipexole,SmallMoleculeDrug,P18825,Alpha-2C adrenergic receptor,ADRA2C,462.0
2430,DB00413,Pramipexole,SmallMoleculeDrug,P21728,D(1A) dopamine receptor,DRD1,446.0
2431,DB00413,Pramipexole,SmallMoleculeDrug,P21918,D(1B) dopamine receptor,DRD5,477.0
2432,DB00414,Acetohexamide,SmallMoleculeDrug,P48048,ATP-sensitive inward rectifier potassium channel 1,KCNJ1,391.0
2438,DB00415,Ampicillin,SmallMoleculeDrug,P46059,Solute carrier family 15 member 1,SLC15A1,708.0
2439,DB00415,Ampicillin,SmallMoleculeDrug,Q16348,Solute carrier family 15 member 2,SLC15A2,729.0
2440,DB00415,Ampicillin,SmallMoleculeDrug,Q02763,Angiopoietin-1 receptor,TEK,1124.0
2441,DB00416,Metocurine Iodide,SmallMoleculeDrug,Q15822,Neuronal acetylcholine receptor subunit alpha-2,CHRNA2,529.0
2446,DB00417,Phenoxymethylpenicillin,SmallMoleculeDrug,P46059,Solute carrier family 15 member 1,SLC15A1,708.0
2447,DB00418,Secobarbital,SmallMoleculeDrug,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,456.0
2448,DB00418,Secobarbital,SmallMoleculeDrug,P47869,Gamma-aminobutyric acid receptor subunit alpha-2,GABRA2,451.0
2449,DB00418,Secobarbital,SmallMoleculeDrug,P34903,Gamma-aminobutyric acid receptor subunit alpha-3,GABRA3,492.0
2450,DB00418,Secobarbital,SmallMoleculeDrug,P48169,Gamma-aminobutyric acid receptor subunit alpha-4,GABRA4,554.0
2451,DB00418,Secobarbital,SmallMoleculeDrug,P31644,Gamma-aminobutyric acid receptor subunit alpha-5,GABRA5,462.0
2452,DB00418,Secobarbital,SmallMoleculeDrug,Q16445,Gamma-aminobutyric acid receptor subunit alpha-6,GABRA6,453.0
2453,DB00418,Secobarbital,SmallMoleculeDrug,P43681,Neuronal acetylcholine receptor subunit alpha-4,CHRNA4,627.0
2454,DB00418,Secobarbital,SmallMoleculeDrug,P36544,Neuronal acetylcholine receptor subunit alpha-7,CHRNA7,502.0
2455,DB00418,Secobarbital,SmallMoleculeDrug,P42262,Glutamate receptor 2,GRIA2,883.0
2456,DB00418,Secobarbital,SmallMoleculeDrug,Q13002,"Glutamate receptor ionotropic, kainate 2",GRIK2,908.0
2457,DB00418,Secobarbital,SmallMoleculeDrug,Q05586,"Glutamate receptor ionotropic, NMDA 1",GRIN1,938.0
2458,DB00418,Secobarbital,SmallMoleculeDrug,Q12879,"Glutamate receptor ionotropic, NMDA 2A",GRIN2A,1464.0
2459,DB00418,Secobarbital,SmallMoleculeDrug,Q13224,"Glutamate receptor ionotropic, NMDA 2B",GRIN2B,1484.0
2460,DB00418,Secobarbital,SmallMoleculeDrug,Q14957,"Glutamate receptor ionotropic, NMDA 2C",GRIN2C,1233.0
2461,DB00418,Secobarbital,SmallMoleculeDrug,O15399,"Glutamate receptor ionotropic, NMDA 2D",GRIN2D,1336.0
2462,DB00418,Secobarbital,SmallMoleculeDrug,Q8TCU5,"Glutamate receptor ionotropic, NMDA 3A",GRIN3A,1115.0
2463,DB00418,Secobarbital,SmallMoleculeDrug,O60391,"Glutamate receptor ionotropic, NMDA 3B",GRIN3B,1043.0
2464,DB00419,Miglustat,SmallMoleculeDrug,Q16739,Ceramide glucosyltransferase,UGCG,394.0
2465,DB00420,Promazine,SmallMoleculeDrug,P14416,D(2) dopamine receptor,DRD2,443.0
2466,DB00420,Promazine,SmallMoleculeDrug,P28223,5-hydroxytryptamine receptor 2A,HTR2A,471.0
2467,DB00420,Promazine,SmallMoleculeDrug,P28335,5-hydroxytryptamine receptor 2C,HTR2C,458.0
2468,DB00420,Promazine,SmallMoleculeDrug,P21728,D(1A) dopamine receptor,DRD1,446.0
2469,DB00420,Promazine,SmallMoleculeDrug,P21917,D(4) dopamine receptor,DRD4,467.0
2470,DB00420,Promazine,SmallMoleculeDrug,P08173,Muscarinic acetylcholine receptor M4,CHRM4,479.0
2471,DB00420,Promazine,SmallMoleculeDrug,P08172,Muscarinic acetylcholine receptor M2,CHRM2,466.0
2472,DB00420,Promazine,SmallMoleculeDrug,P20309,Muscarinic acetylcholine receptor M3,CHRM3,590.0
2473,DB00420,Promazine,SmallMoleculeDrug,P11229,Muscarinic acetylcholine receptor M1,CHRM1,460.0
2474,DB00420,Promazine,SmallMoleculeDrug,P35368,Alpha-1B adrenergic receptor,ADRA1B,520.0
2475,DB00420,Promazine,SmallMoleculeDrug,P08912,Muscarinic acetylcholine receptor M5,CHRM5,532.0
2476,DB00420,Promazine,SmallMoleculeDrug,P35348,Alpha-1A adrenergic receptor,ADRA1A,466.0
2477,DB00420,Promazine,SmallMoleculeDrug,P35367,Histamine H1 receptor,HRH1,487.0
2478,DB00420,Promazine,SmallMoleculeDrug,P25100,Alpha-1D adrenergic receptor,ADRA1D,572.0
2479,DB00421,Spironolactone,SmallMoleculeDrug,P08235,Mineralocorticoid receptor,NR3C2,984.0
2480,DB00421,Spironolactone,SmallMoleculeDrug,P10275,Androgen receptor,AR,920.0
2481,DB00421,Spironolactone,SmallMoleculeDrug,P06401,Progesterone receptor,PGR,933.0
2482,DB00421,Spironolactone,SmallMoleculeDrug,P04150,Glucocorticoid receptor,NR3C1,777.0
2483,DB00421,Spironolactone,SmallMoleculeDrug,P19099,"Cytochrome P450 11B2, mitochondrial",CYP11B2,503.0
2484,DB00421,Spironolactone,SmallMoleculeDrug,P18405,3-oxo-5-alpha-steroid 4-dehydrogenase 1,SRD5A1,259.0
2485,DB00421,Spironolactone,SmallMoleculeDrug,P31213,3-oxo-5-alpha-steroid 4-dehydrogenase 2,SRD5A2,254.0
2486,DB00421,Spironolactone,SmallMoleculeDrug,Q9H8P0,Polyprenol reductase,SRD5A3,318.0
2487,DB00421,Spironolactone,SmallMoleculeDrug,P04278,Sex hormone-binding globulin,SHBG,402.0
2488,DB00421,Spironolactone,SmallMoleculeDrug,Q06432,Voltage-dependent calcium channel gamma-1 subunit,CACNG1,222.0
2489,DB00421,Spironolactone,SmallMoleculeDrug,P54289,Voltage-dependent calcium channel subunit alpha-2/delta-1,CACNA2D1,1103.0
2490,DB00421,Spironolactone,SmallMoleculeDrug,Q9NY47,Voltage-dependent calcium channel subunit alpha-2/delta-2,CACNA2D2,1150.0
2491,DB00421,Spironolactone,SmallMoleculeDrug,Q8IZS8,Voltage-dependent calcium channel subunit alpha-2/delta-3,CACNA2D3,1091.0
2492,DB00421,Spironolactone,SmallMoleculeDrug,Q13936,Voltage-dependent L-type calcium channel subunit alpha-1C,CACNA1C,2221.0
2493,DB00421,Spironolactone,SmallMoleculeDrug,Q01668,Voltage-dependent L-type calcium channel subunit alpha-1D,CACNA1D,2161.0
2494,DB00421,Spironolactone,SmallMoleculeDrug,O60840,Voltage-dependent L-type calcium channel subunit alpha-1F,CACNA1F,1977.0
2495,DB00421,Spironolactone,SmallMoleculeDrug,Q13698,Voltage-dependent L-type calcium channel subunit alpha-1S,CACNA1S,1873.0
2496,DB00421,Spironolactone,SmallMoleculeDrug,Q6TME4,Voltage-dependent L-type calcium channel subunit beta-1,CACNB1,216.0
2497,DB00421,Spironolactone,SmallMoleculeDrug,Q02641,Voltage-dependent L-type calcium channel subunit beta-1,CACNB1,598.0
2498,DB00421,Spironolactone,SmallMoleculeDrug,Q08289,Voltage-dependent L-type calcium channel subunit beta-2,CACNB2,660.0
2499,DB00421,Spironolactone,SmallMoleculeDrug,P54284,Voltage-dependent L-type calcium channel subunit beta-3,CACNB3,484.0
2500,DB00421,Spironolactone,SmallMoleculeDrug,O00305,Voltage-dependent L-type calcium channel subunit beta-4,CACNB4,520.0
2501,DB00421,Spironolactone,SmallMoleculeDrug,Q00975,Voltage-dependent N-type calcium channel subunit alpha-1B,CACNA1B,2339.0
2502,DB00421,Spironolactone,SmallMoleculeDrug,O00555,Voltage-dependent P/Q-type calcium channel subunit alpha-1A,CACNA1A,2505.0
2503,DB00421,Spironolactone,SmallMoleculeDrug,O43497,Voltage-dependent T-type calcium channel subunit alpha-1G,CACNA1G,2377.0
2504,DB00421,Spironolactone,SmallMoleculeDrug,O95180,Voltage-dependent T-type calcium channel subunit alpha-1H,CACNA1H,2353.0
2505,DB00421,Spironolactone,SmallMoleculeDrug,Q9P0X4,Voltage-dependent T-type calcium channel subunit alpha-1I,CACNA1I,2223.0
2506,DB00422,Methylphenidate,SmallMoleculeDrug,Q01959,Sodium-dependent dopamine transporter,SLC6A3,620.0
2507,DB00422,Methylphenidate,SmallMoleculeDrug,P23975,Sodium-dependent noradrenaline transporter,SLC6A2,617.0
2508,DB00422,Methylphenidate,SmallMoleculeDrug,P31645,Sodium-dependent serotonin transporter,SLC6A4,630.0
2509,DB00423,Methocarbamol,SmallMoleculeDrug,P00915,Carbonic anhydrase 1,CA1,261.0
2510,DB00424,Hyoscyamine,SmallMoleculeDrug,P11229,Muscarinic acetylcholine receptor M1,CHRM1,460.0
2511,DB00424,Hyoscyamine,SmallMoleculeDrug,P08172,Muscarinic acetylcholine receptor M2,CHRM2,466.0
2512,DB00424,Hyoscyamine,SmallMoleculeDrug,P20309,Muscarinic acetylcholine receptor M3,CHRM3,590.0
2513,DB00424,Hyoscyamine,SmallMoleculeDrug,P08173,Muscarinic acetylcholine receptor M4,CHRM4,479.0
2514,DB00425,Zolpidem,SmallMoleculeDrug,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,456.0
2515,DB00425,Zolpidem,SmallMoleculeDrug,P47869,Gamma-aminobutyric acid receptor subunit alpha-2,GABRA2,451.0
2516,DB00425,Zolpidem,SmallMoleculeDrug,P34903,Gamma-aminobutyric acid receptor subunit alpha-3,GABRA3,492.0
2519,DB00427,Triprolidine,SmallMoleculeDrug,P35367,Histamine H1 receptor,HRH1,487.0
2520,DB00428,Streptozocin,SmallMoleculeDrug,P11168,"Solute carrier family 2, facilitated glucose transporter member 2",SLC2A2,524.0
2522,DB00429,Carboprost Tromethamine,SmallMoleculeDrug,P34995,Prostaglandin E2 receptor EP1 subtype,PTGER1,402.0
2530,DB00431,Lindane,SmallMoleculeDrug,P18505,Gamma-aminobutyric acid receptor subunit beta-1,GABRB1,474.0
2531,DB00431,Lindane,SmallMoleculeDrug,P23415,Glycine receptor subunit alpha-1,GLRA1,457.0
2532,DB00431,Lindane,SmallMoleculeDrug,P23416,Glycine receptor subunit alpha-2,GLRA2,452.0
2533,DB00431,Lindane,SmallMoleculeDrug,O75311,Glycine receptor subunit alpha-3,GLRA3,464.0
2534,DB00431,Lindane,SmallMoleculeDrug,P48167,Glycine receptor subunit beta,GLRB,497.0
2535,DB00432,Trifluridine,SmallMoleculeDrug,P04818,Thymidylate synthase,TYMS,313.0
2536,DB00433,Prochlorperazine,SmallMoleculeDrug,P14416,D(2) dopamine receptor,DRD2,443.0
2537,DB00434,Cyproheptadine,SmallMoleculeDrug,P35367,Histamine H1 receptor,HRH1,487.0
2538,DB00434,Cyproheptadine,SmallMoleculeDrug,P28223,5-hydroxytryptamine receptor 2A,HTR2A,471.0
2539,DB00434,Cyproheptadine,SmallMoleculeDrug,P28335,5-hydroxytryptamine receptor 2C,HTR2C,458.0
2540,DB00434,Cyproheptadine,SmallMoleculeDrug,P11229,Muscarinic acetylcholine receptor M1,CHRM1,460.0
2541,DB00434,Cyproheptadine,SmallMoleculeDrug,P08172,Muscarinic acetylcholine receptor M2,CHRM2,466.0
2542,DB00434,Cyproheptadine,SmallMoleculeDrug,P20309,Muscarinic acetylcholine receptor M3,CHRM3,590.0
2543,DB00435,Nitric Oxide,SmallMoleculeDrug,P33402,Guanylate cyclase soluble subunit alpha-2,GUCY1A2,732.0
2544,DB00436,Bendroflumethiazide,SmallMoleculeDrug,P55017,Solute carrier family 12 member 3,SLC12A3,1021.0
2545,DB00436,Bendroflumethiazide,SmallMoleculeDrug,Q12791,Calcium-activated potassium channel subunit alpha-1,KCNMA1,1236.0
2546,DB00436,Bendroflumethiazide,SmallMoleculeDrug,P00915,Carbonic anhydrase 1,CA1,261.0
2547,DB00436,Bendroflumethiazide,SmallMoleculeDrug,P00918,Carbonic anhydrase 2,CA2,260.0
2548,DB00436,Bendroflumethiazide,SmallMoleculeDrug,P22748,Carbonic anhydrase 4,CA4,312.0
2549,DB00437,Allopurinol,SmallMoleculeDrug,P47989,Xanthine dehydrogenase/oxidase,XDH,1333.0
2559,DB00439,Cerivastatin,SmallMoleculeDrug,P04035,3-hydroxy-3-methylglutaryl-coenzyme A reductase,HMGCR,888.0
2560,DB00440,Trimethoprim,SmallMoleculeDrug,P04818,Thymidylate synthase,TYMS,313.0
2561,DB00440,Trimethoprim,SmallMoleculeDrug,P00374,Dihydrofolate reductase,DHFR,187.0
2562,DB00441,Gemcitabine,SmallMoleculeDrug,P23921,Ribonucleoside-diphosphate reductase large subunit,RRM1,792.0
2563,DB00441,Gemcitabine,SmallMoleculeDrug,P04818,Thymidylate synthase,TYMS,313.0
2564,DB00441,Gemcitabine,SmallMoleculeDrug,P30085,UMP-CMP kinase,CMPK1,196.0
2565,DB00443,Betamethasone,SmallMoleculeDrug,P04150,Glucocorticoid receptor,NR3C1,777.0
2566,DB00444,Teniposide,SmallMoleculeDrug,P11388,DNA topoisomerase 2-alpha,TOP2A,1531.0
2567,DB00445,Epirubicin,SmallMoleculeDrug,O14646,Chromodomain-helicase-DNA-binding protein 1,CHD1,1710.0
2568,DB00445,Epirubicin,SmallMoleculeDrug,P11388,DNA topoisomerase 2-alpha,TOP2A,1531.0
2571,DB00446,Chloramphenicol,SmallMoleculeDrug,P08174,Complement decay-accelerating factor,CD55,381.0
2574,DB00448,Lansoprazole,SmallMoleculeDrug,P20648,Potassium-transporting ATPase alpha chain 1,ATP4A,1035.0
2575,DB00449,Dipivefrin,SmallMoleculeDrug,P35348,Alpha-1A adrenergic receptor,ADRA1A,466.0
2576,DB00449,Dipivefrin,SmallMoleculeDrug,P08913,Alpha-2A adrenergic receptor,ADRA2A,450.0
2577,DB00449,Dipivefrin,SmallMoleculeDrug,P07550,Beta-2 adrenergic receptor,ADRB2,413.0
2578,DB00449,Dipivefrin,SmallMoleculeDrug,P06276,Cholinesterase,BCHE,602.0
2579,DB00449,Dipivefrin,SmallMoleculeDrug,P22303,Acetylcholinesterase,ACHE,614.0
2580,DB00450,Droperidol,SmallMoleculeDrug,P14416,D(2) dopamine receptor,DRD2,443.0
2581,DB00450,Droperidol,SmallMoleculeDrug,P35348,Alpha-1A adrenergic receptor,ADRA1A,466.0
2582,DB00451,Levothyroxine,SmallMoleculeDrug,P10827,Thyroid hormone receptor alpha,THRA,490.0
2583,DB00451,Levothyroxine,SmallMoleculeDrug,P10828,Thyroid hormone receptor beta,THRB,461.0
2585,DB00452,Framycetin,SmallMoleculeDrug,P61073,C-X-C chemokine receptor type 4,CXCR4,352.0
2588,DB00454,Pethidine,SmallMoleculeDrug,P41145,Kappa-type opioid receptor,OPRK1,380.0
2589,DB00454,Pethidine,SmallMoleculeDrug,Q05586,"Glutamate receptor ionotropic, NMDA 1",GRIN1,938.0
2590,DB00454,Pethidine,SmallMoleculeDrug,Q13224,"Glutamate receptor ionotropic, NMDA 2B",GRIN2B,1484.0
2591,DB00454,Pethidine,SmallMoleculeDrug,Q12879,"Glutamate receptor ionotropic, NMDA 2A",GRIN2A,1464.0
2592,DB00454,Pethidine,SmallMoleculeDrug,Q14957,"Glutamate receptor ionotropic, NMDA 2C",GRIN2C,1233.0
2593,DB00454,Pethidine,SmallMoleculeDrug,O15399,"Glutamate receptor ionotropic, NMDA 2D",GRIN2D,1336.0
2594,DB00454,Pethidine,SmallMoleculeDrug,P11229,Muscarinic acetylcholine receptor M1,CHRM1,460.0
2595,DB00454,Pethidine,SmallMoleculeDrug,P08172,Muscarinic acetylcholine receptor M2,CHRM2,466.0
2596,DB00454,Pethidine,SmallMoleculeDrug,P20309,Muscarinic acetylcholine receptor M3,CHRM3,590.0
2597,DB00454,Pethidine,SmallMoleculeDrug,P08173,Muscarinic acetylcholine receptor M4,CHRM4,479.0
2598,DB00454,Pethidine,SmallMoleculeDrug,P08912,Muscarinic acetylcholine receptor M5,CHRM5,532.0
2599,DB00454,Pethidine,SmallMoleculeDrug,P35372,Mu-type opioid receptor,OPRM1,400.0
2600,DB00454,Pethidine,SmallMoleculeDrug,Q01959,Sodium-dependent dopamine transporter,SLC6A3,620.0
2601,DB00454,Pethidine,SmallMoleculeDrug,P23975,Sodium-dependent noradrenaline transporter,SLC6A2,617.0
2602,DB00454,Pethidine,SmallMoleculeDrug,P31645,Sodium-dependent serotonin transporter,SLC6A4,630.0
2603,DB00455,Loratadine,SmallMoleculeDrug,P35367,Histamine H1 receptor,HRH1,487.0
2612,DB00457,Prazosin,SmallMoleculeDrug,P35348,Alpha-1A adrenergic receptor,ADRA1A,466.0
2613,DB00457,Prazosin,SmallMoleculeDrug,P35368,Alpha-1B adrenergic receptor,ADRA1B,520.0
2614,DB00457,Prazosin,SmallMoleculeDrug,P25100,Alpha-1D adrenergic receptor,ADRA1D,572.0
2615,DB00457,Prazosin,SmallMoleculeDrug,Q12809,Potassium voltage-gated channel subfamily H member 2,KCNH2,1159.0
2616,DB00457,Prazosin,SmallMoleculeDrug,Q9H252,Potassium voltage-gated channel subfamily H member 6,KCNH6,994.0
2617,DB00457,Prazosin,SmallMoleculeDrug,Q9NS40,Potassium voltage-gated channel subfamily H member 7,KCNH7,1196.0
2618,DB00457,Prazosin,SmallMoleculeDrug,P08913,Alpha-2A adrenergic receptor,ADRA2A,450.0
2619,DB00457,Prazosin,SmallMoleculeDrug,P18089,Alpha-2B adrenergic receptor,ADRA2B,450.0
2620,DB00458,Imipramine,SmallMoleculeDrug,P23975,Sodium-dependent noradrenaline transporter,SLC6A2,617.0
2621,DB00458,Imipramine,SmallMoleculeDrug,P31645,Sodium-dependent serotonin transporter,SLC6A4,630.0
2622,DB00458,Imipramine,SmallMoleculeDrug,P28223,5-hydroxytryptamine receptor 2A,HTR2A,471.0
2623,DB00458,Imipramine,SmallMoleculeDrug,P35367,Histamine H1 receptor,HRH1,487.0
2624,DB00458,Imipramine,SmallMoleculeDrug,P35348,Alpha-1A adrenergic receptor,ADRA1A,466.0
2625,DB00458,Imipramine,SmallMoleculeDrug,P25100,Alpha-1D adrenergic receptor,ADRA1D,572.0
2626,DB00458,Imipramine,SmallMoleculeDrug,P11229,Muscarinic acetylcholine receptor M1,CHRM1,460.0
2627,DB00458,Imipramine,SmallMoleculeDrug,P08172,Muscarinic acetylcholine receptor M2,CHRM2,466.0
2628,DB00458,Imipramine,SmallMoleculeDrug,P20309,Muscarinic acetylcholine receptor M3,CHRM3,590.0
2629,DB00458,Imipramine,SmallMoleculeDrug,P08173,Muscarinic acetylcholine receptor M4,CHRM4,479.0
2630,DB00458,Imipramine,SmallMoleculeDrug,P08912,Muscarinic acetylcholine receptor M5,CHRM5,532.0
2631,DB00458,Imipramine,SmallMoleculeDrug,Q9NZV8,Potassium voltage-gated channel subfamily D member 2,KCND2,630.0
2632,DB00458,Imipramine,SmallMoleculeDrug,Q9UK17,Potassium voltage-gated channel subfamily D member 3,KCND3,655.0
2633,DB00458,Imipramine,SmallMoleculeDrug,P28335,5-hydroxytryptamine receptor 2C,HTR2C,458.0
2634,DB00458,Imipramine,SmallMoleculeDrug,P35368,Alpha-1B adrenergic receptor,ADRA1B,520.0
2635,DB00458,Imipramine,SmallMoleculeDrug,P34969,5-hydroxytryptamine receptor 7,HTR7,479.0
2636,DB00458,Imipramine,SmallMoleculeDrug,P21728,D(1A) dopamine receptor,DRD1,446.0
2637,DB00458,Imipramine,SmallMoleculeDrug,P21918,D(1B) dopamine receptor,DRD5,477.0
2638,DB00458,Imipramine,SmallMoleculeDrug,P14416,D(2) dopamine receptor,DRD2,443.0
2639,DB00458,Imipramine,SmallMoleculeDrug,Q12809,Potassium voltage-gated channel subfamily H member 2,KCNH2,1159.0
2640,DB00458,Imipramine,SmallMoleculeDrug,Q01959,Sodium-dependent dopamine transporter,SLC6A3,620.0
2641,DB00458,Imipramine,SmallMoleculeDrug,P08908,5-hydroxytryptamine receptor 1A,HTR1A,422.0
2642,DB00458,Imipramine,SmallMoleculeDrug,P50406,5-hydroxytryptamine receptor 6,HTR6,440.0
2643,DB00459,Acitretin,SmallMoleculeDrug,P19793,Retinoic acid receptor RXR-alpha,RXRA,462.0
2644,DB00459,Acitretin,SmallMoleculeDrug,P10276,Retinoic acid receptor alpha,RARA,462.0
2645,DB00459,Acitretin,SmallMoleculeDrug,P10826,Retinoic acid receptor beta,RARB,455.0
2646,DB00459,Acitretin,SmallMoleculeDrug,P13631,Retinoic acid receptor gamma,RARG,454.0
2647,DB00459,Acitretin,SmallMoleculeDrug,P28702,Retinoic acid receptor RXR-beta,RXRB,533.0
2648,DB00459,Acitretin,SmallMoleculeDrug,P48443,Retinoic acid receptor RXR-gamma,RXRG,463.0
2649,DB00459,Acitretin,SmallMoleculeDrug,P09455,Retinol-binding protein 1,RBP1,135.0
2650,DB00461,Nabumetone,SmallMoleculeDrug,P35354,Prostaglandin G/H synthase 2,PTGS2,604.0
2651,DB00461,Nabumetone,SmallMoleculeDrug,P23219,Prostaglandin G/H synthase 1,PTGS1,599.0
2652,DB00462,Methylscopolamine bromide,SmallMoleculeDrug,P11229,Muscarinic acetylcholine receptor M1,CHRM1,460.0
2653,DB00462,Methylscopolamine bromide,SmallMoleculeDrug,P08172,Muscarinic acetylcholine receptor M2,CHRM2,466.0
2654,DB00462,Methylscopolamine bromide,SmallMoleculeDrug,P20309,Muscarinic acetylcholine receptor M3,CHRM3,590.0
2655,DB00463,Metharbital,SmallMoleculeDrug,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,456.0
2656,DB00463,Metharbital,SmallMoleculeDrug,P47869,Gamma-aminobutyric acid receptor subunit alpha-2,GABRA2,451.0
2657,DB00463,Metharbital,SmallMoleculeDrug,P34903,Gamma-aminobutyric acid receptor subunit alpha-3,GABRA3,492.0
2658,DB00463,Metharbital,SmallMoleculeDrug,P48169,Gamma-aminobutyric acid receptor subunit alpha-4,GABRA4,554.0
2659,DB00463,Metharbital,SmallMoleculeDrug,P31644,Gamma-aminobutyric acid receptor subunit alpha-5,GABRA5,462.0
2660,DB00463,Metharbital,SmallMoleculeDrug,Q16445,Gamma-aminobutyric acid receptor subunit alpha-6,GABRA6,453.0
2661,DB00463,Metharbital,SmallMoleculeDrug,P43681,Neuronal acetylcholine receptor subunit alpha-4,CHRNA4,627.0
2662,DB00463,Metharbital,SmallMoleculeDrug,P36544,Neuronal acetylcholine receptor subunit alpha-7,CHRNA7,502.0
2663,DB00463,Metharbital,SmallMoleculeDrug,P42262,Glutamate receptor 2,GRIA2,883.0
2664,DB00463,Metharbital,SmallMoleculeDrug,Q13002,"Glutamate receptor ionotropic, kainate 2",GRIK2,908.0
2665,DB00463,Metharbital,SmallMoleculeDrug,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,456.0
2666,DB00463,Metharbital,SmallMoleculeDrug,P47869,Gamma-aminobutyric acid receptor subunit alpha-2,GABRA2,451.0
2667,DB00463,Metharbital,SmallMoleculeDrug,P34903,Gamma-aminobutyric acid receptor subunit alpha-3,GABRA3,492.0
2668,DB00463,Metharbital,SmallMoleculeDrug,P48169,Gamma-aminobutyric acid receptor subunit alpha-4,GABRA4,554.0
2669,DB00463,Metharbital,SmallMoleculeDrug,P31644,Gamma-aminobutyric acid receptor subunit alpha-5,GABRA5,462.0
2670,DB00463,Metharbital,SmallMoleculeDrug,Q16445,Gamma-aminobutyric acid receptor subunit alpha-6,GABRA6,453.0
2671,DB00463,Metharbital,SmallMoleculeDrug,P18505,Gamma-aminobutyric acid receptor subunit beta-1,GABRB1,474.0
2672,DB00463,Metharbital,SmallMoleculeDrug,P47870,Gamma-aminobutyric acid receptor subunit beta-2,GABRB2,512.0
2673,DB00463,Metharbital,SmallMoleculeDrug,P28472,Gamma-aminobutyric acid receptor subunit beta-3,GABRB3,473.0
2674,DB00463,Metharbital,SmallMoleculeDrug,O14764,Gamma-aminobutyric acid receptor subunit delta,GABRD,452.0
2675,DB00463,Metharbital,SmallMoleculeDrug,P78334,Gamma-aminobutyric acid receptor subunit epsilon,GABRE,506.0
2676,DB00463,Metharbital,SmallMoleculeDrug,Q8N1C3,Gamma-aminobutyric acid receptor subunit gamma-1,GABRG1,465.0
2677,DB00463,Metharbital,SmallMoleculeDrug,P18507,Gamma-aminobutyric acid receptor subunit gamma-2,GABRG2,467.0
2678,DB00463,Metharbital,SmallMoleculeDrug,Q99928,Gamma-aminobutyric acid receptor subunit gamma-3,GABRG3,467.0
2679,DB00463,Metharbital,SmallMoleculeDrug,O00591,Gamma-aminobutyric acid receptor subunit pi,GABRP,440.0
2680,DB00463,Metharbital,SmallMoleculeDrug,Q9UN88,Gamma-aminobutyric acid receptor subunit theta,GABRQ,632.0
2681,DB00464,Sodium Tetradecyl Sulfate,SmallMoleculeDrug,P04070,Vitamin K-dependent protein C,PROC,461.0
2682,DB00464,Sodium Tetradecyl Sulfate,SmallMoleculeDrug,P07225,Vitamin K-dependent protein S,PROS1,676.0
2683,DB00465,Ketorolac,SmallMoleculeDrug,P35354,Prostaglandin G/H synthase 2,PTGS2,604.0
2684,DB00465,Ketorolac,SmallMoleculeDrug,P23219,Prostaglandin G/H synthase 1,PTGS1,599.0
2685,DB00466,Picrotoxin,SmallMoleculeDrug,P24046,Gamma-aminobutyric acid receptor subunit rho-1,GABRR1,479.0
2686,DB00466,Picrotoxin,SmallMoleculeDrug,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,456.0
2687,DB00466,Picrotoxin,SmallMoleculeDrug,P23416,Glycine receptor subunit alpha-2,GLRA2,452.0
2688,DB00466,Picrotoxin,SmallMoleculeDrug,O75311,Glycine receptor subunit alpha-3,GLRA3,464.0
2691,DB00467,Enoxacin,SmallMoleculeDrug,P11388,DNA topoisomerase 2-alpha,TOP2A,1531.0
2692,DB00468,Quinine,SmallMoleculeDrug,P14770,Platelet glycoprotein IX,GP9,177.0
2693,DB00468,Quinine,SmallMoleculeDrug,O15554,Intermediate conductance calcium-activated potassium channel protein 4,KCNN4,427.0
2694,DB00469,Tenoxicam,SmallMoleculeDrug,P35354,Prostaglandin G/H synthase 2,PTGS2,604.0
2695,DB00469,Tenoxicam,SmallMoleculeDrug,P23219,Prostaglandin G/H synthase 1,PTGS1,599.0
2696,DB00470,Dronabinol,SmallMoleculeDrug,P21554,Cannabinoid receptor 1,CNR1,472.0
2697,DB00470,Dronabinol,SmallMoleculeDrug,P34972,Cannabinoid receptor 2,CNR2,360.0
2698,DB00471,Montelukast,SmallMoleculeDrug,Q9Y271,Cysteinyl leukotriene receptor 1,CYSLTR1,337.0
2699,DB00471,Montelukast,SmallMoleculeDrug,P09917,Arachidonate 5-lipoxygenase,ALOX5,674.0
2700,DB00472,Fluoxetine,SmallMoleculeDrug,P31645,Sodium-dependent serotonin transporter,SLC6A4,630.0
2701,DB00473,Hexylcaine,SmallMoleculeDrug,Q14524,Sodium channel protein type 5 subunit alpha,SCN5A,2016.0
2702,DB00473,Hexylcaine,SmallMoleculeDrug,Q9Y5Y9,Sodium channel protein type 10 subunit alpha,SCN10A,1956.0
2703,DB00474,Methohexital,SmallMoleculeDrug,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,456.0
2704,DB00475,Chlordiazepoxide,SmallMoleculeDrug,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,456.0
2705,DB00475,Chlordiazepoxide,SmallMoleculeDrug,P47869,Gamma-aminobutyric acid receptor subunit alpha-2,GABRA2,451.0
2706,DB00475,Chlordiazepoxide,SmallMoleculeDrug,P34903,Gamma-aminobutyric acid receptor subunit alpha-3,GABRA3,492.0
2707,DB00475,Chlordiazepoxide,SmallMoleculeDrug,P48169,Gamma-aminobutyric acid receptor subunit alpha-4,GABRA4,554.0
2708,DB00475,Chlordiazepoxide,SmallMoleculeDrug,P31644,Gamma-aminobutyric acid receptor subunit alpha-5,GABRA5,462.0
2709,DB00475,Chlordiazepoxide,SmallMoleculeDrug,Q16445,Gamma-aminobutyric acid receptor subunit alpha-6,GABRA6,453.0
2710,DB00475,Chlordiazepoxide,SmallMoleculeDrug,P18505,Gamma-aminobutyric acid receptor subunit beta-1,GABRB1,474.0
2711,DB00475,Chlordiazepoxide,SmallMoleculeDrug,P47870,Gamma-aminobutyric acid receptor subunit beta-2,GABRB2,512.0
2712,DB00475,Chlordiazepoxide,SmallMoleculeDrug,P28472,Gamma-aminobutyric acid receptor subunit beta-3,GABRB3,473.0
2713,DB00475,Chlordiazepoxide,SmallMoleculeDrug,O14764,Gamma-aminobutyric acid receptor subunit delta,GABRD,452.0
2714,DB00475,Chlordiazepoxide,SmallMoleculeDrug,P78334,Gamma-aminobutyric acid receptor subunit epsilon,GABRE,506.0
2715,DB00475,Chlordiazepoxide,SmallMoleculeDrug,Q8N1C3,Gamma-aminobutyric acid receptor subunit gamma-1,GABRG1,465.0
2716,DB00475,Chlordiazepoxide,SmallMoleculeDrug,P18507,Gamma-aminobutyric acid receptor subunit gamma-2,GABRG2,467.0
2717,DB00475,Chlordiazepoxide,SmallMoleculeDrug,Q99928,Gamma-aminobutyric acid receptor subunit gamma-3,GABRG3,467.0
2718,DB00475,Chlordiazepoxide,SmallMoleculeDrug,O00591,Gamma-aminobutyric acid receptor subunit pi,GABRP,440.0
2719,DB00475,Chlordiazepoxide,SmallMoleculeDrug,Q9UN88,Gamma-aminobutyric acid receptor subunit theta,GABRQ,632.0
2720,DB00476,Duloxetine,SmallMoleculeDrug,P31645,Sodium-dependent serotonin transporter,SLC6A4,630.0
2721,DB00476,Duloxetine,SmallMoleculeDrug,P23975,Sodium-dependent noradrenaline transporter,SLC6A2,617.0
2722,DB00476,Duloxetine,SmallMoleculeDrug,Q01959,Sodium-dependent dopamine transporter,SLC6A3,620.0
2723,DB00477,Chlorpromazine,SmallMoleculeDrug,P14416,D(2) dopamine receptor,DRD2,443.0
2724,DB00477,Chlorpromazine,SmallMoleculeDrug,P21728,D(1A) dopamine receptor,DRD1,446.0
2725,DB00477,Chlorpromazine,SmallMoleculeDrug,P28223,5-hydroxytryptamine receptor 2A,HTR2A,471.0
2726,DB00477,Chlorpromazine,SmallMoleculeDrug,P08908,5-hydroxytryptamine receptor 1A,HTR1A,422.0
2727,DB00477,Chlorpromazine,SmallMoleculeDrug,P35348,Alpha-1A adrenergic receptor,ADRA1A,466.0
2728,DB00477,Chlorpromazine,SmallMoleculeDrug,P35368,Alpha-1B adrenergic receptor,ADRA1B,520.0
2729,DB00477,Chlorpromazine,SmallMoleculeDrug,P35367,Histamine H1 receptor,HRH1,487.0
2730,DB00477,Chlorpromazine,SmallMoleculeDrug,Q12809,Potassium voltage-gated channel subfamily H member 2,KCNH2,1159.0
2731,DB00477,Chlorpromazine,SmallMoleculeDrug,P21728,D(1A) dopamine receptor,DRD1,446.0
2732,DB00477,Chlorpromazine,SmallMoleculeDrug,P21918,D(1B) dopamine receptor,DRD5,477.0
2733,DB00477,Chlorpromazine,SmallMoleculeDrug,P35462,D(3) dopamine receptor,DRD3,400.0
2734,DB00477,Chlorpromazine,SmallMoleculeDrug,P21917,D(4) dopamine receptor,DRD4,467.0
2735,DB00477,Chlorpromazine,SmallMoleculeDrug,P21918,D(1B) dopamine receptor,DRD5,477.0
2736,DB00477,Chlorpromazine,SmallMoleculeDrug,P28335,5-hydroxytryptamine receptor 2C,HTR2C,458.0
2737,DB00477,Chlorpromazine,SmallMoleculeDrug,P28223,5-hydroxytryptamine receptor 2A,HTR2A,471.0
2738,DB00477,Chlorpromazine,SmallMoleculeDrug,P41595,5-hydroxytryptamine receptor 2B,HTR2B,481.0
2739,DB00477,Chlorpromazine,SmallMoleculeDrug,P28335,5-hydroxytryptamine receptor 2C,HTR2C,458.0
2740,DB00477,Chlorpromazine,SmallMoleculeDrug,P35348,Alpha-1A adrenergic receptor,ADRA1A,466.0
2741,DB00477,Chlorpromazine,SmallMoleculeDrug,P35368,Alpha-1B adrenergic receptor,ADRA1B,520.0
2742,DB00477,Chlorpromazine,SmallMoleculeDrug,P25100,Alpha-1D adrenergic receptor,ADRA1D,572.0
2743,DB00477,Chlorpromazine,SmallMoleculeDrug,P08913,Alpha-2A adrenergic receptor,ADRA2A,450.0
2744,DB00477,Chlorpromazine,SmallMoleculeDrug,P18089,Alpha-2B adrenergic receptor,ADRA2B,450.0
2745,DB00477,Chlorpromazine,SmallMoleculeDrug,P18825,Alpha-2C adrenergic receptor,ADRA2C,462.0
2746,DB00477,Chlorpromazine,SmallMoleculeDrug,P11229,Muscarinic acetylcholine receptor M1,CHRM1,460.0
2747,DB00477,Chlorpromazine,SmallMoleculeDrug,P20309,Muscarinic acetylcholine receptor M3,CHRM3,590.0
2748,DB00477,Chlorpromazine,SmallMoleculeDrug,P17405,Sphingomyelin phosphodiesterase,SMPD1,629.0
2750,DB00477,Chlorpromazine,SmallMoleculeDrug,P02763,Alpha-1-acid glycoprotein 1,ORM1,201.0
2751,DB00477,Chlorpromazine,SmallMoleculeDrug,P19652,Alpha-1-acid glycoprotein 2,ORM2,201.0
2752,DB00477,Chlorpromazine,SmallMoleculeDrug,P50406,5-hydroxytryptamine receptor 6,HTR6,440.0
2753,DB00477,Chlorpromazine,SmallMoleculeDrug,P34969,5-hydroxytryptamine receptor 7,HTR7,479.0
2754,DB00477,Chlorpromazine,SmallMoleculeDrug,Q9H3N8,Histamine H4 receptor,HRH4,390.0
2757,DB00480,Lenalidomide,SmallMoleculeDrug,Q96SW2,Protein cereblon,CRBN,442.0
2758,DB00480,Lenalidomide,SmallMoleculeDrug,O14788,Tumor necrosis factor ligand superfamily member 11,TNFSF11,317.0
2759,DB00480,Lenalidomide,SmallMoleculeDrug,P33151,Cadherin-5,CDH5,784.0
2760,DB00480,Lenalidomide,SmallMoleculeDrug,P35354,Prostaglandin G/H synthase 2,PTGS2,604.0
2761,DB00481,Raloxifene,SmallMoleculeDrug,P03372,Estrogen receptor,ESR1,595.0
2762,DB00481,Raloxifene,SmallMoleculeDrug,Q92731,Estrogen receptor beta,ESR2,530.0
2763,DB00482,Celecoxib,SmallMoleculeDrug,P35354,Prostaglandin G/H synthase 2,PTGS2,604.0
2764,DB00482,Celecoxib,SmallMoleculeDrug,O15530,3-phosphoinositide-dependent protein kinase 1,PDPK1,556.0
2765,DB00483,Gallamine Triethiodide,SmallMoleculeDrug,P08172,Muscarinic acetylcholine receptor M2,CHRM2,466.0
2766,DB00483,Gallamine Triethiodide,SmallMoleculeDrug,P22303,Acetylcholinesterase,ACHE,614.0
2767,DB00483,Gallamine Triethiodide,SmallMoleculeDrug,Q15822,Neuronal acetylcholine receptor subunit alpha-2,CHRNA2,529.0
2768,DB00484,Brimonidine,SmallMoleculeDrug,P08913,Alpha-2A adrenergic receptor,ADRA2A,450.0
2769,DB00484,Brimonidine,SmallMoleculeDrug,P18089,Alpha-2B adrenergic receptor,ADRA2B,450.0
2770,DB00484,Brimonidine,SmallMoleculeDrug,P18825,Alpha-2C adrenergic receptor,ADRA2C,462.0
2778,DB00486,Nabilone,SmallMoleculeDrug,P34972,Cannabinoid receptor 2,CNR2,360.0
2779,DB00486,Nabilone,SmallMoleculeDrug,P21554,Cannabinoid receptor 1,CNR1,472.0
2782,DB00487,Pefloxacin,SmallMoleculeDrug,P11388,DNA topoisomerase 2-alpha,TOP2A,1531.0
2784,DB00489,Sotalol,SmallMoleculeDrug,Q12809,Potassium voltage-gated channel subfamily H member 2,KCNH2,1159.0
2785,DB00489,Sotalol,SmallMoleculeDrug,P08588,Beta-1 adrenergic receptor,ADRB1,477.0
2786,DB00489,Sotalol,SmallMoleculeDrug,P07550,Beta-2 adrenergic receptor,ADRB2,413.0
2787,DB00490,Buspirone,SmallMoleculeDrug,P08908,5-hydroxytryptamine receptor 1A,HTR1A,422.0
2788,DB00490,Buspirone,SmallMoleculeDrug,P14416,D(2) dopamine receptor,DRD2,443.0
2789,DB00491,Miglitol,SmallMoleculeDrug,O43451,"Maltase-glucoamylase, intestinal",MGAM,1857.0
2790,DB00491,Miglitol,SmallMoleculeDrug,P10253,Lysosomal alpha-glucosidase,GAA,952.0
2791,DB00491,Miglitol,SmallMoleculeDrug,Q14697,Neutral alpha-glucosidase AB,GANAB,944.0
2792,DB00491,Miglitol,SmallMoleculeDrug,Q8TET4,Neutral alpha-glucosidase C,GANC,914.0
2793,DB00492,Fosinopril,SmallMoleculeDrug,P12821,Angiotensin-converting enzyme,ACE,1306.0
2799,DB00493,Cefotaxime,SmallMoleculeDrug,Q4U2R8,Solute carrier family 22 member 6,SLC22A6,563.0
2800,DB00493,Cefotaxime,SmallMoleculeDrug,Q8TCC7,Solute carrier family 22 member 8,SLC22A8,542.0
2801,DB00493,Cefotaxime,SmallMoleculeDrug,Q9NSA0,Solute carrier family 22 member 11,SLC22A11,550.0
2802,DB00493,Cefotaxime,SmallMoleculeDrug,Q9Y694,Solute carrier family 22 member 7,SLC22A7,548.0
2803,DB00493,Cefotaxime,SmallMoleculeDrug,P46059,Solute carrier family 15 member 1,SLC15A1,708.0
2804,DB00493,Cefotaxime,SmallMoleculeDrug,P02768,Serum albumin,ALB,609.0
2806,DB00493,Cefotaxime,SmallMoleculeDrug,Q16348,Solute carrier family 15 member 2,SLC15A2,729.0
2807,DB00494,Entacapone,SmallMoleculeDrug,P21964,Catechol O-methyltransferase,COMT,271.0
2809,DB00495,Zidovudine,SmallMoleculeDrug,O14746,Telomerase reverse transcriptase,TERT,1132.0
2810,DB00496,Darifenacin,SmallMoleculeDrug,P20309,Muscarinic acetylcholine receptor M3,CHRM3,590.0
2811,DB00496,Darifenacin,SmallMoleculeDrug,P11229,Muscarinic acetylcholine receptor M1,CHRM1,460.0
2812,DB00496,Darifenacin,SmallMoleculeDrug,P08172,Muscarinic acetylcholine receptor M2,CHRM2,466.0
2813,DB00496,Darifenacin,SmallMoleculeDrug,P08173,Muscarinic acetylcholine receptor M4,CHRM4,479.0
2814,DB00496,Darifenacin,SmallMoleculeDrug,P08912,Muscarinic acetylcholine receptor M5,CHRM5,532.0
2815,DB00497,Oxycodone,SmallMoleculeDrug,P35372,Mu-type opioid receptor,OPRM1,400.0
2816,DB00497,Oxycodone,SmallMoleculeDrug,P41145,Kappa-type opioid receptor,OPRK1,380.0
2817,DB00497,Oxycodone,SmallMoleculeDrug,P41143,Delta-type opioid receptor,OPRD1,372.0
2818,DB00497,Oxycodone,SmallMoleculeDrug,P02763,Alpha-1-acid glycoprotein 1,ORM1,201.0
2819,DB00497,Oxycodone,SmallMoleculeDrug,P19652,Alpha-1-acid glycoprotein 2,ORM2,201.0
2820,DB00498,Phenindione,SmallMoleculeDrug,Q9BQB6,Vitamin K epoxide reductase complex subunit 1,VKORC1,163.0
2821,DB00499,Flutamide,SmallMoleculeDrug,P10275,Androgen receptor,AR,920.0
2822,DB00499,Flutamide,SmallMoleculeDrug,P35869,Aryl hydrocarbon receptor,AHR,848.0
2823,DB00500,Tolmetin,SmallMoleculeDrug,P35354,Prostaglandin G/H synthase 2,PTGS2,604.0
2824,DB00500,Tolmetin,SmallMoleculeDrug,P23219,Prostaglandin G/H synthase 1,PTGS1,599.0
2825,DB00501,Cimetidine,SmallMoleculeDrug,P25021,Histamine H2 receptor,HRH2,359.0
2826,DB00502,Haloperidol,SmallMoleculeDrug,P14416,D(2) dopamine receptor,DRD2,443.0
2827,DB00502,Haloperidol,SmallMoleculeDrug,P21728,D(1A) dopamine receptor,DRD1,446.0
2828,DB00502,Haloperidol,SmallMoleculeDrug,Q13224,"Glutamate receptor ionotropic, NMDA 2B",GRIN2B,1484.0
2829,DB00502,Haloperidol,SmallMoleculeDrug,P28223,5-hydroxytryptamine receptor 2A,HTR2A,471.0
2830,DB00502,Haloperidol,SmallMoleculeDrug,P35462,D(3) dopamine receptor,DRD3,400.0
2832,DB00504,Levallorphan,SmallMoleculeDrug,P35372,Mu-type opioid receptor,OPRM1,400.0
2833,DB00505,Tridihexethyl,SmallMoleculeDrug,P20309,Muscarinic acetylcholine receptor M3,CHRM3,590.0
2834,DB00505,Tridihexethyl,SmallMoleculeDrug,P11229,Muscarinic acetylcholine receptor M1,CHRM1,460.0
2835,DB00505,Tridihexethyl,SmallMoleculeDrug,P08172,Muscarinic acetylcholine receptor M2,CHRM2,466.0
2837,DB00508,Triflupromazine,SmallMoleculeDrug,P21728,D(1A) dopamine receptor,DRD1,446.0
2838,DB00508,Triflupromazine,SmallMoleculeDrug,P14416,D(2) dopamine receptor,DRD2,443.0
2839,DB00508,Triflupromazine,SmallMoleculeDrug,P41595,5-hydroxytryptamine receptor 2B,HTR2B,481.0
2840,DB00508,Triflupromazine,SmallMoleculeDrug,P11229,Muscarinic acetylcholine receptor M1,CHRM1,460.0
2841,DB00508,Triflupromazine,SmallMoleculeDrug,P08172,Muscarinic acetylcholine receptor M2,CHRM2,466.0
2842,DB00509,Dextrothyroxine,SmallMoleculeDrug,P10827,Thyroid hormone receptor alpha,THRA,490.0
2843,DB00509,Dextrothyroxine,SmallMoleculeDrug,P10828,Thyroid hormone receptor beta,THRB,461.0
2844,DB00509,Dextrothyroxine,SmallMoleculeDrug,P07202,Thyroid peroxidase,TPO,933.0
2845,DB00511,Acetyldigitoxin,SmallMoleculeDrug,P05023,Sodium/potassium-transporting ATPase subunit alpha-1,ATP1A1,1023.0
2847,DB00512,Vancomycin,SmallMoleculeDrug,P02768,Serum albumin,ALB,609.0
2849,DB00513,Aminocaproic Acid,SmallMoleculeDrug,P00747,Plasminogen,PLG,810.0
2850,DB00513,Aminocaproic Acid,SmallMoleculeDrug,P00750,Tissue-type plasminogen activator,PLAT,562.0
2851,DB00513,Aminocaproic Acid,SmallMoleculeDrug,P08519,Apolipoprotein(a),LPA,4548.0
2852,DB00514,Dextromethorphan,SmallMoleculeDrug,Q99720,Sigma non-opioid intracellular receptor 1,SIGMAR1,223.0
2853,DB00514,Dextromethorphan,SmallMoleculeDrug,Q5T1J1,"HCG20471, isoform CRA_c",SIGMAR1,134.0
2854,DB00514,Dextromethorphan,SmallMoleculeDrug,Q8TCU5,"Glutamate receptor ionotropic, NMDA 3A",GRIN3A,1115.0
2855,DB00514,Dextromethorphan,SmallMoleculeDrug,Q15822,Neuronal acetylcholine receptor subunit alpha-2,CHRNA2,529.0
2856,DB00514,Dextromethorphan,SmallMoleculeDrug,P31645,Sodium-dependent serotonin transporter,SLC6A4,630.0
2857,DB00514,Dextromethorphan,SmallMoleculeDrug,O00264,Membrane-associated progesterone receptor component 1,PGRMC1,195.0
2858,DB00514,Dextromethorphan,SmallMoleculeDrug,P32297,Neuronal acetylcholine receptor subunit alpha-3,CHRNA3,505.0
2859,DB00514,Dextromethorphan,SmallMoleculeDrug,P43681,Neuronal acetylcholine receptor subunit alpha-4,CHRNA4,627.0
2860,DB00514,Dextromethorphan,SmallMoleculeDrug,P30926,Neuronal acetylcholine receptor subunit beta-4,CHRNB4,498.0
2861,DB00514,Dextromethorphan,SmallMoleculeDrug,P17787,Neuronal acetylcholine receptor subunit beta-2,CHRNB2,502.0
2862,DB00514,Dextromethorphan,SmallMoleculeDrug,P36544,Neuronal acetylcholine receptor subunit alpha-7,CHRNA7,502.0
2863,DB00514,Dextromethorphan,SmallMoleculeDrug,P35372,Mu-type opioid receptor,OPRM1,400.0
2864,DB00514,Dextromethorphan,SmallMoleculeDrug,P41143,Delta-type opioid receptor,OPRD1,372.0
2865,DB00514,Dextromethorphan,SmallMoleculeDrug,P41145,Kappa-type opioid receptor,OPRK1,380.0
2866,DB00514,Dextromethorphan,SmallMoleculeDrug,P04839,Cytochrome b-245 heavy chain,CYBB,570.0
2867,DB00514,Dextromethorphan,SmallMoleculeDrug,P13498,Cytochrome b-245 light chain,CYBA,195.0
2868,DB00514,Dextromethorphan,SmallMoleculeDrug,P14598,Neutrophil cytosol factor 1,NCF1,390.0
2869,DB00514,Dextromethorphan,SmallMoleculeDrug,P19878,Neutrophil cytosol factor 2,NCF2,526.0
2870,DB00514,Dextromethorphan,SmallMoleculeDrug,Q15080,Neutrophil cytosol factor 4,NCF4,339.0
2871,DB00514,Dextromethorphan,SmallMoleculeDrug,P63000,Ras-related C3 botulinum toxin substrate 1,RAC1,192.0
2872,DB00514,Dextromethorphan,SmallMoleculeDrug,P15153,Ras-related C3 botulinum toxin substrate 2,RAC2,192.0
2873,DB00514,Dextromethorphan,SmallMoleculeDrug,P23975,Sodium-dependent noradrenaline transporter,SLC6A2,617.0
2874,DB00517,Anisotropine Methylbromide,SmallMoleculeDrug,P11229,Muscarinic acetylcholine receptor M1,CHRM1,460.0
2875,DB00517,Anisotropine Methylbromide,SmallMoleculeDrug,P08172,Muscarinic acetylcholine receptor M2,CHRM2,466.0
2876,DB00517,Anisotropine Methylbromide,SmallMoleculeDrug,P20309,Muscarinic acetylcholine receptor M3,CHRM3,590.0
2878,DB00518,Albendazole,SmallMoleculeDrug,Q71U36,Tubulin alpha-1A chain,TUBA1A,451.0
2879,DB00518,Albendazole,SmallMoleculeDrug,P68371,Tubulin beta-4B chain,TUBB4B,445.0
2881,DB00519,Trandolapril,SmallMoleculeDrug,P12821,Angiotensin-converting enzyme,ACE,1306.0
2883,DB00521,Carteolol,SmallMoleculeDrug,P07550,Beta-2 adrenergic receptor,ADRB2,413.0
2884,DB00521,Carteolol,SmallMoleculeDrug,P08588,Beta-1 adrenergic receptor,ADRB1,477.0
2885,DB00522,Bentiromide,SmallMoleculeDrug,P05981,Serine protease hepsin,HPN,417.0
2886,DB00523,Alitretinoin,SmallMoleculeDrug,P10276,Retinoic acid receptor alpha,RARA,462.0
2887,DB00523,Alitretinoin,SmallMoleculeDrug,P19793,Retinoic acid receptor RXR-alpha,RXRA,462.0
2888,DB00523,Alitretinoin,SmallMoleculeDrug,P10826,Retinoic acid receptor beta,RARB,455.0
2889,DB00523,Alitretinoin,SmallMoleculeDrug,P28702,Retinoic acid receptor RXR-beta,RXRB,533.0
2890,DB00523,Alitretinoin,SmallMoleculeDrug,P13631,Retinoic acid receptor gamma,RARG,454.0
2891,DB00523,Alitretinoin,SmallMoleculeDrug,P48443,Retinoic acid receptor RXR-gamma,RXRG,463.0
2892,DB00524,Metolazone,SmallMoleculeDrug,P55017,Solute carrier family 12 member 3,SLC12A3,1021.0
2894,DB00527,Cinchocaine,SmallMoleculeDrug,Q9Y5Y9,Sodium channel protein type 10 subunit alpha,SCN10A,1956.0
2895,DB00527,Cinchocaine,SmallMoleculeDrug,Q14524,Sodium channel protein type 5 subunit alpha,SCN5A,2016.0
2897,DB00528,Lercanidipine,SmallMoleculeDrug,Q06432,Voltage-dependent calcium channel gamma-1 subunit,CACNG1,222.0
2900,DB00530,Erlotinib,SmallMoleculeDrug,P00533,Epidermal growth factor receptor,EGFR,1210.0
2901,DB00530,Erlotinib,SmallMoleculeDrug,O75469,Nuclear receptor subfamily 1 group I member 2,NR1I2,434.0
2902,DB00532,Mephenytoin,SmallMoleculeDrug,Q14524,Sodium channel protein type 5 subunit alpha,SCN5A,2016.0
2903,DB00533,Rofecoxib,SmallMoleculeDrug,P35354,Prostaglandin G/H synthase 2,PTGS2,604.0
2904,DB00533,Rofecoxib,SmallMoleculeDrug,P15502,Elastin,ELN,786.0
2905,DB00534,Chlormerodrin,SmallMoleculeDrug,Q13621,Solute carrier family 12 member 1,SLC12A1,1099.0
2906,DB00534,Chlormerodrin,SmallMoleculeDrug,P51649,"Succinate-semialdehyde dehydrogenase, mitochondrial",ALDH5A1,535.0
2909,DB00535,Cefdinir,SmallMoleculeDrug,P05164,Myeloperoxidase,MPO,745.0
2911,DB00536,Guanidine,SmallMoleculeDrug,Q14353,Guanidinoacetate N-methyltransferase,GAMT,236.0
2912,DB00536,Guanidine,SmallMoleculeDrug,P07998,Ribonuclease pancreatic,RNASE1,156.0
2913,DB00536,Guanidine,SmallMoleculeDrug,P78352,Disks large homolog 4,DLG4,724.0
2915,DB00536,Guanidine,SmallMoleculeDrug,P05091,"Aldehyde dehydrogenase, mitochondrial",ALDH2,517.0
2919,DB00537,Ciprofloxacin,SmallMoleculeDrug,P11388,DNA topoisomerase 2-alpha,TOP2A,1531.0
2920,DB00537,Ciprofloxacin,SmallMoleculeDrug,Q12809,Potassium voltage-gated channel subfamily H member 2,KCNH2,1159.0
2928,DB00539,Toremifene,SmallMoleculeDrug,P03372,Estrogen receptor,ESR1,595.0
2929,DB00540,Nortriptyline,SmallMoleculeDrug,P23975,Sodium-dependent noradrenaline transporter,SLC6A2,617.0
2930,DB00540,Nortriptyline,SmallMoleculeDrug,P31645,Sodium-dependent serotonin transporter,SLC6A4,630.0
2931,DB00540,Nortriptyline,SmallMoleculeDrug,P28223,5-hydroxytryptamine receptor 2A,HTR2A,471.0
2932,DB00540,Nortriptyline,SmallMoleculeDrug,P08908,5-hydroxytryptamine receptor 1A,HTR1A,422.0
2933,DB00540,Nortriptyline,SmallMoleculeDrug,P35367,Histamine H1 receptor,HRH1,487.0
2934,DB00540,Nortriptyline,SmallMoleculeDrug,P35348,Alpha-1A adrenergic receptor,ADRA1A,466.0
2935,DB00540,Nortriptyline,SmallMoleculeDrug,P25100,Alpha-1D adrenergic receptor,ADRA1D,572.0
2936,DB00540,Nortriptyline,SmallMoleculeDrug,P11229,Muscarinic acetylcholine receptor M1,CHRM1,460.0
2937,DB00540,Nortriptyline,SmallMoleculeDrug,P08172,Muscarinic acetylcholine receptor M2,CHRM2,466.0
2938,DB00540,Nortriptyline,SmallMoleculeDrug,P20309,Muscarinic acetylcholine receptor M3,CHRM3,590.0
2939,DB00540,Nortriptyline,SmallMoleculeDrug,P08173,Muscarinic acetylcholine receptor M4,CHRM4,479.0
2940,DB00540,Nortriptyline,SmallMoleculeDrug,P08912,Muscarinic acetylcholine receptor M5,CHRM5,532.0
2941,DB00540,Nortriptyline,SmallMoleculeDrug,P28335,5-hydroxytryptamine receptor 2C,HTR2C,458.0
2942,DB00540,Nortriptyline,SmallMoleculeDrug,P50406,5-hydroxytryptamine receptor 6,HTR6,440.0
2943,DB00540,Nortriptyline,SmallMoleculeDrug,P35368,Alpha-1B adrenergic receptor,ADRA1B,520.0
2944,DB00540,Nortriptyline,SmallMoleculeDrug,P08913,Alpha-2A adrenergic receptor,ADRA2A,450.0
2945,DB00540,Nortriptyline,SmallMoleculeDrug,P18089,Alpha-2B adrenergic receptor,ADRA2B,450.0
2946,DB00540,Nortriptyline,SmallMoleculeDrug,P18825,Alpha-2C adrenergic receptor,ADRA2C,462.0
2947,DB00540,Nortriptyline,SmallMoleculeDrug,P08588,Beta-1 adrenergic receptor,ADRB1,477.0
2948,DB00540,Nortriptyline,SmallMoleculeDrug,P07550,Beta-2 adrenergic receptor,ADRB2,413.0
2949,DB00540,Nortriptyline,SmallMoleculeDrug,P13945,Beta-3 adrenergic receptor,ADRB3,408.0
2950,DB00540,Nortriptyline,SmallMoleculeDrug,P14416,D(2) dopamine receptor,DRD2,443.0
2951,DB00540,Nortriptyline,SmallMoleculeDrug,O00264,Membrane-associated progesterone receptor component 1,PGRMC1,195.0
2952,DB00540,Nortriptyline,SmallMoleculeDrug,Q99720,Sigma non-opioid intracellular receptor 1,SIGMAR1,223.0
2954,DB00541,Vincristine,SmallMoleculeDrug,P07437,Tubulin beta chain,TUBB,444.0
2955,DB00541,Vincristine,SmallMoleculeDrug,P68366,Tubulin alpha-4A chain,TUBA4A,448.0
2956,DB00542,Benazepril,SmallMoleculeDrug,P12821,Angiotensin-converting enzyme,ACE,1306.0
2957,DB00543,Amoxapine,SmallMoleculeDrug,P23975,Sodium-dependent noradrenaline transporter,SLC6A2,617.0
2958,DB00543,Amoxapine,SmallMoleculeDrug,P31645,Sodium-dependent serotonin transporter,SLC6A4,630.0
2959,DB00543,Amoxapine,SmallMoleculeDrug,P14416,D(2) dopamine receptor,DRD2,443.0
2960,DB00543,Amoxapine,SmallMoleculeDrug,P21728,D(1A) dopamine receptor,DRD1,446.0
2961,DB00543,Amoxapine,SmallMoleculeDrug,P08913,Alpha-2A adrenergic receptor,ADRA2A,450.0
2962,DB00543,Amoxapine,SmallMoleculeDrug,P35348,Alpha-1A adrenergic receptor,ADRA1A,466.0
2963,DB00543,Amoxapine,SmallMoleculeDrug,P11229,Muscarinic acetylcholine receptor M1,CHRM1,460.0
2964,DB00543,Amoxapine,SmallMoleculeDrug,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,456.0
2965,DB00543,Amoxapine,SmallMoleculeDrug,P28223,5-hydroxytryptamine receptor 2A,HTR2A,471.0
2966,DB00543,Amoxapine,SmallMoleculeDrug,P28335,5-hydroxytryptamine receptor 2C,HTR2C,458.0
2967,DB00543,Amoxapine,SmallMoleculeDrug,P50406,5-hydroxytryptamine receptor 6,HTR6,440.0
2968,DB00543,Amoxapine,SmallMoleculeDrug,P34969,5-hydroxytryptamine receptor 7,HTR7,479.0
2969,DB00543,Amoxapine,SmallMoleculeDrug,P35462,D(3) dopamine receptor,DRD3,400.0
2970,DB00543,Amoxapine,SmallMoleculeDrug,P21917,D(4) dopamine receptor,DRD4,467.0
2971,DB00543,Amoxapine,SmallMoleculeDrug,P35367,Histamine H1 receptor,HRH1,487.0
2972,DB00543,Amoxapine,SmallMoleculeDrug,P35348,Alpha-1A adrenergic receptor,ADRA1A,466.0
2973,DB00543,Amoxapine,SmallMoleculeDrug,P35368,Alpha-1B adrenergic receptor,ADRA1B,520.0
2974,DB00543,Amoxapine,SmallMoleculeDrug,P25100,Alpha-1D adrenergic receptor,ADRA1D,572.0
2975,DB00543,Amoxapine,SmallMoleculeDrug,P11229,Muscarinic acetylcholine receptor M1,CHRM1,460.0
2976,DB00543,Amoxapine,SmallMoleculeDrug,P08172,Muscarinic acetylcholine receptor M2,CHRM2,466.0
2977,DB00543,Amoxapine,SmallMoleculeDrug,P20309,Muscarinic acetylcholine receptor M3,CHRM3,590.0
2978,DB00543,Amoxapine,SmallMoleculeDrug,P08173,Muscarinic acetylcholine receptor M4,CHRM4,479.0
2979,DB00543,Amoxapine,SmallMoleculeDrug,P08912,Muscarinic acetylcholine receptor M5,CHRM5,532.0
2980,DB00543,Amoxapine,SmallMoleculeDrug,P41595,5-hydroxytryptamine receptor 2B,HTR2B,481.0
2981,DB00543,Amoxapine,SmallMoleculeDrug,P46098,5-hydroxytryptamine receptor 3A,HTR3A,478.0
2982,DB00543,Amoxapine,SmallMoleculeDrug,P08908,5-hydroxytryptamine receptor 1A,HTR1A,422.0
2983,DB00543,Amoxapine,SmallMoleculeDrug,P28222,5-hydroxytryptamine receptor 1B,HTR1B,390.0
2984,DB00543,Amoxapine,SmallMoleculeDrug,P08913,Alpha-2A adrenergic receptor,ADRA2A,450.0
2985,DB00543,Amoxapine,SmallMoleculeDrug,P18089,Alpha-2B adrenergic receptor,ADRA2B,450.0
2986,DB00543,Amoxapine,SmallMoleculeDrug,P18825,Alpha-2C adrenergic receptor,ADRA2C,462.0
2987,DB00543,Amoxapine,SmallMoleculeDrug,Q9H3N8,Histamine H4 receptor,HRH4,390.0
2988,DB00543,Amoxapine,SmallMoleculeDrug,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,456.0
2989,DB00543,Amoxapine,SmallMoleculeDrug,P47869,Gamma-aminobutyric acid receptor subunit alpha-2,GABRA2,451.0
2990,DB00543,Amoxapine,SmallMoleculeDrug,P34903,Gamma-aminobutyric acid receptor subunit alpha-3,GABRA3,492.0
2991,DB00543,Amoxapine,SmallMoleculeDrug,P48169,Gamma-aminobutyric acid receptor subunit alpha-4,GABRA4,554.0
2992,DB00543,Amoxapine,SmallMoleculeDrug,P31644,Gamma-aminobutyric acid receptor subunit alpha-5,GABRA5,462.0
2993,DB00543,Amoxapine,SmallMoleculeDrug,Q16445,Gamma-aminobutyric acid receptor subunit alpha-6,GABRA6,453.0
2994,DB00543,Amoxapine,SmallMoleculeDrug,P18505,Gamma-aminobutyric acid receptor subunit beta-1,GABRB1,474.0
2995,DB00543,Amoxapine,SmallMoleculeDrug,P47870,Gamma-aminobutyric acid receptor subunit beta-2,GABRB2,512.0
2996,DB00543,Amoxapine,SmallMoleculeDrug,P28472,Gamma-aminobutyric acid receptor subunit beta-3,GABRB3,473.0
2997,DB00543,Amoxapine,SmallMoleculeDrug,O14764,Gamma-aminobutyric acid receptor subunit delta,GABRD,452.0
2998,DB00543,Amoxapine,SmallMoleculeDrug,P78334,Gamma-aminobutyric acid receptor subunit epsilon,GABRE,506.0
2999,DB00543,Amoxapine,SmallMoleculeDrug,Q8N1C3,Gamma-aminobutyric acid receptor subunit gamma-1,GABRG1,465.0
3000,DB00543,Amoxapine,SmallMoleculeDrug,P18507,Gamma-aminobutyric acid receptor subunit gamma-2,GABRG2,467.0
3001,DB00543,Amoxapine,SmallMoleculeDrug,Q99928,Gamma-aminobutyric acid receptor subunit gamma-3,GABRG3,467.0
3002,DB00543,Amoxapine,SmallMoleculeDrug,O00591,Gamma-aminobutyric acid receptor subunit pi,GABRP,440.0
3003,DB00543,Amoxapine,SmallMoleculeDrug,Q9UN88,Gamma-aminobutyric acid receptor subunit theta,GABRQ,632.0
3004,DB00543,Amoxapine,SmallMoleculeDrug,Q01959,Sodium-dependent dopamine transporter,SLC6A3,620.0
3005,DB00544,Fluorouracil,SmallMoleculeDrug,P04818,Thymidylate synthase,TYMS,313.0
3006,DB00545,Pyridostigmine,SmallMoleculeDrug,P22303,Acetylcholinesterase,ACHE,614.0
3007,DB00545,Pyridostigmine,SmallMoleculeDrug,P06276,Cholinesterase,BCHE,602.0
3008,DB00546,Adinazolam,SmallMoleculeDrug,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,456.0
3009,DB00546,Adinazolam,SmallMoleculeDrug,P47869,Gamma-aminobutyric acid receptor subunit alpha-2,GABRA2,451.0
3010,DB00546,Adinazolam,SmallMoleculeDrug,P34903,Gamma-aminobutyric acid receptor subunit alpha-3,GABRA3,492.0
3011,DB00546,Adinazolam,SmallMoleculeDrug,P31644,Gamma-aminobutyric acid receptor subunit alpha-5,GABRA5,462.0
3012,DB00546,Adinazolam,SmallMoleculeDrug,Q8N1C3,Gamma-aminobutyric acid receptor subunit gamma-1,GABRG1,465.0
3013,DB00546,Adinazolam,SmallMoleculeDrug,P18507,Gamma-aminobutyric acid receptor subunit gamma-2,GABRG2,467.0
3014,DB00546,Adinazolam,SmallMoleculeDrug,Q99928,Gamma-aminobutyric acid receptor subunit gamma-3,GABRG3,467.0
3015,DB00546,Adinazolam,SmallMoleculeDrug,P18505,Gamma-aminobutyric acid receptor subunit beta-1,GABRB1,474.0
3016,DB00546,Adinazolam,SmallMoleculeDrug,P47870,Gamma-aminobutyric acid receptor subunit beta-2,GABRB2,512.0
3017,DB00546,Adinazolam,SmallMoleculeDrug,P28472,Gamma-aminobutyric acid receptor subunit beta-3,GABRB3,473.0
3018,DB00546,Adinazolam,SmallMoleculeDrug,O14764,Gamma-aminobutyric acid receptor subunit delta,GABRD,452.0
3019,DB00546,Adinazolam,SmallMoleculeDrug,P78334,Gamma-aminobutyric acid receptor subunit epsilon,GABRE,506.0
3020,DB00546,Adinazolam,SmallMoleculeDrug,O00591,Gamma-aminobutyric acid receptor subunit pi,GABRP,440.0
3021,DB00546,Adinazolam,SmallMoleculeDrug,P24046,Gamma-aminobutyric acid receptor subunit rho-1,GABRR1,479.0
3022,DB00546,Adinazolam,SmallMoleculeDrug,P28476,Gamma-aminobutyric acid receptor subunit rho-2,GABRR2,465.0
3023,DB00546,Adinazolam,SmallMoleculeDrug,A8MPY1,Gamma-aminobutyric acid receptor subunit rho-3,GABRR3,467.0
3024,DB00547,Desoximetasone,SmallMoleculeDrug,P04150,Glucocorticoid receptor,NR3C1,777.0
3026,DB00548,Azelaic Acid,SmallMoleculeDrug,P51857,3-oxo-5-beta-steroid 4-dehydrogenase,AKR1D1,326.0
3027,DB00548,Azelaic Acid,SmallMoleculeDrug,P31213,3-oxo-5-alpha-steroid 4-dehydrogenase 2,SRD5A2,254.0
3028,DB00548,Azelaic Acid,SmallMoleculeDrug,P14679,Tyrosinase,TYR,529.0
3030,DB00549,Zafirlukast,SmallMoleculeDrug,Q9Y271,Cysteinyl leukotriene receptor 1,CYSLTR1,337.0
3031,DB00550,Propylthiouracil,SmallMoleculeDrug,P07202,Thyroid peroxidase,TPO,933.0
3033,DB00551,Acetohydroxamic Acid,SmallMoleculeDrug,P39900,Macrophage metalloelastase,MMP12,470.0
3034,DB00552,Pentostatin,SmallMoleculeDrug,P00813,Adenosine deaminase,ADA,363.0
3035,DB00554,Piroxicam,SmallMoleculeDrug,P35354,Prostaglandin G/H synthase 2,PTGS2,604.0
3036,DB00554,Piroxicam,SmallMoleculeDrug,P23219,Prostaglandin G/H synthase 1,PTGS1,599.0
3037,DB00555,Lamotrigine,SmallMoleculeDrug,Q99250,Sodium channel protein type 2 subunit alpha,SCN2A,2005.0
3038,DB00557,Hydroxyzine,SmallMoleculeDrug,P35367,Histamine H1 receptor,HRH1,487.0
3041,DB00558,Zanamivir,SmallMoleculeDrug,Q9Y3R4,Sialidase-2,NEU2,380.0
3042,DB00559,Bosentan,SmallMoleculeDrug,P25101,Endothelin-1 receptor,EDNRA,427.0
3043,DB00559,Bosentan,SmallMoleculeDrug,P24530,Endothelin B receptor,EDNRB,442.0
3049,DB00561,Doxapram,SmallMoleculeDrug,O14649,Potassium channel subfamily K member 3,KCNK3,394.0
3050,DB00561,Doxapram,SmallMoleculeDrug,Q9NPC2,Potassium channel subfamily K member 9,KCNK9,374.0
3051,DB00562,Benzthiazide,SmallMoleculeDrug,P55017,Solute carrier family 12 member 3,SLC12A3,1021.0
3052,DB00562,Benzthiazide,SmallMoleculeDrug,P00915,Carbonic anhydrase 1,CA1,261.0
3053,DB00562,Benzthiazide,SmallMoleculeDrug,P00918,Carbonic anhydrase 2,CA2,260.0
3054,DB00562,Benzthiazide,SmallMoleculeDrug,P22748,Carbonic anhydrase 4,CA4,312.0
3055,DB00562,Benzthiazide,SmallMoleculeDrug,Q16790,Carbonic anhydrase 9,CA9,459.0
3056,DB00562,Benzthiazide,SmallMoleculeDrug,O43570,Carbonic anhydrase 12,CA12,354.0
3057,DB00563,Methotrexate,SmallMoleculeDrug,P00374,Dihydrofolate reductase,DHFR,187.0
3058,DB00564,Carbamazepine,SmallMoleculeDrug,Q14524,Sodium channel protein type 5 subunit alpha,SCN5A,2016.0
3059,DB00565,Cisatracurium besylate,SmallMoleculeDrug,Q15822,Neuronal acetylcholine receptor subunit alpha-2,CHRNA2,529.0
3065,DB00568,Cinnarizine,SmallMoleculeDrug,P35367,Histamine H1 receptor,HRH1,487.0
3066,DB00568,Cinnarizine,SmallMoleculeDrug,Q13936,Voltage-dependent L-type calcium channel subunit alpha-1C,CACNA1C,2221.0
3067,DB00568,Cinnarizine,SmallMoleculeDrug,Q01668,Voltage-dependent L-type calcium channel subunit alpha-1D,CACNA1D,2161.0
3068,DB00568,Cinnarizine,SmallMoleculeDrug,O60840,Voltage-dependent L-type calcium channel subunit alpha-1F,CACNA1F,1977.0
3069,DB00568,Cinnarizine,SmallMoleculeDrug,Q13698,Voltage-dependent L-type calcium channel subunit alpha-1S,CACNA1S,1873.0
3070,DB00568,Cinnarizine,SmallMoleculeDrug,O43497,Voltage-dependent T-type calcium channel subunit alpha-1G,CACNA1G,2377.0
3071,DB00568,Cinnarizine,SmallMoleculeDrug,O95180,Voltage-dependent T-type calcium channel subunit alpha-1H,CACNA1H,2353.0
3072,DB00568,Cinnarizine,SmallMoleculeDrug,Q9P0X4,Voltage-dependent T-type calcium channel subunit alpha-1I,CACNA1I,2223.0
3073,DB00568,Cinnarizine,SmallMoleculeDrug,P14416,D(2) dopamine receptor,DRD2,443.0
3074,DB00568,Cinnarizine,SmallMoleculeDrug,P21728,D(1A) dopamine receptor,DRD1,446.0
3075,DB00568,Cinnarizine,SmallMoleculeDrug,P21918,D(1B) dopamine receptor,DRD5,477.0
3076,DB00568,Cinnarizine,SmallMoleculeDrug,P11229,Muscarinic acetylcholine receptor M1,CHRM1,460.0
3077,DB00568,Cinnarizine,SmallMoleculeDrug,P08172,Muscarinic acetylcholine receptor M2,CHRM2,466.0
3078,DB00568,Cinnarizine,SmallMoleculeDrug,P20309,Muscarinic acetylcholine receptor M3,CHRM3,590.0
3079,DB00568,Cinnarizine,SmallMoleculeDrug,P08173,Muscarinic acetylcholine receptor M4,CHRM4,479.0
3080,DB00568,Cinnarizine,SmallMoleculeDrug,P08912,Muscarinic acetylcholine receptor M5,CHRM5,532.0
3081,DB00569,Fondaparinux sodium,SmallMoleculeDrug,P01008,Antithrombin-III,SERPINC1,464.0
3082,DB00569,Fondaparinux sodium,SmallMoleculeDrug,P00742,Coagulation factor X,F10,488.0
3083,DB00570,Vinblastine,SmallMoleculeDrug,Q71U36,Tubulin alpha-1A chain,TUBA1A,451.0
3084,DB00570,Vinblastine,SmallMoleculeDrug,P07437,Tubulin beta chain,TUBB,444.0
3085,DB00570,Vinblastine,SmallMoleculeDrug,Q9UJT1,Tubulin delta chain,TUBD1,453.0
3086,DB00570,Vinblastine,SmallMoleculeDrug,P23258,Tubulin gamma-1 chain,TUBG1,451.0
3087,DB00570,Vinblastine,SmallMoleculeDrug,Q9UJT0,Tubulin epsilon chain,TUBE1,475.0
3088,DB00570,Vinblastine,SmallMoleculeDrug,P05412,Transcription factor AP-1,JUN,331.0
3089,DB00571,Propranolol,SmallMoleculeDrug,P08588,Beta-1 adrenergic receptor,ADRB1,477.0
3090,DB00571,Propranolol,SmallMoleculeDrug,P07550,Beta-2 adrenergic receptor,ADRB2,413.0
3091,DB00571,Propranolol,SmallMoleculeDrug,P13945,Beta-3 adrenergic receptor,ADRB3,408.0
3092,DB00571,Propranolol,SmallMoleculeDrug,P08908,5-hydroxytryptamine receptor 1A,HTR1A,422.0
3093,DB00571,Propranolol,SmallMoleculeDrug,P28222,5-hydroxytryptamine receptor 1B,HTR1B,390.0
3094,DB00572,Atropine,SmallMoleculeDrug,P11229,Muscarinic acetylcholine receptor M1,CHRM1,460.0
3095,DB00572,Atropine,SmallMoleculeDrug,P08172,Muscarinic acetylcholine receptor M2,CHRM2,466.0
3096,DB00572,Atropine,SmallMoleculeDrug,P20309,Muscarinic acetylcholine receptor M3,CHRM3,590.0
3097,DB00572,Atropine,SmallMoleculeDrug,P08173,Muscarinic acetylcholine receptor M4,CHRM4,479.0
3098,DB00572,Atropine,SmallMoleculeDrug,P08912,Muscarinic acetylcholine receptor M5,CHRM5,532.0
3099,DB00573,Fenoprofen,SmallMoleculeDrug,P35354,Prostaglandin G/H synthase 2,PTGS2,604.0
3100,DB00573,Fenoprofen,SmallMoleculeDrug,P23219,Prostaglandin G/H synthase 1,PTGS1,599.0
3101,DB00574,Fenfluramine,SmallMoleculeDrug,P31645,Sodium-dependent serotonin transporter,SLC6A4,630.0
3102,DB00574,Fenfluramine,SmallMoleculeDrug,P41595,5-hydroxytryptamine receptor 2B,HTR2B,481.0
3103,DB00574,Fenfluramine,SmallMoleculeDrug,P28335,5-hydroxytryptamine receptor 2C,HTR2C,458.0
3104,DB00575,Clonidine,SmallMoleculeDrug,P08913,Alpha-2A adrenergic receptor,ADRA2A,450.0
3105,DB00575,Clonidine,SmallMoleculeDrug,P18089,Alpha-2B adrenergic receptor,ADRA2B,450.0
3106,DB00575,Clonidine,SmallMoleculeDrug,P18825,Alpha-2C adrenergic receptor,ADRA2C,462.0
3107,DB00575,Clonidine,SmallMoleculeDrug,P35348,Alpha-1A adrenergic receptor,ADRA1A,466.0
3108,DB00575,Clonidine,SmallMoleculeDrug,P35368,Alpha-1B adrenergic receptor,ADRA1B,520.0
3109,DB00575,Clonidine,SmallMoleculeDrug,P25100,Alpha-1D adrenergic receptor,ADRA1D,572.0
3113,DB00579,Mazindol,SmallMoleculeDrug,P23975,Sodium-dependent noradrenaline transporter,SLC6A2,617.0
3114,DB00579,Mazindol,SmallMoleculeDrug,Q01959,Sodium-dependent dopamine transporter,SLC6A3,620.0
3115,DB00579,Mazindol,SmallMoleculeDrug,P31645,Sodium-dependent serotonin transporter,SLC6A4,630.0
3116,DB00580,Valdecoxib,SmallMoleculeDrug,P35354,Prostaglandin G/H synthase 2,PTGS2,604.0
3119,DB00583,L-Carnitine,SmallMoleculeDrug,Q9H015,Solute carrier family 22 member 4,SLC22A4,551.0
3120,DB00583,L-Carnitine,SmallMoleculeDrug,O76082,Solute carrier family 22 member 5,SLC22A5,557.0
3121,DB00583,L-Carnitine,SmallMoleculeDrug,P43155,Carnitine O-acetyltransferase,CRAT,626.0
3122,DB00583,L-Carnitine,SmallMoleculeDrug,Q8N8R3,Mitochondrial basic amino acids transporter,SLC25A29,303.0
3123,DB00583,L-Carnitine,SmallMoleculeDrug,O43772,Mitochondrial carnitine/acylcarnitine carrier protein,SLC25A20,301.0
3124,DB00583,L-Carnitine,SmallMoleculeDrug,Q9UKG9,Peroxisomal carnitine O-octanoyltransferase,CROT,612.0
3125,DB00583,L-Carnitine,SmallMoleculeDrug,P23786,"Carnitine O-palmitoyltransferase 2, mitochondrial",CPT2,658.0
3126,DB00583,L-Carnitine,SmallMoleculeDrug,P50416,"Carnitine O-palmitoyltransferase 1, liver isoform",CPT1A,773.0
3127,DB00583,L-Carnitine,SmallMoleculeDrug,P47989,Xanthine dehydrogenase/oxidase,XDH,1333.0
3128,DB00583,L-Carnitine,SmallMoleculeDrug,P23141,Liver carboxylesterase 1,CES1,567.0
3129,DB00583,L-Carnitine,SmallMoleculeDrug,P05164,Myeloperoxidase,MPO,745.0
3130,DB00584,Enalapril,SmallMoleculeDrug,P12821,Angiotensin-converting enzyme,ACE,1306.0
3131,DB00585,Nizatidine,SmallMoleculeDrug,P25021,Histamine H2 receptor,HRH2,359.0
3132,DB00586,Diclofenac,SmallMoleculeDrug,P35354,Prostaglandin G/H synthase 2,PTGS2,604.0
3133,DB00586,Diclofenac,SmallMoleculeDrug,P23219,Prostaglandin G/H synthase 1,PTGS1,599.0
3134,DB00586,Diclofenac,SmallMoleculeDrug,P09917,Arachidonate 5-lipoxygenase,ALOX5,674.0
3135,DB00586,Diclofenac,SmallMoleculeDrug,P35499,Sodium channel protein type 4 subunit alpha,SCN4A,1836.0
3136,DB00586,Diclofenac,SmallMoleculeDrug,P78348,Acid-sensing ion channel 1,ASIC1,528.0
3137,DB00586,Diclofenac,SmallMoleculeDrug,O43526,Potassium voltage-gated channel subfamily KQT member 2,KCNQ2,872.0
3138,DB00586,Diclofenac,SmallMoleculeDrug,O43525,Potassium voltage-gated channel subfamily KQT member 3,KCNQ3,872.0
3139,DB00586,Diclofenac,SmallMoleculeDrug,P14555,"Phospholipase A2, membrane associated",PLA2G2A,144.0
3140,DB00587,Cinalukast,SmallMoleculeDrug,Q9Y271,Cysteinyl leukotriene receptor 1,CYSLTR1,337.0
3141,DB00588,Fluticasone Propionate,SmallMoleculeDrug,P04150,Glucocorticoid receptor,NR3C1,777.0
3142,DB00588,Fluticasone Propionate,SmallMoleculeDrug,P06401,Progesterone receptor,PGR,933.0
3143,DB00588,Fluticasone Propionate,SmallMoleculeDrug,P47712,Cytosolic phospholipase A2,PLA2G4A,749.0
3144,DB00588,Fluticasone Propionate,SmallMoleculeDrug,P08235,Mineralocorticoid receptor,NR3C2,984.0
3145,DB00589,Lisuride,SmallMoleculeDrug,P14416,D(2) dopamine receptor,DRD2,443.0
3146,DB00589,Lisuride,SmallMoleculeDrug,P35462,D(3) dopamine receptor,DRD3,400.0
3147,DB00589,Lisuride,SmallMoleculeDrug,P21917,D(4) dopamine receptor,DRD4,467.0
3148,DB00589,Lisuride,SmallMoleculeDrug,P21728,D(1A) dopamine receptor,DRD1,446.0
3149,DB00589,Lisuride,SmallMoleculeDrug,P21918,D(1B) dopamine receptor,DRD5,477.0
3150,DB00589,Lisuride,SmallMoleculeDrug,P08908,5-hydroxytryptamine receptor 1A,HTR1A,422.0
3151,DB00589,Lisuride,SmallMoleculeDrug,P28221,5-hydroxytryptamine receptor 1D,HTR1D,377.0
3152,DB00589,Lisuride,SmallMoleculeDrug,P41595,5-hydroxytryptamine receptor 2B,HTR2B,481.0
3153,DB00589,Lisuride,SmallMoleculeDrug,P28223,5-hydroxytryptamine receptor 2A,HTR2A,471.0
3154,DB00589,Lisuride,SmallMoleculeDrug,P28335,5-hydroxytryptamine receptor 2C,HTR2C,458.0
3155,DB00589,Lisuride,SmallMoleculeDrug,P28222,5-hydroxytryptamine receptor 1B,HTR1B,390.0
3156,DB00589,Lisuride,SmallMoleculeDrug,P08913,Alpha-2A adrenergic receptor,ADRA2A,450.0
3157,DB00589,Lisuride,SmallMoleculeDrug,P18089,Alpha-2B adrenergic receptor,ADRA2B,450.0
3158,DB00589,Lisuride,SmallMoleculeDrug,P18825,Alpha-2C adrenergic receptor,ADRA2C,462.0
3159,DB00590,Doxazosin,SmallMoleculeDrug,P35348,Alpha-1A adrenergic receptor,ADRA1A,466.0
3160,DB00590,Doxazosin,SmallMoleculeDrug,P35368,Alpha-1B adrenergic receptor,ADRA1B,520.0
3161,DB00590,Doxazosin,SmallMoleculeDrug,P25100,Alpha-1D adrenergic receptor,ADRA1D,572.0
3162,DB00590,Doxazosin,SmallMoleculeDrug,Q12809,Potassium voltage-gated channel subfamily H member 2,KCNH2,1159.0
3163,DB00590,Doxazosin,SmallMoleculeDrug,Q9H252,Potassium voltage-gated channel subfamily H member 6,KCNH6,994.0
3164,DB00590,Doxazosin,SmallMoleculeDrug,Q9NS40,Potassium voltage-gated channel subfamily H member 7,KCNH7,1196.0
3165,DB00591,Fluocinolone Acetonide,SmallMoleculeDrug,P04150,Glucocorticoid receptor,NR3C1,777.0
3166,DB00592,Piperazine,SmallMoleculeDrug,P28472,Gamma-aminobutyric acid receptor subunit beta-3,GABRB3,473.0
3167,DB00593,Ethosuximide,SmallMoleculeDrug,O43497,Voltage-dependent T-type calcium channel subunit alpha-1G,CACNA1G,2377.0
3168,DB00594,Amiloride,SmallMoleculeDrug,P37088,Amiloride-sensitive sodium channel subunit alpha,SCNN1A,669.0
3169,DB00594,Amiloride,SmallMoleculeDrug,P51168,Amiloride-sensitive sodium channel subunit beta,SCNN1B,640.0
3170,DB00594,Amiloride,SmallMoleculeDrug,P51170,Amiloride-sensitive sodium channel subunit gamma,SCNN1G,649.0
3171,DB00594,Amiloride,SmallMoleculeDrug,P51172,Amiloride-sensitive sodium channel subunit delta,SCNN1D,638.0
3172,DB00594,Amiloride,SmallMoleculeDrug,P19801,Amiloride-sensitive amine oxidase [copper-containing],AOC1,751.0
3173,DB00594,Amiloride,SmallMoleculeDrug,Q16515,Acid-sensing ion channel 2,ASIC2,512.0
3174,DB00594,Amiloride,SmallMoleculeDrug,P78348,Acid-sensing ion channel 1,ASIC1,528.0
3175,DB00594,Amiloride,SmallMoleculeDrug,P19634,Sodium/hydrogen exchanger 1,SLC9A1,815.0
3176,DB00594,Amiloride,SmallMoleculeDrug,P00749,Urokinase-type plasminogen activator,PLAU,431.0
3179,DB00596,Ulobetasol,SmallMoleculeDrug,P04150,Glucocorticoid receptor,NR3C1,777.0
3180,DB00598,Labetalol,SmallMoleculeDrug,P08588,Beta-1 adrenergic receptor,ADRB1,477.0
3181,DB00598,Labetalol,SmallMoleculeDrug,P07550,Beta-2 adrenergic receptor,ADRB2,413.0
3182,DB00598,Labetalol,SmallMoleculeDrug,P35348,Alpha-1A adrenergic receptor,ADRA1A,466.0
3183,DB00598,Labetalol,SmallMoleculeDrug,P35368,Alpha-1B adrenergic receptor,ADRA1B,520.0
3184,DB00598,Labetalol,SmallMoleculeDrug,P25100,Alpha-1D adrenergic receptor,ADRA1D,572.0
3185,DB00599,Thiopental,SmallMoleculeDrug,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,456.0
3186,DB00599,Thiopental,SmallMoleculeDrug,P47869,Gamma-aminobutyric acid receptor subunit alpha-2,GABRA2,451.0
3187,DB00599,Thiopental,SmallMoleculeDrug,P34903,Gamma-aminobutyric acid receptor subunit alpha-3,GABRA3,492.0
3188,DB00599,Thiopental,SmallMoleculeDrug,P48169,Gamma-aminobutyric acid receptor subunit alpha-4,GABRA4,554.0
3189,DB00599,Thiopental,SmallMoleculeDrug,P31644,Gamma-aminobutyric acid receptor subunit alpha-5,GABRA5,462.0
3190,DB00599,Thiopental,SmallMoleculeDrug,Q16445,Gamma-aminobutyric acid receptor subunit alpha-6,GABRA6,453.0
3191,DB00599,Thiopental,SmallMoleculeDrug,P43681,Neuronal acetylcholine receptor subunit alpha-4,CHRNA4,627.0
3192,DB00599,Thiopental,SmallMoleculeDrug,P36544,Neuronal acetylcholine receptor subunit alpha-7,CHRNA7,502.0
3193,DB00599,Thiopental,SmallMoleculeDrug,P42262,Glutamate receptor 2,GRIA2,883.0
3194,DB00599,Thiopental,SmallMoleculeDrug,Q13002,"Glutamate receptor ionotropic, kainate 2",GRIK2,908.0
3195,DB00599,Thiopental,SmallMoleculeDrug,O00519,Fatty-acid amide hydrolase 1,FAAH,579.0
3196,DB00600,Monobenzone,SmallMoleculeDrug,P14679,Tyrosinase,TYR,529.0
3197,DB00602,Ivermectin,SmallMoleculeDrug,O75311,Glycine receptor subunit alpha-3,GLRA3,464.0
3198,DB00602,Ivermectin,SmallMoleculeDrug,P28472,Gamma-aminobutyric acid receptor subunit beta-3,GABRB3,473.0
3199,DB00603,Medroxyprogesterone acetate,SmallMoleculeDrug,P06401,Progesterone receptor,PGR,933.0
3200,DB00603,Medroxyprogesterone acetate,SmallMoleculeDrug,P03372,Estrogen receptor,ESR1,595.0
3201,DB00604,Cisapride,SmallMoleculeDrug,Q13639,5-hydroxytryptamine receptor 4,HTR4,388.0
3202,DB00604,Cisapride,SmallMoleculeDrug,P46098,5-hydroxytryptamine receptor 3A,HTR3A,478.0
3203,DB00604,Cisapride,SmallMoleculeDrug,P28223,5-hydroxytryptamine receptor 2A,HTR2A,471.0
3204,DB00604,Cisapride,SmallMoleculeDrug,Q12809,Potassium voltage-gated channel subfamily H member 2,KCNH2,1159.0
3205,DB00605,Sulindac,SmallMoleculeDrug,P35354,Prostaglandin G/H synthase 2,PTGS2,604.0
3206,DB00605,Sulindac,SmallMoleculeDrug,P23219,Prostaglandin G/H synthase 1,PTGS1,599.0
3207,DB00605,Sulindac,SmallMoleculeDrug,P15121,Aldose reductase,AKR1B1,316.0
3208,DB00605,Sulindac,SmallMoleculeDrug,P27361,Mitogen-activated protein kinase 3,MAPK3,379.0
3209,DB00605,Sulindac,SmallMoleculeDrug,Q03181,Peroxisome proliferator-activated receptor delta,PPARD,441.0
3210,DB00605,Sulindac,SmallMoleculeDrug,Q9Y5Y4,Prostaglandin D2 receptor 2,PTGDR2,395.0
3211,DB00606,Cyclothiazide,SmallMoleculeDrug,P54710,Sodium/potassium-transporting ATPase subunit gamma,FXYD2,66.0
3212,DB00606,Cyclothiazide,SmallMoleculeDrug,P00915,Carbonic anhydrase 1,CA1,261.0
3213,DB00606,Cyclothiazide,SmallMoleculeDrug,P00918,Carbonic anhydrase 2,CA2,260.0
3214,DB00606,Cyclothiazide,SmallMoleculeDrug,P22748,Carbonic anhydrase 4,CA4,312.0
3220,DB00608,Chloroquine,SmallMoleculeDrug,P09210,Glutathione S-transferase A2,GSTA2,222.0
3221,DB00608,Chloroquine,SmallMoleculeDrug,P01375,Tumor necrosis factor,TNF,233.0
3222,DB00608,Chloroquine,SmallMoleculeDrug,Q9NR96,Toll-like receptor 9,TLR9,1032.0
3226,DB00610,Metaraminol,SmallMoleculeDrug,P35348,Alpha-1A adrenergic receptor,ADRA1A,466.0
3227,DB00611,Butorphanol,SmallMoleculeDrug,P41145,Kappa-type opioid receptor,OPRK1,380.0
3228,DB00611,Butorphanol,SmallMoleculeDrug,P41143,Delta-type opioid receptor,OPRD1,372.0
3229,DB00611,Butorphanol,SmallMoleculeDrug,P35372,Mu-type opioid receptor,OPRM1,400.0
3230,DB00612,Bisoprolol,SmallMoleculeDrug,P08588,Beta-1 adrenergic receptor,ADRB1,477.0
3231,DB00612,Bisoprolol,SmallMoleculeDrug,P07550,Beta-2 adrenergic receptor,ADRB2,413.0
3232,DB00613,Amodiaquine,SmallMoleculeDrug,P50135,Histamine N-methyltransferase,HNMT,292.0
3236,DB00615,Rifabutin,SmallMoleculeDrug,P07900,Heat shock protein HSP 90-alpha,HSP90AA1,732.0
3237,DB00615,Rifabutin,SmallMoleculeDrug,P14625,Endoplasmin,HSP90B1,803.0
3238,DB00616,Candoxatril,SmallMoleculeDrug,P08473,Neprilysin,MME,750.0
3239,DB00616,Candoxatril,SmallMoleculeDrug,P12821,Angiotensin-converting enzyme,ACE,1306.0
3240,DB00617,Paramethadione,SmallMoleculeDrug,Q9P0X4,Voltage-dependent T-type calcium channel subunit alpha-1I,CACNA1I,2223.0
3243,DB00619,Imatinib,SmallMoleculeDrug,A9UF02,BCR/ABL fusion protein isoform X9,BCR/ABL,1644.0
3244,DB00619,Imatinib,SmallMoleculeDrug,P10721,Mast/stem cell growth factor receptor Kit,KIT,976.0
3245,DB00619,Imatinib,SmallMoleculeDrug,O43519,RET proto-oncogene,RET,23.0
3246,DB00619,Imatinib,SmallMoleculeDrug,P04629,High affinity nerve growth factor receptor,NTRK1,796.0
3247,DB00619,Imatinib,SmallMoleculeDrug,P07333,Macrophage colony-stimulating factor 1 receptor,CSF1R,972.0
3248,DB00619,Imatinib,SmallMoleculeDrug,P16234,Platelet-derived growth factor receptor alpha,PDGFRA,1089.0
3249,DB00619,Imatinib,SmallMoleculeDrug,Q08345,Epithelial discoidin domain-containing receptor 1,DDR1,913.0
3250,DB00619,Imatinib,SmallMoleculeDrug,P00519,Tyrosine-protein kinase ABL1,ABL1,1130.0
3251,DB00619,Imatinib,SmallMoleculeDrug,P09619,Platelet-derived growth factor receptor beta,PDGFRB,1106.0
3252,DB00620,Triamcinolone,SmallMoleculeDrug,P04150,Glucocorticoid receptor,NR3C1,777.0
3253,DB00621,Oxandrolone,SmallMoleculeDrug,P10275,Androgen receptor,AR,920.0
3254,DB00622,Nicardipine,SmallMoleculeDrug,Q13936,Voltage-dependent L-type calcium channel subunit alpha-1C,CACNA1C,2221.0
3255,DB00622,Nicardipine,SmallMoleculeDrug,Q08289,Voltage-dependent L-type calcium channel subunit beta-2,CACNB2,660.0
3256,DB00622,Nicardipine,SmallMoleculeDrug,Q01668,Voltage-dependent L-type calcium channel subunit alpha-1D,CACNA1D,2161.0
3257,DB00622,Nicardipine,SmallMoleculeDrug,P54289,Voltage-dependent calcium channel subunit alpha-2/delta-1,CACNA2D1,1103.0
3258,DB00622,Nicardipine,SmallMoleculeDrug,P54750,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A",PDE1A,535.0
3259,DB00622,Nicardipine,SmallMoleculeDrug,Q01064,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B",PDE1B,536.0
3260,DB00622,Nicardipine,SmallMoleculeDrug,P35348,Alpha-1A adrenergic receptor,ADRA1A,466.0
3261,DB00622,Nicardipine,SmallMoleculeDrug,P35368,Alpha-1B adrenergic receptor,ADRA1B,520.0
3262,DB00622,Nicardipine,SmallMoleculeDrug,P25100,Alpha-1D adrenergic receptor,ADRA1D,572.0
3263,DB00622,Nicardipine,SmallMoleculeDrug,P11229,Muscarinic acetylcholine receptor M1,CHRM1,460.0
3264,DB00622,Nicardipine,SmallMoleculeDrug,P08172,Muscarinic acetylcholine receptor M2,CHRM2,466.0
3265,DB00622,Nicardipine,SmallMoleculeDrug,P20309,Muscarinic acetylcholine receptor M3,CHRM3,590.0
3266,DB00622,Nicardipine,SmallMoleculeDrug,P08173,Muscarinic acetylcholine receptor M4,CHRM4,479.0
3267,DB00622,Nicardipine,SmallMoleculeDrug,P08912,Muscarinic acetylcholine receptor M5,CHRM5,532.0
3269,DB00623,Fluphenazine,SmallMoleculeDrug,P14416,D(2) dopamine receptor,DRD2,443.0
3270,DB00623,Fluphenazine,SmallMoleculeDrug,P21728,D(1A) dopamine receptor,DRD1,446.0
3272,DB00624,Testosterone,SmallMoleculeDrug,P10275,Androgen receptor,AR,920.0
3274,DB00626,Bacitracin,SmallMoleculeDrug,P14735,Insulin-degrading enzyme,IDE,1019.0
3275,DB00626,Bacitracin,SmallMoleculeDrug,P01023,Alpha-2-macroglobulin,A2M,1474.0
3276,DB00627,Niacin,SmallMoleculeDrug,P49019,Hydroxycarboxylic acid receptor 3,HCAR3,387.0
3277,DB00627,Niacin,SmallMoleculeDrug,Q8TDS4,Hydroxycarboxylic acid receptor 2,HCAR2,363.0
3278,DB00627,Niacin,SmallMoleculeDrug,Q15274,Nicotinate-nucleotide pyrophosphorylase [carboxylating],QPRT,297.0
3279,DB00627,Niacin,SmallMoleculeDrug,P40261,Nicotinamide N-methyltransferase,NNMT,264.0
3280,DB00628,Clorazepate,SmallMoleculeDrug,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,456.0
3281,DB00628,Clorazepate,SmallMoleculeDrug,P47869,Gamma-aminobutyric acid receptor subunit alpha-2,GABRA2,451.0
3282,DB00628,Clorazepate,SmallMoleculeDrug,P34903,Gamma-aminobutyric acid receptor subunit alpha-3,GABRA3,492.0
3283,DB00628,Clorazepate,SmallMoleculeDrug,P48169,Gamma-aminobutyric acid receptor subunit alpha-4,GABRA4,554.0
3284,DB00628,Clorazepate,SmallMoleculeDrug,P31644,Gamma-aminobutyric acid receptor subunit alpha-5,GABRA5,462.0
3285,DB00628,Clorazepate,SmallMoleculeDrug,Q16445,Gamma-aminobutyric acid receptor subunit alpha-6,GABRA6,453.0
3286,DB00628,Clorazepate,SmallMoleculeDrug,P18505,Gamma-aminobutyric acid receptor subunit beta-1,GABRB1,474.0
3287,DB00628,Clorazepate,SmallMoleculeDrug,P47870,Gamma-aminobutyric acid receptor subunit beta-2,GABRB2,512.0
3288,DB00628,Clorazepate,SmallMoleculeDrug,P28472,Gamma-aminobutyric acid receptor subunit beta-3,GABRB3,473.0
3289,DB00628,Clorazepate,SmallMoleculeDrug,O14764,Gamma-aminobutyric acid receptor subunit delta,GABRD,452.0
3290,DB00628,Clorazepate,SmallMoleculeDrug,P78334,Gamma-aminobutyric acid receptor subunit epsilon,GABRE,506.0
3291,DB00628,Clorazepate,SmallMoleculeDrug,Q8N1C3,Gamma-aminobutyric acid receptor subunit gamma-1,GABRG1,465.0
3292,DB00628,Clorazepate,SmallMoleculeDrug,P18507,Gamma-aminobutyric acid receptor subunit gamma-2,GABRG2,467.0
3293,DB00628,Clorazepate,SmallMoleculeDrug,Q99928,Gamma-aminobutyric acid receptor subunit gamma-3,GABRG3,467.0
3294,DB00628,Clorazepate,SmallMoleculeDrug,O00591,Gamma-aminobutyric acid receptor subunit pi,GABRP,440.0
3295,DB00628,Clorazepate,SmallMoleculeDrug,Q9UN88,Gamma-aminobutyric acid receptor subunit theta,GABRQ,632.0
3296,DB00628,Clorazepate,SmallMoleculeDrug,P30536,Translocator protein,TSPO,169.0
3297,DB00629,Guanabenz,SmallMoleculeDrug,P08913,Alpha-2A adrenergic receptor,ADRA2A,450.0
3298,DB00629,Guanabenz,SmallMoleculeDrug,P18089,Alpha-2B adrenergic receptor,ADRA2B,450.0
3299,DB00630,Alendronic acid,SmallMoleculeDrug,P14324,Farnesyl pyrophosphate synthase,FDPS,419.0
3300,DB00630,Alendronic acid,SmallMoleculeDrug,P29074,Tyrosine-protein phosphatase non-receptor type 4,PTPN4,926.0
3301,DB00630,Alendronic acid,SmallMoleculeDrug,Q13332,Receptor-type tyrosine-protein phosphatase S,PTPRS,1948.0
3302,DB00630,Alendronic acid,SmallMoleculeDrug,P23469,Receptor-type tyrosine-protein phosphatase epsilon,PTPRE,700.0
3303,DB00630,Alendronic acid,SmallMoleculeDrug,P38606,V-type proton ATPase catalytic subunit A,ATP6V1A,617.0
3304,DB00631,Clofarabine,SmallMoleculeDrug,P09884,DNA polymerase alpha catalytic subunit,POLA1,1462.0
3305,DB00631,Clofarabine,SmallMoleculeDrug,P23921,Ribonucleoside-diphosphate reductase large subunit,RRM1,792.0
3308,DB00633,Dexmedetomidine,SmallMoleculeDrug,P08913,Alpha-2A adrenergic receptor,ADRA2A,450.0
3312,DB00635,Prednisone,SmallMoleculeDrug,P04150,Glucocorticoid receptor,NR3C1,777.0
3313,DB00635,Prednisone,SmallMoleculeDrug,P28845,Corticosteroid 11-beta-dehydrogenase isozyme 1,HSD11B1,292.0
3314,DB00636,Clofibrate,SmallMoleculeDrug,Q07869,Peroxisome proliferator-activated receptor alpha,PPARA,468.0
3315,DB00637,Astemizole,SmallMoleculeDrug,P35367,Histamine H1 receptor,HRH1,487.0
3316,DB00637,Astemizole,SmallMoleculeDrug,Q12809,Potassium voltage-gated channel subfamily H member 2,KCNH2,1159.0
3318,DB00640,Adenosine,SmallMoleculeDrug,P29274,Adenosine receptor A2a,ADORA2A,412.0
3319,DB00640,Adenosine,SmallMoleculeDrug,P29275,Adenosine receptor A2b,ADORA2B,332.0
3320,DB00640,Adenosine,SmallMoleculeDrug,P0DMS8,Adenosine receptor A3,ADORA3,318.0
3321,DB00640,Adenosine,SmallMoleculeDrug,P30542,Adenosine receptor A1,ADORA1,326.0
3322,DB00641,Simvastatin,SmallMoleculeDrug,P04035,3-hydroxy-3-methylglutaryl-coenzyme A reductase,HMGCR,888.0
3323,DB00641,Simvastatin,SmallMoleculeDrug,P05107,Integrin beta-2,ITGB2,769.0
3324,DB00642,Pemetrexed,SmallMoleculeDrug,P04818,Thymidylate synthase,TYMS,313.0
3325,DB00642,Pemetrexed,SmallMoleculeDrug,P31939,Bifunctional purine biosynthesis protein PURH,ATIC,592.0
3326,DB00642,Pemetrexed,SmallMoleculeDrug,P00374,Dihydrofolate reductase,DHFR,187.0
3327,DB00642,Pemetrexed,SmallMoleculeDrug,P22102,Trifunctional purine biosynthetic protein adenosine-3,GART,1010.0
3328,DB00643,Mebendazole,SmallMoleculeDrug,Q71U36,Tubulin alpha-1A chain,TUBA1A,451.0
3329,DB00643,Mebendazole,SmallMoleculeDrug,P68371,Tubulin beta-4B chain,TUBB4B,445.0
3330,DB00644,Gonadorelin,SmallMoleculeDrug,P30968,Gonadotropin-releasing hormone receptor,GNRHR,328.0
3331,DB00644,Gonadorelin,SmallMoleculeDrug,Q96P88,Putative gonadotropin-releasing hormone II receptor,GNRHR2,292.0
3332,DB00645,Dyclonine,SmallMoleculeDrug,Q9Y5Y9,Sodium channel protein type 10 subunit alpha,SCN10A,1956.0
3333,DB00647,Dextropropoxyphene,SmallMoleculeDrug,P35372,Mu-type opioid receptor,OPRM1,400.0
3334,DB00647,Dextropropoxyphene,SmallMoleculeDrug,P41143,Delta-type opioid receptor,OPRD1,372.0
3335,DB00647,Dextropropoxyphene,SmallMoleculeDrug,P41145,Kappa-type opioid receptor,OPRK1,380.0
3336,DB00648,Mitotane,SmallMoleculeDrug,P15538,"Cytochrome P450 11B1, mitochondrial",CYP11B1,503.0
3337,DB00648,Mitotane,SmallMoleculeDrug,P10109,"Adrenodoxin, mitochondrial",FDX1,184.0
3339,DB00651,Dyphylline,SmallMoleculeDrug,Q07343,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B",PDE4B,736.0
3340,DB00651,Dyphylline,SmallMoleculeDrug,P27815,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A",PDE4A,886.0
3341,DB00651,Dyphylline,SmallMoleculeDrug,Q08493,"cAMP-specific 3',5'-cyclic phosphodiesterase 4C",PDE4C,712.0
3342,DB00651,Dyphylline,SmallMoleculeDrug,Q08499,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",PDE4D,809.0
3343,DB00651,Dyphylline,SmallMoleculeDrug,P30542,Adenosine receptor A1,ADORA1,326.0
3344,DB00651,Dyphylline,SmallMoleculeDrug,P29274,Adenosine receptor A2a,ADORA2A,412.0
3345,DB00651,Dyphylline,SmallMoleculeDrug,Q13946,"High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A",PDE7A,482.0
3346,DB00651,Dyphylline,SmallMoleculeDrug,Q9NP56,"cAMP-specific 3',5'-cyclic phosphodiesterase 7B",PDE7B,450.0
3347,DB00652,Pentazocine,SmallMoleculeDrug,P35372,Mu-type opioid receptor,OPRM1,400.0
3348,DB00652,Pentazocine,SmallMoleculeDrug,P41145,Kappa-type opioid receptor,OPRK1,380.0
3349,DB00652,Pentazocine,SmallMoleculeDrug,Q99720,Sigma non-opioid intracellular receptor 1,SIGMAR1,223.0
3350,DB00653,Magnesium Sulfate,SmallMoleculeDrug,Q06432,Voltage-dependent calcium channel gamma-1 subunit,CACNG1,222.0
3351,DB00653,Magnesium Sulfate,SmallMoleculeDrug,P54289,Voltage-dependent calcium channel subunit alpha-2/delta-1,CACNA2D1,1103.0
3352,DB00653,Magnesium Sulfate,SmallMoleculeDrug,Q13936,Voltage-dependent L-type calcium channel subunit alpha-1C,CACNA1C,2221.0
3353,DB00653,Magnesium Sulfate,SmallMoleculeDrug,Q02641,Voltage-dependent L-type calcium channel subunit beta-1,CACNB1,598.0
3354,DB00653,Magnesium Sulfate,SmallMoleculeDrug,Q08289,Voltage-dependent L-type calcium channel subunit beta-2,CACNB2,660.0
3355,DB00653,Magnesium Sulfate,SmallMoleculeDrug,Q13698,Voltage-dependent L-type calcium channel subunit alpha-1S,CACNA1S,1873.0
3356,DB00654,Latanoprost,SmallMoleculeDrug,P43088,Prostaglandin F2-alpha receptor,PTGFR,359.0
3357,DB00655,Estrone,SmallMoleculeDrug,P03372,Estrogen receptor,ESR1,595.0
3358,DB00656,Trazodone,SmallMoleculeDrug,P28223,5-hydroxytryptamine receptor 2A,HTR2A,471.0
3359,DB00656,Trazodone,SmallMoleculeDrug,P28335,5-hydroxytryptamine receptor 2C,HTR2C,458.0
3360,DB00656,Trazodone,SmallMoleculeDrug,P31645,Sodium-dependent serotonin transporter,SLC6A4,630.0
3361,DB00656,Trazodone,SmallMoleculeDrug,P08908,5-hydroxytryptamine receptor 1A,HTR1A,422.0
3362,DB00656,Trazodone,SmallMoleculeDrug,P35367,Histamine H1 receptor,HRH1,487.0
3363,DB00656,Trazodone,SmallMoleculeDrug,P35348,Alpha-1A adrenergic receptor,ADRA1A,466.0
3364,DB00656,Trazodone,SmallMoleculeDrug,P08913,Alpha-2A adrenergic receptor,ADRA2A,450.0
3365,DB00657,Mecamylamine,SmallMoleculeDrug,Q15822,Neuronal acetylcholine receptor subunit alpha-2,CHRNA2,529.0
3366,DB00659,Acamprosate,SmallMoleculeDrug,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,456.0
3367,DB00659,Acamprosate,SmallMoleculeDrug,P47869,Gamma-aminobutyric acid receptor subunit alpha-2,GABRA2,451.0
3368,DB00659,Acamprosate,SmallMoleculeDrug,P34903,Gamma-aminobutyric acid receptor subunit alpha-3,GABRA3,492.0
3369,DB00659,Acamprosate,SmallMoleculeDrug,P48169,Gamma-aminobutyric acid receptor subunit alpha-4,GABRA4,554.0
3370,DB00659,Acamprosate,SmallMoleculeDrug,P31644,Gamma-aminobutyric acid receptor subunit alpha-5,GABRA5,462.0
3371,DB00659,Acamprosate,SmallMoleculeDrug,Q16445,Gamma-aminobutyric acid receptor subunit alpha-6,GABRA6,453.0
3372,DB00659,Acamprosate,SmallMoleculeDrug,P18505,Gamma-aminobutyric acid receptor subunit beta-1,GABRB1,474.0
3373,DB00659,Acamprosate,SmallMoleculeDrug,P47870,Gamma-aminobutyric acid receptor subunit beta-2,GABRB2,512.0
3374,DB00659,Acamprosate,SmallMoleculeDrug,P28472,Gamma-aminobutyric acid receptor subunit beta-3,GABRB3,473.0
3375,DB00659,Acamprosate,SmallMoleculeDrug,O14764,Gamma-aminobutyric acid receptor subunit delta,GABRD,452.0
3376,DB00659,Acamprosate,SmallMoleculeDrug,P78334,Gamma-aminobutyric acid receptor subunit epsilon,GABRE,506.0
3377,DB00659,Acamprosate,SmallMoleculeDrug,Q8N1C3,Gamma-aminobutyric acid receptor subunit gamma-1,GABRG1,465.0
3378,DB00659,Acamprosate,SmallMoleculeDrug,P18507,Gamma-aminobutyric acid receptor subunit gamma-2,GABRG2,467.0
3379,DB00659,Acamprosate,SmallMoleculeDrug,Q99928,Gamma-aminobutyric acid receptor subunit gamma-3,GABRG3,467.0
3380,DB00659,Acamprosate,SmallMoleculeDrug,O00591,Gamma-aminobutyric acid receptor subunit pi,GABRP,440.0
3381,DB00659,Acamprosate,SmallMoleculeDrug,Q9UN88,Gamma-aminobutyric acid receptor subunit theta,GABRQ,632.0
3382,DB00659,Acamprosate,SmallMoleculeDrug,Q05586,"Glutamate receptor ionotropic, NMDA 1",GRIN1,938.0
3383,DB00659,Acamprosate,SmallMoleculeDrug,Q12879,"Glutamate receptor ionotropic, NMDA 2A",GRIN2A,1464.0
3384,DB00659,Acamprosate,SmallMoleculeDrug,Q13224,"Glutamate receptor ionotropic, NMDA 2B",GRIN2B,1484.0
3385,DB00659,Acamprosate,SmallMoleculeDrug,Q14957,"Glutamate receptor ionotropic, NMDA 2C",GRIN2C,1233.0
3386,DB00659,Acamprosate,SmallMoleculeDrug,O15399,"Glutamate receptor ionotropic, NMDA 2D",GRIN2D,1336.0
3387,DB00659,Acamprosate,SmallMoleculeDrug,Q8TCU5,"Glutamate receptor ionotropic, NMDA 3A",GRIN3A,1115.0
3388,DB00659,Acamprosate,SmallMoleculeDrug,O60391,"Glutamate receptor ionotropic, NMDA 3B",GRIN3B,1043.0
3389,DB00659,Acamprosate,SmallMoleculeDrug,P41594,Metabotropic glutamate receptor 5,GRM5,1212.0
3390,DB00661,Verapamil,SmallMoleculeDrug,Q13936,Voltage-dependent L-type calcium channel subunit alpha-1C,CACNA1C,2221.0
3391,DB00661,Verapamil,SmallMoleculeDrug,Q01668,Voltage-dependent L-type calcium channel subunit alpha-1D,CACNA1D,2161.0
3392,DB00661,Verapamil,SmallMoleculeDrug,O60840,Voltage-dependent L-type calcium channel subunit alpha-1F,CACNA1F,1977.0
3393,DB00661,Verapamil,SmallMoleculeDrug,Q13698,Voltage-dependent L-type calcium channel subunit alpha-1S,CACNA1S,1873.0
3394,DB00661,Verapamil,SmallMoleculeDrug,Q02641,Voltage-dependent L-type calcium channel subunit beta-1,CACNB1,598.0
3395,DB00661,Verapamil,SmallMoleculeDrug,Q08289,Voltage-dependent L-type calcium channel subunit beta-2,CACNB2,660.0
3396,DB00661,Verapamil,SmallMoleculeDrug,P54284,Voltage-dependent L-type calcium channel subunit beta-3,CACNB3,484.0
3397,DB00661,Verapamil,SmallMoleculeDrug,O00305,Voltage-dependent L-type calcium channel subunit beta-4,CACNB4,520.0
3398,DB00661,Verapamil,SmallMoleculeDrug,Q9P0X4,Voltage-dependent T-type calcium channel subunit alpha-1I,CACNA1I,2223.0
3399,DB00661,Verapamil,SmallMoleculeDrug,O43497,Voltage-dependent T-type calcium channel subunit alpha-1G,CACNA1G,2377.0
3400,DB00661,Verapamil,SmallMoleculeDrug,Q00975,Voltage-dependent N-type calcium channel subunit alpha-1B,CACNA1B,2339.0
3401,DB00661,Verapamil,SmallMoleculeDrug,O00555,Voltage-dependent P/Q-type calcium channel subunit alpha-1A,CACNA1A,2505.0
3402,DB00661,Verapamil,SmallMoleculeDrug,Q12809,Potassium voltage-gated channel subfamily H member 2,KCNH2,1159.0
3403,DB00661,Verapamil,SmallMoleculeDrug,Q14524,Sodium channel protein type 5 subunit alpha,SCN5A,2016.0
3404,DB00661,Verapamil,SmallMoleculeDrug,Q14654,ATP-sensitive inward rectifier potassium channel 11,KCNJ11,390.0
3405,DB00661,Verapamil,SmallMoleculeDrug,P31645,Sodium-dependent serotonin transporter,SLC6A4,630.0
3406,DB00663,Flumethasone,SmallMoleculeDrug,P04150,Glucocorticoid receptor,NR3C1,777.0
3408,DB00665,Nilutamide,SmallMoleculeDrug,P10275,Androgen receptor,AR,920.0
3409,DB00666,Nafarelin,SmallMoleculeDrug,P30968,Gonadotropin-releasing hormone receptor,GNRHR,328.0
3410,DB00666,Nafarelin,SmallMoleculeDrug,Q96P88,Putative gonadotropin-releasing hormone II receptor,GNRHR2,292.0
3411,DB00668,Epinephrine,SmallMoleculeDrug,P35348,Alpha-1A adrenergic receptor,ADRA1A,466.0
3412,DB00668,Epinephrine,SmallMoleculeDrug,P35368,Alpha-1B adrenergic receptor,ADRA1B,520.0
3413,DB00668,Epinephrine,SmallMoleculeDrug,P08588,Beta-1 adrenergic receptor,ADRB1,477.0
3414,DB00668,Epinephrine,SmallMoleculeDrug,P07550,Beta-2 adrenergic receptor,ADRB2,413.0
3415,DB00668,Epinephrine,SmallMoleculeDrug,P08913,Alpha-2A adrenergic receptor,ADRA2A,450.0
3416,DB00668,Epinephrine,SmallMoleculeDrug,P18089,Alpha-2B adrenergic receptor,ADRA2B,450.0
3417,DB00668,Epinephrine,SmallMoleculeDrug,P25100,Alpha-1D adrenergic receptor,ADRA1D,572.0
3418,DB00668,Epinephrine,SmallMoleculeDrug,P00439,Phenylalanine-4-hydroxylase,PAH,452.0
3419,DB00668,Epinephrine,SmallMoleculeDrug,P18825,Alpha-2C adrenergic receptor,ADRA2C,462.0
3420,DB00668,Epinephrine,SmallMoleculeDrug,P13945,Beta-3 adrenergic receptor,ADRB3,408.0
3421,DB00668,Epinephrine,SmallMoleculeDrug,P01375,Tumor necrosis factor,TNF,233.0
3422,DB00669,Sumatriptan,SmallMoleculeDrug,P28221,5-hydroxytryptamine receptor 1D,HTR1D,377.0
3423,DB00669,Sumatriptan,SmallMoleculeDrug,P28222,5-hydroxytryptamine receptor 1B,HTR1B,390.0
3424,DB00669,Sumatriptan,SmallMoleculeDrug,P30939,5-hydroxytryptamine receptor 1F,HTR1F,366.0
3425,DB00669,Sumatriptan,SmallMoleculeDrug,P08908,5-hydroxytryptamine receptor 1A,HTR1A,422.0
3426,DB00670,Pirenzepine,SmallMoleculeDrug,P11229,Muscarinic acetylcholine receptor M1,CHRM1,460.0
3428,DB00672,Chlorpropamide,SmallMoleculeDrug,Q09428,ATP-binding cassette sub-family C member 8,ABCC8,1581.0
3429,DB00673,Aprepitant,SmallMoleculeDrug,P25103,Substance-P receptor,TACR1,407.0
3430,DB00674,Galantamine,SmallMoleculeDrug,P22303,Acetylcholinesterase,ACHE,614.0
3431,DB00674,Galantamine,SmallMoleculeDrug,P02708,Acetylcholine receptor subunit alpha,CHRNA1,482.0
3432,DB00674,Galantamine,SmallMoleculeDrug,P11230,Acetylcholine receptor subunit beta,CHRNB1,501.0
3433,DB00674,Galantamine,SmallMoleculeDrug,Q07001,Acetylcholine receptor subunit delta,CHRND,517.0
3434,DB00674,Galantamine,SmallMoleculeDrug,P07510,Acetylcholine receptor subunit gamma,CHRNG,517.0
3435,DB00674,Galantamine,SmallMoleculeDrug,Q04844,Acetylcholine receptor subunit epsilon,CHRNE,493.0
3436,DB00674,Galantamine,SmallMoleculeDrug,Q15822,Neuronal acetylcholine receptor subunit alpha-2,CHRNA2,529.0
3437,DB00674,Galantamine,SmallMoleculeDrug,P32297,Neuronal acetylcholine receptor subunit alpha-3,CHRNA3,505.0
3438,DB00674,Galantamine,SmallMoleculeDrug,P43681,Neuronal acetylcholine receptor subunit alpha-4,CHRNA4,627.0
3439,DB00674,Galantamine,SmallMoleculeDrug,P30532,Neuronal acetylcholine receptor subunit alpha-5,CHRNA5,468.0
3440,DB00674,Galantamine,SmallMoleculeDrug,Q15825,Neuronal acetylcholine receptor subunit alpha-6,CHRNA6,494.0
3441,DB00674,Galantamine,SmallMoleculeDrug,P36544,Neuronal acetylcholine receptor subunit alpha-7,CHRNA7,502.0
3442,DB00674,Galantamine,SmallMoleculeDrug,Q9UGM1,Neuronal acetylcholine receptor subunit alpha-9,CHRNA9,479.0
3443,DB00674,Galantamine,SmallMoleculeDrug,Q9GZZ6,Neuronal acetylcholine receptor subunit alpha-10,CHRNA10,450.0
3444,DB00674,Galantamine,SmallMoleculeDrug,P17787,Neuronal acetylcholine receptor subunit beta-2,CHRNB2,502.0
3445,DB00674,Galantamine,SmallMoleculeDrug,Q05901,Neuronal acetylcholine receptor subunit beta-3,CHRNB3,458.0
3446,DB00674,Galantamine,SmallMoleculeDrug,P30926,Neuronal acetylcholine receptor subunit beta-4,CHRNB4,498.0
3447,DB00674,Galantamine,SmallMoleculeDrug,P06276,Cholinesterase,BCHE,602.0
3448,DB00675,Tamoxifen,SmallMoleculeDrug,P03372,Estrogen receptor,ESR1,595.0
3449,DB00675,Tamoxifen,SmallMoleculeDrug,Q92731,Estrogen receptor beta,ESR2,530.0
3450,DB00675,Tamoxifen,SmallMoleculeDrug,Q15125,"3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase",EBP,230.0
3451,DB00675,Tamoxifen,SmallMoleculeDrug,P17252,Protein kinase C alpha type,PRKCA,672.0
3452,DB00675,Tamoxifen,SmallMoleculeDrug,P05771,Protein kinase C beta type,PRKCB,671.0
3453,DB00675,Tamoxifen,SmallMoleculeDrug,Q05655,Protein kinase C delta type,PRKCD,676.0
3454,DB00675,Tamoxifen,SmallMoleculeDrug,Q02156,Protein kinase C epsilon type,PRKCE,737.0
3455,DB00675,Tamoxifen,SmallMoleculeDrug,P05129,Protein kinase C gamma type,PRKCG,697.0
3456,DB00675,Tamoxifen,SmallMoleculeDrug,P41743,Protein kinase C iota type,PRKCI,596.0
3457,DB00675,Tamoxifen,SmallMoleculeDrug,Q04759,Protein kinase C theta type,PRKCQ,706.0
3458,DB00675,Tamoxifen,SmallMoleculeDrug,Q05513,Protein kinase C zeta type,PRKCZ,592.0
3459,DB00677,Isoflurophate,SmallMoleculeDrug,P22303,Acetylcholinesterase,ACHE,614.0
3460,DB00677,Isoflurophate,SmallMoleculeDrug,P06276,Cholinesterase,BCHE,602.0
3461,DB00678,Losartan,SmallMoleculeDrug,P30556,Type-1 angiotensin II receptor,AGTR1,359.0
3462,DB00679,Thioridazine,SmallMoleculeDrug,P14416,D(2) dopamine receptor,DRD2,443.0
3463,DB00679,Thioridazine,SmallMoleculeDrug,P21728,D(1A) dopamine receptor,DRD1,446.0
3464,DB00679,Thioridazine,SmallMoleculeDrug,P35348,Alpha-1A adrenergic receptor,ADRA1A,466.0
3465,DB00679,Thioridazine,SmallMoleculeDrug,P35368,Alpha-1B adrenergic receptor,ADRA1B,520.0
3466,DB00679,Thioridazine,SmallMoleculeDrug,P28223,5-hydroxytryptamine receptor 2A,HTR2A,471.0
3467,DB00679,Thioridazine,SmallMoleculeDrug,Q12809,Potassium voltage-gated channel subfamily H member 2,KCNH2,1159.0
3468,DB00680,Moricizine,SmallMoleculeDrug,Q14524,Sodium channel protein type 5 subunit alpha,SCN5A,2016.0
3469,DB00682,Warfarin,SmallMoleculeDrug,Q9BQB6,Vitamin K epoxide reductase complex subunit 1,VKORC1,163.0
3470,DB00683,Midazolam,SmallMoleculeDrug,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,456.0
3471,DB00683,Midazolam,SmallMoleculeDrug,P47869,Gamma-aminobutyric acid receptor subunit alpha-2,GABRA2,451.0
3472,DB00683,Midazolam,SmallMoleculeDrug,P34903,Gamma-aminobutyric acid receptor subunit alpha-3,GABRA3,492.0
3473,DB00683,Midazolam,SmallMoleculeDrug,P48169,Gamma-aminobutyric acid receptor subunit alpha-4,GABRA4,554.0
3474,DB00683,Midazolam,SmallMoleculeDrug,P31644,Gamma-aminobutyric acid receptor subunit alpha-5,GABRA5,462.0
3475,DB00683,Midazolam,SmallMoleculeDrug,P18505,Gamma-aminobutyric acid receptor subunit beta-1,GABRB1,474.0
3476,DB00683,Midazolam,SmallMoleculeDrug,P28472,Gamma-aminobutyric acid receptor subunit beta-3,GABRB3,473.0
3477,DB00683,Midazolam,SmallMoleculeDrug,P47870,Gamma-aminobutyric acid receptor subunit beta-2,GABRB2,512.0
3478,DB00683,Midazolam,SmallMoleculeDrug,Q16445,Gamma-aminobutyric acid receptor subunit alpha-6,GABRA6,453.0
3479,DB00683,Midazolam,SmallMoleculeDrug,Q8N1C3,Gamma-aminobutyric acid receptor subunit gamma-1,GABRG1,465.0
3480,DB00683,Midazolam,SmallMoleculeDrug,P18507,Gamma-aminobutyric acid receptor subunit gamma-2,GABRG2,467.0
3481,DB00683,Midazolam,SmallMoleculeDrug,Q99928,Gamma-aminobutyric acid receptor subunit gamma-3,GABRG3,467.0
3482,DB00683,Midazolam,SmallMoleculeDrug,O14764,Gamma-aminobutyric acid receptor subunit delta,GABRD,452.0
3483,DB00683,Midazolam,SmallMoleculeDrug,P78334,Gamma-aminobutyric acid receptor subunit epsilon,GABRE,506.0
3484,DB00683,Midazolam,SmallMoleculeDrug,O00591,Gamma-aminobutyric acid receptor subunit pi,GABRP,440.0
3485,DB00683,Midazolam,SmallMoleculeDrug,P24046,Gamma-aminobutyric acid receptor subunit rho-1,GABRR1,479.0
3486,DB00683,Midazolam,SmallMoleculeDrug,P28476,Gamma-aminobutyric acid receptor subunit rho-2,GABRR2,465.0
3487,DB00683,Midazolam,SmallMoleculeDrug,A8MPY1,Gamma-aminobutyric acid receptor subunit rho-3,GABRR3,467.0
3488,DB00683,Midazolam,SmallMoleculeDrug,Q9UN88,Gamma-aminobutyric acid receptor subunit theta,GABRQ,632.0
3492,DB00685,Trovafloxacin,SmallMoleculeDrug,P11388,DNA topoisomerase 2-alpha,TOP2A,1531.0
3493,DB00686,Pentosan Polysulfate,SmallMoleculeDrug,P09038,Fibroblast growth factor 2,FGF2,288.0
3494,DB00686,Pentosan Polysulfate,SmallMoleculeDrug,P05230,Fibroblast growth factor 1,FGF1,155.0
3495,DB00686,Pentosan Polysulfate,SmallMoleculeDrug,P08620,Fibroblast growth factor 4,FGF4,206.0
3496,DB00687,Fludrocortisone,SmallMoleculeDrug,P08235,Mineralocorticoid receptor,NR3C2,984.0
3497,DB00687,Fludrocortisone,SmallMoleculeDrug,P04150,Glucocorticoid receptor,NR3C1,777.0
3498,DB00687,Fludrocortisone,SmallMoleculeDrug,P10275,Androgen receptor,AR,920.0
3499,DB00688,Mycophenolate mofetil,SmallMoleculeDrug,P20839,Inosine-5'-monophosphate dehydrogenase 1,IMPDH1,514.0
3500,DB00688,Mycophenolate mofetil,SmallMoleculeDrug,P12268,Inosine-5'-monophosphate dehydrogenase 2,IMPDH2,514.0
3502,DB00690,Flurazepam,SmallMoleculeDrug,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,456.0
3503,DB00690,Flurazepam,SmallMoleculeDrug,P47869,Gamma-aminobutyric acid receptor subunit alpha-2,GABRA2,451.0
3504,DB00690,Flurazepam,SmallMoleculeDrug,P34903,Gamma-aminobutyric acid receptor subunit alpha-3,GABRA3,492.0
3505,DB00690,Flurazepam,SmallMoleculeDrug,P48169,Gamma-aminobutyric acid receptor subunit alpha-4,GABRA4,554.0
3506,DB00690,Flurazepam,SmallMoleculeDrug,P31644,Gamma-aminobutyric acid receptor subunit alpha-5,GABRA5,462.0
3507,DB00690,Flurazepam,SmallMoleculeDrug,Q16445,Gamma-aminobutyric acid receptor subunit alpha-6,GABRA6,453.0
3508,DB00690,Flurazepam,SmallMoleculeDrug,P18505,Gamma-aminobutyric acid receptor subunit beta-1,GABRB1,474.0
3509,DB00690,Flurazepam,SmallMoleculeDrug,P47870,Gamma-aminobutyric acid receptor subunit beta-2,GABRB2,512.0
3510,DB00690,Flurazepam,SmallMoleculeDrug,P28472,Gamma-aminobutyric acid receptor subunit beta-3,GABRB3,473.0
3511,DB00690,Flurazepam,SmallMoleculeDrug,Q8N1C3,Gamma-aminobutyric acid receptor subunit gamma-1,GABRG1,465.0
3512,DB00690,Flurazepam,SmallMoleculeDrug,P18507,Gamma-aminobutyric acid receptor subunit gamma-2,GABRG2,467.0
3513,DB00690,Flurazepam,SmallMoleculeDrug,Q99928,Gamma-aminobutyric acid receptor subunit gamma-3,GABRG3,467.0
3514,DB00690,Flurazepam,SmallMoleculeDrug,O14764,Gamma-aminobutyric acid receptor subunit delta,GABRD,452.0
3515,DB00690,Flurazepam,SmallMoleculeDrug,P78334,Gamma-aminobutyric acid receptor subunit epsilon,GABRE,506.0
3516,DB00690,Flurazepam,SmallMoleculeDrug,O00591,Gamma-aminobutyric acid receptor subunit pi,GABRP,440.0
3517,DB00690,Flurazepam,SmallMoleculeDrug,P24046,Gamma-aminobutyric acid receptor subunit rho-1,GABRR1,479.0
3518,DB00690,Flurazepam,SmallMoleculeDrug,P28476,Gamma-aminobutyric acid receptor subunit rho-2,GABRR2,465.0
3519,DB00690,Flurazepam,SmallMoleculeDrug,A8MPY1,Gamma-aminobutyric acid receptor subunit rho-3,GABRR3,467.0
3520,DB00690,Flurazepam,SmallMoleculeDrug,Q9UN88,Gamma-aminobutyric acid receptor subunit theta,GABRQ,632.0
3521,DB00691,Moexipril,SmallMoleculeDrug,P12821,Angiotensin-converting enzyme,ACE,1306.0
3522,DB00691,Moexipril,SmallMoleculeDrug,Q9BYF1,Angiotensin-converting enzyme 2,ACE2,805.0
3523,DB00692,Phentolamine,SmallMoleculeDrug,P08913,Alpha-2A adrenergic receptor,ADRA2A,450.0
3524,DB00692,Phentolamine,SmallMoleculeDrug,P35348,Alpha-1A adrenergic receptor,ADRA1A,466.0
3525,DB00693,Fluorescein,SmallMoleculeDrug,P06310,Ig kappa chain V-II region RPMI 6410,IGKV2-30,120.0
3526,DB00694,Daunorubicin,SmallMoleculeDrug,P11388,DNA topoisomerase 2-alpha,TOP2A,1531.0
3527,DB00694,Daunorubicin,SmallMoleculeDrug,Q02880,DNA topoisomerase 2-beta,TOP2B,1626.0
3528,DB00695,Furosemide,SmallMoleculeDrug,Q13621,Solute carrier family 12 member 1,SLC12A1,1099.0
3529,DB00695,Furosemide,SmallMoleculeDrug,P00918,Carbonic anhydrase 2,CA2,260.0
3530,DB00696,Ergotamine,SmallMoleculeDrug,P28221,5-hydroxytryptamine receptor 1D,HTR1D,377.0
3531,DB00696,Ergotamine,SmallMoleculeDrug,P28222,5-hydroxytryptamine receptor 1B,HTR1B,390.0
3532,DB00696,Ergotamine,SmallMoleculeDrug,P28223,5-hydroxytryptamine receptor 2A,HTR2A,471.0
3533,DB00696,Ergotamine,SmallMoleculeDrug,P14416,D(2) dopamine receptor,DRD2,443.0
3534,DB00696,Ergotamine,SmallMoleculeDrug,P35348,Alpha-1A adrenergic receptor,ADRA1A,466.0
3535,DB00696,Ergotamine,SmallMoleculeDrug,P35368,Alpha-1B adrenergic receptor,ADRA1B,520.0
3536,DB00696,Ergotamine,SmallMoleculeDrug,P25100,Alpha-1D adrenergic receptor,ADRA1D,572.0
3537,DB00696,Ergotamine,SmallMoleculeDrug,P08913,Alpha-2A adrenergic receptor,ADRA2A,450.0
3538,DB00696,Ergotamine,SmallMoleculeDrug,P18089,Alpha-2B adrenergic receptor,ADRA2B,450.0
3539,DB00696,Ergotamine,SmallMoleculeDrug,P23975,Sodium-dependent noradrenaline transporter,SLC6A2,617.0
3540,DB00696,Ergotamine,SmallMoleculeDrug,P21728,D(1A) dopamine receptor,DRD1,446.0
3541,DB00696,Ergotamine,SmallMoleculeDrug,P21918,D(1B) dopamine receptor,DRD5,477.0
3542,DB00696,Ergotamine,SmallMoleculeDrug,P08908,5-hydroxytryptamine receptor 1A,HTR1A,422.0
3543,DB00696,Ergotamine,SmallMoleculeDrug,P30939,5-hydroxytryptamine receptor 1F,HTR1F,366.0
3544,DB00696,Ergotamine,SmallMoleculeDrug,P28335,5-hydroxytryptamine receptor 2C,HTR2C,458.0
3545,DB00697,Tizanidine,SmallMoleculeDrug,P08913,Alpha-2A adrenergic receptor,ADRA2A,450.0
3546,DB00697,Tizanidine,SmallMoleculeDrug,P18089,Alpha-2B adrenergic receptor,ADRA2B,450.0
3547,DB00697,Tizanidine,SmallMoleculeDrug,P18825,Alpha-2C adrenergic receptor,ADRA2C,462.0
3548,DB00697,Tizanidine,SmallMoleculeDrug,Q9Y2I1,Nischarin,NISCH,1504.0
3552,DB00699,Nicergoline,SmallMoleculeDrug,P35348,Alpha-1A adrenergic receptor,ADRA1A,466.0
3553,DB00700,Eplerenone,SmallMoleculeDrug,P08235,Mineralocorticoid receptor,NR3C2,984.0
3555,DB00703,Methazolamide,SmallMoleculeDrug,P00915,Carbonic anhydrase 1,CA1,261.0
3556,DB00703,Methazolamide,SmallMoleculeDrug,P00918,Carbonic anhydrase 2,CA2,260.0
3557,DB00703,Methazolamide,SmallMoleculeDrug,P22748,Carbonic anhydrase 4,CA4,312.0
3558,DB00703,Methazolamide,SmallMoleculeDrug,P43166,Carbonic anhydrase 7,CA7,264.0
3559,DB00704,Naltrexone,SmallMoleculeDrug,P41143,Delta-type opioid receptor,OPRD1,372.0
3560,DB00704,Naltrexone,SmallMoleculeDrug,P35372,Mu-type opioid receptor,OPRM1,400.0
3561,DB00704,Naltrexone,SmallMoleculeDrug,P41145,Kappa-type opioid receptor,OPRK1,380.0
3562,DB00704,Naltrexone,SmallMoleculeDrug,Q5T1J1,"HCG20471, isoform CRA_c",SIGMAR1,134.0
3564,DB00706,Tamsulosin,SmallMoleculeDrug,P35348,Alpha-1A adrenergic receptor,ADRA1A,466.0
3565,DB00706,Tamsulosin,SmallMoleculeDrug,P25100,Alpha-1D adrenergic receptor,ADRA1D,572.0
3566,DB00706,Tamsulosin,SmallMoleculeDrug,P35368,Alpha-1B adrenergic receptor,ADRA1B,520.0
3567,DB00707,Porfimer,SmallMoleculeDrug,P01130,Low-density lipoprotein receptor,LDLR,860.0
3568,DB00707,Porfimer,SmallMoleculeDrug,P12314,High affinity immunoglobulin gamma Fc receptor I,FCGR1A,374.0
3569,DB00708,Sufentanil,SmallMoleculeDrug,P35372,Mu-type opioid receptor,OPRM1,400.0
3570,DB00708,Sufentanil,SmallMoleculeDrug,P41143,Delta-type opioid receptor,OPRD1,372.0
3571,DB00708,Sufentanil,SmallMoleculeDrug,P41145,Kappa-type opioid receptor,OPRK1,380.0
3574,DB00710,Ibandronate,SmallMoleculeDrug,P14324,Farnesyl pyrophosphate synthase,FDPS,419.0
3575,DB00711,Diethylcarbamazine,SmallMoleculeDrug,P09917,Arachidonate 5-lipoxygenase,ALOX5,674.0
3576,DB00711,Diethylcarbamazine,SmallMoleculeDrug,P23219,Prostaglandin G/H synthase 1,PTGS1,599.0
3577,DB00712,Flurbiprofen,SmallMoleculeDrug,P23219,Prostaglandin G/H synthase 1,PTGS1,599.0
3578,DB00712,Flurbiprofen,SmallMoleculeDrug,P35354,Prostaglandin G/H synthase 2,PTGS2,604.0
3585,DB00713,Oxacillin,SmallMoleculeDrug,P46059,Solute carrier family 15 member 1,SLC15A1,708.0
3587,DB00713,Oxacillin,SmallMoleculeDrug,Q16348,Solute carrier family 15 member 2,SLC15A2,729.0
3588,DB00714,Apomorphine,SmallMoleculeDrug,P35462,D(3) dopamine receptor,DRD3,400.0
3589,DB00714,Apomorphine,SmallMoleculeDrug,P21917,D(4) dopamine receptor,DRD4,467.0
3590,DB00714,Apomorphine,SmallMoleculeDrug,P14416,D(2) dopamine receptor,DRD2,443.0
3591,DB00714,Apomorphine,SmallMoleculeDrug,P18825,Alpha-2C adrenergic receptor,ADRA2C,462.0
3592,DB00714,Apomorphine,SmallMoleculeDrug,P18089,Alpha-2B adrenergic receptor,ADRA2B,450.0
3593,DB00714,Apomorphine,SmallMoleculeDrug,P28335,5-hydroxytryptamine receptor 2C,HTR2C,458.0
3594,DB00714,Apomorphine,SmallMoleculeDrug,P21918,D(1B) dopamine receptor,DRD5,477.0
3595,DB00714,Apomorphine,SmallMoleculeDrug,P08908,5-hydroxytryptamine receptor 1A,HTR1A,422.0
3596,DB00714,Apomorphine,SmallMoleculeDrug,P28223,5-hydroxytryptamine receptor 2A,HTR2A,471.0
3597,DB00714,Apomorphine,SmallMoleculeDrug,P41595,5-hydroxytryptamine receptor 2B,HTR2B,481.0
3598,DB00714,Apomorphine,SmallMoleculeDrug,P08913,Alpha-2A adrenergic receptor,ADRA2A,450.0
3599,DB00714,Apomorphine,SmallMoleculeDrug,P21728,D(1A) dopamine receptor,DRD1,446.0
3600,DB00714,Apomorphine,SmallMoleculeDrug,P28221,5-hydroxytryptamine receptor 1D,HTR1D,377.0
3601,DB00714,Apomorphine,SmallMoleculeDrug,P28222,5-hydroxytryptamine receptor 1B,HTR1B,390.0
3602,DB00714,Apomorphine,SmallMoleculeDrug,Q9NYX4,Neuron-specific vesicular protein calcyon,CALY,217.0
3603,DB00715,Paroxetine,SmallMoleculeDrug,P31645,Sodium-dependent serotonin transporter,SLC6A4,630.0
3604,DB00715,Paroxetine,SmallMoleculeDrug,P23975,Sodium-dependent noradrenaline transporter,SLC6A2,617.0
3605,DB00715,Paroxetine,SmallMoleculeDrug,P28223,5-hydroxytryptamine receptor 2A,HTR2A,471.0
3606,DB00715,Paroxetine,SmallMoleculeDrug,P11229,Muscarinic acetylcholine receptor M1,CHRM1,460.0
3607,DB00715,Paroxetine,SmallMoleculeDrug,P08172,Muscarinic acetylcholine receptor M2,CHRM2,466.0
3608,DB00715,Paroxetine,SmallMoleculeDrug,P20309,Muscarinic acetylcholine receptor M3,CHRM3,590.0
3609,DB00715,Paroxetine,SmallMoleculeDrug,P08173,Muscarinic acetylcholine receptor M4,CHRM4,479.0
3610,DB00715,Paroxetine,SmallMoleculeDrug,P08912,Muscarinic acetylcholine receptor M5,CHRM5,532.0
3611,DB00716,Nedocromil,SmallMoleculeDrug,Q9Y271,Cysteinyl leukotriene receptor 1,CYSLTR1,337.0
3612,DB00716,Nedocromil,SmallMoleculeDrug,Q9NS75,Cysteinyl leukotriene receptor 2,CYSLTR2,346.0
3613,DB00716,Nedocromil,SmallMoleculeDrug,P21462,fMet-Leu-Phe receptor,FPR1,350.0
3614,DB00716,Nedocromil,SmallMoleculeDrug,Q13258,Prostaglandin D2 receptor,PTGDR,359.0
3615,DB00716,Nedocromil,SmallMoleculeDrug,P07900,Heat shock protein HSP 90-alpha,HSP90AA1,732.0
3616,DB00717,Norethisterone,SmallMoleculeDrug,P06401,Progesterone receptor,PGR,933.0
3618,DB00719,Azatadine,SmallMoleculeDrug,P35367,Histamine H1 receptor,HRH1,487.0
3619,DB00720,Clodronate,SmallMoleculeDrug,P12235,ADP/ATP translocase 1,SLC25A4,298.0
3620,DB00720,Clodronate,SmallMoleculeDrug,P05141,ADP/ATP translocase 2,SLC25A5,298.0
3621,DB00720,Clodronate,SmallMoleculeDrug,P12236,ADP/ATP translocase 3,SLC25A6,298.0
3622,DB00721,Procaine,SmallMoleculeDrug,Q9Y5Y9,Sodium channel protein type 10 subunit alpha,SCN10A,1956.0
3623,DB00721,Procaine,SmallMoleculeDrug,Q8TCU5,"Glutamate receptor ionotropic, NMDA 3A",GRIN3A,1115.0
3624,DB00721,Procaine,SmallMoleculeDrug,P46098,5-hydroxytryptamine receptor 3A,HTR3A,478.0
3625,DB00721,Procaine,SmallMoleculeDrug,Q01959,Sodium-dependent dopamine transporter,SLC6A3,620.0
3626,DB00721,Procaine,SmallMoleculeDrug,Q15822,Neuronal acetylcholine receptor subunit alpha-2,CHRNA2,529.0
3627,DB00721,Procaine,SmallMoleculeDrug,Q12791,Calcium-activated potassium channel subunit alpha-1,KCNMA1,1236.0
3628,DB00721,Procaine,SmallMoleculeDrug,Q16558,Calcium-activated potassium channel subunit beta-1,KCNMB1,191.0
3629,DB00721,Procaine,SmallMoleculeDrug,Q9Y691,Calcium-activated potassium channel subunit beta-2,KCNMB2,235.0
3630,DB00721,Procaine,SmallMoleculeDrug,Q9NPA1,Calcium-activated potassium channel subunit beta-3,KCNMB3,279.0
3631,DB00721,Procaine,SmallMoleculeDrug,Q86W47,Calcium-activated potassium channel subunit beta-4,KCNMB4,210.0
3632,DB00721,Procaine,SmallMoleculeDrug,O15554,Intermediate conductance calcium-activated potassium channel protein 4,KCNN4,427.0
3633,DB00721,Procaine,SmallMoleculeDrug,Q92952,Small conductance calcium-activated potassium channel protein 1,KCNN1,543.0
3634,DB00721,Procaine,SmallMoleculeDrug,Q9H2S1,Small conductance calcium-activated potassium channel protein 2,KCNN2,579.0
3635,DB00721,Procaine,SmallMoleculeDrug,Q9UGI6,Small conductance calcium-activated potassium channel protein 3,KCNN3,736.0
3636,DB00721,Procaine,SmallMoleculeDrug,P21397,Amine oxidase [flavin-containing] A,MAOA,527.0
3637,DB00721,Procaine,SmallMoleculeDrug,P27338,Amine oxidase [flavin-containing] B,MAOB,520.0
3638,DB00722,Lisinopril,SmallMoleculeDrug,P12821,Angiotensin-converting enzyme,ACE,1306.0
3639,DB00722,Lisinopril,SmallMoleculeDrug,Q9BYF1,Angiotensin-converting enzyme 2,ACE2,805.0
3640,DB00723,Methoxamine,SmallMoleculeDrug,P35348,Alpha-1A adrenergic receptor,ADRA1A,466.0
3641,DB00723,Methoxamine,SmallMoleculeDrug,P35368,Alpha-1B adrenergic receptor,ADRA1B,520.0
3642,DB00723,Methoxamine,SmallMoleculeDrug,P25100,Alpha-1D adrenergic receptor,ADRA1D,572.0
3643,DB00724,Imiquimod,SmallMoleculeDrug,Q9NYK1,Toll-like receptor 7,TLR7,1049.0
3644,DB00724,Imiquimod,SmallMoleculeDrug,Q9NR97,Toll-like receptor 8,TLR8,1041.0
3645,DB00725,Homatropine Methylbromide,SmallMoleculeDrug,P08172,Muscarinic acetylcholine receptor M2,CHRM2,466.0
3646,DB00725,Homatropine Methylbromide,SmallMoleculeDrug,P11229,Muscarinic acetylcholine receptor M1,CHRM1,460.0
3647,DB00725,Homatropine Methylbromide,SmallMoleculeDrug,P08173,Muscarinic acetylcholine receptor M4,CHRM4,479.0
3648,DB00725,Homatropine Methylbromide,SmallMoleculeDrug,P08912,Muscarinic acetylcholine receptor M5,CHRM5,532.0
3649,DB00725,Homatropine Methylbromide,SmallMoleculeDrug,P20309,Muscarinic acetylcholine receptor M3,CHRM3,590.0
3650,DB00726,Trimipramine,SmallMoleculeDrug,P31645,Sodium-dependent serotonin transporter,SLC6A4,630.0
3651,DB00726,Trimipramine,SmallMoleculeDrug,P23975,Sodium-dependent noradrenaline transporter,SLC6A2,617.0
3652,DB00726,Trimipramine,SmallMoleculeDrug,Q01959,Sodium-dependent dopamine transporter,SLC6A3,620.0
3653,DB00726,Trimipramine,SmallMoleculeDrug,P28223,5-hydroxytryptamine receptor 2A,HTR2A,471.0
3654,DB00726,Trimipramine,SmallMoleculeDrug,P08908,5-hydroxytryptamine receptor 1A,HTR1A,422.0
3655,DB00726,Trimipramine,SmallMoleculeDrug,P35348,Alpha-1A adrenergic receptor,ADRA1A,466.0
3656,DB00726,Trimipramine,SmallMoleculeDrug,P35368,Alpha-1B adrenergic receptor,ADRA1B,520.0
3657,DB00726,Trimipramine,SmallMoleculeDrug,P14416,D(2) dopamine receptor,DRD2,443.0
3658,DB00726,Trimipramine,SmallMoleculeDrug,P18089,Alpha-2B adrenergic receptor,ADRA2B,450.0
3659,DB00726,Trimipramine,SmallMoleculeDrug,P35367,Histamine H1 receptor,HRH1,487.0
3660,DB00726,Trimipramine,SmallMoleculeDrug,P28335,5-hydroxytryptamine receptor 2C,HTR2C,458.0
3661,DB00726,Trimipramine,SmallMoleculeDrug,P46098,5-hydroxytryptamine receptor 3A,HTR3A,478.0
3662,DB00726,Trimipramine,SmallMoleculeDrug,P28221,5-hydroxytryptamine receptor 1D,HTR1D,377.0
3663,DB00726,Trimipramine,SmallMoleculeDrug,P08913,Alpha-2A adrenergic receptor,ADRA2A,450.0
3664,DB00726,Trimipramine,SmallMoleculeDrug,P21728,D(1A) dopamine receptor,DRD1,446.0
3665,DB00726,Trimipramine,SmallMoleculeDrug,P21918,D(1B) dopamine receptor,DRD5,477.0
3666,DB00726,Trimipramine,SmallMoleculeDrug,P08588,Beta-1 adrenergic receptor,ADRB1,477.0
3667,DB00726,Trimipramine,SmallMoleculeDrug,P07550,Beta-2 adrenergic receptor,ADRB2,413.0
3668,DB00726,Trimipramine,SmallMoleculeDrug,P13945,Beta-3 adrenergic receptor,ADRB3,408.0
3669,DB00726,Trimipramine,SmallMoleculeDrug,P11229,Muscarinic acetylcholine receptor M1,CHRM1,460.0
3670,DB00726,Trimipramine,SmallMoleculeDrug,P08172,Muscarinic acetylcholine receptor M2,CHRM2,466.0
3671,DB00726,Trimipramine,SmallMoleculeDrug,P20309,Muscarinic acetylcholine receptor M3,CHRM3,590.0
3672,DB00726,Trimipramine,SmallMoleculeDrug,P08173,Muscarinic acetylcholine receptor M4,CHRM4,479.0
3673,DB00726,Trimipramine,SmallMoleculeDrug,P08912,Muscarinic acetylcholine receptor M5,CHRM5,532.0
3675,DB00727,Nitroglycerin,SmallMoleculeDrug,P16066,Atrial natriuretic peptide receptor 1,NPR1,1061.0
3676,DB00728,Rocuronium,SmallMoleculeDrug,Q15822,Neuronal acetylcholine receptor subunit alpha-2,CHRNA2,529.0
3677,DB00728,Rocuronium,SmallMoleculeDrug,P08172,Muscarinic acetylcholine receptor M2,CHRM2,466.0
3678,DB00728,Rocuronium,SmallMoleculeDrug,P46098,5-hydroxytryptamine receptor 3A,HTR3A,478.0
3679,DB00729,Diphemanil Methylsulfate,SmallMoleculeDrug,P20309,Muscarinic acetylcholine receptor M3,CHRM3,590.0
3681,DB00731,Nateglinide,SmallMoleculeDrug,Q09428,ATP-binding cassette sub-family C member 8,ABCC8,1581.0
3682,DB00731,Nateglinide,SmallMoleculeDrug,P37231,Peroxisome proliferator-activated receptor gamma,PPARG,505.0
3683,DB00732,Atracurium besylate,SmallMoleculeDrug,Q15822,Neuronal acetylcholine receptor subunit alpha-2,CHRNA2,529.0
3684,DB00733,Pralidoxime,SmallMoleculeDrug,P22303,Acetylcholinesterase,ACHE,614.0
3685,DB00733,Pralidoxime,SmallMoleculeDrug,P06276,Cholinesterase,BCHE,602.0
3686,DB00734,Risperidone,SmallMoleculeDrug,P28223,5-hydroxytryptamine receptor 2A,HTR2A,471.0
3687,DB00734,Risperidone,SmallMoleculeDrug,P14416,D(2) dopamine receptor,DRD2,443.0
3688,DB00734,Risperidone,SmallMoleculeDrug,P35462,D(3) dopamine receptor,DRD3,400.0
3689,DB00734,Risperidone,SmallMoleculeDrug,P21917,D(4) dopamine receptor,DRD4,467.0
3690,DB00734,Risperidone,SmallMoleculeDrug,P35348,Alpha-1A adrenergic receptor,ADRA1A,466.0
3691,DB00734,Risperidone,SmallMoleculeDrug,P35368,Alpha-1B adrenergic receptor,ADRA1B,520.0
3692,DB00734,Risperidone,SmallMoleculeDrug,P28221,5-hydroxytryptamine receptor 1D,HTR1D,377.0
3693,DB00734,Risperidone,SmallMoleculeDrug,P35367,Histamine H1 receptor,HRH1,487.0
3694,DB00734,Risperidone,SmallMoleculeDrug,P08913,Alpha-2A adrenergic receptor,ADRA2A,450.0
3695,DB00734,Risperidone,SmallMoleculeDrug,P18089,Alpha-2B adrenergic receptor,ADRA2B,450.0
3696,DB00734,Risperidone,SmallMoleculeDrug,P18825,Alpha-2C adrenergic receptor,ADRA2C,462.0
3697,DB00734,Risperidone,SmallMoleculeDrug,P28335,5-hydroxytryptamine receptor 2C,HTR2C,458.0
3698,DB00734,Risperidone,SmallMoleculeDrug,P08908,5-hydroxytryptamine receptor 1A,HTR1A,422.0
3699,DB00734,Risperidone,SmallMoleculeDrug,P21728,D(1A) dopamine receptor,DRD1,446.0
3700,DB00735,Naftifine,SmallMoleculeDrug,Q14534,Squalene monooxygenase,SQLE,574.0
3701,DB00736,Esomeprazole,SmallMoleculeDrug,P20648,Potassium-transporting ATPase alpha chain 1,ATP4A,1035.0
3702,DB00737,Meclizine,SmallMoleculeDrug,P35367,Histamine H1 receptor,HRH1,487.0
3703,DB00738,Pentamidine,SmallMoleculeDrug,O14717,tRNA (cytosine(38)-C(5))-methyltransferase,TRDMT1,391.0
3709,DB00740,Riluzole,SmallMoleculeDrug,Q14524,Sodium channel protein type 5 subunit alpha,SCN5A,2016.0
3710,DB00740,Riluzole,SmallMoleculeDrug,Q9UPY5,Cystine/glutamate transporter,SLC7A11,501.0
3711,DB00741,Hydrocortisone,SmallMoleculeDrug,P04150,Glucocorticoid receptor,NR3C1,777.0
3712,DB00741,Hydrocortisone,SmallMoleculeDrug,P04083,Annexin A1,ANXA1,346.0
3713,DB00744,Zileuton,SmallMoleculeDrug,P09917,Arachidonate 5-lipoxygenase,ALOX5,674.0
3714,DB00745,Modafinil,SmallMoleculeDrug,Q01959,Sodium-dependent dopamine transporter,SLC6A3,620.0
3715,DB00745,Modafinil,SmallMoleculeDrug,P35368,Alpha-1B adrenergic receptor,ADRA1B,520.0
3716,DB00747,Scopolamine,SmallMoleculeDrug,P11229,Muscarinic acetylcholine receptor M1,CHRM1,460.0
3717,DB00747,Scopolamine,SmallMoleculeDrug,P14410,"Sucrase-isomaltase, intestinal",SI,1827.0
3718,DB00747,Scopolamine,SmallMoleculeDrug,P08172,Muscarinic acetylcholine receptor M2,CHRM2,466.0
3719,DB00747,Scopolamine,SmallMoleculeDrug,P20309,Muscarinic acetylcholine receptor M3,CHRM3,590.0
3720,DB00747,Scopolamine,SmallMoleculeDrug,P08173,Muscarinic acetylcholine receptor M4,CHRM4,479.0
3721,DB00747,Scopolamine,SmallMoleculeDrug,P08912,Muscarinic acetylcholine receptor M5,CHRM5,532.0
3722,DB00748,Carbinoxamine,SmallMoleculeDrug,P35367,Histamine H1 receptor,HRH1,487.0
3723,DB00749,Etodolac,SmallMoleculeDrug,P35354,Prostaglandin G/H synthase 2,PTGS2,604.0
3724,DB00749,Etodolac,SmallMoleculeDrug,P23219,Prostaglandin G/H synthase 1,PTGS1,599.0
3725,DB00749,Etodolac,SmallMoleculeDrug,P19793,Retinoic acid receptor RXR-alpha,RXRA,462.0
3726,DB00750,Prilocaine,SmallMoleculeDrug,Q14524,Sodium channel protein type 5 subunit alpha,SCN5A,2016.0
3727,DB00751,Epinastine,SmallMoleculeDrug,P35367,Histamine H1 receptor,HRH1,487.0
3728,DB00751,Epinastine,SmallMoleculeDrug,P25021,Histamine H2 receptor,HRH2,359.0
3729,DB00751,Epinastine,SmallMoleculeDrug,P35348,Alpha-1A adrenergic receptor,ADRA1A,466.0
3730,DB00751,Epinastine,SmallMoleculeDrug,P08913,Alpha-2A adrenergic receptor,ADRA2A,450.0
3731,DB00751,Epinastine,SmallMoleculeDrug,P28223,5-hydroxytryptamine receptor 2A,HTR2A,471.0
3732,DB00751,Epinastine,SmallMoleculeDrug,P34969,5-hydroxytryptamine receptor 7,HTR7,479.0
3733,DB00752,Tranylcypromine,SmallMoleculeDrug,P21397,Amine oxidase [flavin-containing] A,MAOA,527.0
3734,DB00752,Tranylcypromine,SmallMoleculeDrug,P27338,Amine oxidase [flavin-containing] B,MAOB,520.0
3735,DB00753,Isoflurane,SmallMoleculeDrug,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,456.0
3736,DB00753,Isoflurane,SmallMoleculeDrug,P98194,Calcium-transporting ATPase type 2C member 1,ATP2C1,919.0
3737,DB00753,Isoflurane,SmallMoleculeDrug,P23415,Glycine receptor subunit alpha-1,GLRA1,457.0
3738,DB00753,Isoflurane,SmallMoleculeDrug,P42261,Glutamate receptor 1,GRIA1,906.0
3739,DB00753,Isoflurane,SmallMoleculeDrug,Q09470,Potassium voltage-gated channel subfamily A member 1,KCNA1,495.0
3740,DB00753,Isoflurane,SmallMoleculeDrug,P30049,"ATP synthase subunit delta, mitochondrial",ATP5D,168.0
3742,DB00753,Isoflurane,SmallMoleculeDrug,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,456.0
3743,DB00753,Isoflurane,SmallMoleculeDrug,P47869,Gamma-aminobutyric acid receptor subunit alpha-2,GABRA2,451.0
3744,DB00753,Isoflurane,SmallMoleculeDrug,P34903,Gamma-aminobutyric acid receptor subunit alpha-3,GABRA3,492.0
3745,DB00753,Isoflurane,SmallMoleculeDrug,P48169,Gamma-aminobutyric acid receptor subunit alpha-4,GABRA4,554.0
3746,DB00753,Isoflurane,SmallMoleculeDrug,P31644,Gamma-aminobutyric acid receptor subunit alpha-5,GABRA5,462.0
3747,DB00753,Isoflurane,SmallMoleculeDrug,Q16445,Gamma-aminobutyric acid receptor subunit alpha-6,GABRA6,453.0
3748,DB00753,Isoflurane,SmallMoleculeDrug,P18505,Gamma-aminobutyric acid receptor subunit beta-1,GABRB1,474.0
3749,DB00753,Isoflurane,SmallMoleculeDrug,P47870,Gamma-aminobutyric acid receptor subunit beta-2,GABRB2,512.0
3750,DB00753,Isoflurane,SmallMoleculeDrug,P28472,Gamma-aminobutyric acid receptor subunit beta-3,GABRB3,473.0
3751,DB00753,Isoflurane,SmallMoleculeDrug,O14764,Gamma-aminobutyric acid receptor subunit delta,GABRD,452.0
3752,DB00753,Isoflurane,SmallMoleculeDrug,P78334,Gamma-aminobutyric acid receptor subunit epsilon,GABRE,506.0
3753,DB00753,Isoflurane,SmallMoleculeDrug,Q8N1C3,Gamma-aminobutyric acid receptor subunit gamma-1,GABRG1,465.0
3754,DB00753,Isoflurane,SmallMoleculeDrug,P18507,Gamma-aminobutyric acid receptor subunit gamma-2,GABRG2,467.0
3755,DB00753,Isoflurane,SmallMoleculeDrug,Q99928,Gamma-aminobutyric acid receptor subunit gamma-3,GABRG3,467.0
3756,DB00753,Isoflurane,SmallMoleculeDrug,O00591,Gamma-aminobutyric acid receptor subunit pi,GABRP,440.0
3757,DB00753,Isoflurane,SmallMoleculeDrug,Q9UN88,Gamma-aminobutyric acid receptor subunit theta,GABRQ,632.0
3758,DB00754,Ethotoin,SmallMoleculeDrug,Q14524,Sodium channel protein type 5 subunit alpha,SCN5A,2016.0
3759,DB00755,Tretinoin,SmallMoleculeDrug,P28702,Retinoic acid receptor RXR-beta,RXRB,533.0
3760,DB00755,Tretinoin,SmallMoleculeDrug,P48443,Retinoic acid receptor RXR-gamma,RXRG,463.0
3761,DB00755,Tretinoin,SmallMoleculeDrug,P13631,Retinoic acid receptor gamma,RARG,454.0
3762,DB00755,Tretinoin,SmallMoleculeDrug,P00352,Retinal dehydrogenase 1,ALDH1A1,501.0
3763,DB00755,Tretinoin,SmallMoleculeDrug,Q8NFJ5,Retinoic acid-induced protein 3,GPRC5A,357.0
3764,DB00755,Tretinoin,SmallMoleculeDrug,P51843,Nuclear receptor subfamily 0 group B member 1,NR0B1,470.0
3765,DB00755,Tretinoin,SmallMoleculeDrug,O94788,Retinal dehydrogenase 2,ALDH1A2,518.0
3766,DB00755,Tretinoin,SmallMoleculeDrug,P49788,Retinoic acid receptor responder protein 1,RARRES1,294.0
3768,DB00756,Hexachlorophene,SmallMoleculeDrug,O14521,"Succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial",SDHD,159.0
3769,DB00756,Hexachlorophene,SmallMoleculeDrug,P00367,"Glutamate dehydrogenase 1, mitochondrial",GLUD1,558.0
3770,DB00757,Dolasetron,SmallMoleculeDrug,P46098,5-hydroxytryptamine receptor 3A,HTR3A,478.0
3771,DB00758,Clopidogrel,SmallMoleculeDrug,Q9H244,P2Y purinoceptor 12,P2RY12,342.0
3777,DB00759,Tetracycline,SmallMoleculeDrug,P04156,Major prion protein,PRNP,253.0
3779,DB00759,Tetracycline,SmallMoleculeDrug,Q9UM07,Protein-arginine deiminase type-4,PADI4,663.0
3781,DB00761,Potassium Chloride,SmallMoleculeDrug,P55011,Solute carrier family 12 member 2,SLC12A2,1212.0
3782,DB00761,Potassium Chloride,SmallMoleculeDrug,Q13621,Solute carrier family 12 member 1,SLC12A1,1099.0
3783,DB00761,Potassium Chloride,SmallMoleculeDrug,Q9H2X9,Solute carrier family 12 member 5,SLC12A5,1139.0
3784,DB00761,Potassium Chloride,SmallMoleculeDrug,Q9UHW9,Solute carrier family 12 member 6,SLC12A6,1150.0
3785,DB00761,Potassium Chloride,SmallMoleculeDrug,Q9Y666,Solute carrier family 12 member 7,SLC12A7,1083.0
3786,DB00761,Potassium Chloride,SmallMoleculeDrug,Q9UP95,Solute carrier family 12 member 4,SLC12A4,1085.0
3787,DB00762,Irinotecan,SmallMoleculeDrug,P11387,DNA topoisomerase 1,TOP1,765.0
3788,DB00762,Irinotecan,SmallMoleculeDrug,Q969P6,"DNA topoisomerase I, mitochondrial",TOP1MT,601.0
3789,DB00763,Methimazole,SmallMoleculeDrug,P07202,Thyroid peroxidase,TPO,933.0
3790,DB00764,Mometasone,SmallMoleculeDrug,P04150,Glucocorticoid receptor,NR3C1,777.0
3791,DB00765,Metyrosine,SmallMoleculeDrug,P07101,Tyrosine 3-monooxygenase,TH,528.0
3793,DB00767,Benzquinamide,SmallMoleculeDrug,P35367,Histamine H1 receptor,HRH1,487.0
3794,DB00767,Benzquinamide,SmallMoleculeDrug,P08173,Muscarinic acetylcholine receptor M4,CHRM4,479.0
3795,DB00767,Benzquinamide,SmallMoleculeDrug,P11229,Muscarinic acetylcholine receptor M1,CHRM1,460.0
3796,DB00767,Benzquinamide,SmallMoleculeDrug,P08912,Muscarinic acetylcholine receptor M5,CHRM5,532.0
3797,DB00767,Benzquinamide,SmallMoleculeDrug,P08172,Muscarinic acetylcholine receptor M2,CHRM2,466.0
3798,DB00767,Benzquinamide,SmallMoleculeDrug,P20309,Muscarinic acetylcholine receptor M3,CHRM3,590.0
3799,DB00768,Olopatadine,SmallMoleculeDrug,P35367,Histamine H1 receptor,HRH1,487.0
3800,DB00768,Olopatadine,SmallMoleculeDrug,P23297,Protein S100-A1,S100A1,94.0
3801,DB00768,Olopatadine,SmallMoleculeDrug,P80511,Protein S100-A12,S100A12,92.0
3802,DB00768,Olopatadine,SmallMoleculeDrug,P04271,Protein S100-B,S100B,92.0
3803,DB00768,Olopatadine,SmallMoleculeDrug,Q99584,Protein S100-A13,S100A13,98.0
3804,DB00768,Olopatadine,SmallMoleculeDrug,P29034,Protein S100-A2,S100A2,98.0
3805,DB00769,Hydrocortamate,SmallMoleculeDrug,P04150,Glucocorticoid receptor,NR3C1,777.0
3806,DB00770,Alprostadil,SmallMoleculeDrug,P43116,Prostaglandin E2 receptor EP2 subtype,PTGER2,358.0
3807,DB00770,Alprostadil,SmallMoleculeDrug,P34995,Prostaglandin E2 receptor EP1 subtype,PTGER1,402.0
3808,DB00771,Clidinium,SmallMoleculeDrug,P11229,Muscarinic acetylcholine receptor M1,CHRM1,460.0
3809,DB00772,Malathion,SmallMoleculeDrug,P06276,Cholinesterase,BCHE,602.0
3810,DB00773,Etoposide,SmallMoleculeDrug,P11388,DNA topoisomerase 2-alpha,TOP2A,1531.0
3811,DB00773,Etoposide,SmallMoleculeDrug,Q02880,DNA topoisomerase 2-beta,TOP2B,1626.0
3812,DB00774,Hydroflumethiazide,SmallMoleculeDrug,Q13621,Solute carrier family 12 member 1,SLC12A1,1099.0
3813,DB00774,Hydroflumethiazide,SmallMoleculeDrug,P00915,Carbonic anhydrase 1,CA1,261.0
3814,DB00774,Hydroflumethiazide,SmallMoleculeDrug,P00918,Carbonic anhydrase 2,CA2,260.0
3815,DB00774,Hydroflumethiazide,SmallMoleculeDrug,P22748,Carbonic anhydrase 4,CA4,312.0
3816,DB00774,Hydroflumethiazide,SmallMoleculeDrug,Q16790,Carbonic anhydrase 9,CA9,459.0
3817,DB00774,Hydroflumethiazide,SmallMoleculeDrug,O43570,Carbonic anhydrase 12,CA12,354.0
3818,DB00774,Hydroflumethiazide,SmallMoleculeDrug,P05023,Sodium/potassium-transporting ATPase subunit alpha-1,ATP1A1,1023.0
3819,DB00774,Hydroflumethiazide,SmallMoleculeDrug,Q12791,Calcium-activated potassium channel subunit alpha-1,KCNMA1,1236.0
3820,DB00775,Tirofiban,SmallMoleculeDrug,P08514,Integrin alpha-IIb,ITGA2B,1039.0
3821,DB00775,Tirofiban,SmallMoleculeDrug,P05106,Integrin beta-3,ITGB3,788.0
3822,DB00776,Oxcarbazepine,SmallMoleculeDrug,Q14524,Sodium channel protein type 5 subunit alpha,SCN5A,2016.0
3823,DB00777,Propiomazine,SmallMoleculeDrug,P35367,Histamine H1 receptor,HRH1,487.0
3824,DB00777,Propiomazine,SmallMoleculeDrug,P28223,5-hydroxytryptamine receptor 2A,HTR2A,471.0
3825,DB00777,Propiomazine,SmallMoleculeDrug,P28335,5-hydroxytryptamine receptor 2C,HTR2C,458.0
3826,DB00777,Propiomazine,SmallMoleculeDrug,P14416,D(2) dopamine receptor,DRD2,443.0
3827,DB00777,Propiomazine,SmallMoleculeDrug,P21728,D(1A) dopamine receptor,DRD1,446.0
3828,DB00777,Propiomazine,SmallMoleculeDrug,P21917,D(4) dopamine receptor,DRD4,467.0
3829,DB00777,Propiomazine,SmallMoleculeDrug,P35348,Alpha-1A adrenergic receptor,ADRA1A,466.0
3830,DB00777,Propiomazine,SmallMoleculeDrug,P35368,Alpha-1B adrenergic receptor,ADRA1B,520.0
3831,DB00777,Propiomazine,SmallMoleculeDrug,P25100,Alpha-1D adrenergic receptor,ADRA1D,572.0
3832,DB00777,Propiomazine,SmallMoleculeDrug,P20309,Muscarinic acetylcholine receptor M3,CHRM3,590.0
3833,DB00777,Propiomazine,SmallMoleculeDrug,P08912,Muscarinic acetylcholine receptor M5,CHRM5,532.0
3834,DB00777,Propiomazine,SmallMoleculeDrug,P08172,Muscarinic acetylcholine receptor M2,CHRM2,466.0
3835,DB00777,Propiomazine,SmallMoleculeDrug,P08173,Muscarinic acetylcholine receptor M4,CHRM4,479.0
3836,DB00777,Propiomazine,SmallMoleculeDrug,P11229,Muscarinic acetylcholine receptor M1,CHRM1,460.0
3838,DB00778,Roxithromycin,SmallMoleculeDrug,P08183,Multidrug resistance protein 1,ABCB1,1280.0
3839,DB00780,Phenelzine,SmallMoleculeDrug,P21397,Amine oxidase [flavin-containing] A,MAOA,527.0
3840,DB00780,Phenelzine,SmallMoleculeDrug,P27338,Amine oxidase [flavin-containing] B,MAOB,520.0
3841,DB00780,Phenelzine,SmallMoleculeDrug,Q16853,Membrane primary amine oxidase,AOC3,763.0
3842,DB00780,Phenelzine,SmallMoleculeDrug,P80404,"4-aminobutyrate aminotransferase, mitochondrial",ABAT,500.0
3843,DB00780,Phenelzine,SmallMoleculeDrug,P24298,Alanine aminotransferase 1,GPT,496.0
3844,DB00780,Phenelzine,SmallMoleculeDrug,Q8TD30,Alanine aminotransferase 2,GPT2,523.0
3845,DB00780,Phenelzine,SmallMoleculeDrug,Q9UGI5,Glutamic acid decarboxylase,GAD65,419.0
3846,DB00782,Propantheline,SmallMoleculeDrug,P11229,Muscarinic acetylcholine receptor M1,CHRM1,460.0
3847,DB00783,Estradiol,SmallMoleculeDrug,P03372,Estrogen receptor,ESR1,595.0
3848,DB00783,Estradiol,SmallMoleculeDrug,Q92731,Estrogen receptor beta,ESR2,530.0
3849,DB00783,Estradiol,SmallMoleculeDrug,O75469,Nuclear receptor subfamily 1 group I member 2,NR1I2,434.0
3850,DB00784,Mefenamic acid,SmallMoleculeDrug,P35354,Prostaglandin G/H synthase 2,PTGS2,604.0
3851,DB00784,Mefenamic acid,SmallMoleculeDrug,P23219,Prostaglandin G/H synthase 1,PTGS1,599.0
3852,DB00785,Cryptenamine,SmallMoleculeDrug,P08172,Muscarinic acetylcholine receptor M2,CHRM2,466.0
3853,DB00785,Cryptenamine,SmallMoleculeDrug,P11229,Muscarinic acetylcholine receptor M1,CHRM1,460.0
3854,DB00785,Cryptenamine,SmallMoleculeDrug,P20309,Muscarinic acetylcholine receptor M3,CHRM3,590.0
3855,DB00785,Cryptenamine,SmallMoleculeDrug,P08173,Muscarinic acetylcholine receptor M4,CHRM4,479.0
3856,DB00785,Cryptenamine,SmallMoleculeDrug,P08912,Muscarinic acetylcholine receptor M5,CHRM5,532.0
3857,DB00786,Marimastat,SmallMoleculeDrug,P03956,Interstitial collagenase,MMP1,469.0
3858,DB00786,Marimastat,SmallMoleculeDrug,P08253,72 kDa type IV collagenase,MMP2,660.0
3859,DB00786,Marimastat,SmallMoleculeDrug,P08254,Stromelysin-1,MMP3,477.0
3860,DB00786,Marimastat,SmallMoleculeDrug,P09237,Matrilysin,MMP7,267.0
3861,DB00786,Marimastat,SmallMoleculeDrug,P22894,Neutrophil collagenase,MMP8,467.0
3862,DB00786,Marimastat,SmallMoleculeDrug,P14780,Matrix metalloproteinase-9,MMP9,707.0
3863,DB00786,Marimastat,SmallMoleculeDrug,P09238,Stromelysin-2,MMP10,476.0
3864,DB00786,Marimastat,SmallMoleculeDrug,P24347,Stromelysin-3,MMP11,488.0
3865,DB00786,Marimastat,SmallMoleculeDrug,P39900,Macrophage metalloelastase,MMP12,470.0
3866,DB00786,Marimastat,SmallMoleculeDrug,P45452,Collagenase 3,MMP13,471.0
3867,DB00786,Marimastat,SmallMoleculeDrug,P50281,Matrix metalloproteinase-14,MMP14,582.0
3868,DB00786,Marimastat,SmallMoleculeDrug,P51511,Matrix metalloproteinase-15,MMP15,669.0
3869,DB00786,Marimastat,SmallMoleculeDrug,P51512,Matrix metalloproteinase-16,MMP16,607.0
3870,DB00786,Marimastat,SmallMoleculeDrug,Q9ULZ9,Matrix metalloproteinase-17,MMP17,603.0
3871,DB00786,Marimastat,SmallMoleculeDrug,Q99542,Matrix metalloproteinase-19,MMP19,508.0
3872,DB00786,Marimastat,SmallMoleculeDrug,O60882,Matrix metalloproteinase-20,MMP20,483.0
3873,DB00786,Marimastat,SmallMoleculeDrug,Q8N119,Matrix metalloproteinase-21,MMP21,569.0
3874,DB00786,Marimastat,SmallMoleculeDrug,O75900,Matrix metalloproteinase-23,MMP23A,390.0
3875,DB00786,Marimastat,SmallMoleculeDrug,Q9Y5R2,Matrix metalloproteinase-24,MMP24,645.0
3876,DB00786,Marimastat,SmallMoleculeDrug,Q9NPA2,Matrix metalloproteinase-25,MMP25,562.0
3877,DB00786,Marimastat,SmallMoleculeDrug,Q9NRE1,Matrix metalloproteinase-26,MMP26,261.0
3878,DB00786,Marimastat,SmallMoleculeDrug,Q9H306,Matrix metalloproteinase-27,MMP27,513.0
3879,DB00786,Marimastat,SmallMoleculeDrug,Q9H239,Matrix metalloproteinase-28,MMP28,520.0
3883,DB00788,Naproxen,SmallMoleculeDrug,P23219,Prostaglandin G/H synthase 1,PTGS1,599.0
3885,DB00788,Naproxen,SmallMoleculeDrug,P35354,Prostaglandin G/H synthase 2,PTGS2,604.0
3886,DB00789,Gadopentetate dimeglumine,SmallMoleculeDrug,P52209,"6-phosphogluconate dehydrogenase, decarboxylating",PGD,483.0
3887,DB00790,Perindopril,SmallMoleculeDrug,P12821,Angiotensin-converting enzyme,ACE,1306.0
3888,DB00792,Tripelennamine,SmallMoleculeDrug,P35367,Histamine H1 receptor,HRH1,487.0
3889,DB00794,Primidone,SmallMoleculeDrug,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,456.0
3890,DB00794,Primidone,SmallMoleculeDrug,P47869,Gamma-aminobutyric acid receptor subunit alpha-2,GABRA2,451.0
3891,DB00794,Primidone,SmallMoleculeDrug,P34903,Gamma-aminobutyric acid receptor subunit alpha-3,GABRA3,492.0
3892,DB00794,Primidone,SmallMoleculeDrug,P48169,Gamma-aminobutyric acid receptor subunit alpha-4,GABRA4,554.0
3893,DB00794,Primidone,SmallMoleculeDrug,P31644,Gamma-aminobutyric acid receptor subunit alpha-5,GABRA5,462.0
3894,DB00794,Primidone,SmallMoleculeDrug,Q16445,Gamma-aminobutyric acid receptor subunit alpha-6,GABRA6,453.0
3895,DB00794,Primidone,SmallMoleculeDrug,P43681,Neuronal acetylcholine receptor subunit alpha-4,CHRNA4,627.0
3896,DB00794,Primidone,SmallMoleculeDrug,P36544,Neuronal acetylcholine receptor subunit alpha-7,CHRNA7,502.0
3897,DB00794,Primidone,SmallMoleculeDrug,P42262,Glutamate receptor 2,GRIA2,883.0
3898,DB00794,Primidone,SmallMoleculeDrug,Q13002,"Glutamate receptor ionotropic, kainate 2",GRIK2,908.0
3899,DB00794,Primidone,SmallMoleculeDrug,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,456.0
3900,DB00794,Primidone,SmallMoleculeDrug,P47869,Gamma-aminobutyric acid receptor subunit alpha-2,GABRA2,451.0
3901,DB00794,Primidone,SmallMoleculeDrug,P34903,Gamma-aminobutyric acid receptor subunit alpha-3,GABRA3,492.0
3902,DB00794,Primidone,SmallMoleculeDrug,P48169,Gamma-aminobutyric acid receptor subunit alpha-4,GABRA4,554.0
3903,DB00794,Primidone,SmallMoleculeDrug,P31644,Gamma-aminobutyric acid receptor subunit alpha-5,GABRA5,462.0
3904,DB00794,Primidone,SmallMoleculeDrug,Q16445,Gamma-aminobutyric acid receptor subunit alpha-6,GABRA6,453.0
3905,DB00794,Primidone,SmallMoleculeDrug,P18505,Gamma-aminobutyric acid receptor subunit beta-1,GABRB1,474.0
3906,DB00794,Primidone,SmallMoleculeDrug,P47870,Gamma-aminobutyric acid receptor subunit beta-2,GABRB2,512.0
3907,DB00794,Primidone,SmallMoleculeDrug,P28472,Gamma-aminobutyric acid receptor subunit beta-3,GABRB3,473.0
3908,DB00794,Primidone,SmallMoleculeDrug,O14764,Gamma-aminobutyric acid receptor subunit delta,GABRD,452.0
3909,DB00794,Primidone,SmallMoleculeDrug,P78334,Gamma-aminobutyric acid receptor subunit epsilon,GABRE,506.0
3910,DB00794,Primidone,SmallMoleculeDrug,Q8N1C3,Gamma-aminobutyric acid receptor subunit gamma-1,GABRG1,465.0
3911,DB00794,Primidone,SmallMoleculeDrug,P18507,Gamma-aminobutyric acid receptor subunit gamma-2,GABRG2,467.0
3912,DB00794,Primidone,SmallMoleculeDrug,Q99928,Gamma-aminobutyric acid receptor subunit gamma-3,GABRG3,467.0
3913,DB00794,Primidone,SmallMoleculeDrug,O00591,Gamma-aminobutyric acid receptor subunit pi,GABRP,440.0
3914,DB00794,Primidone,SmallMoleculeDrug,Q9UN88,Gamma-aminobutyric acid receptor subunit theta,GABRQ,632.0
3915,DB00795,Sulfasalazine,SmallMoleculeDrug,P09917,Arachidonate 5-lipoxygenase,ALOX5,674.0
3916,DB00795,Sulfasalazine,SmallMoleculeDrug,P35354,Prostaglandin G/H synthase 2,PTGS2,604.0
3917,DB00795,Sulfasalazine,SmallMoleculeDrug,P23219,Prostaglandin G/H synthase 1,PTGS1,599.0
3918,DB00795,Sulfasalazine,SmallMoleculeDrug,P37231,Peroxisome proliferator-activated receptor gamma,PPARG,505.0
3919,DB00795,Sulfasalazine,SmallMoleculeDrug,O15111,Inhibitor of nuclear factor kappa-B kinase subunit alpha,CHUK,745.0
3920,DB00795,Sulfasalazine,SmallMoleculeDrug,O14920,Inhibitor of nuclear factor kappa-B kinase subunit beta,IKBKB,756.0
3921,DB00795,Sulfasalazine,SmallMoleculeDrug,Q9UPY5,Cystine/glutamate transporter,SLC7A11,501.0
3922,DB00795,Sulfasalazine,SmallMoleculeDrug,P24752,"Acetyl-CoA acetyltransferase, mitochondrial",ACAT1,427.0
3923,DB00795,Sulfasalazine,SmallMoleculeDrug,P24557,Thromboxane-A synthase,TBXAS1,533.0
3924,DB00795,Sulfasalazine,SmallMoleculeDrug,P04054,Phospholipase A2,PLA2G1B,148.0
3925,DB00796,Candesartan,SmallMoleculeDrug,P30556,Type-1 angiotensin II receptor,AGTR1,359.0
3926,DB00797,Tolazoline,SmallMoleculeDrug,P35348,Alpha-1A adrenergic receptor,ADRA1A,466.0
3927,DB00797,Tolazoline,SmallMoleculeDrug,P08913,Alpha-2A adrenergic receptor,ADRA2A,450.0
3928,DB00797,Tolazoline,SmallMoleculeDrug,P35367,Histamine H1 receptor,HRH1,487.0
3929,DB00797,Tolazoline,SmallMoleculeDrug,P25021,Histamine H2 receptor,HRH2,359.0
3930,DB00797,Tolazoline,SmallMoleculeDrug,P18825,Alpha-2C adrenergic receptor,ADRA2C,462.0
3931,DB00797,Tolazoline,SmallMoleculeDrug,P18089,Alpha-2B adrenergic receptor,ADRA2B,450.0
3933,DB00798,Gentamicin,SmallMoleculeDrug,P98164,Low-density lipoprotein receptor-related protein 2,LRP2,4655.0
3935,DB00798,Gentamicin,SmallMoleculeDrug,P00374,Dihydrofolate reductase,DHFR,187.0
3936,DB00799,Tazarotene,SmallMoleculeDrug,P10276,Retinoic acid receptor alpha,RARA,462.0
3937,DB00799,Tazarotene,SmallMoleculeDrug,P28702,Retinoic acid receptor RXR-beta,RXRB,533.0
3938,DB00799,Tazarotene,SmallMoleculeDrug,P13631,Retinoic acid receptor gamma,RARG,454.0
3939,DB00799,Tazarotene,SmallMoleculeDrug,P10826,Retinoic acid receptor beta,RARB,455.0
3940,DB00800,Fenoldopam,SmallMoleculeDrug,P21918,D(1B) dopamine receptor,DRD5,477.0
3941,DB00800,Fenoldopam,SmallMoleculeDrug,P21728,D(1A) dopamine receptor,DRD1,446.0
3942,DB00800,Fenoldopam,SmallMoleculeDrug,P18089,Alpha-2B adrenergic receptor,ADRA2B,450.0
3943,DB00800,Fenoldopam,SmallMoleculeDrug,P18825,Alpha-2C adrenergic receptor,ADRA2C,462.0
3944,DB00800,Fenoldopam,SmallMoleculeDrug,P08913,Alpha-2A adrenergic receptor,ADRA2A,450.0
3945,DB00800,Fenoldopam,SmallMoleculeDrug,P35368,Alpha-1B adrenergic receptor,ADRA1B,520.0
3946,DB00800,Fenoldopam,SmallMoleculeDrug,P25100,Alpha-1D adrenergic receptor,ADRA1D,572.0
3947,DB00800,Fenoldopam,SmallMoleculeDrug,P35348,Alpha-1A adrenergic receptor,ADRA1A,466.0
3948,DB00801,Halazepam,SmallMoleculeDrug,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,456.0
3949,DB00801,Halazepam,SmallMoleculeDrug,P47869,Gamma-aminobutyric acid receptor subunit alpha-2,GABRA2,451.0
3950,DB00801,Halazepam,SmallMoleculeDrug,P34903,Gamma-aminobutyric acid receptor subunit alpha-3,GABRA3,492.0
3951,DB00801,Halazepam,SmallMoleculeDrug,P31644,Gamma-aminobutyric acid receptor subunit alpha-5,GABRA5,462.0
3952,DB00801,Halazepam,SmallMoleculeDrug,Q8N1C3,Gamma-aminobutyric acid receptor subunit gamma-1,GABRG1,465.0
3953,DB00801,Halazepam,SmallMoleculeDrug,P18507,Gamma-aminobutyric acid receptor subunit gamma-2,GABRG2,467.0
3954,DB00801,Halazepam,SmallMoleculeDrug,Q99928,Gamma-aminobutyric acid receptor subunit gamma-3,GABRG3,467.0
3955,DB00801,Halazepam,SmallMoleculeDrug,P18505,Gamma-aminobutyric acid receptor subunit beta-1,GABRB1,474.0
3956,DB00801,Halazepam,SmallMoleculeDrug,P47870,Gamma-aminobutyric acid receptor subunit beta-2,GABRB2,512.0
3957,DB00801,Halazepam,SmallMoleculeDrug,P28472,Gamma-aminobutyric acid receptor subunit beta-3,GABRB3,473.0
3958,DB00801,Halazepam,SmallMoleculeDrug,O14764,Gamma-aminobutyric acid receptor subunit delta,GABRD,452.0
3959,DB00801,Halazepam,SmallMoleculeDrug,P78334,Gamma-aminobutyric acid receptor subunit epsilon,GABRE,506.0
3960,DB00801,Halazepam,SmallMoleculeDrug,O00591,Gamma-aminobutyric acid receptor subunit pi,GABRP,440.0
3961,DB00801,Halazepam,SmallMoleculeDrug,P24046,Gamma-aminobutyric acid receptor subunit rho-1,GABRR1,479.0
3962,DB00801,Halazepam,SmallMoleculeDrug,P28476,Gamma-aminobutyric acid receptor subunit rho-2,GABRR2,465.0
3963,DB00801,Halazepam,SmallMoleculeDrug,A8MPY1,Gamma-aminobutyric acid receptor subunit rho-3,GABRR3,467.0
3964,DB00801,Halazepam,SmallMoleculeDrug,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,456.0
3965,DB00801,Halazepam,SmallMoleculeDrug,P47869,Gamma-aminobutyric acid receptor subunit alpha-2,GABRA2,451.0
3966,DB00801,Halazepam,SmallMoleculeDrug,P34903,Gamma-aminobutyric acid receptor subunit alpha-3,GABRA3,492.0
3967,DB00801,Halazepam,SmallMoleculeDrug,P48169,Gamma-aminobutyric acid receptor subunit alpha-4,GABRA4,554.0
3968,DB00801,Halazepam,SmallMoleculeDrug,P31644,Gamma-aminobutyric acid receptor subunit alpha-5,GABRA5,462.0
3969,DB00801,Halazepam,SmallMoleculeDrug,Q16445,Gamma-aminobutyric acid receptor subunit alpha-6,GABRA6,453.0
3970,DB00801,Halazepam,SmallMoleculeDrug,P18505,Gamma-aminobutyric acid receptor subunit beta-1,GABRB1,474.0
3971,DB00801,Halazepam,SmallMoleculeDrug,P47870,Gamma-aminobutyric acid receptor subunit beta-2,GABRB2,512.0
3972,DB00801,Halazepam,SmallMoleculeDrug,P28472,Gamma-aminobutyric acid receptor subunit beta-3,GABRB3,473.0
3973,DB00801,Halazepam,SmallMoleculeDrug,O14764,Gamma-aminobutyric acid receptor subunit delta,GABRD,452.0
3974,DB00801,Halazepam,SmallMoleculeDrug,P78334,Gamma-aminobutyric acid receptor subunit epsilon,GABRE,506.0
3975,DB00801,Halazepam,SmallMoleculeDrug,Q8N1C3,Gamma-aminobutyric acid receptor subunit gamma-1,GABRG1,465.0
3976,DB00801,Halazepam,SmallMoleculeDrug,P18507,Gamma-aminobutyric acid receptor subunit gamma-2,GABRG2,467.0
3977,DB00801,Halazepam,SmallMoleculeDrug,Q99928,Gamma-aminobutyric acid receptor subunit gamma-3,GABRG3,467.0
3978,DB00801,Halazepam,SmallMoleculeDrug,O00591,Gamma-aminobutyric acid receptor subunit pi,GABRP,440.0
3979,DB00801,Halazepam,SmallMoleculeDrug,Q9UN88,Gamma-aminobutyric acid receptor subunit theta,GABRQ,632.0
3980,DB00802,Alfentanil,SmallMoleculeDrug,P35372,Mu-type opioid receptor,OPRM1,400.0
3981,DB00804,Dicyclomine,SmallMoleculeDrug,P11229,Muscarinic acetylcholine receptor M1,CHRM1,460.0
3982,DB00804,Dicyclomine,SmallMoleculeDrug,P08172,Muscarinic acetylcholine receptor M2,CHRM2,466.0
3983,DB00805,Minaprine,SmallMoleculeDrug,P21397,Amine oxidase [flavin-containing] A,MAOA,527.0
3984,DB00805,Minaprine,SmallMoleculeDrug,P41595,5-hydroxytryptamine receptor 2B,HTR2B,481.0
3985,DB00805,Minaprine,SmallMoleculeDrug,P28223,5-hydroxytryptamine receptor 2A,HTR2A,471.0
3986,DB00805,Minaprine,SmallMoleculeDrug,P28335,5-hydroxytryptamine receptor 2C,HTR2C,458.0
3987,DB00805,Minaprine,SmallMoleculeDrug,P22303,Acetylcholinesterase,ACHE,614.0
3988,DB00805,Minaprine,SmallMoleculeDrug,P31645,Sodium-dependent serotonin transporter,SLC6A4,630.0
3989,DB00805,Minaprine,SmallMoleculeDrug,P21728,D(1A) dopamine receptor,DRD1,446.0
3990,DB00805,Minaprine,SmallMoleculeDrug,P14416,D(2) dopamine receptor,DRD2,443.0
3991,DB00805,Minaprine,SmallMoleculeDrug,P11229,Muscarinic acetylcholine receptor M1,CHRM1,460.0
3992,DB00806,Pentoxifylline,SmallMoleculeDrug,Q07343,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B",PDE4B,736.0
3993,DB00806,Pentoxifylline,SmallMoleculeDrug,P30542,Adenosine receptor A1,ADORA1,326.0
3994,DB00806,Pentoxifylline,SmallMoleculeDrug,O76074,"cGMP-specific 3',5'-cyclic phosphodiesterase",PDE5A,875.0
3995,DB00806,Pentoxifylline,SmallMoleculeDrug,P27815,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A",PDE4A,886.0
3996,DB00806,Pentoxifylline,SmallMoleculeDrug,P29274,Adenosine receptor A2a,ADORA2A,412.0
3997,DB00806,Pentoxifylline,SmallMoleculeDrug,P21589,5'-nucleotidase,NT5E,574.0
3998,DB00807,Proparacaine,SmallMoleculeDrug,Q9Y5Y9,Sodium channel protein type 10 subunit alpha,SCN10A,1956.0
3999,DB00808,Indapamide,SmallMoleculeDrug,P51787,Potassium voltage-gated channel subfamily KQT member 1,KCNQ1,676.0
4000,DB00808,Indapamide,SmallMoleculeDrug,P15382,Potassium voltage-gated channel subfamily E member 1,KCNE1,129.0
4001,DB00809,Tropicamide,SmallMoleculeDrug,P08173,Muscarinic acetylcholine receptor M4,CHRM4,479.0
4002,DB00809,Tropicamide,SmallMoleculeDrug,P11229,Muscarinic acetylcholine receptor M1,CHRM1,460.0
4003,DB00809,Tropicamide,SmallMoleculeDrug,P08172,Muscarinic acetylcholine receptor M2,CHRM2,466.0
4004,DB00809,Tropicamide,SmallMoleculeDrug,P20309,Muscarinic acetylcholine receptor M3,CHRM3,590.0
4005,DB00810,Biperiden,SmallMoleculeDrug,P11229,Muscarinic acetylcholine receptor M1,CHRM1,460.0
4006,DB00810,Biperiden,SmallMoleculeDrug,Q15822,Neuronal acetylcholine receptor subunit alpha-2,CHRNA2,529.0
4007,DB00811,Ribavirin,SmallMoleculeDrug,P20839,Inosine-5'-monophosphate dehydrogenase 1,IMPDH1,514.0
4008,DB00811,Ribavirin,SmallMoleculeDrug,P55263,Adenosine kinase,ADK,362.0
4009,DB00811,Ribavirin,SmallMoleculeDrug,P12268,Inosine-5'-monophosphate dehydrogenase 2,IMPDH2,514.0
4012,DB00811,Ribavirin,SmallMoleculeDrug,P49902,Cytosolic purine 5'-nucleotidase,NT5C2,561.0
4013,DB00811,Ribavirin,SmallMoleculeDrug,P22413,Ectonucleotide pyrophosphatase/phosphodiesterase family member 1,ENPP1,925.0
4015,DB00812,Phenylbutazone,SmallMoleculeDrug,P35354,Prostaglandin G/H synthase 2,PTGS2,604.0
4016,DB00812,Phenylbutazone,SmallMoleculeDrug,Q16647,Prostacyclin synthase,PTGIS,500.0
4017,DB00812,Phenylbutazone,SmallMoleculeDrug,P23219,Prostaglandin G/H synthase 1,PTGS1,599.0
4018,DB00813,Fentanyl,SmallMoleculeDrug,P35372,Mu-type opioid receptor,OPRM1,400.0
4019,DB00813,Fentanyl,SmallMoleculeDrug,P41143,Delta-type opioid receptor,OPRD1,372.0
4020,DB00813,Fentanyl,SmallMoleculeDrug,P41145,Kappa-type opioid receptor,OPRK1,380.0
4021,DB00814,Meloxicam,SmallMoleculeDrug,P35354,Prostaglandin G/H synthase 2,PTGS2,604.0
4022,DB00814,Meloxicam,SmallMoleculeDrug,P23219,Prostaglandin G/H synthase 1,PTGS1,599.0
4023,DB00816,Orciprenaline,SmallMoleculeDrug,P07550,Beta-2 adrenergic receptor,ADRB2,413.0
4026,DB00818,Propofol,SmallMoleculeDrug,P47870,Gamma-aminobutyric acid receptor subunit beta-2,GABRB2,512.0
4027,DB00818,Propofol,SmallMoleculeDrug,P28472,Gamma-aminobutyric acid receptor subunit beta-3,GABRB3,473.0
4028,DB00818,Propofol,SmallMoleculeDrug,P35499,Sodium channel protein type 4 subunit alpha,SCN4A,1836.0
4029,DB00818,Propofol,SmallMoleculeDrug,Q99250,Sodium channel protein type 2 subunit alpha,SCN2A,2005.0
4030,DB00818,Propofol,SmallMoleculeDrug,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,456.0
4031,DB00818,Propofol,SmallMoleculeDrug,P47869,Gamma-aminobutyric acid receptor subunit alpha-2,GABRA2,451.0
4032,DB00818,Propofol,SmallMoleculeDrug,P34903,Gamma-aminobutyric acid receptor subunit alpha-3,GABRA3,492.0
4033,DB00818,Propofol,SmallMoleculeDrug,P48169,Gamma-aminobutyric acid receptor subunit alpha-4,GABRA4,554.0
4034,DB00818,Propofol,SmallMoleculeDrug,P31644,Gamma-aminobutyric acid receptor subunit alpha-5,GABRA5,462.0
4035,DB00818,Propofol,SmallMoleculeDrug,Q16445,Gamma-aminobutyric acid receptor subunit alpha-6,GABRA6,453.0
4036,DB00818,Propofol,SmallMoleculeDrug,P18505,Gamma-aminobutyric acid receptor subunit beta-1,GABRB1,474.0
4037,DB00818,Propofol,SmallMoleculeDrug,P47870,Gamma-aminobutyric acid receptor subunit beta-2,GABRB2,512.0
4038,DB00818,Propofol,SmallMoleculeDrug,P28472,Gamma-aminobutyric acid receptor subunit beta-3,GABRB3,473.0
4039,DB00818,Propofol,SmallMoleculeDrug,O14764,Gamma-aminobutyric acid receptor subunit delta,GABRD,452.0
4040,DB00818,Propofol,SmallMoleculeDrug,P78334,Gamma-aminobutyric acid receptor subunit epsilon,GABRE,506.0
4041,DB00818,Propofol,SmallMoleculeDrug,Q8N1C3,Gamma-aminobutyric acid receptor subunit gamma-1,GABRG1,465.0
4042,DB00818,Propofol,SmallMoleculeDrug,P18507,Gamma-aminobutyric acid receptor subunit gamma-2,GABRG2,467.0
4043,DB00818,Propofol,SmallMoleculeDrug,Q99928,Gamma-aminobutyric acid receptor subunit gamma-3,GABRG3,467.0
4044,DB00818,Propofol,SmallMoleculeDrug,O00591,Gamma-aminobutyric acid receptor subunit pi,GABRP,440.0
4045,DB00818,Propofol,SmallMoleculeDrug,Q9UN88,Gamma-aminobutyric acid receptor subunit theta,GABRQ,632.0
4046,DB00819,Acetazolamide,SmallMoleculeDrug,P00915,Carbonic anhydrase 1,CA1,261.0
4047,DB00819,Acetazolamide,SmallMoleculeDrug,Q9ULX7,Carbonic anhydrase 14,CA14,337.0
4048,DB00819,Acetazolamide,SmallMoleculeDrug,P00918,Carbonic anhydrase 2,CA2,260.0
4049,DB00819,Acetazolamide,SmallMoleculeDrug,P07451,Carbonic anhydrase 3,CA3,260.0
4050,DB00819,Acetazolamide,SmallMoleculeDrug,P22748,Carbonic anhydrase 4,CA4,312.0
4051,DB00819,Acetazolamide,SmallMoleculeDrug,P43166,Carbonic anhydrase 7,CA7,264.0
4052,DB00819,Acetazolamide,SmallMoleculeDrug,P29972,Aquaporin-1,AQP1,269.0
4053,DB00820,Tadalafil,SmallMoleculeDrug,O76074,"cGMP-specific 3',5'-cyclic phosphodiesterase",PDE5A,875.0
4054,DB00820,Tadalafil,SmallMoleculeDrug,Q9HCR9,"Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A",PDE11A,933.0
4055,DB00821,Carprofen,SmallMoleculeDrug,P35354,Prostaglandin G/H synthase 2,PTGS2,604.0
4056,DB00821,Carprofen,SmallMoleculeDrug,P23219,Prostaglandin G/H synthase 1,PTGS1,599.0
4057,DB00822,Disulfiram,SmallMoleculeDrug,P05091,"Aldehyde dehydrogenase, mitochondrial",ALDH2,517.0
4058,DB00822,Disulfiram,SmallMoleculeDrug,P09172,Dopamine beta-hydroxylase,DBH,617.0
4059,DB00823,Ethynodiol diacetate,SmallMoleculeDrug,P06401,Progesterone receptor,PGR,933.0
4060,DB00823,Ethynodiol diacetate,SmallMoleculeDrug,P03372,Estrogen receptor,ESR1,595.0
4061,DB00824,Enprofylline,SmallMoleculeDrug,P27815,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A",PDE4A,886.0
4062,DB00824,Enprofylline,SmallMoleculeDrug,Q07343,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B",PDE4B,736.0
4063,DB00824,Enprofylline,SmallMoleculeDrug,P29275,Adenosine receptor A2b,ADORA2B,332.0
4064,DB00824,Enprofylline,SmallMoleculeDrug,P30542,Adenosine receptor A1,ADORA1,326.0
4065,DB00824,Enprofylline,SmallMoleculeDrug,P29274,Adenosine receptor A2a,ADORA2A,412.0
4066,DB00824,Enprofylline,SmallMoleculeDrug,P0DMS8,Adenosine receptor A3,ADORA3,318.0
4067,DB00825,Menthol,SmallMoleculeDrug,Q7Z2W7,Transient receptor potential cation channel subfamily M member 8,TRPM8,1104.0
4068,DB00825,Menthol,SmallMoleculeDrug,O75762,Transient receptor potential cation channel subfamily A member 1,TRPA1,1119.0
4069,DB00825,Menthol,SmallMoleculeDrug,Q8NET8,Transient receptor potential cation channel subfamily V member 3,TRPV3,790.0
4070,DB00825,Menthol,SmallMoleculeDrug,P41145,Kappa-type opioid receptor,OPRK1,380.0
4073,DB00829,Diazepam,SmallMoleculeDrug,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,456.0
4074,DB00829,Diazepam,SmallMoleculeDrug,P47869,Gamma-aminobutyric acid receptor subunit alpha-2,GABRA2,451.0
4075,DB00829,Diazepam,SmallMoleculeDrug,P34903,Gamma-aminobutyric acid receptor subunit alpha-3,GABRA3,492.0
4076,DB00829,Diazepam,SmallMoleculeDrug,P31644,Gamma-aminobutyric acid receptor subunit alpha-5,GABRA5,462.0
4077,DB00829,Diazepam,SmallMoleculeDrug,P18505,Gamma-aminobutyric acid receptor subunit beta-1,GABRB1,474.0
4078,DB00829,Diazepam,SmallMoleculeDrug,P47870,Gamma-aminobutyric acid receptor subunit beta-2,GABRB2,512.0
4079,DB00829,Diazepam,SmallMoleculeDrug,P28472,Gamma-aminobutyric acid receptor subunit beta-3,GABRB3,473.0
4080,DB00829,Diazepam,SmallMoleculeDrug,Q8N1C3,Gamma-aminobutyric acid receptor subunit gamma-1,GABRG1,465.0
4081,DB00829,Diazepam,SmallMoleculeDrug,P18507,Gamma-aminobutyric acid receptor subunit gamma-2,GABRG2,467.0
4082,DB00829,Diazepam,SmallMoleculeDrug,Q99928,Gamma-aminobutyric acid receptor subunit gamma-3,GABRG3,467.0
4083,DB00829,Diazepam,SmallMoleculeDrug,O14764,Gamma-aminobutyric acid receptor subunit delta,GABRD,452.0
4084,DB00829,Diazepam,SmallMoleculeDrug,P78334,Gamma-aminobutyric acid receptor subunit epsilon,GABRE,506.0
4085,DB00829,Diazepam,SmallMoleculeDrug,O00591,Gamma-aminobutyric acid receptor subunit pi,GABRP,440.0
4086,DB00829,Diazepam,SmallMoleculeDrug,P24046,Gamma-aminobutyric acid receptor subunit rho-1,GABRR1,479.0
4087,DB00829,Diazepam,SmallMoleculeDrug,P28476,Gamma-aminobutyric acid receptor subunit rho-2,GABRR2,465.0
4088,DB00829,Diazepam,SmallMoleculeDrug,A8MPY1,Gamma-aminobutyric acid receptor subunit rho-3,GABRR3,467.0
4089,DB00829,Diazepam,SmallMoleculeDrug,Q9UN88,Gamma-aminobutyric acid receptor subunit theta,GABRQ,632.0
4090,DB00829,Diazepam,SmallMoleculeDrug,P30536,Translocator protein,TSPO,169.0
4091,DB00829,Diazepam,SmallMoleculeDrug,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,456.0
4092,DB00829,Diazepam,SmallMoleculeDrug,P47869,Gamma-aminobutyric acid receptor subunit alpha-2,GABRA2,451.0
4093,DB00829,Diazepam,SmallMoleculeDrug,P34903,Gamma-aminobutyric acid receptor subunit alpha-3,GABRA3,492.0
4094,DB00829,Diazepam,SmallMoleculeDrug,P48169,Gamma-aminobutyric acid receptor subunit alpha-4,GABRA4,554.0
4095,DB00829,Diazepam,SmallMoleculeDrug,P31644,Gamma-aminobutyric acid receptor subunit alpha-5,GABRA5,462.0
4096,DB00829,Diazepam,SmallMoleculeDrug,Q16445,Gamma-aminobutyric acid receptor subunit alpha-6,GABRA6,453.0
4097,DB00829,Diazepam,SmallMoleculeDrug,P18505,Gamma-aminobutyric acid receptor subunit beta-1,GABRB1,474.0
4098,DB00829,Diazepam,SmallMoleculeDrug,P47870,Gamma-aminobutyric acid receptor subunit beta-2,GABRB2,512.0
4099,DB00829,Diazepam,SmallMoleculeDrug,P28472,Gamma-aminobutyric acid receptor subunit beta-3,GABRB3,473.0
4100,DB00829,Diazepam,SmallMoleculeDrug,O14764,Gamma-aminobutyric acid receptor subunit delta,GABRD,452.0
4101,DB00829,Diazepam,SmallMoleculeDrug,P78334,Gamma-aminobutyric acid receptor subunit epsilon,GABRE,506.0
4102,DB00829,Diazepam,SmallMoleculeDrug,Q8N1C3,Gamma-aminobutyric acid receptor subunit gamma-1,GABRG1,465.0
4103,DB00829,Diazepam,SmallMoleculeDrug,P18507,Gamma-aminobutyric acid receptor subunit gamma-2,GABRG2,467.0
4104,DB00829,Diazepam,SmallMoleculeDrug,Q99928,Gamma-aminobutyric acid receptor subunit gamma-3,GABRG3,467.0
4105,DB00829,Diazepam,SmallMoleculeDrug,O00591,Gamma-aminobutyric acid receptor subunit pi,GABRP,440.0
4106,DB00829,Diazepam,SmallMoleculeDrug,Q9UN88,Gamma-aminobutyric acid receptor subunit theta,GABRQ,632.0
4107,DB00830,Phenmetrazine,SmallMoleculeDrug,P23975,Sodium-dependent noradrenaline transporter,SLC6A2,617.0
4108,DB00830,Phenmetrazine,SmallMoleculeDrug,Q01959,Sodium-dependent dopamine transporter,SLC6A3,620.0
4109,DB00831,Trifluoperazine,SmallMoleculeDrug,P14416,D(2) dopamine receptor,DRD2,443.0
4110,DB00831,Trifluoperazine,SmallMoleculeDrug,Q9NYX4,Neuron-specific vesicular protein calcyon,CALY,217.0
4111,DB00831,Trifluoperazine,SmallMoleculeDrug,P35348,Alpha-1A adrenergic receptor,ADRA1A,466.0
4113,DB00831,Trifluoperazine,SmallMoleculeDrug,P63316,"Troponin C, slow skeletal and cardiac muscles",TNNC1,161.0
4114,DB00831,Trifluoperazine,SmallMoleculeDrug,P26447,Protein S100-A4,S100A4,101.0
4117,DB00834,Mifepristone,SmallMoleculeDrug,P06401,Progesterone receptor,PGR,933.0
4118,DB00834,Mifepristone,SmallMoleculeDrug,P04150,Glucocorticoid receptor,NR3C1,777.0
4119,DB00835,Brompheniramine,SmallMoleculeDrug,P35367,Histamine H1 receptor,HRH1,487.0
4120,DB00835,Brompheniramine,SmallMoleculeDrug,P11229,Muscarinic acetylcholine receptor M1,CHRM1,460.0
4121,DB00835,Brompheniramine,SmallMoleculeDrug,P08172,Muscarinic acetylcholine receptor M2,CHRM2,466.0
4122,DB00835,Brompheniramine,SmallMoleculeDrug,P20309,Muscarinic acetylcholine receptor M3,CHRM3,590.0
4123,DB00835,Brompheniramine,SmallMoleculeDrug,P08173,Muscarinic acetylcholine receptor M4,CHRM4,479.0
4124,DB00835,Brompheniramine,SmallMoleculeDrug,P08912,Muscarinic acetylcholine receptor M5,CHRM5,532.0
4125,DB00836,Loperamide,SmallMoleculeDrug,P35372,Mu-type opioid receptor,OPRM1,400.0
4126,DB00836,Loperamide,SmallMoleculeDrug,P41143,Delta-type opioid receptor,OPRD1,372.0
4127,DB00836,Loperamide,SmallMoleculeDrug,P41145,Kappa-type opioid receptor,OPRK1,380.0
4128,DB00836,Loperamide,SmallMoleculeDrug,O00555,Voltage-dependent P/Q-type calcium channel subunit alpha-1A,CACNA1A,2505.0
4129,DB00836,Loperamide,SmallMoleculeDrug,P01189,Pro-opiomelanocortin,POMC,267.0
4131,DB00837,Progabide,SmallMoleculeDrug,Q9UBS5,Gamma-aminobutyric acid type B receptor subunit 1,GABBR1,961.0
4132,DB00837,Progabide,SmallMoleculeDrug,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,456.0
4133,DB00838,Clocortolone,SmallMoleculeDrug,P04150,Glucocorticoid receptor,NR3C1,777.0
4134,DB00839,Tolazamide,SmallMoleculeDrug,Q09428,ATP-binding cassette sub-family C member 8,ABCC8,1581.0
4135,DB00839,Tolazamide,SmallMoleculeDrug,Q14654,ATP-sensitive inward rectifier potassium channel 11,KCNJ11,390.0
4136,DB00841,Dobutamine,SmallMoleculeDrug,P08588,Beta-1 adrenergic receptor,ADRB1,477.0
4137,DB00841,Dobutamine,SmallMoleculeDrug,P07550,Beta-2 adrenergic receptor,ADRB2,413.0
4138,DB00842,Oxazepam,SmallMoleculeDrug,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,456.0
4139,DB00842,Oxazepam,SmallMoleculeDrug,P47869,Gamma-aminobutyric acid receptor subunit alpha-2,GABRA2,451.0
4140,DB00842,Oxazepam,SmallMoleculeDrug,P34903,Gamma-aminobutyric acid receptor subunit alpha-3,GABRA3,492.0
4141,DB00842,Oxazepam,SmallMoleculeDrug,P48169,Gamma-aminobutyric acid receptor subunit alpha-4,GABRA4,554.0
4142,DB00842,Oxazepam,SmallMoleculeDrug,P31644,Gamma-aminobutyric acid receptor subunit alpha-5,GABRA5,462.0
4143,DB00842,Oxazepam,SmallMoleculeDrug,Q16445,Gamma-aminobutyric acid receptor subunit alpha-6,GABRA6,453.0
4144,DB00842,Oxazepam,SmallMoleculeDrug,P18505,Gamma-aminobutyric acid receptor subunit beta-1,GABRB1,474.0
4145,DB00842,Oxazepam,SmallMoleculeDrug,P47870,Gamma-aminobutyric acid receptor subunit beta-2,GABRB2,512.0
4146,DB00842,Oxazepam,SmallMoleculeDrug,P28472,Gamma-aminobutyric acid receptor subunit beta-3,GABRB3,473.0
4147,DB00842,Oxazepam,SmallMoleculeDrug,Q8N1C3,Gamma-aminobutyric acid receptor subunit gamma-1,GABRG1,465.0
4148,DB00842,Oxazepam,SmallMoleculeDrug,P18507,Gamma-aminobutyric acid receptor subunit gamma-2,GABRG2,467.0
4149,DB00842,Oxazepam,SmallMoleculeDrug,Q99928,Gamma-aminobutyric acid receptor subunit gamma-3,GABRG3,467.0
4150,DB00842,Oxazepam,SmallMoleculeDrug,O14764,Gamma-aminobutyric acid receptor subunit delta,GABRD,452.0
4151,DB00842,Oxazepam,SmallMoleculeDrug,P78334,Gamma-aminobutyric acid receptor subunit epsilon,GABRE,506.0
4152,DB00842,Oxazepam,SmallMoleculeDrug,O00591,Gamma-aminobutyric acid receptor subunit pi,GABRP,440.0
4153,DB00842,Oxazepam,SmallMoleculeDrug,P24046,Gamma-aminobutyric acid receptor subunit rho-1,GABRR1,479.0
4154,DB00842,Oxazepam,SmallMoleculeDrug,P28476,Gamma-aminobutyric acid receptor subunit rho-2,GABRR2,465.0
4155,DB00842,Oxazepam,SmallMoleculeDrug,A8MPY1,Gamma-aminobutyric acid receptor subunit rho-3,GABRR3,467.0
4156,DB00842,Oxazepam,SmallMoleculeDrug,Q9UN88,Gamma-aminobutyric acid receptor subunit theta,GABRQ,632.0
4157,DB00842,Oxazepam,SmallMoleculeDrug,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,456.0
4158,DB00842,Oxazepam,SmallMoleculeDrug,P47869,Gamma-aminobutyric acid receptor subunit alpha-2,GABRA2,451.0
4159,DB00842,Oxazepam,SmallMoleculeDrug,P34903,Gamma-aminobutyric acid receptor subunit alpha-3,GABRA3,492.0
4160,DB00842,Oxazepam,SmallMoleculeDrug,P48169,Gamma-aminobutyric acid receptor subunit alpha-4,GABRA4,554.0
4161,DB00842,Oxazepam,SmallMoleculeDrug,P31644,Gamma-aminobutyric acid receptor subunit alpha-5,GABRA5,462.0
4162,DB00842,Oxazepam,SmallMoleculeDrug,Q16445,Gamma-aminobutyric acid receptor subunit alpha-6,GABRA6,453.0
4163,DB00842,Oxazepam,SmallMoleculeDrug,P18505,Gamma-aminobutyric acid receptor subunit beta-1,GABRB1,474.0
4164,DB00842,Oxazepam,SmallMoleculeDrug,P47870,Gamma-aminobutyric acid receptor subunit beta-2,GABRB2,512.0
4165,DB00842,Oxazepam,SmallMoleculeDrug,P28472,Gamma-aminobutyric acid receptor subunit beta-3,GABRB3,473.0
4166,DB00842,Oxazepam,SmallMoleculeDrug,O14764,Gamma-aminobutyric acid receptor subunit delta,GABRD,452.0
4167,DB00842,Oxazepam,SmallMoleculeDrug,P78334,Gamma-aminobutyric acid receptor subunit epsilon,GABRE,506.0
4168,DB00842,Oxazepam,SmallMoleculeDrug,Q8N1C3,Gamma-aminobutyric acid receptor subunit gamma-1,GABRG1,465.0
4169,DB00842,Oxazepam,SmallMoleculeDrug,P18507,Gamma-aminobutyric acid receptor subunit gamma-2,GABRG2,467.0
4170,DB00842,Oxazepam,SmallMoleculeDrug,Q99928,Gamma-aminobutyric acid receptor subunit gamma-3,GABRG3,467.0
4171,DB00842,Oxazepam,SmallMoleculeDrug,O00591,Gamma-aminobutyric acid receptor subunit pi,GABRP,440.0
4172,DB00842,Oxazepam,SmallMoleculeDrug,Q9UN88,Gamma-aminobutyric acid receptor subunit theta,GABRQ,632.0
4173,DB00843,Donepezil,SmallMoleculeDrug,P22303,Acetylcholinesterase,ACHE,614.0
4174,DB00843,Donepezil,SmallMoleculeDrug,P28223,5-hydroxytryptamine receptor 2A,HTR2A,471.0
4175,DB00844,Nalbuphine,SmallMoleculeDrug,P41145,Kappa-type opioid receptor,OPRK1,380.0
4176,DB00844,Nalbuphine,SmallMoleculeDrug,P35372,Mu-type opioid receptor,OPRM1,400.0
4177,DB00844,Nalbuphine,SmallMoleculeDrug,P41143,Delta-type opioid receptor,OPRD1,372.0
4179,DB00845,Clofazimine,SmallMoleculeDrug,O95342,Bile salt export pump,ABCB11,1321.0
4180,DB00846,Flurandrenolide,SmallMoleculeDrug,P04150,Glucocorticoid receptor,NR3C1,777.0
4181,DB00847,Cysteamine,SmallMoleculeDrug,P61278,Somatostatin,SST,116.0
4182,DB00847,Cysteamine,SmallMoleculeDrug,P49146,Neuropeptide Y receptor type 2,NPY2R,381.0
4183,DB00848,Levamisole,SmallMoleculeDrug,P32297,Neuronal acetylcholine receptor subunit alpha-3,CHRNA3,505.0
4184,DB00848,Levamisole,SmallMoleculeDrug,P10696,"Alkaline phosphatase, placental-like",ALPPL2,532.0
4189,DB00849,Methylphenobarbital,SmallMoleculeDrug,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,456.0
4190,DB00849,Methylphenobarbital,SmallMoleculeDrug,P47869,Gamma-aminobutyric acid receptor subunit alpha-2,GABRA2,451.0
4191,DB00849,Methylphenobarbital,SmallMoleculeDrug,P34903,Gamma-aminobutyric acid receptor subunit alpha-3,GABRA3,492.0
4192,DB00849,Methylphenobarbital,SmallMoleculeDrug,P48169,Gamma-aminobutyric acid receptor subunit alpha-4,GABRA4,554.0
4193,DB00849,Methylphenobarbital,SmallMoleculeDrug,P31644,Gamma-aminobutyric acid receptor subunit alpha-5,GABRA5,462.0
4194,DB00849,Methylphenobarbital,SmallMoleculeDrug,Q16445,Gamma-aminobutyric acid receptor subunit alpha-6,GABRA6,453.0
4195,DB00849,Methylphenobarbital,SmallMoleculeDrug,P43681,Neuronal acetylcholine receptor subunit alpha-4,CHRNA4,627.0
4196,DB00849,Methylphenobarbital,SmallMoleculeDrug,P36544,Neuronal acetylcholine receptor subunit alpha-7,CHRNA7,502.0
4197,DB00849,Methylphenobarbital,SmallMoleculeDrug,P42262,Glutamate receptor 2,GRIA2,883.0
4198,DB00849,Methylphenobarbital,SmallMoleculeDrug,Q13002,"Glutamate receptor ionotropic, kainate 2",GRIK2,908.0
4199,DB00850,Perphenazine,SmallMoleculeDrug,P14416,D(2) dopamine receptor,DRD2,443.0
4200,DB00850,Perphenazine,SmallMoleculeDrug,P21728,D(1A) dopamine receptor,DRD1,446.0
4202,DB00851,Dacarbazine,SmallMoleculeDrug,Q14181,DNA polymerase alpha subunit B,POLA2,598.0
4203,DB00851,Dacarbazine,SmallMoleculeDrug,P52209,"6-phosphogluconate dehydrogenase, decarboxylating",PGD,483.0
4204,DB00852,Pseudoephedrine,SmallMoleculeDrug,P23975,Sodium-dependent noradrenaline transporter,SLC6A2,617.0
4205,DB00852,Pseudoephedrine,SmallMoleculeDrug,Q01959,Sodium-dependent dopamine transporter,SLC6A3,620.0
4206,DB00852,Pseudoephedrine,SmallMoleculeDrug,P35348,Alpha-1A adrenergic receptor,ADRA1A,466.0
4207,DB00852,Pseudoephedrine,SmallMoleculeDrug,P08913,Alpha-2A adrenergic receptor,ADRA2A,450.0
4208,DB00852,Pseudoephedrine,SmallMoleculeDrug,P31645,Sodium-dependent serotonin transporter,SLC6A4,630.0
4209,DB00852,Pseudoephedrine,SmallMoleculeDrug,P07550,Beta-2 adrenergic receptor,ADRB2,413.0
4210,DB00852,Pseudoephedrine,SmallMoleculeDrug,P08588,Beta-1 adrenergic receptor,ADRB1,477.0
4211,DB00852,Pseudoephedrine,SmallMoleculeDrug,O95644,"Nuclear factor of activated T-cells, cytoplasmic 1",NFATC1,943.0
4212,DB00852,Pseudoephedrine,SmallMoleculeDrug,P01375,Tumor necrosis factor,TNF,233.0
4213,DB00852,Pseudoephedrine,SmallMoleculeDrug,P18846,Cyclic AMP-dependent transcription factor ATF-1,ATF1,271.0
4214,DB00852,Pseudoephedrine,SmallMoleculeDrug,P15336,Cyclic AMP-dependent transcription factor ATF-2,ATF2,505.0
4215,DB00852,Pseudoephedrine,SmallMoleculeDrug,P18847,Cyclic AMP-dependent transcription factor ATF-3,ATF3,181.0
4216,DB00852,Pseudoephedrine,SmallMoleculeDrug,P18848,Cyclic AMP-dependent transcription factor ATF-4,ATF4,351.0
4217,DB00852,Pseudoephedrine,SmallMoleculeDrug,Q9Y2D1,Cyclic AMP-dependent transcription factor ATF-5,ATF5,282.0
4218,DB00852,Pseudoephedrine,SmallMoleculeDrug,P18850,Cyclic AMP-dependent transcription factor ATF-6 alpha,ATF6,670.0
4219,DB00852,Pseudoephedrine,SmallMoleculeDrug,P17544,Cyclic AMP-dependent transcription factor ATF-7,ATF7,494.0
4220,DB00852,Pseudoephedrine,SmallMoleculeDrug,Q8WYK2,Jun dimerization protein 2,JDP2,163.0
4221,DB00852,Pseudoephedrine,SmallMoleculeDrug,P01100,Proto-oncogene c-Fos,FOS,380.0
4222,DB00852,Pseudoephedrine,SmallMoleculeDrug,P05412,Transcription factor AP-1,JUN,331.0
4223,DB00852,Pseudoephedrine,SmallMoleculeDrug,P60568,Interleukin-2,IL2,153.0
4224,DB00854,Levorphanol,SmallMoleculeDrug,P35372,Mu-type opioid receptor,OPRM1,400.0
4225,DB00854,Levorphanol,SmallMoleculeDrug,P41143,Delta-type opioid receptor,OPRD1,372.0
4226,DB00854,Levorphanol,SmallMoleculeDrug,P41145,Kappa-type opioid receptor,OPRK1,380.0
4227,DB00855,Aminolevulinic acid,SmallMoleculeDrug,P13716,Delta-aminolevulinic acid dehydratase,ALAD,330.0
4228,DB00857,Terbinafine,SmallMoleculeDrug,Q14534,Squalene monooxygenase,SQLE,574.0
4229,DB00858,Drostanolone,SmallMoleculeDrug,P10275,Androgen receptor,AR,920.0
4230,DB00860,Prednisolone,SmallMoleculeDrug,P04150,Glucocorticoid receptor,NR3C1,777.0
4231,DB00861,Diflunisal,SmallMoleculeDrug,P35354,Prostaglandin G/H synthase 2,PTGS2,604.0
4232,DB00861,Diflunisal,SmallMoleculeDrug,P23219,Prostaglandin G/H synthase 1,PTGS1,599.0
4233,DB00862,Vardenafil,SmallMoleculeDrug,O76074,"cGMP-specific 3',5'-cyclic phosphodiesterase",PDE5A,875.0
4234,DB00862,Vardenafil,SmallMoleculeDrug,P18545,"Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma",PDE6G,87.0
4235,DB00862,Vardenafil,SmallMoleculeDrug,Q13956,"Retinal cone rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma",PDE6H,83.0
4236,DB00863,Ranitidine,SmallMoleculeDrug,P25021,Histamine H2 receptor,HRH2,359.0
4237,DB00864,Tacrolimus,SmallMoleculeDrug,P62942,Peptidyl-prolyl cis-trans isomerase FKBP1A,FKBP1A,108.0
4238,DB00865,Benzphetamine,SmallMoleculeDrug,Q05940,Synaptic vesicular amine transporter,SLC18A2,514.0
4239,DB00865,Benzphetamine,SmallMoleculeDrug,P08913,Alpha-2A adrenergic receptor,ADRA2A,450.0
4240,DB00865,Benzphetamine,SmallMoleculeDrug,P35348,Alpha-1A adrenergic receptor,ADRA1A,466.0
4241,DB00865,Benzphetamine,SmallMoleculeDrug,Q01959,Sodium-dependent dopamine transporter,SLC6A3,620.0
4242,DB00866,Alprenolol,SmallMoleculeDrug,P08588,Beta-1 adrenergic receptor,ADRB1,477.0
4243,DB00866,Alprenolol,SmallMoleculeDrug,P07550,Beta-2 adrenergic receptor,ADRB2,413.0
4244,DB00866,Alprenolol,SmallMoleculeDrug,P08908,5-hydroxytryptamine receptor 1A,HTR1A,422.0
4245,DB00867,Ritodrine,SmallMoleculeDrug,P07550,Beta-2 adrenergic receptor,ADRB2,413.0
4246,DB00868,Benzonatate,SmallMoleculeDrug,Q14524,Sodium channel protein type 5 subunit alpha,SCN5A,2016.0
4247,DB00869,Dorzolamide,SmallMoleculeDrug,P00918,Carbonic anhydrase 2,CA2,260.0
4248,DB00869,Dorzolamide,SmallMoleculeDrug,P22748,Carbonic anhydrase 4,CA4,312.0
4249,DB00869,Dorzolamide,SmallMoleculeDrug,P00915,Carbonic anhydrase 1,CA1,261.0
4250,DB00870,Suprofen,SmallMoleculeDrug,P23219,Prostaglandin G/H synthase 1,PTGS1,599.0
4251,DB00870,Suprofen,SmallMoleculeDrug,P35354,Prostaglandin G/H synthase 2,PTGS2,604.0
4252,DB00871,Terbutaline,SmallMoleculeDrug,P07550,Beta-2 adrenergic receptor,ADRB2,413.0
4253,DB00872,Conivaptan,SmallMoleculeDrug,P37288,Vasopressin V1a receptor,AVPR1A,418.0
4254,DB00872,Conivaptan,SmallMoleculeDrug,P30518,Vasopressin V2 receptor,AVPR2,371.0
4255,DB00873,Loteprednol,SmallMoleculeDrug,P04150,Glucocorticoid receptor,NR3C1,777.0
4256,DB00875,Flupentixol,SmallMoleculeDrug,P14416,D(2) dopamine receptor,DRD2,443.0
4257,DB00875,Flupentixol,SmallMoleculeDrug,P28223,5-hydroxytryptamine receptor 2A,HTR2A,471.0
4258,DB00875,Flupentixol,SmallMoleculeDrug,P21728,D(1A) dopamine receptor,DRD1,446.0
4259,DB00875,Flupentixol,SmallMoleculeDrug,P35348,Alpha-1A adrenergic receptor,ADRA1A,466.0
4260,DB00875,Flupentixol,SmallMoleculeDrug,P11229,Muscarinic acetylcholine receptor M1,CHRM1,460.0
4261,DB00876,Eprosartan,SmallMoleculeDrug,P30556,Type-1 angiotensin II receptor,AGTR1,359.0
4262,DB00877,Sirolimus,SmallMoleculeDrug,P42345,Serine/threonine-protein kinase mTOR,MTOR,2549.0
4263,DB00877,Sirolimus,SmallMoleculeDrug,P62942,Peptidyl-prolyl cis-trans isomerase FKBP1A,FKBP1A,108.0
4264,DB00877,Sirolimus,SmallMoleculeDrug,P09038,Fibroblast growth factor 2,FGF2,288.0
4266,DB00880,Chlorothiazide,SmallMoleculeDrug,P55017,Solute carrier family 12 member 3,SLC12A3,1021.0
4267,DB00880,Chlorothiazide,SmallMoleculeDrug,P00915,Carbonic anhydrase 1,CA1,261.0
4268,DB00880,Chlorothiazide,SmallMoleculeDrug,P00918,Carbonic anhydrase 2,CA2,260.0
4269,DB00880,Chlorothiazide,SmallMoleculeDrug,P22748,Carbonic anhydrase 4,CA4,312.0
4270,DB00881,Quinapril,SmallMoleculeDrug,P12821,Angiotensin-converting enzyme,ACE,1306.0
4271,DB00882,Clomifene,SmallMoleculeDrug,P03372,Estrogen receptor,ESR1,595.0
4272,DB00883,Isosorbide Dinitrate,SmallMoleculeDrug,P16066,Atrial natriuretic peptide receptor 1,NPR1,1061.0
4273,DB00884,Risedronate,SmallMoleculeDrug,P14324,Farnesyl pyrophosphate synthase,FDPS,419.0
4274,DB00886,Omapatrilat,SmallMoleculeDrug,P12821,Angiotensin-converting enzyme,ACE,1306.0
4275,DB00886,Omapatrilat,SmallMoleculeDrug,P08473,Neprilysin,MME,750.0
4276,DB00887,Bumetanide,SmallMoleculeDrug,Q13621,Solute carrier family 12 member 1,SLC12A1,1099.0
4277,DB00887,Bumetanide,SmallMoleculeDrug,P55011,Solute carrier family 12 member 2,SLC12A2,1212.0
4278,DB00887,Bumetanide,SmallMoleculeDrug,Q9UP95,Solute carrier family 12 member 4,SLC12A4,1085.0
4279,DB00887,Bumetanide,SmallMoleculeDrug,Q9H2X9,Solute carrier family 12 member 5,SLC12A5,1139.0
4280,DB00887,Bumetanide,SmallMoleculeDrug,P13569,Cystic fibrosis transmembrane conductance regulator,CFTR,1480.0
4281,DB00889,Granisetron,SmallMoleculeDrug,P46098,5-hydroxytryptamine receptor 3A,HTR3A,478.0
4282,DB00890,Dienestrol,SmallMoleculeDrug,P03372,Estrogen receptor,ESR1,595.0
4284,DB00892,Oxybuprocaine,SmallMoleculeDrug,Q9Y5Y9,Sodium channel protein type 10 subunit alpha,SCN10A,1956.0
4285,DB00893,Iron Dextran,SmallMoleculeDrug,P68871,Hemoglobin subunit beta,HBB,147.0
4286,DB00893,Iron Dextran,SmallMoleculeDrug,P69905,Hemoglobin subunit alpha,HBA1;,142.0
4287,DB00893,Iron Dextran,SmallMoleculeDrug,P02794,Ferritin heavy chain,FTH1,183.0
4288,DB00893,Iron Dextran,SmallMoleculeDrug,P02792,Ferritin light chain,FTL,175.0
4289,DB00894,Testolactone,SmallMoleculeDrug,P11511,Aromatase,CYP19A1,503.0
4290,DB00895,Benzylpenicilloyl Polylysine,SmallMoleculeDrug,P30273,High affinity immunoglobulin epsilon receptor subunit gamma,FCER1G,86.0
4291,DB00895,Benzylpenicilloyl Polylysine,SmallMoleculeDrug,P12319,High affinity immunoglobulin epsilon receptor subunit alpha,FCER1A,257.0
4292,DB00896,Rimexolone,SmallMoleculeDrug,P04150,Glucocorticoid receptor,NR3C1,777.0
4293,DB00897,Triazolam,SmallMoleculeDrug,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,456.0
4294,DB00897,Triazolam,SmallMoleculeDrug,P47869,Gamma-aminobutyric acid receptor subunit alpha-2,GABRA2,451.0
4295,DB00897,Triazolam,SmallMoleculeDrug,P34903,Gamma-aminobutyric acid receptor subunit alpha-3,GABRA3,492.0
4296,DB00897,Triazolam,SmallMoleculeDrug,P48169,Gamma-aminobutyric acid receptor subunit alpha-4,GABRA4,554.0
4297,DB00897,Triazolam,SmallMoleculeDrug,P31644,Gamma-aminobutyric acid receptor subunit alpha-5,GABRA5,462.0
4298,DB00897,Triazolam,SmallMoleculeDrug,Q16445,Gamma-aminobutyric acid receptor subunit alpha-6,GABRA6,453.0
4299,DB00897,Triazolam,SmallMoleculeDrug,P18505,Gamma-aminobutyric acid receptor subunit beta-1,GABRB1,474.0
4300,DB00897,Triazolam,SmallMoleculeDrug,P47870,Gamma-aminobutyric acid receptor subunit beta-2,GABRB2,512.0
4301,DB00897,Triazolam,SmallMoleculeDrug,P28472,Gamma-aminobutyric acid receptor subunit beta-3,GABRB3,473.0
4302,DB00897,Triazolam,SmallMoleculeDrug,Q8N1C3,Gamma-aminobutyric acid receptor subunit gamma-1,GABRG1,465.0
4303,DB00897,Triazolam,SmallMoleculeDrug,P18507,Gamma-aminobutyric acid receptor subunit gamma-2,GABRG2,467.0
4304,DB00897,Triazolam,SmallMoleculeDrug,Q99928,Gamma-aminobutyric acid receptor subunit gamma-3,GABRG3,467.0
4305,DB00897,Triazolam,SmallMoleculeDrug,O14764,Gamma-aminobutyric acid receptor subunit delta,GABRD,452.0
4306,DB00897,Triazolam,SmallMoleculeDrug,P78334,Gamma-aminobutyric acid receptor subunit epsilon,GABRE,506.0
4307,DB00897,Triazolam,SmallMoleculeDrug,O00591,Gamma-aminobutyric acid receptor subunit pi,GABRP,440.0
4308,DB00897,Triazolam,SmallMoleculeDrug,P24046,Gamma-aminobutyric acid receptor subunit rho-1,GABRR1,479.0
4309,DB00897,Triazolam,SmallMoleculeDrug,P28476,Gamma-aminobutyric acid receptor subunit rho-2,GABRR2,465.0
4310,DB00897,Triazolam,SmallMoleculeDrug,A8MPY1,Gamma-aminobutyric acid receptor subunit rho-3,GABRR3,467.0
4311,DB00897,Triazolam,SmallMoleculeDrug,Q9UN88,Gamma-aminobutyric acid receptor subunit theta,GABRQ,632.0
4312,DB00897,Triazolam,SmallMoleculeDrug,P30536,Translocator protein,TSPO,169.0
4313,DB00897,Triazolam,SmallMoleculeDrug,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,456.0
4314,DB00897,Triazolam,SmallMoleculeDrug,P47869,Gamma-aminobutyric acid receptor subunit alpha-2,GABRA2,451.0
4315,DB00897,Triazolam,SmallMoleculeDrug,P34903,Gamma-aminobutyric acid receptor subunit alpha-3,GABRA3,492.0
4316,DB00897,Triazolam,SmallMoleculeDrug,P48169,Gamma-aminobutyric acid receptor subunit alpha-4,GABRA4,554.0
4317,DB00897,Triazolam,SmallMoleculeDrug,P31644,Gamma-aminobutyric acid receptor subunit alpha-5,GABRA5,462.0
4318,DB00897,Triazolam,SmallMoleculeDrug,Q16445,Gamma-aminobutyric acid receptor subunit alpha-6,GABRA6,453.0
4319,DB00897,Triazolam,SmallMoleculeDrug,P18505,Gamma-aminobutyric acid receptor subunit beta-1,GABRB1,474.0
4320,DB00897,Triazolam,SmallMoleculeDrug,P47870,Gamma-aminobutyric acid receptor subunit beta-2,GABRB2,512.0
4321,DB00897,Triazolam,SmallMoleculeDrug,P28472,Gamma-aminobutyric acid receptor subunit beta-3,GABRB3,473.0
4322,DB00897,Triazolam,SmallMoleculeDrug,O14764,Gamma-aminobutyric acid receptor subunit delta,GABRD,452.0
4323,DB00897,Triazolam,SmallMoleculeDrug,P78334,Gamma-aminobutyric acid receptor subunit epsilon,GABRE,506.0
4324,DB00897,Triazolam,SmallMoleculeDrug,Q8N1C3,Gamma-aminobutyric acid receptor subunit gamma-1,GABRG1,465.0
4325,DB00897,Triazolam,SmallMoleculeDrug,P18507,Gamma-aminobutyric acid receptor subunit gamma-2,GABRG2,467.0
4326,DB00897,Triazolam,SmallMoleculeDrug,Q99928,Gamma-aminobutyric acid receptor subunit gamma-3,GABRG3,467.0
4327,DB00897,Triazolam,SmallMoleculeDrug,O00591,Gamma-aminobutyric acid receptor subunit pi,GABRP,440.0
4328,DB00897,Triazolam,SmallMoleculeDrug,Q9UN88,Gamma-aminobutyric acid receptor subunit theta,GABRQ,632.0
4329,DB00898,Ethanol,SmallMoleculeDrug,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,456.0
4330,DB00898,Ethanol,SmallMoleculeDrug,Q8TCU5,"Glutamate receptor ionotropic, NMDA 3A",GRIN3A,1115.0
4331,DB00898,Ethanol,SmallMoleculeDrug,P23415,Glycine receptor subunit alpha-1,GLRA1,457.0
4332,DB00898,Ethanol,SmallMoleculeDrug,P23416,Glycine receptor subunit alpha-2,GLRA2,452.0
4333,DB00898,Ethanol,SmallMoleculeDrug,Q02641,Voltage-dependent L-type calcium channel subunit beta-1,CACNB1,598.0
4334,DB00898,Ethanol,SmallMoleculeDrug,P46098,5-hydroxytryptamine receptor 3A,HTR3A,478.0
4335,DB00898,Ethanol,SmallMoleculeDrug,P47869,Gamma-aminobutyric acid receptor subunit alpha-2,GABRA2,451.0
4336,DB00898,Ethanol,SmallMoleculeDrug,Q9GZZ6,Neuronal acetylcholine receptor subunit alpha-10,CHRNA10,450.0
4337,DB00898,Ethanol,SmallMoleculeDrug,Q13936,Voltage-dependent L-type calcium channel subunit alpha-1C,CACNA1C,2221.0
4338,DB00898,Ethanol,SmallMoleculeDrug,P31644,Gamma-aminobutyric acid receptor subunit alpha-5,GABRA5,462.0
4339,DB00898,Ethanol,SmallMoleculeDrug,P48169,Gamma-aminobutyric acid receptor subunit alpha-4,GABRA4,554.0
4340,DB00898,Ethanol,SmallMoleculeDrug,P34903,Gamma-aminobutyric acid receptor subunit alpha-3,GABRA3,492.0
4341,DB00898,Ethanol,SmallMoleculeDrug,P42261,Glutamate receptor 1,GRIA1,906.0
4342,DB00898,Ethanol,SmallMoleculeDrug,Q06432,Voltage-dependent calcium channel gamma-1 subunit,CACNG1,222.0
4343,DB00898,Ethanol,SmallMoleculeDrug,Q15822,Neuronal acetylcholine receptor subunit alpha-2,CHRNA2,529.0
4344,DB00898,Ethanol,SmallMoleculeDrug,Q16445,Gamma-aminobutyric acid receptor subunit alpha-6,GABRA6,453.0
4345,DB00898,Ethanol,SmallMoleculeDrug,P42262,Glutamate receptor 2,GRIA2,883.0
4346,DB00898,Ethanol,SmallMoleculeDrug,P48058,Glutamate receptor 4,GRIA4,902.0
4347,DB00898,Ethanol,SmallMoleculeDrug,P42263,Glutamate receptor 3,GRIA3,894.0
4348,DB00898,Ethanol,SmallMoleculeDrug,P43681,Neuronal acetylcholine receptor subunit alpha-4,CHRNA4,627.0
4349,DB00898,Ethanol,SmallMoleculeDrug,P17787,Neuronal acetylcholine receptor subunit beta-2,CHRNB2,502.0
4350,DB00898,Ethanol,SmallMoleculeDrug,P48549,G protein-activated inward rectifier potassium channel 1,KCNJ3,501.0
4351,DB00898,Ethanol,SmallMoleculeDrug,P48051,G protein-activated inward rectifier potassium channel 2,KCNJ6,423.0
4352,DB00898,Ethanol,SmallMoleculeDrug,P19320,Vascular cell adhesion protein 1,VCAM1,739.0
4353,DB00898,Ethanol,SmallMoleculeDrug,Q99808,Equilibrative nucleoside transporter 1,SLC29A1,456.0
4354,DB00898,Ethanol,SmallMoleculeDrug,P48544,G protein-activated inward rectifier potassium channel 4,KCNJ5,419.0
4355,DB00898,Ethanol,SmallMoleculeDrug,P36544,Neuronal acetylcholine receptor subunit alpha-7,CHRNA7,502.0
4356,DB00898,Ethanol,SmallMoleculeDrug,Q9UGM1,Neuronal acetylcholine receptor subunit alpha-9,CHRNA9,479.0
4357,DB00898,Ethanol,SmallMoleculeDrug,P18505,Gamma-aminobutyric acid receptor subunit beta-1,GABRB1,474.0
4358,DB00898,Ethanol,SmallMoleculeDrug,P28472,Gamma-aminobutyric acid receptor subunit beta-3,GABRB3,473.0
4359,DB00898,Ethanol,SmallMoleculeDrug,P47870,Gamma-aminobutyric acid receptor subunit beta-2,GABRB2,512.0
4360,DB00898,Ethanol,SmallMoleculeDrug,Q13698,Voltage-dependent L-type calcium channel subunit alpha-1S,CACNA1S,1873.0
4361,DB00898,Ethanol,SmallMoleculeDrug,Q01668,Voltage-dependent L-type calcium channel subunit alpha-1D,CACNA1D,2161.0
4362,DB00898,Ethanol,SmallMoleculeDrug,P30926,Neuronal acetylcholine receptor subunit beta-4,CHRNB4,498.0
4363,DB00898,Ethanol,SmallMoleculeDrug,P32297,Neuronal acetylcholine receptor subunit alpha-3,CHRNA3,505.0
4364,DB00898,Ethanol,SmallMoleculeDrug,P30532,Neuronal acetylcholine receptor subunit alpha-5,CHRNA5,468.0
4365,DB00898,Ethanol,SmallMoleculeDrug,Q15825,Neuronal acetylcholine receptor subunit alpha-6,CHRNA6,494.0
4366,DB00898,Ethanol,SmallMoleculeDrug,Q05901,Neuronal acetylcholine receptor subunit beta-3,CHRNB3,458.0
4367,DB00898,Ethanol,SmallMoleculeDrug,Q8N1C3,Gamma-aminobutyric acid receptor subunit gamma-1,GABRG1,465.0
4368,DB00898,Ethanol,SmallMoleculeDrug,Q99928,Gamma-aminobutyric acid receptor subunit gamma-3,GABRG3,467.0
4369,DB00898,Ethanol,SmallMoleculeDrug,P78334,Gamma-aminobutyric acid receptor subunit epsilon,GABRE,506.0
4370,DB00898,Ethanol,SmallMoleculeDrug,O00591,Gamma-aminobutyric acid receptor subunit pi,GABRP,440.0
4371,DB00898,Ethanol,SmallMoleculeDrug,Q9UN88,Gamma-aminobutyric acid receptor subunit theta,GABRQ,632.0
4372,DB00898,Ethanol,SmallMoleculeDrug,O14764,Gamma-aminobutyric acid receptor subunit delta,GABRD,452.0
4373,DB00898,Ethanol,SmallMoleculeDrug,Q14542,Equilibrative nucleoside transporter 2,SLC29A2,456.0
4374,DB00898,Ethanol,SmallMoleculeDrug,A5X5Y0,5-hydroxytryptamine receptor 3E,HTR3E,456.0
4375,DB00898,Ethanol,SmallMoleculeDrug,O95264,5-hydroxytryptamine receptor 3B,HTR3B,441.0
4376,DB00898,Ethanol,SmallMoleculeDrug,Q70Z44,5-hydroxytryptamine receptor 3D,HTR3D,454.0
4377,DB00898,Ethanol,SmallMoleculeDrug,Q8WXA8,5-hydroxytryptamine receptor 3C,HTR3C,447.0
4378,DB00898,Ethanol,SmallMoleculeDrug,Q9Y698,Voltage-dependent calcium channel gamma-2 subunit,CACNG2,323.0
4379,DB00898,Ethanol,SmallMoleculeDrug,Q92806,G protein-activated inward rectifier potassium channel 3,KCNJ9,393.0
4380,DB00899,Remifentanil,SmallMoleculeDrug,P35372,Mu-type opioid receptor,OPRM1,400.0
4381,DB00899,Remifentanil,SmallMoleculeDrug,P41143,Delta-type opioid receptor,OPRD1,372.0
4382,DB00899,Remifentanil,SmallMoleculeDrug,P41145,Kappa-type opioid receptor,OPRK1,380.0
4384,DB00900,Didanosine,SmallMoleculeDrug,P00491,Purine nucleoside phosphorylase,PNP,289.0
4385,DB00901,Bitolterol,SmallMoleculeDrug,P07550,Beta-2 adrenergic receptor,ADRB2,413.0
4386,DB00902,Methdilazine,SmallMoleculeDrug,P35367,Histamine H1 receptor,HRH1,487.0
4387,DB00903,Etacrynic acid,SmallMoleculeDrug,P05023,Sodium/potassium-transporting ATPase subunit alpha-1,ATP1A1,1023.0
4388,DB00903,Etacrynic acid,SmallMoleculeDrug,Q13621,Solute carrier family 12 member 1,SLC12A1,1099.0
4389,DB00904,Ondansetron,SmallMoleculeDrug,P46098,5-hydroxytryptamine receptor 3A,HTR3A,478.0
4390,DB00904,Ondansetron,SmallMoleculeDrug,Q13639,5-hydroxytryptamine receptor 4,HTR4,388.0
4391,DB00904,Ondansetron,SmallMoleculeDrug,P35372,Mu-type opioid receptor,OPRM1,400.0
4392,DB00904,Ondansetron,SmallMoleculeDrug,P08908,5-hydroxytryptamine receptor 1A,HTR1A,422.0
4393,DB00904,Ondansetron,SmallMoleculeDrug,P28222,5-hydroxytryptamine receptor 1B,HTR1B,390.0
4394,DB00905,Bimatoprost,SmallMoleculeDrug,P43088,Prostaglandin F2-alpha receptor,PTGFR,359.0
4395,DB00905,Bimatoprost,SmallMoleculeDrug,P34995,Prostaglandin E2 receptor EP1 subtype,PTGER1,402.0
4396,DB00905,Bimatoprost,SmallMoleculeDrug,P43115,Prostaglandin E2 receptor EP3 subtype,PTGER3,390.0
4397,DB00905,Bimatoprost,SmallMoleculeDrug,P42330,Aldo-keto reductase family 1 member C3,AKR1C3,323.0
4398,DB00906,Tiagabine,SmallMoleculeDrug,P30531,Sodium- and chloride-dependent GABA transporter 1,SLC6A1,599.0
4399,DB00907,Cocaine,SmallMoleculeDrug,Q01959,Sodium-dependent dopamine transporter,SLC6A3,620.0
4400,DB00907,Cocaine,SmallMoleculeDrug,P23975,Sodium-dependent noradrenaline transporter,SLC6A2,617.0
4401,DB00907,Cocaine,SmallMoleculeDrug,P31645,Sodium-dependent serotonin transporter,SLC6A4,630.0
4402,DB00907,Cocaine,SmallMoleculeDrug,Q14524,Sodium channel protein type 5 subunit alpha,SCN5A,2016.0
4403,DB00907,Cocaine,SmallMoleculeDrug,Q9UI33,Sodium channel protein type 11 subunit alpha,SCN11A,1791.0
4404,DB00907,Cocaine,SmallMoleculeDrug,Q9Y5Y9,Sodium channel protein type 10 subunit alpha,SCN10A,1956.0
4405,DB00907,Cocaine,SmallMoleculeDrug,P11229,Muscarinic acetylcholine receptor M1,CHRM1,460.0
4406,DB00907,Cocaine,SmallMoleculeDrug,P08172,Muscarinic acetylcholine receptor M2,CHRM2,466.0
4407,DB00908,Quinidine,SmallMoleculeDrug,Q14524,Sodium channel protein type 5 subunit alpha,SCN5A,2016.0
4408,DB00908,Quinidine,SmallMoleculeDrug,O00180,Potassium channel subfamily K member 1,KCNK1,336.0
4409,DB00908,Quinidine,SmallMoleculeDrug,Q9Y257,Potassium channel subfamily K member 6,KCNK6,313.0
4410,DB00908,Quinidine,SmallMoleculeDrug,Q12809,Potassium voltage-gated channel subfamily H member 2,KCNH2,1159.0
4411,DB00909,Zonisamide,SmallMoleculeDrug,P35498,Sodium channel protein type 1 subunit alpha,SCN1A,2009.0
4412,DB00909,Zonisamide,SmallMoleculeDrug,Q99250,Sodium channel protein type 2 subunit alpha,SCN2A,2005.0
4413,DB00909,Zonisamide,SmallMoleculeDrug,Q9NY46,Sodium channel protein type 3 subunit alpha,SCN3A,2000.0
4414,DB00909,Zonisamide,SmallMoleculeDrug,P35499,Sodium channel protein type 4 subunit alpha,SCN4A,1836.0
4415,DB00909,Zonisamide,SmallMoleculeDrug,Q14524,Sodium channel protein type 5 subunit alpha,SCN5A,2016.0
4416,DB00909,Zonisamide,SmallMoleculeDrug,Q15858,Sodium channel protein type 9 subunit alpha,SCN9A,1988.0
4417,DB00909,Zonisamide,SmallMoleculeDrug,Q9UI33,Sodium channel protein type 11 subunit alpha,SCN11A,1791.0
4418,DB00909,Zonisamide,SmallMoleculeDrug,Q07699,Sodium channel subunit beta-1,SCN1B,218.0
4419,DB00909,Zonisamide,SmallMoleculeDrug,O60939,Sodium channel subunit beta-2,SCN2B,215.0
4420,DB00909,Zonisamide,SmallMoleculeDrug,Q9NY72,Sodium channel subunit beta-3,SCN3B,215.0
4421,DB00909,Zonisamide,SmallMoleculeDrug,Q8IWT1,Sodium channel subunit beta-4,SCN4B,228.0
4422,DB00909,Zonisamide,SmallMoleculeDrug,O43497,Voltage-dependent T-type calcium channel subunit alpha-1G,CACNA1G,2377.0
4423,DB00909,Zonisamide,SmallMoleculeDrug,O95180,Voltage-dependent T-type calcium channel subunit alpha-1H,CACNA1H,2353.0
4424,DB00909,Zonisamide,SmallMoleculeDrug,Q9P0X4,Voltage-dependent T-type calcium channel subunit alpha-1I,CACNA1I,2223.0
4425,DB00909,Zonisamide,SmallMoleculeDrug,P00915,Carbonic anhydrase 1,CA1,261.0
4426,DB00909,Zonisamide,SmallMoleculeDrug,P00918,Carbonic anhydrase 2,CA2,260.0
4427,DB00909,Zonisamide,SmallMoleculeDrug,P07451,Carbonic anhydrase 3,CA3,260.0
4428,DB00909,Zonisamide,SmallMoleculeDrug,P22748,Carbonic anhydrase 4,CA4,312.0
4429,DB00909,Zonisamide,SmallMoleculeDrug,P35218,"Carbonic anhydrase 5A, mitochondrial",CA5A,305.0
4430,DB00909,Zonisamide,SmallMoleculeDrug,Q9Y2D0,"Carbonic anhydrase 5B, mitochondrial",CA5B,317.0
4431,DB00909,Zonisamide,SmallMoleculeDrug,P23280,Carbonic anhydrase 6,CA6,308.0
4432,DB00909,Zonisamide,SmallMoleculeDrug,P43166,Carbonic anhydrase 7,CA7,264.0
4433,DB00909,Zonisamide,SmallMoleculeDrug,P35219,Carbonic anhydrase-related protein,CA8,290.0
4434,DB00909,Zonisamide,SmallMoleculeDrug,Q16790,Carbonic anhydrase 9,CA9,459.0
4435,DB00909,Zonisamide,SmallMoleculeDrug,Q9NS85,Carbonic anhydrase-related protein 10,CA10,328.0
4436,DB00909,Zonisamide,SmallMoleculeDrug,O75493,Carbonic anhydrase-related protein 11,CA11,328.0
4437,DB00909,Zonisamide,SmallMoleculeDrug,O43570,Carbonic anhydrase 12,CA12,354.0
4438,DB00909,Zonisamide,SmallMoleculeDrug,Q8N1Q1,Carbonic anhydrase 13,CA13,262.0
4439,DB00909,Zonisamide,SmallMoleculeDrug,Q9ULX7,Carbonic anhydrase 14,CA14,337.0
4440,DB00909,Zonisamide,SmallMoleculeDrug,P27338,Amine oxidase [flavin-containing] B,MAOB,520.0
4441,DB00909,Zonisamide,SmallMoleculeDrug,P21397,Amine oxidase [flavin-containing] A,MAOA,527.0
4442,DB00910,Paricalcitol,SmallMoleculeDrug,P11473,Vitamin D3 receptor,VDR,427.0
4443,DB00912,Repaglinide,SmallMoleculeDrug,Q09428,ATP-binding cassette sub-family C member 8,ABCC8,1581.0
4444,DB00912,Repaglinide,SmallMoleculeDrug,P37231,Peroxisome proliferator-activated receptor gamma,PPARG,505.0
4445,DB00913,Anileridine,SmallMoleculeDrug,P35372,Mu-type opioid receptor,OPRM1,400.0
4446,DB00914,Phenformin,SmallMoleculeDrug,Q13131,5'-AMP-activated protein kinase catalytic subunit alpha-1,PRKAA1,559.0
4447,DB00914,Phenformin,SmallMoleculeDrug,Q15842,ATP-sensitive inward rectifier potassium channel 8,KCNJ8,424.0
4449,DB00915,Amantadine,SmallMoleculeDrug,Q8TCU5,"Glutamate receptor ionotropic, NMDA 3A",GRIN3A,1115.0
4450,DB00915,Amantadine,SmallMoleculeDrug,P14416,D(2) dopamine receptor,DRD2,443.0
4453,DB00916,Metronidazole,SmallMoleculeDrug,Q16850,Lanosterol 14-alpha demethylase,CYP51A1,503.0
4454,DB00917,Dinoprostone,SmallMoleculeDrug,P43116,Prostaglandin E2 receptor EP2 subtype,PTGER2,358.0
4455,DB00917,Dinoprostone,SmallMoleculeDrug,P34995,Prostaglandin E2 receptor EP1 subtype,PTGER1,402.0
4456,DB00917,Dinoprostone,SmallMoleculeDrug,P43115,Prostaglandin E2 receptor EP3 subtype,PTGER3,390.0
4457,DB00917,Dinoprostone,SmallMoleculeDrug,P35408,Prostaglandin E2 receptor EP4 subtype,PTGER4,488.0
4458,DB00918,Almotriptan,SmallMoleculeDrug,P28222,5-hydroxytryptamine receptor 1B,HTR1B,390.0
4459,DB00918,Almotriptan,SmallMoleculeDrug,P28221,5-hydroxytryptamine receptor 1D,HTR1D,377.0
4461,DB00920,Ketotifen,SmallMoleculeDrug,P35367,Histamine H1 receptor,HRH1,487.0
4462,DB00920,Ketotifen,SmallMoleculeDrug,P52209,"6-phosphogluconate dehydrogenase, decarboxylating",PGD,483.0
4463,DB00921,Buprenorphine,SmallMoleculeDrug,P35372,Mu-type opioid receptor,OPRM1,400.0
4464,DB00921,Buprenorphine,SmallMoleculeDrug,P41145,Kappa-type opioid receptor,OPRK1,380.0
4465,DB00921,Buprenorphine,SmallMoleculeDrug,P41143,Delta-type opioid receptor,OPRD1,372.0
4466,DB00922,Levosimendan,SmallMoleculeDrug,P63316,"Troponin C, slow skeletal and cardiac muscles",TNNC1,161.0
4467,DB00922,Levosimendan,SmallMoleculeDrug,Q14654,ATP-sensitive inward rectifier potassium channel 11,KCNJ11,390.0
4468,DB00922,Levosimendan,SmallMoleculeDrug,Q15842,ATP-sensitive inward rectifier potassium channel 8,KCNJ8,424.0
4469,DB00922,Levosimendan,SmallMoleculeDrug,Q14432,"cGMP-inhibited 3',5'-cyclic phosphodiesterase A",PDE3A,1141.0
4471,DB00924,Cyclobenzaprine,SmallMoleculeDrug,P28223,5-hydroxytryptamine receptor 2A,HTR2A,471.0
4472,DB00925,Phenoxybenzamine,SmallMoleculeDrug,P35348,Alpha-1A adrenergic receptor,ADRA1A,466.0
4473,DB00925,Phenoxybenzamine,SmallMoleculeDrug,P08913,Alpha-2A adrenergic receptor,ADRA2A,450.0
4474,DB00925,Phenoxybenzamine,SmallMoleculeDrug,P18825,Alpha-2C adrenergic receptor,ADRA2C,462.0
4475,DB00925,Phenoxybenzamine,SmallMoleculeDrug,P18089,Alpha-2B adrenergic receptor,ADRA2B,450.0
4477,DB00925,Phenoxybenzamine,SmallMoleculeDrug,P07550,Beta-2 adrenergic receptor,ADRB2,413.0
4478,DB00925,Phenoxybenzamine,SmallMoleculeDrug,P35368,Alpha-1B adrenergic receptor,ADRA1B,520.0
4479,DB00925,Phenoxybenzamine,SmallMoleculeDrug,P25100,Alpha-1D adrenergic receptor,ADRA1D,572.0
4480,DB00926,Etretinate,SmallMoleculeDrug,P10276,Retinoic acid receptor alpha,RARA,462.0
4481,DB00926,Etretinate,SmallMoleculeDrug,P19793,Retinoic acid receptor RXR-alpha,RXRA,462.0
4482,DB00926,Etretinate,SmallMoleculeDrug,P10826,Retinoic acid receptor beta,RARB,455.0
4483,DB00926,Etretinate,SmallMoleculeDrug,P48443,Retinoic acid receptor RXR-gamma,RXRG,463.0
4484,DB00926,Etretinate,SmallMoleculeDrug,P28702,Retinoic acid receptor RXR-beta,RXRB,533.0
4485,DB00926,Etretinate,SmallMoleculeDrug,P13631,Retinoic acid receptor gamma,RARG,454.0
4486,DB00927,Famotidine,SmallMoleculeDrug,P25021,Histamine H2 receptor,HRH2,359.0
4487,DB00928,Azacitidine,SmallMoleculeDrug,P26358,DNA (cytosine-5)-methyltransferase 1,DNMT1,1616.0
4488,DB00929,Misoprostol,SmallMoleculeDrug,P43115,Prostaglandin E2 receptor EP3 subtype,PTGER3,390.0
4489,DB00929,Misoprostol,SmallMoleculeDrug,P43116,Prostaglandin E2 receptor EP2 subtype,PTGER2,358.0
4490,DB00929,Misoprostol,SmallMoleculeDrug,P35408,Prostaglandin E2 receptor EP4 subtype,PTGER4,488.0
4492,DB00933,Mesoridazine,SmallMoleculeDrug,P28223,5-hydroxytryptamine receptor 2A,HTR2A,471.0
4493,DB00933,Mesoridazine,SmallMoleculeDrug,P14416,D(2) dopamine receptor,DRD2,443.0
4494,DB00934,Maprotiline,SmallMoleculeDrug,P23975,Sodium-dependent noradrenaline transporter,SLC6A2,617.0
4495,DB00934,Maprotiline,SmallMoleculeDrug,P35367,Histamine H1 receptor,HRH1,487.0
4496,DB00934,Maprotiline,SmallMoleculeDrug,P11229,Muscarinic acetylcholine receptor M1,CHRM1,460.0
4497,DB00934,Maprotiline,SmallMoleculeDrug,P08172,Muscarinic acetylcholine receptor M2,CHRM2,466.0
4498,DB00934,Maprotiline,SmallMoleculeDrug,P20309,Muscarinic acetylcholine receptor M3,CHRM3,590.0
4499,DB00934,Maprotiline,SmallMoleculeDrug,P08173,Muscarinic acetylcholine receptor M4,CHRM4,479.0
4500,DB00934,Maprotiline,SmallMoleculeDrug,P08912,Muscarinic acetylcholine receptor M5,CHRM5,532.0
4501,DB00934,Maprotiline,SmallMoleculeDrug,P35348,Alpha-1A adrenergic receptor,ADRA1A,466.0
4502,DB00934,Maprotiline,SmallMoleculeDrug,P35368,Alpha-1B adrenergic receptor,ADRA1B,520.0
4503,DB00934,Maprotiline,SmallMoleculeDrug,P25100,Alpha-1D adrenergic receptor,ADRA1D,572.0
4504,DB00934,Maprotiline,SmallMoleculeDrug,P28223,5-hydroxytryptamine receptor 2A,HTR2A,471.0
4505,DB00934,Maprotiline,SmallMoleculeDrug,P28335,5-hydroxytryptamine receptor 2C,HTR2C,458.0
4506,DB00934,Maprotiline,SmallMoleculeDrug,P34969,5-hydroxytryptamine receptor 7,HTR7,479.0
4507,DB00934,Maprotiline,SmallMoleculeDrug,P14416,D(2) dopamine receptor,DRD2,443.0
4508,DB00934,Maprotiline,SmallMoleculeDrug,P08913,Alpha-2A adrenergic receptor,ADRA2A,450.0
4509,DB00934,Maprotiline,SmallMoleculeDrug,P18089,Alpha-2B adrenergic receptor,ADRA2B,450.0
4510,DB00934,Maprotiline,SmallMoleculeDrug,P18825,Alpha-2C adrenergic receptor,ADRA2C,462.0
4511,DB00935,Oxymetazoline,SmallMoleculeDrug,P35348,Alpha-1A adrenergic receptor,ADRA1A,466.0
4512,DB00935,Oxymetazoline,SmallMoleculeDrug,P08913,Alpha-2A adrenergic receptor,ADRA2A,450.0
4513,DB00935,Oxymetazoline,SmallMoleculeDrug,P18825,Alpha-2C adrenergic receptor,ADRA2C,462.0
4514,DB00935,Oxymetazoline,SmallMoleculeDrug,P18089,Alpha-2B adrenergic receptor,ADRA2B,450.0
4515,DB00935,Oxymetazoline,SmallMoleculeDrug,P35368,Alpha-1B adrenergic receptor,ADRA1B,520.0
4516,DB00935,Oxymetazoline,SmallMoleculeDrug,P25100,Alpha-1D adrenergic receptor,ADRA1D,572.0
4517,DB00936,Salicylic acid,SmallMoleculeDrug,P23219,Prostaglandin G/H synthase 1,PTGS1,599.0
4518,DB00936,Salicylic acid,SmallMoleculeDrug,P35354,Prostaglandin G/H synthase 2,PTGS2,604.0
4519,DB00936,Salicylic acid,SmallMoleculeDrug,Q04828,Aldo-keto reductase family 1 member C1,AKR1C1,323.0
4520,DB00937,Diethylpropion,SmallMoleculeDrug,P23975,Sodium-dependent noradrenaline transporter,SLC6A2,617.0
4521,DB00937,Diethylpropion,SmallMoleculeDrug,Q01959,Sodium-dependent dopamine transporter,SLC6A3,620.0
4522,DB00938,Salmeterol,SmallMoleculeDrug,P07550,Beta-2 adrenergic receptor,ADRB2,413.0
4523,DB00939,Meclofenamic acid,SmallMoleculeDrug,P23219,Prostaglandin G/H synthase 1,PTGS1,599.0
4524,DB00939,Meclofenamic acid,SmallMoleculeDrug,P35354,Prostaglandin G/H synthase 2,PTGS2,604.0
4525,DB00939,Meclofenamic acid,SmallMoleculeDrug,P09917,Arachidonate 5-lipoxygenase,ALOX5,674.0
4526,DB00939,Meclofenamic acid,SmallMoleculeDrug,O43526,Potassium voltage-gated channel subfamily KQT member 2,KCNQ2,872.0
4527,DB00939,Meclofenamic acid,SmallMoleculeDrug,O43525,Potassium voltage-gated channel subfamily KQT member 3,KCNQ3,872.0
4528,DB00940,Methantheline,SmallMoleculeDrug,P11229,Muscarinic acetylcholine receptor M1,CHRM1,460.0
4529,DB00940,Methantheline,SmallMoleculeDrug,P25021,Histamine H2 receptor,HRH2,359.0
4530,DB00941,Hexafluronium,SmallMoleculeDrug,P06276,Cholinesterase,BCHE,602.0
4531,DB00942,Cycrimine,SmallMoleculeDrug,P11229,Muscarinic acetylcholine receptor M1,CHRM1,460.0
4533,DB00944,Demecarium,SmallMoleculeDrug,P22303,Acetylcholinesterase,ACHE,614.0
4534,DB00944,Demecarium,SmallMoleculeDrug,P06276,Cholinesterase,BCHE,602.0
4535,DB00945,Acetylsalicylic acid,SmallMoleculeDrug,P23219,Prostaglandin G/H synthase 1,PTGS1,599.0
4536,DB00945,Acetylsalicylic acid,SmallMoleculeDrug,P35354,Prostaglandin G/H synthase 2,PTGS2,604.0
4537,DB00945,Acetylsalicylic acid,SmallMoleculeDrug,Q04828,Aldo-keto reductase family 1 member C1,AKR1C1,323.0
4538,DB00945,Acetylsalicylic acid,SmallMoleculeDrug,Q13131,5'-AMP-activated protein kinase catalytic subunit alpha-1,PRKAA1,559.0
4539,DB00945,Acetylsalicylic acid,SmallMoleculeDrug,P54646,5'-AMP-activated protein kinase catalytic subunit alpha-2,PRKAA2,552.0
4540,DB00945,Acetylsalicylic acid,SmallMoleculeDrug,Q9Y478,5'-AMP-activated protein kinase subunit beta-1,PRKAB1,270.0
4541,DB00945,Acetylsalicylic acid,SmallMoleculeDrug,O43741,5'-AMP-activated protein kinase subunit beta-2,PRKAB2,272.0
4542,DB00945,Acetylsalicylic acid,SmallMoleculeDrug,P54619,5'-AMP-activated protein kinase subunit gamma-1,PRKAG1,331.0
4543,DB00945,Acetylsalicylic acid,SmallMoleculeDrug,Q9UGJ0,5'-AMP-activated protein kinase subunit gamma-2,PRKAG2,569.0
4544,DB00945,Acetylsalicylic acid,SmallMoleculeDrug,Q9UGI9,5'-AMP-activated protein kinase subunit gamma-3,PRKAG3,489.0
4545,DB00945,Acetylsalicylic acid,SmallMoleculeDrug,P25101,Endothelin-1 receptor,EDNRA,427.0
4546,DB00945,Acetylsalicylic acid,SmallMoleculeDrug,O14920,Inhibitor of nuclear factor kappa-B kinase subunit beta,IKBKB,756.0
4547,DB00945,Acetylsalicylic acid,SmallMoleculeDrug,P04637,Cellular tumor antigen p53,TP53,393.0
4548,DB00945,Acetylsalicylic acid,SmallMoleculeDrug,P11021,78 kDa glucose-regulated protein,HSPA5,654.0
4549,DB00945,Acetylsalicylic acid,SmallMoleculeDrug,P51812,Ribosomal protein S6 kinase alpha-3,RPS6KA3,740.0
4550,DB00945,Acetylsalicylic acid,SmallMoleculeDrug,P25963,NF-kappa-B inhibitor alpha,NFKBIA,317.0
4551,DB00945,Acetylsalicylic acid,SmallMoleculeDrug,Q00653,Nuclear factor NF-kappa-B p100 subunit,NFKB2,900.0
4552,DB00945,Acetylsalicylic acid,SmallMoleculeDrug,P19838,Nuclear factor NF-kappa-B p105 subunit,NFKB1,968.0
4553,DB00946,Phenprocoumon,SmallMoleculeDrug,Q9BQB6,Vitamin K epoxide reductase complex subunit 1,VKORC1,163.0
4554,DB00947,Fulvestrant,SmallMoleculeDrug,P03372,Estrogen receptor,ESR1,595.0
4558,DB00949,Felbamate,SmallMoleculeDrug,Q13224,"Glutamate receptor ionotropic, NMDA 2B",GRIN2B,1484.0
4559,DB00949,Felbamate,SmallMoleculeDrug,Q8TCU5,"Glutamate receptor ionotropic, NMDA 3A",GRIN3A,1115.0
4560,DB00949,Felbamate,SmallMoleculeDrug,Q12879,"Glutamate receptor ionotropic, NMDA 2A",GRIN2A,1464.0
4561,DB00950,Fexofenadine,SmallMoleculeDrug,P35367,Histamine H1 receptor,HRH1,487.0
4564,DB00951,Isoniazid,SmallMoleculeDrug,P10632,Cytochrome P450 2C8,CYP2C8,490.0
4565,DB00951,Isoniazid,SmallMoleculeDrug,P05177,Cytochrome P450 1A2,CYP1A2,515.0
4566,DB00951,Isoniazid,SmallMoleculeDrug,P08684,Cytochrome P450 3A4,CYP3A4,503.0
4567,DB00951,Isoniazid,SmallMoleculeDrug,P33261,Cytochrome P450 2C19,CYP2C19,490.0
4569,DB00952,Naratriptan,SmallMoleculeDrug,P28221,5-hydroxytryptamine receptor 1D,HTR1D,377.0
4570,DB00952,Naratriptan,SmallMoleculeDrug,P28222,5-hydroxytryptamine receptor 1B,HTR1B,390.0
4571,DB00952,Naratriptan,SmallMoleculeDrug,P30939,5-hydroxytryptamine receptor 1F,HTR1F,366.0
4572,DB00952,Naratriptan,SmallMoleculeDrug,P08908,5-hydroxytryptamine receptor 1A,HTR1A,422.0
4573,DB00953,Rizatriptan,SmallMoleculeDrug,P28221,5-hydroxytryptamine receptor 1D,HTR1D,377.0
4574,DB00953,Rizatriptan,SmallMoleculeDrug,P28222,5-hydroxytryptamine receptor 1B,HTR1B,390.0
4575,DB00953,Rizatriptan,SmallMoleculeDrug,P30939,5-hydroxytryptamine receptor 1F,HTR1F,366.0
4577,DB00956,Hydrocodone,SmallMoleculeDrug,P35372,Mu-type opioid receptor,OPRM1,400.0
4578,DB00956,Hydrocodone,SmallMoleculeDrug,P41143,Delta-type opioid receptor,OPRD1,372.0
4579,DB00957,Norgestimate,SmallMoleculeDrug,P06401,Progesterone receptor,PGR,933.0
4580,DB00957,Norgestimate,SmallMoleculeDrug,P03372,Estrogen receptor,ESR1,595.0
4581,DB00959,Methylprednisolone,SmallMoleculeDrug,P04150,Glucocorticoid receptor,NR3C1,777.0
4582,DB00960,Pindolol,SmallMoleculeDrug,P08588,Beta-1 adrenergic receptor,ADRB1,477.0
4583,DB00960,Pindolol,SmallMoleculeDrug,P07550,Beta-2 adrenergic receptor,ADRB2,413.0
4584,DB00960,Pindolol,SmallMoleculeDrug,P08908,5-hydroxytryptamine receptor 1A,HTR1A,422.0
4585,DB00960,Pindolol,SmallMoleculeDrug,P28222,5-hydroxytryptamine receptor 1B,HTR1B,390.0
4586,DB00961,Mepivacaine,SmallMoleculeDrug,Q9Y5Y9,Sodium channel protein type 10 subunit alpha,SCN10A,1956.0
4587,DB00962,Zaleplon,SmallMoleculeDrug,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,456.0
4588,DB00962,Zaleplon,SmallMoleculeDrug,P30536,Translocator protein,TSPO,169.0
4589,DB00963,Bromfenac,SmallMoleculeDrug,P35354,Prostaglandin G/H synthase 2,PTGS2,604.0
4590,DB00963,Bromfenac,SmallMoleculeDrug,P23219,Prostaglandin G/H synthase 1,PTGS1,599.0
4591,DB00964,Apraclonidine,SmallMoleculeDrug,P08913,Alpha-2A adrenergic receptor,ADRA2A,450.0
4592,DB00964,Apraclonidine,SmallMoleculeDrug,P35348,Alpha-1A adrenergic receptor,ADRA1A,466.0
4593,DB00964,Apraclonidine,SmallMoleculeDrug,P18089,Alpha-2B adrenergic receptor,ADRA2B,450.0
4594,DB00966,Telmisartan,SmallMoleculeDrug,P30556,Type-1 angiotensin II receptor,AGTR1,359.0
4595,DB00966,Telmisartan,SmallMoleculeDrug,P37231,Peroxisome proliferator-activated receptor gamma,PPARG,505.0
4596,DB00967,Desloratadine,SmallMoleculeDrug,P35367,Histamine H1 receptor,HRH1,487.0
4597,DB00968,Methyldopa,SmallMoleculeDrug,P08913,Alpha-2A adrenergic receptor,ADRA2A,450.0
4598,DB00968,Methyldopa,SmallMoleculeDrug,P20711,Aromatic-L-amino-acid decarboxylase,DDC,480.0
4599,DB00969,Alosetron,SmallMoleculeDrug,P46098,5-hydroxytryptamine receptor 3A,HTR3A,478.0
4600,DB00970,Dactinomycin,SmallMoleculeDrug,P11388,DNA topoisomerase 2-alpha,TOP2A,1531.0
4601,DB00970,Dactinomycin,SmallMoleculeDrug,Q02880,DNA topoisomerase 2-beta,TOP2B,1626.0
4602,DB00972,Azelastine,SmallMoleculeDrug,P35367,Histamine H1 receptor,HRH1,487.0
4603,DB00973,Ezetimibe,SmallMoleculeDrug,P35610,Sterol O-acyltransferase 1,SOAT1,550.0
4604,DB00973,Ezetimibe,SmallMoleculeDrug,Q9UHC9,Niemann-Pick C1-like protein 1,NPC1L1,1359.0
4605,DB00973,Ezetimibe,SmallMoleculeDrug,P15144,Aminopeptidase N,ANPEP,967.0
4606,DB00975,Dipyridamole,SmallMoleculeDrug,Q9Y233,"cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A",PDE10A,779.0
4607,DB00975,Dipyridamole,SmallMoleculeDrug,P00813,Adenosine deaminase,ADA,363.0
4608,DB00975,Dipyridamole,SmallMoleculeDrug,O76074,"cGMP-specific 3',5'-cyclic phosphodiesterase",PDE5A,875.0
4609,DB00975,Dipyridamole,SmallMoleculeDrug,P27815,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A",PDE4A,886.0
4610,DB00977,Ethinyl Estradiol,SmallMoleculeDrug,P03372,Estrogen receptor,ESR1,595.0
4611,DB00977,Ethinyl Estradiol,SmallMoleculeDrug,O75469,Nuclear receptor subfamily 1 group I member 2,NR1I2,434.0
4614,DB00978,Lomefloxacin,SmallMoleculeDrug,P11388,DNA topoisomerase 2-alpha,TOP2A,1531.0
4615,DB00979,Cyclopentolate,SmallMoleculeDrug,P11229,Muscarinic acetylcholine receptor M1,CHRM1,460.0
4616,DB00980,Ramelteon,SmallMoleculeDrug,P48039,Melatonin receptor type 1A,MTNR1A,350.0
4617,DB00980,Ramelteon,SmallMoleculeDrug,P49286,Melatonin receptor type 1B,MTNR1B,362.0
4618,DB00981,Physostigmine,SmallMoleculeDrug,P22303,Acetylcholinesterase,ACHE,614.0
4619,DB00982,Isotretinoin,SmallMoleculeDrug,P10276,Retinoic acid receptor alpha,RARA,462.0
4620,DB00983,Formoterol,SmallMoleculeDrug,P07550,Beta-2 adrenergic receptor,ADRB2,413.0
4621,DB00984,Nandrolone phenpropionate,SmallMoleculeDrug,P10275,Androgen receptor,AR,920.0
4622,DB00985,Dimenhydrinate,SmallMoleculeDrug,P35367,Histamine H1 receptor,HRH1,487.0
4623,DB00986,Glycopyrronium,SmallMoleculeDrug,P11229,Muscarinic acetylcholine receptor M1,CHRM1,460.0
4624,DB00986,Glycopyrronium,SmallMoleculeDrug,P20309,Muscarinic acetylcholine receptor M3,CHRM3,590.0
4625,DB00986,Glycopyrronium,SmallMoleculeDrug,P08172,Muscarinic acetylcholine receptor M2,CHRM2,466.0
4626,DB00987,Cytarabine,SmallMoleculeDrug,P06746,DNA polymerase beta,POLB,335.0
4627,DB00988,Dopamine,SmallMoleculeDrug,P14416,D(2) dopamine receptor,DRD2,443.0
4628,DB00988,Dopamine,SmallMoleculeDrug,P21728,D(1A) dopamine receptor,DRD1,446.0
4629,DB00988,Dopamine,SmallMoleculeDrug,P21918,D(1B) dopamine receptor,DRD5,477.0
4630,DB00988,Dopamine,SmallMoleculeDrug,P35462,D(3) dopamine receptor,DRD3,400.0
4631,DB00988,Dopamine,SmallMoleculeDrug,P21917,D(4) dopamine receptor,DRD4,467.0
4632,DB00988,Dopamine,SmallMoleculeDrug,Q01959,Sodium-dependent dopamine transporter,SLC6A3,620.0
4633,DB00988,Dopamine,SmallMoleculeDrug,P09172,Dopamine beta-hydroxylase,DBH,617.0
4634,DB00988,Dopamine,SmallMoleculeDrug,P08908,5-hydroxytryptamine receptor 1A,HTR1A,422.0
4635,DB00988,Dopamine,SmallMoleculeDrug,P34969,5-hydroxytryptamine receptor 7,HTR7,479.0
4636,DB00988,Dopamine,SmallMoleculeDrug,P21728,D(1A) dopamine receptor,DRD1,446.0
4637,DB00988,Dopamine,SmallMoleculeDrug,P21918,D(1B) dopamine receptor,DRD5,477.0
4638,DB00988,Dopamine,SmallMoleculeDrug,P23975,Sodium-dependent noradrenaline transporter,SLC6A2,617.0
4639,DB00988,Dopamine,SmallMoleculeDrug,P31645,Sodium-dependent serotonin transporter,SLC6A4,630.0
4640,DB00989,Rivastigmine,SmallMoleculeDrug,P22303,Acetylcholinesterase,ACHE,614.0
4641,DB00989,Rivastigmine,SmallMoleculeDrug,P06276,Cholinesterase,BCHE,602.0
4642,DB00990,Exemestane,SmallMoleculeDrug,P11511,Aromatase,CYP19A1,503.0
4643,DB00991,Oxaprozin,SmallMoleculeDrug,P23219,Prostaglandin G/H synthase 1,PTGS1,599.0
4644,DB00991,Oxaprozin,SmallMoleculeDrug,P35354,Prostaglandin G/H synthase 2,PTGS2,604.0
4645,DB00992,Methyl aminolevulinate,SmallMoleculeDrug,P12314,High affinity immunoglobulin gamma Fc receptor I,FCGR1A,374.0
4646,DB00993,Azathioprine,SmallMoleculeDrug,P00492,Hypoxanthine-guanine phosphoribosyltransferase,HPRT1,218.0
4648,DB00995,Auranofin,SmallMoleculeDrug,P30044,"Peroxiredoxin-5, mitochondrial",PRDX5,214.0
4649,DB00995,Auranofin,SmallMoleculeDrug,O14920,Inhibitor of nuclear factor kappa-B kinase subunit beta,IKBKB,756.0
4650,DB00996,Gabapentin,SmallMoleculeDrug,P54289,Voltage-dependent calcium channel subunit alpha-2/delta-1,CACNA2D1,1103.0
4651,DB00996,Gabapentin,SmallMoleculeDrug,Q9NY47,Voltage-dependent calcium channel subunit alpha-2/delta-2,CACNA2D2,1150.0
4652,DB00996,Gabapentin,SmallMoleculeDrug,Q00975,Voltage-dependent N-type calcium channel subunit alpha-1B,CACNA1B,2339.0
4653,DB00996,Gabapentin,SmallMoleculeDrug,P30542,Adenosine receptor A1,ADORA1,326.0
4654,DB00996,Gabapentin,SmallMoleculeDrug,Q05586,"Glutamate receptor ionotropic, NMDA 1",GRIN1,938.0
4655,DB00996,Gabapentin,SmallMoleculeDrug,Q12879,"Glutamate receptor ionotropic, NMDA 2A",GRIN2A,1464.0
4656,DB00996,Gabapentin,SmallMoleculeDrug,Q13224,"Glutamate receptor ionotropic, NMDA 2B",GRIN2B,1484.0
4657,DB00996,Gabapentin,SmallMoleculeDrug,Q14957,"Glutamate receptor ionotropic, NMDA 2C",GRIN2C,1233.0
4658,DB00996,Gabapentin,SmallMoleculeDrug,O15399,"Glutamate receptor ionotropic, NMDA 2D",GRIN2D,1336.0
4659,DB00996,Gabapentin,SmallMoleculeDrug,Q8TCU5,"Glutamate receptor ionotropic, NMDA 3A",GRIN3A,1115.0
4660,DB00996,Gabapentin,SmallMoleculeDrug,O60391,"Glutamate receptor ionotropic, NMDA 3B",GRIN3B,1043.0
4661,DB00997,Doxorubicin,SmallMoleculeDrug,P11388,DNA topoisomerase 2-alpha,TOP2A,1531.0
4662,DB00998,Frovatriptan,SmallMoleculeDrug,P28221,5-hydroxytryptamine receptor 1D,HTR1D,377.0
4663,DB00998,Frovatriptan,SmallMoleculeDrug,P28222,5-hydroxytryptamine receptor 1B,HTR1B,390.0
4664,DB00999,Hydrochlorothiazide,SmallMoleculeDrug,P55017,Solute carrier family 12 member 3,SLC12A3,1021.0
4665,DB00999,Hydrochlorothiazide,SmallMoleculeDrug,P00915,Carbonic anhydrase 1,CA1,261.0
4666,DB00999,Hydrochlorothiazide,SmallMoleculeDrug,P00918,Carbonic anhydrase 2,CA2,260.0
4667,DB00999,Hydrochlorothiazide,SmallMoleculeDrug,P22748,Carbonic anhydrase 4,CA4,312.0
4668,DB00999,Hydrochlorothiazide,SmallMoleculeDrug,Q16790,Carbonic anhydrase 9,CA9,459.0
4669,DB00999,Hydrochlorothiazide,SmallMoleculeDrug,O43570,Carbonic anhydrase 12,CA12,354.0
4670,DB00999,Hydrochlorothiazide,SmallMoleculeDrug,Q12791,Calcium-activated potassium channel subunit alpha-1,KCNMA1,1236.0
4675,DB01001,Salbutamol,SmallMoleculeDrug,P07550,Beta-2 adrenergic receptor,ADRB2,413.0
4676,DB01001,Salbutamol,SmallMoleculeDrug,P08588,Beta-1 adrenergic receptor,ADRB1,477.0
4677,DB01002,Levobupivacaine,SmallMoleculeDrug,Q9Y5Y9,Sodium channel protein type 10 subunit alpha,SCN10A,1956.0
4678,DB01003,Cromoglicic acid,SmallMoleculeDrug,Q12791,Calcium-activated potassium channel subunit alpha-1,KCNMA1,1236.0
4679,DB01003,Cromoglicic acid,SmallMoleculeDrug,P25815,Protein S100-P,S100P,95.0
4682,DB01005,Hydroxyurea,SmallMoleculeDrug,P23921,Ribonucleoside-diphosphate reductase large subunit,RRM1,792.0
4683,DB01006,Letrozole,SmallMoleculeDrug,P11511,Aromatase,CYP19A1,503.0
4685,DB01007,Tioconazole,SmallMoleculeDrug,Q16850,Lanosterol 14-alpha demethylase,CYP51A1,503.0
4686,DB01009,Ketoprofen,SmallMoleculeDrug,P23219,Prostaglandin G/H synthase 1,PTGS1,599.0
4687,DB01009,Ketoprofen,SmallMoleculeDrug,P35354,Prostaglandin G/H synthase 2,PTGS2,604.0
4688,DB01009,Ketoprofen,SmallMoleculeDrug,P25024,C-X-C chemokine receptor type 1,CXCR1,350.0
4689,DB01010,Edrophonium,SmallMoleculeDrug,P22303,Acetylcholinesterase,ACHE,614.0
4690,DB01010,Edrophonium,SmallMoleculeDrug,P06276,Cholinesterase,BCHE,602.0
4691,DB01011,Metyrapone,SmallMoleculeDrug,P15538,"Cytochrome P450 11B1, mitochondrial",CYP11B1,503.0
4693,DB01012,Cinacalcet,SmallMoleculeDrug,P41180,Extracellular calcium-sensing receptor,CASR,1078.0
4694,DB01013,Clobetasol propionate,SmallMoleculeDrug,P04150,Glucocorticoid receptor,NR3C1,777.0
4695,DB01014,Balsalazide,SmallMoleculeDrug,P37231,Peroxisome proliferator-activated receptor gamma,PPARG,505.0
4696,DB01014,Balsalazide,SmallMoleculeDrug,P35354,Prostaglandin G/H synthase 2,PTGS2,604.0
4697,DB01014,Balsalazide,SmallMoleculeDrug,P23219,Prostaglandin G/H synthase 1,PTGS1,599.0
4698,DB01014,Balsalazide,SmallMoleculeDrug,P09917,Arachidonate 5-lipoxygenase,ALOX5,674.0
4701,DB01016,Glyburide,SmallMoleculeDrug,Q09428,ATP-binding cassette sub-family C member 8,ABCC8,1581.0
4702,DB01016,Glyburide,SmallMoleculeDrug,Q14654,ATP-sensitive inward rectifier potassium channel 11,KCNJ11,390.0
4703,DB01016,Glyburide,SmallMoleculeDrug,P48544,G protein-activated inward rectifier potassium channel 4,KCNJ5,419.0
4704,DB01016,Glyburide,SmallMoleculeDrug,O60706,ATP-binding cassette sub-family C member 9,ABCC9,1549.0
4705,DB01016,Glyburide,SmallMoleculeDrug,O95342,Bile salt export pump,ABCB11,1321.0
4706,DB01016,Glyburide,SmallMoleculeDrug,O95477,ATP-binding cassette sub-family A member 1,ABCA1,2261.0
4707,DB01016,Glyburide,SmallMoleculeDrug,P13569,Cystic fibrosis transmembrane conductance regulator,CFTR,1480.0
4708,DB01016,Glyburide,SmallMoleculeDrug,Q14654,ATP-sensitive inward rectifier potassium channel 11,KCNJ11,390.0
4709,DB01016,Glyburide,SmallMoleculeDrug,Q15842,ATP-sensitive inward rectifier potassium channel 8,KCNJ8,424.0
4710,DB01016,Glyburide,SmallMoleculeDrug,P50416,"Carnitine O-palmitoyltransferase 1, liver isoform",CPT1A,773.0
4713,DB01017,Minocycline,SmallMoleculeDrug,P01584,Interleukin-1 beta,IL1B,269.0
4714,DB01017,Minocycline,SmallMoleculeDrug,P09917,Arachidonate 5-lipoxygenase,ALOX5,674.0
4715,DB01017,Minocycline,SmallMoleculeDrug,P14780,Matrix metalloproteinase-9,MMP9,707.0
4716,DB01017,Minocycline,SmallMoleculeDrug,P15692,Vascular endothelial growth factor A,VEGFA,232.0
4717,DB01017,Minocycline,SmallMoleculeDrug,P29466,Caspase-1,CASP1,404.0
4718,DB01017,Minocycline,SmallMoleculeDrug,P42574,Caspase-3,CASP3,277.0
4719,DB01017,Minocycline,SmallMoleculeDrug,P99999,Cytochrome c,CYCS,105.0
4720,DB01018,Guanfacine,SmallMoleculeDrug,P08913,Alpha-2A adrenergic receptor,ADRA2A,450.0
4721,DB01018,Guanfacine,SmallMoleculeDrug,P18089,Alpha-2B adrenergic receptor,ADRA2B,450.0
4722,DB01019,Bethanechol,SmallMoleculeDrug,P08172,Muscarinic acetylcholine receptor M2,CHRM2,466.0
4723,DB01020,Isosorbide Mononitrate,SmallMoleculeDrug,P33402,Guanylate cyclase soluble subunit alpha-2,GUCY1A2,732.0
4724,DB01021,Trichlormethiazide,SmallMoleculeDrug,Q13621,Solute carrier family 12 member 1,SLC12A1,1099.0
4725,DB01021,Trichlormethiazide,SmallMoleculeDrug,P05023,Sodium/potassium-transporting ATPase subunit alpha-1,ATP1A1,1023.0
4726,DB01021,Trichlormethiazide,SmallMoleculeDrug,P00915,Carbonic anhydrase 1,CA1,261.0
4727,DB01021,Trichlormethiazide,SmallMoleculeDrug,P00918,Carbonic anhydrase 2,CA2,260.0
4728,DB01021,Trichlormethiazide,SmallMoleculeDrug,P22748,Carbonic anhydrase 4,CA4,312.0
4729,DB01022,Phylloquinone,SmallMoleculeDrug,P38435,Vitamin K-dependent gamma-carboxylase,GGCX,758.0
4730,DB01022,Phylloquinone,SmallMoleculeDrug,P02818,Osteocalcin,BGLAP,100.0
4731,DB01023,Felodipine,SmallMoleculeDrug,Q13936,Voltage-dependent L-type calcium channel subunit alpha-1C,CACNA1C,2221.0
4732,DB01023,Felodipine,SmallMoleculeDrug,P54289,Voltage-dependent calcium channel subunit alpha-2/delta-1,CACNA2D1,1103.0
4733,DB01023,Felodipine,SmallMoleculeDrug,Q08289,Voltage-dependent L-type calcium channel subunit beta-2,CACNB2,660.0
4734,DB01023,Felodipine,SmallMoleculeDrug,Q01668,Voltage-dependent L-type calcium channel subunit alpha-1D,CACNA1D,2161.0
4735,DB01023,Felodipine,SmallMoleculeDrug,Q13698,Voltage-dependent L-type calcium channel subunit alpha-1S,CACNA1S,1873.0
4736,DB01023,Felodipine,SmallMoleculeDrug,O95180,Voltage-dependent T-type calcium channel subunit alpha-1H,CACNA1H,2353.0
4737,DB01023,Felodipine,SmallMoleculeDrug,Q9NY47,Voltage-dependent calcium channel subunit alpha-2/delta-2,CACNA2D2,1150.0
4739,DB01023,Felodipine,SmallMoleculeDrug,Q01064,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B",PDE1B,536.0
4740,DB01023,Felodipine,SmallMoleculeDrug,P54750,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A",PDE1A,535.0
4741,DB01023,Felodipine,SmallMoleculeDrug,P08235,Mineralocorticoid receptor,NR3C2,984.0
4742,DB01023,Felodipine,SmallMoleculeDrug,P02585,"Troponin C, skeletal muscle",TNNC2,160.0
4743,DB01023,Felodipine,SmallMoleculeDrug,P63316,"Troponin C, slow skeletal and cardiac muscles",TNNC1,161.0
4744,DB01024,Mycophenolic acid,SmallMoleculeDrug,P20839,Inosine-5'-monophosphate dehydrogenase 1,IMPDH1,514.0
4745,DB01024,Mycophenolic acid,SmallMoleculeDrug,P12268,Inosine-5'-monophosphate dehydrogenase 2,IMPDH2,514.0
4746,DB01025,Amlexanox,SmallMoleculeDrug,P80511,Protein S100-A12,S100A12,92.0
4747,DB01025,Amlexanox,SmallMoleculeDrug,Q99584,Protein S100-A13,S100A13,98.0
4748,DB01025,Amlexanox,SmallMoleculeDrug,P08700,Interleukin-3,IL3,152.0
4749,DB01025,Amlexanox,SmallMoleculeDrug,P05230,Fibroblast growth factor 1,FGF1,155.0
4751,DB01026,Ketoconazole,SmallMoleculeDrug,P10275,Androgen receptor,AR,920.0
4752,DB01026,Ketoconazole,SmallMoleculeDrug,P08686,Steroid 21-hydroxylase,CYP21A2,494.0
4753,DB01026,Ketoconazole,SmallMoleculeDrug,P11511,Aromatase,CYP19A1,503.0
4754,DB01028,Methoxyflurane,SmallMoleculeDrug,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,456.0
4755,DB01028,Methoxyflurane,SmallMoleculeDrug,P42261,Glutamate receptor 1,GRIA1,906.0
4756,DB01028,Methoxyflurane,SmallMoleculeDrug,P23415,Glycine receptor subunit alpha-1,GLRA1,457.0
4757,DB01028,Methoxyflurane,SmallMoleculeDrug,P98194,Calcium-transporting ATPase type 2C member 1,ATP2C1,919.0
4758,DB01028,Methoxyflurane,SmallMoleculeDrug,Q09470,Potassium voltage-gated channel subfamily A member 1,KCNA1,495.0
4759,DB01028,Methoxyflurane,SmallMoleculeDrug,P30049,"ATP synthase subunit delta, mitochondrial",ATP5D,168.0
4760,DB01028,Methoxyflurane,SmallMoleculeDrug,P03886,NADH-ubiquinone oxidoreductase chain 1,MT-ND1,318.0
4761,DB01028,Methoxyflurane,SmallMoleculeDrug,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,456.0
4762,DB01028,Methoxyflurane,SmallMoleculeDrug,P47869,Gamma-aminobutyric acid receptor subunit alpha-2,GABRA2,451.0
4763,DB01028,Methoxyflurane,SmallMoleculeDrug,P34903,Gamma-aminobutyric acid receptor subunit alpha-3,GABRA3,492.0
4764,DB01028,Methoxyflurane,SmallMoleculeDrug,P48169,Gamma-aminobutyric acid receptor subunit alpha-4,GABRA4,554.0
4765,DB01028,Methoxyflurane,SmallMoleculeDrug,P31644,Gamma-aminobutyric acid receptor subunit alpha-5,GABRA5,462.0
4766,DB01028,Methoxyflurane,SmallMoleculeDrug,Q16445,Gamma-aminobutyric acid receptor subunit alpha-6,GABRA6,453.0
4767,DB01028,Methoxyflurane,SmallMoleculeDrug,P18505,Gamma-aminobutyric acid receptor subunit beta-1,GABRB1,474.0
4768,DB01028,Methoxyflurane,SmallMoleculeDrug,P47870,Gamma-aminobutyric acid receptor subunit beta-2,GABRB2,512.0
4769,DB01028,Methoxyflurane,SmallMoleculeDrug,P28472,Gamma-aminobutyric acid receptor subunit beta-3,GABRB3,473.0
4770,DB01028,Methoxyflurane,SmallMoleculeDrug,O14764,Gamma-aminobutyric acid receptor subunit delta,GABRD,452.0
4771,DB01028,Methoxyflurane,SmallMoleculeDrug,P78334,Gamma-aminobutyric acid receptor subunit epsilon,GABRE,506.0
4772,DB01028,Methoxyflurane,SmallMoleculeDrug,Q8N1C3,Gamma-aminobutyric acid receptor subunit gamma-1,GABRG1,465.0
4773,DB01028,Methoxyflurane,SmallMoleculeDrug,P18507,Gamma-aminobutyric acid receptor subunit gamma-2,GABRG2,467.0
4774,DB01028,Methoxyflurane,SmallMoleculeDrug,Q99928,Gamma-aminobutyric acid receptor subunit gamma-3,GABRG3,467.0
4775,DB01028,Methoxyflurane,SmallMoleculeDrug,O00591,Gamma-aminobutyric acid receptor subunit pi,GABRP,440.0
4776,DB01028,Methoxyflurane,SmallMoleculeDrug,Q9UN88,Gamma-aminobutyric acid receptor subunit theta,GABRQ,632.0
4777,DB01029,Irbesartan,SmallMoleculeDrug,P30556,Type-1 angiotensin II receptor,AGTR1,359.0
4778,DB01029,Irbesartan,SmallMoleculeDrug,P05412,Transcription factor AP-1,JUN,331.0
4779,DB01030,Topotecan,SmallMoleculeDrug,P11387,DNA topoisomerase 1,TOP1,765.0
4780,DB01030,Topotecan,SmallMoleculeDrug,Q969P6,"DNA topoisomerase I, mitochondrial",TOP1MT,601.0
4781,DB01031,Ethinamate,SmallMoleculeDrug,P00915,Carbonic anhydrase 1,CA1,261.0
4782,DB01031,Ethinamate,SmallMoleculeDrug,P00918,Carbonic anhydrase 2,CA2,260.0
4783,DB01032,Probenecid,SmallMoleculeDrug,Q4U2R8,Solute carrier family 22 member 6,SLC22A6,563.0
4784,DB01032,Probenecid,SmallMoleculeDrug,Q9NSA0,Solute carrier family 22 member 11,SLC22A11,550.0
4785,DB01032,Probenecid,SmallMoleculeDrug,Q8TCC7,Solute carrier family 22 member 8,SLC22A8,542.0
4786,DB01032,Probenecid,SmallMoleculeDrug,Q96RD7,Pannexin-1,PANX1,426.0
4787,DB01033,Mercaptopurine,SmallMoleculeDrug,P00492,Hypoxanthine-guanine phosphoribosyltransferase,HPRT1,218.0
4788,DB01033,Mercaptopurine,SmallMoleculeDrug,Q06203,Amidophosphoribosyltransferase,PPAT,517.0
4789,DB01033,Mercaptopurine,SmallMoleculeDrug,P20839,Inosine-5'-monophosphate dehydrogenase 1,IMPDH1,514.0
4790,DB01033,Mercaptopurine,SmallMoleculeDrug,P12268,Inosine-5'-monophosphate dehydrogenase 2,IMPDH2,514.0
4794,DB01034,Cerulenin,SmallMoleculeDrug,P49327,Fatty acid synthase,FASN,2511.0
4795,DB01035,Procainamide,SmallMoleculeDrug,Q14524,Sodium channel protein type 5 subunit alpha,SCN5A,2016.0
4796,DB01035,Procainamide,SmallMoleculeDrug,P26358,DNA (cytosine-5)-methyltransferase 1,DNMT1,1616.0
4797,DB01036,Tolterodine,SmallMoleculeDrug,P20309,Muscarinic acetylcholine receptor M3,CHRM3,590.0
4798,DB01036,Tolterodine,SmallMoleculeDrug,P08172,Muscarinic acetylcholine receptor M2,CHRM2,466.0
4799,DB01036,Tolterodine,SmallMoleculeDrug,P08912,Muscarinic acetylcholine receptor M5,CHRM5,532.0
4800,DB01036,Tolterodine,SmallMoleculeDrug,P11229,Muscarinic acetylcholine receptor M1,CHRM1,460.0
4801,DB01036,Tolterodine,SmallMoleculeDrug,P08173,Muscarinic acetylcholine receptor M4,CHRM4,479.0
4802,DB01037,Selegiline,SmallMoleculeDrug,P27338,Amine oxidase [flavin-containing] B,MAOB,520.0
4803,DB01037,Selegiline,SmallMoleculeDrug,P21397,Amine oxidase [flavin-containing] A,MAOA,527.0
4804,DB01038,Carphenazine,SmallMoleculeDrug,P14416,D(2) dopamine receptor,DRD2,443.0
4805,DB01038,Carphenazine,SmallMoleculeDrug,P21728,D(1A) dopamine receptor,DRD1,446.0
4806,DB01038,Carphenazine,SmallMoleculeDrug,P21918,D(1B) dopamine receptor,DRD5,477.0
4807,DB01039,Fenofibrate,SmallMoleculeDrug,Q07869,Peroxisome proliferator-activated receptor alpha,PPARA,468.0
4808,DB01039,Fenofibrate,SmallMoleculeDrug,O43923,Matrix metalloproteinase-25,mmp20,183.0
4809,DB01041,Thalidomide,SmallMoleculeDrug,Q96SW2,Protein cereblon,CRBN,442.0
4810,DB01041,Thalidomide,SmallMoleculeDrug,P01375,Tumor necrosis factor,TNF,233.0
4811,DB01041,Thalidomide,SmallMoleculeDrug,P19838,Nuclear factor NF-kappa-B p105 subunit,NFKB1,968.0
4812,DB01041,Thalidomide,SmallMoleculeDrug,P21802,Fibroblast growth factor receptor 2,FGFR2,821.0
4813,DB01041,Thalidomide,SmallMoleculeDrug,P35354,Prostaglandin G/H synthase 2,PTGS2,604.0
4814,DB01041,Thalidomide,SmallMoleculeDrug,P02763,Alpha-1-acid glycoprotein 1,ORM1,201.0
4815,DB01041,Thalidomide,SmallMoleculeDrug,P19652,Alpha-1-acid glycoprotein 2,ORM2,201.0
4816,DB01043,Memantine,SmallMoleculeDrug,Q8TCU5,"Glutamate receptor ionotropic, NMDA 3A",GRIN3A,1115.0
4817,DB01043,Memantine,SmallMoleculeDrug,Q12879,"Glutamate receptor ionotropic, NMDA 2A",GRIN2A,1464.0
4818,DB01043,Memantine,SmallMoleculeDrug,Q13224,"Glutamate receptor ionotropic, NMDA 2B",GRIN2B,1484.0
4819,DB01043,Memantine,SmallMoleculeDrug,P46098,5-hydroxytryptamine receptor 3A,HTR3A,478.0
4820,DB01043,Memantine,SmallMoleculeDrug,Q693P7,Alpha-7 nicotinic cholinergic receptor subunit,CHRNA7,28.0
4821,DB01043,Memantine,SmallMoleculeDrug,P14416,D(2) dopamine receptor,DRD2,443.0
4822,DB01043,Memantine,SmallMoleculeDrug,Q05586,"Glutamate receptor ionotropic, NMDA 1",GRIN1,938.0
4829,DB01045,Rifampicin,SmallMoleculeDrug,O75469,Nuclear receptor subfamily 1 group I member 2,NR1I2,434.0
4830,DB01045,Rifampicin,SmallMoleculeDrug,Q9Y6L6,Solute carrier organic anion transporter family member 1B1,SLCO1B1,691.0
4831,DB01045,Rifampicin,SmallMoleculeDrug,P46721,Solute carrier organic anion transporter family member 1A2,SLCO1A2,670.0
4832,DB01045,Rifampicin,SmallMoleculeDrug,Q9NPD5,Solute carrier organic anion transporter family member 1B3,SLCO1B3,702.0
4833,DB01045,Rifampicin,SmallMoleculeDrug,Q16850,Lanosterol 14-alpha demethylase,CYP51A1,503.0
4834,DB01045,Rifampicin,SmallMoleculeDrug,P02768,Serum albumin,ALB,609.0
4835,DB01045,Rifampicin,SmallMoleculeDrug,O94956,Solute carrier organic anion transporter family member 2B1,SLCO2B1,709.0
4836,DB01046,Lubiprostone,SmallMoleculeDrug,P51788,Chloride channel protein 2,CLCN2,898.0
4837,DB01047,Fluocinonide,SmallMoleculeDrug,P04150,Glucocorticoid receptor,NR3C1,777.0
4838,DB01047,Fluocinonide,SmallMoleculeDrug,Q99835,Smoothened homolog,SMO,787.0
4840,DB01049,Ergoloid mesylate,SmallMoleculeDrug,P08913,Alpha-2A adrenergic receptor,ADRA2A,450.0
4841,DB01049,Ergoloid mesylate,SmallMoleculeDrug,P18089,Alpha-2B adrenergic receptor,ADRA2B,450.0
4842,DB01049,Ergoloid mesylate,SmallMoleculeDrug,P18825,Alpha-2C adrenergic receptor,ADRA2C,462.0
4843,DB01049,Ergoloid mesylate,SmallMoleculeDrug,P35348,Alpha-1A adrenergic receptor,ADRA1A,466.0
4844,DB01049,Ergoloid mesylate,SmallMoleculeDrug,P35368,Alpha-1B adrenergic receptor,ADRA1B,520.0
4845,DB01049,Ergoloid mesylate,SmallMoleculeDrug,P25100,Alpha-1D adrenergic receptor,ADRA1D,572.0
4846,DB01049,Ergoloid mesylate,SmallMoleculeDrug,O94956,Solute carrier organic anion transporter family member 2B1,SLCO2B1,709.0
4847,DB01049,Ergoloid mesylate,SmallMoleculeDrug,P08908,5-hydroxytryptamine receptor 1A,HTR1A,422.0
4848,DB01049,Ergoloid mesylate,SmallMoleculeDrug,P28222,5-hydroxytryptamine receptor 1B,HTR1B,390.0
4849,DB01049,Ergoloid mesylate,SmallMoleculeDrug,P28221,5-hydroxytryptamine receptor 1D,HTR1D,377.0
4850,DB01049,Ergoloid mesylate,SmallMoleculeDrug,P28566,5-hydroxytryptamine receptor 1E,HTR1E,365.0
4851,DB01049,Ergoloid mesylate,SmallMoleculeDrug,P30939,5-hydroxytryptamine receptor 1F,HTR1F,366.0
4852,DB01049,Ergoloid mesylate,SmallMoleculeDrug,P28223,5-hydroxytryptamine receptor 2A,HTR2A,471.0
4853,DB01049,Ergoloid mesylate,SmallMoleculeDrug,P41595,5-hydroxytryptamine receptor 2B,HTR2B,481.0
4854,DB01049,Ergoloid mesylate,SmallMoleculeDrug,P28335,5-hydroxytryptamine receptor 2C,HTR2C,458.0
4855,DB01049,Ergoloid mesylate,SmallMoleculeDrug,P46098,5-hydroxytryptamine receptor 3A,HTR3A,478.0
4856,DB01049,Ergoloid mesylate,SmallMoleculeDrug,O95264,5-hydroxytryptamine receptor 3B,HTR3B,441.0
4857,DB01049,Ergoloid mesylate,SmallMoleculeDrug,Q8WXA8,5-hydroxytryptamine receptor 3C,HTR3C,447.0
4858,DB01049,Ergoloid mesylate,SmallMoleculeDrug,Q70Z44,5-hydroxytryptamine receptor 3D,HTR3D,454.0
4859,DB01049,Ergoloid mesylate,SmallMoleculeDrug,A5X5Y0,5-hydroxytryptamine receptor 3E,HTR3E,456.0
4860,DB01049,Ergoloid mesylate,SmallMoleculeDrug,Q13639,5-hydroxytryptamine receptor 4,HTR4,388.0
4861,DB01049,Ergoloid mesylate,SmallMoleculeDrug,P50406,5-hydroxytryptamine receptor 6,HTR6,440.0
4862,DB01049,Ergoloid mesylate,SmallMoleculeDrug,P34969,5-hydroxytryptamine receptor 7,HTR7,479.0
4863,DB01049,Ergoloid mesylate,SmallMoleculeDrug,P21728,D(1A) dopamine receptor,DRD1,446.0
4864,DB01049,Ergoloid mesylate,SmallMoleculeDrug,P14416,D(2) dopamine receptor,DRD2,443.0
4865,DB01049,Ergoloid mesylate,SmallMoleculeDrug,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,456.0
4866,DB01049,Ergoloid mesylate,SmallMoleculeDrug,P47869,Gamma-aminobutyric acid receptor subunit alpha-2,GABRA2,451.0
4867,DB01049,Ergoloid mesylate,SmallMoleculeDrug,P34903,Gamma-aminobutyric acid receptor subunit alpha-3,GABRA3,492.0
4868,DB01049,Ergoloid mesylate,SmallMoleculeDrug,P48169,Gamma-aminobutyric acid receptor subunit alpha-4,GABRA4,554.0
4869,DB01049,Ergoloid mesylate,SmallMoleculeDrug,P31644,Gamma-aminobutyric acid receptor subunit alpha-5,GABRA5,462.0
4870,DB01049,Ergoloid mesylate,SmallMoleculeDrug,Q16445,Gamma-aminobutyric acid receptor subunit alpha-6,GABRA6,453.0
4871,DB01049,Ergoloid mesylate,SmallMoleculeDrug,P18505,Gamma-aminobutyric acid receptor subunit beta-1,GABRB1,474.0
4872,DB01049,Ergoloid mesylate,SmallMoleculeDrug,P47870,Gamma-aminobutyric acid receptor subunit beta-2,GABRB2,512.0
4873,DB01049,Ergoloid mesylate,SmallMoleculeDrug,P28472,Gamma-aminobutyric acid receptor subunit beta-3,GABRB3,473.0
4874,DB01049,Ergoloid mesylate,SmallMoleculeDrug,O14764,Gamma-aminobutyric acid receptor subunit delta,GABRD,452.0
4875,DB01049,Ergoloid mesylate,SmallMoleculeDrug,P78334,Gamma-aminobutyric acid receptor subunit epsilon,GABRE,506.0
4876,DB01049,Ergoloid mesylate,SmallMoleculeDrug,Q8N1C3,Gamma-aminobutyric acid receptor subunit gamma-1,GABRG1,465.0
4877,DB01049,Ergoloid mesylate,SmallMoleculeDrug,P18507,Gamma-aminobutyric acid receptor subunit gamma-2,GABRG2,467.0
4878,DB01049,Ergoloid mesylate,SmallMoleculeDrug,Q99928,Gamma-aminobutyric acid receptor subunit gamma-3,GABRG3,467.0
4879,DB01049,Ergoloid mesylate,SmallMoleculeDrug,O00591,Gamma-aminobutyric acid receptor subunit pi,GABRP,440.0
4880,DB01049,Ergoloid mesylate,SmallMoleculeDrug,Q9UN88,Gamma-aminobutyric acid receptor subunit theta,GABRQ,632.0
4881,DB01050,Ibuprofen,SmallMoleculeDrug,P35354,Prostaglandin G/H synthase 2,PTGS2,604.0
4882,DB01050,Ibuprofen,SmallMoleculeDrug,P23219,Prostaglandin G/H synthase 1,PTGS1,599.0
4883,DB01050,Ibuprofen,SmallMoleculeDrug,P10415,Apoptosis regulator Bcl-2,BCL2,239.0
4884,DB01050,Ibuprofen,SmallMoleculeDrug,P07204,Thrombomodulin,THBD,575.0
4885,DB01050,Ibuprofen,SmallMoleculeDrug,P00750,Tissue-type plasminogen activator,PLAT,562.0
4886,DB01050,Ibuprofen,SmallMoleculeDrug,P12104,"Fatty acid-binding protein, intestinal",FABP2,132.0
4887,DB01050,Ibuprofen,SmallMoleculeDrug,P37231,Peroxisome proliferator-activated receptor gamma,PPARG,505.0
4888,DB01050,Ibuprofen,SmallMoleculeDrug,P13569,Cystic fibrosis transmembrane conductance regulator,CFTR,1480.0
4893,DB01053,Benzylpenicillin,SmallMoleculeDrug,Q8TCC7,Solute carrier family 22 member 8,SLC22A8,542.0
4894,DB01053,Benzylpenicillin,SmallMoleculeDrug,P46059,Solute carrier family 15 member 1,SLC15A1,708.0
4895,DB01053,Benzylpenicillin,SmallMoleculeDrug,Q16348,Solute carrier family 15 member 2,SLC15A2,729.0
4896,DB01054,Nitrendipine,SmallMoleculeDrug,Q13936,Voltage-dependent L-type calcium channel subunit alpha-1C,CACNA1C,2221.0
4897,DB01054,Nitrendipine,SmallMoleculeDrug,P54289,Voltage-dependent calcium channel subunit alpha-2/delta-1,CACNA2D1,1103.0
4898,DB01054,Nitrendipine,SmallMoleculeDrug,Q08289,Voltage-dependent L-type calcium channel subunit beta-2,CACNB2,660.0
4899,DB01054,Nitrendipine,SmallMoleculeDrug,Q06432,Voltage-dependent calcium channel gamma-1 subunit,CACNG1,222.0
4900,DB01054,Nitrendipine,SmallMoleculeDrug,Q01668,Voltage-dependent L-type calcium channel subunit alpha-1D,CACNA1D,2161.0
4901,DB01054,Nitrendipine,SmallMoleculeDrug,Q13698,Voltage-dependent L-type calcium channel subunit alpha-1S,CACNA1S,1873.0
4902,DB01054,Nitrendipine,SmallMoleculeDrug,Q9NY47,Voltage-dependent calcium channel subunit alpha-2/delta-2,CACNA2D2,1150.0
4903,DB01054,Nitrendipine,SmallMoleculeDrug,O95180,Voltage-dependent T-type calcium channel subunit alpha-1H,CACNA1H,2353.0
4904,DB01055,Mimosine,SmallMoleculeDrug,P34896,"Serine hydroxymethyltransferase, cytosolic",SHMT1,483.0
4905,DB01055,Mimosine,SmallMoleculeDrug,P13500,C-C motif chemokine 2,CCL2,99.0
4906,DB01055,Mimosine,SmallMoleculeDrug,P14679,Tyrosinase,TYR,529.0
4907,DB01056,Tocainide,SmallMoleculeDrug,Q14524,Sodium channel protein type 5 subunit alpha,SCN5A,2016.0
4908,DB01057,Echothiophate,SmallMoleculeDrug,P06276,Cholinesterase,BCHE,602.0
4911,DB01059,Norfloxacin,SmallMoleculeDrug,P11388,DNA topoisomerase 2-alpha,TOP2A,1531.0
4914,DB01062,Oxybutynin,SmallMoleculeDrug,P20309,Muscarinic acetylcholine receptor M3,CHRM3,590.0
4915,DB01062,Oxybutynin,SmallMoleculeDrug,P08172,Muscarinic acetylcholine receptor M2,CHRM2,466.0
4916,DB01062,Oxybutynin,SmallMoleculeDrug,P11229,Muscarinic acetylcholine receptor M1,CHRM1,460.0
4917,DB01063,Acetophenazine,SmallMoleculeDrug,P14416,D(2) dopamine receptor,DRD2,443.0
4918,DB01063,Acetophenazine,SmallMoleculeDrug,P21728,D(1A) dopamine receptor,DRD1,446.0
4919,DB01064,Isoprenaline,SmallMoleculeDrug,P08588,Beta-1 adrenergic receptor,ADRB1,477.0
4920,DB01064,Isoprenaline,SmallMoleculeDrug,P07550,Beta-2 adrenergic receptor,ADRB2,413.0
4921,DB01064,Isoprenaline,SmallMoleculeDrug,P13945,Beta-3 adrenergic receptor,ADRB3,408.0
4922,DB01064,Isoprenaline,SmallMoleculeDrug,P28482,Mitogen-activated protein kinase 1,MAPK1,360.0
4923,DB01064,Isoprenaline,SmallMoleculeDrug,P27986,Phosphatidylinositol 3-kinase regulatory subunit alpha,PIK3R1,724.0
4924,DB01064,Isoprenaline,SmallMoleculeDrug,O00459,Phosphatidylinositol 3-kinase regulatory subunit beta,PIK3R2,728.0
4925,DB01064,Isoprenaline,SmallMoleculeDrug,Q92569,Phosphatidylinositol 3-kinase regulatory subunit gamma,PIK3R3,461.0
4927,DB01065,Melatonin,SmallMoleculeDrug,P48039,Melatonin receptor type 1A,MTNR1A,350.0
4928,DB01065,Melatonin,SmallMoleculeDrug,P49286,Melatonin receptor type 1B,MTNR1B,362.0
4929,DB01065,Melatonin,SmallMoleculeDrug,P03372,Estrogen receptor,ESR1,595.0
4930,DB01065,Melatonin,SmallMoleculeDrug,Q92753,Nuclear receptor ROR-beta,RORB,470.0
4932,DB01065,Melatonin,SmallMoleculeDrug,P05164,Myeloperoxidase,MPO,745.0
4933,DB01065,Melatonin,SmallMoleculeDrug,P11678,Eosinophil peroxidase,EPX,715.0
4934,DB01065,Melatonin,SmallMoleculeDrug,P27797,Calreticulin,CALR,417.0
4935,DB01065,Melatonin,SmallMoleculeDrug,P46597,Acetylserotonin O-methyltransferase,ASMT,345.0
4936,DB01065,Melatonin,SmallMoleculeDrug,P16083,Ribosyldihydronicotinamide dehydrogenase [quinone],NQO2,231.0
4939,DB01067,Glipizide,SmallMoleculeDrug,Q09428,ATP-binding cassette sub-family C member 8,ABCC8,1581.0
4940,DB01067,Glipizide,SmallMoleculeDrug,P37231,Peroxisome proliferator-activated receptor gamma,PPARG,505.0
4941,DB01068,Clonazepam,SmallMoleculeDrug,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,456.0
4942,DB01068,Clonazepam,SmallMoleculeDrug,P47869,Gamma-aminobutyric acid receptor subunit alpha-2,GABRA2,451.0
4943,DB01068,Clonazepam,SmallMoleculeDrug,P34903,Gamma-aminobutyric acid receptor subunit alpha-3,GABRA3,492.0
4944,DB01068,Clonazepam,SmallMoleculeDrug,P48169,Gamma-aminobutyric acid receptor subunit alpha-4,GABRA4,554.0
4945,DB01068,Clonazepam,SmallMoleculeDrug,P31644,Gamma-aminobutyric acid receptor subunit alpha-5,GABRA5,462.0
4946,DB01068,Clonazepam,SmallMoleculeDrug,Q16445,Gamma-aminobutyric acid receptor subunit alpha-6,GABRA6,453.0
4947,DB01068,Clonazepam,SmallMoleculeDrug,P18505,Gamma-aminobutyric acid receptor subunit beta-1,GABRB1,474.0
4948,DB01068,Clonazepam,SmallMoleculeDrug,P47870,Gamma-aminobutyric acid receptor subunit beta-2,GABRB2,512.0
4949,DB01068,Clonazepam,SmallMoleculeDrug,P28472,Gamma-aminobutyric acid receptor subunit beta-3,GABRB3,473.0
4950,DB01068,Clonazepam,SmallMoleculeDrug,O14764,Gamma-aminobutyric acid receptor subunit delta,GABRD,452.0
4951,DB01068,Clonazepam,SmallMoleculeDrug,P78334,Gamma-aminobutyric acid receptor subunit epsilon,GABRE,506.0
4952,DB01068,Clonazepam,SmallMoleculeDrug,Q8N1C3,Gamma-aminobutyric acid receptor subunit gamma-1,GABRG1,465.0
4953,DB01068,Clonazepam,SmallMoleculeDrug,P18507,Gamma-aminobutyric acid receptor subunit gamma-2,GABRG2,467.0
4954,DB01068,Clonazepam,SmallMoleculeDrug,Q99928,Gamma-aminobutyric acid receptor subunit gamma-3,GABRG3,467.0
4955,DB01068,Clonazepam,SmallMoleculeDrug,O00591,Gamma-aminobutyric acid receptor subunit pi,GABRP,440.0
4956,DB01068,Clonazepam,SmallMoleculeDrug,Q9UN88,Gamma-aminobutyric acid receptor subunit theta,GABRQ,632.0
4957,DB01068,Clonazepam,SmallMoleculeDrug,P30536,Translocator protein,TSPO,169.0
4958,DB01069,Promethazine,SmallMoleculeDrug,P35367,Histamine H1 receptor,HRH1,487.0
4959,DB01069,Promethazine,SmallMoleculeDrug,P14416,D(2) dopamine receptor,DRD2,443.0
4960,DB01069,Promethazine,SmallMoleculeDrug,P11229,Muscarinic acetylcholine receptor M1,CHRM1,460.0
4961,DB01069,Promethazine,SmallMoleculeDrug,P08172,Muscarinic acetylcholine receptor M2,CHRM2,466.0
4962,DB01069,Promethazine,SmallMoleculeDrug,P20309,Muscarinic acetylcholine receptor M3,CHRM3,590.0
4963,DB01069,Promethazine,SmallMoleculeDrug,P08173,Muscarinic acetylcholine receptor M4,CHRM4,479.0
4964,DB01069,Promethazine,SmallMoleculeDrug,P08912,Muscarinic acetylcholine receptor M5,CHRM5,532.0
4965,DB01069,Promethazine,SmallMoleculeDrug,P35348,Alpha-1A adrenergic receptor,ADRA1A,466.0
4966,DB01069,Promethazine,SmallMoleculeDrug,P28223,5-hydroxytryptamine receptor 2A,HTR2A,471.0
4968,DB01070,Dihydrotachysterol,SmallMoleculeDrug,P11473,Vitamin D3 receptor,VDR,427.0
4969,DB01071,Mequitazine,SmallMoleculeDrug,P35367,Histamine H1 receptor,HRH1,487.0
4971,DB01073,Fludarabine,SmallMoleculeDrug,P23921,Ribonucleoside-diphosphate reductase large subunit,RRM1,792.0
4972,DB01073,Fludarabine,SmallMoleculeDrug,P09884,DNA polymerase alpha catalytic subunit,POLA1,1462.0
4973,DB01073,Fludarabine,SmallMoleculeDrug,P27707,Deoxycytidine kinase,DCK,260.0
4974,DB01074,Perhexiline,SmallMoleculeDrug,P50416,"Carnitine O-palmitoyltransferase 1, liver isoform",CPT1A,773.0
4975,DB01074,Perhexiline,SmallMoleculeDrug,P23786,"Carnitine O-palmitoyltransferase 2, mitochondrial",CPT2,658.0
4976,DB01075,Diphenhydramine,SmallMoleculeDrug,P35367,Histamine H1 receptor,HRH1,487.0
4977,DB01075,Diphenhydramine,SmallMoleculeDrug,P08172,Muscarinic acetylcholine receptor M2,CHRM2,466.0
4978,DB01076,Atorvastatin,SmallMoleculeDrug,P04035,3-hydroxy-3-methylglutaryl-coenzyme A reductase,HMGCR,888.0
4979,DB01076,Atorvastatin,SmallMoleculeDrug,P27487,Dipeptidyl peptidase 4,DPP4,766.0
4980,DB01076,Atorvastatin,SmallMoleculeDrug,P35869,Aryl hydrocarbon receptor,AHR,848.0
4981,DB01077,Etidronic acid,SmallMoleculeDrug,Q13332,Receptor-type tyrosine-protein phosphatase S,PTPRS,1948.0
4982,DB01077,Etidronic acid,SmallMoleculeDrug,P38606,V-type proton ATPase catalytic subunit A,ATP6V1A,617.0
4983,DB01078,Deslanoside,SmallMoleculeDrug,P05023,Sodium/potassium-transporting ATPase subunit alpha-1,ATP1A1,1023.0
4984,DB01079,Tegaserod,SmallMoleculeDrug,Q13639,5-hydroxytryptamine receptor 4,HTR4,388.0
4985,DB01079,Tegaserod,SmallMoleculeDrug,P41595,5-hydroxytryptamine receptor 2B,HTR2B,481.0
4986,DB01079,Tegaserod,SmallMoleculeDrug,P28335,5-hydroxytryptamine receptor 2C,HTR2C,458.0
4987,DB01079,Tegaserod,SmallMoleculeDrug,P28223,5-hydroxytryptamine receptor 2A,HTR2A,471.0
4988,DB01080,Vigabatrin,SmallMoleculeDrug,Q9UBS5,Gamma-aminobutyric acid type B receptor subunit 1,GABBR1,961.0
4989,DB01080,Vigabatrin,SmallMoleculeDrug,P80404,"4-aminobutyrate aminotransferase, mitochondrial",ABAT,500.0
4990,DB01081,Diphenoxylate,SmallMoleculeDrug,P35372,Mu-type opioid receptor,OPRM1,400.0
4991,DB01081,Diphenoxylate,SmallMoleculeDrug,P41143,Delta-type opioid receptor,OPRD1,372.0
4993,DB01082,Streptomycin,SmallMoleculeDrug,Q9UM07,Protein-arginine deiminase type-4,PADI4,663.0
4994,DB01083,Orlistat,SmallMoleculeDrug,P16233,Pancreatic triacylglycerol lipase,PNLIP,465.0
4995,DB01083,Orlistat,SmallMoleculeDrug,P07098,Gastric triacylglycerol lipase,LIPF,398.0
4996,DB01083,Orlistat,SmallMoleculeDrug,P49327,Fatty acid synthase,FASN,2511.0
4997,DB01084,Emedastine,SmallMoleculeDrug,P35367,Histamine H1 receptor,HRH1,487.0
4998,DB01085,Pilocarpine,SmallMoleculeDrug,P20309,Muscarinic acetylcholine receptor M3,CHRM3,590.0
4999,DB01085,Pilocarpine,SmallMoleculeDrug,P11229,Muscarinic acetylcholine receptor M1,CHRM1,460.0
5000,DB01085,Pilocarpine,SmallMoleculeDrug,P08172,Muscarinic acetylcholine receptor M2,CHRM2,466.0
5001,DB01086,Benzocaine,SmallMoleculeDrug,Q9Y5Y9,Sodium channel protein type 10 subunit alpha,SCN10A,1956.0
5002,DB01087,Primaquine,SmallMoleculeDrug,P08729,"Keratin, type II cytoskeletal 7",KRT7,469.0
5003,DB01087,Primaquine,SmallMoleculeDrug,P16083,Ribosyldihydronicotinamide dehydrogenase [quinone],NQO2,231.0
5004,DB01088,Iloprost,SmallMoleculeDrug,P43119,Prostacyclin receptor,PTGIR,386.0
5005,DB01088,Iloprost,SmallMoleculeDrug,P34995,Prostaglandin E2 receptor EP1 subtype,PTGER1,402.0
5006,DB01088,Iloprost,SmallMoleculeDrug,P27815,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A",PDE4A,886.0
5007,DB01088,Iloprost,SmallMoleculeDrug,Q07343,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B",PDE4B,736.0
5008,DB01088,Iloprost,SmallMoleculeDrug,Q08493,"cAMP-specific 3',5'-cyclic phosphodiesterase 4C",PDE4C,712.0
5009,DB01088,Iloprost,SmallMoleculeDrug,Q08499,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",PDE4D,809.0
5010,DB01088,Iloprost,SmallMoleculeDrug,P00750,Tissue-type plasminogen activator,PLAT,562.0
5011,DB01089,Deserpidine,SmallMoleculeDrug,Q05940,Synaptic vesicular amine transporter,SLC18A2,514.0
5012,DB01090,Pentolinium,SmallMoleculeDrug,Q9GZZ6,Neuronal acetylcholine receptor subunit alpha-10,CHRNA10,450.0
5013,DB01090,Pentolinium,SmallMoleculeDrug,P32297,Neuronal acetylcholine receptor subunit alpha-3,CHRNA3,505.0
5014,DB01090,Pentolinium,SmallMoleculeDrug,P30926,Neuronal acetylcholine receptor subunit beta-4,CHRNB4,498.0
5015,DB01091,Butenafine,SmallMoleculeDrug,Q14534,Squalene monooxygenase,SQLE,574.0
5016,DB01092,Ouabain,SmallMoleculeDrug,P05023,Sodium/potassium-transporting ATPase subunit alpha-1,ATP1A1,1023.0
5017,DB01094,Hesperetin,SmallMoleculeDrug,P35610,Sterol O-acyltransferase 1,SOAT1,550.0
5018,DB01094,Hesperetin,SmallMoleculeDrug,O75908,Sterol O-acyltransferase 2,SOAT2,522.0
5019,DB01094,Hesperetin,SmallMoleculeDrug,P55157,Microsomal triglyceride transfer protein large subunit,MTTP,894.0
5020,DB01095,Fluvastatin,SmallMoleculeDrug,P04035,3-hydroxy-3-methylglutaryl-coenzyme A reductase,HMGCR,888.0
5021,DB01097,Leflunomide,SmallMoleculeDrug,Q02127,"Dihydroorotate dehydrogenase (quinone), mitochondrial",DHODH,395.0
5022,DB01097,Leflunomide,SmallMoleculeDrug,P35869,Aryl hydrocarbon receptor,AHR,848.0
5023,DB01097,Leflunomide,SmallMoleculeDrug,Q14289,Protein-tyrosine kinase 2-beta,PTK2B,1009.0
5024,DB01098,Rosuvastatin,SmallMoleculeDrug,P04035,3-hydroxy-3-methylglutaryl-coenzyme A reductase,HMGCR,888.0
5025,DB01099,Flucytosine,SmallMoleculeDrug,P26358,DNA (cytosine-5)-methyltransferase 1,DNMT1,1616.0
5027,DB01100,Pimozide,SmallMoleculeDrug,P14416,D(2) dopamine receptor,DRD2,443.0
5028,DB01100,Pimozide,SmallMoleculeDrug,P35462,D(3) dopamine receptor,DRD3,400.0
5029,DB01100,Pimozide,SmallMoleculeDrug,Q12809,Potassium voltage-gated channel subfamily H member 2,KCNH2,1159.0
5031,DB01101,Capecitabine,SmallMoleculeDrug,P04818,Thymidylate synthase,TYMS,313.0
5032,DB01102,Arbutamine,SmallMoleculeDrug,P08588,Beta-1 adrenergic receptor,ADRB1,477.0
5033,DB01102,Arbutamine,SmallMoleculeDrug,P07550,Beta-2 adrenergic receptor,ADRB2,413.0
5034,DB01102,Arbutamine,SmallMoleculeDrug,P13945,Beta-3 adrenergic receptor,ADRB3,408.0
5035,DB01103,Quinacrine,SmallMoleculeDrug,O60733,85/88 kDa calcium-independent phospholipase A2,PLA2G6,806.0
5036,DB01103,Quinacrine,SmallMoleculeDrug,P47712,Cytosolic phospholipase A2,PLA2G4A,749.0
5037,DB01103,Quinacrine,SmallMoleculeDrug,Q15111,Inactive phospholipase C-like protein 1,PLCL1,1095.0
5038,DB01104,Sertraline,SmallMoleculeDrug,P31645,Sodium-dependent serotonin transporter,SLC6A4,630.0
5039,DB01104,Sertraline,SmallMoleculeDrug,Q01959,Sodium-dependent dopamine transporter,SLC6A3,620.0
5040,DB01105,Sibutramine,SmallMoleculeDrug,P23975,Sodium-dependent noradrenaline transporter,SLC6A2,617.0
5041,DB01105,Sibutramine,SmallMoleculeDrug,P31645,Sodium-dependent serotonin transporter,SLC6A4,630.0
5042,DB01105,Sibutramine,SmallMoleculeDrug,Q01959,Sodium-dependent dopamine transporter,SLC6A3,620.0
5043,DB01106,Levocabastine,SmallMoleculeDrug,P35367,Histamine H1 receptor,HRH1,487.0
5044,DB01106,Levocabastine,SmallMoleculeDrug,O95665,Neurotensin receptor type 2,NTSR2,410.0
5045,DB01107,Methyprylon,SmallMoleculeDrug,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,456.0
5046,DB01107,Methyprylon,SmallMoleculeDrug,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,456.0
5047,DB01107,Methyprylon,SmallMoleculeDrug,P47869,Gamma-aminobutyric acid receptor subunit alpha-2,GABRA2,451.0
5048,DB01107,Methyprylon,SmallMoleculeDrug,P34903,Gamma-aminobutyric acid receptor subunit alpha-3,GABRA3,492.0
5049,DB01107,Methyprylon,SmallMoleculeDrug,P48169,Gamma-aminobutyric acid receptor subunit alpha-4,GABRA4,554.0
5050,DB01107,Methyprylon,SmallMoleculeDrug,P31644,Gamma-aminobutyric acid receptor subunit alpha-5,GABRA5,462.0
5051,DB01107,Methyprylon,SmallMoleculeDrug,Q16445,Gamma-aminobutyric acid receptor subunit alpha-6,GABRA6,453.0
5052,DB01107,Methyprylon,SmallMoleculeDrug,P18505,Gamma-aminobutyric acid receptor subunit beta-1,GABRB1,474.0
5053,DB01107,Methyprylon,SmallMoleculeDrug,P47870,Gamma-aminobutyric acid receptor subunit beta-2,GABRB2,512.0
5054,DB01107,Methyprylon,SmallMoleculeDrug,P28472,Gamma-aminobutyric acid receptor subunit beta-3,GABRB3,473.0
5055,DB01107,Methyprylon,SmallMoleculeDrug,O14764,Gamma-aminobutyric acid receptor subunit delta,GABRD,452.0
5056,DB01107,Methyprylon,SmallMoleculeDrug,P78334,Gamma-aminobutyric acid receptor subunit epsilon,GABRE,506.0
5057,DB01107,Methyprylon,SmallMoleculeDrug,Q8N1C3,Gamma-aminobutyric acid receptor subunit gamma-1,GABRG1,465.0
5058,DB01107,Methyprylon,SmallMoleculeDrug,P18507,Gamma-aminobutyric acid receptor subunit gamma-2,GABRG2,467.0
5059,DB01107,Methyprylon,SmallMoleculeDrug,Q99928,Gamma-aminobutyric acid receptor subunit gamma-3,GABRG3,467.0
5060,DB01107,Methyprylon,SmallMoleculeDrug,O00591,Gamma-aminobutyric acid receptor subunit pi,GABRP,440.0
5061,DB01107,Methyprylon,SmallMoleculeDrug,Q9UN88,Gamma-aminobutyric acid receptor subunit theta,GABRQ,632.0
5062,DB01108,Trilostane,SmallMoleculeDrug,P14060,3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 1,HSD3B1,373.0
5063,DB01108,Trilostane,SmallMoleculeDrug,P26439,3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 2,HSD3B2,372.0
5064,DB01108,Trilostane,SmallMoleculeDrug,P03372,Estrogen receptor,ESR1,595.0
5065,DB01108,Trilostane,SmallMoleculeDrug,Q92731,Estrogen receptor beta,ESR2,530.0
5066,DB01109,Heparin,SmallMoleculeDrug,P01008,Antithrombin-III,SERPINC1,464.0
5067,DB01109,Heparin,SmallMoleculeDrug,P00742,Coagulation factor X,F10,488.0
5068,DB01109,Heparin,SmallMoleculeDrug,P16109,P-selectin,SELP,830.0
5070,DB01110,Miconazole,SmallMoleculeDrug,P29474,"Nitric oxide synthase, endothelial",NOS3,1203.0
5071,DB01110,Miconazole,SmallMoleculeDrug,P35228,"Nitric oxide synthase, inducible",NOS2,1153.0
5072,DB01110,Miconazole,SmallMoleculeDrug,Q12791,Calcium-activated potassium channel subunit alpha-1,KCNMA1,1236.0
5073,DB01110,Miconazole,SmallMoleculeDrug,Q16558,Calcium-activated potassium channel subunit beta-1,KCNMB1,191.0
5074,DB01110,Miconazole,SmallMoleculeDrug,Q9Y691,Calcium-activated potassium channel subunit beta-2,KCNMB2,235.0
5075,DB01110,Miconazole,SmallMoleculeDrug,Q9NPA1,Calcium-activated potassium channel subunit beta-3,KCNMB3,279.0
5076,DB01110,Miconazole,SmallMoleculeDrug,Q86W47,Calcium-activated potassium channel subunit beta-4,KCNMB4,210.0
5077,DB01110,Miconazole,SmallMoleculeDrug,O15554,Intermediate conductance calcium-activated potassium channel protein 4,KCNN4,427.0
5078,DB01110,Miconazole,SmallMoleculeDrug,Q92952,Small conductance calcium-activated potassium channel protein 1,KCNN1,543.0
5079,DB01110,Miconazole,SmallMoleculeDrug,Q9H2S1,Small conductance calcium-activated potassium channel protein 2,KCNN2,579.0
5080,DB01110,Miconazole,SmallMoleculeDrug,Q9UGI6,Small conductance calcium-activated potassium channel protein 3,KCNN3,736.0
5081,DB01110,Miconazole,SmallMoleculeDrug,Q12809,Potassium voltage-gated channel subfamily H member 2,KCNH2,1159.0
5082,DB01110,Miconazole,SmallMoleculeDrug,Q9H252,Potassium voltage-gated channel subfamily H member 6,KCNH6,994.0
5083,DB01110,Miconazole,SmallMoleculeDrug,Q9NS40,Potassium voltage-gated channel subfamily H member 7,KCNH7,1196.0
5085,DB01113,Papaverine,SmallMoleculeDrug,Q07343,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B",PDE4B,736.0
5086,DB01113,Papaverine,SmallMoleculeDrug,Q9Y233,"cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A",PDE10A,779.0
5087,DB01114,Chlorphenamine,SmallMoleculeDrug,P35367,Histamine H1 receptor,HRH1,487.0
5088,DB01114,Chlorphenamine,SmallMoleculeDrug,P31645,Sodium-dependent serotonin transporter,SLC6A4,630.0
5089,DB01114,Chlorphenamine,SmallMoleculeDrug,P23975,Sodium-dependent noradrenaline transporter,SLC6A2,617.0
5090,DB01114,Chlorphenamine,SmallMoleculeDrug,Q01959,Sodium-dependent dopamine transporter,SLC6A3,620.0
5091,DB01115,Nifedipine,SmallMoleculeDrug,Q13936,Voltage-dependent L-type calcium channel subunit alpha-1C,CACNA1C,2221.0
5092,DB01115,Nifedipine,SmallMoleculeDrug,P54289,Voltage-dependent calcium channel subunit alpha-2/delta-1,CACNA2D1,1103.0
5093,DB01115,Nifedipine,SmallMoleculeDrug,Q08289,Voltage-dependent L-type calcium channel subunit beta-2,CACNB2,660.0
5094,DB01115,Nifedipine,SmallMoleculeDrug,Q01668,Voltage-dependent L-type calcium channel subunit alpha-1D,CACNA1D,2161.0
5095,DB01115,Nifedipine,SmallMoleculeDrug,Q13698,Voltage-dependent L-type calcium channel subunit alpha-1S,CACNA1S,1873.0
5097,DB01115,Nifedipine,SmallMoleculeDrug,Q09470,Potassium voltage-gated channel subfamily A member 1,KCNA1,495.0
5098,DB01115,Nifedipine,SmallMoleculeDrug,O95180,Voltage-dependent T-type calcium channel subunit alpha-1H,CACNA1H,2353.0
5099,DB01116,Trimethaphan,SmallMoleculeDrug,Q9GZZ6,Neuronal acetylcholine receptor subunit alpha-10,CHRNA10,450.0
5102,DB01117,Atovaquone,SmallMoleculeDrug,Q02127,"Dihydroorotate dehydrogenase (quinone), mitochondrial",DHODH,395.0
5103,DB01118,Amiodarone,SmallMoleculeDrug,Q12809,Potassium voltage-gated channel subfamily H member 2,KCNH2,1159.0
5104,DB01118,Amiodarone,SmallMoleculeDrug,P08588,Beta-1 adrenergic receptor,ADRB1,477.0
5105,DB01118,Amiodarone,SmallMoleculeDrug,O95180,Voltage-dependent T-type calcium channel subunit alpha-1H,CACNA1H,2353.0
5106,DB01118,Amiodarone,SmallMoleculeDrug,Q9NY47,Voltage-dependent calcium channel subunit alpha-2/delta-2,CACNA2D2,1150.0
5107,DB01119,Diazoxide,SmallMoleculeDrug,Q14654,ATP-sensitive inward rectifier potassium channel 11,KCNJ11,390.0
5108,DB01119,Diazoxide,SmallMoleculeDrug,P00915,Carbonic anhydrase 1,CA1,261.0
5109,DB01119,Diazoxide,SmallMoleculeDrug,P00918,Carbonic anhydrase 2,CA2,260.0
5110,DB01119,Diazoxide,SmallMoleculeDrug,P05023,Sodium/potassium-transporting ATPase subunit alpha-1,ATP1A1,1023.0
5111,DB01119,Diazoxide,SmallMoleculeDrug,Q12791,Calcium-activated potassium channel subunit alpha-1,KCNMA1,1236.0
5112,DB01119,Diazoxide,SmallMoleculeDrug,P55017,Solute carrier family 12 member 3,SLC12A3,1021.0
5113,DB01120,Gliclazide,SmallMoleculeDrug,Q09428,ATP-binding cassette sub-family C member 8,ABCC8,1581.0
5114,DB01120,Gliclazide,SmallMoleculeDrug,P15692,Vascular endothelial growth factor A,VEGFA,232.0
5115,DB01121,Phenacemide,SmallMoleculeDrug,P35498,Sodium channel protein type 1 subunit alpha,SCN1A,2009.0
5116,DB01122,Ambenonium,SmallMoleculeDrug,P22303,Acetylcholinesterase,ACHE,614.0
5117,DB01123,Proflavine,SmallMoleculeDrug,P00734,Prothrombin,F2,622.0
5120,DB01124,Tolbutamide,SmallMoleculeDrug,Q09428,ATP-binding cassette sub-family C member 8,ABCC8,1581.0
5121,DB01124,Tolbutamide,SmallMoleculeDrug,P48048,ATP-sensitive inward rectifier potassium channel 1,KCNJ1,391.0
5122,DB01125,Anisindione,SmallMoleculeDrug,P38435,Vitamin K-dependent gamma-carboxylase,GGCX,758.0
5123,DB01126,Dutasteride,SmallMoleculeDrug,P31213,3-oxo-5-alpha-steroid 4-dehydrogenase 2,SRD5A2,254.0
5124,DB01126,Dutasteride,SmallMoleculeDrug,P18405,3-oxo-5-alpha-steroid 4-dehydrogenase 1,SRD5A1,259.0
5126,DB01128,Bicalutamide,SmallMoleculeDrug,P10275,Androgen receptor,AR,920.0
5127,DB01129,Rabeprazole,SmallMoleculeDrug,P20648,Potassium-transporting ATPase alpha chain 1,ATP4A,1035.0
5128,DB01130,Prednicarbate,SmallMoleculeDrug,P04150,Glucocorticoid receptor,NR3C1,777.0
5129,DB01131,Proguanil,SmallMoleculeDrug,P00374,Dihydrofolate reductase,DHFR,187.0
5131,DB01132,Pioglitazone,SmallMoleculeDrug,P37231,Peroxisome proliferator-activated receptor gamma,PPARG,505.0
5132,DB01133,Tiludronic acid,SmallMoleculeDrug,P38606,V-type proton ATPase catalytic subunit A,ATP6V1A,617.0
5133,DB01133,Tiludronic acid,SmallMoleculeDrug,P18031,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,435.0
5134,DB01134,Desoxycorticosterone Pivalate,SmallMoleculeDrug,P08235,Mineralocorticoid receptor,NR3C2,984.0
5135,DB01135,Doxacurium chloride,SmallMoleculeDrug,Q15822,Neuronal acetylcholine receptor subunit alpha-2,CHRNA2,529.0
5136,DB01135,Doxacurium chloride,SmallMoleculeDrug,P08172,Muscarinic acetylcholine receptor M2,CHRM2,466.0
5137,DB01136,Carvedilol,SmallMoleculeDrug,P08588,Beta-1 adrenergic receptor,ADRB1,477.0
5138,DB01136,Carvedilol,SmallMoleculeDrug,P35348,Alpha-1A adrenergic receptor,ADRA1A,466.0
5139,DB01136,Carvedilol,SmallMoleculeDrug,O95298,NADH dehydrogenase [ubiquinone] 1 subunit C2,NDUFC2,119.0
5140,DB01136,Carvedilol,SmallMoleculeDrug,P07550,Beta-2 adrenergic receptor,ADRB2,413.0
5141,DB01136,Carvedilol,SmallMoleculeDrug,P15692,Vascular endothelial growth factor A,VEGFA,232.0
5142,DB01136,Carvedilol,SmallMoleculeDrug,P16860,Natriuretic peptides B,NPPB,134.0
5143,DB01136,Carvedilol,SmallMoleculeDrug,P17302,Gap junction alpha-1 protein,GJA1,382.0
5144,DB01136,Carvedilol,SmallMoleculeDrug,Q12809,Potassium voltage-gated channel subfamily H member 2,KCNH2,1159.0
5145,DB01136,Carvedilol,SmallMoleculeDrug,P19320,Vascular cell adhesion protein 1,VCAM1,739.0
5146,DB01136,Carvedilol,SmallMoleculeDrug,P25100,Alpha-1D adrenergic receptor,ADRA1D,572.0
5147,DB01136,Carvedilol,SmallMoleculeDrug,P35368,Alpha-1B adrenergic receptor,ADRA1B,520.0
5148,DB01136,Carvedilol,SmallMoleculeDrug,P18825,Alpha-2C adrenergic receptor,ADRA2C,462.0
5149,DB01136,Carvedilol,SmallMoleculeDrug,P18089,Alpha-2B adrenergic receptor,ADRA2B,450.0
5150,DB01136,Carvedilol,SmallMoleculeDrug,P08913,Alpha-2A adrenergic receptor,ADRA2A,450.0
5151,DB01136,Carvedilol,SmallMoleculeDrug,P16581,E-selectin,SELE,610.0
5152,DB01136,Carvedilol,SmallMoleculeDrug,Q16665,Hypoxia-inducible factor 1-alpha,HIF1A,826.0
5155,DB01137,Levofloxacin,SmallMoleculeDrug,P11388,DNA topoisomerase 2-alpha,TOP2A,1531.0
5156,DB01138,Sulfinpyrazone,SmallMoleculeDrug,Q92887,Canalicular multispecific organic anion transporter 1,ABCC2,1545.0
5157,DB01138,Sulfinpyrazone,SmallMoleculeDrug,P33527,Multidrug resistance-associated protein 1,ABCC1,1531.0
5164,DB01142,Doxepin,SmallMoleculeDrug,P35367,Histamine H1 receptor,HRH1,487.0
5165,DB01142,Doxepin,SmallMoleculeDrug,P25021,Histamine H2 receptor,HRH2,359.0
5166,DB01142,Doxepin,SmallMoleculeDrug,P23975,Sodium-dependent noradrenaline transporter,SLC6A2,617.0
5167,DB01142,Doxepin,SmallMoleculeDrug,P31645,Sodium-dependent serotonin transporter,SLC6A4,630.0
5168,DB01142,Doxepin,SmallMoleculeDrug,P28223,5-hydroxytryptamine receptor 2A,HTR2A,471.0
5169,DB01142,Doxepin,SmallMoleculeDrug,P41595,5-hydroxytryptamine receptor 2B,HTR2B,481.0
5170,DB01142,Doxepin,SmallMoleculeDrug,P28335,5-hydroxytryptamine receptor 2C,HTR2C,458.0
5171,DB01142,Doxepin,SmallMoleculeDrug,P11229,Muscarinic acetylcholine receptor M1,CHRM1,460.0
5172,DB01142,Doxepin,SmallMoleculeDrug,P08172,Muscarinic acetylcholine receptor M2,CHRM2,466.0
5173,DB01142,Doxepin,SmallMoleculeDrug,P20309,Muscarinic acetylcholine receptor M3,CHRM3,590.0
5174,DB01142,Doxepin,SmallMoleculeDrug,P08173,Muscarinic acetylcholine receptor M4,CHRM4,479.0
5175,DB01142,Doxepin,SmallMoleculeDrug,P08912,Muscarinic acetylcholine receptor M5,CHRM5,532.0
5176,DB01142,Doxepin,SmallMoleculeDrug,P35348,Alpha-1A adrenergic receptor,ADRA1A,466.0
5177,DB01142,Doxepin,SmallMoleculeDrug,P35368,Alpha-1B adrenergic receptor,ADRA1B,520.0
5178,DB01142,Doxepin,SmallMoleculeDrug,P25100,Alpha-1D adrenergic receptor,ADRA1D,572.0
5179,DB01142,Doxepin,SmallMoleculeDrug,P08908,5-hydroxytryptamine receptor 1A,HTR1A,422.0
5180,DB01142,Doxepin,SmallMoleculeDrug,P08913,Alpha-2A adrenergic receptor,ADRA2A,450.0
5181,DB01142,Doxepin,SmallMoleculeDrug,P18089,Alpha-2B adrenergic receptor,ADRA2B,450.0
5182,DB01142,Doxepin,SmallMoleculeDrug,P18825,Alpha-2C adrenergic receptor,ADRA2C,462.0
5183,DB01142,Doxepin,SmallMoleculeDrug,P14416,D(2) dopamine receptor,DRD2,443.0
5184,DB01142,Doxepin,SmallMoleculeDrug,P50406,5-hydroxytryptamine receptor 6,HTR6,440.0
5185,DB01142,Doxepin,SmallMoleculeDrug,Q9H3N8,Histamine H4 receptor,HRH4,390.0
5186,DB01142,Doxepin,SmallMoleculeDrug,Q12809,Potassium voltage-gated channel subfamily H member 2,KCNH2,1159.0
5187,DB01143,Amifostine,SmallMoleculeDrug,P10696,"Alkaline phosphatase, placental-like",ALPPL2,532.0
5188,DB01143,Amifostine,SmallMoleculeDrug,P22413,Ectonucleotide pyrophosphatase/phosphodiesterase family member 1,ENPP1,925.0
5189,DB01144,Diclofenamide,SmallMoleculeDrug,P00915,Carbonic anhydrase 1,CA1,261.0
5190,DB01144,Diclofenamide,SmallMoleculeDrug,P00918,Carbonic anhydrase 2,CA2,260.0
5191,DB01144,Diclofenamide,SmallMoleculeDrug,P22748,Carbonic anhydrase 4,CA4,312.0
5192,DB01144,Diclofenamide,SmallMoleculeDrug,P43166,Carbonic anhydrase 7,CA7,264.0
5194,DB01146,Diphenylpyraline,SmallMoleculeDrug,P35367,Histamine H1 receptor,HRH1,487.0
5195,DB01146,Diphenylpyraline,SmallMoleculeDrug,Q01959,Sodium-dependent dopamine transporter,SLC6A3,620.0
5202,DB01148,Flavoxate,SmallMoleculeDrug,P08172,Muscarinic acetylcholine receptor M2,CHRM2,466.0
5203,DB01148,Flavoxate,SmallMoleculeDrug,P11229,Muscarinic acetylcholine receptor M1,CHRM1,460.0
5204,DB01149,Nefazodone,SmallMoleculeDrug,P28223,5-hydroxytryptamine receptor 2A,HTR2A,471.0
5205,DB01149,Nefazodone,SmallMoleculeDrug,P28335,5-hydroxytryptamine receptor 2C,HTR2C,458.0
5206,DB01149,Nefazodone,SmallMoleculeDrug,P31645,Sodium-dependent serotonin transporter,SLC6A4,630.0
5207,DB01149,Nefazodone,SmallMoleculeDrug,P08908,5-hydroxytryptamine receptor 1A,HTR1A,422.0
5208,DB01149,Nefazodone,SmallMoleculeDrug,P23975,Sodium-dependent noradrenaline transporter,SLC6A2,617.0
5209,DB01149,Nefazodone,SmallMoleculeDrug,Q01959,Sodium-dependent dopamine transporter,SLC6A3,620.0
5210,DB01149,Nefazodone,SmallMoleculeDrug,P35368,Alpha-1B adrenergic receptor,ADRA1B,520.0
5211,DB01149,Nefazodone,SmallMoleculeDrug,P08913,Alpha-2A adrenergic receptor,ADRA2A,450.0
5212,DB01149,Nefazodone,SmallMoleculeDrug,P35348,Alpha-1A adrenergic receptor,ADRA1A,466.0
5216,DB01151,Desipramine,SmallMoleculeDrug,P23975,Sodium-dependent noradrenaline transporter,SLC6A2,617.0
5217,DB01151,Desipramine,SmallMoleculeDrug,P31645,Sodium-dependent serotonin transporter,SLC6A4,630.0
5218,DB01151,Desipramine,SmallMoleculeDrug,P28223,5-hydroxytryptamine receptor 2A,HTR2A,471.0
5219,DB01151,Desipramine,SmallMoleculeDrug,P07550,Beta-2 adrenergic receptor,ADRB2,413.0
5220,DB01151,Desipramine,SmallMoleculeDrug,P08588,Beta-1 adrenergic receptor,ADRB1,477.0
5221,DB01151,Desipramine,SmallMoleculeDrug,P17405,Sphingomyelin phosphodiesterase,SMPD1,629.0
5222,DB01151,Desipramine,SmallMoleculeDrug,P35367,Histamine H1 receptor,HRH1,487.0
5223,DB01151,Desipramine,SmallMoleculeDrug,P35348,Alpha-1A adrenergic receptor,ADRA1A,466.0
5224,DB01151,Desipramine,SmallMoleculeDrug,P35368,Alpha-1B adrenergic receptor,ADRA1B,520.0
5225,DB01151,Desipramine,SmallMoleculeDrug,P25100,Alpha-1D adrenergic receptor,ADRA1D,572.0
5226,DB01151,Desipramine,SmallMoleculeDrug,P11229,Muscarinic acetylcholine receptor M1,CHRM1,460.0
5227,DB01151,Desipramine,SmallMoleculeDrug,P08172,Muscarinic acetylcholine receptor M2,CHRM2,466.0
5228,DB01151,Desipramine,SmallMoleculeDrug,P20309,Muscarinic acetylcholine receptor M3,CHRM3,590.0
5229,DB01151,Desipramine,SmallMoleculeDrug,P08173,Muscarinic acetylcholine receptor M4,CHRM4,479.0
5230,DB01151,Desipramine,SmallMoleculeDrug,P08912,Muscarinic acetylcholine receptor M5,CHRM5,532.0
5231,DB01151,Desipramine,SmallMoleculeDrug,P08908,5-hydroxytryptamine receptor 1A,HTR1A,422.0
5232,DB01151,Desipramine,SmallMoleculeDrug,P28335,5-hydroxytryptamine receptor 2C,HTR2C,458.0
5233,DB01151,Desipramine,SmallMoleculeDrug,P14416,D(2) dopamine receptor,DRD2,443.0
5234,DB01151,Desipramine,SmallMoleculeDrug,P08913,Alpha-2A adrenergic receptor,ADRA2A,450.0
5235,DB01151,Desipramine,SmallMoleculeDrug,P18089,Alpha-2B adrenergic receptor,ADRA2B,450.0
5236,DB01151,Desipramine,SmallMoleculeDrug,P18825,Alpha-2C adrenergic receptor,ADRA2C,462.0
5238,DB01154,Thiamylal,SmallMoleculeDrug,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,456.0
5239,DB01154,Thiamylal,SmallMoleculeDrug,Q15842,ATP-sensitive inward rectifier potassium channel 8,KCNJ8,424.0
5240,DB01154,Thiamylal,SmallMoleculeDrug,Q14654,ATP-sensitive inward rectifier potassium channel 11,KCNJ11,390.0
5243,DB01156,Bupropion,SmallMoleculeDrug,Q01959,Sodium-dependent dopamine transporter,SLC6A3,620.0
5244,DB01156,Bupropion,SmallMoleculeDrug,P23975,Sodium-dependent noradrenaline transporter,SLC6A2,617.0
5245,DB01156,Bupropion,SmallMoleculeDrug,P32297,Neuronal acetylcholine receptor subunit alpha-3,CHRNA3,505.0
5246,DB01157,Trimetrexate,SmallMoleculeDrug,P00374,Dihydrofolate reductase,DHFR,187.0
5247,DB01158,Bretylium,SmallMoleculeDrug,P05023,Sodium/potassium-transporting ATPase subunit alpha-1,ATP1A1,1023.0
5248,DB01159,Halothane,SmallMoleculeDrug,O14649,Potassium channel subfamily K member 3,KCNK3,394.0
5249,DB01159,Halothane,SmallMoleculeDrug,Q9NPC2,Potassium channel subfamily K member 9,KCNK9,374.0
5250,DB01159,Halothane,SmallMoleculeDrug,Q12791,Calcium-activated potassium channel subunit alpha-1,KCNMA1,1236.0
5251,DB01159,Halothane,SmallMoleculeDrug,Q8TCU5,"Glutamate receptor ionotropic, NMDA 3A",GRIN3A,1115.0
5252,DB01159,Halothane,SmallMoleculeDrug,O60391,"Glutamate receptor ionotropic, NMDA 3B",GRIN3B,1043.0
5253,DB01159,Halothane,SmallMoleculeDrug,Q12879,"Glutamate receptor ionotropic, NMDA 2A",GRIN2A,1464.0
5254,DB01159,Halothane,SmallMoleculeDrug,P23415,Glycine receptor subunit alpha-1,GLRA1,457.0
5255,DB01159,Halothane,SmallMoleculeDrug,P08100,Rhodopsin,RHO,348.0
5256,DB01159,Halothane,SmallMoleculeDrug,P48051,G protein-activated inward rectifier potassium channel 2,KCNJ6,423.0
5257,DB01159,Halothane,SmallMoleculeDrug,P48549,G protein-activated inward rectifier potassium channel 1,KCNJ3,501.0
5258,DB01159,Halothane,SmallMoleculeDrug,P03886,NADH-ubiquinone oxidoreductase chain 1,MT-ND1,318.0
5259,DB01159,Halothane,SmallMoleculeDrug,O15554,Intermediate conductance calcium-activated potassium channel protein 4,KCNN4,427.0
5260,DB01159,Halothane,SmallMoleculeDrug,P30049,"ATP synthase subunit delta, mitochondrial",ATP5D,168.0
5261,DB01159,Halothane,SmallMoleculeDrug,P98194,Calcium-transporting ATPase type 2C member 1,ATP2C1,919.0
5262,DB01159,Halothane,SmallMoleculeDrug,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,456.0
5263,DB01159,Halothane,SmallMoleculeDrug,P59768,Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-2,GNG2,71.0
5264,DB01159,Halothane,SmallMoleculeDrug,Q6W5P4,Neuropeptide S receptor,NPSR1,371.0
5265,DB01159,Halothane,SmallMoleculeDrug,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,456.0
5266,DB01159,Halothane,SmallMoleculeDrug,P47869,Gamma-aminobutyric acid receptor subunit alpha-2,GABRA2,451.0
5267,DB01159,Halothane,SmallMoleculeDrug,P34903,Gamma-aminobutyric acid receptor subunit alpha-3,GABRA3,492.0
5268,DB01159,Halothane,SmallMoleculeDrug,P48169,Gamma-aminobutyric acid receptor subunit alpha-4,GABRA4,554.0
5269,DB01159,Halothane,SmallMoleculeDrug,P31644,Gamma-aminobutyric acid receptor subunit alpha-5,GABRA5,462.0
5270,DB01159,Halothane,SmallMoleculeDrug,Q16445,Gamma-aminobutyric acid receptor subunit alpha-6,GABRA6,453.0
5271,DB01159,Halothane,SmallMoleculeDrug,P18505,Gamma-aminobutyric acid receptor subunit beta-1,GABRB1,474.0
5272,DB01159,Halothane,SmallMoleculeDrug,P47870,Gamma-aminobutyric acid receptor subunit beta-2,GABRB2,512.0
5273,DB01159,Halothane,SmallMoleculeDrug,P28472,Gamma-aminobutyric acid receptor subunit beta-3,GABRB3,473.0
5274,DB01159,Halothane,SmallMoleculeDrug,O14764,Gamma-aminobutyric acid receptor subunit delta,GABRD,452.0
5275,DB01159,Halothane,SmallMoleculeDrug,P78334,Gamma-aminobutyric acid receptor subunit epsilon,GABRE,506.0
5276,DB01159,Halothane,SmallMoleculeDrug,Q8N1C3,Gamma-aminobutyric acid receptor subunit gamma-1,GABRG1,465.0
5277,DB01159,Halothane,SmallMoleculeDrug,P18507,Gamma-aminobutyric acid receptor subunit gamma-2,GABRG2,467.0
5278,DB01159,Halothane,SmallMoleculeDrug,Q99928,Gamma-aminobutyric acid receptor subunit gamma-3,GABRG3,467.0
5279,DB01159,Halothane,SmallMoleculeDrug,O00591,Gamma-aminobutyric acid receptor subunit pi,GABRP,440.0
5280,DB01159,Halothane,SmallMoleculeDrug,Q9UN88,Gamma-aminobutyric acid receptor subunit theta,GABRQ,632.0
5281,DB01160,Dinoprost Tromethamine,SmallMoleculeDrug,P43088,Prostaglandin F2-alpha receptor,PTGFR,359.0
5282,DB01160,Dinoprost Tromethamine,SmallMoleculeDrug,P43119,Prostacyclin receptor,PTGIR,386.0
5283,DB01161,Chloroprocaine,SmallMoleculeDrug,Q9Y5Y9,Sodium channel protein type 10 subunit alpha,SCN10A,1956.0
5284,DB01161,Chloroprocaine,SmallMoleculeDrug,Q8TCU5,"Glutamate receptor ionotropic, NMDA 3A",GRIN3A,1115.0
5285,DB01161,Chloroprocaine,SmallMoleculeDrug,Q9GZZ6,Neuronal acetylcholine receptor subunit alpha-10,CHRNA10,450.0
5286,DB01161,Chloroprocaine,SmallMoleculeDrug,P46098,5-hydroxytryptamine receptor 3A,HTR3A,478.0
5287,DB01161,Chloroprocaine,SmallMoleculeDrug,Q01959,Sodium-dependent dopamine transporter,SLC6A3,620.0
5288,DB01162,Terazosin,SmallMoleculeDrug,P35348,Alpha-1A adrenergic receptor,ADRA1A,466.0
5289,DB01162,Terazosin,SmallMoleculeDrug,P35368,Alpha-1B adrenergic receptor,ADRA1B,520.0
5290,DB01162,Terazosin,SmallMoleculeDrug,P25100,Alpha-1D adrenergic receptor,ADRA1D,572.0
5291,DB01162,Terazosin,SmallMoleculeDrug,Q12809,Potassium voltage-gated channel subfamily H member 2,KCNH2,1159.0
5292,DB01162,Terazosin,SmallMoleculeDrug,Q9H252,Potassium voltage-gated channel subfamily H member 6,KCNH6,994.0
5293,DB01162,Terazosin,SmallMoleculeDrug,Q9NS40,Potassium voltage-gated channel subfamily H member 7,KCNH7,1196.0
5302,DB01165,Ofloxacin,SmallMoleculeDrug,P11388,DNA topoisomerase 2-alpha,TOP2A,1531.0
5303,DB01166,Cilostazol,SmallMoleculeDrug,Q14432,"cGMP-inhibited 3',5'-cyclic phosphodiesterase A",PDE3A,1141.0
5304,DB01167,Itraconazole,SmallMoleculeDrug,Q16850,Lanosterol 14-alpha demethylase,CYP51A1,503.0
5306,DB01168,Procarbazine,SmallMoleculeDrug,P21397,Amine oxidase [flavin-containing] A,MAOA,527.0
5307,DB01168,Procarbazine,SmallMoleculeDrug,P27338,Amine oxidase [flavin-containing] B,MAOB,520.0
5308,DB01169,Arsenic trioxide,SmallMoleculeDrug,O14920,Inhibitor of nuclear factor kappa-B kinase subunit beta,IKBKB,756.0
5309,DB01169,Arsenic trioxide,SmallMoleculeDrug,Q16881,"Thioredoxin reductase 1, cytoplasmic",TXNRD1,649.0
5310,DB01169,Arsenic trioxide,SmallMoleculeDrug,P05412,Transcription factor AP-1,JUN,331.0
5311,DB01169,Arsenic trioxide,SmallMoleculeDrug,P24385,G1/S-specific cyclin-D1,CCND1,295.0
5312,DB01169,Arsenic trioxide,SmallMoleculeDrug,P27361,Mitogen-activated protein kinase 3,MAPK3,379.0
5313,DB01169,Arsenic trioxide,SmallMoleculeDrug,P28482,Mitogen-activated protein kinase 1,MAPK1,360.0
5314,DB01169,Arsenic trioxide,SmallMoleculeDrug,P31749,RAC-alpha serine/threonine-protein kinase,AKT1,480.0
5315,DB01170,Guanethidine,SmallMoleculeDrug,P23975,Sodium-dependent noradrenaline transporter,SLC6A2,617.0
5316,DB01171,Moclobemide,SmallMoleculeDrug,P21397,Amine oxidase [flavin-containing] A,MAOA,527.0
5318,DB01173,Orphenadrine,SmallMoleculeDrug,O15399,"Glutamate receptor ionotropic, NMDA 2D",GRIN2D,1336.0
5319,DB01173,Orphenadrine,SmallMoleculeDrug,Q05586,"Glutamate receptor ionotropic, NMDA 1",GRIN1,938.0
5320,DB01173,Orphenadrine,SmallMoleculeDrug,O60391,"Glutamate receptor ionotropic, NMDA 3B",GRIN3B,1043.0
5321,DB01173,Orphenadrine,SmallMoleculeDrug,Q8TCU5,"Glutamate receptor ionotropic, NMDA 3A",GRIN3A,1115.0
5322,DB01173,Orphenadrine,SmallMoleculeDrug,P35367,Histamine H1 receptor,HRH1,487.0
5323,DB01173,Orphenadrine,SmallMoleculeDrug,P23975,Sodium-dependent noradrenaline transporter,SLC6A2,617.0
5324,DB01173,Orphenadrine,SmallMoleculeDrug,Q9Y5Y9,Sodium channel protein type 10 subunit alpha,SCN10A,1956.0
5325,DB01174,Phenobarbital,SmallMoleculeDrug,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,456.0
5326,DB01174,Phenobarbital,SmallMoleculeDrug,P43681,Neuronal acetylcholine receptor subunit alpha-4,CHRNA4,627.0
5327,DB01174,Phenobarbital,SmallMoleculeDrug,P36544,Neuronal acetylcholine receptor subunit alpha-7,CHRNA7,502.0
5328,DB01174,Phenobarbital,SmallMoleculeDrug,P42262,Glutamate receptor 2,GRIA2,883.0
5329,DB01174,Phenobarbital,SmallMoleculeDrug,Q13002,"Glutamate receptor ionotropic, kainate 2",GRIK2,908.0
5330,DB01174,Phenobarbital,SmallMoleculeDrug,Q05586,"Glutamate receptor ionotropic, NMDA 1",GRIN1,938.0
5331,DB01174,Phenobarbital,SmallMoleculeDrug,Q12879,"Glutamate receptor ionotropic, NMDA 2A",GRIN2A,1464.0
5332,DB01174,Phenobarbital,SmallMoleculeDrug,Q13224,"Glutamate receptor ionotropic, NMDA 2B",GRIN2B,1484.0
5333,DB01174,Phenobarbital,SmallMoleculeDrug,Q14957,"Glutamate receptor ionotropic, NMDA 2C",GRIN2C,1233.0
5334,DB01174,Phenobarbital,SmallMoleculeDrug,O15399,"Glutamate receptor ionotropic, NMDA 2D",GRIN2D,1336.0
5335,DB01174,Phenobarbital,SmallMoleculeDrug,Q8TCU5,"Glutamate receptor ionotropic, NMDA 3A",GRIN3A,1115.0
5336,DB01174,Phenobarbital,SmallMoleculeDrug,O60391,"Glutamate receptor ionotropic, NMDA 3B",GRIN3B,1043.0
5337,DB01175,Escitalopram,SmallMoleculeDrug,P31645,Sodium-dependent serotonin transporter,SLC6A4,630.0
5338,DB01175,Escitalopram,SmallMoleculeDrug,Q01959,Sodium-dependent dopamine transporter,SLC6A3,620.0
5339,DB01175,Escitalopram,SmallMoleculeDrug,P23975,Sodium-dependent noradrenaline transporter,SLC6A2,617.0
5340,DB01175,Escitalopram,SmallMoleculeDrug,P35348,Alpha-1A adrenergic receptor,ADRA1A,466.0
5341,DB01175,Escitalopram,SmallMoleculeDrug,P11229,Muscarinic acetylcholine receptor M1,CHRM1,460.0
5342,DB01175,Escitalopram,SmallMoleculeDrug,P35367,Histamine H1 receptor,HRH1,487.0
5343,DB01176,Cyclizine,SmallMoleculeDrug,P35367,Histamine H1 receptor,HRH1,487.0
5344,DB01176,Cyclizine,SmallMoleculeDrug,P49888,Estrogen sulfotransferase,SULT1E1,294.0
5345,DB01177,Idarubicin,SmallMoleculeDrug,P11388,DNA topoisomerase 2-alpha,TOP2A,1531.0
5346,DB01178,Chlormezanone,SmallMoleculeDrug,P30536,Translocator protein,TSPO,169.0
5347,DB01179,Podofilox,SmallMoleculeDrug,P11388,DNA topoisomerase 2-alpha,TOP2A,1531.0
5348,DB01179,Podofilox,SmallMoleculeDrug,P68366,Tubulin alpha-4A chain,TUBA4A,448.0
5349,DB01179,Podofilox,SmallMoleculeDrug,P07437,Tubulin beta chain,TUBB,444.0
5350,DB01180,Rescinnamine,SmallMoleculeDrug,P12821,Angiotensin-converting enzyme,ACE,1306.0
5351,DB01182,Propafenone,SmallMoleculeDrug,Q14524,Sodium channel protein type 5 subunit alpha,SCN5A,2016.0
5352,DB01182,Propafenone,SmallMoleculeDrug,Q12809,Potassium voltage-gated channel subfamily H member 2,KCNH2,1159.0
5353,DB01183,Naloxone,SmallMoleculeDrug,P35372,Mu-type opioid receptor,OPRM1,400.0
5354,DB01183,Naloxone,SmallMoleculeDrug,P41143,Delta-type opioid receptor,OPRD1,372.0
5355,DB01183,Naloxone,SmallMoleculeDrug,P41145,Kappa-type opioid receptor,OPRK1,380.0
5356,DB01183,Naloxone,SmallMoleculeDrug,P16220,Cyclic AMP-responsive element-binding protein 1,CREB1,341.0
5357,DB01183,Naloxone,SmallMoleculeDrug,P03372,Estrogen receptor,ESR1,595.0
5358,DB01183,Naloxone,SmallMoleculeDrug,O00206,Toll-like receptor 4,TLR4,839.0
5359,DB01184,Domperidone,SmallMoleculeDrug,P14416,D(2) dopamine receptor,DRD2,443.0
5360,DB01184,Domperidone,SmallMoleculeDrug,P35462,D(3) dopamine receptor,DRD3,400.0
5361,DB01185,Fluoxymesterone,SmallMoleculeDrug,P10275,Androgen receptor,AR,920.0
5362,DB01185,Fluoxymesterone,SmallMoleculeDrug,P03372,Estrogen receptor,ESR1,595.0
5363,DB01185,Fluoxymesterone,SmallMoleculeDrug,P16471,Prolactin receptor,PRLR,622.0
5364,DB01185,Fluoxymesterone,SmallMoleculeDrug,P04150,Glucocorticoid receptor,NR3C1,777.0
5365,DB01186,Pergolide,SmallMoleculeDrug,P14416,D(2) dopamine receptor,DRD2,443.0
5366,DB01186,Pergolide,SmallMoleculeDrug,P35462,D(3) dopamine receptor,DRD3,400.0
5367,DB01186,Pergolide,SmallMoleculeDrug,P21917,D(4) dopamine receptor,DRD4,467.0
5368,DB01186,Pergolide,SmallMoleculeDrug,P08908,5-hydroxytryptamine receptor 1A,HTR1A,422.0
5369,DB01186,Pergolide,SmallMoleculeDrug,P41595,5-hydroxytryptamine receptor 2B,HTR2B,481.0
5370,DB01186,Pergolide,SmallMoleculeDrug,P28223,5-hydroxytryptamine receptor 2A,HTR2A,471.0
5371,DB01186,Pergolide,SmallMoleculeDrug,P28221,5-hydroxytryptamine receptor 1D,HTR1D,377.0
5372,DB01186,Pergolide,SmallMoleculeDrug,P18089,Alpha-2B adrenergic receptor,ADRA2B,450.0
5373,DB01186,Pergolide,SmallMoleculeDrug,P08913,Alpha-2A adrenergic receptor,ADRA2A,450.0
5374,DB01186,Pergolide,SmallMoleculeDrug,P18825,Alpha-2C adrenergic receptor,ADRA2C,462.0
5375,DB01186,Pergolide,SmallMoleculeDrug,P21918,D(1B) dopamine receptor,DRD5,477.0
5376,DB01186,Pergolide,SmallMoleculeDrug,P21728,D(1A) dopamine receptor,DRD1,446.0
5377,DB01186,Pergolide,SmallMoleculeDrug,P28222,5-hydroxytryptamine receptor 1B,HTR1B,390.0
5378,DB01186,Pergolide,SmallMoleculeDrug,P28335,5-hydroxytryptamine receptor 2C,HTR2C,458.0
5379,DB01186,Pergolide,SmallMoleculeDrug,P35348,Alpha-1A adrenergic receptor,ADRA1A,466.0
5380,DB01186,Pergolide,SmallMoleculeDrug,P35368,Alpha-1B adrenergic receptor,ADRA1B,520.0
5381,DB01186,Pergolide,SmallMoleculeDrug,P25100,Alpha-1D adrenergic receptor,ADRA1D,572.0
5382,DB01188,Ciclopirox,SmallMoleculeDrug,P05023,Sodium/potassium-transporting ATPase subunit alpha-1,ATP1A1,1023.0
5383,DB01189,Desflurane,SmallMoleculeDrug,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,456.0
5384,DB01189,Desflurane,SmallMoleculeDrug,P47869,Gamma-aminobutyric acid receptor subunit alpha-2,GABRA2,451.0
5385,DB01189,Desflurane,SmallMoleculeDrug,P34903,Gamma-aminobutyric acid receptor subunit alpha-3,GABRA3,492.0
5386,DB01189,Desflurane,SmallMoleculeDrug,P48169,Gamma-aminobutyric acid receptor subunit alpha-4,GABRA4,554.0
5387,DB01189,Desflurane,SmallMoleculeDrug,P31644,Gamma-aminobutyric acid receptor subunit alpha-5,GABRA5,462.0
5388,DB01189,Desflurane,SmallMoleculeDrug,Q16445,Gamma-aminobutyric acid receptor subunit alpha-6,GABRA6,453.0
5389,DB01189,Desflurane,SmallMoleculeDrug,P18505,Gamma-aminobutyric acid receptor subunit beta-1,GABRB1,474.0
5390,DB01189,Desflurane,SmallMoleculeDrug,P47870,Gamma-aminobutyric acid receptor subunit beta-2,GABRB2,512.0
5391,DB01189,Desflurane,SmallMoleculeDrug,P28472,Gamma-aminobutyric acid receptor subunit beta-3,GABRB3,473.0
5392,DB01189,Desflurane,SmallMoleculeDrug,O14764,Gamma-aminobutyric acid receptor subunit delta,GABRD,452.0
5393,DB01189,Desflurane,SmallMoleculeDrug,P78334,Gamma-aminobutyric acid receptor subunit epsilon,GABRE,506.0
5394,DB01189,Desflurane,SmallMoleculeDrug,Q8N1C3,Gamma-aminobutyric acid receptor subunit gamma-1,GABRG1,465.0
5395,DB01189,Desflurane,SmallMoleculeDrug,P18507,Gamma-aminobutyric acid receptor subunit gamma-2,GABRG2,467.0
5396,DB01189,Desflurane,SmallMoleculeDrug,Q99928,Gamma-aminobutyric acid receptor subunit gamma-3,GABRG3,467.0
5397,DB01189,Desflurane,SmallMoleculeDrug,O00591,Gamma-aminobutyric acid receptor subunit pi,GABRP,440.0
5398,DB01189,Desflurane,SmallMoleculeDrug,Q9UN88,Gamma-aminobutyric acid receptor subunit theta,GABRQ,632.0
5399,DB01189,Desflurane,SmallMoleculeDrug,P23415,Glycine receptor subunit alpha-1,GLRA1,457.0
5400,DB01189,Desflurane,SmallMoleculeDrug,P42261,Glutamate receptor 1,GRIA1,906.0
5401,DB01189,Desflurane,SmallMoleculeDrug,Q09470,Potassium voltage-gated channel subfamily A member 1,KCNA1,495.0
5402,DB01189,Desflurane,SmallMoleculeDrug,P98194,Calcium-transporting ATPase type 2C member 1,ATP2C1,919.0
5403,DB01189,Desflurane,SmallMoleculeDrug,P30049,"ATP synthase subunit delta, mitochondrial",ATP5D,168.0
5404,DB01189,Desflurane,SmallMoleculeDrug,P03886,NADH-ubiquinone oxidoreductase chain 1,MT-ND1,318.0
5406,DB01191,Dexfenfluramine,SmallMoleculeDrug,P31645,Sodium-dependent serotonin transporter,SLC6A4,630.0
5407,DB01191,Dexfenfluramine,SmallMoleculeDrug,P28335,5-hydroxytryptamine receptor 2C,HTR2C,458.0
5408,DB01192,Oxymorphone,SmallMoleculeDrug,P35372,Mu-type opioid receptor,OPRM1,400.0
5409,DB01192,Oxymorphone,SmallMoleculeDrug,P41143,Delta-type opioid receptor,OPRD1,372.0
5410,DB01193,Acebutolol,SmallMoleculeDrug,P08588,Beta-1 adrenergic receptor,ADRB1,477.0
5411,DB01193,Acebutolol,SmallMoleculeDrug,P07550,Beta-2 adrenergic receptor,ADRB2,413.0
5412,DB01194,Brinzolamide,SmallMoleculeDrug,P00918,Carbonic anhydrase 2,CA2,260.0
5413,DB01194,Brinzolamide,SmallMoleculeDrug,P00915,Carbonic anhydrase 1,CA1,261.0
5414,DB01194,Brinzolamide,SmallMoleculeDrug,P22748,Carbonic anhydrase 4,CA4,312.0
5415,DB01194,Brinzolamide,SmallMoleculeDrug,P35218,"Carbonic anhydrase 5A, mitochondrial",CA5A,305.0
5416,DB01195,Flecainide,SmallMoleculeDrug,Q14524,Sodium channel protein type 5 subunit alpha,SCN5A,2016.0
5417,DB01195,Flecainide,SmallMoleculeDrug,P35499,Sodium channel protein type 4 subunit alpha,SCN4A,1836.0
5418,DB01196,Estramustine,SmallMoleculeDrug,P11137,Microtubule-associated protein 2,MAP2,1827.0
5419,DB01196,Estramustine,SmallMoleculeDrug,P78559,Microtubule-associated protein 1A,MAP1A,2803.0
5420,DB01196,Estramustine,SmallMoleculeDrug,P03372,Estrogen receptor,ESR1,595.0
5421,DB01196,Estramustine,SmallMoleculeDrug,Q92731,Estrogen receptor beta,ESR2,530.0
5422,DB01197,Captopril,SmallMoleculeDrug,P12821,Angiotensin-converting enzyme,ACE,1306.0
5423,DB01197,Captopril,SmallMoleculeDrug,P08253,72 kDa type IV collagenase,MMP2,660.0
5424,DB01197,Captopril,SmallMoleculeDrug,P14780,Matrix metalloproteinase-9,MMP9,707.0
5425,DB01197,Captopril,SmallMoleculeDrug,P09960,Leukotriene A-4 hydrolase,LTA4H,611.0
5426,DB01198,Zopiclone,SmallMoleculeDrug,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,456.0
5427,DB01198,Zopiclone,SmallMoleculeDrug,P47869,Gamma-aminobutyric acid receptor subunit alpha-2,GABRA2,451.0
5428,DB01198,Zopiclone,SmallMoleculeDrug,P34903,Gamma-aminobutyric acid receptor subunit alpha-3,GABRA3,492.0
5429,DB01198,Zopiclone,SmallMoleculeDrug,P31644,Gamma-aminobutyric acid receptor subunit alpha-5,GABRA5,462.0
5430,DB01198,Zopiclone,SmallMoleculeDrug,P30536,Translocator protein,TSPO,169.0
5431,DB01199,Tubocurarine,SmallMoleculeDrug,Q15822,Neuronal acetylcholine receptor subunit alpha-2,CHRNA2,529.0
5432,DB01199,Tubocurarine,SmallMoleculeDrug,P46098,5-hydroxytryptamine receptor 3A,HTR3A,478.0
5433,DB01199,Tubocurarine,SmallMoleculeDrug,P22303,Acetylcholinesterase,ACHE,614.0
5434,DB01200,Bromocriptine,SmallMoleculeDrug,P14416,D(2) dopamine receptor,DRD2,443.0
5435,DB01200,Bromocriptine,SmallMoleculeDrug,P35462,D(3) dopamine receptor,DRD3,400.0
5436,DB01200,Bromocriptine,SmallMoleculeDrug,P28221,5-hydroxytryptamine receptor 1D,HTR1D,377.0
5437,DB01200,Bromocriptine,SmallMoleculeDrug,P08913,Alpha-2A adrenergic receptor,ADRA2A,450.0
5438,DB01200,Bromocriptine,SmallMoleculeDrug,P08908,5-hydroxytryptamine receptor 1A,HTR1A,422.0
5439,DB01200,Bromocriptine,SmallMoleculeDrug,P18825,Alpha-2C adrenergic receptor,ADRA2C,462.0
5440,DB01200,Bromocriptine,SmallMoleculeDrug,P18089,Alpha-2B adrenergic receptor,ADRA2B,450.0
5441,DB01200,Bromocriptine,SmallMoleculeDrug,P41595,5-hydroxytryptamine receptor 2B,HTR2B,481.0
5442,DB01200,Bromocriptine,SmallMoleculeDrug,P21917,D(4) dopamine receptor,DRD4,467.0
5443,DB01200,Bromocriptine,SmallMoleculeDrug,P28223,5-hydroxytryptamine receptor 2A,HTR2A,471.0
5444,DB01200,Bromocriptine,SmallMoleculeDrug,P28222,5-hydroxytryptamine receptor 1B,HTR1B,390.0
5445,DB01200,Bromocriptine,SmallMoleculeDrug,P28335,5-hydroxytryptamine receptor 2C,HTR2C,458.0
5446,DB01200,Bromocriptine,SmallMoleculeDrug,P21918,D(1B) dopamine receptor,DRD5,477.0
5447,DB01200,Bromocriptine,SmallMoleculeDrug,P21728,D(1A) dopamine receptor,DRD1,446.0
5448,DB01200,Bromocriptine,SmallMoleculeDrug,P35348,Alpha-1A adrenergic receptor,ADRA1A,466.0
5449,DB01200,Bromocriptine,SmallMoleculeDrug,P35368,Alpha-1B adrenergic receptor,ADRA1B,520.0
5450,DB01200,Bromocriptine,SmallMoleculeDrug,P25100,Alpha-1D adrenergic receptor,ADRA1D,572.0
5451,DB01200,Bromocriptine,SmallMoleculeDrug,P34969,5-hydroxytryptamine receptor 7,HTR7,479.0
5453,DB01202,Levetiracetam,SmallMoleculeDrug,Q7L0J3,Synaptic vesicle glycoprotein 2A,SV2A,742.0
5454,DB01202,Levetiracetam,SmallMoleculeDrug,Q00975,Voltage-dependent N-type calcium channel subunit alpha-1B,CACNA1B,2339.0
5455,DB01203,Nadolol,SmallMoleculeDrug,P08588,Beta-1 adrenergic receptor,ADRB1,477.0
5456,DB01203,Nadolol,SmallMoleculeDrug,P07550,Beta-2 adrenergic receptor,ADRB2,413.0
5457,DB01204,Mitoxantrone,SmallMoleculeDrug,P11388,DNA topoisomerase 2-alpha,TOP2A,1531.0
5458,DB01205,Flumazenil,SmallMoleculeDrug,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,456.0
5459,DB01205,Flumazenil,SmallMoleculeDrug,P18507,Gamma-aminobutyric acid receptor subunit gamma-2,GABRG2,467.0
5460,DB01205,Flumazenil,SmallMoleculeDrug,P31644,Gamma-aminobutyric acid receptor subunit alpha-5,GABRA5,462.0
5461,DB01205,Flumazenil,SmallMoleculeDrug,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,456.0
5462,DB01205,Flumazenil,SmallMoleculeDrug,P47869,Gamma-aminobutyric acid receptor subunit alpha-2,GABRA2,451.0
5463,DB01205,Flumazenil,SmallMoleculeDrug,P34903,Gamma-aminobutyric acid receptor subunit alpha-3,GABRA3,492.0
5464,DB01205,Flumazenil,SmallMoleculeDrug,P48169,Gamma-aminobutyric acid receptor subunit alpha-4,GABRA4,554.0
5465,DB01205,Flumazenil,SmallMoleculeDrug,P31644,Gamma-aminobutyric acid receptor subunit alpha-5,GABRA5,462.0
5466,DB01205,Flumazenil,SmallMoleculeDrug,Q16445,Gamma-aminobutyric acid receptor subunit alpha-6,GABRA6,453.0
5467,DB01205,Flumazenil,SmallMoleculeDrug,P18505,Gamma-aminobutyric acid receptor subunit beta-1,GABRB1,474.0
5468,DB01205,Flumazenil,SmallMoleculeDrug,P47870,Gamma-aminobutyric acid receptor subunit beta-2,GABRB2,512.0
5469,DB01205,Flumazenil,SmallMoleculeDrug,P28472,Gamma-aminobutyric acid receptor subunit beta-3,GABRB3,473.0
5470,DB01205,Flumazenil,SmallMoleculeDrug,O14764,Gamma-aminobutyric acid receptor subunit delta,GABRD,452.0
5471,DB01205,Flumazenil,SmallMoleculeDrug,P78334,Gamma-aminobutyric acid receptor subunit epsilon,GABRE,506.0
5472,DB01205,Flumazenil,SmallMoleculeDrug,Q8N1C3,Gamma-aminobutyric acid receptor subunit gamma-1,GABRG1,465.0
5473,DB01205,Flumazenil,SmallMoleculeDrug,P18507,Gamma-aminobutyric acid receptor subunit gamma-2,GABRG2,467.0
5474,DB01205,Flumazenil,SmallMoleculeDrug,Q99928,Gamma-aminobutyric acid receptor subunit gamma-3,GABRG3,467.0
5475,DB01205,Flumazenil,SmallMoleculeDrug,O00591,Gamma-aminobutyric acid receptor subunit pi,GABRP,440.0
5476,DB01205,Flumazenil,SmallMoleculeDrug,Q9UN88,Gamma-aminobutyric acid receptor subunit theta,GABRQ,632.0
5477,DB01206,Lomustine,SmallMoleculeDrug,Q9H169,Stathmin-4,STMN4,189.0
5478,DB01207,Ridogrel,SmallMoleculeDrug,P21731,Thromboxane A2 receptor,TBXA2R,343.0
5479,DB01207,Ridogrel,SmallMoleculeDrug,P24557,Thromboxane-A synthase,TBXAS1,533.0
5482,DB01208,Sparfloxacin,SmallMoleculeDrug,P11388,DNA topoisomerase 2-alpha,TOP2A,1531.0
5483,DB01209,Dezocine,SmallMoleculeDrug,P35372,Mu-type opioid receptor,OPRM1,400.0
5484,DB01209,Dezocine,SmallMoleculeDrug,P41145,Kappa-type opioid receptor,OPRK1,380.0
5485,DB01210,Levobunolol,SmallMoleculeDrug,P07550,Beta-2 adrenergic receptor,ADRB2,413.0
5486,DB01210,Levobunolol,SmallMoleculeDrug,P08588,Beta-1 adrenergic receptor,ADRB1,477.0
5488,DB01211,Clarithromycin,SmallMoleculeDrug,Q12809,Potassium voltage-gated channel subfamily H member 2,KCNH2,1159.0
5489,DB01211,Clarithromycin,SmallMoleculeDrug,Q9Y6L6,Solute carrier organic anion transporter family member 1B1,SLCO1B1,691.0
5490,DB01211,Clarithromycin,SmallMoleculeDrug,Q9NPD5,Solute carrier organic anion transporter family member 1B3,SLCO1B3,702.0
5492,DB01212,Ceftriaxone,SmallMoleculeDrug,Q9NSA0,Solute carrier family 22 member 11,SLC22A11,550.0
5493,DB01212,Ceftriaxone,SmallMoleculeDrug,Q4U2R8,Solute carrier family 22 member 6,SLC22A6,563.0
5494,DB01212,Ceftriaxone,SmallMoleculeDrug,Q8TCC7,Solute carrier family 22 member 8,SLC22A8,542.0
5495,DB01212,Ceftriaxone,SmallMoleculeDrug,P46059,Solute carrier family 15 member 1,SLC15A1,708.0
5496,DB01213,Fomepizole,SmallMoleculeDrug,P07327,Alcohol dehydrogenase 1A,ADH1A,375.0
5497,DB01213,Fomepizole,SmallMoleculeDrug,P00325,Alcohol dehydrogenase 1B,ADH1B,375.0
5498,DB01213,Fomepizole,SmallMoleculeDrug,P00326,Alcohol dehydrogenase 1C,ADH1C,375.0
5499,DB01213,Fomepizole,SmallMoleculeDrug,P04040,Catalase,CAT,527.0
5500,DB01214,Metipranolol,SmallMoleculeDrug,P07550,Beta-2 adrenergic receptor,ADRB2,413.0
5501,DB01214,Metipranolol,SmallMoleculeDrug,P08588,Beta-1 adrenergic receptor,ADRB1,477.0
5502,DB01215,Estazolam,SmallMoleculeDrug,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,456.0
5503,DB01215,Estazolam,SmallMoleculeDrug,P47869,Gamma-aminobutyric acid receptor subunit alpha-2,GABRA2,451.0
5504,DB01215,Estazolam,SmallMoleculeDrug,P34903,Gamma-aminobutyric acid receptor subunit alpha-3,GABRA3,492.0
5505,DB01215,Estazolam,SmallMoleculeDrug,P31644,Gamma-aminobutyric acid receptor subunit alpha-5,GABRA5,462.0
5506,DB01215,Estazolam,SmallMoleculeDrug,Q8N1C3,Gamma-aminobutyric acid receptor subunit gamma-1,GABRG1,465.0
5507,DB01215,Estazolam,SmallMoleculeDrug,P18507,Gamma-aminobutyric acid receptor subunit gamma-2,GABRG2,467.0
5508,DB01215,Estazolam,SmallMoleculeDrug,Q99928,Gamma-aminobutyric acid receptor subunit gamma-3,GABRG3,467.0
5509,DB01215,Estazolam,SmallMoleculeDrug,P18505,Gamma-aminobutyric acid receptor subunit beta-1,GABRB1,474.0
5510,DB01215,Estazolam,SmallMoleculeDrug,P47870,Gamma-aminobutyric acid receptor subunit beta-2,GABRB2,512.0
5511,DB01215,Estazolam,SmallMoleculeDrug,P28472,Gamma-aminobutyric acid receptor subunit beta-3,GABRB3,473.0
5512,DB01215,Estazolam,SmallMoleculeDrug,O14764,Gamma-aminobutyric acid receptor subunit delta,GABRD,452.0
5513,DB01215,Estazolam,SmallMoleculeDrug,P78334,Gamma-aminobutyric acid receptor subunit epsilon,GABRE,506.0
5514,DB01215,Estazolam,SmallMoleculeDrug,O00591,Gamma-aminobutyric acid receptor subunit pi,GABRP,440.0
5515,DB01215,Estazolam,SmallMoleculeDrug,P24046,Gamma-aminobutyric acid receptor subunit rho-1,GABRR1,479.0
5516,DB01215,Estazolam,SmallMoleculeDrug,P28476,Gamma-aminobutyric acid receptor subunit rho-2,GABRR2,465.0
5517,DB01215,Estazolam,SmallMoleculeDrug,A8MPY1,Gamma-aminobutyric acid receptor subunit rho-3,GABRR3,467.0
5518,DB01215,Estazolam,SmallMoleculeDrug,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,456.0
5519,DB01215,Estazolam,SmallMoleculeDrug,P47869,Gamma-aminobutyric acid receptor subunit alpha-2,GABRA2,451.0
5520,DB01215,Estazolam,SmallMoleculeDrug,P34903,Gamma-aminobutyric acid receptor subunit alpha-3,GABRA3,492.0
5521,DB01215,Estazolam,SmallMoleculeDrug,P48169,Gamma-aminobutyric acid receptor subunit alpha-4,GABRA4,554.0
5522,DB01215,Estazolam,SmallMoleculeDrug,P31644,Gamma-aminobutyric acid receptor subunit alpha-5,GABRA5,462.0
5523,DB01215,Estazolam,SmallMoleculeDrug,Q16445,Gamma-aminobutyric acid receptor subunit alpha-6,GABRA6,453.0
5524,DB01215,Estazolam,SmallMoleculeDrug,P18505,Gamma-aminobutyric acid receptor subunit beta-1,GABRB1,474.0
5525,DB01215,Estazolam,SmallMoleculeDrug,P47870,Gamma-aminobutyric acid receptor subunit beta-2,GABRB2,512.0
5526,DB01215,Estazolam,SmallMoleculeDrug,P28472,Gamma-aminobutyric acid receptor subunit beta-3,GABRB3,473.0
5527,DB01215,Estazolam,SmallMoleculeDrug,O14764,Gamma-aminobutyric acid receptor subunit delta,GABRD,452.0
5528,DB01215,Estazolam,SmallMoleculeDrug,P78334,Gamma-aminobutyric acid receptor subunit epsilon,GABRE,506.0
5529,DB01215,Estazolam,SmallMoleculeDrug,Q8N1C3,Gamma-aminobutyric acid receptor subunit gamma-1,GABRG1,465.0
5530,DB01215,Estazolam,SmallMoleculeDrug,P18507,Gamma-aminobutyric acid receptor subunit gamma-2,GABRG2,467.0
5531,DB01215,Estazolam,SmallMoleculeDrug,Q99928,Gamma-aminobutyric acid receptor subunit gamma-3,GABRG3,467.0
5532,DB01215,Estazolam,SmallMoleculeDrug,O00591,Gamma-aminobutyric acid receptor subunit pi,GABRP,440.0
5533,DB01215,Estazolam,SmallMoleculeDrug,Q9UN88,Gamma-aminobutyric acid receptor subunit theta,GABRQ,632.0
5534,DB01216,Finasteride,SmallMoleculeDrug,P31213,3-oxo-5-alpha-steroid 4-dehydrogenase 2,SRD5A2,254.0
5535,DB01216,Finasteride,SmallMoleculeDrug,P18405,3-oxo-5-alpha-steroid 4-dehydrogenase 1,SRD5A1,259.0
5536,DB01216,Finasteride,SmallMoleculeDrug,P51857,3-oxo-5-beta-steroid 4-dehydrogenase,AKR1D1,326.0
5537,DB01217,Anastrozole,SmallMoleculeDrug,P11511,Aromatase,CYP19A1,503.0
5538,DB01218,Halofantrine,SmallMoleculeDrug,Q12809,Potassium voltage-gated channel subfamily H member 2,KCNH2,1159.0
5540,DB01219,Dantrolene,SmallMoleculeDrug,P21817,Ryanodine receptor 1,RYR1,5038.0
5542,DB01220,Rifaximin,SmallMoleculeDrug,O75469,Nuclear receptor subfamily 1 group I member 2,NR1I2,434.0
5543,DB01221,Ketamine,SmallMoleculeDrug,Q8TCU5,"Glutamate receptor ionotropic, NMDA 3A",GRIN3A,1115.0
5544,DB01221,Ketamine,SmallMoleculeDrug,P25103,Substance-P receptor,TACR1,407.0
5545,DB01221,Ketamine,SmallMoleculeDrug,P14416,D(2) dopamine receptor,DRD2,443.0
5546,DB01221,Ketamine,SmallMoleculeDrug,P41143,Delta-type opioid receptor,OPRD1,372.0
5547,DB01221,Ketamine,SmallMoleculeDrug,P23975,Sodium-dependent noradrenaline transporter,SLC6A2,617.0
5548,DB01221,Ketamine,SmallMoleculeDrug,P41145,Kappa-type opioid receptor,OPRK1,380.0
5549,DB01221,Ketamine,SmallMoleculeDrug,P35372,Mu-type opioid receptor,OPRM1,400.0
5550,DB01221,Ketamine,SmallMoleculeDrug,P11229,Muscarinic acetylcholine receptor M1,CHRM1,460.0
5551,DB01221,Ketamine,SmallMoleculeDrug,P08172,Muscarinic acetylcholine receptor M2,CHRM2,466.0
5552,DB01221,Ketamine,SmallMoleculeDrug,P20309,Muscarinic acetylcholine receptor M3,CHRM3,590.0
5553,DB01221,Ketamine,SmallMoleculeDrug,P08173,Muscarinic acetylcholine receptor M4,CHRM4,479.0
5554,DB01221,Ketamine,SmallMoleculeDrug,P08912,Muscarinic acetylcholine receptor M5,CHRM5,532.0
5555,DB01221,Ketamine,SmallMoleculeDrug,P28223,5-hydroxytryptamine receptor 2A,HTR2A,471.0
5556,DB01221,Ketamine,SmallMoleculeDrug,P41595,5-hydroxytryptamine receptor 2B,HTR2B,481.0
5557,DB01221,Ketamine,SmallMoleculeDrug,P28335,5-hydroxytryptamine receptor 2C,HTR2C,458.0
5558,DB01221,Ketamine,SmallMoleculeDrug,P08908,5-hydroxytryptamine receptor 1A,HTR1A,422.0
5559,DB01221,Ketamine,SmallMoleculeDrug,P28222,5-hydroxytryptamine receptor 1B,HTR1B,390.0
5560,DB01221,Ketamine,SmallMoleculeDrug,P28221,5-hydroxytryptamine receptor 1D,HTR1D,377.0
5561,DB01221,Ketamine,SmallMoleculeDrug,P28566,5-hydroxytryptamine receptor 1E,HTR1E,365.0
5562,DB01221,Ketamine,SmallMoleculeDrug,P30939,5-hydroxytryptamine receptor 1F,HTR1F,366.0
5563,DB01222,Budesonide,SmallMoleculeDrug,P04150,Glucocorticoid receptor,NR3C1,777.0
5564,DB01223,Aminophylline,SmallMoleculeDrug,Q14432,"cGMP-inhibited 3',5'-cyclic phosphodiesterase A",PDE3A,1141.0
5565,DB01223,Aminophylline,SmallMoleculeDrug,P30542,Adenosine receptor A1,ADORA1,326.0
5566,DB01223,Aminophylline,SmallMoleculeDrug,P0DMS8,Adenosine receptor A3,ADORA3,318.0
5567,DB01223,Aminophylline,SmallMoleculeDrug,Q92769,Histone deacetylase 2,HDAC2,488.0
5568,DB01224,Quetiapine,SmallMoleculeDrug,P28223,5-hydroxytryptamine receptor 2A,HTR2A,471.0
5569,DB01224,Quetiapine,SmallMoleculeDrug,P14416,D(2) dopamine receptor,DRD2,443.0
5570,DB01224,Quetiapine,SmallMoleculeDrug,P08908,5-hydroxytryptamine receptor 1A,HTR1A,422.0
5571,DB01224,Quetiapine,SmallMoleculeDrug,P28222,5-hydroxytryptamine receptor 1B,HTR1B,390.0
5572,DB01224,Quetiapine,SmallMoleculeDrug,P28221,5-hydroxytryptamine receptor 1D,HTR1D,377.0
5573,DB01224,Quetiapine,SmallMoleculeDrug,P28566,5-hydroxytryptamine receptor 1E,HTR1E,365.0
5574,DB01224,Quetiapine,SmallMoleculeDrug,P28335,5-hydroxytryptamine receptor 2C,HTR2C,458.0
5575,DB01224,Quetiapine,SmallMoleculeDrug,P46098,5-hydroxytryptamine receptor 3A,HTR3A,478.0
5576,DB01224,Quetiapine,SmallMoleculeDrug,P50406,5-hydroxytryptamine receptor 6,HTR6,440.0
5577,DB01224,Quetiapine,SmallMoleculeDrug,P34969,5-hydroxytryptamine receptor 7,HTR7,479.0
5578,DB01224,Quetiapine,SmallMoleculeDrug,P21728,D(1A) dopamine receptor,DRD1,446.0
5579,DB01224,Quetiapine,SmallMoleculeDrug,P21918,D(1B) dopamine receptor,DRD5,477.0
5580,DB01224,Quetiapine,SmallMoleculeDrug,P35462,D(3) dopamine receptor,DRD3,400.0
5581,DB01224,Quetiapine,SmallMoleculeDrug,P21917,D(4) dopamine receptor,DRD4,467.0
5582,DB01224,Quetiapine,SmallMoleculeDrug,P35367,Histamine H1 receptor,HRH1,487.0
5583,DB01224,Quetiapine,SmallMoleculeDrug,P35348,Alpha-1A adrenergic receptor,ADRA1A,466.0
5584,DB01224,Quetiapine,SmallMoleculeDrug,P35368,Alpha-1B adrenergic receptor,ADRA1B,520.0
5585,DB01224,Quetiapine,SmallMoleculeDrug,P25100,Alpha-1D adrenergic receptor,ADRA1D,572.0
5586,DB01224,Quetiapine,SmallMoleculeDrug,P08913,Alpha-2A adrenergic receptor,ADRA2A,450.0
5587,DB01224,Quetiapine,SmallMoleculeDrug,P18089,Alpha-2B adrenergic receptor,ADRA2B,450.0
5588,DB01224,Quetiapine,SmallMoleculeDrug,P18825,Alpha-2C adrenergic receptor,ADRA2C,462.0
5589,DB01224,Quetiapine,SmallMoleculeDrug,P11229,Muscarinic acetylcholine receptor M1,CHRM1,460.0
5590,DB01224,Quetiapine,SmallMoleculeDrug,P08172,Muscarinic acetylcholine receptor M2,CHRM2,466.0
5591,DB01224,Quetiapine,SmallMoleculeDrug,P20309,Muscarinic acetylcholine receptor M3,CHRM3,590.0
5592,DB01224,Quetiapine,SmallMoleculeDrug,P08173,Muscarinic acetylcholine receptor M4,CHRM4,479.0
5593,DB01224,Quetiapine,SmallMoleculeDrug,P08912,Muscarinic acetylcholine receptor M5,CHRM5,532.0
5594,DB01225,Enoxaparin,SmallMoleculeDrug,P01008,Antithrombin-III,SERPINC1,464.0
5595,DB01225,Enoxaparin,SmallMoleculeDrug,P00742,Coagulation factor X,F10,488.0
5596,DB01226,Mivacurium,SmallMoleculeDrug,Q15822,Neuronal acetylcholine receptor subunit alpha-2,CHRNA2,529.0
5597,DB01226,Mivacurium,SmallMoleculeDrug,P08172,Muscarinic acetylcholine receptor M2,CHRM2,466.0
5598,DB01226,Mivacurium,SmallMoleculeDrug,P20309,Muscarinic acetylcholine receptor M3,CHRM3,590.0
5599,DB01226,Mivacurium,SmallMoleculeDrug,P06276,Cholinesterase,BCHE,602.0
5600,DB01227,Levomethadyl Acetate,SmallMoleculeDrug,P35372,Mu-type opioid receptor,OPRM1,400.0
5601,DB01227,Levomethadyl Acetate,SmallMoleculeDrug,P30926,Neuronal acetylcholine receptor subunit beta-4,CHRNB4,498.0
5602,DB01227,Levomethadyl Acetate,SmallMoleculeDrug,P32297,Neuronal acetylcholine receptor subunit alpha-3,CHRNA3,505.0
5603,DB01228,Encainide,SmallMoleculeDrug,Q14524,Sodium channel protein type 5 subunit alpha,SCN5A,2016.0
5604,DB01229,Paclitaxel,SmallMoleculeDrug,Q9H4B7,Tubulin beta-1 chain,TUBB1,451.0
5605,DB01229,Paclitaxel,SmallMoleculeDrug,P10415,Apoptosis regulator Bcl-2,BCL2,239.0
5606,DB01229,Paclitaxel,SmallMoleculeDrug,O75469,Nuclear receptor subfamily 1 group I member 2,NR1I2,434.0
5607,DB01229,Paclitaxel,SmallMoleculeDrug,P27816,Microtubule-associated protein 4,MAP4,1152.0
5608,DB01229,Paclitaxel,SmallMoleculeDrug,P11137,Microtubule-associated protein 2,MAP2,1827.0
5609,DB01229,Paclitaxel,SmallMoleculeDrug,P10636,Microtubule-associated protein tau,MAPT,758.0
5610,DB01231,Diphenidol,SmallMoleculeDrug,P11229,Muscarinic acetylcholine receptor M1,CHRM1,460.0
5611,DB01231,Diphenidol,SmallMoleculeDrug,P20309,Muscarinic acetylcholine receptor M3,CHRM3,590.0
5612,DB01231,Diphenidol,SmallMoleculeDrug,P08172,Muscarinic acetylcholine receptor M2,CHRM2,466.0
5614,DB01233,Metoclopramide,SmallMoleculeDrug,P14416,D(2) dopamine receptor,DRD2,443.0
5615,DB01233,Metoclopramide,SmallMoleculeDrug,P11229,Muscarinic acetylcholine receptor M1,CHRM1,460.0
5616,DB01233,Metoclopramide,SmallMoleculeDrug,Q13639,5-hydroxytryptamine receptor 4,HTR4,388.0
5617,DB01233,Metoclopramide,SmallMoleculeDrug,P46098,5-hydroxytryptamine receptor 3A,HTR3A,478.0
5618,DB01234,Dexamethasone,SmallMoleculeDrug,P04150,Glucocorticoid receptor,NR3C1,777.0
5619,DB01234,Dexamethasone,SmallMoleculeDrug,P51843,Nuclear receptor subfamily 0 group B member 1,NR0B1,470.0
5620,DB01234,Dexamethasone,SmallMoleculeDrug,P04083,Annexin A1,ANXA1,346.0
5621,DB01234,Dexamethasone,SmallMoleculeDrug,P35228,"Nitric oxide synthase, inducible",NOS2,1153.0
5622,DB01235,Levodopa,SmallMoleculeDrug,P21728,D(1A) dopamine receptor,DRD1,446.0
5623,DB01235,Levodopa,SmallMoleculeDrug,P21918,D(1B) dopamine receptor,DRD5,477.0
5624,DB01235,Levodopa,SmallMoleculeDrug,P14416,D(2) dopamine receptor,DRD2,443.0
5625,DB01235,Levodopa,SmallMoleculeDrug,P35462,D(3) dopamine receptor,DRD3,400.0
5626,DB01235,Levodopa,SmallMoleculeDrug,P21917,D(4) dopamine receptor,DRD4,467.0
5627,DB01236,Sevoflurane,SmallMoleculeDrug,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,456.0
5628,DB01236,Sevoflurane,SmallMoleculeDrug,P23415,Glycine receptor subunit alpha-1,GLRA1,457.0
5629,DB01236,Sevoflurane,SmallMoleculeDrug,P42261,Glutamate receptor 1,GRIA1,906.0
5630,DB01236,Sevoflurane,SmallMoleculeDrug,Q09470,Potassium voltage-gated channel subfamily A member 1,KCNA1,495.0
5631,DB01236,Sevoflurane,SmallMoleculeDrug,P98194,Calcium-transporting ATPase type 2C member 1,ATP2C1,919.0
5632,DB01236,Sevoflurane,SmallMoleculeDrug,P30049,"ATP synthase subunit delta, mitochondrial",ATP5D,168.0
5633,DB01236,Sevoflurane,SmallMoleculeDrug,P03886,NADH-ubiquinone oxidoreductase chain 1,MT-ND1,318.0
5634,DB01236,Sevoflurane,SmallMoleculeDrug,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,456.0
5635,DB01236,Sevoflurane,SmallMoleculeDrug,P47869,Gamma-aminobutyric acid receptor subunit alpha-2,GABRA2,451.0
5636,DB01236,Sevoflurane,SmallMoleculeDrug,P34903,Gamma-aminobutyric acid receptor subunit alpha-3,GABRA3,492.0
5637,DB01236,Sevoflurane,SmallMoleculeDrug,P48169,Gamma-aminobutyric acid receptor subunit alpha-4,GABRA4,554.0
5638,DB01236,Sevoflurane,SmallMoleculeDrug,P31644,Gamma-aminobutyric acid receptor subunit alpha-5,GABRA5,462.0
5639,DB01236,Sevoflurane,SmallMoleculeDrug,Q16445,Gamma-aminobutyric acid receptor subunit alpha-6,GABRA6,453.0
5640,DB01236,Sevoflurane,SmallMoleculeDrug,P18505,Gamma-aminobutyric acid receptor subunit beta-1,GABRB1,474.0
5641,DB01236,Sevoflurane,SmallMoleculeDrug,P47870,Gamma-aminobutyric acid receptor subunit beta-2,GABRB2,512.0
5642,DB01236,Sevoflurane,SmallMoleculeDrug,P28472,Gamma-aminobutyric acid receptor subunit beta-3,GABRB3,473.0
5643,DB01236,Sevoflurane,SmallMoleculeDrug,O14764,Gamma-aminobutyric acid receptor subunit delta,GABRD,452.0
5644,DB01236,Sevoflurane,SmallMoleculeDrug,P78334,Gamma-aminobutyric acid receptor subunit epsilon,GABRE,506.0
5645,DB01236,Sevoflurane,SmallMoleculeDrug,Q8N1C3,Gamma-aminobutyric acid receptor subunit gamma-1,GABRG1,465.0
5646,DB01236,Sevoflurane,SmallMoleculeDrug,P18507,Gamma-aminobutyric acid receptor subunit gamma-2,GABRG2,467.0
5647,DB01236,Sevoflurane,SmallMoleculeDrug,Q99928,Gamma-aminobutyric acid receptor subunit gamma-3,GABRG3,467.0
5648,DB01236,Sevoflurane,SmallMoleculeDrug,O00591,Gamma-aminobutyric acid receptor subunit pi,GABRP,440.0
5649,DB01236,Sevoflurane,SmallMoleculeDrug,Q9UN88,Gamma-aminobutyric acid receptor subunit theta,GABRQ,632.0
5650,DB01237,Bromodiphenhydramine,SmallMoleculeDrug,P35367,Histamine H1 receptor,HRH1,487.0
5651,DB01238,Aripiprazole,SmallMoleculeDrug,P28223,5-hydroxytryptamine receptor 2A,HTR2A,471.0
5652,DB01238,Aripiprazole,SmallMoleculeDrug,P14416,D(2) dopamine receptor,DRD2,443.0
5653,DB01238,Aripiprazole,SmallMoleculeDrug,P08908,5-hydroxytryptamine receptor 1A,HTR1A,422.0
5654,DB01238,Aripiprazole,SmallMoleculeDrug,P28222,5-hydroxytryptamine receptor 1B,HTR1B,390.0
5655,DB01238,Aripiprazole,SmallMoleculeDrug,P28221,5-hydroxytryptamine receptor 1D,HTR1D,377.0
5656,DB01238,Aripiprazole,SmallMoleculeDrug,P28566,5-hydroxytryptamine receptor 1E,HTR1E,365.0
5657,DB01238,Aripiprazole,SmallMoleculeDrug,P28335,5-hydroxytryptamine receptor 2C,HTR2C,458.0
5658,DB01238,Aripiprazole,SmallMoleculeDrug,P46098,5-hydroxytryptamine receptor 3A,HTR3A,478.0
5659,DB01238,Aripiprazole,SmallMoleculeDrug,P50406,5-hydroxytryptamine receptor 6,HTR6,440.0
5660,DB01238,Aripiprazole,SmallMoleculeDrug,P34969,5-hydroxytryptamine receptor 7,HTR7,479.0
5661,DB01238,Aripiprazole,SmallMoleculeDrug,P21728,D(1A) dopamine receptor,DRD1,446.0
5662,DB01238,Aripiprazole,SmallMoleculeDrug,P21918,D(1B) dopamine receptor,DRD5,477.0
5663,DB01238,Aripiprazole,SmallMoleculeDrug,P35462,D(3) dopamine receptor,DRD3,400.0
5664,DB01238,Aripiprazole,SmallMoleculeDrug,P21917,D(4) dopamine receptor,DRD4,467.0
5665,DB01238,Aripiprazole,SmallMoleculeDrug,P35367,Histamine H1 receptor,HRH1,487.0
5666,DB01238,Aripiprazole,SmallMoleculeDrug,P35348,Alpha-1A adrenergic receptor,ADRA1A,466.0
5667,DB01238,Aripiprazole,SmallMoleculeDrug,P35368,Alpha-1B adrenergic receptor,ADRA1B,520.0
5668,DB01238,Aripiprazole,SmallMoleculeDrug,P08913,Alpha-2A adrenergic receptor,ADRA2A,450.0
5669,DB01238,Aripiprazole,SmallMoleculeDrug,P18089,Alpha-2B adrenergic receptor,ADRA2B,450.0
5670,DB01238,Aripiprazole,SmallMoleculeDrug,P18825,Alpha-2C adrenergic receptor,ADRA2C,462.0
5671,DB01238,Aripiprazole,SmallMoleculeDrug,P11229,Muscarinic acetylcholine receptor M1,CHRM1,460.0
5672,DB01238,Aripiprazole,SmallMoleculeDrug,P08172,Muscarinic acetylcholine receptor M2,CHRM2,466.0
5673,DB01238,Aripiprazole,SmallMoleculeDrug,P20309,Muscarinic acetylcholine receptor M3,CHRM3,590.0
5674,DB01238,Aripiprazole,SmallMoleculeDrug,P08173,Muscarinic acetylcholine receptor M4,CHRM4,479.0
5675,DB01238,Aripiprazole,SmallMoleculeDrug,P08912,Muscarinic acetylcholine receptor M5,CHRM5,532.0
5676,DB01239,Chlorprothixene,SmallMoleculeDrug,P14416,D(2) dopamine receptor,DRD2,443.0
5677,DB01239,Chlorprothixene,SmallMoleculeDrug,P21728,D(1A) dopamine receptor,DRD1,446.0
5678,DB01239,Chlorprothixene,SmallMoleculeDrug,P35462,D(3) dopamine receptor,DRD3,400.0
5679,DB01239,Chlorprothixene,SmallMoleculeDrug,P28223,5-hydroxytryptamine receptor 2A,HTR2A,471.0
5680,DB01239,Chlorprothixene,SmallMoleculeDrug,P41595,5-hydroxytryptamine receptor 2B,HTR2B,481.0
5681,DB01239,Chlorprothixene,SmallMoleculeDrug,P28335,5-hydroxytryptamine receptor 2C,HTR2C,458.0
5682,DB01239,Chlorprothixene,SmallMoleculeDrug,P35367,Histamine H1 receptor,HRH1,487.0
5683,DB01239,Chlorprothixene,SmallMoleculeDrug,P11229,Muscarinic acetylcholine receptor M1,CHRM1,460.0
5684,DB01239,Chlorprothixene,SmallMoleculeDrug,P08172,Muscarinic acetylcholine receptor M2,CHRM2,466.0
5685,DB01239,Chlorprothixene,SmallMoleculeDrug,P20309,Muscarinic acetylcholine receptor M3,CHRM3,590.0
5686,DB01239,Chlorprothixene,SmallMoleculeDrug,P08173,Muscarinic acetylcholine receptor M4,CHRM4,479.0
5687,DB01239,Chlorprothixene,SmallMoleculeDrug,P08912,Muscarinic acetylcholine receptor M5,CHRM5,532.0
5688,DB01240,Epoprostenol,SmallMoleculeDrug,Q9H244,P2Y purinoceptor 12,P2RY12,342.0
5689,DB01240,Epoprostenol,SmallMoleculeDrug,P43119,Prostacyclin receptor,PTGIR,386.0
5690,DB01240,Epoprostenol,SmallMoleculeDrug,Q16647,Prostacyclin synthase,PTGIS,500.0
5691,DB01241,Gemfibrozil,SmallMoleculeDrug,Q07869,Peroxisome proliferator-activated receptor alpha,PPARA,468.0
5692,DB01242,Clomipramine,SmallMoleculeDrug,P31645,Sodium-dependent serotonin transporter,SLC6A4,630.0
5693,DB01242,Clomipramine,SmallMoleculeDrug,P28223,5-hydroxytryptamine receptor 2A,HTR2A,471.0
5694,DB01242,Clomipramine,SmallMoleculeDrug,P41595,5-hydroxytryptamine receptor 2B,HTR2B,481.0
5695,DB01242,Clomipramine,SmallMoleculeDrug,P28335,5-hydroxytryptamine receptor 2C,HTR2C,458.0
5696,DB01242,Clomipramine,SmallMoleculeDrug,P23975,Sodium-dependent noradrenaline transporter,SLC6A2,617.0
5697,DB01242,Clomipramine,SmallMoleculeDrug,P09211,Glutathione S-transferase P,GSTP1,210.0
5698,DB01244,Bepridil,SmallMoleculeDrug,O00555,Voltage-dependent P/Q-type calcium channel subunit alpha-1A,CACNA1A,2505.0
5699,DB01244,Bepridil,SmallMoleculeDrug,O95180,Voltage-dependent T-type calcium channel subunit alpha-1H,CACNA1H,2353.0
5700,DB01244,Bepridil,SmallMoleculeDrug,Q9NY47,Voltage-dependent calcium channel subunit alpha-2/delta-2,CACNA2D2,1150.0
5701,DB01244,Bepridil,SmallMoleculeDrug,P05023,Sodium/potassium-transporting ATPase subunit alpha-1,ATP1A1,1023.0
5702,DB01244,Bepridil,SmallMoleculeDrug,P51787,Potassium voltage-gated channel subfamily KQT member 1,KCNQ1,676.0
5703,DB01244,Bepridil,SmallMoleculeDrug,P63316,"Troponin C, slow skeletal and cardiac muscles",TNNC1,161.0
5705,DB01244,Bepridil,SmallMoleculeDrug,Q01064,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B",PDE1B,536.0
5706,DB01244,Bepridil,SmallMoleculeDrug,P54750,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A",PDE1A,535.0
5707,DB01245,Decamethonium,SmallMoleculeDrug,Q15822,Neuronal acetylcholine receptor subunit alpha-2,CHRNA2,529.0
5708,DB01245,Decamethonium,SmallMoleculeDrug,P22303,Acetylcholinesterase,ACHE,614.0
5709,DB01246,Alimemazine,SmallMoleculeDrug,P35367,Histamine H1 receptor,HRH1,487.0
5710,DB01247,Isocarboxazid,SmallMoleculeDrug,P21397,Amine oxidase [flavin-containing] A,MAOA,527.0
5711,DB01247,Isocarboxazid,SmallMoleculeDrug,P27338,Amine oxidase [flavin-containing] B,MAOB,520.0
5712,DB01248,Docetaxel,SmallMoleculeDrug,Q9H4B7,Tubulin beta-1 chain,TUBB1,451.0
5713,DB01248,Docetaxel,SmallMoleculeDrug,P10415,Apoptosis regulator Bcl-2,BCL2,239.0
5714,DB01248,Docetaxel,SmallMoleculeDrug,P11137,Microtubule-associated protein 2,MAP2,1827.0
5715,DB01248,Docetaxel,SmallMoleculeDrug,P27816,Microtubule-associated protein 4,MAP4,1152.0
5716,DB01248,Docetaxel,SmallMoleculeDrug,P10636,Microtubule-associated protein tau,MAPT,758.0
5717,DB01248,Docetaxel,SmallMoleculeDrug,O75469,Nuclear receptor subfamily 1 group I member 2,NR1I2,434.0
5718,DB01250,Olsalazine,SmallMoleculeDrug,P51580,Thiopurine S-methyltransferase,TPMT,245.0
5719,DB01250,Olsalazine,SmallMoleculeDrug,P01579,Interferon gamma,IFNG,166.0
5720,DB01251,Gliquidone,SmallMoleculeDrug,Q09428,ATP-binding cassette sub-family C member 8,ABCC8,1581.0
5721,DB01251,Gliquidone,SmallMoleculeDrug,Q15842,ATP-sensitive inward rectifier potassium channel 8,KCNJ8,424.0
5722,DB01252,Mitiglinide,SmallMoleculeDrug,Q09428,ATP-binding cassette sub-family C member 8,ABCC8,1581.0
5723,DB01252,Mitiglinide,SmallMoleculeDrug,P37231,Peroxisome proliferator-activated receptor gamma,PPARG,505.0
5724,DB01253,Ergonovine,SmallMoleculeDrug,P35348,Alpha-1A adrenergic receptor,ADRA1A,466.0
5725,DB01254,Dasatinib,SmallMoleculeDrug,P00519,Tyrosine-protein kinase ABL1,ABL1,1130.0
5726,DB01254,Dasatinib,SmallMoleculeDrug,P12931,Proto-oncogene tyrosine-protein kinase Src,SRC,536.0
5727,DB01254,Dasatinib,SmallMoleculeDrug,P29317,Ephrin type-A receptor 2,EPHA2,976.0
5728,DB01254,Dasatinib,SmallMoleculeDrug,P06239,Tyrosine-protein kinase Lck,LCK,509.0
5729,DB01254,Dasatinib,SmallMoleculeDrug,P07947,Tyrosine-protein kinase Yes,YES1,543.0
5730,DB01254,Dasatinib,SmallMoleculeDrug,P10721,Mast/stem cell growth factor receptor Kit,KIT,976.0
5731,DB01254,Dasatinib,SmallMoleculeDrug,P09619,Platelet-derived growth factor receptor beta,PDGFRB,1106.0
5732,DB01254,Dasatinib,SmallMoleculeDrug,P51692,Signal transducer and activator of transcription 5B,STAT5B,787.0
5733,DB01254,Dasatinib,SmallMoleculeDrug,P42684,Abelson tyrosine-protein kinase 2,ABL2,1182.0
5734,DB01254,Dasatinib,SmallMoleculeDrug,P06241,Tyrosine-protein kinase Fyn,FYN,537.0
5735,DB01255,Lisdexamfetamine,SmallMoleculeDrug,Q01959,Sodium-dependent dopamine transporter,SLC6A3,620.0
5736,DB01255,Lisdexamfetamine,SmallMoleculeDrug,P35368,Alpha-1B adrenergic receptor,ADRA1B,520.0
5738,DB01257,Eculizumab,BiotechDrug,P01031,Complement C5,C5,1676.0
5739,DB01259,Lapatinib,SmallMoleculeDrug,P00533,Epidermal growth factor receptor,EGFR,1210.0
5740,DB01259,Lapatinib,SmallMoleculeDrug,P04626,Receptor tyrosine-protein kinase erbB-2,ERBB2,1255.0
5741,DB01260,Desonide,SmallMoleculeDrug,P04150,Glucocorticoid receptor,NR3C1,777.0
5742,DB01261,Sitagliptin,SmallMoleculeDrug,P27487,Dipeptidyl peptidase 4,DPP4,766.0
5743,DB01262,Decitabine,SmallMoleculeDrug,P26358,DNA (cytosine-5)-methyltransferase 1,DNMT1,1616.0
5747,DB01267,Paliperidone,SmallMoleculeDrug,P28223,5-hydroxytryptamine receptor 2A,HTR2A,471.0
5748,DB01267,Paliperidone,SmallMoleculeDrug,P14416,D(2) dopamine receptor,DRD2,443.0
5749,DB01267,Paliperidone,SmallMoleculeDrug,P35367,Histamine H1 receptor,HRH1,487.0
5750,DB01267,Paliperidone,SmallMoleculeDrug,P35348,Alpha-1A adrenergic receptor,ADRA1A,466.0
5751,DB01267,Paliperidone,SmallMoleculeDrug,P35368,Alpha-1B adrenergic receptor,ADRA1B,520.0
5752,DB01267,Paliperidone,SmallMoleculeDrug,P21917,D(4) dopamine receptor,DRD4,467.0
5753,DB01267,Paliperidone,SmallMoleculeDrug,P28221,5-hydroxytryptamine receptor 1D,HTR1D,377.0
5754,DB01267,Paliperidone,SmallMoleculeDrug,P35462,D(3) dopamine receptor,DRD3,400.0
5755,DB01267,Paliperidone,SmallMoleculeDrug,P28335,5-hydroxytryptamine receptor 2C,HTR2C,458.0
5756,DB01267,Paliperidone,SmallMoleculeDrug,P08913,Alpha-2A adrenergic receptor,ADRA2A,450.0
5757,DB01267,Paliperidone,SmallMoleculeDrug,P18089,Alpha-2B adrenergic receptor,ADRA2B,450.0
5758,DB01267,Paliperidone,SmallMoleculeDrug,P18825,Alpha-2C adrenergic receptor,ADRA2C,462.0
5759,DB01267,Paliperidone,SmallMoleculeDrug,P08908,5-hydroxytryptamine receptor 1A,HTR1A,422.0
5760,DB01267,Paliperidone,SmallMoleculeDrug,P21728,D(1A) dopamine receptor,DRD1,446.0
5761,DB01267,Paliperidone,SmallMoleculeDrug,P08684,Cytochrome P450 3A4,CYP3A4,503.0
5762,DB01267,Paliperidone,SmallMoleculeDrug,P10635,Cytochrome P450 2D6,CYP2D6,497.0
5763,DB01267,Paliperidone,SmallMoleculeDrug,P20815,Cytochrome P450 3A5,CYP3A5,502.0
5764,DB01268,Sunitinib,SmallMoleculeDrug,P09619,Platelet-derived growth factor receptor beta,PDGFRB,1106.0
5765,DB01268,Sunitinib,SmallMoleculeDrug,P17948,Vascular endothelial growth factor receptor 1,FLT1,1338.0
5766,DB01268,Sunitinib,SmallMoleculeDrug,P10721,Mast/stem cell growth factor receptor Kit,KIT,976.0
5767,DB01268,Sunitinib,SmallMoleculeDrug,P35968,Vascular endothelial growth factor receptor 2,KDR,1356.0
5768,DB01268,Sunitinib,SmallMoleculeDrug,P35916,Vascular endothelial growth factor receptor 3,FLT4,1363.0
5769,DB01268,Sunitinib,SmallMoleculeDrug,P36888,Receptor-type tyrosine-protein kinase FLT3,FLT3,993.0
5770,DB01268,Sunitinib,SmallMoleculeDrug,P07333,Macrophage colony-stimulating factor 1 receptor,CSF1R,972.0
5771,DB01268,Sunitinib,SmallMoleculeDrug,P16234,Platelet-derived growth factor receptor alpha,PDGFRA,1089.0
5772,DB01269,Panitumumab,BiotechDrug,P00533,Epidermal growth factor receptor,EGFR,1210.0
5773,DB01270,Ranibizumab,BiotechDrug,P15692,Vascular endothelial growth factor A,VEGFA,232.0
5774,DB01271,Idursulfase,BiotechDrug,O60664,Perilipin-3,PLIN3,434.0
5775,DB01272,Alglucosidase alfa,BiotechDrug,P20645,Cation-dependent mannose-6-phosphate receptor,M6PR,277.0
5776,DB01273,Varenicline,SmallMoleculeDrug,P43681,Neuronal acetylcholine receptor subunit alpha-4,CHRNA4,627.0
5777,DB01273,Varenicline,SmallMoleculeDrug,P36544,Neuronal acetylcholine receptor subunit alpha-7,CHRNA7,502.0
5778,DB01273,Varenicline,SmallMoleculeDrug,P32297,Neuronal acetylcholine receptor subunit alpha-3,CHRNA3,505.0
5779,DB01273,Varenicline,SmallMoleculeDrug,Q15825,Neuronal acetylcholine receptor subunit alpha-6,CHRNA6,494.0
5780,DB01274,Arformoterol,SmallMoleculeDrug,P07550,Beta-2 adrenergic receptor,ADRB2,413.0
5781,DB01275,Hydralazine,SmallMoleculeDrug,Q16853,Membrane primary amine oxidase,AOC3,763.0
5782,DB01275,Hydralazine,SmallMoleculeDrug,P13674,Prolyl 4-hydroxylase subunit alpha-1,P4HA1,534.0
5783,DB01276,Exenatide,BiotechDrug,P43220,Glucagon-like peptide 1 receptor,GLP1R,463.0
5784,DB01277,Mecasermin,BiotechDrug,P08069,Insulin-like growth factor 1 receptor,IGF1R,1367.0
5785,DB01277,Mecasermin,BiotechDrug,P17936,Insulin-like growth factor-binding protein 3,IGFBP3,291.0
5786,DB01277,Mecasermin,BiotechDrug,P06213,Insulin receptor,INSR,1382.0
5787,DB01277,Mecasermin,BiotechDrug,P11717,Cation-independent mannose-6-phosphate receptor,IGF2R,2491.0
5788,DB01278,Pramlintide,BiotechDrug,P30988,Calcitonin receptor,CALCR,508.0
5789,DB01278,Pramlintide,BiotechDrug,O60894,Receptor activity-modifying protein 1,RAMP1,148.0
5790,DB01278,Pramlintide,BiotechDrug,O60895,Receptor activity-modifying protein 2,RAMP2,175.0
5791,DB01278,Pramlintide,BiotechDrug,O60896,Receptor activity-modifying protein 3,RAMP3,148.0
5792,DB01279,Galsulfase,BiotechDrug,O60664,Perilipin-3,PLIN3,434.0
5793,DB01280,Nelarabine,SmallMoleculeDrug,P09884,DNA polymerase alpha catalytic subunit,POLA1,1462.0
5794,DB01281,Abatacept,BiotechDrug,P33681,T-lymphocyte activation antigen CD80,CD80,288.0
5795,DB01281,Abatacept,BiotechDrug,P42081,T-lymphocyte activation antigen CD86,CD86,329.0
5796,DB01282,Carbetocin,SmallMoleculeDrug,P30559,Oxytocin receptor,OXTR,389.0
5797,DB01283,Lumiracoxib,SmallMoleculeDrug,P35354,Prostaglandin G/H synthase 2,PTGS2,604.0
5798,DB01283,Lumiracoxib,SmallMoleculeDrug,P23219,Prostaglandin G/H synthase 1,PTGS1,599.0
5799,DB01284,Tetracosactide,SmallMoleculeDrug,Q01718,Adrenocorticotropic hormone receptor,MC2R,297.0
5800,DB01285,Corticotropin,BiotechDrug,Q01718,Adrenocorticotropic hormone receptor,MC2R,297.0
5801,DB01285,Corticotropin,BiotechDrug,P06850,Corticoliberin,CRH,196.0
5802,DB01288,Fenoterol,SmallMoleculeDrug,P07550,Beta-2 adrenergic receptor,ADRB2,413.0
5803,DB01288,Fenoterol,SmallMoleculeDrug,P08588,Beta-1 adrenergic receptor,ADRB1,477.0
5804,DB01288,Fenoterol,SmallMoleculeDrug,P13945,Beta-3 adrenergic receptor,ADRB3,408.0
5805,DB01289,Glisoxepide,SmallMoleculeDrug,Q15842,ATP-sensitive inward rectifier potassium channel 8,KCNJ8,424.0
5806,DB01291,Pirbuterol,SmallMoleculeDrug,P07550,Beta-2 adrenergic receptor,ADRB2,413.0
5807,DB01291,Pirbuterol,SmallMoleculeDrug,P08588,Beta-1 adrenergic receptor,ADRB1,477.0
5808,DB01295,Bevantolol,SmallMoleculeDrug,P08588,Beta-1 adrenergic receptor,ADRB1,477.0
5809,DB01295,Bevantolol,SmallMoleculeDrug,P07550,Beta-2 adrenergic receptor,ADRB2,413.0
5810,DB01295,Bevantolol,SmallMoleculeDrug,P35348,Alpha-1A adrenergic receptor,ADRA1A,466.0
5811,DB01296,Glucosamine,SmallMoleculeDrug,P14780,Matrix metalloproteinase-9,MMP9,707.0
5812,DB01296,Glucosamine,SmallMoleculeDrug,Q00653,Nuclear factor NF-kappa-B p100 subunit,NFKB2,900.0
5813,DB01296,Glucosamine,SmallMoleculeDrug,P01375,Tumor necrosis factor,TNF,233.0
5814,DB01296,Glucosamine,SmallMoleculeDrug,P01579,Interferon gamma,IFNG,166.0
5816,DB01297,Practolol,SmallMoleculeDrug,P08588,Beta-1 adrenergic receptor,ADRB1,477.0
5821,DB01303,Oxtriphylline,SmallMoleculeDrug,Q14432,"cGMP-inhibited 3',5'-cyclic phosphodiesterase A",PDE3A,1141.0
5822,DB01303,Oxtriphylline,SmallMoleculeDrug,P27815,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A",PDE4A,886.0
5823,DB01303,Oxtriphylline,SmallMoleculeDrug,P29274,Adenosine receptor A2a,ADORA2A,412.0
5824,DB01303,Oxtriphylline,SmallMoleculeDrug,P30542,Adenosine receptor A1,ADORA1,326.0
5825,DB01303,Oxtriphylline,SmallMoleculeDrug,Q92769,Histone deacetylase 2,HDAC2,488.0
5826,DB01306,Insulin Aspart,BiotechDrug,P06213,Insulin receptor,INSR,1382.0
5827,DB01307,Insulin Detemir,BiotechDrug,P06213,Insulin receptor,INSR,1382.0
5828,DB01309,Insulin Glulisine,BiotechDrug,P06213,Insulin receptor,INSR,1382.0
5830,DB01320,Fosphenytoin,SmallMoleculeDrug,Q14524,Sodium channel protein type 5 subunit alpha,SCN5A,2016.0
5832,DB01324,Polythiazide,SmallMoleculeDrug,P55017,Solute carrier family 12 member 3,SLC12A3,1021.0
5833,DB01325,Quinethazone,SmallMoleculeDrug,P00915,Carbonic anhydrase 1,CA1,261.0
5834,DB01325,Quinethazone,SmallMoleculeDrug,P00918,Carbonic anhydrase 2,CA2,260.0
5835,DB01325,Quinethazone,SmallMoleculeDrug,Q13621,Solute carrier family 12 member 1,SLC12A1,1099.0
5836,DB01325,Quinethazone,SmallMoleculeDrug,P55011,Solute carrier family 12 member 2,SLC12A2,1212.0
5837,DB01325,Quinethazone,SmallMoleculeDrug,P55017,Solute carrier family 12 member 3,SLC12A3,1021.0
5844,DB01327,Cefazolin,SmallMoleculeDrug,P27169,Serum paraoxonase/arylesterase 1,PON1,355.0
5877,DB01336,Metocurine,SmallMoleculeDrug,Q15822,Neuronal acetylcholine receptor subunit alpha-2,CHRNA2,529.0
5878,DB01336,Metocurine,SmallMoleculeDrug,P08172,Muscarinic acetylcholine receptor M2,CHRM2,466.0
5879,DB01337,Pancuronium,SmallMoleculeDrug,Q15822,Neuronal acetylcholine receptor subunit alpha-2,CHRNA2,529.0
5880,DB01337,Pancuronium,SmallMoleculeDrug,P08172,Muscarinic acetylcholine receptor M2,CHRM2,466.0
5881,DB01337,Pancuronium,SmallMoleculeDrug,P20309,Muscarinic acetylcholine receptor M3,CHRM3,590.0
5882,DB01338,Pipecuronium,SmallMoleculeDrug,Q15822,Neuronal acetylcholine receptor subunit alpha-2,CHRNA2,529.0
5883,DB01338,Pipecuronium,SmallMoleculeDrug,P08172,Muscarinic acetylcholine receptor M2,CHRM2,466.0
5884,DB01338,Pipecuronium,SmallMoleculeDrug,P20309,Muscarinic acetylcholine receptor M3,CHRM3,590.0
5885,DB01339,Vecuronium,SmallMoleculeDrug,Q15822,Neuronal acetylcholine receptor subunit alpha-2,CHRNA2,529.0
5886,DB01340,Cilazapril,SmallMoleculeDrug,P12821,Angiotensin-converting enzyme,ACE,1306.0
5887,DB01341,Dihydroquinidine barbiturate,SmallMoleculeDrug,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,456.0
5888,DB01342,Forasartan,SmallMoleculeDrug,P30556,Type-1 angiotensin II receptor,AGTR1,359.0
5889,DB01345,Potassium,SmallMoleculeDrug,P05023,Sodium/potassium-transporting ATPase subunit alpha-1,ATP1A1,1023.0
5890,DB01346,Quinidine barbiturate,SmallMoleculeDrug,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,456.0
5891,DB01346,Quinidine barbiturate,SmallMoleculeDrug,P47869,Gamma-aminobutyric acid receptor subunit alpha-2,GABRA2,451.0
5892,DB01346,Quinidine barbiturate,SmallMoleculeDrug,Q14524,Sodium channel protein type 5 subunit alpha,SCN5A,2016.0
5893,DB01346,Quinidine barbiturate,SmallMoleculeDrug,O00180,Potassium channel subfamily K member 1,KCNK1,336.0
5894,DB01346,Quinidine barbiturate,SmallMoleculeDrug,P42262,Glutamate receptor 2,GRIA2,883.0
5895,DB01347,Saprisartan,SmallMoleculeDrug,P30556,Type-1 angiotensin II receptor,AGTR1,359.0
5896,DB01348,Spirapril,SmallMoleculeDrug,P12821,Angiotensin-converting enzyme,ACE,1306.0
5897,DB01349,Tasosartan,SmallMoleculeDrug,P30556,Type-1 angiotensin II receptor,AGTR1,359.0
5898,DB01349,Tasosartan,SmallMoleculeDrug,P50052,Type-2 angiotensin II receptor,AGTR2,363.0
5899,DB01351,Amobarbital,SmallMoleculeDrug,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,456.0
5900,DB01351,Amobarbital,SmallMoleculeDrug,P47869,Gamma-aminobutyric acid receptor subunit alpha-2,GABRA2,451.0
5901,DB01351,Amobarbital,SmallMoleculeDrug,P34903,Gamma-aminobutyric acid receptor subunit alpha-3,GABRA3,492.0
5902,DB01351,Amobarbital,SmallMoleculeDrug,P48169,Gamma-aminobutyric acid receptor subunit alpha-4,GABRA4,554.0
5903,DB01351,Amobarbital,SmallMoleculeDrug,P31644,Gamma-aminobutyric acid receptor subunit alpha-5,GABRA5,462.0
5904,DB01351,Amobarbital,SmallMoleculeDrug,Q16445,Gamma-aminobutyric acid receptor subunit alpha-6,GABRA6,453.0
5905,DB01351,Amobarbital,SmallMoleculeDrug,P43681,Neuronal acetylcholine receptor subunit alpha-4,CHRNA4,627.0
5906,DB01351,Amobarbital,SmallMoleculeDrug,P36544,Neuronal acetylcholine receptor subunit alpha-7,CHRNA7,502.0
5907,DB01351,Amobarbital,SmallMoleculeDrug,P42262,Glutamate receptor 2,GRIA2,883.0
5908,DB01351,Amobarbital,SmallMoleculeDrug,Q13002,"Glutamate receptor ionotropic, kainate 2",GRIK2,908.0
5909,DB01352,Aprobarbital,SmallMoleculeDrug,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,456.0
5910,DB01352,Aprobarbital,SmallMoleculeDrug,P47869,Gamma-aminobutyric acid receptor subunit alpha-2,GABRA2,451.0
5911,DB01352,Aprobarbital,SmallMoleculeDrug,P34903,Gamma-aminobutyric acid receptor subunit alpha-3,GABRA3,492.0
5912,DB01352,Aprobarbital,SmallMoleculeDrug,P48169,Gamma-aminobutyric acid receptor subunit alpha-4,GABRA4,554.0
5913,DB01352,Aprobarbital,SmallMoleculeDrug,P31644,Gamma-aminobutyric acid receptor subunit alpha-5,GABRA5,462.0
5914,DB01352,Aprobarbital,SmallMoleculeDrug,Q16445,Gamma-aminobutyric acid receptor subunit alpha-6,GABRA6,453.0
5915,DB01352,Aprobarbital,SmallMoleculeDrug,P43681,Neuronal acetylcholine receptor subunit alpha-4,CHRNA4,627.0
5916,DB01352,Aprobarbital,SmallMoleculeDrug,P36544,Neuronal acetylcholine receptor subunit alpha-7,CHRNA7,502.0
5917,DB01352,Aprobarbital,SmallMoleculeDrug,P42262,Glutamate receptor 2,GRIA2,883.0
5918,DB01352,Aprobarbital,SmallMoleculeDrug,Q13002,"Glutamate receptor ionotropic, kainate 2",GRIK2,908.0
5919,DB01353,Butethal,SmallMoleculeDrug,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,456.0
5920,DB01353,Butethal,SmallMoleculeDrug,P47869,Gamma-aminobutyric acid receptor subunit alpha-2,GABRA2,451.0
5921,DB01353,Butethal,SmallMoleculeDrug,P34903,Gamma-aminobutyric acid receptor subunit alpha-3,GABRA3,492.0
5922,DB01353,Butethal,SmallMoleculeDrug,P48169,Gamma-aminobutyric acid receptor subunit alpha-4,GABRA4,554.0
5923,DB01353,Butethal,SmallMoleculeDrug,P31644,Gamma-aminobutyric acid receptor subunit alpha-5,GABRA5,462.0
5924,DB01353,Butethal,SmallMoleculeDrug,Q16445,Gamma-aminobutyric acid receptor subunit alpha-6,GABRA6,453.0
5925,DB01353,Butethal,SmallMoleculeDrug,P43681,Neuronal acetylcholine receptor subunit alpha-4,CHRNA4,627.0
5926,DB01353,Butethal,SmallMoleculeDrug,P36544,Neuronal acetylcholine receptor subunit alpha-7,CHRNA7,502.0
5927,DB01353,Butethal,SmallMoleculeDrug,P42262,Glutamate receptor 2,GRIA2,883.0
5928,DB01353,Butethal,SmallMoleculeDrug,Q13002,"Glutamate receptor ionotropic, kainate 2",GRIK2,908.0
5929,DB01354,Heptabarbital,SmallMoleculeDrug,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,456.0
5930,DB01354,Heptabarbital,SmallMoleculeDrug,P47869,Gamma-aminobutyric acid receptor subunit alpha-2,GABRA2,451.0
5931,DB01354,Heptabarbital,SmallMoleculeDrug,P34903,Gamma-aminobutyric acid receptor subunit alpha-3,GABRA3,492.0
5932,DB01354,Heptabarbital,SmallMoleculeDrug,P48169,Gamma-aminobutyric acid receptor subunit alpha-4,GABRA4,554.0
5933,DB01354,Heptabarbital,SmallMoleculeDrug,P31644,Gamma-aminobutyric acid receptor subunit alpha-5,GABRA5,462.0
5934,DB01354,Heptabarbital,SmallMoleculeDrug,Q16445,Gamma-aminobutyric acid receptor subunit alpha-6,GABRA6,453.0
5935,DB01354,Heptabarbital,SmallMoleculeDrug,P43681,Neuronal acetylcholine receptor subunit alpha-4,CHRNA4,627.0
5936,DB01354,Heptabarbital,SmallMoleculeDrug,P36544,Neuronal acetylcholine receptor subunit alpha-7,CHRNA7,502.0
5937,DB01354,Heptabarbital,SmallMoleculeDrug,P42262,Glutamate receptor 2,GRIA2,883.0
5938,DB01354,Heptabarbital,SmallMoleculeDrug,Q13002,"Glutamate receptor ionotropic, kainate 2",GRIK2,908.0
5939,DB01355,Hexobarbital,SmallMoleculeDrug,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,456.0
5940,DB01355,Hexobarbital,SmallMoleculeDrug,P47869,Gamma-aminobutyric acid receptor subunit alpha-2,GABRA2,451.0
5941,DB01355,Hexobarbital,SmallMoleculeDrug,P34903,Gamma-aminobutyric acid receptor subunit alpha-3,GABRA3,492.0
5942,DB01355,Hexobarbital,SmallMoleculeDrug,P48169,Gamma-aminobutyric acid receptor subunit alpha-4,GABRA4,554.0
5943,DB01355,Hexobarbital,SmallMoleculeDrug,P31644,Gamma-aminobutyric acid receptor subunit alpha-5,GABRA5,462.0
5944,DB01355,Hexobarbital,SmallMoleculeDrug,Q16445,Gamma-aminobutyric acid receptor subunit alpha-6,GABRA6,453.0
5945,DB01355,Hexobarbital,SmallMoleculeDrug,P43681,Neuronal acetylcholine receptor subunit alpha-4,CHRNA4,627.0
5946,DB01355,Hexobarbital,SmallMoleculeDrug,P36544,Neuronal acetylcholine receptor subunit alpha-7,CHRNA7,502.0
5947,DB01355,Hexobarbital,SmallMoleculeDrug,P42262,Glutamate receptor 2,GRIA2,883.0
5948,DB01355,Hexobarbital,SmallMoleculeDrug,Q13002,"Glutamate receptor ionotropic, kainate 2",GRIK2,908.0
5949,DB01356,Lithium,SmallMoleculeDrug,P49841,Glycogen synthase kinase-3 beta,GSK3B,420.0
5950,DB01356,Lithium,SmallMoleculeDrug,P29218,Inositol monophosphatase 1,IMPA1,277.0
5951,DB01356,Lithium,SmallMoleculeDrug,O14732,Inositol monophosphatase 2,IMPA2,288.0
5952,DB01356,Lithium,SmallMoleculeDrug,P42263,Glutamate receptor 3,GRIA3,894.0
5953,DB01357,Mestranol,SmallMoleculeDrug,P03372,Estrogen receptor,ESR1,595.0
5954,DB01359,Penbutolol,SmallMoleculeDrug,P08588,Beta-1 adrenergic receptor,ADRB1,477.0
5955,DB01359,Penbutolol,SmallMoleculeDrug,P07550,Beta-2 adrenergic receptor,ADRB2,413.0
5956,DB01359,Penbutolol,SmallMoleculeDrug,P08908,5-hydroxytryptamine receptor 1A,HTR1A,422.0
5957,DB01359,Penbutolol,SmallMoleculeDrug,P28222,5-hydroxytryptamine receptor 1B,HTR1B,390.0
5960,DB01363,Ephedra,SmallMoleculeDrug,Q01959,Sodium-dependent dopamine transporter,SLC6A3,620.0
5961,DB01363,Ephedra,SmallMoleculeDrug,P23975,Sodium-dependent noradrenaline transporter,SLC6A2,617.0
5962,DB01363,Ephedra,SmallMoleculeDrug,P08913,Alpha-2A adrenergic receptor,ADRA2A,450.0
5963,DB01363,Ephedra,SmallMoleculeDrug,P18089,Alpha-2B adrenergic receptor,ADRA2B,450.0
5964,DB01363,Ephedra,SmallMoleculeDrug,P18825,Alpha-2C adrenergic receptor,ADRA2C,462.0
5965,DB01363,Ephedra,SmallMoleculeDrug,P21397,Amine oxidase [flavin-containing] A,MAOA,527.0
5966,DB01363,Ephedra,SmallMoleculeDrug,P27338,Amine oxidase [flavin-containing] B,MAOB,520.0
5967,DB01363,Ephedra,SmallMoleculeDrug,P08588,Beta-1 adrenergic receptor,ADRB1,477.0
5968,DB01363,Ephedra,SmallMoleculeDrug,P07550,Beta-2 adrenergic receptor,ADRB2,413.0
5969,DB01363,Ephedra,SmallMoleculeDrug,P13945,Beta-3 adrenergic receptor,ADRB3,408.0
5970,DB01363,Ephedra,SmallMoleculeDrug,P31645,Sodium-dependent serotonin transporter,SLC6A4,630.0
5971,DB01363,Ephedra,SmallMoleculeDrug,Q05940,Synaptic vesicular amine transporter,SLC18A2,514.0
5972,DB01363,Ephedra,SmallMoleculeDrug,P54219,Chromaffin granule amine transporter,SLC18A1,525.0
5973,DB01364,Ephedrine,SmallMoleculeDrug,P23975,Sodium-dependent noradrenaline transporter,SLC6A2,617.0
5974,DB01364,Ephedrine,SmallMoleculeDrug,P35348,Alpha-1A adrenergic receptor,ADRA1A,466.0
5975,DB01364,Ephedrine,SmallMoleculeDrug,Q05940,Synaptic vesicular amine transporter,SLC18A2,514.0
5976,DB01364,Ephedrine,SmallMoleculeDrug,P22303,Acetylcholinesterase,ACHE,614.0
5977,DB01365,Mephentermine,SmallMoleculeDrug,P35348,Alpha-1A adrenergic receptor,ADRA1A,466.0
5978,DB01365,Mephentermine,SmallMoleculeDrug,P35368,Alpha-1B adrenergic receptor,ADRA1B,520.0
5979,DB01365,Mephentermine,SmallMoleculeDrug,P25100,Alpha-1D adrenergic receptor,ADRA1D,572.0
5980,DB01365,Mephentermine,SmallMoleculeDrug,P08913,Alpha-2A adrenergic receptor,ADRA2A,450.0
5981,DB01365,Mephentermine,SmallMoleculeDrug,P18089,Alpha-2B adrenergic receptor,ADRA2B,450.0
5982,DB01365,Mephentermine,SmallMoleculeDrug,P18825,Alpha-2C adrenergic receptor,ADRA2C,462.0
5983,DB01365,Mephentermine,SmallMoleculeDrug,P08588,Beta-1 adrenergic receptor,ADRB1,477.0
5984,DB01365,Mephentermine,SmallMoleculeDrug,P07550,Beta-2 adrenergic receptor,ADRB2,413.0
5985,DB01365,Mephentermine,SmallMoleculeDrug,P13945,Beta-3 adrenergic receptor,ADRB3,408.0
5986,DB01366,Procaterol,SmallMoleculeDrug,P07550,Beta-2 adrenergic receptor,ADRB2,413.0
5987,DB01367,Rasagiline,SmallMoleculeDrug,P27338,Amine oxidase [flavin-containing] B,MAOB,520.0
5988,DB01367,Rasagiline,SmallMoleculeDrug,P10415,Apoptosis regulator Bcl-2,BCL2,239.0
5991,DB01370,Aluminium,SmallMoleculeDrug,P02787,Serotransferrin,TF,698.0
5992,DB01370,Aluminium,SmallMoleculeDrug,P05023,Sodium/potassium-transporting ATPase subunit alpha-1,ATP1A1,1023.0
5993,DB01373,Calcium,SmallMoleculeDrug,Q13936,Voltage-dependent L-type calcium channel subunit alpha-1C,CACNA1C,2221.0
5994,DB01373,Calcium,SmallMoleculeDrug,P98194,Calcium-transporting ATPase type 2C member 1,ATP2C1,919.0
5995,DB01373,Calcium,SmallMoleculeDrug,P02585,"Troponin C, skeletal muscle",TNNC2,160.0
5996,DB01373,Calcium,SmallMoleculeDrug,P63316,"Troponin C, slow skeletal and cardiac muscles",TNNC1,161.0
5997,DB01373,Calcium,SmallMoleculeDrug,Q01082,"Spectrin beta chain, non-erythrocytic 1",SPTBN1,2364.0
5998,DB01373,Calcium,SmallMoleculeDrug,P04271,Protein S100-B,S100B,92.0
5999,DB01373,Calcium,SmallMoleculeDrug,P20810,Calpastatin,CAST,708.0
6000,DB01373,Calcium,SmallMoleculeDrug,P49747,Cartilage oligomeric matrix protein,COMP,757.0
6002,DB01375,Aluminium monostearate,SmallMoleculeDrug,P63316,"Troponin C, slow skeletal and cardiac muscles",TNNC1,161.0
6003,DB01375,Aluminium monostearate,SmallMoleculeDrug,P21796,Voltage-dependent anion-selective channel protein 1,VDAC1,283.0
6004,DB01375,Aluminium monostearate,SmallMoleculeDrug,P45880,Voltage-dependent anion-selective channel protein 2,VDAC2,294.0
6005,DB01375,Aluminium monostearate,SmallMoleculeDrug,Q9Y277,Voltage-dependent anion-selective channel protein 3,VDAC3,283.0
6006,DB01378,Magnesium,SmallMoleculeDrug,P05023,Sodium/potassium-transporting ATPase subunit alpha-1,ATP1A1,1023.0
6007,DB01380,Cortisone acetate,SmallMoleculeDrug,P04150,Glucocorticoid receptor,NR3C1,777.0
6008,DB01381,Ginkgo biloba,SmallMoleculeDrug,P23975,Sodium-dependent noradrenaline transporter,SLC6A2,617.0
6009,DB01381,Ginkgo biloba,SmallMoleculeDrug,P14555,"Phospholipase A2, membrane associated",PLA2G2A,144.0
6010,DB01381,Ginkgo biloba,SmallMoleculeDrug,P23415,Glycine receptor subunit alpha-1,GLRA1,457.0
6011,DB01381,Ginkgo biloba,SmallMoleculeDrug,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,456.0
6012,DB01381,Ginkgo biloba,SmallMoleculeDrug,P47870,Gamma-aminobutyric acid receptor subunit beta-2,GABRB2,512.0
6013,DB01381,Ginkgo biloba,SmallMoleculeDrug,P18507,Gamma-aminobutyric acid receptor subunit gamma-2,GABRG2,467.0
6014,DB01382,Glycodiazine,SmallMoleculeDrug,P48048,ATP-sensitive inward rectifier potassium channel 1,KCNJ1,391.0
6015,DB01382,Glycodiazine,SmallMoleculeDrug,Q09428,ATP-binding cassette sub-family C member 8,ABCC8,1581.0
6016,DB01384,Paramethasone,SmallMoleculeDrug,P04150,Glucocorticoid receptor,NR3C1,777.0
6017,DB01388,Mibefradil,SmallMoleculeDrug,O43497,Voltage-dependent T-type calcium channel subunit alpha-1G,CACNA1G,2377.0
6018,DB01388,Mibefradil,SmallMoleculeDrug,O95180,Voltage-dependent T-type calcium channel subunit alpha-1H,CACNA1H,2353.0
6019,DB01388,Mibefradil,SmallMoleculeDrug,Q13936,Voltage-dependent L-type calcium channel subunit alpha-1C,CACNA1C,2221.0
6020,DB01388,Mibefradil,SmallMoleculeDrug,Q01668,Voltage-dependent L-type calcium channel subunit alpha-1D,CACNA1D,2161.0
6021,DB01388,Mibefradil,SmallMoleculeDrug,O60840,Voltage-dependent L-type calcium channel subunit alpha-1F,CACNA1F,1977.0
6022,DB01388,Mibefradil,SmallMoleculeDrug,Q9P0X4,Voltage-dependent T-type calcium channel subunit alpha-1I,CACNA1I,2223.0
6023,DB01388,Mibefradil,SmallMoleculeDrug,Q13698,Voltage-dependent L-type calcium channel subunit alpha-1S,CACNA1S,1873.0
6024,DB01388,Mibefradil,SmallMoleculeDrug,Q02641,Voltage-dependent L-type calcium channel subunit beta-1,CACNB1,598.0
6025,DB01388,Mibefradil,SmallMoleculeDrug,Q08289,Voltage-dependent L-type calcium channel subunit beta-2,CACNB2,660.0
6026,DB01388,Mibefradil,SmallMoleculeDrug,P54284,Voltage-dependent L-type calcium channel subunit beta-3,CACNB3,484.0
6027,DB01388,Mibefradil,SmallMoleculeDrug,O00305,Voltage-dependent L-type calcium channel subunit beta-4,CACNB4,520.0
6028,DB01392,Yohimbine,SmallMoleculeDrug,P08913,Alpha-2A adrenergic receptor,ADRA2A,450.0
6029,DB01392,Yohimbine,SmallMoleculeDrug,P18089,Alpha-2B adrenergic receptor,ADRA2B,450.0
6030,DB01392,Yohimbine,SmallMoleculeDrug,P18825,Alpha-2C adrenergic receptor,ADRA2C,462.0
6031,DB01392,Yohimbine,SmallMoleculeDrug,P08908,5-hydroxytryptamine receptor 1A,HTR1A,422.0
6032,DB01392,Yohimbine,SmallMoleculeDrug,P28222,5-hydroxytryptamine receptor 1B,HTR1B,390.0
6033,DB01392,Yohimbine,SmallMoleculeDrug,P28221,5-hydroxytryptamine receptor 1D,HTR1D,377.0
6034,DB01392,Yohimbine,SmallMoleculeDrug,P14416,D(2) dopamine receptor,DRD2,443.0
6035,DB01392,Yohimbine,SmallMoleculeDrug,P35462,D(3) dopamine receptor,DRD3,400.0
6036,DB01392,Yohimbine,SmallMoleculeDrug,P28223,5-hydroxytryptamine receptor 2A,HTR2A,471.0
6037,DB01392,Yohimbine,SmallMoleculeDrug,P28335,5-hydroxytryptamine receptor 2C,HTR2C,458.0
6038,DB01392,Yohimbine,SmallMoleculeDrug,P48048,ATP-sensitive inward rectifier potassium channel 1,KCNJ1,391.0
6039,DB01392,Yohimbine,SmallMoleculeDrug,P78508,ATP-sensitive inward rectifier potassium channel 10,KCNJ10,379.0
6040,DB01392,Yohimbine,SmallMoleculeDrug,Q14654,ATP-sensitive inward rectifier potassium channel 11,KCNJ11,390.0
6041,DB01392,Yohimbine,SmallMoleculeDrug,Q14500,ATP-sensitive inward rectifier potassium channel 12,KCNJ12,433.0
6042,DB01392,Yohimbine,SmallMoleculeDrug,Q9UNX9,ATP-sensitive inward rectifier potassium channel 14,KCNJ14,436.0
6043,DB01392,Yohimbine,SmallMoleculeDrug,Q99712,ATP-sensitive inward rectifier potassium channel 15,KCNJ15,375.0
6044,DB01392,Yohimbine,SmallMoleculeDrug,Q15842,ATP-sensitive inward rectifier potassium channel 8,KCNJ8,424.0
6045,DB01392,Yohimbine,SmallMoleculeDrug,P41595,5-hydroxytryptamine receptor 2B,HTR2B,481.0
6046,DB01393,Bezafibrate,SmallMoleculeDrug,Q07869,Peroxisome proliferator-activated receptor alpha,PPARA,468.0
6047,DB01393,Bezafibrate,SmallMoleculeDrug,Q03181,Peroxisome proliferator-activated receptor delta,PPARD,441.0
6048,DB01393,Bezafibrate,SmallMoleculeDrug,P37231,Peroxisome proliferator-activated receptor gamma,PPARG,505.0
6049,DB01394,Colchicine,SmallMoleculeDrug,Q9H4B7,Tubulin beta-1 chain,TUBB1,451.0
6050,DB01394,Colchicine,SmallMoleculeDrug,P07437,Tubulin beta chain,TUBB,444.0
6051,DB01395,Drospirenone,SmallMoleculeDrug,P06401,Progesterone receptor,PGR,933.0
6052,DB01395,Drospirenone,SmallMoleculeDrug,P08235,Mineralocorticoid receptor,NR3C2,984.0
6053,DB01395,Drospirenone,SmallMoleculeDrug,P10275,Androgen receptor,AR,920.0
6054,DB01396,Digitoxin,SmallMoleculeDrug,P05023,Sodium/potassium-transporting ATPase subunit alpha-1,ATP1A1,1023.0
6055,DB01397,Magnesium salicylate,SmallMoleculeDrug,P35354,Prostaglandin G/H synthase 2,PTGS2,604.0
6056,DB01397,Magnesium salicylate,SmallMoleculeDrug,P23219,Prostaglandin G/H synthase 1,PTGS1,599.0
6057,DB01399,Salsalate,SmallMoleculeDrug,P35354,Prostaglandin G/H synthase 2,PTGS2,604.0
6058,DB01399,Salsalate,SmallMoleculeDrug,P23219,Prostaglandin G/H synthase 1,PTGS1,599.0
6059,DB01400,Neostigmine,SmallMoleculeDrug,P22303,Acetylcholinesterase,ACHE,614.0
6060,DB01401,Trisalicylate-choline,SmallMoleculeDrug,P23219,Prostaglandin G/H synthase 1,PTGS1,599.0
6061,DB01401,Trisalicylate-choline,SmallMoleculeDrug,P35354,Prostaglandin G/H synthase 2,PTGS2,604.0
6062,DB01403,Methotrimeprazine,SmallMoleculeDrug,P14416,D(2) dopamine receptor,DRD2,443.0
6063,DB01403,Methotrimeprazine,SmallMoleculeDrug,P21728,D(1A) dopamine receptor,DRD1,446.0
6064,DB01403,Methotrimeprazine,SmallMoleculeDrug,P21918,D(1B) dopamine receptor,DRD5,477.0
6065,DB01403,Methotrimeprazine,SmallMoleculeDrug,P35462,D(3) dopamine receptor,DRD3,400.0
6066,DB01403,Methotrimeprazine,SmallMoleculeDrug,P21917,D(4) dopamine receptor,DRD4,467.0
6067,DB01403,Methotrimeprazine,SmallMoleculeDrug,P28223,5-hydroxytryptamine receptor 2A,HTR2A,471.0
6068,DB01403,Methotrimeprazine,SmallMoleculeDrug,P28335,5-hydroxytryptamine receptor 2C,HTR2C,458.0
6069,DB01403,Methotrimeprazine,SmallMoleculeDrug,P35367,Histamine H1 receptor,HRH1,487.0
6070,DB01403,Methotrimeprazine,SmallMoleculeDrug,P11229,Muscarinic acetylcholine receptor M1,CHRM1,460.0
6071,DB01403,Methotrimeprazine,SmallMoleculeDrug,P08172,Muscarinic acetylcholine receptor M2,CHRM2,466.0
6072,DB01403,Methotrimeprazine,SmallMoleculeDrug,P20309,Muscarinic acetylcholine receptor M3,CHRM3,590.0
6073,DB01403,Methotrimeprazine,SmallMoleculeDrug,P08173,Muscarinic acetylcholine receptor M4,CHRM4,479.0
6074,DB01403,Methotrimeprazine,SmallMoleculeDrug,P08912,Muscarinic acetylcholine receptor M5,CHRM5,532.0
6075,DB01403,Methotrimeprazine,SmallMoleculeDrug,P35348,Alpha-1A adrenergic receptor,ADRA1A,466.0
6076,DB01403,Methotrimeprazine,SmallMoleculeDrug,P35368,Alpha-1B adrenergic receptor,ADRA1B,520.0
6077,DB01403,Methotrimeprazine,SmallMoleculeDrug,P25100,Alpha-1D adrenergic receptor,ADRA1D,572.0
6078,DB01403,Methotrimeprazine,SmallMoleculeDrug,P08913,Alpha-2A adrenergic receptor,ADRA2A,450.0
6079,DB01403,Methotrimeprazine,SmallMoleculeDrug,P18089,Alpha-2B adrenergic receptor,ADRA2B,450.0
6080,DB01403,Methotrimeprazine,SmallMoleculeDrug,P18825,Alpha-2C adrenergic receptor,ADRA2C,462.0
6081,DB01404,Ginseng,SmallMoleculeDrug,P05231,Interleukin-6,IL6,212.0
6082,DB01404,Ginseng,SmallMoleculeDrug,P35354,Prostaglandin G/H synthase 2,PTGS2,604.0
6083,DB01404,Ginseng,SmallMoleculeDrug,P35869,Aryl hydrocarbon receptor,AHR,848.0
6086,DB01406,Danazol,SmallMoleculeDrug,P03372,Estrogen receptor,ESR1,595.0
6087,DB01406,Danazol,SmallMoleculeDrug,P10275,Androgen receptor,AR,920.0
6088,DB01406,Danazol,SmallMoleculeDrug,P06401,Progesterone receptor,PGR,933.0
6089,DB01406,Danazol,SmallMoleculeDrug,P30968,Gonadotropin-releasing hormone receptor,GNRHR,328.0
6090,DB01406,Danazol,SmallMoleculeDrug,Q96P88,Putative gonadotropin-releasing hormone II receptor,GNRHR2,292.0
6091,DB01406,Danazol,SmallMoleculeDrug,P13500,C-C motif chemokine 2,CCL2,99.0
6092,DB01407,Clenbuterol,SmallMoleculeDrug,P07550,Beta-2 adrenergic receptor,ADRB2,413.0
6093,DB01407,Clenbuterol,SmallMoleculeDrug,P08588,Beta-1 adrenergic receptor,ADRB1,477.0
6094,DB01407,Clenbuterol,SmallMoleculeDrug,P13945,Beta-3 adrenergic receptor,ADRB3,408.0
6095,DB01407,Clenbuterol,SmallMoleculeDrug,P01138,Beta-nerve growth factor,NGF,241.0
6096,DB01407,Clenbuterol,SmallMoleculeDrug,P01375,Tumor necrosis factor,TNF,233.0
6097,DB01408,Bambuterol,SmallMoleculeDrug,P07550,Beta-2 adrenergic receptor,ADRB2,413.0
6098,DB01409,Tiotropium,SmallMoleculeDrug,P20309,Muscarinic acetylcholine receptor M3,CHRM3,590.0
6099,DB01409,Tiotropium,SmallMoleculeDrug,P11229,Muscarinic acetylcholine receptor M1,CHRM1,460.0
6100,DB01409,Tiotropium,SmallMoleculeDrug,P08172,Muscarinic acetylcholine receptor M2,CHRM2,466.0
6101,DB01410,Ciclesonide,SmallMoleculeDrug,P04150,Glucocorticoid receptor,NR3C1,777.0
6102,DB01411,Pranlukast,SmallMoleculeDrug,Q9Y271,Cysteinyl leukotriene receptor 1,CYSLTR1,337.0
6103,DB01411,Pranlukast,SmallMoleculeDrug,P01375,Tumor necrosis factor,TNF,233.0
6104,DB01411,Pranlukast,SmallMoleculeDrug,P05113,Interleukin-5,IL5,134.0
6105,DB01411,Pranlukast,SmallMoleculeDrug,P12724,Eosinophil cationic protein,RNASE3,160.0
6106,DB01411,Pranlukast,SmallMoleculeDrug,P19838,Nuclear factor NF-kappa-B p105 subunit,NFKB1,968.0
6107,DB01411,Pranlukast,SmallMoleculeDrug,Q02817,Mucin-2,MUC2,5179.0
6108,DB01412,Theobromine,SmallMoleculeDrug,P30542,Adenosine receptor A1,ADORA1,326.0
6109,DB01412,Theobromine,SmallMoleculeDrug,P29274,Adenosine receptor A2a,ADORA2A,412.0
6110,DB01412,Theobromine,SmallMoleculeDrug,Q07343,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B",PDE4B,736.0
6122,DB01418,Acenocoumarol,SmallMoleculeDrug,Q9BQB6,Vitamin K epoxide reductase complex subunit 1,VKORC1,163.0
6123,DB01419,Antrafenine,SmallMoleculeDrug,P23219,Prostaglandin G/H synthase 1,PTGS1,599.0
6124,DB01419,Antrafenine,SmallMoleculeDrug,P35354,Prostaglandin G/H synthase 2,PTGS2,604.0
6125,DB01420,Testosterone Propionate,SmallMoleculeDrug,P10275,Androgen receptor,AR,920.0
6127,DB01422,Nitroxoline,SmallMoleculeDrug,P50579,Methionine aminopeptidase 2,METAP2,478.0
6128,DB01425,Alizapride,SmallMoleculeDrug,P14416,D(2) dopamine receptor,DRD2,443.0
6129,DB01426,Ajmaline,SmallMoleculeDrug,Q14524,Sodium channel protein type 5 subunit alpha,SCN5A,2016.0
6130,DB01427,Amrinone,SmallMoleculeDrug,Q14432,"cGMP-inhibited 3',5'-cyclic phosphodiesterase A",PDE3A,1141.0
6131,DB01427,Amrinone,SmallMoleculeDrug,Q07343,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B",PDE4B,736.0
6132,DB01427,Amrinone,SmallMoleculeDrug,P01375,Tumor necrosis factor,TNF,233.0
6133,DB01429,Aprindine,SmallMoleculeDrug,Q14524,Sodium channel protein type 5 subunit alpha,SCN5A,2016.0
6135,DB01430,Almitrine,SmallMoleculeDrug,P05023,Sodium/potassium-transporting ATPase subunit alpha-1,ATP1A1,1023.0
6136,DB01431,Allylestrenol,SmallMoleculeDrug,P06401,Progesterone receptor,PGR,933.0
6137,DB01431,Allylestrenol,SmallMoleculeDrug,P03372,Estrogen receptor,ESR1,595.0
6138,DB01433,Methadyl Acetate,SmallMoleculeDrug,P35372,Mu-type opioid receptor,OPRM1,400.0
6139,DB01435,Antipyrine,SmallMoleculeDrug,P35354,Prostaglandin G/H synthase 2,PTGS2,604.0
6140,DB01435,Antipyrine,SmallMoleculeDrug,P23219,Prostaglandin G/H synthase 1,PTGS1,599.0
6141,DB01436,Alfacalcidol,SmallMoleculeDrug,P11473,Vitamin D3 receptor,VDR,427.0
6142,DB01436,Alfacalcidol,SmallMoleculeDrug,O15528,"25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial",CYP27B1,508.0
6143,DB01437,Glutethimide,SmallMoleculeDrug,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,456.0
6144,DB01437,Glutethimide,SmallMoleculeDrug,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,456.0
6145,DB01437,Glutethimide,SmallMoleculeDrug,P47869,Gamma-aminobutyric acid receptor subunit alpha-2,GABRA2,451.0
6146,DB01437,Glutethimide,SmallMoleculeDrug,P34903,Gamma-aminobutyric acid receptor subunit alpha-3,GABRA3,492.0
6147,DB01437,Glutethimide,SmallMoleculeDrug,P48169,Gamma-aminobutyric acid receptor subunit alpha-4,GABRA4,554.0
6148,DB01437,Glutethimide,SmallMoleculeDrug,P31644,Gamma-aminobutyric acid receptor subunit alpha-5,GABRA5,462.0
6149,DB01437,Glutethimide,SmallMoleculeDrug,Q16445,Gamma-aminobutyric acid receptor subunit alpha-6,GABRA6,453.0
6150,DB01437,Glutethimide,SmallMoleculeDrug,P18505,Gamma-aminobutyric acid receptor subunit beta-1,GABRB1,474.0
6151,DB01437,Glutethimide,SmallMoleculeDrug,P47870,Gamma-aminobutyric acid receptor subunit beta-2,GABRB2,512.0
6152,DB01437,Glutethimide,SmallMoleculeDrug,P28472,Gamma-aminobutyric acid receptor subunit beta-3,GABRB3,473.0
6153,DB01437,Glutethimide,SmallMoleculeDrug,O14764,Gamma-aminobutyric acid receptor subunit delta,GABRD,452.0
6154,DB01437,Glutethimide,SmallMoleculeDrug,P78334,Gamma-aminobutyric acid receptor subunit epsilon,GABRE,506.0
6155,DB01437,Glutethimide,SmallMoleculeDrug,Q8N1C3,Gamma-aminobutyric acid receptor subunit gamma-1,GABRG1,465.0
6156,DB01437,Glutethimide,SmallMoleculeDrug,P18507,Gamma-aminobutyric acid receptor subunit gamma-2,GABRG2,467.0
6157,DB01437,Glutethimide,SmallMoleculeDrug,Q99928,Gamma-aminobutyric acid receptor subunit gamma-3,GABRG3,467.0
6158,DB01437,Glutethimide,SmallMoleculeDrug,O00591,Gamma-aminobutyric acid receptor subunit pi,GABRP,440.0
6159,DB01437,Glutethimide,SmallMoleculeDrug,Q9UN88,Gamma-aminobutyric acid receptor subunit theta,GABRQ,632.0
6160,DB01438,Phenazopyridine,SmallMoleculeDrug,P35498,Sodium channel protein type 1 subunit alpha,SCN1A,2009.0
6161,DB01439,3-Methylthiofentanyl,SmallMoleculeDrug,P35372,Mu-type opioid receptor,OPRM1,400.0
6162,DB01439,3-Methylthiofentanyl,SmallMoleculeDrug,P41143,Delta-type opioid receptor,OPRD1,372.0
6163,DB01439,3-Methylthiofentanyl,SmallMoleculeDrug,P41145,Kappa-type opioid receptor,OPRK1,380.0
6164,DB01440,Gamma Hydroxybutyric Acid,SmallMoleculeDrug,Q9HAB3,"Solute carrier family 52, riboflavin transporter, member 2",SLC52A2,445.0
6165,DB01440,Gamma Hydroxybutyric Acid,SmallMoleculeDrug,P18505,Gamma-aminobutyric acid receptor subunit beta-1,GABRB1,474.0
6166,DB01442,MMDA,SmallMoleculeDrug,P28223,5-hydroxytryptamine receptor 2A,HTR2A,471.0
6167,DB01442,MMDA,SmallMoleculeDrug,Q01959,Sodium-dependent dopamine transporter,SLC6A3,620.0
6168,DB01442,MMDA,SmallMoleculeDrug,P31645,Sodium-dependent serotonin transporter,SLC6A4,630.0
6169,DB01442,MMDA,SmallMoleculeDrug,P23975,Sodium-dependent noradrenaline transporter,SLC6A2,617.0
6170,DB01442,MMDA,SmallMoleculeDrug,Q05940,Synaptic vesicular amine transporter,SLC18A2,514.0
6171,DB01442,MMDA,SmallMoleculeDrug,P54219,Chromaffin granule amine transporter,SLC18A1,525.0
6172,DB01442,MMDA,SmallMoleculeDrug,P21397,Amine oxidase [flavin-containing] A,MAOA,527.0
6173,DB01442,MMDA,SmallMoleculeDrug,P27338,Amine oxidase [flavin-containing] B,MAOB,520.0
6174,DB01444,Dimethylthiambutene,SmallMoleculeDrug,P35372,Mu-type opioid receptor,OPRM1,400.0
6175,DB01444,Dimethylthiambutene,SmallMoleculeDrug,P41143,Delta-type opioid receptor,OPRD1,372.0
6176,DB01452,Heroin,SmallMoleculeDrug,P35372,Mu-type opioid receptor,OPRM1,400.0
6177,DB01452,Heroin,SmallMoleculeDrug,P41145,Kappa-type opioid receptor,OPRK1,380.0
6178,DB01452,Heroin,SmallMoleculeDrug,P41143,Delta-type opioid receptor,OPRD1,372.0
6179,DB01454,"3,4-Methylenedioxymethamphetamine",SmallMoleculeDrug,P31645,Sodium-dependent serotonin transporter,SLC6A4,630.0
6180,DB01454,"3,4-Methylenedioxymethamphetamine",SmallMoleculeDrug,Q05940,Synaptic vesicular amine transporter,SLC18A2,514.0
6181,DB01454,"3,4-Methylenedioxymethamphetamine",SmallMoleculeDrug,Q01959,Sodium-dependent dopamine transporter,SLC6A3,620.0
6182,DB01454,"3,4-Methylenedioxymethamphetamine",SmallMoleculeDrug,P28223,5-hydroxytryptamine receptor 2A,HTR2A,471.0
6183,DB01454,"3,4-Methylenedioxymethamphetamine",SmallMoleculeDrug,P41595,5-hydroxytryptamine receptor 2B,HTR2B,481.0
6184,DB01454,"3,4-Methylenedioxymethamphetamine",SmallMoleculeDrug,P28335,5-hydroxytryptamine receptor 2C,HTR2C,458.0
6185,DB01454,"3,4-Methylenedioxymethamphetamine",SmallMoleculeDrug,P23975,Sodium-dependent noradrenaline transporter,SLC6A2,617.0
6186,DB01463,Fencamfamine,SmallMoleculeDrug,Q01959,Sodium-dependent dopamine transporter,SLC6A3,620.0
6187,DB01466,Ethylmorphine,SmallMoleculeDrug,P35372,Mu-type opioid receptor,OPRM1,400.0
6188,DB01472,4-Methoxyamphetamine,SmallMoleculeDrug,Q01959,Sodium-dependent dopamine transporter,SLC6A3,620.0
6189,DB01472,4-Methoxyamphetamine,SmallMoleculeDrug,P31645,Sodium-dependent serotonin transporter,SLC6A4,630.0
6190,DB01472,4-Methoxyamphetamine,SmallMoleculeDrug,Q05940,Synaptic vesicular amine transporter,SLC18A2,514.0
6191,DB01472,4-Methoxyamphetamine,SmallMoleculeDrug,P35348,Alpha-1A adrenergic receptor,ADRA1A,466.0
6192,DB01472,4-Methoxyamphetamine,SmallMoleculeDrug,P08913,Alpha-2A adrenergic receptor,ADRA2A,450.0
6193,DB01472,4-Methoxyamphetamine,SmallMoleculeDrug,P21397,Amine oxidase [flavin-containing] A,MAOA,527.0
6194,DB01472,4-Methoxyamphetamine,SmallMoleculeDrug,P27338,Amine oxidase [flavin-containing] B,MAOB,520.0
6195,DB01481,Delta1-dihydrotestosterone,SmallMoleculeDrug,P10275,Androgen receptor,AR,920.0
6196,DB01483,Barbital,SmallMoleculeDrug,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,456.0
6197,DB01483,Barbital,SmallMoleculeDrug,P47869,Gamma-aminobutyric acid receptor subunit alpha-2,GABRA2,451.0
6198,DB01483,Barbital,SmallMoleculeDrug,P34903,Gamma-aminobutyric acid receptor subunit alpha-3,GABRA3,492.0
6199,DB01483,Barbital,SmallMoleculeDrug,P48169,Gamma-aminobutyric acid receptor subunit alpha-4,GABRA4,554.0
6200,DB01483,Barbital,SmallMoleculeDrug,P31644,Gamma-aminobutyric acid receptor subunit alpha-5,GABRA5,462.0
6201,DB01483,Barbital,SmallMoleculeDrug,Q16445,Gamma-aminobutyric acid receptor subunit alpha-6,GABRA6,453.0
6202,DB01483,Barbital,SmallMoleculeDrug,P43681,Neuronal acetylcholine receptor subunit alpha-4,CHRNA4,627.0
6203,DB01483,Barbital,SmallMoleculeDrug,P36544,Neuronal acetylcholine receptor subunit alpha-7,CHRNA7,502.0
6204,DB01483,Barbital,SmallMoleculeDrug,P42262,Glutamate receptor 2,GRIA2,883.0
6205,DB01483,Barbital,SmallMoleculeDrug,Q13002,"Glutamate receptor ionotropic, kainate 2",GRIK2,908.0
6206,DB01488,Dimethyltryptamine,SmallMoleculeDrug,P50406,5-hydroxytryptamine receptor 6,HTR6,440.0
6207,DB01488,Dimethyltryptamine,SmallMoleculeDrug,P28223,5-hydroxytryptamine receptor 2A,HTR2A,471.0
6208,DB01488,Dimethyltryptamine,SmallMoleculeDrug,Q99720,Sigma non-opioid intracellular receptor 1,SIGMAR1,223.0
6209,DB01496,Barbituric acid derivative,SmallMoleculeDrug,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,456.0
6210,DB01496,Barbituric acid derivative,SmallMoleculeDrug,P47869,Gamma-aminobutyric acid receptor subunit alpha-2,GABRA2,451.0
6211,DB01496,Barbituric acid derivative,SmallMoleculeDrug,P34903,Gamma-aminobutyric acid receptor subunit alpha-3,GABRA3,492.0
6212,DB01496,Barbituric acid derivative,SmallMoleculeDrug,P48169,Gamma-aminobutyric acid receptor subunit alpha-4,GABRA4,554.0
6213,DB01496,Barbituric acid derivative,SmallMoleculeDrug,P31644,Gamma-aminobutyric acid receptor subunit alpha-5,GABRA5,462.0
6214,DB01496,Barbituric acid derivative,SmallMoleculeDrug,Q16445,Gamma-aminobutyric acid receptor subunit alpha-6,GABRA6,453.0
6215,DB01496,Barbituric acid derivative,SmallMoleculeDrug,P43681,Neuronal acetylcholine receptor subunit alpha-4,CHRNA4,627.0
6216,DB01496,Barbituric acid derivative,SmallMoleculeDrug,P36544,Neuronal acetylcholine receptor subunit alpha-7,CHRNA7,502.0
6217,DB01496,Barbituric acid derivative,SmallMoleculeDrug,P42262,Glutamate receptor 2,GRIA2,883.0
6218,DB01496,Barbituric acid derivative,SmallMoleculeDrug,Q13002,"Glutamate receptor ionotropic, kainate 2",GRIK2,908.0
6219,DB01497,Etorphine,SmallMoleculeDrug,P35372,Mu-type opioid receptor,OPRM1,400.0
6220,DB01497,Etorphine,SmallMoleculeDrug,P41143,Delta-type opioid receptor,OPRD1,372.0
6221,DB01497,Etorphine,SmallMoleculeDrug,P41145,Kappa-type opioid receptor,OPRK1,380.0
6222,DB01497,Etorphine,SmallMoleculeDrug,P41146,Nociceptin receptor,OPRL1,370.0
6223,DB01497,Etorphine,SmallMoleculeDrug,O60858,E3 ubiquitin-protein ligase TRIM13,TRIM13,407.0
6224,DB01497,Etorphine,SmallMoleculeDrug,P01189,Pro-opiomelanocortin,POMC,267.0
6225,DB01520,Tenocyclidine,SmallMoleculeDrug,Q8TCU5,"Glutamate receptor ionotropic, NMDA 3A",GRIN3A,1115.0
6226,DB01520,Tenocyclidine,SmallMoleculeDrug,O60391,"Glutamate receptor ionotropic, NMDA 3B",GRIN3B,1043.0
6227,DB01520,Tenocyclidine,SmallMoleculeDrug,Q12879,"Glutamate receptor ionotropic, NMDA 2A",GRIN2A,1464.0
6228,DB01520,Tenocyclidine,SmallMoleculeDrug,Q14957,"Glutamate receptor ionotropic, NMDA 2C",GRIN2C,1233.0
6229,DB01520,Tenocyclidine,SmallMoleculeDrug,Q13224,"Glutamate receptor ionotropic, NMDA 2B",GRIN2B,1484.0
6230,DB01520,Tenocyclidine,SmallMoleculeDrug,O15399,"Glutamate receptor ionotropic, NMDA 2D",GRIN2D,1336.0
6231,DB01520,Tenocyclidine,SmallMoleculeDrug,Q693P7,Alpha-7 nicotinic cholinergic receptor subunit,CHRNA7,28.0
6232,DB01535,Carfentanil,SmallMoleculeDrug,P35372,Mu-type opioid receptor,OPRM1,400.0
6233,DB01535,Carfentanil,SmallMoleculeDrug,P41143,Delta-type opioid receptor,OPRD1,372.0
6234,DB01535,Carfentanil,SmallMoleculeDrug,P41145,Kappa-type opioid receptor,OPRK1,380.0
6235,DB01536,4-Androstenedione,SmallMoleculeDrug,P14061,Estradiol 17-beta-dehydrogenase 1,HSD17B1,328.0
6236,DB01536,4-Androstenedione,SmallMoleculeDrug,P14060,3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 1,HSD3B1,373.0
6238,DB01536,4-Androstenedione,SmallMoleculeDrug,P42330,Aldo-keto reductase family 1 member C3,AKR1C3,323.0
6239,DB01541,Boldenone,SmallMoleculeDrug,P10275,Androgen receptor,AR,920.0
6240,DB01544,Flunitrazepam,SmallMoleculeDrug,P30536,Translocator protein,TSPO,169.0
6241,DB01544,Flunitrazepam,SmallMoleculeDrug,P47869,Gamma-aminobutyric acid receptor subunit alpha-2,GABRA2,451.0
6242,DB01544,Flunitrazepam,SmallMoleculeDrug,P48169,Gamma-aminobutyric acid receptor subunit alpha-4,GABRA4,554.0
6243,DB01544,Flunitrazepam,SmallMoleculeDrug,P31644,Gamma-aminobutyric acid receptor subunit alpha-5,GABRA5,462.0
6244,DB01544,Flunitrazepam,SmallMoleculeDrug,Q16445,Gamma-aminobutyric acid receptor subunit alpha-6,GABRA6,453.0
6245,DB01544,Flunitrazepam,SmallMoleculeDrug,P34903,Gamma-aminobutyric acid receptor subunit alpha-3,GABRA3,492.0
6246,DB01548,Diprenorphine,SmallMoleculeDrug,P35372,Mu-type opioid receptor,OPRM1,400.0
6247,DB01548,Diprenorphine,SmallMoleculeDrug,P41143,Delta-type opioid receptor,OPRD1,372.0
6248,DB01548,Diprenorphine,SmallMoleculeDrug,P41145,Kappa-type opioid receptor,OPRK1,380.0
6249,DB01548,Diprenorphine,SmallMoleculeDrug,O60858,E3 ubiquitin-protein ligase TRIM13,TRIM13,407.0
6250,DB01549,Rolicyclidine,SmallMoleculeDrug,Q8TCU5,"Glutamate receptor ionotropic, NMDA 3A",GRIN3A,1115.0
6251,DB01549,Rolicyclidine,SmallMoleculeDrug,P14416,D(2) dopamine receptor,DRD2,443.0
6252,DB01558,Bromazepam,SmallMoleculeDrug,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,456.0
6253,DB01558,Bromazepam,SmallMoleculeDrug,P47869,Gamma-aminobutyric acid receptor subunit alpha-2,GABRA2,451.0
6254,DB01558,Bromazepam,SmallMoleculeDrug,P34903,Gamma-aminobutyric acid receptor subunit alpha-3,GABRA3,492.0
6255,DB01558,Bromazepam,SmallMoleculeDrug,P48169,Gamma-aminobutyric acid receptor subunit alpha-4,GABRA4,554.0
6256,DB01558,Bromazepam,SmallMoleculeDrug,P31644,Gamma-aminobutyric acid receptor subunit alpha-5,GABRA5,462.0
6257,DB01558,Bromazepam,SmallMoleculeDrug,Q16445,Gamma-aminobutyric acid receptor subunit alpha-6,GABRA6,453.0
6258,DB01558,Bromazepam,SmallMoleculeDrug,P18505,Gamma-aminobutyric acid receptor subunit beta-1,GABRB1,474.0
6259,DB01558,Bromazepam,SmallMoleculeDrug,P47870,Gamma-aminobutyric acid receptor subunit beta-2,GABRB2,512.0
6260,DB01558,Bromazepam,SmallMoleculeDrug,P28472,Gamma-aminobutyric acid receptor subunit beta-3,GABRB3,473.0
6261,DB01558,Bromazepam,SmallMoleculeDrug,Q8N1C3,Gamma-aminobutyric acid receptor subunit gamma-1,GABRG1,465.0
6262,DB01558,Bromazepam,SmallMoleculeDrug,P18507,Gamma-aminobutyric acid receptor subunit gamma-2,GABRG2,467.0
6263,DB01558,Bromazepam,SmallMoleculeDrug,Q99928,Gamma-aminobutyric acid receptor subunit gamma-3,GABRG3,467.0
6264,DB01558,Bromazepam,SmallMoleculeDrug,O14764,Gamma-aminobutyric acid receptor subunit delta,GABRD,452.0
6265,DB01558,Bromazepam,SmallMoleculeDrug,P78334,Gamma-aminobutyric acid receptor subunit epsilon,GABRE,506.0
6266,DB01558,Bromazepam,SmallMoleculeDrug,O00591,Gamma-aminobutyric acid receptor subunit pi,GABRP,440.0
6267,DB01558,Bromazepam,SmallMoleculeDrug,P24046,Gamma-aminobutyric acid receptor subunit rho-1,GABRR1,479.0
6268,DB01558,Bromazepam,SmallMoleculeDrug,P28476,Gamma-aminobutyric acid receptor subunit rho-2,GABRR2,465.0
6269,DB01558,Bromazepam,SmallMoleculeDrug,A8MPY1,Gamma-aminobutyric acid receptor subunit rho-3,GABRR3,467.0
6270,DB01558,Bromazepam,SmallMoleculeDrug,Q9UN88,Gamma-aminobutyric acid receptor subunit theta,GABRQ,632.0
6271,DB01559,Clotiazepam,SmallMoleculeDrug,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,456.0
6272,DB01559,Clotiazepam,SmallMoleculeDrug,P47869,Gamma-aminobutyric acid receptor subunit alpha-2,GABRA2,451.0
6273,DB01559,Clotiazepam,SmallMoleculeDrug,P34903,Gamma-aminobutyric acid receptor subunit alpha-3,GABRA3,492.0
6274,DB01559,Clotiazepam,SmallMoleculeDrug,P31644,Gamma-aminobutyric acid receptor subunit alpha-5,GABRA5,462.0
6275,DB01559,Clotiazepam,SmallMoleculeDrug,Q8N1C3,Gamma-aminobutyric acid receptor subunit gamma-1,GABRG1,465.0
6276,DB01559,Clotiazepam,SmallMoleculeDrug,P18507,Gamma-aminobutyric acid receptor subunit gamma-2,GABRG2,467.0
6277,DB01559,Clotiazepam,SmallMoleculeDrug,Q99928,Gamma-aminobutyric acid receptor subunit gamma-3,GABRG3,467.0
6278,DB01559,Clotiazepam,SmallMoleculeDrug,P18505,Gamma-aminobutyric acid receptor subunit beta-1,GABRB1,474.0
6279,DB01559,Clotiazepam,SmallMoleculeDrug,P47870,Gamma-aminobutyric acid receptor subunit beta-2,GABRB2,512.0
6280,DB01559,Clotiazepam,SmallMoleculeDrug,P28472,Gamma-aminobutyric acid receptor subunit beta-3,GABRB3,473.0
6281,DB01559,Clotiazepam,SmallMoleculeDrug,O14764,Gamma-aminobutyric acid receptor subunit delta,GABRD,452.0
6282,DB01559,Clotiazepam,SmallMoleculeDrug,P78334,Gamma-aminobutyric acid receptor subunit epsilon,GABRE,506.0
6283,DB01559,Clotiazepam,SmallMoleculeDrug,O00591,Gamma-aminobutyric acid receptor subunit pi,GABRP,440.0
6284,DB01559,Clotiazepam,SmallMoleculeDrug,P24046,Gamma-aminobutyric acid receptor subunit rho-1,GABRR1,479.0
6285,DB01559,Clotiazepam,SmallMoleculeDrug,P28476,Gamma-aminobutyric acid receptor subunit rho-2,GABRR2,465.0
6286,DB01559,Clotiazepam,SmallMoleculeDrug,A8MPY1,Gamma-aminobutyric acid receptor subunit rho-3,GABRR3,467.0
6287,DB01561,Androstanedione,SmallMoleculeDrug,P14061,Estradiol 17-beta-dehydrogenase 1,HSD17B1,328.0
6289,DB01564,Calusterone,SmallMoleculeDrug,P10275,Androgen receptor,AR,920.0
6290,DB01565,Dihydromorphine,SmallMoleculeDrug,P35372,Mu-type opioid receptor,OPRM1,400.0
6291,DB01565,Dihydromorphine,SmallMoleculeDrug,P41143,Delta-type opioid receptor,OPRD1,372.0
6292,DB01565,Dihydromorphine,SmallMoleculeDrug,P41145,Kappa-type opioid receptor,OPRK1,380.0
6293,DB01565,Dihydromorphine,SmallMoleculeDrug,O60858,E3 ubiquitin-protein ligase TRIM13,TRIM13,407.0
6294,DB01565,Dihydromorphine,SmallMoleculeDrug,P01189,Pro-opiomelanocortin,POMC,267.0
6295,DB01567,Fludiazepam,SmallMoleculeDrug,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,456.0
6296,DB01567,Fludiazepam,SmallMoleculeDrug,P47869,Gamma-aminobutyric acid receptor subunit alpha-2,GABRA2,451.0
6297,DB01567,Fludiazepam,SmallMoleculeDrug,P34903,Gamma-aminobutyric acid receptor subunit alpha-3,GABRA3,492.0
6298,DB01567,Fludiazepam,SmallMoleculeDrug,P31644,Gamma-aminobutyric acid receptor subunit alpha-5,GABRA5,462.0
6299,DB01567,Fludiazepam,SmallMoleculeDrug,Q8N1C3,Gamma-aminobutyric acid receptor subunit gamma-1,GABRG1,465.0
6300,DB01567,Fludiazepam,SmallMoleculeDrug,P18507,Gamma-aminobutyric acid receptor subunit gamma-2,GABRG2,467.0
6301,DB01567,Fludiazepam,SmallMoleculeDrug,Q99928,Gamma-aminobutyric acid receptor subunit gamma-3,GABRG3,467.0
6302,DB01567,Fludiazepam,SmallMoleculeDrug,P18505,Gamma-aminobutyric acid receptor subunit beta-1,GABRB1,474.0
6303,DB01567,Fludiazepam,SmallMoleculeDrug,P47870,Gamma-aminobutyric acid receptor subunit beta-2,GABRB2,512.0
6304,DB01567,Fludiazepam,SmallMoleculeDrug,P28472,Gamma-aminobutyric acid receptor subunit beta-3,GABRB3,473.0
6305,DB01567,Fludiazepam,SmallMoleculeDrug,O14764,Gamma-aminobutyric acid receptor subunit delta,GABRD,452.0
6306,DB01567,Fludiazepam,SmallMoleculeDrug,P78334,Gamma-aminobutyric acid receptor subunit epsilon,GABRE,506.0
6307,DB01567,Fludiazepam,SmallMoleculeDrug,O00591,Gamma-aminobutyric acid receptor subunit pi,GABRP,440.0
6308,DB01567,Fludiazepam,SmallMoleculeDrug,P24046,Gamma-aminobutyric acid receptor subunit rho-1,GABRR1,479.0
6309,DB01567,Fludiazepam,SmallMoleculeDrug,P28476,Gamma-aminobutyric acid receptor subunit rho-2,GABRR2,465.0
6310,DB01567,Fludiazepam,SmallMoleculeDrug,A8MPY1,Gamma-aminobutyric acid receptor subunit rho-3,GABRR3,467.0
6311,DB01569,Formebolone,SmallMoleculeDrug,P80365,Corticosteroid 11-beta-dehydrogenase isozyme 2,HSD11B2,405.0
6312,DB01571,3-Methylfentanyl,SmallMoleculeDrug,P35372,Mu-type opioid receptor,OPRM1,400.0
6313,DB01571,3-Methylfentanyl,SmallMoleculeDrug,P41143,Delta-type opioid receptor,OPRD1,372.0
6314,DB01571,3-Methylfentanyl,SmallMoleculeDrug,P41145,Kappa-type opioid receptor,OPRK1,380.0
6315,DB01576,Dextroamphetamine,SmallMoleculeDrug,Q05940,Synaptic vesicular amine transporter,SLC18A2,514.0
6316,DB01576,Dextroamphetamine,SmallMoleculeDrug,P23975,Sodium-dependent noradrenaline transporter,SLC6A2,617.0
6317,DB01576,Dextroamphetamine,SmallMoleculeDrug,Q01959,Sodium-dependent dopamine transporter,SLC6A3,620.0
6318,DB01576,Dextroamphetamine,SmallMoleculeDrug,Q96RJ0,Trace amine-associated receptor 1,TAAR1,339.0
6319,DB01576,Dextroamphetamine,SmallMoleculeDrug,P35348,Alpha-1A adrenergic receptor,ADRA1A,466.0
6320,DB01576,Dextroamphetamine,SmallMoleculeDrug,P35368,Alpha-1B adrenergic receptor,ADRA1B,520.0
6321,DB01577,Methamphetamine,SmallMoleculeDrug,Q01959,Sodium-dependent dopamine transporter,SLC6A3,620.0
6322,DB01577,Methamphetamine,SmallMoleculeDrug,P31645,Sodium-dependent serotonin transporter,SLC6A4,630.0
6323,DB01577,Methamphetamine,SmallMoleculeDrug,P23975,Sodium-dependent noradrenaline transporter,SLC6A2,617.0
6324,DB01577,Methamphetamine,SmallMoleculeDrug,Q05940,Synaptic vesicular amine transporter,SLC18A2,514.0
6325,DB01577,Methamphetamine,SmallMoleculeDrug,P54219,Chromaffin granule amine transporter,SLC18A1,525.0
6326,DB01577,Methamphetamine,SmallMoleculeDrug,Q96RJ0,Trace amine-associated receptor 1,TAAR1,339.0
6327,DB01577,Methamphetamine,SmallMoleculeDrug,P08913,Alpha-2A adrenergic receptor,ADRA2A,450.0
6328,DB01577,Methamphetamine,SmallMoleculeDrug,P18089,Alpha-2B adrenergic receptor,ADRA2B,450.0
6329,DB01577,Methamphetamine,SmallMoleculeDrug,P18825,Alpha-2C adrenergic receptor,ADRA2C,462.0
6330,DB01577,Methamphetamine,SmallMoleculeDrug,P21397,Amine oxidase [flavin-containing] A,MAOA,527.0
6331,DB01577,Methamphetamine,SmallMoleculeDrug,P27338,Amine oxidase [flavin-containing] B,MAOB,520.0
6332,DB01579,Phendimetrazine,SmallMoleculeDrug,P35348,Alpha-1A adrenergic receptor,ADRA1A,466.0
6333,DB01579,Phendimetrazine,SmallMoleculeDrug,P23975,Sodium-dependent noradrenaline transporter,SLC6A2,617.0
6334,DB01579,Phendimetrazine,SmallMoleculeDrug,P35368,Alpha-1B adrenergic receptor,ADRA1B,520.0
6335,DB01580,Oxprenolol,SmallMoleculeDrug,P08588,Beta-1 adrenergic receptor,ADRB1,477.0
6336,DB01580,Oxprenolol,SmallMoleculeDrug,P07550,Beta-2 adrenergic receptor,ADRB2,413.0
6339,DB01583,Liotrix,SmallMoleculeDrug,P10827,Thyroid hormone receptor alpha,THRA,490.0
6340,DB01583,Liotrix,SmallMoleculeDrug,P10828,Thyroid hormone receptor beta,THRB,461.0
6341,DB01586,Ursodeoxycholic acid,SmallMoleculeDrug,P52895,Aldo-keto reductase family 1 member C2,AKR1C2,323.0
6342,DB01587,Ketazolam,SmallMoleculeDrug,P30536,Translocator protein,TSPO,169.0
6343,DB01587,Ketazolam,SmallMoleculeDrug,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,456.0
6344,DB01587,Ketazolam,SmallMoleculeDrug,P18505,Gamma-aminobutyric acid receptor subunit beta-1,GABRB1,474.0
6345,DB01587,Ketazolam,SmallMoleculeDrug,Q8N1C3,Gamma-aminobutyric acid receptor subunit gamma-1,GABRG1,465.0
6346,DB01587,Ketazolam,SmallMoleculeDrug,O14764,Gamma-aminobutyric acid receptor subunit delta,GABRD,452.0
6347,DB01587,Ketazolam,SmallMoleculeDrug,P78334,Gamma-aminobutyric acid receptor subunit epsilon,GABRE,506.0
6348,DB01588,Prazepam,SmallMoleculeDrug,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,456.0
6349,DB01588,Prazepam,SmallMoleculeDrug,P47869,Gamma-aminobutyric acid receptor subunit alpha-2,GABRA2,451.0
6350,DB01588,Prazepam,SmallMoleculeDrug,P34903,Gamma-aminobutyric acid receptor subunit alpha-3,GABRA3,492.0
6351,DB01588,Prazepam,SmallMoleculeDrug,P31644,Gamma-aminobutyric acid receptor subunit alpha-5,GABRA5,462.0
6352,DB01588,Prazepam,SmallMoleculeDrug,Q8N1C3,Gamma-aminobutyric acid receptor subunit gamma-1,GABRG1,465.0
6353,DB01588,Prazepam,SmallMoleculeDrug,P18507,Gamma-aminobutyric acid receptor subunit gamma-2,GABRG2,467.0
6354,DB01588,Prazepam,SmallMoleculeDrug,Q99928,Gamma-aminobutyric acid receptor subunit gamma-3,GABRG3,467.0
6355,DB01588,Prazepam,SmallMoleculeDrug,P18505,Gamma-aminobutyric acid receptor subunit beta-1,GABRB1,474.0
6356,DB01588,Prazepam,SmallMoleculeDrug,P47870,Gamma-aminobutyric acid receptor subunit beta-2,GABRB2,512.0
6357,DB01588,Prazepam,SmallMoleculeDrug,P28472,Gamma-aminobutyric acid receptor subunit beta-3,GABRB3,473.0
6358,DB01588,Prazepam,SmallMoleculeDrug,O14764,Gamma-aminobutyric acid receptor subunit delta,GABRD,452.0
6359,DB01588,Prazepam,SmallMoleculeDrug,P78334,Gamma-aminobutyric acid receptor subunit epsilon,GABRE,506.0
6360,DB01588,Prazepam,SmallMoleculeDrug,O00591,Gamma-aminobutyric acid receptor subunit pi,GABRP,440.0
6361,DB01588,Prazepam,SmallMoleculeDrug,P24046,Gamma-aminobutyric acid receptor subunit rho-1,GABRR1,479.0
6362,DB01588,Prazepam,SmallMoleculeDrug,P28476,Gamma-aminobutyric acid receptor subunit rho-2,GABRR2,465.0
6363,DB01588,Prazepam,SmallMoleculeDrug,A8MPY1,Gamma-aminobutyric acid receptor subunit rho-3,GABRR3,467.0
6364,DB01588,Prazepam,SmallMoleculeDrug,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,456.0
6365,DB01588,Prazepam,SmallMoleculeDrug,P47869,Gamma-aminobutyric acid receptor subunit alpha-2,GABRA2,451.0
6366,DB01588,Prazepam,SmallMoleculeDrug,P34903,Gamma-aminobutyric acid receptor subunit alpha-3,GABRA3,492.0
6367,DB01588,Prazepam,SmallMoleculeDrug,P48169,Gamma-aminobutyric acid receptor subunit alpha-4,GABRA4,554.0
6368,DB01588,Prazepam,SmallMoleculeDrug,P31644,Gamma-aminobutyric acid receptor subunit alpha-5,GABRA5,462.0
6369,DB01588,Prazepam,SmallMoleculeDrug,Q16445,Gamma-aminobutyric acid receptor subunit alpha-6,GABRA6,453.0
6370,DB01588,Prazepam,SmallMoleculeDrug,P18505,Gamma-aminobutyric acid receptor subunit beta-1,GABRB1,474.0
6371,DB01588,Prazepam,SmallMoleculeDrug,P47870,Gamma-aminobutyric acid receptor subunit beta-2,GABRB2,512.0
6372,DB01588,Prazepam,SmallMoleculeDrug,P28472,Gamma-aminobutyric acid receptor subunit beta-3,GABRB3,473.0
6373,DB01588,Prazepam,SmallMoleculeDrug,O14764,Gamma-aminobutyric acid receptor subunit delta,GABRD,452.0
6374,DB01588,Prazepam,SmallMoleculeDrug,P78334,Gamma-aminobutyric acid receptor subunit epsilon,GABRE,506.0
6375,DB01588,Prazepam,SmallMoleculeDrug,Q8N1C3,Gamma-aminobutyric acid receptor subunit gamma-1,GABRG1,465.0
6376,DB01588,Prazepam,SmallMoleculeDrug,P18507,Gamma-aminobutyric acid receptor subunit gamma-2,GABRG2,467.0
6377,DB01588,Prazepam,SmallMoleculeDrug,Q99928,Gamma-aminobutyric acid receptor subunit gamma-3,GABRG3,467.0
6378,DB01588,Prazepam,SmallMoleculeDrug,O00591,Gamma-aminobutyric acid receptor subunit pi,GABRP,440.0
6379,DB01588,Prazepam,SmallMoleculeDrug,Q9UN88,Gamma-aminobutyric acid receptor subunit theta,GABRQ,632.0
6380,DB01589,Quazepam,SmallMoleculeDrug,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,456.0
6381,DB01589,Quazepam,SmallMoleculeDrug,P47869,Gamma-aminobutyric acid receptor subunit alpha-2,GABRA2,451.0
6382,DB01589,Quazepam,SmallMoleculeDrug,P34903,Gamma-aminobutyric acid receptor subunit alpha-3,GABRA3,492.0
6383,DB01589,Quazepam,SmallMoleculeDrug,P31644,Gamma-aminobutyric acid receptor subunit alpha-5,GABRA5,462.0
6384,DB01589,Quazepam,SmallMoleculeDrug,Q8N1C3,Gamma-aminobutyric acid receptor subunit gamma-1,GABRG1,465.0
6385,DB01589,Quazepam,SmallMoleculeDrug,P18507,Gamma-aminobutyric acid receptor subunit gamma-2,GABRG2,467.0
6386,DB01589,Quazepam,SmallMoleculeDrug,Q99928,Gamma-aminobutyric acid receptor subunit gamma-3,GABRG3,467.0
6387,DB01589,Quazepam,SmallMoleculeDrug,P18505,Gamma-aminobutyric acid receptor subunit beta-1,GABRB1,474.0
6388,DB01589,Quazepam,SmallMoleculeDrug,P28472,Gamma-aminobutyric acid receptor subunit beta-3,GABRB3,473.0
6389,DB01589,Quazepam,SmallMoleculeDrug,O14764,Gamma-aminobutyric acid receptor subunit delta,GABRD,452.0
6390,DB01589,Quazepam,SmallMoleculeDrug,P78334,Gamma-aminobutyric acid receptor subunit epsilon,GABRE,506.0
6391,DB01589,Quazepam,SmallMoleculeDrug,O00591,Gamma-aminobutyric acid receptor subunit pi,GABRP,440.0
6392,DB01589,Quazepam,SmallMoleculeDrug,P24046,Gamma-aminobutyric acid receptor subunit rho-1,GABRR1,479.0
6393,DB01589,Quazepam,SmallMoleculeDrug,P28476,Gamma-aminobutyric acid receptor subunit rho-2,GABRR2,465.0
6394,DB01589,Quazepam,SmallMoleculeDrug,A8MPY1,Gamma-aminobutyric acid receptor subunit rho-3,GABRR3,467.0
6395,DB01589,Quazepam,SmallMoleculeDrug,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,456.0
6396,DB01589,Quazepam,SmallMoleculeDrug,P47869,Gamma-aminobutyric acid receptor subunit alpha-2,GABRA2,451.0
6397,DB01589,Quazepam,SmallMoleculeDrug,P34903,Gamma-aminobutyric acid receptor subunit alpha-3,GABRA3,492.0
6398,DB01589,Quazepam,SmallMoleculeDrug,P48169,Gamma-aminobutyric acid receptor subunit alpha-4,GABRA4,554.0
6399,DB01589,Quazepam,SmallMoleculeDrug,P31644,Gamma-aminobutyric acid receptor subunit alpha-5,GABRA5,462.0
6400,DB01589,Quazepam,SmallMoleculeDrug,Q16445,Gamma-aminobutyric acid receptor subunit alpha-6,GABRA6,453.0
6401,DB01589,Quazepam,SmallMoleculeDrug,P18505,Gamma-aminobutyric acid receptor subunit beta-1,GABRB1,474.0
6402,DB01589,Quazepam,SmallMoleculeDrug,P47870,Gamma-aminobutyric acid receptor subunit beta-2,GABRB2,512.0
6403,DB01589,Quazepam,SmallMoleculeDrug,P28472,Gamma-aminobutyric acid receptor subunit beta-3,GABRB3,473.0
6404,DB01589,Quazepam,SmallMoleculeDrug,O14764,Gamma-aminobutyric acid receptor subunit delta,GABRD,452.0
6405,DB01589,Quazepam,SmallMoleculeDrug,P78334,Gamma-aminobutyric acid receptor subunit epsilon,GABRE,506.0
6406,DB01589,Quazepam,SmallMoleculeDrug,Q8N1C3,Gamma-aminobutyric acid receptor subunit gamma-1,GABRG1,465.0
6407,DB01589,Quazepam,SmallMoleculeDrug,P18507,Gamma-aminobutyric acid receptor subunit gamma-2,GABRG2,467.0
6408,DB01589,Quazepam,SmallMoleculeDrug,Q99928,Gamma-aminobutyric acid receptor subunit gamma-3,GABRG3,467.0
6409,DB01589,Quazepam,SmallMoleculeDrug,O00591,Gamma-aminobutyric acid receptor subunit pi,GABRP,440.0
6410,DB01589,Quazepam,SmallMoleculeDrug,Q9UN88,Gamma-aminobutyric acid receptor subunit theta,GABRQ,632.0
6411,DB01590,Everolimus,SmallMoleculeDrug,P42345,Serine/threonine-protein kinase mTOR,MTOR,2549.0
6412,DB01591,Solifenacin,SmallMoleculeDrug,P20309,Muscarinic acetylcholine receptor M3,CHRM3,590.0
6413,DB01591,Solifenacin,SmallMoleculeDrug,P11229,Muscarinic acetylcholine receptor M1,CHRM1,460.0
6414,DB01591,Solifenacin,SmallMoleculeDrug,P08172,Muscarinic acetylcholine receptor M2,CHRM2,466.0
6415,DB01591,Solifenacin,SmallMoleculeDrug,P08173,Muscarinic acetylcholine receptor M4,CHRM4,479.0
6416,DB01591,Solifenacin,SmallMoleculeDrug,P08912,Muscarinic acetylcholine receptor M5,CHRM5,532.0
6417,DB01594,Cinolazepam,SmallMoleculeDrug,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,456.0
6418,DB01594,Cinolazepam,SmallMoleculeDrug,P47869,Gamma-aminobutyric acid receptor subunit alpha-2,GABRA2,451.0
6419,DB01594,Cinolazepam,SmallMoleculeDrug,P34903,Gamma-aminobutyric acid receptor subunit alpha-3,GABRA3,492.0
6420,DB01594,Cinolazepam,SmallMoleculeDrug,P31644,Gamma-aminobutyric acid receptor subunit alpha-5,GABRA5,462.0
6421,DB01594,Cinolazepam,SmallMoleculeDrug,Q8N1C3,Gamma-aminobutyric acid receptor subunit gamma-1,GABRG1,465.0
6422,DB01594,Cinolazepam,SmallMoleculeDrug,P18507,Gamma-aminobutyric acid receptor subunit gamma-2,GABRG2,467.0
6423,DB01594,Cinolazepam,SmallMoleculeDrug,Q99928,Gamma-aminobutyric acid receptor subunit gamma-3,GABRG3,467.0
6424,DB01594,Cinolazepam,SmallMoleculeDrug,P18505,Gamma-aminobutyric acid receptor subunit beta-1,GABRB1,474.0
6425,DB01594,Cinolazepam,SmallMoleculeDrug,P47870,Gamma-aminobutyric acid receptor subunit beta-2,GABRB2,512.0
6426,DB01594,Cinolazepam,SmallMoleculeDrug,P28472,Gamma-aminobutyric acid receptor subunit beta-3,GABRB3,473.0
6427,DB01594,Cinolazepam,SmallMoleculeDrug,O14764,Gamma-aminobutyric acid receptor subunit delta,GABRD,452.0
6428,DB01594,Cinolazepam,SmallMoleculeDrug,P78334,Gamma-aminobutyric acid receptor subunit epsilon,GABRE,506.0
6429,DB01594,Cinolazepam,SmallMoleculeDrug,O00591,Gamma-aminobutyric acid receptor subunit pi,GABRP,440.0
6430,DB01594,Cinolazepam,SmallMoleculeDrug,P24046,Gamma-aminobutyric acid receptor subunit rho-1,GABRR1,479.0
6431,DB01594,Cinolazepam,SmallMoleculeDrug,P28476,Gamma-aminobutyric acid receptor subunit rho-2,GABRR2,465.0
6432,DB01594,Cinolazepam,SmallMoleculeDrug,A8MPY1,Gamma-aminobutyric acid receptor subunit rho-3,GABRR3,467.0
6433,DB01595,Nitrazepam,SmallMoleculeDrug,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,456.0
6434,DB01595,Nitrazepam,SmallMoleculeDrug,P47869,Gamma-aminobutyric acid receptor subunit alpha-2,GABRA2,451.0
6435,DB01595,Nitrazepam,SmallMoleculeDrug,P34903,Gamma-aminobutyric acid receptor subunit alpha-3,GABRA3,492.0
6436,DB01595,Nitrazepam,SmallMoleculeDrug,P48169,Gamma-aminobutyric acid receptor subunit alpha-4,GABRA4,554.0
6437,DB01595,Nitrazepam,SmallMoleculeDrug,P31644,Gamma-aminobutyric acid receptor subunit alpha-5,GABRA5,462.0
6438,DB01595,Nitrazepam,SmallMoleculeDrug,Q16445,Gamma-aminobutyric acid receptor subunit alpha-6,GABRA6,453.0
6439,DB01595,Nitrazepam,SmallMoleculeDrug,P18505,Gamma-aminobutyric acid receptor subunit beta-1,GABRB1,474.0
6440,DB01595,Nitrazepam,SmallMoleculeDrug,P47870,Gamma-aminobutyric acid receptor subunit beta-2,GABRB2,512.0
6441,DB01595,Nitrazepam,SmallMoleculeDrug,P28472,Gamma-aminobutyric acid receptor subunit beta-3,GABRB3,473.0
6442,DB01595,Nitrazepam,SmallMoleculeDrug,Q8N1C3,Gamma-aminobutyric acid receptor subunit gamma-1,GABRG1,465.0
6443,DB01595,Nitrazepam,SmallMoleculeDrug,P18507,Gamma-aminobutyric acid receptor subunit gamma-2,GABRG2,467.0
6444,DB01595,Nitrazepam,SmallMoleculeDrug,Q99928,Gamma-aminobutyric acid receptor subunit gamma-3,GABRG3,467.0
6445,DB01595,Nitrazepam,SmallMoleculeDrug,O14764,Gamma-aminobutyric acid receptor subunit delta,GABRD,452.0
6446,DB01595,Nitrazepam,SmallMoleculeDrug,P78334,Gamma-aminobutyric acid receptor subunit epsilon,GABRE,506.0
6447,DB01595,Nitrazepam,SmallMoleculeDrug,O00591,Gamma-aminobutyric acid receptor subunit pi,GABRP,440.0
6448,DB01595,Nitrazepam,SmallMoleculeDrug,P24046,Gamma-aminobutyric acid receptor subunit rho-1,GABRR1,479.0
6449,DB01595,Nitrazepam,SmallMoleculeDrug,P28476,Gamma-aminobutyric acid receptor subunit rho-2,GABRR2,465.0
6450,DB01595,Nitrazepam,SmallMoleculeDrug,A8MPY1,Gamma-aminobutyric acid receptor subunit rho-3,GABRR3,467.0
6451,DB01595,Nitrazepam,SmallMoleculeDrug,Q9UN88,Gamma-aminobutyric acid receptor subunit theta,GABRQ,632.0
6452,DB01595,Nitrazepam,SmallMoleculeDrug,P35498,Sodium channel protein type 1 subunit alpha,SCN1A,2009.0
6453,DB01597,Cilastatin,SmallMoleculeDrug,P16444,Dipeptidase 1,DPEP1,411.0
6459,DB01599,Probucol,SmallMoleculeDrug,O95477,ATP-binding cassette sub-family A member 1,ABCA1,2261.0
6460,DB01599,Probucol,SmallMoleculeDrug,P23141,Liver carboxylesterase 1,CES1,567.0
6461,DB01600,Tiaprofenic acid,SmallMoleculeDrug,P35354,Prostaglandin G/H synthase 2,PTGS2,604.0
6462,DB01600,Tiaprofenic acid,SmallMoleculeDrug,P23219,Prostaglandin G/H synthase 1,PTGS1,599.0
6476,DB01608,Propericiazine,SmallMoleculeDrug,P21728,D(1A) dopamine receptor,DRD1,446.0
6477,DB01608,Propericiazine,SmallMoleculeDrug,P08913,Alpha-2A adrenergic receptor,ADRA2A,450.0
6478,DB01608,Propericiazine,SmallMoleculeDrug,P35368,Alpha-1B adrenergic receptor,ADRA1B,520.0
6479,DB01611,Hydroxychloroquine,SmallMoleculeDrug,Q9NYK1,Toll-like receptor 7,TLR7,1049.0
6480,DB01611,Hydroxychloroquine,SmallMoleculeDrug,Q9NR96,Toll-like receptor 9,TLR9,1032.0
6481,DB01612,Amyl Nitrite,SmallMoleculeDrug,P16066,Atrial natriuretic peptide receptor 1,NPR1,1061.0
6482,DB01613,Erythrityl Tetranitrate,SmallMoleculeDrug,P16066,Atrial natriuretic peptide receptor 1,NPR1,1061.0
6483,DB01613,Erythrityl Tetranitrate,SmallMoleculeDrug,P20594,Atrial natriuretic peptide receptor 2,NPR2,1047.0
6484,DB01614,Acepromazine,SmallMoleculeDrug,P14416,D(2) dopamine receptor,DRD2,443.0
6485,DB01614,Acepromazine,SmallMoleculeDrug,P21728,D(1A) dopamine receptor,DRD1,446.0
6486,DB01614,Acepromazine,SmallMoleculeDrug,P28223,5-hydroxytryptamine receptor 2A,HTR2A,471.0
6487,DB01614,Acepromazine,SmallMoleculeDrug,P08908,5-hydroxytryptamine receptor 1A,HTR1A,422.0
6488,DB01614,Acepromazine,SmallMoleculeDrug,P35348,Alpha-1A adrenergic receptor,ADRA1A,466.0
6489,DB01614,Acepromazine,SmallMoleculeDrug,P35368,Alpha-1B adrenergic receptor,ADRA1B,520.0
6490,DB01615,Aceprometazine,SmallMoleculeDrug,P35367,Histamine H1 receptor,HRH1,487.0
6491,DB01616,Alverine,SmallMoleculeDrug,P08908,5-hydroxytryptamine receptor 1A,HTR1A,422.0
6492,DB01618,Molindone,SmallMoleculeDrug,P14416,D(2) dopamine receptor,DRD2,443.0
6493,DB01618,Molindone,SmallMoleculeDrug,P08908,5-hydroxytryptamine receptor 1A,HTR1A,422.0
6494,DB01618,Molindone,SmallMoleculeDrug,P28223,5-hydroxytryptamine receptor 2A,HTR2A,471.0
6495,DB01618,Molindone,SmallMoleculeDrug,P11229,Muscarinic acetylcholine receptor M1,CHRM1,460.0
6496,DB01619,Phenindamine,SmallMoleculeDrug,P35367,Histamine H1 receptor,HRH1,487.0
6497,DB01620,Pheniramine,SmallMoleculeDrug,P35367,Histamine H1 receptor,HRH1,487.0
6498,DB01621,Pipotiazine,SmallMoleculeDrug,P14416,D(2) dopamine receptor,DRD2,443.0
6499,DB01621,Pipotiazine,SmallMoleculeDrug,P21728,D(1A) dopamine receptor,DRD1,446.0
6500,DB01621,Pipotiazine,SmallMoleculeDrug,P28223,5-hydroxytryptamine receptor 2A,HTR2A,471.0
6501,DB01621,Pipotiazine,SmallMoleculeDrug,P08908,5-hydroxytryptamine receptor 1A,HTR1A,422.0
6502,DB01622,Thioproperazine,SmallMoleculeDrug,P14416,D(2) dopamine receptor,DRD2,443.0
6503,DB01622,Thioproperazine,SmallMoleculeDrug,P21728,D(1A) dopamine receptor,DRD1,446.0
6504,DB01622,Thioproperazine,SmallMoleculeDrug,P28223,5-hydroxytryptamine receptor 2A,HTR2A,471.0
6505,DB01622,Thioproperazine,SmallMoleculeDrug,P08908,5-hydroxytryptamine receptor 1A,HTR1A,422.0
6506,DB01622,Thioproperazine,SmallMoleculeDrug,P35348,Alpha-1A adrenergic receptor,ADRA1A,466.0
6507,DB01622,Thioproperazine,SmallMoleculeDrug,P35368,Alpha-1B adrenergic receptor,ADRA1B,520.0
6508,DB01623,Thiothixene,SmallMoleculeDrug,P14416,D(2) dopamine receptor,DRD2,443.0
6509,DB01623,Thiothixene,SmallMoleculeDrug,P21728,D(1A) dopamine receptor,DRD1,446.0
6510,DB01623,Thiothixene,SmallMoleculeDrug,P28223,5-hydroxytryptamine receptor 2A,HTR2A,471.0
6511,DB01624,Zuclopenthixol,SmallMoleculeDrug,P21728,D(1A) dopamine receptor,DRD1,446.0
6512,DB01624,Zuclopenthixol,SmallMoleculeDrug,P21918,D(1B) dopamine receptor,DRD5,477.0
6513,DB01624,Zuclopenthixol,SmallMoleculeDrug,P14416,D(2) dopamine receptor,DRD2,443.0
6514,DB01624,Zuclopenthixol,SmallMoleculeDrug,P35348,Alpha-1A adrenergic receptor,ADRA1A,466.0
6515,DB01624,Zuclopenthixol,SmallMoleculeDrug,P08913,Alpha-2A adrenergic receptor,ADRA2A,450.0
6516,DB01624,Zuclopenthixol,SmallMoleculeDrug,P28223,5-hydroxytryptamine receptor 2A,HTR2A,471.0
6517,DB01624,Zuclopenthixol,SmallMoleculeDrug,P35367,Histamine H1 receptor,HRH1,487.0
6518,DB01625,Isopropamide,SmallMoleculeDrug,P20309,Muscarinic acetylcholine receptor M3,CHRM3,590.0
6519,DB01625,Isopropamide,SmallMoleculeDrug,P08173,Muscarinic acetylcholine receptor M4,CHRM4,479.0
6520,DB01626,Pargyline,SmallMoleculeDrug,P27338,Amine oxidase [flavin-containing] B,MAOB,520.0
6521,DB01626,Pargyline,SmallMoleculeDrug,P21397,Amine oxidase [flavin-containing] A,MAOA,527.0
6523,DB01628,Etoricoxib,SmallMoleculeDrug,P35354,Prostaglandin G/H synthase 2,PTGS2,604.0
6525,DB01630,SC-74020,SmallMoleculeDrug,P08253,72 kDa type IV collagenase,MMP2,660.0
6526,DB01631,Methyl Nonanoate (Ester),SmallMoleculeDrug,P80188,Neutrophil gelatinase-associated lipocalin,LCN2,198.0
6527,DB01631,Methyl Nonanoate (Ester),SmallMoleculeDrug,P01857,Ig gamma-1 chain C region,IGHG1,330.0
6529,DB01632,Alpha-Phosphoribosylpyrophosphoric Acid,SmallMoleculeDrug,P07741,Adenine phosphoribosyltransferase,APRT,180.0
6531,DB01632,Alpha-Phosphoribosylpyrophosphoric Acid,SmallMoleculeDrug,P00492,Hypoxanthine-guanine phosphoribosyltransferase,HPRT1,218.0
6533,DB01632,Alpha-Phosphoribosylpyrophosphoric Acid,SmallMoleculeDrug,Q9NWZ5,Uridine-cytidine kinase-like 1,UCKL1,548.0
6541,DB01640,"(5r)-6-(4-{[2-(3-Iodobenzyl)-3-Oxocyclohex-1-En-1-Yl]Amino}Phenyl)-5-Methyl-4,5-Dihydropyridazin-3(2h)-One",SmallMoleculeDrug,Q13370,"cGMP-inhibited 3',5'-cyclic phosphodiesterase B",PDE3B,1112.0
6546,DB01643,Thymidine-5'-Phosphate,SmallMoleculeDrug,P23919,Thymidylate kinase,DTYMK,212.0
6551,DB01643,Thymidine-5'-Phosphate,SmallMoleculeDrug,P04818,Thymidylate synthase,TYMS,313.0
6554,DB01644,"3,6-Dihydroxy-Xanthene-9-Propionic Acid",SmallMoleculeDrug,P00390,"Glutathione reductase, mitochondrial",GSR,522.0
6555,DB01645,Genistein,SmallMoleculeDrug,Q92731,Estrogen receptor beta,ESR2,530.0
6556,DB01645,Genistein,SmallMoleculeDrug,P11388,DNA topoisomerase 2-alpha,TOP2A,1531.0
6557,DB01645,Genistein,SmallMoleculeDrug,Q14289,Protein-tyrosine kinase 2-beta,PTK2B,1009.0
6558,DB01645,Genistein,SmallMoleculeDrug,Q15788,Nuclear receptor coactivator 1,NCOA1,1441.0
6559,DB01645,Genistein,SmallMoleculeDrug,P03372,Estrogen receptor,ESR1,595.0
6560,DB01645,Genistein,SmallMoleculeDrug,Q15596,Nuclear receptor coactivator 2,NCOA2,1464.0
6562,DB01646,N-Acetylmethionine,SmallMoleculeDrug,P08100,Rhodopsin,RHO,348.0
6563,DB01647,(R)-Mesopram,SmallMoleculeDrug,Q07343,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B",PDE4B,736.0
6564,DB01649,7-Methyl-Gpppa,SmallMoleculeDrug,Q96C86,m7GpppX diphosphatase,DCPS,337.0
6565,DB01649,7-Methyl-Gpppa,SmallMoleculeDrug,P06730,Eukaryotic translation initiation factor 4E,EIF4E,217.0
6567,DB01651,"Methyl 4,6-O-[(1r)-1-Carboxyethylidene]-Beta-D-Galactopyranoside",SmallMoleculeDrug,P02743,Serum amyloid P-component,APCS,223.0
6571,DB01656,Roflumilast,SmallMoleculeDrug,Q08499,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",PDE4D,809.0
6572,DB01656,Roflumilast,SmallMoleculeDrug,P27815,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A",PDE4A,886.0
6573,DB01656,Roflumilast,SmallMoleculeDrug,Q07343,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B",PDE4B,736.0
6574,DB01656,Roflumilast,SmallMoleculeDrug,Q08493,"cAMP-specific 3',5'-cyclic phosphodiesterase 4C",PDE4C,712.0
6577,DB01660,Adenosine-5'-Diphosphate Monothiophosphate,SmallMoleculeDrug,Q10588,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,BST1,318.0
6580,DB01660,Adenosine-5'-Diphosphate Monothiophosphate,SmallMoleculeDrug,P17600,Synapsin-1,SYN1,705.0
6581,DB01660,Adenosine-5'-Diphosphate Monothiophosphate,SmallMoleculeDrug,O14874,"[3-methyl-2-oxobutanoate dehydrogenase [lipoamide]] kinase, mitochondrial",BCKDK,412.0
6583,DB01662,Trans-O-Hydroxy-Alpha-Methyl Cinnamate,SmallMoleculeDrug,P17538,Chymotrypsinogen B,CTRB1,263.0
6585,DB01664,(S)-Des-Me-Ampa,SmallMoleculeDrug,P42262,Glutamate receptor 2,GRIA2,883.0
6586,DB01665,ZK-800270,SmallMoleculeDrug,P07477,Trypsin-1,PRSS1,247.0
6588,DB01666,D-Myo-Inositol-Hexasulphate,SmallMoleculeDrug,P19883,Follistatin,FST,344.0
6589,DB01667,8-azaguanine,SmallMoleculeDrug,P00491,Purine nucleoside phosphorylase,PNP,289.0
6593,DB01671,4-(Hydroxymercury)Benzoic Acid,SmallMoleculeDrug,P00918,Carbonic anhydrase 2,CA2,260.0
6595,DB01672,"2,3-Dihydroxy-Benzoic Acid",SmallMoleculeDrug,P80188,Neutrophil gelatinase-associated lipocalin,LCN2,198.0
6598,DB01675,Methacrylyl-Coenzyme A,SmallMoleculeDrug,Q9UKU7,"Isobutyryl-CoA dehydrogenase, mitochondrial",ACAD8,415.0
6603,DB01677,Fumarate,SmallMoleculeDrug,P23368,"NAD-dependent malic enzyme, mitochondrial",ME2,584.0
6604,DB01677,Fumarate,SmallMoleculeDrug,P16930,Fumarylacetoacetase,FAH,419.0
6605,DB01678,RU84687,SmallMoleculeDrug,P12931,Proto-oncogene tyrosine-protein kinase Src,SRC,536.0
6606,DB01681,Benzene Hexacarboxylic Acid,SmallMoleculeDrug,P15259,Phosphoglycerate mutase 2,PGAM2,253.0
6608,DB01684,1-Hydroxy-1-Thio-Glycerol,SmallMoleculeDrug,P48147,Prolyl endopeptidase,PREP,710.0
6609,DB01685,"4-[5-Pyridin-4-Yl-1h-[1,2,4]Triazol-3-Yl]-Pyridine-2-Carbonitrile",SmallMoleculeDrug,P47989,Xanthine dehydrogenase/oxidase,XDH,1333.0
6610,DB01686,"N,N-dimethylarginine",SmallMoleculeDrug,P35228,"Nitric oxide synthase, inducible",NOS2,1153.0
6611,DB01686,"N,N-dimethylarginine",SmallMoleculeDrug,P29474,"Nitric oxide synthase, endothelial",NOS3,1203.0
6613,DB01689,Inhibitor Idd 384,SmallMoleculeDrug,P15121,Aldose reductase,AKR1B1,316.0
6618,DB01692,Dithioerythritol,SmallMoleculeDrug,P04183,"Thymidine kinase, cytosolic",TK1,234.0
6620,DB01694,D-tartaric acid,SmallMoleculeDrug,Q9P2W7,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 1,B3GAT1,334.0
6621,DB01694,D-tartaric acid,SmallMoleculeDrug,Q9NP99,Triggering receptor expressed on myeloid cells 1,TREM1,234.0
6622,DB01694,D-tartaric acid,SmallMoleculeDrug,P26196,Probable ATP-dependent RNA helicase DDX6,DDX6,483.0
6624,DB01694,D-tartaric acid,SmallMoleculeDrug,Q9NWT6,Hypoxia-inducible factor 1-alpha inhibitor,HIF1AN,349.0
6627,DB01694,D-tartaric acid,SmallMoleculeDrug,P21283,V-type proton ATPase subunit C 1,ATP6V1C1,382.0
6632,DB01695,N-Hydroxy-4-Phosphono-Butanamide,SmallMoleculeDrug,P60174,Triosephosphate isomerase,TPI1,286.0
6633,DB01698,Rutin,SmallMoleculeDrug,P42330,Aldo-keto reductase family 1 member C3,AKR1C3,323.0
6634,DB01699,(4e)-4-Aminohex-4-Enoic Acid,SmallMoleculeDrug,P80404,"4-aminobutyrate aminotransferase, mitochondrial",ABAT,500.0
6635,DB01700,Aicar,SmallMoleculeDrug,P31939,Bifunctional purine biosynthesis protein PURH,ATIC,592.0
6643,DB01704,"2,4-Dihydroxy-Trans Cinnamic Acid",SmallMoleculeDrug,P17538,Chymotrypsinogen B,CTRB1,263.0
6644,DB01705,Bis(5-Amidino-Benzimidazolyl)Methane,SmallMoleculeDrug,P07477,Trypsin-1,PRSS1,247.0
6646,DB01708,Prasterone,SmallMoleculeDrug,P03372,Estrogen receptor,ESR1,595.0
6647,DB01708,Prasterone,SmallMoleculeDrug,Q92731,Estrogen receptor beta,ESR2,530.0
6648,DB01708,Prasterone,SmallMoleculeDrug,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,456.0
6649,DB01708,Prasterone,SmallMoleculeDrug,P47869,Gamma-aminobutyric acid receptor subunit alpha-2,GABRA2,451.0
6650,DB01708,Prasterone,SmallMoleculeDrug,P34903,Gamma-aminobutyric acid receptor subunit alpha-3,GABRA3,492.0
6651,DB01708,Prasterone,SmallMoleculeDrug,P48169,Gamma-aminobutyric acid receptor subunit alpha-4,GABRA4,554.0
6652,DB01708,Prasterone,SmallMoleculeDrug,P31644,Gamma-aminobutyric acid receptor subunit alpha-5,GABRA5,462.0
6653,DB01708,Prasterone,SmallMoleculeDrug,Q16445,Gamma-aminobutyric acid receptor subunit alpha-6,GABRA6,453.0
6654,DB01708,Prasterone,SmallMoleculeDrug,P18505,Gamma-aminobutyric acid receptor subunit beta-1,GABRB1,474.0
6655,DB01708,Prasterone,SmallMoleculeDrug,P47870,Gamma-aminobutyric acid receptor subunit beta-2,GABRB2,512.0
6656,DB01708,Prasterone,SmallMoleculeDrug,P28472,Gamma-aminobutyric acid receptor subunit beta-3,GABRB3,473.0
6657,DB01708,Prasterone,SmallMoleculeDrug,O14764,Gamma-aminobutyric acid receptor subunit delta,GABRD,452.0
6658,DB01708,Prasterone,SmallMoleculeDrug,P78334,Gamma-aminobutyric acid receptor subunit epsilon,GABRE,506.0
6659,DB01708,Prasterone,SmallMoleculeDrug,Q8N1C3,Gamma-aminobutyric acid receptor subunit gamma-1,GABRG1,465.0
6660,DB01708,Prasterone,SmallMoleculeDrug,P18507,Gamma-aminobutyric acid receptor subunit gamma-2,GABRG2,467.0
6661,DB01708,Prasterone,SmallMoleculeDrug,Q99928,Gamma-aminobutyric acid receptor subunit gamma-3,GABRG3,467.0
6662,DB01708,Prasterone,SmallMoleculeDrug,O00591,Gamma-aminobutyric acid receptor subunit pi,GABRP,440.0
6663,DB01708,Prasterone,SmallMoleculeDrug,Q9UN88,Gamma-aminobutyric acid receptor subunit theta,GABRQ,632.0
6664,DB01708,Prasterone,SmallMoleculeDrug,Q05586,"Glutamate receptor ionotropic, NMDA 1",GRIN1,938.0
6665,DB01708,Prasterone,SmallMoleculeDrug,Q12879,"Glutamate receptor ionotropic, NMDA 2A",GRIN2A,1464.0
6666,DB01708,Prasterone,SmallMoleculeDrug,Q13224,"Glutamate receptor ionotropic, NMDA 2B",GRIN2B,1484.0
6667,DB01708,Prasterone,SmallMoleculeDrug,Q14957,"Glutamate receptor ionotropic, NMDA 2C",GRIN2C,1233.0
6668,DB01708,Prasterone,SmallMoleculeDrug,O15399,"Glutamate receptor ionotropic, NMDA 2D",GRIN2D,1336.0
6669,DB01708,Prasterone,SmallMoleculeDrug,Q8TCU5,"Glutamate receptor ionotropic, NMDA 3A",GRIN3A,1115.0
6670,DB01708,Prasterone,SmallMoleculeDrug,O60391,"Glutamate receptor ionotropic, NMDA 3B",GRIN3B,1043.0
6671,DB01708,Prasterone,SmallMoleculeDrug,P10275,Androgen receptor,AR,920.0
6672,DB01708,Prasterone,SmallMoleculeDrug,P14061,Estradiol 17-beta-dehydrogenase 1,HSD17B1,328.0
6673,DB01708,Prasterone,SmallMoleculeDrug,Q06520,Bile salt sulfotransferase,SULT2A1,285.0
6674,DB01708,Prasterone,SmallMoleculeDrug,O00204,Sulfotransferase family cytosolic 2B member 1,SULT2B1,365.0
6675,DB01708,Prasterone,SmallMoleculeDrug,Q07869,Peroxisome proliferator-activated receptor alpha,PPARA,468.0
6676,DB01708,Prasterone,SmallMoleculeDrug,Q99720,Sigma non-opioid intracellular receptor 1,SIGMAR1,223.0
6677,DB01708,Prasterone,SmallMoleculeDrug,O75469,Nuclear receptor subfamily 1 group I member 2,NR1I2,434.0
6678,DB01708,Prasterone,SmallMoleculeDrug,Q14994,Nuclear receptor subfamily 1 group I member 3,NR1I3,352.0
6684,DB01710,Porphyrin Fe(Iii),SmallMoleculeDrug,P02144,Myoglobin,MB,154.0
6685,DB01711,"2,3,4,5,6-Pentafluorobenzyl Alcohol",SmallMoleculeDrug,P00326,Alcohol dehydrogenase 1C,ADH1C,375.0
6686,DB01712,"(3r)-4-(P-Toluenesulfonyl)-1,4-Thiazane-3-Carboxylicacid-L-Phenylalanine Ethyl Ester",SmallMoleculeDrug,P62942,Peptidyl-prolyl cis-trans isomerase FKBP1A,FKBP1A,108.0
6692,DB01717,Bis(Adenosine)-5'-Pentaphosphate,SmallMoleculeDrug,P54819,"Adenylate kinase 2, mitochondrial",AK2,239.0
6693,DB01717,Bis(Adenosine)-5'-Pentaphosphate,SmallMoleculeDrug,Q96MA6,Adenylate kinase 8,AK8,479.0
6695,DB01717,Bis(Adenosine)-5'-Pentaphosphate,SmallMoleculeDrug,P00568,Adenylate kinase isoenzyme 1,AK1,194.0
6701,DB01723,"{3-[3-(3,4-Dimethoxy-Phenyl)-1-(1-{1-[2-(3,4,5-Trimethoxy-Phenyl)-Butyryl]-Piperidin-2yl}-Vinyloxy)-Propyl]-Phenoxy}-Acetic Acid",SmallMoleculeDrug,P62942,Peptidyl-prolyl cis-trans isomerase FKBP1A,FKBP1A,108.0
6702,DB01725,CRA_7806,SmallMoleculeDrug,P07477,Trypsin-1,PRSS1,247.0
6706,DB01727,Isocitric Acid,SmallMoleculeDrug,Q99798,"Aconitate hydratase, mitochondrial",ACO2,780.0
6707,DB01727,Isocitric Acid,SmallMoleculeDrug,P48735,"Isocitrate dehydrogenase [NADP], mitochondrial",IDH2,452.0
6708,DB01727,Isocitric Acid,SmallMoleculeDrug,O75874,Isocitrate dehydrogenase [NADP] cytoplasmic,IDH1,414.0
6710,DB01728,"3-[Aminoethylphosphoryl]-[1,2-Di-Palmitoyl]-Sn-Glycerol",SmallMoleculeDrug,P08100,Rhodopsin,RHO,348.0
6711,DB01731,(S)-Wiskostatin,SmallMoleculeDrug,P42768,Wiskott-Aldrich syndrome protein,WAS,502.0
6713,DB01733,L-Phospholactate,SmallMoleculeDrug,P14618,Pyruvate kinase PKM,PKM,531.0
6714,DB01734,3-(Oxalyl-Amino)-Naphthalene-2-Carboxylic Acid,SmallMoleculeDrug,P18031,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,435.0
6716,DB01736,[3-(Dodecanoylamino)Propyl](Hydroxy)Dimethylammonium,SmallMoleculeDrug,P12235,ADP/ATP translocase 1,SLC25A4,298.0
6717,DB01737,"Nalpha-(2-Naphthylsulfonylglycyl)-3-Amidino-D,L-Phenylalanine-Isopropylester",SmallMoleculeDrug,P07477,Trypsin-1,PRSS1,247.0
6718,DB01738,O-Phosphoethanolamine,SmallMoleculeDrug,P05771,Protein kinase C beta type,PRKCB,671.0
6719,DB01741,CRA_17693,SmallMoleculeDrug,P07477,Trypsin-1,PRSS1,247.0
6720,DB01742,(3r)-1-Acetyl-3-Methylpiperidine,SmallMoleculeDrug,P62937,Peptidyl-prolyl cis-trans isomerase A,PPIA,165.0
6723,DB01745,N-Alpha-(2-Naphthylsulfonyl)-N(3-Amidino-L-Phenylalaninyl)Isopipecolinic Acid Methyl Ester,SmallMoleculeDrug,P07477,Trypsin-1,PRSS1,247.0
6725,DB01748,N-Benzyl-4-Sulfamoyl-Benzamide,SmallMoleculeDrug,P00918,Carbonic anhydrase 2,CA2,260.0
6726,DB01750,Naphthalen-1-Yl-Acetic Acid,SmallMoleculeDrug,P63208,S-phase kinase-associated protein 1,SKP1,163.0
6730,DB01752,S-Adenosyl-L-Homocysteine,SmallMoleculeDrug,P22061,Protein-L-isoaspartate(D-aspartate) O-methyltransferase,PCMT1,227.0
6732,DB01752,S-Adenosyl-L-Homocysteine,SmallMoleculeDrug,P11086,Phenylethanolamine N-methyltransferase,PNMT,282.0
6736,DB01752,S-Adenosyl-L-Homocysteine,SmallMoleculeDrug,O60678,Protein arginine N-methyltransferase 3,PRMT3,531.0
6737,DB01752,S-Adenosyl-L-Homocysteine,SmallMoleculeDrug,P50135,Histamine N-methyltransferase,HNMT,292.0
6740,DB01752,S-Adenosyl-L-Homocysteine,SmallMoleculeDrug,O14717,tRNA (cytosine(38)-C(5))-methyltransferase,TRDMT1,391.0
6741,DB01752,S-Adenosyl-L-Homocysteine,SmallMoleculeDrug,Q14749,Glycine N-methyltransferase,GNMT,295.0
6746,DB01752,S-Adenosyl-L-Homocysteine,SmallMoleculeDrug,Q99873,Protein arginine N-methyltransferase 1,PRMT1,361.0
6749,DB01752,S-Adenosyl-L-Homocysteine,SmallMoleculeDrug,Q8WTS6,Histone-lysine N-methyltransferase SETD7,SETD7,366.0
6752,DB01752,S-Adenosyl-L-Homocysteine,SmallMoleculeDrug,Q9H2P9,Diphthine methyl ester synthase,DPH5,285.0
6760,DB01752,S-Adenosyl-L-Homocysteine,SmallMoleculeDrug,Q86VU5,Catechol O-methyltransferase domain-containing protein 1,COMTD1,262.0
6762,DB01752,S-Adenosyl-L-Homocysteine,SmallMoleculeDrug,Q14353,Guanidinoacetate N-methyltransferase,GAMT,236.0
6764,DB01754,"3,4-Dihydroxy-1-Methylquinolin-2(1h)-One",SmallMoleculeDrug,P11309,Serine/threonine-protein kinase pim-1,PIM1,404.0
6766,DB01756,D-4-Phosphoerythronic Acid,SmallMoleculeDrug,P49247,Ribose-5-phosphate isomerase,RPIA,311.0
6768,DB01760,2-Methoxy-3-Isopropylpyrazine,SmallMoleculeDrug,Q8WX39,Epididymal-specific lipocalin-9,LCN9,176.0
6769,DB01761,4-[5-[2-(1-Phenyl-Ethylamino)-Pyrimidin-4-Yl]-1-Methyl-4-(3-Trifluoromethylphenyl)-1h-Imidazol-2-Yl]-Piperidine,SmallMoleculeDrug,Q16539,Mitogen-activated protein kinase 14,MAPK14,360.0
6770,DB01762,Acetoacetic Acid,SmallMoleculeDrug,P16930,Fumarylacetoacetase,FAH,419.0
6771,DB01763,7-thionicotinamide-adenine-dinucleotide phosphate,SmallMoleculeDrug,Q13423,"NAD(P) transhydrogenase, mitochondrial",NNT,1086.0
6773,DB01765,"(5-Oxo-5,6-Dihydro-Indolo[1,2-a]Quinazolin-7-Yl)-Acetic Acid",SmallMoleculeDrug,P68400,Casein kinase II subunit alpha,CSNK2A1,391.0
6774,DB01766,Beta-(2-Naphthyl)-Alanine,SmallMoleculeDrug,P54577,"Tyrosine--tRNA ligase, cytoplasmic",YARS,528.0
6775,DB01766,Beta-(2-Naphthyl)-Alanine,SmallMoleculeDrug,Q13526,Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1,PIN1,163.0
6776,DB01766,Beta-(2-Naphthyl)-Alanine,SmallMoleculeDrug,P00734,Prothrombin,F2,622.0
6777,DB01767,Hemi-Babim,SmallMoleculeDrug,P07477,Trypsin-1,PRSS1,247.0
6778,DB01767,Hemi-Babim,SmallMoleculeDrug,P00734,Prothrombin,F2,622.0
6780,DB01771,CRA_10991,SmallMoleculeDrug,P07477,Trypsin-1,PRSS1,247.0
6781,DB01772,"3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl]-4-(5-Fluoro-1-Methyl-1h-Indol-3-Yl)-Pyrrole-2,5-Dione",SmallMoleculeDrug,P49841,Glycogen synthase kinase-3 beta,GSK3B,420.0
6785,DB01776,M-Cresol,SmallMoleculeDrug,P01308,Insulin,INS,110.0
6786,DB01777,Coa-S-Trimethylene-Acetyl-Tryptamine,SmallMoleculeDrug,Q16613,Serotonin N-acetyltransferase,AANAT,207.0
6789,DB01780,Fusicoccin,SmallMoleculeDrug,P62258,14-3-3 protein epsilon,YWHAE,255.0
6790,DB01782,"2,6-Dihydroanthra/1,9-Cd/Pyrazol-6-One",SmallMoleculeDrug,P53779,Mitogen-activated protein kinase 10,MAPK10,464.0
6791,DB01782,"2,6-Dihydroanthra/1,9-Cd/Pyrazol-6-One",SmallMoleculeDrug,Q9UQF2,C-Jun-amino-terminal kinase-interacting protein 1,MAPK8IP1,711.0
6792,DB01782,"2,6-Dihydroanthra/1,9-Cd/Pyrazol-6-One",SmallMoleculeDrug,P45983,Mitogen-activated protein kinase 8,MAPK8,427.0
6793,DB01782,"2,6-Dihydroanthra/1,9-Cd/Pyrazol-6-One",SmallMoleculeDrug,P33981,Dual specificity protein kinase TTK,TTK,857.0
6795,DB01784,4-Flourobenzenesulfonamide,SmallMoleculeDrug,P00918,Carbonic anhydrase 2,CA2,260.0
6796,DB01785,Dimethylallyl Diphosphate,SmallMoleculeDrug,P14324,Farnesyl pyrophosphate synthase,FDPS,419.0
6797,DB01785,Dimethylallyl Diphosphate,SmallMoleculeDrug,Q13907,Isopentenyl-diphosphate Delta-isomerase 1,IDI1,227.0
6803,DB01790,"Sp-Adenosine-3',5'-Cyclic-Monophosphorothioate",SmallMoleculeDrug,P10644,cAMP-dependent protein kinase type I-alpha regulatory subunit,PRKAR1A,381.0
6804,DB01791,Piclamilast,SmallMoleculeDrug,P27815,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A",PDE4A,886.0
6805,DB01791,Piclamilast,SmallMoleculeDrug,Q07343,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B",PDE4B,736.0
6806,DB01791,Piclamilast,SmallMoleculeDrug,Q08493,"cAMP-specific 3',5'-cyclic phosphodiesterase 4C",PDE4C,712.0
6807,DB01791,Piclamilast,SmallMoleculeDrug,Q08499,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",PDE4D,809.0
6809,DB01793,I-5,SmallMoleculeDrug,P49841,Glycogen synthase kinase-3 beta,GSK3B,420.0
6815,DB01800,"N,4-Dihydroxy-N-Oxo-3-(Sulfooxy)Benzenaminium",SmallMoleculeDrug,P15289,Arylsulfatase A,ARSA,507.0
6818,DB01805,Monoisopropylphosphorylserine,SmallMoleculeDrug,P07478,Trypsin-2,PRSS2,247.0
6820,DB01805,Monoisopropylphosphorylserine,SmallMoleculeDrug,P07477,Trypsin-1,PRSS1,247.0
6821,DB01805,Monoisopropylphosphorylserine,SmallMoleculeDrug,P22303,Acetylcholinesterase,ACHE,614.0
6823,DB01807,"N-[(3z)-5-Tert-Butyl-2-Phenyl-1,2-Dihydro-3h-Pyrazol-3-Ylidene]-N'-(4-Chlorophenyl)Urea",SmallMoleculeDrug,Q16539,Mitogen-activated protein kinase 14,MAPK14,360.0
6825,DB01809,"1-Ter-Butyl-3-P-Tolyl-1h-Pyrazolo[3,4-D]Pyrimidin-4-Ylamine",SmallMoleculeDrug,P08631,Tyrosine-protein kinase HCK,HCK,526.0
6826,DB01809,"1-Ter-Butyl-3-P-Tolyl-1h-Pyrazolo[3,4-D]Pyrimidin-4-Ylamine",SmallMoleculeDrug,P07949,Proto-oncogene tyrosine-protein kinase receptor Ret,RET,1114.0
6828,DB01810,"[1-(1-Methyl-4,5-Dioxo-Pent-2-Enylcarbamoyl)-2-Phenyl-Ethyl]-Carbamic Acid Benzyl Ester",SmallMoleculeDrug,Q9UBX1,Cathepsin F,CTSF,484.0
6829,DB01811,"3h-Indole-5,6-Diol",SmallMoleculeDrug,P02788,Lactotransferrin,LTF,710.0
6830,DB01812,Adenosine-3'-5'-Diphosphate,SmallMoleculeDrug,O14792,Heparan sulfate glucosamine 3-O-sulfotransferase 1,HS3ST1,307.0
6831,DB01812,Adenosine-3'-5'-Diphosphate,SmallMoleculeDrug,O00204,Sulfotransferase family cytosolic 2B member 1,SULT2B1,365.0
6832,DB01812,Adenosine-3'-5'-Diphosphate,SmallMoleculeDrug,P10153,Non-secretory ribonuclease,RNASE2,161.0
6833,DB01812,Adenosine-3'-5'-Diphosphate,SmallMoleculeDrug,P50225,Sulfotransferase 1A1,SULT1A1,295.0
6834,DB01812,Adenosine-3'-5'-Diphosphate,SmallMoleculeDrug,Q9Y663,Heparan sulfate glucosamine 3-O-sulfotransferase 3A1,HS3ST3A1,406.0
6835,DB01812,Adenosine-3'-5'-Diphosphate,SmallMoleculeDrug,P07998,Ribonuclease pancreatic,RNASE1,156.0
6836,DB01812,Adenosine-3'-5'-Diphosphate,SmallMoleculeDrug,Q06520,Bile salt sulfotransferase,SULT2A1,285.0
6837,DB01812,Adenosine-3'-5'-Diphosphate,SmallMoleculeDrug,P49888,Estrogen sulfotransferase,SULT1E1,294.0
6838,DB01812,Adenosine-3'-5'-Diphosphate,SmallMoleculeDrug,P52848,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,NDST1,882.0
6840,DB01812,Adenosine-3'-5'-Diphosphate,SmallMoleculeDrug,O43704,Sulfotransferase family cytosolic 1B member 1,SULT1B1,296.0
6848,DB01818,O3-Sulfonylgalactose,SmallMoleculeDrug,P11226,Mannose-binding protein C,MBL2,248.0
6851,DB01819,Phosphoenolpyruvate,SmallMoleculeDrug,P13929,Beta-enolase,ENO3,434.0
6853,DB01819,Phosphoenolpyruvate,SmallMoleculeDrug,P35558,"Phosphoenolpyruvate carboxykinase, cytosolic [GTP]",PCK1,622.0
6856,DB01820,"Compound 12, N-Acetyl-4-[(Carboxycarbonyl)(2-Carboxyphenyl)Amino]-N-Pentyl-1-Napthylalaniamide",SmallMoleculeDrug,P18031,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,435.0
6857,DB01821,"L-N(Omega)-Nitroarginine-2,4-L-Diaminobutyric Amide",SmallMoleculeDrug,P29474,"Nitric oxide synthase, endothelial",NOS3,1203.0
6858,DB01821,"L-N(Omega)-Nitroarginine-2,4-L-Diaminobutyric Amide",SmallMoleculeDrug,P29475,"Nitric oxide synthase, brain",NOS1,1434.0
6860,DB01823,Beta-D-Glucopyranose Spirohydantoin,SmallMoleculeDrug,P11217,"Glycogen phosphorylase, muscle form",PYGM,842.0
6866,DB01826,N-Butyl Isocyanide,SmallMoleculeDrug,P02144,Myoglobin,MB,154.0
6867,DB01827,"2,3,5,6-Tetrafluoro-4-Methoxy-Benzamide",SmallMoleculeDrug,P17931,Galectin-3,LGALS3,250.0
6870,DB01830,"{4-[2-Acetylamino-2-(3-Carbamoyl-2-Cyclohexylmethoxy-6,7,8,9-Tetrahydro-5h-Benzocyclohepten-5ylcarbamoyl)-Ethyl]-2-Phosphono-Phenyl}-Phosphonic Acid",SmallMoleculeDrug,P06239,Tyrosine-protein kinase Lck,LCK,509.0
6871,DB01831,Tryptophanyl-5'amp,SmallMoleculeDrug,P23381,"Tryptophan--tRNA ligase, cytoplasmic",WARS,471.0
6873,DB01832,4-[Hydroxy-[Methyl-Phosphinoyl]]-3-Oxo-Butanoic Acid,SmallMoleculeDrug,P16930,Fumarylacetoacetase,FAH,419.0
6874,DB01833,L-2-Amino-4-(Guanidinooxy)Butyric Acid,SmallMoleculeDrug,P29474,"Nitric oxide synthase, endothelial",NOS3,1203.0
6875,DB01834,"(9r,10r)-9-(S-Glutathionyl)-10-Hydroxy-9,10-Dihydrophenanthrene",SmallMoleculeDrug,P09211,Glutathione S-transferase P,GSTP1,210.0
6876,DB01834,"(9r,10r)-9-(S-Glutathionyl)-10-Hydroxy-9,10-Dihydrophenanthrene",SmallMoleculeDrug,P09488,Glutathione S-transferase Mu 1,GSTM1,218.0
6877,DB01835,4r-Fluoro-N6-Ethanimidoyl-L-Lysine,SmallMoleculeDrug,P35228,"Nitric oxide synthase, inducible",NOS2,1153.0
6878,DB01836,"[4-(6-Chloro-Naphthalene-2-Sulfonyl)-Piperazin-1-Yl]-(3,4,5,6-Tetrahydro-2h-[1,4']Bipyridinyl-4-Yl)-Methanone",SmallMoleculeDrug,P07477,Trypsin-1,PRSS1,247.0
6879,DB01837,O-acetyl-L-serine,SmallMoleculeDrug,P23219,Prostaglandin G/H synthase 1,PTGS1,599.0
6880,DB01839,"1,2-Propanediol",SmallMoleculeDrug,P00488,Coagulation factor XIII A chain,F13A1,732.0
6885,DB01840,2-Deoxy-D-Glucitol 6-(E)-Vinylhomophosphonate,SmallMoleculeDrug,Q9NPH2,Inositol-3-phosphate synthase 1,ISYNA1,558.0
6891,DB01842,3'-Phosphate-Adenosine-5'-Diphosphate,SmallMoleculeDrug,P07998,Ribonuclease pancreatic,RNASE1,156.0
6893,DB01843,"3-Amino-8,9,10-Trihydroxy-7-Hydroxymethyl-6-Oxa-1,3-Diaza-Spiro[4.5]Decane-2,4-Dione",SmallMoleculeDrug,P11217,"Glycogen phosphorylase, muscle form",PYGM,842.0
6894,DB01844,Dimethylformamide,SmallMoleculeDrug,Q9UNI1,Chymotrypsin-like elastase family member 1,CELA1,258.0
6895,DB01844,Dimethylformamide,SmallMoleculeDrug,P00797,Renin,REN,406.0
6901,DB01851,Tetrabutylammonium Ion,SmallMoleculeDrug,P01834,Ig kappa chain C region,IGKC,107.0
6902,DB01852,Kaempherol,SmallMoleculeDrug,Q6NUS8,UDP-glucuronosyltransferase 3A1,UGT3A1,523.0
6905,DB01854,5-Bromonicotinamide,SmallMoleculeDrug,P52961,GPI-linked NAD(P)(+)--arginine ADP-ribosyltransferase 1,ART1,327.0
6909,DB01858,[1-(4-Fluorobenzyl)Cyclobutyl]Methyl (1s)-1-[Oxo(1h-Pyrazol-5-Ylamino)Acetyl]Pentylcarbamate,SmallMoleculeDrug,P43235,Cathepsin K,CTSK,329.0
6911,DB01860,Cordycepin Triphosphate,SmallMoleculeDrug,P51003,Poly(A) polymerase alpha,PAPOLA,745.0
6913,DB01861,Uridine diphosphate glucose,SmallMoleculeDrug,P46976,Glycogenin-1,GYG1,350.0
6916,DB01861,Uridine diphosphate glucose,SmallMoleculeDrug,Q14376,UDP-glucose 4-epimerase,GALE,348.0
6920,DB01861,Uridine diphosphate glucose,SmallMoleculeDrug,Q7Z4J2,Glycosyltransferase 6 domain-containing protein 1,GLT6D1,308.0
6924,DB01863,"Inositol 1,3,4,5-Tetrakisphosphate",SmallMoleculeDrug,P31749,RAC-alpha serine/threonine-protein kinase,AKT1,480.0
6925,DB01863,"Inositol 1,3,4,5-Tetrakisphosphate",SmallMoleculeDrug,Q9H4M7,Pleckstrin homology domain-containing family A member 4,PLEKHA4,779.0
6926,DB01863,"Inositol 1,3,4,5-Tetrakisphosphate",SmallMoleculeDrug,Q06187,Tyrosine-protein kinase BTK,BTK,659.0
6927,DB01863,"Inositol 1,3,4,5-Tetrakisphosphate",SmallMoleculeDrug,Q9UN19,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,DAPP1,280.0
6928,DB01863,"Inositol 1,3,4,5-Tetrakisphosphate",SmallMoleculeDrug,P23677,Inositol-trisphosphate 3-kinase A,ITPKA,461.0
6929,DB01863,"Inositol 1,3,4,5-Tetrakisphosphate",SmallMoleculeDrug,Q99418,Cytohesin-2,CYTH2,400.0
6930,DB01863,"Inositol 1,3,4,5-Tetrakisphosphate",SmallMoleculeDrug,O43739,Cytohesin-3,CYTH3,400.0
6931,DB01863,"Inositol 1,3,4,5-Tetrakisphosphate",SmallMoleculeDrug,O15530,3-phosphoinositide-dependent protein kinase 1,PDPK1,556.0
6932,DB01864,5'-Guanosine-Diphosphate-Monothiophosphate,SmallMoleculeDrug,P62330,ADP-ribosylation factor 6,ARF6,175.0
6933,DB01864,5'-Guanosine-Diphosphate-Monothiophosphate,SmallMoleculeDrug,Q08188,Protein-glutamine gamma-glutamyltransferase E,TGM3,693.0
6935,DB01864,5'-Guanosine-Diphosphate-Monothiophosphate,SmallMoleculeDrug,P62491,Ras-related protein Rab-11A,RAB11A,216.0
6937,DB01866,RU79256,SmallMoleculeDrug,P12931,Proto-oncogene tyrosine-protein kinase Src,SRC,536.0
6939,DB01870,"1,4-Dithio-Alpha-D-Mannose",SmallMoleculeDrug,P19961,Alpha-amylase 2B,AMY2B,511.0
6941,DB01871,[1-(1-Benzyl-3-Hydroxy-2-Oxo-Propylcarbamoyl)-2-Phenyl-Ethyl]-Carbamic Acid Benzyl Ester,SmallMoleculeDrug,Q9UBX1,Cathepsin F,CTSF,484.0
6946,DB01873,Epothilone D,SmallMoleculeDrug,Q13748,Tubulin alpha-3C/D chain,TUBA3C,450.0
6947,DB01873,Epothilone D,SmallMoleculeDrug,P07437,Tubulin beta chain,TUBB,444.0
6948,DB01873,Epothilone D,SmallMoleculeDrug,Q9H4B7,Tubulin beta-1 chain,TUBB1,451.0
6949,DB01873,Epothilone D,SmallMoleculeDrug,P68371,Tubulin beta-4B chain,TUBB4B,445.0
6950,DB01873,Epothilone D,SmallMoleculeDrug,P04350,Tubulin beta-4A chain,TUBB4A,444.0
6951,DB01873,Epothilone D,SmallMoleculeDrug,P68366,Tubulin alpha-4A chain,TUBA4A,448.0
6952,DB01873,Epothilone D,SmallMoleculeDrug,Q13509,Tubulin beta-3 chain,TUBB3,450.0
6953,DB01873,Epothilone D,SmallMoleculeDrug,Q9BQE3,Tubulin alpha-1C chain,TUBA1C,449.0
6954,DB01873,Epothilone D,SmallMoleculeDrug,Q9NY65,Tubulin alpha-8 chain,TUBA8,449.0
6955,DB01873,Epothilone D,SmallMoleculeDrug,P68363,Tubulin alpha-1B chain,TUBA1B,451.0
6956,DB01873,Epothilone D,SmallMoleculeDrug,Q71U36,Tubulin alpha-1A chain,TUBA1A,451.0
6958,DB01876,Bis(5-Amidino-2-Benzimidazolyl)Methanone,SmallMoleculeDrug,P07477,Trypsin-1,PRSS1,247.0
6959,DB01877,"N-Hydroxy 1n(4-Methoxyphenyl)Sulfonyl-4-(Z,E-N-Methoxyimino)Pyrrolidine-2r-Carboxamide",SmallMoleculeDrug,P08254,Stromelysin-1,MMP3,477.0
6963,DB01880,"3,4-Dihydroxycinnamic Acid",SmallMoleculeDrug,P14174,Macrophage migration inhibitory factor,MIF,115.0
6968,DB01884,2-Amino-3-Methyl-1-Pyrrolidin-1-Yl-Butan-1-One,SmallMoleculeDrug,P27487,Dipeptidyl peptidase 4,DPP4,766.0
6972,DB01888,"4-[5-(Trans-4-Aminocyclohexylamino)-3-Isopropylpyrazolo[1,5-a]Pyrimidin-7-Ylamino]-N,N-Dimethylbenzenesulfonamide",SmallMoleculeDrug,P24941,Cyclin-dependent kinase 2,CDK2,298.0
6973,DB01889,"16,17-Androstene-3-Ol",SmallMoleculeDrug,Q14994,Nuclear receptor subfamily 1 group I member 3,NR1I3,352.0
6974,DB01890,"N,N-bis(3-(D-gluconamido)propyl)deoxycholamide",SmallMoleculeDrug,P05019,Insulin-like growth factor I,IGF1,195.0
6975,DB01890,"N,N-bis(3-(D-gluconamido)propyl)deoxycholamide",SmallMoleculeDrug,Q07869,Peroxisome proliferator-activated receptor alpha,PPARA,468.0
6978,DB01892,Hyperforin,SmallMoleculeDrug,P23219,Prostaglandin G/H synthase 1,PTGS1,599.0
6979,DB01892,Hyperforin,SmallMoleculeDrug,O75469,Nuclear receptor subfamily 1 group I member 2,NR1I2,434.0
6980,DB01892,Hyperforin,SmallMoleculeDrug,P09917,Arachidonate 5-lipoxygenase,ALOX5,674.0
6981,DB01893,N6-Benzyl Adenosine-5'-Diphosphate,SmallMoleculeDrug,P12931,Proto-oncogene tyrosine-protein kinase Src,SRC,536.0
6984,DB01897,2-(2f-Benzothiazolyl)-5-Styryl-3-(4f-Phthalhydrazidyl)Tetrazolium Chloride,SmallMoleculeDrug,O60760,Hematopoietic prostaglandin D synthase,HPGDS,199.0
6986,DB01901,Sucrosofate,SmallMoleculeDrug,P05230,Fibroblast growth factor 1,FGF1,155.0
6987,DB01902,"1-Ethyl-Pyrrolidine-2,5-Dione",SmallMoleculeDrug,P46459,Vesicle-fusing ATPase,NSF,744.0
6988,DB01902,"1-Ethyl-Pyrrolidine-2,5-Dione",SmallMoleculeDrug,Q86YB8,ERO1-like protein beta,ERO1B,467.0
6995,DB01905,2-(2-Hydroxy-5-Methoxy-Phenyl)-1h-Benzoimidazole-5-Carboxamidine,SmallMoleculeDrug,P07477,Trypsin-1,PRSS1,247.0
6996,DB01905,2-(2-Hydroxy-5-Methoxy-Phenyl)-1h-Benzoimidazole-5-Carboxamidine,SmallMoleculeDrug,P00749,Urokinase-type plasminogen activator,PLAU,431.0
6998,DB01908,RU85493,SmallMoleculeDrug,P12931,Proto-oncogene tyrosine-protein kinase Src,SRC,536.0
7010,DB01915,S-Hydroxycysteine,SmallMoleculeDrug,P01024,Complement C3,C3,1663.0
7012,DB01915,S-Hydroxycysteine,SmallMoleculeDrug,P09211,Glutathione S-transferase P,GSTP1,210.0
7013,DB01915,S-Hydroxycysteine,SmallMoleculeDrug,Q9BWD1,"Acetyl-CoA acetyltransferase, cytosolic",ACAT2,397.0
7014,DB01915,S-Hydroxycysteine,SmallMoleculeDrug,P08263,Glutathione S-transferase A1,GSTA1,222.0
7015,DB01915,S-Hydroxycysteine,SmallMoleculeDrug,P02689,Myelin P2 protein,PMP2,132.0
7018,DB01917,Putrescine,SmallMoleculeDrug,P11926,Ornithine decarboxylase,ODC1,461.0
7019,DB01917,Putrescine,SmallMoleculeDrug,P17707,S-adenosylmethionine decarboxylase proenzyme,AMD1,334.0
7022,DB01919,Pentanal,SmallMoleculeDrug,P17612,cAMP-dependent protein kinase catalytic subunit alpha,PRKACA,351.0
7025,DB01922,"Maltosyl-Alpha (1,4)-D-Gluconhydroximo-1,5-Lactam",SmallMoleculeDrug,P04746,Pancreatic alpha-amylase,AMY2A,511.0
7028,DB01926,Carboxymycobactin S,SmallMoleculeDrug,P80188,Neutrophil gelatinase-associated lipocalin,LCN2,198.0
7029,DB01927,Duroquinone,SmallMoleculeDrug,P15559,NAD(P)H dehydrogenase [quinone] 1,NQO1,274.0
7031,DB01929,"5-Chloryl-2,4,6-Quinazolinetriamine",SmallMoleculeDrug,Q86XF0,"Dihydrofolate reductase, mitochondrial",DHFR2,187.0
7033,DB01931,"Dcka, 5,7-Dichlorokynurenic Acid",SmallMoleculeDrug,Q05586,"Glutamate receptor ionotropic, NMDA 1",GRIN1,938.0
7035,DB01933,7-Hydroxystaurosporine,SmallMoleculeDrug,O15530,3-phosphoinositide-dependent protein kinase 1,PDPK1,556.0
7042,DB01939,5-Amidino-Benzimidazole,SmallMoleculeDrug,P07477,Trypsin-1,PRSS1,247.0
7043,DB01940,Balanol Analog 2,SmallMoleculeDrug,P17612,cAMP-dependent protein kinase catalytic subunit alpha,PRKACA,351.0
7044,DB01941,"6-[1-(3,5,5,8,8-Pentamethyl-5,6,7,8-Tetrahydronaphthalen-2-Yl)Cyclopropyl]Pyridine-3-Carboxylic Acid",SmallMoleculeDrug,P28702,Retinoic acid receptor RXR-beta,RXRB,533.0
7045,DB01942,Formic Acid,SmallMoleculeDrug,P09601,Heme oxygenase 1,HMOX1,288.0
7046,DB01942,Formic Acid,SmallMoleculeDrug,P07998,Ribonuclease pancreatic,RNASE1,156.0
7054,DB01942,Formic Acid,SmallMoleculeDrug,Q13363,C-terminal-binding protein 1,CTBP1,440.0
7057,DB01942,Formic Acid,SmallMoleculeDrug,O14936,Peripheral plasma membrane protein CASK,CASK,926.0
7060,DB01942,Formic Acid,SmallMoleculeDrug,Q9BVM4,Gamma-glutamylaminecyclotransferase,GGACT,153.0
7061,DB01942,Formic Acid,SmallMoleculeDrug,P20472,Parvalbumin alpha,PVALB,110.0
7062,DB01942,Formic Acid,SmallMoleculeDrug,P14621,Acylphosphatase-2,ACYP2,99.0
7066,DB01942,Formic Acid,SmallMoleculeDrug,P29475,"Nitric oxide synthase, brain",NOS1,1434.0
7072,DB01942,Formic Acid,SmallMoleculeDrug,Q9NQX3,Gephyrin,GPHN,736.0
7074,DB01942,Formic Acid,SmallMoleculeDrug,Q99418,Cytohesin-2,CYTH2,400.0
7091,DB01942,Formic Acid,SmallMoleculeDrug,P05230,Fibroblast growth factor 1,FGF1,155.0
7094,DB01942,Formic Acid,SmallMoleculeDrug,P00918,Carbonic anhydrase 2,CA2,260.0
7095,DB01944,(S)-blebbistatin,SmallMoleculeDrug,Q7Z406,Myosin-14,MYH14,1995.0
7096,DB01946,"3-[1-(3-Aminopropyl)-1h-Indol-3-Yl]-4-(1-Methyl-1h-Indol-3-Yl)-1h-Pyrrole-2,5-Dione",SmallMoleculeDrug,O15530,3-phosphoinositide-dependent protein kinase 1,PDPK1,556.0
7097,DB01946,"3-[1-(3-Aminopropyl)-1h-Indol-3-Yl]-4-(1-Methyl-1h-Indol-3-Yl)-1h-Pyrrole-2,5-Dione",SmallMoleculeDrug,Q09013,Myotonin-protein kinase,DMPK,629.0
7098,DB01947,RU78262,SmallMoleculeDrug,P12931,Proto-oncogene tyrosine-protein kinase Src,SRC,536.0
7099,DB01948,"1-(2,6-Dichlorophenyl)-5-(2,4-Difluorophenyl)-7-Piperidin-4-Yl-3,4-Dihydroquinolin-2(1h)-One",SmallMoleculeDrug,Q16539,Mitogen-activated protein kinase 14,MAPK14,360.0
7100,DB01949,"2-Amino-N,3,3-Trimethylbutanamide",SmallMoleculeDrug,P14780,Matrix metalloproteinase-9,MMP9,707.0
7101,DB01950,"N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thiazol-2-Yl)Urea",SmallMoleculeDrug,P49841,Glycogen synthase kinase-3 beta,GSK3B,420.0
7102,DB01951,Gpi-1046,SmallMoleculeDrug,P62942,Peptidyl-prolyl cis-trans isomerase FKBP1A,FKBP1A,108.0
7104,DB01953,Inhibitor of P38 Kinase,SmallMoleculeDrug,Q16539,Mitogen-activated protein kinase 14,MAPK14,360.0
7105,DB01954,Rolipram,SmallMoleculeDrug,Q08499,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",PDE4D,809.0
7106,DB01954,Rolipram,SmallMoleculeDrug,Q07343,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B",PDE4B,736.0
7107,DB01955,"1,4-Butanediol",SmallMoleculeDrug,Q9UKM7,"Endoplasmic reticulum mannosyl-oligosaccharide 1,2-alpha-mannosidase",MAN1B1,699.0
7108,DB01955,"1,4-Butanediol",SmallMoleculeDrug,P14555,"Phospholipase A2, membrane associated",PLA2G2A,144.0
7109,DB01955,"1,4-Butanediol",SmallMoleculeDrug,Q9NZK7,Group IIE secretory phospholipase A2,PLA2G2E,142.0
7116,DB01958,"5-[4-Tert-Butylphenylsulfanyl]-2,4-Quinazolinediamine",SmallMoleculeDrug,Q86XF0,"Dihydrofolate reductase, mitochondrial",DHFR2,187.0
7117,DB01959,"3,5-Dimethyl-1-(3-Nitrophenyl)-1h-Pyrazole-4-Carboxylic Acid Ethyl Ester",SmallMoleculeDrug,Q07343,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B",PDE4B,736.0
7118,DB01959,"3,5-Dimethyl-1-(3-Nitrophenyl)-1h-Pyrazole-4-Carboxylic Acid Ethyl Ester",SmallMoleculeDrug,Q08499,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",PDE4D,809.0
7119,DB01960,7n-Methyl-8-Hydroguanosine-5'-Diphosphate,SmallMoleculeDrug,Q96C86,m7GpppX diphosphatase,DCPS,337.0
7121,DB01960,7n-Methyl-8-Hydroguanosine-5'-Diphosphate,SmallMoleculeDrug,P06730,Eukaryotic translation initiation factor 4E,EIF4E,217.0
7122,DB01961,Cytidine-3'-Monophosphate,SmallMoleculeDrug,P07998,Ribonuclease pancreatic,RNASE1,156.0
7123,DB01962,Phosphonotyrosine,SmallMoleculeDrug,P08631,Tyrosine-protein kinase HCK,HCK,526.0
7124,DB01962,Phosphonotyrosine,SmallMoleculeDrug,P12931,Proto-oncogene tyrosine-protein kinase Src,SRC,536.0
7125,DB01962,Phosphonotyrosine,SmallMoleculeDrug,P10721,Mast/stem cell growth factor receptor Kit,KIT,976.0
7126,DB01963,Phenylethane Boronic Acid,SmallMoleculeDrug,P17538,Chymotrypsinogen B,CTRB1,263.0
7127,DB01964,AL5424,SmallMoleculeDrug,P00918,Carbonic anhydrase 2,CA2,260.0
7130,DB01966,Di-Stearoyl-3-Sn-Phosphatidylethanolamine,SmallMoleculeDrug,P07602,Prosaposin,PSAP,524.0
7134,DB01969,Trifluoroacetonyl Coenzyme A,SmallMoleculeDrug,O75390,"Citrate synthase, mitochondrial",CS,466.0
7135,DB01970,"Hg9a-9, Nonanoyl-N-Hydroxyethylglucamide",SmallMoleculeDrug,Q13370,"cGMP-inhibited 3',5'-cyclic phosphodiesterase B",PDE3B,1112.0
7137,DB01972,Guanosine-5'-Monophosphate,SmallMoleculeDrug,Q16774,Guanylate kinase,GUK1,197.0
7140,DB01972,Guanosine-5'-Monophosphate,SmallMoleculeDrug,P78352,Disks large homolog 4,DLG4,724.0
7141,DB01972,Guanosine-5'-Monophosphate,SmallMoleculeDrug,P36959,GMP reductase 1,GMPR,345.0
7142,DB01972,Guanosine-5'-Monophosphate,SmallMoleculeDrug,O76074,"cGMP-specific 3',5'-cyclic phosphodiesterase",PDE5A,875.0
7143,DB01972,Guanosine-5'-Monophosphate,SmallMoleculeDrug,P49773,Histidine triad nucleotide-binding protein 1,HINT1,126.0
7144,DB01972,Guanosine-5'-Monophosphate,SmallMoleculeDrug,P31939,Bifunctional purine biosynthesis protein PURH,ATIC,592.0
7147,DB01972,Guanosine-5'-Monophosphate,SmallMoleculeDrug,Q08188,Protein-glutamine gamma-glutamyltransferase E,TGM3,693.0
7152,DB01973,O-Benzylsulfonyl-Serine,SmallMoleculeDrug,P07478,Trypsin-2,PRSS2,247.0
7158,DB01977,6-(N-Phenylcarbamyl)-2-Naphthalenecarboxamidine,SmallMoleculeDrug,P00749,Urokinase-type plasminogen activator,PLAU,431.0
7160,DB01979,Methyl alpha-D-mannoside,SmallMoleculeDrug,P11226,Mannose-binding protein C,MBL2,248.0
7165,DB01983,2(S)-Amino-6-Boronohexanoic Acid,SmallMoleculeDrug,P05089,Arginase-1,ARG1,322.0
7176,DB01988,6((S)-3-Benzylpiperazin-1-Yl)-3-(Naphthalen-2-Yl)-4-(Pyridin-4-Yl)Pyrazine,SmallMoleculeDrug,Q16539,Mitogen-activated protein kinase 14,MAPK14,360.0
7177,DB01989,Carbobenzoxy-Pro-Lys-Phe-Y(Po2)-Ala-Pro-Ome,SmallMoleculeDrug,Q9Y6L7,Tolloid-like protein 2,TLL2,1015.0
7178,DB01990,Cholesterol-Sulfate,SmallMoleculeDrug,P35398,Nuclear receptor ROR-alpha,RORA,523.0
7181,DB01992,Coenzyme A,SmallMoleculeDrug,P07108,Acyl-CoA-binding protein,DBI,87.0
7183,DB01992,Coenzyme A,SmallMoleculeDrug,P43155,Carnitine O-acetyltransferase,CRAT,626.0
7193,DB01992,Coenzyme A,SmallMoleculeDrug,P04035,3-hydroxy-3-methylglutaryl-coenzyme A reductase,HMGCR,888.0
7195,DB01992,Coenzyme A,SmallMoleculeDrug,Q92993,Histone acetyltransferase KAT5,KAT5,513.0
7197,DB01992,Coenzyme A,SmallMoleculeDrug,Q9BWD1,"Acetyl-CoA acetyltransferase, cytosolic",ACAT2,397.0
7200,DB01992,Coenzyme A,SmallMoleculeDrug,O75390,"Citrate synthase, mitochondrial",CS,466.0
7212,DB01992,Coenzyme A,SmallMoleculeDrug,Q92830,Histone acetyltransferase KAT2A,KAT2A,837.0
7214,DB01992,Coenzyme A,SmallMoleculeDrug,Q92831,Histone acetyltransferase KAT2B,KAT2B,832.0
7226,DB01996,3-Methylpyridine,SmallMoleculeDrug,P45452,Collagenase 3,MMP13,471.0
7227,DB01996,3-Methylpyridine,SmallMoleculeDrug,P08254,Stromelysin-1,MMP3,477.0
7228,DB01997,3-Bromo-7-Nitroindazole,SmallMoleculeDrug,P29474,"Nitric oxide synthase, endothelial",NOS3,1203.0
7229,DB01997,3-Bromo-7-Nitroindazole,SmallMoleculeDrug,P29475,"Nitric oxide synthase, brain",NOS1,1434.0
7230,DB01997,3-Bromo-7-Nitroindazole,SmallMoleculeDrug,P35228,"Nitric oxide synthase, inducible",NOS2,1153.0
7231,DB01998,"2-[3,4-Dihydroxy-2-Hydroxymethyl-5-(2-Hydroxy-Nonyl)-Tetrahydro-Furan-2-Yloxy]-6-Hydroxymethyl-Tetra Hydro-Pyran-3,4,5-Triol",SmallMoleculeDrug,P01009,Alpha-1-antitrypsin,SERPINA1,418.0
7235,DB02001,"5-(4-Morpholin-4-Yl-Phenylsulfanyl)-2,4-Quinazolinediamine",SmallMoleculeDrug,Q86XF0,"Dihydrofolate reductase, mitochondrial",DHFR2,187.0
7237,DB02004,"5-(Aminomethyl)-6-(2,4-Dichlorophenyl)-2-(3,5-Dimethoxyphenyl)Pyrimidin-4-Amine",SmallMoleculeDrug,P27487,Dipeptidyl peptidase 4,DPP4,766.0
7239,DB02007,alpha-D-glucose 6-phosphate,SmallMoleculeDrug,P19367,Hexokinase-1,HK1,917.0
7242,DB02007,alpha-D-glucose 6-phosphate,SmallMoleculeDrug,P11217,"Glycogen phosphorylase, muscle form",PYGM,842.0
7246,DB02007,alpha-D-glucose 6-phosphate,SmallMoleculeDrug,P06744,Glucose-6-phosphate isomerase,GPI,558.0
7247,DB02007,alpha-D-glucose 6-phosphate,SmallMoleculeDrug,P15121,Aldose reductase,AKR1B1,316.0
7248,DB02008,1-(2-Fluorobenzyl)-3-Butyl-8-(N-Acetyl-4-Aminobenzyl)-Xanthine,SmallMoleculeDrug,P35558,"Phosphoenolpyruvate carboxykinase, cytosolic [GTP]",PCK1,622.0
7250,DB02010,Staurosporine,SmallMoleculeDrug,P06239,Tyrosine-protein kinase Lck,LCK,509.0
7251,DB02010,Staurosporine,SmallMoleculeDrug,P11309,Serine/threonine-protein kinase pim-1,PIM1,404.0
7252,DB02010,Staurosporine,SmallMoleculeDrug,Q08881,Tyrosine-protein kinase ITK/TSK,ITK,620.0
7253,DB02010,Staurosporine,SmallMoleculeDrug,P43405,Tyrosine-protein kinase SYK,SYK,635.0
7254,DB02010,Staurosporine,SmallMoleculeDrug,P49137,MAP kinase-activated protein kinase 2,MAPKAPK2,400.0
7255,DB02010,Staurosporine,SmallMoleculeDrug,P49841,Glycogen synthase kinase-3 beta,GSK3B,420.0
7256,DB02010,Staurosporine,SmallMoleculeDrug,P41240,Tyrosine-protein kinase CSK,CSK,450.0
7257,DB02010,Staurosporine,SmallMoleculeDrug,P24941,Cyclin-dependent kinase 2,CDK2,298.0
7258,DB02010,Staurosporine,SmallMoleculeDrug,P48736,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",PIK3CG,1102.0
7259,DB02010,Staurosporine,SmallMoleculeDrug,O15530,3-phosphoinositide-dependent protein kinase 1,PDPK1,556.0
7260,DB02010,Staurosporine,SmallMoleculeDrug,Q04759,Protein kinase C theta type,PRKCQ,706.0
7261,DB02010,Staurosporine,SmallMoleculeDrug,P43403,Tyrosine-protein kinase ZAP-70,ZAP70,619.0
7262,DB02011,N-(Phosphonoacetyl)-L-Ornithine,SmallMoleculeDrug,P00480,"Ornithine carbamoyltransferase, mitochondrial",OTC,354.0
7263,DB02014,Compound 9,SmallMoleculeDrug,P18031,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,435.0
7266,DB02016,R048-8071,SmallMoleculeDrug,P48449,Lanosterol synthase,LSS,732.0
7268,DB02018,Amido Phenyl Pyruvic Acid,SmallMoleculeDrug,P20231,Tryptase beta-2,TPSB2,275.0
7270,DB02020,Alrestatin,SmallMoleculeDrug,P15121,Aldose reductase,AKR1B1,316.0
7271,DB02021,Fidarestat,SmallMoleculeDrug,P15121,Aldose reductase,AKR1B1,316.0
7279,DB02027,N-{(4s)-4-Amino-5-[(2-Aminoethyl)Amino]Pentyl}-N'-Nitroguanidine,SmallMoleculeDrug,P29474,"Nitric oxide synthase, endothelial",NOS3,1203.0
7280,DB02027,N-{(4s)-4-Amino-5-[(2-Aminoethyl)Amino]Pentyl}-N'-Nitroguanidine,SmallMoleculeDrug,P29475,"Nitric oxide synthase, brain",NOS1,1434.0
7281,DB02028,"L-Alpha-Glycerophospho-D-Myo-Inositol-4,5-Bis-Phosphate",SmallMoleculeDrug,P50607,Tubby protein homolog,TUB,506.0
7282,DB02029,N-Cyclohexyl-N'-(4-Iodophenyl)Urea,SmallMoleculeDrug,P34913,Bifunctional epoxide hydrolase 2,EPHX2,555.0
7286,DB02032,1-(3-Mercapto-2-Methyl-Propionyl)-Pyrrolidine-2-Carboxylic Acid,SmallMoleculeDrug,P12821,Angiotensin-converting enzyme,ACE,1306.0
7293,DB02034,Swainsonine,SmallMoleculeDrug,Q16706,Alpha-mannosidase 2,MAN2A1,1144.0
7294,DB02035,1-Hexadecylsulfonyl Fluoride,SmallMoleculeDrug,P50897,Palmitoyl-protein thioesterase 1,PPT1,306.0
7300,DB02039,S-Acetyl-Cysteine,SmallMoleculeDrug,Q92993,Histone acetyltransferase KAT5,KAT5,513.0
7308,DB02044,N-(3-(Aminomethyl)Benzyl)Acetamidine,SmallMoleculeDrug,P29474,"Nitric oxide synthase, endothelial",NOS3,1203.0
7309,DB02044,N-(3-(Aminomethyl)Benzyl)Acetamidine,SmallMoleculeDrug,P35228,"Nitric oxide synthase, inducible",NOS2,1153.0
7310,DB02044,N-(3-(Aminomethyl)Benzyl)Acetamidine,SmallMoleculeDrug,P29475,"Nitric oxide synthase, brain",NOS1,1434.0
7311,DB02045,Amylamine,SmallMoleculeDrug,P07477,Trypsin-1,PRSS1,247.0
7312,DB02046,N-[(Furan-2-Yl)Carbonyl]-(S)-Leucyl-(R)-[1-Amino-2(1h-Indol-3-Yl)Ethyl]-Phosphonic Acid,SmallMoleculeDrug,Q9UKQ2,Disintegrin and metalloproteinase domain-containing protein 28,ADAM28,775.0
7313,DB02047,"2-(1,1'-Biphenyl-4-Yl)Propanoic Acid",SmallMoleculeDrug,P23219,Prostaglandin G/H synthase 1,PTGS1,599.0
7314,DB02048,"1,2,4-Triazole-Carboxamidine",SmallMoleculeDrug,P29474,"Nitric oxide synthase, endothelial",NOS3,1203.0
7315,DB02049,2-{4-[4-(4-Chloro-Phenoxy)-Benzenesulfonyl]-Tetrahydro-Pyran-4-Yl}-N-Hydroxy-Acetamide,SmallMoleculeDrug,P45452,Collagenase 3,MMP13,471.0
7317,DB02052,Indirubin-3'-Monoxime,SmallMoleculeDrug,Q00535,Cyclin-dependent-like kinase 5,CDK5,292.0
7318,DB02052,Indirubin-3'-Monoxime,SmallMoleculeDrug,P06493,Cyclin-dependent kinase 1,CDK1,297.0
7319,DB02052,Indirubin-3'-Monoxime,SmallMoleculeDrug,P49841,Glycogen synthase kinase-3 beta,GSK3B,420.0
7320,DB02052,Indirubin-3'-Monoxime,SmallMoleculeDrug,Q15078,Cyclin-dependent kinase 5 activator 1,CDK5R1,307.0
7321,DB02052,Indirubin-3'-Monoxime,SmallMoleculeDrug,P24941,Cyclin-dependent kinase 2,CDK2,298.0
7325,DB02054,Gabaculine,SmallMoleculeDrug,P04181,"Ornithine aminotransferase, mitochondrial",OAT,439.0
7327,DB02056,"(5e,13e)-9,15-Dihydroxy-11-Oxoprosta-5,13-Dien-1-Oicacid",SmallMoleculeDrug,P42330,Aldo-keto reductase family 1 member C3,AKR1C3,323.0
7328,DB02057,(S)-AMPA,SmallMoleculeDrug,P42262,Glutamate receptor 2,GRIA2,883.0
7329,DB02058,SU4984,SmallMoleculeDrug,P21802,Fibroblast growth factor receptor 2,FGFR2,821.0
7330,DB02058,SU4984,SmallMoleculeDrug,P11362,Fibroblast growth factor receptor 1,FGFR1,822.0
7332,DB02059,Adenosine-5-Diphosphoribose,SmallMoleculeDrug,P13639,Elongation factor 2,EEF2,858.0
7333,DB02059,Adenosine-5-Diphosphoribose,SmallMoleculeDrug,P04406,Glyceraldehyde-3-phosphate dehydrogenase,GAPDH,335.0
7335,DB02059,Adenosine-5-Diphosphoribose,SmallMoleculeDrug,Q9NXA8,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",SIRT5,310.0
7341,DB02059,Adenosine-5-Diphosphoribose,SmallMoleculeDrug,Q9NTG7,"NAD-dependent protein deacetylase sirtuin-3, mitochondrial",SIRT3,399.0
7346,DB02062,"N-[3-[(1-Aminoethyl)(Hydroxy)Phosphoryl]-2-(1,1'-Biphenyl-4-Ylmethyl)Propanoyl]Alanine",SmallMoleculeDrug,P08473,Neprilysin,MME,750.0
7347,DB02062,"N-[3-[(1-Aminoethyl)(Hydroxy)Phosphoryl]-2-(1,1'-Biphenyl-4-Ylmethyl)Propanoyl]Alanine",SmallMoleculeDrug,P09960,Leukotriene A-4 hydrolase,LTA4H,611.0
7348,DB02063,CRA_16847,SmallMoleculeDrug,P07477,Trypsin-1,PRSS1,247.0
7351,DB02067,Triglu-5-Formyl-Tetrahydrofolate,SmallMoleculeDrug,P34896,"Serine hydroxymethyltransferase, cytosolic",SHMT1,483.0
7352,DB02068,Delta-Amino Valeric Acid,SmallMoleculeDrug,P50440,"Glycine amidinotransferase, mitochondrial",GATM,423.0
7353,DB02068,Delta-Amino Valeric Acid,SmallMoleculeDrug,P13716,Delta-aminolevulinic acid dehydratase,ALAD,330.0
7354,DB02069,N-(2-Flouro-Benzyl)-4-Sulfamoyl-Benzamide,SmallMoleculeDrug,P00918,Carbonic anhydrase 2,CA2,260.0
7355,DB02071,WAY-151693,SmallMoleculeDrug,P45452,Collagenase 3,MMP13,471.0
7356,DB02072,"2-(Oxalyl-Amino)-4,7-Dihydro-5h-Thieno[2,3-C]Thiopyran-3-Carboxylic Acid",SmallMoleculeDrug,P18031,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,435.0
7357,DB02073,Biliverdine Ix Alpha,SmallMoleculeDrug,P09601,Heme oxygenase 1,HMOX1,288.0
7358,DB02073,Biliverdine Ix Alpha,SmallMoleculeDrug,P02144,Myoglobin,MB,154.0
7359,DB02073,Biliverdine Ix Alpha,SmallMoleculeDrug,P30043,Flavin reductase (NADPH),BLVRB,206.0
7361,DB02076,6-Phosphogluconic Acid,SmallMoleculeDrug,P52209,"6-phosphogluconate dehydrogenase, decarboxylating",PGD,483.0
7362,DB02076,6-Phosphogluconic Acid,SmallMoleculeDrug,P06744,Glucose-6-phosphate isomerase,GPI,558.0
7364,DB02077,L-N(Omega)-Nitroarginine-(4r)-Amino-L-Proline Amide,SmallMoleculeDrug,P29474,"Nitric oxide synthase, endothelial",NOS3,1203.0
7365,DB02077,L-N(Omega)-Nitroarginine-(4r)-Amino-L-Proline Amide,SmallMoleculeDrug,P29475,"Nitric oxide synthase, brain",NOS1,1434.0
7367,DB02078,1-Methoxy-2-[2-(2-Methoxy-Ethoxy]-Ethane,SmallMoleculeDrug,P35080,Profilin-2,PFN2,140.0
7371,DB02078,1-Methoxy-2-[2-(2-Methoxy-Ethoxy]-Ethane,SmallMoleculeDrug,P06241,Tyrosine-protein kinase Fyn,FYN,537.0
7372,DB02078,1-Methoxy-2-[2-(2-Methoxy-Ethoxy]-Ethane,SmallMoleculeDrug,P30405,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",PPIF,207.0
7376,DB02079,Aminooxyacetic acid,SmallMoleculeDrug,P21549,Serine--pyruvate aminotransferase,AGXT,392.0
7377,DB02080,"1-{2-[2-(2-Methoxyethoxy)Ethoxy]Ethoxy}-4-(1,1,3,3-Tetramethylbutyl)Benzene",SmallMoleculeDrug,P14555,"Phospholipase A2, membrane associated",PLA2G2A,144.0
7379,DB02081,Bis-Benzamidine,SmallMoleculeDrug,P07477,Trypsin-1,PRSS1,247.0
7380,DB02082,Phosphoaminophosphonic Acid Guanylate Ester,SmallMoleculeDrug,Q92930,Ras-related protein Rab-8B,RAB8B,207.0
7382,DB02084,CRA_17312,SmallMoleculeDrug,P07477,Trypsin-1,PRSS1,247.0
7385,DB02087,"3,5-Difluorobenzenesulfonamide",SmallMoleculeDrug,P00918,Carbonic anhydrase 2,CA2,260.0
7387,DB02089,CP-526423,SmallMoleculeDrug,P06737,"Glycogen phosphorylase, liver form",PYGL,847.0
7388,DB02090,A Disubstituted Succinyl Caprolactam Hydroxymate Mmp3inhibitor,SmallMoleculeDrug,P08254,Stromelysin-1,MMP3,477.0
7389,DB02091,"4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Ylamine",SmallMoleculeDrug,P24941,Cyclin-dependent kinase 2,CDK2,298.0
7390,DB02091,"4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Ylamine",SmallMoleculeDrug,P20248,Cyclin-A2,CCNA2,432.0
7392,DB02093,5-Phospho-D-Arabinohydroxamic Acid,SmallMoleculeDrug,P06744,Glucose-6-phosphate isomerase,GPI,558.0
7394,DB02095,Isatin,SmallMoleculeDrug,P27338,Amine oxidase [flavin-containing] B,MAOB,520.0
7395,DB02096,FR221647,SmallMoleculeDrug,P00813,Adenosine deaminase,ADA,363.0
7396,DB02097,Cytidine,SmallMoleculeDrug,Q9BZX2,Uridine-cytidine kinase 2,UCK2,261.0
7397,DB02098,Adenosine-2'-5'-Diphosphate,SmallMoleculeDrug,P12724,Eosinophil cationic protein,RNASE3,160.0
7398,DB02098,Adenosine-2'-5'-Diphosphate,SmallMoleculeDrug,P07998,Ribonuclease pancreatic,RNASE1,156.0
7399,DB02098,Adenosine-2'-5'-Diphosphate,SmallMoleculeDrug,P10153,Non-secretory ribonuclease,RNASE2,161.0
7400,DB02101,"(S,R)-fidarestat",SmallMoleculeDrug,P15121,Aldose reductase,AKR1B1,316.0
7402,DB02103,2-Chlorodideoxyadenosine,SmallMoleculeDrug,P14625,Endoplasmin,HSP90B1,803.0
7403,DB02104,"2,4-Diamino-5-Methyl-6-[(3,4,5-Trimethoxy-N-Methylanilino)Methyl]Pyrido[2,3-D]Pyrimidine",SmallMoleculeDrug,P00374,Dihydrofolate reductase,DHFR,187.0
7404,DB02105,"3,5-Dinitrocatechol",SmallMoleculeDrug,P21964,Catechol O-methyltransferase,COMT,271.0
7405,DB02106,"[3,5-Dibromo-4-(4-Hydroxy-3-Phenethylcarbamoyl-Phenoxy)-Phenyl]-Acetic Acid",SmallMoleculeDrug,P10828,Thyroid hormone receptor beta,THRB,461.0
7406,DB02107,Leucine - Reduced Carbonyl,SmallMoleculeDrug,Q6UWN8,Serine protease inhibitor Kazal-type 6,SPINK6,80.0
7407,DB02108,2-Aminoethanimidic Acid,SmallMoleculeDrug,P07858,Cathepsin B,CTSB,339.0
7409,DB02109,Hadacidin,SmallMoleculeDrug,Q8N142,Adenylosuccinate synthetase isozyme 1,ADSSL1,457.0
7411,DB02110,Protoporphyrin Ix Containing Co,SmallMoleculeDrug,P23219,Prostaglandin G/H synthase 1,PTGS1,599.0
7412,DB02110,Protoporphyrin Ix Containing Co,SmallMoleculeDrug,P99999,Cytochrome c,CYCS,105.0
7414,DB02112,Zk-806450,SmallMoleculeDrug,P07477,Trypsin-1,PRSS1,247.0
7416,DB02114,Para-Isopropylaniline,SmallMoleculeDrug,Q9UNI1,Chymotrypsin-like elastase family member 1,CELA1,258.0
7417,DB02115,Daidzin,SmallMoleculeDrug,P05091,"Aldehyde dehydrogenase, mitochondrial",ALDH2,517.0
7418,DB02116,Olomoucine,SmallMoleculeDrug,P24941,Cyclin-dependent kinase 2,CDK2,298.0
7419,DB02116,Olomoucine,SmallMoleculeDrug,Q00535,Cyclin-dependent-like kinase 5,CDK5,292.0
7420,DB02116,Olomoucine,SmallMoleculeDrug,P06493,Cyclin-dependent kinase 1,CDK1,297.0
7421,DB02116,Olomoucine,SmallMoleculeDrug,P28482,Mitogen-activated protein kinase 1,MAPK1,360.0
7422,DB02118,CP-271485,SmallMoleculeDrug,P39900,Macrophage metalloelastase,MMP12,470.0
7437,DB02126,4-Carboxycinnamic Acid,SmallMoleculeDrug,P69905,Hemoglobin subunit alpha,HBA1;,142.0
7438,DB02126,4-Carboxycinnamic Acid,SmallMoleculeDrug,P68871,Hemoglobin subunit beta,HBB,147.0
7444,DB02131,N-1-Methylheptylformamide,SmallMoleculeDrug,P00326,Alcohol dehydrogenase 1C,ADH1C,375.0
7445,DB02132,"[3-(4-Bromo-2-Fluoro-Benzyl)-7-Chloro-2,4-Dioxo-3,4-Dihydro-2h-Quinazolin-1-Yl]-Acetic Acid",SmallMoleculeDrug,P15121,Aldose reductase,AKR1B1,316.0
7454,DB02140,N1-(1-Dimethylcarbamoyl-2-Phenyl-Ethyl)-2-Oxo-N4-(2-Pyridin-2-Yl-Ethyl)-Succinamide,SmallMoleculeDrug,P09668,Pro-cathepsin H,CTSH,335.0
7455,DB02141,"S,S'-(1,4-Phenylene-Bis(1,2-Ethanediyl))Bis-Isothiourea",SmallMoleculeDrug,P29474,"Nitric oxide synthase, endothelial",NOS3,1203.0
7462,DB02142,Pyridoxamine-5'-Phosphate,SmallMoleculeDrug,Q16773,Kynurenine--oxoglutarate transaminase 1,KYAT1,422.0
7464,DB02142,Pyridoxamine-5'-Phosphate,SmallMoleculeDrug,O15382,"Branched-chain-amino-acid aminotransferase, mitochondrial",BCAT2,392.0
7466,DB02143,N-Isopropyl-N'-Hydroxyguanidine,SmallMoleculeDrug,P29475,"Nitric oxide synthase, brain",NOS1,1434.0
7467,DB02144,"1,2-Diacyl-Sn-Glycero-3-Phosphoinositol",SmallMoleculeDrug,Q00169,Phosphatidylinositol transfer protein alpha isoform,PITPNA,270.0
7470,DB02148,3-Amino-4-Oxybenzyl-2-Butanone,SmallMoleculeDrug,P07858,Cathepsin B,CTSB,339.0
7473,DB02152,K-252a,SmallMoleculeDrug,P08581,Hepatocyte growth factor receptor,MET,1390.0
7474,DB02152,K-252a,SmallMoleculeDrug,Q02750,Dual specificity mitogen-activated protein kinase kinase 1,MAP2K1,393.0
7477,DB02153,3-Sulfinoalanine,SmallMoleculeDrug,P51003,Poly(A) polymerase alpha,PAPOLA,745.0
7479,DB02153,3-Sulfinoalanine,SmallMoleculeDrug,P00390,"Glutathione reductase, mitochondrial",GSR,522.0
7483,DB02153,3-Sulfinoalanine,SmallMoleculeDrug,P32119,Peroxiredoxin-2,PRDX2,198.0
7490,DB02155,Balanol Analog 8,SmallMoleculeDrug,P17612,cAMP-dependent protein kinase catalytic subunit alpha,PRKACA,351.0
7491,DB02158,"(1s)-1-(9-Deazaadenin-9-Yl)-1,4,5-Trideoxy-1,4-Imino-5-Methylthio-D-Ribitol",SmallMoleculeDrug,Q13126,S-methyl-5'-thioadenosine phosphorylase,MTAP,283.0
7494,DB02159,(R)-Propylene glycol,SmallMoleculeDrug,P61626,Lysozyme C,LYZ,148.0
7496,DB02161,Hydroxy-Phenyl-Acetic Acid 8-Methyl-8-Aza-Bicyclo[3.2.1]Oct-3-Yl Ester,SmallMoleculeDrug,P23141,Liver carboxylesterase 1,CES1,567.0
7497,DB02162,5'-O-(N-Ethyl-Sulfamoyl)Adenosine,SmallMoleculeDrug,P49773,Histidine triad nucleotide-binding protein 1,HINT1,126.0
7499,DB02164,N-Sulfo-Flavin Mononucleotide,SmallMoleculeDrug,Q9UJM8,Hydroxyacid oxidase 1,HAO1,370.0
7500,DB02165,Zinc Trihydroxide,SmallMoleculeDrug,P09488,Glutathione S-transferase Mu 1,GSTM1,218.0
7501,DB02166,Propidium,SmallMoleculeDrug,P22303,Acetylcholinesterase,ACHE,614.0
7503,DB02169,"9,10-Deepithio-9,10-Didehydroacanthifolicin",SmallMoleculeDrug,P36873,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,PPP1CC,323.0
7504,DB02170,"1,8-Di-Hydroxy-4-Nitro-Xanthen-9-One",SmallMoleculeDrug,P68400,Casein kinase II subunit alpha,CSNK2A1,391.0
7509,DB02175,Malonic acid,SmallMoleculeDrug,P12931,Proto-oncogene tyrosine-protein kinase Src,SRC,536.0
7511,DB02175,Malonic acid,SmallMoleculeDrug,P09012,U1 small nuclear ribonucleoprotein A,SNRPA,282.0
7514,DB02177,1-Acetyl-4-(4-{4-[(2-Ethoxyphenyl)Thio]-3-Nitrophenyl}Pyridin-2-Yl)Piperazine,SmallMoleculeDrug,P20701,Integrin alpha-L,ITGAL,1170.0
7517,DB02180,Myristoyl-Coa,SmallMoleculeDrug,O60551,Glycylpeptide N-tetradecanoyltransferase 2,NMT2,498.0
7518,DB02181,2'-Deoxyguanosine-5'-Triphosphate,SmallMoleculeDrug,P15531,Nucleoside diphosphate kinase A,NME1,152.0
7521,DB02183,Adenosine-5'-Ditungstate,SmallMoleculeDrug,P49773,Histidine triad nucleotide-binding protein 1,HINT1,126.0
7523,DB02185,"2,4-Dihydroxy-7-(Methyloxy)-2h-1,4-Benzoxazin-3(4h)-One",SmallMoleculeDrug,Q6UWM7,Lactase-like protein,LCTL,567.0
7526,DB02187,Equilin,SmallMoleculeDrug,P14061,Estradiol 17-beta-dehydrogenase 1,HSD17B1,328.0
7528,DB02189,"2',3'-Dideoxyadenosine-5'-Triphosphate",SmallMoleculeDrug,P04053,DNA nucleotidylexotransferase,DNTT,509.0
7533,DB02193,2-(2-Hydroxy-Phenyl)-1h-Benzoimidazole-5-Carboxamidine,SmallMoleculeDrug,P00734,Prothrombin,F2,622.0
7534,DB02193,2-(2-Hydroxy-Phenyl)-1h-Benzoimidazole-5-Carboxamidine,SmallMoleculeDrug,P07477,Trypsin-1,PRSS1,247.0
7535,DB02193,2-(2-Hydroxy-Phenyl)-1h-Benzoimidazole-5-Carboxamidine,SmallMoleculeDrug,P00749,Urokinase-type plasminogen activator,PLAU,431.0
7536,DB02195,"3-(4-Fluorophenyl)-1-Hydroxy-2-(Pyridin-4-Yl)-1h-Pyrrolo[3,2-B]Pyridine",SmallMoleculeDrug,Q16539,Mitogen-activated protein kinase 14,MAPK14,360.0
7537,DB02196,Uridine-Diphosphate-N-Acetylgalactosamine,SmallMoleculeDrug,Q9UBQ6,Exostosin-like 2,EXTL2,330.0
7538,DB02196,Uridine-Diphosphate-N-Acetylgalactosamine,SmallMoleculeDrug,Q16222,UDP-N-acetylhexosamine pyrophosphorylase,UAP1,522.0
7539,DB02196,Uridine-Diphosphate-N-Acetylgalactosamine,SmallMoleculeDrug,Q14376,UDP-glucose 4-epimerase,GALE,348.0
7541,DB02196,Uridine-Diphosphate-N-Acetylgalactosamine,SmallMoleculeDrug,P16442,Histo-blood group ABO system transferase,ABO,354.0
7544,DB02197,"4-[(4-Imidazo[1,2-a]Pyridin-3-Ylpyrimidin-2-Yl)Amino]Benzenesulfonamide",SmallMoleculeDrug,P24941,Cyclin-dependent kinase 2,CDK2,298.0
7545,DB02198,2-Bromoacetyl Group,SmallMoleculeDrug,P23219,Prostaglandin G/H synthase 1,PTGS1,599.0
7548,DB02201,Malonate Ion,SmallMoleculeDrug,Q99470,Stromal cell-derived factor 2,SDF2,211.0
7550,DB02205,"6-(1,1-Dimethylallyl)-2-(1-Hydroxy-1-Methylethyl)-2,3-Dihydro-7h-Furo[3,2-G]Chromen-7-One",SmallMoleculeDrug,O14556,"Glyceraldehyde-3-phosphate dehydrogenase, testis-specific",GAPDHS,408.0
7551,DB02207,7-Nitroindazole,SmallMoleculeDrug,P29474,"Nitric oxide synthase, endothelial",NOS3,1203.0
7552,DB02207,7-Nitroindazole,SmallMoleculeDrug,P35228,"Nitric oxide synthase, inducible",NOS2,1153.0
7554,DB02209,Pyridoxine-5'-Phosphate,SmallMoleculeDrug,P11926,Ornithine decarboxylase,ODC1,461.0
7556,DB02210,"Hexane-1,6-Diol",SmallMoleculeDrug,P01112,GTPase HRas,HRAS,189.0
7557,DB02210,"Hexane-1,6-Diol",SmallMoleculeDrug,P04150,Glucocorticoid receptor,NR3C1,777.0
7560,DB02210,"Hexane-1,6-Diol",SmallMoleculeDrug,P04054,Phospholipase A2,PLA2G1B,148.0
7561,DB02211,N-Methyl-N-Propargyl-1(R)-Aminoindan,SmallMoleculeDrug,P27338,Amine oxidase [flavin-containing] B,MAOB,520.0
7565,DB02215,Furoyl-Leucine,SmallMoleculeDrug,Q9UKQ2,Disintegrin and metalloproteinase domain-containing protein 28,ADAM28,775.0
7566,DB02216,S-Methylcysteine,SmallMoleculeDrug,P07339,Cathepsin D,CTSD,412.0
7567,DB02216,S-Methylcysteine,SmallMoleculeDrug,P16455,Methylated-DNA--protein-cysteine methyltransferase,MGMT,207.0
7568,DB02217,Dpb-T,SmallMoleculeDrug,Q9NPB1,"5'(3')-deoxyribonucleotidase, mitochondrial",NT5M,228.0
7569,DB02218,"N-[4-Hydroxymethyl-Cyclohexan-6-Yl-1,2,3-Triol]-4,6-Dideoxy-4-Aminoglucopyranoside",SmallMoleculeDrug,P04746,Pancreatic alpha-amylase,AMY2A,511.0
7571,DB02218,"N-[4-Hydroxymethyl-Cyclohexan-6-Yl-1,2,3-Triol]-4,6-Dideoxy-4-Aminoglucopyranoside",SmallMoleculeDrug,P19961,Alpha-amylase 2B,AMY2B,511.0
7572,DB02220,Al7089a,SmallMoleculeDrug,P00918,Carbonic anhydrase 2,CA2,260.0
7573,DB02221,"4-(Aminosulfonyl)-N-[(2,4,6-Trifluorophenyl)Methyl]-Benzamide",SmallMoleculeDrug,P00918,Carbonic anhydrase 2,CA2,260.0
7574,DB02222,"2,6-Diamino-(S)-9-[2-(Phosphonomethoxy)Propyl]Purine",SmallMoleculeDrug,P00491,Purine nucleoside phosphorylase,PNP,289.0
7577,DB02226,"3,8-Diamino-6-Phenyl-5-[6-[1-[2-[(1,2,3,4-Tetrahydro-9-Acridinyl)Amino]Ethyl]-1h-1,2,3-Triazol-4-Yl]Hexyl]-Phenanthridinium",SmallMoleculeDrug,P22303,Acetylcholinesterase,ACHE,614.0
7581,DB02230,Immucillin-G,SmallMoleculeDrug,P00491,Purine nucleoside phosphorylase,PNP,289.0
7586,DB02234,Ethylisothiourea,SmallMoleculeDrug,P35228,"Nitric oxide synthase, inducible",NOS2,1153.0
7587,DB02234,Ethylisothiourea,SmallMoleculeDrug,P29474,"Nitric oxide synthase, endothelial",NOS3,1203.0
7589,DB02235,L-methionine (R)-S-oxide,SmallMoleculeDrug,P05067,Amyloid beta A4 protein,APP,770.0
7593,DB02236,Glycinamide Ribonucleotide,SmallMoleculeDrug,P22102,Trifunctional purine biosynthetic protein adenosine-3,GART,1010.0
7597,DB02239,Laevulinic Acid,SmallMoleculeDrug,P13716,Delta-aminolevulinic acid dehydratase,ALAD,330.0
7600,DB02243,4-Morpholin-4-Yl-Piperidine-1-Carboxylic Acid [1-(3-Benzenesulfonyl-1-Propyl-Allylcarbamoyl)-2-Phenylethyl]-Amide,SmallMoleculeDrug,Q9UBX1,Cathepsin F,CTSF,484.0
7602,DB02249,2-Ethoxyethanol,SmallMoleculeDrug,P00326,Alcohol dehydrogenase 1C,ADH1C,375.0
7603,DB02250,Cu-Bicyclam,SmallMoleculeDrug,P61626,Lysozyme C,LYZ,148.0
7611,DB02255,GM6001,SmallMoleculeDrug,Q9UKQ2,Disintegrin and metalloproteinase domain-containing protein 28,ADAM28,775.0
7612,DB02255,GM6001,SmallMoleculeDrug,P16112,Aggrecan core protein,ACAN,2415.0
7616,DB02258,SR11254,SmallMoleculeDrug,P13631,Retinoic acid receptor gamma,RARG,454.0
7617,DB02259,"3-(3,5-Dibromo-4-Hydroxy-Benzoyl)-2-Ethyl-Benzofuran-6-Sulfonic Acid (4-Sulfamoyl-Phenyl)-Amide",SmallMoleculeDrug,P18031,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,435.0
7619,DB02260,4-Oxosebacic Acid,SmallMoleculeDrug,P13716,Delta-aminolevulinic acid dehydratase,ALAD,330.0
7620,DB02261,Platelet Activating Factor,SmallMoleculeDrug,P17900,Ganglioside GM2 activator,GM2A,193.0
7623,DB02262,Orotic Acid,SmallMoleculeDrug,Q02127,"Dihydroorotate dehydrogenase (quinone), mitochondrial",DHODH,395.0
7629,DB02264,O2-Sulfo-Glucuronic Acid,SmallMoleculeDrug,P05230,Fibroblast growth factor 1,FGF1,155.0
7630,DB02264,O2-Sulfo-Glucuronic Acid,SmallMoleculeDrug,P14210,Hepatocyte growth factor,HGF,728.0
7631,DB02264,O2-Sulfo-Glucuronic Acid,SmallMoleculeDrug,Q9Y663,Heparan sulfate glucosamine 3-O-sulfotransferase 3A1,HS3ST3A1,406.0
7634,DB02266,Flufenamic Acid,SmallMoleculeDrug,P35354,Prostaglandin G/H synthase 2,PTGS2,604.0
7635,DB02266,Flufenamic Acid,SmallMoleculeDrug,P23219,Prostaglandin G/H synthase 1,PTGS1,599.0
7636,DB02266,Flufenamic Acid,SmallMoleculeDrug,P42330,Aldo-keto reductase family 1 member C3,AKR1C3,323.0
7637,DB02266,Flufenamic Acid,SmallMoleculeDrug,P10275,Androgen receptor,AR,920.0
7638,DB02267,Argininosuccinate,SmallMoleculeDrug,P04424,Argininosuccinate lyase,ASL,464.0
7641,DB02269,[4-({[5-Benzyloxy-1-(3-Carbamimidoyl-Benzyl)-1h-Indole-2-Carbonyl]-Amino}-Methyl)-Phenyl]-Trimethyl-Ammonium,SmallMoleculeDrug,P07477,Trypsin-1,PRSS1,247.0
7645,DB02271,S-(2-Oxo)Pentadecylcoa,SmallMoleculeDrug,O60551,Glycylpeptide N-tetradecanoyltransferase 2,NMT2,498.0
7646,DB02272,Porphobilinogen,SmallMoleculeDrug,P13716,Delta-aminolevulinic acid dehydratase,ALAD,330.0
7649,DB02277,1-(5-Tert-Butyl-2-Methyl-2h-Pyrazol-3-Yl)-3-(4-Chloro-Phenyl)-Urea,SmallMoleculeDrug,Q16539,Mitogen-activated protein kinase 14,MAPK14,360.0
7651,DB02279,Benzoylformic Acid,SmallMoleculeDrug,Q9UJM8,Hydroxyacid oxidase 1,HAO1,370.0
7655,DB02281,Formycin,SmallMoleculeDrug,Q13126,S-methyl-5'-thioadenosine phosphorylase,MTAP,283.0
7657,DB02282,5'-Deoxy-5'-Methylthioadenosine,SmallMoleculeDrug,Q13126,S-methyl-5'-thioadenosine phosphorylase,MTAP,283.0
7659,DB02285,Protoporphyrin Ix,SmallMoleculeDrug,P02792,Ferritin light chain,FTL,175.0
7660,DB02287,2-(2-Hydroxy-Phenyl)-3h-Benzoimidazole-5-Carboxamidine,SmallMoleculeDrug,P07477,Trypsin-1,PRSS1,247.0
7661,DB02288,CRA_9334,SmallMoleculeDrug,P07477,Trypsin-1,PRSS1,247.0
7664,DB02292,"6-Oxo-8,9,10,11-Tetrahydro-7h-Cyclohepta[C][1]Benzopyran-3-O-Sulfamate",SmallMoleculeDrug,P00918,Carbonic anhydrase 2,CA2,260.0
7666,DB02296,1-Hydroxy-3-Methylbutane,SmallMoleculeDrug,P00797,Renin,REN,406.0
7667,DB02297,2-Amino-6-Chloropyrazine,SmallMoleculeDrug,P24941,Cyclin-dependent kinase 2,CDK2,298.0
7668,DB02299,Arginineamide,SmallMoleculeDrug,P22459,Potassium voltage-gated channel subfamily A member 4,KCNA4,653.0
7669,DB02300,Calcipotriol,SmallMoleculeDrug,P11473,Vitamin D3 receptor,VDR,427.0
7674,DB02303,"(5s)-5-Iododihydro-2,4(1h,3h)-Pyrimidinedione",SmallMoleculeDrug,Q12882,Dihydropyrimidine dehydrogenase [NADP(+)],DPYD,1025.0
7676,DB02306,Palmitoyl-Linoleoyl Phosphatidylcholine,SmallMoleculeDrug,Q9UKL6,Phosphatidylcholine transfer protein,PCTP,214.0
7678,DB02308,"4-(1,3,2-Dioxaborolan-2-Yloxy)Butan-1-Aminium",SmallMoleculeDrug,P35030,Trypsin-3,PRSS3,304.0
7679,DB02309,5--Monophosphate-9-Beta-D-Ribofuranosyl Xanthine,SmallMoleculeDrug,P31939,Bifunctional purine biosynthesis protein PURH,ATIC,592.0
7680,DB02309,5--Monophosphate-9-Beta-D-Ribofuranosyl Xanthine,SmallMoleculeDrug,P00492,Hypoxanthine-guanine phosphoribosyltransferase,HPRT1,218.0
7681,DB02310,"3,5,6,8-Tetramethyl-N-Methyl Phenanthrolinium",SmallMoleculeDrug,P50579,Methionine aminopeptidase 2,METAP2,478.0
7682,DB02311,Methyl Methylsulfinylmethyl Sulfide,SmallMoleculeDrug,P62942,Peptidyl-prolyl cis-trans isomerase FKBP1A,FKBP1A,108.0
7687,DB02315,Cyclic Guanosine Monophosphate,SmallMoleculeDrug,O00408,"cGMP-dependent 3',5'-cyclic phosphodiesterase",PDE2A,941.0
7688,DB02315,Cyclic Guanosine Monophosphate,SmallMoleculeDrug,Q9UL51,Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2,HCN2,889.0
7689,DB02315,Cyclic Guanosine Monophosphate,SmallMoleculeDrug,P10644,cAMP-dependent protein kinase type I-alpha regulatory subunit,PRKAR1A,381.0
7692,DB02318,2-Deoxy-2-Fluoro-Alpha-D-Mannosyl Fluoride,SmallMoleculeDrug,Q16706,Alpha-mannosidase 2,MAN2A1,1144.0
7694,DB02320,1-N-Acetyl-Beta-D-Glucosamine,SmallMoleculeDrug,P11217,"Glycogen phosphorylase, muscle form",PYGM,842.0
7695,DB02320,1-N-Acetyl-Beta-D-Glucosamine,SmallMoleculeDrug,P06737,"Glycogen phosphorylase, liver form",PYGL,847.0
7697,DB02322,Heparin Disaccharide I-S,SmallMoleculeDrug,P13501,C-C motif chemokine 5,CCL5,91.0
7698,DB02323,EM-1745,SmallMoleculeDrug,P14061,Estradiol 17-beta-dehydrogenase 1,HSD17B1,328.0
7700,DB02325,Isopropyl Alcohol,SmallMoleculeDrug,O60942,mRNA-capping enzyme,RNGTT,597.0
7703,DB02325,Isopropyl Alcohol,SmallMoleculeDrug,Q9BV57,"1,2-dihydroxy-3-keto-5-methylthiopentene dioxygenase",ADI1,179.0
7704,DB02325,Isopropyl Alcohol,SmallMoleculeDrug,P30793,GTP cyclohydrolase 1,GCH1,250.0
7705,DB02325,Isopropyl Alcohol,SmallMoleculeDrug,P43026,Growth/differentiation factor 5,GDF5,501.0
7708,DB02325,Isopropyl Alcohol,SmallMoleculeDrug,P07998,Ribonuclease pancreatic,RNASE1,156.0
7710,DB02325,Isopropyl Alcohol,SmallMoleculeDrug,P07478,Trypsin-2,PRSS2,247.0
7713,DB02325,Isopropyl Alcohol,SmallMoleculeDrug,P14555,"Phospholipase A2, membrane associated",PLA2G2A,144.0
7714,DB02325,Isopropyl Alcohol,SmallMoleculeDrug,P17900,Ganglioside GM2 activator,GM2A,193.0
7717,DB02325,Isopropyl Alcohol,SmallMoleculeDrug,Q13231,Chitotriosidase-1,CHIT1,466.0
7719,DB02325,Isopropyl Alcohol,SmallMoleculeDrug,Q7Z4W1,L-xylulose reductase,DCXR,244.0
7720,DB02325,Isopropyl Alcohol,SmallMoleculeDrug,P30041,Peroxiredoxin-6,PRDX6,224.0
7722,DB02325,Isopropyl Alcohol,SmallMoleculeDrug,P01375,Tumor necrosis factor,TNF,233.0
7723,DB02325,Isopropyl Alcohol,SmallMoleculeDrug,P13686,Tartrate-resistant acid phosphatase type 5,ACP5,325.0
7724,DB02325,Isopropyl Alcohol,SmallMoleculeDrug,P23526,Adenosylhomocysteinase,AHCY,432.0
7725,DB02325,Isopropyl Alcohol,SmallMoleculeDrug,Q13838,Spliceosome RNA helicase DDX39B,DDX39B,428.0
7730,DB02326,1-Hydroxyamine-2-Isobutylmalonic Acid,SmallMoleculeDrug,P22894,Neutrophil collagenase,MMP8,467.0
7734,DB02328,2-[(3-Hydroxy-2-Methyl-5-Phosphonooxymethyl-Pyridin-4-Ylmethyl)-Imino]-5-Phosphono-Pent-3-Enoic Acid,SmallMoleculeDrug,P32929,Cystathionine gamma-lyase,CTH,405.0
7736,DB02329,Carbenoxolone,SmallMoleculeDrug,P28845,Corticosteroid 11-beta-dehydrogenase isozyme 1,HSD11B1,292.0
7745,DB02335,2-Aminothiazoline,SmallMoleculeDrug,P29474,"Nitric oxide synthase, endothelial",NOS3,1203.0
7746,DB02336,RU83876,SmallMoleculeDrug,P12931,Proto-oncogene tyrosine-protein kinase Src,SRC,536.0
7747,DB02337,S-(D-Carboxybutyl)-L-Homocysteine,SmallMoleculeDrug,Q93088,Betaine--homocysteine S-methyltransferase 1,BHMT,406.0
7748,DB02338,Nadph Dihydro-Nicotinamide-Adenine-Dinucleotidephosphate,SmallMoleculeDrug,Q16881,"Thioredoxin reductase 1, cytoplasmic",TXNRD1,649.0
7752,DB02338,Nadph Dihydro-Nicotinamide-Adenine-Dinucleotidephosphate,SmallMoleculeDrug,Q12882,Dihydropyrimidine dehydrogenase [NADP(+)],DPYD,1025.0
7753,DB02338,Nadph Dihydro-Nicotinamide-Adenine-Dinucleotidephosphate,SmallMoleculeDrug,Q9UDR5,"Alpha-aminoadipic semialdehyde synthase, mitochondrial",AASS,926.0
7755,DB02340,N-Acetyl-Serine,SmallMoleculeDrug,P00488,Coagulation factor XIII A chain,F13A1,732.0
7756,DB02341,"Mdl 101,146",SmallMoleculeDrug,Q9UNI1,Chymotrypsin-like elastase family member 1,CELA1,258.0
7757,DB02341,"Mdl 101,146",SmallMoleculeDrug,P08246,Neutrophil elastase,ELANE,267.0
7758,DB02342,2-Methoxyestradiol,SmallMoleculeDrug,Q16665,Hypoxia-inducible factor 1-alpha,HIF1A,826.0
7759,DB02342,2-Methoxyestradiol,SmallMoleculeDrug,P21964,Catechol O-methyltransferase,COMT,271.0
7760,DB02342,2-Methoxyestradiol,SmallMoleculeDrug,P04798,Cytochrome P450 1A1,CYP1A1,512.0
7761,DB02342,2-Methoxyestradiol,SmallMoleculeDrug,Q16678,Cytochrome P450 1B1,CYP1B1,543.0
7762,DB02342,2-Methoxyestradiol,SmallMoleculeDrug,P11511,Aromatase,CYP19A1,503.0
7765,DB02343,"3,6,9,12,15-Pentaoxaheptadecane",SmallMoleculeDrug,P22303,Acetylcholinesterase,ACHE,614.0
7766,DB02345,Selenocysteine,SmallMoleculeDrug,P49913,Cathelicidin antimicrobial peptide,CAMP,170.0
7767,DB02345,Selenocysteine,SmallMoleculeDrug,P15531,Nucleoside diphosphate kinase A,NME1,152.0
7771,DB02347,2-Amino-3-(5-Tert-Butyl-3-(Phosphonomethoxy)-4-Isoxazolyl)Propionic Acid,SmallMoleculeDrug,P42262,Glutamate receptor 2,GRIA2,883.0
7772,DB02348,Fluoro-Phosphite Ion,SmallMoleculeDrug,P11217,"Glycogen phosphorylase, muscle form",PYGM,842.0
7773,DB02350,"N-Hydroxy-4-[(4-Methoxylphenyl)Sulfonyl]-2,2-Dimethyl-Hexahydro-1,4-Thiazepine-3(S)-Carboxamide",SmallMoleculeDrug,P08254,Stromelysin-1,MMP3,477.0
7774,DB02352,3-(Benzyloxy)Pyridin-2-Amine,SmallMoleculeDrug,Q16539,Mitogen-activated protein kinase 14,MAPK14,360.0
7775,DB02352,3-(Benzyloxy)Pyridin-2-Amine,SmallMoleculeDrug,P09960,Leukotriene A-4 hydrolase,LTA4H,611.0
7776,DB02353,Heparin Disaccharide Iii-S,SmallMoleculeDrug,P13501,C-C motif chemokine 5,CCL5,91.0
7777,DB02354,4-{[1-Methyl-5-(2-Methyl-Benzoimidazol-1-Ylmethyl)-1h-Benzoimidazol-2-Ylmethyl]-Amino}-Benzamidine,SmallMoleculeDrug,P07477,Trypsin-1,PRSS1,247.0
7779,DB02358,LY374571,SmallMoleculeDrug,P11586,"C-1-tetrahydrofolate synthase, cytoplasmic",MTHFD1,935.0
7780,DB02359,"9-Butyl-8-(2,5-Dimethoxy-Benzyl)-9h-Purin-6-Ylamine",SmallMoleculeDrug,P07900,Heat shock protein HSP 90-alpha,HSP90AA1,732.0
7781,DB02360,Bis-Napthyl Beta-Ketophosphonic Acid,SmallMoleculeDrug,P08311,Cathepsin G,CTSG,255.0
7786,DB02363,2'-Monophosphoadenosine-5'-Diphosphate,SmallMoleculeDrug,P07998,Ribonuclease pancreatic,RNASE1,156.0
7791,DB02366,CRA_10762,SmallMoleculeDrug,P07477,Trypsin-1,PRSS1,247.0
7792,DB02367,(1n)-4-N-Butoxyphenylsulfonyl-(2r)-N-Hydroxycarboxamido-(4s)-Methanesulfonylamino-Pyrrolidine,SmallMoleculeDrug,P08254,Stromelysin-1,MMP3,477.0
7795,DB02371,"2-(2-Hydroxy-1,1-Dihydroxymethyl-Ethylamino)-Ethanesulfonic Acid",SmallMoleculeDrug,P09871,Complement C1s subcomponent,C1S,688.0
7796,DB02373,Adenosine Monotungstate,SmallMoleculeDrug,P49789,Bis(5'-adenosyl)-triphosphatase,FHIT,147.0
7798,DB02375,Myricetin,SmallMoleculeDrug,P48736,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",PIK3CG,1102.0
7799,DB02376,"D-Gluconhydroximo-1,5-Lactam",SmallMoleculeDrug,P09848,Lactase-phlorizin hydrolase,LCT,1927.0
7801,DB02377,Guanine,SmallMoleculeDrug,P00491,Purine nucleoside phosphorylase,PNP,289.0
7804,DB02377,Guanine,SmallMoleculeDrug,P30793,GTP cyclohydrolase 1,GCH1,250.0
7805,DB02378,MMI-175,SmallMoleculeDrug,P56817,Beta-secretase 1,BACE1,501.0
7806,DB02379,Beta-D-Glucose,SmallMoleculeDrug,P11217,"Glycogen phosphorylase, muscle form",PYGM,842.0
7808,DB02379,Beta-D-Glucose,SmallMoleculeDrug,P35557,Glucokinase,GCK,465.0
7822,DB02379,Beta-D-Glucose,SmallMoleculeDrug,Q7Z4J2,Glycosyltransferase 6 domain-containing protein 1,GLT6D1,308.0
7823,DB02379,Beta-D-Glucose,SmallMoleculeDrug,P46926,Glucosamine-6-phosphate isomerase 1,GNPDA1,289.0
7825,DB02379,Beta-D-Glucose,SmallMoleculeDrug,Q9BW91,"ADP-ribose pyrophosphatase, mitochondrial",NUDT9,350.0
7826,DB02379,Beta-D-Glucose,SmallMoleculeDrug,O60264,SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 5,SMARCA5,1052.0
7829,DB02379,Beta-D-Glucose,SmallMoleculeDrug,P04745,Alpha-amylase 1,AMY1A,511.0
7832,DB02379,Beta-D-Glucose,SmallMoleculeDrug,O14594,Neurocan core protein,NCAN,1321.0
7841,DB02379,Beta-D-Glucose,SmallMoleculeDrug,Q6UWM7,Lactase-like protein,LCTL,567.0
7843,DB02379,Beta-D-Glucose,SmallMoleculeDrug,P04746,Pancreatic alpha-amylase,AMY2A,511.0
7849,DB02379,Beta-D-Glucose,SmallMoleculeDrug,Q701N4,Keratin-associated protein 5-2,KRTAP5-2,177.0
7850,DB02379,Beta-D-Glucose,SmallMoleculeDrug,Q9BZZ2,Sialoadhesin,SIGLEC1,1709.0
7859,DB02379,Beta-D-Glucose,SmallMoleculeDrug,P02144,Myoglobin,MB,154.0
7860,DB02379,Beta-D-Glucose,SmallMoleculeDrug,P05162,Galectin-2,LGALS2,132.0
7861,DB02379,Beta-D-Glucose,SmallMoleculeDrug,P23219,Prostaglandin G/H synthase 1,PTGS1,599.0
7862,DB02379,Beta-D-Glucose,SmallMoleculeDrug,P19367,Hexokinase-1,HK1,917.0
7872,DB02379,Beta-D-Glucose,SmallMoleculeDrug,P47929,Galectin-7,LGALS7,136.0
7874,DB02379,Beta-D-Glucose,SmallMoleculeDrug,Q6L8H2,Keratin-associated protein 5-3,KRTAP5-3,238.0
7877,DB02379,Beta-D-Glucose,SmallMoleculeDrug,P19961,Alpha-amylase 2B,AMY2B,511.0
7890,DB02379,Beta-D-Glucose,SmallMoleculeDrug,P06737,"Glycogen phosphorylase, liver form",PYGL,847.0
7891,DB02379,Beta-D-Glucose,SmallMoleculeDrug,P35247,Pulmonary surfactant-associated protein D,SFTPD,375.0
7892,DB02379,Beta-D-Glucose,SmallMoleculeDrug,P01574,Interferon beta,IFNB1,187.0
7896,DB02381,Nor-N-Omega-Hydroxy-L-Arginine,SmallMoleculeDrug,P05089,Arginase-1,ARG1,322.0
7899,DB02383,Tolrestat,SmallMoleculeDrug,P15121,Aldose reductase,AKR1B1,316.0
7900,DB02383,Tolrestat,SmallMoleculeDrug,P14550,Alcohol dehydrogenase [NADP(+)],AKR1A1,325.0
7901,DB02383,Tolrestat,SmallMoleculeDrug,O60218,Aldo-keto reductase family 1 member B10,AKR1B10,316.0
7903,DB02386,Leucine Phosphonic Acid,SmallMoleculeDrug,P28838,Cytosol aminopeptidase,LAP3,519.0
7905,DB02388,"Cyclohexyl-{4-[5-(3,4-Dichlorophenyl)-2-Piperidin-4-Yl-3-Propyl-3h-Imidazol-4-Yl]-Pyrimidin-2-Yl}Amine",SmallMoleculeDrug,P53779,Mitogen-activated protein kinase 10,MAPK10,464.0
7906,DB02391,"2-Amino-7-[2-(2-Hydroxy-1-Hydroxymethyl-Ethylamino)-Ethyl]-1,7-Dihydro-Purin-6-One",SmallMoleculeDrug,P00491,Purine nucleoside phosphorylase,PNP,289.0
7907,DB02393,"D-Gluco-2,5-Anhydro-1-Deoxy-1-Phosphonohexitol-6-Phosphate",SmallMoleculeDrug,P16118,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 1",PFKFB1,471.0
7909,DB02395,"3-Hydroxymethyl-5-Aziridinyl-1methyl-2-[1h-Indole-4,7-Dione]-Propanol",SmallMoleculeDrug,P15559,NAD(P)H dehydrogenase [quinone] 1,NQO1,274.0
7910,DB02396,Methylethylamine,SmallMoleculeDrug,P02144,Myoglobin,MB,154.0
7911,DB02398,6-[N-(4-(Aminomethyl)Phenyl)Carbamyl]-2-Naphthalenecarboxamidine,SmallMoleculeDrug,P00749,Urokinase-type plasminogen activator,PLAU,431.0
7913,DB02400,"5-Methoxy-1,2-Dimethyl-3-(4-Nitrophenoxymethyl)Indole-4,7-Dione",SmallMoleculeDrug,P15559,NAD(P)H dehydrogenase [quinone] 1,NQO1,274.0
7915,DB02401,"4-Hydroxy-1,2,5-Oxadiazole-3-Carboxylic Acid",SmallMoleculeDrug,P07195,L-lactate dehydrogenase B chain,LDHB,334.0
7917,DB02402,"5-(4-Methoxyphenoxy)-2,4-Quinazolinediamine",SmallMoleculeDrug,Q86XF0,"Dihydrofolate reductase, mitochondrial",DHFR2,187.0
7919,DB02404,1-Deoxy-1-Thio-Heptaethylene Glycol,SmallMoleculeDrug,P22303,Acetylcholinesterase,ACHE,614.0
7920,DB02405,12-Bromododecanoic Acid,SmallMoleculeDrug,P09466,Glycodelin,PAEP,180.0
7922,DB02407,6-O-Cyclohexylmethyl Guanine,SmallMoleculeDrug,P24941,Cyclin-dependent kinase 2,CDK2,298.0
7923,DB02407,6-O-Cyclohexylmethyl Guanine,SmallMoleculeDrug,P20248,Cyclin-A2,CCNA2,432.0
7933,DB02418,"(R,R)-2,3-Butanediol",SmallMoleculeDrug,P62837,Ubiquitin-conjugating enzyme E2 D2,UBE2D2,147.0
7934,DB02419,Ethyl Oxo(Piperidin-1-Yl)Acetate,SmallMoleculeDrug,P62937,Peptidyl-prolyl cis-trans isomerase A,PPIA,165.0
7935,DB02420,"[[4-(Aminomethyl)Phenyl]Amino]Oxo-Acetic Acid,",SmallMoleculeDrug,P18031,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,435.0
7937,DB02422,Methyl-2-S-(Alpha-D-Mannopyranosyl)-2-Thio-Alpha-D-Mannopyranoside,SmallMoleculeDrug,Q9UKM7,"Endoplasmic reticulum mannosyl-oligosaccharide 1,2-alpha-mannosidase",MAN1B1,699.0
7938,DB02424,Geldanamycin,SmallMoleculeDrug,P08238,Heat shock protein HSP 90-beta,HSP90AB1,724.0
7939,DB02424,Geldanamycin,SmallMoleculeDrug,P07900,Heat shock protein HSP 90-alpha,HSP90AA1,732.0
7941,DB02426,Carboxyatractyloside,SmallMoleculeDrug,P12235,ADP/ATP translocase 1,SLC25A4,298.0
7943,DB02427,"2,4-Diamino-6-[N-(2',5'-Dimethoxybenzyl)-N-Methylamino]Quinazoline",SmallMoleculeDrug,P00374,Dihydrofolate reductase,DHFR,187.0
7945,DB02429,4-(Aminosulfonyl)-N-[(4-Fluorophenyl)Methyl]-Benzamide,SmallMoleculeDrug,P00918,Carbonic anhydrase 2,CA2,260.0
7953,DB02431,Cytidine-5'-Triphosphate,SmallMoleculeDrug,Q9BZX2,Uridine-cytidine kinase 2,UCK2,261.0
7955,DB02432,RU90395,SmallMoleculeDrug,P12931,Proto-oncogene tyrosine-protein kinase Src,SRC,536.0
7960,DB02435,Aminomethylcyclohexane,SmallMoleculeDrug,P07477,Trypsin-1,PRSS1,247.0
7961,DB02436,2-{4-[(2s)-2-[({[(1s)-1-Carboxy-2-Phenylethyl]Amino}Carbonyl)Amino]-3-Oxo-3-(Pentylamino)Propyl]Phenoxy}Malonic Acid,SmallMoleculeDrug,P18031,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,435.0
7969,DB02445,2-Deoxy-2-Amino Glucitol-6-Phosphate,SmallMoleculeDrug,P46926,Glucosamine-6-phosphate isomerase 1,GNPDA1,289.0
7973,DB02447,"3,8,9,10-Tetrahydroxy-7-Hydroxymethyl-6-Oxa-1,3-Diaza-Spiro[4.5]Decane-2,4-Dione",SmallMoleculeDrug,P11217,"Glycogen phosphorylase, muscle form",PYGM,842.0
7974,DB02448,N-Tridecanoic Acid,SmallMoleculeDrug,P14555,"Phospholipase A2, membrane associated",PLA2G2A,144.0
7975,DB02448,N-Tridecanoic Acid,SmallMoleculeDrug,P04054,Phospholipase A2,PLA2G1B,148.0
7976,DB02448,N-Tridecanoic Acid,SmallMoleculeDrug,Q9NZK7,Group IIE secretory phospholipase A2,PLA2G2E,142.0
7977,DB02449,3-(1h-Indol-3-Yl)-2-[4-(4-Phenyl-Piperidin-1-Yl)-Benzenesulfonylamino]-Propionic Acid,SmallMoleculeDrug,P08254,Stromelysin-1,MMP3,477.0
7984,DB02452,Thymidine-5'-Triphosphate,SmallMoleculeDrug,O00142,"Thymidine kinase 2, mitochondrial",TK2,265.0
7987,DB02452,Thymidine-5'-Triphosphate,SmallMoleculeDrug,P04183,"Thymidine kinase, cytosolic",TK1,234.0
7992,DB02457,Undecyl-Phosphinic Acid Butyl Ester,SmallMoleculeDrug,P07098,Gastric triacylglycerol lipase,LIPF,398.0
7993,DB02458,"Glutathione S-(2,4 Dinitrobenzene)",SmallMoleculeDrug,P09488,Glutathione S-transferase Mu 1,GSTM1,218.0
7994,DB02458,"Glutathione S-(2,4 Dinitrobenzene)",SmallMoleculeDrug,P28161,Glutathione S-transferase Mu 2,GSTM2,218.0
7995,DB02459,4-Guanidinobenzoic Acid,SmallMoleculeDrug,P00751,Complement factor B,CFB,764.0
7998,DB02462,Thiocoumarin,SmallMoleculeDrug,P35228,"Nitric oxide synthase, inducible",NOS2,1153.0
7999,DB02463,2-(2-Hydroxy-Phenyl)-1h-Indole-5-Carboxamidine,SmallMoleculeDrug,P07477,Trypsin-1,PRSS1,247.0
8000,DB02464,Benzylamine,SmallMoleculeDrug,P07478,Trypsin-2,PRSS2,247.0
8001,DB02464,Benzylamine,SmallMoleculeDrug,P07477,Trypsin-1,PRSS1,247.0
8002,DB02465,Methoxy arachidonyl fluorophosphonate,SmallMoleculeDrug,O00519,Fatty-acid amide hydrolase 1,FAAH,579.0
8003,DB02466,"4-[3-Oxo-3-(5,5,8,8-Tetramethyl-5,6,7,8-Tetrahydro-Naphthalen-2-Yl)-Propenyl]-Benzoic Acid",SmallMoleculeDrug,P13631,Retinoic acid receptor gamma,RARG,454.0
8005,DB02467,L-methionine (S)-S-oxide,SmallMoleculeDrug,P20339,Ras-related protein Rab-5A,RAB5A,215.0
8010,DB02468,12-Phenylheme,SmallMoleculeDrug,P09601,Heme oxygenase 1,HMOX1,288.0
8013,DB02471,Nojirimycine Tetrazole,SmallMoleculeDrug,P09848,Lactase-phlorizin hydrolase,LCT,1927.0
8014,DB02471,Nojirimycine Tetrazole,SmallMoleculeDrug,P11217,"Glycogen phosphorylase, muscle form",PYGM,842.0
8015,DB02471,Nojirimycine Tetrazole,SmallMoleculeDrug,Q6UWM7,Lactase-like protein,LCTL,567.0
8016,DB02472,"6-Hydroxy-7,8-Dihydro Purine Nucleoside",SmallMoleculeDrug,P00813,Adenosine deaminase,ADA,363.0
8017,DB02473,"6-[N-(1-Isopropyl-3,4-Dihydro-7-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine",SmallMoleculeDrug,P00749,Urokinase-type plasminogen activator,PLAU,431.0
8021,DB02479,(R)-N-(3-Indol-1-Yl-2-Methyl-Propyl)-4-Sulfamoyl-Benzamide,SmallMoleculeDrug,P00918,Carbonic anhydrase 2,CA2,260.0
8023,DB02481,N-Benzylformamide,SmallMoleculeDrug,P00325,Alcohol dehydrogenase 1B,ADH1B,375.0
8024,DB02482,Phosphonothreonine,SmallMoleculeDrug,P08100,Rhodopsin,RHO,348.0
8025,DB02482,Phosphonothreonine,SmallMoleculeDrug,P17612,cAMP-dependent protein kinase catalytic subunit alpha,PRKACA,351.0
8026,DB02482,Phosphonothreonine,SmallMoleculeDrug,P22694,cAMP-dependent protein kinase catalytic subunit beta,PRKACB,351.0
8027,DB02482,Phosphonothreonine,SmallMoleculeDrug,P50613,Cyclin-dependent kinase 7,CDK7,346.0
8029,DB02482,Phosphonothreonine,SmallMoleculeDrug,P31949,Protein S100-A11,S100A11,105.0
8030,DB02482,Phosphonothreonine,SmallMoleculeDrug,P53778,Mitogen-activated protein kinase 12,MAPK12,367.0
8031,DB02482,Phosphonothreonine,SmallMoleculeDrug,Q04759,Protein kinase C theta type,PRKCQ,706.0
8032,DB02482,Phosphonothreonine,SmallMoleculeDrug,O14965,Aurora kinase A,AURKA,403.0
8033,DB02482,Phosphonothreonine,SmallMoleculeDrug,P28482,Mitogen-activated protein kinase 1,MAPK1,360.0
8034,DB02483,Etheno-Nad,SmallMoleculeDrug,P00338,L-lactate dehydrogenase A chain,LDHA,332.0
8035,DB02483,Etheno-Nad,SmallMoleculeDrug,Q10588,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,BST1,318.0
8037,DB02485,Cytidine-5'-Monophosphate-5-N-Acetylneuraminic Acid,SmallMoleculeDrug,Q8NFW8,N-acylneuraminate cytidylyltransferase,CMAS,434.0
8038,DB02486,2-Hydroxyethyl Disulfide,SmallMoleculeDrug,P08263,Glutathione S-transferase A1,GSTA1,222.0
8041,DB02490,(Diaminomethyl-Methyl-Amino)-Acetic Acid,SmallMoleculeDrug,P06732,Creatine kinase M-type,CKM,381.0
8042,DB02491,4-[4-(1-Amino-1-Methylethyl)Phenyl]-5-Chloro-N-[4-(2-Morpholin-4-Ylethyl)Phenyl]Pyrimidin-2-Amine,SmallMoleculeDrug,P21802,Fibroblast growth factor receptor 2,FGFR2,821.0
8043,DB02492,Ghavamiol,SmallMoleculeDrug,Q16706,Alpha-mannosidase 2,MAN2A1,1144.0
8046,DB02494,Alpha-Hydroxy-Beta-Phenyl-Propionic Acid,SmallMoleculeDrug,Q96L21,60S ribosomal protein L10-like,RPL10L,214.0
8047,DB02494,Alpha-Hydroxy-Beta-Phenyl-Propionic Acid,SmallMoleculeDrug,P40429,60S ribosomal protein L13a,RPL13A,203.0
8048,DB02494,Alpha-Hydroxy-Beta-Phenyl-Propionic Acid,SmallMoleculeDrug,P62829,60S ribosomal protein L23,RPL23,140.0
8049,DB02494,Alpha-Hydroxy-Beta-Phenyl-Propionic Acid,SmallMoleculeDrug,P61313,60S ribosomal protein L15,RPL15,204.0
8050,DB02494,Alpha-Hydroxy-Beta-Phenyl-Propionic Acid,SmallMoleculeDrug,P84098,60S ribosomal protein L19,RPL19,196.0
8051,DB02494,Alpha-Hydroxy-Beta-Phenyl-Propionic Acid,SmallMoleculeDrug,P62750,60S ribosomal protein L23a,RPL23A,156.0
8052,DB02494,Alpha-Hydroxy-Beta-Phenyl-Propionic Acid,SmallMoleculeDrug,Q9UHA3,Probable ribosome biogenesis protein RLP24,RSL24D1,163.0
8053,DB02494,Alpha-Hydroxy-Beta-Phenyl-Propionic Acid,SmallMoleculeDrug,Q9UNX3,60S ribosomal protein L26-like 1,RPL26L1,145.0
8054,DB02494,Alpha-Hydroxy-Beta-Phenyl-Propionic Acid,SmallMoleculeDrug,P62917,60S ribosomal protein L8,RPL8,257.0
8055,DB02494,Alpha-Hydroxy-Beta-Phenyl-Propionic Acid,SmallMoleculeDrug,P61927,60S ribosomal protein L37,RPL37,97.0
8056,DB02494,Alpha-Hydroxy-Beta-Phenyl-Propionic Acid,SmallMoleculeDrug,P39023,60S ribosomal protein L3,RPL3,403.0
8057,DB02494,Alpha-Hydroxy-Beta-Phenyl-Propionic Acid,SmallMoleculeDrug,P62913,60S ribosomal protein L11,RPL11,178.0
8058,DB02494,Alpha-Hydroxy-Beta-Phenyl-Propionic Acid,SmallMoleculeDrug,P55769,NHP2-like protein 1,SNU13,128.0
8059,DB02494,Alpha-Hydroxy-Beta-Phenyl-Propionic Acid,SmallMoleculeDrug,P15085,Carboxypeptidase A1,CPA1,419.0
8063,DB02497,L-Alpha-Glycerophosphorylserine,SmallMoleculeDrug,P08758,Annexin A5,ANXA5,320.0
8064,DB02498,Carba-Nicotinamide-Adenine-Dinucleotide,SmallMoleculeDrug,P09874,Poly [ADP-ribose] polymerase 1,PARP1,1014.0
8065,DB02499,Dinor-N(Omega)-Hydroxy-L-Arginine,SmallMoleculeDrug,P05089,Arginase-1,ARG1,322.0
8069,DB02504,[3-(1-Benzyl-3-Carbamoylmethyl-2-Methyl-1h-Indol-5-Yloxy)-Propyl-]-Phosphonic Acid,SmallMoleculeDrug,P14555,"Phospholipase A2, membrane associated",PLA2G2A,144.0
8071,DB02506,"2,6,8-Trimethyl-3-Amino-9-Benzyl-9-Methoxynonanoic Acid",SmallMoleculeDrug,P62136,Serine/threonine-protein phosphatase PP1-alpha catalytic subunit,PPP1CA,330.0
8072,DB02506,"2,6,8-Trimethyl-3-Amino-9-Benzyl-9-Methoxynonanoic Acid",SmallMoleculeDrug,P30153,Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A alpha isoform,PPP2R1A,589.0
8073,DB02506,"2,6,8-Trimethyl-3-Amino-9-Benzyl-9-Methoxynonanoic Acid",SmallMoleculeDrug,P67775,Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform,PPP2CA,309.0
8074,DB02506,"2,6,8-Trimethyl-3-Amino-9-Benzyl-9-Methoxynonanoic Acid",SmallMoleculeDrug,Q13362,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform,PPP2R5C,524.0
8075,DB02506,"2,6,8-Trimethyl-3-Amino-9-Benzyl-9-Methoxynonanoic Acid",SmallMoleculeDrug,P63151,Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B alpha isoform,PPP2R2A,447.0
8076,DB02507,4-Hydroxy-3-[(1s)-3-Oxo-1-Phenylbutyl]-2h-Chromen-2-One,SmallMoleculeDrug,P11712,Cytochrome P450 2C9,CYP2C9,490.0
8078,DB02508,Isopentyl Pyrophosphate,SmallMoleculeDrug,P14324,Farnesyl pyrophosphate synthase,FDPS,419.0
8081,DB02509,Farnesol,SmallMoleculeDrug,P27338,Amine oxidase [flavin-containing] B,MAOB,520.0
8082,DB02510,'5'-O-(N-(L-Prolyl)-Sulfamoyl)Adenosine,SmallMoleculeDrug,P07814,Bifunctional glutamate/proline--tRNA ligase,EPRS,1512.0
8084,DB02512,"1,6-Fructose Diphosphate (Linear Form)",SmallMoleculeDrug,P04075,Fructose-bisphosphate aldolase A,ALDOA,364.0
8085,DB02512,"1,6-Fructose Diphosphate (Linear Form)",SmallMoleculeDrug,P05062,Fructose-bisphosphate aldolase B,ALDOB,364.0
8087,DB02515,3-Phosphoglycerol,SmallMoleculeDrug,P16118,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 1",PFKFB1,471.0
8088,DB02515,3-Phosphoglycerol,SmallMoleculeDrug,P05062,Fructose-bisphosphate aldolase B,ALDOB,364.0
8093,DB02518,N-Acetylalanine,SmallMoleculeDrug,P15121,Aldose reductase,AKR1B1,316.0
8094,DB02519,Indirubin-5-Sulphonate,SmallMoleculeDrug,P11217,"Glycogen phosphorylase, muscle form",PYGM,842.0
8100,DB02526,CRA_10655,SmallMoleculeDrug,P07477,Trypsin-1,PRSS1,247.0
8101,DB02526,CRA_10655,SmallMoleculeDrug,P00749,Urokinase-type plasminogen activator,PLAU,431.0
8102,DB02527,Cyclic Adenosine Monophosphate,SmallMoleculeDrug,Q9UL51,Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2,HCN2,889.0
8103,DB02527,Cyclic Adenosine Monophosphate,SmallMoleculeDrug,P10644,cAMP-dependent protein kinase type I-alpha regulatory subunit,PRKAR1A,381.0
8104,DB02527,Cyclic Adenosine Monophosphate,SmallMoleculeDrug,P31323,cAMP-dependent protein kinase type II-beta regulatory subunit,PRKAR2B,418.0
8108,DB02528,Tetrazolyl Histidine,SmallMoleculeDrug,P02144,Myoglobin,MB,154.0
8110,DB02530,Gamma(Amino)-Butyric Acid,SmallMoleculeDrug,P50440,"Glycine amidinotransferase, mitochondrial",GATM,423.0
8113,DB02532,"2,4,6-Triaminoquinazoline",SmallMoleculeDrug,P0CG22,Putative dehydrogenase/reductase SDR family member 4-like 1,DHRS4L1,281.0
8114,DB02533,Aminoguanidine,SmallMoleculeDrug,P35228,"Nitric oxide synthase, inducible",NOS2,1153.0
8116,DB02535,Aminodi(Ethyloxy)Ethylaminocarbonylbenzenesulfonamide,SmallMoleculeDrug,P00918,Carbonic anhydrase 2,CA2,260.0
8118,DB02538,"N-[4-(2-Methylimidazo[1,2-a]Pyridin-3-Yl)-2-Pyrimidinyl]Acetamide",SmallMoleculeDrug,P24941,Cyclin-dependent kinase 2,CDK2,298.0
8119,DB02539,S-Ethylisothiourea,SmallMoleculeDrug,P35228,"Nitric oxide synthase, inducible",NOS2,1153.0
8121,DB02541,4-Hydroxybutan-1-Aminium,SmallMoleculeDrug,P35030,Trypsin-3,PRSS3,304.0
8122,DB02542,(4s)-5-Fluoro-L-Leucine,SmallMoleculeDrug,P0CG47,Polyubiquitin-B,UBB,229.0
8125,DB02545,Fexaramine,SmallMoleculeDrug,Q96RI1,Bile acid receptor,NR1H4,486.0
8126,DB02546,Vorinostat,SmallMoleculeDrug,Q13547,Histone deacetylase 1,HDAC1,482.0
8127,DB02546,Vorinostat,SmallMoleculeDrug,Q92769,Histone deacetylase 2,HDAC2,488.0
8128,DB02546,Vorinostat,SmallMoleculeDrug,O15379,Histone deacetylase 3,HDAC3,428.0
8129,DB02546,Vorinostat,SmallMoleculeDrug,Q9UBN7,Histone deacetylase 6,HDAC6,1215.0
8130,DB02546,Vorinostat,SmallMoleculeDrug,Q9BY41,Histone deacetylase 8,HDAC8,377.0
8132,DB02547,Guanosine-5'-Diphosphate-Rhamnose,SmallMoleculeDrug,O60547,"GDP-mannose 4,6 dehydratase",GMDS,372.0
8133,DB02548,D-glucitol 6-phosphate,SmallMoleculeDrug,P06744,Glucose-6-phosphate isomerase,GPI,558.0
8135,DB02550,"8-(2-Chloro-3,4,5-Trimethoxy-Benzyl)-2-Fluoro-9-Pent-4-Ylnyl-9h-Purin-6-Ylamine",SmallMoleculeDrug,P07900,Heat shock protein HSP 90-alpha,HSP90AA1,732.0
8136,DB02551,"6-[N-(4-Ethyl-1,2,3,4-Tetrahydro-6-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine",SmallMoleculeDrug,P00749,Urokinase-type plasminogen activator,PLAU,431.0
8140,DB02552,Geranyl Diphosphate,SmallMoleculeDrug,P14324,Farnesyl pyrophosphate synthase,FDPS,419.0
8142,DB02552,Geranyl Diphosphate,SmallMoleculeDrug,O95749,Geranylgeranyl pyrophosphate synthase,GGPS1,300.0
8145,DB02553,Glutathionylspermidine Disulfide,SmallMoleculeDrug,P00390,"Glutathione reductase, mitochondrial",GSR,522.0
8146,DB02555,SP4160,SmallMoleculeDrug,P60568,Interleukin-2,IL2,153.0
8147,DB02556,D-Phenylalanine,SmallMoleculeDrug,Q16773,Kynurenine--oxoglutarate transaminase 1,KYAT1,422.0
8148,DB02556,D-Phenylalanine,SmallMoleculeDrug,P06850,Corticoliberin,CRH,196.0
8149,DB02557,Phosphoramidon,SmallMoleculeDrug,P08473,Neprilysin,MME,750.0
8150,DB02558,N-(3-Phenyl-2-Sulfanylpropanoyl)Phenylalanylalanine,SmallMoleculeDrug,P08473,Neprilysin,MME,750.0
8151,DB02559,"6-(Octahydro-1h-Indol-1-Ylmethyl)Decahydroquinazoline-2,4-Diamine",SmallMoleculeDrug,P00374,Dihydrofolate reductase,DHFR,187.0
8155,DB02562,"Quinonoid 7,8-Tetrahydrobiopterin",SmallMoleculeDrug,P00439,Phenylalanine-4-hydroxylase,PAH,452.0
8156,DB02563,Hexanoyl-Coenzyme A,SmallMoleculeDrug,P30084,"Enoyl-CoA hydratase, mitochondrial",ECHS1,290.0
8157,DB02565,4-Dimethylamino-N-(6-Hydroxycarbamoyethyl)Benzamide-N-Hydroxy-7-(4-Dimethyla Minobenzoyl)Aminoheptanamide,SmallMoleculeDrug,Q9BY41,Histone deacetylase 8,HDAC8,377.0
8161,DB02568,Peldesine,SmallMoleculeDrug,P00491,Purine nucleoside phosphorylase,PNP,289.0
8162,DB02569,"2',3'-Dehydro-2',3'-Deoxy-Thymidine 5'-Diphosphate",SmallMoleculeDrug,P15531,Nucleoside diphosphate kinase A,NME1,152.0
8163,DB02570,PD150606,SmallMoleculeDrug,P04632,Calpain small subunit 1,CAPNS1,268.0
8166,DB02573,"2'-Deoxycytidine-2'-Deoxyadenosine-3',5'-Monophosphate",SmallMoleculeDrug,P07998,Ribonuclease pancreatic,RNASE1,156.0
8171,DB02580,1-(2-Methoxy-Ethoxy)-2-{2-[2-(2-Methoxy-Ethoxy]-Ethoxy}-Ethane,SmallMoleculeDrug,P35080,Profilin-2,PFN2,140.0
8182,DB02581,"5-[2,3-Dichloro-4-(5-{1-[2-(2-Guanidino-4-Methyl-Pentanoylamino)-Acetyl]-Piperidin-4-Yl}-1-Methyl-1h-Pyrazol-3-Yl)-Phenoxymethyl]-Furan-2-Carboxylic Acid",SmallMoleculeDrug,P60568,Interleukin-2,IL2,153.0
8183,DB02583,"N6-(2,5-Dimethoxy-Benzyl)-N6-Methyl-Pyrido[2,3-D]Pyrimidine-2,4,6-Triamine",SmallMoleculeDrug,P00374,Dihydrofolate reductase,DHFR,187.0
8184,DB02585,4-(Hydroxymethyl)Benzamidine,SmallMoleculeDrug,P35030,Trypsin-3,PRSS3,304.0
8186,DB02587,Colforsin,SmallMoleculeDrug,Q08462,Adenylate cyclase type 2,ADCY2,1091.0
8187,DB02587,Colforsin,SmallMoleculeDrug,P63092,Guanine nucleotide-binding protein G(s) subunit alpha isoforms short,GNAS,394.0
8188,DB02587,Colforsin,SmallMoleculeDrug,O95622,Adenylate cyclase type 5,ADCY5,1261.0
8190,DB02589,Se-Ethyl-Isoselenourea,SmallMoleculeDrug,P29474,"Nitric oxide synthase, endothelial",NOS3,1203.0
8196,DB02594,2'-Deoxycytidine,SmallMoleculeDrug,O00142,"Thymidine kinase 2, mitochondrial",TK2,265.0
8197,DB02594,2'-Deoxycytidine,SmallMoleculeDrug,P27707,Deoxycytidine kinase,DCK,260.0
8203,DB02596,"Alpha,Beta-Methyleneadenosine-5'-Triphosphate",SmallMoleculeDrug,Q96T66,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 3,NMNAT3,252.0
8209,DB02597,"[2(R,S)-2-Sulfanylheptanoyl]-Phe-Ala",SmallMoleculeDrug,P08473,Neprilysin,MME,750.0
8211,DB02598,"N-Alpha-Acetyl-3,5-Diiodotyrosylglycine",SmallMoleculeDrug,P19021,Peptidyl-glycine alpha-amidating monooxygenase,PAM,973.0
8214,DB02602,AL7182,SmallMoleculeDrug,P00918,Carbonic anhydrase 2,CA2,260.0
8215,DB02603,1-Amino-6-Cyclohex-3-Enylmethyloxypurine,SmallMoleculeDrug,P24941,Cyclin-dependent kinase 2,CDK2,298.0
8216,DB02604,2-Deoxy-Glucose-6-Phosphate,SmallMoleculeDrug,P11217,"Glycogen phosphorylase, muscle form",PYGM,842.0
8218,DB02607,Adenosine Phosphonoacetic Acid,SmallMoleculeDrug,P15531,Nucleoside diphosphate kinase A,NME1,152.0
8221,DB02610,"N-(2,3,4,5,6-Pentaflouro-Benzyl)-4-Sulfamoyl-Benzamide",SmallMoleculeDrug,P00918,Carbonic anhydrase 2,CA2,260.0
8222,DB02611,Balanol Analog 1,SmallMoleculeDrug,P17612,cAMP-dependent protein kinase catalytic subunit alpha,PRKACA,351.0
8224,DB02613,"Decylamine-N,N-Dimethyl-N-Oxide",SmallMoleculeDrug,Q02127,"Dihydroorotate dehydrogenase (quinone), mitochondrial",DHODH,395.0
8226,DB02613,"Decylamine-N,N-Dimethyl-N-Oxide",SmallMoleculeDrug,P54317,Pancreatic lipase-related protein 2,PNLIPRP2,469.0
8229,DB02615,Compound 19,SmallMoleculeDrug,P18031,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,435.0
8230,DB02615,Compound 19,SmallMoleculeDrug,P03372,Estrogen receptor,ESR1,595.0
8231,DB02616,FR117016,SmallMoleculeDrug,P00813,Adenosine deaminase,ADA,363.0
8233,DB02620,Sp7343-Sp7964,SmallMoleculeDrug,P18031,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,435.0
8234,DB02621,Latrunculin A,SmallMoleculeDrug,P68133,"Actin, alpha skeletal muscle",ACTA1,377.0
8235,DB02621,Latrunculin A,SmallMoleculeDrug,P06396,Gelsolin,GSN,782.0
8237,DB02622,2-(Oxalyl-Amino)-Benzoic Acid,SmallMoleculeDrug,P18031,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,435.0
8238,DB02623,Aminophosphonic Acid-Guanylate Ester,SmallMoleculeDrug,P60953,Cell division control protein 42 homolog,CDC42,191.0
8239,DB02624,Homoserine Lactone,SmallMoleculeDrug,P19634,Sodium/hydrogen exchanger 1,SLC9A1,815.0
8243,DB02628,"1-[3,3-Dimethyl-2-(2-Methylamino-Propionylamino)-Butyryl]-Pyrrolidine-2-Carboxylic Acid(1,2,3,4-Tetrahydro-Naphthalen-1-Yl)-Amide",SmallMoleculeDrug,P98170,E3 ubiquitin-protein ligase XIAP,XIAP,497.0
8246,DB02631,"5-Chloro-6-[(2-Iminopyrrolidin-1-Yl)Methyl]Pyrimidine-2,4(1h,3h)-Dione",SmallMoleculeDrug,P19971,Thymidine phosphorylase,TYMP,482.0
8249,DB02633,Cibacron Blue,SmallMoleculeDrug,P15559,NAD(P)H dehydrogenase [quinone] 1,NQO1,274.0
8250,DB02633,Cibacron Blue,SmallMoleculeDrug,P09211,Glutathione S-transferase P,GSTP1,210.0
8251,DB02635,N-[O-Phosphono-Pyridoxyl]-Isoleucine,SmallMoleculeDrug,O15382,"Branched-chain-amino-acid aminotransferase, mitochondrial",BCAT2,392.0
8252,DB02636,"9-Hydroxy-8-Methoxy-6-Nitro-Phenanthrol[3,4-D][1,3]Dioxole-5-Carboxylic Acid",SmallMoleculeDrug,Q9NZK7,Group IIE secretory phospholipase A2,PLA2G2E,142.0
8253,DB02637,Oxaloacetate Ion,SmallMoleculeDrug,O75390,"Citrate synthase, mitochondrial",CS,466.0
8255,DB02637,Oxaloacetate Ion,SmallMoleculeDrug,P35270,Sepiapterin reductase,SPR,261.0
8258,DB02638,Terlipressin,SmallMoleculeDrug,P30518,Vasopressin V2 receptor,AVPR2,371.0
8259,DB02638,Terlipressin,SmallMoleculeDrug,P47901,Vasopressin V1b receptor,AVPR1B,424.0
8260,DB02638,Terlipressin,SmallMoleculeDrug,P37288,Vasopressin V1a receptor,AVPR1A,418.0
8261,DB02640,Fumagillin,SmallMoleculeDrug,P50579,Methionine aminopeptidase 2,METAP2,478.0
8267,DB02643,"N-Dodecyl-N,N-Dimethyl-3-Ammonio-1-Propanesulfonate",SmallMoleculeDrug,P05019,Insulin-like growth factor I,IGF1,195.0
8268,DB02643,"N-Dodecyl-N,N-Dimethyl-3-Ammonio-1-Propanesulfonate",SmallMoleculeDrug,P27338,Amine oxidase [flavin-containing] B,MAOB,520.0
8269,DB02644,N-Omega-Propyl-L-Arginine,SmallMoleculeDrug,P35228,"Nitric oxide synthase, inducible",NOS2,1153.0
8270,DB02644,N-Omega-Propyl-L-Arginine,SmallMoleculeDrug,P29475,"Nitric oxide synthase, brain",NOS1,1434.0
8272,DB02646,Nitrosoethane,SmallMoleculeDrug,P02144,Myoglobin,MB,154.0
8273,DB02647,N-(5-Cyclopropyl-1h-Pyrazol-3-Yl)Benzamide,SmallMoleculeDrug,P24941,Cyclin-dependent kinase 2,CDK2,298.0
8274,DB02648,(3-Carboxy-2-(R)-Hydroxy-Propyl)-Trimethyl-Ammonium,SmallMoleculeDrug,P43155,Carnitine O-acetyltransferase,CRAT,626.0
8275,DB02648,(3-Carboxy-2-(R)-Hydroxy-Propyl)-Trimethyl-Ammonium,SmallMoleculeDrug,Q9UKG9,Peroxisomal carnitine O-octanoyltransferase,CROT,612.0
8277,DB02651,"{[2-(1h-1,2,3-Benzotriazol-1-Yl)-2-(3,4-Difluorophenyl)Propane-1,3-Diyl]Bis[4,1-Phenylene(Difluoromethylene)]}Bis(Phosphonic Acid)",SmallMoleculeDrug,P18031,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,435.0
8278,DB02652,L-[(N-Hydroxyamino)Carbonyl]Phenylalanine,SmallMoleculeDrug,P15085,Carboxypeptidase A1,CPA1,419.0
8282,DB02656,2-(4-Morpholinyl)-8-Phenyl-4h-1-Benzopyran-4-One,SmallMoleculeDrug,P11309,Serine/threonine-protein kinase pim-1,PIM1,404.0
8283,DB02656,2-(4-Morpholinyl)-8-Phenyl-4h-1-Benzopyran-4-One,SmallMoleculeDrug,P48736,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",PIK3CG,1102.0
8287,DB02659,Cholic Acid,SmallMoleculeDrug,P22830,"Ferrochelatase, mitochondrial",FECH,423.0
8288,DB02659,Cholic Acid,SmallMoleculeDrug,P00326,Alcohol dehydrogenase 1C,ADH1C,375.0
8289,DB02659,Cholic Acid,SmallMoleculeDrug,P62508,Estrogen-related receptor gamma,ESRRG,458.0
8290,DB02659,Cholic Acid,SmallMoleculeDrug,P51161,Gastrotropin,FABP6,128.0
8291,DB02659,Cholic Acid,SmallMoleculeDrug,P13073,"Cytochrome c oxidase subunit 4 isoform 1, mitochondrial",COX4I1,169.0
8292,DB02659,Cholic Acid,SmallMoleculeDrug,P00395,Cytochrome c oxidase subunit 1,MT-CO1,513.0
8293,DB02659,Cholic Acid,SmallMoleculeDrug,P00403,Cytochrome c oxidase subunit 2,MT-CO2,227.0
8294,DB02659,Cholic Acid,SmallMoleculeDrug,P00414,Cytochrome c oxidase subunit 3,MT-CO3,261.0
8295,DB02659,Cholic Acid,SmallMoleculeDrug,P20674,"Cytochrome c oxidase subunit 5A, mitochondrial",COX5A,150.0
8296,DB02659,Cholic Acid,SmallMoleculeDrug,P10606,"Cytochrome c oxidase subunit 5B, mitochondrial",COX5B,129.0
8297,DB02659,Cholic Acid,SmallMoleculeDrug,P09669,Cytochrome c oxidase subunit 6C,COX6C,75.0
8298,DB02659,Cholic Acid,SmallMoleculeDrug,P24311,"Cytochrome c oxidase subunit 7B, mitochondrial",COX7B,80.0
8299,DB02659,Cholic Acid,SmallMoleculeDrug,P15954,"Cytochrome c oxidase subunit 7C, mitochondrial",COX7C,63.0
8300,DB02659,Cholic Acid,SmallMoleculeDrug,P10176,"Cytochrome c oxidase subunit 8A, mitochondrial",COX8A,69.0
8301,DB02659,Cholic Acid,SmallMoleculeDrug,Q02221,"Cytochrome c oxidase subunit 6A2, mitochondrial",COX6A2,97.0
8302,DB02659,Cholic Acid,SmallMoleculeDrug,P14854,Cytochrome c oxidase subunit 6B1,COX6B1,86.0
8303,DB02659,Cholic Acid,SmallMoleculeDrug,P24310,"Cytochrome c oxidase subunit 7A1, mitochondrial",COX7A1,79.0
8304,DB02659,Cholic Acid,SmallMoleculeDrug,P04054,Phospholipase A2,PLA2G1B,148.0
8305,DB02659,Cholic Acid,SmallMoleculeDrug,P23141,Liver carboxylesterase 1,CES1,567.0
8306,DB02659,Cholic Acid,SmallMoleculeDrug,Q7KZA3,Ferrochelatase,DKFZp686P18130,416.0
8308,DB02660,Filaminast,SmallMoleculeDrug,Q07343,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B",PDE4B,736.0
8309,DB02661,"Adenosine-5'-Diphosphate-2',3'-Vanadate",SmallMoleculeDrug,O43252,Bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthase 1,PAPSS1,624.0
8310,DB02662,Novo Nordisk a/S Compound,SmallMoleculeDrug,P18031,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,435.0
8313,DB02665,Trans-2-Phenylcyclopropylamine,SmallMoleculeDrug,P07477,Trypsin-1,PRSS1,247.0
8320,DB02670,4-Deoxy-Alpha-D-Glucose,SmallMoleculeDrug,O60264,SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 5,SMARCA5,1052.0
8321,DB02671,1-Methylimidazole,SmallMoleculeDrug,P02144,Myoglobin,MB,154.0
8323,DB02673,"(4ar,6s,8ar)-11-[8-(1,3-Dioxo-1,3-Dihydro-2h-Isoindol-2-Yl)Octyl]-6-Hydroxy-3-Methoxy-5,6,9,10-Tetrahydro-4ah-[1]Benzofuro[3a,3,2-Ef][2]Benzazepin-11-Ium",SmallMoleculeDrug,P22303,Acetylcholinesterase,ACHE,614.0
8325,DB02676,"2-[3-(2-Hydroxy-1,1-Dihydroxymethyl-Ethylamino)-Propylamino]-2-Hydroxymethyl-Propane-1,3-Diol",SmallMoleculeDrug,Q08499,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",PDE4D,809.0
8327,DB02678,2-Deoxy-2-Aminogalactose,SmallMoleculeDrug,P47929,Galectin-7,LGALS7,136.0
8328,DB02679,Cyanamide,SmallMoleculeDrug,P00918,Carbonic anhydrase 2,CA2,260.0
8330,DB02681,Meta Vanadate,SmallMoleculeDrug,P61024,Cyclin-dependent kinases regulatory subunit 1,CKS1B,79.0
8334,DB02684,5'-O-(N-(L-Cysteinyl)-Sulfamoyl)Adenosine,SmallMoleculeDrug,P07814,Bifunctional glutamate/proline--tRNA ligase,EPRS,1512.0
8335,DB02685,3-Methylphenylalanine,SmallMoleculeDrug,P07858,Cathepsin B,CTSB,339.0
8338,DB02689,S-{2-[Amino(Dihydroxy)-Lambda~4~-Sulfanyl]Ethyl}-D-Cysteine,SmallMoleculeDrug,P05089,Arginase-1,ARG1,322.0
8339,DB02690,NU1025,SmallMoleculeDrug,P09874,Poly [ADP-ribose] polymerase 1,PARP1,1014.0
8340,DB02691,N-Cholylglycine,SmallMoleculeDrug,P51161,Gastrotropin,FABP6,128.0
8344,DB02696,"6-Aminohexyl-Uridine-C1,5'-Diphosphate",SmallMoleculeDrug,P15291,"Beta-1,4-galactosyltransferase 1",B4GALT1,398.0
8345,DB02697,Hydroxyaminovaline,SmallMoleculeDrug,P45452,Collagenase 3,MMP13,471.0
8346,DB02697,Hydroxyaminovaline,SmallMoleculeDrug,P08254,Stromelysin-1,MMP3,477.0
8349,DB02701,Nicotinamide,SmallMoleculeDrug,P00338,L-lactate dehydrogenase A chain,LDHA,332.0
8350,DB02701,Nicotinamide,SmallMoleculeDrug,P09874,Poly [ADP-ribose] polymerase 1,PARP1,1014.0
8351,DB02701,Nicotinamide,SmallMoleculeDrug,Q9NXA8,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",SIRT5,310.0
8352,DB02701,Nicotinamide,SmallMoleculeDrug,Q10588,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,BST1,318.0
8358,DB02705,"6-[N-(1-Isopropyl-1,2,3,4-Tetrahydro-7-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine",SmallMoleculeDrug,P00749,Urokinase-type plasminogen activator,PLAU,431.0
8360,DB02709,Resveratrol,SmallMoleculeDrug,P16083,Ribosyldihydronicotinamide dehydrogenase [quinone],NQO2,231.0
8361,DB02709,Resveratrol,SmallMoleculeDrug,P68400,Casein kinase II subunit alpha,CSNK2A1,391.0
8362,DB02709,Resveratrol,SmallMoleculeDrug,P23219,Prostaglandin G/H synthase 1,PTGS1,599.0
8363,DB02709,Resveratrol,SmallMoleculeDrug,P35354,Prostaglandin G/H synthase 2,PTGS2,604.0
8364,DB02710,"2,3,-Dihydroxybenzoylserine",SmallMoleculeDrug,P80188,Neutrophil gelatinase-associated lipocalin,LCN2,198.0
8366,DB02712,Sorbinil,SmallMoleculeDrug,P15121,Aldose reductase,AKR1B1,316.0
8368,DB02714,3'-Uridinemonophosphate,SmallMoleculeDrug,P07998,Ribonuclease pancreatic,RNASE1,156.0
8369,DB02715,Compound 18,SmallMoleculeDrug,P03372,Estrogen receptor,ESR1,595.0
8370,DB02716,7-Methyl-Guanosine-5'-Triphosphate,SmallMoleculeDrug,P06730,Eukaryotic translation initiation factor 4E,EIF4E,217.0
8374,DB02719,C-(1-Hydrogyl-Beta-D-Glucopyranosyl) Formamide,SmallMoleculeDrug,P11217,"Glycogen phosphorylase, muscle form",PYGM,842.0
8375,DB02720,Alpha-D-Glucopyranosyl-2-Carboxylic Acid Amide,SmallMoleculeDrug,P11217,"Glycogen phosphorylase, muscle form",PYGM,842.0
8377,DB02721,4-Iodopyrazole,SmallMoleculeDrug,P00326,Alcohol dehydrogenase 1C,ADH1C,375.0
8378,DB02721,4-Iodopyrazole,SmallMoleculeDrug,P00325,Alcohol dehydrogenase 1B,ADH1B,375.0
8379,DB02721,4-Iodopyrazole,SmallMoleculeDrug,P07327,Alcohol dehydrogenase 1A,ADH1A,375.0
8381,DB02723,"4-Oxo-2-Phenylmethanesulfonyl-Octahydro-Pyrrolo[1,2-a]Pyrazine-6-Carboxylic Acid [1-(N-Hydroxycarbamimidoyl)-Piperidin-4-Ylmethyl]-Amide",SmallMoleculeDrug,P00734,Prothrombin,F2,622.0
8387,DB02726,2-Phosphoglycolic Acid,SmallMoleculeDrug,P60174,Triosephosphate isomerase,TPI1,286.0
8388,DB02726,2-Phosphoglycolic Acid,SmallMoleculeDrug,P14618,Pyruvate kinase PKM,PKM,531.0
8391,DB02726,2-Phosphoglycolic Acid,SmallMoleculeDrug,P09104,Gamma-enolase,ENO2,434.0
8394,DB02726,2-Phosphoglycolic Acid,SmallMoleculeDrug,P30613,Pyruvate kinase PKLR,PKLR,574.0
8397,DB02726,2-Phosphoglycolic Acid,SmallMoleculeDrug,P13929,Beta-enolase,ENO3,434.0
8398,DB02727,N-Butyl-N'-Hydroxyguanidine,SmallMoleculeDrug,P29475,"Nitric oxide synthase, brain",NOS1,1434.0
8399,DB02728,7-Hydroxy-2-Oxo-Chromene-3-Carboxylic Acid Ethyl Ester,SmallMoleculeDrug,P14174,Macrophage migration inhibitory factor,MIF,115.0
8401,DB02730,4-Methylthio-Alpha-D-Mannose,SmallMoleculeDrug,P19961,Alpha-amylase 2B,AMY2B,511.0
8402,DB02731,Ethylmercurithiosalicylic acid,SmallMoleculeDrug,P55809,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",OXCT1,520.0
8405,DB02733,Purvalanol,SmallMoleculeDrug,P11802,Cyclin-dependent kinase 4,CDK4,303.0
8406,DB02733,Purvalanol,SmallMoleculeDrug,P28482,Mitogen-activated protein kinase 1,MAPK1,360.0
8407,DB02733,Purvalanol,SmallMoleculeDrug,P27361,Mitogen-activated protein kinase 3,MAPK3,379.0
8408,DB02733,Purvalanol,SmallMoleculeDrug,P24941,Cyclin-dependent kinase 2,CDK2,298.0
8409,DB02733,Purvalanol,SmallMoleculeDrug,P78362,SRSF protein kinase 2,SRPK2,688.0
8412,DB02735,2-Amino-3-Oxo-4-Sulfo-Butyric Acid,SmallMoleculeDrug,P08842,Steryl-sulfatase,STS,583.0
8416,DB02740,3-Indolebutyric Acid,SmallMoleculeDrug,P61769,Beta-2-microglobulin,B2M,119.0
8417,DB02740,3-Indolebutyric Acid,SmallMoleculeDrug,P01848,T-cell receptor alpha chain C region,TRAC,142.0
8418,DB02740,3-Indolebutyric Acid,SmallMoleculeDrug,P01850,T-cell receptor beta-1 chain C region,TRBC1,177.0
8419,DB02740,3-Indolebutyric Acid,SmallMoleculeDrug,P01892,"HLA class I histocompatibility antigen, A-2 alpha chain",HLA-A,365.0
8420,DB02741,CD564,SmallMoleculeDrug,P13631,Retinoic acid receptor gamma,RARG,454.0
8422,DB02742,Kifunensine,SmallMoleculeDrug,Q16706,Alpha-mannosidase 2,MAN2A1,1144.0
8423,DB02742,Kifunensine,SmallMoleculeDrug,Q9UKM7,"Endoplasmic reticulum mannosyl-oligosaccharide 1,2-alpha-mannosidase",MAN1B1,699.0
8425,DB02744,RPR131247,SmallMoleculeDrug,P07477,Trypsin-1,PRSS1,247.0
8426,DB02745,Uridine,SmallMoleculeDrug,P62312,U6 snRNA-associated Sm-like protein LSm6,LSM6,80.0
8430,DB02750,S-(Methylmercury)-L-Cysteine,SmallMoleculeDrug,Q7Z2Z2,Elongation factor Tu GTP-binding domain-containing protein 1,EFL1,1120.0
8431,DB02751,N-[Amino(Imino)Methyl]Glycine,SmallMoleculeDrug,Q14353,Guanidinoacetate N-methyltransferase,GAMT,236.0
8434,DB02754,"9-Butyl-8-(3,4,5-Trimethoxybenzyl)-9h-Purin-6-Amine",SmallMoleculeDrug,P08238,Heat shock protein HSP 90-beta,HSP90AB1,724.0
8435,DB02754,"9-Butyl-8-(3,4,5-Trimethoxybenzyl)-9h-Purin-6-Amine",SmallMoleculeDrug,P07900,Heat shock protein HSP 90-alpha,HSP90AA1,732.0
8436,DB02755,1-3 Sugar Ring of Pentamannosyl 6-Phosphate,SmallMoleculeDrug,P20645,Cation-dependent mannose-6-phosphate receptor,M6PR,277.0
8437,DB02757,Pyrazole,SmallMoleculeDrug,P00326,Alcohol dehydrogenase 1C,ADH1C,375.0
8440,DB02758,Indolylpropionic Acid,SmallMoleculeDrug,Q9NZK7,Group IIE secretory phospholipase A2,PLA2G2E,142.0
8441,DB02759,4-Methylumbelliferyl Chitobiose,SmallMoleculeDrug,P61626,Lysozyme C,LYZ,148.0
8446,DB02761,S-Mercaptocysteine,SmallMoleculeDrug,Q16762,Thiosulfate sulfurtransferase,TST,297.0
8451,DB02762,RU79072,SmallMoleculeDrug,P12931,Proto-oncogene tyrosine-protein kinase Src,SRC,536.0
8453,DB02763,5-Mercapto-2-Nitro-Benzoic Acid,SmallMoleculeDrug,P29460,Interleukin-12 subunit beta,IL12B,328.0
8458,DB02767,3-Hydroxy-Myristic Acid,SmallMoleculeDrug,Q9Y6Y9,Lymphocyte antigen 96,LY96,160.0
8459,DB02767,3-Hydroxy-Myristic Acid,SmallMoleculeDrug,O00206,Toll-like receptor 4,TLR4,839.0
8467,DB02772,Sucrose,SmallMoleculeDrug,O00244,Copper transport protein ATOX1,ATOX1,68.0
8468,DB02772,Sucrose,SmallMoleculeDrug,Q9Y3I0,tRNA-splicing ligase RtcB homolog,RTCB,505.0
8474,DB02772,Sucrose,SmallMoleculeDrug,P68133,"Actin, alpha skeletal muscle",ACTA1,377.0
8477,DB02772,Sucrose,SmallMoleculeDrug,P61626,Lysozyme C,LYZ,148.0
8479,DB02773,(3-Chloro-4-Propoxy-Phenyl)-Acetic Acid,SmallMoleculeDrug,P23219,Prostaglandin G/H synthase 1,PTGS1,599.0
8480,DB02774,"1,3-Propandiol",SmallMoleculeDrug,P84077,ADP-ribosylation factor 1,ARF1,181.0
8484,DB02778,"2,5-Anhydroglucitol-1,6-Biphosphate",SmallMoleculeDrug,P09467,"Fructose-1,6-bisphosphatase 1",FBP1,338.0
8485,DB02779,Dodecane-Trimethylamine,SmallMoleculeDrug,Q06124,Tyrosine-protein phosphatase non-receptor type 11,PTPN11,597.0
8487,DB02783,4'-Deoxy-4'-Acetylyamino-Pyridoxal-5'-Phosphate,SmallMoleculeDrug,P00505,"Aspartate aminotransferase, mitochondrial",GOT2,430.0
8489,DB02784,N-[4-(2-{2-[3-(2-Bromo-Acetylamino)-Propionylamino]-3-Hydroxy-Propionylamino}-Ethyl)-Phenyl]-Oxalamic Acid,SmallMoleculeDrug,P18031,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,435.0
8493,DB02789,Pregnenolone,SmallMoleculeDrug,O00204,Sulfotransferase family cytosolic 2B member 1,SULT2B1,365.0
8497,DB02795,P-Anisic Acid,SmallMoleculeDrug,P04054,Phospholipase A2,PLA2G1B,148.0
8498,DB02795,P-Anisic Acid,SmallMoleculeDrug,Q9NZK7,Group IIE secretory phospholipase A2,PLA2G2E,142.0
8499,DB02796,9-Deazainosine,SmallMoleculeDrug,P00491,Purine nucleoside phosphorylase,PNP,289.0
8503,DB02800,5-Hydroxymethylene-6-Hydrofolic Acid,SmallMoleculeDrug,P34896,"Serine hydroxymethyltransferase, cytosolic",SHMT1,483.0
8508,DB02803,"3-Phenyl-1,2-Propandiol",SmallMoleculeDrug,P00797,Renin,REN,406.0
8510,DB02805,Uracil arabinose-3'-phosphate,SmallMoleculeDrug,P07998,Ribonuclease pancreatic,RNASE1,156.0
8513,DB02811,Diethylphosphono Group,SmallMoleculeDrug,P06276,Cholinesterase,BCHE,602.0
8515,DB02812,"(2s,4r)-1-Acetyl-N-[(1s)-4-[(Aminoiminomethyl)Amino]-1-(2-Benzothiazolylcarbonyl)Butyl]-4-Hydroxy-2-Pyrrolidinecarboxamide",SmallMoleculeDrug,P07477,Trypsin-1,PRSS1,247.0
8517,DB02813,"2-Acetamido-2-Deoxy-D-Glucono-1,5-Lactone",SmallMoleculeDrug,P07686,Beta-hexosaminidase subunit beta,HEXB,556.0
8520,DB02818,Iodo-Willardiine,SmallMoleculeDrug,P42262,Glutamate receptor 2,GRIA2,883.0
8522,DB02820,"1-Azepan-1-Yl-2-Phenyl-2-(4-Thioxo-1,4-Dihydro-Pyrazolo[3,4-D]Pyrimidin-5-Yl)Ethanone Adduct",SmallMoleculeDrug,Q99714,3-hydroxyacyl-CoA dehydrogenase type-2,HSD17B10,261.0
8523,DB02821,Canaline,SmallMoleculeDrug,P04181,"Ornithine aminotransferase, mitochondrial",OAT,439.0
8524,DB02822,Para-Bromobenzyl Alcohol,SmallMoleculeDrug,P00326,Alcohol dehydrogenase 1C,ADH1C,375.0
8528,DB02824,N-Pyridoxyl-Glycine-5-Monophosphate,SmallMoleculeDrug,P34896,"Serine hydroxymethyltransferase, cytosolic",SHMT1,483.0
8529,DB02824,N-Pyridoxyl-Glycine-5-Monophosphate,SmallMoleculeDrug,P11926,Ornithine decarboxylase,ODC1,461.0
8530,DB02825,Methylphosphonic Acid Ester Group,SmallMoleculeDrug,P22303,Acetylcholinesterase,ACHE,614.0
8531,DB02827,"7-(1,1-Dioxo-1h-Benzo[D]Isothiazol-3-Yloxymethyl)-2-(Oxalyl-Amino)-4,7-Dihydro-5h-Thieno[2,3-C]Pyran-3-Carboxylic Acid",SmallMoleculeDrug,P18031,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,435.0
8534,DB02830,FR236913,SmallMoleculeDrug,P00813,Adenosine deaminase,ADA,363.0
8536,DB02831,Dihydrogenphosphate Ion,SmallMoleculeDrug,Q7Z4W1,L-xylulose reductase,DCXR,244.0
8538,DB02833,[4-(2-Amino-4-Methyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]-(3-Nitro-Phenyl)-Amine,SmallMoleculeDrug,P24941,Cyclin-dependent kinase 2,CDK2,298.0
8539,DB02833,[4-(2-Amino-4-Methyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]-(3-Nitro-Phenyl)-Amine,SmallMoleculeDrug,P20248,Cyclin-A2,CCNA2,432.0
8540,DB02834,IDD552,SmallMoleculeDrug,P15121,Aldose reductase,AKR1B1,316.0
8542,DB02835,"Alpha-D-Glucose 1,6-Bisphosphate",SmallMoleculeDrug,P36871,Phosphoglucomutase-1,PGM1,562.0
8545,DB02837,O4-Sulfonylgalactose,SmallMoleculeDrug,P11226,Mannose-binding protein C,MBL2,248.0
8546,DB02838,"3,4-Dihydro-2h-Pyrrolium-5-Carboxylate",SmallMoleculeDrug,P14920,D-amino-acid oxidase,DAO,347.0
8549,DB02840,"4-(1,3-Benzodioxol-5-Yl)-5-(5-Ethyl-2,4-Dihydroxyphenyl)-2h-Pyrazole-3-Carboxylic Acid",SmallMoleculeDrug,P07900,Heat shock protein HSP 90-alpha,HSP90AA1,732.0
8554,DB02843,Alpha-D-Glucose-1-Phosphate,SmallMoleculeDrug,P11217,"Glycogen phosphorylase, muscle form",PYGM,842.0
8560,DB02845,Methylphosphinic Acid,SmallMoleculeDrug,P06276,Cholinesterase,BCHE,602.0
8561,DB02845,Methylphosphinic Acid,SmallMoleculeDrug,P22303,Acetylcholinesterase,ACHE,614.0
8562,DB02846,L-thioproline,SmallMoleculeDrug,P08758,Annexin A5,ANXA5,320.0
8563,DB02848,"{4-[3-(6,7-Diethoxy-Quinazolin-4-Ylamino)-Phenyl]-Thiazol-2-Yl}-Methanol",SmallMoleculeDrug,P09467,"Fructose-1,6-bisphosphatase 1",FBP1,338.0
8565,DB02850,(1-Tert-Butyl-5-Hydroxy-1h-Pyrazol-4-Yl)-(6-Methanesulfonyl-4'-Methoxy-2-Methyl-Biphenyl-3-Yl)-Methanone,SmallMoleculeDrug,P32754,4-hydroxyphenylpyruvate dioxygenase,HPD,393.0
8567,DB02852,Domoic Acid,SmallMoleculeDrug,Q13002,"Glutamate receptor ionotropic, kainate 2",GRIK2,908.0
8568,DB02854,Aetiocholanolone,SmallMoleculeDrug,Q06520,Bile salt sulfotransferase,SULT2A1,285.0
8569,DB02854,Aetiocholanolone,SmallMoleculeDrug,Q8NBQ5,Estradiol 17-beta-dehydrogenase 11,HSD17B11,300.0
8571,DB02854,Aetiocholanolone,SmallMoleculeDrug,P01859,Ig gamma-2 chain C region,IGHG2,326.0
8572,DB02855,N-(3-Propylcarbamoyloxirane-2-Carbonyl)-Isoleucyl-Proline,SmallMoleculeDrug,P07858,Cathepsin B,CTSB,339.0
8575,DB02857,Guanosine,SmallMoleculeDrug,P00491,Purine nucleoside phosphorylase,PNP,289.0
8578,DB02859,Soraphen A,SmallMoleculeDrug,O00763,Acetyl-CoA carboxylase 2,ACACB,2458.0
8579,DB02860,Calyculin A,SmallMoleculeDrug,P36873,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,PPP1CC,323.0
8580,DB02861,"4-(Aminosulfonyl)-N-[(3,4,5-Trifluorophenyl)Methyl]-Benzamide",SmallMoleculeDrug,P00918,Carbonic anhydrase 2,CA2,260.0
8583,DB02866,Dansylamide,SmallMoleculeDrug,P00918,Carbonic anhydrase 2,CA2,260.0
8586,DB02869,3-amino-5-phenylpentane,SmallMoleculeDrug,O60911,Cathepsin L2,CTSV,334.0
8587,DB02869,3-amino-5-phenylpentane,SmallMoleculeDrug,P43235,Cathepsin K,CTSK,329.0
8589,DB02871,3-Butylthiolane 1-Oxide,SmallMoleculeDrug,P00326,Alcohol dehydrogenase 1C,ADH1C,375.0
8590,DB02872,"Cis-[4,5-Bis-(4-Bromophenyl)-2-(2-Ethoxy-4-Methoxyphenyl)-4,5-Dihydroimidazol-1-Yl]-[4-(2-Hydroxyethyl)Piperazin-1-Yl]Methanone",SmallMoleculeDrug,Q00987,E3 ubiquitin-protein ligase Mdm2,MDM2,491.0
8591,DB02873,"1-(2,6-Dichlorophenyl)-5-(2,4-Difluorophenyl)-7-Piperazin-1-Yl-3,4-Dihydroquinazolin-2(1h)-One",SmallMoleculeDrug,Q16539,Mitogen-activated protein kinase 14,MAPK14,360.0
8592,DB02875,CRA_1802,SmallMoleculeDrug,P07477,Trypsin-1,PRSS1,247.0
8594,DB02877,TTNPB,SmallMoleculeDrug,P10826,Retinoic acid receptor beta,RARB,455.0
8595,DB02878,3-(2-Aminoethyl)-4-(Aminomethyl)Heptanedioic Acid,SmallMoleculeDrug,P13716,Delta-aminolevulinic acid dehydratase,ALAD,330.0
8598,DB02884,Beta-Cyclohexyl-Alanine,SmallMoleculeDrug,P08048,Zinc finger Y-chromosomal protein,ZFY,801.0
8600,DB02887,"2',3'-Dehydro-2',3'-Deoxy-Thymidine 5'-Triphosphate",SmallMoleculeDrug,P15531,Nucleoside diphosphate kinase A,NME1,152.0
8601,DB02888,FKB-001,SmallMoleculeDrug,P62942,Peptidyl-prolyl cis-trans isomerase FKBP1A,FKBP1A,108.0
8602,DB02889,"4-O-(4,6-Dideoxy-4-{[4,5,6-Trihydroxy-3-(Hydroxymethyl)Cyclohex-2-En-1-Yl]Amino}-Beta-D-Lyxo-Hexopyranosyl)-Alpha-D-Erythro-Hexopyranose",SmallMoleculeDrug,P04746,Pancreatic alpha-amylase,AMY2A,511.0
8603,DB02890,6-Hydroxyuridine-5'-Phosphate,SmallMoleculeDrug,P11172,Uridine 5'-monophosphate synthase,UMPS,480.0
8606,DB02893,D-Methionine,SmallMoleculeDrug,P50579,Methionine aminopeptidase 2,METAP2,478.0
8608,DB02894,"Sulfamic Acid 2,3-O-(1-Methylethylidene)-4,5-O-Sulfonyl-Beta-Fructopyranose Ester",SmallMoleculeDrug,P00918,Carbonic anhydrase 2,CA2,260.0
8609,DB02895,3-(Prop-2-Ene-1-Sulfinyl)-Propene-1-Thiol,SmallMoleculeDrug,P00390,"Glutathione reductase, mitochondrial",GSR,522.0
8613,DB02898,5-{[(2-Amino-9h-Purin-6-Yl)Oxy]Methyl}-2-Pyrrolidinone,SmallMoleculeDrug,P24941,Cyclin-dependent kinase 2,CDK2,298.0
8622,DB02900,alpha-D-mannose 6-phosphate,SmallMoleculeDrug,P11717,Cation-independent mannose-6-phosphate receptor,IGF2R,2491.0
8623,DB02900,alpha-D-mannose 6-phosphate,SmallMoleculeDrug,P20645,Cation-dependent mannose-6-phosphate receptor,M6PR,277.0
8624,DB02901,Dihydrotestosterone,SmallMoleculeDrug,P14061,Estradiol 17-beta-dehydrogenase 1,HSD17B1,328.0
8625,DB02901,Dihydrotestosterone,SmallMoleculeDrug,P10275,Androgen receptor,AR,920.0
8626,DB02902,3'-Phosphate-Adenosine-5'-Phosphate Sulfate,SmallMoleculeDrug,P49888,Estrogen sulfotransferase,SULT1E1,294.0
8632,DB02908,RU78783,SmallMoleculeDrug,P12931,Proto-oncogene tyrosine-protein kinase Src,SRC,536.0
8635,DB02910,Octanoyl-Coenzyme A,SmallMoleculeDrug,P30084,"Enoyl-CoA hydratase, mitochondrial",ECHS1,290.0
8636,DB02910,Octanoyl-Coenzyme A,SmallMoleculeDrug,P42126,"Enoyl-CoA delta isomerase 1, mitochondrial",ECI1,302.0
8637,DB02910,Octanoyl-Coenzyme A,SmallMoleculeDrug,P11310,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",ACADM,421.0
8638,DB02911,"2,4-Diamino-6-Phenyl-5,6,7,8,-Tetrahydropteridine",SmallMoleculeDrug,P29474,"Nitric oxide synthase, endothelial",NOS3,1203.0
8640,DB02915,"4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]-(4-Trifluoromethyl-Phenyl)-Amine",SmallMoleculeDrug,P24941,Cyclin-dependent kinase 2,CDK2,298.0
8641,DB02915,"4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]-(4-Trifluoromethyl-Phenyl)-Amine",SmallMoleculeDrug,P20248,Cyclin-A2,CCNA2,432.0
8642,DB02917,N-Hydroxy-4-(Methyl{[5-(2-Pyridinyl)-2-Thienyl]Sulfonyl}Amino)Benzamide,SmallMoleculeDrug,Q9BY41,Histone deacetylase 8,HDAC8,377.0
8643,DB02918,6-(4-Difluoromethoxy-3-Methoxy-Phenyl)-2h-Pyridazin-3-One,SmallMoleculeDrug,Q08499,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",PDE4D,809.0
8644,DB02919,"2,4-Diamino-6-[N-(3',4',5'-Trimethoxybenzyl)-N-Methylamino]Pyrido[2,3-D]Pyrimidine",SmallMoleculeDrug,P00374,Dihydrofolate reductase,DHFR,187.0
8649,DB02924,"D-Limonene 1,2-Epoxide",SmallMoleculeDrug,Q8WX39,Epididymal-specific lipocalin-9,LCN9,176.0
8650,DB02925,Piretanide,SmallMoleculeDrug,Q13621,Solute carrier family 12 member 1,SLC12A1,1099.0
8653,DB02929,K201,SmallMoleculeDrug,P08758,Annexin A5,ANXA5,320.0
8657,DB02930,Phosphothiophosphoric Acid-Adenylate Ester,SmallMoleculeDrug,P16118,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 1",PFKFB1,471.0
8658,DB02930,Phosphothiophosphoric Acid-Adenylate Ester,SmallMoleculeDrug,P54278,Mismatch repair endonuclease PMS2,PMS2,862.0
8662,DB02931,Coa-S-Acetyl Tryptamine,SmallMoleculeDrug,Q16613,Serotonin N-acetyltransferase,AANAT,207.0
8663,DB02932,(2r)-N-[4-Cyano-3-(Trifluoromethyl)Phenyl]-3-[(4-Fluorophenyl)Sulfonyl]-2-Hydroxy-2-Methylpropanamide,SmallMoleculeDrug,P10275,Androgen receptor,AR,920.0
8664,DB02933,5'-Deoxy-5'-(Methylthio)-Tubercidin,SmallMoleculeDrug,Q13126,S-methyl-5'-thioadenosine phosphorylase,MTAP,283.0
8667,DB02935,1-Methoxy-2-(2-Methoxyethoxy)Ethane,SmallMoleculeDrug,P14625,Endoplasmin,HSP90B1,803.0
8668,DB02936,4-(1-Benzyl-3-Carbamoylmethyl-2-Methyl-1h-Indol-5-Yloxy)-Butyric Acid,SmallMoleculeDrug,P14555,"Phospholipase A2, membrane associated",PLA2G2A,144.0
8671,DB02938,Heptanoic Acid,SmallMoleculeDrug,P04054,Phospholipase A2,PLA2G1B,148.0
8675,DB02942,"Inositol 1,3-Bisphosphate",SmallMoleculeDrug,Q15075,Early endosome antigen 1,EEA1,1411.0
8676,DB02943,N-(4-Aminobutanoyl)-S-(4-Methoxybenzyl)-L-Cysteinylglycine,SmallMoleculeDrug,P08263,Glutathione S-transferase A1,GSTA1,222.0
8681,DB02950,Hymenialdisine,SmallMoleculeDrug,Q00535,Cyclin-dependent-like kinase 5,CDK5,292.0
8682,DB02950,Hymenialdisine,SmallMoleculeDrug,P06493,Cyclin-dependent kinase 1,CDK1,297.0
8683,DB02950,Hymenialdisine,SmallMoleculeDrug,P24941,Cyclin-dependent kinase 2,CDK2,298.0
8686,DB02952,Alpha-Aminoisobutyric Acid,SmallMoleculeDrug,P06850,Corticoliberin,CRH,196.0
8687,DB02952,Alpha-Aminoisobutyric Acid,SmallMoleculeDrug,P01303,Pro-neuropeptide Y,NPY,97.0
8688,DB02953,2-Thiomethyl-3-Phenylpropanoic Acid,SmallMoleculeDrug,P22894,Neutrophil collagenase,MMP8,467.0
8695,DB02963,"(5-Chloropyrazolo[1,5-a]Pyrimidin-7-Yl)-(4-Methanesulfonylphenyl)Amine",SmallMoleculeDrug,P24941,Cyclin-dependent kinase 2,CDK2,298.0
8696,DB02964,"8,9,10-Trihydroxy-7-Hydroxymethyl-2-Thioxo-6-Oxa-1,3-Diaza-Spiro[4.5]Decan-4-One",SmallMoleculeDrug,P11217,"Glycogen phosphorylase, muscle form",PYGM,842.0
8698,DB02966,Fluoro-Willardiine,SmallMoleculeDrug,P42262,Glutamate receptor 2,GRIA2,883.0
8699,DB02967,N-Ethylmaleimide,SmallMoleculeDrug,Q05315,Galectin-10,CLC,142.0
8705,DB02973,4-(5-Bromo-2-Oxo-2h-Indol-3-Ylazo)-Benzenesulfonamide,SmallMoleculeDrug,P24941,Cyclin-dependent kinase 2,CDK2,298.0
8706,DB02974,4-(4-Chlorophenyl)Imidazole,SmallMoleculeDrug,P20813,Cytochrome P450 2B6,CYP2B6,491.0
8710,DB02977,PNU177836,SmallMoleculeDrug,P18031,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,435.0
8711,DB02979,"N1,N14-Bis((S-Methyl)Isothioureido)Tetradecane",SmallMoleculeDrug,P29474,"Nitric oxide synthase, endothelial",NOS3,1203.0
8714,DB02983,Para-Mercury-Benzenesulfonic Acid,SmallMoleculeDrug,Q05315,Galectin-10,CLC,142.0
8715,DB02983,Para-Mercury-Benzenesulfonic Acid,SmallMoleculeDrug,Q92731,Estrogen receptor beta,ESR2,530.0
8716,DB02984,"4-[3-Methylsulfanylanilino]-6,7-Dimethoxyquinazoline",SmallMoleculeDrug,Q16539,Mitogen-activated protein kinase 14,MAPK14,360.0
8718,DB02986,"N-(2-Thienylmethyl)-2,5-Thiophenedisulfonamide",SmallMoleculeDrug,P00918,Carbonic anhydrase 2,CA2,260.0
8719,DB02987,Cysteine-S-Acetamide,SmallMoleculeDrug,P00973,2'-5'-oligoadenylate synthase 1,OAS1,400.0
8720,DB02987,Cysteine-S-Acetamide,SmallMoleculeDrug,P07998,Ribonuclease pancreatic,RNASE1,156.0
8721,DB02988,Imino-Tryptophan,SmallMoleculeDrug,P14920,D-amino-acid oxidase,DAO,347.0
8722,DB02989,CRA_10972,SmallMoleculeDrug,P07477,Trypsin-1,PRSS1,247.0
8724,DB02991,S-Ethyl-N-[4-(Trifluoromethyl)Phenyl]Isothiourea,SmallMoleculeDrug,P29475,"Nitric oxide synthase, brain",NOS1,1434.0
8727,DB02994,Hydroxydimethylarsine Oxide,SmallMoleculeDrug,P29474,"Nitric oxide synthase, endothelial",NOS3,1203.0
8728,DB02994,Hydroxydimethylarsine Oxide,SmallMoleculeDrug,P15121,Aldose reductase,AKR1B1,316.0
8729,DB02994,Hydroxydimethylarsine Oxide,SmallMoleculeDrug,P11488,Guanine nucleotide-binding protein G(t) subunit alpha-1,GNAT1,350.0
8731,DB02996,2-(Thiomethylene)-4-Methylpentanoic Acid,SmallMoleculeDrug,Q9UKQ2,Disintegrin and metalloproteinase domain-containing protein 28,ADAM28,775.0
8732,DB02998,Methyltrienolone,SmallMoleculeDrug,P06401,Progesterone receptor,PGR,933.0
8733,DB02998,Methyltrienolone,SmallMoleculeDrug,P10275,Androgen receptor,AR,920.0
8734,DB02998,Methyltrienolone,SmallMoleculeDrug,Q15596,Nuclear receptor coactivator 2,NCOA2,1464.0
8735,DB02999,Quisqualate,SmallMoleculeDrug,P42262,Glutamate receptor 2,GRIA2,883.0
8736,DB02999,Quisqualate,SmallMoleculeDrug,Q13002,"Glutamate receptor ionotropic, kainate 2",GRIK2,908.0
8739,DB03003,Glutathione Sulfonic Acid,SmallMoleculeDrug,Q03013,Glutathione S-transferase Mu 4,GSTM4,218.0
8740,DB03003,Glutathione Sulfonic Acid,SmallMoleculeDrug,P08263,Glutathione S-transferase A1,GSTA1,222.0
8741,DB03003,Glutathione Sulfonic Acid,SmallMoleculeDrug,P09211,Glutathione S-transferase P,GSTP1,210.0
8742,DB03005,"3,8-Diamino-6-Phenyl-5-[6-[1-[2-[(1,2,3,4-Tetrahydro-9-Acridinyl)Amino]Ethyl]-1h-1,2,3-Triazol-5-Yl]Hexyl]-Phenanthridinium",SmallMoleculeDrug,P22303,Acetylcholinesterase,ACHE,614.0
8743,DB03006,Arsanilic acid,SmallMoleculeDrug,P61626,Lysozyme C,LYZ,148.0
8744,DB03008,5-Fluoro-Beta-L-Gulosyl Fluoride,SmallMoleculeDrug,Q16706,Alpha-mannosidase 2,MAN2A1,1144.0
8745,DB03010,Epothilone B,SmallMoleculeDrug,Q13748,Tubulin alpha-3C/D chain,TUBA3C,450.0
8746,DB03010,Epothilone B,SmallMoleculeDrug,P07437,Tubulin beta chain,TUBB,444.0
8747,DB03010,Epothilone B,SmallMoleculeDrug,Q9H4B7,Tubulin beta-1 chain,TUBB1,451.0
8748,DB03010,Epothilone B,SmallMoleculeDrug,P68371,Tubulin beta-4B chain,TUBB4B,445.0
8749,DB03010,Epothilone B,SmallMoleculeDrug,P04350,Tubulin beta-4A chain,TUBB4A,444.0
8750,DB03010,Epothilone B,SmallMoleculeDrug,P68366,Tubulin alpha-4A chain,TUBA4A,448.0
8751,DB03010,Epothilone B,SmallMoleculeDrug,Q13509,Tubulin beta-3 chain,TUBB3,450.0
8752,DB03010,Epothilone B,SmallMoleculeDrug,Q9BQE3,Tubulin alpha-1C chain,TUBA1C,449.0
8753,DB03010,Epothilone B,SmallMoleculeDrug,Q9NY65,Tubulin alpha-8 chain,TUBA8,449.0
8754,DB03010,Epothilone B,SmallMoleculeDrug,P68363,Tubulin alpha-1B chain,TUBA1B,451.0
8755,DB03010,Epothilone B,SmallMoleculeDrug,Q71U36,Tubulin alpha-1A chain,TUBA1A,451.0
8757,DB03012,Phenylalanine-N-Sulfonamide,SmallMoleculeDrug,P15085,Carboxypeptidase A1,CPA1,419.0
8759,DB03013,Di(N-Acetyl-D-Glucosamine),SmallMoleculeDrug,P61626,Lysozyme C,LYZ,148.0
8760,DB03013,Di(N-Acetyl-D-Glucosamine),SmallMoleculeDrug,P15291,"Beta-1,4-galactosyltransferase 1",B4GALT1,398.0
8761,DB03015,"6-Hydroxy-1,6-Dihydro Purine Nucleoside",SmallMoleculeDrug,P00813,Adenosine deaminase,ADA,363.0
8762,DB03016,CRA_1801,SmallMoleculeDrug,P07477,Trypsin-1,PRSS1,247.0
8763,DB03017,Lauric Acid,SmallMoleculeDrug,P11766,Alcohol dehydrogenase class-3,ADH5,374.0
8766,DB03017,Lauric Acid,SmallMoleculeDrug,P17900,Ganglioside GM2 activator,GM2A,193.0
8771,DB03017,Lauric Acid,SmallMoleculeDrug,P41235,Hepatocyte nuclear factor 4-alpha,HNF4A,474.0
8772,DB03017,Lauric Acid,SmallMoleculeDrug,P14555,"Phospholipase A2, membrane associated",PLA2G2A,144.0
8773,DB03017,Lauric Acid,SmallMoleculeDrug,P98155,Very low-density lipoprotein receptor,VLDLR,873.0
8774,DB03017,Lauric Acid,SmallMoleculeDrug,Q9NZD2,Glycolipid transfer protein,GLTP,209.0
8776,DB03017,Lauric Acid,SmallMoleculeDrug,P02788,Lactotransferrin,LTF,710.0
8778,DB03017,Lauric Acid,SmallMoleculeDrug,P07360,Complement component C8 gamma chain,C8G,202.0
8779,DB03017,Lauric Acid,SmallMoleculeDrug,Q9UNK4,Group IID secretory phospholipase A2,PLA2G2D,145.0
8781,DB03017,Lauric Acid,SmallMoleculeDrug,Q9Y6Y9,Lymphocyte antigen 96,LY96,160.0
8782,DB03017,Lauric Acid,SmallMoleculeDrug,O00206,Toll-like receptor 4,TLR4,839.0
8784,DB03019,"4-(2,5-Dichloro-Thiophen-3-Yl)-Pyrimidin-2-Ylamine",SmallMoleculeDrug,P24941,Cyclin-dependent kinase 2,CDK2,298.0
8785,DB03020,5-Beta-D-Ribofuranosylnicotinamide Adenine Dinucleotide,SmallMoleculeDrug,P00326,Alcohol dehydrogenase 1C,ADH1C,375.0
8786,DB03021,Ulapualide A,SmallMoleculeDrug,P68133,"Actin, alpha skeletal muscle",ACTA1,377.0
8788,DB03023,"1-Tert-Butyl-3-(4-Chloro-Phenyl)-1h-Pyrazolo[3,4-D]Pyrimidin-4-Ylamine",SmallMoleculeDrug,P06239,Tyrosine-protein kinase Lck,LCK,509.0
8789,DB03023,"1-Tert-Butyl-3-(4-Chloro-Phenyl)-1h-Pyrazolo[3,4-D]Pyrimidin-4-Ylamine",SmallMoleculeDrug,P07948,Tyrosine-protein kinase Lyn,LYN,512.0
8790,DB03023,"1-Tert-Butyl-3-(4-Chloro-Phenyl)-1h-Pyrazolo[3,4-D]Pyrimidin-4-Ylamine",SmallMoleculeDrug,P12931,Proto-oncogene tyrosine-protein kinase Src,SRC,536.0
8791,DB03024,2-Methyl-3-(2-Aminothiazolo)Propanal,SmallMoleculeDrug,P00797,Renin,REN,406.0
8792,DB03026,Phosphoglycolohydroxamic Acid,SmallMoleculeDrug,P60174,Triosephosphate isomerase,TPI1,286.0
8798,DB03028,1h-Benoximidazole-2-Carboxylic Acid,SmallMoleculeDrug,P07339,Cathepsin D,CTSD,412.0
8801,DB03032,S-Octylglutathione,SmallMoleculeDrug,Q03013,Glutathione S-transferase Mu 4,GSTM4,218.0
8802,DB03033,1-Methyloxy-4-Sulfone-Benzene,SmallMoleculeDrug,P45452,Collagenase 3,MMP13,471.0
8803,DB03033,1-Methyloxy-4-Sulfone-Benzene,SmallMoleculeDrug,P08254,Stromelysin-1,MMP3,477.0
8805,DB03035,"1,8-Di-Hydroxy-4-Nitro-Anthraquinone",SmallMoleculeDrug,P68400,Casein kinase II subunit alpha,CSNK2A1,391.0
8808,DB03039,"4-(Aminosulfonyl)-N-[(2,5-Difluorophenyl)Methyl]-Benzamide",SmallMoleculeDrug,P00918,Carbonic anhydrase 2,CA2,260.0
8809,DB03040,Nitrilotriacetic Acid,SmallMoleculeDrug,P02788,Lactotransferrin,LTF,710.0
8811,DB03041,UDP-alpha-D-glucuronic acid,SmallMoleculeDrug,O94766,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,B3GAT3,335.0
8813,DB03042,5-Phosphoarabinonic Acid,SmallMoleculeDrug,P06744,Glucose-6-phosphate isomerase,GPI,558.0
8814,DB03044,1-(5-Tert-Butyl-2-P-Tolyl-2h-Pyrazol-3-Yl)-3-[4-(2-Morpholin-4-Yl-Ethoxy)-Naphthalen-1-Yl]-Urea,SmallMoleculeDrug,Q16539,Mitogen-activated protein kinase 14,MAPK14,360.0
8816,DB03046,7-Methoxy-8-[1-(Methylsulfonyl)-1h-Pyrazol-4-Yl]Naphthalene-2-Carboximidamide,SmallMoleculeDrug,P00749,Urokinase-type plasminogen activator,PLAU,431.0
8817,DB03048,6-Carboxymethyluracil,SmallMoleculeDrug,Q12882,Dihydropyrimidine dehydrogenase [NADP(+)],DPYD,1025.0
8821,DB03052,Dazoxiben,SmallMoleculeDrug,P24557,Thromboxane-A synthase,TBXAS1,533.0
8823,DB03056,4-Piperidino-Piperidine,SmallMoleculeDrug,P23141,Liver carboxylesterase 1,CES1,567.0
8825,DB03058,2-Aminobenzyl alcohol,SmallMoleculeDrug,P00746,Complement factor D,CFD,253.0
8830,DB03059,Acetoacetyl-Coenzyme A,SmallMoleculeDrug,Q16836,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",HADH,314.0
8832,DB03059,Acetoacetyl-Coenzyme A,SmallMoleculeDrug,P16219,"Short-chain specific acyl-CoA dehydrogenase, mitochondrial",ACADS,412.0
8833,DB03059,Acetoacetyl-Coenzyme A,SmallMoleculeDrug,P30084,"Enoyl-CoA hydratase, mitochondrial",ECHS1,290.0
8834,DB03060,Sri-9662,SmallMoleculeDrug,P00374,Dihydrofolate reductase,DHFR,187.0
8835,DB03061,(R)-N-(1-Methyl-Hexyl)-Formamide,SmallMoleculeDrug,P00326,Alcohol dehydrogenase 1C,ADH1C,375.0
8837,DB03062,(1-Methyl-1h-Imidazol-2-Yl)-(3-Methyl-4-{3-[(Pyridin-3-Ylmethyl)-Amino]-Propoxy}-Benzofuran-2-Yl)-Methanone,SmallMoleculeDrug,P30419,Glycylpeptide N-tetradecanoyltransferase 1,NMT1,496.0
8839,DB03064,"3-Decyl-2,5-Dioxo-4-Hydroxy-3-Pyrroline",SmallMoleculeDrug,Q9UJM8,Hydroxyacid oxidase 1,HAO1,370.0
8840,DB03065,7-Nitroindazole-2-Carboxamidine,SmallMoleculeDrug,P29474,"Nitric oxide synthase, endothelial",NOS3,1203.0
8842,DB03067,"4-{2,4-Bis[(3-Nitrobenzoyl)Amino]Phenoxy}Phthalic Acid",SmallMoleculeDrug,P11217,"Glycogen phosphorylase, muscle form",PYGM,842.0
8845,DB03070,Selenazole-4-Carboxyamide-Adenine Dinucleotide,SmallMoleculeDrug,P12268,Inosine-5'-monophosphate dehydrogenase 2,IMPDH2,514.0
8846,DB03072,"2-{3-[4-(4-Fluorophenyl)-3,6-Dihydro-1(2h)-Pyridinyl]Propyl}-8-Methyl-4(3h)-Quinazolinone",SmallMoleculeDrug,P09874,Poly [ADP-ribose] polymerase 1,PARP1,1014.0
8847,DB03073,3-Methoxybenzamide,SmallMoleculeDrug,P09874,Poly [ADP-ribose] polymerase 1,PARP1,1014.0
8853,DB03078,PASBN,SmallMoleculeDrug,P12931,Proto-oncogene tyrosine-protein kinase Src,SRC,536.0
8855,DB03080,17-Dmag,SmallMoleculeDrug,P07900,Heat shock protein HSP 90-alpha,HSP90AA1,732.0
8856,DB03081,Crc200 (Chiron-Behring),SmallMoleculeDrug,P07477,Trypsin-1,PRSS1,247.0
8857,DB03082,6-[(Z)-Amino(Imino)Methyl]-N-[4-(Aminomethyl)Phenyl]-4-(Pyrimidin-2-Ylamino)-2-Naphthamide,SmallMoleculeDrug,P00749,Urokinase-type plasminogen activator,PLAU,431.0
8858,DB03083,IC261,SmallMoleculeDrug,P78368,Casein kinase I isoform gamma-2,CSNK1G2,415.0
8859,DB03084,"Cyclopropyl-{4-[5-(3,4-Dichlorophenyl)-2-[(1-Methyl)-Piperidin]-4-Yl-3-Propyl-3h-Imidazol-4-Yl]-Pyrimidin-2-Yl}Amine",SmallMoleculeDrug,P53779,Mitogen-activated protein kinase 10,MAPK10,464.0
8860,DB03085,Hydroxyacetic Acid,SmallMoleculeDrug,P11413,Glucose-6-phosphate 1-dehydrogenase,G6PD,515.0
8862,DB03086,"N'-(2s,3r)-3-Amino-4-Cyclohexyl-2-Hydroxy-Butano-N-(4-Methylphenyl)Hydrazide",SmallMoleculeDrug,P50579,Methionine aminopeptidase 2,METAP2,478.0
8863,DB03087,2-(Sec-Butyl)Thiazole,SmallMoleculeDrug,Q8WX39,Epididymal-specific lipocalin-9,LCN9,176.0
8864,DB03088,Pyroglutamic Acid,SmallMoleculeDrug,P15692,Vascular endothelial growth factor A,VEGFA,232.0
8865,DB03088,Pyroglutamic Acid,SmallMoleculeDrug,P04746,Pancreatic alpha-amylase,AMY2A,511.0
8866,DB03088,Pyroglutamic Acid,SmallMoleculeDrug,P0CG04,Ig lambda-1 chain C regions,IGLC1,106.0
8867,DB03088,Pyroglutamic Acid,SmallMoleculeDrug,P01709,Ig lambda chain V-II region MGC,IGLV2-8,118.0
8868,DB03088,Pyroglutamic Acid,SmallMoleculeDrug,Q03403,Trefoil factor 2,TFF2,129.0
8870,DB03088,Pyroglutamic Acid,SmallMoleculeDrug,Q9UKQ2,Disintegrin and metalloproteinase domain-containing protein 28,ADAM28,775.0
8873,DB03088,Pyroglutamic Acid,SmallMoleculeDrug,Q701N4,Keratin-associated protein 5-2,KRTAP5-2,177.0
8874,DB03088,Pyroglutamic Acid,SmallMoleculeDrug,O43612,Orexin,HCRT,131.0
8875,DB03088,Pyroglutamic Acid,SmallMoleculeDrug,P80075,C-C motif chemokine 8,CCL8,99.0
8877,DB03088,Pyroglutamic Acid,SmallMoleculeDrug,P19961,Alpha-amylase 2B,AMY2B,511.0
8878,DB03088,Pyroglutamic Acid,SmallMoleculeDrug,P03950,Angiogenin,ANG,147.0
8880,DB03088,Pyroglutamic Acid,SmallMoleculeDrug,P04745,Alpha-amylase 1,AMY1A,511.0
8884,DB03092,5-Hydroxymethyl-Chonduritol,SmallMoleculeDrug,P04745,Alpha-amylase 1,AMY1A,511.0
8885,DB03092,5-Hydroxymethyl-Chonduritol,SmallMoleculeDrug,P04746,Pancreatic alpha-amylase,AMY2A,511.0
8886,DB03092,5-Hydroxymethyl-Chonduritol,SmallMoleculeDrug,P19961,Alpha-amylase 2B,AMY2B,511.0
8887,DB03093,"8-(2,5-Dimethoxy-Benzyl)-2-Fluoro-9h-Purin-6-Ylamine",SmallMoleculeDrug,P07900,Heat shock protein HSP 90-alpha,HSP90AA1,732.0
8888,DB03095,Tetramethylammonium Ion,SmallMoleculeDrug,Q14376,UDP-glucose 4-epimerase,GALE,348.0
8889,DB03096,N-Aminoethylmorpholine,SmallMoleculeDrug,P07339,Cathepsin D,CTSD,412.0
8892,DB03100,6-Nitroindazole,SmallMoleculeDrug,P35228,"Nitric oxide synthase, inducible",NOS2,1153.0
8893,DB03100,6-Nitroindazole,SmallMoleculeDrug,P29474,"Nitric oxide synthase, endothelial",NOS3,1203.0
8895,DB03101,Ribose-1-Phosphate,SmallMoleculeDrug,P00491,Purine nucleoside phosphorylase,PNP,289.0
8896,DB03102,"2-(Oxalyl-Amino)-4,7-Dihydro-5h-Thieno[2,3-C]Pyran-3-Carboxylic Acid",SmallMoleculeDrug,P18031,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,435.0
8897,DB03103,Thymidine-5'- Diphosphate,SmallMoleculeDrug,P15531,Nucleoside diphosphate kinase A,NME1,152.0
8898,DB03104,RU82129,SmallMoleculeDrug,P12931,Proto-oncogene tyrosine-protein kinase Src,SRC,536.0
8900,DB03106,Myo-Inositol,SmallMoleculeDrug,P04062,Glucosylceramidase,GBA,536.0
8902,DB03106,Myo-Inositol,SmallMoleculeDrug,O14735,CDP-diacylglycerol--inositol 3-phosphatidyltransferase,CDIPT,213.0
8907,DB03109,N-Acetyl-D-Allosamine,SmallMoleculeDrug,Q13231,Chitotriosidase-1,CHIT1,466.0
8908,DB03110,2-Chlorophenol,SmallMoleculeDrug,Q16539,Mitogen-activated protein kinase 14,MAPK14,360.0
8912,DB03114,PAS219,SmallMoleculeDrug,P12931,Proto-oncogene tyrosine-protein kinase Src,SRC,536.0
8913,DB03115,"5-Bromo-N-(2,3-Dihydroxypropoxy)-3,4-Difluoro-2-[(2-Fluoro-4-Iodophenyl)Amino]Benzamide",SmallMoleculeDrug,Q02750,Dual specificity mitogen-activated protein kinase kinase 1,MAP2K1,393.0
8917,DB03120,Para-Toluene Sulfonate,SmallMoleculeDrug,P61626,Lysozyme C,LYZ,148.0
8918,DB03120,Para-Toluene Sulfonate,SmallMoleculeDrug,P09668,Pro-cathepsin H,CTSH,335.0
8919,DB03121,1-Benzyl-5-Methoxy-2-Methyl-1h-Indol-3-Yl)-Acetic Acid,SmallMoleculeDrug,P14555,"Phospholipase A2, membrane associated",PLA2G2A,144.0
8920,DB03124,5-[4-(1-Carboxymethyl-2-Oxo-Propylcarbamoyl)-Benzylsulfamoyl]-2-Hydroxy-Benzoic Acid,SmallMoleculeDrug,P42574,Caspase-3,CASP3,277.0
8922,DB03125,"2,4-Diamino-5-(3,4,5-Trimethoxy-Benzyl)-Pyrimidin-1-Ium",SmallMoleculeDrug,P00374,Dihydrofolate reductase,DHFR,187.0
8923,DB03126,Mant-Adp,SmallMoleculeDrug,Q7Z406,Myosin-14,MYH14,1995.0
8924,DB03127,Benzamidine,SmallMoleculeDrug,Q92876,Kallikrein-6,KLK6,244.0
8925,DB03127,Benzamidine,SmallMoleculeDrug,P07478,Trypsin-2,PRSS2,247.0
8926,DB03127,Benzamidine,SmallMoleculeDrug,P35030,Trypsin-3,PRSS3,304.0
8927,DB03127,Benzamidine,SmallMoleculeDrug,O00244,Copper transport protein ATOX1,ATOX1,68.0
8928,DB03127,Benzamidine,SmallMoleculeDrug,P42126,"Enoyl-CoA delta isomerase 1, mitochondrial",ECI1,302.0
8930,DB03127,Benzamidine,SmallMoleculeDrug,Q9Y5Y6,Suppressor of tumorigenicity 14 protein,ST14,855.0
8931,DB03127,Benzamidine,SmallMoleculeDrug,P00749,Urokinase-type plasminogen activator,PLAU,431.0
8932,DB03127,Benzamidine,SmallMoleculeDrug,P07477,Trypsin-1,PRSS1,247.0
8933,DB03127,Benzamidine,SmallMoleculeDrug,P68400,Casein kinase II subunit alpha,CSNK2A1,391.0
8934,DB03128,Acetylcholine,SmallMoleculeDrug,P22303,Acetylcholinesterase,ACHE,614.0
8935,DB03129,"[3-(1,3,2-Dioxaborolan-2-Yloxy)Propyl]Guanidine",SmallMoleculeDrug,P35030,Trypsin-3,PRSS3,304.0
8936,DB03130,S-P-Nitrobenzyloxycarbonylglutathione,SmallMoleculeDrug,Q04760,Lactoylglutathione lyase,GLO1,184.0
8938,DB03132,3-(2-Benzothiazolylthio)-1-Propanesulfonic Acid,SmallMoleculeDrug,P60174,Triosephosphate isomerase,TPI1,286.0
8939,DB03133,"2-(Beta-D-Glucopyranosyl)-5-Methyl-1,2,3-Benzimidazole",SmallMoleculeDrug,P11217,"Glycogen phosphorylase, muscle form",PYGM,842.0
8941,DB03135,[2(Formyl-Hydroxy-Amino)-Ethyl]-Phosphonic Acid,SmallMoleculeDrug,P60174,Triosephosphate isomerase,TPI1,286.0
8942,DB03136,4-Iodobenzo[B]Thiophene-2-Carboxamidine,SmallMoleculeDrug,P00734,Prothrombin,F2,622.0
8943,DB03136,4-Iodobenzo[B]Thiophene-2-Carboxamidine,SmallMoleculeDrug,P07477,Trypsin-1,PRSS1,247.0
8944,DB03136,4-Iodobenzo[B]Thiophene-2-Carboxamidine,SmallMoleculeDrug,P00749,Urokinase-type plasminogen activator,PLAU,431.0
8945,DB03137,"8-(2,5-Dimethoxy-Benzyl)-2-Fluoro-9-Pent-9h-Purin-6-Ylamine",SmallMoleculeDrug,P07900,Heat shock protein HSP 90-alpha,HSP90AA1,732.0
8955,DB03144,N-Omega-Hydroxy-L-Arginine,SmallMoleculeDrug,P29474,"Nitric oxide synthase, endothelial",NOS3,1203.0
8957,DB03144,N-Omega-Hydroxy-L-Arginine,SmallMoleculeDrug,P35228,"Nitric oxide synthase, inducible",NOS2,1153.0
8958,DB03144,N-Omega-Hydroxy-L-Arginine,SmallMoleculeDrug,P05089,Arginase-1,ARG1,322.0
8959,DB03144,N-Omega-Hydroxy-L-Arginine,SmallMoleculeDrug,P29475,"Nitric oxide synthase, brain",NOS1,1434.0
8965,DB03147,Flavin adenine dinucleotide,SmallMoleculeDrug,P16435,NADPH--cytochrome P450 reductase,POR,677.0
8966,DB03147,Flavin adenine dinucleotide,SmallMoleculeDrug,Q92947,"Glutaryl-CoA dehydrogenase, mitochondrial",GCDH,438.0
8967,DB03147,Flavin adenine dinucleotide,SmallMoleculeDrug,P11310,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",ACADM,421.0
8968,DB03147,Flavin adenine dinucleotide,SmallMoleculeDrug,P14920,D-amino-acid oxidase,DAO,347.0
8971,DB03147,Flavin adenine dinucleotide,SmallMoleculeDrug,P21397,Amine oxidase [flavin-containing] A,MAOA,527.0
8972,DB03147,Flavin adenine dinucleotide,SmallMoleculeDrug,P16219,"Short-chain specific acyl-CoA dehydrogenase, mitochondrial",ACADS,412.0
8973,DB03147,Flavin adenine dinucleotide,SmallMoleculeDrug,Q96RQ9,L-amino-acid oxidase,IL4I1,567.0
8977,DB03147,Flavin adenine dinucleotide,SmallMoleculeDrug,P29475,"Nitric oxide synthase, brain",NOS1,1434.0
8978,DB03147,Flavin adenine dinucleotide,SmallMoleculeDrug,P15559,NAD(P)H dehydrogenase [quinone] 1,NQO1,274.0
8981,DB03147,Flavin adenine dinucleotide,SmallMoleculeDrug,Q86YB8,ERO1-like protein beta,ERO1B,467.0
8982,DB03147,Flavin adenine dinucleotide,SmallMoleculeDrug,P00390,"Glutathione reductase, mitochondrial",GSR,522.0
8984,DB03147,Flavin adenine dinucleotide,SmallMoleculeDrug,P00387,NADH-cytochrome b5 reductase 3,CYB5R3,301.0
8993,DB03147,Flavin adenine dinucleotide,SmallMoleculeDrug,P16083,Ribosyldihydronicotinamide dehydrogenase [quinone],NQO2,231.0
8994,DB03147,Flavin adenine dinucleotide,SmallMoleculeDrug,P26440,"Isovaleryl-CoA dehydrogenase, mitochondrial",IVD,423.0
8995,DB03147,Flavin adenine dinucleotide,SmallMoleculeDrug,P47989,Xanthine dehydrogenase/oxidase,XDH,1333.0
8999,DB03147,Flavin adenine dinucleotide,SmallMoleculeDrug,Q12882,Dihydropyrimidine dehydrogenase [NADP(+)],DPYD,1025.0
9003,DB03147,Flavin adenine dinucleotide,SmallMoleculeDrug,Q16881,"Thioredoxin reductase 1, cytoplasmic",TXNRD1,649.0
9005,DB03147,Flavin adenine dinucleotide,SmallMoleculeDrug,Q9UKU7,"Isobutyryl-CoA dehydrogenase, mitochondrial",ACAD8,415.0
9007,DB03147,Flavin adenine dinucleotide,SmallMoleculeDrug,O95831,"Apoptosis-inducing factor 1, mitochondrial",AIFM1,613.0
9015,DB03147,Flavin adenine dinucleotide,SmallMoleculeDrug,P09622,"Dihydrolipoyl dehydrogenase, mitochondrial",DLD,509.0
9017,DB03147,Flavin adenine dinucleotide,SmallMoleculeDrug,Q9UHQ9,NADH-cytochrome b5 reductase 1,CYB5R1,305.0
9019,DB03147,Flavin adenine dinucleotide,SmallMoleculeDrug,P27338,Amine oxidase [flavin-containing] B,MAOB,520.0
9020,DB03147,Flavin adenine dinucleotide,SmallMoleculeDrug,P22570,"NADPH:adrenodoxin oxidoreductase, mitochondrial",FDXR,491.0
9021,DB03147,Flavin adenine dinucleotide,SmallMoleculeDrug,Q15067,Peroxisomal acyl-coenzyme A oxidase 1,ACOX1,660.0
9023,DB03147,Flavin adenine dinucleotide,SmallMoleculeDrug,P55789,FAD-linked sulfhydryl oxidase ALR,GFER,205.0
9051,DB03149,Phenylalanylmethane,SmallMoleculeDrug,P23946,Chymase,CMA1,247.0
9053,DB03150,"2',3'-Dideoxythymidine-5'-Monophosphate",SmallMoleculeDrug,P23919,Thymidylate kinase,DTYMK,212.0
9058,DB03152,B-2-Octylglucoside,SmallMoleculeDrug,Q08188,Protein-glutamine gamma-glutamyltransferase E,TGM3,693.0
9064,DB03152,B-2-Octylglucoside,SmallMoleculeDrug,P08100,Rhodopsin,RHO,348.0
9065,DB03153,"3h-Pyrazolo[4,3-D]Pyrimidin-7-Ol",SmallMoleculeDrug,P00492,Hypoxanthine-guanine phosphoribosyltransferase,HPRT1,218.0
9066,DB03154,{[7-(Difluoro-Phosphono-Methyl)-Naphthalen-2-Yl]-Difluoro-Methyl}-Phosphonic Acid,SmallMoleculeDrug,P18031,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,435.0
9067,DB03155,"1-(2-Deoxy-2-Fluoro-3-O-Phosphono-Beta-L-Ribofuranosyl)Pyrimidine-2,4(1h,3h)-Dione",SmallMoleculeDrug,P07998,Ribonuclease pancreatic,RNASE1,156.0
9072,DB03158,"D-Myo-Inositol-1,4-Bisphosphate",SmallMoleculeDrug,P32019,"Type II inositol 1,4,5-trisphosphate 5-phosphatase",INPP5B,993.0
9073,DB03159,CRA_8696,SmallMoleculeDrug,P00734,Prothrombin,F2,622.0
9074,DB03159,CRA_8696,SmallMoleculeDrug,P07477,Trypsin-1,PRSS1,247.0
9075,DB03159,CRA_8696,SmallMoleculeDrug,P00749,Urokinase-type plasminogen activator,PLAU,431.0
9084,DB03169,(S)-Hmg-Coa,SmallMoleculeDrug,P04035,3-hydroxy-3-methylglutaryl-coenzyme A reductase,HMGCR,888.0
9091,DB03173,CRA_10433,SmallMoleculeDrug,P07477,Trypsin-1,PRSS1,247.0
9093,DB03175,1-Proponol,SmallMoleculeDrug,P61626,Lysozyme C,LYZ,148.0
9094,DB03176,"3,5-Dichloro-4-[(4-Hydroxy-3-Isopropylphenoxy)Phenylacetic Acid",SmallMoleculeDrug,P10828,Thyroid hormone receptor beta,THRB,461.0
9095,DB03176,"3,5-Dichloro-4-[(4-Hydroxy-3-Isopropylphenoxy)Phenylacetic Acid",SmallMoleculeDrug,P10827,Thyroid hormone receptor alpha,THRA,490.0
9098,DB03179,Sinapoyl Coenzyme A,SmallMoleculeDrug,Q86VU5,Catechol O-methyltransferase domain-containing protein 1,COMTD1,262.0
9100,DB03181,"2-[4-(4-Hydroxy-3-Isopropyl-Phenoxy)-3,5-Dimethyl-Phenyl]-2h-[1,2,4]Triazine-3,5-Dione",SmallMoleculeDrug,P10828,Thyroid hormone receptor beta,THRB,461.0
9101,DB03182,Alpha-Fluoro-Carboxymethyldethia Coenzyme a Complex,SmallMoleculeDrug,O75390,"Citrate synthase, mitochondrial",CS,466.0
9102,DB03183,"1-(4-Aminophenyl)-3,5-Dimethyl-1h-Pyrazole-4-Carboxylic Acid Ethyl Ester",SmallMoleculeDrug,Q08499,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",PDE4D,809.0
9103,DB03185,"1-Beta-Ribofuranosyl-1,3-Diazepinone",SmallMoleculeDrug,P32320,Cytidine deaminase,CDA,146.0
9104,DB03186,U-Pi-a-Pi,SmallMoleculeDrug,P07998,Ribonuclease pancreatic,RNASE1,156.0
9105,DB03187,6-(Hydroxyethyldithio)-8-(Aminomethylthio)Octanoic Acid,SmallMoleculeDrug,P23434,"Glycine cleavage system H protein, mitochondrial",GCSH,173.0
9106,DB03189,Cu-Cyclam,SmallMoleculeDrug,P61626,Lysozyme C,LYZ,148.0
9108,DB03191,3-Oxiran-2ylalanine,SmallMoleculeDrug,Q00266,S-adenosylmethionine synthase isoform type-1,MAT1A,395.0
9109,DB03192,3r-Hydroxydecanoyl-Coa,SmallMoleculeDrug,P51659,Peroxisomal multifunctional enzyme type 2,HSD17B4,736.0
9110,DB03193,Stearic acid,SmallMoleculeDrug,Q9UNK4,Group IID secretory phospholipase A2,PLA2G2D,145.0
9111,DB03194,beta-L-methyl-fucose,SmallMoleculeDrug,P11226,Mannose-binding protein C,MBL2,248.0
9112,DB03195,"Phosphoric Acid Mono-[3-Fluoro-5-(5-Methyl-2,4-Dioxo-3,4-Dihydro-2h-Pyrimidin-1-Yl)-Tetrahyro-Furan-2-Ylmethyl] Ester",SmallMoleculeDrug,P23919,Thymidylate kinase,DTYMK,212.0
9118,DB03201,D-Cysteine,SmallMoleculeDrug,P15085,Carboxypeptidase A1,CPA1,419.0
9119,DB03202,"2-[5-Methanesulfonylamino-2-(4-Aminophenyl)-6-Oxo-1,6-Dihydro-1-Pyrimidinyl]-N-(3,3,3-Trifluoro-1-Isopropyl-2-Oxopropyl)Acetamide",SmallMoleculeDrug,Q9UNI1,Chymotrypsin-like elastase family member 1,CELA1,258.0
9120,DB03203,Sphingosine,SmallMoleculeDrug,Q9NZD2,Glycolipid transfer protein,GLTP,209.0
9125,DB03203,Sphingosine,SmallMoleculeDrug,P15151,Poliovirus receptor,PVR,417.0
9131,DB03206,Duvoglustat,SmallMoleculeDrug,Q9UKM7,"Endoplasmic reticulum mannosyl-oligosaccharide 1,2-alpha-mannosidase",MAN1B1,699.0
9136,DB03207,"2-(Biphenyl-4-Sulfonyl)-1,2,3,4-Tetrahydro-Isoquinoline-3-Carboxylic Acid",SmallMoleculeDrug,P22894,Neutrophil collagenase,MMP8,467.0
9140,DB03213,Bis(5-Amidino-2-Benzimidazolyl)Methane Ketone,SmallMoleculeDrug,P07477,Trypsin-1,PRSS1,247.0
9141,DB03214,Vinylglycine,SmallMoleculeDrug,Q96QU6,1-aminocyclopropane-1-carboxylate synthase-like protein 1,ACCS,501.0
9142,DB03214,Vinylglycine,SmallMoleculeDrug,Q96RQ9,L-amino-acid oxidase,IL4I1,567.0
9144,DB03216,"(1'r,2's)-9-(2-Hydroxy-3'-Keto-Cyclopenten-1-Yl)Adenine",SmallMoleculeDrug,P23526,Adenosylhomocysteinase,AHCY,432.0
9145,DB03217,DPI59,SmallMoleculeDrug,P12931,Proto-oncogene tyrosine-protein kinase Src,SRC,536.0
9146,DB03218,N-Acetyl-N'-Beta-D-Glucopyranosyl Urea,SmallMoleculeDrug,P11217,"Glycogen phosphorylase, muscle form",PYGM,842.0
9148,DB03220,FR233623,SmallMoleculeDrug,P00813,Adenosine deaminase,ADA,363.0
9149,DB03221,AL7099A,SmallMoleculeDrug,P00918,Carbonic anhydrase 2,CA2,260.0
9151,DB03222,2'-Deoxyadenosine 5'-Triphosphate,SmallMoleculeDrug,P06746,DNA polymerase beta,POLB,335.0
9156,DB03223,Diphthamide,SmallMoleculeDrug,P13639,Elongation factor 2,EEF2,858.0
9158,DB03225,D-Tryptophan,SmallMoleculeDrug,P14920,D-amino-acid oxidase,DAO,347.0
9160,DB03226,Trifluoroethanol,SmallMoleculeDrug,P00326,Alcohol dehydrogenase 1C,ADH1C,375.0
9161,DB03226,Trifluoroethanol,SmallMoleculeDrug,P01112,GTPase HRas,HRAS,189.0
9162,DB03227,Nicotinamide Mononucleotide,SmallMoleculeDrug,Q9HAN9,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,NMNAT1,279.0
9163,DB03227,Nicotinamide Mononucleotide,SmallMoleculeDrug,Q96T66,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 3,NMNAT3,252.0
9164,DB03227,Nicotinamide Mononucleotide,SmallMoleculeDrug,Q10588,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,BST1,318.0
9172,DB03233,"Phosphoric Acid Mono-[3-Amino-5-(5-Methyl-2,4-Dioxo-3,4-Dihydro-2h-Pyrimidin-1-Yl)-Tetrahydro-Furan-2-Ylmethyl] Ester",SmallMoleculeDrug,P23919,Thymidylate kinase,DTYMK,212.0
9177,DB03240,"(S)-2-Amino-3-(1,3,5,7-Pentahydro-2,4-Dioxo-Cyclopenta[E]Pyrimidin-1-Yl) Proionic Acid",SmallMoleculeDrug,P42262,Glutamate receptor 2,GRIA2,883.0
9180,DB03243,4-Fluorobenzylamine,SmallMoleculeDrug,P07477,Trypsin-1,PRSS1,247.0
9181,DB03245,S-4-Nitrobutyryl-Coa,SmallMoleculeDrug,Q92947,"Glutaryl-CoA dehydrogenase, mitochondrial",GCDH,438.0
9188,DB03247,Riboflavin Monophosphate,SmallMoleculeDrug,O75676,Ribosomal protein S6 kinase alpha-4,RPS6KA4,772.0
9190,DB03247,Riboflavin Monophosphate,SmallMoleculeDrug,Q9NYQ3,Hydroxyacid oxidase 2,HAO2,351.0
9197,DB03247,Riboflavin Monophosphate,SmallMoleculeDrug,P16435,NADPH--cytochrome P450 reductase,POR,677.0
9198,DB03247,Riboflavin Monophosphate,SmallMoleculeDrug,Q96CD2,Phosphopantothenoylcysteine decarboxylase,PPCDC,204.0
9207,DB03247,Riboflavin Monophosphate,SmallMoleculeDrug,P30043,Flavin reductase (NADPH),BLVRB,206.0
9208,DB03247,Riboflavin Monophosphate,SmallMoleculeDrug,Q9UJM8,Hydroxyacid oxidase 1,HAO1,370.0
9209,DB03247,Riboflavin Monophosphate,SmallMoleculeDrug,Q9NVS9,Pyridoxine-5'-phosphate oxidase,PNPO,261.0
9211,DB03247,Riboflavin Monophosphate,SmallMoleculeDrug,Q969G6,Riboflavin kinase,RFK,155.0
9213,DB03247,Riboflavin Monophosphate,SmallMoleculeDrug,P29475,"Nitric oxide synthase, brain",NOS1,1434.0
9215,DB03247,Riboflavin Monophosphate,SmallMoleculeDrug,Q12882,Dihydropyrimidine dehydrogenase [NADP(+)],DPYD,1025.0
9216,DB03247,Riboflavin Monophosphate,SmallMoleculeDrug,Q02127,"Dihydroorotate dehydrogenase (quinone), mitochondrial",DHODH,395.0
9233,DB03247,Riboflavin Monophosphate,SmallMoleculeDrug,O00141,Serine/threonine-protein kinase Sgk1,SGK1,431.0
9238,DB03250,"2-(Beta-D-Glucopyranosyl)-5-Methyl-1,3,4-Benzothiazole",SmallMoleculeDrug,P11217,"Glycogen phosphorylase, muscle form",PYGM,842.0
9239,DB03251,RWJ-51084,SmallMoleculeDrug,P07477,Trypsin-1,PRSS1,247.0
9242,DB03253,(2s)-Pyrrolidin-2-Ylmethylamine,SmallMoleculeDrug,P27487,Dipeptidyl peptidase 4,DPP4,766.0
9251,DB03256,(6R)-Folinic acid,SmallMoleculeDrug,O95954,Formimidoyltransferase-cyclodeaminase,FTCD,541.0
9259,DB03262,"Al-6619, [2h-Thieno[3,2-E]-1,2-Thiazine-6-Sulfonamide,2-(3-Hydroxyphenyl)-3-(4-Morpholinyl)-, 1,1-Dioxide]",SmallMoleculeDrug,P00918,Carbonic anhydrase 2,CA2,260.0
9262,DB03267,1-Allyl-3-Butyl-8-(N-Acetyl-4-Aminobenzyl)-Xanthine,SmallMoleculeDrug,P35558,"Phosphoenolpyruvate carboxykinase, cytosolic [GTP]",PCK1,622.0
9263,DB03268,RU82197,SmallMoleculeDrug,P12931,Proto-oncogene tyrosine-protein kinase Src,SRC,536.0
9264,DB03270,"2,6-Difluorobenzenesulfonamide",SmallMoleculeDrug,P00918,Carbonic anhydrase 2,CA2,260.0
9265,DB03273,3'-Oxo-Adenosine,SmallMoleculeDrug,P23526,Adenosylhomocysteinase,AHCY,432.0
9267,DB03276,"4-[(10s,14s,18s)-18-(2-Amino-2-Oxoethyl)-14-(1-Naphthylmethyl)-8,17,20-Trioxo-7,16,19-Triazaspiro[5.14]Icos-11-En-10-Yl]Benzylphosphonic Acid",SmallMoleculeDrug,P62993,Growth factor receptor-bound protein 2,GRB2,217.0
9269,DB03277,alpha-maltotriose,SmallMoleculeDrug,P19961,Alpha-amylase 2B,AMY2B,511.0
9271,DB03279,Dodecyl-Alpha-D-Maltoside,SmallMoleculeDrug,P13631,Retinoic acid receptor gamma,RARG,454.0
9272,DB03280,P1-(5'-Adenosyl)P5-(5'-Thymidyl)Pentaphosphate,SmallMoleculeDrug,P23919,Thymidylate kinase,DTYMK,212.0
9278,DB03283,beta-L-fucose,SmallMoleculeDrug,P22303,Acetylcholinesterase,ACHE,614.0
9280,DB03286,C-(1-Azido-Alpha-D-Glucopyranosyl) Formamide,SmallMoleculeDrug,P11217,"Glycogen phosphorylase, muscle form",PYGM,842.0
9281,DB03288,5-Chloro-1h-Indole-2-Carboxylic Acid{[Cyclopentyl-(2-Hydroxy-Ethyl)-Carbamoyl]-Methyl}-Amide,SmallMoleculeDrug,P06737,"Glycogen phosphorylase, liver form",PYGL,847.0
9284,DB03292,D-2-Amino-3-Phosphono-Propionic Acid,SmallMoleculeDrug,P78330,Phosphoserine phosphatase,PSPH,225.0
9285,DB03294,"1-Methyl-3-Oxo-1,3-Dihydro-Benzo[C]Isothiazole-5-Sulfonic Acid Amide",SmallMoleculeDrug,P00918,Carbonic anhydrase 2,CA2,260.0
9287,DB03297,Benzylsulfinic Acid,SmallMoleculeDrug,P05981,Serine protease hepsin,HPN,417.0
9291,DB03297,Benzylsulfinic Acid,SmallMoleculeDrug,P04179,"Superoxide dismutase [Mn], mitochondrial",SOD2,222.0
9292,DB03297,Benzylsulfinic Acid,SmallMoleculeDrug,P23946,Chymase,CMA1,247.0
9294,DB03298,Phenylphosphate,SmallMoleculeDrug,P12931,Proto-oncogene tyrosine-protein kinase Src,SRC,536.0
9299,DB03305,N5-Iminoethyl-L-Ornithine,SmallMoleculeDrug,P29474,"Nitric oxide synthase, endothelial",NOS3,1203.0
9300,DB03306,RU78300,SmallMoleculeDrug,P12931,Proto-oncogene tyrosine-protein kinase Src,SRC,536.0
9301,DB03307,4-[(6-Amino-4-Pyrimidinyl)Amino]Benzenesulfonamide,SmallMoleculeDrug,P24941,Cyclin-dependent kinase 2,CDK2,298.0
9305,DB03309,N-Cyclohexyltaurine,SmallMoleculeDrug,P19622,Homeobox protein engrailed-2,EN2,333.0
9308,DB03309,N-Cyclohexyltaurine,SmallMoleculeDrug,O00204,Sulfotransferase family cytosolic 2B member 1,SULT2B1,365.0
9309,DB03310,Oxidized Glutathione Disulfide,SmallMoleculeDrug,P28161,Glutathione S-transferase Mu 2,GSTM2,218.0
9310,DB03310,Oxidized Glutathione Disulfide,SmallMoleculeDrug,P00390,"Glutathione reductase, mitochondrial",GSR,522.0
9311,DB03311,"3-(3,5-Dibromo-4-Hydroxy-Benzoyl)-2-Ethyl-Benzofuran-6-Sulfonic Acid [4-(Thiazol-2-Ylsulfamoyl)-Phenyl]-Amide",SmallMoleculeDrug,P18031,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,435.0
9319,DB03314,Fluorotryptophane,SmallMoleculeDrug,P60174,Triosephosphate isomerase,TPI1,286.0
9320,DB03314,Fluorotryptophane,SmallMoleculeDrug,P09488,Glutathione S-transferase Mu 1,GSTM1,218.0
9324,DB03316,"1,4-Diethylene Dioxide",SmallMoleculeDrug,Q9Y275,Tumor necrosis factor ligand superfamily member 13B,TNFSF13B,285.0
9325,DB03316,"1,4-Diethylene Dioxide",SmallMoleculeDrug,Q9Y6I3,Epsin-1,EPN1,576.0
9327,DB03316,"1,4-Diethylene Dioxide",SmallMoleculeDrug,P10600,Transforming growth factor beta-3,TGFB3,412.0
9337,DB03317,Heme C,SmallMoleculeDrug,P11712,Cytochrome P450 2C9,CYP2C9,490.0
9350,DB03317,Heme C,SmallMoleculeDrug,P99999,Cytochrome c,CYCS,105.0
9351,DB03319,(S)-ATPA,SmallMoleculeDrug,P42262,Glutamate receptor 2,GRIA2,883.0
9355,DB03323,Maltose,SmallMoleculeDrug,P19961,Alpha-amylase 2B,AMY2B,511.0
9364,DB03326,"deoxycytidylyl-3',5'-guanosine",SmallMoleculeDrug,P07998,Ribonuclease pancreatic,RNASE1,156.0
9366,DB03328,dioxothiomolybdenum(VI) ion,SmallMoleculeDrug,P47989,Xanthine dehydrogenase/oxidase,XDH,1333.0
9367,DB03329,2-Pyridinethiol,SmallMoleculeDrug,P07858,Cathepsin B,CTSB,339.0
9368,DB03330,S-(N-Hydroxy-N-Iodophenylcarbamoyl)Glutathione,SmallMoleculeDrug,Q04760,Lactoylglutathione lyase,GLO1,184.0
9369,DB03331,"N-Naphthalen-1-Ylmethyl-2'-[3,5-Dimethoxybenzamido]-2'-Deoxy-Adenosine",SmallMoleculeDrug,O14556,"Glyceraldehyde-3-phosphate dehydrogenase, testis-specific",GAPDHS,408.0
9370,DB03332,"5,6-Cyclic-Tetrahydropteridine",SmallMoleculeDrug,P29474,"Nitric oxide synthase, endothelial",NOS3,1203.0
9371,DB03333,(4-sulfamoyl-phenyl)-thiocarbamic acid O-(2-thiophen-3-yl-ethyl) ester,SmallMoleculeDrug,P00918,Carbonic anhydrase 2,CA2,260.0
9373,DB03336,BIA,SmallMoleculeDrug,P21964,Catechol O-methyltransferase,COMT,271.0
9374,DB03337,1-(2-Amidinophenyl)-3-(Phenoxyphenyl)Urea,SmallMoleculeDrug,P07477,Trypsin-1,PRSS1,247.0
9375,DB03338,Heptyl-Beta-D-Glucopyranoside,SmallMoleculeDrug,Q03181,Peroxisome proliferator-activated receptor delta,PPARD,441.0
9376,DB03338,Heptyl-Beta-D-Glucopyranoside,SmallMoleculeDrug,P62942,Peptidyl-prolyl cis-trans isomerase FKBP1A,FKBP1A,108.0
9378,DB03341,Coa-S-Acetyl 5-Bromotryptamine,SmallMoleculeDrug,Q16613,Serotonin N-acetyltransferase,AANAT,207.0
9381,DB03344,"Inositol-(1,3,4,5,6)-Pentakisphosphate",SmallMoleculeDrug,O43739,Cytohesin-3,CYTH3,400.0
9383,DB03345,Beta-Mercaptoethanol,SmallMoleculeDrug,Q04760,Lactoylglutathione lyase,GLO1,184.0
9384,DB03345,Beta-Mercaptoethanol,SmallMoleculeDrug,Q9NVS9,Pyridoxine-5'-phosphate oxidase,PNPO,261.0
9386,DB03345,Beta-Mercaptoethanol,SmallMoleculeDrug,P01009,Alpha-1-antitrypsin,SERPINA1,418.0
9387,DB03345,Beta-Mercaptoethanol,SmallMoleculeDrug,P09382,Galectin-1,LGALS1,135.0
9389,DB03345,Beta-Mercaptoethanol,SmallMoleculeDrug,Q96GD3,Polycomb protein SCMH1,SCMH1,660.0
9392,DB03346,"3,5,3',5'-Tetrachloro-Biphenyl-4,4'-Diol",SmallMoleculeDrug,P49888,Estrogen sulfotransferase,SULT1E1,294.0
9395,DB03348,Huperzine B,SmallMoleculeDrug,P22303,Acetylcholinesterase,ACHE,614.0
9396,DB03349,8-Bromo-Adenosine-5'-Monophosphate,SmallMoleculeDrug,Q07343,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B",PDE4B,736.0
9397,DB03349,8-Bromo-Adenosine-5'-Monophosphate,SmallMoleculeDrug,P49773,Histidine triad nucleotide-binding protein 1,HINT1,126.0
9400,DB03351,Sri-9439,SmallMoleculeDrug,P00374,Dihydrofolate reductase,DHFR,187.0
9405,DB03354,"2-(Beta-D-Glucopyranosyl)-5-Methyl-1,3,4-Oxadiazole",SmallMoleculeDrug,P11217,"Glycogen phosphorylase, muscle form",PYGM,842.0
9410,DB03359,"M-(N,N,N-Trimethylammonio)-2,2,2-Trifluoro-1,1-Dihydroxyethylbenzene",SmallMoleculeDrug,P22303,Acetylcholinesterase,ACHE,614.0
9414,DB03365,"4-[3-Hydroxyanilino]-6,7-Dimethoxyquinazoline",SmallMoleculeDrug,P24941,Cyclin-dependent kinase 2,CDK2,298.0
9415,DB03367,PF-00356231,SmallMoleculeDrug,P39900,Macrophage metalloelastase,MMP12,470.0
9416,DB03368,"5-Methyl-5-(4-Phenoxy-Phenyl)-Pyrimidine-2,4,6-Trione",SmallMoleculeDrug,P08254,Stromelysin-1,MMP3,477.0
9418,DB03370,FR239087,SmallMoleculeDrug,P00813,Adenosine deaminase,ADA,363.0
9420,DB03372,"3-Mercapto-1-(1,3,4,9-Tetrahydro-B-Carbolin-2-Yl)-Propan-1-One",SmallMoleculeDrug,P60568,Interleukin-2,IL2,153.0
9421,DB03373,ZK-806711,SmallMoleculeDrug,P07477,Trypsin-1,PRSS1,247.0
9422,DB03374,"3,5-Diiodotyrosine",SmallMoleculeDrug,P61925,cAMP-dependent protein kinase inhibitor alpha,PKIA,76.0
9423,DB03374,"3,5-Diiodotyrosine",SmallMoleculeDrug,P17612,cAMP-dependent protein kinase catalytic subunit alpha,PRKACA,351.0
9425,DB03374,"3,5-Diiodotyrosine",SmallMoleculeDrug,P07477,Trypsin-1,PRSS1,247.0
9427,DB03374,"3,5-Diiodotyrosine",SmallMoleculeDrug,Q6PHW0,Iodotyrosine deiodinase 1,IYD,289.0
9428,DB03376,'5'-O-(N-(L-Alanyl)-Sulfamoyl)Adenosine,SmallMoleculeDrug,P07814,Bifunctional glutamate/proline--tRNA ligase,EPRS,1512.0
9429,DB03379,2-Carboxyethylphosphonic Acid,SmallMoleculeDrug,P60174,Triosephosphate isomerase,TPI1,286.0
9430,DB03380,L-Tyrosinamide,SmallMoleculeDrug,P01303,Pro-neuropeptide Y,NPY,97.0
9431,DB03380,L-Tyrosinamide,SmallMoleculeDrug,Q86WA6,Valacyclovir hydrolase,BPHL,291.0
9432,DB03381,Hexadecanal,SmallMoleculeDrug,P08100,Rhodopsin,RHO,348.0
9433,DB03381,Hexadecanal,SmallMoleculeDrug,P07108,Acyl-CoA-binding protein,DBI,87.0
9435,DB03382,S-Oxy Cysteine,SmallMoleculeDrug,P48147,Prolyl endopeptidase,PREP,710.0
9439,DB03382,S-Oxy Cysteine,SmallMoleculeDrug,P00441,Superoxide dismutase [Cu-Zn],SOD1,154.0
9441,DB03383,5-Chloro-1h-Indole-2-Carboxylic Acid [1-(4-Fluorobenzyl)-2-(4-Hydroxypiperidin-1yl)-2-Oxoethyl]Amide,SmallMoleculeDrug,P11217,"Glycogen phosphorylase, muscle form",PYGM,842.0
9442,DB03384,Fica,SmallMoleculeDrug,P55210,Caspase-7,CASP7,303.0
9443,DB03385,4-Methylimidazole,SmallMoleculeDrug,P00918,Carbonic anhydrase 2,CA2,260.0
9444,DB03385,4-Methylimidazole,SmallMoleculeDrug,P02144,Myoglobin,MB,154.0
9445,DB03385,4-Methylimidazole,SmallMoleculeDrug,P35218,"Carbonic anhydrase 5A, mitochondrial",CA5A,305.0
9460,DB03389,alpha-D-Xylopyranose,SmallMoleculeDrug,P09848,Lactase-phlorizin hydrolase,LCT,1927.0
9463,DB03390,N-Propyl-Tartramic Acid,SmallMoleculeDrug,P15309,Prostatic acid phosphatase,ACPP,386.0
9464,DB03392,"(3,4,5-Trihydroxy-6-Hydroxymethyl-Tetrahydro-Pyran-2-Yl)-Phosphoramidic Acid Dimethyl Ester",SmallMoleculeDrug,P11217,"Glycogen phosphorylase, muscle form",PYGM,842.0
9465,DB03393,"(3s,6s,9r,10r,11s,12s,13e,15e,18s,21s)-18-{(1e,3e,7s,8s)-9-[(2s,3r,4s,5s,6r,9s,11s)-9-Ethyl-4-Hydroxy-3,5,11-Trimethyl-8-Oxo-1-Oxa-7-Azaspiro[5.5]Undec-2-Yl]-8-Hydroxy-1,7-Dimethylnona-1,3-Dienyl}-10,12-Dihydroxy-3-(3-Hydroxybenzyl)-6-Isopropyl-11-Methyl-",SmallMoleculeDrug,P62937,Peptidyl-prolyl cis-trans isomerase A,PPIA,165.0
9466,DB03395,Enalkiren,SmallMoleculeDrug,P00797,Renin,REN,406.0
9467,DB03396,"(E)-(2r,3r,4s,5r)-3,4,5-Trihydroxy-2-Methoxy-8,8-Dimethyl-Non-6-Enoic Acid ((3s,6r)-6-Hydroxy-2-Oxo-Azepan-3-Yl)-Amide",SmallMoleculeDrug,P50579,Methionine aminopeptidase 2,METAP2,478.0
9469,DB03397,Uridine-Diphosphate-N-Acetylglucosamine,SmallMoleculeDrug,Q16222,UDP-N-acetylhexosamine pyrophosphorylase,UAP1,522.0
9471,DB03397,Uridine-Diphosphate-N-Acetylglucosamine,SmallMoleculeDrug,Q14376,UDP-glucose 4-epimerase,GALE,348.0
9474,DB03397,Uridine-Diphosphate-N-Acetylglucosamine,SmallMoleculeDrug,Q9UBQ6,Exostosin-like 2,EXTL2,330.0
9475,DB03397,Uridine-Diphosphate-N-Acetylglucosamine,SmallMoleculeDrug,P26572,"Alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase",MGAT1,445.0
9476,DB03399,Ethyl Isocyanide,SmallMoleculeDrug,P02144,Myoglobin,MB,154.0
9478,DB03401,"D-Myo-Inositol-1,4,5-Triphosphate",SmallMoleculeDrug,Q99418,Cytohesin-2,CYTH2,400.0
9479,DB03401,"D-Myo-Inositol-1,4,5-Triphosphate",SmallMoleculeDrug,Q9Y6I3,Epsin-1,EPN1,576.0
9480,DB03401,"D-Myo-Inositol-1,4,5-Triphosphate",SmallMoleculeDrug,P51178,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-1",PLCD1,756.0
9481,DB03401,"D-Myo-Inositol-1,4,5-Triphosphate",SmallMoleculeDrug,P35241,Radixin,RDX,583.0
9482,DB03401,"D-Myo-Inositol-1,4,5-Triphosphate",SmallMoleculeDrug,Q01082,"Spectrin beta chain, non-erythrocytic 1",SPTBN1,2364.0
9483,DB03401,"D-Myo-Inositol-1,4,5-Triphosphate",SmallMoleculeDrug,Q14643,"Inositol 1,4,5-trisphosphate receptor type 1",ITPR1,2758.0
9484,DB03401,"D-Myo-Inositol-1,4,5-Triphosphate",SmallMoleculeDrug,P23677,Inositol-trisphosphate 3-kinase A,ITPKA,461.0
9486,DB03403,Cytidine-5'-Monophosphate,SmallMoleculeDrug,P30085,UMP-CMP kinase,CMPK1,196.0
9489,DB03403,Cytidine-5'-Monophosphate,SmallMoleculeDrug,Q9BZX2,Uridine-cytidine kinase 2,UCK2,261.0
9494,DB03405,1-[N[(Phenylmethoxy)Carbonyl]-L-Leucyl-4-[[N/N-[(Phenylmethoxy)Carbonyl]-/Nl-Leucyl]Amino]-3-Pyrrolidinone/N,SmallMoleculeDrug,P43235,Cathepsin K,CTSK,329.0
9495,DB03408,gamma-Glutamylcysteine,SmallMoleculeDrug,P48637,Glutathione synthetase,GSS,474.0
9499,DB03413,Deoxyuridine-5'-Diphosphate,SmallMoleculeDrug,P33316,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",DUT,252.0
9504,DB03414,5-Thio-a/B-D-Mannopyranosylamine,SmallMoleculeDrug,Q16706,Alpha-mannosidase 2,MAN2A1,1144.0
9505,DB03415,3-Thiaoctanoyl-Coenzyme A,SmallMoleculeDrug,P11310,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",ACADM,421.0
9507,DB03417,1-(4-Tert-Butylcarbamoyl-Piperazine-1-Carbonyl)-3-(3-Guanidino-Propyl)-4-Oxo-Azetidine-2-Carboxylic Acid,SmallMoleculeDrug,P07477,Trypsin-1,PRSS1,247.0
9511,DB03419,Uracil,SmallMoleculeDrug,Q12882,Dihydropyrimidine dehydrogenase [NADP(+)],DPYD,1025.0
9512,DB03419,Uracil,SmallMoleculeDrug,Q9NWZ5,Uridine-cytidine kinase-like 1,UCKL1,548.0
9518,DB03424,Ubenimex,SmallMoleculeDrug,P09960,Leukotriene A-4 hydrolase,LTA4H,611.0
9520,DB03425,"2s,4r-4-Methylglutamate",SmallMoleculeDrug,Q13002,"Glutamate receptor ionotropic, kainate 2",GRIK2,908.0
9521,DB03428,SU9516,SmallMoleculeDrug,Q00535,Cyclin-dependent-like kinase 5,CDK5,292.0
9522,DB03428,SU9516,SmallMoleculeDrug,P06493,Cyclin-dependent kinase 1,CDK1,297.0
9523,DB03428,SU9516,SmallMoleculeDrug,P24941,Cyclin-dependent kinase 2,CDK2,298.0
9524,DB03429,Cardiolipin,SmallMoleculeDrug,P12235,ADP/ATP translocase 1,SLC25A4,298.0
9525,DB03430,(2s)-Hydroxy(4-Hydroxyphenyl)Ethanenitrile,SmallMoleculeDrug,Q6UWM7,Lactase-like protein,LCTL,567.0
9528,DB03434,3[N-Morpholino]Propane Sulfonic Acid,SmallMoleculeDrug,P22749,Granulysin,GNLY,145.0
9530,DB03435,Uridine-5'-Diphosphate,SmallMoleculeDrug,Q9UBQ6,Exostosin-like 2,EXTL2,330.0
9531,DB03435,Uridine-5'-Diphosphate,SmallMoleculeDrug,Q7Z4J2,Glycosyltransferase 6 domain-containing protein 1,GLT6D1,308.0
9533,DB03435,Uridine-5'-Diphosphate,SmallMoleculeDrug,P30085,UMP-CMP kinase,CMPK1,196.0
9536,DB03435,Uridine-5'-Diphosphate,SmallMoleculeDrug,O94766,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,B3GAT3,335.0
9538,DB03435,Uridine-5'-Diphosphate,SmallMoleculeDrug,P16442,Histo-blood group ABO system transferase,ABO,354.0
9541,DB03435,Uridine-5'-Diphosphate,SmallMoleculeDrug,Q9P2W7,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 1,B3GAT1,334.0
9544,DB03435,Uridine-5'-Diphosphate,SmallMoleculeDrug,P46976,Glycogenin-1,GYG1,350.0
9547,DB03439,"4,6-Dideoxy-4-Amino-Alpha-D-Glucose",SmallMoleculeDrug,P04745,Alpha-amylase 1,AMY1A,511.0
9548,DB03439,"4,6-Dideoxy-4-Amino-Alpha-D-Glucose",SmallMoleculeDrug,P04746,Pancreatic alpha-amylase,AMY2A,511.0
9550,DB03441,2-Benzyl-3-Iodopropanoic Acid,SmallMoleculeDrug,P15085,Carboxypeptidase A1,CPA1,419.0
9551,DB03442,2-[5-Hydroxy-3-Methyl-1-(2-Methyl-4-Sulfo-Phenyl)-1h-Pyrazol-4-Ylazo]-4-Sulfo-Benzoic Acid,SmallMoleculeDrug,P31939,Bifunctional purine biosynthesis protein PURH,ATIC,592.0
9552,DB03443,Bis(5-Amidino-Benzimidazolyl)Methanone Zinc,SmallMoleculeDrug,P07477,Trypsin-1,PRSS1,247.0
9553,DB03444,"(3e)-6'-Bromo-2,3'-Biindole-2',3(1h,1'h)-Dione 3-Oxime",SmallMoleculeDrug,P49841,Glycogen synthase kinase-3 beta,GSK3B,420.0
9556,DB03447,Uridylyl-2'-5'-Phospho-Adenosine,SmallMoleculeDrug,P07998,Ribonuclease pancreatic,RNASE1,156.0
9557,DB03448,2'-Deoxyuridine 3'-Monophosphate,SmallMoleculeDrug,P34096,Ribonuclease 4,RNASE4,147.0
9558,DB03448,2'-Deoxyuridine 3'-Monophosphate,SmallMoleculeDrug,P07998,Ribonuclease pancreatic,RNASE1,156.0
9559,DB03449,N-(4-(2-((3-Chlorophenylmethyl)Amino)Ethyl)Phenyl)-2-Thiophecarboxamidine,SmallMoleculeDrug,P35228,"Nitric oxide synthase, inducible",NOS2,1153.0
9560,DB03449,N-(4-(2-((3-Chlorophenylmethyl)Amino)Ethyl)Phenyl)-2-Thiophecarboxamidine,SmallMoleculeDrug,P29475,"Nitric oxide synthase, brain",NOS1,1434.0
9563,DB03451,"1-alpha, 25-dihydroxyl-20-epi-22-oxa-24, 26 ,27-trihomovitamin D3",SmallMoleculeDrug,P11473,Vitamin D3 receptor,VDR,427.0
9565,DB03453,(R)N[2-[1-(aminoiminomethyl)-3-piperidinyl]-1-oxoethyl]-4-(phenylethynyl)-l-phenylalanine methylester,SmallMoleculeDrug,P60568,Interleukin-2,IL2,153.0
9567,DB03455,(1H-indol-3-yl)-(2-mercapto-ethoxyimino)-acetic acid,SmallMoleculeDrug,P60568,Interleukin-2,IL2,153.0
9568,DB03456,N2-[(benzyloxy)carbonyl]-n1-[(3S)-1-cyanopyrrolidin-3-yl]-l-leucinamide,SmallMoleculeDrug,P43235,Cathepsin K,CTSK,329.0
9570,DB03459,Sparfosic acid,SmallMoleculeDrug,P27708,CAD protein,CAD,2225.0
9571,DB03461,2'-Monophosphoadenosine 5'-Diphosphoribose,SmallMoleculeDrug,P00325,Alcohol dehydrogenase 1B,ADH1B,375.0
9572,DB03461,2'-Monophosphoadenosine 5'-Diphosphoribose,SmallMoleculeDrug,P16435,NADPH--cytochrome P450 reductase,POR,677.0
9578,DB03461,2'-Monophosphoadenosine 5'-Diphosphoribose,SmallMoleculeDrug,P48163,NADP-dependent malic enzyme,ME1,572.0
9582,DB03461,2'-Monophosphoadenosine 5'-Diphosphoribose,SmallMoleculeDrug,P15121,Aldose reductase,AKR1B1,316.0
9584,DB03461,2'-Monophosphoadenosine 5'-Diphosphoribose,SmallMoleculeDrug,P52895,Aldo-keto reductase family 1 member C2,AKR1C2,323.0
9585,DB03461,2'-Monophosphoadenosine 5'-Diphosphoribose,SmallMoleculeDrug,P14061,Estradiol 17-beta-dehydrogenase 1,HSD17B1,328.0
9586,DB03461,2'-Monophosphoadenosine 5'-Diphosphoribose,SmallMoleculeDrug,Q13423,"NAD(P) transhydrogenase, mitochondrial",NNT,1086.0
9587,DB03461,2'-Monophosphoadenosine 5'-Diphosphoribose,SmallMoleculeDrug,P28845,Corticosteroid 11-beta-dehydrogenase isozyme 1,HSD11B1,292.0
9588,DB03461,2'-Monophosphoadenosine 5'-Diphosphoribose,SmallMoleculeDrug,P35270,Sepiapterin reductase,SPR,261.0
9590,DB03461,2'-Monophosphoadenosine 5'-Diphosphoribose,SmallMoleculeDrug,Q7Z4W1,L-xylulose reductase,DCXR,244.0
9591,DB03461,2'-Monophosphoadenosine 5'-Diphosphoribose,SmallMoleculeDrug,O75874,Isocitrate dehydrogenase [NADP] cytoplasmic,IDH1,414.0
9593,DB03461,2'-Monophosphoadenosine 5'-Diphosphoribose,SmallMoleculeDrug,Q04828,Aldo-keto reductase family 1 member C1,AKR1C1,323.0
9594,DB03461,2'-Monophosphoadenosine 5'-Diphosphoribose,SmallMoleculeDrug,P29475,"Nitric oxide synthase, brain",NOS1,1434.0
9595,DB03461,2'-Monophosphoadenosine 5'-Diphosphoribose,SmallMoleculeDrug,P11413,Glucose-6-phosphate 1-dehydrogenase,G6PD,515.0
9596,DB03461,2'-Monophosphoadenosine 5'-Diphosphoribose,SmallMoleculeDrug,P00374,Dihydrofolate reductase,DHFR,187.0
9598,DB03461,2'-Monophosphoadenosine 5'-Diphosphoribose,SmallMoleculeDrug,P11586,"C-1-tetrahydrofolate synthase, cytoplasmic",MTHFD1,935.0
9599,DB03461,2'-Monophosphoadenosine 5'-Diphosphoribose,SmallMoleculeDrug,P42330,Aldo-keto reductase family 1 member C3,AKR1C3,323.0
9600,DB03461,2'-Monophosphoadenosine 5'-Diphosphoribose,SmallMoleculeDrug,P30043,Flavin reductase (NADPH),BLVRB,206.0
9603,DB03461,2'-Monophosphoadenosine 5'-Diphosphoribose,SmallMoleculeDrug,Q08257,Quinone oxidoreductase,CRYZ,329.0
9604,DB03461,2'-Monophosphoadenosine 5'-Diphosphoribose,SmallMoleculeDrug,Q6UWP2,Dehydrogenase/reductase SDR family member 11,DHRS11,260.0
9605,DB03461,2'-Monophosphoadenosine 5'-Diphosphoribose,SmallMoleculeDrug,P04035,3-hydroxy-3-methylglutaryl-coenzyme A reductase,HMGCR,888.0
9606,DB03461,2'-Monophosphoadenosine 5'-Diphosphoribose,SmallMoleculeDrug,P40925,"Malate dehydrogenase, cytoplasmic",MDH1,334.0
9609,DB03461,2'-Monophosphoadenosine 5'-Diphosphoribose,SmallMoleculeDrug,Q92506,Estradiol 17-beta-dehydrogenase 8,HSD17B8,261.0
9610,DB03461,2'-Monophosphoadenosine 5'-Diphosphoribose,SmallMoleculeDrug,P14550,Alcohol dehydrogenase [NADP(+)],AKR1A1,325.0
9612,DB03461,2'-Monophosphoadenosine 5'-Diphosphoribose,SmallMoleculeDrug,Q16698,"2,4-dienoyl-CoA reductase, mitochondrial",DECR1,335.0
9619,DB03461,2'-Monophosphoadenosine 5'-Diphosphoribose,SmallMoleculeDrug,P22570,"NADPH:adrenodoxin oxidoreductase, mitochondrial",FDXR,491.0
9624,DB03461,2'-Monophosphoadenosine 5'-Diphosphoribose,SmallMoleculeDrug,Q14914,Prostaglandin reductase 1,PTGR1,329.0
9626,DB03461,2'-Monophosphoadenosine 5'-Diphosphoribose,SmallMoleculeDrug,O60218,Aldo-keto reductase family 1 member B10,AKR1B10,316.0
9629,DB03461,2'-Monophosphoadenosine 5'-Diphosphoribose,SmallMoleculeDrug,P0CG22,Putative dehydrogenase/reductase SDR family member 4-like 1,DHRS4L1,281.0
9634,DB03465,2-Phospho-D-Glyceric Acid,SmallMoleculeDrug,P13929,Beta-enolase,ENO3,434.0
9635,DB03466,BMS184394,SmallMoleculeDrug,P13631,Retinoic acid receptor gamma,RARG,454.0
9637,DB03468,"1,2,3,4-Tetrahydro-Isoquinoline-7-Sulfonic Acid Amide",SmallMoleculeDrug,P11086,Phenylethanolamine N-methyltransferase,PNMT,282.0
9641,DB03471,6-Phenyl-4(R)-(7-Phenyl-Heptanoylamino)-Hexanoic Acid,SmallMoleculeDrug,P14555,"Phospholipase A2, membrane associated",PLA2G2A,144.0
9646,DB03476,Trans-6-(2-Phenylcyclopropyl)-Naphthalene-2-Carboxamidine,SmallMoleculeDrug,P00749,Urokinase-type plasminogen activator,PLAU,431.0
9647,DB03477,1-Phenylsulfonamide-3-Trifluoromethyl-5-Parabromophenylpyrazole,SmallMoleculeDrug,P35354,Prostaglandin G/H synthase 2,PTGS2,604.0
9648,DB03478,2'-O-Acetyl Adenosine-5-Diphosphoribose,SmallMoleculeDrug,Q9NXA8,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",SIRT5,310.0
9649,DB03479,"8,9,10-Trihydroxy-7-Hydroxymethyl-3-Methyl-6-Oxa-1,3-Diaza-Spiro[4.5]Decane-2,4-Dione",SmallMoleculeDrug,P11217,"Glycogen phosphorylase, muscle form",PYGM,842.0
9650,DB03480,Brequinar Analog,SmallMoleculeDrug,Q02127,"Dihydroorotate dehydrogenase (quinone), mitochondrial",DHODH,395.0
9653,DB03483,4-Benzoylamino-4-{1-{1-Carbamoyl-2-[4-(Difluoro-Phosphono-Methyl)-Phenyl]-Ethylcarbamoyl}-2-[4-(Difluoro-Phosphono-Methyl)-Phenyl]-Ethylcarbamoyl}-Butyric Acid,SmallMoleculeDrug,P18031,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,435.0
9654,DB03484,L-Alpha-Glycerophosphorylethanolamine,SmallMoleculeDrug,P08758,Annexin A5,ANXA5,320.0
9655,DB03485,Alpha-D-Fucose,SmallMoleculeDrug,P02788,Lactotransferrin,LTF,710.0
9657,DB03486,Phosphomethylphosphonic Acid Guanosyl Ester,SmallMoleculeDrug,Q8WVQ1,Soluble calcium-activated nucleotidase 1,CANT1,401.0
9658,DB03487,3-Aminosuccinimide,SmallMoleculeDrug,P61626,Lysozyme C,LYZ,148.0
9662,DB03490,"3-Pyridin-4-Yl-2,4-Dihydro-Indeno[1,2-.C.]Pyrazole",SmallMoleculeDrug,P24941,Cyclin-dependent kinase 2,CDK2,298.0
9663,DB03491,2'-Deoxyguanosine-5'-Diphosphate,SmallMoleculeDrug,P15531,Nucleoside diphosphate kinase A,NME1,152.0
9666,DB03494,CRA_10950,SmallMoleculeDrug,P07477,Trypsin-1,PRSS1,247.0
9667,DB03495,"4,6-Dideoxy-4-{[4,5,6-Trihydroxy-3-(Hydroxymethyl)Cyclohex-2-En-1-Yl]Amino}-Alpha-D-Lyxo-Hexopyranosyl-(1->4)-Alpha-D-Threo-Hexopyranosyl-(1->6)-Alpha-L-Threo-Hexopyranose",SmallMoleculeDrug,P04746,Pancreatic alpha-amylase,AMY2A,511.0
9668,DB03496,Flavopiridol,SmallMoleculeDrug,P24941,Cyclin-dependent kinase 2,CDK2,298.0
9669,DB03496,Flavopiridol,SmallMoleculeDrug,Q00535,Cyclin-dependent-like kinase 5,CDK5,292.0
9670,DB03496,Flavopiridol,SmallMoleculeDrug,P50750,Cyclin-dependent kinase 9,CDK9,372.0
9671,DB03496,Flavopiridol,SmallMoleculeDrug,P06493,Cyclin-dependent kinase 1,CDK1,297.0
9672,DB03496,Flavopiridol,SmallMoleculeDrug,Q00534,Cyclin-dependent kinase 6,CDK6,326.0
9673,DB03496,Flavopiridol,SmallMoleculeDrug,P00533,Epidermal growth factor receptor,EGFR,1210.0
9674,DB03496,Flavopiridol,SmallMoleculeDrug,P11802,Cyclin-dependent kinase 4,CDK4,303.0
9675,DB03496,Flavopiridol,SmallMoleculeDrug,P49336,Cyclin-dependent kinase 8,CDK8,464.0
9676,DB03496,Flavopiridol,SmallMoleculeDrug,P50613,Cyclin-dependent kinase 7,CDK7,346.0
9677,DB03496,Flavopiridol,SmallMoleculeDrug,P11217,"Glycogen phosphorylase, muscle form",PYGM,842.0
9682,DB03499,Malate Ion,SmallMoleculeDrug,P23368,"NAD-dependent malic enzyme, mitochondrial",ME2,584.0
9683,DB03499,Malate Ion,SmallMoleculeDrug,O75390,"Citrate synthase, mitochondrial",CS,466.0
9686,DB03501,Galactose-uridine-5'-diphosphate,SmallMoleculeDrug,P15291,"Beta-1,4-galactosyltransferase 1",B4GALT1,398.0
9687,DB03501,Galactose-uridine-5'-diphosphate,SmallMoleculeDrug,P16442,Histo-blood group ABO system transferase,ABO,354.0
9688,DB03501,Galactose-uridine-5'-diphosphate,SmallMoleculeDrug,Q14376,UDP-glucose 4-epimerase,GALE,348.0
9691,DB03504,"9-Butyl-8-(2-Chloro-3,4,5-Trimethoxy-Benzyl)-9h-Purin-6-Ylamine",SmallMoleculeDrug,P07900,Heat shock protein HSP 90-alpha,HSP90AA1,732.0
9693,DB03506,9-Deazaadenine,SmallMoleculeDrug,P07741,Adenine phosphoribosyltransferase,APRT,180.0
9694,DB03507,"6-[3-(4-Morpholinyl)Propyl]-2-(3-Nitrophenyl)-5-Thioxo-5,6,-Dihydro-7h-Thienol[2',3':4,5]Pyrrolo[1,2-C]Imidazol-7-One",SmallMoleculeDrug,P19438,Tumor necrosis factor receptor superfamily member 1A,TNFRSF1A,455.0
9695,DB03509,2-(4-Chlorophenyl)-5-Quinoxalinecarboxamide,SmallMoleculeDrug,P09874,Poly [ADP-ribose] polymerase 1,PARP1,1014.0
9696,DB03510,6-O-Phosphoryl Inosine Monophosphate,SmallMoleculeDrug,Q8N142,Adenylosuccinate synthetase isozyme 1,ADSSL1,457.0
9698,DB03512,"Uridine-2',3'-Vanadate",SmallMoleculeDrug,P07998,Ribonuclease pancreatic,RNASE1,156.0
9701,DB03516,Eniluracil,SmallMoleculeDrug,Q12882,Dihydropyrimidine dehydrogenase [NADP(+)],DPYD,1025.0
9702,DB03516,Eniluracil,SmallMoleculeDrug,Q06278,Aldehyde oxidase,AOX1,1338.0
9703,DB03516,Eniluracil,SmallMoleculeDrug,P47989,Xanthine dehydrogenase/oxidase,XDH,1333.0
9706,DB03519,2-Amino-Pentanoic Acid,SmallMoleculeDrug,P00480,"Ornithine carbamoyltransferase, mitochondrial",OTC,354.0
9708,DB03523,"6-Fluoro-2-(2'-Fluoro-1,1'-Biphenyl-4-Yl)-3-Methylquinoline-4-Carboxylic Acid",SmallMoleculeDrug,Q02127,"Dihydroorotate dehydrogenase (quinone), mitochondrial",DHODH,395.0
9710,DB03525,RU79073,SmallMoleculeDrug,P12931,Proto-oncogene tyrosine-protein kinase Src,SRC,536.0
9711,DB03526,AL5927,SmallMoleculeDrug,P00918,Carbonic anhydrase 2,CA2,260.0
9715,DB03531,Flavin-Adenine Dinucleotide-N5-Isobutyl Ketone,SmallMoleculeDrug,P14920,D-amino-acid oxidase,DAO,347.0
9719,DB03535,Z-Pro-Prolinal,SmallMoleculeDrug,P48147,Prolyl endopeptidase,PREP,710.0
9722,DB03536,Benzoyl-Arginine-Alanine-Methyl Ketone,SmallMoleculeDrug,Q9UBX1,Cathepsin F,CTSF,484.0
9723,DB03539,2-(Acetylamino)-2-Deoxy-6-O-Methyl-Alpha-D-Allopyranose,SmallMoleculeDrug,Q13231,Chitotriosidase-1,CHIT1,466.0
9728,DB03541,"10-Propargyl-5,8-Dideazafolic Acid",SmallMoleculeDrug,P16083,Ribosyldihydronicotinamide dehydrogenase [quinone],NQO2,231.0
9729,DB03541,"10-Propargyl-5,8-Dideazafolic Acid",SmallMoleculeDrug,P04818,Thymidylate synthase,TYMS,313.0
9730,DB03541,"10-Propargyl-5,8-Dideazafolic Acid",SmallMoleculeDrug,P0CG22,Putative dehydrogenase/reductase SDR family member 4-like 1,DHRS4L1,281.0
9731,DB03542,L-Myo-Inositol-1-Phosphate,SmallMoleculeDrug,P29218,Inositol monophosphatase 1,IMPA1,277.0
9736,DB03546,10-CF3C(OH)2-DDACTHF,SmallMoleculeDrug,P22102,Trifunctional purine biosynthetic protein adenosine-3,GART,1010.0
9739,DB03551,"4'-Deaza-1'-Aza-2'-Deoxy-1'-(9-Methylene)-Immucillin-H, (3r,4r)-N-[9-Deazahypoxanthin-9-Yl)Methyl]-4-Hydroxymethyl-Pyrrolidin-3-Ol",SmallMoleculeDrug,P00491,Purine nucleoside phosphorylase,PNP,289.0
9741,DB03552,Meta-Tyrosine,SmallMoleculeDrug,P07101,Tyrosine 3-monooxygenase,TH,528.0
9745,DB03554,5-Iodouracil,SmallMoleculeDrug,Q12882,Dihydropyrimidine dehydrogenase [NADP(+)],DPYD,1025.0
9746,DB03555,CRA_11092,SmallMoleculeDrug,P07477,Trypsin-1,PRSS1,247.0
9747,DB03556,"2-(2-{2-[2-(2-{2-[2-(2-Ethoxy-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethanol, Polyethyleneglycol Peg400",SmallMoleculeDrug,P16152,Carbonyl reductase [NADPH] 1,CBR1,277.0
9749,DB03557,N-{1-[5-(1-Carbamoyl-2-Mercapto-Ethylcarbamoyl)-Pentylcarbamoyl]-2-[4-(Difluoro-Phosphono-Methyl)-Phenyl]-Ethyl}-3-{2-[4-(Difluoro-Phosphono-Methyl)-Phenyl]-Acetylamino}-Succinamic Acid,SmallMoleculeDrug,P18031,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,435.0
9751,DB03559,Cyclohexylformamide,SmallMoleculeDrug,P00326,Alcohol dehydrogenase 1C,ADH1C,375.0
9752,DB03559,Cyclohexylformamide,SmallMoleculeDrug,P08319,Alcohol dehydrogenase 4,ADH4,380.0
9756,DB03565,1-O-Octyl-2-Heptylphosphonyl-Sn-Glycero-3-Phosphoethanolamine,SmallMoleculeDrug,P04054,Phospholipase A2,PLA2G1B,148.0
9758,DB03566,Spermidine,SmallMoleculeDrug,Q16881,"Thioredoxin reductase 1, cytoplasmic",TXNRD1,649.0
9760,DB03568,Butyric Acid,SmallMoleculeDrug,P06276,Cholinesterase,BCHE,602.0
9768,DB03572,FR230513,SmallMoleculeDrug,P00813,Adenosine deaminase,ADA,363.0
9770,DB03573,WRR-99,SmallMoleculeDrug,Q9UBX1,Cathepsin F,CTSF,484.0
9772,DB03575,Phencyclidine,SmallMoleculeDrug,Q8TCU5,"Glutamate receptor ionotropic, NMDA 3A",GRIN3A,1115.0
9773,DB03575,Phencyclidine,SmallMoleculeDrug,Q99720,Sigma non-opioid intracellular receptor 1,SIGMAR1,223.0
9775,DB03577,Alpha-Benzyl-Aminobenzyl-Phosphonic Acid,SmallMoleculeDrug,P15309,Prostatic acid phosphatase,ACPP,386.0
9777,DB03581,Glucose-6-Phosphate,SmallMoleculeDrug,P06744,Glucose-6-phosphate isomerase,GPI,558.0
9779,DB03583,"(2e,3s)-3-Hydroxy-5'-[(4-Hydroxypiperidin-1-Yl)Sulfonyl]-3-Methyl-1,3-Dihydro-2,3'-Biindol-2'(1'h)-One",SmallMoleculeDrug,P24941,Cyclin-dependent kinase 2,CDK2,298.0
9784,DB03585,Oxyphenbutazone,SmallMoleculeDrug,Q9NZK7,Group IIE secretory phospholipase A2,PLA2G2E,142.0
9786,DB03587,Pyruvoyl Group,SmallMoleculeDrug,P04054,Phospholipase A2,PLA2G1B,148.0
9787,DB03588,Diphenylacetic Acid,SmallMoleculeDrug,P07858,Cathepsin B,CTSB,339.0
9788,DB03589,Alpha-Ketomalonic Acid,SmallMoleculeDrug,P23368,"NAD-dependent malic enzyme, mitochondrial",ME2,584.0
9791,DB03591,RU82209,SmallMoleculeDrug,P12931,Proto-oncogene tyrosine-protein kinase Src,SRC,536.0
9794,DB03593,N7-Methyl-Guanosine-5'-Monophosphate,SmallMoleculeDrug,Q96C86,m7GpppX diphosphatase,DCPS,337.0
9795,DB03594,"1,2,4-Triazole",SmallMoleculeDrug,P00918,Carbonic anhydrase 2,CA2,260.0
9796,DB03595,CRA_9785,SmallMoleculeDrug,P07477,Trypsin-1,PRSS1,247.0
9797,DB03596,N-[2-(1h-Indol-5-Yl)-Butyl]-4-Sulfamoyl-Benzamide,SmallMoleculeDrug,P00918,Carbonic anhydrase 2,CA2,260.0
9798,DB03597,Gamma-Glutamyl[S-(2-Iodobenzyl)Cysteinyl]Glycine,SmallMoleculeDrug,O76083,"High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A",PDE9A,593.0
9799,DB03597,Gamma-Glutamyl[S-(2-Iodobenzyl)Cysteinyl]Glycine,SmallMoleculeDrug,O76074,"cGMP-specific 3',5'-cyclic phosphodiesterase",PDE5A,875.0
9800,DB03597,Gamma-Glutamyl[S-(2-Iodobenzyl)Cysteinyl]Glycine,SmallMoleculeDrug,Q03013,Glutathione S-transferase Mu 4,GSTM4,218.0
9801,DB03598,"Al-6629, [2h-Thieno[3,2-E]-1,2-Thiazine-6-Sulfonamide,2-(3-Methoxyphenyl)-3-(4-Morpholinyl)-, 1,1-Dioxide]",SmallMoleculeDrug,P00918,Carbonic anhydrase 2,CA2,260.0
9803,DB03600,Decanoic Acid,SmallMoleculeDrug,P09958,Furin,FURIN,794.0
9805,DB03600,Decanoic Acid,SmallMoleculeDrug,Q9NZD2,Glycolipid transfer protein,GLTP,209.0
9808,DB03602,S-Benzyl-Glutathione,SmallMoleculeDrug,P08263,Glutathione S-transferase A1,GSTA1,222.0
9809,DB03602,S-Benzyl-Glutathione,SmallMoleculeDrug,Q04760,Lactoylglutathione lyase,GLO1,184.0
9811,DB03604,"[4-(4-Hydroxy-3-Iodo-Phenoxy)-3,5-Diiodo-Phenyl]-Acetic Acid",SmallMoleculeDrug,P10828,Thyroid hormone receptor beta,THRB,461.0
9813,DB03606,(S)-Rolipram,SmallMoleculeDrug,Q08499,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",PDE4D,809.0
9814,DB03606,(S)-Rolipram,SmallMoleculeDrug,Q07343,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B",PDE4B,736.0
9816,DB03608,Diminazene,SmallMoleculeDrug,P30044,"Peroxiredoxin-5, mitochondrial",PRDX5,214.0
9818,DB03608,Diminazene,SmallMoleculeDrug,P07477,Trypsin-1,PRSS1,247.0
9819,DB03608,Diminazene,SmallMoleculeDrug,P19801,Amiloride-sensitive amine oxidase [copper-containing],AOC1,751.0
9820,DB03609,3-Deoxyguanosine,SmallMoleculeDrug,P00491,Purine nucleoside phosphorylase,PNP,289.0
9821,DB03611,L-2-Amino-4-Methoxy-Cis-but-3-Enoic Acid,SmallMoleculeDrug,Q00266,S-adenosylmethionine synthase isoform type-1,MAT1A,395.0
9822,DB03612,3-Hydroxybutyryl-Coenzyme A,SmallMoleculeDrug,Q16836,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",HADH,314.0
9828,DB03615,Ribostamycin,SmallMoleculeDrug,P07237,Protein disulfide-isomerase,P4HB,508.0
9830,DB03616,Kabiramide C,SmallMoleculeDrug,P68133,"Actin, alpha skeletal muscle",ACTA1,377.0
9833,DB03619,Deoxycholic Acid,SmallMoleculeDrug,Q7Z2Z2,Elongation factor Tu GTP-binding domain-containing protein 1,EFL1,1120.0
9839,DB03621,"L-709,587",SmallMoleculeDrug,P62942,Peptidyl-prolyl cis-trans isomerase FKBP1A,FKBP1A,108.0
9840,DB03622,"2-Hydroxy-5-[4-(2-Hydroxy-Ethyl)-Piperidin-1-Yl]-5-Phenyl-1h-Pyrimidine-4,6-Dione",SmallMoleculeDrug,P22894,Neutrophil collagenase,MMP8,467.0
9841,DB03623,"9-(4-Hydroxyphenyl)-2,7-Phenanthroline",SmallMoleculeDrug,P53779,Mitogen-activated protein kinase 10,MAPK10,464.0
9844,DB03626,"5-Methoxy-1,2-Dimethyl-3-(Phenoxymethyl)Indole-4,7-Dione",SmallMoleculeDrug,P15559,NAD(P)H dehydrogenase [quinone] 1,NQO1,274.0
9846,DB03628,ISO24,SmallMoleculeDrug,P12931,Proto-oncogene tyrosine-protein kinase Src,SRC,536.0
9850,DB03632,Argifin,SmallMoleculeDrug,Q13231,Chitotriosidase-1,CHIT1,466.0
9851,DB03633,Lpc-Ether,SmallMoleculeDrug,P17900,Ganglioside GM2 activator,GM2A,193.0
9852,DB03633,Lpc-Ether,SmallMoleculeDrug,P04054,Phospholipase A2,PLA2G1B,148.0
9854,DB03635,Ethanesulfonic Acid,SmallMoleculeDrug,P02775,Platelet basic protein,PPBP,128.0
9855,DB03636,Glycinamid,SmallMoleculeDrug,P22894,Neutrophil collagenase,MMP8,467.0
9856,DB03637,Guanidine-3-Propanol,SmallMoleculeDrug,P35030,Trypsin-3,PRSS3,304.0
9857,DB03639,1-Guanidinium-7-Aminoheptane,SmallMoleculeDrug,P49366,Deoxyhypusine synthase,DHPS,369.0
9860,DB03642,Benzofuran-2-Carboxylic Acid {(S)-3-Methyl-1-[3-Oxo-1-(Pyridin-2-Ylsulfonyl)Azepan-4-Ylcarbamoyl]Butyl}Amide,SmallMoleculeDrug,P43235,Cathepsin K,CTSK,329.0
9861,DB03643,CRA_1144,SmallMoleculeDrug,P07477,Trypsin-1,PRSS1,247.0
9862,DB03643,CRA_1144,SmallMoleculeDrug,P05981,Serine protease hepsin,HPN,417.0
9864,DB03645,Phosphonoacetohydroxamic Acid,SmallMoleculeDrug,P13929,Beta-enolase,ENO3,434.0
9868,DB03650,(3e)-3-[(4-Hydroxyphenyl)Imino]-1h-Indol-2(3h)-One,SmallMoleculeDrug,P11309,Serine/threonine-protein kinase pim-1,PIM1,404.0
9875,DB03657,1-Deoxy-1-Methoxycarbamido-Beta-D-Glucopyranose,SmallMoleculeDrug,P11217,"Glycogen phosphorylase, muscle form",PYGM,842.0
9880,DB03660,4-Iodo-L-phenylalanine,SmallMoleculeDrug,P27487,Dipeptidyl peptidase 4,DPP4,766.0
9884,DB03661,Cysteinesulfonic Acid,SmallMoleculeDrug,P07711,Cathepsin L1,CTSL,333.0
9888,DB03661,Cysteinesulfonic Acid,SmallMoleculeDrug,Q9H4G4,Golgi-associated plant pathogenesis-related protein 1,GLIPR2,154.0
9892,DB03661,Cysteinesulfonic Acid,SmallMoleculeDrug,P18031,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,435.0
9896,DB03661,Cysteinesulfonic Acid,SmallMoleculeDrug,P30305,M-phase inducer phosphatase 2,CDC25B,580.0
9898,DB03663,"1-[(2-Amino-6,9-Dihydro-1h-Purin-6-Yl)Oxy]-3-Methyl-2-Butanol",SmallMoleculeDrug,P24941,Cyclin-dependent kinase 2,CDK2,298.0
9899,DB03664,P1-(Adenosine-5'-P5-(Uridine-5')Pentaphosphate,SmallMoleculeDrug,P30085,UMP-CMP kinase,CMPK1,196.0
9900,DB03666,3'-Azido-3'-Deoxythymidine-5'-Monophosphate,SmallMoleculeDrug,P23919,Thymidylate kinase,DTYMK,212.0
9902,DB03667,Acetic Acid Salicyloyl-Amino-Ester,SmallMoleculeDrug,P23219,Prostaglandin G/H synthase 1,PTGS1,599.0
9905,DB03670,"2-(Oxalyl-Amino)-4,5,6,7-Tetrahydro-Thieno[2,3-C]Pyridine-3-Carboxylic Acid",SmallMoleculeDrug,P18031,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,435.0
9906,DB03672,9-N-Phenylmethylamino-Tacrine,SmallMoleculeDrug,P06276,Cholinesterase,BCHE,602.0
9907,DB03673,Beta(2-Thienyl)Alanine,SmallMoleculeDrug,P00439,Phenylalanine-4-hydroxylase,PAH,452.0
9910,DB03677,N-Cyclohexyl-N'-Decylurea,SmallMoleculeDrug,P34913,Bifunctional epoxide hydrolase 2,EPHX2,555.0
9912,DB03680,Tartronate,SmallMoleculeDrug,P23368,"NAD-dependent malic enzyme, mitochondrial",ME2,584.0
9913,DB03680,Tartronate,SmallMoleculeDrug,Q16798,"NADP-dependent malic enzyme, mitochondrial",ME3,604.0
9914,DB03683,2-{[Formyl(Hydroxy)Amino]Methyl}-4-Methylpentanoic Acid,SmallMoleculeDrug,P14780,Matrix metalloproteinase-9,MMP9,707.0
9916,DB03685,Uridine-5'-Monophosphate,SmallMoleculeDrug,Q9NWZ5,Uridine-cytidine kinase-like 1,UCKL1,548.0
9919,DB03685,Uridine-5'-Monophosphate,SmallMoleculeDrug,Q7Z4J2,Glycosyltransferase 6 domain-containing protein 1,GLT6D1,308.0
9920,DB03685,Uridine-5'-Monophosphate,SmallMoleculeDrug,P62312,U6 snRNA-associated Sm-like protein LSm6,LSM6,80.0
9922,DB03685,Uridine-5'-Monophosphate,SmallMoleculeDrug,P15291,"Beta-1,4-galactosyltransferase 1",B4GALT1,398.0
9923,DB03685,Uridine-5'-Monophosphate,SmallMoleculeDrug,Q96AZ6,Interferon-stimulated gene 20 kDa protein,ISG20,181.0
9928,DB03686,S-(P-Nitrobenzyl)Glutathione,SmallMoleculeDrug,P09211,Glutathione S-transferase P,GSTP1,210.0
9933,DB03690,"(Z,Z)-4-Hydroxy-N,N,N-Trimethyl-10-Oxo-7-[(1-Oxo-9-Octadecenyl)Oxy]-3,5,9-Trioxa-4-Phosphaheptacos-18-En-1-Aminium-4-Oxide",SmallMoleculeDrug,Q00169,Phosphatidylinositol transfer protein alpha isoform,PITPNA,270.0
9935,DB03691,WRR-112,SmallMoleculeDrug,Q9UBX1,Cathepsin F,CTSF,484.0
9937,DB03693,N-(2-Aminoethyl)-5-Chloroisoquinoline-8-Sulfonamide,SmallMoleculeDrug,P78368,Casein kinase I isoform gamma-2,CSNK1G2,415.0
9938,DB03695,"6-(2,5-Dimethoxy-Benzyl)-5-Methyl-Pyrido[2,3-D]Pyrimidine-2,4-Diamine",SmallMoleculeDrug,P00374,Dihydrofolate reductase,DHFR,187.0
9939,DB03696,Lanosterol,SmallMoleculeDrug,P48449,Lanosterol synthase,LSS,732.0
9940,DB03697,4-Sulfonamide-[1-(4-Aminobutane)]Benzamide,SmallMoleculeDrug,P00918,Carbonic anhydrase 2,CA2,260.0
9944,DB03702,"2-[4-[[(S)-1-[[(S)-2-[[(Rs)-3,3,3-Trifluoro-1-Isopropyl-2-Oxopropyl]Aminocarbonyl]Pyrrolidin-1-Yl-]Carbonyl]-2-Methylpropyl]Aminocarbonyl]Benzoylamino]Acetic Acid",SmallMoleculeDrug,Q9UNI1,Chymotrypsin-like elastase family member 1,CELA1,258.0
9945,DB03703,Cyclohexanol,SmallMoleculeDrug,P00325,Alcohol dehydrogenase 1B,ADH1B,375.0
9946,DB03704,12-Hydroxydodecanoic Acid,SmallMoleculeDrug,P11766,Alcohol dehydrogenase class-3,ADH5,374.0
9948,DB03706,1-Hydroxy-2-S-Glutathionyl-3-Para-Nitrophenoxy-Propane,SmallMoleculeDrug,Q03013,Glutathione S-transferase Mu 4,GSTM4,218.0
9949,DB03707,S-Ethyl-N-Phenyl-Isothiourea,SmallMoleculeDrug,P29474,"Nitric oxide synthase, endothelial",NOS3,1203.0
9950,DB03707,S-Ethyl-N-Phenyl-Isothiourea,SmallMoleculeDrug,P29475,"Nitric oxide synthase, brain",NOS1,1434.0
9952,DB03708,Adenosine-5'-Phosphosulfate,SmallMoleculeDrug,O43252,Bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthase 1,PAPSS1,624.0
9954,DB03709,Bicine,SmallMoleculeDrug,P00747,Plasminogen,PLG,810.0
9956,DB03710,N5-(1-Imino-3-Butenyl)-L-Ornithine,SmallMoleculeDrug,P29475,"Nitric oxide synthase, brain",NOS1,1434.0
9957,DB03711,6-Hydroxy-6-Methyl-Heptan-3-One,SmallMoleculeDrug,Q8WX39,Epididymal-specific lipocalin-9,LCN9,176.0
9958,DB03712,RU85053,SmallMoleculeDrug,P12931,Proto-oncogene tyrosine-protein kinase Src,SRC,536.0
9959,DB03714,4-Carbamoyl-4-{[6-(Difluoro-Phosphono-Methyl)-Naphthalene-2-Carbonyl]-Amino}-Butyric Acid,SmallMoleculeDrug,P18031,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,435.0
9962,DB03719,N-Ethyl-5'-Carboxamido Adenosine,SmallMoleculeDrug,P14625,Endoplasmin,HSP90B1,803.0
9965,DB03721,N-acetyl-alpha-neuraminic acid,SmallMoleculeDrug,Q9BZZ2,Sialoadhesin,SIGLEC1,1709.0
9966,DB03721,N-acetyl-alpha-neuraminic acid,SmallMoleculeDrug,P25311,Zinc-alpha-2-glycoprotein,AZGP1,298.0
9969,DB03721,N-acetyl-alpha-neuraminic acid,SmallMoleculeDrug,P23141,Liver carboxylesterase 1,CES1,567.0
9973,DB03721,N-acetyl-alpha-neuraminic acid,SmallMoleculeDrug,P16109,P-selectin,SELP,830.0
9974,DB03721,N-acetyl-alpha-neuraminic acid,SmallMoleculeDrug,P11226,Mannose-binding protein C,MBL2,248.0
9975,DB03721,N-acetyl-alpha-neuraminic acid,SmallMoleculeDrug,P16581,E-selectin,SELE,610.0
9976,DB03721,N-acetyl-alpha-neuraminic acid,SmallMoleculeDrug,P05451,Lithostathine-1-alpha,REG1A,166.0
9981,DB03722,"3,4-Dihydro-5-Methyl-Isoquinolinone",SmallMoleculeDrug,P09874,Poly [ADP-ribose] polymerase 1,PARP1,1014.0
9984,DB03725,Phosphomethylphosphonic Acid-Guanylate Ester,SmallMoleculeDrug,P35558,"Phosphoenolpyruvate carboxykinase, cytosolic [GTP]",PCK1,622.0
9985,DB03726,Purine Riboside-5'-Monophosphate,SmallMoleculeDrug,P07998,Ribonuclease pancreatic,RNASE1,156.0
9986,DB03727,Coproporphyrin I,SmallMoleculeDrug,P06132,Uroporphyrinogen decarboxylase,UROD,367.0
9988,DB03729,2-Amino-5-Hydroxy-Benzimidazole,SmallMoleculeDrug,P00749,Urokinase-type plasminogen activator,PLAU,431.0
9990,DB03731,S-2-(Boronoethyl)-L-Cysteine,SmallMoleculeDrug,P05089,Arginase-1,ARG1,322.0
9991,DB03731,S-2-(Boronoethyl)-L-Cysteine,SmallMoleculeDrug,P78540,"Arginase-2, mitochondrial",ARG2,354.0
9992,DB03732,Etheno-Nadp,SmallMoleculeDrug,Q10588,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,BST1,318.0
9996,DB03736,2-Cyclopropylmethylenepropanal,SmallMoleculeDrug,P00797,Renin,REN,406.0
9997,DB03737,"4-((3r,4s,5r)-4-Amino-3,5-Dihydroxy-Hex-1-Ynyl)-5-Fluoro-3-[1-(3-Methoxy-1h-Pyrrol-2-Yl)-Meth-(Z)-Ylidene]-1,3-Dihydro-Indol-2-One",SmallMoleculeDrug,P24941,Cyclin-dependent kinase 2,CDK2,298.0
9998,DB03738,Pantothenoylaminoethenethiol,SmallMoleculeDrug,Q96CD2,Phosphopantothenoylcysteine decarboxylase,PPCDC,204.0
10002,DB03740,N-acetyl-alpha-D-glucosamine,SmallMoleculeDrug,P01857,Ig gamma-1 chain C region,IGHG1,330.0
10003,DB03740,N-acetyl-alpha-D-glucosamine,SmallMoleculeDrug,P12821,Angiotensin-converting enzyme,ACE,1306.0
10004,DB03740,N-acetyl-alpha-D-glucosamine,SmallMoleculeDrug,P22303,Acetylcholinesterase,ACHE,614.0
10005,DB03740,N-acetyl-alpha-D-glucosamine,SmallMoleculeDrug,P04062,Glucosylceramidase,GBA,536.0
10007,DB03740,N-acetyl-alpha-D-glucosamine,SmallMoleculeDrug,Q9Y286,Sialic acid-binding Ig-like lectin 7,SIGLEC7,467.0
10010,DB03742,Compound 4-D,SmallMoleculeDrug,P03372,Estrogen receptor,ESR1,595.0
10011,DB03744,"Cp403700, (S)-1-{2-[(5-Chloro-1h-Indole-2-Carbonyl)-Amino]-3-Phenyl-Propionyl}-Azetidine-3-Carboxylate",SmallMoleculeDrug,P06737,"Glycogen phosphorylase, liver form",PYGL,847.0
10016,DB03747,"3ar,5r,6s,7r,7ar-5-Hydroxymethyl-2-Methyl-5,6,7,7a-Tetrahydro-3ah-Pyrano[3,2-D]Thiazole-6,7-Diol",SmallMoleculeDrug,P07686,Beta-hexosaminidase subunit beta,HEXB,556.0
10018,DB03749,"4-(1h-Imidazol-4-Yl)-3-(5-Ethyl-2,4-Dihydroxy-Phenyl)-1h-Pyrazole",SmallMoleculeDrug,P07900,Heat shock protein HSP 90-alpha,HSP90AA1,732.0
10027,DB03752,P-(2'-Iodo-5'-Thenoyl)Hydrotropic Acid,SmallMoleculeDrug,P23219,Prostaglandin G/H synthase 1,PTGS1,599.0
10028,DB03753,Flurbiprofen Methyl Ester,SmallMoleculeDrug,P23219,Prostaglandin G/H synthase 1,PTGS1,599.0
10031,DB03754,Tris,SmallMoleculeDrug,Q8WVQ1,Soluble calcium-activated nucleotidase 1,CANT1,401.0
10035,DB03754,Tris,SmallMoleculeDrug,Q96FI4,Endonuclease 8-like 1,NEIL1,390.0
10037,DB03754,Tris,SmallMoleculeDrug,P17707,S-adenosylmethionine decarboxylase proenzyme,AMD1,334.0
10039,DB03754,Tris,SmallMoleculeDrug,P15692,Vascular endothelial growth factor A,VEGFA,232.0
10041,DB03754,Tris,SmallMoleculeDrug,P07585,Decorin,DCN,359.0
10043,DB03757,(Tert-Butyloxycarbonyl)-Alanyl-Alanyl-Amine,SmallMoleculeDrug,Q9UNI1,Chymotrypsin-like elastase family member 1,CELA1,258.0
10044,DB03758,Radicicol,SmallMoleculeDrug,P08238,Heat shock protein HSP 90-beta,HSP90AB1,724.0
10045,DB03758,Radicicol,SmallMoleculeDrug,P14625,Endoplasmin,HSP90B1,803.0
10046,DB03758,Radicicol,SmallMoleculeDrug,P10515,"Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex, mitochondrial",DLAT,647.0
10047,DB03758,Radicicol,SmallMoleculeDrug,Q15120,"[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 3, mitochondrial",PDK3,406.0
10049,DB03759,FG-9041,SmallMoleculeDrug,P42262,Glutamate receptor 2,GRIA2,883.0
10051,DB03760,Dihydrolipoic Acid,SmallMoleculeDrug,P23434,"Glycine cleavage system H protein, mitochondrial",GCSH,173.0
10052,DB03760,Dihydrolipoic Acid,SmallMoleculeDrug,P10515,"Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex, mitochondrial",DLAT,647.0
10053,DB03760,Dihydrolipoic Acid,SmallMoleculeDrug,Q15120,"[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 3, mitochondrial",PDK3,406.0
10059,DB03765,2'-cytidylic acid,SmallMoleculeDrug,P07998,Ribonuclease pancreatic,RNASE1,156.0
10061,DB03766,Propanoic Acid,SmallMoleculeDrug,Q9NQX3,Gephyrin,GPHN,736.0
10064,DB03767,Morpholine-4-Carboxylic Acid [1s-(2-Benzyloxy-1r-Cyano-Ethylcarbamoyl)-3-Methyl-Butyl]Amide,SmallMoleculeDrug,P25774,Cathepsin S,CTSS,331.0
10066,DB03769,D-Eritadenine,SmallMoleculeDrug,P23526,Adenosylhomocysteinase,AHCY,432.0
10068,DB03772,"2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,5-Diol",SmallMoleculeDrug,P16442,Histo-blood group ABO system transferase,ABO,354.0
10070,DB03773,6-Deoxy-Alpha-D-Glucose,SmallMoleculeDrug,P04746,Pancreatic alpha-amylase,AMY2A,511.0
10075,DB03777,Rbt205 Inhibitor,SmallMoleculeDrug,P11309,Serine/threonine-protein kinase pim-1,PIM1,404.0
10076,DB03777,Rbt205 Inhibitor,SmallMoleculeDrug,O15530,3-phosphoinositide-dependent protein kinase 1,PDPK1,556.0
10077,DB03777,Rbt205 Inhibitor,SmallMoleculeDrug,P41743,Protein kinase C iota type,PRKCI,596.0
10080,DB03781,"2-[4-(2,4-Dichlorophenoxy)Phenoxy]Propanoic Acid",SmallMoleculeDrug,O00763,Acetyl-CoA carboxylase 2,ACACB,2458.0
10081,DB03782,N-(1-Adamantyl)-N'-(4-Guanidinobenzyl)Urea,SmallMoleculeDrug,P00749,Urokinase-type plasminogen activator,PLAU,431.0
10082,DB03783,Phenacetin,SmallMoleculeDrug,P23219,Prostaglandin G/H synthase 1,PTGS1,599.0
10083,DB03784,Elaidoylamide,SmallMoleculeDrug,P14555,"Phospholipase A2, membrane associated",PLA2G2A,144.0
10086,DB03788,GC-24,SmallMoleculeDrug,P10828,Thyroid hormone receptor beta,THRB,461.0
10088,DB03791,"(3-{3-[[2-Chloro-3-(Trifluoromethyl)Benzyl](2,2-Diphenylethyl)Amino]Propoxy}Phenyl)Acetic Acid",SmallMoleculeDrug,P55055,Oxysterols receptor LXR-beta,NR1H2,460.0
10089,DB03792,"5-Amino-1h-Pyrimidine-2,4-Dione",SmallMoleculeDrug,P07998,Ribonuclease pancreatic,RNASE1,156.0
10093,DB03793,Benzoic Acid,SmallMoleculeDrug,P14920,D-amino-acid oxidase,DAO,347.0
10094,DB03793,Benzoic Acid,SmallMoleculeDrug,P52758,Ribonuclease UK114,RIDA,137.0
10096,DB03793,Benzoic Acid,SmallMoleculeDrug,P51151,Ras-related protein Rab-9A,RAB9A,201.0
10102,DB03793,Benzoic Acid,SmallMoleculeDrug,P30044,"Peroxiredoxin-5, mitochondrial",PRDX5,214.0
10106,DB03796,Palmitic Acid,SmallMoleculeDrug,P09466,Glycodelin,PAEP,180.0
10107,DB03796,Palmitic Acid,SmallMoleculeDrug,Q14541,Hepatocyte nuclear factor 4-gamma,HNF4G,408.0
10109,DB03796,Palmitic Acid,SmallMoleculeDrug,P10632,Cytochrome P450 2C8,CYP2C8,490.0
10110,DB03796,Palmitic Acid,SmallMoleculeDrug,O43617,Trafficking protein particle complex subunit 3,TRAPPC3,180.0
10112,DB03796,Palmitic Acid,SmallMoleculeDrug,P08100,Rhodopsin,RHO,348.0
10113,DB03796,Palmitic Acid,SmallMoleculeDrug,O76054,SEC14-like protein 2,SEC14L2,403.0
10114,DB03796,Palmitic Acid,SmallMoleculeDrug,P50897,Palmitoyl-protein thioesterase 1,PPT1,306.0
10115,DB03796,Palmitic Acid,SmallMoleculeDrug,P02689,Myelin P2 protein,PMP2,132.0
10116,DB03796,Palmitic Acid,SmallMoleculeDrug,P00709,Alpha-lactalbumin,LALBA,142.0
10125,DB03800,2'-deoxyuridylic acid,SmallMoleculeDrug,P04818,Thymidylate synthase,TYMS,313.0
10147,DB03801,Lysine Nz-Carboxylic Acid,SmallMoleculeDrug,P24941,Cyclin-dependent kinase 2,CDK2,298.0
10148,DB03802,"1-[4-(Octahydro-Pyrido[1,2-a]Pyrazin-2-Yl)-Phenyl]-2-Phenyl-1,2,3,4-Tetrahydro-Isoquinolin-6-Ol",SmallMoleculeDrug,P03372,Estrogen receptor,ESR1,595.0
10151,DB03805,Antiproliferative Agent A771726,SmallMoleculeDrug,Q02127,"Dihydroorotate dehydrogenase (quinone), mitochondrial",DHODH,395.0
10152,DB03807,"1-(2-Chlorophenyl)-3,5-Dimethyl-1h-Pyrazole-4-Carboxylic Acid Ethyl Ester",SmallMoleculeDrug,Q07343,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B",PDE4B,736.0
10155,DB03809,9-Butyl-8-(3-Methoxybenzyl)-9h-Purin-6-Amine,SmallMoleculeDrug,P07900,Heat shock protein HSP 90-alpha,HSP90AA1,732.0
10161,DB03814,2-(N-Morpholino)-Ethanesulfonic Acid,SmallMoleculeDrug,P22303,Acetylcholinesterase,ACHE,614.0
10165,DB03814,2-(N-Morpholino)-Ethanesulfonic Acid,SmallMoleculeDrug,P28845,Corticosteroid 11-beta-dehydrogenase isozyme 1,HSD11B1,292.0
10172,DB03814,2-(N-Morpholino)-Ethanesulfonic Acid,SmallMoleculeDrug,P15291,"Beta-1,4-galactosyltransferase 1",B4GALT1,398.0
10181,DB03814,2-(N-Morpholino)-Ethanesulfonic Acid,SmallMoleculeDrug,P09417,Dihydropteridine reductase,QDPR,244.0
10182,DB03814,2-(N-Morpholino)-Ethanesulfonic Acid,SmallMoleculeDrug,P04424,Argininosuccinate lyase,ASL,464.0
10184,DB03814,2-(N-Morpholino)-Ethanesulfonic Acid,SmallMoleculeDrug,P36405,ADP-ribosylation factor-like protein 3,ARL3,182.0
10187,DB03814,2-(N-Morpholino)-Ethanesulfonic Acid,SmallMoleculeDrug,Q9Y468,Lethal(3)malignant brain tumor-like protein 1,L3MBTL1,752.0
10188,DB03814,2-(N-Morpholino)-Ethanesulfonic Acid,SmallMoleculeDrug,P06276,Cholinesterase,BCHE,602.0
10190,DB03814,2-(N-Morpholino)-Ethanesulfonic Acid,SmallMoleculeDrug,P30041,Peroxiredoxin-6,PRDX6,224.0
10193,DB03814,2-(N-Morpholino)-Ethanesulfonic Acid,SmallMoleculeDrug,Q8IWL2,Pulmonary surfactant-associated protein A1,SFTPA1,248.0
10197,DB03814,2-(N-Morpholino)-Ethanesulfonic Acid,SmallMoleculeDrug,Q6NXR0,Interferon-inducible GTPase 5,IRGC,463.0
10198,DB03814,2-(N-Morpholino)-Ethanesulfonic Acid,SmallMoleculeDrug,P23946,Chymase,CMA1,247.0
10199,DB03814,2-(N-Morpholino)-Ethanesulfonic Acid,SmallMoleculeDrug,P09211,Glutathione S-transferase P,GSTP1,210.0
10205,DB03821,2-Amino-3-Hydroxy-3-Phosphonooxy-Propionic Acid,SmallMoleculeDrug,P15289,Arylsulfatase A,ARSA,507.0
10207,DB03822,Ethyl Dihydrogen Phosphate,SmallMoleculeDrug,P06276,Cholinesterase,BCHE,602.0
10208,DB03824,"7-Iodo-1,2,3,4-Tetrahydro-Isoquinoline",SmallMoleculeDrug,P11086,Phenylethanolamine N-methyltransferase,PNMT,282.0
10212,DB03828,RU78299,SmallMoleculeDrug,P12931,Proto-oncogene tyrosine-protein kinase Src,SRC,536.0
10214,DB03832,"3-Carboxy-N,N,N-Trimethyl-2-(Octanoyloxy)Propan-1-Aminium",SmallMoleculeDrug,Q9UKG9,Peroxisomal carnitine O-octanoyltransferase,CROT,612.0
10217,DB03835,"N-(8,9,10-Trihydroxy-7-Hydroxymethyl-2,4-Dioxo-6-Oxa-1,3-Diaza-Spiro[4.5]Dec-3-Yl-Acetamide",SmallMoleculeDrug,P11217,"Glycogen phosphorylase, muscle form",PYGM,842.0
10219,DB03837,Morpholine-4-Carboxylic Acid (1-(3-Benzenesulfonyl-1-Phenethylallylcarbamoyl)-3-Methylbutyl)-Amide,SmallMoleculeDrug,P25774,Cathepsin S,CTSS,331.0
10221,DB03841,Y-700,SmallMoleculeDrug,P47989,Xanthine dehydrogenase/oxidase,XDH,1333.0
10224,DB03844,"N-(2,6-Diflouro-Benzyl)-4-Sulfamoyl-Benzamide",SmallMoleculeDrug,P00918,Carbonic anhydrase 2,CA2,260.0
10225,DB03845,P1-(5'-Adenosyl)P5-(5'-(3'azido-3'-Deoxythymidyl))Pentaphosphate,SmallMoleculeDrug,P23919,Thymidylate kinase,DTYMK,212.0
10227,DB03847,Gamma-Carboxy-Glutamic Acid,SmallMoleculeDrug,P00734,Prothrombin,F2,622.0
10228,DB03847,Gamma-Carboxy-Glutamic Acid,SmallMoleculeDrug,P02818,Osteocalcin,BGLAP,100.0
10229,DB03847,Gamma-Carboxy-Glutamic Acid,SmallMoleculeDrug,P00742,Coagulation factor X,F10,488.0
10230,DB03848,Benzenesulfonyl,SmallMoleculeDrug,P55055,Oxysterols receptor LXR-beta,NR1H2,460.0
10231,DB03849,Cilomilast,SmallMoleculeDrug,Q08499,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",PDE4D,809.0
10232,DB03849,Cilomilast,SmallMoleculeDrug,Q07343,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B",PDE4B,736.0
10233,DB03850,Jaspisamide A,SmallMoleculeDrug,P68133,"Actin, alpha skeletal muscle",ACTA1,377.0
10236,DB03856,Alpha-Difluoromethylornithine,SmallMoleculeDrug,P11926,Ornithine decarboxylase,ODC1,461.0
10239,DB03860,"N-Butyl-11-[(7r,8r,9s,13s,14s,17s)-3,17-Dihydroxy-13-Methyl-7,8,9,11,12,13,14,15,16,17-Decahydro-6h-Cyclopenta[a]Phenanthren-7-Yl]-N-Methylundecanamide",SmallMoleculeDrug,Q92731,Estrogen receptor beta,ESR2,530.0
10240,DB03861,"(2r,3r,4s,5r)-2-Acetamido-3,4-Dihydroxy-5-Hydroxymethyl-Piperidinium",SmallMoleculeDrug,P07686,Beta-hexosaminidase subunit beta,HEXB,556.0
10241,DB03861,"(2r,3r,4s,5r)-2-Acetamido-3,4-Dihydroxy-5-Hydroxymethyl-Piperidinium",SmallMoleculeDrug,Q9Y691,Calcium-activated potassium channel subunit beta-2,KCNMB2,235.0
10246,DB03864,Monothioglycerol,SmallMoleculeDrug,P48147,Prolyl endopeptidase,PREP,710.0
10247,DB03865,6-Chloro-2-(2-Hydroxy-Biphenyl-3-Yl)-1h-Indole-5-Carboxamidine,SmallMoleculeDrug,P00734,Prothrombin,F2,622.0
10248,DB03865,6-Chloro-2-(2-Hydroxy-Biphenyl-3-Yl)-1h-Indole-5-Carboxamidine,SmallMoleculeDrug,P07477,Trypsin-1,PRSS1,247.0
10249,DB03865,6-Chloro-2-(2-Hydroxy-Biphenyl-3-Yl)-1h-Indole-5-Carboxamidine,SmallMoleculeDrug,P00749,Urokinase-type plasminogen activator,PLAU,431.0
10250,DB03865,6-Chloro-2-(2-Hydroxy-Biphenyl-3-Yl)-1h-Indole-5-Carboxamidine,SmallMoleculeDrug,P05981,Serine protease hepsin,HPN,417.0
10251,DB03866,Prostaglandin G2,SmallMoleculeDrug,P35354,Prostaglandin G/H synthase 2,PTGS2,604.0
10252,DB03867,Meta-Nitro-Tyrosine,SmallMoleculeDrug,P00390,"Glutathione reductase, mitochondrial",GSR,522.0
10259,DB03876,"Thieno[2,3-B]Pyridine-2-Carboxamidine",SmallMoleculeDrug,P07477,Trypsin-1,PRSS1,247.0
10260,DB03876,"Thieno[2,3-B]Pyridine-2-Carboxamidine",SmallMoleculeDrug,P00749,Urokinase-type plasminogen activator,PLAU,431.0
10261,DB03877,AL4623,SmallMoleculeDrug,P00918,Carbonic anhydrase 2,CA2,260.0
10263,DB03878,N-[4-Methyl-3-[[4-(3-Pyridinyl)-2-Pyrimidinyl]Amino]Phenyl]-3-Pyridinecarboxamide,SmallMoleculeDrug,P00519,Tyrosine-protein kinase ABL1,ABL1,1130.0
10264,DB03879,alpha-L-methyl-fucose,SmallMoleculeDrug,P11226,Mannose-binding protein C,MBL2,248.0
10266,DB03880,Batimastat,SmallMoleculeDrug,P22894,Neutrophil collagenase,MMP8,467.0
10267,DB03880,Batimastat,SmallMoleculeDrug,P39900,Macrophage metalloelastase,MMP12,470.0
10268,DB03880,Batimastat,SmallMoleculeDrug,P51512,Matrix metalloproteinase-16,MMP16,607.0
10269,DB03880,Batimastat,SmallMoleculeDrug,Q9UKQ2,Disintegrin and metalloproteinase domain-containing protein 28,ADAM28,775.0
10270,DB03880,Batimastat,SmallMoleculeDrug,Q9UNA0,A disintegrin and metalloproteinase with thrombospondin motifs 5,ADAMTS5,930.0
10271,DB03881,MT-Immucillin-H,SmallMoleculeDrug,P00491,Purine nucleoside phosphorylase,PNP,289.0
10273,DB03882,"5-Alpha-Androstane-3-Beta,17beta-Diol",SmallMoleculeDrug,Q92731,Estrogen receptor beta,ESR2,530.0
10275,DB03884,3-Phenylpyruvic Acid,SmallMoleculeDrug,Q9UJM8,Hydroxyacid oxidase 1,HAO1,370.0
10280,DB03886,Biopterin,SmallMoleculeDrug,P35270,Sepiapterin reductase,SPR,261.0
10281,DB03886,Biopterin,SmallMoleculeDrug,Q03393,6-pyruvoyl tetrahydrobiopterin synthase,PTS,145.0
10282,DB03886,Biopterin,SmallMoleculeDrug,P00374,Dihydrofolate reductase,DHFR,187.0
10285,DB03889,S-(N-Hydroxy-N-Bromophenylcarbamoyl)Glutathione,SmallMoleculeDrug,Q16775,"Hydroxyacylglutathione hydrolase, mitochondrial",HAGH,308.0
10286,DB03890,N-[2-(1-Formyl-2-Methyl-Propyl)-1-(4-Piperidin-1-Yl-but-2-Enoyl)-Pyrrolidin-3-Yl]-Methanesulfonamide,SmallMoleculeDrug,Q9UNI1,Chymotrypsin-like elastase family member 1,CELA1,258.0
10287,DB03891,"1,5-Bis(N-Benzyloxycarbonyl-L-Leucinyl)Carbohydrazide",SmallMoleculeDrug,P43235,Cathepsin K,CTSK,329.0
10288,DB03892,5-N-Allyl-Arginine,SmallMoleculeDrug,P29475,"Nitric oxide synthase, brain",NOS1,1434.0
10289,DB03893,Thionicotinamide-Adenine-Dinucleotide,SmallMoleculeDrug,P04406,Glyceraldehyde-3-phosphate dehydrogenase,GAPDH,335.0
10290,DB03894,N-Propargyl-1(S)-Aminoindan,SmallMoleculeDrug,P27338,Amine oxidase [flavin-containing] B,MAOB,520.0
10292,DB03896,Triphospate,SmallMoleculeDrug,P51003,Poly(A) polymerase alpha,PAPOLA,745.0
10296,DB03899,9-Butyl-8-(4-Methoxybenzyl)-9h-Purin-6-Amine,SmallMoleculeDrug,P07900,Heat shock protein HSP 90-alpha,HSP90AA1,732.0
10297,DB03900,2-Methyl-2-Propanol,SmallMoleculeDrug,P07998,Ribonuclease pancreatic,RNASE1,156.0
10298,DB03900,2-Methyl-2-Propanol,SmallMoleculeDrug,P60174,Triosephosphate isomerase,TPI1,286.0
10299,DB03900,2-Methyl-2-Propanol,SmallMoleculeDrug,P50579,Methionine aminopeptidase 2,METAP2,478.0
10303,DB03902,Oxalic Acid,SmallMoleculeDrug,P12931,Proto-oncogene tyrosine-protein kinase Src,SRC,536.0
10304,DB03903,Tmr,SmallMoleculeDrug,P68133,"Actin, alpha skeletal muscle",ACTA1,377.0
10305,DB03904,Urea,SmallMoleculeDrug,P05089,Arginase-1,ARG1,322.0
10306,DB03904,Urea,SmallMoleculeDrug,P00918,Carbonic anhydrase 2,CA2,260.0
10308,DB03904,Urea,SmallMoleculeDrug,P35222,Catenin beta-1,CTNNB1,781.0
10312,DB03906,2-Phenylheme,SmallMoleculeDrug,P09601,Heme oxygenase 1,HMOX1,288.0
10313,DB03907,"N-{3-[5-(6-Amino-Purin-9-Yl)-3,4-Dihydroxy-Tetrahydro-Furan-2-Yl]-Allyl}-2,3-Dihydroxy-5-Nitro-Benzamide",SmallMoleculeDrug,P21964,Catechol O-methyltransferase,COMT,271.0
10320,DB03909,"Adenosine-5'-[Beta, Gamma-Methylene]Triphosphate",SmallMoleculeDrug,P06213,Insulin receptor,INSR,1382.0
10321,DB03909,"Adenosine-5'-[Beta, Gamma-Methylene]Triphosphate",SmallMoleculeDrug,O14983,Sarcoplasmic/endoplasmic reticulum calcium ATPase 1,ATP2A1,1001.0
10322,DB03909,"Adenosine-5'-[Beta, Gamma-Methylene]Triphosphate",SmallMoleculeDrug,O00764,Pyridoxal kinase,PDXK,312.0
10323,DB03909,"Adenosine-5'-[Beta, Gamma-Methylene]Triphosphate",SmallMoleculeDrug,P00558,Phosphoglycerate kinase 1,PGK1,417.0
10328,DB03909,"Adenosine-5'-[Beta, Gamma-Methylene]Triphosphate",SmallMoleculeDrug,Q12756,Kinesin-like protein KIF1A,KIF1A,1690.0
10329,DB03910,"S,S'-(1,3-Phenylene-Bis(1,2-Ethanediyl))Bis-Isothiourea",SmallMoleculeDrug,P29474,"Nitric oxide synthase, endothelial",NOS3,1203.0
10337,DB03918,"6S-5,6,7,8-Tetrahydrobiopterin",SmallMoleculeDrug,P29474,"Nitric oxide synthase, endothelial",NOS3,1203.0
10339,DB03921,4-(3-Pyridin-2-Yl-1h-Pyrazol-4-Yl)Quinoline,SmallMoleculeDrug,P36897,TGF-beta receptor type-1,TGFBR1,503.0
10340,DB03923,Feruloyl Coenzyme A,SmallMoleculeDrug,Q86VU5,Catechol O-methyltransferase domain-containing protein 1,COMTD1,262.0
10341,DB03924,"5,8-Di-Amino-1,4-Dihydroxy-Anthraquinone",SmallMoleculeDrug,P68400,Casein kinase II subunit alpha,CSNK2A1,391.0
10342,DB03925,ONO-6818,SmallMoleculeDrug,P08246,Neutrophil elastase,ELANE,267.0
10343,DB03925,ONO-6818,SmallMoleculeDrug,Q9UNI1,Chymotrypsin-like elastase family member 1,CELA1,258.0
10345,DB03928,"Carboxymethylthio-3-(3-Chlorophenyl)-1,2,4-Oxadiazol",SmallMoleculeDrug,P32929,Cystathionine gamma-lyase,CTH,405.0
10346,DB03929,D-Serine,SmallMoleculeDrug,P23415,Glycine receptor subunit alpha-1,GLRA1,457.0
10347,DB03929,D-Serine,SmallMoleculeDrug,Q05586,"Glutamate receptor ionotropic, NMDA 1",GRIN1,938.0
10348,DB03929,D-Serine,SmallMoleculeDrug,P29508,Serpin B3,SERPINB3,390.0
10351,DB03932,LFA703,SmallMoleculeDrug,P20701,Integrin alpha-L,ITGAL,1170.0
10353,DB03934,Protoporphyrin Ix Containing Zn,SmallMoleculeDrug,P99999,Cytochrome c,CYCS,105.0
10354,DB03935,"1,4-Dideoxy-O2-Sulfo-Glucuronic Acid",SmallMoleculeDrug,P09038,Fibroblast growth factor 2,FGF2,288.0
10355,DB03935,"1,4-Dideoxy-O2-Sulfo-Glucuronic Acid",SmallMoleculeDrug,P08758,Annexin A5,ANXA5,320.0
10358,DB03937,Erythose-4-Phosphate,SmallMoleculeDrug,P06744,Glucose-6-phosphate isomerase,GPI,558.0
10364,DB03940,Oxamic Acid,SmallMoleculeDrug,P00338,L-lactate dehydrogenase A chain,LDHA,332.0
10365,DB03940,Oxamic Acid,SmallMoleculeDrug,P07195,L-lactate dehydrogenase B chain,LDHB,334.0
10371,DB03944,"5-[1-(3,4-Dimethoxy-Benzoyl)-1,2,3,4-Tetrahydro-Quinolin-6-Yl]-6-Methyl-3,6-Dihydro-[1,3,4]Thiadiazin-2-One",SmallMoleculeDrug,P63316,"Troponin C, slow skeletal and cardiac muscles",TNNC1,161.0
10372,DB03945,"N,N,N-Trimethyl-2-(phosphonooxy)ethanaminium",SmallMoleculeDrug,P02741,C-reactive protein,CRP,224.0
10373,DB03945,"N,N,N-Trimethyl-2-(phosphonooxy)ethanaminium",SmallMoleculeDrug,Q96BH3,Epididymal sperm-binding protein 1,ELSPBP1,223.0
10376,DB03948,"6-Chloropurine Riboside, 5'-Monophosphate",SmallMoleculeDrug,P20839,Inosine-5'-monophosphate dehydrogenase 1,IMPDH1,514.0
10377,DB03948,"6-Chloropurine Riboside, 5'-Monophosphate",SmallMoleculeDrug,P12268,Inosine-5'-monophosphate dehydrogenase 2,IMPDH2,514.0
10379,DB03950,(S)-N-(3-Indol-1-Yl-2-Methyl-Propyl)-4-Sulfamoyl-Benzamide,SmallMoleculeDrug,P00918,Carbonic anhydrase 2,CA2,260.0
10380,DB03951,16g,SmallMoleculeDrug,P46926,Glucosamine-6-phosphate isomerase 1,GNPDA1,289.0
10383,DB03953,L-Thiocitrulline,SmallMoleculeDrug,P35228,"Nitric oxide synthase, inducible",NOS2,1153.0
10384,DB03955,1-deoxymannojirimycin,SmallMoleculeDrug,Q16706,Alpha-mannosidase 2,MAN2A1,1144.0
10385,DB03956,"D-Myo-Inositol-2,4,5-Trisphosphate",SmallMoleculeDrug,P51178,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-1",PLCD1,756.0
10386,DB03957,SP2456,SmallMoleculeDrug,P60568,Interleukin-2,IL2,153.0
10387,DB03958,7-methyl-guanosine-5'-triphosphate-5'-guanosine,SmallMoleculeDrug,Q96C86,m7GpppX diphosphatase,DCPS,337.0
10389,DB03959,"N,O6-Disulfo-Glucosamine",SmallMoleculeDrug,P09038,Fibroblast growth factor 2,FGF2,288.0
10390,DB03959,"N,O6-Disulfo-Glucosamine",SmallMoleculeDrug,P05230,Fibroblast growth factor 1,FGF1,155.0
10391,DB03959,"N,O6-Disulfo-Glucosamine",SmallMoleculeDrug,Q9Y663,Heparan sulfate glucosamine 3-O-sulfotransferase 3A1,HS3ST3A1,406.0
10392,DB03959,"N,O6-Disulfo-Glucosamine",SmallMoleculeDrug,P14210,Hepatocyte growth factor,HGF,728.0
10394,DB03959,"N,O6-Disulfo-Glucosamine",SmallMoleculeDrug,P08758,Annexin A5,ANXA5,320.0
10396,DB03962,Nicotinamide 8-Bromo-Adenine Dinucleotide Phosphate,SmallMoleculeDrug,P52209,"6-phosphogluconate dehydrogenase, decarboxylating",PGD,483.0
10397,DB03963,S-(Dimethylarsenic)Cysteine,SmallMoleculeDrug,O60603,Toll-like receptor 2,TLR2,784.0
10400,DB03963,S-(Dimethylarsenic)Cysteine,SmallMoleculeDrug,P29474,"Nitric oxide synthase, endothelial",NOS3,1203.0
10401,DB03963,S-(Dimethylarsenic)Cysteine,SmallMoleculeDrug,Q9Y678,Coatomer subunit gamma-1,COPG1,874.0
10403,DB03963,S-(Dimethylarsenic)Cysteine,SmallMoleculeDrug,Q13426,DNA repair protein XRCC4,XRCC4,336.0
10405,DB03964,4-Hydroxy-Aconitate Ion,SmallMoleculeDrug,Q99798,"Aconitate hydratase, mitochondrial",ACO2,780.0
10407,DB03967,Dodecyl Sulfate,SmallMoleculeDrug,P61626,Lysozyme C,LYZ,148.0
10409,DB03968,"1-Methyl-2-Oxy-5,5-Dimethyl Pyrrolidine",SmallMoleculeDrug,P00797,Renin,REN,406.0
10416,DB03971,Acarbose Derived Hexasaccharide,SmallMoleculeDrug,P04746,Pancreatic alpha-amylase,AMY2A,511.0
10418,DB03974,L-Homoarginine,SmallMoleculeDrug,P29474,"Nitric oxide synthase, endothelial",NOS3,1203.0
10420,DB03975,Mercuribenzoic Acid,SmallMoleculeDrug,P00918,Carbonic anhydrase 2,CA2,260.0
10421,DB03976,Phosphorylisopropane,SmallMoleculeDrug,P07477,Trypsin-1,PRSS1,247.0
10422,DB03976,Phosphorylisopropane,SmallMoleculeDrug,P07478,Trypsin-2,PRSS2,247.0
10423,DB03976,Phosphorylisopropane,SmallMoleculeDrug,P17538,Chymotrypsinogen B,CTRB1,263.0
10424,DB03977,N-Trimethyllysine,SmallMoleculeDrug,P99999,Cytochrome c,CYCS,105.0
10428,DB03978,Tyrosinal,SmallMoleculeDrug,P54577,"Tyrosine--tRNA ligase, cytoplasmic",YARS,528.0
10431,DB03980,4-(Fluorophenyl)-1-Cyclopropylmethyl-5-(2-Amino-4-Pyrimidinyl)Imidazole,SmallMoleculeDrug,Q16539,Mitogen-activated protein kinase 14,MAPK14,360.0
10432,DB03981,"1,4-Dideoxy-5-Dehydro-O2-Sulfo-Glucuronic Acid",SmallMoleculeDrug,P08758,Annexin A5,ANXA5,320.0
10433,DB03981,"1,4-Dideoxy-5-Dehydro-O2-Sulfo-Glucuronic Acid",SmallMoleculeDrug,P09038,Fibroblast growth factor 2,FGF2,288.0
10434,DB03981,"1,4-Dideoxy-5-Dehydro-O2-Sulfo-Glucuronic Acid",SmallMoleculeDrug,Q9Y663,Heparan sulfate glucosamine 3-O-sulfotransferase 3A1,HS3ST3A1,406.0
10435,DB03982,"Compound 5, 2-(Naphthalen-1-Yl-Oxalyl-Amino)-Benzoicacid",SmallMoleculeDrug,P18031,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,435.0
10436,DB03983,"(Molybdopterin-S,S)-Dioxo-Thio-Molybdenum(V)",SmallMoleculeDrug,P51687,"Sulfite oxidase, mitochondrial",SUOX,545.0
10437,DB03984,Morpholine-4-Carboxylic Acid [1-(2-Benzylsulfanyl-1-Formyl-Ethylcarbamoyl)-2-Phenyl-Ethyl]-Amide,SmallMoleculeDrug,P25774,Cathepsin S,CTSS,331.0
10440,DB03987,"2,4-Diamino-6-[N-(3',5'-Dimethoxybenzyl)-N-Methylamino]Pyrido[2,3-D]Pyrimidine",SmallMoleculeDrug,P00374,Dihydrofolate reductase,DHFR,187.0
10441,DB03988,"2,6-Diamino-Hexanoic Acid Amide",SmallMoleculeDrug,P18509,Pituitary adenylate cyclase-activating polypeptide,ADCYAP1,176.0
10447,DB03991,"2-Deoxy-2,3-Dehydro-N-Acetyl-Neuraminic Acid",SmallMoleculeDrug,Q9Y3R4,Sialidase-2,NEU2,380.0
10450,DB03994,Ethanolamine,SmallMoleculeDrug,P12429,Annexin A3,ANXA3,323.0
10454,DB03996,"3-[(5s)-1-Acetyl-3-(2-Chlorophenyl)-4,5-Dihydro-1h-Pyrazol-5-Yl]Phenol",SmallMoleculeDrug,P52732,Kinesin-like protein KIF11,KIF11,1056.0
10458,DB04000,Bromo-Willardiine,SmallMoleculeDrug,P42262,Glutamate receptor 2,GRIA2,883.0
10459,DB04001,6-(Oxalyl-Amino)-1h-Indole-5-Carboxylic Acid,SmallMoleculeDrug,P18031,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,435.0
10460,DB04002,4-Sulfonamide-[4-(Thiomethylaminobutane)]Benzamide,SmallMoleculeDrug,P00918,Carbonic anhydrase 2,CA2,260.0
10461,DB04003,(4-{2-Acetylamino-2-[1-(3-Carbamoyl-4-Cyclohexylmethoxy-Phenyl)-Ethylcarbamoyl}-Ethyl}-2-Phosphono-Phenoxy)-Acetic Acid,SmallMoleculeDrug,P06239,Tyrosine-protein kinase Lck,LCK,509.0
10463,DB04005,Uridine 5'-Triphosphate,SmallMoleculeDrug,Q9BZX2,Uridine-cytidine kinase 2,UCK2,261.0
10466,DB04006,"[2-Amino-6-(2,6-Difluoro-Benzoyl)-Imidazo[1,2-a]Pyridin-3-Yl]-Phenyl-Methanone",SmallMoleculeDrug,P24941,Cyclin-dependent kinase 2,CDK2,298.0
10468,DB04008,Bis(5-Amidino-Benzimidazolyl)Methane Zinc,SmallMoleculeDrug,P07477,Trypsin-1,PRSS1,247.0
10469,DB04009,Dimethyl Propionate Ester Heme,SmallMoleculeDrug,P00167,Cytochrome b5,CYB5A,134.0
10470,DB04010,2-(3'-Methoxyphenyl) Benzimidazole-4-Carboxamide,SmallMoleculeDrug,P09874,Poly [ADP-ribose] polymerase 1,PARP1,1014.0
10471,DB04012,"(3r)-4-(P-Toluenesulfonyl)-1,4-Thiazane-3-Carboxylicacid-L-Leucine",SmallMoleculeDrug,P62942,Peptidyl-prolyl cis-trans isomerase FKBP1A,FKBP1A,108.0
10472,DB04013,1-Deoxy-1-Methoxycarbamido-Beta-D-Gluco-2-Heptulopyranosonamide,SmallMoleculeDrug,P11217,"Glycogen phosphorylase, muscle form",PYGM,842.0
10473,DB04014,Alsterpaullone,SmallMoleculeDrug,Q00535,Cyclin-dependent-like kinase 5,CDK5,292.0
10474,DB04014,Alsterpaullone,SmallMoleculeDrug,P06493,Cyclin-dependent kinase 1,CDK1,297.0
10475,DB04014,Alsterpaullone,SmallMoleculeDrug,P49841,Glycogen synthase kinase-3 beta,GSK3B,420.0
10478,DB04016,2-[3-({Methyl[1-(2-Naphthoyl)Piperidin-4-Yl]Amino}Carbonyl)-2-Naphthyl]-1-(1-Naphthyl)-2-Oxoethylphosphonic Acid,SmallMoleculeDrug,P08311,Cathepsin G,CTSG,255.0
10479,DB04016,2-[3-({Methyl[1-(2-Naphthoyl)Piperidin-4-Yl]Amino}Carbonyl)-2-Naphthyl]-1-(1-Naphthyl)-2-Oxoethylphosphonic Acid,SmallMoleculeDrug,P23946,Chymase,CMA1,247.0
10480,DB04017,"N-Methyl-N-Propargyl-3-(2,4-Dichlorophenoxy)Propylamine",SmallMoleculeDrug,P21397,Amine oxidase [flavin-containing] A,MAOA,527.0
10481,DB04018,S-Isopropyl-Isothiourea,SmallMoleculeDrug,P29474,"Nitric oxide synthase, endothelial",NOS3,1203.0
10482,DB04020,"4-(2-{[4-{[3-(4-Chlorophenyl)Propyl]Sulfanyl}-6-(1-Piperazinyl)-1,3,5-Triazin-2-Yl]Amino}Ethyl)Phenol",SmallMoleculeDrug,Q92731,Estrogen receptor beta,ESR2,530.0
10483,DB04021,MF268,SmallMoleculeDrug,P22303,Acetylcholinesterase,ACHE,614.0
10488,DB04027,D-Arginine,SmallMoleculeDrug,P06732,Creatine kinase M-type,CKM,381.0
10501,DB04036,Coenzyme a Persulfide,SmallMoleculeDrug,P26440,"Isovaleryl-CoA dehydrogenase, mitochondrial",IVD,423.0
10510,DB04043,Carboxymycobactin T,SmallMoleculeDrug,P80188,Neutrophil gelatinase-associated lipocalin,LCN2,198.0
10511,DB04044,4-{2-[(3-Nitrobenzoyl)Amino]Phenoxy}Phthalic Acid,SmallMoleculeDrug,P11217,"Glycogen phosphorylase, muscle form",PYGM,842.0
10515,DB04048,N-Carbamoyl-Alanine,SmallMoleculeDrug,P32119,Peroxiredoxin-2,PRDX2,198.0
10516,DB04050,N-Propyl Isocyanide,SmallMoleculeDrug,P02144,Myoglobin,MB,154.0
10520,DB04054,"9-Butyl-8-(2,5-Dimethoxy-Benzyl)-2-Fluoro-9h-Purin-6-Ylamine",SmallMoleculeDrug,P07900,Heat shock protein HSP 90-alpha,HSP90AA1,732.0
10521,DB04055,"2,3-Dicarboxy-4-(2-Chloro-Phenyl)-1-Ethyl-5-Isopropoxycarbonyl-6-Methyl-Pyridinium",SmallMoleculeDrug,P11217,"Glycogen phosphorylase, muscle form",PYGM,842.0
10522,DB04057,"Beta-Dadf, Msa, Multisubstrate Adduct Inhibitor",SmallMoleculeDrug,P31939,Bifunctional purine biosynthesis protein PURH,ATIC,592.0
10524,DB04058,D-[(Amino)Carbonyl]Phenylalanine,SmallMoleculeDrug,P15085,Carboxypeptidase A1,CPA1,419.0
10525,DB04059,8-(Pyrimidin-2-Ylamino)Naphthalene-2-Carboximidamide,SmallMoleculeDrug,P00749,Urokinase-type plasminogen activator,PLAU,431.0
10530,DB04065,N-Cyclopentyl-N-Cyclobutylformamide,SmallMoleculeDrug,P07327,Alcohol dehydrogenase 1A,ADH1A,375.0
10533,DB04066,Para-Coumaric Acid,SmallMoleculeDrug,Q14914,Prostaglandin reductase 1,PTGR1,329.0
10537,DB04068,Fudp,SmallMoleculeDrug,P15531,Nucleoside diphosphate kinase A,NME1,152.0
10538,DB04069,"5,6-Dihydro-Benzo[H]Cinnolin-3-Ylamine",SmallMoleculeDrug,P53355,Death-associated protein kinase 1,DAPK1,1430.0
10540,DB04071,Cpad,SmallMoleculeDrug,P00326,Alcohol dehydrogenase 1C,ADH1C,375.0
10541,DB04072,Alpha-Methylisocitric Acid,SmallMoleculeDrug,Q99798,"Aconitate hydratase, mitochondrial",ACO2,780.0
10546,DB04074,Alpha-ketoisovalerate,SmallMoleculeDrug,O15382,"Branched-chain-amino-acid aminotransferase, mitochondrial",BCAT2,392.0
10549,DB04076,Hypoxanthine,SmallMoleculeDrug,P00491,Purine nucleoside phosphorylase,PNP,289.0
10552,DB04077,Glycerol,SmallMoleculeDrug,O14717,tRNA (cytosine(38)-C(5))-methyltransferase,TRDMT1,391.0
10555,DB04077,Glycerol,SmallMoleculeDrug,P00325,Alcohol dehydrogenase 1B,ADH1B,375.0
10556,DB04077,Glycerol,SmallMoleculeDrug,Q14643,"Inositol 1,4,5-trisphosphate receptor type 1",ITPR1,2758.0
10557,DB04077,Glycerol,SmallMoleculeDrug,P09466,Glycodelin,PAEP,180.0
10558,DB04077,Glycerol,SmallMoleculeDrug,P17050,Alpha-N-acetylgalactosaminidase,NAGA,411.0
10561,DB04077,Glycerol,SmallMoleculeDrug,P37173,TGF-beta receptor type-2,TGFBR2,567.0
10564,DB04077,Glycerol,SmallMoleculeDrug,P84077,ADP-ribosylation factor 1,ARF1,181.0
10566,DB04077,Glycerol,SmallMoleculeDrug,O43252,Bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthase 1,PAPSS1,624.0
10569,DB04077,Glycerol,SmallMoleculeDrug,O60760,Hematopoietic prostaglandin D synthase,HPGDS,199.0
10571,DB04077,Glycerol,SmallMoleculeDrug,P09211,Glutathione S-transferase P,GSTP1,210.0
10572,DB04077,Glycerol,SmallMoleculeDrug,Q9NZK7,Group IIE secretory phospholipase A2,PLA2G2E,142.0
10573,DB04077,Glycerol,SmallMoleculeDrug,Q9NPH2,Inositol-3-phosphate synthase 1,ISYNA1,558.0
10576,DB04079,"Heptane-1,2,3-Triol",SmallMoleculeDrug,P08100,Rhodopsin,RHO,348.0
10577,DB04080,RU78191,SmallMoleculeDrug,P12931,Proto-oncogene tyrosine-protein kinase Src,SRC,536.0
10578,DB04081,"(4s-Trans)-4-(Methylamino)-5,6-Dihydro-6-Methyl-4h-Thieno(2,3-B)Thiopyran-2-Sulfonamide-7,7-Dioxide",SmallMoleculeDrug,P00918,Carbonic anhydrase 2,CA2,260.0
10586,DB04083,N'-Pyridoxyl-Lysine-5'-Monophosphate,SmallMoleculeDrug,Q16773,Kynurenine--oxoglutarate transaminase 1,KYAT1,422.0
10587,DB04083,N'-Pyridoxyl-Lysine-5'-Monophosphate,SmallMoleculeDrug,P11926,Ornithine decarboxylase,ODC1,461.0
10589,DB04083,N'-Pyridoxyl-Lysine-5'-Monophosphate,SmallMoleculeDrug,P11217,"Glycogen phosphorylase, muscle form",PYGM,842.0
10590,DB04083,N'-Pyridoxyl-Lysine-5'-Monophosphate,SmallMoleculeDrug,P21549,Serine--pyruvate aminotransferase,AGXT,392.0
10597,DB04088,N-(Allyloxycarbonyl)-4-[N-(Carboxy-Formyl)-2-(Benzoic Acid)-Amino]-L-Phenylalaninyl-Amino-Butyloxy-(6-Hydroxy-Benzoic Acid Methyl Ester),SmallMoleculeDrug,P18031,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,435.0
10598,DB04089,AL5300,SmallMoleculeDrug,P00918,Carbonic anhydrase 2,CA2,260.0
10599,DB04090,"2,5-Diaziridin-1-Yl-3-(Hydroxymethyl)-6-Methylcyclohexa-2,5-Diene-1,4-Dione",SmallMoleculeDrug,P15559,NAD(P)H dehydrogenase [quinone] 1,NQO1,274.0
10601,DB04094,4-Hydroxy-2-Butanone,SmallMoleculeDrug,P62942,Peptidyl-prolyl cis-trans isomerase FKBP1A,FKBP1A,108.0
10604,DB04098,Balanol,SmallMoleculeDrug,P17612,cAMP-dependent protein kinase catalytic subunit alpha,PRKACA,351.0
10606,DB04099,Deamido-Nad+,SmallMoleculeDrug,Q9HAN9,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,NMNAT1,279.0
10608,DB04099,Deamido-Nad+,SmallMoleculeDrug,Q96T66,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 3,NMNAT3,252.0
10612,DB04101,"N-[4-(2,4-Dimethyl-1,3-Thiazol-5-Yl)Pyrimidin-2-Yl]-N'-Hydroxyimidoformamide",SmallMoleculeDrug,P24941,Cyclin-dependent kinase 2,CDK2,298.0
10615,DB04105,N-Heptylformamide,SmallMoleculeDrug,P00325,Alcohol dehydrogenase 1B,ADH1B,375.0
10616,DB04106,Fotemustine,SmallMoleculeDrug,Q16881,"Thioredoxin reductase 1, cytoplasmic",TXNRD1,649.0
10617,DB04107,[(1-{2[(4-Carbamimidoyl-Phenylamino)-Methyl]-1-Methyl-1h-Benzoimidazol-5-Yl}-Cyclopropyl)-Pyridin-2-Yl-Methyleneaminooxy]-Acetic Acid Ethyl Ester,SmallMoleculeDrug,P07477,Trypsin-1,PRSS1,247.0
10618,DB04108,"(2s,3r)-3-Amino-2-Hydroxy-5-(Ethylsulfanyl)Pentanoyl-((S)-(-)-(1-Naphthyl)Ethyl)Amide",SmallMoleculeDrug,P50579,Methionine aminopeptidase 2,METAP2,478.0
10619,DB04109,"[4-(1,3,2-Dioxaborolan-2-Yloxy)Methyl]Benzamidine",SmallMoleculeDrug,P35030,Trypsin-3,PRSS3,304.0
10620,DB04112,1-Octadecyl-2-Acetamido-2-Deoxy-Sn-Glycerol-3-Phosphoethylmethyl Sulfide,SmallMoleculeDrug,P14555,"Phospholipase A2, membrane associated",PLA2G2A,144.0
10621,DB04113,N-Formylpiperidine,SmallMoleculeDrug,P00326,Alcohol dehydrogenase 1C,ADH1C,375.0
10622,DB04114,"3-Chloro-9-Ethyl-6,7,8,9,10,11-Hexahydro-7,11-Methanocycloocta[B]Quinolin-12-Amine",SmallMoleculeDrug,P22303,Acetylcholinesterase,ACHE,614.0
10625,DB04117,"4-(N,N-Dimethylamino)Cinnamoyl-Coa",SmallMoleculeDrug,P30084,"Enoyl-CoA hydratase, mitochondrial",ECHS1,290.0
10626,DB04119,Hexatantalum Dodecabromide,SmallMoleculeDrug,Q9UQM7,Calcium/calmodulin-dependent protein kinase type II subunit alpha,CAMK2A,478.0
10627,DB04119,Hexatantalum Dodecabromide,SmallMoleculeDrug,P22314,Ubiquitin-like modifier-activating enzyme 1,UBA1,1058.0
10630,DB04121,Guanosine-3'-Monophosphate-5'-Diphosphate,SmallMoleculeDrug,P84077,ADP-ribosylation factor 1,ARF1,181.0
10634,DB04125,N-Alpha-(2-Naphthylsulfonyl)-N(3-Amidino-L-Phenylalaninyl)-4-Acetyl-Piperazine,SmallMoleculeDrug,P07477,Trypsin-1,PRSS1,247.0
10635,DB04126,N-[1-Hydroxycarboxyethyl-Carbonyl]Leucylamino-2-Methyl-Butane,SmallMoleculeDrug,P07858,Cathepsin B,CTSB,339.0
10636,DB04126,N-[1-Hydroxycarboxyethyl-Carbonyl]Leucylamino-2-Methyl-Butane,SmallMoleculeDrug,P09668,Pro-cathepsin H,CTSH,335.0
10639,DB04129,Willardiine,SmallMoleculeDrug,P42262,Glutamate receptor 2,GRIA2,883.0
10642,DB04132,S-Hexylglutathione,SmallMoleculeDrug,Q04760,Lactoylglutathione lyase,GLO1,184.0
10643,DB04132,S-Hexylglutathione,SmallMoleculeDrug,Q03013,Glutathione S-transferase Mu 4,GSTM4,218.0
10644,DB04132,S-Hexylglutathione,SmallMoleculeDrug,P09211,Glutathione S-transferase P,GSTP1,210.0
10646,DB04132,S-Hexylglutathione,SmallMoleculeDrug,P08263,Glutathione S-transferase A1,GSTA1,222.0
10647,DB04132,S-Hexylglutathione,SmallMoleculeDrug,P0CG29,Glutathione S-transferase theta-2,GSTT2,244.0
10651,DB04136,Lysophosphotidylserine,SmallMoleculeDrug,P00734,Prothrombin,F2,622.0
10652,DB04137,Guanosine-5'-Triphosphate,SmallMoleculeDrug,P20339,Ras-related protein Rab-5A,RAB5A,215.0
10655,DB04137,Guanosine-5'-Triphosphate,SmallMoleculeDrug,Q9NWZ5,Uridine-cytidine kinase-like 1,UCKL1,548.0
10656,DB04137,Guanosine-5'-Triphosphate,SmallMoleculeDrug,P01112,GTPase HRas,HRAS,189.0
10658,DB04137,Guanosine-5'-Triphosphate,SmallMoleculeDrug,P61587,Rho-related GTP-binding protein RhoE,RND3,244.0
10660,DB04137,Guanosine-5'-Triphosphate,SmallMoleculeDrug,Q15382,GTP-binding protein Rheb,RHEB,184.0
10662,DB04137,Guanosine-5'-Triphosphate,SmallMoleculeDrug,P16118,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 1",PFKFB1,471.0
10665,DB04137,Guanosine-5'-Triphosphate,SmallMoleculeDrug,P84077,ADP-ribosylation factor 1,ARF1,181.0
10668,DB04137,Guanosine-5'-Triphosphate,SmallMoleculeDrug,P00367,"Glutamate dehydrogenase 1, mitochondrial",GLUD1,558.0
10669,DB04137,Guanosine-5'-Triphosphate,SmallMoleculeDrug,Q8N142,Adenylosuccinate synthetase isozyme 1,ADSSL1,457.0
10670,DB04137,Guanosine-5'-Triphosphate,SmallMoleculeDrug,P10114,Ras-related protein Rap-2a,RAP2A,183.0
10673,DB04140,1-Benzyl-3-(4-Methoxy-Benzenesulfonyl)-6-Oxo-Hexahydro-Pyrimidine-4-Carboxylic Acid Hydroxyamide,SmallMoleculeDrug,P08254,Stromelysin-1,MMP3,477.0
10674,DB04141,"2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol",SmallMoleculeDrug,P16442,Histo-blood group ABO system transferase,ABO,354.0
10675,DB04141,"2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol",SmallMoleculeDrug,P08574,"Cytochrome c1, heme protein, mitochondrial",CYC1,325.0
10676,DB04141,"2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol",SmallMoleculeDrug,P00156,Cytochrome b,MT-CYB,380.0
10677,DB04141,"2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol",SmallMoleculeDrug,P31930,"Cytochrome b-c1 complex subunit 1, mitochondrial",UQCRC1,480.0
10678,DB04141,"2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol",SmallMoleculeDrug,P22695,"Cytochrome b-c1 complex subunit 2, mitochondrial",UQCRC2,453.0
10679,DB04141,"2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol",SmallMoleculeDrug,P07919,"Cytochrome b-c1 complex subunit 6, mitochondrial",UQCRH,91.0
10680,DB04141,"2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol",SmallMoleculeDrug,O14949,Cytochrome b-c1 complex subunit 8,UQCRQ,82.0
10681,DB04141,"2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol",SmallMoleculeDrug,P47985,"Cytochrome b-c1 complex subunit Rieske, mitochondrial",UQCRFS1,274.0
10682,DB04141,"2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol",SmallMoleculeDrug,P14927,Cytochrome b-c1 complex subunit 7,UQCRB,111.0
10683,DB04141,"2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol",SmallMoleculeDrug,Q9UDW1,Cytochrome b-c1 complex subunit 9,UQCR10,63.0
10684,DB04141,"2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol",SmallMoleculeDrug,P31040,"Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial",SDHA,664.0
10685,DB04141,"2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol",SmallMoleculeDrug,P21912,"Succinate dehydrogenase [ubiquinone] iron-sulfur subunit, mitochondrial",SDHB,280.0
10686,DB04141,"2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol",SmallMoleculeDrug,O14521,"Succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial",SDHD,159.0
10687,DB04141,"2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol",SmallMoleculeDrug,Q16134,"Electron transfer flavoprotein-ubiquinone oxidoreductase, mitochondrial",ETFDH,617.0
10688,DB04141,"2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol",SmallMoleculeDrug,Q99643,"Succinate dehydrogenase cytochrome b560 subunit, mitochondrial",SDHC,169.0
10689,DB04142,"3-(3,5-Dibromo-4-Hydroxy-Benzoyl)-2-Ethyl-Benzofuran-6-Sulfonic Acid Dimethylamide",SmallMoleculeDrug,P18031,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,435.0
10692,DB04144,"Cis-[4,5-Bis-(4-Chlorophenyl)-2-(2-Isopropoxy-4-Methoxyphenyl)-4,5-Dihyd Roimidazol-1-Yl]-Piperazin-1-Yl-Methanone",SmallMoleculeDrug,Q00987,E3 ubiquitin-protein ligase Mdm2,MDM2,491.0
10696,DB04147,Lauryl Dimethylamine-N-Oxide,SmallMoleculeDrug,P27338,Amine oxidase [flavin-containing] B,MAOB,520.0
10704,DB04147,Lauryl Dimethylamine-N-Oxide,SmallMoleculeDrug,P01764,Ig heavy chain V-III region 23,IGHV3-23,117.0
10710,DB04147,Lauryl Dimethylamine-N-Oxide,SmallMoleculeDrug,P60981,Destrin,DSTN,165.0
10711,DB04147,Lauryl Dimethylamine-N-Oxide,SmallMoleculeDrug,P08100,Rhodopsin,RHO,348.0
10713,DB04147,Lauryl Dimethylamine-N-Oxide,SmallMoleculeDrug,Q14494,Nuclear factor erythroid 2-related factor 1,NFE2L1,772.0
10718,DB04147,Lauryl Dimethylamine-N-Oxide,SmallMoleculeDrug,P02689,Myelin P2 protein,PMP2,132.0
10725,DB04147,Lauryl Dimethylamine-N-Oxide,SmallMoleculeDrug,P23528,Cofilin-1,CFL1,166.0
10737,DB04147,Lauryl Dimethylamine-N-Oxide,SmallMoleculeDrug,Q02127,"Dihydroorotate dehydrogenase (quinone), mitochondrial",DHODH,395.0
10742,DB04149,(R)-Rolipram,SmallMoleculeDrug,Q07343,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B",PDE4B,736.0
10743,DB04149,(R)-Rolipram,SmallMoleculeDrug,Q08499,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",PDE4D,809.0
10744,DB04150,Threonine Derivative,SmallMoleculeDrug,P19021,Peptidyl-glycine alpha-amidating monooxygenase,PAM,973.0
10745,DB04151,4-Methyl-Histidine,SmallMoleculeDrug,P68133,"Actin, alpha skeletal muscle",ACTA1,377.0
10746,DB04152,"2-Amino-3-(3-Hydroxy-7,8-Dihydro-6h-Cyclohepta[D]-4-Isoxazolyl)Propionic Acid",SmallMoleculeDrug,P42262,Glutamate receptor 2,GRIA2,883.0
10747,DB04153,S-Hydroxymethyl Glutathione,SmallMoleculeDrug,P11766,Alcohol dehydrogenase class-3,ADH5,374.0
10751,DB04156,Aspartate Beryllium Trifluoride,SmallMoleculeDrug,Q9GZU7,Carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1,CTDSP1,261.0
10765,DB04163,"5-Phenylsulfanyl-2,4-Quinazolinediamine",SmallMoleculeDrug,Q86XF0,"Dihydrofolate reductase, mitochondrial",DHFR2,187.0
10768,DB04166,2-Aminobenzoic Acid,SmallMoleculeDrug,Q96RQ9,L-amino-acid oxidase,IL4I1,567.0
10769,DB04166,2-Aminobenzoic Acid,SmallMoleculeDrug,P14920,D-amino-acid oxidase,DAO,347.0
10774,DB04172,"[2,4,6-Triisopropyl-Phenylsulfonyl-L-[3-Amidino-Phenylalanine]]-Piperazine-N'-Beta-Alanine",SmallMoleculeDrug,P00749,Urokinase-type plasminogen activator,PLAU,431.0
10776,DB04173,Fructose,SmallMoleculeDrug,P49789,Bis(5'-adenosyl)-triphosphatase,FHIT,147.0
10778,DB04175,Mdl-29951,SmallMoleculeDrug,P09467,"Fructose-1,6-bisphosphatase 1",FBP1,338.0
10780,DB04178,Di-Stearoyl-3-Sn-Phosphatidylcholine,SmallMoleculeDrug,P17213,Bactericidal permeability-increasing protein,BPI,487.0
10781,DB04178,Di-Stearoyl-3-Sn-Phosphatidylcholine,SmallMoleculeDrug,P12235,ADP/ATP translocase 1,SLC25A4,298.0
10783,DB04180,"4-(Aminosulfonyl)-N-[(2,4-Difluorophenyl)Methyl]-Benzamide",SmallMoleculeDrug,P00918,Carbonic anhydrase 2,CA2,260.0
10787,DB04185,Norvaline,SmallMoleculeDrug,P00480,"Ornithine carbamoyltransferase, mitochondrial",OTC,354.0
10788,DB04185,Norvaline,SmallMoleculeDrug,P50440,"Glycine amidinotransferase, mitochondrial",GATM,423.0
10789,DB04186,"N'-(Pyrrolidino[2,1-B]Isoindolin-4-On-8-Yl)-N-(Pyridin-2-Yl)Urea",SmallMoleculeDrug,P24941,Cyclin-dependent kinase 2,CDK2,298.0
10790,DB04187,"(9s,10s)-9-(S-Glutathionyl)-10-Hydroxy-9,10-Dihydrophenanthrene",SmallMoleculeDrug,P09488,Glutathione S-transferase Mu 1,GSTM1,218.0
10793,DB04194,Chitotriose,SmallMoleculeDrug,P61626,Lysozyme C,LYZ,148.0
10794,DB04195,Heptulose-2-Phosphate,SmallMoleculeDrug,P11217,"Glycogen phosphorylase, muscle form",PYGM,842.0
10796,DB04197,Descarboxy-nor-N(Omega)-Hydroxy-L-Arginine,SmallMoleculeDrug,P05089,Arginase-1,ARG1,322.0
10802,DB04200,Matairesinol,SmallMoleculeDrug,Q6PKH6,Dehydrogenase/reductase SDR family member 4-like 2,DHRS4L2,230.0
10805,DB04203,3-Mercuri-4-Aminobenzenesulfonamide,SmallMoleculeDrug,P00918,Carbonic anhydrase 2,CA2,260.0
10806,DB04204,[(4-{4-[4-(Difluoro-Phosphono-Methyl)-Phenyl]-Butyl}-Phenyl)-Difluoro-Methyl]-Phosphonic Acid,SmallMoleculeDrug,P18031,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,435.0
10810,DB04207,N-(5-Amino-5-Carboxypentyl)Glutamic Acid,SmallMoleculeDrug,Q9UDR5,"Alpha-aminoadipic semialdehyde synthase, mitochondrial",AASS,926.0
10816,DB04213,N-Cyclohexyl-N'-(Propyl)Phenyl Urea,SmallMoleculeDrug,P34913,Bifunctional epoxide hydrolase 2,EPHX2,555.0
10817,DB04214,4-Nitrophenyl Phosphate,SmallMoleculeDrug,P24666,Low molecular weight phosphotyrosine protein phosphatase,ACP1,158.0
10818,DB04214,4-Nitrophenyl Phosphate,SmallMoleculeDrug,Q9BVJ7,Dual specificity protein phosphatase 23,DUSP23,150.0
10819,DB04215,CRA_9076,SmallMoleculeDrug,P07477,Trypsin-1,PRSS1,247.0
10820,DB04216,Quercetin,SmallMoleculeDrug,P08631,Tyrosine-protein kinase HCK,HCK,526.0
10821,DB04216,Quercetin,SmallMoleculeDrug,P48736,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",PIK3CG,1102.0
10822,DB04216,Quercetin,SmallMoleculeDrug,Q6NUS8,UDP-glucuronosyltransferase 3A1,UGT3A1,523.0
10823,DB04216,Quercetin,SmallMoleculeDrug,P25705,"ATP synthase subunit alpha, mitochondrial",ATP5A1,553.0
10824,DB04216,Quercetin,SmallMoleculeDrug,P06576,"ATP synthase subunit beta, mitochondrial",ATP5B,529.0
10825,DB04216,Quercetin,SmallMoleculeDrug,P36542,"ATP synthase subunit gamma, mitochondrial",ATP5C1,298.0
10826,DB04216,Quercetin,SmallMoleculeDrug,P11309,Serine/threonine-protein kinase pim-1,PIM1,404.0
10828,DB04216,Quercetin,SmallMoleculeDrug,Q6NVY1,"3-hydroxyisobutyryl-CoA hydrolase, mitochondrial",HIBCH,386.0
10830,DB04216,Quercetin,SmallMoleculeDrug,O94768,Serine/threonine-protein kinase 17B,STK17B,372.0
10831,DB04217,L-2-amino-3-butynoic acid,SmallMoleculeDrug,P32929,Cystathionine gamma-lyase,CTH,405.0
10833,DB04218,1-Deaza-Adenosine,SmallMoleculeDrug,P00813,Adenosine deaminase,ADA,363.0
10836,DB04223,Nitroarginine,SmallMoleculeDrug,P29474,"Nitric oxide synthase, endothelial",NOS3,1203.0
10837,DB04223,Nitroarginine,SmallMoleculeDrug,P29475,"Nitric oxide synthase, brain",NOS1,1434.0
10838,DB04224,Oleic Acid,SmallMoleculeDrug,Q9NZD2,Glycolipid transfer protein,GLTP,209.0
10840,DB04224,Oleic Acid,SmallMoleculeDrug,P02689,Myelin P2 protein,PMP2,132.0
10843,DB04230,Nitromethyldethia Coenzyme A,SmallMoleculeDrug,O75390,"Citrate synthase, mitochondrial",CS,466.0
10845,DB04232,N-Hydroxy-1-(4-Methoxyphenyl)Sulfonyl-4-Benzyloxycarbonyl-Piperazine-2-Carboxamide,SmallMoleculeDrug,P08254,Stromelysin-1,MMP3,477.0
10853,DB04233,(Hydroxyethyloxy)Tri(Ethyloxy)Octane,SmallMoleculeDrug,P04118,Colipase,CLPS,112.0
10854,DB04233,(Hydroxyethyloxy)Tri(Ethyloxy)Octane,SmallMoleculeDrug,P16233,Pancreatic triacylglycerol lipase,PNLIP,465.0
10855,DB04233,(Hydroxyethyloxy)Tri(Ethyloxy)Octane,SmallMoleculeDrug,P08100,Rhodopsin,RHO,348.0
10871,DB04234,N2-({[(4-Bromophenyl)Methyl]Oxy}Carbonyl)-N1-[(1s)-1-Formylpentyl]-L-Leucinamide,SmallMoleculeDrug,P43235,Cathepsin K,CTSK,329.0
10872,DB04235,4-Amino Hexanoic Acid,SmallMoleculeDrug,P80404,"4-aminobutyrate aminotransferase, mitochondrial",ABAT,500.0
10873,DB04237,Tris(Hydroxyethyl)Aminomethane,SmallMoleculeDrug,P04745,Alpha-amylase 1,AMY1A,511.0
10876,DB04238,N-Alpha-(2-Naphthylsulfonyl)-N-(3-Amidino-L-Phenylalaninyl)-D-Pipecolinic Acid,SmallMoleculeDrug,P07477,Trypsin-1,PRSS1,247.0
10884,DB04244,1-[2-(3-Biphenyl)-4-Methylvaleryl)]Amino-3-(2-Pyridylsulfonyl)Amino-2-Propanone,SmallMoleculeDrug,P43235,Cathepsin K,CTSK,329.0
10886,DB04246,CRA_23653,SmallMoleculeDrug,P07477,Trypsin-1,PRSS1,247.0
10888,DB04249,Zinc Substituted Heme C,SmallMoleculeDrug,P99999,Cytochrome c,CYCS,105.0
10889,DB04250,Butyrylthiocholine,SmallMoleculeDrug,P06276,Cholinesterase,BCHE,602.0
10891,DB04251,Monoisopropyl Ester Phosphonic Acid Group,SmallMoleculeDrug,P06276,Cholinesterase,BCHE,602.0
10894,DB04253,CB1954,SmallMoleculeDrug,P16083,Ribosyldihydronicotinamide dehydrogenase [quinone],NQO2,231.0
10895,DB04254,"8-Benzo[1,3]Dioxol-,5-Ylmethyl-9-Butyl-2-Fluoro-9h-Purin-6-Ylamine",SmallMoleculeDrug,P07900,Heat shock protein HSP 90-alpha,HSP90AA1,732.0
10897,DB04256,4-(1-Amino-1-Carboxy-Ethyl)-Benzoic Acid,SmallMoleculeDrug,Q13255,Metabotropic glutamate receptor 1,GRM1,1194.0
10901,DB04258,Seocalcitol,SmallMoleculeDrug,P11473,Vitamin D3 receptor,VDR,427.0
10902,DB04260,"9-(5,5-Difluoro-5-Phosphonopentyl)Guanine",SmallMoleculeDrug,P00491,Purine nucleoside phosphorylase,PNP,289.0
10905,DB04263,Geneticin,SmallMoleculeDrug,P11926,Ornithine decarboxylase,ODC1,461.0
10913,DB04268,Methylumbelliferyl Chitotriose,SmallMoleculeDrug,P61626,Lysozyme C,LYZ,148.0
10914,DB04269,Cyclotheonamide A,SmallMoleculeDrug,P07477,Trypsin-1,PRSS1,247.0
10915,DB04270,(S)-3-(4-(2-Carbazol-9-Yl-Ethoxy)-Phenyl)-2-Ethoxy-Propionic Acid,SmallMoleculeDrug,P37231,Peroxisome proliferator-activated receptor gamma,PPARG,505.0
10916,DB04271,"3,5-Dimethyl-1h-Pyrazole-4-Carboxylic Acid Ethyl Ester",SmallMoleculeDrug,Q08499,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",PDE4D,809.0
10923,DB04272,Citric Acid,SmallMoleculeDrug,Q96RQ9,L-amino-acid oxidase,IL4I1,567.0
10924,DB04272,Citric Acid,SmallMoleculeDrug,P14174,Macrophage migration inhibitory factor,MIF,115.0
10925,DB04272,Citric Acid,SmallMoleculeDrug,Q9GZU7,Carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1,CTDSP1,261.0
10930,DB04272,Citric Acid,SmallMoleculeDrug,O14964,Hepatocyte growth factor-regulated tyrosine kinase substrate,HGS,777.0
10934,DB04272,Citric Acid,SmallMoleculeDrug,P40926,"Malate dehydrogenase, mitochondrial",MDH2,338.0
10937,DB04272,Citric Acid,SmallMoleculeDrug,P15086,Carboxypeptidase B,CPB1,417.0
10944,DB04272,Citric Acid,SmallMoleculeDrug,P62312,U6 snRNA-associated Sm-like protein LSm6,LSM6,80.0
10945,DB04272,Citric Acid,SmallMoleculeDrug,Q9HB21,Pleckstrin homology domain-containing family A member 1,PLEKHA1,404.0
10950,DB04272,Citric Acid,SmallMoleculeDrug,P07360,Complement component C8 gamma chain,C8G,202.0
10956,DB04272,Citric Acid,SmallMoleculeDrug,P07741,Adenine phosphoribosyltransferase,APRT,180.0
10957,DB04272,Citric Acid,SmallMoleculeDrug,P03950,Angiogenin,ANG,147.0
10961,DB04272,Citric Acid,SmallMoleculeDrug,Q9BZX2,Uridine-cytidine kinase 2,UCK2,261.0
10962,DB04272,Citric Acid,SmallMoleculeDrug,Q9Y275,Tumor necrosis factor ligand superfamily member 13B,TNFSF13B,285.0
10964,DB04272,Citric Acid,SmallMoleculeDrug,Q93088,Betaine--homocysteine S-methyltransferase 1,BHMT,406.0
10968,DB04272,Citric Acid,SmallMoleculeDrug,P15121,Aldose reductase,AKR1B1,316.0
10969,DB04272,Citric Acid,SmallMoleculeDrug,Q9BY32,Inosine triphosphate pyrophosphatase,ITPA,194.0
10970,DB04272,Citric Acid,SmallMoleculeDrug,O75390,"Citrate synthase, mitochondrial",CS,466.0
10972,DB04272,Citric Acid,SmallMoleculeDrug,Q9Y663,Heparan sulfate glucosamine 3-O-sulfotransferase 3A1,HS3ST3A1,406.0
10974,DB04272,Citric Acid,SmallMoleculeDrug,O76074,"cGMP-specific 3',5'-cyclic phosphodiesterase",PDE5A,875.0
10976,DB04272,Citric Acid,SmallMoleculeDrug,P12931,Proto-oncogene tyrosine-protein kinase Src,SRC,536.0
10978,DB04272,Citric Acid,SmallMoleculeDrug,P07998,Ribonuclease pancreatic,RNASE1,156.0
10980,DB04272,Citric Acid,SmallMoleculeDrug,Q14749,Glycine N-methyltransferase,GNMT,295.0
10981,DB04272,Citric Acid,SmallMoleculeDrug,P12724,Eosinophil cationic protein,RNASE3,160.0
10983,DB04273,"8,9-Dichloro-2,3,4,5-Tetrahydro-1h-Benzo[C]Azepine",SmallMoleculeDrug,P11086,Phenylethanolamine N-methyltransferase,PNMT,282.0
10984,DB04275,N-Acetyl Serotonin,SmallMoleculeDrug,P35270,Sepiapterin reductase,SPR,261.0
10986,DB04276,N-[N-[1-Hydroxycarboxyethyl-Carbonyl]Leucylamino-Butyl]-Guanidine,SmallMoleculeDrug,P07384,Calpain-1 catalytic subunit,CAPN1,714.0
10988,DB04278,2-[2-(2-Cyclohexyl-2-Guanidino-Acetylamino)-Acetylamino]-N-(3-Mercapto-Propyl)-Propionamide,SmallMoleculeDrug,P60568,Interleukin-2,IL2,153.0
10992,DB04281,"2-[4-(4-Chlorophenyl)Cyclohexylidene]-3,4-Dihydroxy-1(2h)-Naphthalenone",SmallMoleculeDrug,Q02127,"Dihydroorotate dehydrogenase (quinone), mitochondrial",DHODH,395.0
10995,DB04282,2-deoxy-2-fluoro-?-D-glucose,SmallMoleculeDrug,P09848,Lactase-phlorizin hydrolase,LCT,1927.0
10998,DB04285,"{4-[(2s,4e)-2-(1,3-Benzothiazol-2-Yl)-2-(1h-1,2,3-Benzotriazol-1-Yl)-5-Phenylpent-4-Enyl]Phenyl}(Difluoro)Methylphosphonic Acid",SmallMoleculeDrug,P18031,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,435.0
11001,DB04287,(S)-5-(4-Benzyloxy-Phenyl)-4-(7-Phenyl-Heptanoylamino)-Pentanoic Acid,SmallMoleculeDrug,P14555,"Phospholipase A2, membrane associated",PLA2G2A,144.0
11002,DB04288,2-[Trans-(4-Aminocyclohexyl)Amino]-6-(Benzyl-Amino)-9-Cyclopentylpurine,SmallMoleculeDrug,P24941,Cyclin-dependent kinase 2,CDK2,298.0
11007,DB04295,N-Benzoyl-N'-Beta-D-Glucopyranosyl Urea,SmallMoleculeDrug,P11217,"Glycogen phosphorylase, muscle form",PYGM,842.0
11009,DB04297,"7-[4-(Dimethylamino)Phenyl]-N-Hydroxy-4,6-Dimethyl-7-Oxo-2,4-Heptadienamide",SmallMoleculeDrug,Q9BY41,Histone deacetylase 8,HDAC8,377.0
11011,DB04297,"7-[4-(Dimethylamino)Phenyl]-N-Hydroxy-4,6-Dimethyl-7-Oxo-2,4-Heptadienamide",SmallMoleculeDrug,Q8WUI4,Histone deacetylase 7,HDAC7,952.0
11013,DB04299,Maleic Acid,SmallMoleculeDrug,P17174,"Aspartate aminotransferase, cytoplasmic",GOT1,413.0
11018,DB04301,Bis(5-Amidino-2-Benzimidazolyl)Methane Ketone Hydrate,SmallMoleculeDrug,P07477,Trypsin-1,PRSS1,247.0
11025,DB04306,"5-[(4-Methylphenyl)Sulfanyl]-2,4-Quinazolinediamine",SmallMoleculeDrug,Q86XF0,"Dihydrofolate reductase, mitochondrial",DHFR2,187.0
11026,DB04307,5-Hydroxy-N-Propargyl-1(R)-Aminoindan,SmallMoleculeDrug,P27338,Amine oxidase [flavin-containing] B,MAOB,520.0
11037,DB04310,2-[(Formyl-Hydroxy-Amino)-Methyl]-Heptanoic Acid [1-(2-Hydroxymethyl-Pyrrolidine-1-Carbonyl)-2-Methyl-Propyl]-Amide,SmallMoleculeDrug,Q9HBH1,"Peptide deformylase, mitochondrial",PDF,243.0
11038,DB04311,4-Phenylbutylamine,SmallMoleculeDrug,P07477,Trypsin-1,PRSS1,247.0
11039,DB04312,"2,3-Difluorobenzyl Alcohol",SmallMoleculeDrug,P00326,Alcohol dehydrogenase 1C,ADH1C,375.0
11041,DB04315,Guanosine-5'-Diphosphate,SmallMoleculeDrug,Q8N142,Adenylosuccinate synthetase isozyme 1,ADSSL1,457.0
11043,DB04315,Guanosine-5'-Diphosphate,SmallMoleculeDrug,P49411,"Elongation factor Tu, mitochondrial",TUFM,452.0
11047,DB04315,Guanosine-5'-Diphosphate,SmallMoleculeDrug,P41091,Eukaryotic translation initiation factor 2 subunit 3,EIF2S3,472.0
11048,DB04315,Guanosine-5'-Diphosphate,SmallMoleculeDrug,P63096,Guanine nucleotide-binding protein G(i) subunit alpha-1,GNAI1,354.0
11050,DB04315,Guanosine-5'-Diphosphate,SmallMoleculeDrug,P11488,Guanine nucleotide-binding protein G(t) subunit alpha-1,GNAT1,350.0
11052,DB04315,Guanosine-5'-Diphosphate,SmallMoleculeDrug,P51151,Ras-related protein Rab-9A,RAB9A,201.0
11053,DB04315,Guanosine-5'-Diphosphate,SmallMoleculeDrug,P15531,Nucleoside diphosphate kinase A,NME1,152.0
11054,DB04315,Guanosine-5'-Diphosphate,SmallMoleculeDrug,Q15382,GTP-binding protein Rheb,RHEB,184.0
11055,DB04315,Guanosine-5'-Diphosphate,SmallMoleculeDrug,P60953,Cell division control protein 42 homolog,CDC42,191.0
11057,DB04315,Guanosine-5'-Diphosphate,SmallMoleculeDrug,P84077,ADP-ribosylation factor 1,ARF1,181.0
11058,DB04315,Guanosine-5'-Diphosphate,SmallMoleculeDrug,P13639,Elongation factor 2,EEF2,858.0
11060,DB04315,Guanosine-5'-Diphosphate,SmallMoleculeDrug,P10114,Ras-related protein Rap-2a,RAP2A,183.0
11061,DB04315,Guanosine-5'-Diphosphate,SmallMoleculeDrug,Q7Z2Z2,Elongation factor Tu GTP-binding domain-containing protein 1,EFL1,1120.0
11062,DB04315,Guanosine-5'-Diphosphate,SmallMoleculeDrug,P40616,ADP-ribosylation factor-like protein 1,ARL1,181.0
11063,DB04315,Guanosine-5'-Diphosphate,SmallMoleculeDrug,P62826,GTP-binding nuclear protein Ran,RAN,216.0
11064,DB04315,Guanosine-5'-Diphosphate,SmallMoleculeDrug,P51149,Ras-related protein Rab-7a,RAB7A,207.0
11065,DB04315,Guanosine-5'-Diphosphate,SmallMoleculeDrug,Q6NXR0,Interferon-inducible GTPase 5,IRGC,463.0
11066,DB04315,Guanosine-5'-Diphosphate,SmallMoleculeDrug,P15170,Eukaryotic peptide chain release factor GTP-binding subunit ERF3A,GSPT1,499.0
11067,DB04315,Guanosine-5'-Diphosphate,SmallMoleculeDrug,P20339,Ras-related protein Rab-5A,RAB5A,215.0
11068,DB04315,Guanosine-5'-Diphosphate,SmallMoleculeDrug,P01112,GTPase HRas,HRAS,189.0
11069,DB04315,Guanosine-5'-Diphosphate,SmallMoleculeDrug,P68104,Elongation factor 1-alpha 1,EEF1A1,462.0
11070,DB04315,Guanosine-5'-Diphosphate,SmallMoleculeDrug,P61586,Transforming protein RhoA,RHOA,193.0
11071,DB04315,Guanosine-5'-Diphosphate,SmallMoleculeDrug,P18085,ADP-ribosylation factor 4,ARF4,180.0
11072,DB04315,Guanosine-5'-Diphosphate,SmallMoleculeDrug,P21980,Protein-glutamine gamma-glutamyltransferase 2,TGM2,687.0
11073,DB04315,Guanosine-5'-Diphosphate,SmallMoleculeDrug,O60547,"GDP-mannose 4,6 dehydratase",GMDS,372.0
11074,DB04315,Guanosine-5'-Diphosphate,SmallMoleculeDrug,P62491,Ras-related protein Rab-11A,RAB11A,216.0
11075,DB04315,Guanosine-5'-Diphosphate,SmallMoleculeDrug,P11233,Ras-related protein Ral-A,RALA,206.0
11078,DB04315,Guanosine-5'-Diphosphate,SmallMoleculeDrug,Q96KC2,ADP-ribosylation factor-like protein 5B,ARL5B,179.0
11080,DB04315,Guanosine-5'-Diphosphate,SmallMoleculeDrug,Q08188,Protein-glutamine gamma-glutamyltransferase E,TGM3,693.0
11082,DB04315,Guanosine-5'-Diphosphate,SmallMoleculeDrug,Q92930,Ras-related protein Rab-8B,RAB8B,207.0
11083,DB04315,Guanosine-5'-Diphosphate,SmallMoleculeDrug,P62330,ADP-ribosylation factor 6,ARF6,175.0
11084,DB04315,Guanosine-5'-Diphosphate,SmallMoleculeDrug,P36405,ADP-ribosylation factor-like protein 3,ARL3,182.0
11085,DB04315,Guanosine-5'-Diphosphate,SmallMoleculeDrug,P22392,Nucleoside diphosphate kinase B,NME2,152.0
11087,DB04315,Guanosine-5'-Diphosphate,SmallMoleculeDrug,P63000,Ras-related C3 botulinum toxin substrate 1,RAC1,192.0
11089,DB04315,Guanosine-5'-Diphosphate,SmallMoleculeDrug,Q9Y6B6,GTP-binding protein SAR1b,SAR1B,198.0
11091,DB04315,Guanosine-5'-Diphosphate,SmallMoleculeDrug,Q9Y689,ADP-ribosylation factor-like protein 5A,ARL5A,179.0
11092,DB04316,D-[(N-Hydroxyamino)Carbonyl]Phenylalanine,SmallMoleculeDrug,P15085,Carboxypeptidase A1,CPA1,419.0
11094,DB04318,1-Benzyloxycarbonylamino-2-Phenyl-Ethyl)-{2-[1-Carbamoyl-2-(1h-Indol-3-Yl)-Ethylcarbamoyl]-5-Phenyl-Pentyl}-Phosphinic Acid,SmallMoleculeDrug,P24347,Stromelysin-3,MMP11,488.0
11098,DB04322,LY249543,SmallMoleculeDrug,P11586,"C-1-tetrahydrofolate synthase, cytoplasmic",MTHFD1,935.0
11099,DB04324,Ovalicin,SmallMoleculeDrug,P50579,Methionine aminopeptidase 2,METAP2,478.0
11100,DB04324,Ovalicin,SmallMoleculeDrug,P53582,Methionine aminopeptidase 1,METAP1,386.0
11102,DB04325,2-Phenylethylamine,SmallMoleculeDrug,P07478,Trypsin-2,PRSS2,247.0
11103,DB04325,2-Phenylethylamine,SmallMoleculeDrug,P07477,Trypsin-1,PRSS1,247.0
11104,DB04326,"1,3-Dihydroxyacetonephosphate",SmallMoleculeDrug,P04075,Fructose-bisphosphate aldolase A,ALDOA,364.0
11105,DB04326,"1,3-Dihydroxyacetonephosphate",SmallMoleculeDrug,P60174,Triosephosphate isomerase,TPI1,286.0
11106,DB04326,"1,3-Dihydroxyacetonephosphate",SmallMoleculeDrug,P05062,Fructose-bisphosphate aldolase B,ALDOB,364.0
11109,DB04327,Phosphatidylethanolamine,SmallMoleculeDrug,Q9UNN8,Endothelial protein C receptor,PROCR,238.0
11113,DB04331,Monastrol,SmallMoleculeDrug,P52732,Kinesin-like protein KIF11,KIF11,1056.0
11114,DB04334,6-hydroxydopa quinone,SmallMoleculeDrug,Q16853,Membrane primary amine oxidase,AOC3,763.0
11118,DB04335,Inosine,SmallMoleculeDrug,P00491,Purine nucleoside phosphorylase,PNP,289.0
11120,DB04336,1-(4-Amidinophenyl)-3-(4-Chlorophenyl)Urea,SmallMoleculeDrug,P07477,Trypsin-1,PRSS1,247.0
11121,DB04337,Methyl Isocyanide,SmallMoleculeDrug,P02144,Myoglobin,MB,154.0
11122,DB04338,SB220025,SmallMoleculeDrug,Q16539,Mitogen-activated protein kinase 14,MAPK14,360.0
11123,DB04338,SB220025,SmallMoleculeDrug,P28482,Mitogen-activated protein kinase 1,MAPK1,360.0
11124,DB04339,Carbocisteine,SmallMoleculeDrug,P09211,Glutathione S-transferase P,GSTP1,210.0
11132,DB04345,"7,8-dimethylalloxazine",SmallMoleculeDrug,P30043,Flavin reductase (NADPH),BLVRB,206.0
11136,DB04348,Taurocholic Acid,SmallMoleculeDrug,P19835,Bile salt-activated lipase,CEL,753.0
11137,DB04348,Taurocholic Acid,SmallMoleculeDrug,P51161,Gastrotropin,FABP6,128.0
11141,DB04350,Argadin,SmallMoleculeDrug,Q13231,Chitotriosidase-1,CHIT1,466.0
11142,DB04351,Aconitate Ion,SmallMoleculeDrug,Q99798,"Aconitate hydratase, mitochondrial",ACO2,780.0
11145,DB04352,"[(2r,3s,4s,5r)-3,4,5-Trihydroxytetrahydrofuran-2-Yl]Methyl Dihydrogen Phosphate",SmallMoleculeDrug,Q9BW91,"ADP-ribose pyrophosphatase, mitochondrial",NUDT9,350.0
11147,DB04356,9-Deazaguanine,SmallMoleculeDrug,P00492,Hypoxanthine-guanine phosphoribosyltransferase,HPRT1,218.0
11151,DB04363,Mesobiliverdin Iv Alpha,SmallMoleculeDrug,P30043,Flavin reductase (NADPH),BLVRB,206.0
11152,DB04365,Arecoline,SmallMoleculeDrug,P11229,Muscarinic acetylcholine receptor M1,CHRM1,460.0
11153,DB04366,3'-Deoxy 3'-Amino Adenosine-5'-Diphosphate,SmallMoleculeDrug,P15531,Nucleoside diphosphate kinase A,NME1,152.0
11154,DB04367,Debromohymenialdisine,SmallMoleculeDrug,Q07912,Activated CDC42 kinase 1,TNK2,1038.0
11155,DB04367,Debromohymenialdisine,SmallMoleculeDrug,P49759,Dual specificity protein kinase CLK1,CLK1,484.0
11157,DB04368,Bb-3497,SmallMoleculeDrug,Q9HBH1,"Peptide deformylase, mitochondrial",PDF,243.0
11158,DB04369,"1,3,2-Dioxaborolan-2-Ol",SmallMoleculeDrug,P35030,Trypsin-3,PRSS3,304.0
11159,DB04371,AL6528,SmallMoleculeDrug,P00918,Carbonic anhydrase 2,CA2,260.0
11160,DB04372,Di-Linoleoyl-3-Sn-Phosphatidylcholine,SmallMoleculeDrug,Q9UKL6,Phosphatidylcholine transfer protein,PCTP,214.0
11162,DB04374,"4-Carboxy-5-(1-Pentyl)Hexylsulfanyl-1,2,3-Triazole",SmallMoleculeDrug,Q9UJM8,Hydroxyacid oxidase 1,HAO1,370.0
11164,DB04376,13-Acetylphorbol,SmallMoleculeDrug,Q05655,Protein kinase C delta type,PRKCD,676.0
11165,DB04377,3-Hydroxy-3-Methyl-Glutaric Acid,SmallMoleculeDrug,P04035,3-hydroxy-3-methylglutaryl-coenzyme A reductase,HMGCR,888.0
11167,DB04379,N-Methyl-N-(Methylbenzyl)Formamide,SmallMoleculeDrug,P00797,Renin,REN,406.0
11169,DB04381,Crotonaldehyde,SmallMoleculeDrug,P05091,"Aldehyde dehydrogenase, mitochondrial",ALDH2,517.0
11173,DB04387,1-Hydroxy-2-Amino-3-Cyclohexylpropane,SmallMoleculeDrug,P00797,Renin,REN,406.0
11176,DB04389,Ado-P-Ch2-P-Ps-Ado,SmallMoleculeDrug,P49789,Bis(5'-adenosyl)-triphosphatase,FHIT,147.0
11177,DB04391,Aeruginosin 98-B,SmallMoleculeDrug,P07477,Trypsin-1,PRSS1,247.0
11179,DB04392,"Bishydroxy[2h-1-Benzopyran-2-One,1,2-Benzopyrone]",SmallMoleculeDrug,P15559,NAD(P)H dehydrogenase [quinone] 1,NQO1,274.0
11182,DB04394,3-Nitro-4-(2-Oxo-Pyrrolidin-1-Yl)-Benzenesulfonamide,SmallMoleculeDrug,P00918,Carbonic anhydrase 2,CA2,260.0
11184,DB04395,Phosphoaminophosphonic Acid-Adenylate Ester,SmallMoleculeDrug,P29323,Ephrin type-B receptor 2,EPHB2,1055.0
11186,DB04395,Phosphoaminophosphonic Acid-Adenylate Ester,SmallMoleculeDrug,P13569,Cystic fibrosis transmembrane conductance regulator,CFTR,1480.0
11187,DB04395,Phosphoaminophosphonic Acid-Adenylate Ester,SmallMoleculeDrug,P55072,Transitional endoplasmic reticulum ATPase,VCP,806.0
11188,DB04395,Phosphoaminophosphonic Acid-Adenylate Ester,SmallMoleculeDrug,Q96QT4,Transient receptor potential cation channel subfamily M member 7,TRPM7,1865.0
11189,DB04395,Phosphoaminophosphonic Acid-Adenylate Ester,SmallMoleculeDrug,Q12756,Kinesin-like protein KIF1A,KIF1A,1690.0
11190,DB04395,Phosphoaminophosphonic Acid-Adenylate Ester,SmallMoleculeDrug,P49368,T-complex protein 1 subunit gamma,CCT3,545.0
11192,DB04395,Phosphoaminophosphonic Acid-Adenylate Ester,SmallMoleculeDrug,P78362,SRSF protein kinase 2,SRPK2,688.0
11193,DB04395,Phosphoaminophosphonic Acid-Adenylate Ester,SmallMoleculeDrug,P53778,Mitogen-activated protein kinase 12,MAPK12,367.0
11198,DB04395,Phosphoaminophosphonic Acid-Adenylate Ester,SmallMoleculeDrug,P51570,Galactokinase,GALK1,392.0
11200,DB04395,Phosphoaminophosphonic Acid-Adenylate Ester,SmallMoleculeDrug,Q06609,DNA repair protein RAD51 homolog 1,RAD51,339.0
11202,DB04395,Phosphoaminophosphonic Acid-Adenylate Ester,SmallMoleculeDrug,P49841,Glycogen synthase kinase-3 beta,GSK3B,420.0
11203,DB04395,Phosphoaminophosphonic Acid-Adenylate Ester,SmallMoleculeDrug,P23919,Thymidylate kinase,DTYMK,212.0
11205,DB04395,Phosphoaminophosphonic Acid-Adenylate Ester,SmallMoleculeDrug,P08069,Insulin-like growth factor 1 receptor,IGF1R,1367.0
11206,DB04395,Phosphoaminophosphonic Acid-Adenylate Ester,SmallMoleculeDrug,P11309,Serine/threonine-protein kinase pim-1,PIM1,404.0
11209,DB04395,Phosphoaminophosphonic Acid-Adenylate Ester,SmallMoleculeDrug,P19367,Hexokinase-1,HK1,917.0
11211,DB04395,Phosphoaminophosphonic Acid-Adenylate Ester,SmallMoleculeDrug,P06239,Tyrosine-protein kinase Lck,LCK,509.0
11212,DB04395,Phosphoaminophosphonic Acid-Adenylate Ester,SmallMoleculeDrug,P68400,Casein kinase II subunit alpha,CSNK2A1,391.0
11213,DB04395,Phosphoaminophosphonic Acid-Adenylate Ester,SmallMoleculeDrug,P29317,Ephrin type-A receptor 2,EPHA2,976.0
11215,DB04395,Phosphoaminophosphonic Acid-Adenylate Ester,SmallMoleculeDrug,P53779,Mitogen-activated protein kinase 10,MAPK10,464.0
11221,DB04395,Phosphoaminophosphonic Acid-Adenylate Ester,SmallMoleculeDrug,Q99661,Kinesin-like protein KIF2C,KIF2C,725.0
11222,DB04395,Phosphoaminophosphonic Acid-Adenylate Ester,SmallMoleculeDrug,P23677,Inositol-trisphosphate 3-kinase A,ITPKA,461.0
11223,DB04395,Phosphoaminophosphonic Acid-Adenylate Ester,SmallMoleculeDrug,Q02880,DNA topoisomerase 2-beta,TOP2B,1626.0
11224,DB04395,Phosphoaminophosphonic Acid-Adenylate Ester,SmallMoleculeDrug,P48637,Glutathione synthetase,GSS,474.0
11226,DB04395,Phosphoaminophosphonic Acid-Adenylate Ester,SmallMoleculeDrug,Q16877,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 4",PFKFB4,469.0
11228,DB04395,Phosphoaminophosphonic Acid-Adenylate Ester,SmallMoleculeDrug,P53355,Death-associated protein kinase 1,DAPK1,1430.0
11230,DB04395,Phosphoaminophosphonic Acid-Adenylate Ester,SmallMoleculeDrug,P68133,"Actin, alpha skeletal muscle",ACTA1,377.0
11234,DB04396,Thiodigalactoside,SmallMoleculeDrug,O14594,Neurocan core protein,NCAN,1321.0
11235,DB04396,Thiodigalactoside,SmallMoleculeDrug,P09382,Galectin-1,LGALS1,135.0
11236,DB04397,Alpha-D-Glucose-1-Phosphate-6-Vanadate,SmallMoleculeDrug,P36871,Phosphoglucomutase-1,PGM1,562.0
11239,DB04400,"7,8-Dihydrobiopterin",SmallMoleculeDrug,P07101,Tyrosine 3-monooxygenase,TH,528.0
11240,DB04400,"7,8-Dihydrobiopterin",SmallMoleculeDrug,P61457,Pterin-4-alpha-carbinolamine dehydratase,PCBD1,104.0
11241,DB04400,"7,8-Dihydrobiopterin",SmallMoleculeDrug,P00439,Phenylalanine-4-hydroxylase,PAH,452.0
11243,DB04400,"7,8-Dihydrobiopterin",SmallMoleculeDrug,P35228,"Nitric oxide synthase, inducible",NOS2,1153.0
11248,DB04404,Allosamizoline,SmallMoleculeDrug,Q13231,Chitotriosidase-1,CHIT1,466.0
11249,DB04405,"2-[2-(1,3-Dioxo-1,3-Dihydro-2h-Isoindol-2-Yl)Ethyl]-4-(4'-Ethoxy-1,1'-Biphenyl-4-Yl)-4-Oxobutanoic Acid",SmallMoleculeDrug,P39900,Macrophage metalloelastase,MMP12,470.0
11250,DB04407,4-[4-(4-Methyl-2-Methylamino-Thiazol-5-Yl)-Pyrimidin-2-Ylamino]-Phenol,SmallMoleculeDrug,P24941,Cyclin-dependent kinase 2,CDK2,298.0
11252,DB04409,Naphthalene Trisulfonate,SmallMoleculeDrug,P05230,Fibroblast growth factor 1,FGF1,155.0
11253,DB04410,3-Phenylpropylamine,SmallMoleculeDrug,P07478,Trypsin-2,PRSS2,247.0
11254,DB04410,3-Phenylpropylamine,SmallMoleculeDrug,P07477,Trypsin-1,PRSS1,247.0
11257,DB04416,"R-2-{[4'-Methoxy-(1,1'-Biphenyl)-4-Yl]-Sulfonyl}-Amino-6-Methoxy-Hex-4-Ynoic Acid",SmallMoleculeDrug,P08254,Stromelysin-1,MMP3,477.0
11258,DB04417,P-Nitrophenol,SmallMoleculeDrug,P50225,Sulfotransferase 1A1,SULT1A1,295.0
11259,DB04417,P-Nitrophenol,SmallMoleculeDrug,P19961,Alpha-amylase 2B,AMY2B,511.0
11260,DB04418,Adenylosuccinic Acid,SmallMoleculeDrug,Q8N142,Adenylosuccinate synthetase isozyme 1,ADSSL1,457.0
11261,DB04419,Norleucine,SmallMoleculeDrug,P01270,Parathyroid hormone,PTH,115.0
11262,DB04419,Norleucine,SmallMoleculeDrug,P20823,Hepatocyte nuclear factor 1-alpha,HNF1A,631.0
11263,DB04419,Norleucine,SmallMoleculeDrug,P00439,Phenylalanine-4-hydroxylase,PAH,452.0
11267,DB04424,RPR128515,SmallMoleculeDrug,P07477,Trypsin-1,PRSS1,247.0
11269,DB04426,Alpha-Methyl-N-Acetyl-D-Glucosamine,SmallMoleculeDrug,P11226,Mannose-binding protein C,MBL2,248.0
11273,DB04432,ZK-805623,SmallMoleculeDrug,P07477,Trypsin-1,PRSS1,247.0
11275,DB04434,Naphthyridine Inhibitor,SmallMoleculeDrug,P36897,TGF-beta receptor type-1,TGFBR1,503.0
11276,DB04436,3-Fluorotyrosine,SmallMoleculeDrug,P04179,"Superoxide dismutase [Mn], mitochondrial",SOD2,222.0
11279,DB04440,Purine Riboside,SmallMoleculeDrug,P00813,Adenosine deaminase,ADA,363.0
11281,DB04442,"2-(2-Oxo-1,2-Dihydro-Pyridin-3-Yl)-1h-Benzoimidazole-5-Carboxamidine",SmallMoleculeDrug,P07477,Trypsin-1,PRSS1,247.0
11283,DB04444,Tetrafluoroaluminate Ion,SmallMoleculeDrug,P63096,Guanine nucleotide-binding protein G(i) subunit alpha-1,GNAI1,354.0
11284,DB04444,Tetrafluoroaluminate Ion,SmallMoleculeDrug,O14983,Sarcoplasmic/endoplasmic reticulum calcium ATPase 1,ATP2A1,1001.0
11285,DB04444,Tetrafluoroaluminate Ion,SmallMoleculeDrug,P11488,Guanine nucleotide-binding protein G(t) subunit alpha-1,GNAT1,350.0
11286,DB04444,Tetrafluoroaluminate Ion,SmallMoleculeDrug,P30085,UMP-CMP kinase,CMPK1,196.0
11287,DB04444,Tetrafluoroaluminate Ion,SmallMoleculeDrug,P35749,Myosin-11,MYH11,1972.0
11288,DB04444,Tetrafluoroaluminate Ion,SmallMoleculeDrug,Q7Z406,Myosin-14,MYH14,1995.0
11291,DB04445,Mercury Diiodide,SmallMoleculeDrug,Q06520,Bile salt sulfotransferase,SULT2A1,285.0
11292,DB04446,Benzo[B]Thiophene-2-Carboxamidine,SmallMoleculeDrug,P07477,Trypsin-1,PRSS1,247.0
11297,DB04447,"1,4-Dithiothreitol",SmallMoleculeDrug,P09382,Galectin-1,LGALS1,135.0
11298,DB04447,"1,4-Dithiothreitol",SmallMoleculeDrug,Q9UQM7,Calcium/calmodulin-dependent protein kinase type II subunit alpha,CAMK2A,478.0
11300,DB04447,"1,4-Dithiothreitol",SmallMoleculeDrug,P00352,Retinal dehydrogenase 1,ALDH1A1,501.0
11303,DB04447,"1,4-Dithiothreitol",SmallMoleculeDrug,Q96QT4,Transient receptor potential cation channel subfamily M member 7,TRPM7,1865.0
11307,DB04447,"1,4-Dithiothreitol",SmallMoleculeDrug,Q9UJ68,Mitochondrial peptide methionine sulfoxide reductase,MSRA,235.0
11309,DB04447,"1,4-Dithiothreitol",SmallMoleculeDrug,O15169,Axin-1,AXIN1,862.0
11310,DB04447,"1,4-Dithiothreitol",SmallMoleculeDrug,P23284,Peptidyl-prolyl cis-trans isomerase B,PPIB,216.0
11313,DB04447,"1,4-Dithiothreitol",SmallMoleculeDrug,P60174,Triosephosphate isomerase,TPI1,286.0
11314,DB04447,"1,4-Dithiothreitol",SmallMoleculeDrug,O43708,Maleylacetoacetate isomerase,GSTZ1,216.0
11315,DB04447,"1,4-Dithiothreitol",SmallMoleculeDrug,P04035,3-hydroxy-3-methylglutaryl-coenzyme A reductase,HMGCR,888.0
11317,DB04448,"2,4-Difluorobenzyl Alcohol 2,4-Difluoro-1-(Hydroxymethyl)Benzene",SmallMoleculeDrug,P00326,Alcohol dehydrogenase 1C,ADH1C,375.0
11318,DB04450,Heptyl 1-Thiohexopyranoside,SmallMoleculeDrug,P08100,Rhodopsin,RHO,348.0
11323,DB04451,4-Methylpiperazin-1-Yl Carbonyl Group,SmallMoleculeDrug,O60911,Cathepsin L2,CTSV,334.0
11325,DB04453,"4-O-(4,6-Dideoxy-4-{[4-[(4-O-Hexopyranosylhexopyranosyl)Oxy]-5,6-Dihydroxy-3-(Hydroxymethyl)Cyclohex-2-En-1-Yl]Amino}Hexopyranosyl)Hexopyranose",SmallMoleculeDrug,P04746,Pancreatic alpha-amylase,AMY2A,511.0
11326,DB04454,Alpha-Aminobutyric Acid,SmallMoleculeDrug,P01133,Pro-epidermal growth factor,EGF,1207.0
11328,DB04454,Alpha-Aminobutyric Acid,SmallMoleculeDrug,P50440,"Glycine amidinotransferase, mitochondrial",GATM,423.0
11336,DB04459,"3,4-Dichloroisocoumarin",SmallMoleculeDrug,P00746,Complement factor D,CFD,253.0
11338,DB04461,Coproporphyrin Iii,SmallMoleculeDrug,P06132,Uroporphyrinogen decarboxylase,UROD,367.0
11339,DB04462,Tetrabromo-2-Benzotriazole,SmallMoleculeDrug,P68400,Casein kinase II subunit alpha,CSNK2A1,391.0
11340,DB04463,"3-(4-Amino-1-Tert-Butyl-1h-Pyrazolo[3,4-D]Pyrimidin-3-Yl)Phenol",SmallMoleculeDrug,P16152,Carbonyl reductase [NADPH] 1,CBR1,277.0
11342,DB04464,N-Formylmethionine,SmallMoleculeDrug,P07998,Ribonuclease pancreatic,RNASE1,156.0
11343,DB04464,N-Formylmethionine,SmallMoleculeDrug,Q16740,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",CLPP,277.0
11344,DB04464,N-Formylmethionine,SmallMoleculeDrug,Q92696,Geranylgeranyl transferase type-2 subunit alpha,RABGGTA,567.0
11345,DB04464,N-Formylmethionine,SmallMoleculeDrug,P53611,Geranylgeranyl transferase type-2 subunit beta,RABGGTB,331.0
11354,DB04464,N-Formylmethionine,SmallMoleculeDrug,P01008,Antithrombin-III,SERPINC1,464.0
11355,DB04464,N-Formylmethionine,SmallMoleculeDrug,P61769,Beta-2-microglobulin,B2M,119.0
11356,DB04464,N-Formylmethionine,SmallMoleculeDrug,P03886,NADH-ubiquinone oxidoreductase chain 1,MT-ND1,318.0
11357,DB04464,N-Formylmethionine,SmallMoleculeDrug,P03989,"HLA class I histocompatibility antigen, B-27 alpha chain",HLA-B,362.0
11361,DB04464,N-Formylmethionine,SmallMoleculeDrug,P29377,Protein S100-G,S100G,79.0
11363,DB04464,N-Formylmethionine,SmallMoleculeDrug,P13073,"Cytochrome c oxidase subunit 4 isoform 1, mitochondrial",COX4I1,169.0
11364,DB04464,N-Formylmethionine,SmallMoleculeDrug,P00395,Cytochrome c oxidase subunit 1,MT-CO1,513.0
11365,DB04464,N-Formylmethionine,SmallMoleculeDrug,P00403,Cytochrome c oxidase subunit 2,MT-CO2,227.0
11366,DB04464,N-Formylmethionine,SmallMoleculeDrug,P00414,Cytochrome c oxidase subunit 3,MT-CO3,261.0
11367,DB04464,N-Formylmethionine,SmallMoleculeDrug,P20674,"Cytochrome c oxidase subunit 5A, mitochondrial",COX5A,150.0
11368,DB04464,N-Formylmethionine,SmallMoleculeDrug,P10606,"Cytochrome c oxidase subunit 5B, mitochondrial",COX5B,129.0
11369,DB04464,N-Formylmethionine,SmallMoleculeDrug,P09669,Cytochrome c oxidase subunit 6C,COX6C,75.0
11370,DB04464,N-Formylmethionine,SmallMoleculeDrug,P24311,"Cytochrome c oxidase subunit 7B, mitochondrial",COX7B,80.0
11371,DB04464,N-Formylmethionine,SmallMoleculeDrug,P15954,"Cytochrome c oxidase subunit 7C, mitochondrial",COX7C,63.0
11372,DB04464,N-Formylmethionine,SmallMoleculeDrug,P10176,"Cytochrome c oxidase subunit 8A, mitochondrial",COX8A,69.0
11373,DB04464,N-Formylmethionine,SmallMoleculeDrug,Q02221,"Cytochrome c oxidase subunit 6A2, mitochondrial",COX6A2,97.0
11374,DB04464,N-Formylmethionine,SmallMoleculeDrug,P14854,Cytochrome c oxidase subunit 6B1,COX6B1,86.0
11375,DB04464,N-Formylmethionine,SmallMoleculeDrug,P24310,"Cytochrome c oxidase subunit 7A1, mitochondrial",COX7A1,79.0
11378,DB04464,N-Formylmethionine,SmallMoleculeDrug,P04271,Protein S100-B,S100B,92.0
11380,DB04464,N-Formylmethionine,SmallMoleculeDrug,P0CG48,Polyubiquitin-C,UBC,685.0
11384,DB04465,Lactose,SmallMoleculeDrug,Q7Z4J2,Glycosyltransferase 6 domain-containing protein 1,GLT6D1,308.0
11385,DB04465,Lactose,SmallMoleculeDrug,Q9NZD2,Glycolipid transfer protein,GLTP,209.0
11392,DB04466,SR12813,SmallMoleculeDrug,O75469,Nuclear receptor subfamily 1 group I member 2,NR1I2,434.0
11396,DB04468,Afimoxifene,SmallMoleculeDrug,Q92731,Estrogen receptor beta,ESR2,530.0
11397,DB04468,Afimoxifene,SmallMoleculeDrug,P62508,Estrogen-related receptor gamma,ESRRG,458.0
11398,DB04468,Afimoxifene,SmallMoleculeDrug,P03372,Estrogen receptor,ESR1,595.0
11399,DB04469,"1-(4-Methoxyphenyl)-3,5-Dimethyl-1h-Pyrazole-4-Carboxylic Acid Ethyl Ester",SmallMoleculeDrug,Q08499,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",PDE4D,809.0
11400,DB04470,CRA_10656,SmallMoleculeDrug,P07477,Trypsin-1,PRSS1,247.0
11401,DB04471,"2-Phenyl-1-[4-(2-Piperidin-1-Yl-Ethoxy)-Phenyl]-1,2,3,4-Tetrahydro-Isoquinolin-6-Ol",SmallMoleculeDrug,P03372,Estrogen receptor,ESR1,595.0
11403,DB04472,(R)-1-Para-Nitro-Phenyl-2-Azido-Ethanol,SmallMoleculeDrug,O00182,Galectin-9,LGALS9,355.0
11406,DB04473,Alpha-L-Fucose,SmallMoleculeDrug,P01857,Ig gamma-1 chain C region,IGHG1,330.0
11409,DB04474,1-Anilino-8-Naphthalene Sulfonate,SmallMoleculeDrug,P31151,Protein S100-A7,S100A7,101.0
11410,DB04476,"Trencam-3,2-Hopo",SmallMoleculeDrug,P80188,Neutrophil gelatinase-associated lipocalin,LCN2,198.0
11411,DB04477,"N-1,2,3,4-Tetrahydronaphth-1-Yl-2'-[3,5-Dimethoxybenzamido]-2'-Deoxy-Adenosine",SmallMoleculeDrug,O14556,"Glyceraldehyde-3-phosphate dehydrogenase, testis-specific",GAPDHS,408.0
11412,DB04478,"Cp-166572, 2-Hydroxymethyl-4-(4-N,N-Dimethylaminosulfonyl-1-Piperazino)-Pyrimidine",SmallMoleculeDrug,Q00796,Sorbitol dehydrogenase,SORD,357.0
11413,DB04480,"3-(4-Fluorophenyl)-2-(6-Methylpyridin-2-Yl)-5,6-Dihydro-4h-Pyrrolo[1,2-B]Pyrazole",SmallMoleculeDrug,P36897,TGF-beta receptor type-1,TGFBR1,503.0
11419,DB04485,Deoxythymidine,SmallMoleculeDrug,O00142,"Thymidine kinase 2, mitochondrial",TK2,265.0
11425,DB04487,N-Methylleucine,SmallMoleculeDrug,P02778,C-X-C motif chemokine 10,CXCL10,98.0
11427,DB04489,Guanidinoethylmercaptosuccinic acid,SmallMoleculeDrug,O75976,Carboxypeptidase D,CPD,1380.0
11429,DB04491,Diisopropylphosphono Group,SmallMoleculeDrug,P00751,Complement factor B,CFB,764.0
11431,DB04491,Diisopropylphosphono Group,SmallMoleculeDrug,P27487,Dipeptidyl peptidase 4,DPP4,766.0
11434,DB04493,Fructose-6-Phosphate,SmallMoleculeDrug,P09467,"Fructose-1,6-bisphosphatase 1",FBP1,338.0
11435,DB04493,Fructose-6-Phosphate,SmallMoleculeDrug,P16118,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 1",PFKFB1,471.0
11437,DB04493,Fructose-6-Phosphate,SmallMoleculeDrug,Q16877,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 4",PFKFB4,469.0
11438,DB04493,Fructose-6-Phosphate,SmallMoleculeDrug,P06744,Glucose-6-phosphate isomerase,GPI,558.0
11440,DB04495,RU81843,SmallMoleculeDrug,P12931,Proto-oncogene tyrosine-protein kinase Src,SRC,536.0
11447,DB04505,"8-(2-Chloro-3,4,5-Trimethoxy-Benzyl)-9-Pent-4-Ylnyl-9h-Purin-6-Ylamine",SmallMoleculeDrug,P07900,Heat shock protein HSP 90-alpha,HSP90AA1,732.0
11449,DB04509,N-Methylnaloxonium,SmallMoleculeDrug,P23141,Liver carboxylesterase 1,CES1,567.0
11450,DB04510,3-Phosphoglyceric Acid,SmallMoleculeDrug,P00558,Phosphoglycerate kinase 1,PGK1,417.0
11454,DB04510,3-Phosphoglyceric Acid,SmallMoleculeDrug,P15259,Phosphoglycerate mutase 2,PGAM2,253.0
11455,DB04510,3-Phosphoglyceric Acid,SmallMoleculeDrug,P60174,Triosephosphate isomerase,TPI1,286.0
11457,DB04512,2-Isobutyl-3-Methoxypyrazine,SmallMoleculeDrug,Q8WX39,Epididymal-specific lipocalin-9,LCN9,176.0
11459,DB04513,N-(6-Aminohexyl)-5-Chloro-1-Naphthalenesulfonamide,SmallMoleculeDrug,P63316,"Troponin C, slow skeletal and cardiac muscles",TNNC1,161.0
11460,DB04513,N-(6-Aminohexyl)-5-Chloro-1-Naphthalenesulfonamide,SmallMoleculeDrug,P19429,"Troponin I, cardiac muscle",TNNI3,210.0
11461,DB04514,Phosphoric Acid-2'-[2'-Deoxy-Uridine]Ester-5'-Guanosine Ester,SmallMoleculeDrug,P07998,Ribonuclease pancreatic,RNASE1,156.0
11463,DB04516,2-Deoxy-Glucitol-6-Phosphate,SmallMoleculeDrug,Q9NPH2,Inositol-3-phosphate synthase 1,ISYNA1,558.0
11465,DB04518,"3-[4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Ylamino]-Phenol",SmallMoleculeDrug,P24941,Cyclin-dependent kinase 2,CDK2,298.0
11470,DB04521,GSHNA,SmallMoleculeDrug,Q16772,Glutathione S-transferase A3,GSTA3,222.0
11471,DB04522,Phosphonoserine,SmallMoleculeDrug,P17612,cAMP-dependent protein kinase catalytic subunit alpha,PRKACA,351.0
11475,DB04522,Phosphonoserine,SmallMoleculeDrug,P29508,Serpin B3,SERPINB3,390.0
11477,DB04522,Phosphonoserine,SmallMoleculeDrug,P08100,Rhodopsin,RHO,348.0
11478,DB04522,Phosphonoserine,SmallMoleculeDrug,Q9UL54,Serine/threonine-protein kinase TAO2,TAOK2,1235.0
11479,DB04522,Phosphonoserine,SmallMoleculeDrug,Q03721,Potassium voltage-gated channel subfamily C member 4,KCNC4,635.0
11480,DB04522,Phosphonoserine,SmallMoleculeDrug,P05451,Lithostathine-1-alpha,REG1A,166.0
11481,DB04522,Phosphonoserine,SmallMoleculeDrug,Q15796,Mothers against decapentaplegic homolog 2,SMAD2,467.0
11485,DB04522,Phosphonoserine,SmallMoleculeDrug,P13569,Cystic fibrosis transmembrane conductance regulator,CFTR,1480.0
11486,DB04522,Phosphonoserine,SmallMoleculeDrug,O15530,3-phosphoinositide-dependent protein kinase 1,PDPK1,556.0
11487,DB04522,Phosphonoserine,SmallMoleculeDrug,P11309,Serine/threonine-protein kinase pim-1,PIM1,404.0
11488,DB04522,Phosphonoserine,SmallMoleculeDrug,Q04759,Protein kinase C theta type,PRKCQ,706.0
11489,DB04522,Phosphonoserine,SmallMoleculeDrug,P06737,"Glycogen phosphorylase, liver form",PYGL,847.0
11491,DB04522,Phosphonoserine,SmallMoleculeDrug,P11217,"Glycogen phosphorylase, muscle form",PYGM,842.0
11492,DB04523,Tert-Butyl(1s)-1-Cyclohexyl-2-Oxoethylcarbamate,SmallMoleculeDrug,P43235,Cathepsin K,CTSK,329.0
11494,DB04525,2-(Carboxymethoxy)-5-[(2s)-2-({(2s)-2-[(3-Carboxypropanoyl)Amino] -3-Phenylpropanoyl}Amino)-3-Oxo-3-(Pentylamino)Propyl]Benzoic Acid,SmallMoleculeDrug,P18031,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,435.0
11496,DB04527,Beta-Hydroxyasparagine,SmallMoleculeDrug,O00187,Mannan-binding lectin serine protease 2,MASP2,686.0
11500,DB04530,"S,S-(2-Hydroxyethyl)Thiocysteine",SmallMoleculeDrug,P36952,Serpin B5,SERPINB5,375.0
11502,DB04530,"S,S-(2-Hydroxyethyl)Thiocysteine",SmallMoleculeDrug,Q01064,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B",PDE1B,536.0
11503,DB04530,"S,S-(2-Hydroxyethyl)Thiocysteine",SmallMoleculeDrug,O60493,Sorting nexin-3,SNX3,162.0
11505,DB04530,"S,S-(2-Hydroxyethyl)Thiocysteine",SmallMoleculeDrug,Q99418,Cytohesin-2,CYTH2,400.0
11507,DB04530,"S,S-(2-Hydroxyethyl)Thiocysteine",SmallMoleculeDrug,Q07343,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B",PDE4B,736.0
11508,DB04530,"S,S-(2-Hydroxyethyl)Thiocysteine",SmallMoleculeDrug,P04818,Thymidylate synthase,TYMS,313.0
11509,DB04530,"S,S-(2-Hydroxyethyl)Thiocysteine",SmallMoleculeDrug,P17612,cAMP-dependent protein kinase catalytic subunit alpha,PRKACA,351.0
11510,DB04530,"S,S-(2-Hydroxyethyl)Thiocysteine",SmallMoleculeDrug,P11309,Serine/threonine-protein kinase pim-1,PIM1,404.0
11511,DB04530,"S,S-(2-Hydroxyethyl)Thiocysteine",SmallMoleculeDrug,P05089,Arginase-1,ARG1,322.0
11516,DB04531,Benzylcysteine,SmallMoleculeDrug,P16455,Methylated-DNA--protein-cysteine methyltransferase,MGMT,207.0
11520,DB04534,5-Nitroindazole,SmallMoleculeDrug,P35228,"Nitric oxide synthase, inducible",NOS2,1153.0
11521,DB04534,5-Nitroindazole,SmallMoleculeDrug,P29474,"Nitric oxide synthase, endothelial",NOS3,1203.0
11523,DB04537,L-Tryptophanamide,SmallMoleculeDrug,P23381,"Tryptophan--tRNA ligase, cytoplasmic",WARS,471.0
11527,DB04540,Cholesterol,SmallMoleculeDrug,P35398,Nuclear receptor ROR-alpha,RORA,523.0
11529,DB04542,3'-Azido-3'-Deoxythymidine-5'-Diphosphate,SmallMoleculeDrug,P15531,Nucleoside diphosphate kinase A,NME1,152.0
11531,DB04544,1-Deoxy-1-Acetylamino-Beta-D-Gluco-2-Heptulopyranosonamide,SmallMoleculeDrug,P11217,"Glycogen phosphorylase, muscle form",PYGM,842.0
11541,DB04549,"4-(Aminosulfonyl)-N-[(2,3,4-Trifluorophenyl)Methyl]-Benzamide",SmallMoleculeDrug,P00918,Carbonic anhydrase 2,CA2,260.0
11544,DB04551,"beta-D-fructofuranose 1,6-bisphosphate",SmallMoleculeDrug,P30613,Pyruvate kinase PKLR,PKLR,574.0
11545,DB04552,Niflumic Acid,SmallMoleculeDrug,P04054,Phospholipase A2,PLA2G1B,148.0
11546,DB04552,Niflumic Acid,SmallMoleculeDrug,P35354,Prostaglandin G/H synthase 2,PTGS2,604.0
11547,DB04552,Niflumic Acid,SmallMoleculeDrug,P51800,Chloride channel protein ClC-Ka,CLCNKA,687.0
11548,DB04552,Niflumic Acid,SmallMoleculeDrug,P23219,Prostaglandin G/H synthase 1,PTGS1,599.0
11549,DB04552,Niflumic Acid,SmallMoleculeDrug,P47712,Cytosolic phospholipase A2,PLA2G4A,749.0
11550,DB04552,Niflumic Acid,SmallMoleculeDrug,O60656,UDP-glucuronosyltransferase 1-9,UGT1A9,530.0
11560,DB04556,3-[(1s)-1-(Dimethylamino)Ethyl]Phenol,SmallMoleculeDrug,P22303,Acetylcholinesterase,ACHE,614.0
11562,DB04557,Arachidonic Acid,SmallMoleculeDrug,P23219,Prostaglandin G/H synthase 1,PTGS1,599.0
11563,DB04559,N-(Chlorophenyl)-N'-Hydroxyguanidine,SmallMoleculeDrug,P29474,"Nitric oxide synthase, endothelial",NOS3,1203.0
11565,DB04560,"4,7-Dioxosebacic Acid",SmallMoleculeDrug,P13716,Delta-aminolevulinic acid dehydratase,ALAD,330.0
11568,DB04562,Tricarballylic Acid,SmallMoleculeDrug,Q99798,"Aconitate hydratase, mitochondrial",ACO2,780.0
11569,DB04563,CRA_9678,SmallMoleculeDrug,P07477,Trypsin-1,PRSS1,247.0
11570,DB04564,Gluconolactone,SmallMoleculeDrug,P09848,Lactase-phlorizin hydrolase,LCT,1927.0
11573,DB04566,Inosinic Acid,SmallMoleculeDrug,Q8N142,Adenylosuccinate synthetase isozyme 1,ADSSL1,457.0
11577,DB04566,Inosinic Acid,SmallMoleculeDrug,P11217,"Glycogen phosphorylase, muscle form",PYGM,842.0
11579,DB04566,Inosinic Acid,SmallMoleculeDrug,P12268,Inosine-5'-monophosphate dehydrogenase 2,IMPDH2,514.0
11586,DB04573,Estriol,SmallMoleculeDrug,P03372,Estrogen receptor,ESR1,595.0
11587,DB04573,Estriol,SmallMoleculeDrug,Q92731,Estrogen receptor beta,ESR2,530.0
11588,DB04574,Estrone sulfate,SmallMoleculeDrug,P03372,Estrogen receptor,ESR1,595.0
11589,DB04574,Estrone sulfate,SmallMoleculeDrug,Q92731,Estrogen receptor beta,ESR2,530.0
11590,DB04575,Quinestrol,SmallMoleculeDrug,P03372,Estrogen receptor,ESR1,595.0
11591,DB04576,Fleroxacin,SmallMoleculeDrug,P11388,DNA topoisomerase 2-alpha,TOP2A,1531.0
11594,DB04577,1-(1-phenylcyclopentyl)methylamine,SmallMoleculeDrug,P27487,Dipeptidyl peptidase 4,DPP4,766.0
11595,DB04578,"(S)-2-[(R)-3-amino-4-(2-fluorophenyl)butyryl]-1,2,3,4-tetrahydroisoquinoline-3-carboxamide",SmallMoleculeDrug,P27487,Dipeptidyl peptidase 4,DPP4,766.0
11596,DB04579,"N-{[(2S,3S)-3-(ETHOXYCARBONYL)OXIRAN-2-YL]CARBONYL}-",SmallMoleculeDrug,P07858,Cathepsin B,CTSB,339.0
11598,DB04581,1-benzylimidazole,SmallMoleculeDrug,Q16769,Glutaminyl-peptide cyclotransferase,QPCT,361.0
11599,DB04583,"5-(AMINOCARBONYL)-1,1':4',1''-TERPHENYL-3-CARBOXYLICACID",SmallMoleculeDrug,Q02127,"Dihydroorotate dehydrogenase (quinone), mitochondrial",DHODH,395.0
11600,DB04585,DEHYDRO-2(S)-AMINO-6-BORONOHEXANOIC ACID,SmallMoleculeDrug,P05089,Arginase-1,ARG1,322.0
11602,DB04588,"N-[4-(AMINOSULFONYL)BENZYL]-5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-1H-PYRAZOLE-4-CARBOXAMIDE",SmallMoleculeDrug,P07900,Heat shock protein HSP 90-alpha,HSP90AA1,732.0
11603,DB04590,(2R)-({4-[AMINO(IMINO)METHYL]PHENYL}AMINO){5-ETHOXY-2-FLUORO-3-[(3R)-TETRAHYDROFURAN-3-YLOXY]PHENYL}ACETICACID,SmallMoleculeDrug,P08709,Coagulation factor VII,F7,466.0
11604,DB04591,"N-{2,2-DIFLUORO-2-[(2R)-PIPERIDIN-2-YL]ETHYL}-2-[2-(1H-1,2,4-TRIAZOL-1-YL)BENZYL][1,3]OXAZOLO[4,5-C]PYRIDIN-4-AMINE",SmallMoleculeDrug,P00734,Prothrombin,F2,622.0
11606,DB04593,3-({1-[3-CARBAMIMIDOYL-1-(4-CARBAMIMIDOYL-BENZYLCARBAMOYL)-PROPYLCARBAMOYL]-2-METHYL-BUTYLSULFAMOYL}-METHYL)-BENZOIC ACID,SmallMoleculeDrug,P08709,Coagulation factor VII,F7,466.0
11607,DB04594,3-hydroxyglutaric acid,SmallMoleculeDrug,P35914,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",HMGCL,325.0
11611,DB04599,Aniracetam,SmallMoleculeDrug,P28223,5-hydroxytryptamine receptor 2A,HTR2A,471.0
11612,DB04599,Aniracetam,SmallMoleculeDrug,P14416,D(2) dopamine receptor,DRD2,443.0
11613,DB04599,Aniracetam,SmallMoleculeDrug,P42262,Glutamate receptor 2,GRIA2,883.0
11614,DB04599,Aniracetam,SmallMoleculeDrug,P42263,Glutamate receptor 3,GRIA3,894.0
11615,DB04600,"4-[(3-BROMO-4-O-SULFAMOYLBENZYL)(4-CYANOPHENYL)AMINO]-4H-[1,2,4]-TRIAZOLE",SmallMoleculeDrug,P00918,Carbonic anhydrase 2,CA2,260.0
11616,DB04601,"4-[(4-O-SULFAMOYLBENZYL)(4-CYANOPHENYL)AMINO]-4H-[1,2,4]-TRIAZOLE",SmallMoleculeDrug,P00918,Carbonic anhydrase 2,CA2,260.0
11617,DB04602,PUROMYCIN AMINONUCLEOSIDE-5'-MONOPHOSPHATE,SmallMoleculeDrug,P61927,60S ribosomal protein L37,RPL37,97.0
11618,DB04604,5-iodotubercidin,SmallMoleculeDrug,P78368,Casein kinase I isoform gamma-2,CSNK1G2,415.0
11619,DB04604,5-iodotubercidin,SmallMoleculeDrug,Q8TF76,Serine/threonine-protein kinase haspin,GSG2,798.0
11620,DB04604,5-iodotubercidin,SmallMoleculeDrug,P27361,Mitogen-activated protein kinase 3,MAPK3,379.0
11622,DB04606,2-[2-ETHANESULFONYLAMINO-3-(5-PROPOXY-1H-INDOL-3-YL)-PROPIONYLAMINO]-PENTANEDIOIC ACID 5-AMIDE 1-(4-CARBAMIMIDOYL-BENZYLAMIDE),SmallMoleculeDrug,P08709,Coagulation factor VII,F7,466.0
11623,DB04607,"PHENYLAMINOIMIDAZO(1,2-ALPHA)PYRIDINE",SmallMoleculeDrug,P24941,Cyclin-dependent kinase 2,CDK2,298.0
11624,DB04608,"9-HYDROXY-4-PHENYL-6H-PYRROLO[3,4-C]CARBAZOLE-1,3-DIONE",SmallMoleculeDrug,P30291,Wee1-like protein kinase,WEE1,646.0
11627,DB04612,"N-METHYLALANYL-3-METHYLVALYL-4-PHENOXY-N-(1,2,3,4-TETRAHYDRONAPHTHALEN-1-YL)PROLINAMIDE",SmallMoleculeDrug,P98170,E3 ubiquitin-protein ligase XIAP,XIAP,497.0
11628,DB04614,(R)-tacrine(10)-hupyridone,SmallMoleculeDrug,P22303,Acetylcholinesterase,ACHE,614.0
11629,DB04615,(S)-tacrine(10)-hupyridone,SmallMoleculeDrug,P22303,Acetylcholinesterase,ACHE,614.0
11630,DB04616,TACRINE(8)-4-AMINOQUINOLINE,SmallMoleculeDrug,P22303,Acetylcholinesterase,ACHE,614.0
11631,DB04617,"(9S)-9-[(8-AMMONIOOCTYL)AMINO]-1,2,3,4,9,10-HEXAHYDROACRIDINIUM",SmallMoleculeDrug,P22303,Acetylcholinesterase,ACHE,614.0
11632,DB04618,"4,6-DIDEOXY-4-{[4-[(4-O-HEXOPYRANOSYLHEXOPYRANOSYL)OXY]-5,6-DIHYDROXY-3-(HYDROXYMETHYL)CYCLOHEX-2-EN-1-YL]AMINO}HEXOPYRANOSYL-(1->4)HEXOPYRANOSYL-(1->4)HEXOPYRANOSE",SmallMoleculeDrug,P04746,Pancreatic alpha-amylase,AMY2A,511.0
11634,DB04620,Cycloleucine,SmallMoleculeDrug,Q05586,"Glutamate receptor ionotropic, NMDA 1",GRIN1,938.0
11635,DB04622,N-ACETYLHISTAMINE,SmallMoleculeDrug,Q16769,Glutaminyl-peptide cyclotransferase,QPCT,361.0
11641,DB04629,Aplyronine A,SmallMoleculeDrug,P68133,"Actin, alpha skeletal muscle",ACTA1,377.0
11642,DB04630,Aldosterone,SmallMoleculeDrug,P08235,Mineralocorticoid receptor,NR3C2,984.0
11647,DB04632,4-(2-HYDROXYBENZYLAMINO)-N-(3-(4-FLUOROPHENOXY)PHENYL)PIPERIDINE-1-SULFONAMIDE,SmallMoleculeDrug,Q16539,Mitogen-activated protein kinase 14,MAPK14,360.0
11648,DB04633,"N-ethyl-N-[3-(propylamino)propyl]propane-1,3-diamine",SmallMoleculeDrug,P21673,Diamine acetyltransferase 1,SAT1,171.0
11652,DB04636,Glutamine t-butyl ester,SmallMoleculeDrug,Q16769,Glutaminyl-peptide cyclotransferase,QPCT,361.0
11654,DB04638,"2,5-DI-(TERT-BUTYL)-1,4,BENZOHYDROQUINONE",SmallMoleculeDrug,O14983,Sarcoplasmic/endoplasmic reticulum calcium ATPase 1,ATP2A1,1001.0
11656,DB04639,Biphenylalanine,SmallMoleculeDrug,P01857,Ig gamma-1 chain C region,IGHG1,330.0
11660,DB04642,"7-{2,6-DICHLORO-4-[3-(2-CHLORO-BENZOYL)-UREIDO]-PHENOXY}-HEPTANOIC ACID",SmallMoleculeDrug,P11217,"Glycogen phosphorylase, muscle form",PYGM,842.0
11661,DB04643,"4-{3-CHLORO-4-[3-(2,4-DICHLORO-BENZOYL)-UREIDO]-PHENOXY}-BUTYRIC ACID",SmallMoleculeDrug,P11217,"Glycogen phosphorylase, muscle form",PYGM,842.0
11662,DB04644,"4-{4-[3-(2,4-DICHLORO-BENZOYL)-UREIDO]-2,3-DIMETHYL-PHENOXY}-BUTYRIC ACID",SmallMoleculeDrug,P11217,"Glycogen phosphorylase, muscle form",PYGM,842.0
11663,DB04645,"5-{3-[3-(2,4-DICHLORO-BENZOYL)-UREIDO]-2-METHYL-PHENOXY}-PENTANOIC ACID",SmallMoleculeDrug,P11217,"Glycogen phosphorylase, muscle form",PYGM,842.0
11674,DB04648,S-propylamine-L-cysteine,SmallMoleculeDrug,P05089,Arginase-1,ARG1,322.0
11678,DB04652,"(11-BETA)-11,21-DIHYDROXY-PREGN-4-ENE-3,20-DIONE",SmallMoleculeDrug,P08235,Mineralocorticoid receptor,NR3C2,984.0
11679,DB04652,"(11-BETA)-11,21-DIHYDROXY-PREGN-4-ENE-3,20-DIONE",SmallMoleculeDrug,P28845,Corticosteroid 11-beta-dehydrogenase isozyme 1,HSD11B1,292.0
11680,DB04652,"(11-BETA)-11,21-DIHYDROXY-PREGN-4-ENE-3,20-DIONE",SmallMoleculeDrug,Q15788,Nuclear receptor coactivator 1,NCOA1,1441.0
11681,DB04653,CBZ-LEU-LEU-TYR-CH2F,SmallMoleculeDrug,P07384,Calpain-1 catalytic subunit,CAPN1,714.0
11682,DB04654,4-PIPERIDIN-4-YLBUTANAL,SmallMoleculeDrug,P07477,Trypsin-1,PRSS1,247.0
11683,DB04654,4-PIPERIDIN-4-YLBUTANAL,SmallMoleculeDrug,P20231,Tryptase beta-2,TPSB2,275.0
11684,DB04655,"METOPRINE, METHODICHLOROPHEN",SmallMoleculeDrug,P50135,Histamine N-methyltransferase,HNMT,292.0
11686,DB04657,Carboxin,SmallMoleculeDrug,P31040,"Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial",SDHA,664.0
11688,DB04659,"(1S,2S,3R,4S,5S)-2,3,4-TRIHYDROXY-5-(HYDROXYMETHYL)CYCLOHEXYL (1E)-2-PHENYL-N-(SULFOOXY)ETHANIMIDOTHIOATE",SmallMoleculeDrug,P09848,Lactase-phlorizin hydrolase,LCT,1927.0
11689,DB04660,Choline alfoscerate,SmallMoleculeDrug,P17900,Ganglioside GM2 activator,GM2A,193.0
11690,DB04661,Cis-tetracosenoyl sulfatide,SmallMoleculeDrug,P15813,Antigen-presenting glycoprotein CD1d,CD1D,335.0
11691,DB04662,OLOMOUCINE II,SmallMoleculeDrug,P24941,Cyclin-dependent kinase 2,CDK2,298.0
11692,DB04664,Cyclohexyl-pentyl-maltoside,SmallMoleculeDrug,P20813,Cytochrome P450 2B6,CYP2B6,491.0
11693,DB04665,2H-1-BENZOPYRAN-2-ONE,SmallMoleculeDrug,P11509,Cytochrome P450 2A6,CYP2A6,494.0
11694,DB04669,TRIAZOLOPYRIMIDINE,SmallMoleculeDrug,P24941,Cyclin-dependent kinase 2,CDK2,298.0
11696,DB04672,"cyclic 3',5'-thymidine monophosphate",SmallMoleculeDrug,Q9NPB1,"5'(3')-deoxyribonucleotidase, mitochondrial",NT5M,228.0
11697,DB04673,4-[(5-CHLOROINDOL-2-YL)SULFONYL]-2-(2-METHYLPROPYL)-1-[[5-(PYRIDIN-4-YL)PYRIMIDIN-2-YL]CARBONYL]PIPERAZINE,SmallMoleculeDrug,P00742,Coagulation factor X,F10,488.0
11698,DB04674,"2-HYDROXY-3,5-DIIODOBENZOIC ACID",SmallMoleculeDrug,P25101,Endothelin-1 receptor,EDNRA,427.0
11699,DB04674,"2-HYDROXY-3,5-DIIODOBENZOIC ACID",SmallMoleculeDrug,Q04828,Aldo-keto reductase family 1 member C1,AKR1C1,323.0
11700,DB04675,"(2S,5R,8S,11R,12S,15S,18S,19S,E)-8-ISOBUTYL-18-((5S,6S)-6-METHOXY-3,5-DIMETHYL-7-PHENYLHEPTYL)-1,2,5,12,15,19-HEXAMETHYL-3,6,9,13,16,20,25-HEPTAOXO-1,4,7,10,14,17,21-HEPTAAZACYCLOPENTACOS-21-ENE-11,22-DICARBOXYLIC ACID",SmallMoleculeDrug,P36873,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,PPP1CC,323.0
11701,DB04676,Dansyllysine,SmallMoleculeDrug,P01877,Ig alpha-2 chain C region,IGHA2,340.0
11702,DB04677,N-METHYL-N-[(1R)-1-METHYL-2-PHENYLETHYL]PROP-2-EN-1-AMINE,SmallMoleculeDrug,P27338,Amine oxidase [flavin-containing] B,MAOB,520.0
11703,DB04678,H TYPE II TRISACCHARIDE,SmallMoleculeDrug,P16442,Histo-blood group ABO system transferase,ABO,354.0
11704,DB04679,H TYPE I TRISACCHARIDE,SmallMoleculeDrug,P16442,Histo-blood group ABO system transferase,ABO,354.0
11705,DB04680,GALACTOSE GREASE,SmallMoleculeDrug,P16442,Histo-blood group ABO system transferase,ABO,354.0
11706,DB04681,BETA-METHYLLACTOSIDE,SmallMoleculeDrug,P16442,Histo-blood group ABO system transferase,ABO,354.0
11707,DB04682,Octylphenoxy polyethoxyethanol,SmallMoleculeDrug,P02585,"Troponin C, skeletal muscle",TNNC2,160.0
11708,DB04683,"(2R)-3-{[{[(2S)-2,3-DIHYDROXYPROPYL]OXY}(HYDROXY)PHOSPHORYL]OXY}-2-[(9E)-HEXADEC-9-ENOYLOXY]PROPYL (9E)-OCTADEC-9-ENOATE",SmallMoleculeDrug,Q13285,Steroidogenic factor 1,NR5A1,461.0
11710,DB04685,"1-{(2S,5S)-4-FLUORO-5-[(TRITYLOXY)METHYL]TETRAHYDROFURAN-2-YL}PYRIMIDINE-2,4(1H,3H)-DIONE",SmallMoleculeDrug,P33316,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",DUT,252.0
11712,DB04688,ECGONINE METHYL ESTER,SmallMoleculeDrug,P01859,Ig gamma-2 chain C region,IGHG2,326.0
11713,DB04688,ECGONINE METHYL ESTER,SmallMoleculeDrug,P01834,Ig kappa chain C region,IGKC,107.0
11714,DB04689,2-{5-[3-(6-BENZOYL-1-PROPYLNAPHTHALEN-2-YLOXY)PROPOXY]INDOL-1-YL}ETHANOIC ACID,SmallMoleculeDrug,P37231,Peroxisome proliferator-activated receptor gamma,PPARG,505.0
11715,DB04690,Camptothecin,SmallMoleculeDrug,P11387,DNA topoisomerase 1,TOP1,765.0
11718,DB04695,FARNESYL THIOPYROPHOSPHATE,SmallMoleculeDrug,O95749,Geranylgeranyl pyrophosphate synthase,GGPS1,300.0
11719,DB04695,FARNESYL THIOPYROPHOSPHATE,SmallMoleculeDrug,Q03426,Mevalonate kinase,MVK,396.0
11722,DB04697,TRANS-4-(GUANIDINOMETHYL)-CYCLOHEXANE-L-YL-D-3-CYCLOHEXYLALANYL-L-AZETIDINE-2-YL-D-TYROSINYL-L-HOMOARGININAMIDE,SmallMoleculeDrug,P00734,Prothrombin,F2,622.0
11725,DB04700,GLUTATHIONE SULFINATE,SmallMoleculeDrug,Q9Y2Q3,Glutathione S-transferase kappa 1,GSTK1,226.0
11726,DB04701,S-METHYL-GLUTATHIONE,SmallMoleculeDrug,P28161,Glutathione S-transferase Mu 2,GSTM2,218.0
11728,DB04703,HESPERIDIN,SmallMoleculeDrug,Q96GD4,Aurora kinase B,AURKB,344.0
11729,DB04707,HYDROXYFASUDIL,SmallMoleculeDrug,Q13464,Rho-associated protein kinase 1,ROCK1,1354.0
11730,DB04707,HYDROXYFASUDIL,SmallMoleculeDrug,P17612,cAMP-dependent protein kinase catalytic subunit alpha,PRKACA,351.0
11731,DB04707,HYDROXYFASUDIL,SmallMoleculeDrug,P61925,cAMP-dependent protein kinase inhibitor alpha,PKIA,76.0
11732,DB04709,"(3AALPHA,4ALPHA,7ALPHA,7AALPHA)- 3A,4,7,7A-TETRAHYDRO-2-(4-NITRO-1-NAPHTHALENYL)-4,7-ETHANO-1H-ISOINDOLE-1,3(2H)-DIONE",SmallMoleculeDrug,P10275,Androgen receptor,AR,920.0
11735,DB04714,ISOPENTENYL PYROPHOSPHATE,SmallMoleculeDrug,P14324,Farnesyl pyrophosphate synthase,FDPS,419.0
11736,DB04714,ISOPENTENYL PYROPHOSPHATE,SmallMoleculeDrug,O95749,Geranylgeranyl pyrophosphate synthase,GGPS1,300.0
11740,DB04715,IMIDAZOPYRIDAZIN 1,SmallMoleculeDrug,P11309,Serine/threonine-protein kinase pim-1,PIM1,404.0
11741,DB04716,"2-(1,1-DIMETHYLETHYL)9-FLUORO-3,6-DIHYDRO-7H-BENZ[H]-IMIDAZ[4,5-F]ISOQUINOLIN-7-ONE",SmallMoleculeDrug,O60674,Tyrosine-protein kinase JAK2,JAK2,1132.0
11742,DB04716,"2-(1,1-DIMETHYLETHYL)9-FLUORO-3,6-DIHYDRO-7H-BENZ[H]-IMIDAZ[4,5-F]ISOQUINOLIN-7-ONE",SmallMoleculeDrug,O43293,Death-associated protein kinase 3,DAPK3,454.0
11743,DB04716,"2-(1,1-DIMETHYLETHYL)9-FLUORO-3,6-DIHYDRO-7H-BENZ[H]-IMIDAZ[4,5-F]ISOQUINOLIN-7-ONE",SmallMoleculeDrug,P23458,Tyrosine-protein kinase JAK1,JAK1,1154.0
11744,DB04716,"2-(1,1-DIMETHYLETHYL)9-FLUORO-3,6-DIHYDRO-7H-BENZ[H]-IMIDAZ[4,5-F]ISOQUINOLIN-7-ONE",SmallMoleculeDrug,P52333,Tyrosine-protein kinase JAK3,JAK3,1124.0
11745,DB04716,"2-(1,1-DIMETHYLETHYL)9-FLUORO-3,6-DIHYDRO-7H-BENZ[H]-IMIDAZ[4,5-F]ISOQUINOLIN-7-ONE",SmallMoleculeDrug,P29597,Non-receptor tyrosine-protein kinase TYK2,TYK2,1187.0
11746,DB04719,"DIMETHYL-(4,5,6,7-TETRABROMO-1H-BENZOIMIDAZOL-2-YL)-AMINE",SmallMoleculeDrug,P68400,Casein kinase II subunit alpha,CSNK2A1,391.0
11747,DB04720,"S-METHYL-4,5,6,7-TETRABROMO-BENZIMIDAZOLE",SmallMoleculeDrug,P68400,Casein kinase II subunit alpha,CSNK2A1,391.0
11748,DB04721,"N1,N2-ETHYLENE-2-METHYLAMINO-4,5,6,7-TETRABROMO-BENZIMIDAZOLE",SmallMoleculeDrug,P68400,Casein kinase II subunit alpha,CSNK2A1,391.0
11749,DB04722,"2-(3-CHLORO-6-{[2,2-DIFLUORO-2-(1-OXIDOPYRIDIN-2-YL)ETHYL]AMINO}-1-OXIDOPYRIDIN-2-YL)-N-[1-(3-CHLOROPHENYL)ETHYL]ACETAMIDE",SmallMoleculeDrug,P00734,Prothrombin,F2,622.0
11750,DB04723,2-(3-GUANIDINOPHENYL)-3-MERCAPTOPROPANOIC ACID,SmallMoleculeDrug,P15086,Carboxypeptidase B,CPB1,417.0
11751,DB04724,"(S)-2-((S)-3-ISOBUTYL-2,5-DIOXO-4-QUINOLIN-3-YLMETHYL-[1,4]DIAZEPAN-1YL)-N-METHYL-3-NAPHTALEN-2-YL-PROPIONAMIDE",SmallMoleculeDrug,P20701,Integrin alpha-L,ITGAL,1170.0
11752,DB04725,Licofelone,SmallMoleculeDrug,Q9NZK7,Group IIE secretory phospholipase A2,PLA2G2E,142.0
11753,DB04725,Licofelone,SmallMoleculeDrug,P35354,Prostaglandin G/H synthase 2,PTGS2,604.0
11754,DB04725,Licofelone,SmallMoleculeDrug,P09917,Arachidonate 5-lipoxygenase,ALOX5,674.0
11755,DB04727,"N-(4-{4-AMINO-6-[4-(METHYLOXY)PHENYL]FURO[2,3-D]PYRIMIDIN-5-YL}PHENYL)-N'-[2-FLUORO-5-(TRIFLUOROMETHYL)PHENYL]UREA",SmallMoleculeDrug,P35968,Vascular endothelial growth factor receptor 2,KDR,1356.0
11760,DB04733,"1,6-DI-O-PHOSPHONO-D-MANNITOL",SmallMoleculeDrug,P04075,Fructose-bisphosphate aldolase A,ALDOA,364.0
11763,DB04736,"2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE(BETA1-4)-2-ACETAMIDO-1,6-ANHYDRO-3-O-[(R)-1-CARBOXYETHYL]-2-DEOXY-BETA-D-GLUCOPYRANOSE-L-ALANYL-GAMMA-D-GLUTAMYL-MESO-DIAMINOPIMELYL-D-ALANINE",SmallMoleculeDrug,Q96LB9,Peptidoglycan recognition protein 3,PGLYRP3,341.0
11764,DB04738,Motuporin,SmallMoleculeDrug,P36873,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,PPP1CC,323.0
11765,DB04739,4-[(4-METHYL-1-PIPERAZINYL)METHYL]-N-[3-[[4-(3-PYRIDINYL)-2-PYRIMIDINYL]AMINO]PHENYL]-BENZAMIDE,SmallMoleculeDrug,P12931,Proto-oncogene tyrosine-protein kinase Src,SRC,536.0
11767,DB04741,Myxothiazol,SmallMoleculeDrug,P31930,"Cytochrome b-c1 complex subunit 1, mitochondrial",UQCRC1,480.0
11769,DB04743,Nimesulide,SmallMoleculeDrug,P35354,Prostaglandin G/H synthase 2,PTGS2,604.0
11770,DB04743,Nimesulide,SmallMoleculeDrug,Q9NZK7,Group IIE secretory phospholipase A2,PLA2G2E,142.0
11771,DB04743,Nimesulide,SmallMoleculeDrug,P02788,Lactotransferrin,LTF,710.0
11776,DB04751,Purvalanol A,SmallMoleculeDrug,P12931,Proto-oncogene tyrosine-protein kinase Src,SRC,536.0
11777,DB04751,Purvalanol A,SmallMoleculeDrug,Q9Y6M4,Casein kinase I isoform gamma-3,CSNK1G3,447.0
11778,DB04751,Purvalanol A,SmallMoleculeDrug,Q15418,Ribosomal protein S6 kinase alpha-1,RPS6KA1,735.0
11779,DB04752,Phosphatidyl ethanol,SmallMoleculeDrug,Q13285,Steroidogenic factor 1,NR5A1,461.0
11780,DB04753,"9-DEAZAINOSINE-2',3'-O-ETHYLIDENEPHOSPHONATE",SmallMoleculeDrug,P00491,Purine nucleoside phosphorylase,PNP,289.0
11781,DB04754,"GUANOSINE-2',3'-O-ETHYLIDENEPHOSPHONATE",SmallMoleculeDrug,P00491,Purine nucleoside phosphorylase,PNP,289.0
11782,DB04757,"GUANOSINE-2',3'-O-METHYLIDENEPHOSPHONATE",SmallMoleculeDrug,P00491,Purine nucleoside phosphorylase,PNP,289.0
11783,DB04758,2-[2-ETHANESULFONYLAMINO-3-(1H-INDOL-3-YL)-PROPIONYLAMINO]-PENTANEDIOIC ACID 5-AMIDE 1-(4-CARBAMIM IDOYL-BENZYLAMIDE),SmallMoleculeDrug,P08709,Coagulation factor VII,F7,466.0
11784,DB04759,"PYRIMIDINE-4,6-DICARBOXYLIC ACID BIS-(3-METHYL-BENZYLAMIDE)",SmallMoleculeDrug,P45452,Collagenase 3,MMP13,471.0
11785,DB04760,"PYRIMIDINE-4,6-DICARBOXYLIC ACID BIS-(4-FLUORO-3-METHYL-BENZYLAMIDE)",SmallMoleculeDrug,P45452,Collagenase 3,MMP13,471.0
11786,DB04761,"PYRIMIDINE-4,6-DICARBOXYLIC ACID BIS-[(PYRIDIN-3-YLMETHYL)-AMIDE]",SmallMoleculeDrug,P45452,Collagenase 3,MMP13,471.0
11788,DB04763,"1-N-(4-SULFAMOYLPHENYL-ETHYL)-2,4,6-TRIMETHYLPYRIDINIUM",SmallMoleculeDrug,P00918,Carbonic anhydrase 2,CA2,260.0
11789,DB04764,[4-(3-AMINOMETHYL-PHENYL)-PIPERIDIN-1-YL]-(5-PHENETHYL- PYRIDIN-3-YL)-METHANONE,SmallMoleculeDrug,P20231,Tryptase beta-2,TPSB2,275.0
11791,DB04767,N-[1-(4-CARBAMIMIDOYL-BENZYLCARBAMOYL)-3-METHYLSULFANYL-PROPYL]-3-HYDROXY-2-PROPOXYAMINO-BUTYRAMID,SmallMoleculeDrug,P08709,Coagulation factor VII,F7,466.0
11792,DB04768,Pyrithiamine Pyrophosphate,SmallMoleculeDrug,Q9H3S4,Thiamin pyrophosphokinase 1,TPK1,243.0
11793,DB04769,"5-QUINOXALIN-6-YLMETHYLENE-THIAZOLIDINE-2,4-DIONE",SmallMoleculeDrug,P48736,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",PIK3CG,1102.0
11794,DB04770,"O6-(R)-ROSCOVITINE, R-2-(6-BENZYLOXY-9-ISOPROPYL-9H-PURIN-2-YLAMINO)-BUTAN-1-OL",SmallMoleculeDrug,O00764,Pyridoxal kinase,PDXK,312.0
11795,DB04771,1-GUANIDINO-4-(N-NITRO-BENZOYLAMINO-L-LEUCYL-L-PROLYLAMINO)BUTANE,SmallMoleculeDrug,P00734,Prothrombin,F2,622.0
11796,DB04772,1-GUANIDINO-4-(N-PHENYLMETHANESULFONYL-L-LEUCYL-L-PROLYLAMINO)BUTANE,SmallMoleculeDrug,P00734,Prothrombin,F2,622.0
11798,DB04774,Reidispongiolide A,SmallMoleculeDrug,P68133,"Actin, alpha skeletal muscle",ACTA1,377.0
11799,DB04775,Reidispongiolide C,SmallMoleculeDrug,P68133,"Actin, alpha skeletal muscle",ACTA1,377.0
11800,DB04776,(2R)-2-({6-[benzyl(methyl)amino]-9-isopropyl-9H-purin-2-yl}amino)butan-1-ol,SmallMoleculeDrug,O00764,Pyridoxal kinase,PDXK,312.0
11802,DB04779,ETHYL (1E)-2-PHENYL-N-(SULFOOXY)ETHANIMIDOTHIOATE,SmallMoleculeDrug,P09848,Lactase-phlorizin hydrolase,LCT,1927.0
11803,DB04781,5-hydroxyvaleric acid,SmallMoleculeDrug,P13716,Delta-aminolevulinic acid dehydratase,ALAD,330.0
11805,DB04783,Sphinxolide B,SmallMoleculeDrug,P68133,"Actin, alpha skeletal muscle",ACTA1,377.0
11807,DB04786,Suramin,SmallMoleculeDrug,P41231,P2Y purinoceptor 2,P2RY2,377.0
11808,DB04786,Suramin,SmallMoleculeDrug,Q9NXA8,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",SIRT5,310.0
11809,DB04786,Suramin,SmallMoleculeDrug,P23945,Follicle-stimulating hormone receptor,FSHR,695.0
11810,DB04786,Suramin,SmallMoleculeDrug,P21817,Ryanodine receptor 1,RYR1,5038.0
11811,DB04786,Suramin,SmallMoleculeDrug,P00734,Prothrombin,F2,622.0
11812,DB04786,Suramin,SmallMoleculeDrug,P14555,"Phospholipase A2, membrane associated",PLA2G2A,144.0
11814,DB04787,Tanaproget,SmallMoleculeDrug,P06401,Progesterone receptor,PGR,933.0
11817,DB04789,5-methyltetrahydrofolic acid,SmallMoleculeDrug,P48728,"Aminomethyltransferase, mitochondrial",AMT,403.0
11818,DB04790,"2,5-bis-o-{3-[amino(imino)methyl]phenyl}-1,4:3,6-dianhydro-d-glucitol",SmallMoleculeDrug,P07477,Trypsin-1,PRSS1,247.0
11819,DB04791,"2-O-(4'-AMIDINOPHENYL)-5-O-(3''-AMIDINOPHENYL)-1,4:3,6-DIANHYDRO-D-SORBITOL",SmallMoleculeDrug,P07477,Trypsin-1,PRSS1,247.0
11820,DB04792,"2,5-O,O-BIS-{4',4''-AMIDINOPHENYL}-1,4:3,6-DIANHYDRO-D-SORBITOL",SmallMoleculeDrug,P07477,Trypsin-1,PRSS1,247.0
11821,DB04793,"2-O-(3'-AMIDINOPHENYL)-5-O-(4''-AMIDINOPHENYL}-1,4:3,6-DIANHYDRO-D-SORBITOL",SmallMoleculeDrug,P07477,Trypsin-1,PRSS1,247.0
11823,DB04794,Bifonazole,SmallMoleculeDrug,P20813,Cytochrome P450 2B6,CYP2B6,491.0
11824,DB04795,Thenoyltrifluoroacetone,SmallMoleculeDrug,P23141,Liver carboxylesterase 1,CES1,567.0
11825,DB04795,Thenoyltrifluoroacetone,SmallMoleculeDrug,P31040,"Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial",SDHA,664.0
11826,DB04796,Inecalcitol,SmallMoleculeDrug,P11473,Vitamin D3 receptor,VDR,427.0
11827,DB04797,Triazolopyridine,SmallMoleculeDrug,Q16539,Mitogen-activated protein kinase 14,MAPK14,360.0
11828,DB04798,THIO-ATPA,SmallMoleculeDrug,P42262,Glutamate receptor 2,GRIA2,883.0
11829,DB04799,"5-n-undecyl-6-hydroxy-4,7-dioxobenzothiazole",SmallMoleculeDrug,P08574,"Cytochrome c1, heme protein, mitochondrial",CYC1,325.0
11830,DB04799,"5-n-undecyl-6-hydroxy-4,7-dioxobenzothiazole",SmallMoleculeDrug,P00156,Cytochrome b,MT-CYB,380.0
11831,DB04799,"5-n-undecyl-6-hydroxy-4,7-dioxobenzothiazole",SmallMoleculeDrug,P31930,"Cytochrome b-c1 complex subunit 1, mitochondrial",UQCRC1,480.0
11832,DB04799,"5-n-undecyl-6-hydroxy-4,7-dioxobenzothiazole",SmallMoleculeDrug,P22695,"Cytochrome b-c1 complex subunit 2, mitochondrial",UQCRC2,453.0
11833,DB04799,"5-n-undecyl-6-hydroxy-4,7-dioxobenzothiazole",SmallMoleculeDrug,P07919,"Cytochrome b-c1 complex subunit 6, mitochondrial",UQCRH,91.0
11834,DB04799,"5-n-undecyl-6-hydroxy-4,7-dioxobenzothiazole",SmallMoleculeDrug,O14949,Cytochrome b-c1 complex subunit 8,UQCRQ,82.0
11835,DB04799,"5-n-undecyl-6-hydroxy-4,7-dioxobenzothiazole",SmallMoleculeDrug,P47985,"Cytochrome b-c1 complex subunit Rieske, mitochondrial",UQCRFS1,274.0
11836,DB04799,"5-n-undecyl-6-hydroxy-4,7-dioxobenzothiazole",SmallMoleculeDrug,O14957,Cytochrome b-c1 complex subunit 10,UQCR11,56.0
11837,DB04799,"5-n-undecyl-6-hydroxy-4,7-dioxobenzothiazole",SmallMoleculeDrug,P14927,Cytochrome b-c1 complex subunit 7,UQCRB,111.0
11838,DB04799,"5-n-undecyl-6-hydroxy-4,7-dioxobenzothiazole",SmallMoleculeDrug,Q9UDW1,Cytochrome b-c1 complex subunit 9,UQCR10,63.0
11839,DB04800,1-METHYL-3-PHENYL-1H-PYRAZOL-5-YLSULFAMIC ACID,SmallMoleculeDrug,P18031,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,435.0
11840,DB04801,(11E)-OCTADEC-11-ENOIC ACID,SmallMoleculeDrug,Q03181,Peroxisome proliferator-activated receptor delta,PPARD,441.0
11841,DB04803,Verdoheme,SmallMoleculeDrug,P09601,Heme oxygenase 1,HMOX1,288.0
11842,DB04805,Virginiamycin S1,SmallMoleculeDrug,P61927,60S ribosomal protein L37,RPL37,97.0
11847,DB04817,Metamizole,SmallMoleculeDrug,P23219,Prostaglandin G/H synthase 1,PTGS1,599.0
11848,DB04820,Nialamide,SmallMoleculeDrug,P27338,Amine oxidase [flavin-containing] B,MAOB,520.0
11849,DB04820,Nialamide,SmallMoleculeDrug,P21397,Amine oxidase [flavin-containing] A,MAOA,527.0
11850,DB04820,Nialamide,SmallMoleculeDrug,P21964,Catechol O-methyltransferase,COMT,271.0
11851,DB04821,Nomifensine,SmallMoleculeDrug,P23975,Sodium-dependent noradrenaline transporter,SLC6A2,617.0
11852,DB04821,Nomifensine,SmallMoleculeDrug,Q01959,Sodium-dependent dopamine transporter,SLC6A3,620.0
11853,DB04821,Nomifensine,SmallMoleculeDrug,P27338,Amine oxidase [flavin-containing] B,MAOB,520.0
11854,DB04821,Nomifensine,SmallMoleculeDrug,P21397,Amine oxidase [flavin-containing] A,MAOA,527.0
11855,DB04821,Nomifensine,SmallMoleculeDrug,P05164,Myeloperoxidase,MPO,745.0
11856,DB04824,Phenolphthalein,SmallMoleculeDrug,O60656,UDP-glucuronosyltransferase 1-9,UGT1A9,530.0
11858,DB04825,Prenylamine,SmallMoleculeDrug,Q9H1R3,"Myosin light chain kinase 2, skeletal/cardiac muscle",MYLK2,596.0
11859,DB04828,Zomepirac,SmallMoleculeDrug,Q9Y5Y4,Prostaglandin D2 receptor 2,PTGDR2,395.0
11860,DB04829,Lysergic Acid Diethylamide,SmallMoleculeDrug,P08908,5-hydroxytryptamine receptor 1A,HTR1A,422.0
11861,DB04832,Zimelidine,SmallMoleculeDrug,P31645,Sodium-dependent serotonin transporter,SLC6A4,630.0
11862,DB04832,Zimelidine,SmallMoleculeDrug,P27338,Amine oxidase [flavin-containing] B,MAOB,520.0
11863,DB04832,Zimelidine,SmallMoleculeDrug,P21397,Amine oxidase [flavin-containing] A,MAOA,527.0
11864,DB04835,Maraviroc,SmallMoleculeDrug,P51681,C-C chemokine receptor type 5,CCR5,352.0
11865,DB04836,Amineptine,SmallMoleculeDrug,P23975,Sodium-dependent noradrenaline transporter,SLC6A2,617.0
11866,DB04836,Amineptine,SmallMoleculeDrug,P31645,Sodium-dependent serotonin transporter,SLC6A4,630.0
11867,DB04837,Clofedanol,SmallMoleculeDrug,P35367,Histamine H1 receptor,HRH1,487.0
11868,DB04838,Cyclandelate,SmallMoleculeDrug,P54289,Voltage-dependent calcium channel subunit alpha-2/delta-1,CACNA2D1,1103.0
11869,DB04838,Cyclandelate,SmallMoleculeDrug,P23141,Liver carboxylesterase 1,CES1,567.0
11870,DB04839,Cyproterone acetate,SmallMoleculeDrug,P10275,Androgen receptor,AR,920.0
11871,DB04840,Debrisoquin,SmallMoleculeDrug,P23975,Sodium-dependent noradrenaline transporter,SLC6A2,617.0
11872,DB04841,Flunarizine,SmallMoleculeDrug,O43497,Voltage-dependent T-type calcium channel subunit alpha-1G,CACNA1G,2377.0
11873,DB04841,Flunarizine,SmallMoleculeDrug,O95180,Voltage-dependent T-type calcium channel subunit alpha-1H,CACNA1H,2353.0
11874,DB04841,Flunarizine,SmallMoleculeDrug,Q9P0X4,Voltage-dependent T-type calcium channel subunit alpha-1I,CACNA1I,2223.0
11875,DB04841,Flunarizine,SmallMoleculeDrug,P35367,Histamine H1 receptor,HRH1,487.0
11877,DB04842,Fluspirilene,SmallMoleculeDrug,P14416,D(2) dopamine receptor,DRD2,443.0
11878,DB04842,Fluspirilene,SmallMoleculeDrug,P28223,5-hydroxytryptamine receptor 2A,HTR2A,471.0
11879,DB04842,Fluspirilene,SmallMoleculeDrug,Q06432,Voltage-dependent calcium channel gamma-1 subunit,CACNG1,222.0
11880,DB04843,Mepenzolate,SmallMoleculeDrug,P11229,Muscarinic acetylcholine receptor M1,CHRM1,460.0
11881,DB04843,Mepenzolate,SmallMoleculeDrug,P20309,Muscarinic acetylcholine receptor M3,CHRM3,590.0
11882,DB04844,Tetrabenazine,SmallMoleculeDrug,Q05940,Synaptic vesicular amine transporter,SLC18A2,514.0
11883,DB04844,Tetrabenazine,SmallMoleculeDrug,P14416,D(2) dopamine receptor,DRD2,443.0
11884,DB04845,Ixabepilone,SmallMoleculeDrug,Q13509,Tubulin beta-3 chain,TUBB3,450.0
11885,DB04846,Celiprolol,SmallMoleculeDrug,P08588,Beta-1 adrenergic receptor,ADRB1,477.0
11886,DB04846,Celiprolol,SmallMoleculeDrug,P07550,Beta-2 adrenergic receptor,ADRB2,413.0
11887,DB04847,FG-4592,SmallMoleculeDrug,Q9GZT9,Egl nine homolog 1,EGLN1,426.0
11888,DB04847,FG-4592,SmallMoleculeDrug,Q96KS0,Egl nine homolog 2,EGLN2,407.0
11889,DB04847,FG-4592,SmallMoleculeDrug,Q9H6Z9,Egl nine homolog 3,EGLN3,239.0
11890,DB04849,AZD2171,SmallMoleculeDrug,P35968,Vascular endothelial growth factor receptor 2,KDR,1356.0
11891,DB04850,Posizolid,SmallMoleculeDrug,P21397,Amine oxidase [flavin-containing] A,MAOA,527.0
11892,DB04851,Biricodar dicitrate,SmallMoleculeDrug,Q2M3G0,ATP-binding cassette sub-family B member 5,ABCB5,1257.0
11893,DB04851,Biricodar dicitrate,SmallMoleculeDrug,P33527,Multidrug resistance-associated protein 1,ABCC1,1531.0
11894,DB04851,Biricodar dicitrate,SmallMoleculeDrug,Q9UNQ0,ATP-binding cassette sub-family G member 2,ABCG2,655.0
11895,DB04852,Implitapide,SmallMoleculeDrug,P55157,Microsomal triglyceride transfer protein large subunit,MTTP,894.0
11896,DB04853,Binodenoson,SmallMoleculeDrug,P29274,Adenosine receptor A2a,ADORA2A,412.0
11897,DB04854,Febuxostat,SmallMoleculeDrug,P47989,Xanthine dehydrogenase/oxidase,XDH,1333.0
11898,DB04855,Dronedarone,SmallMoleculeDrug,P35348,Alpha-1A adrenergic receptor,ADRA1A,466.0
11899,DB04855,Dronedarone,SmallMoleculeDrug,P35368,Alpha-1B adrenergic receptor,ADRA1B,520.0
11900,DB04855,Dronedarone,SmallMoleculeDrug,P25100,Alpha-1D adrenergic receptor,ADRA1D,572.0
11901,DB04855,Dronedarone,SmallMoleculeDrug,P08913,Alpha-2A adrenergic receptor,ADRA2A,450.0
11902,DB04855,Dronedarone,SmallMoleculeDrug,P18089,Alpha-2B adrenergic receptor,ADRA2B,450.0
11903,DB04855,Dronedarone,SmallMoleculeDrug,P18825,Alpha-2C adrenergic receptor,ADRA2C,462.0
11904,DB04855,Dronedarone,SmallMoleculeDrug,P08588,Beta-1 adrenergic receptor,ADRB1,477.0
11905,DB04855,Dronedarone,SmallMoleculeDrug,Q12809,Potassium voltage-gated channel subfamily H member 2,KCNH2,1159.0
11906,DB04855,Dronedarone,SmallMoleculeDrug,Q13936,Voltage-dependent L-type calcium channel subunit alpha-1C,CACNA1C,2221.0
11907,DB04855,Dronedarone,SmallMoleculeDrug,Q01668,Voltage-dependent L-type calcium channel subunit alpha-1D,CACNA1D,2161.0
11908,DB04855,Dronedarone,SmallMoleculeDrug,O60840,Voltage-dependent L-type calcium channel subunit alpha-1F,CACNA1F,1977.0
11909,DB04855,Dronedarone,SmallMoleculeDrug,Q13698,Voltage-dependent L-type calcium channel subunit alpha-1S,CACNA1S,1873.0
11910,DB04855,Dronedarone,SmallMoleculeDrug,Q02641,Voltage-dependent L-type calcium channel subunit beta-1,CACNB1,598.0
11911,DB04855,Dronedarone,SmallMoleculeDrug,Q08289,Voltage-dependent L-type calcium channel subunit beta-2,CACNB2,660.0
11912,DB04855,Dronedarone,SmallMoleculeDrug,P54284,Voltage-dependent L-type calcium channel subunit beta-3,CACNB3,484.0
11913,DB04855,Dronedarone,SmallMoleculeDrug,O00305,Voltage-dependent L-type calcium channel subunit beta-4,CACNB4,520.0
11914,DB04855,Dronedarone,SmallMoleculeDrug,P35498,Sodium channel protein type 1 subunit alpha,SCN1A,2009.0
11915,DB04855,Dronedarone,SmallMoleculeDrug,O95069,Potassium channel subfamily K member 2,KCNK2,426.0
11916,DB04856,Dexloxiglumide,SmallMoleculeDrug,P32238,Cholecystokinin receptor type A,CCKAR,428.0
11917,DB04857,Brasofensine,SmallMoleculeDrug,P14416,D(2) dopamine receptor,DRD2,443.0
11918,DB04859,Zanapezil,SmallMoleculeDrug,P22303,Acetylcholinesterase,ACHE,614.0
11919,DB04860,Isatoribine,SmallMoleculeDrug,Q9NYK1,Toll-like receptor 7,TLR7,1049.0
11920,DB04861,Nebivolol,SmallMoleculeDrug,P08588,Beta-1 adrenergic receptor,ADRB1,477.0
11921,DB04861,Nebivolol,SmallMoleculeDrug,P07550,Beta-2 adrenergic receptor,ADRB2,413.0
11923,DB04863,Lefradafiban,SmallMoleculeDrug,P08514,Integrin alpha-IIb,ITGA2B,1039.0
11924,DB04863,Lefradafiban,SmallMoleculeDrug,P05106,Integrin beta-3,ITGB3,788.0
11925,DB04864,Huperzine A,SmallMoleculeDrug,P22303,Acetylcholinesterase,ACHE,614.0
11926,DB04864,Huperzine A,SmallMoleculeDrug,P22303,Acetylcholinesterase,ACHE,614.0
11928,DB04865,Omacetaxine mepesuccinate,SmallMoleculeDrug,P39023,60S ribosomal protein L3,RPL3,403.0
11929,DB04866,Halofuginone,SmallMoleculeDrug,P02452,Collagen alpha-1(I) chain,COL1A1,1464.0
11930,DB04866,Halofuginone,SmallMoleculeDrug,P08253,72 kDa type IV collagenase,MMP2,660.0
11931,DB04867,Lintitript,SmallMoleculeDrug,P32238,Cholecystokinin receptor type A,CCKAR,428.0
11932,DB04868,Nilotinib,SmallMoleculeDrug,P00519,Tyrosine-protein kinase ABL1,ABL1,1130.0
11933,DB04868,Nilotinib,SmallMoleculeDrug,P10721,Mast/stem cell growth factor receptor Kit,KIT,976.0
11934,DB04869,Olcegepant,SmallMoleculeDrug,P06881,Calcitonin gene-related peptide 1,CALCA,128.0
11935,DB04871,Lorcaserin,SmallMoleculeDrug,P28335,5-hydroxytryptamine receptor 2C,HTR2C,458.0
11936,DB04872,Osanetant,SmallMoleculeDrug,P29371,Neuromedin-K receptor,TACR3,465.0
11937,DB04873,Piboserod,SmallMoleculeDrug,Q13639,5-hydroxytryptamine receptor 4,HTR4,388.0
11938,DB04875,Pralnacasan,SmallMoleculeDrug,P29466,Caspase-1,CASP1,404.0
11939,DB04876,Vildagliptin,SmallMoleculeDrug,P27487,Dipeptidyl peptidase 4,DPP4,766.0
11940,DB04877,Voacamine,SmallMoleculeDrug,P08183,Multidrug resistance protein 1,ABCB1,1280.0
11941,DB04878,Voglibose,SmallMoleculeDrug,O43451,"Maltase-glucoamylase, intestinal",MGAM,1857.0
11942,DB04879,Vatalanib,SmallMoleculeDrug,P17948,Vascular endothelial growth factor receptor 1,FLT1,1338.0
11943,DB04879,Vatalanib,SmallMoleculeDrug,P35968,Vascular endothelial growth factor receptor 2,KDR,1356.0
11944,DB04879,Vatalanib,SmallMoleculeDrug,P35916,Vascular endothelial growth factor receptor 3,FLT4,1363.0
11945,DB04880,Enoximone,SmallMoleculeDrug,Q14432,"cGMP-inhibited 3',5'-cyclic phosphodiesterase A",PDE3A,1141.0
11946,DB04881,Elacridar,SmallMoleculeDrug,P08183,Multidrug resistance protein 1,ABCB1,1280.0
11947,DB04882,Edotecarin,SmallMoleculeDrug,P11387,DNA topoisomerase 1,TOP1,765.0
11948,DB04883,Darusentan,SmallMoleculeDrug,P25101,Endothelin-1 receptor,EDNRA,427.0
11949,DB04884,Dapoxetine,SmallMoleculeDrug,P08908,5-hydroxytryptamine receptor 1A,HTR1A,422.0
11950,DB04884,Dapoxetine,SmallMoleculeDrug,P28222,5-hydroxytryptamine receptor 1B,HTR1B,390.0
11951,DB04884,Dapoxetine,SmallMoleculeDrug,P28335,5-hydroxytryptamine receptor 2C,HTR2C,458.0
11952,DB04885,Cilansetron,SmallMoleculeDrug,P46098,5-hydroxytryptamine receptor 3A,HTR3A,478.0
11955,DB04888,Bifeprunox,SmallMoleculeDrug,P14416,D(2) dopamine receptor,DRD2,443.0
11956,DB04888,Bifeprunox,SmallMoleculeDrug,P08908,5-hydroxytryptamine receptor 1A,HTR1A,422.0
11957,DB04889,Bicifadine,SmallMoleculeDrug,P23975,Sodium-dependent noradrenaline transporter,SLC6A2,617.0
11958,DB04889,Bicifadine,SmallMoleculeDrug,P31645,Sodium-dependent serotonin transporter,SLC6A4,630.0
11959,DB04889,Bicifadine,SmallMoleculeDrug,P14416,D(2) dopamine receptor,DRD2,443.0
11960,DB04890,Bepotastine,SmallMoleculeDrug,P35367,Histamine H1 receptor,HRH1,487.0
11961,DB04892,Phenserine,SmallMoleculeDrug,P22303,Acetylcholinesterase,ACHE,614.0
11962,DB04892,Phenserine,SmallMoleculeDrug,P06276,Cholinesterase,BCHE,602.0
11963,DB04893,AZD3409,SmallMoleculeDrug,P49356,Protein farnesyltransferase subunit beta,FNTB,437.0
11964,DB04893,AZD3409,SmallMoleculeDrug,P49354,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,FNTA,379.0
11965,DB04894,Vapreotide,SmallMoleculeDrug,P30874,Somatostatin receptor type 2,SSTR2,369.0
11966,DB04894,Vapreotide,SmallMoleculeDrug,P35346,Somatostatin receptor type 5,SSTR5,364.0
11967,DB04894,Vapreotide,SmallMoleculeDrug,P25103,Substance-P receptor,TACR1,407.0
11968,DB04895,Pegaptanib,BiotechDrug,O14786,Neuropilin-1,NRP1,923.0
11969,DB04896,Milnacipran,SmallMoleculeDrug,P31645,Sodium-dependent serotonin transporter,SLC6A4,630.0
11970,DB04896,Milnacipran,SmallMoleculeDrug,P23975,Sodium-dependent noradrenaline transporter,SLC6A2,617.0
11971,DB04896,Milnacipran,SmallMoleculeDrug,Q05586,"Glutamate receptor ionotropic, NMDA 1",GRIN1,938.0
11972,DB04896,Milnacipran,SmallMoleculeDrug,Q12879,"Glutamate receptor ionotropic, NMDA 2A",GRIN2A,1464.0
11973,DB04896,Milnacipran,SmallMoleculeDrug,Q13224,"Glutamate receptor ionotropic, NMDA 2B",GRIN2B,1484.0
11974,DB04896,Milnacipran,SmallMoleculeDrug,Q14957,"Glutamate receptor ionotropic, NMDA 2C",GRIN2C,1233.0
11975,DB04896,Milnacipran,SmallMoleculeDrug,O15399,"Glutamate receptor ionotropic, NMDA 2D",GRIN2D,1336.0
11976,DB04896,Milnacipran,SmallMoleculeDrug,Q8TCU5,"Glutamate receptor ionotropic, NMDA 3A",GRIN3A,1115.0
11977,DB04896,Milnacipran,SmallMoleculeDrug,O60391,"Glutamate receptor ionotropic, NMDA 3B",GRIN3B,1043.0
11978,DB04898,Ximelagatran,SmallMoleculeDrug,P00734,Prothrombin,F2,622.0
11979,DB04899,Nesiritide,BiotechDrug,P16066,Atrial natriuretic peptide receptor 1,NPR1,1061.0
11980,DB04899,Nesiritide,BiotechDrug,P20594,Atrial natriuretic peptide receptor 2,NPR2,1047.0
11981,DB04899,Nesiritide,BiotechDrug,P17342,Atrial natriuretic peptide receptor 3,NPR3,541.0
11982,DB04901,Galiximab,BiotechDrug,P33681,T-lymphocyte activation antigen CD80,CD80,288.0
11983,DB04902,AZD6140,SmallMoleculeDrug,Q9H244,P2Y purinoceptor 12,P2RY12,342.0
11984,DB04903,Pagoclone,SmallMoleculeDrug,P47869,Gamma-aminobutyric acid receptor subunit alpha-2,GABRA2,451.0
11985,DB04903,Pagoclone,SmallMoleculeDrug,P34903,Gamma-aminobutyric acid receptor subunit alpha-3,GABRA3,492.0
11986,DB04905,Tesmilifene,SmallMoleculeDrug,P08183,Multidrug resistance protein 1,ABCB1,1280.0
11987,DB04905,Tesmilifene,SmallMoleculeDrug,P35367,Histamine H1 receptor,HRH1,487.0
11988,DB04906,ISA247,SmallMoleculeDrug,P63098,Calcineurin subunit B type 1,PPP3R1,170.0
11989,DB04906,ISA247,SmallMoleculeDrug,Q96LZ3,Calcineurin subunit B type 2,PPP3R2,170.0
11990,DB04908,Flibanserin,SmallMoleculeDrug,P08908,5-hydroxytryptamine receptor 1A,HTR1A,422.0
11991,DB04908,Flibanserin,SmallMoleculeDrug,P28223,5-hydroxytryptamine receptor 2A,HTR2A,471.0
11992,DB04908,Flibanserin,SmallMoleculeDrug,P21917,D(4) dopamine receptor,DRD4,467.0
11993,DB04910,Oxibendazole,SmallMoleculeDrug,P68371,Tubulin beta-4B chain,TUBB4B,445.0
11994,DB04912,Stannsoporfin,SmallMoleculeDrug,P09601,Heme oxygenase 1,HMOX1,288.0
11995,DB04912,Stannsoporfin,SmallMoleculeDrug,P30519,Heme oxygenase 2,HMOX2,316.0
11996,DB04915,Phenoxodiol,SmallMoleculeDrug,Q16206,Ecto-NOX disulfide-thiol exchanger 2,ENOX2,610.0
11997,DB04917,Renzapride,SmallMoleculeDrug,P46098,5-hydroxytryptamine receptor 3A,HTR3A,478.0
11998,DB04917,Renzapride,SmallMoleculeDrug,Q13639,5-hydroxytryptamine receptor 4,HTR4,388.0
12002,DB04919,Alfimeprase,BiotechDrug,P02671,Fibrinogen alpha chain,FGA,866.0
12003,DB04919,Alfimeprase,BiotechDrug,P02675,Fibrinogen beta chain,FGB,491.0
12004,DB04920,Clevidipine,SmallMoleculeDrug,O60840,Voltage-dependent L-type calcium channel subunit alpha-1F,CACNA1F,1977.0
12005,DB04920,Clevidipine,SmallMoleculeDrug,Q13698,Voltage-dependent L-type calcium channel subunit alpha-1S,CACNA1S,1873.0
12006,DB04920,Clevidipine,SmallMoleculeDrug,Q01668,Voltage-dependent L-type calcium channel subunit alpha-1D,CACNA1D,2161.0
12007,DB04920,Clevidipine,SmallMoleculeDrug,Q13936,Voltage-dependent L-type calcium channel subunit alpha-1C,CACNA1C,2221.0
12008,DB04922,XP13512,SmallMoleculeDrug,P54289,Voltage-dependent calcium channel subunit alpha-2/delta-1,CACNA2D1,1103.0
12009,DB04922,XP13512,SmallMoleculeDrug,Q9NY47,Voltage-dependent calcium channel subunit alpha-2/delta-2,CACNA2D2,1150.0
12010,DB04924,Itopride,SmallMoleculeDrug,P14416,D(2) dopamine receptor,DRD2,443.0
12011,DB04924,Itopride,SmallMoleculeDrug,P20309,Muscarinic acetylcholine receptor M3,CHRM3,590.0
12012,DB04925,Desmoteplase,BiotechDrug,P00747,Plasminogen,PLG,810.0
12013,DB04926,Neramexane,SmallMoleculeDrug,Q8TCU5,"Glutamate receptor ionotropic, NMDA 3A",GRIN3A,1115.0
12014,DB04927,NM100060,SmallMoleculeDrug,Q14534,Squalene monooxygenase,SQLE,574.0
12015,DB04929,DG031,SmallMoleculeDrug,P20292,Arachidonate 5-lipoxygenase-activating protein,ALOX5AP,161.0
12016,DB04930,Permethrin,SmallMoleculeDrug,P35498,Sodium channel protein type 1 subunit alpha,SCN1A,2009.0
12017,DB04931,Afamelanotide,SmallMoleculeDrug,Q01726,Melanocyte-stimulating hormone receptor,MC1R,317.0
12018,DB04932,Defibrotide,BiotechDrug,P30542,Adenosine receptor A1,ADORA1,326.0
12019,DB04932,Defibrotide,BiotechDrug,P29274,Adenosine receptor A2a,ADORA2A,412.0
12020,DB04932,Defibrotide,BiotechDrug,P29275,Adenosine receptor A2b,ADORA2B,332.0
12021,DB04933,Eritoran,SmallMoleculeDrug,O00206,Toll-like receptor 4,TLR4,839.0
12023,DB04937,GV1001,BiotechDrug,O14746,Telomerase reverse transcriptase,TERT,1132.0
12024,DB04938,Ospemifene,SmallMoleculeDrug,P03372,Estrogen receptor,ESR1,595.0
12025,DB04940,E7389,SmallMoleculeDrug,P10415,Apoptosis regulator Bcl-2,BCL2,239.0
12026,DB04940,E7389,SmallMoleculeDrug,Q9H4B7,Tubulin beta-1 chain,TUBB1,451.0
12027,DB04941,Crofelemer,SmallMoleculeDrug,P13569,Cystic fibrosis transmembrane conductance regulator,CFTR,1480.0
12028,DB04941,Crofelemer,SmallMoleculeDrug,Q5XXA6,Anoctamin-1,ANO1,986.0
12029,DB04942,Tamibarotene,SmallMoleculeDrug,P10276,Retinoic acid receptor alpha,RARA,462.0
12030,DB04942,Tamibarotene,SmallMoleculeDrug,P10826,Retinoic acid receptor beta,RARB,455.0
12031,DB04946,Iloperidone,SmallMoleculeDrug,P28223,5-hydroxytryptamine receptor 2A,HTR2A,471.0
12032,DB04946,Iloperidone,SmallMoleculeDrug,P14416,D(2) dopamine receptor,DRD2,443.0
12033,DB04946,Iloperidone,SmallMoleculeDrug,P21728,D(1A) dopamine receptor,DRD1,446.0
12034,DB04946,Iloperidone,SmallMoleculeDrug,P35462,D(3) dopamine receptor,DRD3,400.0
12035,DB04946,Iloperidone,SmallMoleculeDrug,P21917,D(4) dopamine receptor,DRD4,467.0
12036,DB04946,Iloperidone,SmallMoleculeDrug,P08908,5-hydroxytryptamine receptor 1A,HTR1A,422.0
12037,DB04946,Iloperidone,SmallMoleculeDrug,P50406,5-hydroxytryptamine receptor 6,HTR6,440.0
12038,DB04946,Iloperidone,SmallMoleculeDrug,P34969,5-hydroxytryptamine receptor 7,HTR7,479.0
12039,DB04946,Iloperidone,SmallMoleculeDrug,P35348,Alpha-1A adrenergic receptor,ADRA1A,466.0
12040,DB04946,Iloperidone,SmallMoleculeDrug,P35367,Histamine H1 receptor,HRH1,487.0
12041,DB04946,Iloperidone,SmallMoleculeDrug,P18825,Alpha-2C adrenergic receptor,ADRA2C,462.0
12042,DB04947,Altropane,SmallMoleculeDrug,Q01959,Sodium-dependent dopamine transporter,SLC6A3,620.0
12043,DB04948,Lofexidine,SmallMoleculeDrug,P08913,Alpha-2A adrenergic receptor,ADRA2A,450.0
12044,DB04951,Pirfenidone,SmallMoleculeDrug,P09958,Furin,FURIN,794.0
12045,DB04953,Ezogabine,SmallMoleculeDrug,O43526,Potassium voltage-gated channel subfamily KQT member 2,KCNQ2,872.0
12046,DB04953,Ezogabine,SmallMoleculeDrug,O43525,Potassium voltage-gated channel subfamily KQT member 3,KCNQ3,872.0
12047,DB04953,Ezogabine,SmallMoleculeDrug,P56696,Potassium voltage-gated channel subfamily KQT member 4,KCNQ4,695.0
12048,DB04953,Ezogabine,SmallMoleculeDrug,Q9NR82,Potassium voltage-gated channel subfamily KQT member 5,KCNQ5,932.0
12049,DB04954,Tecadenoson,SmallMoleculeDrug,P30542,Adenosine receptor A1,ADORA1,326.0
12050,DB04956,Afelimomab,BiotechDrug,P01375,Tumor necrosis factor,TNF,233.0
12051,DB04957,Azimilide,SmallMoleculeDrug,P15382,Potassium voltage-gated channel subfamily E member 1,KCNE1,129.0
12052,DB04957,Azimilide,SmallMoleculeDrug,P51787,Potassium voltage-gated channel subfamily KQT member 1,KCNQ1,676.0
12053,DB04957,Azimilide,SmallMoleculeDrug,Q12809,Potassium voltage-gated channel subfamily H member 2,KCNH2,1159.0
12054,DB04958,Epratuzumab,BiotechDrug,P20273,B-cell receptor CD22,CD22,847.0
12055,DB04959,HspE7,BiotechDrug,P08729,"Keratin, type II cytoskeletal 7",KRT7,469.0
12056,DB04959,HspE7,BiotechDrug,Q5T4S7,E3 ubiquitin-protein ligase UBR4,UBR4,5183.0
12057,DB04960,Tipifarnib,SmallMoleculeDrug,P49356,Protein farnesyltransferase subunit beta,FNTB,437.0
12058,DB04964,Oregovomab,BiotechDrug,Q8WXI7,Mucin-16,MUC16,14507.0
12059,DB04967,Lucanthone,SmallMoleculeDrug,P11388,DNA topoisomerase 2-alpha,TOP2A,1531.0
12060,DB04967,Lucanthone,SmallMoleculeDrug,P27695,DNA-(apurinic or apyrimidinic site) lyase,APEX1,318.0
12061,DB04967,Lucanthone,SmallMoleculeDrug,P11387,DNA topoisomerase 1,TOP1,765.0
12062,DB04970,Lesopitron,SmallMoleculeDrug,P08908,5-hydroxytryptamine receptor 1A,HTR1A,422.0
12063,DB04971,Reglixane,SmallMoleculeDrug,Q07869,Peroxisome proliferator-activated receptor alpha,PPARA,468.0
12064,DB04971,Reglixane,SmallMoleculeDrug,P37231,Peroxisome proliferator-activated receptor gamma,PPARG,505.0
12065,DB04972,Canfosfamide,SmallMoleculeDrug,P09211,Glutathione S-transferase P,GSTP1,210.0
12066,DB04973,LErafAON,BiotechDrug,P04049,RAF proto-oncogene serine/threonine-protein kinase,RAF1,648.0
12067,DB04974,AP1903,SmallMoleculeDrug,P42345,Serine/threonine-protein kinase mTOR,MTOR,2549.0
12068,DB04975,Banoxantrone,SmallMoleculeDrug,P11388,DNA topoisomerase 2-alpha,TOP2A,1531.0
12069,DB04978,SP1049C,SmallMoleculeDrug,P11388,DNA topoisomerase 2-alpha,TOP2A,1531.0
12070,DB04982,Talampanel,SmallMoleculeDrug,P42261,Glutamate receptor 1,GRIA1,906.0
12071,DB04982,Talampanel,SmallMoleculeDrug,P42262,Glutamate receptor 2,GRIA2,883.0
12072,DB04982,Talampanel,SmallMoleculeDrug,P42263,Glutamate receptor 3,GRIA3,894.0
12073,DB04982,Talampanel,SmallMoleculeDrug,P48058,Glutamate receptor 4,GRIA4,902.0
12074,DB04983,Denufosol,SmallMoleculeDrug,P41231,P2Y purinoceptor 2,P2RY2,377.0
12075,DB04985,PCK3145,BiotechDrug,P08865,40S ribosomal protein SA,RPSA,295.0
12076,DB04988,IGN311,BiotechDrug,P00533,Epidermal growth factor receptor,EGFR,1210.0
12077,DB04988,IGN311,BiotechDrug,P04626,Receptor tyrosine-protein kinase erbB-2,ERBB2,1255.0
12078,DB04991,XL784,SmallMoleculeDrug,O14672,Disintegrin and metalloproteinase domain-containing protein 10,ADAM10,748.0
12079,DB04997,ATL1102,SmallMoleculeDrug,P13612,Integrin alpha-4,ITGA4,1032.0
12080,DB04998,AGRO100,SmallMoleculeDrug,Q9Y6K9,NF-kappa-B essential modulator,IKBKG,419.0
12081,DB05001,PSN9301,SmallMoleculeDrug,P27487,Dipeptidyl peptidase 4,DPP4,766.0
12082,DB05003,Imexon,SmallMoleculeDrug,P31350,Ribonucleoside-diphosphate reductase subunit M2,RRM2,389.0
12083,DB05003,Imexon,SmallMoleculeDrug,P23921,Ribonucleoside-diphosphate reductase large subunit,RRM1,792.0
12084,DB05004,AC162352,SmallMoleculeDrug,P49146,Neuropeptide Y receptor type 2,NPY2R,381.0
12085,DB05004,AC162352,SmallMoleculeDrug,P25929,Neuropeptide Y receptor type 1,NPY1R,384.0
12086,DB05004,AC162352,SmallMoleculeDrug,Q15761,Neuropeptide Y receptor type 5,NPY5R,445.0
12087,DB05004,AC162352,SmallMoleculeDrug,P50391,Neuropeptide Y receptor type 4,NPY4R,375.0
12088,DB05005,CCX282,SmallMoleculeDrug,P51686,C-C chemokine receptor type 9,CCR9,369.0
12089,DB05007,XL647,SmallMoleculeDrug,P01133,Pro-epidermal growth factor,EGF,1207.0
12090,DB05007,XL647,SmallMoleculeDrug,P54760,Ephrin type-B receptor 4,EPHB4,987.0
12091,DB05007,XL647,SmallMoleculeDrug,P04626,Receptor tyrosine-protein kinase erbB-2,ERBB2,1255.0
12092,DB05009,Apadenoson,SmallMoleculeDrug,P29274,Adenosine receptor A2a,ADORA2A,412.0
12093,DB05010,SGS742,SmallMoleculeDrug,Q9UBS5,Gamma-aminobutyric acid type B receptor subunit 1,GABBR1,961.0
12094,DB05010,SGS742,SmallMoleculeDrug,O75899,Gamma-aminobutyric acid type B receptor subunit 2,GABBR2,941.0
12095,DB05012,XEN2174,SmallMoleculeDrug,P23975,Sodium-dependent noradrenaline transporter,SLC6A2,617.0
12096,DB05013,Ingenol Mebutate,SmallMoleculeDrug,Q05655,Protein kinase C delta type,PRKCD,676.0
12097,DB05013,Ingenol Mebutate,SmallMoleculeDrug,P17252,Protein kinase C alpha type,PRKCA,672.0
12098,DB05014,XL999,SmallMoleculeDrug,P22607,Fibroblast growth factor receptor 3,FGFR3,806.0
12099,DB05014,XL999,SmallMoleculeDrug,P11362,Fibroblast growth factor receptor 1,FGFR1,822.0
12100,DB05014,XL999,SmallMoleculeDrug,P35968,Vascular endothelial growth factor receptor 2,KDR,1356.0
12101,DB05014,XL999,SmallMoleculeDrug,P36888,Receptor-type tyrosine-protein kinase FLT3,FLT3,993.0
12102,DB05014,XL999,SmallMoleculeDrug,P09619,Platelet-derived growth factor receptor beta,PDGFRB,1106.0
12103,DB05014,XL999,SmallMoleculeDrug,O43519,RET proto-oncogene,RET,23.0
12104,DB05015,Belinostat,SmallMoleculeDrug,Q13547,Histone deacetylase 1,HDAC1,482.0
12105,DB05015,Belinostat,SmallMoleculeDrug,Q969S8,Histone deacetylase 10,HDAC10,669.0
12106,DB05015,Belinostat,SmallMoleculeDrug,Q96DB2,Histone deacetylase 11,HDAC11,347.0
12107,DB05015,Belinostat,SmallMoleculeDrug,Q92769,Histone deacetylase 2,HDAC2,488.0
12108,DB05015,Belinostat,SmallMoleculeDrug,O15379,Histone deacetylase 3,HDAC3,428.0
12109,DB05015,Belinostat,SmallMoleculeDrug,P56524,Histone deacetylase 4,HDAC4,1084.0
12110,DB05015,Belinostat,SmallMoleculeDrug,Q9UQL6,Histone deacetylase 5,HDAC5,1122.0
12111,DB05015,Belinostat,SmallMoleculeDrug,Q9UBN7,Histone deacetylase 6,HDAC6,1215.0
12112,DB05015,Belinostat,SmallMoleculeDrug,Q8WUI4,Histone deacetylase 7,HDAC7,952.0
12113,DB05015,Belinostat,SmallMoleculeDrug,Q9BY41,Histone deacetylase 8,HDAC8,377.0
12114,DB05015,Belinostat,SmallMoleculeDrug,Q9UKV0,Histone deacetylase 9,HDAC9,1011.0
12115,DB05017,YSIL6,SmallMoleculeDrug,P01375,Tumor necrosis factor,TNF,233.0
12116,DB05017,YSIL6,SmallMoleculeDrug,P05231,Interleukin-6,IL6,212.0
12117,DB05018,Migalastat,SmallMoleculeDrug,P06280,Alpha-galactosidase A,GLA,429.0
12119,DB05022,Amonafide,SmallMoleculeDrug,P11388,DNA topoisomerase 2-alpha,TOP2A,1531.0
12120,DB05022,Amonafide,SmallMoleculeDrug,Q02880,DNA topoisomerase 2-beta,TOP2B,1626.0
12121,DB05023,ATL1101,SmallMoleculeDrug,P08069,Insulin-like growth factor 1 receptor,IGF1R,1367.0
12122,DB05024,CTA018,SmallMoleculeDrug,Q07973,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",CYP24A1,514.0
12123,DB05024,CTA018,SmallMoleculeDrug,P11473,Vitamin D3 receptor,VDR,427.0
12124,DB05025,Arimoclomol,SmallMoleculeDrug,P00441,Superoxide dismutase [Cu-Zn],SOD1,154.0
12125,DB05026,APD125,SmallMoleculeDrug,P28223,5-hydroxytryptamine receptor 2A,HTR2A,471.0
12126,DB05030,XL880,SmallMoleculeDrug,P14210,Hepatocyte growth factor,HGF,728.0
12127,DB05030,XL880,SmallMoleculeDrug,P35968,Vascular endothelial growth factor receptor 2,KDR,1356.0
12128,DB05032,REV131,SmallMoleculeDrug,Q9H3N8,Histamine H4 receptor,HRH4,390.0
12129,DB05033,INCB7839,SmallMoleculeDrug,Q13443,Disintegrin and metalloproteinase domain-containing protein 9,ADAM9,819.0
12130,DB05034,Ularitide,SmallMoleculeDrug,P16066,Atrial natriuretic peptide receptor 1,NPR1,1061.0
12131,DB05035,KB2115,SmallMoleculeDrug,P10827,Thyroid hormone receptor alpha,THRA,490.0
12132,DB05035,KB2115,SmallMoleculeDrug,P10828,Thyroid hormone receptor beta,THRB,461.0
12133,DB05036,Grn163l,SmallMoleculeDrug,Q86US8,Telomerase-binding protein EST1A,SMG6,1419.0
12134,DB05036,Grn163l,SmallMoleculeDrug,Q96KG9,N-terminal kinase-like protein,SCYL1,808.0
12135,DB05036,Grn163l,SmallMoleculeDrug,Q15185,Prostaglandin E synthase 3,PTGES3,160.0
12136,DB05036,Grn163l,SmallMoleculeDrug,O14746,Telomerase reverse transcriptase,TERT,1132.0
12137,DB05037,AT7519,SmallMoleculeDrug,P06493,Cyclin-dependent kinase 1,CDK1,297.0
12138,DB05037,AT7519,SmallMoleculeDrug,P24941,Cyclin-dependent kinase 2,CDK2,298.0
12139,DB05038,Anatibant,SmallMoleculeDrug,P30411,B2 bradykinin receptor,BDKRB2,391.0
12140,DB05039,Indacaterol,SmallMoleculeDrug,P07550,Beta-2 adrenergic receptor,ADRB2,413.0
12141,DB05041,RP101,SmallMoleculeDrug,Q16831,Uridine phosphorylase 1,UPP1,310.0
12142,DB05041,RP101,SmallMoleculeDrug,O95045,Uridine phosphorylase 2,UPP2,317.0
12143,DB05042,SGS518,SmallMoleculeDrug,P50406,5-hydroxytryptamine receptor 6,HTR6,440.0
12144,DB05044,PSN357,SmallMoleculeDrug,P06737,"Glycogen phosphorylase, liver form",PYGL,847.0
12145,DB05045,TM30338,SmallMoleculeDrug,P50391,Neuropeptide Y receptor type 4,NPY4R,375.0
12146,DB05045,TM30338,SmallMoleculeDrug,P49146,Neuropeptide Y receptor type 2,NPY2R,381.0
12147,DB05046,V1003,SmallMoleculeDrug,P41145,Kappa-type opioid receptor,OPRK1,380.0
12148,DB05046,V1003,SmallMoleculeDrug,P35372,Mu-type opioid receptor,OPRM1,400.0
12149,DB05047,CX717,SmallMoleculeDrug,P48058,Glutamate receptor 4,GRIA4,902.0
12150,DB05047,CX717,SmallMoleculeDrug,P23560,Brain-derived neurotrophic factor,BDNF,247.0
12151,DB05047,CX717,SmallMoleculeDrug,P42261,Glutamate receptor 1,GRIA1,906.0
12152,DB05047,CX717,SmallMoleculeDrug,P42262,Glutamate receptor 2,GRIA2,883.0
12153,DB05047,CX717,SmallMoleculeDrug,P42263,Glutamate receptor 3,GRIA3,894.0
12154,DB05049,DDP733,SmallMoleculeDrug,P46098,5-hydroxytryptamine receptor 3A,HTR3A,478.0
12155,DB05050,ADL5859,SmallMoleculeDrug,P41143,Delta-type opioid receptor,OPRD1,372.0
12156,DB05052,MF101,SmallMoleculeDrug,Q92731,Estrogen receptor beta,ESR2,530.0
12157,DB05053,MB07803,SmallMoleculeDrug,P09467,"Fructose-1,6-bisphosphatase 1",FBP1,338.0
12160,DB05062,INCB9471,SmallMoleculeDrug,P51681,C-C chemokine receptor type 5,CCR5,352.0
12161,DB05064,INCB13739,SmallMoleculeDrug,P28845,Corticosteroid 11-beta-dehydrogenase isozyme 1,HSD11B1,292.0
12162,DB05065,PHX1149,SmallMoleculeDrug,P27487,Dipeptidyl peptidase 4,DPP4,766.0
12163,DB05066,AV411,SmallMoleculeDrug,P01584,Interleukin-1 beta,IL1B,269.0
12164,DB05066,AV411,SmallMoleculeDrug,P01375,Tumor necrosis factor,TNF,233.0
12165,DB05066,AV411,SmallMoleculeDrug,P05231,Interleukin-6,IL6,212.0
12166,DB05066,AV411,SmallMoleculeDrug,P22301,Interleukin-10,IL10,178.0
12167,DB05066,AV411,SmallMoleculeDrug,P20783,Neurotrophin-3,NTF3,257.0
12168,DB05066,AV411,SmallMoleculeDrug,P39905,Glial cell line-derived neurotrophic factor,GDNF,211.0
12169,DB05066,AV411,SmallMoleculeDrug,P34130,Neurotrophin-4,NTF4,210.0
12170,DB05069,ATG003,SmallMoleculeDrug,Q9GZZ6,Neuronal acetylcholine receptor subunit alpha-10,CHRNA10,450.0
12171,DB05069,ATG003,SmallMoleculeDrug,Q9UGM1,Neuronal acetylcholine receptor subunit alpha-9,CHRNA9,479.0
12172,DB05070,ADX10059,SmallMoleculeDrug,P41594,Metabotropic glutamate receptor 5,GRM5,1212.0
12173,DB05072,AV608,SmallMoleculeDrug,P25103,Substance-P receptor,TACR1,407.0
12174,DB05073,SRT501,SmallMoleculeDrug,Q96EB6,NAD-dependent protein deacetylase sirtuin-1,SIRT1,747.0
12175,DB05075,TG100801,SmallMoleculeDrug,P17948,Vascular endothelial growth factor receptor 1,FLT1,1338.0
12176,DB05075,TG100801,SmallMoleculeDrug,P35968,Vascular endothelial growth factor receptor 2,KDR,1356.0
12177,DB05075,TG100801,SmallMoleculeDrug,P35916,Vascular endothelial growth factor receptor 3,FLT4,1363.0
12178,DB05075,TG100801,SmallMoleculeDrug,P41240,Tyrosine-protein kinase CSK,CSK,450.0
12179,DB05077,SLV319,SmallMoleculeDrug,P21554,Cannabinoid receptor 1,CNR1,472.0
12180,DB05078,AER001,SmallMoleculeDrug,P24394,Interleukin-4 receptor subunit alpha,IL4R,825.0
12181,DB05078,AER001,SmallMoleculeDrug,Q14627,Interleukin-13 receptor subunit alpha-2,IL13RA2,380.0
12182,DB05079,HY10275,SmallMoleculeDrug,P35367,Histamine H1 receptor,HRH1,487.0
12183,DB05079,HY10275,SmallMoleculeDrug,P28223,5-hydroxytryptamine receptor 2A,HTR2A,471.0
12184,DB05080,OBE101,SmallMoleculeDrug,P35367,Histamine H1 receptor,HRH1,487.0
12185,DB05080,OBE101,SmallMoleculeDrug,Q9Y5N1,Histamine H3 receptor,HRH3,445.0
12186,DB05087,Ganaxolone,SmallMoleculeDrug,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,456.0
12187,DB05087,Ganaxolone,SmallMoleculeDrug,P47869,Gamma-aminobutyric acid receptor subunit alpha-2,GABRA2,451.0
12188,DB05087,Ganaxolone,SmallMoleculeDrug,P34903,Gamma-aminobutyric acid receptor subunit alpha-3,GABRA3,492.0
12189,DB05087,Ganaxolone,SmallMoleculeDrug,P48169,Gamma-aminobutyric acid receptor subunit alpha-4,GABRA4,554.0
12190,DB05087,Ganaxolone,SmallMoleculeDrug,P31644,Gamma-aminobutyric acid receptor subunit alpha-5,GABRA5,462.0
12191,DB05087,Ganaxolone,SmallMoleculeDrug,Q16445,Gamma-aminobutyric acid receptor subunit alpha-6,GABRA6,453.0
12192,DB05091,M0002,SmallMoleculeDrug,P30518,Vasopressin V2 receptor,AVPR2,371.0
12193,DB05092,CDP323,SmallMoleculeDrug,P13612,Integrin alpha-4,ITGA4,1032.0
12194,DB05094,MDV3100,SmallMoleculeDrug,P10275,Androgen receptor,AR,920.0
12195,DB05095,Cimicoxib,SmallMoleculeDrug,P35354,Prostaglandin G/H synthase 2,PTGS2,604.0
12196,DB05096,LY2140023,SmallMoleculeDrug,Q14416,Metabotropic glutamate receptor 2,GRM2,872.0
12197,DB05096,LY2140023,SmallMoleculeDrug,Q14832,Metabotropic glutamate receptor 3,GRM3,879.0
12198,DB05097,Labetuzumab,BiotechDrug,Q14081,Carcinoembryonic antigen,nan,44.0
12199,DB05098,Leptin,SmallMoleculeDrug,P48357,Leptin receptor,LEPR,1165.0
12200,DB05099,Ancrod,SmallMoleculeDrug,P02671,Fibrinogen alpha chain,FGA,866.0
12201,DB05101,Matuzumab,BiotechDrug,P00533,Epidermal growth factor receptor,EGFR,1210.0
12203,DB05104,Asimadoline,SmallMoleculeDrug,P41145,Kappa-type opioid receptor,OPRK1,380.0
12205,DB05107,16-Bromoepiandrosterone,SmallMoleculeDrug,P11413,Glucose-6-phosphate 1-dehydrogenase,G6PD,515.0
12206,DB05110,VIR201,BiotechDrug,P01579,Interferon gamma,IFNG,166.0
12207,DB05111,Fontolizumab,BiotechDrug,P01579,Interferon gamma,IFNG,166.0
12208,DB05115,NN344,SmallMoleculeDrug,P06213,Insulin receptor,INSR,1382.0
12209,DB05116,NB1011,SmallMoleculeDrug,P04818,Thymidylate synthase,TYMS,313.0
12210,DB05120,AT1391,SmallMoleculeDrug,P06213,Insulin receptor,INSR,1382.0
12211,DB05122,R1295,SmallMoleculeDrug,P13612,Integrin alpha-4,ITGA4,1032.0
12212,DB05122,R1295,SmallMoleculeDrug,P16144,Integrin beta-4,ITGB4,1822.0
12213,DB05122,R1295,SmallMoleculeDrug,P26010,Integrin beta-7,ITGB7,798.0
12214,DB05125,SC12267,SmallMoleculeDrug,Q02127,"Dihydroorotate dehydrogenase (quinone), mitochondrial",DHODH,395.0
12215,DB05127,ANA971,SmallMoleculeDrug,Q9NYK1,Toll-like receptor 7,TLR7,1049.0
12216,DB05129,Elsamitrucin,SmallMoleculeDrug,P11387,DNA topoisomerase 1,TOP1,765.0
12217,DB05129,Elsamitrucin,SmallMoleculeDrug,P11388,DNA topoisomerase 2-alpha,TOP2A,1531.0
12218,DB05130,INCB3284,SmallMoleculeDrug,P41597,C-C chemokine receptor type 2,CCR2,374.0
12219,DB05131,TTP889,SmallMoleculeDrug,P00740,Coagulation factor IX,F9,461.0
12220,DB05133,VP025,SmallMoleculeDrug,P01584,Interleukin-1 beta,IL1B,269.0
12221,DB05134,CNF1010,SmallMoleculeDrug,P07900,Heat shock protein HSP 90-alpha,HSP90AA1,732.0
12222,DB05134,CNF1010,SmallMoleculeDrug,P08238,Heat shock protein HSP 90-beta,HSP90AB1,724.0
12223,DB05137,Lobeline,SmallMoleculeDrug,Q9UGM1,Neuronal acetylcholine receptor subunit alpha-9,CHRNA9,479.0
12224,DB05137,Lobeline,SmallMoleculeDrug,Q9GZZ6,Neuronal acetylcholine receptor subunit alpha-10,CHRNA10,450.0
12225,DB05139,CR002,BiotechDrug,Q9GZP0,Platelet-derived growth factor D,PDGFD,370.0
12226,DB05141,LY2181308,SmallMoleculeDrug,O15392,Baculoviral IAP repeat-containing protein 5,BIRC5,142.0
12227,DB05142,ND7001,SmallMoleculeDrug,Q8IW54,"Phosphodiesterase 2A, cGMP-stimulated",PDE2A,941.0
12228,DB05142,ND7001,SmallMoleculeDrug,O00408,"cGMP-dependent 3',5'-cyclic phosphodiesterase",PDE2A,941.0
12229,DB05146,XL820,SmallMoleculeDrug,P35968,Vascular endothelial growth factor receptor 2,KDR,1356.0
12230,DB05146,XL820,SmallMoleculeDrug,P10721,Mast/stem cell growth factor receptor Kit,KIT,976.0
12231,DB05146,XL820,SmallMoleculeDrug,P16234,Platelet-derived growth factor receptor alpha,PDGFRA,1089.0
12232,DB05146,XL820,SmallMoleculeDrug,P09619,Platelet-derived growth factor receptor beta,PDGFRB,1106.0
12233,DB05147,CYT997,SmallMoleculeDrug,Q71U36,Tubulin alpha-1A chain,TUBA1A,451.0
12234,DB05147,CYT997,SmallMoleculeDrug,P68363,Tubulin alpha-1B chain,TUBA1B,451.0
12235,DB05147,CYT997,SmallMoleculeDrug,Q9BQE3,Tubulin alpha-1C chain,TUBA1C,449.0
12236,DB05147,CYT997,SmallMoleculeDrug,P68366,Tubulin alpha-4A chain,TUBA4A,448.0
12237,DB05147,CYT997,SmallMoleculeDrug,Q13748,Tubulin alpha-3C/D chain,TUBA3C,450.0
12238,DB05147,CYT997,SmallMoleculeDrug,Q6PEY2,Tubulin alpha-3E chain,TUBA3E,450.0
12239,DB05147,CYT997,SmallMoleculeDrug,Q9H853,Putative tubulin-like protein alpha-4B,TUBA4B,241.0
12240,DB05147,CYT997,SmallMoleculeDrug,Q9H4B7,Tubulin beta-1 chain,TUBB1,451.0
12241,DB05147,CYT997,SmallMoleculeDrug,Q13885,Tubulin beta-2A chain,TUBB2A,445.0
12242,DB05147,CYT997,SmallMoleculeDrug,Q9BVA1,Tubulin beta-2B chain,TUBB2B,445.0
12243,DB05147,CYT997,SmallMoleculeDrug,P68371,Tubulin beta-4B chain,TUBB4B,445.0
12244,DB05147,CYT997,SmallMoleculeDrug,Q13509,Tubulin beta-3 chain,TUBB3,450.0
12245,DB05147,CYT997,SmallMoleculeDrug,P04350,Tubulin beta-4A chain,TUBB4A,444.0
12246,DB05147,CYT997,SmallMoleculeDrug,P07437,Tubulin beta chain,TUBB,444.0
12247,DB05147,CYT997,SmallMoleculeDrug,Q9BUF5,Tubulin beta-6 chain,TUBB6,446.0
12248,DB05149,XL844,SmallMoleculeDrug,O96017,Serine/threonine-protein kinase Chk2,CHEK2,543.0
12249,DB05149,XL844,SmallMoleculeDrug,O14757,Serine/threonine-protein kinase Chk1,CHEK1,476.0
12250,DB05150,CAD106,SmallMoleculeDrug,P05067,Amyloid beta A4 protein,APP,770.0
12251,DB05152,NGX267,SmallMoleculeDrug,P11229,Muscarinic acetylcholine receptor M1,CHRM1,460.0
12252,DB05153,XL184,SmallMoleculeDrug,P08581,Hepatocyte growth factor receptor,MET,1390.0
12253,DB05153,XL184,SmallMoleculeDrug,P35968,Vascular endothelial growth factor receptor 2,KDR,1356.0
12254,DB05153,XL184,SmallMoleculeDrug,P10721,Mast/stem cell growth factor receptor Kit,KIT,976.0
12255,DB05153,XL184,SmallMoleculeDrug,Q02763,Angiopoietin-1 receptor,TEK,1124.0
12256,DB05155,CR665,SmallMoleculeDrug,P41145,Kappa-type opioid receptor,OPRK1,380.0
12257,DB05157,KC706,SmallMoleculeDrug,Q16539,Mitogen-activated protein kinase 14,MAPK14,360.0
12258,DB05157,KC706,SmallMoleculeDrug,Q15759,Mitogen-activated protein kinase 11,MAPK11,364.0
12259,DB05157,KC706,SmallMoleculeDrug,P53778,Mitogen-activated protein kinase 12,MAPK12,367.0
12260,DB05157,KC706,SmallMoleculeDrug,O15264,Mitogen-activated protein kinase 13,MAPK13,365.0
12261,DB05159,CCX915,SmallMoleculeDrug,P41597,C-C chemokine receptor type 2,CCR2,374.0
12262,DB05161,Elafin,SmallMoleculeDrug,P08246,Neutrophil elastase,ELANE,267.0
12263,DB05161,Elafin,SmallMoleculeDrug,P24158,Myeloblastin,PRTN3,256.0
12264,DB05162,GSK716155,SmallMoleculeDrug,P43220,Glucagon-like peptide 1 receptor,GLP1R,463.0
12265,DB05164,CMLVAX100,BiotechDrug,A1Z199,BCR/ABL p210 fusion protein,BCR/ABL,97.0
12266,DB05165,LY2275796,SmallMoleculeDrug,P06730,Eukaryotic translation initiation factor 4E,EIF4E,217.0
12267,DB05166,APD668,SmallMoleculeDrug,Q8TDV5,Glucose-dependent insulinotropic receptor,GPR119,335.0
12268,DB05168,EC145,SmallMoleculeDrug,P14207,Folate receptor beta,FOLR2,255.0
12269,DB05168,EC145,SmallMoleculeDrug,P41439,Folate receptor gamma,FOLR3,243.0
12270,DB05168,EC145,SmallMoleculeDrug,P15328,Folate receptor alpha,FOLR1,257.0
12271,DB05169,AT9283,SmallMoleculeDrug,O14965,Aurora kinase A,AURKA,403.0
12272,DB05169,AT9283,SmallMoleculeDrug,Q96GD4,Aurora kinase B,AURKB,344.0
12273,DB05171,E2012,SmallMoleculeDrug,Q96BI3,Gamma-secretase subunit APH-1A,APH1A,265.0
12274,DB05171,E2012,SmallMoleculeDrug,Q9NZ42,Gamma-secretase subunit PEN-2,PSENEN,101.0
12275,DB05177,DG051,SmallMoleculeDrug,P09960,Leukotriene A-4 hydrolase,LTA4H,611.0
12276,DB05183,MLN0415,SmallMoleculeDrug,O14920,Inhibitor of nuclear factor kappa-B kinase subunit beta,IKBKB,756.0
12277,DB05184,XL228,SmallMoleculeDrug,P08069,Insulin-like growth factor 1 receptor,IGF1R,1367.0
12278,DB05184,XL228,SmallMoleculeDrug,P12931,Proto-oncogene tyrosine-protein kinase Src,SRC,536.0
12279,DB05184,XL228,SmallMoleculeDrug,P00519,Tyrosine-protein kinase ABL1,ABL1,1130.0
12280,DB05184,XL228,SmallMoleculeDrug,P42684,Abelson tyrosine-protein kinase 2,ABL2,1182.0
12281,DB05187,GFT505,SmallMoleculeDrug,Q07869,Peroxisome proliferator-activated receptor alpha,PPARA,468.0
12282,DB05187,GFT505,SmallMoleculeDrug,Q03181,Peroxisome proliferator-activated receptor delta,PPARD,441.0
12283,DB05187,GFT505,SmallMoleculeDrug,P37231,Peroxisome proliferator-activated receptor gamma,PPARG,505.0
12284,DB05188,KD3010,SmallMoleculeDrug,Q03181,Peroxisome proliferator-activated receptor delta,PPARD,441.0
12285,DB05190,XL281,SmallMoleculeDrug,P15056,Serine/threonine-protein kinase B-raf,BRAF,766.0
12286,DB05190,XL281,SmallMoleculeDrug,P04049,RAF proto-oncogene serine/threonine-protein kinase,RAF1,648.0
12287,DB05191,Atl146e,SmallMoleculeDrug,P29274,Adenosine receptor A2a,ADORA2A,412.0
12288,DB05192,MB07811,SmallMoleculeDrug,P10828,Thyroid hormone receptor beta,THRB,461.0
12289,DB05194,KB002,SmallMoleculeDrug,P15509,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,CSF2RA,400.0
12290,DB05194,KB002,SmallMoleculeDrug,P04141,Granulocyte-macrophage colony-stimulating factor,CSF2,144.0
12291,DB05194,KB002,SmallMoleculeDrug,Q16498,GM-CSF receptor alpha subunit,CSF2RA,25.0
12292,DB05198,CYC116,SmallMoleculeDrug,O14965,Aurora kinase A,AURKA,403.0
12293,DB05198,CYC116,SmallMoleculeDrug,P35968,Vascular endothelial growth factor receptor 2,KDR,1356.0
12294,DB05199,LX1031,SmallMoleculeDrug,P17752,Tryptophan 5-hydroxylase 1,TPH1,444.0
12295,DB05200,AT2220,SmallMoleculeDrug,P10253,Lysosomal alpha-glucosidase,GAA,952.0
12296,DB05201,V24343,SmallMoleculeDrug,P21554,Cannabinoid receptor 1,CNR1,472.0
12297,DB05202,ARC1779,BiotechDrug,P04275,von Willebrand factor,VWF,2813.0
12298,DB05202,ARC1779,BiotechDrug,P07359,Platelet glycoprotein Ib alpha chain,GP1BA,652.0
12299,DB05203,SPP1148,SmallMoleculeDrug,Q9BYF1,Angiotensin-converting enzyme 2,ACE2,805.0
12300,DB05203,SPP1148,SmallMoleculeDrug,P00797,Renin,REN,406.0
12301,DB05204,XL418,SmallMoleculeDrug,Q06187,Tyrosine-protein kinase BTK,BTK,659.0
12302,DB05205,CX157,SmallMoleculeDrug,P21397,Amine oxidase [flavin-containing] A,MAOA,527.0
12303,DB05206,PS433540,SmallMoleculeDrug,P01019,Angiotensinogen,AGT,485.0
12304,DB05206,PS433540,SmallMoleculeDrug,P25101,Endothelin-1 receptor,EDNRA,427.0
12305,DB05207,SD118,SmallMoleculeDrug,P01375,Tumor necrosis factor,TNF,233.0
12306,DB05207,SD118,SmallMoleculeDrug,P14778,Interleukin-1 receptor type 1,IL1R1,569.0
12307,DB05209,SYM001,SmallMoleculeDrug,A6PZ59,Rhesus blood group D antigen,RHD,417.0
12308,DB05210,SF1126,SmallMoleculeDrug,P27986,Phosphatidylinositol 3-kinase regulatory subunit alpha,PIK3R1,724.0
12309,DB05210,SF1126,SmallMoleculeDrug,O00459,Phosphatidylinositol 3-kinase regulatory subunit beta,PIK3R2,728.0
12310,DB05210,SF1126,SmallMoleculeDrug,Q92569,Phosphatidylinositol 3-kinase regulatory subunit gamma,PIK3R3,461.0
12311,DB05210,SF1126,SmallMoleculeDrug,P78527,DNA-dependent protein kinase catalytic subunit,PRKDC,4128.0
12312,DB05210,SF1126,SmallMoleculeDrug,P42345,Serine/threonine-protein kinase mTOR,MTOR,2549.0
12313,DB05212,HE3286,SmallMoleculeDrug,P19838,Nuclear factor NF-kappa-B p105 subunit,NFKB1,968.0
12314,DB05212,HE3286,SmallMoleculeDrug,Q00653,Nuclear factor NF-kappa-B p100 subunit,NFKB2,900.0
12315,DB05213,AC220,SmallMoleculeDrug,P36888,Receptor-type tyrosine-protein kinase FLT3,FLT3,993.0
12316,DB05214,KD7040,SmallMoleculeDrug,P35228,"Nitric oxide synthase, inducible",NOS2,1153.0
12317,DB05216,MP470,SmallMoleculeDrug,P10721,Mast/stem cell growth factor receptor Kit,KIT,976.0
12318,DB05216,MP470,SmallMoleculeDrug,P08581,Hepatocyte growth factor receptor,MET,1390.0
12319,DB05216,MP470,SmallMoleculeDrug,P07949,Proto-oncogene tyrosine-protein kinase receptor Ret,RET,1114.0
12320,DB05216,MP470,SmallMoleculeDrug,P16234,Platelet-derived growth factor receptor alpha,PDGFRA,1089.0
12321,DB05216,MP470,SmallMoleculeDrug,P36888,Receptor-type tyrosine-protein kinase FLT3,FLT3,993.0
12322,DB05216,MP470,SmallMoleculeDrug,Q06609,DNA repair protein RAD51 homolog 1,RAD51,339.0
12323,DB05217,GMX1777,SmallMoleculeDrug,P43490,Nicotinamide phosphoribosyltransferase,NAMPT,491.0
12324,DB05218,PN0621,BiotechDrug,P01375,Tumor necrosis factor,TNF,233.0
12325,DB05219,Crisaborole,SmallMoleculeDrug,P27815,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A",PDE4A,886.0
12326,DB05219,Crisaborole,SmallMoleculeDrug,Q07343,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B",PDE4B,736.0
12327,DB05219,Crisaborole,SmallMoleculeDrug,Q08493,"cAMP-specific 3',5'-cyclic phosphodiesterase 4C",PDE4C,712.0
12328,DB05219,Crisaborole,SmallMoleculeDrug,Q08499,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",PDE4D,809.0
12329,DB05220,MLN8237,SmallMoleculeDrug,O14965,Aurora kinase A,AURKA,403.0
12331,DB05223,SB939,SmallMoleculeDrug,Q13547,Histone deacetylase 1,HDAC1,482.0
12332,DB05223,SB939,SmallMoleculeDrug,Q92769,Histone deacetylase 2,HDAC2,488.0
12333,DB05223,SB939,SmallMoleculeDrug,O15379,Histone deacetylase 3,HDAC3,428.0
12334,DB05223,SB939,SmallMoleculeDrug,Q9UBN7,Histone deacetylase 6,HDAC6,1215.0
12336,DB05225,AM103,SmallMoleculeDrug,P20292,Arachidonate 5-lipoxygenase-activating protein,ALOX5AP,161.0
12338,DB05227,APD791,SmallMoleculeDrug,P28223,5-hydroxytryptamine receptor 2A,HTR2A,471.0
12340,DB05229,Beraprost,SmallMoleculeDrug,P43119,Prostacyclin receptor,PTGIR,386.0
12341,DB05232,Tetrodotoxin,SmallMoleculeDrug,P35498,Sodium channel protein type 1 subunit alpha,SCN1A,2009.0
12342,DB05232,Tetrodotoxin,SmallMoleculeDrug,Q99250,Sodium channel protein type 2 subunit alpha,SCN2A,2005.0
12343,DB05232,Tetrodotoxin,SmallMoleculeDrug,Q9NY46,Sodium channel protein type 3 subunit alpha,SCN3A,2000.0
12344,DB05232,Tetrodotoxin,SmallMoleculeDrug,Q9UQD0,Sodium channel protein type 8 subunit alpha,SCN8A,1980.0
12345,DB05233,AP1081,SmallMoleculeDrug,P03372,Estrogen receptor,ESR1,595.0
12346,DB05234,LGD2941,SmallMoleculeDrug,P10275,Androgen receptor,AR,920.0
12347,DB05235,NRP409,SmallMoleculeDrug,Q14894,Ketimine reductase mu-crystallin,CRYM,314.0
12348,DB05235,NRP409,SmallMoleculeDrug,P10827,Thyroid hormone receptor alpha,THRA,490.0
12349,DB05238,PLX4032,SmallMoleculeDrug,P15056,Serine/threonine-protein kinase B-raf,BRAF,766.0
12350,DB05239,Cobimetinib,SmallMoleculeDrug,Q02750,Dual specificity mitogen-activated protein kinase kinase 1,MAP2K1,393.0
12351,DB05240,XL147,SmallMoleculeDrug,P42336,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform",PIK3CA,1068.0
12352,DB05241,XL765,SmallMoleculeDrug,P42336,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform",PIK3CA,1068.0
12353,DB05241,XL765,SmallMoleculeDrug,P48736,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",PIK3CG,1102.0
12354,DB05241,XL765,SmallMoleculeDrug,O00329,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform",PIK3CD,1044.0
12355,DB05241,XL765,SmallMoleculeDrug,P42338,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform",PIK3CB,1070.0
12356,DB05241,XL765,SmallMoleculeDrug,P42345,Serine/threonine-protein kinase mTOR,MTOR,2549.0
12357,DB05243,XL019,SmallMoleculeDrug,O60674,Tyrosine-protein kinase JAK2,JAK2,1132.0
12358,DB05246,Methsuximide,SmallMoleculeDrug,O43497,Voltage-dependent T-type calcium channel subunit alpha-1G,CACNA1G,2377.0
12359,DB05249,FavId,SmallMoleculeDrug,Q99062,Granulocyte colony-stimulating factor receptor,CSF3R,836.0
12360,DB05250,681323,SmallMoleculeDrug,P01375,Tumor necrosis factor,TNF,233.0
12361,DB05250,681323,SmallMoleculeDrug,P01584,Interleukin-1 beta,IL1B,269.0
12362,DB05250,681323,SmallMoleculeDrug,P05231,Interleukin-6,IL6,212.0
12363,DB05252,ACCLAIM,SmallMoleculeDrug,P35228,"Nitric oxide synthase, inducible",NOS2,1153.0
12364,DB05253,Proellex,SmallMoleculeDrug,P06401,Progesterone receptor,PGR,933.0
12365,DB05254,Plasmin,SmallMoleculeDrug,P05121,Plasminogen activator inhibitor 1,SERPINE1,402.0
12366,DB05254,Plasmin,SmallMoleculeDrug,P00749,Urokinase-type plasminogen activator,PLAU,431.0
12367,DB05255,751689,SmallMoleculeDrug,P41180,Extracellular calcium-sensing receptor,CASR,1078.0
12368,DB05255,751689,SmallMoleculeDrug,Q5T601,Adhesion G-protein coupled receptor F1,ADGRF1,910.0
12369,DB05256,659032,SmallMoleculeDrug,Q13093,Platelet-activating factor acetylhydrolase,PLA2G7,441.0
12370,DB05258,Natural alpha interferon,BiotechDrug,P17181,Interferon alpha/beta receptor 1,IFNAR1,557.0
12371,DB05259,Glatiramer Acetate,BiotechDrug,P04229,"HLA class II histocompatibility antigen, DRB1-1 beta chain",HLA-DRB1,266.0
12372,DB05260,Gallium nitrate,SmallMoleculeDrug,P31350,Ribonucleoside-diphosphate reductase subunit M2,RRM2,389.0
12373,DB05260,Gallium nitrate,SmallMoleculeDrug,P21281,"V-type proton ATPase subunit B, brain isoform",ATP6V1B2,511.0
12374,DB05260,Gallium nitrate,SmallMoleculeDrug,P02818,Osteocalcin,BGLAP,100.0
12376,DB05260,Gallium nitrate,SmallMoleculeDrug,P01584,Interleukin-1 beta,IL1B,269.0
12377,DB05262,Oxypurinol,SmallMoleculeDrug,P47989,Xanthine dehydrogenase/oxidase,XDH,1333.0
12378,DB05264,NPI 32101,SmallMoleculeDrug,P32927,Cytokine receptor common subunit beta,CSF2RB,897.0
12379,DB05265,Ecabet,SmallMoleculeDrug,Q8NFA2,NADPH oxidase organizer 1,NOXO1,376.0
12381,DB05266,Ibudilast,SmallMoleculeDrug,P27815,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A",PDE4A,886.0
12382,DB05266,Ibudilast,SmallMoleculeDrug,Q07343,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B",PDE4B,736.0
12383,DB05266,Ibudilast,SmallMoleculeDrug,Q08493,"cAMP-specific 3',5'-cyclic phosphodiesterase 4C",PDE4C,712.0
12384,DB05266,Ibudilast,SmallMoleculeDrug,Q08499,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",PDE4D,809.0
12385,DB05266,Ibudilast,SmallMoleculeDrug,Q14432,"cGMP-inhibited 3',5'-cyclic phosphodiesterase A",PDE3A,1141.0
12386,DB05268,iCo-007,SmallMoleculeDrug,P04049,RAF proto-oncogene serine/threonine-protein kinase,RAF1,648.0
12387,DB05271,Rotigotine,SmallMoleculeDrug,P35462,D(3) dopamine receptor,DRD3,400.0
12388,DB05271,Rotigotine,SmallMoleculeDrug,P21917,D(4) dopamine receptor,DRD4,467.0
12389,DB05271,Rotigotine,SmallMoleculeDrug,P14416,D(2) dopamine receptor,DRD2,443.0
12390,DB05271,Rotigotine,SmallMoleculeDrug,P21918,D(1B) dopamine receptor,DRD5,477.0
12391,DB05271,Rotigotine,SmallMoleculeDrug,P21728,D(1A) dopamine receptor,DRD1,446.0
12392,DB05271,Rotigotine,SmallMoleculeDrug,P08908,5-hydroxytryptamine receptor 1A,HTR1A,422.0
12393,DB05271,Rotigotine,SmallMoleculeDrug,P18089,Alpha-2B adrenergic receptor,ADRA2B,450.0
12395,DB05280,SLV 308,SmallMoleculeDrug,P14416,D(2) dopamine receptor,DRD2,443.0
12396,DB05280,SLV 308,SmallMoleculeDrug,P35462,D(3) dopamine receptor,DRD3,400.0
12397,DB05280,SLV 308,SmallMoleculeDrug,P21917,D(4) dopamine receptor,DRD4,467.0
12398,DB05280,SLV 308,SmallMoleculeDrug,P08908,5-hydroxytryptamine receptor 1A,HTR1A,422.0
12399,DB05281,S-8184,SmallMoleculeDrug,P68366,Tubulin alpha-4A chain,TUBA4A,448.0
12400,DB05281,S-8184,SmallMoleculeDrug,P10415,Apoptosis regulator Bcl-2,BCL2,239.0
12401,DB05282,MCC,SmallMoleculeDrug,O95831,"Apoptosis-inducing factor 1, mitochondrial",AIFM1,613.0
12402,DB05284,CA4P,SmallMoleculeDrug,P07437,Tubulin beta chain,TUBB,444.0
12403,DB05289,MPC-7869,SmallMoleculeDrug,Q9Y6K9,NF-kappa-B essential modulator,IKBKG,419.0
12404,DB05290,SPP 301,SmallMoleculeDrug,P25101,Endothelin-1 receptor,EDNRA,427.0
12405,DB05294,Vandetanib,SmallMoleculeDrug,P15692,Vascular endothelial growth factor A,VEGFA,232.0
12406,DB05294,Vandetanib,SmallMoleculeDrug,P00533,Epidermal growth factor receptor,EGFR,1210.0
12407,DB05294,Vandetanib,SmallMoleculeDrug,Q13882,Protein-tyrosine kinase 6,PTK6,451.0
12408,DB05294,Vandetanib,SmallMoleculeDrug,Q02763,Angiopoietin-1 receptor,TEK,1124.0
12409,DB05295,Eldecalcitol,SmallMoleculeDrug,P11473,Vitamin D3 receptor,VDR,427.0
12410,DB05297,DHA-paclitaxel,SmallMoleculeDrug,P10415,Apoptosis regulator Bcl-2,BCL2,239.0
12411,DB05298,OPC-6535,SmallMoleculeDrug,Q08499,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",PDE4D,809.0
12412,DB05299,keyhole limpet hemocyanin,BiotechDrug,P60568,Interleukin-2,IL2,153.0
12413,DB05301,LAX-101,SmallMoleculeDrug,Q13393,Phospholipase D1,PLD1,1074.0
12414,DB05301,LAX-101,SmallMoleculeDrug,P29466,Caspase-1,CASP1,404.0
12415,DB05303,OMS-103HP,SmallMoleculeDrug,P01375,Tumor necrosis factor,TNF,233.0
12416,DB05303,OMS-103HP,SmallMoleculeDrug,P14778,Interleukin-1 receptor type 1,IL1R1,569.0
12417,DB05304,WX-G250,SmallMoleculeDrug,Q16790,Carbonic anhydrase 9,CA9,459.0
12418,DB05304,WX-G250,SmallMoleculeDrug,P60568,Interleukin-2,IL2,153.0
12419,DB05305,Cintredekin Besudotox,BiotechDrug,P35225,Interleukin-13,IL13,146.0
12420,DB05307,CHF-1512,SmallMoleculeDrug,P20711,Aromatic-L-amino-acid decarboxylase,DDC,480.0
12421,DB05308,ANX-510,SmallMoleculeDrug,P04818,Thymidylate synthase,TYMS,313.0
12422,DB05309,TP-508,SmallMoleculeDrug,P08620,Fibroblast growth factor 4,FGF4,206.0
12423,DB05311,Ecallantide,SmallMoleculeDrug,P03952,Plasma kallikrein,KLKB1,638.0
12424,DB05314,DN-101,SmallMoleculeDrug,P32320,Cytidine deaminase,CDA,146.0
12425,DB05316,Pimavanserin,SmallMoleculeDrug,P28223,5-hydroxytryptamine receptor 2A,HTR2A,471.0
12426,DB05316,Pimavanserin,SmallMoleculeDrug,P14416,D(2) dopamine receptor,DRD2,443.0
12427,DB05317,TAK-475,SmallMoleculeDrug,P37268,Squalene synthase,FDFT1,417.0
12428,DB05317,TAK-475,SmallMoleculeDrug,P04035,3-hydroxy-3-methylglutaryl-coenzyme A reductase,HMGCR,888.0
12430,DB05319,oportuzumab monatox,BiotechDrug,P16422,Epithelial cell adhesion molecule,EPCAM,314.0
12432,DB05324,HuMax-EGFr,BiotechDrug,P00533,Epidermal growth factor receptor,EGFR,1210.0
12433,DB05327,AS-3201,SmallMoleculeDrug,P15121,Aldose reductase,AKR1B1,316.0
12435,DB05332,Romiplostim,BiotechDrug,P40238,Thrombopoietin receptor,MPL,635.0
12436,DB05337,SOT-107,BiotechDrug,P48060,Glioma pathogenesis-related protein 1,GLIPR1,266.0
12437,DB05338,atamestane-plus-toremifene,SmallMoleculeDrug,P11511,Aromatase,CYP19A1,503.0
12438,DB05338,atamestane-plus-toremifene,SmallMoleculeDrug,P03372,Estrogen receptor,ESR1,595.0
12439,DB05339,MN-305,SmallMoleculeDrug,P08908,5-hydroxytryptamine receptor 1A,HTR1A,422.0
12440,DB05341,C1-INH,BiotechDrug,P05155,Plasma protease C1 inhibitor,SERPING1,500.0
12442,DB05342,SP-01A,SmallMoleculeDrug,P04035,3-hydroxy-3-methylglutaryl-coenzyme A reductase,HMGCR,888.0
12443,DB05343,ONO-2506,SmallMoleculeDrug,P04271,Protein S100-B,S100B,92.0
12444,DB05345,SO-101,SmallMoleculeDrug,P35367,Histamine H1 receptor,HRH1,487.0
12445,DB05351,TAK-390MR,SmallMoleculeDrug,P20648,Potassium-transporting ATPase alpha chain 1,ATP4A,1035.0
12446,DB05358,TAK-491,SmallMoleculeDrug,Q9BYF1,Angiotensin-converting enzyme 2,ACE2,805.0
12447,DB05359,VEC-162,SmallMoleculeDrug,P48039,Melatonin receptor type 1A,MTNR1A,350.0
12448,DB05359,VEC-162,SmallMoleculeDrug,P49286,Melatonin receptor type 1B,MTNR1B,362.0
12449,DB05360,KW-3902,SmallMoleculeDrug,P30542,Adenosine receptor A1,ADORA1,326.0
12450,DB05361,SR-123781A,SmallMoleculeDrug,P01008,Antithrombin-III,SERPINC1,464.0
12451,DB05361,SR-123781A,SmallMoleculeDrug,P25116,Proteinase-activated receptor 1,F2R,425.0
12452,DB05362,SSR-126517E,SmallMoleculeDrug,P00742,Coagulation factor X,F10,488.0
12453,DB05364,ROX-888,SmallMoleculeDrug,P10147,C-C motif chemokine 3,CCL3,92.0
12454,DB05367,Actelion-1,SmallMoleculeDrug,P25101,Endothelin-1 receptor,EDNRA,427.0
12455,DB05369,HZT-501,SmallMoleculeDrug,P25021,Histamine H2 receptor,HRH2,359.0
12456,DB05372,CP-945598,SmallMoleculeDrug,P21554,Cannabinoid receptor 1,CNR1,472.0
12457,DB05374,Rindopepimut,SmallMoleculeDrug,P00533,Epidermal growth factor receptor,EGFR,1210.0
12458,DB05381,Histamine,SmallMoleculeDrug,P35367,Histamine H1 receptor,HRH1,487.0
12459,DB05381,Histamine,SmallMoleculeDrug,P25021,Histamine H2 receptor,HRH2,359.0
12460,DB05381,Histamine,SmallMoleculeDrug,Q9Y5N1,Histamine H3 receptor,HRH3,445.0
12461,DB05381,Histamine,SmallMoleculeDrug,Q9H3N8,Histamine H4 receptor,HRH4,390.0
12462,DB05382,molecular iodine,SmallMoleculeDrug,P03915,NADH-ubiquinone oxidoreductase chain 5,MT-ND5,603.0
12463,DB05383,pimagedine HCl,SmallMoleculeDrug,P15121,Aldose reductase,AKR1B1,316.0
12464,DB05383,pimagedine HCl,SmallMoleculeDrug,P35625,Metalloproteinase inhibitor 3,TIMP3,211.0
12465,DB05386,recombinant human GM-CSF,BiotechDrug,P15509,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,CSF2RA,400.0
12466,DB05386,recombinant human GM-CSF,BiotechDrug,Q16498,GM-CSF receptor alpha subunit,CSF2RA,25.0
12467,DB05387,AE-941,SmallMoleculeDrug,P08253,72 kDa type IV collagenase,MMP2,660.0
12468,DB05387,AE-941,SmallMoleculeDrug,P14780,Matrix metalloproteinase-9,MMP9,707.0
12469,DB05387,AE-941,SmallMoleculeDrug,P39900,Macrophage metalloelastase,MMP12,470.0
12470,DB05389,WF10,SmallMoleculeDrug,Q7L5Y9,Macrophage erythroblast attacher,MAEA,396.0
12471,DB05389,WF10,SmallMoleculeDrug,Q86VB7,Scavenger receptor cysteine-rich type 1 protein M130,CD163,1156.0
12472,DB05390,INS 316,SmallMoleculeDrug,P41231,P2Y purinoceptor 2,P2RY2,377.0
12473,DB05391,liposomal prostaglandin E1,SmallMoleculeDrug,P07359,Platelet glycoprotein Ib alpha chain,GP1BA,652.0
12474,DB05395,SR 58611,SmallMoleculeDrug,P13945,Beta-3 adrenergic receptor,ADRB3,408.0
12476,DB05398,C31G,SmallMoleculeDrug,P21926,CD9 antigen,CD9,228.0
12477,DB05399,AGI-1067,SmallMoleculeDrug,P19320,Vascular cell adhesion protein 1,VCAM1,739.0
12478,DB05403,CEP-1347,SmallMoleculeDrug,P53778,Mitogen-activated protein kinase 12,MAPK12,367.0
12479,DB05404,AZD 3355,SmallMoleculeDrug,P04637,Cellular tumor antigen p53,TP53,393.0
12480,DB05407,TBC-3711,SmallMoleculeDrug,P05305,Endothelin-1,EDN1,212.0
12481,DB05408,IDN-6556,SmallMoleculeDrug,P29466,Caspase-1,CASP1,404.0
12482,DB05408,IDN-6556,SmallMoleculeDrug,P42574,Caspase-3,CASP3,277.0
12483,DB05408,IDN-6556,SmallMoleculeDrug,P55210,Caspase-7,CASP7,303.0
12484,DB05412,SCIO-469,SmallMoleculeDrug,Q16539,Mitogen-activated protein kinase 14,MAPK14,360.0
12485,DB05412,SCIO-469,SmallMoleculeDrug,P01375,Tumor necrosis factor,TNF,233.0
12486,DB05412,SCIO-469,SmallMoleculeDrug,P01584,Interleukin-1 beta,IL1B,269.0
12487,DB05412,SCIO-469,SmallMoleculeDrug,P00403,Cytochrome c oxidase subunit 2,MT-CO2,227.0
12488,DB05413,T-1249,SmallMoleculeDrug,P05154,Plasma serine protease inhibitor,SERPINA5,406.0
12490,DB05415,OSI-461,SmallMoleculeDrug,O76074,"cGMP-specific 3',5'-cyclic phosphodiesterase",PDE5A,875.0
12491,DB05417,GW 468816,SmallMoleculeDrug,P23415,Glycine receptor subunit alpha-1,GLRA1,457.0
12492,DB05418,GW 597599,SmallMoleculeDrug,P25103,Substance-P receptor,TACR1,407.0
12493,DB05419,ADX-10061,SmallMoleculeDrug,Q9NYX4,Neuron-specific vesicular protein calcyon,CALY,217.0
12494,DB05420,gallium maltolate,SmallMoleculeDrug,P23921,Ribonucleoside-diphosphate reductase large subunit,RRM1,792.0
12495,DB05421,CP-122721,SmallMoleculeDrug,P25103,Substance-P receptor,TACR1,407.0
12496,DB05422,OPC-14523,SmallMoleculeDrug,P31645,Sodium-dependent serotonin transporter,SLC6A4,630.0
12497,DB05423,ORG-34517,SmallMoleculeDrug,P04150,Glucocorticoid receptor,NR3C1,777.0
12498,DB05424,CI-1033,SmallMoleculeDrug,P00533,Epidermal growth factor receptor,EGFR,1210.0
12499,DB05428,motexafin gadolinium,SmallMoleculeDrug,Q16881,"Thioredoxin reductase 1, cytoplasmic",TXNRD1,649.0
12500,DB05428,motexafin gadolinium,SmallMoleculeDrug,Q9NNW7,"Thioredoxin reductase 2, mitochondrial",TXNRD2,524.0
12501,DB05428,motexafin gadolinium,SmallMoleculeDrug,P31350,Ribonucleoside-diphosphate reductase subunit M2,RRM2,389.0
12502,DB05429,CAT-213,BiotechDrug,P51671,Eotaxin,CCL11,97.0
12503,DB05431,MLN-977,SmallMoleculeDrug,P09917,Arachidonate 5-lipoxygenase,ALOX5,674.0
12504,DB05432,DAS-431 IV,SmallMoleculeDrug,Q9NYX4,Neuron-specific vesicular protein calcyon,CALY,217.0
12505,DB05434,ABT-510,SmallMoleculeDrug,P09038,Fibroblast growth factor 2,FGF2,288.0
12506,DB05434,ABT-510,SmallMoleculeDrug,P14210,Hepatocyte growth factor,HGF,728.0
12507,DB05434,ABT-510,SmallMoleculeDrug,P15692,Vascular endothelial growth factor A,VEGFA,232.0
12508,DB05434,ABT-510,SmallMoleculeDrug,P10145,Interleukin-8,CXCL8,99.0
12509,DB05435,TNX-355,BiotechDrug,Q5NUL3,Free fatty acid receptor 4,FFAR4,377.0
12510,DB05442,Etiprednol dicloacetate,SmallMoleculeDrug,P01584,Interleukin-1 beta,IL1B,269.0
12511,DB05443,ADL 10-0101,SmallMoleculeDrug,P41145,Kappa-type opioid receptor,OPRK1,380.0
12512,DB05446,LJP 1082,SmallMoleculeDrug,P02749,Beta-2-glycoprotein 1,APOH,345.0
12513,DB05447,AVI-4557,SmallMoleculeDrug,P41235,Hepatocyte nuclear factor 4-alpha,HNF4A,474.0
12514,DB05448,PX-12,SmallMoleculeDrug,Q16881,"Thioredoxin reductase 1, cytoplasmic",TXNRD1,649.0
12515,DB05449,FM-VP4,SmallMoleculeDrug,P08183,Multidrug resistance protein 1,ABCB1,1280.0
12516,DB05451,P54,SmallMoleculeDrug,Q00653,Nuclear factor NF-kappa-B p100 subunit,NFKB2,900.0
12517,DB05451,P54,SmallMoleculeDrug,P19838,Nuclear factor NF-kappa-B p105 subunit,NFKB1,968.0
12518,DB05452,PH-284,SmallMoleculeDrug,P37288,Vasopressin V1a receptor,AVPR1A,418.0
12519,DB05452,PH-284,SmallMoleculeDrug,P47901,Vasopressin V1b receptor,AVPR1B,424.0
12520,DB05455,SR 121463,SmallMoleculeDrug,P47901,Vasopressin V1b receptor,AVPR1B,424.0
12521,DB05457,OSI-7904L,SmallMoleculeDrug,P04818,Thymidylate synthase,TYMS,313.0
12522,DB05458,ABT-089,SmallMoleculeDrug,P43681,Neuronal acetylcholine receptor subunit alpha-4,CHRNA4,627.0
12523,DB05458,ABT-089,SmallMoleculeDrug,P17787,Neuronal acetylcholine receptor subunit beta-2,CHRNB2,502.0
12524,DB05459,Briakinumab,BiotechDrug,P29460,Interleukin-12 subunit beta,IL12B,328.0
12525,DB05459,Briakinumab,BiotechDrug,Q9NPF7,Interleukin-23 subunit alpha,IL23A,189.0
12526,DB05460,TLK-199,SmallMoleculeDrug,P09211,Glutathione S-transferase P,GSTP1,210.0
12527,DB05461,OPC-28326,SmallMoleculeDrug,P41595,5-hydroxytryptamine receptor 2B,HTR2B,481.0
12528,DB05461,OPC-28326,SmallMoleculeDrug,P18825,Alpha-2C adrenergic receptor,ADRA2C,462.0
12529,DB05461,OPC-28326,SmallMoleculeDrug,P18089,Alpha-2B adrenergic receptor,ADRA2B,450.0
12530,DB05463,ISS-1018,SmallMoleculeDrug,Q9NR96,Toll-like receptor 9,TLR9,1032.0
12531,DB05464,NOX-700,SmallMoleculeDrug,Q00653,Nuclear factor NF-kappa-B p100 subunit,NFKB2,900.0
12532,DB05464,NOX-700,SmallMoleculeDrug,P19838,Nuclear factor NF-kappa-B p105 subunit,NFKB1,968.0
12533,DB05465,MLN-518,SmallMoleculeDrug,P36888,Receptor-type tyrosine-protein kinase FLT3,FLT3,993.0
12534,DB05465,MLN-518,SmallMoleculeDrug,Q9GZP0,Platelet-derived growth factor D,PDGFD,370.0
12535,DB05466,R673,SmallMoleculeDrug,P25103,Substance-P receptor,TACR1,407.0
12536,DB05467,R667,SmallMoleculeDrug,P13631,Retinoic acid receptor gamma,RARG,454.0
12537,DB05468,R411,SmallMoleculeDrug,P13612,Integrin alpha-4,ITGA4,1032.0
12538,DB05469,R450,SmallMoleculeDrug,P35348,Alpha-1A adrenergic receptor,ADRA1A,466.0
12539,DB05469,R450,SmallMoleculeDrug,P35368,Alpha-1B adrenergic receptor,ADRA1B,520.0
12540,DB05469,R450,SmallMoleculeDrug,P25100,Alpha-1D adrenergic receptor,ADRA1D,572.0
12541,DB05470,VX-702,SmallMoleculeDrug,Q16539,Mitogen-activated protein kinase 14,MAPK14,360.0
12542,DB05470,VX-702,SmallMoleculeDrug,P01375,Tumor necrosis factor,TNF,233.0
12543,DB05470,VX-702,SmallMoleculeDrug,P01584,Interleukin-1 beta,IL1B,269.0
12544,DB05470,VX-702,SmallMoleculeDrug,P05231,Interleukin-6,IL6,212.0
12545,DB05471,SGN-30,BiotechDrug,P19838,Nuclear factor NF-kappa-B p105 subunit,NFKB1,968.0
12546,DB05471,SGN-30,BiotechDrug,Q00653,Nuclear factor NF-kappa-B p100 subunit,NFKB2,900.0
12547,DB05472,omega interferon,SmallMoleculeDrug,P17181,Interferon alpha/beta receptor 1,IFNAR1,557.0
12548,DB05472,omega interferon,SmallMoleculeDrug,P48551,Interferon alpha/beta receptor 2,IFNAR2,515.0
12549,DB05475,SCV-07,SmallMoleculeDrug,O60603,Toll-like receptor 2,TLR2,784.0
12550,DB05475,SCV-07,SmallMoleculeDrug,O00206,Toll-like receptor 4,TLR4,839.0
12551,DB05475,SCV-07,SmallMoleculeDrug,Q9NYK1,Toll-like receptor 7,TLR7,1049.0
12552,DB05475,SCV-07,SmallMoleculeDrug,Q9NR96,Toll-like receptor 9,TLR9,1032.0
12553,DB05476,WX-UK1,SmallMoleculeDrug,Q03405,Urokinase plasminogen activator surface receptor,PLAUR,335.0
12554,DB05478,Pradefovir Mesylate,SmallMoleculeDrug,P08684,Cytochrome P450 3A4,CYP3A4,503.0
12555,DB05479,CZEN 002,SmallMoleculeDrug,Q01726,Melanocyte-stimulating hormone receptor,MC1R,317.0
12556,DB05481,Recombinant alpha 1-antitrypsin,SmallMoleculeDrug,P01009,Alpha-1-antitrypsin,SERPINA1,418.0
12557,DB05482,LE-SN38,SmallMoleculeDrug,P11387,DNA topoisomerase 1,TOP1,765.0
12558,DB05483,PCL-016,SmallMoleculeDrug,Q5T4S7,E3 ubiquitin-protein ligase UBR4,UBR4,5183.0
12559,DB05483,PCL-016,SmallMoleculeDrug,P08048,Zinc finger Y-chromosomal protein,ZFY,801.0
12560,DB05484,MDX-018,SmallMoleculeDrug,P10145,Interleukin-8,CXCL8,99.0
12561,DB05486,MLN-1202,SmallMoleculeDrug,P41597,C-C chemokine receptor type 2,CCR2,374.0
12562,DB05487,CC-8490,SmallMoleculeDrug,P03372,Estrogen receptor,ESR1,595.0
12563,DB05487,CC-8490,SmallMoleculeDrug,Q00653,Nuclear factor NF-kappa-B p100 subunit,NFKB2,900.0
12564,DB05487,CC-8490,SmallMoleculeDrug,P19838,Nuclear factor NF-kappa-B p105 subunit,NFKB1,968.0
12566,DB05488,99mTc-ciprofloxacin,SmallMoleculeDrug,Q02880,DNA topoisomerase 2-beta,TOP2B,1626.0
12568,DB05490,T131,SmallMoleculeDrug,P37231,Peroxisome proliferator-activated receptor gamma,PPARG,505.0
12569,DB05492,Epicept NP-1,SmallMoleculeDrug,P35372,Mu-type opioid receptor,OPRM1,400.0
12570,DB05492,Epicept NP-1,SmallMoleculeDrug,P28223,5-hydroxytryptamine receptor 2A,HTR2A,471.0
12571,DB05492,Epicept NP-1,SmallMoleculeDrug,P41595,5-hydroxytryptamine receptor 2B,HTR2B,481.0
12572,DB05492,Epicept NP-1,SmallMoleculeDrug,P28335,5-hydroxytryptamine receptor 2C,HTR2C,458.0
12573,DB05492,Epicept NP-1,SmallMoleculeDrug,P35348,Alpha-1A adrenergic receptor,ADRA1A,466.0
12574,DB05492,Epicept NP-1,SmallMoleculeDrug,P35368,Alpha-1B adrenergic receptor,ADRA1B,520.0
12575,DB05492,Epicept NP-1,SmallMoleculeDrug,P25100,Alpha-1D adrenergic receptor,ADRA1D,572.0
12576,DB05492,Epicept NP-1,SmallMoleculeDrug,P08913,Alpha-2A adrenergic receptor,ADRA2A,450.0
12577,DB05492,Epicept NP-1,SmallMoleculeDrug,P18089,Alpha-2B adrenergic receptor,ADRA2B,450.0
12578,DB05492,Epicept NP-1,SmallMoleculeDrug,P18825,Alpha-2C adrenergic receptor,ADRA2C,462.0
12579,DB05492,Epicept NP-1,SmallMoleculeDrug,P35367,Histamine H1 receptor,HRH1,487.0
12580,DB05492,Epicept NP-1,SmallMoleculeDrug,P41146,Nociceptin receptor,OPRL1,370.0
12581,DB05494,CP-4055,SmallMoleculeDrug,P27707,Deoxycytidine kinase,DCK,260.0
12582,DB05495,PG-530742,SmallMoleculeDrug,P14780,Matrix metalloproteinase-9,MMP9,707.0
12583,DB05501,AMD-070,SmallMoleculeDrug,P61073,C-X-C chemokine receptor type 4,CXCR4,352.0
12584,DB05501,AMD-070,SmallMoleculeDrug,P51681,C-C chemokine receptor type 5,CCR5,352.0
12585,DB05505,NM-702,SmallMoleculeDrug,P24557,Thromboxane-A synthase,TBXAS1,533.0
12586,DB05506,ISIS 113715,SmallMoleculeDrug,P18031,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,435.0
12587,DB05507,VX-765,SmallMoleculeDrug,P29466,Caspase-1,CASP1,404.0
12588,DB05507,VX-765,SmallMoleculeDrug,P01584,Interleukin-1 beta,IL1B,269.0
12589,DB05508,PTI-901,SmallMoleculeDrug,Q5T1J1,"HCG20471, isoform CRA_c",SIGMAR1,134.0
12590,DB05509,LI-301,SmallMoleculeDrug,P35372,Mu-type opioid receptor,OPRM1,400.0
12591,DB05509,LI-301,SmallMoleculeDrug,P08908,5-hydroxytryptamine receptor 1A,HTR1A,422.0
12592,DB05510,Huperzine-A,SmallMoleculeDrug,P22303,Acetylcholinesterase,ACHE,614.0
12593,DB05511,CF-101,SmallMoleculeDrug,P0DMS8,Adenosine receptor A3,ADORA3,318.0
12595,DB05578,Ramucirumab,BiotechDrug,P35968,Vascular endothelial growth factor receptor 2,KDR,1356.0
12596,DB05595,Farletuzumab,BiotechDrug,P15328,Folate receptor alpha,FOLR1,257.0
12597,DB05630,Sodium stibogluconate,SmallMoleculeDrug,P11387,DNA topoisomerase 1,TOP1,765.0
12598,DB05651,MGCD-0103,SmallMoleculeDrug,Q13547,Histone deacetylase 1,HDAC1,482.0
12599,DB05651,MGCD-0103,SmallMoleculeDrug,O15379,Histone deacetylase 3,HDAC3,428.0
12600,DB05651,MGCD-0103,SmallMoleculeDrug,Q92769,Histone deacetylase 2,HDAC2,488.0
12601,DB05655,TD-5108,SmallMoleculeDrug,Q13639,5-hydroxytryptamine receptor 4,HTR4,388.0
12602,DB05657,TZP-101,SmallMoleculeDrug,Q92847,Growth hormone secretagogue receptor type 1,GHSR,366.0
12607,DB05662,NP-50301,SmallMoleculeDrug,P03372,Estrogen receptor,ESR1,595.0
12608,DB05675,EP-2104R,BiotechDrug,P02671,Fibrinogen alpha chain,FGA,866.0
12609,DB05676,Apremilast,SmallMoleculeDrug,Q08499,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",PDE4D,809.0
12610,DB05676,Apremilast,SmallMoleculeDrug,P27815,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A",PDE4A,886.0
12611,DB05676,Apremilast,SmallMoleculeDrug,Q07343,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B",PDE4B,736.0
12612,DB05676,Apremilast,SmallMoleculeDrug,P01375,Tumor necrosis factor,TNF,233.0
12613,DB05676,Apremilast,SmallMoleculeDrug,P60568,Interleukin-2,IL2,153.0
12614,DB05676,Apremilast,SmallMoleculeDrug,P01579,Interferon gamma,IFNG,166.0
12615,DB05676,Apremilast,SmallMoleculeDrug,P29474,"Nitric oxide synthase, endothelial",NOS3,1203.0
12616,DB05679,Ustekinumab,BiotechDrug,P29460,Interleukin-12 subunit beta,IL12B,328.0
12617,DB05679,Ustekinumab,BiotechDrug,P29460,Interleukin-12 subunit beta,IL12B,328.0
12618,DB05679,Ustekinumab,BiotechDrug,Q9NPF7,Interleukin-23 subunit alpha,IL23A,189.0
12619,DB05685,FX06,BiotechDrug,P33151,Cadherin-5,CDH5,784.0
12620,DB05687,BL-1020,SmallMoleculeDrug,P14416,D(2) dopamine receptor,DRD2,443.0
12621,DB05687,BL-1020,SmallMoleculeDrug,P28223,5-hydroxytryptamine receptor 2A,HTR2A,471.0
12622,DB05688,CRx-119,SmallMoleculeDrug,P31645,Sodium-dependent serotonin transporter,SLC6A4,630.0
12623,DB05688,CRx-119,SmallMoleculeDrug,P23975,Sodium-dependent noradrenaline transporter,SLC6A2,617.0
12624,DB05692,SCH-530348,SmallMoleculeDrug,P25116,Proteinase-activated receptor 1,F2R,425.0
12625,DB05694,NBI-56418,SmallMoleculeDrug,P30968,Gonadotropin-releasing hormone receptor,GNRHR,328.0
12626,DB05708,GTS-21,SmallMoleculeDrug,P36544,Neuronal acetylcholine receptor subunit alpha-7,CHRNA7,502.0
12627,DB05712,AZD-9684,SmallMoleculeDrug,Q96IY4,Carboxypeptidase B2,CPB2,423.0
12628,DB05713,LY-517717,SmallMoleculeDrug,P00742,Coagulation factor X,F10,488.0
12629,DB05715,Genz-112638,SmallMoleculeDrug,Q16739,Ceramide glucosyltransferase,UGCG,394.0
12630,DB05736,MIV-701,SmallMoleculeDrug,P43235,Cathepsin K,CTSK,329.0
12631,DB05739,CYT006-AngQb,BiotechDrug,P30556,Type-1 angiotensin II receptor,AGTR1,359.0
12632,DB05739,CYT006-AngQb,BiotechDrug,P50052,Type-2 angiotensin II receptor,AGTR2,363.0
12633,DB05740,RPI-78M,SmallMoleculeDrug,Q15822,Neuronal acetylcholine receptor subunit alpha-2,CHRNA2,529.0
12634,DB05740,RPI-78M,SmallMoleculeDrug,P17787,Neuronal acetylcholine receptor subunit beta-2,CHRNB2,502.0
12635,DB05740,RPI-78M,SmallMoleculeDrug,P36544,Neuronal acetylcholine receptor subunit alpha-7,CHRNA7,502.0
12636,DB05740,RPI-78M,SmallMoleculeDrug,P43681,Neuronal acetylcholine receptor subunit alpha-4,CHRNA4,627.0
12637,DB05740,RPI-78M,SmallMoleculeDrug,Q9GZZ6,Neuronal acetylcholine receptor subunit alpha-10,CHRNA10,450.0
12638,DB05740,RPI-78M,SmallMoleculeDrug,Q9UGM1,Neuronal acetylcholine receptor subunit alpha-9,CHRNA9,479.0
12639,DB05743,MAP-0004,SmallMoleculeDrug,P28222,5-hydroxytryptamine receptor 1B,HTR1B,390.0
12640,DB05743,MAP-0004,SmallMoleculeDrug,P28221,5-hydroxytryptamine receptor 1D,HTR1D,377.0
12641,DB05743,MAP-0004,SmallMoleculeDrug,P28223,5-hydroxytryptamine receptor 2A,HTR2A,471.0
12642,DB05744,CRx-139,SmallMoleculeDrug,P01375,Tumor necrosis factor,TNF,233.0
12643,DB05744,CRx-139,SmallMoleculeDrug,P05231,Interleukin-6,IL6,212.0
12644,DB05744,CRx-139,SmallMoleculeDrug,P02741,C-reactive protein,CRP,224.0
12645,DB05744,CRx-139,SmallMoleculeDrug,P22301,Interleukin-10,IL10,178.0
12646,DB05745,CHR-2797,SmallMoleculeDrug,P55786,Puromycin-sensitive aminopeptidase,NPEPPS,919.0
12647,DB05745,CHR-2797,SmallMoleculeDrug,P09960,Leukotriene A-4 hydrolase,LTA4H,611.0
12648,DB05749,MPI-674,SmallMoleculeDrug,P11511,Aromatase,CYP19A1,503.0
12649,DB05750,AVE-1625,SmallMoleculeDrug,P21554,Cannabinoid receptor 1,CNR1,472.0
12650,DB05752,ALKS 27,SmallMoleculeDrug,P11229,Muscarinic acetylcholine receptor M1,CHRM1,460.0
12651,DB05752,ALKS 27,SmallMoleculeDrug,P08172,Muscarinic acetylcholine receptor M2,CHRM2,466.0
12652,DB05752,ALKS 27,SmallMoleculeDrug,P20309,Muscarinic acetylcholine receptor M3,CHRM3,590.0
12653,DB05752,ALKS 27,SmallMoleculeDrug,P08173,Muscarinic acetylcholine receptor M4,CHRM4,479.0
12654,DB05752,ALKS 27,SmallMoleculeDrug,P08912,Muscarinic acetylcholine receptor M5,CHRM5,532.0
12655,DB05758,CYT007-TNFQb,BiotechDrug,P01375,Tumor necrosis factor,TNF,233.0
12656,DB05759,IMC-A12,BiotechDrug,P08069,Insulin-like growth factor 1 receptor,IGF1R,1367.0
12657,DB05760,MK-0974,SmallMoleculeDrug,P06881,Calcitonin gene-related peptide 1,CALCA,128.0
12658,DB05760,MK-0974,SmallMoleculeDrug,P10092,Calcitonin gene-related peptide 2,CALCB,127.0
12659,DB05764,ABT-263,SmallMoleculeDrug,P10415,Apoptosis regulator Bcl-2,BCL2,239.0
12660,DB05764,ABT-263,SmallMoleculeDrug,Q92843,Bcl-2-like protein 2,BCL2L2,193.0
12661,DB05764,ABT-263,SmallMoleculeDrug,Q92934,Bcl2-associated agonist of cell death,BAD,168.0
12662,DB05766,ACP-104,SmallMoleculeDrug,P11229,Muscarinic acetylcholine receptor M1,CHRM1,460.0
12663,DB05766,ACP-104,SmallMoleculeDrug,P14416,D(2) dopamine receptor,DRD2,443.0
12664,DB05766,ACP-104,SmallMoleculeDrug,P35462,D(3) dopamine receptor,DRD3,400.0
12665,DB05767,HMPL-004,SmallMoleculeDrug,P01375,Tumor necrosis factor,TNF,233.0
12666,DB05767,HMPL-004,SmallMoleculeDrug,P01584,Interleukin-1 beta,IL1B,269.0
12667,DB05767,HMPL-004,SmallMoleculeDrug,P05231,Interleukin-6,IL6,212.0
12668,DB05767,HMPL-004,SmallMoleculeDrug,Q00653,Nuclear factor NF-kappa-B p100 subunit,NFKB2,900.0
12669,DB05767,HMPL-004,SmallMoleculeDrug,P19838,Nuclear factor NF-kappa-B p105 subunit,NFKB1,968.0
12670,DB05771,LLL-3348,SmallMoleculeDrug,P22301,Interleukin-10,IL10,178.0
12671,DB05773,Trastuzumab emtansine,BiotechDrug,P04626,Receptor tyrosine-protein kinase erbB-2,ERBB2,1255.0
12672,DB05774,IMC-11F8,SmallMoleculeDrug,P00533,Epidermal growth factor receptor,EGFR,1210.0
12673,DB05777,Thrombomodulin Alfa,BiotechDrug,P00734,Prothrombin,F2,622.0
12674,DB05777,Thrombomodulin Alfa,BiotechDrug,P12259,Coagulation factor V,F5,2224.0
12675,DB05785,LGD-1550,SmallMoleculeDrug,P10276,Retinoic acid receptor alpha,RARA,462.0
12676,DB05785,LGD-1550,SmallMoleculeDrug,P10826,Retinoic acid receptor beta,RARB,455.0
12677,DB05785,LGD-1550,SmallMoleculeDrug,P13631,Retinoic acid receptor gamma,RARG,454.0
12678,DB05785,LGD-1550,SmallMoleculeDrug,P05412,Transcription factor AP-1,JUN,331.0
12679,DB05786,MGI-114,SmallMoleculeDrug,Q96AE4,Far upstream element-binding protein 1,FUBP1,644.0
12680,DB05787,LM-609,BiotechDrug,P05106,Integrin beta-3,ITGB3,788.0
12681,DB05790,SR 140333,SmallMoleculeDrug,P25103,Substance-P receptor,TACR1,407.0
12682,DB05792,SR 31747,SmallMoleculeDrug,Q5T1J1,"HCG20471, isoform CRA_c",SIGMAR1,134.0
12683,DB05793,PRO-542,BiotechDrug,Q5NUL3,Free fatty acid receptor 4,FFAR4,377.0
12684,DB05796,SLV 306,SmallMoleculeDrug,P08473,Neprilysin,MME,750.0
12685,DB05797,TNX-901,SmallMoleculeDrug,P12319,High affinity immunoglobulin epsilon receptor subunit alpha,FCER1A,257.0
12686,DB05798,GEM-231,SmallMoleculeDrug,P13861,cAMP-dependent protein kinase type II-alpha regulatory subunit,PRKAR2A,404.0
12687,DB05798,GEM-231,SmallMoleculeDrug,P10644,cAMP-dependent protein kinase type I-alpha regulatory subunit,PRKAR1A,381.0
12688,DB05801,GTI 2040,SmallMoleculeDrug,P31350,Ribonucleoside-diphosphate reductase subunit M2,RRM2,389.0
12689,DB05802,MLN-02,SmallMoleculeDrug,P26010,Integrin beta-7,ITGB7,798.0
12690,DB05802,MLN-02,SmallMoleculeDrug,P13612,Integrin alpha-4,ITGA4,1032.0
12691,DB05806,BNP 1350,SmallMoleculeDrug,P11387,DNA topoisomerase 1,TOP1,765.0
12692,DB05812,Abiraterone,SmallMoleculeDrug,P05093,"Steroid 17-alpha-hydroxylase/17,20 lyase",CYP17A1,508.0
12693,DB05814,GPI-1485,SmallMoleculeDrug,P62942,Peptidyl-prolyl cis-trans isomerase FKBP1A,FKBP1A,108.0
12694,DB05816,intranasal apomorphine,SmallMoleculeDrug,P14416,D(2) dopamine receptor,DRD2,443.0
12695,DB05816,intranasal apomorphine,SmallMoleculeDrug,P21728,D(1A) dopamine receptor,DRD1,446.0
12696,DB05822,NCX 4016,SmallMoleculeDrug,P23219,Prostaglandin G/H synthase 1,PTGS1,599.0
12697,DB05824,CNS-5161,SmallMoleculeDrug,Q05586,"Glutamate receptor ionotropic, NMDA 1",GRIN1,938.0
12698,DB05829,Parathyroid hormone,BiotechDrug,Q03431,Parathyroid hormone/parathyroid hormone-related peptide receptor,PTH1R,593.0
12699,DB05829,Parathyroid hormone,BiotechDrug,P49190,Parathyroid hormone 2 receptor,PTH2R,550.0
12700,DB05831,ING-1,SmallMoleculeDrug,P16422,Epithelial cell adhesion molecule,EPCAM,314.0
12701,DB05838,OPC-51803,SmallMoleculeDrug,P30518,Vasopressin V2 receptor,AVPR2,371.0
12702,DB05846,Mito-4509,SmallMoleculeDrug,P05067,Amyloid beta A4 protein,APP,770.0
12703,DB05848,humanized SMART Anti-IL-12 Antibody,BiotechDrug,P29460,Interleukin-12 subunit beta,IL12B,328.0
12704,DB05849,NCX 950,SmallMoleculeDrug,P07550,Beta-2 adrenergic receptor,ADRB2,413.0
12705,DB05854,CLX-0921,SmallMoleculeDrug,P37231,Peroxisome proliferator-activated receptor gamma,PPARG,505.0
12706,DB05855,Rivanicline,SmallMoleculeDrug,P17787,Neuronal acetylcholine receptor subunit beta-2,CHRNB2,502.0
12707,DB05855,Rivanicline,SmallMoleculeDrug,P10145,Interleukin-8,CXCL8,99.0
12708,DB05864,PPI-2458,SmallMoleculeDrug,P50579,Methionine aminopeptidase 2,METAP2,478.0
12709,DB05867,99mTc-14 F7 Mab,BiotechDrug,Q9UNP4,"Lactosylceramide alpha-2,3-sialyltransferase",ST3GAL5,418.0
12711,DB05869,CTI-01,SmallMoleculeDrug,P01375,Tumor necrosis factor,TNF,233.0
12712,DB05869,CTI-01,SmallMoleculeDrug,P09429,High mobility group protein B1,HMGB1,215.0
12714,DB05876,PDE4,SmallMoleculeDrug,P27815,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A",PDE4A,886.0
12715,DB05879,AME-527,BiotechDrug,P01375,Tumor necrosis factor,TNF,233.0
12716,DB05882,CHF 4227,SmallMoleculeDrug,P03372,Estrogen receptor,ESR1,595.0
12717,DB05882,CHF 4227,SmallMoleculeDrug,Q92731,Estrogen receptor beta,ESR2,530.0
12718,DB05883,ABX-PTH,BiotechDrug,P01270,Parathyroid hormone,PTH,115.0
12720,DB05890,VEGF-AS,SmallMoleculeDrug,P15692,Vascular endothelial growth factor A,VEGFA,232.0
12721,DB05892,RI 624,BiotechDrug,P01138,Beta-nerve growth factor,NGF,241.0
12722,DB05895,HGS-TR2J,BiotechDrug,O14763,Tumor necrosis factor receptor superfamily member 10B,TNFRSF10B,440.0
12723,DB05897,rhIGFBP-3,SmallMoleculeDrug,P08069,Insulin-like growth factor 1 receptor,IGF1R,1367.0
12724,DB05900,INSM-18,SmallMoleculeDrug,P08069,Insulin-like growth factor 1 receptor,IGF1R,1367.0
12725,DB05900,INSM-18,SmallMoleculeDrug,P00533,Epidermal growth factor receptor,EGFR,1210.0
12726,DB05905,TD-2749,SmallMoleculeDrug,Q13639,5-hydroxytryptamine receptor 4,HTR4,388.0
12727,DB05913,OSI-930,SmallMoleculeDrug,P10721,Mast/stem cell growth factor receptor Kit,KIT,976.0
12728,DB05913,OSI-930,SmallMoleculeDrug,P17948,Vascular endothelial growth factor receptor 1,FLT1,1338.0
12729,DB05915,MYO-029,BiotechDrug,O14793,Growth/differentiation factor 8,MSTN,375.0
12730,DB05916,CT-011,BiotechDrug,Q15116,Programmed cell death protein 1,PDCD1,288.0
12731,DB05920,RTA 744,SmallMoleculeDrug,P11388,DNA topoisomerase 2-alpha,TOP2A,1531.0
12732,DB05921,CRA-024781,SmallMoleculeDrug,Q13547,Histone deacetylase 1,HDAC1,482.0
12733,DB05930,SB-559448,SmallMoleculeDrug,P40238,Thrombopoietin receptor,MPL,635.0
12734,DB05990,Obeticholic acid,SmallMoleculeDrug,Q96RI1,Bile acid receptor,NR1H4,486.0
12735,DB06016,Cariprazine,SmallMoleculeDrug,P35462,D(3) dopamine receptor,DRD3,400.0
12736,DB06016,Cariprazine,SmallMoleculeDrug,P14416,D(2) dopamine receptor,DRD2,443.0
12737,DB06016,Cariprazine,SmallMoleculeDrug,P08908,5-hydroxytryptamine receptor 1A,HTR1A,422.0
12738,DB06016,Cariprazine,SmallMoleculeDrug,P41595,5-hydroxytryptamine receptor 2B,HTR2B,481.0
12739,DB06016,Cariprazine,SmallMoleculeDrug,P28223,5-hydroxytryptamine receptor 2A,HTR2A,471.0
12740,DB06016,Cariprazine,SmallMoleculeDrug,P35367,Histamine H1 receptor,HRH1,487.0
12743,DB06042,ZEN-012,SmallMoleculeDrug,P07437,Tubulin beta chain,TUBB,444.0
12744,DB06042,ZEN-012,SmallMoleculeDrug,Q9H4B7,Tubulin beta-1 chain,TUBB1,451.0
12745,DB06042,ZEN-012,SmallMoleculeDrug,Q13509,Tubulin beta-3 chain,TUBB3,450.0
12746,DB06042,ZEN-012,SmallMoleculeDrug,P04350,Tubulin beta-4A chain,TUBB4A,444.0
12747,DB06042,ZEN-012,SmallMoleculeDrug,P11388,DNA topoisomerase 2-alpha,TOP2A,1531.0
12748,DB06042,ZEN-012,SmallMoleculeDrug,Q02880,DNA topoisomerase 2-beta,TOP2B,1626.0
12749,DB06043,Olaratumab,BiotechDrug,P16234,Platelet-derived growth factor receptor alpha,PDGFRA,1089.0
12751,DB06060,ADX-48621,SmallMoleculeDrug,P41594,Metabotropic glutamate receptor 5,GRM5,1212.0
12752,DB06061,AZD-8330,SmallMoleculeDrug,Q13233,Mitogen-activated protein kinase kinase kinase 1,MAP3K1,1512.0
12753,DB06062,XOMA 052,BiotechDrug,P01584,Interleukin-1 beta,IL1B,269.0
12754,DB06064,KAI-1455,SmallMoleculeDrug,Q02156,Protein kinase C epsilon type,PRKCE,737.0
12755,DB06069,XMT-1001,SmallMoleculeDrug,P11387,DNA topoisomerase 1,TOP1,765.0
12756,DB06070,SNX-5422,SmallMoleculeDrug,P07900,Heat shock protein HSP 90-alpha,HSP90AA1,732.0
12757,DB06070,SNX-5422,SmallMoleculeDrug,P08238,Heat shock protein HSP 90-beta,HSP90AB1,724.0
12758,DB06073,CTS-21166,SmallMoleculeDrug,P56817,Beta-secretase 1,BACE1,501.0
12759,DB06077,Lumateperone,SmallMoleculeDrug,P28223,5-hydroxytryptamine receptor 2A,HTR2A,471.0
12760,DB06077,Lumateperone,SmallMoleculeDrug,P14416,D(2) dopamine receptor,DRD2,443.0
12761,DB06080,ABT-869,SmallMoleculeDrug,P36888,Receptor-type tyrosine-protein kinase FLT3,FLT3,993.0
12762,DB06080,ABT-869,SmallMoleculeDrug,P17948,Vascular endothelial growth factor receptor 1,FLT1,1338.0
12763,DB06080,ABT-869,SmallMoleculeDrug,P35968,Vascular endothelial growth factor receptor 2,KDR,1356.0
12764,DB06080,ABT-869,SmallMoleculeDrug,P35916,Vascular endothelial growth factor receptor 3,FLT4,1363.0
12765,DB06080,ABT-869,SmallMoleculeDrug,P10721,Mast/stem cell growth factor receptor Kit,KIT,976.0
12766,DB06080,ABT-869,SmallMoleculeDrug,P07333,Macrophage colony-stimulating factor 1 receptor,CSF1R,972.0
12767,DB06089,ICA-105665,SmallMoleculeDrug,P51787,Potassium voltage-gated channel subfamily KQT member 1,KCNQ1,676.0
12768,DB06089,ICA-105665,SmallMoleculeDrug,O43525,Potassium voltage-gated channel subfamily KQT member 3,KCNQ3,872.0
12769,DB06089,ICA-105665,SmallMoleculeDrug,P56696,Potassium voltage-gated channel subfamily KQT member 4,KCNQ4,695.0
12770,DB06089,ICA-105665,SmallMoleculeDrug,Q9NR82,Potassium voltage-gated channel subfamily KQT member 5,KCNQ5,932.0
12771,DB06089,ICA-105665,SmallMoleculeDrug,O43526,Potassium voltage-gated channel subfamily KQT member 2,KCNQ2,872.0
12772,DB06090,Bradanicline,SmallMoleculeDrug,Q693P7,Alpha-7 nicotinic cholinergic receptor subunit,CHRNA7,28.0
12773,DB06094,OGX-427,SmallMoleculeDrug,P04792,Heat shock protein beta-1,HSPB1,205.0
12774,DB06096,NXN-188,SmallMoleculeDrug,P29475,"Nitric oxide synthase, brain",NOS1,1434.0
12775,DB06096,NXN-188,SmallMoleculeDrug,P28222,5-hydroxytryptamine receptor 1B,HTR1B,390.0
12776,DB06096,NXN-188,SmallMoleculeDrug,P28221,5-hydroxytryptamine receptor 1D,HTR1D,377.0
12777,DB06097,GSK-923295,SmallMoleculeDrug,Q02224,Centromere-associated protein E,CENPE,2701.0
12778,DB06098,PRLX 93936,SmallMoleculeDrug,P45880,Voltage-dependent anion-selective channel protein 2,VDAC2,294.0
12779,DB06098,PRLX 93936,SmallMoleculeDrug,Q9Y277,Voltage-dependent anion-selective channel protein 3,VDAC3,283.0
12780,DB06101,IMC-1C11,BiotechDrug,P17948,Vascular endothelial growth factor receptor 1,FLT1,1338.0
12781,DB06101,IMC-1C11,BiotechDrug,P35968,Vascular endothelial growth factor receptor 2,KDR,1356.0
12782,DB06101,IMC-1C11,BiotechDrug,P35916,Vascular endothelial growth factor receptor 3,FLT4,1363.0
12783,DB06103,VX-148,SmallMoleculeDrug,P20839,Inosine-5'-monophosphate dehydrogenase 1,IMPDH1,514.0
12784,DB06103,VX-148,SmallMoleculeDrug,P12268,Inosine-5'-monophosphate dehydrogenase 2,IMPDH2,514.0
12785,DB06127,KRP-104,SmallMoleculeDrug,P27487,Dipeptidyl peptidase 4,DPP4,766.0
12786,DB06144,Sertindole,SmallMoleculeDrug,P14416,D(2) dopamine receptor,DRD2,443.0
12787,DB06144,Sertindole,SmallMoleculeDrug,P28223,5-hydroxytryptamine receptor 2A,HTR2A,471.0
12788,DB06144,Sertindole,SmallMoleculeDrug,P28335,5-hydroxytryptamine receptor 2C,HTR2C,458.0
12789,DB06144,Sertindole,SmallMoleculeDrug,P50406,5-hydroxytryptamine receptor 6,HTR6,440.0
12790,DB06144,Sertindole,SmallMoleculeDrug,Q12809,Potassium voltage-gated channel subfamily H member 2,KCNH2,1159.0
12791,DB06144,Sertindole,SmallMoleculeDrug,P35348,Alpha-1A adrenergic receptor,ADRA1A,466.0
12792,DB06144,Sertindole,SmallMoleculeDrug,P35368,Alpha-1B adrenergic receptor,ADRA1B,520.0
12793,DB06144,Sertindole,SmallMoleculeDrug,P25100,Alpha-1D adrenergic receptor,ADRA1D,572.0
12796,DB06148,Mianserin,SmallMoleculeDrug,P08913,Alpha-2A adrenergic receptor,ADRA2A,450.0
12797,DB06148,Mianserin,SmallMoleculeDrug,P28223,5-hydroxytryptamine receptor 2A,HTR2A,471.0
12798,DB06148,Mianserin,SmallMoleculeDrug,P28335,5-hydroxytryptamine receptor 2C,HTR2C,458.0
12799,DB06148,Mianserin,SmallMoleculeDrug,P35367,Histamine H1 receptor,HRH1,487.0
12800,DB06148,Mianserin,SmallMoleculeDrug,P23975,Sodium-dependent noradrenaline transporter,SLC6A2,617.0
12801,DB06148,Mianserin,SmallMoleculeDrug,P31645,Sodium-dependent serotonin transporter,SLC6A4,630.0
12802,DB06148,Mianserin,SmallMoleculeDrug,Q9H3N8,Histamine H4 receptor,HRH4,390.0
12803,DB06148,Mianserin,SmallMoleculeDrug,P08908,5-hydroxytryptamine receptor 1A,HTR1A,422.0
12804,DB06148,Mianserin,SmallMoleculeDrug,P18825,Alpha-2C adrenergic receptor,ADRA2C,462.0
12805,DB06148,Mianserin,SmallMoleculeDrug,P41595,5-hydroxytryptamine receptor 2B,HTR2B,481.0
12806,DB06148,Mianserin,SmallMoleculeDrug,P30939,5-hydroxytryptamine receptor 1F,HTR1F,366.0
12807,DB06148,Mianserin,SmallMoleculeDrug,P18089,Alpha-2B adrenergic receptor,ADRA2B,450.0
12808,DB06148,Mianserin,SmallMoleculeDrug,P35462,D(3) dopamine receptor,DRD3,400.0
12809,DB06148,Mianserin,SmallMoleculeDrug,P41145,Kappa-type opioid receptor,OPRK1,380.0
12810,DB06148,Mianserin,SmallMoleculeDrug,Q01959,Sodium-dependent dopamine transporter,SLC6A3,620.0
12811,DB06148,Mianserin,SmallMoleculeDrug,P34969,5-hydroxytryptamine receptor 7,HTR7,479.0
12812,DB06148,Mianserin,SmallMoleculeDrug,P14416,D(2) dopamine receptor,DRD2,443.0
12813,DB06148,Mianserin,SmallMoleculeDrug,P50406,5-hydroxytryptamine receptor 6,HTR6,440.0
12814,DB06148,Mianserin,SmallMoleculeDrug,P35348,Alpha-1A adrenergic receptor,ADRA1A,466.0
12815,DB06148,Mianserin,SmallMoleculeDrug,P35368,Alpha-1B adrenergic receptor,ADRA1B,520.0
12816,DB06148,Mianserin,SmallMoleculeDrug,P25100,Alpha-1D adrenergic receptor,ADRA1D,572.0
12817,DB06148,Mianserin,SmallMoleculeDrug,P21728,D(1A) dopamine receptor,DRD1,446.0
12818,DB06148,Mianserin,SmallMoleculeDrug,P21918,D(1B) dopamine receptor,DRD5,477.0
12819,DB06151,Acetylcysteine,SmallMoleculeDrug,Q03154,Aminoacylase-1,ACY1,408.0
12820,DB06151,Acetylcysteine,SmallMoleculeDrug,O15111,Inhibitor of nuclear factor kappa-B kinase subunit alpha,CHUK,745.0
12821,DB06151,Acetylcysteine,SmallMoleculeDrug,O14920,Inhibitor of nuclear factor kappa-B kinase subunit beta,IKBKB,756.0
12822,DB06151,Acetylcysteine,SmallMoleculeDrug,P48637,Glutathione synthetase,GSS,474.0
12823,DB06151,Acetylcysteine,SmallMoleculeDrug,Q9UPY5,Cystine/glutamate transporter,SLC7A11,501.0
12824,DB06151,Acetylcysteine,SmallMoleculeDrug,Q13224,"Glutamate receptor ionotropic, NMDA 2B",GRIN2B,1484.0
12825,DB06151,Acetylcysteine,SmallMoleculeDrug,Q05586,"Glutamate receptor ionotropic, NMDA 1",GRIN1,938.0
12826,DB06151,Acetylcysteine,SmallMoleculeDrug,Q12879,"Glutamate receptor ionotropic, NMDA 2A",GRIN2A,1464.0
12827,DB06151,Acetylcysteine,SmallMoleculeDrug,O15399,"Glutamate receptor ionotropic, NMDA 2D",GRIN2D,1336.0
12828,DB06151,Acetylcysteine,SmallMoleculeDrug,Q8TCU5,"Glutamate receptor ionotropic, NMDA 3A",GRIN3A,1115.0
12829,DB06155,Rimonabant,SmallMoleculeDrug,P21554,Cannabinoid receptor 1,CNR1,472.0
12830,DB06168,Canakinumab,BiotechDrug,P01584,Interleukin-1 beta,IL1B,269.0
12831,DB06176,Romidepsin,SmallMoleculeDrug,Q13547,Histone deacetylase 1,HDAC1,482.0
12832,DB06176,Romidepsin,SmallMoleculeDrug,Q92769,Histone deacetylase 2,HDAC2,488.0
12833,DB06176,Romidepsin,SmallMoleculeDrug,P56524,Histone deacetylase 4,HDAC4,1084.0
12834,DB06176,Romidepsin,SmallMoleculeDrug,Q9UBN7,Histone deacetylase 6,HDAC6,1215.0
12835,DB06186,Ipilimumab,BiotechDrug,P16410,Cytotoxic T-lymphocyte protein 4,CTLA4,223.0
12836,DB06190,Solabegron,SmallMoleculeDrug,P13945,Beta-3 adrenergic receptor,ADRB3,408.0
12837,DB06196,Icatibant,SmallMoleculeDrug,P30411,B2 bradykinin receptor,BDKRB2,391.0
12838,DB06196,Icatibant,SmallMoleculeDrug,P15144,Aminopeptidase N,ANPEP,967.0
12839,DB06201,Rufinamide,SmallMoleculeDrug,P41594,Metabotropic glutamate receptor 5,GRM5,1212.0
12840,DB06201,Rufinamide,SmallMoleculeDrug,Q15858,Sodium channel protein type 9 subunit alpha,SCN9A,1988.0
12841,DB06202,Lasofoxifene,SmallMoleculeDrug,P03372,Estrogen receptor,ESR1,595.0
12842,DB06202,Lasofoxifene,SmallMoleculeDrug,Q92731,Estrogen receptor beta,ESR2,530.0
12843,DB06203,Alogliptin,SmallMoleculeDrug,P27487,Dipeptidyl peptidase 4,DPP4,766.0
12844,DB06204,Tapentadol,SmallMoleculeDrug,P35372,Mu-type opioid receptor,OPRM1,400.0
12845,DB06204,Tapentadol,SmallMoleculeDrug,P23975,Sodium-dependent noradrenaline transporter,SLC6A2,617.0
12846,DB06204,Tapentadol,SmallMoleculeDrug,P41145,Kappa-type opioid receptor,OPRK1,380.0
12847,DB06204,Tapentadol,SmallMoleculeDrug,P41143,Delta-type opioid receptor,OPRD1,372.0
12848,DB06204,Tapentadol,SmallMoleculeDrug,P46098,5-hydroxytryptamine receptor 3A,HTR3A,478.0
12849,DB06204,Tapentadol,SmallMoleculeDrug,P31645,Sodium-dependent serotonin transporter,SLC6A4,630.0
12850,DB06205,Hyaluronidase (Human Recombinant),BiotechDrug,P01137,Transforming growth factor beta-1,TGFB1,390.0
12851,DB06207,Silodosin,SmallMoleculeDrug,P35348,Alpha-1A adrenergic receptor,ADRA1A,466.0
12852,DB06207,Silodosin,SmallMoleculeDrug,P35368,Alpha-1B adrenergic receptor,ADRA1B,520.0
12853,DB06207,Silodosin,SmallMoleculeDrug,P25100,Alpha-1D adrenergic receptor,ADRA1D,572.0
12854,DB06209,Prasugrel,SmallMoleculeDrug,Q9H244,P2Y purinoceptor 12,P2RY12,342.0
12855,DB06210,Eltrombopag,SmallMoleculeDrug,P40238,Thrombopoietin receptor,MPL,635.0
12861,DB06212,Tolvaptan,SmallMoleculeDrug,P30518,Vasopressin V2 receptor,AVPR2,371.0
12862,DB06212,Tolvaptan,SmallMoleculeDrug,P37288,Vasopressin V1a receptor,AVPR1A,418.0
12863,DB06213,Regadenoson,SmallMoleculeDrug,P29274,Adenosine receptor A2a,ADORA2A,412.0
12864,DB06216,Asenapine,SmallMoleculeDrug,P14416,D(2) dopamine receptor,DRD2,443.0
12865,DB06216,Asenapine,SmallMoleculeDrug,P28223,5-hydroxytryptamine receptor 2A,HTR2A,471.0
12866,DB06216,Asenapine,SmallMoleculeDrug,P08908,5-hydroxytryptamine receptor 1A,HTR1A,422.0
12867,DB06216,Asenapine,SmallMoleculeDrug,P28222,5-hydroxytryptamine receptor 1B,HTR1B,390.0
12868,DB06216,Asenapine,SmallMoleculeDrug,P41595,5-hydroxytryptamine receptor 2B,HTR2B,481.0
12869,DB06216,Asenapine,SmallMoleculeDrug,P28335,5-hydroxytryptamine receptor 2C,HTR2C,458.0
12870,DB06216,Asenapine,SmallMoleculeDrug,P47898,5-hydroxytryptamine receptor 5A,HTR5A,357.0
12871,DB06216,Asenapine,SmallMoleculeDrug,P50406,5-hydroxytryptamine receptor 6,HTR6,440.0
12872,DB06216,Asenapine,SmallMoleculeDrug,P34969,5-hydroxytryptamine receptor 7,HTR7,479.0
12873,DB06216,Asenapine,SmallMoleculeDrug,P08913,Alpha-2A adrenergic receptor,ADRA2A,450.0
12874,DB06216,Asenapine,SmallMoleculeDrug,P18089,Alpha-2B adrenergic receptor,ADRA2B,450.0
12875,DB06216,Asenapine,SmallMoleculeDrug,P18825,Alpha-2C adrenergic receptor,ADRA2C,462.0
12876,DB06216,Asenapine,SmallMoleculeDrug,P35348,Alpha-1A adrenergic receptor,ADRA1A,466.0
12877,DB06216,Asenapine,SmallMoleculeDrug,P21728,D(1A) dopamine receptor,DRD1,446.0
12878,DB06216,Asenapine,SmallMoleculeDrug,P35462,D(3) dopamine receptor,DRD3,400.0
12879,DB06216,Asenapine,SmallMoleculeDrug,P21917,D(4) dopamine receptor,DRD4,467.0
12880,DB06216,Asenapine,SmallMoleculeDrug,P35367,Histamine H1 receptor,HRH1,487.0
12881,DB06216,Asenapine,SmallMoleculeDrug,P25021,Histamine H2 receptor,HRH2,359.0
12882,DB06216,Asenapine,SmallMoleculeDrug,P08588,Beta-1 adrenergic receptor,ADRB1,477.0
12883,DB06216,Asenapine,SmallMoleculeDrug,P07550,Beta-2 adrenergic receptor,ADRB2,413.0
12884,DB06218,Lacosamide,SmallMoleculeDrug,Q15858,Sodium channel protein type 9 subunit alpha,SCN9A,1988.0
12885,DB06218,Lacosamide,SmallMoleculeDrug,Q9NY46,Sodium channel protein type 3 subunit alpha,SCN3A,2000.0
12886,DB06218,Lacosamide,SmallMoleculeDrug,Q9Y5Y9,Sodium channel protein type 10 subunit alpha,SCN10A,1956.0
12887,DB06228,Rivaroxaban,SmallMoleculeDrug,P00742,Coagulation factor X,F10,488.0
12888,DB06237,Avanafil,SmallMoleculeDrug,O76074,"cGMP-specific 3',5'-cyclic phosphodiesterase",PDE5A,875.0
12889,DB06243,Eflornithine,SmallMoleculeDrug,P11926,Ornithine decarboxylase,ODC1,461.0
12890,DB06262,Droxidopa,SmallMoleculeDrug,P35348,Alpha-1A adrenergic receptor,ADRA1A,466.0
12891,DB06262,Droxidopa,SmallMoleculeDrug,P35368,Alpha-1B adrenergic receptor,ADRA1B,520.0
12892,DB06262,Droxidopa,SmallMoleculeDrug,P25100,Alpha-1D adrenergic receptor,ADRA1D,572.0
12893,DB06262,Droxidopa,SmallMoleculeDrug,P08913,Alpha-2A adrenergic receptor,ADRA2A,450.0
12894,DB06262,Droxidopa,SmallMoleculeDrug,P18089,Alpha-2B adrenergic receptor,ADRA2B,450.0
12895,DB06262,Droxidopa,SmallMoleculeDrug,P18825,Alpha-2C adrenergic receptor,ADRA2C,462.0
12896,DB06262,Droxidopa,SmallMoleculeDrug,P08588,Beta-1 adrenergic receptor,ADRB1,477.0
12897,DB06262,Droxidopa,SmallMoleculeDrug,P07550,Beta-2 adrenergic receptor,ADRB2,413.0
12898,DB06262,Droxidopa,SmallMoleculeDrug,P13945,Beta-3 adrenergic receptor,ADRB3,408.0
12899,DB06262,Droxidopa,SmallMoleculeDrug,P00439,Phenylalanine-4-hydroxylase,PAH,452.0
12900,DB06263,Amrubicin,SmallMoleculeDrug,P11388,DNA topoisomerase 2-alpha,TOP2A,1531.0
12901,DB06267,Udenafil,SmallMoleculeDrug,O76074,"cGMP-specific 3',5'-cyclic phosphodiesterase",PDE5A,875.0
12902,DB06268,Sitaxentan,SmallMoleculeDrug,P25101,Endothelin-1 receptor,EDNRA,427.0
12903,DB06268,Sitaxentan,SmallMoleculeDrug,P24530,Endothelin B receptor,EDNRB,442.0
12904,DB06271,Sulodexide,BiotechDrug,P05546,Heparin cofactor 2,SERPIND1,499.0
12905,DB06271,Sulodexide,BiotechDrug,P01008,Antithrombin-III,SERPINC1,464.0
12906,DB06273,Tocilizumab,BiotechDrug,P08887,Interleukin-6 receptor subunit alpha,IL6R,468.0
12907,DB06274,Alvimopan,SmallMoleculeDrug,P35372,Mu-type opioid receptor,OPRM1,400.0
12908,DB06274,Alvimopan,SmallMoleculeDrug,P41145,Kappa-type opioid receptor,OPRK1,380.0
12909,DB06274,Alvimopan,SmallMoleculeDrug,P41143,Delta-type opioid receptor,OPRD1,372.0
12910,DB06282,Levocetirizine,SmallMoleculeDrug,P35367,Histamine H1 receptor,HRH1,487.0
12911,DB06285,Teriparatide,BiotechDrug,Q03431,Parathyroid hormone/parathyroid hormone-related peptide receptor,PTH1R,593.0
12912,DB06287,Temsirolimus,SmallMoleculeDrug,P42345,Serine/threonine-protein kinase mTOR,MTOR,2549.0
12913,DB06288,Amisulpride,SmallMoleculeDrug,P14416,D(2) dopamine receptor,DRD2,443.0
12914,DB06288,Amisulpride,SmallMoleculeDrug,P35462,D(3) dopamine receptor,DRD3,400.0
12915,DB06288,Amisulpride,SmallMoleculeDrug,P34969,5-hydroxytryptamine receptor 7,HTR7,479.0
12916,DB06288,Amisulpride,SmallMoleculeDrug,P28223,5-hydroxytryptamine receptor 2A,HTR2A,471.0
12918,DB06292,Dapagliflozin,SmallMoleculeDrug,P31639,Sodium/glucose cotransporter 2,SLC5A2,672.0
12919,DB06317,Elotuzumab,BiotechDrug,Q9NQ25,SLAM family member 7,SLAMF7,335.0
12920,DB06335,Saxagliptin,SmallMoleculeDrug,P27487,Dipeptidyl peptidase 4,DPP4,766.0
12921,DB06366,Pertuzumab,BiotechDrug,P04626,Receptor tyrosine-protein kinase erbB-2,ERBB2,1255.0
12922,DB06372,Rilonacept,BiotechDrug,P01584,Interleukin-1 beta,IL1B,269.0
12923,DB06372,Rilonacept,BiotechDrug,P01583,Interleukin-1 alpha,IL1A,271.0
12924,DB06372,Rilonacept,BiotechDrug,P18510,Interleukin-1 receptor antagonist protein,IL1RN,177.0
12925,DB06401,Bazedoxifene,SmallMoleculeDrug,P03372,Estrogen receptor,ESR1,595.0
12926,DB06403,Ambrisentan,SmallMoleculeDrug,P25101,Endothelin-1 receptor,EDNRA,427.0
12927,DB06403,Ambrisentan,SmallMoleculeDrug,P24530,Endothelin B receptor,EDNRB,442.0
12928,DB06404,C1 Esterase Inhibitor (Human),BiotechDrug,P00736,Complement C1r subcomponent,C1R,705.0
12929,DB06404,C1 Esterase Inhibitor (Human),BiotechDrug,P09871,Complement C1s subcomponent,C1S,688.0
12930,DB06404,C1 Esterase Inhibitor (Human),BiotechDrug,P03952,Plasma kallikrein,KLKB1,638.0
12931,DB06404,C1 Esterase Inhibitor (Human),BiotechDrug,P00748,Coagulation factor XII,F12,615.0
12932,DB06404,C1 Esterase Inhibitor (Human),BiotechDrug,P00734,Prothrombin,F2,622.0
12933,DB06404,C1 Esterase Inhibitor (Human),BiotechDrug,P03951,Coagulation factor XI,F11,625.0
12934,DB06404,C1 Esterase Inhibitor (Human),BiotechDrug,P00750,Tissue-type plasminogen activator,PLAT,562.0
12935,DB06410,Doxercalciferol,SmallMoleculeDrug,P11473,Vitamin D3 receptor,VDR,427.0
12936,DB06412,Oxymetholone,SmallMoleculeDrug,P10275,Androgen receptor,AR,920.0
12937,DB06412,Oxymetholone,SmallMoleculeDrug,P16860,Natriuretic peptides B,NPPB,134.0
12938,DB06413,Armodafinil,SmallMoleculeDrug,Q01959,Sodium-dependent dopamine transporter,SLC6A3,620.0
12939,DB06439,Tyloxapol,SmallMoleculeDrug,P06858,Lipoprotein lipase,LPL,475.0
12940,DB06441,Cangrelor,SmallMoleculeDrug,Q9H244,P2Y purinoceptor 12,P2RY12,342.0
12941,DB06471,Naxifylline,SmallMoleculeDrug,P30542,Adenosine receptor A1,ADORA1,326.0
12942,DB06480,Prucalopride,SmallMoleculeDrug,Q13639,5-hydroxytryptamine receptor 4,HTR4,388.0
12943,DB06512,Deramciclane,SmallMoleculeDrug,P28223,5-hydroxytryptamine receptor 2A,HTR2A,471.0
12944,DB06512,Deramciclane,SmallMoleculeDrug,P28335,5-hydroxytryptamine receptor 2C,HTR2C,458.0
12945,DB06579,Adipiplon,SmallMoleculeDrug,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,456.0
12946,DB06579,Adipiplon,SmallMoleculeDrug,P47869,Gamma-aminobutyric acid receptor subunit alpha-2,GABRA2,451.0
12947,DB06579,Adipiplon,SmallMoleculeDrug,P34903,Gamma-aminobutyric acid receptor subunit alpha-3,GABRA3,492.0
12948,DB06579,Adipiplon,SmallMoleculeDrug,P48169,Gamma-aminobutyric acid receptor subunit alpha-4,GABRA4,554.0
12949,DB06579,Adipiplon,SmallMoleculeDrug,P31644,Gamma-aminobutyric acid receptor subunit alpha-5,GABRA5,462.0
12950,DB06579,Adipiplon,SmallMoleculeDrug,Q16445,Gamma-aminobutyric acid receptor subunit alpha-6,GABRA6,453.0
12951,DB06579,Adipiplon,SmallMoleculeDrug,Q8N1C3,Gamma-aminobutyric acid receptor subunit gamma-1,GABRG1,465.0
12952,DB06579,Adipiplon,SmallMoleculeDrug,P18507,Gamma-aminobutyric acid receptor subunit gamma-2,GABRG2,467.0
12953,DB06579,Adipiplon,SmallMoleculeDrug,Q99928,Gamma-aminobutyric acid receptor subunit gamma-3,GABRG3,467.0
12955,DB06589,Pazopanib,SmallMoleculeDrug,P17948,Vascular endothelial growth factor receptor 1,FLT1,1338.0
12956,DB06589,Pazopanib,SmallMoleculeDrug,P35968,Vascular endothelial growth factor receptor 2,KDR,1356.0
12957,DB06589,Pazopanib,SmallMoleculeDrug,P35916,Vascular endothelial growth factor receptor 3,FLT4,1363.0
12958,DB06589,Pazopanib,SmallMoleculeDrug,P16234,Platelet-derived growth factor receptor alpha,PDGFRA,1089.0
12959,DB06589,Pazopanib,SmallMoleculeDrug,P09619,Platelet-derived growth factor receptor beta,PDGFRB,1106.0
12960,DB06589,Pazopanib,SmallMoleculeDrug,P10721,Mast/stem cell growth factor receptor Kit,KIT,976.0
12961,DB06589,Pazopanib,SmallMoleculeDrug,P22607,Fibroblast growth factor receptor 3,FGFR3,806.0
12962,DB06589,Pazopanib,SmallMoleculeDrug,Q08881,Tyrosine-protein kinase ITK/TSK,ITK,620.0
12963,DB06589,Pazopanib,SmallMoleculeDrug,P05230,Fibroblast growth factor 1,FGF1,155.0
12964,DB06589,Pazopanib,SmallMoleculeDrug,Q9UQQ2,SH2B adapter protein 3,SH2B3,575.0
12965,DB06594,Agomelatine,SmallMoleculeDrug,P28335,5-hydroxytryptamine receptor 2C,HTR2C,458.0
12966,DB06594,Agomelatine,SmallMoleculeDrug,P48039,Melatonin receptor type 1A,MTNR1A,350.0
12967,DB06594,Agomelatine,SmallMoleculeDrug,P49286,Melatonin receptor type 1B,MTNR1B,362.0
12968,DB06603,Panobinostat,SmallMoleculeDrug,Q13547,Histone deacetylase 1,HDAC1,482.0
12969,DB06603,Panobinostat,SmallMoleculeDrug,Q969S8,Histone deacetylase 10,HDAC10,669.0
12970,DB06603,Panobinostat,SmallMoleculeDrug,Q96DB2,Histone deacetylase 11,HDAC11,347.0
12971,DB06603,Panobinostat,SmallMoleculeDrug,Q92769,Histone deacetylase 2,HDAC2,488.0
12972,DB06603,Panobinostat,SmallMoleculeDrug,O15379,Histone deacetylase 3,HDAC3,428.0
12973,DB06603,Panobinostat,SmallMoleculeDrug,P56524,Histone deacetylase 4,HDAC4,1084.0
12974,DB06603,Panobinostat,SmallMoleculeDrug,Q9UQL6,Histone deacetylase 5,HDAC5,1122.0
12975,DB06603,Panobinostat,SmallMoleculeDrug,Q9UBN7,Histone deacetylase 6,HDAC6,1215.0
12976,DB06603,Panobinostat,SmallMoleculeDrug,Q8WUI4,Histone deacetylase 7,HDAC7,952.0
12977,DB06603,Panobinostat,SmallMoleculeDrug,Q9BY41,Histone deacetylase 8,HDAC8,377.0
12978,DB06603,Panobinostat,SmallMoleculeDrug,Q9UKV0,Histone deacetylase 9,HDAC9,1011.0
12979,DB06605,Apixaban,SmallMoleculeDrug,P00742,Coagulation factor X,F10,488.0
12980,DB06612,Mepolizumab,BiotechDrug,P05113,Interleukin-5,IL5,134.0
12983,DB06616,Bosutinib,SmallMoleculeDrug,P11274,Breakpoint cluster region protein,BCR,1271.0
12984,DB06616,Bosutinib,SmallMoleculeDrug,P00519,Tyrosine-protein kinase ABL1,ABL1,1130.0
12985,DB06616,Bosutinib,SmallMoleculeDrug,P07948,Tyrosine-protein kinase Lyn,LYN,512.0
12986,DB06616,Bosutinib,SmallMoleculeDrug,P08631,Tyrosine-protein kinase HCK,HCK,526.0
12987,DB06616,Bosutinib,SmallMoleculeDrug,P12931,Proto-oncogene tyrosine-protein kinase Src,SRC,536.0
12988,DB06616,Bosutinib,SmallMoleculeDrug,P24941,Cyclin-dependent kinase 2,CDK2,298.0
12989,DB06616,Bosutinib,SmallMoleculeDrug,Q02750,Dual specificity mitogen-activated protein kinase kinase 1,MAP2K1,393.0
12990,DB06616,Bosutinib,SmallMoleculeDrug,P36507,Dual specificity mitogen-activated protein kinase kinase 2,MAP2K2,400.0
12991,DB06616,Bosutinib,SmallMoleculeDrug,Q9Y2U5,Mitogen-activated protein kinase kinase kinase 2,MAP3K2,619.0
12992,DB06616,Bosutinib,SmallMoleculeDrug,Q13555,Calcium/calmodulin-dependent protein kinase type II subunit gamma,CAMK2G,558.0
12993,DB06623,Flupirtine,SmallMoleculeDrug,P08913,Alpha-2A adrenergic receptor,ADRA2A,450.0
12994,DB06626,Axitinib,SmallMoleculeDrug,P17948,Vascular endothelial growth factor receptor 1,FLT1,1338.0
12995,DB06626,Axitinib,SmallMoleculeDrug,P35968,Vascular endothelial growth factor receptor 2,KDR,1356.0
12996,DB06626,Axitinib,SmallMoleculeDrug,P35916,Vascular endothelial growth factor receptor 3,FLT4,1363.0
12997,DB06637,Dalfampridine,SmallMoleculeDrug,Q09470,Potassium voltage-gated channel subfamily A member 1,KCNA1,495.0
12998,DB06637,Dalfampridine,SmallMoleculeDrug,P16389,Potassium voltage-gated channel subfamily A member 2,KCNA2,499.0
12999,DB06637,Dalfampridine,SmallMoleculeDrug,P22001,Potassium voltage-gated channel subfamily A member 3,KCNA3,575.0
13000,DB06637,Dalfampridine,SmallMoleculeDrug,P22459,Potassium voltage-gated channel subfamily A member 4,KCNA4,653.0
13001,DB06637,Dalfampridine,SmallMoleculeDrug,P22460,Potassium voltage-gated channel subfamily A member 5,KCNA5,613.0
13002,DB06637,Dalfampridine,SmallMoleculeDrug,P17658,Potassium voltage-gated channel subfamily A member 6,KCNA6,529.0
13003,DB06637,Dalfampridine,SmallMoleculeDrug,Q96RP8,Potassium voltage-gated channel subfamily A member 7,KCNA7,456.0
13004,DB06637,Dalfampridine,SmallMoleculeDrug,Q16322,Potassium voltage-gated channel subfamily A member 10,KCNA10,511.0
13005,DB06637,Dalfampridine,SmallMoleculeDrug,Q14721,Potassium voltage-gated channel subfamily B member 1,KCNB1,858.0
13006,DB06637,Dalfampridine,SmallMoleculeDrug,Q92953,Potassium voltage-gated channel subfamily B member 2,KCNB2,911.0
13007,DB06637,Dalfampridine,SmallMoleculeDrug,P48547,Potassium voltage-gated channel subfamily C member 1,KCNC1,511.0
13008,DB06637,Dalfampridine,SmallMoleculeDrug,Q96PR1,Potassium voltage-gated channel subfamily C member 2,KCNC2,638.0
13009,DB06637,Dalfampridine,SmallMoleculeDrug,Q14003,Potassium voltage-gated channel subfamily C member 3,KCNC3,757.0
13010,DB06637,Dalfampridine,SmallMoleculeDrug,Q9NSA2,Potassium voltage-gated channel subfamily D member 1,KCND1,647.0
13011,DB06637,Dalfampridine,SmallMoleculeDrug,Q9NZV8,Potassium voltage-gated channel subfamily D member 2,KCND2,630.0
13012,DB06637,Dalfampridine,SmallMoleculeDrug,Q9UK17,Potassium voltage-gated channel subfamily D member 3,KCND3,655.0
13013,DB06643,Denosumab,BiotechDrug,O14788,Tumor necrosis factor ligand superfamily member 11,TNFSF11,317.0
13014,DB06650,Ofatumumab,BiotechDrug,P11836,B-lymphocyte antigen CD20,MS4A1,297.0
13015,DB06654,Safinamide,SmallMoleculeDrug,P27338,Amine oxidase [flavin-containing] B,MAOB,520.0
13016,DB06655,Liraglutide,BiotechDrug,P43220,Glucagon-like peptide 1 receptor,GLP1R,463.0
13017,DB06663,Pasireotide,SmallMoleculeDrug,P30872,Somatostatin receptor type 1,SSTR1,391.0
13018,DB06663,Pasireotide,SmallMoleculeDrug,P30874,Somatostatin receptor type 2,SSTR2,369.0
13019,DB06663,Pasireotide,SmallMoleculeDrug,P32745,Somatostatin receptor type 3,SSTR3,418.0
13020,DB06663,Pasireotide,SmallMoleculeDrug,P35346,Somatostatin receptor type 5,SSTR5,364.0
13021,DB06674,Golimumab,BiotechDrug,P01375,Tumor necrosis factor,TNF,233.0
13022,DB06678,Esmirtazapine,SmallMoleculeDrug,P35367,Histamine H1 receptor,HRH1,487.0
13023,DB06678,Esmirtazapine,SmallMoleculeDrug,P28223,5-hydroxytryptamine receptor 2A,HTR2A,471.0
13024,DB06678,Esmirtazapine,SmallMoleculeDrug,P41595,5-hydroxytryptamine receptor 2B,HTR2B,481.0
13025,DB06678,Esmirtazapine,SmallMoleculeDrug,P28335,5-hydroxytryptamine receptor 2C,HTR2C,458.0
13026,DB06678,Esmirtazapine,SmallMoleculeDrug,P08913,Alpha-2A adrenergic receptor,ADRA2A,450.0
13027,DB06678,Esmirtazapine,SmallMoleculeDrug,P18089,Alpha-2B adrenergic receptor,ADRA2B,450.0
13028,DB06678,Esmirtazapine,SmallMoleculeDrug,P18825,Alpha-2C adrenergic receptor,ADRA2C,462.0
13029,DB06681,Belatacept,BiotechDrug,P42081,T-lymphocyte activation antigen CD86,CD86,329.0
13030,DB06681,Belatacept,BiotechDrug,P33681,T-lymphocyte activation antigen CD80,CD80,288.0
13031,DB06684,Vilazodone,SmallMoleculeDrug,P08908,5-hydroxytryptamine receptor 1A,HTR1A,422.0
13032,DB06688,Sipuleucel-T,BiotechDrug,P15309,Prostatic acid phosphatase,ACPP,386.0
13033,DB06689,Ethanolamine Oleate,SmallMoleculeDrug,P00748,Coagulation factor XII,F12,615.0
13034,DB06691,Mepyramine,SmallMoleculeDrug,P35367,Histamine H1 receptor,HRH1,487.0
13035,DB06692,Aprotinin,BiotechDrug,P07477,Trypsin-1,PRSS1,247.0
13036,DB06692,Aprotinin,BiotechDrug,P17538,Chymotrypsinogen B,CTRB1,263.0
13037,DB06692,Aprotinin,BiotechDrug,P00747,Plasminogen,PLG,810.0
13038,DB06692,Aprotinin,BiotechDrug,P06870,Kallikrein-1,KLK1,262.0
13039,DB06693,Mevastatin,SmallMoleculeDrug,P04035,3-hydroxy-3-methylglutaryl-coenzyme A reductase,HMGCR,888.0
13040,DB06694,Xylometazoline,SmallMoleculeDrug,P35348,Alpha-1A adrenergic receptor,ADRA1A,466.0
13041,DB06694,Xylometazoline,SmallMoleculeDrug,P08913,Alpha-2A adrenergic receptor,ADRA2A,450.0
13042,DB06694,Xylometazoline,SmallMoleculeDrug,P18089,Alpha-2B adrenergic receptor,ADRA2B,450.0
13043,DB06694,Xylometazoline,SmallMoleculeDrug,P35368,Alpha-1B adrenergic receptor,ADRA1B,520.0
13044,DB06694,Xylometazoline,SmallMoleculeDrug,P25100,Alpha-1D adrenergic receptor,ADRA1D,572.0
13045,DB06694,Xylometazoline,SmallMoleculeDrug,P18825,Alpha-2C adrenergic receptor,ADRA2C,462.0
13046,DB06695,Dabigatran etexilate,SmallMoleculeDrug,P00734,Prothrombin,F2,622.0
13048,DB06698,Betahistine,SmallMoleculeDrug,P35367,Histamine H1 receptor,HRH1,487.0
13049,DB06698,Betahistine,SmallMoleculeDrug,Q9Y5N1,Histamine H3 receptor,HRH3,445.0
13050,DB06699,Degarelix,SmallMoleculeDrug,P30968,Gonadotropin-releasing hormone receptor,GNRHR,328.0
13051,DB06700,Desvenlafaxine,SmallMoleculeDrug,P31645,Sodium-dependent serotonin transporter,SLC6A4,630.0
13052,DB06700,Desvenlafaxine,SmallMoleculeDrug,P23975,Sodium-dependent noradrenaline transporter,SLC6A2,617.0
13053,DB06701,Dexmethylphenidate,SmallMoleculeDrug,Q01959,Sodium-dependent dopamine transporter,SLC6A3,620.0
13054,DB06701,Dexmethylphenidate,SmallMoleculeDrug,P23975,Sodium-dependent noradrenaline transporter,SLC6A2,617.0
13055,DB06701,Dexmethylphenidate,SmallMoleculeDrug,P31645,Sodium-dependent serotonin transporter,SLC6A4,630.0
13056,DB06702,Fesoterodine,SmallMoleculeDrug,P20309,Muscarinic acetylcholine receptor M3,CHRM3,590.0
13057,DB06702,Fesoterodine,SmallMoleculeDrug,P08173,Muscarinic acetylcholine receptor M4,CHRM4,479.0
13058,DB06702,Fesoterodine,SmallMoleculeDrug,P11229,Muscarinic acetylcholine receptor M1,CHRM1,460.0
13059,DB06702,Fesoterodine,SmallMoleculeDrug,P08172,Muscarinic acetylcholine receptor M2,CHRM2,466.0
13060,DB06702,Fesoterodine,SmallMoleculeDrug,P08912,Muscarinic acetylcholine receptor M5,CHRM5,532.0
13061,DB06706,Isometheptene,SmallMoleculeDrug,P35348,Alpha-1A adrenergic receptor,ADRA1A,466.0
13062,DB06706,Isometheptene,SmallMoleculeDrug,Q05940,Synaptic vesicular amine transporter,SLC18A2,514.0
13063,DB06707,Levonordefrin,SmallMoleculeDrug,P08913,Alpha-2A adrenergic receptor,ADRA2A,450.0
13064,DB06707,Levonordefrin,SmallMoleculeDrug,P18089,Alpha-2B adrenergic receptor,ADRA2B,450.0
13065,DB06707,Levonordefrin,SmallMoleculeDrug,P18825,Alpha-2C adrenergic receptor,ADRA2C,462.0
13066,DB06709,Methacholine,SmallMoleculeDrug,P20309,Muscarinic acetylcholine receptor M3,CHRM3,590.0
13067,DB06710,Methyltestosterone,SmallMoleculeDrug,P10275,Androgen receptor,AR,920.0
13068,DB06711,Naphazoline,SmallMoleculeDrug,P35348,Alpha-1A adrenergic receptor,ADRA1A,466.0
13069,DB06711,Naphazoline,SmallMoleculeDrug,P08913,Alpha-2A adrenergic receptor,ADRA2A,450.0
13070,DB06712,Nilvadipine,SmallMoleculeDrug,Q13936,Voltage-dependent L-type calcium channel subunit alpha-1C,CACNA1C,2221.0
13071,DB06712,Nilvadipine,SmallMoleculeDrug,P54289,Voltage-dependent calcium channel subunit alpha-2/delta-1,CACNA2D1,1103.0
13072,DB06712,Nilvadipine,SmallMoleculeDrug,Q08289,Voltage-dependent L-type calcium channel subunit beta-2,CACNB2,660.0
13073,DB06712,Nilvadipine,SmallMoleculeDrug,Q01668,Voltage-dependent L-type calcium channel subunit alpha-1D,CACNA1D,2161.0
13074,DB06712,Nilvadipine,SmallMoleculeDrug,Q13698,Voltage-dependent L-type calcium channel subunit alpha-1S,CACNA1S,1873.0
13075,DB06712,Nilvadipine,SmallMoleculeDrug,Q8IZS8,Voltage-dependent calcium channel subunit alpha-2/delta-3,CACNA2D3,1091.0
13076,DB06713,Norelgestromin,SmallMoleculeDrug,P06401,Progesterone receptor,PGR,933.0
13077,DB06714,Propylhexedrine,SmallMoleculeDrug,Q05940,Synaptic vesicular amine transporter,SLC18A2,514.0
13078,DB06714,Propylhexedrine,SmallMoleculeDrug,Q96RJ0,Trace amine-associated receptor 1,TAAR1,339.0
13079,DB06716,Fospropofol,SmallMoleculeDrug,P47870,Gamma-aminobutyric acid receptor subunit beta-2,GABRB2,512.0
13080,DB06716,Fospropofol,SmallMoleculeDrug,P28472,Gamma-aminobutyric acid receptor subunit beta-3,GABRB3,473.0
13081,DB06719,Buserelin,BiotechDrug,P22888,Lutropin-choriogonadotropic hormone receptor,LHCGR,699.0
13082,DB06719,Buserelin,BiotechDrug,P30968,Gonadotropin-releasing hormone receptor,GNRHR,328.0
13083,DB06720,Velaglucerase alfa,BiotechDrug,P04062,Glucosylceramidase,GBA,536.0
13084,DB06725,Lornoxicam,SmallMoleculeDrug,P23219,Prostaglandin G/H synthase 1,PTGS1,599.0
13085,DB06725,Lornoxicam,SmallMoleculeDrug,P35354,Prostaglandin G/H synthase 2,PTGS2,604.0
13086,DB06726,Bufuralol,SmallMoleculeDrug,P08588,Beta-1 adrenergic receptor,ADRB1,477.0
13087,DB06726,Bufuralol,SmallMoleculeDrug,P07550,Beta-2 adrenergic receptor,ADRB2,413.0
13088,DB06726,Bufuralol,SmallMoleculeDrug,P13945,Beta-3 adrenergic receptor,ADRB3,408.0
13090,DB06733,Bafilomycin A1,SmallMoleculeDrug,P38606,V-type proton ATPase catalytic subunit A,ATP6V1A,617.0
13091,DB06734,Bafilomycin B1,SmallMoleculeDrug,P38606,V-type proton ATPase catalytic subunit A,ATP6V1A,617.0
13092,DB06738,Ketobemidone,SmallMoleculeDrug,P35372,Mu-type opioid receptor,OPRM1,400.0
13093,DB06738,Ketobemidone,SmallMoleculeDrug,P41145,Kappa-type opioid receptor,OPRK1,380.0
13094,DB06738,Ketobemidone,SmallMoleculeDrug,P41143,Delta-type opioid receptor,OPRD1,372.0
13095,DB06738,Ketobemidone,SmallMoleculeDrug,Q05586,"Glutamate receptor ionotropic, NMDA 1",GRIN1,938.0
13096,DB06738,Ketobemidone,SmallMoleculeDrug,Q12879,"Glutamate receptor ionotropic, NMDA 2A",GRIN2A,1464.0
13097,DB06738,Ketobemidone,SmallMoleculeDrug,Q13224,"Glutamate receptor ionotropic, NMDA 2B",GRIN2B,1484.0
13098,DB06738,Ketobemidone,SmallMoleculeDrug,Q14957,"Glutamate receptor ionotropic, NMDA 2C",GRIN2C,1233.0
13099,DB06738,Ketobemidone,SmallMoleculeDrug,O15399,"Glutamate receptor ionotropic, NMDA 2D",GRIN2D,1336.0
13100,DB06738,Ketobemidone,SmallMoleculeDrug,Q8TCU5,"Glutamate receptor ionotropic, NMDA 3A",GRIN3A,1115.0
13101,DB06738,Ketobemidone,SmallMoleculeDrug,O60391,"Glutamate receptor ionotropic, NMDA 3B",GRIN3B,1043.0
13102,DB06741,Gavestinel,SmallMoleculeDrug,Q05586,"Glutamate receptor ionotropic, NMDA 1",GRIN1,938.0
13103,DB06741,Gavestinel,SmallMoleculeDrug,Q12879,"Glutamate receptor ionotropic, NMDA 2A",GRIN2A,1464.0
13104,DB06741,Gavestinel,SmallMoleculeDrug,Q13224,"Glutamate receptor ionotropic, NMDA 2B",GRIN2B,1484.0
13105,DB06741,Gavestinel,SmallMoleculeDrug,Q14957,"Glutamate receptor ionotropic, NMDA 2C",GRIN2C,1233.0
13106,DB06741,Gavestinel,SmallMoleculeDrug,O15399,"Glutamate receptor ionotropic, NMDA 2D",GRIN2D,1336.0
13107,DB06741,Gavestinel,SmallMoleculeDrug,Q8TCU5,"Glutamate receptor ionotropic, NMDA 3A",GRIN3A,1115.0
13108,DB06741,Gavestinel,SmallMoleculeDrug,O60391,"Glutamate receptor ionotropic, NMDA 3B",GRIN3B,1043.0
13109,DB06751,Drotaverine,SmallMoleculeDrug,P27815,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A",PDE4A,886.0
13110,DB06751,Drotaverine,SmallMoleculeDrug,Q13936,Voltage-dependent L-type calcium channel subunit alpha-1C,CACNA1C,2221.0
13111,DB06764,Tetryzoline,SmallMoleculeDrug,P35348,Alpha-1A adrenergic receptor,ADRA1A,466.0
13112,DB06766,Alcaftadine,SmallMoleculeDrug,P35367,Histamine H1 receptor,HRH1,487.0
13117,DB06772,Cabazitaxel,SmallMoleculeDrug,P68366,Tubulin alpha-4A chain,TUBA4A,448.0
13118,DB06772,Cabazitaxel,SmallMoleculeDrug,Q9H4B7,Tubulin beta-1 chain,TUBB1,451.0
13119,DB06774,Capsaicin,SmallMoleculeDrug,Q8NER1,Transient receptor potential cation channel subfamily V member 1,TRPV1,839.0
13120,DB06775,Carglumic Acid,SmallMoleculeDrug,P31327,"Carbamoyl-phosphate synthase [ammonia], mitochondrial",CPS1,1500.0
13121,DB06777,Chenodeoxycholic acid,SmallMoleculeDrug,Q96RI1,Bile acid receptor,NR1H4,486.0
13122,DB06779,Dalteparin,SmallMoleculeDrug,P01008,Antithrombin-III,SERPINC1,464.0
13123,DB06779,Dalteparin,SmallMoleculeDrug,P15692,Vascular endothelial growth factor A,VEGFA,232.0
13124,DB06779,Dalteparin,SmallMoleculeDrug,P10646,Tissue factor pathway inhibitor,TFPI,304.0
13125,DB06779,Dalteparin,SmallMoleculeDrug,P16109,P-selectin,SELP,830.0
13126,DB06781,Difluprednate,SmallMoleculeDrug,P04150,Glucocorticoid receptor,NR3C1,777.0
13127,DB06785,Ganirelix,SmallMoleculeDrug,P30968,Gonadotropin-releasing hormone receptor,GNRHR,328.0
13128,DB06786,Halcinonide,SmallMoleculeDrug,Q99835,Smoothened homolog,SMO,787.0
13129,DB06788,Histrelin,SmallMoleculeDrug,P30968,Gonadotropin-releasing hormone receptor,GNRHR,328.0
13130,DB06789,Hydroxyprogesterone caproate,SmallMoleculeDrug,P06401,Progesterone receptor,PGR,933.0
13131,DB06791,Lanreotide,SmallMoleculeDrug,P30874,Somatostatin receptor type 2,SSTR2,369.0
13132,DB06791,Lanreotide,SmallMoleculeDrug,P35346,Somatostatin receptor type 5,SSTR5,364.0
13133,DB06795,Mafenide,SmallMoleculeDrug,P23280,Carbonic anhydrase 6,CA6,308.0
13134,DB06800,Methylnaltrexone,SmallMoleculeDrug,P35372,Mu-type opioid receptor,OPRM1,400.0
13135,DB06800,Methylnaltrexone,SmallMoleculeDrug,P41145,Kappa-type opioid receptor,OPRK1,380.0
13136,DB06802,Nepafenac,SmallMoleculeDrug,P23219,Prostaglandin G/H synthase 1,PTGS1,599.0
13137,DB06802,Nepafenac,SmallMoleculeDrug,P35354,Prostaglandin G/H synthase 2,PTGS2,604.0
13138,DB06809,Plerixafor,SmallMoleculeDrug,P61073,C-X-C chemokine receptor type 4,CXCR4,352.0
13139,DB06813,Pralatrexate,SmallMoleculeDrug,P00374,Dihydrofolate reductase,DHFR,187.0
13140,DB06813,Pralatrexate,SmallMoleculeDrug,P04818,Thymidylate synthase,TYMS,313.0
13142,DB06822,Tinzaparin,SmallMoleculeDrug,P01008,Antithrombin-III,SERPINC1,464.0
13143,DB06822,Tinzaparin,SmallMoleculeDrug,P13612,Integrin alpha-4,ITGA4,1032.0
13144,DB06822,Tinzaparin,SmallMoleculeDrug,P48061,Stromal cell-derived factor 1,CXCL12,93.0
13145,DB06825,Triptorelin,SmallMoleculeDrug,P30968,Gonadotropin-releasing hormone receptor,GNRHR,328.0
13146,DB06828,5-[2-(1H-pyrrol-1-yl)ethoxy]-1H-indole,SmallMoleculeDrug,P09960,Leukotriene A-4 hydrolase,LTA4H,611.0
13147,DB06829,4-BROMO-3-(CARBOXYMETHOXY)-5-[3-(CYCLOHEXYLAMINO)PHENYL]THIOPHENE-2-CARBOXYLIC ACID,SmallMoleculeDrug,P18031,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,435.0
13148,DB06830,"(1-HYDROXYHEPTANE-1,1-DIYL)BIS(PHOSPHONIC ACID)",SmallMoleculeDrug,O95749,Geranylgeranyl pyrophosphate synthase,GGPS1,300.0
13149,DB06831,2-((9H-PURIN-6-YLTHIO)METHYL)-5-CHLORO-3-(2-METHOXYPHENYL)QUINAZOLIN-4(3H)-ONE,SmallMoleculeDrug,P48736,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",PIK3CG,1102.0
13150,DB06831,2-((9H-PURIN-6-YLTHIO)METHYL)-5-CHLORO-3-(2-METHOXYPHENYL)QUINAZOLIN-4(3H)-ONE,SmallMoleculeDrug,O00329,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform",PIK3CD,1044.0
13151,DB06832,"2-(3-FLUORO-4-HYDROXYPHENYL)-7-VINYL-1,3-BENZOXAZOL-5-OL",SmallMoleculeDrug,Q92731,Estrogen receptor beta,ESR2,530.0
13152,DB06832,"2-(3-FLUORO-4-HYDROXYPHENYL)-7-VINYL-1,3-BENZOXAZOL-5-OL",SmallMoleculeDrug,Q15788,Nuclear receptor coactivator 1,NCOA1,1441.0
13153,DB06833,1-CYCLOHEXYL-N-{[1-(4-METHYLPHENYL)-1H-INDOL-3-YL]METHYL}METHANAMINE,SmallMoleculeDrug,P11474,Steroid hormone receptor ERR1,ESRRA,423.0
13154,DB06834,"N-(2-hydroxy-1,1-dimethylethyl)-1-methyl-3-(1H-pyrrolo[2,3-b]pyridin-2-yl)-1H-indole-5-carboxamide",SmallMoleculeDrug,P43405,Tyrosine-protein kinase SYK,SYK,635.0
13155,DB06835,(2S)-2-[3-(AMINOMETHYL)PHENYL]-3-{(S)-HYDROXY[(1R)-2-METHYL-1-{[(2-PHENYLETHYL)SULFONYL]AMINO}PROPYL]PHOSPHORYL}PROPANOIC ACID,SmallMoleculeDrug,P15086,Carboxypeptidase B,CPB1,417.0
13156,DB06836,N-(5-(4-CHLORO-3-(2-HYDROXY-ETHYLSULFAMOYL)- PHENYLTHIAZOLE-2-YL)-ACETAMIDE,SmallMoleculeDrug,P48736,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",PIK3CG,1102.0
13157,DB06836,N-(5-(4-CHLORO-3-(2-HYDROXY-ETHYLSULFAMOYL)- PHENYLTHIAZOLE-2-YL)-ACETAMIDE,SmallMoleculeDrug,Q8NEB9,Phosphatidylinositol 3-kinase catalytic subunit type 3,PIK3C3,887.0
13158,DB06837,"(2R)-N~4~-hydroxy-2-(3-hydroxybenzyl)-N~1~-[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]butanediamide",SmallMoleculeDrug,Q9UNA0,A disintegrin and metalloproteinase with thrombospondin motifs 5,ADAMTS5,930.0
13160,DB06838,methyl L-phenylalaninate,SmallMoleculeDrug,P00734,Prothrombin,F2,622.0
13161,DB06840,"diethyl [(1R)-1,5-diaminopentyl]boronate",SmallMoleculeDrug,P07477,Trypsin-1,PRSS1,247.0
13162,DB06841,D-phenylalanyl-N-[(1S)-4-{[amino(iminio)methyl]amino}-1-(chloroacetyl)butyl]-L-prolinamide,SmallMoleculeDrug,P00734,Prothrombin,F2,622.0
13163,DB06842,(4R)-4-(3-butoxy-4-methoxybenzyl)imidazolidin-2-one,SmallMoleculeDrug,P27815,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A",PDE4A,886.0
13164,DB06842,(4R)-4-(3-butoxy-4-methoxybenzyl)imidazolidin-2-one,SmallMoleculeDrug,Q08499,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",PDE4D,809.0
13165,DB06843,"2',5'-DIDEOXY-ADENOSINE 3'-MONOPHOSPHATE",SmallMoleculeDrug,P63092,Guanine nucleotide-binding protein G(s) subunit alpha isoforms short,GNAS,394.0
13166,DB06843,"2',5'-DIDEOXY-ADENOSINE 3'-MONOPHOSPHATE",SmallMoleculeDrug,Q08462,Adenylate cyclase type 2,ADCY2,1091.0
13167,DB06843,"2',5'-DIDEOXY-ADENOSINE 3'-MONOPHOSPHATE",SmallMoleculeDrug,O95622,Adenylate cyclase type 5,ADCY5,1261.0
13168,DB06844,"4-[(7-OXO-7H-THIAZOLO[5,4-E]INDOL-8-YLMETHYL)-AMINO]-N-PYRIDIN-2-YL-BENZENESULFONAMIDE",SmallMoleculeDrug,P20248,Cyclin-A2,CCNA2,432.0
13169,DB06844,"4-[(7-OXO-7H-THIAZOLO[5,4-E]INDOL-8-YLMETHYL)-AMINO]-N-PYRIDIN-2-YL-BENZENESULFONAMIDE",SmallMoleculeDrug,P24941,Cyclin-dependent kinase 2,CDK2,298.0
13170,DB06845,(S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclopentylamino)ethanoyl)pyrrolidine-2-carboxamide,SmallMoleculeDrug,P07477,Trypsin-1,PRSS1,247.0
13171,DB06845,(S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclopentylamino)ethanoyl)pyrrolidine-2-carboxamide,SmallMoleculeDrug,P00734,Prothrombin,F2,622.0
13172,DB06846,"7-[3-(4-FLUORO-PHENYL)-1-ISOPROPYL-1H-INDOL-2-YL]-3,5-DIHYDROXY-HEPTANOIC ACID",SmallMoleculeDrug,P04035,3-hydroxy-3-methylglutaryl-coenzyme A reductase,HMGCR,888.0
13174,DB06848,"1-(1'-{[3-(methylsulfanyl)-2-benzothiophen-1-yl]carbonyl}spiro[1-benzofuran-3,4'-piperidin]-5-yl)methanamine",SmallMoleculeDrug,Q15661,Tryptase alpha/beta-1,TPSAB1,275.0
13175,DB06849,"1-[1'-(3-phenylacryloyl)spiro[1-benzofuran-3,4'-piperidin]-5-yl]methanamine",SmallMoleculeDrug,Q15661,Tryptase alpha/beta-1,TPSAB1,275.0
13176,DB06850,(S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclohexylamino)ethanoyl)pyrrolidine-2-carboxamide,SmallMoleculeDrug,P07477,Trypsin-1,PRSS1,247.0
13177,DB06850,(S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclohexylamino)ethanoyl)pyrrolidine-2-carboxamide,SmallMoleculeDrug,P00734,Prothrombin,F2,622.0
13179,DB06851,N-(pyridin-3-ylmethyl)aniline,SmallMoleculeDrug,P09960,Leukotriene A-4 hydrolase,LTA4H,611.0
13180,DB06852,4-[(3S)-1-AZABICYCLO[2.2.2]OCT-3-YLAMINO]-3-(1H-BENZIMIDAZOL-2-YL)-6-CHLOROQUINOLIN-2(1H)-ONE,SmallMoleculeDrug,O14757,Serine/threonine-protein kinase Chk1,CHEK1,476.0
13181,DB06853,N-cycloheptylglycyl-N-(4-carbamimidoylbenzyl)-L-prolinamide,SmallMoleculeDrug,P07477,Trypsin-1,PRSS1,247.0
13182,DB06853,N-cycloheptylglycyl-N-(4-carbamimidoylbenzyl)-L-prolinamide,SmallMoleculeDrug,P00734,Prothrombin,F2,622.0
13183,DB06854,2-(2-HYDROXY-BIPHENYL)-1H-BENZOIMIDAZOLE-5-CARBOXAMIDINE,SmallMoleculeDrug,P00734,Prothrombin,F2,622.0
13184,DB06854,2-(2-HYDROXY-BIPHENYL)-1H-BENZOIMIDAZOLE-5-CARBOXAMIDINE,SmallMoleculeDrug,P00749,Urokinase-type plasminogen activator,PLAU,431.0
13185,DB06855,6-FLUORO-2-(2-HYDROXY-3-ISOBUTOXY-PHENYL)-1H-BENZOIMIDAZOLE-5-CARBOXAMIDINE,SmallMoleculeDrug,P00749,Urokinase-type plasminogen activator,PLAU,431.0
13186,DB06856,6-FLUORO-2-[2-HYDROXY-3-(2-METHYL-CYCLOHEXYLOXY)-PHENYL]-1H-INDOLE-5-CARBOXAMIDINE,SmallMoleculeDrug,P00749,Urokinase-type plasminogen activator,PLAU,431.0
13187,DB06857,N-(4-CARBAMIMIDOYL-3-CHORO-PHENYL)-2-HYDROXY-3-IODO-5-METHYL-BENZAMIDE,SmallMoleculeDrug,P00749,Urokinase-type plasminogen activator,PLAU,431.0
13188,DB06858,N-cyclooctylglycyl-N-(4-carbamimidoylbenzyl)-L-prolinamide,SmallMoleculeDrug,P00734,Prothrombin,F2,622.0
13189,DB06858,N-cyclooctylglycyl-N-(4-carbamimidoylbenzyl)-L-prolinamide,SmallMoleculeDrug,P07477,Trypsin-1,PRSS1,247.0
13190,DB06859,N-ALLYL-5-AMIDINOAMINOOXY-PROPYLOXY-3-CHLORO-N-CYCLOPENTYLBENZAMIDE,SmallMoleculeDrug,P00734,Prothrombin,F2,622.0
13192,DB06861,6-(2-HYDROXY-CYCLOPENTYL)-7-OXO-HEPTANAMIDINE,SmallMoleculeDrug,P00734,Prothrombin,F2,622.0
13193,DB06862,2-HYDROXY-5-(2-MERCAPTO-ETHYLSULFAMOYL)-BENZOIC ACID,SmallMoleculeDrug,P42574,Caspase-3,CASP3,277.0
13195,DB06865,6-CARBAMIMIDOYL-2-[2-HYDROXY-6-(4-HYDROXY-PHENYL)-INDAN-1-YL]-HEXANOIC ACID,SmallMoleculeDrug,P00734,Prothrombin,F2,622.0
13196,DB06866,6-CARBAMIMIDOYL-2-[2-HYDROXY-5-(3-METHOXY-PHENYL)-INDAN-1-YL]-HEXANOIC ACID,SmallMoleculeDrug,P00734,Prothrombin,F2,622.0
13197,DB06867,"3,6,9,12,15,18-HEXAOXAICOSANE",SmallMoleculeDrug,Q13526,Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1,PIN1,163.0
13198,DB06868,N-(3-chlorobenzyl)-1-(4-methylpentanoyl)-L-prolinamide,SmallMoleculeDrug,P00734,Prothrombin,F2,622.0
13199,DB06869,1-[2-AMINO-2-CYCLOHEXYL-ACETYL]-PYRROLIDINE-3-CARBOXYLIC ACID 5-CHLORO-2-(2-ETHYLCARBAMOYL-ETHOXY)-BENZYLAMIDE,SmallMoleculeDrug,P00734,Prothrombin,F2,622.0
13200,DB06870,"17-HYDROXY-18A-HOMO-19-NOR-17ALPHA-PREGNA-4,9,11-TRIEN-3-ONE",SmallMoleculeDrug,P10275,Androgen receptor,AR,920.0
13201,DB06871,17-METHYL-17-ALPHA-DIHYDROEQUILENIN,SmallMoleculeDrug,P03372,Estrogen receptor,ESR1,595.0
13202,DB06871,17-METHYL-17-ALPHA-DIHYDROEQUILENIN,SmallMoleculeDrug,Q15596,Nuclear receptor coactivator 2,NCOA2,1464.0
13206,DB06875,3-(3-FLUORO-4-HYDROXYPHENYL)-7-HYDROXY-1-NAPHTHONITRILE,SmallMoleculeDrug,Q92731,Estrogen receptor beta,ESR2,530.0
13207,DB06875,3-(3-FLUORO-4-HYDROXYPHENYL)-7-HYDROXY-1-NAPHTHONITRILE,SmallMoleculeDrug,Q15788,Nuclear receptor coactivator 1,NCOA1,1441.0
13208,DB06876,"N-{5-[4-(4-METHYLPIPERAZIN-1-YL)PHENYL]-1H-PYRROLO[2,3-B]PYRIDIN-3-YL}NICOTINAMIDE",SmallMoleculeDrug,O14757,Serine/threonine-protein kinase Chk1,CHEK1,476.0
13209,DB06877,"N,N-DIMETHYL-4-(4-PHENYL-1H-PYRAZOL-3-YL)-1H-PYRROLE-2-CARBOXAMIDE",SmallMoleculeDrug,P28482,Mitogen-activated protein kinase 1,MAPK1,360.0
13210,DB06878,1-[(2R)-2-aminobutanoyl]-N-(3-chlorobenzyl)-L-prolinamide,SmallMoleculeDrug,P00734,Prothrombin,F2,622.0
13211,DB06879,"5-(4'-AMINO-1'-ETHYL-5',8'-DIFLUORO-1'H-SPIRO[PIPERIDINE-4,2'-QUINAZOLINE]-1-YLCARBONYL)PICOLINONITRILE",SmallMoleculeDrug,P35228,"Nitric oxide synthase, inducible",NOS2,1153.0
13212,DB06880,"(1S)-2-[(2S,5R)-2-(AMINOMETHYL)-5-PROP-1-YN-1-YLPYRROLIDIN-1-YL]-1-CYCLOPENTYL-2-OXOETHANAMINE",SmallMoleculeDrug,P27487,Dipeptidyl peptidase 4,DPP4,766.0
13214,DB06882,1-[1-(3-aminophenyl)-3-tert-butyl-1H-pyrazol-5-yl]-3-naphthalen-1-ylurea,SmallMoleculeDrug,P12931,Proto-oncogene tyrosine-protein kinase Src,SRC,536.0
13215,DB06882,1-[1-(3-aminophenyl)-3-tert-butyl-1H-pyrazol-5-yl]-3-naphthalen-1-ylurea,SmallMoleculeDrug,Q16539,Mitogen-activated protein kinase 14,MAPK14,360.0
13216,DB06883,1-[1-(3-aminophenyl)-3-tert-butyl-1H-pyrazol-5-yl]-3-phenylurea,SmallMoleculeDrug,P12931,Proto-oncogene tyrosine-protein kinase Src,SRC,536.0
13217,DB06884,4-HYDROXY-N'-(4-ISOPROPYLBENZYL)BENZOHYDRAZIDE,SmallMoleculeDrug,P62508,Estrogen-related receptor gamma,ESRRG,458.0
13218,DB06884,4-HYDROXY-N'-(4-ISOPROPYLBENZYL)BENZOHYDRAZIDE,SmallMoleculeDrug,P48552,Nuclear receptor-interacting protein 1,NRIP1,1158.0
13220,DB06887,"3(S)-METHYLCARBAMOYL-7-SULFOAMINO-3,4-DIHYDRO-1H-ISOQUINOLINE-2-CARBOXYLIC ACID TERT-BUTYL ESTER",SmallMoleculeDrug,P18031,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,435.0
13221,DB06888,"(13R,15S)-13-METHYL-16-OXA-8,9,12,22,24-PENTAAZAHEXACYCLO[15.6.2.16,9.1,12,15.0,2,7.0,21,25]HEPTACOSA-1(24),2,4,6,17(25),18,20-HEPTAENE-23,26-DIONE",SmallMoleculeDrug,P24941,Cyclin-dependent kinase 2,CDK2,298.0
13224,DB06891,"5-{[(4-AMINO-3-CHLORO-5-FLUOROPHENYL)SULFONYL]AMINO}-1,3,4-THIADIAZOLE-2-SULFONAMIDE",SmallMoleculeDrug,P00918,Carbonic anhydrase 2,CA2,260.0
13225,DB06892,"(5S)-4,5-difluoro-6-[(2-fluoro-4-iodophenyl)imino]-N-(2-hydroxyethoxy)cyclohexa-1,3-diene-1-carboxamide",SmallMoleculeDrug,Q02750,Dual specificity mitogen-activated protein kinase kinase 1,MAP2K1,393.0
13228,DB06894,1-DODECANOL,SmallMoleculeDrug,O00519,Fatty-acid amide hydrolase 1,FAAH,579.0
13229,DB06896,"1-(4-fluorophenyl)-N-[3-fluoro-4-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)phenyl]-2-oxo-1,2-dihydropyridine-3-carboxamide",SmallMoleculeDrug,P08581,Hepatocyte growth factor receptor,MET,1390.0
13230,DB06897,"3-[3-chloro-5-(5-{[(1S)-1-phenylethyl]amino}isoxazolo[5,4-c]pyridin-3-yl)phenyl]propan-1-ol",SmallMoleculeDrug,P53350,Serine/threonine-protein kinase PLK1,PLK1,603.0
13231,DB06898,"4-(2-amino-1-methyl-1H-imidazo[4,5-b]pyridin-6-yl)phenol",SmallMoleculeDrug,P03372,Estrogen receptor,ESR1,595.0
13232,DB06898,"4-(2-amino-1-methyl-1H-imidazo[4,5-b]pyridin-6-yl)phenol",SmallMoleculeDrug,Q15596,Nuclear receptor coactivator 2,NCOA2,1464.0
13233,DB06899,"N-{2-[6-(2,4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)-2,2-DIMETHYL-3-OXO-2,3-DIHYDRO-4H-1,4-BENZOTHIAZIN-4-YL]ETHYL}ACETAMIDE",SmallMoleculeDrug,P00797,Renin,REN,406.0
13234,DB06900,1-[4-(hydroxymethyl)phenyl]guanidine,SmallMoleculeDrug,Q16651,Prostasin,PRSS8,343.0
13235,DB06901,2-(2-HYDROXY-CYCLOPENTYL)-PENT-4-ENAL,SmallMoleculeDrug,P08217,Chymotrypsin-like elastase family member 2A,CELA2A,269.0
13236,DB06902,4-(1-methyl-1-phenylethyl)phenol,SmallMoleculeDrug,P62508,Estrogen-related receptor gamma,ESRRG,458.0
13239,DB06905,"(2S,3S,4E,6E,8S,9S)-3-amino-9-methoxy-2,6,8-trimethyl-10-phenyldeca-4,6-dienoic acid",SmallMoleculeDrug,Q13362,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform,PPP2R5C,524.0
13240,DB06905,"(2S,3S,4E,6E,8S,9S)-3-amino-9-methoxy-2,6,8-trimethyl-10-phenyldeca-4,6-dienoic acid",SmallMoleculeDrug,P67775,Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform,PPP2CA,309.0
13241,DB06905,"(2S,3S,4E,6E,8S,9S)-3-amino-9-methoxy-2,6,8-trimethyl-10-phenyldeca-4,6-dienoic acid",SmallMoleculeDrug,P30153,Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A alpha isoform,PPP2R1A,589.0
13243,DB06908,"(2S)-3-(1-{[2-(2-CHLOROPHENYL)-5-METHYL-1,3-OXAZOL-4-YL]METHYL}-1H-INDOL-5-YL)-2-ETHOXYPROPANOIC ACID",SmallMoleculeDrug,Q15788,Nuclear receptor coactivator 1,NCOA1,1441.0
13244,DB06908,"(2S)-3-(1-{[2-(2-CHLOROPHENYL)-5-METHYL-1,3-OXAZOL-4-YL]METHYL}-1H-INDOL-5-YL)-2-ETHOXYPROPANOIC ACID",SmallMoleculeDrug,P37231,Peroxisome proliferator-activated receptor gamma,PPARG,505.0
13245,DB06909,"1-ethyl-N-(phenylmethyl)-4-(tetrahydro-2H-pyran-4-ylamino)-1H-pyrazolo[3,4-b]pyridine-5-carboxamide",SmallMoleculeDrug,Q07343,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B",PDE4B,736.0
13247,DB06911,D-leucyl-N-(3-chlorobenzyl)-L-prolinamide,SmallMoleculeDrug,P00734,Prothrombin,F2,622.0
13248,DB06912,"UNDECA-3,7-DIENE-1,3,7,11-TETRACARBALDEHYDE",SmallMoleculeDrug,P61626,Lysozyme C,LYZ,148.0
13250,DB06914,"1-({2-[2-(4-CHLOROPHENYL)ETHYL]-1,3-DIOXOLAN-2-YL}METHYL)-1H-IMIDAZOLE",SmallMoleculeDrug,P09601,Heme oxygenase 1,HMOX1,288.0
13251,DB06916,"N-[2-(1,3-BENZODIOXOL-5-YL)ETHYL]-1-[2-(1H-IMIDAZOL-1-YL)-6-METHYLPYRIMIDIN-4-YL]-D-PROLINAMIDE",SmallMoleculeDrug,P35228,"Nitric oxide synthase, inducible",NOS2,1153.0
13252,DB06917,(4-fluorophenyl)(pyridin-4-yl)methanone,SmallMoleculeDrug,P09960,Leukotriene A-4 hydrolase,LTA4H,611.0
13253,DB06918,2-(2-METHYLPHENYL)-1H-INDOLE-6-CARBOXIMIDAMIDE,SmallMoleculeDrug,P07477,Trypsin-1,PRSS1,247.0
13254,DB06919,D-phenylalanyl-N-(3-chlorobenzyl)-L-prolinamide,SmallMoleculeDrug,P00734,Prothrombin,F2,622.0
13255,DB06920,"(2R,4R)-N~1~-(4-CHLOROPHENYL)-N~2~-[2-FLUORO-4-(2-OXOPYRIDIN-1(2H)-YL)PHENYL]-4-METHOXYPYRROLIDINE-1,2-DICARBOXAMIDE",SmallMoleculeDrug,P00742,Coagulation factor X,F10,488.0
13256,DB06921,(2S)-2-[3-(AMINOMETHYL)PHENYL]-3-[(R)-HYDROXY{(1R)-2-METHYL-1-[(PHENYLSULFONYL)AMINO]PROPYL}PHOSPHORYL]PROPANOIC ACID,SmallMoleculeDrug,P15086,Carboxypeptidase B,CPB1,417.0
13258,DB06923,2-(3-METHYLPHENYL)-1H-INDOLE-5-CARBOXIMIDAMIDE,SmallMoleculeDrug,P07477,Trypsin-1,PRSS1,247.0
13259,DB06924,(2R)-2-benzyl-3-nitropropanoic acid,SmallMoleculeDrug,P15085,Carboxypeptidase A1,CPA1,419.0
13260,DB06925,3-(2-AMINOQUINAZOLIN-6-YL)-4-METHYL-N-[3-(TRIFLUOROMETHYL)PHENYL]BENZAMIDE,SmallMoleculeDrug,P06239,Tyrosine-protein kinase Lck,LCK,509.0
13261,DB06926,"(9Z,11E,13S)-13-hydroxyoctadeca-9,11-dienoic acid",SmallMoleculeDrug,P37231,Peroxisome proliferator-activated receptor gamma,PPARG,505.0
13262,DB06927,[5-HYDROXY-2-(4-HYDROXYPHENYL)-1-BENZOFURAN-7-YL]ACETONITRILE,SmallMoleculeDrug,Q92731,Estrogen receptor beta,ESR2,530.0
13263,DB06927,[5-HYDROXY-2-(4-HYDROXYPHENYL)-1-BENZOFURAN-7-YL]ACETONITRILE,SmallMoleculeDrug,Q15788,Nuclear receptor coactivator 1,NCOA1,1441.0
13264,DB06927,[5-HYDROXY-2-(4-HYDROXYPHENYL)-1-BENZOFURAN-7-YL]ACETONITRILE,SmallMoleculeDrug,P03372,Estrogen receptor,ESR1,595.0
13265,DB06928,(2S)-2-{[HYDROXY(4-IODOBENZYL)PHOSPHORYL]METHYL}PENTANEDIOIC ACID,SmallMoleculeDrug,Q04609,Glutamate carboxypeptidase 2,FOLH1,750.0
13266,DB06929,1-butanoyl-N-(4-carbamimidoylbenzyl)-L-prolinamide,SmallMoleculeDrug,P00734,Prothrombin,F2,622.0
13267,DB06930,"N-[amino(imino)methyl]-2-(2,5-diphenyl-1H-pyrrol-1-yl)acetamide",SmallMoleculeDrug,P56817,Beta-secretase 1,BACE1,501.0
13268,DB06931,"(1-HYDROXYNONANE-1,1-DIYL)BIS(PHOSPHONIC ACID)",SmallMoleculeDrug,O95749,Geranylgeranyl pyrophosphate synthase,GGPS1,300.0
13269,DB06932,"10,11-dimethoxy-4-methyldibenzo[c,f]-2,7-naphthyridine-3,6-diamine",SmallMoleculeDrug,O15530,3-phosphoinositide-dependent protein kinase 1,PDPK1,556.0
13270,DB06933,N-(tert-butyl)-4-[5-(pyridin-2-ylamino)quinolin-3-yl]benzenesulfonamide,SmallMoleculeDrug,P53779,Mitogen-activated protein kinase 10,MAPK10,464.0
13272,DB06936,N-(4-carbamimidoylbenzyl)-1-(4-methylpentanoyl)-L-prolinamide,SmallMoleculeDrug,P00734,Prothrombin,F2,622.0
13273,DB06937,"4-(6-HYDROXY-BENZO[D]ISOXAZOL-3-YL)BENZENE-1,3-DIOL",SmallMoleculeDrug,Q92731,Estrogen receptor beta,ESR2,530.0
13274,DB06938,4-[[2-[[4-chloro-3-(trifluoromethyl)phenyl]amino]-3H-benzimidazol-5-yl]oxy]-N-methyl-pyridine-2-carboxamide,SmallMoleculeDrug,P35968,Vascular endothelial growth factor receptor 2,KDR,1356.0
13275,DB06939,"N-(TRANS-4-{(1S,2S)-2-AMINO-3-[(3S)-3-FLUOROPYRROLIDIN-1-YL]-1-METHYL-3-OXOPROPYL}CYCLOHEXYL)-N-METHYLACETAMIDE",SmallMoleculeDrug,P27487,Dipeptidyl peptidase 4,DPP4,766.0
13276,DB06940,"N-ethyl-4-{[5-(methoxycarbamoyl)-2-methylphenyl]amino}-5-methylpyrrolo[2,1-f][1,2,4]triazine-6-carboxamide",SmallMoleculeDrug,Q16539,Mitogen-activated protein kinase 14,MAPK14,360.0
13277,DB06941,(Z)-2-[2-(4-methylpiperazin-1-yl)benzyl]diazenecarbothioamide,SmallMoleculeDrug,P04271,Protein S100-B,S100B,92.0
13278,DB06942,N-(4-carbamimidoylbenzyl)-1-(3-phenylpropanoyl)-L-prolinamide,SmallMoleculeDrug,P00734,Prothrombin,F2,622.0
13279,DB06943,(3S)-1-{[4-(but-2-yn-1-yloxy)phenyl]sulfonyl}pyrrolidine-3-thiol,SmallMoleculeDrug,P78536,Disintegrin and metalloproteinase domain-containing protein 17,ADAM17,824.0
13280,DB06944,N-(3-cyclopropyl-1H-pyrazol-5-yl)-2-(2-naphthyl)acetamide,SmallMoleculeDrug,P20248,Cyclin-A2,CCNA2,432.0
13281,DB06944,N-(3-cyclopropyl-1H-pyrazol-5-yl)-2-(2-naphthyl)acetamide,SmallMoleculeDrug,P24941,Cyclin-dependent kinase 2,CDK2,298.0
13282,DB06945,N-hydroxy-4-({4-[4-(trifluoromethyl)phenoxy]phenyl}sulfonyl)tetrahydro-2H-pyran-4-carboxamide,SmallMoleculeDrug,Q9UNA0,A disintegrin and metalloproteinase with thrombospondin motifs 5,ADAMTS5,930.0
13284,DB06947,1-[(2R)-2-aminobutanoyl]-N-(4-carbamimidoylbenzyl)-L-prolinamide,SmallMoleculeDrug,P00734,Prothrombin,F2,622.0
13285,DB06948,2-ANILINO-6-CYCLOHEXYLMETHOXYPURINE,SmallMoleculeDrug,P20248,Cyclin-A2,CCNA2,432.0
13286,DB06948,2-ANILINO-6-CYCLOHEXYLMETHOXYPURINE,SmallMoleculeDrug,P24941,Cyclin-dependent kinase 2,CDK2,298.0
13289,DB06951,(3R)-3-ethyl-N-[(4-methylphenyl)sulfonyl]-L-aspartic acid,SmallMoleculeDrug,Q9UNI1,Chymotrypsin-like elastase family member 1,CELA1,258.0
13291,DB06953,2-CHLORO-5-(3-CHLORO-PHENYL)-6-[(4-CYANO-PHENYL)-(3-METHYL-3H-IMIDAZOL-4-YL)- METHOXYMETHYL]-NICOTINONITRILE,SmallMoleculeDrug,P49354,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,FNTA,379.0
13292,DB06953,2-CHLORO-5-(3-CHLORO-PHENYL)-6-[(4-CYANO-PHENYL)-(3-METHYL-3H-IMIDAZOL-4-YL)- METHOXYMETHYL]-NICOTINONITRILE,SmallMoleculeDrug,P49356,Protein farnesyltransferase subunit beta,FNTB,437.0
13293,DB06954,"2-(cycloheptylmethyl)-1,1-dioxido-1-benzothiophen-6-yl sulfamate",SmallMoleculeDrug,P00918,Carbonic anhydrase 2,CA2,260.0
13295,DB06956,"N-(4-ACETYLPHENYL)-5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-1H-PYRAZOLE-4-CARBOXAMIDE",SmallMoleculeDrug,P07900,Heat shock protein HSP 90-alpha,HSP90AA1,732.0
13296,DB06957,"4-CHLORO-6-(4-{4-[4-(METHYLSULFONYL)BENZYL]PIPERAZIN-1-YL}-1H-PYRAZOL-5-YL)BENZENE-1,3-DIOL",SmallMoleculeDrug,P07900,Heat shock protein HSP 90-alpha,HSP90AA1,732.0
13297,DB06958,"5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-N-ETHYL-4-PIPERAZIN-1-YL-1H-PYRAZOLE-3-CARBOXAMIDE",SmallMoleculeDrug,P07900,Heat shock protein HSP 90-alpha,HSP90AA1,732.0
13298,DB06959,(1S)-2-(1H-INDOL-3-YL)-1-{[(5-ISOQUINOLIN-6-YLPYRIDIN-3-YL)OXY]METHYL}ETHYLAMINE,SmallMoleculeDrug,P17612,cAMP-dependent protein kinase catalytic subunit alpha,PRKACA,351.0
13299,DB06959,(1S)-2-(1H-INDOL-3-YL)-1-{[(5-ISOQUINOLIN-6-YLPYRIDIN-3-YL)OXY]METHYL}ETHYLAMINE,SmallMoleculeDrug,P61925,cAMP-dependent protein kinase inhibitor alpha,PKIA,76.0
13301,DB06961,"5-(5-chloro-2,4-dihydroxyphenyl)-N-ethyl-4-[4-(morpholin-4-ylmethyl)phenyl]isoxazole-3-carboxamide",SmallMoleculeDrug,P07900,Heat shock protein HSP 90-alpha,HSP90AA1,732.0
13302,DB06962,"(5-(aminomethyl)-2H-spiro[benzofuran-3,4'-piperidine]-1'-yl)(5-(phenylethynyl)furan-2-yl)methanone",SmallMoleculeDrug,P20231,Tryptase beta-2,TPSB2,275.0
13303,DB06963,"3-[3-(3-methyl-6-{[(1S)-1-phenylethyl]amino}-1H-pyrazolo[4,3-c]pyridin-1-yl)phenyl]propanamide",SmallMoleculeDrug,P53350,Serine/threonine-protein kinase PLK1,PLK1,603.0
13304,DB06964,"5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-N-ETHYL-4-(4-METHOXYPHENYL)ISOXAZOLE-3-CARBOXAMIDE",SmallMoleculeDrug,P07900,Heat shock protein HSP 90-alpha,HSP90AA1,732.0
13307,DB06967,"6-ETHYL-5-[9-(3-METHOXYPROPYL)-9H-CARBAZOL-2-YL]PYRIMIDINE-2,4-DIAMINE",SmallMoleculeDrug,P00797,Renin,REN,406.0
13309,DB06969,"2-amino-4-[2,4-dichloro-5-(2-pyrrolidin-1-ylethoxy)phenyl]-N-ethylthieno[2,3-d]pyrimidine-6-carboxamide",SmallMoleculeDrug,P07900,Heat shock protein HSP 90-alpha,HSP90AA1,732.0
13311,DB06971,"N-{2-[(4'-CYANO-1,1'-BIPHENYL-4-YL)OXY]ETHYL}-N'-HYDROXY-N-METHYLUREA",SmallMoleculeDrug,P22894,Neutrophil collagenase,MMP8,467.0
13312,DB06972,"7A-[(4-cyanophenyl)methyl]-6-(3,5-dichlorophenyl)-5-oxo-2,3,5,7A-tetrahydro-1H-pyrrolo[1,2-A]pyrrole-7-carbonitrile",SmallMoleculeDrug,P20701,Integrin alpha-L,ITGAL,1170.0
13313,DB06973,"4,4'-PROPANE-2,2-DIYLDIPHENOL",SmallMoleculeDrug,P62508,Estrogen-related receptor gamma,ESRRG,458.0
13315,DB06976,"1-(5-OXO-2,3,5,9B-TETRAHYDRO-1H-PYRROLO[2,1-A]ISOINDOL-9-YL)-3-(5-PYRROLIDIN-2-YL-1H-PYRAZOL-3-YL)-UREA",SmallMoleculeDrug,P24941,Cyclin-dependent kinase 2,CDK2,298.0
13316,DB06977,(2S)-1-{[5-(1H-INDAZOL-5-YL)PYRIDIN-3-YL]OXY}-3-[(7AS)-7AH-INDOL-3-YL]PROPAN-2-AMINE,SmallMoleculeDrug,P17612,cAMP-dependent protein kinase catalytic subunit alpha,PRKACA,351.0
13318,DB06979,"5-(dodecylthio)-1H-1,2,3-triazole-4-carboxylic acid",SmallMoleculeDrug,Q9UJM8,Hydroxyacid oxidase 1,HAO1,370.0
13319,DB06980,(2S)-2-(1H-indol-3-yl)hexanoic acid,SmallMoleculeDrug,P63208,S-phase kinase-associated protein 1,SKP1,163.0
13320,DB06981,(2S)-2-(1H-indol-3-yl)pentanoic acid,SmallMoleculeDrug,P63208,S-phase kinase-associated protein 1,SKP1,163.0
13321,DB06982,(2S)-8-[(tert-butoxycarbonyl)amino]-2-(1H-indol-3-yl)octanoic acid,SmallMoleculeDrug,P63208,S-phase kinase-associated protein 1,SKP1,163.0
13322,DB06983,"(5-phenyl-7-(pyridin-3-ylmethylamino)pyrazolo[1,5-a]pyrimidin-3-yl)methanol",SmallMoleculeDrug,P24941,Cyclin-dependent kinase 2,CDK2,298.0
13323,DB06984,"(1R,2R,3R,4S,5R)-4-(BENZYLAMINO)-5-(METHYLTHIO)CYCLOPENTANE-1,2,3-TRIOL",SmallMoleculeDrug,Q16706,Alpha-mannosidase 2,MAN2A1,1144.0
13324,DB06986,"2-CHLORO-N-[(1R,2R)-1-HYDROXY-2,3-DIHYDRO-1H-INDEN-2-YL]-6H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE",SmallMoleculeDrug,P11217,"Glycogen phosphorylase, muscle form",PYGM,842.0
13325,DB06987,2-(4-(2-HYDROXY-3-(ISOPROPYLAMINO)PROPOXY)PHENYL)ETHANAMIDE,SmallMoleculeDrug,P02788,Lactotransferrin,LTF,710.0
13326,DB06987,2-(4-(2-HYDROXY-3-(ISOPROPYLAMINO)PROPOXY)PHENYL)ETHANAMIDE,SmallMoleculeDrug,Q9NZK7,Group IIE secretory phospholipase A2,PLA2G2E,142.0
13328,DB06989,{4-[2-BENZYL-3-METHOXY-2-(METHOXYCARBONYL)-3-OXOPROPYL]PHENYL}SULFAMIC ACID,SmallMoleculeDrug,P23467,Receptor-type tyrosine-protein phosphatase beta,PTPRB,1997.0
13329,DB06990,"4-[(1E,7E)-8-(2,6-DIOXO-1,2,3,6-TETRAHYDROPYRIMIDIN-4-YL)-3,6-DIOXA-2,7-DIAZAOCTA-1,7-DIEN-1-YL]BENZOIC ACID",SmallMoleculeDrug,P13051,Uracil-DNA glycosylase,UNG,313.0
13330,DB06991,"N-[2-methyl-5-(methylcarbamoyl)phenyl]-2-{[(1R)-1-methylpropyl]amino}-1,3-thiazole-5-carboxamide",SmallMoleculeDrug,Q16539,Mitogen-activated protein kinase 14,MAPK14,360.0
13331,DB06992,"(3,3-dimethylpiperidin-1-yl)(6-(3-fluoro-4-methylphenyl)pyridin-2-yl)methanone",SmallMoleculeDrug,P28845,Corticosteroid 11-beta-dehydrogenase isozyme 1,HSD11B1,292.0
13332,DB06993,"(2S,3S)-4-cyclopropyl-3-{(3R,5R)-3-[2-fluoro-4-(methylsulfonyl)phenyl]-1,2,4-oxadiazolidin-5-yl}-1-[(3S)-3-fluoropyrrolidin-1-yl]-1-oxobutan-2-amine",SmallMoleculeDrug,P27487,Dipeptidyl peptidase 4,DPP4,766.0
13333,DB06994,"(2S,3S)-3-{3-[2-chloro-4-(methylsulfonyl)phenyl]-1,2,4-oxadiazol-5-yl}-1-cyclopentylidene-4-cyclopropyl-1-fluorobutan-2-amine",SmallMoleculeDrug,P27487,Dipeptidyl peptidase 4,DPP4,766.0
13334,DB06995,N-({4-[(2-aminopyridin-4-yl)oxy]-3-fluorophenyl}carbamoyl)-2-(4-fluorophenyl)acetamide,SmallMoleculeDrug,P08581,Hepatocyte growth factor receptor,MET,1390.0
13335,DB06996,D-leucyl-N-(4-carbamimidoylbenzyl)-L-prolinamide,SmallMoleculeDrug,P00734,Prothrombin,F2,622.0
13336,DB06997,"2-(4-fluorophenyl)-N-{[3-fluoro-4-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)phenyl]carbamoyl}acetamide",SmallMoleculeDrug,P08581,Hepatocyte growth factor receptor,MET,1390.0
13338,DB06999,"N-{3-[(5-chloro-1H-pyrrolo[2,3-b]pyridin-3-yl)carbonyl]-2,4-difluorophenyl}propane-1-sulfonamide",SmallMoleculeDrug,P15056,Serine/threonine-protein kinase B-raf,BRAF,766.0
13339,DB07000,"N-{2,4-difluoro-3-[(5-pyridin-3-yl-1H-pyrrolo[2,3-b]pyridin-3-yl)carbonyl]phenyl}ethanesulfonamide",SmallMoleculeDrug,P15056,Serine/threonine-protein kinase B-raf,BRAF,766.0
13340,DB07001,"(3S,5E)-3-propyl-3,4-dihydrothieno[2,3-f][1,4]oxazepin-5(2H)-imine",SmallMoleculeDrug,P29474,"Nitric oxide synthase, endothelial",NOS3,1203.0
13341,DB07002,4-({4-[(4-methoxypyridin-2-yl)amino]piperidin-1-yl}carbonyl)benzonitrile,SmallMoleculeDrug,P35228,"Nitric oxide synthase, inducible",NOS2,1153.0
13342,DB07003,"(2S)-2-methyl-2,3-dihydrothieno[2,3-f][1,4]oxazepin-5-amine",SmallMoleculeDrug,P35228,"Nitric oxide synthase, inducible",NOS2,1153.0
13343,DB07004,2-[(5-hex-1-yn-1-ylfuran-2-yl)carbonyl]-N-methylhydrazinecarbothioamide,SmallMoleculeDrug,P04271,Protein S100-B,S100B,92.0
13344,DB07005,D-phenylalanyl-N-{4-[amino(iminio)methyl]benzyl}-L-prolinamide,SmallMoleculeDrug,P00734,Prothrombin,F2,622.0
13345,DB07006,"9-HYDROXY-6-(3-HYDROXYPROPYL)-4-(2-METHOXYPHENYL)PYRROLO[3,4-C]CARBAZOLE-1,3(2H,6H)-DIONE",SmallMoleculeDrug,P30291,Wee1-like protein kinase,WEE1,646.0
13346,DB07007,"(3R)-3-[(1,2,3,4-tetrahydroisoquinolin-7-yloxy)methyl]-2,3-dihydrothieno[2,3-f][1,4]oxazepin-5-amine",SmallMoleculeDrug,P35228,"Nitric oxide synthase, inducible",NOS2,1153.0
13347,DB07008,"4-(1,3-BENZODIOXOL-5-YLOXY)-2-[4-(1H-IMIDAZOL-1-YL)PHENOXY]PYRIMIDINE",SmallMoleculeDrug,P35228,"Nitric oxide synthase, inducible",NOS2,1153.0
13348,DB07009,"2-(5-HYDROXY-NAPHTHALEN-1-YL)-1,3-BENZOOXAZOL-6-OL",SmallMoleculeDrug,Q15788,Nuclear receptor coactivator 1,NCOA1,1441.0
13349,DB07009,"2-(5-HYDROXY-NAPHTHALEN-1-YL)-1,3-BENZOOXAZOL-6-OL",SmallMoleculeDrug,Q92731,Estrogen receptor beta,ESR2,530.0
13350,DB07010,N-BENZYL-4-[4-(3-CHLOROPHENYL)-1H-PYRAZOL-3-YL]-1H-PYRROLE-2-CARBOXAMIDE,SmallMoleculeDrug,P28482,Mitogen-activated protein kinase 1,MAPK1,360.0
13351,DB07010,N-BENZYL-4-[4-(3-CHLOROPHENYL)-1H-PYRAZOL-3-YL]-1H-PYRROLE-2-CARBOXAMIDE,SmallMoleculeDrug,P53779,Mitogen-activated protein kinase 10,MAPK10,464.0
13352,DB07011,"(3S)-1-(1,3-BENZODIOXOL-5-YLMETHYL)-3-[4-(1H-IMIDAZOL-1-YL)PHENOXY]PIPERIDINE",SmallMoleculeDrug,P35228,"Nitric oxide synthase, inducible",NOS2,1153.0
13354,DB07013,TERT-BUTYL 4-({[4-(BUT-2-YN-1-YLAMINO)PHENYL]SULFONYL}METHYL)-4-[(HYDROXYAMINO)CARBONYL]PIPERIDINE-1-CARBOXYLATE,SmallMoleculeDrug,P45452,Collagenase 3,MMP13,471.0
13355,DB07014,"2-(1,3-benzodioxol-5-yl)-5-[(3-fluoro-4-methoxybenzyl)sulfanyl]-1,3,4-oxadiazole",SmallMoleculeDrug,P49841,Glycogen synthase kinase-3 beta,GSK3B,420.0
13356,DB07015,"(3R,4R)-4-(pyrrolidin-1-ylcarbonyl)-1-(quinoxalin-2-ylcarbonyl)pyrrolidin-3-amine",SmallMoleculeDrug,P27487,Dipeptidyl peptidase 4,DPP4,766.0
13357,DB07016,"(3R)-8-(dioxidosulfanyl)-3-methyl-1,2,3,4-tetrahydroquinoline",SmallMoleculeDrug,P00734,Prothrombin,F2,622.0
13358,DB07017,"(5S)-2-{[(1S)-1-(4-fluorophenyl)ethyl]amino}-5-(1-hydroxy-1-methylethyl)-5-methyl-1,3-thiazol-4(5H)-one",SmallMoleculeDrug,P28845,Corticosteroid 11-beta-dehydrogenase isozyme 1,HSD11B1,292.0
13360,DB07019,"N-[(5R,14R)-5-AMINO-5,14-DIMETHYL-4-OXO-3-OXA-18-AZATRICYCLO[15.3.1.1~7,11~]DOCOSA-1(21),7(22),8,10,17,19-HEXAEN-19-YL]-N-METHYLMETHANESULFONAMIDE",SmallMoleculeDrug,P56817,Beta-secretase 1,BACE1,501.0
13361,DB07020,"N-{3-[5-(1H-1,2,4-triazol-3-yl)-1H-indazol-3-yl]phenyl}furan-2-carboxamide",SmallMoleculeDrug,P45984,Mitogen-activated protein kinase 9,MAPK9,424.0
13362,DB07021,"(7R,8R)-8-(2,4,5-trifluorophenyl)-6,7,8,9-tetrahydroimidazo[1,2-a:4,5-c']dipyridin-7-amine",SmallMoleculeDrug,P27487,Dipeptidyl peptidase 4,DPP4,766.0
13363,DB07022,3-HYDROXYPROPYL 3-[({7-[AMINO(IMINO)METHYL]-1-NAPHTHYL}AMINO)CARBONYL]BENZENESULFONATE,SmallMoleculeDrug,P03951,Coagulation factor XI,F11,625.0
13364,DB07023,"(1R)-2-{[AMINO(IMINO)METHYL]AMINO}-1-{4-[(4R)-4-(HYDROXYMETHYL)-1,3,2-DIOXABOROLAN-2-YL]PHENYL}ETHYL NICOTINATE",SmallMoleculeDrug,P03951,Coagulation factor XI,F11,625.0
13365,DB07024,"2-(3,4-DIHYDROXYPHENYL)-8-(1,1-DIOXIDOISOTHIAZOLIDIN-2-YL)-3-HYDROXY-6-METHYL-4H-CHROMEN-4-ONE",SmallMoleculeDrug,P24941,Cyclin-dependent kinase 2,CDK2,298.0
13366,DB07025,3-(5-{[4-(AMINOMETHYL)PIPERIDIN-1-YL]METHYL}-1H-INDOL-2-YL)QUINOLIN-2(1H)-ONE,SmallMoleculeDrug,O14757,Serine/threonine-protein kinase Chk1,CHEK1,476.0
13367,DB07026,"(1S,5S,7R)-N~7~-(BIPHENYL-4-YLMETHYL)-N~3~-HYDROXY-6,8-DIOXA-3-AZABICYCLO[3.2.1]OCTANE-3,7-DICARBOXAMIDE",SmallMoleculeDrug,P39900,Macrophage metalloelastase,MMP12,470.0
13368,DB07027,D-phenylalanyl-N-(3-fluorobenzyl)-L-prolinamide,SmallMoleculeDrug,P00734,Prothrombin,F2,622.0
13369,DB07028,(2-{[(4-BROMO-2-FLUOROBENZYL)AMINO]CARBONYL}-5-CHLOROPHENOXY)ACETIC ACID,SmallMoleculeDrug,P15121,Aldose reductase,AKR1B1,316.0
13370,DB07029,"4-(1,3-BENZODIOXOL-5-YLOXY)-2-[4-(1H-IMIDAZOL-1-YL)PHENOXY]-6-METHYLPYRIMIDINE",SmallMoleculeDrug,P35228,"Nitric oxide synthase, inducible",NOS2,1153.0
13371,DB07030,(5-CHLORO-2-{[(3-NITROBENZYL)AMINO]CARBONYL}PHENOXY)ACETIC ACID,SmallMoleculeDrug,P15121,Aldose reductase,AKR1B1,316.0
13372,DB07031,"R-3-FLUORO-4-[2-HYDROXY-2-(5,5,8,8-TETRAMETHYL-5,6,7,8,-TETRAHYDRO-NAPHTALEN-2-YL)-ACETYLAMINO]-BENZOIC ACID",SmallMoleculeDrug,P13631,Retinoic acid receptor gamma,RARG,454.0
13373,DB07032,2-(4-HYDROXY-PHENYL)BENZOFURAN-5-OL,SmallMoleculeDrug,Q92731,Estrogen receptor beta,ESR2,530.0
13374,DB07033,5-HYDROXY-3-[(1R)-1-(1H-PYRROL-2-YL)ETHYL]-2H-INDOL-2-ONE,SmallMoleculeDrug,O15530,3-phosphoinositide-dependent protein kinase 1,PDPK1,556.0
13375,DB07034,"2,2'-{[9-(HYDROXYIMINO)-9H-FLUORENE-2,7-DIYL]BIS(OXY)}DIACETIC ACID",SmallMoleculeDrug,O14757,Serine/threonine-protein kinase Chk1,CHEK1,476.0
13377,DB07036,"(3aS,4R,9bR)-2,2-difluoro-4-(4-hydroxyphenyl)-6-(methoxymethyl)-1,2,3,3a,4,9b-hexahydrocyclopenta[c]chromen-8-ol",SmallMoleculeDrug,Q92731,Estrogen receptor beta,ESR2,530.0
13378,DB07037,(2S)-1-AMINO-3-[(5-NITROQUINOLIN-8-YL)AMINO]PROPAN-2-OL,SmallMoleculeDrug,O14757,Serine/threonine-protein kinase Chk1,CHEK1,476.0
13379,DB07038,2-(cyclohexylamino)benzoic acid,SmallMoleculeDrug,O14757,Serine/threonine-protein kinase Chk1,CHEK1,476.0
13380,DB07039,(2S)-N-(4-cyano-3-iodophenyl)-3-(4-cyanophenoxy)-2-hydroxy-2-methylpropanamide,SmallMoleculeDrug,P10275,Androgen receptor,AR,920.0
13387,DB07045,"(2R,3R,4S,5R)-2-[6-amino-8-[(3,4-dichlorophenyl)methylamino]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol",SmallMoleculeDrug,Q99933,BAG family molecular chaperone regulator 1,BAG1,345.0
13388,DB07045,"(2R,3R,4S,5R)-2-[6-amino-8-[(3,4-dichlorophenyl)methylamino]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol",SmallMoleculeDrug,P11142,Heat shock cognate 71 kDa protein,HSPA8,646.0
13389,DB07046,"2-[(2-chloro-4-iodophenyl)amino]-N-{[(2R)-2,3-dihydroxypropyl]oxy}-3,4-difluorobenzamide",SmallMoleculeDrug,Q02750,Dual specificity mitogen-activated protein kinase kinase 1,MAP2K1,393.0
13390,DB07048,"N-[(2R)-5-(aminosulfonyl)-2,3-dihydro-1H-inden-2-yl]-2-propylpentanamide",SmallMoleculeDrug,P00918,Carbonic anhydrase 2,CA2,260.0
13391,DB07049,(2R)-1-[(4-tert-butylphenyl)sulfonyl]-2-methyl-4-(4-nitrophenyl)piperazine,SmallMoleculeDrug,P28845,Corticosteroid 11-beta-dehydrogenase isozyme 1,HSD11B1,292.0
13392,DB07050,"5-[(phenylsulfonyl)amino]-1,3,4-thiadiazole-2-sulfonamide",SmallMoleculeDrug,P00918,Carbonic anhydrase 2,CA2,260.0
13393,DB07051,"3,5-DIMETHYL-1-PHENYL-1H-PYRAZOLE-4-CARBOXYLIC ACID ETHYL ESTER",SmallMoleculeDrug,Q08499,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",PDE4D,809.0
13395,DB07053,2-{5-[3-(7-PROPYL-3-TRIFLUOROMETHYLBENZO[D]ISOXAZOL-6-YLOXY)PROPOXY]INDOL-1-YL}ETHANOIC ACID,SmallMoleculeDrug,P37231,Peroxisome proliferator-activated receptor gamma,PPARG,505.0
13396,DB07054,(2R)-1-(DIMETHYLAMINO)-3-{4-[(6-{[2-FLUORO-5-(TRIFLUOROMETHYL)PHENYL]AMINO}PYRIMIDIN-4-YL)AMINO]PHENOXY}PROPAN-2-OL,SmallMoleculeDrug,P24941,Cyclin-dependent kinase 2,CDK2,298.0
13398,DB07056,"2-(6-{[(3-chloro-2-methylphenyl)sulfonyl]amino}pyridin-2-yl)-N,N-diethylacetamide",SmallMoleculeDrug,P28845,Corticosteroid 11-beta-dehydrogenase isozyme 1,HSD11B1,292.0
13400,DB07058,"5-[1-(4-methoxyphenyl)-1H-benzimidazol-6-yl]-1,3,4-oxadiazole-2(3H)-thione",SmallMoleculeDrug,P49841,Glycogen synthase kinase-3 beta,GSK3B,420.0
13401,DB07059,"N-{2-[6-(2,4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)-2,2-DIMETHYL-3-OXO-2,3-DIHYDRO-4H-1,4-BENZOXAZIN-4-YL]ETHYL}ACETAMIDE",SmallMoleculeDrug,P00797,Renin,REN,406.0
13402,DB07060,3-(INDOL-3-YL) LACTATE,SmallMoleculeDrug,Q9UJM8,Hydroxyacid oxidase 1,HAO1,370.0
13404,DB07061,"1-(CYCLOHEXYLAMINO)-3-(6-METHYL-3,4-DIHYDRO-1H-CARBAZOL-9(2H)-YL)PROPAN-2-OL",SmallMoleculeDrug,O60551,Glycylpeptide N-tetradecanoyltransferase 2,NMT2,498.0
13406,DB07063,"{3-[(4,5,7-TRIFLUORO-1,3-BENZOTHIAZOL-2-YL)METHYL]-1H-INDOL-1-YL}ACETIC ACID",SmallMoleculeDrug,P15121,Aldose reductase,AKR1B1,316.0
13407,DB07064,"(4R)-4-(3-HYDROXYPHENYL)-N,N,7,8-TETRAMETHYL-3,4-DIHYDROISOQUINOLINE-2(1H)-CARBOXAMIDE",SmallMoleculeDrug,P52732,Kinesin-like protein KIF11,KIF11,1056.0
13408,DB07065,"5-(2,3-dichlorophenyl)-N-(pyridin-4-ylmethyl)-3-thiocyanatopyrazolo[1,5-a]pyrimidin-7-amine",SmallMoleculeDrug,P24941,Cyclin-dependent kinase 2,CDK2,298.0
13409,DB07066,"2-CHLORO-N-[(3R)-2-OXO-1,2,3,4-TETRAHYDROQUINOLIN-3-YL]-6H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE",SmallMoleculeDrug,P11217,"Glycogen phosphorylase, muscle form",PYGM,842.0
13410,DB07067,"(2S,3S)-3-{3-[4-(METHYLSULFONYL)PHENYL]-1,2,4-OXADIAZOL-5-YL}-1-OXO-1-PYRROLIDIN-1-YLBUTAN-2-AMINE",SmallMoleculeDrug,P27487,Dipeptidyl peptidase 4,DPP4,766.0
13411,DB07068,"(4-{4-[(TERT-BUTOXYCARBONYL)AMINO]-2,2-BIS(ETHOXYCARBONYL)BUTYL}PHENYL)SULFAMIC ACID",SmallMoleculeDrug,P23467,Receptor-type tyrosine-protein phosphatase beta,PTPRB,1997.0
13412,DB07069,3-Hydroxyhippuric acid,SmallMoleculeDrug,Q16719,Kynureninase,KYNU,465.0
13413,DB07070,(2S)-2-{3-[({[2-fluoro-4-(trifluoromethyl)phenyl]carbonyl}amino)methyl]-4-methoxybenzyl}butanoic acid,SmallMoleculeDrug,Q03181,Peroxisome proliferator-activated receptor delta,PPARD,441.0
13414,DB07071,"(R)-1-(4-(4-(HYDROXYMETHYL)-1,3,2-DIOXABOROLAN-2-YL)PHENETHYL)GUANIDINE",SmallMoleculeDrug,P03951,Coagulation factor XI,F11,625.0
13415,DB07072,"(1S,2R,5S)-5-[3-(TRIFLUOROMETHYL)-5,6-DIHYDRO[1,2,4]TRIAZOLO[4,3-A]PYRAZIN-7(8H)-YL]-2-(2,4,5-TRIFLUOROPHENYL)CYCLOHEXANAMINE",SmallMoleculeDrug,P27487,Dipeptidyl peptidase 4,DPP4,766.0
13416,DB07073,"5,5-dimethyl-2-morpholin-4-yl-5,6-dihydro-1,3-benzothiazol-7(4H)-one",SmallMoleculeDrug,P48736,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",PIK3CG,1102.0
13417,DB07074,6-CARBAMIMIDOYL-4-(3-HYDROXY-2-METHYL-BENZOYLAMINO)-NAPHTHALENE-2-CARBOXYLIC ACID METHYL ESTER,SmallMoleculeDrug,P03951,Coagulation factor XI,F11,625.0
13418,DB07075,3-(5-{[4-(AMINOMETHYL)PIPERIDIN-1-YL]METHYL}-1H-INDOL-2-YL)-1H-INDAZOLE-6-CARBONITRILE,SmallMoleculeDrug,O14757,Serine/threonine-protein kinase Chk1,CHEK1,476.0
13419,DB07076,6-[(Z)-AMINO(IMINO)METHYL]-N-[3-(CYCLOPENTYLOXY)PHENYL]-2-NAPHTHAMIDE,SmallMoleculeDrug,P00749,Urokinase-type plasminogen activator,PLAU,431.0
13420,DB07077,"(R)-1-(4-(4-(HYDROXYMETHYL)-1,3,2-DIOXABOROLAN-2-YL)PHENYL)GUANIDINE",SmallMoleculeDrug,P03951,Coagulation factor XI,F11,625.0
13421,DB07078,"(3Z)-6-(4-HYDROXY-3-METHOXYPHENYL)-3-(1H-PYRROL-2-YLMETHYLENE)-1,3-DIHYDRO-2H-INDOL-2-ONE",SmallMoleculeDrug,O14757,Serine/threonine-protein kinase Chk1,CHEK1,476.0
13422,DB07079,3-{[4-(but-2-yn-1-yloxy)phenyl]sulfonyl}propane-1-thiol,SmallMoleculeDrug,P78536,Disintegrin and metalloproteinase domain-containing protein 17,ADAM17,824.0
13423,DB07080,"N-(2,2,2-TRIFLUOROETHYL)-N-{4-[2,2,2-TRIFLUORO-1-HYDROXY-1-(TRIFLUOROMETHYL)ETHYL]PHENYL}BENZENESULFONAMIDE",SmallMoleculeDrug,P55055,Oxysterols receptor LXR-beta,NR1H2,460.0
13424,DB07080,"N-(2,2,2-TRIFLUOROETHYL)-N-{4-[2,2,2-TRIFLUORO-1-HYDROXY-1-(TRIFLUOROMETHYL)ETHYL]PHENYL}BENZENESULFONAMIDE",SmallMoleculeDrug,Q15596,Nuclear receptor coactivator 2,NCOA2,1464.0
13425,DB07080,"N-(2,2,2-TRIFLUOROETHYL)-N-{4-[2,2,2-TRIFLUORO-1-HYDROXY-1-(TRIFLUOROMETHYL)ETHYL]PHENYL}BENZENESULFONAMIDE",SmallMoleculeDrug,P28702,Retinoic acid receptor RXR-beta,RXRB,533.0
13426,DB07080,"N-(2,2,2-TRIFLUOROETHYL)-N-{4-[2,2,2-TRIFLUORO-1-HYDROXY-1-(TRIFLUOROMETHYL)ETHYL]PHENYL}BENZENESULFONAMIDE",SmallMoleculeDrug,Q13133,Oxysterols receptor LXR-alpha,NR1H3,447.0
13427,DB07080,"N-(2,2,2-TRIFLUOROETHYL)-N-{4-[2,2,2-TRIFLUORO-1-HYDROXY-1-(TRIFLUOROMETHYL)ETHYL]PHENYL}BENZENESULFONAMIDE",SmallMoleculeDrug,Q15788,Nuclear receptor coactivator 1,NCOA1,1441.0
13428,DB07080,"N-(2,2,2-TRIFLUOROETHYL)-N-{4-[2,2,2-TRIFLUORO-1-HYDROXY-1-(TRIFLUOROMETHYL)ETHYL]PHENYL}BENZENESULFONAMIDE",SmallMoleculeDrug,O75469,Nuclear receptor subfamily 1 group I member 2,NR1I2,434.0
13429,DB07081,"(2R)-4-[(8R)-8-METHYL-2-(TRIFLUOROMETHYL)-5,6-DIHYDRO[1,2,4]TRIAZOLO[1,5-A]PYRAZIN-7(8H)-YL]-4-OXO-1-(2,4,5-TRIFLUOROPHENYL)BUTAN-2-AMINE",SmallMoleculeDrug,P27487,Dipeptidyl peptidase 4,DPP4,766.0
13430,DB07082,"1,1,1,3,3,3-HEXAFLUORO-2-{4-[(2,2,2-TRIFLUOROETHYL)AMINO]PHENYL}PROPAN-2-OL",SmallMoleculeDrug,P55055,Oxysterols receptor LXR-beta,NR1H2,460.0
13431,DB07083,beta-phenyl-D-phenylalanyl-N-propyl-L-prolinamide,SmallMoleculeDrug,P00734,Prothrombin,F2,622.0
13434,DB07086,"4-[(1S,2S,5S)-5-(HYDROXYMETHYL)-8-METHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL",SmallMoleculeDrug,Q15596,Nuclear receptor coactivator 2,NCOA2,1464.0
13435,DB07086,"4-[(1S,2S,5S)-5-(HYDROXYMETHYL)-8-METHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL",SmallMoleculeDrug,P03372,Estrogen receptor,ESR1,595.0
13436,DB07087,"4-[(1S,2S,5S,9R)-5-(HYDROXYMETHYL)-8,9-DIMETHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL",SmallMoleculeDrug,P03372,Estrogen receptor,ESR1,595.0
13437,DB07087,"4-[(1S,2S,5S,9R)-5-(HYDROXYMETHYL)-8,9-DIMETHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL",SmallMoleculeDrug,Q15596,Nuclear receptor coactivator 2,NCOA2,1464.0
13438,DB07088,(S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclopentyloxy)ethanoyl)pyrrolidine-2-carboxamide,SmallMoleculeDrug,P07477,Trypsin-1,PRSS1,247.0
13439,DB07088,(S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclopentyloxy)ethanoyl)pyrrolidine-2-carboxamide,SmallMoleculeDrug,P00734,Prothrombin,F2,622.0
13440,DB07089,N-[amino(imino)methyl]-2-[2-(2-chlorophenyl)-4-(4-propoxyphenyl)-3-thienyl]acetamide,SmallMoleculeDrug,P56817,Beta-secretase 1,BACE1,501.0
13442,DB07091,(S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclohexyloxy)ethanoyl)pyrrolidine-2-carboxamide,SmallMoleculeDrug,P07477,Trypsin-1,PRSS1,247.0
13443,DB07091,(S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclohexyloxy)ethanoyl)pyrrolidine-2-carboxamide,SmallMoleculeDrug,P00734,Prothrombin,F2,622.0
13444,DB07092,"(2S,3S)-3-AMINO-4-(3,3-DIFLUOROPYRROLIDIN-1-YL)-N,N-DIMETHYL-4-OXO-2-(TRANS-4-[1,2,4]TRIAZOLO[1,5-A]PYRIDIN-6-YLCYCLOHEXYL)BUTANAMIDE",SmallMoleculeDrug,P27487,Dipeptidyl peptidase 4,DPP4,766.0
13445,DB07093,"{3-[(5-CHLORO-1,3-BENZOTHIAZOL-2-YL)METHYL]-2,4-DIOXO-3,4-DIHYDROPYRIMIDIN-1(2H)-YL}ACETIC ACID",SmallMoleculeDrug,P15121,Aldose reductase,AKR1B1,316.0
13446,DB07094,"1-(2,2'-bithiophen-5-yl)methanamine",SmallMoleculeDrug,P09960,Leukotriene A-4 hydrolase,LTA4H,611.0
13447,DB07095,(S)-N-(4-carbamimidoylbenzyl)-1-(3-cyclopentylpropanoyl)pyrrolidine-2-carboxamide,SmallMoleculeDrug,P07477,Trypsin-1,PRSS1,247.0
13448,DB07095,(S)-N-(4-carbamimidoylbenzyl)-1-(3-cyclopentylpropanoyl)pyrrolidine-2-carboxamide,SmallMoleculeDrug,P00734,Prothrombin,F2,622.0
13449,DB07096,"6-AMINO-BENZO[DE]ISOQUINOLINE-1,3-DIONE",SmallMoleculeDrug,P09874,Poly [ADP-ribose] polymerase 1,PARP1,1014.0
13452,DB07099,N-[4-(benzyloxy)phenyl]glycinamide,SmallMoleculeDrug,P09960,Leukotriene A-4 hydrolase,LTA4H,611.0
13453,DB07100,"4-CHLORO-6-(4-PIPERAZIN-1-YL-1H-PYRAZOL-5-YL)BENZENE-1,3-DIOL",SmallMoleculeDrug,P07900,Heat shock protein HSP 90-alpha,HSP90AA1,732.0
13454,DB07101,"N-{[(2R)-2,3-dihydroxypropyl]oxy}-3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]benzamide",SmallMoleculeDrug,Q02750,Dual specificity mitogen-activated protein kinase kinase 1,MAP2K1,393.0
13455,DB07102,(2S)-2-amino-5-oxo-5-[(4-phenylmethoxyphenyl)amino]pentanoic acid,SmallMoleculeDrug,P09960,Leukotriene A-4 hydrolase,LTA4H,611.0
13457,DB07104,4-amino-N-[4-(benzyloxy)phenyl]butanamide,SmallMoleculeDrug,P09960,Leukotriene A-4 hydrolase,LTA4H,611.0
13458,DB07105,2-[2-(4-CHLORO-PHENYLSULFANYL)-ACETYLAMINO]-3-(4-GUANIDINO-PHENYL)-PROPIONAMIDE,SmallMoleculeDrug,P00734,Prothrombin,F2,622.0
13459,DB07106,4-(DIMETHYLAMINO)BUTYL IMIDOTHIOCARBAMATE,SmallMoleculeDrug,P50135,Histamine N-methyltransferase,HNMT,292.0
13460,DB07107,(1S)-2-(1H-INDOL-3-YL)-1-[({5-[(E)-2-PYRIDIN-4-YLVINYL]PYRIDIN-3-YL}OXY)METHYL]ETHYLAMINE,SmallMoleculeDrug,P17612,cAMP-dependent protein kinase catalytic subunit alpha,PRKACA,351.0
13461,DB07107,(1S)-2-(1H-INDOL-3-YL)-1-[({5-[(E)-2-PYRIDIN-4-YLVINYL]PYRIDIN-3-YL}OXY)METHYL]ETHYLAMINE,SmallMoleculeDrug,P61925,cAMP-dependent protein kinase inhibitor alpha,PKIA,76.0
13462,DB07108,"4'-FLUORO-1,1'-BIPHENYL-4-CARBOXYLIC ACID",SmallMoleculeDrug,Q07817,Bcl-2-like protein 1,BCL2L1,233.0
13464,DB07110,4-(4-FLUOROBENZYL)PIPERIDINE,SmallMoleculeDrug,P56817,Beta-secretase 1,BACE1,501.0
13465,DB07111,"(4S,5E,7Z,10Z,13Z,16Z,19Z)-4-hydroxydocosa-5,7,10,13,16,19-hexaenoic acid",SmallMoleculeDrug,P37231,Peroxisome proliferator-activated receptor gamma,PPARG,505.0
13466,DB07112,N-[(4-HYDROXY-8-IODOISOQUINOLIN-3-YL)CARBONYL]GLYCINE,SmallMoleculeDrug,Q9GZT9,Egl nine homolog 1,EGLN1,426.0
13467,DB07113,"(2S)-6-(2,4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)-2-(3,5-DIFLUOROPHENYL)-4-(3-METHOXYPROPYL)-2H-1,4-BENZOXAZIN-3(4H)-ONE",SmallMoleculeDrug,P00797,Renin,REN,406.0
13469,DB07115,"N-(4-chlorobenzyl)-N-methylbenzene-1,4-disulfonamide",SmallMoleculeDrug,Q8N1Q1,Carbonic anhydrase 13,CA13,262.0
13470,DB07116,1-(2-DEOXY-5-O-PHOSPHONO-BETA-D-ERYTHRO-PENTOFURANOSYL)-4-METHYL-1H-INDOLE,SmallMoleculeDrug,P13051,Uracil-DNA glycosylase,UNG,313.0
13471,DB07117,"5-(4-PHENOXYPHENYL)-5-(4-PYRIMIDIN-2-YLPIPERAZIN-1-YL)PYRIMIDINE-2,4,6(2H,3H)-TRIONE",SmallMoleculeDrug,P14780,Matrix metalloproteinase-9,MMP9,707.0
13473,DB07119,1-CHLORO-6-(4-HYDROXYPHENYL)-2-NAPHTHOL,SmallMoleculeDrug,Q15788,Nuclear receptor coactivator 1,NCOA1,1441.0
13474,DB07119,1-CHLORO-6-(4-HYDROXYPHENYL)-2-NAPHTHOL,SmallMoleculeDrug,Q92731,Estrogen receptor beta,ESR2,530.0
13475,DB07120,"N4-(N,N-DIPHENYLCARBAMOYL)-AMINOGUANIDINE",SmallMoleculeDrug,P00734,Prothrombin,F2,622.0
13476,DB07121,"4-({4-[(4-AMINOBUT-2-YNYL)OXY]PHENYL}SULFONYL)-N-HYDROXY-2,2-DIMETHYLTHIOMORPHOLINE-3-CARBOXAMIDE",SmallMoleculeDrug,P78536,Disintegrin and metalloproteinase domain-containing protein 17,ADAM17,824.0
13477,DB07122,1-[4-(2-oxo-2-phenylethyl)phenyl]guanidine,SmallMoleculeDrug,P00749,Urokinase-type plasminogen activator,PLAU,431.0
13479,DB07124,"(2S)-1-(6H-INDOL-3-YL)-3-{[5-(7H-PYRAZOLO[3,4-C]PYRIDIN-5-YL)PYRIDIN-3-YL]OXY}PROPAN-2-AMINE",SmallMoleculeDrug,P17612,cAMP-dependent protein kinase catalytic subunit alpha,PRKACA,351.0
13480,DB07125,"4-(6-{[(1R)-1-(hydroxymethyl)propyl]amino}imidazo[1,2-b]pyridazin-3-yl)benzoic acid",SmallMoleculeDrug,O43293,Death-associated protein kinase 3,DAPK3,454.0
13481,DB07126,O6-CYCLOHEXYLMETHOXY-2-(4'-SULPHAMOYLANILINO) PURINE,SmallMoleculeDrug,P20248,Cyclin-A2,CCNA2,432.0
13482,DB07126,O6-CYCLOHEXYLMETHOXY-2-(4'-SULPHAMOYLANILINO) PURINE,SmallMoleculeDrug,P24941,Cyclin-dependent kinase 2,CDK2,298.0
13483,DB07127,"{4-[2,2-BIS(5-METHYL-1,2,4-OXADIAZOL-3-YL)-3-PHENYLPROPYL]PHENYL}SULFAMIC ACID",SmallMoleculeDrug,P23467,Receptor-type tyrosine-protein phosphatase beta,PTPRB,1997.0
13484,DB07128,"N7-BUTYL-N2-(5-CHLORO-2-METHYLPHENYL)-5-METHYL[1,2,4]TRIAZOLO[1,5-A]PYRIMIDINE-2,7-DIAMINE",SmallMoleculeDrug,P00734,Prothrombin,F2,622.0
13485,DB07129,"(2R)-1-(2,6-dimethylphenoxy)propan-2-amine",SmallMoleculeDrug,P00749,Urokinase-type plasminogen activator,PLAU,431.0
13486,DB07130,4-BROMO-3-(CARBOXYMETHOXY)-5-PHENYLTHIOPHENE-2-CARBOXYLIC ACID,SmallMoleculeDrug,P18031,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,435.0
13487,DB07131,(S)-N-(4-carbamimidoylbenzyl)-1-(3-cyclohexylpropanoyl)pyrrolidine-2-carboxamide,SmallMoleculeDrug,P07477,Trypsin-1,PRSS1,247.0
13488,DB07131,(S)-N-(4-carbamimidoylbenzyl)-1-(3-cyclohexylpropanoyl)pyrrolidine-2-carboxamide,SmallMoleculeDrug,P00734,Prothrombin,F2,622.0
13489,DB07132,1-{2-OXO-3-[(1R)-1-(1H-PYRROL-2-YL)ETHYL]-2H-INDOL-5-YL}UREA,SmallMoleculeDrug,O15530,3-phosphoinositide-dependent protein kinase 1,PDPK1,556.0
13490,DB07133,D-phenylalanyl-N-(3-methylbenzyl)-L-prolinamide,SmallMoleculeDrug,P00734,Prothrombin,F2,622.0
13491,DB07134,"5-(4-CHLORO-5-PHENYL-3-THIENYL)-1,2,5-THIADIAZOLIDIN-3-ONE 1,1-DIOXIDE",SmallMoleculeDrug,P18031,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,435.0
13492,DB07135,"(2S,3S)-3-AMINO-4-[(3S)-3-FLUOROPYRROLIDIN-1-YL]-N,N-DIMETHYL-4-OXO-2-(TRANS-4-[1,2,4]TRIAZOLO[1,5-A]PYRIDIN-5-YLCYCLOHEXYL)BUTANAMIDE",SmallMoleculeDrug,P27487,Dipeptidyl peptidase 4,DPP4,766.0
13493,DB07136,(2S)-2-[3-(AMINOMETHYL)PHENYL]-3-{(R)-HYDROXY[(1R)-2-METHYL-1-{[(3-PHENYLPROPYL)SULFONYL]AMINO}PROPYL]PHOSPHORYL}PROPANOIC ACID,SmallMoleculeDrug,P15086,Carboxypeptidase B,CPB1,417.0
13494,DB07137,(2S)-N-[(3Z)-5-CYCLOPROPYL-3H-PYRAZOL-3-YLIDENE]-2-[4-(2-OXOIMIDAZOLIDIN-1-YL)PHENYL]PROPANAMIDE,SmallMoleculeDrug,P20248,Cyclin-A2,CCNA2,432.0
13495,DB07137,(2S)-N-[(3Z)-5-CYCLOPROPYL-3H-PYRAZOL-3-YLIDENE]-2-[4-(2-OXOIMIDAZOLIDIN-1-YL)PHENYL]PROPANAMIDE,SmallMoleculeDrug,P24941,Cyclin-dependent kinase 2,CDK2,298.0
13496,DB07138,"5-(2,6-dichlorophenyl)-2-[(2,4-difluorophenyl)sulfanyl]-6H-pyrimido[1,6-b]pyridazin-6-one",SmallMoleculeDrug,Q16539,Mitogen-activated protein kinase 14,MAPK14,360.0
13497,DB07139,3-[5-(3-nitrophenyl)thiophen-2-yl]propanoic acid,SmallMoleculeDrug,P15121,Aldose reductase,AKR1B1,316.0
13498,DB07140,"5-[(3R)-3-(5-methoxybiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine",SmallMoleculeDrug,P00374,Dihydrofolate reductase,DHFR,187.0
13500,DB07141,"5-[(3R)-3-(5-methoxy-4'-methylbiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine",SmallMoleculeDrug,P00374,Dihydrofolate reductase,DHFR,187.0
13501,DB07142,"5-[(3R)-3-(5-methoxy-3',5'-dimethylbiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine",SmallMoleculeDrug,P00374,Dihydrofolate reductase,DHFR,187.0
13503,DB07143,D-phenylalanyl-N-benzyl-L-prolinamide,SmallMoleculeDrug,P00734,Prothrombin,F2,622.0
13504,DB07144,"5-[(3R)-3-(5-methoxy-2',6'-dimethylbiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine",SmallMoleculeDrug,P00374,Dihydrofolate reductase,DHFR,187.0
13505,DB07145,(2R)-N-HYDROXY-2-[(3S)-3-METHYL-3-{4-[(2-METHYLQUINOLIN-4-YL)METHOXY]PHENYL}-2-OXOPYRROLIDIN-1-YL]PROPANAMIDE,SmallMoleculeDrug,P78536,Disintegrin and metalloproteinase domain-containing protein 17,ADAM17,824.0
13506,DB07146,"2,3-DIPHENYL-N-(2-PIPERAZIN-1-YLETHYL)FURO[2,3-B]PYRIDIN-4-AMINE",SmallMoleculeDrug,P06239,Tyrosine-protein kinase Lck,LCK,509.0
13507,DB07147,"methyl (1R,2S)-2-(hydroxycarbamoyl)-1-{4-[(2-methylquinolin-4-yl)methoxy]benzyl}cyclopropanecarboxylate",SmallMoleculeDrug,P78536,Disintegrin and metalloproteinase domain-containing protein 17,ADAM17,824.0
13508,DB07148,"(6S)-1-chloro-3-[(4-fluorobenzyl)oxy]-6-(pyrrolidin-1-ylcarbonyl)pyrrolo[1,2-a]pyrazin-4(6H)-one",SmallMoleculeDrug,P48147,Prolyl endopeptidase,PREP,710.0
13509,DB07149,"(7S)-2-(2-aminopyrimidin-4-yl)-7-(2-fluoroethyl)-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one",SmallMoleculeDrug,P49841,Glycogen synthase kinase-3 beta,GSK3B,420.0
13510,DB07150,4-(4-HYDROXYPHENYL)-1-NAPHTHALDEHYDE OXIME,SmallMoleculeDrug,Q15788,Nuclear receptor coactivator 1,NCOA1,1441.0
13511,DB07150,4-(4-HYDROXYPHENYL)-1-NAPHTHALDEHYDE OXIME,SmallMoleculeDrug,Q92731,Estrogen receptor beta,ESR2,530.0
13512,DB07151,4-(4-hydroxy-3-methylphenyl)-6-phenylpyrimidin-2(5H)-one,SmallMoleculeDrug,P11309,Serine/threonine-protein kinase pim-1,PIM1,404.0
13513,DB07152,N-[4-(5-fluoro-6-methylpyridin-2-yl)-5-quinoxalin-6-yl-1H-imidazol-2-yl]acetamide,SmallMoleculeDrug,P36897,TGF-beta receptor type-1,TGFBR1,503.0
13515,DB07154,"(3R)-4-[(3R)-3-AMINO-4-(2,4,5-TRIFLUOROPHENYL)BUTANOYL]-3-METHYL-1,4-DIAZEPAN-2-ONE",SmallMoleculeDrug,P27487,Dipeptidyl peptidase 4,DPP4,766.0
13517,DB07156,"(4Z)-6-bromo-4-({[4-(pyrrolidin-1-ylmethyl)phenyl]amino}methylidene)isoquinoline-1,3(2H,4H)-dione",SmallMoleculeDrug,P08069,Insulin-like growth factor 1 receptor,IGF1R,1367.0
13518,DB07157,"(5R,6S,8S)-8-[3-(AMINOMETHYL)PHENYL]-6-HYDROXY-5-ISOPROPYL-3-OXO-1-PHENYL-2,7-DIOXA-4-AZA-6-PHOSPHANONAN-9-OIC ACID 6-OXIDE",SmallMoleculeDrug,P15086,Carboxypeptidase B,CPB1,417.0
13519,DB07158,"5-ETHYL-3-METHYL-1,5-DIHYDRO-4H-PYRAZOLO[4,3-C]QUINOLIN-4-ONE",SmallMoleculeDrug,O14757,Serine/threonine-protein kinase Chk1,CHEK1,476.0
13520,DB07159,"6-({5-fluoro-2-[(3,4,5-trimethoxyphenyl)amino]pyrimidin-4-yl}amino)-2,2-dimethyl-2H-pyrido[3,2-b][1,4]oxazin-3(4H)-one",SmallMoleculeDrug,P43405,Tyrosine-protein kinase SYK,SYK,635.0
13521,DB07160,"N-{[(2S,3S)-3-(ETHOXYCARBONYL)OXIRAN-2-YL]CARBONYL}-L-ISOLEUCINE",SmallMoleculeDrug,P07858,Cathepsin B,CTSB,339.0
13522,DB07161,5-phenyl-1H-indazol-3-amine,SmallMoleculeDrug,O60674,Tyrosine-protein kinase JAK2,JAK2,1132.0
13523,DB07162,4-(3-amino-1H-indazol-5-yl)-N-tert-butylbenzenesulfonamide,SmallMoleculeDrug,O60674,Tyrosine-protein kinase JAK2,JAK2,1132.0
13524,DB07163,5-[(2-AMINOETHYL)AMINO]-6-FLUORO-3-(1H-PYRROL-2-YL)BENZO[CD]INDOL-2(1H)-ONE,SmallMoleculeDrug,P24941,Cyclin-dependent kinase 2,CDK2,298.0
13525,DB07164,"N-cyclopropyl-4-pyrazolo[1,5-b]pyridazin-3-ylpyrimidin-2-amine",SmallMoleculeDrug,P20248,Cyclin-A2,CCNA2,432.0
13526,DB07164,"N-cyclopropyl-4-pyrazolo[1,5-b]pyridazin-3-ylpyrimidin-2-amine",SmallMoleculeDrug,P24941,Cyclin-dependent kinase 2,CDK2,298.0
13527,DB07165,N-(5-CHLORO-BENZO[B]THIOPHEN-3-YLMETHYL)-2-[6-CHLORO-OXO-3-(2-PYRIDIN-2-YL-ETHYLAMINO)-2H-PYRAZIN-1-YL]-ACETAMIDE,SmallMoleculeDrug,P00734,Prothrombin,F2,622.0
13528,DB07167,5-CYANO-FURAN-2-CARBOXYLIC ACID [5-HYDROXYMETHYL-2-(4-METHYL-PIPERIDIN-1-YL)-PHENYL]-AMIDE,SmallMoleculeDrug,P07333,Macrophage colony-stimulating factor 1 receptor,CSF1R,972.0
13529,DB07168,[4-({4-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-6-(methylamino)pyrimidin-2-yl}amino)phenyl]acetonitrile,SmallMoleculeDrug,Q13554,Calcium/calmodulin-dependent protein kinase type II subunit beta,CAMK2B,666.0
13532,DB07171,"5-(2-hydroxyethyl)nonane-1,9-diol",SmallMoleculeDrug,P42892,Endothelin-converting enzyme 1,ECE1,770.0
13533,DB07172,"(5R,6E,8Z,11Z,14Z,17Z)-5-hydroxyicosa-6,8,11,14,17-pentaenoic acid",SmallMoleculeDrug,P37231,Peroxisome proliferator-activated receptor gamma,PPARG,505.0
13534,DB07173,"7-(5-DEOXY-BETA-D-RIBOFURANOSYL)-5-IODO-7H-PYRROLO[2,3-D]PYRIMIDIN-4-AMINE",SmallMoleculeDrug,P55263,Adenosine kinase,ADK,362.0
13535,DB07174,"6-(2,4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)-4-(3-METHOXYPROPYL)-2,2-DIMETHYL-2H-1,4-BENZOXAZIN-3(4H)-ONE",SmallMoleculeDrug,P00797,Renin,REN,406.0
13536,DB07175,N-{2-methyl-5-[(6-phenylpyrimidin-4-yl)amino]phenyl}methanesulfonamide,SmallMoleculeDrug,P56817,Beta-secretase 1,BACE1,501.0
13537,DB07177,"(5E,13E)-11-HYDROXY-9,15-DIOXOPROSTA-5,13-DIEN-1-OIC ACID",SmallMoleculeDrug,Q14914,Prostaglandin reductase 1,PTGR1,329.0
13538,DB07177,"(5E,13E)-11-HYDROXY-9,15-DIOXOPROSTA-5,13-DIEN-1-OIC ACID",SmallMoleculeDrug,Q8N8N7,Prostaglandin reductase 2,PTGR2,351.0
13540,DB07179,"3-((3-bromo-5-o-tolylpyrazolo[1,5-a]pyrimidin-7-ylamino)methyl)pyridine 1-oxide",SmallMoleculeDrug,P24941,Cyclin-dependent kinase 2,CDK2,298.0
13541,DB07180,"5-[(Z)-(5-CHLORO-2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL]-N-(DIETHYLAMINO)ETHYL]-2,4-DIMETHYL-1H-PYRROLE-3-CARBOXAMIDE",SmallMoleculeDrug,P51955,Serine/threonine-protein kinase Nek2,NEK2,445.0
13542,DB07181,"4'-[(1R)-1-amino-2-(2,5-difluorophenyl)ethyl]biphenyl-3-carboxamide",SmallMoleculeDrug,P27487,Dipeptidyl peptidase 4,DPP4,766.0
13543,DB07182,(2S)-2-(3-{[AMINO(IMINO)METHYL]AMINO}PHENYL)-3-[(S)-HYDROXY(3-PHENYLPROPYL)PHOSPHORYL]PROPANOIC ACID,SmallMoleculeDrug,P15086,Carboxypeptidase B,CPB1,417.0
13544,DB07183,N-(4-phenoxyphenyl)-2-[(pyridin-4-ylmethyl)amino]nicotinamide,SmallMoleculeDrug,P35968,Vascular endothelial growth factor receptor 2,KDR,1356.0
13547,DB07186,"4-(4-METHYLPIPERAZIN-1-YL)-N-[5-(2-THIENYLACETYL)-1,5-DIHYDROPYRROLO[3,4-C]PYRAZOL-3-YL]BENZAMIDE",SmallMoleculeDrug,O14965,Aurora kinase A,AURKA,403.0
13548,DB07186,"4-(4-METHYLPIPERAZIN-1-YL)-N-[5-(2-THIENYLACETYL)-1,5-DIHYDROPYRROLO[3,4-C]PYRAZOL-3-YL]BENZAMIDE",SmallMoleculeDrug,P53350,Serine/threonine-protein kinase PLK1,PLK1,603.0
13549,DB07187,6-[(5-CHLORO-3-METHYL-1-BENZOFURAN-2-YL)SULFONYL]PYRIDAZIN-3(2H)-ONE,SmallMoleculeDrug,P15121,Aldose reductase,AKR1B1,316.0
13551,DB07189,"(1S,3R,6S)-4-oxo-6-{4-[(2-phenylquinolin-4-yl)methoxy]phenyl}-5-azaspiro[2.4]heptane-1-carboxylic acid",SmallMoleculeDrug,P78536,Disintegrin and metalloproteinase domain-containing protein 17,ADAM17,824.0
13552,DB07190,3-cyclohexyl-D-alanyl-N-(3-chlorobenzyl)-L-prolinamide,SmallMoleculeDrug,P00734,Prothrombin,F2,622.0
13556,DB07193,"(2R,3R)-7-(methylsulfonyl)-3-(2,4,5-trifluorophenyl)-1,2,3,4-tetrahydropyrido[1,2-a]benzimidazol-2-amine",SmallMoleculeDrug,P27487,Dipeptidyl peptidase 4,DPP4,766.0
13557,DB07194,"2-{2-[(3,5-dimethylphenyl)amino]pyrimidin-4-yl}-N-[(1S)-2-hydroxy-1-methylethyl]-4-methyl-1,3-thiazole-5-carboxamide",SmallMoleculeDrug,P43405,Tyrosine-protein kinase SYK,SYK,635.0
13558,DB07195,"4-[(1S,2S,5S)-5-(HYDROXYMETHYL)-6,8,9-TRIMETHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL",SmallMoleculeDrug,P03372,Estrogen receptor,ESR1,595.0
13559,DB07195,"4-[(1S,2S,5S)-5-(HYDROXYMETHYL)-6,8,9-TRIMETHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL",SmallMoleculeDrug,Q15596,Nuclear receptor coactivator 2,NCOA2,1464.0
13560,DB07196,N-methyl-1-(2-thiophen-2-ylphenyl)methanamine,SmallMoleculeDrug,P09960,Leukotriene A-4 hydrolase,LTA4H,611.0
13561,DB07197,4-BROMO-3-(CARBOXYMETHOXY)-5-(4-HYDROXYPHENYL)THIOPHENE-2-CARBOXYLIC ACID,SmallMoleculeDrug,P18031,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,435.0
13562,DB07198,5-HYDROXY-2-(4-HYDROXYPHENYL)-1-BENZOFURAN-7-CARBONITRILE,SmallMoleculeDrug,Q92731,Estrogen receptor beta,ESR2,530.0
13563,DB07198,5-HYDROXY-2-(4-HYDROXYPHENYL)-1-BENZOFURAN-7-CARBONITRILE,SmallMoleculeDrug,Q15788,Nuclear receptor coactivator 1,NCOA1,1441.0
13568,DB07202,6-CHLORO-3-(3-METHYLISOXAZOL-5-YL)-4-PHENYLQUINOLIN-2(1H)-ONE,SmallMoleculeDrug,P07333,Macrophage colony-stimulating factor 1 receptor,CSF1R,972.0
13569,DB07203,6-CYCLOHEXYLMETHOXY-2-(3'-CHLOROANILINO) PURINE,SmallMoleculeDrug,P20248,Cyclin-A2,CCNA2,432.0
13570,DB07203,6-CYCLOHEXYLMETHOXY-2-(3'-CHLOROANILINO) PURINE,SmallMoleculeDrug,P24941,Cyclin-dependent kinase 2,CDK2,298.0
13571,DB07204,"(1S)-1-(1H-INDOL-3-YLMETHYL)-2-(2-PYRIDIN-4-YL-[1,7]NAPHTYRIDIN-5-YLOXY)-EHYLAMINE",SmallMoleculeDrug,P61925,cAMP-dependent protein kinase inhibitor alpha,PKIA,76.0
13572,DB07204,"(1S)-1-(1H-INDOL-3-YLMETHYL)-2-(2-PYRIDIN-4-YL-[1,7]NAPHTYRIDIN-5-YLOXY)-EHYLAMINE",SmallMoleculeDrug,P17612,cAMP-dependent protein kinase catalytic subunit alpha,PRKACA,351.0
13573,DB07205,N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE,SmallMoleculeDrug,P54577,"Tyrosine--tRNA ligase, cytoplasmic",YARS,528.0
13574,DB07206,6-[2-(1H-INDOL-6-YL)ETHYL]PYRIDIN-2-AMINE,SmallMoleculeDrug,P56817,Beta-secretase 1,BACE1,501.0
13575,DB07207,2-(4-HYDROXY-5-PHENYL-1H-PYRAZOL-3-YL)-1H-BENZOIMIDAZOLE-5-CARBOXAMIDINE,SmallMoleculeDrug,P08709,Coagulation factor VII,F7,466.0
13576,DB07207,2-(4-HYDROXY-5-PHENYL-1H-PYRAZOL-3-YL)-1H-BENZOIMIDAZOLE-5-CARBOXAMIDINE,SmallMoleculeDrug,P13726,Tissue factor,F3,295.0
13577,DB07208,"(8E,10S,12Z)-10-hydroxy-6-oxooctadeca-8,12-dienoic acid",SmallMoleculeDrug,P37231,Peroxisome proliferator-activated receptor gamma,PPARG,505.0
13578,DB07209,"(8R,9Z,12Z)-8-hydroxy-6-oxooctadeca-9,12-dienoic acid",SmallMoleculeDrug,P37231,Peroxisome proliferator-activated receptor gamma,PPARG,505.0
13579,DB07210,"3-bromo-5-phenyl-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine",SmallMoleculeDrug,P24941,Cyclin-dependent kinase 2,CDK2,298.0
13580,DB07211,(2R)-2-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}PROPENE-1-SULFONAMIDE,SmallMoleculeDrug,P00734,Prothrombin,F2,622.0
13581,DB07211,(2R)-2-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}PROPENE-1-SULFONAMIDE,SmallMoleculeDrug,P00742,Coagulation factor X,F10,488.0
13582,DB07212,N-(7-CARBAMIMIDOYL-NAPHTHALEN-1-YL)-3-HYDROXY-2-METHYL-BENZAMIDE,SmallMoleculeDrug,P03951,Coagulation factor XI,F11,625.0
13583,DB07213,"(5-{3-[5-(PIPERIDIN-1-YLMETHYL)-1H-INDOL-2-YL]-1H-INDAZOL-6-YL}-2H-1,2,3-TRIAZOL-4-YL)METHANOL",SmallMoleculeDrug,O14757,Serine/threonine-protein kinase Chk1,CHEK1,476.0
13584,DB07215,"2-METHYL-2-(4-{[({4-METHYL-2-[4-(TRIFLUOROMETHYL)PHENYL]-1,3-THIAZOL-5-YL}CARBONYL)AMINO]METHYL}PHENOXY)PROPANOIC ACID",SmallMoleculeDrug,Q15788,Nuclear receptor coactivator 1,NCOA1,1441.0
13585,DB07215,"2-METHYL-2-(4-{[({4-METHYL-2-[4-(TRIFLUOROMETHYL)PHENYL]-1,3-THIAZOL-5-YL}CARBONYL)AMINO]METHYL}PHENOXY)PROPANOIC ACID",SmallMoleculeDrug,Q07869,Peroxisome proliferator-activated receptor alpha,PPARA,468.0
13586,DB07216,"(11S)-8-CHLORO-11-[1-(METHYLSULFONYL)PIPERIDIN-4-YL]-6-PIPERAZIN-1-YL-11H-BENZO[5,6]CYCLOHEPTA[1,2-B]PYRIDINE",SmallMoleculeDrug,P49354,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,FNTA,379.0
13587,DB07216,"(11S)-8-CHLORO-11-[1-(METHYLSULFONYL)PIPERIDIN-4-YL]-6-PIPERAZIN-1-YL-11H-BENZO[5,6]CYCLOHEPTA[1,2-B]PYRIDINE",SmallMoleculeDrug,P49356,Protein farnesyltransferase subunit beta,FNTB,437.0
13588,DB07217,"N-(3-cyano-4,5,6,7-tetrahydro-1-benzothien-2-yl)-2-fluorobenzamide",SmallMoleculeDrug,P53779,Mitogen-activated protein kinase 10,MAPK10,464.0
13589,DB07218,"6-CHLORO-9-HYDROXY-1,3-DIMETHYL-1,9-DIHYDRO-4H-PYRAZOLO[3,4-B]QUINOLIN-4-ONE",SmallMoleculeDrug,Q9UQF2,C-Jun-amino-terminal kinase-interacting protein 1,MAPK8IP1,711.0
13590,DB07218,"6-CHLORO-9-HYDROXY-1,3-DIMETHYL-1,9-DIHYDRO-4H-PYRAZOLO[3,4-B]QUINOLIN-4-ONE",SmallMoleculeDrug,P45983,Mitogen-activated protein kinase 8,MAPK8,427.0
13591,DB07219,"BENZYL N-({(2S,3S)-3-[(PROPYLAMINO)CARBONYL]OXIRAN-2-YL}CARBONYL)-L-ISOLEUCYL-L-PROLINATE",SmallMoleculeDrug,P07858,Cathepsin B,CTSB,339.0
13592,DB07220,"N-[5-(1,1-DIOXIDOISOTHIAZOLIDIN-2-YL)-1H-INDAZOL-3-YL]-2-(4-PIPERIDIN-1-YLPHENYL)ACETAMIDE",SmallMoleculeDrug,P24941,Cyclin-dependent kinase 2,CDK2,298.0
13593,DB07221,"(2,2-DIPHOSPHONOETHYL)(DODECYL)DIMETHYLPHOSPHONIUM",SmallMoleculeDrug,O95749,Geranylgeranyl pyrophosphate synthase,GGPS1,300.0
13595,DB07223,"METHYL N-({(2S,3S)-3-[(PROPYLAMINO)CARBONYL]OXIRAN-2-YL}CARBONYL)-L-ISOLEUCYL-L-PROLINATE",SmallMoleculeDrug,P07858,Cathepsin B,CTSB,339.0
13596,DB07224,"N-{[(2S,3S)-3-(ETHOXYCARBONYL)OXIRAN-2-YL]CARBONYL}-L-ISOLEUCYL-L-ALANINE",SmallMoleculeDrug,P07858,Cathepsin B,CTSB,339.0
13597,DB07225,"N-{[(2S,3S)-3-(ETHOXYCARBONYL)OXIRAN-2-YL]CARBONYL}-L-ISOLEUCYL-L-ISOLEUCINE",SmallMoleculeDrug,P07858,Cathepsin B,CTSB,339.0
13598,DB07226,"N-[4-(2-CHLOROPHENYL)-1,3-DIOXO-1,2,3,6-TETRAHYDROPYRROLO[3,4-C]CARBAZOL-9-YL]FORMAMIDE",SmallMoleculeDrug,P30291,Wee1-like protein kinase,WEE1,646.0
13599,DB07227,4-[(5-{[4-(3-CHLOROPHENYL)-3-OXOPIPERAZIN-1-YL]METHYL}-1H-IMIDAZOL-1-YL)METHYL]BENZONITRILE,SmallMoleculeDrug,P49354,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,FNTA,379.0
13600,DB07227,4-[(5-{[4-(3-CHLOROPHENYL)-3-OXOPIPERAZIN-1-YL]METHYL}-1H-IMIDAZOL-1-YL)METHYL]BENZONITRILE,SmallMoleculeDrug,P49356,Protein farnesyltransferase subunit beta,FNTB,437.0
13601,DB07227,4-[(5-{[4-(3-CHLOROPHENYL)-3-OXOPIPERAZIN-1-YL]METHYL}-1H-IMIDAZOL-1-YL)METHYL]BENZONITRILE,SmallMoleculeDrug,P53609,Geranylgeranyl transferase type-1 subunit beta,PGGT1B,377.0
13602,DB07228,1-(5-CHLORO-2-METHOXYPHENYL)-3-{6-[2-(DIMETHYLAMINO)-1-METHYLETHOXY]PYRAZIN-2-YL}UREA,SmallMoleculeDrug,O14757,Serine/threonine-protein kinase Chk1,CHEK1,476.0
13603,DB07229,"3-{5-[AMINO(IMINIO)METHYL]-1H-INDOL-2-YL}-5-METHOXY-1,1'-BIPHENYL-2-OLATE",SmallMoleculeDrug,P07477,Trypsin-1,PRSS1,247.0
13604,DB07230,3-BROMO-6-HYDROXY-2-(4-HYDROXYPHENYL)-1H-INDEN-1-ONE,SmallMoleculeDrug,Q92731,Estrogen receptor beta,ESR2,530.0
13605,DB07230,3-BROMO-6-HYDROXY-2-(4-HYDROXYPHENYL)-1H-INDEN-1-ONE,SmallMoleculeDrug,Q15788,Nuclear receptor coactivator 1,NCOA1,1441.0
13606,DB07231,"N-({(2S,3S)-3-[(BENZYLAMINO)CARBONYL]OXIRAN-2-YL}CARBONYL)-L-ISOLEUCYL-L-PROLINE",SmallMoleculeDrug,P07858,Cathepsin B,CTSB,339.0
13607,DB07232,Veliparib,SmallMoleculeDrug,P09874,Poly [ADP-ribose] polymerase 1,PARP1,1014.0
13608,DB07232,Veliparib,SmallMoleculeDrug,Q9UGN5,Poly [ADP-ribose] polymerase 2,PARP2,583.0
13609,DB07233,N-{[4-(but-2-yn-1-yloxy)phenyl]sulfonyl}-5-methyl-D-tryptophan,SmallMoleculeDrug,P78536,Disintegrin and metalloproteinase domain-containing protein 17,ADAM17,824.0
13610,DB07234,"3-{[(1R)-1-phenylethyl]amino}-4-(pyridin-4-ylamino)cyclobut-3-ene-1,2-dione",SmallMoleculeDrug,P49137,MAP kinase-activated protein kinase 2,MAPKAPK2,400.0
13611,DB07235,"N-[(1S)-2-AMINO-1-(2,4-DICHLOROBENZYL)ETHYL]-5-[2-(METHYLAMINO)PYRIMIDIN-4-YL]THIOPHENE-2-CARBOXAMIDE",SmallMoleculeDrug,P17612,cAMP-dependent protein kinase catalytic subunit alpha,PRKACA,351.0
13612,DB07236,3-(6-HYDROXY-NAPHTHALEN-2-YL)-BENZO[D]ISOOXAZOL-6-OL,SmallMoleculeDrug,Q92731,Estrogen receptor beta,ESR2,530.0
13613,DB07236,3-(6-HYDROXY-NAPHTHALEN-2-YL)-BENZO[D]ISOOXAZOL-6-OL,SmallMoleculeDrug,Q15788,Nuclear receptor coactivator 1,NCOA1,1441.0
13614,DB07237,{4-[(2R)-pyrrolidin-2-ylmethoxy]phenyl}(4-thiophen-3-ylphenyl)methanone,SmallMoleculeDrug,P09960,Leukotriene A-4 hydrolase,LTA4H,611.0
13617,DB07239,7-(aminomethyl)-6-(2-chlorophenyl)-1-methyl-1H-benzimidazole-5-carbonitrile,SmallMoleculeDrug,P27487,Dipeptidyl peptidase 4,DPP4,766.0
13619,DB07242,"(4R)-7,8-dichloro-1',9-dimethyl-1-oxo-1,2,4,9-tetrahydrospiro[beta-carboline-3,4'-piperidine]-4-carbonitrile",SmallMoleculeDrug,O43293,Death-associated protein kinase 3,DAPK3,454.0
13620,DB07242,"(4R)-7,8-dichloro-1',9-dimethyl-1-oxo-1,2,4,9-tetrahydrospiro[beta-carboline-3,4'-piperidine]-4-carbonitrile",SmallMoleculeDrug,P11309,Serine/threonine-protein kinase pim-1,PIM1,404.0
13621,DB07243,"(3-ENDO)-8-METHYL-8-AZABICYCLO[3.2.1]OCT-3-YL 1H-PYRROLO[2,3-B]PYRIDINE-3-CARBOXYLATE",SmallMoleculeDrug,O14757,Serine/threonine-protein kinase Chk1,CHEK1,476.0
13622,DB07244,"5-{4-[(3,5-DIFLUOROBENZYL)AMINO]PHENYL}-6-ETHYLPYRIMIDINE-2,4-DIAMINE",SmallMoleculeDrug,P29474,"Nitric oxide synthase, endothelial",NOS3,1203.0
13623,DB07244,"5-{4-[(3,5-DIFLUOROBENZYL)AMINO]PHENYL}-6-ETHYLPYRIMIDINE-2,4-DIAMINE",SmallMoleculeDrug,P00797,Renin,REN,406.0
13624,DB07245,6-[2-(3'-METHOXYBIPHENYL-3-YL)ETHYL]PYRIDIN-2-AMINE,SmallMoleculeDrug,P56817,Beta-secretase 1,BACE1,501.0
13625,DB07246,"(2R)-2-AMINO-3,3,3-TRIFLUORO-N-HYDROXY-2-{[(4-PHENOXYPHENYL)SULFONYL]METHYL}PROPANAMIDE",SmallMoleculeDrug,P14780,Matrix metalloproteinase-9,MMP9,707.0
13626,DB07247,"[2'-HYDROXY-3'-(1H-PYRROLO[3,2-C]PYRIDIN-2-YL)-BIPHENYL-3-YLMETHYL]-UREA",SmallMoleculeDrug,P08709,Coagulation factor VII,F7,466.0
13627,DB07247,"[2'-HYDROXY-3'-(1H-PYRROLO[3,2-C]PYRIDIN-2-YL)-BIPHENYL-3-YLMETHYL]-UREA",SmallMoleculeDrug,P13726,Tissue factor,F3,295.0
13628,DB07248,"7-PYRIDIN-2-YL-N-(3,4,5-TRIMETHOXYPHENYL)-7H-PYRROLO[2,3-D]PYRIMIDIN-2-AMINE",SmallMoleculeDrug,Q05397,Focal adhesion kinase 1,PTK2,1052.0
13629,DB07249,"N-(5-chloro-1,3-benzodioxol-4-yl)-6-methoxy-7-(3-piperidin-1-ylpropoxy)quinazolin-4-amine",SmallMoleculeDrug,P54760,Ephrin type-B receptor 4,EPHB4,987.0
13630,DB07250,"N'-(5-CHLORO-1,3-BENZODIOXOL-4-YL)-N-(3,4,5- TRIMETHOXYPHENYL)PYRIMIDINE-2,4-DIAMINE",SmallMoleculeDrug,P54760,Ephrin type-B receptor 4,EPHB4,987.0
13631,DB07251,"N'-(3-CHLORO-4-METHOXY-PHENYL)-N-(3,4,5-TRIMETHOXYPHENYL)-1,3,5-TRIAZINE-2,4-DIAMINE",SmallMoleculeDrug,P54760,Ephrin type-B receptor 4,EPHB4,987.0
13632,DB07252,"3-({4-[(5-chloro-1,3-benzodioxol-4-yl)amino]pyrimidin-2-yl}amino)benzenesulfonamide",SmallMoleculeDrug,P54760,Ephrin type-B receptor 4,EPHB4,987.0
13633,DB07253,"N'-(5-chloro-1,3-benzodioxol-4-yl)-N-(3-methylsulfonylphenyl)pyrimidine-2,4-diamine",SmallMoleculeDrug,P54760,Ephrin type-B receptor 4,EPHB4,987.0
13634,DB07254,"N-[3-[[4-[(5-CHLORO-1,3-BENZODIOXOL-4-YL)AMINO]PYRIMIDIN-2-YL]AMINO]PHENYL]METHANESULFONAMIDE",SmallMoleculeDrug,P54760,Ephrin type-B receptor 4,EPHB4,987.0
13635,DB07255,"N'-(5-CHLORO-1,3-BENZODIOXOL-4-YL)-N-(3-MORPHOLIN-4-YLPHENYL)PYRIMIDINE-2,4-DIAMINE",SmallMoleculeDrug,P54760,Ephrin type-B receptor 4,EPHB4,987.0
13636,DB07256,"3-({4-[(5-CHLORO-1,3-BENZODIOXOL-4-YL)AMINO]PYRIMIDIN-2-YL}AMINO)BENZAMIDE",SmallMoleculeDrug,P54760,Ephrin type-B receptor 4,EPHB4,987.0
13637,DB07257,"4-(2-chlorophenyl)-8-(2-hydroxyethyl)-6-methylpyrrolo[3,4-e]indole-1,3(2H,6H)-dione",SmallMoleculeDrug,P30291,Wee1-like protein kinase,WEE1,646.0
13638,DB07258,(R)-pyridin-4-yl[4-(2-pyrrolidin-1-ylethoxy)phenyl]methanol,SmallMoleculeDrug,P09960,Leukotriene A-4 hydrolase,LTA4H,611.0
13639,DB07259,1-(4-thiophen-2-ylphenyl)methanamine,SmallMoleculeDrug,P09960,Leukotriene A-4 hydrolase,LTA4H,611.0
13640,DB07260,N-benzyl-4-[(2R)-pyrrolidin-2-ylmethoxy]aniline,SmallMoleculeDrug,P09960,Leukotriene A-4 hydrolase,LTA4H,611.0
13641,DB07261,"THIENO[3,2-B]PYRIDINE-2-SULFONIC ACID [1-(1-AMINO-ISOQUINOLIN-7-YLMETHYL)-2-OXO-PYRROLDIN-3-YL]-AMIDE",SmallMoleculeDrug,P00742,Coagulation factor X,F10,488.0
13643,DB07263,"[{2-bromo-4-[(2R)-3-oxo-2,3-diphenylpropyl]phenyl}(difluoro)methyl]phosphonic acid",SmallMoleculeDrug,P18031,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,435.0
13644,DB07264,(S)-N-(1-(3-CHLORO-4-FLUOROPHENYL)-2-HYDROXYETHYL)-4-(4-(3-CHLOROPHENYL)-1H-PYRAZOL-3-YL)-1H-PYRROLE-2-CARBOXAMIDE,SmallMoleculeDrug,P28482,Mitogen-activated protein kinase 1,MAPK1,360.0
13645,DB07265,"3-(9-HYDROXY-1,3-DIOXO-4-PHENYL-2,3-DIHYDROPYRROLO[3,4-C]CARBAZOL-6(1H)-YL)PROPANOIC ACID",SmallMoleculeDrug,P30291,Wee1-like protein kinase,WEE1,646.0
13646,DB07266,"8-ethyl-3,10,10-trimethyl-4,5,6,8,10,12-hexahydropyrazolo[4',3':6,7]cyclohepta[1,2-b]pyrrolo[2,3-f]indol-9(1H)-one",SmallMoleculeDrug,O14965,Aurora kinase A,AURKA,403.0
13647,DB07267,2-(6-methylpyridin-2-yl)-N-pyridin-4-ylquinazolin-4-amine,SmallMoleculeDrug,P36897,TGF-beta receptor type-1,TGFBR1,503.0
13648,DB07268,2-({2-[(3-HYDROXYPHENYL)AMINO]PYRIMIDIN-4-YL}AMINO)BENZAMIDE,SmallMoleculeDrug,P45983,Mitogen-activated protein kinase 8,MAPK8,427.0
13649,DB07269,(2S)-2-[3-(AMINOMETHYL)PHENYL]-3-[(R)-[(1R)-1-{[(BENZYLOXY)CARBONYL]AMINO}-2-METHYLPROPYL](HYDROXY)PHOSPHORYL]PROPANOIC ACID,SmallMoleculeDrug,P15086,Carboxypeptidase B,CPB1,417.0
13650,DB07270,"N-[7-(3-AMINOPHENYL)-5-METHOXY-1,3-BENZOXAZOL-2-YL]-2,5-DICHLOROBENZENESULFONAMIDE",SmallMoleculeDrug,P09467,"Fructose-1,6-bisphosphatase 1",FBP1,338.0
13651,DB07271,"(3R)-4-[(3R)-3-AMINO-4-(2,4,5-TRIFLUOROPHENYL)BUTANOYL]-3-(2,2,2-TRIFLUOROETHYL)-1,4-DIAZEPAN-2-ONE",SmallMoleculeDrug,P27487,Dipeptidyl peptidase 4,DPP4,766.0
13652,DB07272,"N-(4-AMINO-5-CYANO-6-ETHOXYPYRIDIN-2-YL)-2-(4-BROMO-2,5-DIMETHOXYPHENYL)ACETAMIDE",SmallMoleculeDrug,Q9UQF2,C-Jun-amino-terminal kinase-interacting protein 1,MAPK8IP1,711.0
13653,DB07272,"N-(4-AMINO-5-CYANO-6-ETHOXYPYRIDIN-2-YL)-2-(4-BROMO-2,5-DIMETHOXYPHENYL)ACETAMIDE",SmallMoleculeDrug,P45983,Mitogen-activated protein kinase 8,MAPK8,427.0
13655,DB07274,"N-cyclopropyl-6-[(6,7-dimethoxyquinolin-4-yl)oxy]naphthalene-1-carboxamide",SmallMoleculeDrug,P35968,Vascular endothelial growth factor receptor 2,KDR,1356.0
13657,DB07276,"5-CYANO-N-(2,5-DIMETHOXYBENZYL)-6-ETHOXYPYRIDINE-2-CARBOXAMIDE",SmallMoleculeDrug,Q9UQF2,C-Jun-amino-terminal kinase-interacting protein 1,MAPK8IP1,711.0
13658,DB07276,"5-CYANO-N-(2,5-DIMETHOXYBENZYL)-6-ETHOXYPYRIDINE-2-CARBOXAMIDE",SmallMoleculeDrug,P45983,Mitogen-activated protein kinase 8,MAPK8,427.0
13659,DB07277,2-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}ETHANESULFONAMIDE,SmallMoleculeDrug,P00734,Prothrombin,F2,622.0
13660,DB07277,2-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}ETHANESULFONAMIDE,SmallMoleculeDrug,P00742,Coagulation factor X,F10,488.0
13661,DB07278,2-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}ETHENESULFONAMIDE,SmallMoleculeDrug,P00734,Prothrombin,F2,622.0
13662,DB07278,2-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}ETHENESULFONAMIDE,SmallMoleculeDrug,P00742,Coagulation factor X,F10,488.0
13663,DB07279,N-ETHYL-N-ISOPROPYL-3-METHYL-5-{[(2S)-2-(PYRIDIN-4-YLAMINO)PROPYL]OXY}BENZAMIDE,SmallMoleculeDrug,P00734,Prothrombin,F2,622.0
13664,DB07280,5-[4-(DIMETHYLAMINO)PHENYL]-6-[(6-MORPHOLIN-4-YLPYRIDIN-3-YL)ETHYNYL]PYRIMIDIN-4-AMINE,SmallMoleculeDrug,P55263,Adenosine kinase,ADK,362.0
13665,DB07281,"N~3~-BENZYLPYRIDINE-2,3-DIAMINE",SmallMoleculeDrug,P56817,Beta-secretase 1,BACE1,501.0
13666,DB07284,"N~3~-(3-PYRIDIN-3-YLBENZYL)PYRIDINE-2,3-DIAMINE",SmallMoleculeDrug,P56817,Beta-secretase 1,BACE1,501.0
13667,DB07285,"(3R)-4,4-DIFLUORO-3-[(4-METHOXYPHENYL)SULFONYL]BUTANOIC ACID",SmallMoleculeDrug,P14780,Matrix metalloproteinase-9,MMP9,707.0
13668,DB07286,"2-CHLORO-4-[(7R,7AS)-7-HYDROXY-1,3-DIOXOTETRAHYDRO-1H-PYRROLO[1,2-C]IMIDAZOL-2(3H)-YL]-3-METHYLBENZONITRILE",SmallMoleculeDrug,P10275,Androgen receptor,AR,920.0
13670,DB07288,N-(4-chlorophenyl)-2-[(pyridin-4-ylmethyl)amino]benzamide,SmallMoleculeDrug,P17948,Vascular endothelial growth factor receptor 1,FLT1,1338.0
13671,DB07289,5-[3-(BENZYLAMINO)PHENYL]-4-BROMO-3-(CARBOXYMETHOXY)THIOPHENE-2-CARBOXYLIC ACID,SmallMoleculeDrug,P18031,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,435.0
13674,DB07292,"4-(2-amino-1,3-thiazol-4-yl)phenol",SmallMoleculeDrug,P09960,Leukotriene A-4 hydrolase,LTA4H,611.0
13676,DB07294,"3-FLUORO-4-[2-HYDROXY-2-(5,5,8,8-TETRAMETHYL-5,6,7,8,-TETRAHYDRO-NAPHTALEN-2-YL)-ACETYLAMINO]-BENZOIC ACID",SmallMoleculeDrug,P13631,Retinoic acid receptor gamma,RARG,454.0
13677,DB07295,2-[(7-HYDROXY-NAPHTHALEN-1-YL)-OXALYL-AMINO]-BENZOIC ACID,SmallMoleculeDrug,P18031,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,435.0
13679,DB07297,"5,6-DIPHENYL-N-(2-PIPERAZIN-1-YLETHYL)FURO[2,3-D]PYRIMIDIN-4-AMINE",SmallMoleculeDrug,P06239,Tyrosine-protein kinase Lck,LCK,509.0
13680,DB07298,"3-(CARBOXYMETHOXY)THIENO[2,3-B]PYRIDINE-2-CARBOXYLIC ACID",SmallMoleculeDrug,P18031,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,435.0
13681,DB07299,4-METHYL-PENTANOIC ACID {1-[4-GUANIDINO-1-(THIAZOLE-2-CARBONYL)-BUTYLCARBAMOYL]-2-METHYL-PROPYL}-AMIDE,SmallMoleculeDrug,P03951,Coagulation factor XI,F11,625.0
13682,DB07300,"2-(1H-imidazol-1-yl)-9-methoxy-8-(2-methoxyethoxy)benzo[c][2,7]naphthyridin-4-amine",SmallMoleculeDrug,O15530,3-phosphoinositide-dependent protein kinase 1,PDPK1,556.0
13685,DB07302,"(9S,10E,12Z)-9-hydroxyoctadeca-10,12-dienoic acid",SmallMoleculeDrug,P37231,Peroxisome proliferator-activated receptor gamma,PPARG,505.0
13686,DB07303,"N~3~-[3-(5-METHOXYPYRIDIN-3-YL)BENZYL]PYRIDINE-2,3-DIAMINE",SmallMoleculeDrug,P56817,Beta-secretase 1,BACE1,501.0
13689,DB07306,ETHYL 4-[(4-CHLOROPYRIDIN-2-YL)AMINO]PIPERIDINE-1-CARBOXYLATE,SmallMoleculeDrug,P35228,"Nitric oxide synthase, inducible",NOS2,1153.0
13690,DB07307,N-cyclopropyl-4-methyl-3-[1-(2-methylphenyl)phthalazin-6-yl]benzamide,SmallMoleculeDrug,Q16539,Mitogen-activated protein kinase 14,MAPK14,360.0
13692,DB07309,5-BROMO-2-{[(4-CHLOROPHENYL)SULFONYL]AMINO}BENZOIC ACID,SmallMoleculeDrug,P50579,Methionine aminopeptidase 2,METAP2,478.0
13693,DB07310,"(5S)-2-{[(1S)-1-(2-fluorophenyl)ethyl]amino}-5-methyl-5-(trifluoromethyl)-1,3-thiazol-4(5H)-one",SmallMoleculeDrug,P28845,Corticosteroid 11-beta-dehydrogenase isozyme 1,HSD11B1,292.0
13694,DB07311,"18-CHLORO-11,12,13,14-TETRAHYDRO-1H,10H-8,4-(AZENO)-9,15,1,3,6-BENZODIOXATRIAZACYCLOHEPTADECIN-2-ONE",SmallMoleculeDrug,O14757,Serine/threonine-protein kinase Chk1,CHEK1,476.0
13695,DB07312,"2,5-DICHLORO-N-(5-CHLORO-1,3-BENZOXAZOL-2-YL)BENZENESULFONAMIDE",SmallMoleculeDrug,P09467,"Fructose-1,6-bisphosphatase 1",FBP1,338.0
13696,DB07313,5-METHYL-2-[(PHENYLSULFONYL)AMINO]BENZOIC ACID,SmallMoleculeDrug,P50579,Methionine aminopeptidase 2,METAP2,478.0
13697,DB07314,"1-(5-CHLORO-2,4-DIMETHOXYPHENYL)-3-(5-CYANOPYRAZIN-2-YL)UREA",SmallMoleculeDrug,O14757,Serine/threonine-protein kinase Chk1,CHEK1,476.0
13698,DB07315,"5-chloro-N-{4-[(1R)-1,2-dihydroxyethyl]phenyl}-1H-indole-2-carboxamide",SmallMoleculeDrug,P06737,"Glycogen phosphorylase, liver form",PYGL,847.0
13699,DB07316,"N-{1-[(1-carbamoylcyclopropyl)methyl]piperidin-4-yl}-N-cyclopropyl-4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]benzamide",SmallMoleculeDrug,P28845,Corticosteroid 11-beta-dehydrogenase isozyme 1,HSD11B1,292.0
13700,DB07317,(3E)-3-[(phenylamino)methylidene]dihydrofuran-2(3H)-one,SmallMoleculeDrug,P07900,Heat shock protein HSP 90-alpha,HSP90AA1,732.0
13701,DB07318,"N-[2-(4-AMINO-5,8-DIFLUORO-1,2-DIHYDROQUINAZOLIN-2-YL)ETHYL]-3-FURAMIDE",SmallMoleculeDrug,P35228,"Nitric oxide synthase, inducible",NOS2,1153.0
13702,DB07319,"6-(3-BROMO-2-NAPHTHYL)-1,3,5-TRIAZINE-2,4-DIAMINE",SmallMoleculeDrug,P07900,Heat shock protein HSP 90-alpha,HSP90AA1,732.0
13703,DB07320,"4-(6-{[(4-METHYLCYCLOHEXYL)AMINO]METHYL}-1,4-DIHYDROINDENO[1,2-C]PYRAZOL-3-YL)BENZOIC ACID",SmallMoleculeDrug,O14757,Serine/threonine-protein kinase Chk1,CHEK1,476.0
13704,DB07321,"2,5-DICHLORO-N-[5-METHOXY-7-(6-METHOXYPYRIDIN-3-YL)-1,3-BENZOXAZOL-2-YL]BENZENESULFONAMIDE",SmallMoleculeDrug,P09467,"Fructose-1,6-bisphosphatase 1",FBP1,338.0
13705,DB07322,"2-[(PHENYLSULFONYL)AMINO]-5,6,7,8-TETRAHYDRONAPHTHALENE-1-CARBOXYLIC ACID",SmallMoleculeDrug,P50579,Methionine aminopeptidase 2,METAP2,478.0
13706,DB07323,"2-[({2-[(1Z)-3-(DIMETHYLAMINO)PROP-1-ENYL]-4-FLUOROPHENYL}SULFONYL)AMINO]-5,6,7,8-TETRAHYDRONAPHTHALENE-1-CARBOXYLIC ACID",SmallMoleculeDrug,P50579,Methionine aminopeptidase 2,METAP2,478.0
13707,DB07324,"3-({2-[(2-AMINO-6-METHYLPYRIMIDIN-4-YL)ETHYNYL]BENZYL}AMINO)-1,3-OXAZOL-2(3H)-ONE",SmallMoleculeDrug,P07900,Heat shock protein HSP 90-alpha,HSP90AA1,732.0
13708,DB07325,N-[(2-AMINO-6-METHYLPYRIMIDIN-4-YL)METHYL]-3-{[(E)-(2-OXODIHYDROFURAN-3(2H)-YLIDENE)METHYL]AMINO}BENZENESULFONAMIDE,SmallMoleculeDrug,P07900,Heat shock protein HSP 90-alpha,HSP90AA1,732.0
13709,DB07326,"6-chloro-N-pyrimidin-5-yl-3-{[3-(trifluoromethyl)phenyl]amino}-1,2-benzisoxazole-7-carboxamide",SmallMoleculeDrug,P35968,Vascular endothelial growth factor receptor 2,KDR,1356.0
13712,DB07328,"METHYL 4-{[({[(2R,5S)-5-{[(2S)-2-(AMINOMETHYL)PYRROLIDIN-1-YL]CARBONYL}PYRROLIDIN-2-YL]METHYL}AMINO)CARBONYL]AMINO}BENZOATE",SmallMoleculeDrug,P27487,Dipeptidyl peptidase 4,DPP4,766.0
13713,DB07329,1-[N-4'-NITROBENZYL-N-4'-CARBOXYBUTYLAMINO]METHYLPHOSPHONIC ACID,SmallMoleculeDrug,P01859,Ig gamma-2 chain C region,IGHG2,326.0
13714,DB07330,trans-4-(7-carbamoyl-1H-benzimidazol-2-yl)-1-propylpiperidinium,SmallMoleculeDrug,P09874,Poly [ADP-ribose] polymerase 1,PARP1,1014.0
13718,DB07333,"N-(CYCLOPROPYLMETHYL)-4-(METHYLOXY)-3-({5-[3-(3-PYRIDINYL)PHENYL]-1,3-OXAZOL-2-YL}AMINO)BENZENESULFONAMIDE",SmallMoleculeDrug,P35968,Vascular endothelial growth factor receptor 2,KDR,1356.0
13719,DB07334,"N-[5-(ETHYLSULFONYL)-2-METHOXYPHENYL]-5-[3-(2-PYRIDINYL)PHENYL]-1,3-OXAZOL-2-AMINE",SmallMoleculeDrug,P35968,Vascular endothelial growth factor receptor 2,KDR,1356.0
13720,DB07335,"3-[4-AMINO-1-(1-METHYLETHYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-3-YL]PHENOL",SmallMoleculeDrug,P48736,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",PIK3CG,1102.0
13721,DB07335,"3-[4-AMINO-1-(1-METHYLETHYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-3-YL]PHENOL",SmallMoleculeDrug,P12931,Proto-oncogene tyrosine-protein kinase Src,SRC,536.0
13722,DB07336,4-[3-(1H-BENZIMIDAZOL-2-YL)-1H-INDAZOL-6-YL]-2-METHOXYPHENOL,SmallMoleculeDrug,O14757,Serine/threonine-protein kinase Chk1,CHEK1,476.0
13726,DB07339,"(3S)-3-hydroxy-1-methyl-2,3-dihydro-1H-indole-5,6-dione",SmallMoleculeDrug,P16083,Ribosyldihydronicotinamide dehydrogenase [quinone],NQO2,231.0
13727,DB07340,"N~6~-cyclohexyl-N~2~-(4-morpholin-4-ylphenyl)-9H-purine-2,6-diamine",SmallMoleculeDrug,Q96GD4,Aurora kinase B,AURKB,344.0
13728,DB07340,"N~6~-cyclohexyl-N~2~-(4-morpholin-4-ylphenyl)-9H-purine-2,6-diamine",SmallMoleculeDrug,Q9NQS7,Inner centromere protein,INCENP,918.0
13729,DB07341,"octyl 3-amino-3-deoxy-2-O-(2,6-dideoxy-alpha-L-lyxo-hexopyranosyl)-beta-D-galactopyranoside",SmallMoleculeDrug,P16442,Histo-blood group ABO system transferase,ABO,354.0
13730,DB07342,1-(adamantan-1-yl)-2-(1H-imidazol-1-yl)ethanone,SmallMoleculeDrug,P09601,Heme oxygenase 1,HMOX1,288.0
13732,DB07344,"3,6,9,12,15-PENTAOXAHEPTADECAN-1-OL",SmallMoleculeDrug,Q8IVS2,"Malonyl-CoA-acyl carrier protein transacylase, mitochondrial",MCAT,390.0
13733,DB07345,4-(2-aminoethyl)-2-cyclohexylphenol,SmallMoleculeDrug,P56817,Beta-secretase 1,BACE1,501.0
13734,DB07346,4-(2-aminoethyl)-2-ethylphenol,SmallMoleculeDrug,P56817,Beta-secretase 1,BACE1,501.0
13735,DB07347,4-(2-AMINOETHYL)BENZENESULFONYL FLUORIDE,SmallMoleculeDrug,P04406,Glyceraldehyde-3-phosphate dehydrogenase,GAPDH,335.0
13736,DB07347,4-(2-AMINOETHYL)BENZENESULFONYL FLUORIDE,SmallMoleculeDrug,P21281,"V-type proton ATPase subunit B, brain isoform",ATP6V1B2,511.0
13737,DB07348,"1,6,7,8,9,11A,12,13,14,14A-DECAHYDRO-1,13-DIHYDROXY-6-METHYL-4H-CYCLOPENT[F]OXACYCLOTRIDECIN-4-ONE",SmallMoleculeDrug,Q99418,Cytohesin-2,CYTH2,400.0
13738,DB07348,"1,6,7,8,9,11A,12,13,14,14A-DECAHYDRO-1,13-DIHYDROXY-6-METHYL-4H-CYCLOPENT[F]OXACYCLOTRIDECIN-4-ONE",SmallMoleculeDrug,P84077,ADP-ribosylation factor 1,ARF1,181.0
13743,DB07350,(2E)-N-hydroxy-3-[1-methyl-4-(phenylacetyl)-1H-pyrrol-2-yl]prop-2-enamide,SmallMoleculeDrug,Q9BY41,Histone deacetylase 8,HDAC8,377.0
13744,DB07351,O-(((1R)-((N-(PHENYL-METHOXY-CARBONYL)-ALANYL)-AMINO)METHYL)HYDROXYPHOSPHINYL)3-L-PHENYLLACTATE,SmallMoleculeDrug,P15085,Carboxypeptidase A1,CPA1,419.0
13746,DB07353,"4-(2,5-DIAMINO-5-HYDROXY-PENTYL)-PHENOL",SmallMoleculeDrug,P00734,Prothrombin,F2,622.0
13747,DB07354,"2,3-DIMETHOXY-12H-[1,3]DIOXOLO[5,6]INDENO[1,2-C]ISOQUINOLIN-6-IUM",SmallMoleculeDrug,P11387,DNA topoisomerase 1,TOP1,765.0
13749,DB07356,"(1S)-2-[(2S,5R)-2-(AMINOMETHYL)-5-ETHYNYLPYRROLIDIN-1-YL]-1-CYCLOPENTYL-2-OXOETHANAMINE",SmallMoleculeDrug,P27487,Dipeptidyl peptidase 4,DPP4,766.0
13750,DB07357,"4-AMINO-2-HEXYLOXY-6-HYDROXYMETHYL-TETRAHYDRO-PYRAN-3,5-DIOL",SmallMoleculeDrug,P16442,Histo-blood group ABO system transferase,ABO,354.0
13751,DB07358,"2-amino-N-(4-methyl-1,3-thiazol-2-yl)-5-[(4-methyl-4H-1,2,4-triazol-3-yl)sulfanyl]benzamide",SmallMoleculeDrug,P35557,Glucokinase,GCK,465.0
13752,DB07359,"3-[(4-fluorophenyl)sulfanyl]-N-(4-methyl-1,3-thiazol-2-yl)-6-[(4-methyl-4H-1,2,4-triazol-3-yl)sulfanyl]pyridine-2-carboxamide",SmallMoleculeDrug,P35557,Glucokinase,GCK,465.0
13753,DB07360,"1-{5-[2-(thieno[3,2-d]pyrimidin-4-ylamino)ethyl]-1,3-thiazol-2-yl}-3-[3-(trifluoromethyl)phenyl]urea",SmallMoleculeDrug,O14965,Aurora kinase A,AURKA,403.0
13754,DB07361,"1-(3-chlorophenyl)-3-{5-[2-(thieno[3,2-d]pyrimidin-4-ylamino)ethyl]-1,3-thiazol-2-yl}urea",SmallMoleculeDrug,O14965,Aurora kinase A,AURKA,403.0
13755,DB07362,"1-(5-{2-[(1-methyl-1H-pyrazolo[4,3-d]pyrimidin-7-yl)amino]ethyl}-1,3-thiazol-2-yl)-3-[3-(trifluoromethyl)phenyl]urea",SmallMoleculeDrug,O14965,Aurora kinase A,AURKA,403.0
13756,DB07363,"THIOPHENE-2,5-DISULFONIC ACID 2-AMIDE-5-(4-METHYL-BENZYLAMIDE)",SmallMoleculeDrug,P00918,Carbonic anhydrase 2,CA2,260.0
13757,DB07364,"6-PHENYL[5H]PYRROLO[2,3-B]PYRAZINE",SmallMoleculeDrug,Q00535,Cyclin-dependent-like kinase 5,CDK5,292.0
13758,DB07364,"6-PHENYL[5H]PYRROLO[2,3-B]PYRAZINE",SmallMoleculeDrug,Q15078,Cyclin-dependent kinase 5 activator 1,CDK5R1,307.0
13761,DB07366,2-[N'-(4-AMINO-BUTYL)-HYDRAZINOCARBONYL]-PYRROLIDINE-1-CARBOXYLIC ACID BENZYL ESTER,SmallMoleculeDrug,P00734,Prothrombin,F2,622.0
13763,DB07368,4-(METHYLSULFONYL)BENZENECARBOXIMIDAMIDE,SmallMoleculeDrug,P07477,Trypsin-1,PRSS1,247.0
13764,DB07369,"N-(3-chlorophenyl)-N-methyl-2-oxo-3-[(3,4,5-trimethyl-1H-pyrrol-2-yl)methyl]-2H-indole-5-sulfonamide",SmallMoleculeDrug,P08581,Hepatocyte growth factor receptor,MET,1390.0
13766,DB07371,3-(10-METHYL-ANTHRACEN-9-YL)-PROPIONIC ACID,SmallMoleculeDrug,P01857,Ig gamma-1 chain C region,IGHG1,330.0
13768,DB07374,Anisomycin,SmallMoleculeDrug,Q96L21,60S ribosomal protein L10-like,RPL10L,214.0
13769,DB07374,Anisomycin,SmallMoleculeDrug,P40429,60S ribosomal protein L13a,RPL13A,203.0
13770,DB07374,Anisomycin,SmallMoleculeDrug,P62829,60S ribosomal protein L23,RPL23,140.0
13771,DB07374,Anisomycin,SmallMoleculeDrug,P61313,60S ribosomal protein L15,RPL15,204.0
13772,DB07374,Anisomycin,SmallMoleculeDrug,P84098,60S ribosomal protein L19,RPL19,196.0
13773,DB07374,Anisomycin,SmallMoleculeDrug,P62750,60S ribosomal protein L23a,RPL23A,156.0
13774,DB07374,Anisomycin,SmallMoleculeDrug,Q9UHA3,Probable ribosome biogenesis protein RLP24,RSL24D1,163.0
13775,DB07374,Anisomycin,SmallMoleculeDrug,Q9UNX3,60S ribosomal protein L26-like 1,RPL26L1,145.0
13776,DB07374,Anisomycin,SmallMoleculeDrug,P62917,60S ribosomal protein L8,RPL8,257.0
13777,DB07374,Anisomycin,SmallMoleculeDrug,P61927,60S ribosomal protein L37,RPL37,97.0
13778,DB07374,Anisomycin,SmallMoleculeDrug,P39023,60S ribosomal protein L3,RPL3,403.0
13779,DB07374,Anisomycin,SmallMoleculeDrug,P62913,60S ribosomal protein L11,RPL11,178.0
13780,DB07374,Anisomycin,SmallMoleculeDrug,P55769,NHP2-like protein 1,SNU13,128.0
13781,DB07375,"5-BETA-ANDROSTANE-3,17-DIONE",SmallMoleculeDrug,P01859,Ig gamma-2 chain C region,IGHG2,326.0
13782,DB07375,"5-BETA-ANDROSTANE-3,17-DIONE",SmallMoleculeDrug,P01857,Ig gamma-1 chain C region,IGHG1,330.0
13783,DB07375,"5-BETA-ANDROSTANE-3,17-DIONE",SmallMoleculeDrug,P01834,Ig kappa chain C region,IGKC,107.0
13784,DB07375,"5-BETA-ANDROSTANE-3,17-DIONE",SmallMoleculeDrug,P06310,Ig kappa chain V-II region RPMI 6410,IGKV2-30,120.0
13785,DB07376,5-(DIMETHYLAMINO)-1-NAPHTHALENESULFONIC ACID(DANSYL ACID),SmallMoleculeDrug,P00734,Prothrombin,F2,622.0
13786,DB07376,5-(DIMETHYLAMINO)-1-NAPHTHALENESULFONIC ACID(DANSYL ACID),SmallMoleculeDrug,P08709,Coagulation factor VII,F7,466.0
13787,DB07377,"N'-((2S,3R)-3-AMINO-2-HYDROXY-5-(ISOPROPYLSULFANYL)PENTANOYL)-N-3-CHLOROBENZOYL HYDRAZIDE",SmallMoleculeDrug,P50579,Methionine aminopeptidase 2,METAP2,478.0
13788,DB07378,"4-AMINO-2-OCTYLOXY-6-HYDROXYMETHYL-TETRAHYDRO-PYRAN-3,5-DIOL",SmallMoleculeDrug,P16442,Histo-blood group ABO system transferase,ABO,354.0
13789,DB07379,(2S)-2-({6-[(3-amino-5-chlorophenyl)amino]-9-isopropyl-9H-purin-2-yl}amino)-3-methylbutan-1-ol,SmallMoleculeDrug,Q00534,Cyclin-dependent kinase 6,CDK6,326.0
13791,DB07380,"1,1,1-TRIFLUORO-3-ACETAMIDO-4-PHENYL BUTAN-2-ONE(N-ACETYL-L-PHENYLALANYL TRIFLUOROMETHYL KETONE)",SmallMoleculeDrug,P17538,Chymotrypsinogen B,CTRB1,263.0
13793,DB07382,"N~2~-1H-benzimidazol-5-yl-N~4~-(3-cyclopropyl-1H-pyrazol-5-yl)pyrimidine-2,4-diamine",SmallMoleculeDrug,O75460,Serine/threonine-protein kinase/endoribonuclease IRE1,ERN1,977.0
13794,DB07383,"N-(1-BENZYL-3,3,3-TRIFLUORO-2,2-DIHYDROXY-PROPYL)-ACETAMIDE",SmallMoleculeDrug,P17538,Chymotrypsinogen B,CTRB1,263.0
13795,DB07384,1-ACETYL-2-CARBOXYPIPERIDINE,SmallMoleculeDrug,P25705,"ATP synthase subunit alpha, mitochondrial",ATP5A1,553.0
13796,DB07384,1-ACETYL-2-CARBOXYPIPERIDINE,SmallMoleculeDrug,P06576,"ATP synthase subunit beta, mitochondrial",ATP5B,529.0
13797,DB07384,1-ACETYL-2-CARBOXYPIPERIDINE,SmallMoleculeDrug,P36542,"ATP synthase subunit gamma, mitochondrial",ATP5C1,298.0
13798,DB07385,"3-(HYDROXYMETHYL)-1-METHYL-5-(2-METHYLAZIRIDIN-1-YL)-2-PHENYL-1H-INDOLE-4,7-DIONE",SmallMoleculeDrug,P15559,NAD(P)H dehydrogenase [quinone] 1,NQO1,274.0
13799,DB07387,3-(BUTYLSULPHONYL)-PROPANOIC ACID,SmallMoleculeDrug,P60174,Triosephosphate isomerase,TPI1,286.0
13800,DB07388,ETHYL 4-[(4-METHYLPYRIDIN-2-YL)AMINO]PIPERIDINE-1-CARBOXYLATE,SmallMoleculeDrug,P35228,"Nitric oxide synthase, inducible",NOS2,1153.0
13801,DB07388,ETHYL 4-[(4-METHYLPYRIDIN-2-YL)AMINO]PIPERIDINE-1-CARBOXYLATE,SmallMoleculeDrug,P29474,"Nitric oxide synthase, endothelial",NOS3,1203.0
13802,DB07389,N-[2-(6-AMINO-4-METHYLPYRIDIN-2-YL)ETHYL]-4-CYANOBENZAMIDE,SmallMoleculeDrug,P35228,"Nitric oxide synthase, inducible",NOS2,1153.0
13803,DB07390,"2-[3-(5-MERCAPTO-[1,3,4]THIADIAZOL-2-YL)-UREIDO]-N-METHYL-3-PHENYL-PROPIONAMIDE",SmallMoleculeDrug,P08254,Stromelysin-1,MMP3,477.0
13809,DB07393,"2-(2-PHENYL-3-PYRIDIN-2-YL-4,5,6,7-TETRAHYDRO-2H-ISOPHOSPHINDOL-1-YL)PYRIDINE",SmallMoleculeDrug,P00390,"Glutathione reductase, mitochondrial",GSR,522.0
13810,DB07394,AUROVERTIN B,SmallMoleculeDrug,P25705,"ATP synthase subunit alpha, mitochondrial",ATP5A1,553.0
13811,DB07394,AUROVERTIN B,SmallMoleculeDrug,P06576,"ATP synthase subunit beta, mitochondrial",ATP5B,529.0
13812,DB07394,AUROVERTIN B,SmallMoleculeDrug,P36542,"ATP synthase subunit gamma, mitochondrial",ATP5C1,298.0
13813,DB07395,"4-[3-(2-Chloro-4,5-difluoro-benzoyl)ureido]-3-trifluoromethoxybenzoic acid",SmallMoleculeDrug,P06737,"Glycogen phosphorylase, liver form",PYGL,847.0
13814,DB07396,"1-{2-[3-(2-Chloro-4,5-difluoro-benzoyl)-ureido]-4-fluoro-phenyl}-piperidine-4-carboxylic acid",SmallMoleculeDrug,P06737,"Glycogen phosphorylase, liver form",PYGL,847.0
13815,DB07397,"(5S)-5-(2-amino-2-oxoethyl)-4-oxo-N-[(3-oxo-3,4-dihydro-2H-1,4-benzoxazin-6-yl)methyl]-3,4,5,6,7,8-hexahydro[1]benzothieno[2,3-d]pyrimidine-2-carboxamide",SmallMoleculeDrug,P22894,Neutrophil collagenase,MMP8,467.0
13817,DB07400,1-ETHOXYCARBONYL-D-PHE-PRO-2(4-AMINOBUTYL)HYDRAZINE,SmallMoleculeDrug,P00734,Prothrombin,F2,622.0
13818,DB07401,METHYL (2Z)-2-(2-{[6-(2-CYANOPHENOXY)PYRIMIDIN-4-YL]OXY}PHENYL)-3-METHOXYACRYLATE,SmallMoleculeDrug,P08574,"Cytochrome c1, heme protein, mitochondrial",CYC1,325.0
13819,DB07401,METHYL (2Z)-2-(2-{[6-(2-CYANOPHENOXY)PYRIMIDIN-4-YL]OXY}PHENYL)-3-METHOXYACRYLATE,SmallMoleculeDrug,P00156,Cytochrome b,MT-CYB,380.0
13820,DB07401,METHYL (2Z)-2-(2-{[6-(2-CYANOPHENOXY)PYRIMIDIN-4-YL]OXY}PHENYL)-3-METHOXYACRYLATE,SmallMoleculeDrug,P31930,"Cytochrome b-c1 complex subunit 1, mitochondrial",UQCRC1,480.0
13821,DB07401,METHYL (2Z)-2-(2-{[6-(2-CYANOPHENOXY)PYRIMIDIN-4-YL]OXY}PHENYL)-3-METHOXYACRYLATE,SmallMoleculeDrug,P22695,"Cytochrome b-c1 complex subunit 2, mitochondrial",UQCRC2,453.0
13822,DB07401,METHYL (2Z)-2-(2-{[6-(2-CYANOPHENOXY)PYRIMIDIN-4-YL]OXY}PHENYL)-3-METHOXYACRYLATE,SmallMoleculeDrug,P07919,"Cytochrome b-c1 complex subunit 6, mitochondrial",UQCRH,91.0
13823,DB07401,METHYL (2Z)-2-(2-{[6-(2-CYANOPHENOXY)PYRIMIDIN-4-YL]OXY}PHENYL)-3-METHOXYACRYLATE,SmallMoleculeDrug,O14949,Cytochrome b-c1 complex subunit 8,UQCRQ,82.0
13824,DB07401,METHYL (2Z)-2-(2-{[6-(2-CYANOPHENOXY)PYRIMIDIN-4-YL]OXY}PHENYL)-3-METHOXYACRYLATE,SmallMoleculeDrug,P47985,"Cytochrome b-c1 complex subunit Rieske, mitochondrial",UQCRFS1,274.0
13825,DB07401,METHYL (2Z)-2-(2-{[6-(2-CYANOPHENOXY)PYRIMIDIN-4-YL]OXY}PHENYL)-3-METHOXYACRYLATE,SmallMoleculeDrug,O14957,Cytochrome b-c1 complex subunit 10,UQCR11,56.0
13826,DB07401,METHYL (2Z)-2-(2-{[6-(2-CYANOPHENOXY)PYRIMIDIN-4-YL]OXY}PHENYL)-3-METHOXYACRYLATE,SmallMoleculeDrug,P14927,Cytochrome b-c1 complex subunit 7,UQCRB,111.0
13827,DB07401,METHYL (2Z)-2-(2-{[6-(2-CYANOPHENOXY)PYRIMIDIN-4-YL]OXY}PHENYL)-3-METHOXYACRYLATE,SmallMoleculeDrug,Q9UDW1,Cytochrome b-c1 complex subunit 9,UQCR10,63.0
13828,DB07403,"4-[(3-CHLORO-4-{[(2R)-3,3,3-TRIFLUORO-2-HYDROXY-2-METHYLPROPANOYL]AMINO}PHENYL)SULFONYL]-N,N-DIMETHYLBENZAMIDE",SmallMoleculeDrug,Q15118,"[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial",PDK1,436.0
13830,DB07405,"1-(6-CYANO-3-PYRIDYLCARBONYL)-5',8'-DIFLUOROSPIRO[PIPERIDINE-4,2'(1'H)-QUINAZOLINE]-4'-AMINE",SmallMoleculeDrug,P35228,"Nitric oxide synthase, inducible",NOS2,1153.0
13831,DB07406,"(4R)-N-[4-({[2-(DIMETHYLAMINO)ETHYL]AMINO}CARBONYL)-1,3-THIAZOL-2-YL]-4-METHYL-1-OXO-2,3,4,9-TETRAHYDRO-1H-BETA-CARBOLINE-6-CARBOXAMIDE",SmallMoleculeDrug,P49137,MAP kinase-activated protein kinase 2,MAPKAPK2,400.0
13835,DB07410,[2-(3-DIBENZOFURAN-4-YL-PHENYL)-1-HYDROXY-1-PHOSPHONO-ETHYL]-PHOSPHONIC ACID,SmallMoleculeDrug,O95749,Geranylgeranyl pyrophosphate synthase,GGPS1,300.0
13838,DB07412,1-biphenyl-2-ylmethanamine,SmallMoleculeDrug,P27487,Dipeptidyl peptidase 4,DPP4,766.0
13841,DB07415,4-[(1S)-1-(3-fluoro-4-methoxyphenyl)-2-(2-methoxy-5-nitrophenyl)ethyl]-1H-imidazol-2-amine,SmallMoleculeDrug,P56817,Beta-secretase 1,BACE1,501.0
13843,DB07416,(2S)-2-(BUTYRYLOXY)-3-HYDROXYPROPYL NONANOATE,SmallMoleculeDrug,P01834,Ig kappa chain C region,IGKC,107.0
13846,DB07419,(2S)-3-(4-chloro-3-fluorophenoxy)-N-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamide,SmallMoleculeDrug,P10275,Androgen receptor,AR,920.0
13848,DB07421,"4-{[(1R,2S)-1,2-dihydroxy-2-methyl-3-(4-nitrophenoxy)propyl]amino}-2-(trifluoromethyl)benzonitrile",SmallMoleculeDrug,P10275,Androgen receptor,AR,920.0
13849,DB07422,(2S)-2-hydroxy-2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]-3-(pentafluorophenoxy)propanamide,SmallMoleculeDrug,P10275,Androgen receptor,AR,920.0
13850,DB07423,(2S)-3-[4-(acetylamino)phenoxy]-2-hydroxy-2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]propanamide,SmallMoleculeDrug,P10275,Androgen receptor,AR,920.0
13852,DB07425,"{4-[4-hydroxy-3-(1-methylethyl)benzyl]-3,5-dimethylphenoxy}acetic acid",SmallMoleculeDrug,Q59FW3,"Thyroid hormone receptor, alpha isoform 1 variant",nan,397.0
13853,DB07425,"{4-[4-hydroxy-3-(1-methylethyl)benzyl]-3,5-dimethylphenoxy}acetic acid",SmallMoleculeDrug,P10828,Thyroid hormone receptor beta,THRB,461.0
13855,DB07427,2-[(2-methoxy-5-methylphenoxy)methyl]pyridine,SmallMoleculeDrug,P69905,Hemoglobin subunit alpha,HBA1;,142.0
13856,DB07427,2-[(2-methoxy-5-methylphenoxy)methyl]pyridine,SmallMoleculeDrug,P68871,Hemoglobin subunit beta,HBB,147.0
13857,DB07428,4-[(5-methoxy-2-methylphenoxy)methyl]pyridine,SmallMoleculeDrug,P69905,Hemoglobin subunit alpha,HBA1;,142.0
13858,DB07428,4-[(5-methoxy-2-methylphenoxy)methyl]pyridine,SmallMoleculeDrug,P68871,Hemoglobin subunit beta,HBB,147.0
13860,DB07430,"(10R)-10-methyl-3-(6-methylpyridin-3-yl)-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one",SmallMoleculeDrug,P49137,MAP kinase-activated protein kinase 2,MAPKAPK2,400.0
13861,DB07431,"(3R)-3-(aminomethyl)-9-methoxy-1,2,3,4-tetrahydro-5H-[1]benzothieno[3,2-e][1,4]diazepin-5-one",SmallMoleculeDrug,P49137,MAP kinase-activated protein kinase 2,MAPKAPK2,400.0
13862,DB07431,"(3R)-3-(aminomethyl)-9-methoxy-1,2,3,4-tetrahydro-5H-[1]benzothieno[3,2-e][1,4]diazepin-5-one",SmallMoleculeDrug,P24941,Cyclin-dependent kinase 2,CDK2,298.0
13865,DB07433,(TERT-BUTYLOXYCARBONYL)-ALANYL-AMINO ETHYL-FORMAMIDE,SmallMoleculeDrug,Q9UNI1,Chymotrypsin-like elastase family member 1,CELA1,258.0
13867,DB07435,"1,2,3-TRIHYDROXY-1,2,3,4-TETRAHYDROBENZO[A]PYRENE",SmallMoleculeDrug,Q9UBT6,DNA polymerase kappa,POLK,870.0
13871,DB07437,"1-((2-HYDROXYETHOXY)METHYL)-5-BENZYLPYRIMIDINE-2,4(1H,3H)-DIONE",SmallMoleculeDrug,Q16831,Uridine phosphorylase 1,UPP1,310.0
13873,DB07440,4-TERT-BUTYLBENZENESULFONIC ACID,SmallMoleculeDrug,P00734,Prothrombin,F2,622.0
13874,DB07441,"3-{[(9-CYANO-9,10-DIHYDRO-10-METHYLACRIDIN-9-YL)CARBONYL]AMINO}PROPANOIC ACID",SmallMoleculeDrug,P01857,Ig gamma-1 chain C region,IGHG1,330.0
13875,DB07441,"3-{[(9-CYANO-9,10-DIHYDRO-10-METHYLACRIDIN-9-YL)CARBONYL]AMINO}PROPANOIC ACID",SmallMoleculeDrug,P01834,Ig kappa chain C region,IGKC,107.0
13876,DB07443,(2Z)-N-biphenyl-4-yl-2-cyano-3-hydroxybut-2-enamide,SmallMoleculeDrug,Q02127,"Dihydroorotate dehydrogenase (quinone), mitochondrial",DHODH,395.0
13877,DB07444,"6-(3-AMINOPROPYL)-4,9-DIMETHYLPYRROLO[3,4-C]CARBAZOLE-1,3(2H,6H)-DIONE",SmallMoleculeDrug,P53355,Death-associated protein kinase 1,DAPK1,1430.0
13879,DB07446,N-(biphenyl-4-ylsulfonyl)-D-leucine,SmallMoleculeDrug,P39900,Macrophage metalloelastase,MMP12,470.0
13880,DB07447,5-beta-DIHYDROTESTOSTERONE,SmallMoleculeDrug,P51857,3-oxo-5-beta-steroid 4-dehydrogenase,AKR1D1,326.0
13881,DB07448,(2S)-3-[(R)-[(1S)-1-amino-3-phenylpropyl](hydroxy)phosphoryl]-2-benzylpropanoic acid,SmallMoleculeDrug,P28838,Cytosol aminopeptidase,LAP3,519.0
13882,DB07449,N-[(1S)-1-(AMINOCARBONYL)-4-(ETHANIMIDOYLAMINO)BUTYL]BENZAMIDE,SmallMoleculeDrug,Q9UM07,Protein-arginine deiminase type-4,PADI4,663.0
13883,DB07450,"2[4-BROMO-2-FLUOROPHENYL)METHYL]-6-FLUOROSPIRO[ISOQUINOLINE-4-(1H),3'-PYRROLIDINE]-1,2',3,5'(2H)-TETRONE",SmallMoleculeDrug,P15121,Aldose reductase,AKR1B1,316.0
13886,DB07453,2-PHENYL-4H-BENZO[H]CHROMEN-4-ONE,SmallMoleculeDrug,P05177,Cytochrome P450 1A2,CYP1A2,515.0
13887,DB07454,(R)-3-BROMO-2-HYDROXY-2-METHYL-N-[4-NITRO-3-(TRIFLUOROMETHYL)PHENYL]PROPANAMIDE,SmallMoleculeDrug,P10275,Androgen receptor,AR,920.0
13888,DB07455,"N,N'-[biphenyl-4,4'-diyldi(2R)propane-2,1-diyl]dimethanesulfonamide",SmallMoleculeDrug,P42262,Glutamate receptor 2,GRIA2,883.0
13889,DB07456,"3-(1H-INDOL-3-YL)-4-(1-{2-[(2S)-1-METHYLPYRROLIDINYL]ETHYL}-1H-INDOL-3-YL)-1H-PYRROLE-2,5-DIONE",SmallMoleculeDrug,O15530,3-phosphoinositide-dependent protein kinase 1,PDPK1,556.0
13890,DB07457,"3-[1-(3-AMINOPROPYL)-1H-INDOL-3-YL]-4-(1H-INDOL-3-YL)-1H-PYRROLE-2,5-DIONE",SmallMoleculeDrug,O15530,3-phosphoinositide-dependent protein kinase 1,PDPK1,556.0
13891,DB07458,"3-(1H-INDOL-3-YL)-4-{1-[2-(1-METHYLPYRROLIDIN-2-YL)ETHYL]-1H-INDOL-3-YL}-1H-PYRROLE-2,5-DIONE",SmallMoleculeDrug,P17612,cAMP-dependent protein kinase catalytic subunit alpha,PRKACA,351.0
13892,DB07459,4-PHENOXY-N-(PYRIDIN-2-YLMETHYL)BENZAMIDE,SmallMoleculeDrug,Q16539,Mitogen-activated protein kinase 14,MAPK14,360.0
13893,DB07460,2-({5-CHLORO-2-[(2-METHOXY-4-MORPHOLIN-4-YLPHENYL)AMINO]PYRIMIDIN-4-YL}AMINO)-N-METHYLBENZAMIDE,SmallMoleculeDrug,Q05397,Focal adhesion kinase 1,PTK2,1052.0
13894,DB07461,"3-AMINO-3-BENZYL-9-CARBOXAMIDE[4.3.0]BICYCLO-1,6-DIAZANONAN-2-ONE",SmallMoleculeDrug,P00734,Prothrombin,F2,622.0
13895,DB07462,"(3,4-DIHYDROXY-2-NITROPHENYL)(PHENYL)METHANONE",SmallMoleculeDrug,P21964,Catechol O-methyltransferase,COMT,271.0
13898,DB07465,"(1S,3S,5S)-2-{(2S)-2-amino-2-[(1R,3S,5R,7S)-3-hydroxytricyclo[3.3.1.1~3,7~]dec-1-yl]acetyl}-2-azabicyclo[3.1.0]hexane-3-carbonitrile",SmallMoleculeDrug,P27487,Dipeptidyl peptidase 4,DPP4,766.0
13900,DB07467,"4-chloro-N-[(2S)-2-methyl-2,3-dihydro-1H-indol-1-yl]-3-sulfamoylbenzamide",SmallMoleculeDrug,P00918,Carbonic anhydrase 2,CA2,260.0
13901,DB07468,"(3aS)-3a-hydroxy-5-methyl-1-phenyl-1,2,3,3a-tetrahydro-4H-pyrrolo[2,3-b]quinolin-4-one",SmallMoleculeDrug,Q7Z406,Myosin-14,MYH14,1995.0
13902,DB07469,"(3aS)-3a-hydroxy-7-methyl-1-phenyl-1,2,3,3a-tetrahydro-4H-pyrrolo[2,3-b]quinolin-4-one",SmallMoleculeDrug,Q7Z406,Myosin-14,MYH14,1995.0
13903,DB07470,"(3aS)-3a-hydroxy-1-phenyl-1,2,3,3a-tetrahydro-4H-pyrrolo[2,3-b]quinolin-4-one",SmallMoleculeDrug,Q7Z406,Myosin-14,MYH14,1995.0
13904,DB07471,"5-[5,6-BIS(METHYLOXY)-1H-BENZIMIDAZOL-1-YL]-3-{[1-(2-CHLOROPHENYL)ETHYL]OXY}-2-THIOPHENECARBOXAMIDE",SmallMoleculeDrug,P20248,Cyclin-A2,CCNA2,432.0
13905,DB07471,"5-[5,6-BIS(METHYLOXY)-1H-BENZIMIDAZOL-1-YL]-3-{[1-(2-CHLOROPHENYL)ETHYL]OXY}-2-THIOPHENECARBOXAMIDE",SmallMoleculeDrug,P24941,Cyclin-dependent kinase 2,CDK2,298.0
13908,DB07474,3-[5-(1H-IMIDAZOL-1-YL)-7-METHYL-1H-BENZIMIDAZOL-2-YL]-4-[(PYRIDIN-2-YLMETHYL)AMINO]PYRIDIN-2(1H)-ONE,SmallMoleculeDrug,P08069,Insulin-like growth factor 1 receptor,IGF1R,1367.0
13909,DB07476,N-[4-(AMINOSULFONYL)PHENYL]-2-MERCAPTOBENZAMIDE,SmallMoleculeDrug,P00918,Carbonic anhydrase 2,CA2,260.0
13910,DB07477,BIPHENYL-4-YL-ACETALDEHYDE,SmallMoleculeDrug,P07711,Cathepsin L1,CTSL,333.0
13912,DB07479,"(1S)-1,2,3,4-TETRAHYDRO-BENZO[C]PHENANTHRENE-2,3,4-TRIOL",SmallMoleculeDrug,P06746,DNA polymerase beta,POLB,335.0
13913,DB07480,4-PHOSPHONOOXY-PHENYL-METHYL-[4-PHOSPHONOOXY]BENZEN,SmallMoleculeDrug,P18031,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,435.0
13915,DB07482,(2R)-N-[(2R)-2-(DIHYDROXYBORYL)-1-L-PROLYLPYRROLIDIN-2-YL]-N-[(5R)-5-(DIHYDROXYBORYL)-1-L-PROLYLPYRROLIDIN-2-YL]-L-PROLINAMIDE,SmallMoleculeDrug,P27487,Dipeptidyl peptidase 4,DPP4,766.0
13917,DB07484,"(2R)-4,4-dihydroxy-5-nitro-2-(phenylmethyl)pentanoic acid",SmallMoleculeDrug,P15085,Carboxypeptidase A1,CPA1,419.0
13918,DB07485,"4,4'-cyclohexane-1,1-diyldiphenol",SmallMoleculeDrug,P62508,Estrogen-related receptor gamma,ESRRG,458.0
13919,DB07486,"3-({4-[(1E)-3-morpholin-4-yl-3-oxoprop-1-en-1-yl]-2,3-bis(trifluoromethyl)phenyl}sulfanyl)aniline",SmallMoleculeDrug,P20701,Integrin alpha-L,ITGAL,1170.0
13921,DB07488,"{(2Z)-4-AMINO-2-[(4-METHOXYPHENYL)IMINO]-2,3-DIHYDRO-1,3-THIAZOL-5-YL}(4-METHOXYPHENYL)METHANONE",SmallMoleculeDrug,Q9Y6M4,Casein kinase I isoform gamma-3,CSNK1G3,447.0
13922,DB07489,"{[4-AMINO-2-(3-CHLOROANILINO)-1,3-THIAZOL-5-YL](4-FLUOROPHENYL)METHANONE",SmallMoleculeDrug,Q9Y6M4,Casein kinase I isoform gamma-3,CSNK1G3,447.0
13927,DB07491,"5-amino-2,4,6-tribromobenzene-1,3-dicarboxylic acid",SmallMoleculeDrug,P07477,Trypsin-1,PRSS1,247.0
13929,DB07493,"(2Z)-5'-BROMO-2,3'-BIINDOLE-2',3(1H,1'H)-DIONE AMMONIATE",SmallMoleculeDrug,P24941,Cyclin-dependent kinase 2,CDK2,298.0
13930,DB07494,"(3-EXO)-3-(10,11-DIHYDRO-5H-DIBENZO[A,D][7]ANNULEN-5-YLOXY)-8,8-DIMETHYL-8-AZONIABICYCLO[3.2.1]OCTANE",SmallMoleculeDrug,Q494W8,CHRNA7-FAM7A fusion protein,CHRFAM7A,412.0
13931,DB07495,"5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-N-ETHYL-4-(4-METHOXYPHENYL)-1H-PYRAZOLE-3-CARBOXAMIDE",SmallMoleculeDrug,P07900,Heat shock protein HSP 90-alpha,HSP90AA1,732.0
13934,DB07497,"5-(HEXAHYDRO-2-OXO-1H-THIENO[3,4-D]IMIDAZOL-6-YL)PENTANAL",SmallMoleculeDrug,P11498,"Pyruvate carboxylase, mitochondrial",PC,1178.0
13936,DB07498,"4-[3-(3-NITROPHENYL)-1,2,4-OXADIAZOL-5-YL]BUTANOIC ACID",SmallMoleculeDrug,P15121,Aldose reductase,AKR1B1,316.0
13938,DB07500,(2E)-1-[2-hydroxy-4-methoxy-5-(3-methylbut-2-en-1-yl)phenyl]-3-(4-hydroxyphenyl)prop-2-en-1-one,SmallMoleculeDrug,Q9NZK7,Group IIE secretory phospholipase A2,PLA2G2E,142.0
13939,DB07501,(2S)-1-{4-[(4-ANILINO-5-BROMOPYRIMIDIN-2-YL)AMINO]PHENOXY}-3-(DIMETHYLAMINO)PROPAN-2-OL,SmallMoleculeDrug,P24941,Cyclin-dependent kinase 2,CDK2,298.0
13940,DB07502,"4-bromo-6-(6-hydroxy-1,2-benzisoxazol-3-yl)benzene-1,3-diol",SmallMoleculeDrug,P07900,Heat shock protein HSP 90-alpha,HSP90AA1,732.0
13941,DB07503,"(5E)-5-[(2,2-DIFLUORO-1,3-BENZODIOXOL-5-YL)METHYLENE]-1,3-THIAZOLIDINE-2,4-DIONE",SmallMoleculeDrug,P48736,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",PIK3CG,1102.0
13942,DB07504,(2R)-1-{4-[(4-ANILINO-5-BROMOPYRIMIDIN-2-YL)AMINO]PHENOXY}-3-(DIMETHYLAMINO)PROPAN-2-OL,SmallMoleculeDrug,P24941,Cyclin-dependent kinase 2,CDK2,298.0
13944,DB07506,L-BENZYLSUCCINIC ACID,SmallMoleculeDrug,P15085,Carboxypeptidase A1,CPA1,419.0
13946,DB07506,L-BENZYLSUCCINIC ACID,SmallMoleculeDrug,Q9HB40,Retinoid-inducible serine carboxypeptidase,SCPEP1,452.0
13948,DB07508,4-(5-BENZENESULFONYLAMINO-1-METHYL-1H-BENZOIMIDAZOL-2-YLMETHYL)-BENZAMIDINE,SmallMoleculeDrug,P00734,Prothrombin,F2,622.0
13949,DB07509,difluoro(5-{2-[(5-octyl-1H-pyrrol-2-yl-kappaN)methylidene]-2H-pyrrol-5-yl-kappaN}pentanoato)boron,SmallMoleculeDrug,P37231,Peroxisome proliferator-activated receptor gamma,PPARG,505.0
13952,DB07512,7-[(3-CHLOROBENZYL)OXY]-2-OXO-2H-CHROMENE-4-CARBALDEHYDE,SmallMoleculeDrug,P27338,Amine oxidase [flavin-containing] B,MAOB,520.0
13953,DB07513,7-[(3-CHLOROBENZYL)OXY]-4-[(METHYLAMINO)METHYL]-2H-CHROMEN-2-ONE,SmallMoleculeDrug,P27338,Amine oxidase [flavin-containing] B,MAOB,520.0
13954,DB07514,"3-(2-aminoquinazolin-6-yl)-1-(3,3-dimethylindolin-6-yl)-4-methylpyridin-2(1H)-one",SmallMoleculeDrug,P35968,Vascular endothelial growth factor receptor 2,KDR,1356.0
13955,DB07515,"1-(2-{[(6-AMINO-2-METHYLPYRIDIN-3-YL)METHYL]AMINO}ETHYL)-6-CHLORO-3-[(2,2-DIFLUORO-2-PYRIDIN-2-YLETHYL)AMINO]-1,4-DIHYDROPYRAZIN-2-OL",SmallMoleculeDrug,P00734,Prothrombin,F2,622.0
13958,DB07519,"(6R)-2-amino-6-[2-(3'-methoxybiphenyl-3-yl)ethyl]-3,6-dimethyl-5,6-dihydropyrimidin-4(3H)-one",SmallMoleculeDrug,P56817,Beta-secretase 1,BACE1,501.0
13959,DB07520,"N-[1-(AMINOMETHYL)CYCLOPROPYL]-3-(MORPHOLIN-4-YLSULFONYL)-N~2~-[(1S)-2,2,2-TRIFLUORO-1-(4-FLUOROPHENYL)ETHYL]-L-ALANINAMIDE",SmallMoleculeDrug,P25774,Cathepsin S,CTSS,331.0
13960,DB07521,"6-CHLORO-1-(2-{[(5-CHLORO-1-BENZOTHIEN-3-YL)METHYL]AMINO}ETHYL)-3-[(2-PYRIDIN-2-YLETHYL)AMINO]-1,4-DIHYDROPYRAZIN-2-OL",SmallMoleculeDrug,P00734,Prothrombin,F2,622.0
13961,DB07522,"N-[(2R,3S)-3-AMINO-2-HYDROXY-4-PHENYLBUTYL]NAPHTHALENE-2-SULFONAMIDE",SmallMoleculeDrug,P00734,Prothrombin,F2,622.0
13962,DB07524,"N-phenyl-1H-pyrrolo[2,3-b]pyridin-3-amine",SmallMoleculeDrug,P11309,Serine/threonine-protein kinase pim-1,PIM1,404.0
13963,DB07525,"3-(3-methoxybenzyl)-1H-pyrrolo[2,3-b]pyridine",SmallMoleculeDrug,P11362,Fibroblast growth factor receptor 1,FGFR1,822.0
13965,DB07527,"N-[(2R,3S)-3-AMINO-2-HYDROXY-4-PHENYLBUTYL]-4-METHOXY-2,3,6-TRIMETHYLBENZENESULFONAMIDE",SmallMoleculeDrug,P00734,Prothrombin,F2,622.0
13966,DB07528,3-(2-aminoquinazolin-6-yl)-4-methyl-1-[3-(trifluoromethyl)phenyl]pyridin-2(1H)-one,SmallMoleculeDrug,P35968,Vascular endothelial growth factor receptor 2,KDR,1356.0
13967,DB07529,"2-IMINO-5-(1-PYRIDIN-2-YL-METH-(E)-YLIDENE)-1,3-THIAZOLIDIN-4-ONE",SmallMoleculeDrug,P24941,Cyclin-dependent kinase 2,CDK2,298.0
13968,DB07530,"(1R,3R)-5-[(2E)-3-{(1S,3R)-2,2,3-trimethyl-3-[6,6,6-trifluoro-5-hydroxy-5-(trifluoromethyl)hex-3-yn-1-yl]cyclopentyl}prop-2-en-1-ylidene]cyclohexane-1,3-diol",SmallMoleculeDrug,Q15788,Nuclear receptor coactivator 1,NCOA1,1441.0
13969,DB07530,"(1R,3R)-5-[(2E)-3-{(1S,3R)-2,2,3-trimethyl-3-[6,6,6-trifluoro-5-hydroxy-5-(trifluoromethyl)hex-3-yn-1-yl]cyclopentyl}prop-2-en-1-ylidene]cyclohexane-1,3-diol",SmallMoleculeDrug,P11473,Vitamin D3 receptor,VDR,427.0
13970,DB07531,"4-{5-[(Z)-(2,4-DIOXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}BENZENESULFONAMIDE",SmallMoleculeDrug,P24941,Cyclin-dependent kinase 2,CDK2,298.0
13971,DB07533,"4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]-2-FURYL}-N-METHYLBENZENESULFONAMIDE",SmallMoleculeDrug,P20248,Cyclin-A2,CCNA2,432.0
13972,DB07533,"4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]-2-FURYL}-N-METHYLBENZENESULFONAMIDE",SmallMoleculeDrug,P24941,Cyclin-dependent kinase 2,CDK2,298.0
13973,DB07534,"4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}BENZENESULFONAMIDE",SmallMoleculeDrug,P20248,Cyclin-A2,CCNA2,432.0
13974,DB07534,"4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}BENZENESULFONAMIDE",SmallMoleculeDrug,P24941,Cyclin-dependent kinase 2,CDK2,298.0
13975,DB07535,2-amino-6-[2-(1H-indol-6-yl)ethyl]pyrimidin-4(3H)-one,SmallMoleculeDrug,P56817,Beta-secretase 1,BACE1,501.0
13977,DB07537,"N'-(6-aminopyridin-3-yl)-N-(2-cyclopentylethyl)-4-methyl-benzene-1,3-dicarboxamide",SmallMoleculeDrug,P35968,Vascular endothelial growth factor receptor 2,KDR,1356.0
13978,DB07538,"4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}-2-(TRIFLUOROMETHYL)BENZENESULFONAMIDE",SmallMoleculeDrug,P20248,Cyclin-A2,CCNA2,432.0
13979,DB07538,"4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}-2-(TRIFLUOROMETHYL)BENZENESULFONAMIDE",SmallMoleculeDrug,P24941,Cyclin-dependent kinase 2,CDK2,298.0
13980,DB07539,"4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}BENZOIC ACID",SmallMoleculeDrug,P20248,Cyclin-A2,CCNA2,432.0
13981,DB07539,"4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}BENZOIC ACID",SmallMoleculeDrug,P24941,Cyclin-dependent kinase 2,CDK2,298.0
13982,DB07540,"4-{5-[(1Z)-1-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)ETHYL]-2-FURYL}BENZENESULFONAMIDE",SmallMoleculeDrug,P24941,Cyclin-dependent kinase 2,CDK2,298.0
13984,DB07542,5-AMINO-6-CYCLOHEXYL-4-HYDROXY-2-ISOBUTYL-HEXANOIC ACID,SmallMoleculeDrug,P07339,Cathepsin D,CTSD,412.0
13986,DB07543,(2S)-1-(9H-Carbazol-4-yloxy)-3-(isopropylamino)propan-2-ol,SmallMoleculeDrug,P07550,Beta-2 adrenergic receptor,ADRB2,413.0
13987,DB07544,N'-(5-CHLOROBENZOFURAN-2-CARBONYL)-2-(TRIFLUOROMETHYL)BENZENESULFONOHYDRAZIDE,SmallMoleculeDrug,P54687,"Branched-chain-amino-acid aminotransferase, cytosolic",BCAT1,386.0
13988,DB07545,N-{3-[(4-{[3-(TRIFLUOROMETHYL)PHENYL]AMINO}PYRIMIDIN-2-YL)AMINO]PHENYL}CYCLOPROPANECARBOXAMIDE,SmallMoleculeDrug,O14965,Aurora kinase A,AURKA,403.0
13989,DB07546,[1-(6-{6-[(1-methylethyl)amino]-1H-indazol-1-yl}pyrazin-2-yl)-1H-pyrrol-3-yl]acetic acid,SmallMoleculeDrug,P19784,Casein kinase II subunit alpha',CSNK2A2,350.0
13991,DB07548,"2-(6-CHLORO-3-{[2,2-DIFLUORO-2-(2-PYRIDINYL)ETHYL]AMINO}-2-OXO-1(2H)-PYRAZINYL)-N-[(2-FLUORO-6-PYRIDINYL)METHYL]ACETAMIDE",SmallMoleculeDrug,P00734,Prothrombin,F2,622.0
13992,DB07549,"2-(6-CHLORO-3-{[2,2-DIFLUORO-2-(2-PYRIDINYL)ETHYL]AMINO}-2-OXO-1(2H)-PYRAZINYL)-N-[(2-FLUORO-3-METHYL-6-PYRIDINYL)METHYL]ACETAMIDE",SmallMoleculeDrug,P00734,Prothrombin,F2,622.0
13993,DB07550,"2-(6-CHLORO-3-{[2,2-DIFLUORO-2-(1-OXIDO-2-PYRIDINYL)ETHYL]AMINO}-2-OXO-1(2H)-PYRAZINYL)-N-[(2-FLUOROPHENYL)METHYL]ACETAMIDE",SmallMoleculeDrug,P00734,Prothrombin,F2,622.0
14003,DB07555,"1-(2-nitrophenyl)-2,2,2-trifluoroethyl]-arsenocholine",SmallMoleculeDrug,P22303,Acetylcholinesterase,ACHE,614.0
14004,DB07556,N-HYDROXY-2(R)-[[(4-METHOXYPHENYL)SULFONYL](3-PICOLYL)AMINO]-3-METHYLBUTANAMIDE HYDROCHLORIDE,SmallMoleculeDrug,P39900,Macrophage metalloelastase,MMP12,470.0
14005,DB07556,N-HYDROXY-2(R)-[[(4-METHOXYPHENYL)SULFONYL](3-PICOLYL)AMINO]-3-METHYLBUTANAMIDE HYDROCHLORIDE,SmallMoleculeDrug,P03956,Interstitial collagenase,MMP1,469.0
14006,DB07557,"(5BETA)-PREGNANE-3,20-DIONE",SmallMoleculeDrug,Q15788,Nuclear receptor coactivator 1,NCOA1,1441.0
14007,DB07557,"(5BETA)-PREGNANE-3,20-DIONE",SmallMoleculeDrug,P19793,Retinoic acid receptor RXR-alpha,RXRA,462.0
14008,DB07557,"(5BETA)-PREGNANE-3,20-DIONE",SmallMoleculeDrug,Q14994,Nuclear receptor subfamily 1 group I member 3,NR1I3,352.0
14009,DB07557,"(5BETA)-PREGNANE-3,20-DIONE",SmallMoleculeDrug,P51857,3-oxo-5-beta-steroid 4-dehydrogenase,AKR1D1,326.0
14010,DB07558,2-ACETYLAMINO-4-METHYL-PENTANOIC ACID [1-(1-FORMYL-PENTYLCARBAMOYL)-3-METHYL-BUTYL]-AMIDE,SmallMoleculeDrug,O14818,Proteasome subunit alpha type-7,PSMA7,248.0
14011,DB07559,"(2Z)-2-cyano-N-(2,2'-dichlorobiphenyl-4-yl)-3-hydroxybut-2-enamide",SmallMoleculeDrug,Q02127,"Dihydroorotate dehydrogenase (quinone), mitochondrial",DHODH,395.0
14013,DB07561,(2Z)-2-cyano-N-(3'-ethoxybiphenyl-4-yl)-3-hydroxybut-2-enamide,SmallMoleculeDrug,Q02127,"Dihydroorotate dehydrogenase (quinone), mitochondrial",DHODH,395.0
14014,DB07562,"N-[4-(2,4-DIMETHYL-THIAZOL-5-YL)-PYRIMIDIN-2-YL]-N',N'-DIMETHYL-BENZENE-1,4-DIAMINE",SmallMoleculeDrug,P24941,Cyclin-dependent kinase 2,CDK2,298.0
14015,DB07562,"N-[4-(2,4-DIMETHYL-THIAZOL-5-YL)-PYRIMIDIN-2-YL]-N',N'-DIMETHYL-BENZENE-1,4-DIAMINE",SmallMoleculeDrug,P20248,Cyclin-A2,CCNA2,432.0
14016,DB07563,"1-{7-cyclohexyl-6-[4-(4-methylpiperazin-1-yl)benzyl]-7H-pyrrolo[2,3-d]pyrimidin-2-yl}methanamine",SmallMoleculeDrug,P43235,Cathepsin K,CTSK,329.0
14019,DB07567,"(2R,3R,4S)-3-(4-HYDROXYPHENYL)-4-METHYL-2-[4-(2-PYRROLIDIN-1-YLETHOXY)PHENYL]CHROMAN-6-OL",SmallMoleculeDrug,P03372,Estrogen receptor,ESR1,595.0
14025,DB07573,"(2S)-1-(2,5-dimethylphenoxy)-3-morpholin-4-ylpropan-2-ol",SmallMoleculeDrug,P56817,Beta-secretase 1,BACE1,501.0
14026,DB07574,"2-MERCAPTO-N-[1,2,3,10-TETRAMETHOXY-9-OXO-5,6,7,9-TETRAHYDRO-BENZO[A]HEPTALEN-7-YL]ACETAMIDE",SmallMoleculeDrug,Q9H169,Stathmin-4,STMN4,189.0
14027,DB07574,"2-MERCAPTO-N-[1,2,3,10-TETRAMETHOXY-9-OXO-5,6,7,9-TETRAHYDRO-BENZO[A]HEPTALEN-7-YL]ACETAMIDE",SmallMoleculeDrug,Q9BVA1,Tubulin beta-2B chain,TUBB2B,445.0
14028,DB07574,"2-MERCAPTO-N-[1,2,3,10-TETRAMETHOXY-9-OXO-5,6,7,9-TETRAHYDRO-BENZO[A]HEPTALEN-7-YL]ACETAMIDE",SmallMoleculeDrug,Q71U36,Tubulin alpha-1A chain,TUBA1A,451.0
14029,DB07574,"2-MERCAPTO-N-[1,2,3,10-TETRAMETHOXY-9-OXO-5,6,7,9-TETRAHYDRO-BENZO[A]HEPTALEN-7-YL]ACETAMIDE",SmallMoleculeDrug,Q9BQE3,Tubulin alpha-1C chain,TUBA1C,449.0
14030,DB07574,"2-MERCAPTO-N-[1,2,3,10-TETRAMETHOXY-9-OXO-5,6,7,9-TETRAHYDRO-BENZO[A]HEPTALEN-7-YL]ACETAMIDE",SmallMoleculeDrug,P68363,Tubulin alpha-1B chain,TUBA1B,451.0
14032,DB07577,"6-ETHYL-5-PHENYLPYRIMIDINE-2,4-DIAMINE",SmallMoleculeDrug,P04818,Thymidylate synthase,TYMS,313.0
14034,DB07579,"BIS-1,2-{[(Z)-2-CARBOXY-2-METHYL-1,3-DIOXANE]-5-YLOXYCARBAMOYL}-ETHANE",SmallMoleculeDrug,P02743,Serum amyloid P-component,APCS,223.0
14035,DB07580,"BIS-1,2-{[(Z)-2CARBOXY-2-METHYL-1,3-DIOXANE]-5-YLOXYCARBONYL}-PIPERAZINE",SmallMoleculeDrug,P02743,Serum amyloid P-component,APCS,223.0
14039,DB07583,"(4R,2S)-5'-(4-(4-CHLOROBENZYLOXY)PYRROLIDIN-2-YLMETHANESULFONYL)ISOQUINOLINE",SmallMoleculeDrug,P17612,cAMP-dependent protein kinase catalytic subunit alpha,PRKACA,351.0
14040,DB07583,"(4R,2S)-5'-(4-(4-CHLOROBENZYLOXY)PYRROLIDIN-2-YLMETHANESULFONYL)ISOQUINOLINE",SmallMoleculeDrug,P61925,cAMP-dependent protein kinase inhibitor alpha,PKIA,76.0
14041,DB07584,"N-[2-(5-methyl-4H-1,2,4-triazol-3-yl)phenyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine",SmallMoleculeDrug,P31749,RAC-alpha serine/threonine-protein kinase,AKT1,480.0
14042,DB07584,"N-[2-(5-methyl-4H-1,2,4-triazol-3-yl)phenyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine",SmallMoleculeDrug,P49841,Glycogen synthase kinase-3 beta,GSK3B,420.0
14043,DB07585,"5-(5-chloro-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine",SmallMoleculeDrug,P31749,RAC-alpha serine/threonine-protein kinase,AKT1,480.0
14044,DB07585,"5-(5-chloro-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine",SmallMoleculeDrug,P49841,Glycogen synthase kinase-3 beta,GSK3B,420.0
14045,DB07586,"5-(4-METHYL-BENZOYLAMINO)-BIPHENYL-3,4'-DICARBOXYLIC ACID 3-DIMETHYLAMIDE-4'-HYDROXYAMIDE",SmallMoleculeDrug,Q9BY41,Histone deacetylase 8,HDAC8,377.0
14046,DB07587,"N-(1-CYANOCYCLOPROPYL)-3-({[(2S)-5-OXOPYRROLIDIN-2-YL]METHYL}SULFONYL)-N~2~-[(1S)-2,2,2-TRIFLUORO-1-(4-FLUOROPHENYL)ETHYL]-L-ALANINAMIDE",SmallMoleculeDrug,P25774,Cathepsin S,CTSS,331.0
14048,DB07589,"N-[1-(AMINOMETHYL)CYCLOPROPYL]-3-(BENZYLSULFONYL)-N~2~-[(1S)-2,2,2-TRIFLUORO-1-(4-HYDROXYPHENYL)ETHYL]-L-ALANINAMIDE",SmallMoleculeDrug,P25774,Cathepsin S,CTSS,331.0
14051,DB07592,(1R)-2-METHYL-1-(PHENYLMETHYL)PROPYL[(1S)-1-FORMYLPENTYL]CARBAMATE,SmallMoleculeDrug,P43235,Cathepsin K,CTSK,329.0
14052,DB07593,1-(PHENYLMETHYL)CYCLOPENTYL[(1S)-1-FORMYLPENTYL]CARBAMATE,SmallMoleculeDrug,P43235,Cathepsin K,CTSK,329.0
14053,DB07594,"4-[4-(2,3-DIHYDRO-1,4-BENZODIOXIN-6-YL)-3-METHYL-1H-PYRAZOL-5-YL]-6-ETHYLBENZENE-1,3-DIOL",SmallMoleculeDrug,P08238,Heat shock protein HSP 90-beta,HSP90AB1,724.0
14054,DB07594,"4-[4-(2,3-DIHYDRO-1,4-BENZODIOXIN-6-YL)-3-METHYL-1H-PYRAZOL-5-YL]-6-ETHYLBENZENE-1,3-DIOL",SmallMoleculeDrug,P07900,Heat shock protein HSP 90-alpha,HSP90AA1,732.0
14055,DB07595,"(5Z)-5-(3-BROMOCYCLOHEXA-2,5-DIEN-1-YLIDENE)-N-(PYRIDIN-4-YLMETHYL)-1,5-DIHYDROPYRAZOLO[1,5-A]PYRIMIDIN-7-AMINE",SmallMoleculeDrug,P24941,Cyclin-dependent kinase 2,CDK2,298.0
14056,DB07596,"(17beta)-17-(cyanomethyl)-2-methoxyestra-1(10),2,4-trien-3-yl sulfamate",SmallMoleculeDrug,P00918,Carbonic anhydrase 2,CA2,260.0
14057,DB07597,"CIS-(1R,2S)-2-AMINO-1,2,3,4-TETRAHYDRONAPHTHALEN-1-OL",SmallMoleculeDrug,P11086,Phenylethanolamine N-methyltransferase,PNMT,282.0
14058,DB07598,"2,3,6A,7,8,9-HEXAHYDRO-11H-[1,4]DIOXINO[2,3-G]PYRROLO[2,1-B][1,3]BENZOXAZIN-11-ONE",SmallMoleculeDrug,P42262,Glutamate receptor 2,GRIA2,883.0
14060,DB07601,"4-chloro-6-{5-[(2-morpholin-4-ylethyl)amino]-1,2-benzisoxazol-3-yl}benzene-1,3-diol",SmallMoleculeDrug,P07900,Heat shock protein HSP 90-alpha,HSP90AA1,732.0
14061,DB07602,S-{3-[(4-ANILINOQUINAZOLIN-6-YL)AMINO]-3-OXOPROPYL}-L-CYSTEINE,SmallMoleculeDrug,P00533,Epidermal growth factor receptor,EGFR,1210.0
14062,DB07604,"(6AR,11AS,11BR)-10-ACETYL-9-HYDROXY-7,7-DIMETHYL-2,6,6A,7,11A,11B-HEXAHYDRO-11H-PYRROLO[1',2':2,3]ISOINDOLO[4,5,6-CD]INDOL-11-ONE",SmallMoleculeDrug,O14983,Sarcoplasmic/endoplasmic reticulum calcium ATPase 1,ATP2A1,1001.0
14063,DB07605,"2-({4-[(5-CHLORO-1H-INDOL-2-YL)SULFONYL]PIPERAZIN-1-YL}CARBONYL)THIENO[3,2-B]PYRIDINE 4-OXIDE",SmallMoleculeDrug,P00742,Coagulation factor X,F10,488.0
14064,DB07606,"6-(3,4-DIHYDROXYBENZYL)-3-ETHYL-1-(2,4,6-TRICHLOROPHENYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-4(5H)-ONE",SmallMoleculeDrug,P24941,Cyclin-dependent kinase 2,CDK2,298.0
14065,DB07607,4-[5-(3-IODO-PHENYL)-2-(4-METHANESULFINYL-PHENYL)-1H-IMIDAZOL-4-YL]-PYRIDINE,SmallMoleculeDrug,Q16539,Mitogen-activated protein kinase 14,MAPK14,360.0
14066,DB07608,N-(5-{[(2S)-4-amino-2-(3-chlorophenyl)butanoyl]amino}-1H-indazol-3-yl)benzamide,SmallMoleculeDrug,Q13627,Dual specificity tyrosine-phosphorylation-regulated kinase 1A,DYRK1A,763.0
14067,DB07609,"N,N-DIMETHYL(5-(PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE",SmallMoleculeDrug,P11509,Cytochrome P450 2A6,CYP2A6,494.0
14070,DB07612,6-(3-AMINOPHENYL)-N-(TERT-BUTYL)-2-(TRIFLUOROMETHYL)QUINAZOLIN-4-AMINE,SmallMoleculeDrug,P24941,Cyclin-dependent kinase 2,CDK2,298.0
14071,DB07613,3-phenyl-5-(1H-pyrazol-3-yl)isoxazole,SmallMoleculeDrug,O60760,Hematopoietic prostaglandin D synthase,HPGDS,199.0
14072,DB07614,"PHENYL-5-(1H-PYRAZOL-3-YL)-1,3-THIAZOLE",SmallMoleculeDrug,O60760,Hematopoietic prostaglandin D synthase,HPGDS,199.0
14073,DB07615,Tranilast,SmallMoleculeDrug,O60760,Hematopoietic prostaglandin D synthase,HPGDS,199.0
14074,DB07616,"4-{[4-(4-fluoro-3-methylphenyl)-1,3-thiazol-2-yl]amino}-2-hydroxybenzoic acid",SmallMoleculeDrug,O60760,Hematopoietic prostaglandin D synthase,HPGDS,199.0
14075,DB07617,N-METHYL(5-(PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE,SmallMoleculeDrug,P11509,Cytochrome P450 2A6,CYP2A6,494.0
14076,DB07618,"2-(4-(AMINOMETHYL)PIPERIDIN-1-YL)-N-(3_CYCLOHEXYL-4-OXO-2,4-DIHYDROINDENO[1,2-C]PYRAZOL-5-YL)ACETAMIDE",SmallMoleculeDrug,P24941,Cyclin-dependent kinase 2,CDK2,298.0
14077,DB07619,"N-cyclopropyl-N-(trans-4-pyridin-3-ylcyclohexyl)-4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]benzamide",SmallMoleculeDrug,P28845,Corticosteroid 11-beta-dehydrogenase isozyme 1,HSD11B1,292.0
14080,DB07621,(5-(PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE,SmallMoleculeDrug,P11509,Cytochrome P450 2A6,CYP2A6,494.0
14081,DB07622,"1-(3-(2,4-DIMETHYLTHIAZOL-5-YL)-4-OXO-2,4-DIHYDROINDENO[1,2-C]PYRAZOL-5-YL)-3-(4-METHYLPIPERAZIN-1-YL)UREA",SmallMoleculeDrug,P24941,Cyclin-dependent kinase 2,CDK2,298.0
14082,DB07623,"4,4'-DIPYRIDYL DISULFIDE",SmallMoleculeDrug,P11509,Cytochrome P450 2A6,CYP2A6,494.0
14083,DB07624,"1-{[(3R)-3-methyl-4-({4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]phenyl}sulfonyl)piperazin-1-yl]methyl}cyclopropanecarboxamide",SmallMoleculeDrug,P28845,Corticosteroid 11-beta-dehydrogenase isozyme 1,HSD11B1,292.0
14084,DB07625,"4-(2-aminoethoxy)-N-(2,5-diethoxyphenyl)-3,5-dimethylbenzamide",SmallMoleculeDrug,P00749,Urokinase-type plasminogen activator,PLAU,431.0
14085,DB07626,"4-(2-aminoethoxy)-N-(3-chloro-2-ethoxy-5-piperidin-1-ylphenyl)-3,5-dimethylbenzamide",SmallMoleculeDrug,P00749,Urokinase-type plasminogen activator,PLAU,431.0
14086,DB07627,(2S)-4-METHYL-2-(3-PHENYLTHIOUREIDO)-N-((3S)-TETRAHYDRO-2-HYDROXY-3-FURANYL)PENTANAMIDE,SmallMoleculeDrug,P07384,Calpain-1 catalytic subunit,CAPN1,714.0
14087,DB07628,"6-(2-fluorobenzyl)-2,4-dimethyl-4,6-dihydro-5H-thieno[2',3':4,5]pyrrolo[2,3-d]pyridazin-5-one",SmallMoleculeDrug,P14618,Pyruvate kinase PKM,PKM,531.0
14088,DB07629,"N-((1R,2S)-2-(5-CHLORO-1H-INDOLE-2-CARBOXAMIDO)CYCLOHEXYL)-5-METHYL-4,5,6,7-TETRAHYDROTHIAZOLO[5,4-C]PYRIDINE-2-CARBOXAMIDE",SmallMoleculeDrug,P00742,Coagulation factor X,F10,488.0
14089,DB07630,"N-((1R,2R)-2-(5-CHLORO-1H-INDOLE-2-CARBOXAMIDO)CYCLOHEXYL)-5-METHYL-4,5,6,7-TETRAHYDROTHIAZOLO[5,4-C]PYRIDINE-2-CARBOXAMIDE",SmallMoleculeDrug,P00742,Coagulation factor X,F10,488.0
14091,DB07632,"5-(2-chlorophenyl)-1,3,4-thiadiazole-2-sulfonamide",SmallMoleculeDrug,P00918,Carbonic anhydrase 2,CA2,260.0
14092,DB07633,octyl 3-deoxy-2-O-(6-deoxy-alpha-L-galactopyranosyl)-beta-D-xylo-hexopyranoside,SmallMoleculeDrug,P16442,Histo-blood group ABO system transferase,ABO,354.0
14095,DB07636,"5-HEPTYL-6-HYDROXY-1,3-BENZOTHIAZOLE-4,7-DIONE",SmallMoleculeDrug,P00156,Cytochrome b,MT-CYB,380.0
14096,DB07636,"5-HEPTYL-6-HYDROXY-1,3-BENZOTHIAZOLE-4,7-DIONE",SmallMoleculeDrug,P47985,"Cytochrome b-c1 complex subunit Rieske, mitochondrial",UQCRFS1,274.0
14097,DB07636,"5-HEPTYL-6-HYDROXY-1,3-BENZOTHIAZOLE-4,7-DIONE",SmallMoleculeDrug,P08574,"Cytochrome c1, heme protein, mitochondrial",CYC1,325.0
14098,DB07636,"5-HEPTYL-6-HYDROXY-1,3-BENZOTHIAZOLE-4,7-DIONE",SmallMoleculeDrug,P14927,Cytochrome b-c1 complex subunit 7,UQCRB,111.0
14099,DB07636,"5-HEPTYL-6-HYDROXY-1,3-BENZOTHIAZOLE-4,7-DIONE",SmallMoleculeDrug,Q9UDW1,Cytochrome b-c1 complex subunit 9,UQCR10,63.0
14100,DB07637,"3,5 DIBROMOTYROSINE",SmallMoleculeDrug,P19235,Erythropoietin receptor,EPOR,508.0
14101,DB07638,"(3AS,4R,9BR)-2,2-DIFLUORO-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL",SmallMoleculeDrug,P03372,Estrogen receptor,ESR1,595.0
14102,DB07638,"(3AS,4R,9BR)-2,2-DIFLUORO-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL",SmallMoleculeDrug,Q92731,Estrogen receptor beta,ESR2,530.0
14103,DB07639,3-(7-DIAMINOMETHYL-NAPHTHALEN-2-YL)-PROPIONIC ACID ETHYL ESTER,SmallMoleculeDrug,P00734,Prothrombin,F2,622.0
14106,DB07641,DECYL(DIMETHYL)PHOSPHINE OXIDE,SmallMoleculeDrug,P21397,Amine oxidase [flavin-containing] A,MAOA,527.0
14107,DB07642,"5-{[1-(2-fluorobenzyl)piperidin-4-yl]methoxy}quinazoline-2,4-diamine",SmallMoleculeDrug,Q96C86,m7GpppX diphosphatase,DCPS,337.0
14108,DB07643,"5-{[1-(2,3-dichlorobenzyl)piperidin-4-yl]methoxy}quinazoline-2,4-diamine",SmallMoleculeDrug,Q96C86,m7GpppX diphosphatase,DCPS,337.0
14109,DB07644,"5-[(1S)-1-(3-chlorophenyl)ethoxy]quinazoline-2,4-diamine",SmallMoleculeDrug,Q96C86,m7GpppX diphosphatase,DCPS,337.0
14110,DB07645,SEBACIC ACID,SmallMoleculeDrug,P69905,Hemoglobin subunit alpha,HBA1;,142.0
14111,DB07645,SEBACIC ACID,SmallMoleculeDrug,P68871,Hemoglobin subunit beta,HBB,147.0
14114,DB07646,"UNDECYLAMINE-N,N-DIMETHYL-N-OXIDE",SmallMoleculeDrug,Q02127,"Dihydroorotate dehydrogenase (quinone), mitochondrial",DHODH,395.0
14115,DB07647,"(2R)-1-[(5,6-DIPHENYL-7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL)AMINO]PROPAN-2-OL",SmallMoleculeDrug,O14757,Serine/threonine-protein kinase Chk1,CHEK1,476.0
14116,DB07648,"(2R)-3-{[(4Z)-5,6-DIPHENYL-6,7-DIHYDRO-4H-PYRROLO[2,3-D]PYRIMIDIN-4-YLIDENE]AMINO}PROPANE-1,2-DIOL",SmallMoleculeDrug,O14757,Serine/threonine-protein kinase Chk1,CHEK1,476.0
14119,DB07651,N-ACETYL-L-PHENYLALANYL-4-[DIFLUORO(PHOSPHONO)METHYL]-L-PHENYLALANINAMIDE,SmallMoleculeDrug,P18031,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,435.0
14120,DB07652,"1-[2-DEOXYRIBOFURANOSYL]-2,4-DIFLUORO-5-METHYL-BENZENE-5'MONOPHOSPHATE",SmallMoleculeDrug,Q9UBT6,DNA polymerase kappa,POLK,870.0
14122,DB07653,"N-(5,6-DIPHENYLFURO[2,3-D]PYRIMIDIN-4-YL)GLYCINE",SmallMoleculeDrug,O14757,Serine/threonine-protein kinase Chk1,CHEK1,476.0
14123,DB07654,"(5,6-DIPHENYL-FURO[2,3-D]PYRIMIDIN-4-YLAMINO)-ACETIC",SmallMoleculeDrug,O14757,Serine/threonine-protein kinase Chk1,CHEK1,476.0
14124,DB07655,"3-AMINO-3-BENZYL-[4.3.0]BICYCLO-1,6-DIAZANONAN-2-ONE",SmallMoleculeDrug,O14757,Serine/threonine-protein kinase Chk1,CHEK1,476.0
14125,DB07656,N-[4-(1-BENZOYLPIPERIDIN-4-YL)BUTYL]-3-PYRIDIN-3-YLPROPANAMIDE,SmallMoleculeDrug,P43490,Nicotinamide phosphoribosyltransferase,NAMPT,491.0
14126,DB07657,PHOSPHONIC ACID 2-DODECANOYLAMINO-HEXYL ESTER PROPYL ESTER,SmallMoleculeDrug,P04054,Phospholipase A2,PLA2G1B,148.0
14127,DB07658,AC-(D)PHE-PRO-BOROLYS-OH,SmallMoleculeDrug,P00734,Prothrombin,F2,622.0
14128,DB07659,AC-(D)PHE-PRO-BOROHOMOLYS-OH,SmallMoleculeDrug,P00734,Prothrombin,F2,622.0
14129,DB07660,AC-(D)PHE-PRO-BOROHOMOORNITHINE-OH,SmallMoleculeDrug,P00734,Prothrombin,F2,622.0
14131,DB07662,N-[4-(3-BROMO-PHENYLAMINO)-QUINAZOLIN-6-YL]-ACRYLAMIDE,SmallMoleculeDrug,P12931,Proto-oncogene tyrosine-protein kinase Src,SRC,536.0
14132,DB07662,N-[4-(3-BROMO-PHENYLAMINO)-QUINAZOLIN-6-YL]-ACRYLAMIDE,SmallMoleculeDrug,P00533,Epidermal growth factor receptor,EGFR,1210.0
14134,DB07664,"5-AMINO-3-{[4-(AMINOSULFONYL)PHENYL]AMINO}-N-(2,6-DIFLUOROPHENYL)-1H-1,2,4-TRIAZOLE-1-CARBOTHIOAMIDE",SmallMoleculeDrug,Q9Y6M4,Casein kinase I isoform gamma-3,CSNK1G3,447.0
14135,DB07664,"5-AMINO-3-{[4-(AMINOSULFONYL)PHENYL]AMINO}-N-(2,6-DIFLUOROPHENYL)-1H-1,2,4-TRIAZOLE-1-CARBOTHIOAMIDE",SmallMoleculeDrug,Q9H2G2,STE20-like serine/threonine-protein kinase,SLK,1235.0
14136,DB07664,"5-AMINO-3-{[4-(AMINOSULFONYL)PHENYL]AMINO}-N-(2,6-DIFLUOROPHENYL)-1H-1,2,4-TRIAZOLE-1-CARBOTHIOAMIDE",SmallMoleculeDrug,Q16566,Calcium/calmodulin-dependent protein kinase type IV,CAMK4,473.0
14137,DB07664,"5-AMINO-3-{[4-(AMINOSULFONYL)PHENYL]AMINO}-N-(2,6-DIFLUOROPHENYL)-1H-1,2,4-TRIAZOLE-1-CARBOTHIOAMIDE",SmallMoleculeDrug,P49761,Dual specificity protein kinase CLK3,CLK3,638.0
14138,DB07664,"5-AMINO-3-{[4-(AMINOSULFONYL)PHENYL]AMINO}-N-(2,6-DIFLUOROPHENYL)-1H-1,2,4-TRIAZOLE-1-CARBOTHIOAMIDE",SmallMoleculeDrug,P42684,Abelson tyrosine-protein kinase 2,ABL2,1182.0
14139,DB07665,"N-[2-(carbamimidamidooxy)ethyl]-2-{6-cyano-3-[(2,2-difluoro-2-pyridin-2-ylethyl)amino]-2-fluorophenyl}acetamide",SmallMoleculeDrug,P00734,Prothrombin,F2,622.0
14140,DB07666,"(3R,4S)-1-{6-[3-(METHYLSULFONYL)PHENYL]PYRIMIDIN-4-YL}-4-(2,4,5-TRIFLUOROPHENYL)PYRROLIDIN-3-AMINE",SmallMoleculeDrug,P27487,Dipeptidyl peptidase 4,DPP4,766.0
14142,DB07668,3-(4-DIETHYLAMINO-2-HYDROXY-PHENYL)-2-METHYL-PROPIONIC ACID,SmallMoleculeDrug,P17538,Chymotrypsinogen B,CTRB1,263.0
14146,DB07670,4-METHYL-N-METHYL-N-(2-PHENYL-2H-PYRAZOL-3-YL)BENZENESULFONAMIDE,SmallMoleculeDrug,P33260,Cytochrome P450 2C18,CYP2C18,490.0
14151,DB07672,TRANS-2-(DIMETHYLPHENYLSILYL)-PIPERIDINE-N-OXIDE,SmallMoleculeDrug,P01857,Ig gamma-1 chain C region,IGHG1,330.0
14154,DB07675,(2S)-2-ETHOXY-3-{4-[2-(10H-PHENOXAZIN-10-YL)ETHOXY]PHENYL}PROPANOIC ACID,SmallMoleculeDrug,P37231,Peroxisome proliferator-activated receptor gamma,PPARG,505.0
14155,DB07676,"3-({[(3S)-3,4-dihydroxybutyl]oxy}amino)-1H,2'H-2,3'-biindol-2'-one",SmallMoleculeDrug,P49841,Glycogen synthase kinase-3 beta,GSK3B,420.0
14156,DB07676,"3-({[(3S)-3,4-dihydroxybutyl]oxy}amino)-1H,2'H-2,3'-biindol-2'-one",SmallMoleculeDrug,Q16566,Calcium/calmodulin-dependent protein kinase type IV,CAMK4,473.0
14157,DB07677,"2-methyl-3,5,7,8-tetrahydro-4H-thiopyrano[4,3-d]pyrimidin-4-one",SmallMoleculeDrug,Q9Y6F1,Poly [ADP-ribose] polymerase 3,PARP3,533.0
14158,DB07678,"(9ALPHA,13BETA,17BETA)-2-[(1Z)-BUT-1-EN-1-YL]ESTRA-1,3,5(10)-TRIENE-3,17-DIOL",SmallMoleculeDrug,P03372,Estrogen receptor,ESR1,595.0
14159,DB07678,"(9ALPHA,13BETA,17BETA)-2-[(1Z)-BUT-1-EN-1-YL]ESTRA-1,3,5(10)-TRIENE-3,17-DIOL",SmallMoleculeDrug,Q15596,Nuclear receptor coactivator 2,NCOA2,1464.0
14161,DB07680,[(1S)-1-(5-CHLORO-1-BENZOTHIEN-3-YL)-2-(2-NAPHTHYLAMINO)-2-OXOETHYL]PHOSPHONIC ACID,SmallMoleculeDrug,P23946,Chymase,CMA1,247.0
14162,DB07681,DODECANESULFONATE ION,SmallMoleculeDrug,P06276,Cholinesterase,BCHE,602.0
14163,DB07683,"N-(dibenzo[b,d]thiophen-3-ylsulfonyl)-L-valine",SmallMoleculeDrug,P39900,Macrophage metalloelastase,MMP12,470.0
14164,DB07684,5-(DIMETHYLAMINO)-2-NAPHTHALENESULFONIC ACID,SmallMoleculeDrug,P00750,Tissue-type plasminogen activator,PLAT,562.0
14165,DB07685,"4-{[5-(CYCLOHEXYLMETHOXY)[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL]AMINO}BENZENESULFONAMIDE",SmallMoleculeDrug,P24941,Cyclin-dependent kinase 2,CDK2,298.0
14166,DB07686,"4-{[5-(CYCLOHEXYLAMINO)[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL]AMINO}BENZENESULFONAMIDE",SmallMoleculeDrug,P24941,Cyclin-dependent kinase 2,CDK2,298.0
14167,DB07687,"4-({5-[(4-AMINOCYCLOHEXYL)AMINO][1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL}AMINO)BENZENESULFONAMIDE",SmallMoleculeDrug,P24941,Cyclin-dependent kinase 2,CDK2,298.0
14168,DB07688,"4-{[5-(CYCLOHEXYLOXY)[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL]AMINO}BENZENESULFONAMIDE",SmallMoleculeDrug,P24941,Cyclin-dependent kinase 2,CDK2,298.0
14169,DB07688,"4-{[5-(CYCLOHEXYLOXY)[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL]AMINO}BENZENESULFONAMIDE",SmallMoleculeDrug,P20248,Cyclin-A2,CCNA2,432.0
14170,DB07689,"METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL]AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE",SmallMoleculeDrug,P0CG22,Putative dehydrogenase/reductase SDR family member 4-like 1,DHRS4L1,281.0
14171,DB07691,"2-({[3-(3,4-dihydroisoquinolin-2(1H)-ylsulfonyl)phenyl]carbonyl}amino)benzoic acid",SmallMoleculeDrug,Q03181,Peroxisome proliferator-activated receptor delta,PPARD,441.0
14172,DB07692,"1-[(2,6-difluorophenyl)sulfonyl]-4-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)piperazine",SmallMoleculeDrug,P14618,Pyruvate kinase PKM,PKM,531.0
14173,DB07696,methyl (3S)-3-[(tert-butoxycarbonyl)amino]-4-oxopentanoate,SmallMoleculeDrug,P42574,Caspase-3,CASP3,277.0
14174,DB07697,"1-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)-4-[(4-methoxyphenyl)sulfonyl]piperazine",SmallMoleculeDrug,P14618,Pyruvate kinase PKM,PKM,531.0
14175,DB07698,"3-(3-aminophenyl)-N-(3-chlorophenyl)pyrazolo[1,5-a]pyrimidin-5-amine",SmallMoleculeDrug,Q8TF76,Serine/threonine-protein kinase haspin,GSG2,798.0
14176,DB07700,"3-CARBOXAMIDO-1,3,5(10)-ESTRATRIEN-17(R)-SPIRO-2'(5',5'-DIMETHYL-6'OXO)TETRAHYDROPYRAN",SmallMoleculeDrug,P42330,Aldo-keto reductase family 1 member C3,AKR1C3,323.0
14177,DB07701,"1-BENZYL-4-[(5,6-DIMETHOXY-1-INDANON-2-YL)METHYL]PIPERIDINE",SmallMoleculeDrug,P22303,Acetylcholinesterase,ACHE,614.0
14178,DB07702,"(16ALPHA,17ALPHA)-ESTRA-1,3,5(10)-TRIENE-3,16,17-TRIOL",SmallMoleculeDrug,Q9HCD5,Nuclear receptor coactivator 5,NCOA5,579.0
14179,DB07702,"(16ALPHA,17ALPHA)-ESTRA-1,3,5(10)-TRIENE-3,16,17-TRIOL",SmallMoleculeDrug,Q92731,Estrogen receptor beta,ESR2,530.0
14183,DB07705,"1-[(2S)-2-[(4-CHLOROBENZYL)OXY]-2-(2,4-DICHLOROPHENYL)ETHYL]-1H-IMIDAZOLE",SmallMoleculeDrug,Q16850,Lanosterol 14-alpha demethylase,CYP51A1,503.0
14185,DB07707,"(9BETA,11ALPHA,13ALPHA,14BETA,17ALPHA)-11-(METHOXYMETHYL)ESTRA-1(10),2,4-TRIENE-3,17-DIOL",SmallMoleculeDrug,P03372,Estrogen receptor,ESR1,595.0
14186,DB07707,"(9BETA,11ALPHA,13ALPHA,14BETA,17ALPHA)-11-(METHOXYMETHYL)ESTRA-1(10),2,4-TRIENE-3,17-DIOL",SmallMoleculeDrug,Q15596,Nuclear receptor coactivator 2,NCOA2,1464.0
14187,DB07708,3-CHLORO-2-(4-HYDROXYPHENYL)-2H-INDAZOL-5-OL,SmallMoleculeDrug,P03372,Estrogen receptor,ESR1,595.0
14188,DB07708,3-CHLORO-2-(4-HYDROXYPHENYL)-2H-INDAZOL-5-OL,SmallMoleculeDrug,Q15596,Nuclear receptor coactivator 2,NCOA2,1464.0
14189,DB07710,PHENYLALANYLAMINODI(ETHYLOXY)ETHYL BENZENESULFONAMIDEAMINOCARBONYLBENZENESULFONAMIDE,SmallMoleculeDrug,P00918,Carbonic anhydrase 2,CA2,260.0
14190,DB07711,"(2S,3R)-3-(6-amino-9H-purin-9-yl)nonan-2-ol",SmallMoleculeDrug,P00813,Adenosine deaminase,ADA,363.0
14191,DB07712,3-ETHYL-2-(4-HYDROXYPHENYL)-2H-INDAZOL-5-OL,SmallMoleculeDrug,P03372,Estrogen receptor,ESR1,595.0
14192,DB07712,3-ETHYL-2-(4-HYDROXYPHENYL)-2H-INDAZOL-5-OL,SmallMoleculeDrug,Q15596,Nuclear receptor coactivator 2,NCOA2,1464.0
14193,DB07713,"(1S)-1-{[(4'-METHOXY-1,1'-BIPHENYL-4-YL)SULFONYL]AMINO}-2-METHYLPROPYLPHOSPHONIC ACID",SmallMoleculeDrug,P22894,Neutrophil collagenase,MMP8,467.0
14194,DB07714,"6-(3-METHYL-1,4-DIOXO-1,4-DIHYDRONAPHTHALEN-2-YL)HEXANOIC ACID",SmallMoleculeDrug,P00390,"Glutathione reductase, mitochondrial",GSR,522.0
14195,DB07715,"3-METHYL-1,6,8-TRIHYDROXYANTHRAQUINONE",SmallMoleculeDrug,P68400,Casein kinase II subunit alpha,CSNK2A1,391.0
14198,DB07716,"(4Z)-2,8:7,12:11,15:14,18:17,22-PENTAANHYDRO-4,5,6,9,10,13,19,20,21-NONADEOXY-D-ARABINO-D-ALLO-D-ALLO-DOCOSA-4,9,20-TRIENITOL",SmallMoleculeDrug,P01834,Ig kappa chain C region,IGKC,107.0
14199,DB07717,"(5S,8R,9S,10S,13R,14S,17S)-13-{2-[(3,5-DIFLUOROBENZYL)OXY]ETHYL}-17-HYDROXY-10-METHYLHEXADECAHYDRO-3H-CYCLOPENTA[A]PHENANTHREN-3-ONE",SmallMoleculeDrug,P10275,Androgen receptor,AR,920.0
14200,DB07718,3-(4-HYDROXY-PHENYL)PYRUVIC ACID,SmallMoleculeDrug,P00734,Prothrombin,F2,622.0
14201,DB07718,3-(4-HYDROXY-PHENYL)PYRUVIC ACID,SmallMoleculeDrug,P14174,Macrophage migration inhibitory factor,MIF,115.0
14203,DB07719,"3(R)-METHYLCARBAMOYL-7-SULFOAMINO-3,4-DIHYDRO-1H-ISOQUINOLINE-2-CARBOXYLIC ACID TERT-BUTYL ESTER",SmallMoleculeDrug,P18031,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,435.0
14204,DB07720,EPIBATIDINE,SmallMoleculeDrug,Q494W8,CHRNA7-FAM7A fusion protein,CHRFAM7A,412.0
14207,DB07723,3-(5-methoxy-1H-indol-3-yl)propanoic acid,SmallMoleculeDrug,P37231,Peroxisome proliferator-activated receptor gamma,PPARG,505.0
14208,DB07724,3-{5-methoxy-1-[(4-methoxyphenyl)sulfonyl]-1H-indol-3-yl}propanoic acid,SmallMoleculeDrug,Q15788,Nuclear receptor coactivator 1,NCOA1,1441.0
14209,DB07724,3-{5-methoxy-1-[(4-methoxyphenyl)sulfonyl]-1H-indol-3-yl}propanoic acid,SmallMoleculeDrug,Q07869,Peroxisome proliferator-activated receptor alpha,PPARA,468.0
14210,DB07724,3-{5-methoxy-1-[(4-methoxyphenyl)sulfonyl]-1H-indol-3-yl}propanoic acid,SmallMoleculeDrug,Q03181,Peroxisome proliferator-activated receptor delta,PPARD,441.0
14211,DB07724,3-{5-methoxy-1-[(4-methoxyphenyl)sulfonyl]-1H-indol-3-yl}propanoic acid,SmallMoleculeDrug,P37231,Peroxisome proliferator-activated receptor gamma,PPARG,505.0
14214,DB07728,"2-[2-(2-FLUOROPHENYL)PYRIDIN-4-YL]-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE",SmallMoleculeDrug,P49137,MAP kinase-activated protein kinase 2,MAPKAPK2,400.0
14215,DB07728,"2-[2-(2-FLUOROPHENYL)PYRIDIN-4-YL]-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE",SmallMoleculeDrug,Q16644,MAP kinase-activated protein kinase 3,MAPKAPK3,382.0
14217,DB07730,"5-(3-HYDROXYPHENYL)ISOTHIAZOL-3(2H)-ONE 1,1-DIOXIDE",SmallMoleculeDrug,P18031,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,435.0
14218,DB07731,"4-[(E)-(3,5-DIAMINO-1H-PYRAZOL-4-YL)DIAZENYL]PHENOL",SmallMoleculeDrug,P24941,Cyclin-dependent kinase 2,CDK2,298.0
14221,DB07733,"1-METHYL-3-TRIFLUOROMETHYL-1H-THIENO[2,3-C]PYRAZOLE-5-CARBOXYLIC ACID (2-MERCAPTO-ETHYL)-AMIDE",SmallMoleculeDrug,P29466,Caspase-1,CASP1,404.0
14222,DB07734,N-(1-benzylpiperidin-4-yl)-4-sulfanylbutanamide,SmallMoleculeDrug,P56817,Beta-secretase 1,BACE1,501.0
14223,DB07735,"N-[1-(2,6-dimethoxybenzyl)piperidin-4-yl]-4-sulfanylbutanamide",SmallMoleculeDrug,P56817,Beta-secretase 1,BACE1,501.0
14224,DB07736,(2S)-4-(4-fluorobenzyl)-N-(2-sulfanylethyl)piperazine-2-carboxamide,SmallMoleculeDrug,P56817,Beta-secretase 1,BACE1,501.0
14225,DB07737,(2S)-4-(4-fluorobenzyl)-N-(3-sulfanylpropyl)piperazine-2-carboxamide,SmallMoleculeDrug,P56817,Beta-secretase 1,BACE1,501.0
14226,DB07738,"N-[1-(5-bromo-2,3-dimethoxybenzyl)piperidin-4-yl]-4-sulfanylbutanamide",SmallMoleculeDrug,P56817,Beta-secretase 1,BACE1,501.0
14227,DB07739,"(3R)-3-(FLUOROMETHYL)-7-(THIOMORPHOLIN-4-YLSULFONYL)-1,2,3,4-TETRAHYDROISOQUINOLINE",SmallMoleculeDrug,P11086,Phenylethanolamine N-methyltransferase,PNMT,282.0
14228,DB07740,"(3R,5S,7R,12S,13R)-13-FORMYL-12,14-DIHYDROXY-3,5,7-TRIMETHYLTETRADECANOIC ACID",SmallMoleculeDrug,Q01581,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",HMGCS1,520.0
14229,DB07741,"4-(1R,3AS,4R,8AS,8BR)-[1-DIFLUOROMETHYL-2-(4-FLUOROBENZYL)-3-OXODECAHYDROPYRROLO[3,4-A]PYRROLIZIN-4-YL]BENZAMIDINE",SmallMoleculeDrug,P00734,Prothrombin,F2,622.0
14230,DB07742,"N-(2,3-DIFLUORO-BENZYL)-4-SULFAMOYL-BENZAMIDE",SmallMoleculeDrug,P00918,Carbonic anhydrase 2,CA2,260.0
14233,DB07744,3-[2-(2-BENZYLOXYCARBONYLAMINO-3-METHYL-BUTYRYLAMINO)-PROPIONYLAMINO]-4-OXO-PENTANOIC ACID,SmallMoleculeDrug,P29466,Caspase-1,CASP1,404.0
14236,DB07746,3-ETHYL-6-{[(4-FLUOROPHENYL)SULFONYL]AMINO}-2-METHYLBENZOIC ACID,SmallMoleculeDrug,P50579,Methionine aminopeptidase 2,METAP2,478.0
14237,DB07747,"(3R)-N-(4-CHLOROPHENYL)-3-(HYDROXYMETHYL)-1,2,3,4-TETRAHYDROISOQUINOLINE-7-SULFONAMIDE",SmallMoleculeDrug,P11086,Phenylethanolamine N-methyltransferase,PNMT,282.0
14240,DB07749,2-ACETYLAMINO-4-METHYL-PENTANOIC ACID (1-FORMYL-2-PHENYL-ETHYL)-AMIDE,SmallMoleculeDrug,P17538,Chymotrypsinogen B,CTRB1,263.0
14241,DB07750,"(2R)-1-[4-({4-[(2,5-DICHLOROPHENYL)AMINO]PYRIMIDIN-2-YL}AMINO)PHENOXY]-3-(DIMETHYLAMINO)PROPAN-2-OL",SmallMoleculeDrug,P24941,Cyclin-dependent kinase 2,CDK2,298.0
14242,DB07751,"(2S)-1-[4-({6-[(2,6-DIFLUOROPHENYL)AMINO]PYRIMIDIN-4-YL}AMINO)PHENOXY]-3-(DIMETHYLAMINO)PROPAN-2-OL",SmallMoleculeDrug,P24941,Cyclin-dependent kinase 2,CDK2,298.0
14243,DB07754,N-({(1R)-1-carboxy-2-[(4-fluorobenzyl)sulfanyl]ethyl}carbamoyl)-L-glutamic acid,SmallMoleculeDrug,Q04609,Glutamate carboxypeptidase 2,FOLH1,750.0
14244,DB07755,"(2S)-1-[4-({4-[(2,5-DICHLOROPHENYL)AMINO]PYRIMIDIN-2-YL}AMINO)PHENOXY]-3-(DIMETHYLAMINO)PROPAN-2-OL",SmallMoleculeDrug,P24941,Cyclin-dependent kinase 2,CDK2,298.0
14245,DB07756,"1-[3-({[(4-AMINO-5-FLUORO-2-METHYLQUINOLIN-3-YL)METHYL]THIO}METHYL)PHENYL]-2,2,2-TRIFLUOROETHANE-1,1-DIOL",SmallMoleculeDrug,P22303,Acetylcholinesterase,ACHE,614.0
14246,DB07757,"(9aS)-4-bromo-9a-butyl-7-hydroxy-1,2,9,9a-tetrahydro-3H-fluoren-3-one",SmallMoleculeDrug,Q92731,Estrogen receptor beta,ESR2,530.0
14249,DB07760,"3-[(1E,7E)-8-(2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)-3,6-dioxa-2,7-diazaocta-1,7-dien-1-yl]benzoic acid",SmallMoleculeDrug,P13051,Uracil-DNA glycosylase,UNG,313.0
14250,DB07761,"(2R)-1-[4-({6-[(2,6-DIFLUOROPHENYL)AMINO]PYRIMIDIN-4-YL}AMINO)PHENOXY]-3-(DIMETHYLAMINO)PROPAN-2-OL",SmallMoleculeDrug,P24941,Cyclin-dependent kinase 2,CDK2,298.0
14252,DB07763,"(5S)-3-ANILINO-5-(2,4-DIFLUOROPHENYL)-5-METHYL-1,3-OXAZOLIDINE-2,4-DIONE",SmallMoleculeDrug,P08574,"Cytochrome c1, heme protein, mitochondrial",CYC1,325.0
14253,DB07763,"(5S)-3-ANILINO-5-(2,4-DIFLUOROPHENYL)-5-METHYL-1,3-OXAZOLIDINE-2,4-DIONE",SmallMoleculeDrug,P00156,Cytochrome b,MT-CYB,380.0
14254,DB07763,"(5S)-3-ANILINO-5-(2,4-DIFLUOROPHENYL)-5-METHYL-1,3-OXAZOLIDINE-2,4-DIONE",SmallMoleculeDrug,P31930,"Cytochrome b-c1 complex subunit 1, mitochondrial",UQCRC1,480.0
14255,DB07763,"(5S)-3-ANILINO-5-(2,4-DIFLUOROPHENYL)-5-METHYL-1,3-OXAZOLIDINE-2,4-DIONE",SmallMoleculeDrug,P22695,"Cytochrome b-c1 complex subunit 2, mitochondrial",UQCRC2,453.0
14256,DB07763,"(5S)-3-ANILINO-5-(2,4-DIFLUOROPHENYL)-5-METHYL-1,3-OXAZOLIDINE-2,4-DIONE",SmallMoleculeDrug,P07919,"Cytochrome b-c1 complex subunit 6, mitochondrial",UQCRH,91.0
14257,DB07763,"(5S)-3-ANILINO-5-(2,4-DIFLUOROPHENYL)-5-METHYL-1,3-OXAZOLIDINE-2,4-DIONE",SmallMoleculeDrug,O14949,Cytochrome b-c1 complex subunit 8,UQCRQ,82.0
14258,DB07763,"(5S)-3-ANILINO-5-(2,4-DIFLUOROPHENYL)-5-METHYL-1,3-OXAZOLIDINE-2,4-DIONE",SmallMoleculeDrug,P47985,"Cytochrome b-c1 complex subunit Rieske, mitochondrial",UQCRFS1,274.0
14259,DB07763,"(5S)-3-ANILINO-5-(2,4-DIFLUOROPHENYL)-5-METHYL-1,3-OXAZOLIDINE-2,4-DIONE",SmallMoleculeDrug,O14957,Cytochrome b-c1 complex subunit 10,UQCR11,56.0
14260,DB07763,"(5S)-3-ANILINO-5-(2,4-DIFLUOROPHENYL)-5-METHYL-1,3-OXAZOLIDINE-2,4-DIONE",SmallMoleculeDrug,P14927,Cytochrome b-c1 complex subunit 7,UQCRB,111.0
14261,DB07763,"(5S)-3-ANILINO-5-(2,4-DIFLUOROPHENYL)-5-METHYL-1,3-OXAZOLIDINE-2,4-DIONE",SmallMoleculeDrug,Q9UDW1,Cytochrome b-c1 complex subunit 9,UQCR10,63.0
14262,DB07764,FLUORESCIN,SmallMoleculeDrug,P01857,Ig gamma-1 chain C region,IGHG1,330.0
14263,DB07765,"METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL](METHYL)AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE",SmallMoleculeDrug,P0CG22,Putative dehydrogenase/reductase SDR family member 4-like 1,DHRS4L1,281.0
14264,DB07766,"(2Z,3E)-2,3'-BIINDOLE-2',3(1H,1'H)-DIONE 3-{O-[(3R)-3,4-DIHYDROXYBUTYL]OXIME}",SmallMoleculeDrug,Q9UQM7,Calcium/calmodulin-dependent protein kinase type II subunit alpha,CAMK2A,478.0
14265,DB07766,"(2Z,3E)-2,3'-BIINDOLE-2',3(1H,1'H)-DIONE 3-{O-[(3R)-3,4-DIHYDROXYBUTYL]OXIME}",SmallMoleculeDrug,Q00536,Cyclin-dependent kinase 16,CDK16,496.0
14270,DB07768,"(10ALPHA,13ALPHA,14BETA,17ALPHA)-17-HYDROXYANDROST-4-EN-3-ONE",SmallMoleculeDrug,Q04828,Aldo-keto reductase family 1 member C1,AKR1C1,323.0
14271,DB07768,"(10ALPHA,13ALPHA,14BETA,17ALPHA)-17-HYDROXYANDROST-4-EN-3-ONE",SmallMoleculeDrug,P52895,Aldo-keto reductase family 1 member C2,AKR1C2,323.0
14272,DB07769,S-3-(4-FLUOROPHENOXY)-2-HYDROXY-2-METHYL-N-[4-NITRO-3-(TRIFLUOROMETHYL)PHENYL]PROPANAMIDE,SmallMoleculeDrug,P10275,Androgen receptor,AR,920.0
14274,DB07771,"[(3,7,11-TRIMETHYL-DODECA-2,6,10-TRIENYLOXYCARBAMOYL)-METHYL]-PHOSPHONIC ACID",SmallMoleculeDrug,P01116,GTPase KRas,KRAS,189.0
14275,DB07771,"[(3,7,11-TRIMETHYL-DODECA-2,6,10-TRIENYLOXYCARBAMOYL)-METHYL]-PHOSPHONIC ACID",SmallMoleculeDrug,P49354,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,FNTA,379.0
14276,DB07771,"[(3,7,11-TRIMETHYL-DODECA-2,6,10-TRIENYLOXYCARBAMOYL)-METHYL]-PHOSPHONIC ACID",SmallMoleculeDrug,P49356,Protein farnesyltransferase subunit beta,FNTB,437.0
14277,DB07772,"(1R)-1-{[(4'-METHOXY-1,1'-BIPHENYL-4-YL)SULFONYL]AMINO}-2-METHYLPROPYLPHOSPHONIC ACID",SmallMoleculeDrug,P22894,Neutrophil collagenase,MMP8,467.0
14281,DB07778,FAMOXADONE,SmallMoleculeDrug,P08574,"Cytochrome c1, heme protein, mitochondrial",CYC1,325.0
14282,DB07778,FAMOXADONE,SmallMoleculeDrug,P00156,Cytochrome b,MT-CYB,380.0
14283,DB07778,FAMOXADONE,SmallMoleculeDrug,P31930,"Cytochrome b-c1 complex subunit 1, mitochondrial",UQCRC1,480.0
14284,DB07778,FAMOXADONE,SmallMoleculeDrug,P22695,"Cytochrome b-c1 complex subunit 2, mitochondrial",UQCRC2,453.0
14285,DB07778,FAMOXADONE,SmallMoleculeDrug,P07919,"Cytochrome b-c1 complex subunit 6, mitochondrial",UQCRH,91.0
14286,DB07778,FAMOXADONE,SmallMoleculeDrug,O14949,Cytochrome b-c1 complex subunit 8,UQCRQ,82.0
14287,DB07778,FAMOXADONE,SmallMoleculeDrug,P47985,"Cytochrome b-c1 complex subunit Rieske, mitochondrial",UQCRFS1,274.0
14288,DB07778,FAMOXADONE,SmallMoleculeDrug,O14957,Cytochrome b-c1 complex subunit 10,UQCR11,56.0
14289,DB07778,FAMOXADONE,SmallMoleculeDrug,P14927,Cytochrome b-c1 complex subunit 7,UQCRB,111.0
14290,DB07778,FAMOXADONE,SmallMoleculeDrug,Q9UDW1,Cytochrome b-c1 complex subunit 9,UQCR10,63.0
14291,DB07779,N-({(2S)-1-[(3R)-3-AMINO-4-(2-FLUOROPHENYL)BUTANOYL]PYRROLIDIN-2-YL}METHYL)BENZAMIDE,SmallMoleculeDrug,P27487,Dipeptidyl peptidase 4,DPP4,766.0
14292,DB07780,FARNESYL DIPHOSPHATE,SmallMoleculeDrug,P49354,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,FNTA,379.0
14293,DB07780,FARNESYL DIPHOSPHATE,SmallMoleculeDrug,P49356,Protein farnesyltransferase subunit beta,FNTB,437.0
14294,DB07780,FARNESYL DIPHOSPHATE,SmallMoleculeDrug,P01116,GTPase KRas,KRAS,189.0
14296,DB07780,FARNESYL DIPHOSPHATE,SmallMoleculeDrug,P14324,Farnesyl pyrophosphate synthase,FDPS,419.0
14299,DB07780,FARNESYL DIPHOSPHATE,SmallMoleculeDrug,O95749,Geranylgeranyl pyrophosphate synthase,GGPS1,300.0
14301,DB07780,FARNESYL DIPHOSPHATE,SmallMoleculeDrug,Q92696,Geranylgeranyl transferase type-2 subunit alpha,RABGGTA,567.0
14302,DB07780,FARNESYL DIPHOSPHATE,SmallMoleculeDrug,P53611,Geranylgeranyl transferase type-2 subunit beta,RABGGTB,331.0
14305,DB07783,1-((1R)-1-(HYDROXYMETHYL)-3-{6-[(3-PHENYLPROPANOYL)AMINO]-1H-INDOL-1-YL}PROPYL)-1H-IMIDAZOLE-4-CARBOXAMIDE,SmallMoleculeDrug,P00813,Adenosine deaminase,ADA,363.0
14306,DB07784,"[4-(4-ACETYLAMINO-PHENYL)-3,5-DIOXO-4-AZA-TRICYCLO[5.2.2.0 2,6]UNDEC-1-YLCARBAMOYLOXY]-ACETIC ACID",SmallMoleculeDrug,P01834,Ig kappa chain C region,IGKC,107.0
14307,DB07785,"1-{(1R,2S)-2-HYDROXY-1-[2-(2-NAPHTHYLOXY)ETHYL]PROPYL}-1H-IMIDAZONE-4-CARBOXAMIDE",SmallMoleculeDrug,P00813,Adenosine deaminase,ADA,363.0
14308,DB07786,"1-((1R,2S)-1-{2-[2-(4-CHLOROPHENYL)-1,3-BENZOXAZOL-7-YL]ETHYL}-2-HYDROXYPROPYL)-1H-IMIDAZOLE-4-CARBOXAMIDE",SmallMoleculeDrug,P00813,Adenosine deaminase,ADA,363.0
14309,DB07787,"5-FLUORO-1-[4-(4-PHENYL-3,6-DIHYDROPYRIDIN-1(2H)-YL)BUTYL]QUINAZOLINE-2,4(1H,3H)-DIONE",SmallMoleculeDrug,P09874,Poly [ADP-ribose] polymerase 1,PARP1,1014.0
14310,DB07788,"(3R,5Z,8S,9S,11E)-8,9,16-TRIHYDROXY-14-METHOXY-3-METHYL-3,4,9,10-TETRAHYDRO-1H-2-BENZOXACYCLOTETRADECINE-1,7(8H)-DIONE",SmallMoleculeDrug,P28482,Mitogen-activated protein kinase 1,MAPK1,360.0
14311,DB07789,"1-[5-methyl-2-(trifluoromethyl)furan-3-yl]-3-[(2Z)-5-(2-{[6-(1H-1,2,4-triazol-3-ylamino)pyrimidin-4-yl]amino}ethyl)-1,3-thiazol-2(3H)-ylidene]urea",SmallMoleculeDrug,P53350,Serine/threonine-protein kinase PLK1,PLK1,603.0
14312,DB07790,N-(2-METHOXYETHYL)-4-({4-[2-METHYL-1-(1-METHYLETHYL)-1H-IMIDAZOL-5-YL]PYRIMIDIN-2-YL}AMINO)BENZENESULFONAMIDE,SmallMoleculeDrug,P24941,Cyclin-dependent kinase 2,CDK2,298.0
14313,DB07791,4-{[4-(1-CYCLOPROPYL-2-METHYL-1H-IMIDAZOL-5-YL)PYRIMIDIN-2-YL]AMINO}-N-METHYLBENZENESULFONAMIDE,SmallMoleculeDrug,P24941,Cyclin-dependent kinase 2,CDK2,298.0
14314,DB07792,"(S)-2-CHLORO-N-(1-(2-(2-HYDROXYETHYLAMINO)-2-OXOETHYL)-2-OXO-1,2,3,4-TETRAHYDROQUINOLIN-3-YL)-6H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE",SmallMoleculeDrug,P11217,"Glycogen phosphorylase, muscle form",PYGM,842.0
14315,DB07793,"(2S)-N-[(3S)-1-(2-AMINO-2-OXOETHYL)-2-OXO-1,2,3,4-TETRAHYDROQUINOLIN-3-YL]-2-CHLORO-2H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE",SmallMoleculeDrug,P11217,"Glycogen phosphorylase, muscle form",PYGM,842.0
14316,DB07794,"5-(2-PHENYLPYRAZOLO[1,5-A]PYRIDIN-3-YL)-1H-PYRAZOLO[3,4-C]PYRIDAZIN-3-AMINE",SmallMoleculeDrug,P28482,Mitogen-activated protein kinase 1,MAPK1,360.0
14318,DB07795,"3,7,3',4'-TETRAHYDROXYFLAVONE",SmallMoleculeDrug,Q00534,Cyclin-dependent kinase 6,CDK6,326.0
14319,DB07796,"(3ASR,4RS,8ASR,8BRS)-4-(2-(4-FLUOROBENZYL)-1,3-DIOXODEACAHYDROPYRROLO[3,4-A] PYRROLIZIN-4-YL)BENZAMIDINE",SmallMoleculeDrug,P00734,Prothrombin,F2,622.0
14321,DB07798,"(3R)-3-(FLUOROMETHYL)-N-(3,3,3-TRIFLUOROPROPYL)-1,2,3,4-TETRAHYDROISOQUINOLINE-7-SULFONAMIDE",SmallMoleculeDrug,P11086,Phenylethanolamine N-methyltransferase,PNMT,282.0
14322,DB07800,N-(2-(((5-CHLORO-2-PYRIDINYL)AMINO)SULFONYL)PHENYL)-4-(2-OXO-1(2H)-PYRIDINYL)BENZAMIDE,SmallMoleculeDrug,P00742,Coagulation factor X,F10,488.0
14323,DB07801,N-butyl-3-{[6-(9H-purin-6-ylamino)hexanoyl]amino}benzamide,SmallMoleculeDrug,O14965,Aurora kinase A,AURKA,403.0
14324,DB07802,"3,8-DIBROMO-7-HYDROXY-4-METHYL-2H-CHROMEN-2-ONE",SmallMoleculeDrug,P68400,Casein kinase II subunit alpha,CSNK2A1,391.0
14326,DB07804,"5-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}-1H-1,2,4-TRIAZOLE-3-SULFONAMIDE",SmallMoleculeDrug,P00742,Coagulation factor X,F10,488.0
14329,DB07807,"(3R,4R,5R)-5-(HYDROXYMETHYL)-1-(3-PHENYLPROPYL)PIPERIDINE-3,4-DIOL",SmallMoleculeDrug,P11217,"Glycogen phosphorylase, muscle form",PYGM,842.0
14331,DB07809,4-({[4-(3-METHYLBENZOYL)PYRIDIN-2-YL]AMINO}METHYL)BENZENECARBOXIMIDAMIDE,SmallMoleculeDrug,P00734,Prothrombin,F2,622.0
14333,DB07811,"N-cyclopropyl-2',6-dimethyl-4'-(5-methyl-1,3,4-oxadiazol-2-yl)biphenyl-3-carboxamide",SmallMoleculeDrug,Q16539,Mitogen-activated protein kinase 14,MAPK14,360.0
14334,DB07812,"N-[(1S)-2-amino-1-phenylethyl]-5-(1H-pyrrolo[2,3-b]pyridin-4-yl)thiophene-2-carboxamide",SmallMoleculeDrug,P31751,RAC-beta serine/threonine-protein kinase,AKT2,481.0
14335,DB07812,"N-[(1S)-2-amino-1-phenylethyl]-5-(1H-pyrrolo[2,3-b]pyridin-4-yl)thiophene-2-carboxamide",SmallMoleculeDrug,P49841,Glycogen synthase kinase-3 beta,GSK3B,420.0
14337,DB07814,GIBBERELLIN A3,SmallMoleculeDrug,Q6P093,Arylacetamide deacetylase-like 2,AADACL2,401.0
14338,DB07815,GIBBERELLIN A4,SmallMoleculeDrug,Q6P093,Arylacetamide deacetylase-like 2,AADACL2,401.0
14339,DB07816,N-(P-CYANOPHENYL)-N'-DIPHENYLMETHYL-GUANIDINE-ACETIC ACID,SmallMoleculeDrug,P01857,Ig gamma-1 chain C region,IGHG1,330.0
14347,DB07821,"(1R)-1,2,2-TRIMETHYLPROPYL (R)-METHYLPHOSPHINATE",SmallMoleculeDrug,P23141,Liver carboxylesterase 1,CES1,567.0
14348,DB07821,"(1R)-1,2,2-TRIMETHYLPROPYL (R)-METHYLPHOSPHINATE",SmallMoleculeDrug,Q15102,Platelet-activating factor acetylhydrolase IB subunit gamma,PAFAH1B3,231.0
14349,DB07821,"(1R)-1,2,2-TRIMETHYLPROPYL (R)-METHYLPHOSPHINATE",SmallMoleculeDrug,Q13093,Platelet-activating factor acetylhydrolase,PLA2G7,441.0
14350,DB07822,"(1R)-1,2,2-TRIMETHYLPROPYL (S)-METHYLPHOSPHINATE",SmallMoleculeDrug,P22303,Acetylcholinesterase,ACHE,614.0
14357,DB07827,"4-{[1-METHYL-2,4-DIOXO-6-(3-PHENYLPROP-1-YN-1-YL)-1,4-DIHYDROQUINAZOLIN-3(2H)-YL]METHYL}BENZOIC ACID",SmallMoleculeDrug,P45452,Collagenase 3,MMP13,471.0
14358,DB07829,4-[3-(4-FLUOROPHENYL)-1H-PYRAZOL-4-YL]PYRIDINE,SmallMoleculeDrug,Q16539,Mitogen-activated protein kinase 14,MAPK14,360.0
14359,DB07830,"(4R,5R)-5-AMINO-1-[2-(1,3-BENZODIOXOL-5-YL)ETHYL]-4-(2,4,5-TRIFLUOROPHENYL)PIPERIDIN-2-ONE",SmallMoleculeDrug,P27487,Dipeptidyl peptidase 4,DPP4,766.0
14360,DB07831,"2-{[(6-OXO-1,6-DIHYDROPYRIDIN-3-YL)METHYL]AMINO}-N-[4-PROPYL-3-(TRIFLUOROMETHYL)PHENYL]BENZAMIDE",SmallMoleculeDrug,P00519,Tyrosine-protein kinase ABL1,ABL1,1130.0
14361,DB07832,"4-{4-[(5-hydroxy-2-methylphenyl)amino]quinolin-7-yl}-1,3-thiazole-2-carbaldehyde",SmallMoleculeDrug,Q16539,Mitogen-activated protein kinase 14,MAPK14,360.0
14362,DB07833,"N-(3-cyanophenyl)-2'-methyl-5'-(5-methyl-1,3,4-oxadiazol-2-yl)-4-biphenylcarboxamide",SmallMoleculeDrug,Q16539,Mitogen-activated protein kinase 14,MAPK14,360.0
14363,DB07834,"N-(cyclopropylmethyl)-2'-methyl-5'-(5-methyl-1,3,4-oxadiazol-2-yl)biphenyl-4-carboxamide",SmallMoleculeDrug,Q16539,Mitogen-activated protein kinase 14,MAPK14,360.0
14364,DB07835,"N~3~-cyclopropyl-N~4~'-(cyclopropylmethyl)-6-methylbiphenyl-3,4'-dicarboxamide",SmallMoleculeDrug,Q16539,Mitogen-activated protein kinase 14,MAPK14,360.0
14365,DB07836,1-DECYL-3-TRIFLUORO ETHYL-SN-GLYCERO-2-PHOSPHOMETHANOL,SmallMoleculeDrug,P04054,Phospholipase A2,PLA2G1B,148.0
14366,DB07837,"[4-(5-naphthalen-2-yl-1H-pyrrolo[2,3-b]pyridin-3-yl)phenyl]acetic acid",SmallMoleculeDrug,O00141,Serine/threonine-protein kinase Sgk1,SGK1,431.0
14367,DB07838,(Z)-3-BENZYL-5-(2-HYDROXY-3-NITROBENZYLIDENE)-2-THIOXOTHIAZOLIDIN-4-ONE,SmallMoleculeDrug,O60551,Glycylpeptide N-tetradecanoyltransferase 2,NMT2,498.0
14368,DB07839,"N~2~-1,3-BENZOXAZOL-2-YL-3-CYCLOHEXYL-N-{2-[(4-METHOXYPHENYL)AMINO]ETHYL}-L-ALANINAMIDE",SmallMoleculeDrug,P25774,Cathepsin S,CTSS,331.0
14369,DB07840,"(E)-[4-(3,5-difluorophenyl)-3H-pyrrolo[2,3-b]pyridin-3-ylidene](3-methoxyphenyl)methanol",SmallMoleculeDrug,P11362,Fibroblast growth factor receptor 1,FGFR1,822.0
14370,DB07841,GERANYLGERANYL DIPHOSPHATE,SmallMoleculeDrug,P49354,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,FNTA,379.0
14371,DB07841,GERANYLGERANYL DIPHOSPHATE,SmallMoleculeDrug,P53609,Geranylgeranyl transferase type-1 subunit beta,PGGT1B,377.0
14372,DB07841,GERANYLGERANYL DIPHOSPHATE,SmallMoleculeDrug,P49356,Protein farnesyltransferase subunit beta,FNTB,437.0
14373,DB07841,GERANYLGERANYL DIPHOSPHATE,SmallMoleculeDrug,O95749,Geranylgeranyl pyrophosphate synthase,GGPS1,300.0
14374,DB07841,GERANYLGERANYL DIPHOSPHATE,SmallMoleculeDrug,P14324,Farnesyl pyrophosphate synthase,FDPS,419.0
14375,DB07841,GERANYLGERANYL DIPHOSPHATE,SmallMoleculeDrug,Q92696,Geranylgeranyl transferase type-2 subunit alpha,RABGGTA,567.0
14376,DB07841,GERANYLGERANYL DIPHOSPHATE,SmallMoleculeDrug,P53611,Geranylgeranyl transferase type-2 subunit beta,RABGGTB,331.0
14377,DB07842,(2S)-2-(4-ethylphenoxy)-3-phenylpropanoic acid,SmallMoleculeDrug,P37231,Peroxisome proliferator-activated receptor gamma,PPARG,505.0
14378,DB07843,5-CHLORO-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}-1-BENZOTHIOPHENE-2-SULFONAMIDE,SmallMoleculeDrug,P00742,Coagulation factor X,F10,488.0
14379,DB07844,6-CHLORO-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}-1-BENZOTHIOPHENE-2-SULFONAMIDE,SmallMoleculeDrug,P00742,Coagulation factor X,F10,488.0
14380,DB07845,"2-fluoro-6-{[2-({2-methoxy-4-[(methylsulfonyl)methyl]phenyl}amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino}benzamide",SmallMoleculeDrug,P45983,Mitogen-activated protein kinase 8,MAPK8,427.0
14381,DB07846,"1S,3AS,8AS-TRIMETHYL-1-OXIDO-1,2,3,3A,8,8A-HEXAHYDROPYRROLO[2,3-B]INDOL-5-YL 2-ETHYLPHENYLCARBAMATE",SmallMoleculeDrug,P22303,Acetylcholinesterase,ACHE,614.0
14382,DB07847,6-CHLORO-N-{(3S)-1-[(1S)-1-METHYL-2-(4-MORPHOLINYL)-2-OXO ETHYL]-2-OXO-3-PYRROLIDINYL}-2-NAPHTHALENESULFONAMIDE,SmallMoleculeDrug,P00742,Coagulation factor X,F10,488.0
14383,DB07848,5-CHLORO-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-5-CHLORO-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-SULFONAMIDE,SmallMoleculeDrug,P00742,Coagulation factor X,F10,488.0
14384,DB07849,S-NONYL-CYSTEINE,SmallMoleculeDrug,P09211,Glutathione S-transferase P,GSTP1,210.0
14386,DB07851,"(3R,4S)-1-(3,4-DIMETHOXYPHENYL)-3-(3-METHYLPHENYL)PIPERIDIN-4-AMINE",SmallMoleculeDrug,P27487,Dipeptidyl peptidase 4,DPP4,766.0
14387,DB07852,"1-(3,5-DICHLOROPHENYL)-5-METHYL-1H-1,2,4-TRIAZOLE-3-CARBOXYLIC ACID",SmallMoleculeDrug,P20248,Cyclin-A2,CCNA2,432.0
14388,DB07852,"1-(3,5-DICHLOROPHENYL)-5-METHYL-1H-1,2,4-TRIAZOLE-3-CARBOXYLIC ACID",SmallMoleculeDrug,P24941,Cyclin-dependent kinase 2,CDK2,298.0
14389,DB07853,"[4-({4-[(5-CYCLOPROPYL-1H-PYRAZOL-3-YL)AMINO]QUINAZOLIN-2-YL}IMINO)CYCLOHEXA-2,5-DIEN-1-YL]ACETONITRILE",SmallMoleculeDrug,Q9H2G2,STE20-like serine/threonine-protein kinase,SLK,1235.0
14390,DB07853,"[4-({4-[(5-CYCLOPROPYL-1H-PYRAZOL-3-YL)AMINO]QUINAZOLIN-2-YL}IMINO)CYCLOHEXA-2,5-DIEN-1-YL]ACETONITRILE",SmallMoleculeDrug,Q13557,Calcium/calmodulin-dependent protein kinase type II subunit delta,CAMK2D,499.0
14391,DB07853,"[4-({4-[(5-CYCLOPROPYL-1H-PYRAZOL-3-YL)AMINO]QUINAZOLIN-2-YL}IMINO)CYCLOHEXA-2,5-DIEN-1-YL]ACETONITRILE",SmallMoleculeDrug,Q9P289,Serine/threonine-protein kinase 26,STK26,416.0
14392,DB07854,N-METHYL-1-[4-(9H-PURIN-6-YL)PHENYL]METHANAMINE,SmallMoleculeDrug,P17612,cAMP-dependent protein kinase catalytic subunit alpha,PRKACA,351.0
14393,DB07854,N-METHYL-1-[4-(9H-PURIN-6-YL)PHENYL]METHANAMINE,SmallMoleculeDrug,P61925,cAMP-dependent protein kinase inhibitor alpha,PKIA,76.0
14394,DB07855,(S)-1-PHENYL-1-[4-(9H-PURIN-6-YL)PHENYL]METHANAMINE,SmallMoleculeDrug,P17612,cAMP-dependent protein kinase catalytic subunit alpha,PRKACA,351.0
14395,DB07855,(S)-1-PHENYL-1-[4-(9H-PURIN-6-YL)PHENYL]METHANAMINE,SmallMoleculeDrug,P61925,cAMP-dependent protein kinase inhibitor alpha,PKIA,76.0
14396,DB07856,6-{4-[4-(4-CHLOROPHENYL)PIPERIDIN-4-YL]PHENYL}-9H-PURINE,SmallMoleculeDrug,P17612,cAMP-dependent protein kinase catalytic subunit alpha,PRKACA,351.0
14397,DB07856,6-{4-[4-(4-CHLOROPHENYL)PIPERIDIN-4-YL]PHENYL}-9H-PURINE,SmallMoleculeDrug,P61925,cAMP-dependent protein kinase inhibitor alpha,PKIA,76.0
14398,DB07857,(2R)-2-(4-CHLOROPHENYL)-2-[4-(1H-PYRAZOL-4-YL)PHENYL]ETHANAMINE,SmallMoleculeDrug,P17612,cAMP-dependent protein kinase catalytic subunit alpha,PRKACA,351.0
14399,DB07857,(2R)-2-(4-CHLOROPHENYL)-2-[4-(1H-PYRAZOL-4-YL)PHENYL]ETHANAMINE,SmallMoleculeDrug,P61925,cAMP-dependent protein kinase inhibitor alpha,PKIA,76.0
14400,DB07858,(2S)-2-(4-CHLOROPHENYL)-2-[4-(1H-PYRAZOL-4-YL)PHENYL]ETHANAMINE,SmallMoleculeDrug,P17612,cAMP-dependent protein kinase catalytic subunit alpha,PRKACA,351.0
14401,DB07858,(2S)-2-(4-CHLOROPHENYL)-2-[4-(1H-PYRAZOL-4-YL)PHENYL]ETHANAMINE,SmallMoleculeDrug,P61925,cAMP-dependent protein kinase inhibitor alpha,PKIA,76.0
14402,DB07859,4-(4-CHLOROPHENYL)-4-[4-(1H-PYRAZOL-4-YL)PHENYL]PIPERIDINE,SmallMoleculeDrug,P17612,cAMP-dependent protein kinase catalytic subunit alpha,PRKACA,351.0
14403,DB07859,4-(4-CHLOROPHENYL)-4-[4-(1H-PYRAZOL-4-YL)PHENYL]PIPERIDINE,SmallMoleculeDrug,P61925,cAMP-dependent protein kinase inhibitor alpha,PKIA,76.0
14404,DB07859,4-(4-CHLOROPHENYL)-4-[4-(1H-PYRAZOL-4-YL)PHENYL]PIPERIDINE,SmallMoleculeDrug,P31751,RAC-beta serine/threonine-protein kinase,AKT2,481.0
14405,DB07859,4-(4-CHLOROPHENYL)-4-[4-(1H-PYRAZOL-4-YL)PHENYL]PIPERIDINE,SmallMoleculeDrug,P49841,Glycogen synthase kinase-3 beta,GSK3B,420.0
14406,DB07860,(2R)-2-(4-CHLOROPHENYL)-2-PHENYLETHANAMINE,SmallMoleculeDrug,P17612,cAMP-dependent protein kinase catalytic subunit alpha,PRKACA,351.0
14407,DB07860,(2R)-2-(4-CHLOROPHENYL)-2-PHENYLETHANAMINE,SmallMoleculeDrug,P61925,cAMP-dependent protein kinase inhibitor alpha,PKIA,76.0
14409,DB07862,"7-(1-ETHYL-PROPYL)-7H-PYRROLO-[3,2-F]QUINAZOLINE-1,3-DIAMINE",SmallMoleculeDrug,Q86XF0,"Dihydrofolate reductase, mitochondrial",DHFR2,187.0
14410,DB07863,2-chloro-5-nitro-N-phenylbenzamide,SmallMoleculeDrug,Q15596,Nuclear receptor coactivator 2,NCOA2,1464.0
14411,DB07863,2-chloro-5-nitro-N-phenylbenzamide,SmallMoleculeDrug,P37231,Peroxisome proliferator-activated receptor gamma,PPARG,505.0
14412,DB07863,2-chloro-5-nitro-N-phenylbenzamide,SmallMoleculeDrug,P19793,Retinoic acid receptor RXR-alpha,RXRA,462.0
14415,DB07866,"(5S)-2-(cyclooctylamino)-5-methyl-5-propyl-1,3-thiazol-4(5H)-one",SmallMoleculeDrug,P28845,Corticosteroid 11-beta-dehydrogenase isozyme 1,HSD11B1,292.0
14419,DB07870,(2S)-2-(4-{[3-CHLORO-5-(TRIFLUOROMETHYL)PYRIDIN-2-YL]OXY}PHENOXY)PROPANOIC ACID,SmallMoleculeDrug,O00763,Acetyl-CoA carboxylase 2,ACACB,2458.0
14421,DB07872,5-chloro-N-[(3R)-1-(2-{[2-fluoro-4-(2-oxopyridin-1(2H)-yl)phenyl]amino}-2-oxoethyl)pyrrolidin-3-yl]thiophene-2-carboxamide,SmallMoleculeDrug,P00742,Coagulation factor X,F10,488.0
14422,DB07873,"(1-HYDROXYDODECANE-1,1-DIYL)BIS(PHOSPHONIC ACID)",SmallMoleculeDrug,O95749,Geranylgeranyl pyrophosphate synthase,GGPS1,300.0
14423,DB07874,"(6S)-2-amino-6-(3'-methoxybiphenyl-3-yl)-3,6-dimethyl-5,6-dihydropyrimidin-4(3H)-one",SmallMoleculeDrug,P56817,Beta-secretase 1,BACE1,501.0
14424,DB07875,"5-Chloro-thiophene-2-carboxylic acid ((3S,4S)-1-{[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenylcarbamoyl]-methyl}-4-hydroxy-pyrrolidin-3-yl)-amide",SmallMoleculeDrug,P00742,Coagulation factor X,F10,488.0
14425,DB07876,(S)-2-METHYL-1-[(4-METHYL-5-ISOQUINOLINE)SULFONYL]-HOMOPIPERAZINE,SmallMoleculeDrug,P17612,cAMP-dependent protein kinase catalytic subunit alpha,PRKACA,351.0
14426,DB07876,(S)-2-METHYL-1-[(4-METHYL-5-ISOQUINOLINE)SULFONYL]-HOMOPIPERAZINE,SmallMoleculeDrug,P61925,cAMP-dependent protein kinase inhibitor alpha,PKIA,76.0
14427,DB07876,(S)-2-METHYL-1-[(4-METHYL-5-ISOQUINOLINE)SULFONYL]-HOMOPIPERAZINE,SmallMoleculeDrug,Q13464,Rho-associated protein kinase 1,ROCK1,1354.0
14428,DB07877,"8-(6-BROMO-BENZO[1,3]DIOXOL-5-YLSULFANYL)-9-(3-ISOPROPYLAMINO-PROPYL)-ADENINE",SmallMoleculeDrug,P08238,Heat shock protein HSP 90-beta,HSP90AB1,724.0
14429,DB07877,"8-(6-BROMO-BENZO[1,3]DIOXOL-5-YLSULFANYL)-9-(3-ISOPROPYLAMINO-PROPYL)-ADENINE",SmallMoleculeDrug,P07900,Heat shock protein HSP 90-alpha,HSP90AA1,732.0
14430,DB07878,"N-[(1S)-1-{1-[(1R,3E)-1-ACETYLPENT-3-EN-1-YL]-1H-1,2,3-TRIAZOL-4-YL}-1,2-DIMETHYLPROPYL]BENZAMIDE",SmallMoleculeDrug,P25774,Cathepsin S,CTSS,331.0
14431,DB07879,"N-hydroxy-5-[(3-phenyl-5,6-dihydroimidazo[1,2-a]pyrazin-7(8H)-yl)carbonyl]thiophene-2-carboxamide",SmallMoleculeDrug,P56524,Histone deacetylase 4,HDAC4,1084.0
14433,DB07881,N-{[2-({[1-(4-CARBOXYBUTANOYL)AMINO]-2-PHENYLETHYL}-HYDROXYPHOSPHINYL)OXY]ACETYL}-2-PHENYLETHYLAMINE,SmallMoleculeDrug,P01857,Ig gamma-1 chain C region,IGHG1,330.0
14434,DB07882,"4-{4-[2-(1A,7A-DIMETHYL-4-OXY-OCTAHYDRO-1-OXA-4-AZA-CYCLOPROPA[A]NAPHTHALEN-4-YL) -ACETYLAMINO]-PHENYLCARBAMOYL}-BUTYRIC ACID",SmallMoleculeDrug,P01834,Ig kappa chain C region,IGKC,107.0
14435,DB07883,(2-AMINO-3-PHENYL-BICYCLO[2.2.1]HEPT-2-YL)-PHENYL-METHANONE,SmallMoleculeDrug,P01857,Ig gamma-1 chain C region,IGHG1,330.0
14438,DB07887,"(R)-1-(4-(4-(HYDROXYMETHYL)-1,3,2-DIOXABOROLAN-2-YL)BENZYL)GUANIDINE",SmallMoleculeDrug,P03951,Coagulation factor XI,F11,625.0
14439,DB07888,"3-(4-HYDROXYPHENYL)-4,5-DIHYDRO-5-ISOXAZOLE-ACETIC ACID METHYL ESTER",SmallMoleculeDrug,P14174,Macrophage migration inhibitory factor,MIF,115.0
14440,DB07889,"1-(DIMETHYLAMINO)-3-(4-{{4-(2-METHYLIMIDAZO[1,2-A]PYRIDIN-3-YL)PYRIMIDIN-2-YL]AMINO}PHENOXY)PROPAN-2-OL",SmallMoleculeDrug,P24941,Cyclin-dependent kinase 2,CDK2,298.0
14444,DB07893,PHENYL[1-(N-SUCCINYLAMINO)PENTYL]PHOSPHONATE,SmallMoleculeDrug,P01834,Ig kappa chain C region,IGKC,107.0
14447,DB07895,ALPHA-HYDROXYFARNESYLPHOSPHONIC ACID,SmallMoleculeDrug,P49356,Protein farnesyltransferase subunit beta,FNTB,437.0
14448,DB07895,ALPHA-HYDROXYFARNESYLPHOSPHONIC ACID,SmallMoleculeDrug,P49354,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,FNTA,379.0
14450,DB07897,1-(HYDROXYMETHYLENEAMINO)-8-HYDROXY-OCTANE,SmallMoleculeDrug,P00734,Prothrombin,F2,622.0
14452,DB07899,(2S) N-ACETYL-L-ALANYL-ALPHAL-PHENYLALANYL-CHLOROETHYLKETONE,SmallMoleculeDrug,P17538,Chymotrypsinogen B,CTRB1,263.0
14453,DB07900,3-FORMYL-2-HYDROXY-5-METHYL-HEXANOIC ACID HYDROXYAMIDE,SmallMoleculeDrug,P22894,Neutrophil collagenase,MMP8,467.0
14454,DB07901,5-CHLORO-6-METHYL-N-(2-PHENYLETHYL)-2-PYRIDIN-2-YLPYRIMIDIN-4-AMINE,SmallMoleculeDrug,P53582,Methionine aminopeptidase 1,METAP1,386.0
14455,DB07902,"TERT-BUTYL {2-[(1,3-THIAZOL-2-YLAMINO)CARBONYL]PYRIDIN-3-YL}CARBAMATE",SmallMoleculeDrug,P53582,Methionine aminopeptidase 1,METAP1,386.0
14456,DB07903,"3-[(2,2-DIMETHYLPROPANOYL)AMINO]-N-1,3-THIAZOL-2-YLPYRIDINE-2-CARBOXAMIDE",SmallMoleculeDrug,P53582,Methionine aminopeptidase 1,METAP1,386.0
14457,DB07905,"(1aR,8S,13S,14S,15aR)-5,13,14-trihydroxy-3-methoxy-8-methyl-8,9,13,14,15,15a-hexahydro-6H-oxireno[k][2]benzoxacyclotetradecine-6,12(1aH)-dione",SmallMoleculeDrug,P28482,Mitogen-activated protein kinase 1,MAPK1,360.0
14458,DB07906,"[(3R)-7-NITRO-1,2,3,4-TETRAHYDROISOQUINOLIN-3-YL]METHANOL",SmallMoleculeDrug,P11086,Phenylethanolamine N-methyltransferase,PNMT,282.0
14459,DB07907,(2S)-2-HYDROXYOCTANOIC ACID,SmallMoleculeDrug,Q9UJM8,Hydroxyacid oxidase 1,HAO1,370.0
14461,DB07908,7-HYDROXY-4-METHYL-3-(2-HYDROXY-ETHYL)COUMARIN,SmallMoleculeDrug,P07737,Profilin-1,PFN1,140.0
14462,DB07909,"(1S,2S,5S)2-(4-GLUTARIDYLBENZYL)-5-PHENYL-1-CYCLOHEXANOL",SmallMoleculeDrug,Q7Z3Y4,Uncharacterized protein,nan,236.0
14463,DB07909,"(1S,2S,5S)2-(4-GLUTARIDYLBENZYL)-5-PHENYL-1-CYCLOHEXANOL",SmallMoleculeDrug,P01857,Ig gamma-1 chain C region,IGHG1,330.0
14464,DB07909,"(1S,2S,5S)2-(4-GLUTARIDYLBENZYL)-5-PHENYL-1-CYCLOHEXANOL",SmallMoleculeDrug,P01834,Ig kappa chain C region,IGKC,107.0
14470,DB07912,2-OXOHEPTYLPHOSPHONIC ACID,SmallMoleculeDrug,Q9UHY7,Enolase-phosphatase E1,ENOPH1,261.0
14471,DB07913,HOMOPHENYLALANINYLMETHANE,SmallMoleculeDrug,Q9UBX1,Cathepsin F,CTSF,484.0
14475,DB07916,3-{6-[(8-HYDROXY-QUINOLINE-2-CARBONYL)-AMINO]-2-THIOPHEN-2-YL-HEXANOYLAMINO}-4-OXO-BUTYRI ACID,SmallMoleculeDrug,P29466,Caspase-1,CASP1,404.0
14476,DB07917,4-(BENZHYDRYLOXY)-1-[3-(1H-TETRAAZOL-5-YL)PROPYL]PIPERIDINE,SmallMoleculeDrug,O60760,Hematopoietic prostaglandin D synthase,HPGDS,199.0
14486,DB07919,7-METHOXY-1-METHYL-9H-BETA-CARBOLINE,SmallMoleculeDrug,P21397,Amine oxidase [flavin-containing] A,MAOA,527.0
14487,DB07920,N-oxo-2-[(4-phenylphenyl)sulfonylamino]ethanamide,SmallMoleculeDrug,P39900,Macrophage metalloelastase,MMP12,470.0
14488,DB07921,2-[(4-fluorophenyl)sulfonylamino]-N-oxo-ethanamide,SmallMoleculeDrug,P39900,Macrophage metalloelastase,MMP12,470.0
14489,DB07922,N-oxo-2-(phenylsulfonylamino)ethanamide,SmallMoleculeDrug,P39900,Macrophage metalloelastase,MMP12,470.0
14494,DB07926,N-[3-(N'-HYDROXYCARBOXAMIDO)-2-(2-METHYLPROPYL)-PROPANOYL]-O-TYROSINE-N-METHYLAMIDE,SmallMoleculeDrug,P03956,Interstitial collagenase,MMP1,469.0
14497,DB07929,"N-(TERT-BUTYL)-3,5-DIMETHYL-N'-[(5-METHYL-2,3-DIHYDRO-1,4-BENZODIOXIN-6-YL)CARBONYL]BENZOHYDRAZIDE",SmallMoleculeDrug,Q13133,Oxysterols receptor LXR-alpha,NR1H3,447.0
14498,DB07929,"N-(TERT-BUTYL)-3,5-DIMETHYL-N'-[(5-METHYL-2,3-DIHYDRO-1,4-BENZODIOXIN-6-YL)CARBONYL]BENZOHYDRAZIDE",SmallMoleculeDrug,P28702,Retinoic acid receptor RXR-beta,RXRB,533.0
14499,DB07930,(3R)-3-HYDROXYDODECANOIC ACID,SmallMoleculeDrug,Q15067,Peroxisomal acyl-coenzyme A oxidase 1,ACOX1,660.0
14500,DB07931,Hexestrol,SmallMoleculeDrug,Q04828,Aldo-keto reductase family 1 member C1,AKR1C1,323.0
14501,DB07932,"dimethyl (1R,4S)-5,6-bis(4-hydroxyphenyl)-7-oxabicyclo[2.2.1]hepta-2,5-diene-2,3-dicarboxylate",SmallMoleculeDrug,P03372,Estrogen receptor,ESR1,595.0
14502,DB07932,"dimethyl (1R,4S)-5,6-bis(4-hydroxyphenyl)-7-oxabicyclo[2.2.1]hepta-2,5-diene-2,3-dicarboxylate",SmallMoleculeDrug,Q15596,Nuclear receptor coactivator 2,NCOA2,1464.0
14503,DB07933,"(3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL",SmallMoleculeDrug,Q92731,Estrogen receptor beta,ESR2,530.0
14504,DB07933,"(3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL",SmallMoleculeDrug,P03372,Estrogen receptor,ESR1,595.0
14505,DB07934,[[CYCLOHEXANESULFONYL-GLYCYL]-3[PYRIDIN-4-YL-AMINOMETHYL]ALANYL]PIPERIDINE,SmallMoleculeDrug,P00734,Prothrombin,F2,622.0
14507,DB07936,N-(4-{[(3S)-3-(dimethylamino)pyrrolidin-1-yl]carbonyl}phenyl)-5-fluoro-4-[2-methyl-1-(1-methylethyl)-1H-imidazol-5-yl]pyrimidin-2-amine,SmallMoleculeDrug,P24941,Cyclin-dependent kinase 2,CDK2,298.0
14511,DB07940,"9-(3-IODOBENZYLAMINO)-1,2,3,4-TETRAHYDROACRIDINE",SmallMoleculeDrug,P06276,Cholinesterase,BCHE,602.0
14512,DB07941,"3-{3-bromo-4-[(2,4-difluorobenzyl)oxy]-6-methyl-2-oxopyridin-1(2H)-yl}-N,4-dimethylbenzamide",SmallMoleculeDrug,Q16539,Mitogen-activated protein kinase 14,MAPK14,360.0
14513,DB07942,2-fluoro-4-[4-(4-fluorophenyl)-1H-pyrazol-3-yl]pyridine,SmallMoleculeDrug,Q16539,Mitogen-activated protein kinase 14,MAPK14,360.0
14514,DB07943,2-{4-[5-(4-chlorophenyl)-4-pyrimidin-4-yl-1H-pyrazol-3-yl]piperidin-1-yl}-2-oxoethanol,SmallMoleculeDrug,Q16539,Mitogen-activated protein kinase 14,MAPK14,360.0
14515,DB07944,N-{3-METHYL-5-[2-(PYRIDIN-4-YLAMINO)-ETHOXY]-PHENYL}-BENZENESULFONAMIDE,SmallMoleculeDrug,P00734,Prothrombin,F2,622.0
14516,DB07946,"N-[2-({[amino(imino)methyl]amino}oxy)ethyl]-2-{6-chloro-3-[(2,2-difluoro-2-phenylethyl)amino]-2-fluorophenyl}acetamide",SmallMoleculeDrug,P00734,Prothrombin,F2,622.0
14517,DB07947,ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CHLOROBENZYLOXY)ETHYLAMINO)ETHYL)AMIDE,SmallMoleculeDrug,P17612,cAMP-dependent protein kinase catalytic subunit alpha,PRKACA,351.0
14518,DB07947,ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CHLOROBENZYLOXY)ETHYLAMINO)ETHYL)AMIDE,SmallMoleculeDrug,P61925,cAMP-dependent protein kinase inhibitor alpha,PKIA,76.0
14519,DB07947,ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CHLOROBENZYLOXY)ETHYLAMINO)ETHYL)AMIDE,SmallMoleculeDrug,P31751,RAC-beta serine/threonine-protein kinase,AKT2,481.0
14520,DB07947,ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CHLOROBENZYLOXY)ETHYLAMINO)ETHYL)AMIDE,SmallMoleculeDrug,P49841,Glycogen synthase kinase-3 beta,GSK3B,420.0
14521,DB07949,"({[(3E)-2'-OXO-2',7'-DIHYDRO-2,3'-BIINDOL-3(7H)-YLIDENE]AMINO}OXY)ACETIC ACID",SmallMoleculeDrug,P11217,"Glycogen phosphorylase, muscle form",PYGM,842.0
14522,DB07950,1H-INDOL-3-YLACETIC ACID,SmallMoleculeDrug,Q9NZK7,Group IIE secretory phospholipase A2,PLA2G2E,142.0
14523,DB07950,1H-INDOL-3-YLACETIC ACID,SmallMoleculeDrug,P63208,S-phase kinase-associated protein 1,SKP1,163.0
14524,DB07950,1H-INDOL-3-YLACETIC ACID,SmallMoleculeDrug,Q16773,Kynurenine--oxoglutarate transaminase 1,KYAT1,422.0
14531,DB07954,3-isobutyl-1-methyl-7H-xanthine,SmallMoleculeDrug,O76074,"cGMP-specific 3',5'-cyclic phosphodiesterase",PDE5A,875.0
14532,DB07954,3-isobutyl-1-methyl-7H-xanthine,SmallMoleculeDrug,Q13370,"cGMP-inhibited 3',5'-cyclic phosphodiesterase B",PDE3B,1112.0
14533,DB07954,3-isobutyl-1-methyl-7H-xanthine,SmallMoleculeDrug,Q13946,"High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A",PDE7A,482.0
14534,DB07954,3-isobutyl-1-methyl-7H-xanthine,SmallMoleculeDrug,Q08499,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",PDE4D,809.0
14535,DB07954,3-isobutyl-1-methyl-7H-xanthine,SmallMoleculeDrug,O76083,"High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A",PDE9A,593.0
14536,DB07954,3-isobutyl-1-methyl-7H-xanthine,SmallMoleculeDrug,O60658,"High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A",PDE8A,829.0
14537,DB07954,3-isobutyl-1-methyl-7H-xanthine,SmallMoleculeDrug,O00408,"cGMP-dependent 3',5'-cyclic phosphodiesterase",PDE2A,941.0
14538,DB07954,3-isobutyl-1-methyl-7H-xanthine,SmallMoleculeDrug,P18545,"Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma",PDE6G,87.0
14539,DB07955,(2-BROMOETHYL)(2-'FORMYL-4'-AMINOPHENYL) ACETATE,SmallMoleculeDrug,Q9UNI1,Chymotrypsin-like elastase family member 1,CELA1,258.0
14540,DB07956,[1-(3-CHLORO-2-FORMYL-PHENYLCARBAMOYL)-2-METHYL-PROPYL]-CARBAMIC ACID TERT-BUTYL ESTER,SmallMoleculeDrug,Q9UNI1,Chymotrypsin-like elastase family member 1,CELA1,258.0
14541,DB07957,METHYL(2-ACETOXY-2-(2-CARBOXY-4-AMINO-PHENYL))ACETATE,SmallMoleculeDrug,Q9UNI1,Chymotrypsin-like elastase family member 1,CELA1,258.0
14542,DB07958,(2-CARBAMOYLMETHYL-5-PROPYL-OCTAHYDRO-INDOL-7-YL)ACETIC ACID,SmallMoleculeDrug,Q9NZK7,Group IIE secretory phospholipase A2,PLA2G2E,142.0
14543,DB07959,3-(1H-BENZIMIDAZOL-2-YL)-1H-INDAZOLE,SmallMoleculeDrug,O14757,Serine/threonine-protein kinase Chk1,CHEK1,476.0
14544,DB07960,"5-ACETAMIDO-5,6-DIHYDRO-4-HYDROXY-6-ISOBUTOXY-4H-PYRAN-2-CARBOXYLIC ACID",SmallMoleculeDrug,Q9Y3R4,Sialidase-2,NEU2,380.0
14546,DB07964,"(3S)-4-{[4-(BUT-2-YNYLOXY)PHENYL]SULFONYL}-N-HYDROXY-2,2-DIMETHYLTHIOMORPHOLINE-3-CARBOXAMIDE",SmallMoleculeDrug,P78536,Disintegrin and metalloproteinase domain-containing protein 17,ADAM17,824.0
14547,DB07965,6-(cyclohexylamino)-9-[2-(4-methylpiperazin-1-yl)-ethyl]-9H-purine-2-carbonitrile,SmallMoleculeDrug,P43235,Cathepsin K,CTSK,329.0
14548,DB07966,[4-({4-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]quinazolin-2-yl}amino)phenyl]acetonitrile,SmallMoleculeDrug,P12931,Proto-oncogene tyrosine-protein kinase Src,SRC,536.0
14549,DB07967,9-CYCLOPENTYL-6-[2-(3-IMIDAZOL-1-YL-PROPOXY)-PHENYLAMINO]-9H-PURINE-2-CARBONITRILE,SmallMoleculeDrug,P43235,Cathepsin K,CTSK,329.0
14550,DB07968,N-(2-CHLORO-4-FLUOROBENZOYL)-N'-(5-HYDROXY-2-METHOXYPHENYL)UREA,SmallMoleculeDrug,P06737,"Glycogen phosphorylase, liver form",PYGL,847.0
14551,DB07969,3-[3-(4-methylpiperazin-1-yl)-7-(trifluoromethyl)quinoxalin-5-yl]phenol,SmallMoleculeDrug,P08581,Hepatocyte growth factor receptor,MET,1390.0
14552,DB07970,5-[(2-methyl-5-{[3-(trifluoromethyl)phenyl]carbamoyl}phenyl)amino]pyridine-3-carboxamide,SmallMoleculeDrug,Q15375,Ephrin type-A receptor 7,EPHA7,998.0
14555,DB07973,N-(1-ISOPROPYLPIPERIDIN-4-YL)-1-(3-METHOXYBENZYL)-1H-INDOLE-2-CARBOXAMIDE,SmallMoleculeDrug,P00742,Coagulation factor X,F10,488.0
14556,DB07974,1-{2-[(4-CHLOROPHENYL)AMINO]-2-OXOETHYL}-N-(1-ISOPROPYLPIPERIDIN-4-YL)-1H-INDOLE-2-CARBOXAMIDE,SmallMoleculeDrug,P00742,Coagulation factor X,F10,488.0
14557,DB07975,"2-({[3,5-DIFLUORO-3'-(TRIFLUOROMETHOXY)BIPHENYL-4-YL]AMINO}CARBONYL)CYCLOPENT-1-ENE-1-CARBOXYLIC ACID",SmallMoleculeDrug,Q02127,"Dihydroorotate dehydrogenase (quinone), mitochondrial",DHODH,395.0
14558,DB07976,3-{[(3-FLUORO-3'-METHOXYBIPHENYL-4-YL)AMINO]CARBONYL}THIOPHENE-2-CARBOXYLIC ACID,SmallMoleculeDrug,Q02127,"Dihydroorotate dehydrogenase (quinone), mitochondrial",DHODH,395.0
14559,DB07977,"3-({[3,5-DIFLUORO-3'-(TRIFLUOROMETHOXY)BIPHENYL-4-YL]AMINO}CARBONYL)THIOPHENE-2-CARBOXYLIC ACID",SmallMoleculeDrug,Q02127,"Dihydroorotate dehydrogenase (quinone), mitochondrial",DHODH,395.0
14560,DB07978,"2-({[2,3,5,6-TETRAFLUORO-3'-(TRIFLUOROMETHOXY)BIPHENYL-4-YL]AMINO}CARBONYL)CYCLOPENTA-1,3-DIENE-1-CARBOXYLIC ACID",SmallMoleculeDrug,Q02127,"Dihydroorotate dehydrogenase (quinone), mitochondrial",DHODH,395.0
14561,DB07979,"(2E)-3-(3,4-DIHYDROXYPHENYL)-2-IMINOPROPANOIC ACID",SmallMoleculeDrug,P14920,D-amino-acid oxidase,DAO,347.0
14562,DB07980,(E)-imidacloprid,SmallMoleculeDrug,Q494W8,CHRNA7-FAM7A fusion protein,CHRFAM7A,412.0
14563,DB07981,2-[1-(4-CHLOROBENZOYL)-5-METHOXY-2-METHYL-1H-INDOL-3-YL]-N-[(1R)-1-(HYDROXYMETHYL)PROPYL]ACETAMIDE,SmallMoleculeDrug,P23219,Prostaglandin G/H synthase 1,PTGS1,599.0
14564,DB07982,2-{4-[4-({4-[2-methyl-1-(1-methylethyl)-1H-imidazol-5-yl]pyrimidin-2-yl}amino)phenyl]piperazin-1-yl}-2-oxoethanol,SmallMoleculeDrug,P24941,Cyclin-dependent kinase 2,CDK2,298.0
14565,DB07983,1-(4-IODOBENZOYL)-5-METHOXY-2-METHYL INDOLE-3-ACETIC ACID,SmallMoleculeDrug,P23219,Prostaglandin G/H synthase 1,PTGS1,599.0
14566,DB07984,2-[1-(4-CHLOROBENZOYL)-5-METHOXY-2-METHYL-1H-INDOL-3-YL]-N-[(1S)-1-(HYDROXYMETHYL)PROPYL]ACETAMIDE,SmallMoleculeDrug,P23219,Prostaglandin G/H synthase 1,PTGS1,599.0
14567,DB07985,+/-METHYL 4-(AMINOIMINOMETHYL)-BETA-[3- INH (AMINOIMINO)PHENYL]BENZENE PENTANOATE,SmallMoleculeDrug,P07477,Trypsin-1,PRSS1,247.0
14568,DB07986,[4-(4-PHENYL-PIPERIDIN-1-YL)-BENZENESULFONYLAMINO]-ACETIC ACID,SmallMoleculeDrug,P08254,Stromelysin-1,MMP3,477.0
14569,DB07987,"[2-(5-MERCAPTO-[1,3,4]THIADIAZOL-2-YLCARBAMOYL)-1-PHENYL-ETHYL]-CARBAMIC ACID BENZYL ESTER",SmallMoleculeDrug,P08254,Stromelysin-1,MMP3,477.0
14570,DB07988,"2-[3-(5-MERCAPTO-[1,3,4]THIADIAZOL-2YL)-UREIDO]-N-METHYL-3-PENTAFLUOROPHENYL-PROPIONAMIDE",SmallMoleculeDrug,P08254,Stromelysin-1,MMP3,477.0
14573,DB07991,N-[(1R)-3-(4-HYDROXYPHENYL)-1-METHYLPROPYL]-2-(2-PHENYL-1H-INDOL-3-YL)ACETAMIDE,SmallMoleculeDrug,P03372,Estrogen receptor,ESR1,595.0
14574,DB07993,"N~3~-[3-(1H-INDOL-6-YL)BENZYL]PYRIDINE-2,3-DIAMINE",SmallMoleculeDrug,P56817,Beta-secretase 1,BACE1,501.0
14575,DB07994,"N~3~-[5-(1H-INDOL-6-YL)-2-(PYRIDIN-2-YLMETHOXY)BENZYL]PYRIDINE-2,3-DIAMINE",SmallMoleculeDrug,P56817,Beta-secretase 1,BACE1,501.0
14576,DB07995,N-[2-(4-BROMOCINNAMYLAMINO)ETHYL]-5-ISOQUINOLINE SULFONAMIDE,SmallMoleculeDrug,P17612,cAMP-dependent protein kinase catalytic subunit alpha,PRKACA,351.0
14577,DB07995,N-[2-(4-BROMOCINNAMYLAMINO)ETHYL]-5-ISOQUINOLINE SULFONAMIDE,SmallMoleculeDrug,P61925,cAMP-dependent protein kinase inhibitor alpha,PKIA,76.0
14578,DB07995,N-[2-(4-BROMOCINNAMYLAMINO)ETHYL]-5-ISOQUINOLINE SULFONAMIDE,SmallMoleculeDrug,Q8TF76,Serine/threonine-protein kinase haspin,GSG2,798.0
14579,DB07996,5-(2-methylpiperazine-1-sulfonyl)isoquinoline,SmallMoleculeDrug,P17612,cAMP-dependent protein kinase catalytic subunit alpha,PRKACA,351.0
14580,DB07996,5-(2-methylpiperazine-1-sulfonyl)isoquinoline,SmallMoleculeDrug,P61925,cAMP-dependent protein kinase inhibitor alpha,PKIA,76.0
14581,DB07997,N-[2-(METHYLAMINO)ETHYL]-5-ISOQUINOLINESULFONAMIDE,SmallMoleculeDrug,P17612,cAMP-dependent protein kinase catalytic subunit alpha,PRKACA,351.0
14582,DB07997,N-[2-(METHYLAMINO)ETHYL]-5-ISOQUINOLINESULFONAMIDE,SmallMoleculeDrug,P61925,cAMP-dependent protein kinase inhibitor alpha,PKIA,76.0
14583,DB07999,"{4-[(CARBOXYMETHOXY)CARBONYL]-3,3-DIOXIDO-1-OXONAPHTHO[1,2-D]ISOTHIAZOL-2(1H)-YL}ACETIC ACID",SmallMoleculeDrug,P15121,Aldose reductase,AKR1B1,316.0
14584,DB08000,"2-(CARBOXYMETHYL)-1-OXO-1,2-DIHYDRONAPHTHO[1,2-D]ISOTHIAZOLE-4-CARBOXYLIC ACID 3,3-DIOXIDE",SmallMoleculeDrug,P15121,Aldose reductase,AKR1B1,316.0
14585,DB08001,5-(3-{3-[3-HYDROXY-2-(METHOXYCARBONYL)PHENOXY]PROPENYL}PHENYL)-4-(HYDROXYMETHYL)ISOXAZOLE-3-CARBOXYLIC ACID,SmallMoleculeDrug,P18031,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,435.0
14586,DB08003,ISOTHIAZOLIDINONE ANALOG,SmallMoleculeDrug,P18031,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,435.0
14587,DB08004,"(2S)-2-{[3-(3-aminophenyl)imidazo[1,2-b]pyridazin-6-yl]amino}-3-methylbutan-1-ol",SmallMoleculeDrug,Q8TF76,Serine/threonine-protein kinase haspin,GSG2,798.0
14588,DB08005,4-{[5-chloro-4-(1H-indol-3-yl)pyrimidin-2-yl]amino}-N-ethylpiperidine-1-carboxamide,SmallMoleculeDrug,P53779,Mitogen-activated protein kinase 10,MAPK10,464.0
14589,DB08006,"N-anthracen-2-yl-5-methyl[1,2,4]triazolo[1,5-a]pyrimidin-7-amine",SmallMoleculeDrug,Q02127,"Dihydroorotate dehydrogenase (quinone), mitochondrial",DHODH,395.0
14590,DB08007,(2R)-3-{[(BENZYLAMINO)CARBONYL]AMINO}-2-HYDROXYPROPANOIC ACID,SmallMoleculeDrug,Q9UNI1,Chymotrypsin-like elastase family member 1,CELA1,258.0
14591,DB08008,"5-methyl-N-[4-(trifluoromethyl)phenyl][1,2,4]triazolo[1,5-a]pyrimidin-7-amine",SmallMoleculeDrug,Q02127,"Dihydroorotate dehydrogenase (quinone), mitochondrial",DHODH,395.0
14592,DB08009,"5-[(E)-(5-CHLORO-2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL]-N-[2-(DIETHYLAMINO)ETHYL]-2,4-DIMETHYL-1H-PYRROLE-3-CARBOXAMIDE",SmallMoleculeDrug,Q96NX5,Calcium/calmodulin-dependent protein kinase type 1G,CAMK1G,476.0
14593,DB08010,"(3Z)-1-[(6-fluoro-4H-1,3-benzodioxin-8-yl)methyl]-4-[(E)-2-phenylethenyl]-1H-indole-2,3-dione 3-oxime",SmallMoleculeDrug,P53779,Mitogen-activated protein kinase 10,MAPK10,464.0
14594,DB08011,"(3E)-5-fluoro-1-[(6-fluoro-4H-1,3-benzodioxin-8-yl)methyl]-1H-indole-2,3-dione 3-oxime",SmallMoleculeDrug,P53779,Mitogen-activated protein kinase 10,MAPK10,464.0
14601,DB08015,"(3Z)-1-[(6-fluoro-4H-1,3-benzodioxin-8-yl)methyl]-4-phenyl-1H-indole-2,3-dione 3-oxime",SmallMoleculeDrug,P53779,Mitogen-activated protein kinase 10,MAPK10,464.0
14605,DB08018,"N-{(3S,4S)-4-[(6-AMINO-4-METHYLPYRIDIN-2-YL)METHYL]PYRROLIDIN-3-YL}-N'-(4-CHLOROBENZYL)ETHANE-1,2-DIAMINE",SmallMoleculeDrug,P29475,"Nitric oxide synthase, brain",NOS1,1434.0
14606,DB08018,"N-{(3S,4S)-4-[(6-AMINO-4-METHYLPYRIDIN-2-YL)METHYL]PYRROLIDIN-3-YL}-N'-(4-CHLOROBENZYL)ETHANE-1,2-DIAMINE",SmallMoleculeDrug,P29474,"Nitric oxide synthase, endothelial",NOS3,1203.0
14607,DB08019,"N-{(3R,4S)-4-[(6-amino-4-methylpyridin-2-yl)methyl]pyrrolidin-3-yl}-N'-(3-chlorobenzyl)ethane-1,2-diamine",SmallMoleculeDrug,P29475,"Nitric oxide synthase, brain",NOS1,1434.0
14608,DB08019,"N-{(3R,4S)-4-[(6-amino-4-methylpyridin-2-yl)methyl]pyrrolidin-3-yl}-N'-(3-chlorobenzyl)ethane-1,2-diamine",SmallMoleculeDrug,P29474,"Nitric oxide synthase, endothelial",NOS3,1203.0
14609,DB08020,"(3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-6-(METHOXYMETHYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL",SmallMoleculeDrug,Q92731,Estrogen receptor beta,ESR2,530.0
14610,DB08020,"(3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-6-(METHOXYMETHYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL",SmallMoleculeDrug,P03372,Estrogen receptor,ESR1,595.0
14611,DB08021,5-bromo-N-(3-chloro-2-(4-(prop-2-ynyl)piperazin-1-yl)phenyl)furan-2-carboxamide,SmallMoleculeDrug,P53779,Mitogen-activated protein kinase 10,MAPK10,464.0
14612,DB08022,"(2S)-1,3-benzothiazol-2-yl{2-[(2-pyridin-3-ylethyl)amino]pyrimidin-4-yl}ethanenitrile",SmallMoleculeDrug,P11309,Serine/threonine-protein kinase pim-1,PIM1,404.0
14613,DB08023,"N-cyclohexyl-4-imidazo[1,2-a]pyridin-3-yl-N-methylpyrimidin-2-amine",SmallMoleculeDrug,P53779,Mitogen-activated protein kinase 10,MAPK10,464.0
14614,DB08024,1-[2-(S)-AMINO-3-BIPHENYL-4-YL-PROPIONYL]-PYRROLIDINE-2-(S)-CARBONITRILE,SmallMoleculeDrug,P27487,Dipeptidyl peptidase 4,DPP4,766.0
14615,DB08025,"N-{2'-[(4-FLUOROPHENYL)AMINO]-4,4'-BIPYRIDIN-2-YL}-4-METHOXYCYCLOHEXANECARBOXAMIDE",SmallMoleculeDrug,P53779,Mitogen-activated protein kinase 10,MAPK10,464.0
14616,DB08026,"2-{4-[(4-imidazo[1,2-a]pyridin-3-ylpyrimidin-2-yl)amino]piperidin-1-yl}-N-methylacetamide",SmallMoleculeDrug,P53779,Mitogen-activated protein kinase 10,MAPK10,464.0
14618,DB08028,"BUT-3-ENYL-[5-(4-CHLORO-PHENYL)-3,6-DIHYDRO-[1,3,4]THIADIAZIN-2-YLIDENE]-AMINE",SmallMoleculeDrug,P22894,Neutrophil collagenase,MMP8,467.0
14619,DB08029,N~2~-(biphenyl-4-ylsulfonyl)-N-hydroxy-N~2~-(2-hydroxyethyl)glycinamide,SmallMoleculeDrug,P08254,Stromelysin-1,MMP3,477.0
14620,DB08030,3-[(4'-cyanobiphenyl-4-yl)oxy]-N-hydroxypropanamide,SmallMoleculeDrug,P08254,Stromelysin-1,MMP3,477.0
14622,DB08032,"N,N-DIETHYL-2-[(2-THIENYLCARBONYL)AMINO]-4,5,6,7-TETRAHYDRO-1-BENZOTHIOPHENE-3-CARBOXAMIDE",SmallMoleculeDrug,P52732,Kinesin-like protein KIF11,KIF11,1056.0
14623,DB08033,"(5R)-N,N-DIETHYL-5-METHYL-2-[(THIOPHEN-2-YLCARBONYL)AMINO]-4,5,6,7-TETRAHYDRO-1-BENZOTHIOPHENE-3-CARBOXAMIDE",SmallMoleculeDrug,P52732,Kinesin-like protein KIF11,KIF11,1056.0
14625,DB08035,"1-TERT-BUTYL-3-(2,5-DIMETHYLBENZYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-4-AMINE",SmallMoleculeDrug,P10275,Androgen receptor,AR,920.0
14627,DB08037,"(2S)-4-(2,5-difluorophenyl)-N-[(3R,4S)-3-fluoro-1-methylpiperidin-4-yl]-2-(hydroxymethyl)-N-methyl-2-phenyl-2,5-dihydro-1H-pyrrole-1-carboxamide",SmallMoleculeDrug,P52732,Kinesin-like protein KIF11,KIF11,1056.0
14628,DB08038,"L-alanyl-N-[(1S,2R)-1-benzyl-2-hydroxypropyl]-L-alaninamide",SmallMoleculeDrug,P49862,Kallikrein-7,KLK7,253.0
14630,DB08039,"(3Z)-N,N-DIMETHYL-2-OXO-3-(4,5,6,7-TETRAHYDRO-1H-INDOL-2-YLMETHYLIDENE)-2,3-DIHYDRO-1H-INDOLE-5-SULFONAMIDE",SmallMoleculeDrug,Q13557,Calcium/calmodulin-dependent protein kinase type II subunit delta,CAMK2D,499.0
14631,DB08040,N-[(2R)-2-benzyl-4-(hydroxyamino)-4-oxobutanoyl]-L-alanine,SmallMoleculeDrug,P09960,Leukotriene A-4 hydrolase,LTA4H,611.0
14633,DB08042,"N~4~-methyl-N~4~-(3-methyl-1H-indazol-6-yl)-N~2~-(3,4,5-trimethoxyphenyl)pyrimidine-2,4-diamine",SmallMoleculeDrug,P35968,Vascular endothelial growth factor receptor 2,KDR,1356.0
14634,DB08043,1-[4-(PYRIDIN-4-YLOXY)PHENYL]-3-[3-(TRIFLUOROMETHYL)PHENYL]UREA,SmallMoleculeDrug,P00519,Tyrosine-protein kinase ABL1,ABL1,1130.0
14635,DB08044,"(1S,6R)-3-{[3-(TRIFLUOROMETHYL)-5,6-DIHYDRO[1,2,4]TRIAZOLO[4,3-A]PYRAZIN-7(8H)-YL]CARBONYL}-6-(2,4,5-TRIFLUOROPHENYL)CYCLOHEX-3-EN-1-AMINE",SmallMoleculeDrug,P27487,Dipeptidyl peptidase 4,DPP4,766.0
14636,DB08045,"4-{4-[4-(3-AMINOPROPOXY)PHENYL]-1H-PYRAZOL-5-YL}-6-CHLOROBENZENE-1,3-DIOL",SmallMoleculeDrug,P08238,Heat shock protein HSP 90-beta,HSP90AB1,724.0
14637,DB08046,2-chloro-5-[(1S)-1-hydroxy-3-oxo-2H-isoindol-1-yl]benzenesulfonamide,SmallMoleculeDrug,P00918,Carbonic anhydrase 2,CA2,260.0
14638,DB08047,"4-[1-allyl-7-(trifluoromethyl)-1H-indazol-3-yl]benzene-1,3-diol",SmallMoleculeDrug,P03372,Estrogen receptor,ESR1,595.0
14639,DB08047,"4-[1-allyl-7-(trifluoromethyl)-1H-indazol-3-yl]benzene-1,3-diol",SmallMoleculeDrug,Q15596,Nuclear receptor coactivator 2,NCOA2,1464.0
14640,DB08048,"4-(6-HYDROXY-1H-INDAZOL-3-YL)BENZENE-1,3-DIOL",SmallMoleculeDrug,P03372,Estrogen receptor,ESR1,595.0
14641,DB08048,"4-(6-HYDROXY-1H-INDAZOL-3-YL)BENZENE-1,3-DIOL",SmallMoleculeDrug,Q15596,Nuclear receptor coactivator 2,NCOA2,1464.0
14642,DB08049,"7,8-dihydroxy-4-phenyl-2H-chromen-2-one",SmallMoleculeDrug,P21964,Catechol O-methyltransferase,COMT,271.0
14644,DB08051,"(2R)-4-(2-BENZOYL-1,2-DIAZEPAN-1-YL)-4-OXO-1-(2,4,5-TRIFLUOROPHENYL)BUTAN-2-AMINE",SmallMoleculeDrug,P27487,Dipeptidyl peptidase 4,DPP4,766.0
14645,DB08052,"1-cyclopentyl-3-(1H-pyrrolo[2,3-b]pyridin-5-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine",SmallMoleculeDrug,P12931,Proto-oncogene tyrosine-protein kinase Src,SRC,536.0
14646,DB08053,"1-cyclobutyl-3-(3,4-dimethoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine",SmallMoleculeDrug,P12931,Proto-oncogene tyrosine-protein kinase Src,SRC,536.0
14647,DB08054,"1-(1-methylethyl)-3-quinolin-6-yl-1H-pyrazolo[3,4-d]pyrimidin-4-amine",SmallMoleculeDrug,P12931,Proto-oncogene tyrosine-protein kinase Src,SRC,536.0
14648,DB08055,"N-(2-chlorophenyl)-5-phenylimidazo[1,5-a]pyrazin-8-amine",SmallMoleculeDrug,P06239,Tyrosine-protein kinase Lck,LCK,509.0
14649,DB08056,"N-(2,6-dimethylphenyl)-5-phenylimidazo[1,5-a]pyrazin-8-amine",SmallMoleculeDrug,P06239,Tyrosine-protein kinase Lck,LCK,509.0
14650,DB08057,"N-(2-chloro-6-methylphenyl)-8-[(3S)-3-methylpiperazin-1-yl]imidazo[1,5-a]quinoxalin-4-amine",SmallMoleculeDrug,P06239,Tyrosine-protein kinase Lck,LCK,509.0
14651,DB08058,"4-[3-(1,4-diazepan-1-ylcarbonyl)-4-fluorobenzyl]phthalazin-1(2H)-one",SmallMoleculeDrug,Q9Y6F1,Poly [ADP-ribose] polymerase 3,PARP3,533.0
14652,DB08059,"(1S,6BR,9AS,11R,11BR)-9A,11B-DIMETHYL-1-[(METHYLOXY)METHYL]-3,6,9-TRIOXO-1,6,6B,7,8,9,9A,10,11,11B-DECAHYDRO-3H-FURO[4,3,2-DE]INDENO[4,5-H][2]BENZOPYRAN-11-YL ACETATE",SmallMoleculeDrug,P48736,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",PIK3CG,1102.0
14653,DB08059,"(1S,6BR,9AS,11R,11BR)-9A,11B-DIMETHYL-1-[(METHYLOXY)METHYL]-3,6,9-TRIOXO-1,6,6B,7,8,9,9A,10,11,11B-DECAHYDRO-3H-FURO[4,3,2-DE]INDENO[4,5-H][2]BENZOPYRAN-11-YL ACETATE",SmallMoleculeDrug,P53350,Serine/threonine-protein kinase PLK1,PLK1,603.0
14654,DB08059,"(1S,6BR,9AS,11R,11BR)-9A,11B-DIMETHYL-1-[(METHYLOXY)METHYL]-3,6,9-TRIOXO-1,6,6B,7,8,9,9A,10,11,11B-DECAHYDRO-3H-FURO[4,3,2-DE]INDENO[4,5-H][2]BENZOPYRAN-11-YL ACETATE",SmallMoleculeDrug,P27986,Phosphatidylinositol 3-kinase regulatory subunit alpha,PIK3R1,724.0
14655,DB08059,"(1S,6BR,9AS,11R,11BR)-9A,11B-DIMETHYL-1-[(METHYLOXY)METHYL]-3,6,9-TRIOXO-1,6,6B,7,8,9,9A,10,11,11B-DECAHYDRO-3H-FURO[4,3,2-DE]INDENO[4,5-H][2]BENZOPYRAN-11-YL ACETATE",SmallMoleculeDrug,P42336,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform",PIK3CA,1068.0
14656,DB08060,4-(2-AMINOPHENYL)-4-OXOBUTANOIC ACID,SmallMoleculeDrug,P21549,Serine--pyruvate aminotransferase,AGXT,392.0
14657,DB08061,4-[3-(4-CHLOROPHENYL)-1H-PYRAZOL-5-YL]PIPERIDINE,SmallMoleculeDrug,P00734,Prothrombin,F2,622.0
14658,DB08062,"3-(4-CHLOROPHENYL)-5-(METHYLTHIO)-4H-1,2,4-TRIAZOLE",SmallMoleculeDrug,P00734,Prothrombin,F2,622.0
14659,DB08063,"1-BENZYL-3-(4-METHOXYPHENYLAMINO)-4-PHENYLPYRROLE-2,5-DIONE",SmallMoleculeDrug,P19793,Retinoic acid receptor RXR-alpha,RXRA,462.0
14660,DB08063,"1-BENZYL-3-(4-METHOXYPHENYLAMINO)-4-PHENYLPYRROLE-2,5-DIONE",SmallMoleculeDrug,Q13133,Oxysterols receptor LXR-alpha,NR1H3,447.0
14661,DB08064,N-(3-TERT-BUTYL-1H-PYRAZOL-5-YL)-N'-{4-CHLORO-3-[(PYRIDIN-3-YLOXY)METHYL]PHENYL}UREA,SmallMoleculeDrug,Q16539,Mitogen-activated protein kinase 14,MAPK14,360.0
14662,DB08065,2-(1H-pyrazol-3-yl)-1H-benzimidazole,SmallMoleculeDrug,O14965,Aurora kinase A,AURKA,403.0
14663,DB08066,N-[3-(1H-BENZIMIDAZOL-2-YL)-1H-PYRAZOL-4-YL]BENZAMIDE,SmallMoleculeDrug,O14965,Aurora kinase A,AURKA,403.0
14664,DB08066,N-[3-(1H-BENZIMIDAZOL-2-YL)-1H-PYRAZOL-4-YL]BENZAMIDE,SmallMoleculeDrug,P24941,Cyclin-dependent kinase 2,CDK2,298.0
14665,DB08067,4-[(2-{4-[(CYCLOPROPYLCARBAMOYL)AMINO]-1H-PYRAZOL-3-YL}-1H-BENZIMIDAZOL-6-YL)METHYL]MORPHOLIN-4-IUM,SmallMoleculeDrug,O60674,Tyrosine-protein kinase JAK2,JAK2,1132.0
14666,DB08068,N-[4-CHLORO-3-(PYRIDIN-3-YLOXYMETHYL)-PHENYL]-3-FLUORO-,SmallMoleculeDrug,Q16539,Mitogen-activated protein kinase 14,MAPK14,360.0
14668,DB08070,2-[4-(3-METHYL-1H-PYRAZOL-4-YL)PHENYL]ETHANAMINE,SmallMoleculeDrug,P17612,cAMP-dependent protein kinase catalytic subunit alpha,PRKACA,351.0
14669,DB08070,2-[4-(3-METHYL-1H-PYRAZOL-4-YL)PHENYL]ETHANAMINE,SmallMoleculeDrug,P61925,cAMP-dependent protein kinase inhibitor alpha,PKIA,76.0
14671,DB08072,"4-(2-AMINOETHOXY)-3,5-DICHLORO-N-[3-(1-METHYLETHOXY)PHENYL]BENZAMIDE",SmallMoleculeDrug,P00749,Urokinase-type plasminogen activator,PLAU,431.0
14672,DB08073,(2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1H-INDAZOL-5-YL)PYRIDIN-3-YL]OXY}PROPAN-2-AMINE,SmallMoleculeDrug,P31751,RAC-beta serine/threonine-protein kinase,AKT2,481.0
14673,DB08073,(2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1H-INDAZOL-5-YL)PYRIDIN-3-YL]OXY}PROPAN-2-AMINE,SmallMoleculeDrug,P49841,Glycogen synthase kinase-3 beta,GSK3B,420.0
14674,DB08073,(2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1H-INDAZOL-5-YL)PYRIDIN-3-YL]OXY}PROPAN-2-AMINE,SmallMoleculeDrug,P17612,cAMP-dependent protein kinase catalytic subunit alpha,PRKACA,351.0
14675,DB08073,(2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1H-INDAZOL-5-YL)PYRIDIN-3-YL]OXY}PROPAN-2-AMINE,SmallMoleculeDrug,P61925,cAMP-dependent protein kinase inhibitor alpha,PKIA,76.0
14679,DB08077,"2-[4-({[(3,5-DICHLOROPHENYL)AMINO]CARBONYL}AMINO)PHENOXY]-2-METHYLPROPANOIC ACID",SmallMoleculeDrug,P69905,Hemoglobin subunit alpha,HBA1;,142.0
14680,DB08077,"2-[4-({[(3,5-DICHLOROPHENYL)AMINO]CARBONYL}AMINO)PHENOXY]-2-METHYLPROPANOIC ACID",SmallMoleculeDrug,P68871,Hemoglobin subunit beta,HBB,147.0
14681,DB08078,{4-[3-(4-acetyl-3-hydroxy-2-propylphenoxy)propoxy]phenoxy}acetic acid,SmallMoleculeDrug,Q03181,Peroxisome proliferator-activated receptor delta,PPARD,441.0
14682,DB08079,"7-methoxy-4-[(6-phenyl[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methoxy]quinoline",SmallMoleculeDrug,Q59EB3,Met proto-oncogene variant,nan,712.0
14683,DB08080,LATRUNCULIN B,SmallMoleculeDrug,P68133,"Actin, alpha skeletal muscle",ACTA1,377.0
14684,DB08080,LATRUNCULIN B,SmallMoleculeDrug,Q969V6,MKL/myocardin-like protein 1,MKL1,931.0
14685,DB08080,LATRUNCULIN B,SmallMoleculeDrug,Q8WWL2,Protein spire homolog 2,SPIRE2,714.0
14689,DB08082,N-(2-AMINOETHYL)-P-CHLOROBENZAMIDE,SmallMoleculeDrug,P27338,Amine oxidase [flavin-containing] B,MAOB,520.0
14690,DB08083,"2-(1,3-thiazol-4-yl)-1H-benzimidazole-5-sulfonamide",SmallMoleculeDrug,P00918,Carbonic anhydrase 2,CA2,260.0
14691,DB08084,IDD594,SmallMoleculeDrug,P15121,Aldose reductase,AKR1B1,316.0
14692,DB08085,1-(4-HEXYLPHENYL)PROP-2-EN-1-ONE,SmallMoleculeDrug,P10828,Thyroid hormone receptor beta,THRB,461.0
14694,DB08087,"4-[(7R,7AS)-7-HYDROXY-1,3-DIOXOTETRAHYDRO-1H-PYRROLO[1,2-C]IMIDAZOL-2(3H)-YL]-1-NAPHTHONITRILE",SmallMoleculeDrug,P10275,Androgen receptor,AR,920.0
14695,DB08088,"2-chloro-4-{[(1R,3Z,7S,7aS)-7-hydroxy-1-(trifluoromethyl)tetrahydro-1H-pyrrolo[1,2-c][1,3]oxazol-3-ylidene]amino}-3-methylbenzonitrile",SmallMoleculeDrug,P10275,Androgen receptor,AR,920.0
14696,DB08089,"6-[BIS(2,2,2-TRIFLUOROETHYL)AMINO]-4-(TRIFLUOROMETHYL)QUINOLIN-2(1H)-ONE",SmallMoleculeDrug,P10275,Androgen receptor,AR,920.0
14698,DB08091,3-FLUORO-5-MORPHOLIN-4-YL-N-[3-(2-PYRIDIN-4-YLETHYL)-1H-INDOL-5-YL]BENZAMIDE,SmallMoleculeDrug,Q16539,Mitogen-activated protein kinase 14,MAPK14,360.0
14699,DB08092,3-fluoro-N-1H-indol-5-yl-5-morpholin-4-ylbenzamide,SmallMoleculeDrug,Q16539,Mitogen-activated protein kinase 14,MAPK14,360.0
14700,DB08093,3-(1-NAPHTHYLMETHOXY)PYRIDIN-2-AMINE,SmallMoleculeDrug,Q16539,Mitogen-activated protein kinase 14,MAPK14,360.0
14701,DB08094,"(4-AMINO-2-{[1-(METHYLSULFONYL)PIPERIDIN-4-YL]AMINO}PYRIMIDIN-5-YL)(2,3-DIFLUORO-6-METHOXYPHENYL)METHANONE",SmallMoleculeDrug,P24941,Cyclin-dependent kinase 2,CDK2,298.0
14702,DB08095,"3-(2-CHLOROPHENYL)-1-(2-{[(1S)-2-HYDROXY-1,2-DIMETHYLPROPYL]AMINO}PYRIMIDIN-4-YL)-1-(4-METHOXYPHENYL)UREA",SmallMoleculeDrug,Q16539,Mitogen-activated protein kinase 14,MAPK14,360.0
14703,DB08096,"8-(2-CHLOROPHENYLAMINO)-2-(2,6-DIFLUOROPHENYLAMINO)-9-ETHYL-9H-PURINE-1,7-DIIUM",SmallMoleculeDrug,Q16539,Mitogen-activated protein kinase 14,MAPK14,360.0
14704,DB08097,"2-(2,6-DIFLUOROPHENOXY)-N-(2-FLUOROPHENYL)-9-ISOPROPYL-9H-PURIN-8-AMINE",SmallMoleculeDrug,Q16539,Mitogen-activated protein kinase 14,MAPK14,360.0
14705,DB08098,"[5-(5-nitro-2-furyl)-1,3,4-oxadiazol-2-yl]thio}acetic acid",SmallMoleculeDrug,P15121,Aldose reductase,AKR1B1,316.0
14706,DB08099,"6-ethyl-5-[(2S)-1-(3-methoxypropyl)-2-phenyl-1,2,3,4-tetrahydroquinolin-7-yl]pyrimidine-2,4-diamine",SmallMoleculeDrug,P00797,Renin,REN,406.0
14713,DB08111,"4-[(6-phenyl[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methyl]phenol",SmallMoleculeDrug,Q59EB3,Met proto-oncogene variant,nan,712.0
14715,DB08113,3-pyridin-4-yl-1H-indazole,SmallMoleculeDrug,P17612,cAMP-dependent protein kinase catalytic subunit alpha,PRKACA,351.0
14716,DB08113,3-pyridin-4-yl-1H-indazole,SmallMoleculeDrug,P61925,cAMP-dependent protein kinase inhibitor alpha,PKIA,76.0
14717,DB08114,"5-benzyl-1,3-thiazol-2-amine",SmallMoleculeDrug,P17612,cAMP-dependent protein kinase catalytic subunit alpha,PRKACA,351.0
14718,DB08114,"5-benzyl-1,3-thiazol-2-amine",SmallMoleculeDrug,P61925,cAMP-dependent protein kinase inhibitor alpha,PKIA,76.0
14721,DB08118,"2-(methylamino)-N-(4-methyl-1,3-thiazol-2-yl)-5-[(4-methyl-4H-1,2,4-triazol-3-yl)sulfanyl]benzamide",SmallMoleculeDrug,P35557,Glucokinase,GCK,465.0
14722,DB08119,"1,1,1-TRIFLUORO-3-((N-ACETYL)-L-LEUCYLAMIDO)-4-PHENYL-BUTAN-2-ONE(N-ACETYL-L-LEUCYL-L-PHENYLALANYL TRIFLUOROMETHYL KETONE)",SmallMoleculeDrug,P17538,Chymotrypsinogen B,CTRB1,263.0
14724,DB08121,(2S)-2-(biphenyl-4-yloxy)-3-phenylpropanoic acid,SmallMoleculeDrug,P37231,Peroxisome proliferator-activated receptor gamma,PPARG,505.0
14725,DB08122,"N-METHYL-4-{[(2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL]AMINO}BENZENESULFONAMIDE",SmallMoleculeDrug,P24941,Cyclin-dependent kinase 2,CDK2,298.0
14726,DB08123,"N-METHYL-{4-[2-(7-OXO-6,7-DIHYDRO-8H-[1,3]THIAZOLO[5,4-E]INDOL-8-YLIDENE)HYDRAZINO]PHENYL}METHANESULFONAMIDE",SmallMoleculeDrug,P24941,Cyclin-dependent kinase 2,CDK2,298.0
14727,DB08124,"3-{[(2,2-DIOXIDO-1,3-DIHYDRO-2-BENZOTHIEN-5-YL)AMINO]METHYLENE}-5-(1,3-OXAZOL-5-YL)-1,3-DIHYDRO-2H-INDOL-2-ONE",SmallMoleculeDrug,P24941,Cyclin-dependent kinase 2,CDK2,298.0
14728,DB08125,"4-{[(2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL]AMINO}-N-(1,3-THIAZOL-2-YL)BENZENESULFONAMIDE",SmallMoleculeDrug,P24941,Cyclin-dependent kinase 2,CDK2,298.0
14729,DB08126,"3-{[4-([AMINO(IMINO)METHYL]AMINOSULFONYL)ANILINO]METHYLENE}-2-OXO-2,3-DIHYDRO-1H-INDOLE",SmallMoleculeDrug,P24941,Cyclin-dependent kinase 2,CDK2,298.0
14730,DB08128,"(1S,4R,9S)-5-(trifluoromethyl)-1,2,3,4-tetrahydro-1,4-methanonaphthalen-9-amine",SmallMoleculeDrug,P11086,Phenylethanolamine N-methyltransferase,PNMT,282.0
14731,DB08129,(1R)-2-amino-1-[3-(trifluoromethyl)phenyl]ethanol,SmallMoleculeDrug,P11086,Phenylethanolamine N-methyltransferase,PNMT,282.0
14732,DB08130,"N-(5-{3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]phenyl}-1,3,4-oxadiazol-2-yl)ethane-1,2-diamine",SmallMoleculeDrug,Q02750,Dual specificity mitogen-activated protein kinase kinase 1,MAP2K1,393.0
14734,DB08132,5-hydroxynaphthalene-1-sulfonamide,SmallMoleculeDrug,P24941,Cyclin-dependent kinase 2,CDK2,298.0
14735,DB08133,N-(4-sulfamoylphenyl)-1H-indazole-3-carboxamide,SmallMoleculeDrug,P24941,Cyclin-dependent kinase 2,CDK2,298.0
14736,DB08134,4-[(6-chloropyrazin-2-yl)amino]benzenesulfonamide,SmallMoleculeDrug,P24941,Cyclin-dependent kinase 2,CDK2,298.0
14737,DB08135,N-phenyl-1H-pyrazole-3-carboxamide,SmallMoleculeDrug,P24941,Cyclin-dependent kinase 2,CDK2,298.0
14738,DB08136,4-(acetylamino)-N-(4-fluorophenyl)-1H-pyrazole-3-carboxamide,SmallMoleculeDrug,P24941,Cyclin-dependent kinase 2,CDK2,298.0
14739,DB08137,(4E)-N-(4-fluorophenyl)-4-[(phenylcarbonyl)imino]-4H-pyrazole-3-carboxamide,SmallMoleculeDrug,P24941,Cyclin-dependent kinase 2,CDK2,298.0
14740,DB08138,"{[(2,6-difluorophenyl)carbonyl]amino}-N-(4-fluorophenyl)-1H-pyrazole-3-carboxamide",SmallMoleculeDrug,P24941,Cyclin-dependent kinase 2,CDK2,298.0
14741,DB08139,"5-chloro-7-[(1-methylethyl)amino]pyrazolo[1,5-a]pyrimidine-3-carbonitrile",SmallMoleculeDrug,P24941,Cyclin-dependent kinase 2,CDK2,298.0
14742,DB08140,"5-[(4-AMINOCYCLOHEXYL)AMINO]-7-(PROPAN-2-YLAMINO)PYRAZOLO[1,5-A]PYRIMIDINE-3-CARBONITRILE",SmallMoleculeDrug,P24941,Cyclin-dependent kinase 2,CDK2,298.0
14743,DB08141,"4-{[(2,6-difluorophenyl)carbonyl]amino}-N-[(3S)-piperidin-3-yl]-1H-pyrazole-3-carboxamide",SmallMoleculeDrug,P24941,Cyclin-dependent kinase 2,CDK2,298.0
14744,DB08142,"4-{[(2,6-dichlorophenyl)carbonyl]amino}-N-piperidin-4-yl-1H-pyrazole-3-carboxamide",SmallMoleculeDrug,P24941,Cyclin-dependent kinase 2,CDK2,298.0
14745,DB08143,"5-CHLORO-THIOPHENE-2-CARBOXYLIC ACID ((3S,4S)-4-FLUORO- 1-{[2-FLUORO-4-(2-OXO-2H-PYRIDIN-1-YL)-PHENYLCARBAMOYL]-METHYL}-PYRROLIDIN-3-YL)-AMIDE",SmallMoleculeDrug,P00742,Coagulation factor X,F10,488.0
14749,DB08147,"4-[3-(dibenzylamino)phenyl]-2,4-dioxobutanoic acid",SmallMoleculeDrug,P18031,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,435.0
14750,DB08148,"1-[4-(4-chlorophenyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-yl]methanamine",SmallMoleculeDrug,P17612,cAMP-dependent protein kinase catalytic subunit alpha,PRKACA,351.0
14751,DB08148,"1-[4-(4-chlorophenyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-yl]methanamine",SmallMoleculeDrug,P61925,cAMP-dependent protein kinase inhibitor alpha,PKIA,76.0
14752,DB08149,"1-[4-(4-chlorobenzyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-yl]methanamine",SmallMoleculeDrug,P17612,cAMP-dependent protein kinase catalytic subunit alpha,PRKACA,351.0
14753,DB08149,"1-[4-(4-chlorobenzyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-yl]methanamine",SmallMoleculeDrug,P61925,cAMP-dependent protein kinase inhibitor alpha,PKIA,76.0
14754,DB08150,"4-(4-chlorobenzyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-aminium",SmallMoleculeDrug,P17612,cAMP-dependent protein kinase catalytic subunit alpha,PRKACA,351.0
14755,DB08150,"4-(4-chlorobenzyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-aminium",SmallMoleculeDrug,P61925,cAMP-dependent protein kinase inhibitor alpha,PKIA,76.0
14756,DB08151,"(5R,7R,8S,9S,10R)-7-(hydroxymethyl)-3-phenyl-1,6-dioxa-2-azaspiro[4.5]dec-2-ene-8,9,10-triol",SmallMoleculeDrug,P11217,"Glycogen phosphorylase, muscle form",PYGM,842.0
14757,DB08152,{(2S)-1-[N-(tert-butoxycarbonyl)glycyl]pyrrolidin-2-yl}methyl (3-chlorophenyl)acetate,SmallMoleculeDrug,P00734,Prothrombin,F2,622.0
14758,DB08153,"(5E)-14-CHLORO-15,17-DIHYDROXY-4,7,8,9,10,11-HEXAHYDRO-2-BENZOXACYCLOPENTADECINE-1,12(3H,13H)-DIONE",SmallMoleculeDrug,P08238,Heat shock protein HSP 90-beta,HSP90AB1,724.0
14760,DB08155,N-{2-[4-(AMINOSULFONYL)PHENYL]ETHYL}ACETAMIDE,SmallMoleculeDrug,P00915,Carbonic anhydrase 1,CA1,261.0
14761,DB08155,N-{2-[4-(AMINOSULFONYL)PHENYL]ETHYL}ACETAMIDE,SmallMoleculeDrug,P00918,Carbonic anhydrase 2,CA2,260.0
14762,DB08156,3-[4-(AMINOSULFONYL)PHENYL]PROPANOIC ACID,SmallMoleculeDrug,P00915,Carbonic anhydrase 1,CA1,261.0
14763,DB08156,3-[4-(AMINOSULFONYL)PHENYL]PROPANOIC ACID,SmallMoleculeDrug,P00918,Carbonic anhydrase 2,CA2,260.0
14764,DB08157,ETHYL 3-[4-(AMINOSULFONYL)PHENYL]PROPANOATE,SmallMoleculeDrug,P00915,Carbonic anhydrase 1,CA1,261.0
14765,DB08157,ETHYL 3-[4-(AMINOSULFONYL)PHENYL]PROPANOATE,SmallMoleculeDrug,P00918,Carbonic anhydrase 2,CA2,260.0
14767,DB08159,"4-(5,11-DIOXO-5H-INDENO[1,2-C]ISOQUINOLIN-6(11H)-YL)BUTANOATE",SmallMoleculeDrug,P11387,DNA topoisomerase 1,TOP1,765.0
14770,DB08162,"5-(1,4-DIAZEPAN-1-SULFONYL)ISOQUINOLINE",SmallMoleculeDrug,P61925,cAMP-dependent protein kinase inhibitor alpha,PKIA,76.0
14771,DB08162,"5-(1,4-DIAZEPAN-1-SULFONYL)ISOQUINOLINE",SmallMoleculeDrug,P17612,cAMP-dependent protein kinase catalytic subunit alpha,PRKACA,351.0
14772,DB08162,"5-(1,4-DIAZEPAN-1-SULFONYL)ISOQUINOLINE",SmallMoleculeDrug,Q13464,Rho-associated protein kinase 1,ROCK1,1354.0
14773,DB08162,"5-(1,4-DIAZEPAN-1-SULFONYL)ISOQUINOLINE",SmallMoleculeDrug,O75116,Rho-associated protein kinase 2,ROCK2,1388.0
14774,DB08163,5'-{[4-(aminooxy)butyl](methyl)amino}-5'-deoxy-8-ethenyladenosine,SmallMoleculeDrug,P17707,S-adenosylmethionine decarboxylase proenzyme,AMD1,334.0
14775,DB08164,"(3R,4R)-1-{6-[3-(METHYLSULFONYL)PHENYL]PYRIMIDIN-4-YL}-4-(2,4,5-TRIFLUOROPHENYL)PIPERIDIN-3-AMINE",SmallMoleculeDrug,P27487,Dipeptidyl peptidase 4,DPP4,766.0
14776,DB08165,indane-5-sulfonamide,SmallMoleculeDrug,P00918,Carbonic anhydrase 2,CA2,260.0
14777,DB08166,"(4R)-7-chloro-9-methyl-1-oxo-1,2,4,9-tetrahydrospiro[beta-carboline-3,4'-piperidine]-4-carbonitrile",SmallMoleculeDrug,P11309,Serine/threonine-protein kinase pim-1,PIM1,404.0
14778,DB08167,"3,7-BIS(DIMETHYLAMINO)PHENOTHIAZIN-5-IUM",SmallMoleculeDrug,P22303,Acetylcholinesterase,ACHE,614.0
14781,DB08168,7-AMINO-4-METHYL-CHROMEN-2-ONE,SmallMoleculeDrug,P30405,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",PPIF,207.0
14782,DB08168,7-AMINO-4-METHYL-CHROMEN-2-ONE,SmallMoleculeDrug,Q9BY41,Histone deacetylase 8,HDAC8,377.0
14783,DB08169,(2Z)-N-biphenyl-4-yl-2-cyano-3-cyclopropyl-3-hydroxyprop-2-enamide,SmallMoleculeDrug,Q02127,"Dihydroorotate dehydrogenase (quinone), mitochondrial",DHODH,395.0
14784,DB08170,"(1R)-N,6-DIHYDROXY-7-METHOXY-2-[(4-METHOXYPHENYL)SULFONYL]-1,2,3,4-TETRAHYDROISOQUINOLINE-1-CARBOXAMIDE",SmallMoleculeDrug,P09237,Matrilysin,MMP7,267.0
14786,DB08172,(2Z)-N-(3-chloro-2'-methoxybiphenyl-4-yl)-2-cyano-3-hydroxybut-2-enamide,SmallMoleculeDrug,Q02127,"Dihydroorotate dehydrogenase (quinone), mitochondrial",DHODH,395.0
14787,DB08173,5-CHLORO-N-(2-(4-(2-OXOPYRIDIN-1(2H)-YL)BENZAMIDO)ETHYL)THIOPHENE-2-CARBOXAMIDE,SmallMoleculeDrug,P00742,Coagulation factor X,F10,488.0
14788,DB08174,"5-CHLORO-N-((1R,2S)-2-(4-(2-OXOPYRIDIN-1(2H)-YL)BENZAMIDO) CYCLOPENTYL)THIOPHENE-2-CARBOXAMIDE",SmallMoleculeDrug,P00742,Coagulation factor X,F10,488.0
14789,DB08175,"(2E,4E)-11-METHOXY-3,7,11-TRIMETHYLDODECA-2,4-DIENOIC ACID",SmallMoleculeDrug,Q15596,Nuclear receptor coactivator 2,NCOA2,1464.0
14790,DB08175,"(2E,4E)-11-METHOXY-3,7,11-TRIMETHYLDODECA-2,4-DIENOIC ACID",SmallMoleculeDrug,P28702,Retinoic acid receptor RXR-beta,RXRB,533.0
14791,DB08175,"(2E,4E)-11-METHOXY-3,7,11-TRIMETHYLDODECA-2,4-DIENOIC ACID",SmallMoleculeDrug,Q13133,Oxysterols receptor LXR-alpha,NR1H3,447.0
14792,DB08176,(1Z)-4-(4-FLUOROPHENYL)-2-METHYLIDENEBUTAN-1-IMINE,SmallMoleculeDrug,P27338,Amine oxidase [flavin-containing] B,MAOB,520.0
14794,DB08178,"4-(4-methoxy-1H-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-2-amine",SmallMoleculeDrug,P24941,Cyclin-dependent kinase 2,CDK2,298.0
14795,DB08178,"4-(4-methoxy-1H-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-2-amine",SmallMoleculeDrug,P20248,Cyclin-A2,CCNA2,432.0
14796,DB08179,"methyl 4-(2,3-dihydroxy-5-methylphenoxy)-2-hydroxy-6-methylbenzoate",SmallMoleculeDrug,Q04760,Lactoylglutathione lyase,GLO1,184.0
14797,DB08180,2-[METHYL-(5-GERANYL-4-METHYL-PENT-3-ENYL)-AMINO]-ETHYL-DIPHOSPHATE,SmallMoleculeDrug,P49354,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,FNTA,379.0
14798,DB08180,2-[METHYL-(5-GERANYL-4-METHYL-PENT-3-ENYL)-AMINO]-ETHYL-DIPHOSPHATE,SmallMoleculeDrug,P53609,Geranylgeranyl transferase type-1 subunit beta,PGGT1B,377.0
14800,DB08182,"4-(4-propoxy-1H-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-2-amine",SmallMoleculeDrug,P24941,Cyclin-dependent kinase 2,CDK2,298.0
14801,DB08182,"4-(4-propoxy-1H-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-2-amine",SmallMoleculeDrug,P20248,Cyclin-A2,CCNA2,432.0
14802,DB08183,"3-{(3R,4R)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl}-3-oxopropanenitrile",SmallMoleculeDrug,P23458,Tyrosine-protein kinase JAK1,JAK1,1154.0
14803,DB08183,"3-{(3R,4R)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl}-3-oxopropanenitrile",SmallMoleculeDrug,O60674,Tyrosine-protein kinase JAK2,JAK2,1132.0
14804,DB08183,"3-{(3R,4R)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl}-3-oxopropanenitrile",SmallMoleculeDrug,P52333,Tyrosine-protein kinase JAK3,JAK3,1124.0
14805,DB08183,"3-{(3R,4R)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl}-3-oxopropanenitrile",SmallMoleculeDrug,P29597,Non-receptor tyrosine-protein kinase TYK2,TYK2,1187.0
14806,DB08184,2-(2-METHYLPHENYL)-1H-INDOLE-5-CARBOXIMIDAMIDE,SmallMoleculeDrug,P07477,Trypsin-1,PRSS1,247.0
14834,DB08186,(3E)-4-(1-METHYL-1H-INDOL-3-YL)BUT-3-EN-2-ONE,SmallMoleculeDrug,Q92831,Histone acetyltransferase KAT2B,KAT2B,832.0
14835,DB08187,METHYL-PHE-PRO-AMINO-CYCLOHEXYLGLYCINE,SmallMoleculeDrug,P00734,Prothrombin,F2,622.0
14837,DB08190,N-[2-(2-iodo-5-methoxy-1H-indol-3-yl)ethyl]acetamide,SmallMoleculeDrug,P16083,Ribosyldihydronicotinamide dehydrogenase [quinone],NQO2,231.0
14838,DB08191,"4-(5-phenyl-1H-pyrrolo[2,3-b]pyridin-3-yl)benzoic acid",SmallMoleculeDrug,O00141,Serine/threonine-protein kinase Sgk1,SGK1,431.0
14839,DB08192,2-(4-CARCOXY-5-ISOPROPYLTHIAZOLYL)BENZOPIPERIDINE,SmallMoleculeDrug,P12931,Proto-oncogene tyrosine-protein kinase Src,SRC,536.0
14841,DB08194,"4-methyl-7,8-dihydro-5H-thiopyrano[4,3-d]pyrimidin-2-amine",SmallMoleculeDrug,P07900,Heat shock protein HSP 90-alpha,HSP90AA1,732.0
14842,DB08195,(1R)-2-[(CYANOMETHYL)AMINO]-1-({[2-(DIFLUOROMETHOXY)BENZYL]SULFONYL}METHYL)-2-OXOETHYL MORPHOLINE-4-CARBOXYLATE,SmallMoleculeDrug,P25774,Cathepsin S,CTSS,331.0
14844,DB08197,"(5E,7S)-2-amino-7-(4-fluoro-2-pyridin-3-ylphenyl)-4-methyl-7,8-dihydroquinazolin-5(6H)-one oxime",SmallMoleculeDrug,P07900,Heat shock protein HSP 90-alpha,HSP90AA1,732.0
14845,DB08198,"[(4R)-4-(3-HYDROXYPHENYL)-1,6-DIMETHYL-2-THIOXO-1,2,3,4-TETRAHYDROPYRIMIDIN-5-YL](PHENYL)METHANONE",SmallMoleculeDrug,P52732,Kinesin-like protein KIF11,KIF11,1056.0
14847,DB08200,(1R)-MENTHYL HEXYL PHOSPHONATE GROUP,SmallMoleculeDrug,P06276,Cholinesterase,BCHE,602.0
14848,DB08201,(1S)-MENTHYL HEXYL PHOSPHONATE GROUP,SmallMoleculeDrug,P06276,Cholinesterase,BCHE,602.0
14849,DB08202,4-({[(4-METHYLPIPERAZIN-1-YL)AMINO]CARBONOTHIOYL}AMINO)BENZENESULFONAMIDE,SmallMoleculeDrug,P00918,Carbonic anhydrase 2,CA2,260.0
14850,DB08203,"7-[2-METHOXY-1-(METHOXYMETHYL)ETHYL]-7H-PYRROLO[3,2-F] QUINAZOLINE-1,3-DIAMINE",SmallMoleculeDrug,Q86XF0,"Dihydrofolate reductase, mitochondrial",DHFR2,187.0
14852,DB08208,"2-[(4-ETHYNYL-2-FLUOROPHENYL)AMINO]-3,4-DIFLUORO-N-(2-HYDROXYETHOXY)BENZAMIDE",SmallMoleculeDrug,Q02750,Dual specificity mitogen-activated protein kinase kinase 1,MAP2K1,393.0
14854,DB08210,"2-AMINO-4-FLUORO-5-[(1-METHYL-1H-IMIDAZOL-2-YL)SULFANYL]-N-(1,3-THIAZOL-2-YL)BENZAMIDE",SmallMoleculeDrug,P35557,Glucokinase,GCK,465.0
14857,DB08213,"1-METHYL-5-(2-PHENOXYMETHYL-PYRROLIDINE-1-SULFONYL)-1H-INDOLE-2,3-DIONE",SmallMoleculeDrug,P42574,Caspase-3,CASP3,277.0
14858,DB08214,4-(1H-IMIDAZOL-1-YL)PHENOL,SmallMoleculeDrug,P35228,"Nitric oxide synthase, inducible",NOS2,1153.0
14867,DB08217,"2,2,5,5-TETRAMETHYL-3-(SULFANYLMETHYL)-2,5-DIHYDRO-1H-PYRROL-1-OL",SmallMoleculeDrug,P06730,Eukaryotic translation initiation factor 4E,EIF4E,217.0
14869,DB08217,"2,2,5,5-TETRAMETHYL-3-(SULFANYLMETHYL)-2,5-DIHYDRO-1H-PYRROL-1-OL",SmallMoleculeDrug,P06731,Carcinoembryonic antigen-related cell adhesion molecule 5,CEACAM5,702.0
14871,DB08218,"HYDROXY(OXO)(3-{[(2Z)-4-[3-(1H-1,2,4-TRIAZOL-1-YLMETHYL)PHENYL]PYRIMIDIN-2(5H)-YLIDENE]AMINO}PHENYL)AMMONIUM",SmallMoleculeDrug,P20248,Cyclin-A2,CCNA2,432.0
14872,DB08218,"HYDROXY(OXO)(3-{[(2Z)-4-[3-(1H-1,2,4-TRIAZOL-1-YLMETHYL)PHENYL]PYRIMIDIN-2(5H)-YLIDENE]AMINO}PHENYL)AMMONIUM",SmallMoleculeDrug,P24941,Cyclin-dependent kinase 2,CDK2,298.0
14873,DB08219,"4-METHYL-5-{(2E)-2-[(4-MORPHOLIN-4-YLPHENYL)IMINO]-2,5-DIHYDROPYRIMIDIN-4-YL}-1,3-THIAZOL-2-AMINE",SmallMoleculeDrug,P20248,Cyclin-A2,CCNA2,432.0
14874,DB08219,"4-METHYL-5-{(2E)-2-[(4-MORPHOLIN-4-YLPHENYL)IMINO]-2,5-DIHYDROPYRIMIDIN-4-YL}-1,3-THIAZOL-2-AMINE",SmallMoleculeDrug,P24941,Cyclin-dependent kinase 2,CDK2,298.0
14875,DB08220,"(8alpha,10alpha,13alpha,17beta)-17-[(4-hydroxyphenyl)carbonyl]androsta-3,5-diene-3-carboxylic acid",SmallMoleculeDrug,Q15788,Nuclear receptor coactivator 1,NCOA1,1441.0
14876,DB08220,"(8alpha,10alpha,13alpha,17beta)-17-[(4-hydroxyphenyl)carbonyl]androsta-3,5-diene-3-carboxylic acid",SmallMoleculeDrug,Q96RI1,Bile acid receptor,NR1H4,486.0
14877,DB08221,N-{4-METHYL-3-[(3-PYRIMIDIN-4-YLPYRIDIN-2-YL)AMINO]PHENYL}-3-(TRIFLUOROMETHYL)BENZAMIDE,SmallMoleculeDrug,Q02763,Angiopoietin-1 receptor,TEK,1124.0
14878,DB08222,METHOXYUNDECYLPHOSPHINIC ACID,SmallMoleculeDrug,P04118,Colipase,CLPS,112.0
14879,DB08222,METHOXYUNDECYLPHOSPHINIC ACID,SmallMoleculeDrug,P16233,Pancreatic triacylglycerol lipase,PNLIP,465.0
14880,DB08224,"(1S,7S,8S,8AR)-1,2,3,7,8,8A-HEXAHYDRO-7-METHYL-8-[2-[(2R,4R)-TETRAHYDRO-4-HY DROXY-6-OXO-2H-PYRAN-2-YL]ETHYL]-1-NAPHTHALENOL",SmallMoleculeDrug,P23141,Liver carboxylesterase 1,CES1,567.0
14887,DB08228,"5,8-dimethoxy-1,4-dimethylquinolin-2(1H)-one",SmallMoleculeDrug,P16083,Ribosyldihydronicotinamide dehydrogenase [quinone],NQO2,231.0
14888,DB08229,[N-(3-DIBENZYLCARBAMOYL-OXIRANECARBONYL)-HYDRAZINO]-ACETIC ACID,SmallMoleculeDrug,P42574,Caspase-3,CASP3,277.0
14889,DB08230,"5,7-DIHYDROXY-2-(3,4,5-TRIHYDROXYPHENYL)-4H-CHROMEN-4-ONE",SmallMoleculeDrug,P11309,Serine/threonine-protein kinase pim-1,PIM1,404.0
14894,DB08231,MYRISTIC ACID,SmallMoleculeDrug,P61925,cAMP-dependent protein kinase inhibitor alpha,PKIA,76.0
14895,DB08231,MYRISTIC ACID,SmallMoleculeDrug,P17612,cAMP-dependent protein kinase catalytic subunit alpha,PRKACA,351.0
14902,DB08231,MYRISTIC ACID,SmallMoleculeDrug,O75521,"Enoyl-CoA delta isomerase 2, mitochondrial",ECI2,394.0
14903,DB08231,MYRISTIC ACID,SmallMoleculeDrug,P35243,Recoverin,RCVRN,200.0
14907,DB08231,MYRISTIC ACID,SmallMoleculeDrug,P00519,Tyrosine-protein kinase ABL1,ABL1,1130.0
14910,DB08231,MYRISTIC ACID,SmallMoleculeDrug,P41235,Hepatocyte nuclear factor 4-alpha,HNF4A,474.0
14911,DB08231,MYRISTIC ACID,SmallMoleculeDrug,Q15788,Nuclear receptor coactivator 1,NCOA1,1441.0
14914,DB08231,MYRISTIC ACID,SmallMoleculeDrug,P62942,Peptidyl-prolyl cis-trans isomerase FKBP1A,FKBP1A,108.0
14915,DB08231,MYRISTIC ACID,SmallMoleculeDrug,P63098,Calcineurin subunit B type 1,PPP3R1,170.0
14916,DB08231,MYRISTIC ACID,SmallMoleculeDrug,Q08209,Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform,PPP3CA,521.0
14919,DB08231,MYRISTIC ACID,SmallMoleculeDrug,O43617,Trafficking protein particle complex subunit 3,TRAPPC3,180.0
14920,DB08231,MYRISTIC ACID,SmallMoleculeDrug,P01308,Insulin,INS,110.0
14923,DB08231,MYRISTIC ACID,SmallMoleculeDrug,P17900,Ganglioside GM2 activator,GM2A,193.0
14924,DB08231,MYRISTIC ACID,SmallMoleculeDrug,P62330,ADP-ribosylation factor 6,ARF6,175.0
14925,DB08231,MYRISTIC ACID,SmallMoleculeDrug,Q9Y6Y9,Lymphocyte antigen 96,LY96,160.0
14929,DB08231,MYRISTIC ACID,SmallMoleculeDrug,P84077,ADP-ribosylation factor 1,ARF1,181.0
14930,DB08231,MYRISTIC ACID,SmallMoleculeDrug,P43080,Guanylyl cyclase-activating protein 1,GUCA1A,201.0
14932,DB08231,MYRISTIC ACID,SmallMoleculeDrug,P15151,Poliovirus receptor,PVR,417.0
14933,DB08231,MYRISTIC ACID,SmallMoleculeDrug,O00206,Toll-like receptor 4,TLR4,839.0
14934,DB08232,"{5-(5-AMINO-1H-PYRROLO[3,2-B]PYRIDIN-2-YL)-6-HYDROXY-3'-NITRO-BIPHENYL-3-YL]-ACETIC ACID",SmallMoleculeDrug,P08709,Coagulation factor VII,F7,466.0
14935,DB08232,"{5-(5-AMINO-1H-PYRROLO[3,2-B]PYRIDIN-2-YL)-6-HYDROXY-3'-NITRO-BIPHENYL-3-YL]-ACETIC ACID",SmallMoleculeDrug,P13726,Tissue factor,F3,295.0
14936,DB08233,6-CYCLOHEXYLMETHYLOXY-2-(4'-HYDROXYANILINO)PURINE,SmallMoleculeDrug,P20248,Cyclin-A2,CCNA2,432.0
14937,DB08233,6-CYCLOHEXYLMETHYLOXY-2-(4'-HYDROXYANILINO)PURINE,SmallMoleculeDrug,P24941,Cyclin-dependent kinase 2,CDK2,298.0
14939,DB08234,"5-[3-(2,5-dimethoxyphenyl)prop-1-yn-1-yl]-6-ethylpyrimidine-2,4-diamine",SmallMoleculeDrug,P00374,Dihydrofolate reductase,DHFR,187.0
14942,DB08235,N-[2-(2-methyl-1H-indol-3-yl)ethyl]thiophene-2-carboxamide,SmallMoleculeDrug,O15143,Actin-related protein 2/3 complex subunit 1B,ARPC1B,372.0
14943,DB08235,N-[2-(2-methyl-1H-indol-3-yl)ethyl]thiophene-2-carboxamide,SmallMoleculeDrug,P61160,Actin-related protein 2,ACTR2,394.0
14944,DB08235,N-[2-(2-methyl-1H-indol-3-yl)ethyl]thiophene-2-carboxamide,SmallMoleculeDrug,P61158,Actin-related protein 3,ACTR3,418.0
14945,DB08235,N-[2-(2-methyl-1H-indol-3-yl)ethyl]thiophene-2-carboxamide,SmallMoleculeDrug,O15144,Actin-related protein 2/3 complex subunit 2,ARPC2,300.0
14946,DB08235,N-[2-(2-methyl-1H-indol-3-yl)ethyl]thiophene-2-carboxamide,SmallMoleculeDrug,O15145,Actin-related protein 2/3 complex subunit 3,ARPC3,178.0
14947,DB08235,N-[2-(2-methyl-1H-indol-3-yl)ethyl]thiophene-2-carboxamide,SmallMoleculeDrug,P59998,Actin-related protein 2/3 complex subunit 4,ARPC4,168.0
14948,DB08235,N-[2-(2-methyl-1H-indol-3-yl)ethyl]thiophene-2-carboxamide,SmallMoleculeDrug,O15511,Actin-related protein 2/3 complex subunit 5,ARPC5,151.0
14949,DB08236,"(2S)-2-(3-bromophenyl)-3-(5-chloro-2-hydroxyphenyl)-1,3-thiazolidin-4-one",SmallMoleculeDrug,O15143,Actin-related protein 2/3 complex subunit 1B,ARPC1B,372.0
14950,DB08236,"(2S)-2-(3-bromophenyl)-3-(5-chloro-2-hydroxyphenyl)-1,3-thiazolidin-4-one",SmallMoleculeDrug,P61160,Actin-related protein 2,ACTR2,394.0
14951,DB08236,"(2S)-2-(3-bromophenyl)-3-(5-chloro-2-hydroxyphenyl)-1,3-thiazolidin-4-one",SmallMoleculeDrug,P61158,Actin-related protein 3,ACTR3,418.0
14952,DB08236,"(2S)-2-(3-bromophenyl)-3-(5-chloro-2-hydroxyphenyl)-1,3-thiazolidin-4-one",SmallMoleculeDrug,O15144,Actin-related protein 2/3 complex subunit 2,ARPC2,300.0
14953,DB08236,"(2S)-2-(3-bromophenyl)-3-(5-chloro-2-hydroxyphenyl)-1,3-thiazolidin-4-one",SmallMoleculeDrug,O15145,Actin-related protein 2/3 complex subunit 3,ARPC3,178.0
14954,DB08236,"(2S)-2-(3-bromophenyl)-3-(5-chloro-2-hydroxyphenyl)-1,3-thiazolidin-4-one",SmallMoleculeDrug,P59998,Actin-related protein 2/3 complex subunit 4,ARPC4,168.0
14955,DB08236,"(2S)-2-(3-bromophenyl)-3-(5-chloro-2-hydroxyphenyl)-1,3-thiazolidin-4-one",SmallMoleculeDrug,O15511,Actin-related protein 2/3 complex subunit 5,ARPC5,151.0
14956,DB08237,2'-deoxy-N-(naphthalen-1-ylmethyl)guanosine 5'-(dihydrogen phosphate),SmallMoleculeDrug,Q9UBT6,DNA polymerase kappa,POLK,870.0
14957,DB08238,5-AMINO-NAPHTALENE-2-MONOSULFONATE,SmallMoleculeDrug,P05230,Fibroblast growth factor 1,FGF1,155.0
14958,DB08239,"(2S)-4-(2,5-DIFLUOROPHENYL)-N-METHYL-2-PHENYL-N-PIPERIDIN-4-YL-2,5-DIHYDRO-1H-PYRROLE-1-CARBOXAMIDE",SmallMoleculeDrug,P52732,Kinesin-like protein KIF11,KIF11,1056.0
14959,DB08240,N-(4-CHLOROPHENYL)-3-(PHOSPHONOOXY)NAPHTHALENE-2-CARBOXAMIDE,SmallMoleculeDrug,P04075,Fructose-bisphosphate aldolase A,ALDOA,364.0
14960,DB08241,4-(6-CYCLOHEXYLMETHOXY-9H-PURIN-2-YLAMINO)--BENZAMIDE,SmallMoleculeDrug,P20248,Cyclin-A2,CCNA2,432.0
14961,DB08241,4-(6-CYCLOHEXYLMETHOXY-9H-PURIN-2-YLAMINO)--BENZAMIDE,SmallMoleculeDrug,P24941,Cyclin-dependent kinase 2,CDK2,298.0
14962,DB08242,"N,4-dimethyl-3-[(1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-yl)amino]benzamide",SmallMoleculeDrug,Q16539,Mitogen-activated protein kinase 14,MAPK14,360.0
14963,DB08244,"(1S)-1-CYCLOPROPYL-2-[(2S)-4-(2,5-DIFLUOROPHENYL)-2-PHENYL-2,5-DIHYDRO-1H-PYRROL-1-YL]-2-OXOETHANAMINE",SmallMoleculeDrug,P52732,Kinesin-like protein KIF11,KIF11,1056.0
14965,DB08246,"(2S)-4-(2,5-DIFLUOROPHENYL)-N,N-DIMETHYL-2-PHENYL-2,5-DIHYDRO-1H-PYRROLE-1-CARBOXAMIDE",SmallMoleculeDrug,P52732,Kinesin-like protein KIF11,KIF11,1056.0
14966,DB08247,6-(CYCLOHEXYLMETHOXY)-8-ISOPROPYL-9H-PURIN-2-AMINE,SmallMoleculeDrug,P24941,Cyclin-dependent kinase 2,CDK2,298.0
14967,DB08248,3-(6-CYCLOHEXYLMETHOXY-9H-PURIN-2-YLAMINO)-BENZENESULFONAMIDE,SmallMoleculeDrug,P20248,Cyclin-A2,CCNA2,432.0
14968,DB08248,3-(6-CYCLOHEXYLMETHOXY-9H-PURIN-2-YLAMINO)-BENZENESULFONAMIDE,SmallMoleculeDrug,P24941,Cyclin-dependent kinase 2,CDK2,298.0
14969,DB08249,"3,6,9,12,15-PENTAOXATRICOSAN-1-OL",SmallMoleculeDrug,Q02127,"Dihydroorotate dehydrogenase (quinone), mitochondrial",DHODH,395.0
14973,DB08250,"(5S)-5-(3-AMINOPROPYL)-3-(2,5-DIFLUOROPHENYL)-N-ETHYL-5-PHENYL-4,5-DIHYDRO-1H-PYRAZOLE-1-CARBOXAMIDE",SmallMoleculeDrug,P52732,Kinesin-like protein KIF11,KIF11,1056.0
14974,DB08251,4-[5-(2-CARBOXY-1-FORMYL-ETHYLCARBAMOYL)-PYRIDIN-3-YL]-BENZOIC ACID,SmallMoleculeDrug,P42574,Caspase-3,CASP3,277.0
14977,DB08254,2-NAPHTHALENESULFONIC ACID,SmallMoleculeDrug,P00734,Prothrombin,F2,622.0
14978,DB08254,2-NAPHTHALENESULFONIC ACID,SmallMoleculeDrug,P07477,Trypsin-1,PRSS1,247.0
14980,DB08256,N-[(CYCLOHEXYLAMINO)CARBONYL]GLYCINE,SmallMoleculeDrug,P34913,Bifunctional epoxide hydrolase 2,EPHX2,555.0
14981,DB08257,4-{[(CYCLOHEXYLAMINO)CARBONYL]AMINO}BUTANOIC ACID,SmallMoleculeDrug,P34913,Bifunctional epoxide hydrolase 2,EPHX2,555.0
14982,DB08258,6-{[(CYCLOHEXYLAMINO)CARBONYL]AMINO}HEXANOIC ACID,SmallMoleculeDrug,P34913,Bifunctional epoxide hydrolase 2,EPHX2,555.0
14983,DB08259,7-{[(CYCLOHEXYLAMINO)CARBONYL]AMINO}HEPTANOIC ACID,SmallMoleculeDrug,P34913,Bifunctional epoxide hydrolase 2,EPHX2,555.0
14986,DB08262,"2,6-dicarboxynaphthalene",SmallMoleculeDrug,P69905,Hemoglobin subunit alpha,HBA1;,142.0
14987,DB08262,"2,6-dicarboxynaphthalene",SmallMoleculeDrug,P68871,Hemoglobin subunit beta,HBB,147.0
14988,DB08263,N-(carboxycarbonyl)-D-phenylalanine,SmallMoleculeDrug,Q9NWT6,Hypoxia-inducible factor 1-alpha inhibitor,HIF1AN,349.0
14999,DB08270,"N-(2-AMINOETHYL)-N~2~-{(1S)-1-[4'-(AMINOSULFONYL)BIPHENYL-4-YL]-2,2,2-TRIFLUOROETHYL}-L-LEUCINAMIDE",SmallMoleculeDrug,P43235,Cathepsin K,CTSK,329.0
15000,DB08271,N-ISOBUTYL-N-[4-METHOXYPHENYLSULFONYL]GLYCYL HYDROXAMIC ACID,SmallMoleculeDrug,P09238,Stromelysin-2,MMP10,476.0
15001,DB08271,N-ISOBUTYL-N-[4-METHOXYPHENYLSULFONYL]GLYCYL HYDROXAMIC ACID,SmallMoleculeDrug,P39900,Macrophage metalloelastase,MMP12,470.0
15002,DB08271,N-ISOBUTYL-N-[4-METHOXYPHENYLSULFONYL]GLYCYL HYDROXAMIC ACID,SmallMoleculeDrug,P08254,Stromelysin-1,MMP3,477.0
15003,DB08271,N-ISOBUTYL-N-[4-METHOXYPHENYLSULFONYL]GLYCYL HYDROXAMIC ACID,SmallMoleculeDrug,O60882,Matrix metalloproteinase-20,MMP20,483.0
15006,DB08273,4-HYDROXY-5-IODO-3-NITROPHENYLACETYL-EPSILON-AMINOCAPROIC ACID ANION,SmallMoleculeDrug,P04211,Ig lambda chain V region 4A,IGLV7-43,117.0
15009,DB08276,N-METHYL O-NITROPHENYL AMINOETHYLDIPHOSPHATE BERYLLIUM TRIFLUORIDE,SmallMoleculeDrug,Q7Z406,Myosin-14,MYH14,1995.0
15010,DB08277,"2-(2-CHLORO-4-FLUOROPHENOXY)-2-METHYL-N-[(1R,2S,3S,5S,7S)-5-(METHYLSULFONYL)-2-ADAMANTYL]PROPANAMIDE",SmallMoleculeDrug,P28845,Corticosteroid 11-beta-dehydrogenase isozyme 1,HSD11B1,292.0
15013,DB08280,"(1S,3R,4S,5S,7S)-4-{[2-(4-METHOXYPHENOXY)-2-METHYLPROPANOYL]AMINO}ADAMANTANE-1-CARBOXAMIDE",SmallMoleculeDrug,P28845,Corticosteroid 11-beta-dehydrogenase isozyme 1,HSD11B1,292.0
15016,DB08283,"(2R,3R,4R,5S)-2-(HYDROXYMETHYL)-1-NONYLPIPERIDINE-3,4,5-TRIOL",SmallMoleculeDrug,P04062,Glucosylceramidase,GBA,536.0
15018,DB08285,"(2R)-2-{[4-(benzylamino)-8-(1-methylethyl)pyrazolo[1,5-a][1,3,5]triazin-2-yl]amino}butan-1-ol",SmallMoleculeDrug,P24941,Cyclin-dependent kinase 2,CDK2,298.0
15019,DB08285,"(2R)-2-{[4-(benzylamino)-8-(1-methylethyl)pyrazolo[1,5-a][1,3,5]triazin-2-yl]amino}butan-1-ol",SmallMoleculeDrug,P20248,Cyclin-A2,CCNA2,432.0
15022,DB08287,"(1R,2R)-N-(2-AMINOETHYL)-2-{[(4-METHOXYPHENYL)SULFONYL]METHYL}CYCLOHEXANECARBOXAMIDE",SmallMoleculeDrug,P43235,Cathepsin K,CTSK,329.0
15023,DB08289,N-(PARA-GLUTARAMIDOPHENYL-ETHYL)-PIPERIDINIUM-N-OXIDE,SmallMoleculeDrug,P01834,Ig kappa chain C region,IGKC,107.0
15024,DB08291,N-(3-AMINOPROPYL)-2-NITROBENZENAMINE,SmallMoleculeDrug,Q92831,Histone acetyltransferase KAT2B,KAT2B,832.0
15025,DB08292,"(5Z)-12-CHLORO-13,15-DIHYDROXY-4,7,8,9-TETRAHYDRO-2-BENZOXACYCLOTRIDECINE-1,10(3H,11H)-DIONE",SmallMoleculeDrug,P08238,Heat shock protein HSP 90-beta,HSP90AB1,724.0
15026,DB08293,"(5E)-12-CHLORO-13,15-DIHYDROXY-4,7,8,9-TETRAHYDRO-2-BENZOXACYCLOTRIDECINE-1,10(3H,11H)-DIONE",SmallMoleculeDrug,P08238,Heat shock protein HSP 90-beta,HSP90AB1,724.0
15028,DB08294,2-(4-HYDROXY-3-NITROPHENYL)ACETIC ACID,SmallMoleculeDrug,P01857,Ig gamma-1 chain C region,IGHG1,330.0
15030,DB08295,4-HYDROXY-3-NITROPHENYLACETYL-EPSILON-AMINOCAPROIC ACID ANION,SmallMoleculeDrug,P04211,Ig lambda chain V region 4A,IGLV7-43,117.0
15031,DB08296,5-(PARA-NITROPHENYL PHOSPHONATE)-PENTANOIC ACID,SmallMoleculeDrug,P01857,Ig gamma-1 chain C region,IGHG1,330.0
15033,DB08299,"4-[8-(3-nitrophenyl)-1,7-naphthyridin-6-yl]benzoic acid",SmallMoleculeDrug,P27815,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A",PDE4A,886.0
15034,DB08299,"4-[8-(3-nitrophenyl)-1,7-naphthyridin-6-yl]benzoic acid",SmallMoleculeDrug,Q07343,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B",PDE4B,736.0
15035,DB08299,"4-[8-(3-nitrophenyl)-1,7-naphthyridin-6-yl]benzoic acid",SmallMoleculeDrug,Q08499,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",PDE4D,809.0
15036,DB08300,"1-methyl-3-naphthalen-2-yl-1H-pyrazolo[3,4-d]pyrimidin-4-amine",SmallMoleculeDrug,P48736,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",PIK3CG,1102.0
15037,DB08301,N-({[4-(AMINOSULFONYL)PHENYL]AMINO}CARBONYL)-4-METHYLBENZENESULFONAMIDE,SmallMoleculeDrug,P00918,Carbonic anhydrase 2,CA2,260.0
15038,DB08302,3-[5-(2-nitropent-1-en-1-yl)furan-2-yl]benzoic acid,SmallMoleculeDrug,P37231,Peroxisome proliferator-activated receptor gamma,PPARG,505.0
15039,DB08303,"(3S)-3-cyclopentyl-6-methyl-7-[(4-methylpiperazin-1-yl)sulfonyl]-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide",SmallMoleculeDrug,P42262,Glutamate receptor 2,GRIA2,883.0
15040,DB08304,"(3R)-3-cyclopentyl-7-[(4-methylpiperazin-1-yl)sulfonyl]-3,4-dihydro-2H-1,2-benzothiazine 1,1-dioxide",SmallMoleculeDrug,P42262,Glutamate receptor 2,GRIA2,883.0
15041,DB08305,"(3R)-3-cyclopentyl-6-methyl-7-[(4-methylpiperazin-1-yl)sulfonyl]-3,4-dihydro-2H-1,2-benzothiazine 1,1-dioxide",SmallMoleculeDrug,P42262,Glutamate receptor 2,GRIA2,883.0
15045,DB08309,3-({2-[(4-{[6-(CYCLOHEXYLMETHOXY)-9H-PURIN-2-YL]AMINO}PHENYL)SULFONYL]ETHYL}AMINO)PROPAN-1-OL,SmallMoleculeDrug,P24941,Cyclin-dependent kinase 2,CDK2,298.0
15046,DB08309,3-({2-[(4-{[6-(CYCLOHEXYLMETHOXY)-9H-PURIN-2-YL]AMINO}PHENYL)SULFONYL]ETHYL}AMINO)PROPAN-1-OL,SmallMoleculeDrug,P20248,Cyclin-A2,CCNA2,432.0
15048,DB08312,"6-CYCLOHEXYLMETHYLOXY-5-NITROSO-PYRIMIDINE-2,4-DIAMINE",SmallMoleculeDrug,P24941,Cyclin-dependent kinase 2,CDK2,298.0
15049,DB08313,nocodazole,SmallMoleculeDrug,O60760,Hematopoietic prostaglandin D synthase,HPGDS,199.0
15056,DB08320,"DIETHYL (1R,2S,3R,4S)-5,6-BIS(4-HYDROXYPHENYL)-7-OXABICYCLO[2.2.1]HEPT-5-ENE-2,3-DICARBOXYLATE",SmallMoleculeDrug,P03372,Estrogen receptor,ESR1,595.0
15057,DB08320,"DIETHYL (1R,2S,3R,4S)-5,6-BIS(4-HYDROXYPHENYL)-7-OXABICYCLO[2.2.1]HEPT-5-ENE-2,3-DICARBOXYLATE",SmallMoleculeDrug,Q15596,Nuclear receptor coactivator 2,NCOA2,1464.0
15058,DB08321,"(1S,2S,3R,6R)-4-(hydroxymethyl)-6-(octylamino)cyclohex-4-ene-1,2,3-triol",SmallMoleculeDrug,Q16706,Alpha-mannosidase 2,MAN2A1,1144.0
15059,DB08322,"2-DEOXY-3,4-BIS-O-[3-(4-HYDROXYPHENYL)PROPANOYL]-L-THREO-PENTARIC ACID",SmallMoleculeDrug,P11217,"Glycogen phosphorylase, muscle form",PYGM,842.0
15060,DB08323,3-OXO-N-[(3S)-2-OXOPYRROLIDIN-3-YL]DODECANAMIDE,SmallMoleculeDrug,P01859,Ig gamma-2 chain C region,IGHG2,326.0
15062,DB08325,2-(2-HYDROXYETHYLAMINO)-6-(3-CHLOROANILINO)-9-ISOPROPYLPURINE,SmallMoleculeDrug,Q9HCP0,Casein kinase I isoform gamma-1,CSNK1G1,422.0
15063,DB08325,2-(2-HYDROXYETHYLAMINO)-6-(3-CHLOROANILINO)-9-ISOPROPYLPURINE,SmallMoleculeDrug,Q12866,Tyrosine-protein kinase Mer,MERTK,999.0
15064,DB08326,"2-(6-HYDROXY-1,3-BENZOTHIAZOL-2-YL)-1,3-THIAZOL-4(5H)-ONE",SmallMoleculeDrug,Q96GR2,Long-chain-fatty-acid--CoA ligase ACSBG1,ACSBG1,724.0
15067,DB08329,SULTHIAME,SmallMoleculeDrug,P00918,Carbonic anhydrase 2,CA2,260.0
15068,DB08330,METHYL (2Z)-3-METHOXY-2-{2-[(E)-2-PHENYLVINYL]PHENYL}ACRYLATE,SmallMoleculeDrug,P08574,"Cytochrome c1, heme protein, mitochondrial",CYC1,325.0
15069,DB08330,METHYL (2Z)-3-METHOXY-2-{2-[(E)-2-PHENYLVINYL]PHENYL}ACRYLATE,SmallMoleculeDrug,P00156,Cytochrome b,MT-CYB,380.0
15070,DB08330,METHYL (2Z)-3-METHOXY-2-{2-[(E)-2-PHENYLVINYL]PHENYL}ACRYLATE,SmallMoleculeDrug,P31930,"Cytochrome b-c1 complex subunit 1, mitochondrial",UQCRC1,480.0
15071,DB08330,METHYL (2Z)-3-METHOXY-2-{2-[(E)-2-PHENYLVINYL]PHENYL}ACRYLATE,SmallMoleculeDrug,P22695,"Cytochrome b-c1 complex subunit 2, mitochondrial",UQCRC2,453.0
15072,DB08330,METHYL (2Z)-3-METHOXY-2-{2-[(E)-2-PHENYLVINYL]PHENYL}ACRYLATE,SmallMoleculeDrug,P07919,"Cytochrome b-c1 complex subunit 6, mitochondrial",UQCRH,91.0
15073,DB08330,METHYL (2Z)-3-METHOXY-2-{2-[(E)-2-PHENYLVINYL]PHENYL}ACRYLATE,SmallMoleculeDrug,O14949,Cytochrome b-c1 complex subunit 8,UQCRQ,82.0
15074,DB08330,METHYL (2Z)-3-METHOXY-2-{2-[(E)-2-PHENYLVINYL]PHENYL}ACRYLATE,SmallMoleculeDrug,P47985,"Cytochrome b-c1 complex subunit Rieske, mitochondrial",UQCRFS1,274.0
15075,DB08330,METHYL (2Z)-3-METHOXY-2-{2-[(E)-2-PHENYLVINYL]PHENYL}ACRYLATE,SmallMoleculeDrug,O14957,Cytochrome b-c1 complex subunit 10,UQCR11,56.0
15076,DB08330,METHYL (2Z)-3-METHOXY-2-{2-[(E)-2-PHENYLVINYL]PHENYL}ACRYLATE,SmallMoleculeDrug,P14927,Cytochrome b-c1 complex subunit 7,UQCRB,111.0
15077,DB08330,METHYL (2Z)-3-METHOXY-2-{2-[(E)-2-PHENYLVINYL]PHENYL}ACRYLATE,SmallMoleculeDrug,Q9UDW1,Cytochrome b-c1 complex subunit 9,UQCR10,63.0
15079,DB08332,[2'-CARBOXYLETHYL]-10-METHYL-ANTHRACENE ENDOPEROXIDE,SmallMoleculeDrug,P01857,Ig gamma-1 chain C region,IGHG1,330.0
15080,DB08333,4-HYDROXYBENZALDEHYDE O-(CYCLOHEXYLCARBONYL)OXIME,SmallMoleculeDrug,P14174,Macrophage migration inhibitory factor,MIF,115.0
15081,DB08334,3-FLUORO-4-HYDROXYBENZALDEHYDE O-(CYCLOHEXYLCARBONYL)OXIME,SmallMoleculeDrug,P14174,Macrophage migration inhibitory factor,MIF,115.0
15082,DB08335,"4-HYDROXYBENZALDEHYDE O-(3,3-DIMETHYLBUTANOYL)OXIME",SmallMoleculeDrug,P14174,Macrophage migration inhibitory factor,MIF,115.0
15085,DB08338,"19-(cyclopropylamino)-4,6,7,15-tetrahydro-5H-16,1-(azenometheno)-10,14-(metheno)pyrazolo[4,3-o][1,3,9]triazacyclohexadecin-8(9H)-one",SmallMoleculeDrug,P68400,Casein kinase II subunit alpha,CSNK2A1,391.0
15086,DB08339,"6-(2,6-DICHLOROPHENYL)-2-{[3-(HYDROXYMETHYL)PHENYL]AMINO}-8-METHYLPYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONE",SmallMoleculeDrug,P00519,Tyrosine-protein kinase ABL1,ABL1,1130.0
15087,DB08340,"N,N'-DIPHENYLPYRAZOLO[1,5-A][1,3,5]TRIAZINE-2,4-DIAMINE",SmallMoleculeDrug,P68400,Casein kinase II subunit alpha,CSNK2A1,391.0
15088,DB08341,"4-{[4-{[(1R,2R)-2-(dimethylamino)cyclopentyl]amino}-5-(trifluoromethyl)pyrimidin-2-yl]amino}-N-methylbenzenesulfonamide",SmallMoleculeDrug,Q14289,Protein-tyrosine kinase 2-beta,PTK2B,1009.0
15089,DB08342,S-PALMITOYL-L-CYSTEINE,SmallMoleculeDrug,O75865,Trafficking protein particle complex subunit 6A,TRAPPC6A,159.0
15090,DB08342,S-PALMITOYL-L-CYSTEINE,SmallMoleculeDrug,O43617,Trafficking protein particle complex subunit 3,TRAPPC3,180.0
15091,DB08342,S-PALMITOYL-L-CYSTEINE,SmallMoleculeDrug,Q86SZ2,Trafficking protein particle complex subunit 6B,TRAPPC6B,158.0
15092,DB08342,S-PALMITOYL-L-CYSTEINE,SmallMoleculeDrug,Q8IUR0,Trafficking protein particle complex subunit 5,TRAPPC5,188.0
15093,DB08342,S-PALMITOYL-L-CYSTEINE,SmallMoleculeDrug,Q9Y296,Trafficking protein particle complex subunit 4,TRAPPC4,219.0
15094,DB08342,S-PALMITOYL-L-CYSTEINE,SmallMoleculeDrug,Q9Y5R8,Trafficking protein particle complex subunit 1,TRAPPC1,145.0
15096,DB08345,"4-(2-(1H-IMIDAZOL-4-YL)ETHYLAMINO)-2-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE",SmallMoleculeDrug,P68400,Casein kinase II subunit alpha,CSNK2A1,391.0
15097,DB08346,"(5Z)-13-CHLORO-14,16-DIHYDROXY-3,4,7,8,9,10-HEXAHYDRO-1H-2-BENZOXACYCLOTETRADECINE-1,11(12H)-DIONE",SmallMoleculeDrug,P08238,Heat shock protein HSP 90-beta,HSP90AB1,724.0
15098,DB08347,4-{[(2S)-3-(tert-butylamino)-2-hydroxypropyl]oxy}-3H-indole-2-carbonitrile,SmallMoleculeDrug,P08588,Beta-1 adrenergic receptor,ADRB1,477.0
15100,DB08348,"N~2~,N~2~-DIMETHYL-N~1~-(6-OXO-5,6-DIHYDROPHENANTHRIDIN-2-YL)GLYCINAMIDE",SmallMoleculeDrug,P13639,Elongation factor 2,EEF2,858.0
15102,DB08348,"N~2~,N~2~-DIMETHYL-N~1~-(6-OXO-5,6-DIHYDROPHENANTHRIDIN-2-YL)GLYCINAMIDE",SmallMoleculeDrug,Q9Y6F1,Poly [ADP-ribose] polymerase 3,PARP3,533.0
15103,DB08348,"N~2~,N~2~-DIMETHYL-N~1~-(6-OXO-5,6-DIHYDROPHENANTHRIDIN-2-YL)GLYCINAMIDE",SmallMoleculeDrug,Q460N3,Poly [ADP-ribose] polymerase 15,PARP15,678.0
15104,DB08349,"N-cyclopropyl-3-{[1-(2,4-difluorophenyl)-7-methyl-6-oxo-6,7-dihydro-1H-pyrazolo[3,4-b]pyridin-4-yl]amino}-4-methylbenzamide",SmallMoleculeDrug,Q16539,Mitogen-activated protein kinase 14,MAPK14,360.0
15105,DB08350,"5-[3-(2-METHOXYPHENYL)-1H-PYRROLO[2,3-B]PYRIDIN-5-YL]-N,N-DIMETHYLPYRIDINE-3-CARBOXAMIDE",SmallMoleculeDrug,P00519,Tyrosine-protein kinase ABL1,ABL1,1130.0
15106,DB08351,N-cyclopropyl-4-methyl-3-{2-[(2-morpholin-4-ylethyl)amino]quinazolin-6-yl}benzamide,SmallMoleculeDrug,Q16539,Mitogen-activated protein kinase 14,MAPK14,360.0
15107,DB08352,"6-[4-(2-fluorophenyl)-1,3-oxazol-5-yl]-N-(1-methylethyl)-1,3-benzothiazol-2-amine",SmallMoleculeDrug,Q16539,Mitogen-activated protein kinase 14,MAPK14,360.0
15108,DB08353,"2-(CYCLOHEXYLMETHYLAMINO)-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE",SmallMoleculeDrug,P68400,Casein kinase II subunit alpha,CSNK2A1,391.0
15109,DB08354,"2-(4-CHLOROBENZYLAMINO)-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE",SmallMoleculeDrug,P68400,Casein kinase II subunit alpha,CSNK2A1,391.0
15110,DB08355,"1-methyl-8-(phenylamino)-4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline-3-carboxylic acid",SmallMoleculeDrug,P20248,Cyclin-A2,CCNA2,432.0
15111,DB08355,"1-methyl-8-(phenylamino)-4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline-3-carboxylic acid",SmallMoleculeDrug,P24941,Cyclin-dependent kinase 2,CDK2,298.0
15112,DB08356,"4-[4-(4-methoxyphenyl)-5-methyl-1H-pyrazol-3-yl]benzene-1,3-diol",SmallMoleculeDrug,Q16654,"[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 4, mitochondrial",PDK4,411.0
15113,DB08357,1-ETHOXY-2-(2-ETHOXYETHOXY)ETHANE,SmallMoleculeDrug,P22303,Acetylcholinesterase,ACHE,614.0
15116,DB08358,"2-(2-QUINOLIN-3-YLPYRIDIN-4-YL)-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE",SmallMoleculeDrug,P49137,MAP kinase-activated protein kinase 2,MAPKAPK2,400.0
15117,DB08358,"2-(2-QUINOLIN-3-YLPYRIDIN-4-YL)-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE",SmallMoleculeDrug,Q16644,MAP kinase-activated protein kinase 3,MAPKAPK3,382.0
15119,DB08360,"2-(4-ETHYLPIPERAZIN-1-YL)-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE",SmallMoleculeDrug,P68400,Casein kinase II subunit alpha,CSNK2A1,391.0
15120,DB08361,"2-{[(1R,2S)-2-aminocyclohexyl]amino}-4-[(3-methylphenyl)amino]pyrimidine-5-carboxamide",SmallMoleculeDrug,P43405,Tyrosine-protein kinase SYK,SYK,635.0
15121,DB08362,"N-(3-(8-CYANO-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZIN-2-YLAMINO)PHENYL)ACETAMIDE",SmallMoleculeDrug,P68400,Casein kinase II subunit alpha,CSNK2A1,391.0
15122,DB08363,1-(9-ethyl-9H-carbazol-3-yl)-N-methylmethanamine,SmallMoleculeDrug,P04637,Cellular tumor antigen p53,TP53,393.0
15124,DB08365,"8-bromo-4-(2-chlorophenyl)-N-(2-hydroxyethyl)-6-methyl-1,3-dioxo-1,2,3,6-tetrahydropyrrolo[3,4-e]indole-7-carboxamide",SmallMoleculeDrug,P30291,Wee1-like protein kinase,WEE1,646.0
15127,DB08368,"OCTANE-1,3,5,7-TETRACARBOXYLIC ACID",SmallMoleculeDrug,P15085,Carboxypeptidase A1,CPA1,419.0
15128,DB08369,1-(biphenyl-4-ylmethyl)-1H-imidazole,SmallMoleculeDrug,P20813,Cytochrome P450 2B6,CYP2B6,491.0
15129,DB08370,S-(4-BROMOBENZYL)CYSTEINE,SmallMoleculeDrug,P09211,Glutathione S-transferase P,GSTP1,210.0
15130,DB08371,PARA-(BENZOYL)-PHENYLALANINE,SmallMoleculeDrug,P18031,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,435.0
15131,DB08371,PARA-(BENZOYL)-PHENYLALANINE,SmallMoleculeDrug,P54577,"Tyrosine--tRNA ligase, cytoplasmic",YARS,528.0
15134,DB08373,"4,4'-BIS([H]METHYLSULFONYL)-2,2',5,5'-TETRACHLOROBIPHENYL",SmallMoleculeDrug,P11684,Uteroglobin,SCGB1A1,91.0
15135,DB08374,PHENYLALANYLMETHYLCHLORIDE,SmallMoleculeDrug,P17538,Chymotrypsinogen B,CTRB1,263.0
15140,DB08377,PARA-NITROPHENYL PHOSPHONOBUTANOYL D-ALANINE,SmallMoleculeDrug,P01857,Ig gamma-1 chain C region,IGHG1,330.0
15141,DB08378,"4-[4-(2,5-DIOXO-PYRROLIDIN-1-YL)-PHENYLAMINO]-4-HYDROXY-BUTYRIC ACID",SmallMoleculeDrug,P14649,Myosin light chain 6B,MYL6B,208.0
15142,DB08378,"4-[4-(2,5-DIOXO-PYRROLIDIN-1-YL)-PHENYLAMINO]-4-HYDROXY-BUTYRIC ACID",SmallMoleculeDrug,P19105,Myosin regulatory light chain 12A,MYL12A,171.0
15143,DB08378,"4-[4-(2,5-DIOXO-PYRROLIDIN-1-YL)-PHENYLAMINO]-4-HYDROXY-BUTYRIC ACID",SmallMoleculeDrug,P12883,Myosin-7,MYH7,1935.0
15145,DB08382,"2-(4-{(3S,5S)-5-[(3,3-difluoropyrrolidin-1-yl)carbonyl]pyrrolidin-3-yl}piperazin-1-yl)pyrimidine",SmallMoleculeDrug,P27487,Dipeptidyl peptidase 4,DPP4,766.0
15146,DB08383,"4,5-bis(4-methoxyphenyl)-2-thiophen-2-yl-1H-imidazole",SmallMoleculeDrug,Q9Y233,"cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A",PDE10A,779.0
15147,DB08384,2-({4-[4-(pyridin-4-ylmethyl)-1H-pyrazol-3-yl]phenoxy}methyl)quinoline,SmallMoleculeDrug,Q9Y233,"cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A",PDE10A,779.0
15148,DB08385,4-(quinolin-3-ylmethyl)piperidine-1-carboxylic acid,SmallMoleculeDrug,O00519,Fatty-acid amide hydrolase 1,FAAH,579.0
15149,DB08386,2-{[4-(4-pyridin-4-yl-1H-pyrazol-3-yl)phenoxy]methyl}quinoline,SmallMoleculeDrug,Q9Y233,"cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A",PDE10A,779.0
15150,DB08387,2-{[4-(1-methyl-4-pyridin-4-yl-1H-pyrazol-3-yl)phenoxy]methyl}quinoline,SmallMoleculeDrug,Q9Y233,"cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A",PDE10A,779.0
15151,DB08388,"5-(2-ETHOXYETHYL)-5-[4-(4-FLUOROPHENOXY)PHENOXY]PYRIMIDINE-2,4,6(1H,3H,5H)-TRIONE",SmallMoleculeDrug,P45452,Collagenase 3,MMP13,471.0
15152,DB08389,"6,7-DIMETHOXY-4-[(3R)-3-(2-NAPHTHYLOXY)PYRROLIDIN-1-YL]QUINAZOLINE",SmallMoleculeDrug,Q9Y233,"cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A",PDE10A,779.0
15154,DB08391,"6,7-DIMETHOXY-4-[(3R)-3-(QUINOXALIN-2-YLOXY)PYRROLIDIN-1-YL]QUINAZOLINE",SmallMoleculeDrug,Q9Y233,"cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A",PDE10A,779.0
15155,DB08392,"2-[5,6-BIS-(4-METHOXY-PHENYL)-FURO[2,3-D]PYRIMIDIN-4-YLAMINO]-ETHANOL",SmallMoleculeDrug,O14757,Serine/threonine-protein kinase Chk1,CHEK1,476.0
15156,DB08393,"2-[(5,6-DIPHENYLFURO[2,3-D]PYRIMIDIN-4-YL)AMINO]ETHANOL",SmallMoleculeDrug,O14757,Serine/threonine-protein kinase Chk1,CHEK1,476.0
15157,DB08394,PARA-NITROPHENYLPHOSPHONOBUTANOYL-GLYCINE,SmallMoleculeDrug,P01857,Ig gamma-1 chain C region,IGHG1,330.0
15158,DB08395,2-(ETHOXYMETHYL)-4-(4-FLUOROPHENYL)-3-[2-(2-HYDROXYPHENOXY)PYRIMIDIN-4-YL]ISOXAZOL-5(2H)-ONE,SmallMoleculeDrug,Q16539,Mitogen-activated protein kinase 14,MAPK14,360.0
15159,DB08396,"4-{[(Z)-(5-OXO-2-PHENYL-1,3-OXAZOL-4(5H)-YLIDENE)METHYL]AMINO}BUTANOIC ACID",SmallMoleculeDrug,P01768,Ig heavy chain V-III region CAM,IGHV3-30,117.0
15160,DB08397,6-(DIFLUORO-PHOSPHONO-METHYL)-NAPHTHALENE-2-CARBOXYLIC ACID,SmallMoleculeDrug,P18031,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,435.0
15161,DB08398,"2-AMINO-1-METHYL-6-PHENYLIMIDAZO[4,5-B]PYRIDINE",SmallMoleculeDrug,P03372,Estrogen receptor,ESR1,595.0
15162,DB08398,"2-AMINO-1-METHYL-6-PHENYLIMIDAZO[4,5-B]PYRIDINE",SmallMoleculeDrug,Q15596,Nuclear receptor coactivator 2,NCOA2,1464.0
15163,DB08399,PICEATANNOL,SmallMoleculeDrug,P25705,"ATP synthase subunit alpha, mitochondrial",ATP5A1,553.0
15164,DB08399,PICEATANNOL,SmallMoleculeDrug,P06576,"ATP synthase subunit beta, mitochondrial",ATP5B,529.0
15165,DB08399,PICEATANNOL,SmallMoleculeDrug,P36542,"ATP synthase subunit gamma, mitochondrial",ATP5C1,298.0
15166,DB08400,4-(3-{[5-(trifluoromethyl)pyridin-2-yl]oxy}benzyl)piperidine-1-carboxylic acid,SmallMoleculeDrug,O00519,Fatty-acid amide hydrolase 1,FAAH,579.0
15168,DB08402,"2-[(2,4-DICHLOROBENZOYL)AMINO]-5-(PYRIMIDIN-2-YLOXY)BENZOIC ACID",SmallMoleculeDrug,P37231,Peroxisome proliferator-activated receptor gamma,PPARG,505.0
15169,DB08402,"2-[(2,4-DICHLOROBENZOYL)AMINO]-5-(PYRIMIDIN-2-YLOXY)BENZOIC ACID",SmallMoleculeDrug,Q15596,Nuclear receptor coactivator 2,NCOA2,1464.0
15170,DB08402,"2-[(2,4-DICHLOROBENZOYL)AMINO]-5-(PYRIMIDIN-2-YLOXY)BENZOIC ACID",SmallMoleculeDrug,P19793,Retinoic acid receptor RXR-alpha,RXRA,462.0
15171,DB08403,METHYLAMINO-PHENYLALANYL-LEUCYL-HYDROXAMIC ACID,SmallMoleculeDrug,P03956,Interstitial collagenase,MMP1,469.0
15172,DB08403,METHYLAMINO-PHENYLALANYL-LEUCYL-HYDROXAMIC ACID,SmallMoleculeDrug,P22894,Neutrophil collagenase,MMP8,467.0
15175,DB08406,"[N-(2,4-DIAMINOPTERIDIN-6-YL)-METHYL]-DIBENZ[B,F]AZEPINE",SmallMoleculeDrug,P00374,Dihydrofolate reductase,DHFR,187.0
15178,DB08409,4-NITRO-BENZYLPHOSPHONOBUTANOYL-GLYCINE,SmallMoleculeDrug,P01857,Ig gamma-1 chain C region,IGHG1,330.0
15179,DB08409,4-NITRO-BENZYLPHOSPHONOBUTANOYL-GLYCINE,SmallMoleculeDrug,P01859,Ig gamma-2 chain C region,IGHG2,326.0
15180,DB08410,PARA-NITROBENZYL GLUTARYL GLYCINIC ACID,SmallMoleculeDrug,P01857,Ig gamma-1 chain C region,IGHG1,330.0
15181,DB08411,PARA-NITROPHENYL PHOSPHONOBUTANOYL L-ALANINE,SmallMoleculeDrug,P01857,Ig gamma-1 chain C region,IGHG1,330.0
15182,DB08412,6-{4-[HYDROXY-(4-NITRO-PHENOXY)-PHOSPHORYL]-BUTYRYLAMINO}-HEXANOIC ACID,SmallMoleculeDrug,P01857,Ig gamma-1 chain C region,IGHG1,330.0
15183,DB08413,METHYL-PHOSPHONIC ACID MONO-(4-NITRO-PHENYL) ESTER,SmallMoleculeDrug,P01834,Ig kappa chain C region,IGKC,107.0
15184,DB08413,METHYL-PHOSPHONIC ACID MONO-(4-NITRO-PHENYL) ESTER,SmallMoleculeDrug,P05187,"Alkaline phosphatase, placental type",ALPP,535.0
15186,DB08416,"(9BETA,13ALPHA,14BETA,17ALPHA)-2-METHOXYESTRA-1,3,5(10)-TRIENE-3,17-DIYL DISULFAMATE",SmallMoleculeDrug,P00918,Carbonic anhydrase 2,CA2,260.0
15187,DB08418,"(4aS,4bR,10bS,12aS)-12a-methyl-1,3-dioxo-2-(pyridin-3-ylmethyl)-1,2,3,4,4a,4b,5,6,10b,11,12,12a-dodecahydronaphtho[2,1-f]isoquinolin-8-yl sulfamate",SmallMoleculeDrug,P00918,Carbonic anhydrase 2,CA2,260.0
15189,DB08420,1-{[1-(2-AMINO-3-PHENYL-PROPIONYL)-PYRROLIDINE-2-CARBONYL]-AMINO}-2-(3-CYANO-PHENYL)-ETHANEBORONIC ACID,SmallMoleculeDrug,P07477,Trypsin-1,PRSS1,247.0
15191,DB08422,[PHENYLALANINYL-PROLINYL]-[2-(PYRIDIN-4-YLAMINO)-ETHYL]-AMINE,SmallMoleculeDrug,P00734,Prothrombin,F2,622.0
15192,DB08423,[5-AMINO-1-(4-FLUOROPHENYL)-1H-PYRAZOL-4-YL][3-(PIPERIDIN-4-YLOXY)PHENYL]METHANONE,SmallMoleculeDrug,Q16539,Mitogen-activated protein kinase 14,MAPK14,360.0
15193,DB08424,"[5-AMINO-1-(4-FLUOROPHENYL)-1H-PYRAZOL-4-YL](3-{[(2R)-2,3-DIHYDROXYPROPYL]OXY}PHENYL)METHANONE",SmallMoleculeDrug,Q16539,Mitogen-activated protein kinase 14,MAPK14,360.0
15197,DB08426,"THIENO[3,2-B]PYRIDINE-2-SULFONIC ACID [2-OXO-1-(1H-PYRROLO[2,3-C]PYRIDIN-2-YLMETHYL)-PYRROLIDIN-3-YL]-AMIDE",SmallMoleculeDrug,P00742,Coagulation factor X,F10,488.0
15201,DB08429,N-({(2S)-1-[(3R)-3-amino-4-(3-chlorophenyl)butanoyl]pyrrolidin-2-yl}methyl)-3-(methylsulfonyl)benzamide,SmallMoleculeDrug,P27487,Dipeptidyl peptidase 4,DPP4,766.0
15202,DB08430,PARA-NITROPHENYL 1-THIO-BETA-D-GLUCOPYRANOSIDE,SmallMoleculeDrug,Q6UWM7,Lactase-like protein,LCTL,567.0
15207,DB08435,"(5E,14E)-11-oxoprosta-5,9,12,14-tetraen-1-oic acid",SmallMoleculeDrug,P37231,Peroxisome proliferator-activated receptor gamma,PPARG,505.0
15208,DB08436,"8-BENZO[1,3]DIOXOL-,5-YLMETHYL-9-BUTYL-9H-",SmallMoleculeDrug,P07900,Heat shock protein HSP 90-alpha,HSP90AA1,732.0
15209,DB08437,Puromycin,SmallMoleculeDrug,Q96L21,60S ribosomal protein L10-like,RPL10L,214.0
15210,DB08437,Puromycin,SmallMoleculeDrug,P40429,60S ribosomal protein L13a,RPL13A,203.0
15211,DB08437,Puromycin,SmallMoleculeDrug,P62829,60S ribosomal protein L23,RPL23,140.0
15212,DB08437,Puromycin,SmallMoleculeDrug,P61313,60S ribosomal protein L15,RPL15,204.0
15213,DB08437,Puromycin,SmallMoleculeDrug,P84098,60S ribosomal protein L19,RPL19,196.0
15214,DB08437,Puromycin,SmallMoleculeDrug,P62750,60S ribosomal protein L23a,RPL23A,156.0
15215,DB08437,Puromycin,SmallMoleculeDrug,Q9UHA3,Probable ribosome biogenesis protein RLP24,RSL24D1,163.0
15216,DB08437,Puromycin,SmallMoleculeDrug,Q9UNX3,60S ribosomal protein L26-like 1,RPL26L1,145.0
15217,DB08437,Puromycin,SmallMoleculeDrug,P62917,60S ribosomal protein L8,RPL8,257.0
15218,DB08437,Puromycin,SmallMoleculeDrug,P61927,60S ribosomal protein L37,RPL37,97.0
15219,DB08437,Puromycin,SmallMoleculeDrug,P39023,60S ribosomal protein L3,RPL3,403.0
15220,DB08437,Puromycin,SmallMoleculeDrug,P62913,60S ribosomal protein L11,RPL11,178.0
15223,DB08439,Parecoxib,SmallMoleculeDrug,P35354,Prostaglandin G/H synthase 2,PTGS2,604.0
15224,DB08439,Parecoxib,SmallMoleculeDrug,P02788,Lactotransferrin,LTF,710.0
15226,DB08441,"6-BROMO-13-THIA-2,4,8,12,19-PENTAAZATRICYCLO[12.3.1.1~3,7~]NONADECA-1(18),3(19),4,6,14,16-HEXAENE 13,13-DIOXIDE",SmallMoleculeDrug,P24941,Cyclin-dependent kinase 2,CDK2,298.0
15227,DB08442,"4-{[(2R)-2-(2-methylphenyl)pyrrolidin-1-yl]carbonyl}benzene-1,3-diol",SmallMoleculeDrug,P07900,Heat shock protein HSP 90-alpha,HSP90AA1,732.0
15228,DB08443,"2-(1H-pyrrol-1-ylcarbonyl)benzene-1,3,5-triol",SmallMoleculeDrug,P07900,Heat shock protein HSP 90-alpha,HSP90AA1,732.0
15230,DB08445,"(3R,4S)-1-[6-(6-METHOXYPYRIDIN-3-YL)PYRIMIDIN-4-YL]-4-(2,4,5-TRIFLUOROPHENYL)PYRROLIDIN-3-AMINE",SmallMoleculeDrug,P27487,Dipeptidyl peptidase 4,DPP4,766.0
15232,DB08447,3-{3-[(DIMETHYLAMINO)METHYL]-1H-INDOL-7-YL}PROPAN-1-OL,SmallMoleculeDrug,Q9NZK7,Group IIE secretory phospholipase A2,PLA2G2E,142.0
15233,DB08448,"(4aS)-5-[(2,4-diaminopteridin-6-yl)methyl]-4a,5-dihydro-2H-dibenzo[b,f]azepin-8-ol",SmallMoleculeDrug,P00374,Dihydrofolate reductase,DHFR,187.0
15234,DB08449,"2-(3-((4,5,7-trifluorobenzo[d]thiazol-2-yl)methyl)-1H-pyrrolo[2,3-b]pyridin-1-yl)acetic acid",SmallMoleculeDrug,P15121,Aldose reductase,AKR1B1,316.0
15235,DB08450,N-1H-indazol-5-yl-2-(6-methylpyridin-2-yl)quinazolin-4-amine,SmallMoleculeDrug,P36897,TGF-beta receptor type-1,TGFBR1,503.0
15237,DB08453,2-NONYL-4-HYDROXYQUINOLINE N-OXIDE,SmallMoleculeDrug,P08574,"Cytochrome c1, heme protein, mitochondrial",CYC1,325.0
15238,DB08453,2-NONYL-4-HYDROXYQUINOLINE N-OXIDE,SmallMoleculeDrug,P00156,Cytochrome b,MT-CYB,380.0
15239,DB08453,2-NONYL-4-HYDROXYQUINOLINE N-OXIDE,SmallMoleculeDrug,P31930,"Cytochrome b-c1 complex subunit 1, mitochondrial",UQCRC1,480.0
15240,DB08453,2-NONYL-4-HYDROXYQUINOLINE N-OXIDE,SmallMoleculeDrug,P22695,"Cytochrome b-c1 complex subunit 2, mitochondrial",UQCRC2,453.0
15241,DB08453,2-NONYL-4-HYDROXYQUINOLINE N-OXIDE,SmallMoleculeDrug,P07919,"Cytochrome b-c1 complex subunit 6, mitochondrial",UQCRH,91.0
15242,DB08453,2-NONYL-4-HYDROXYQUINOLINE N-OXIDE,SmallMoleculeDrug,O14949,Cytochrome b-c1 complex subunit 8,UQCRQ,82.0
15243,DB08453,2-NONYL-4-HYDROXYQUINOLINE N-OXIDE,SmallMoleculeDrug,P47985,"Cytochrome b-c1 complex subunit Rieske, mitochondrial",UQCRFS1,274.0
15244,DB08453,2-NONYL-4-HYDROXYQUINOLINE N-OXIDE,SmallMoleculeDrug,O14957,Cytochrome b-c1 complex subunit 10,UQCR11,56.0
15245,DB08453,2-NONYL-4-HYDROXYQUINOLINE N-OXIDE,SmallMoleculeDrug,P14927,Cytochrome b-c1 complex subunit 7,UQCRB,111.0
15246,DB08453,2-NONYL-4-HYDROXYQUINOLINE N-OXIDE,SmallMoleculeDrug,Q9UDW1,Cytochrome b-c1 complex subunit 9,UQCR10,63.0
15255,DB08454,N-(5-METHYL-1H-PYRAZOL-3-YL)-2-PHENYLQUINAZOLIN-4-AMINE,SmallMoleculeDrug,Q8IU85,Calcium/calmodulin-dependent protein kinase type 1D,CAMK1D,385.0
15261,DB08461,"3-[(4-AMINO-1-TERT-BUTYL-1H-PYRAZOLO[3,4-D]PYRIMIDIN-3-YL)METHYL]PHENOL",SmallMoleculeDrug,P10275,Androgen receptor,AR,920.0
15262,DB08462,N-(4-PHENYLAMINO-QUINAZOLIN-6-YL)-ACRYLAMIDE,SmallMoleculeDrug,P12931,Proto-oncogene tyrosine-protein kinase Src,SRC,536.0
15263,DB08463,(2R)-2-({9-(1-methylethyl)-6-[(4-pyridin-2-ylbenzyl)amino]-9H-purin-2-yl}amino)butan-1-ol,SmallMoleculeDrug,P24941,Cyclin-dependent kinase 2,CDK2,298.0
15264,DB08463,(2R)-2-({9-(1-methylethyl)-6-[(4-pyridin-2-ylbenzyl)amino]-9H-purin-2-yl}amino)butan-1-ol,SmallMoleculeDrug,P20248,Cyclin-A2,CCNA2,432.0
15265,DB08464,"METHYL 3-CHLORO-2-{3-[(2,5-DIHYDROXY-4-METHOXYPHENYL)AMINO]-3-OXOPROPYL}-4,6-DIHYDROXYBENZOATE",SmallMoleculeDrug,P08238,Heat shock protein HSP 90-beta,HSP90AB1,724.0
15266,DB08464,"METHYL 3-CHLORO-2-{3-[(2,5-DIHYDROXY-4-METHOXYPHENYL)AMINO]-3-OXOPROPYL}-4,6-DIHYDROXYBENZOATE",SmallMoleculeDrug,P14625,Endoplasmin,HSP90B1,803.0
15267,DB08465,"2-(3-AMINO-2,5,6-TRIMETHOXYPHENYL)ETHYL 5-CHLORO-2,4-DIHYDROXYBENZOATE",SmallMoleculeDrug,P08238,Heat shock protein HSP 90-beta,HSP90AB1,724.0
15268,DB08465,"2-(3-AMINO-2,5,6-TRIMETHOXYPHENYL)ETHYL 5-CHLORO-2,4-DIHYDROXYBENZOATE",SmallMoleculeDrug,P14625,Endoplasmin,HSP90B1,803.0
15269,DB08466,"5-[2-(4-hydroxyphenyl)ethyl]benzene-1,3-diol",SmallMoleculeDrug,P09960,Leukotriene A-4 hydrolase,LTA4H,611.0
15274,DB08473,"5,6-dichloro-1-beta-D-ribofuranosyl-1H-benzimidazole",SmallMoleculeDrug,P68400,Casein kinase II subunit alpha,CSNK2A1,391.0
15277,DB08476,3-AMINO-AZACYCLOTRIDECAN-2-ONE,SmallMoleculeDrug,P22894,Neutrophil collagenase,MMP8,467.0
15278,DB08477,"5-chloro-N-({(5S)-2-oxo-3-[4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl}methyl)thiophene-2-carboxamide",SmallMoleculeDrug,P00742,Coagulation factor X,F10,488.0
15279,DB08478,N-[2-chloro-5-(trifluoromethyl)phenyl]imidodicarbonimidic diamide,SmallMoleculeDrug,P04818,Thymidylate synthase,TYMS,313.0
15280,DB08479,"N-(3,5-dimethoxyphenyl)imidodicarbonimidic diamide",SmallMoleculeDrug,P04818,Thymidylate synthase,TYMS,313.0
15281,DB08480,4-HYDROXY-N-PROPARGYL-1(R)-AMINOINDAN,SmallMoleculeDrug,P27338,Amine oxidase [flavin-containing] B,MAOB,520.0
15283,DB08482,[[1-[N-HYDROXY-ACETAMIDYL]-3-METHYL-BUTYL]-CARBONYL-LEUCINYL]-ALANINE ETHYL ESTER,SmallMoleculeDrug,P03956,Interstitial collagenase,MMP1,469.0
15284,DB08484,4-AMINO-N-[(2-SULFANYLETHYL)CARBAMOYL]BENZENESULFONAMIDE,SmallMoleculeDrug,P09467,"Fructose-1,6-bisphosphatase 1",FBP1,338.0
15286,DB08486,"2-{4-[(3,5-DIMETHYLANILINO)-CARBONYL-METHYL]-PHENOXY}-2-METHYLPROPIONIC ACID",SmallMoleculeDrug,P69905,Hemoglobin subunit alpha,HBA1;,142.0
15287,DB08486,"2-{4-[(3,5-DIMETHYLANILINO)-CARBONYL-METHYL]-PHENOXY}-2-METHYLPROPIONIC ACID",SmallMoleculeDrug,P68871,Hemoglobin subunit beta,HBB,147.0
15288,DB08487,3-({4-[(6-CHLORO-1-BENZOTHIEN-2-YL)SULFONYL]-2-OXOPIPERAZIN-1-YL}METHYL)BENZENECARBOXIMIDAMIDE,SmallMoleculeDrug,P00742,Coagulation factor X,F10,488.0
15289,DB08488,"4-{[(E)-2-(5-CHLOROTHIEN-2-YL)VINYL]SULFONYL}-1-(1H-PYRROLO[3,2-C]PYRIDIN-2-YLMETHYL)PIPERAZIN-2-ONE",SmallMoleculeDrug,P00742,Coagulation factor X,F10,488.0
15290,DB08489,"N4-HYDROXY-2-ISOBUTYL-N1-(9-OXO-1,8-DIAZA-TRICYCLO[10.6.1.013,18]NONADECA-12(19),13,15,17-TETRAEN-10-YL)-SUCCINAMIDE",SmallMoleculeDrug,P09237,Matrilysin,MMP7,267.0
15291,DB08490,4-[4-(4-CHLORO-PHENOXY)-BENZENESULFONYLMETHYL]-TETRAHYDRO-PYRAN-4-CARBOXYLIC ACID HYDROXYAMIDE,SmallMoleculeDrug,P45452,Collagenase 3,MMP13,471.0
15292,DB08491,N-HYDROXY-2-[4-(4-PHENOXY-BENZENESULFONYL)-TETRAHYDRO-PYRAN-4-YL]-ACETAMIDE,SmallMoleculeDrug,P03956,Interstitial collagenase,MMP1,469.0
15293,DB08492,(2E)-3-(2-OCT-1-YN-1-YLPHENYL)ACRYLIC ACID,SmallMoleculeDrug,P16050,Arachidonate 15-lipoxygenase,ALOX15,662.0
15294,DB08493,"5-METHYL-3-(9-OXO-1,8-DIAZA-TRICYCLO[10.6.1.013,18]NONADECA-12(19),13,15,17-TETRAEN-10-YLCARBAMOYL)-HEXANOIC ACID",SmallMoleculeDrug,P09237,Matrilysin,MMP7,267.0
15296,DB08495,4-({4-[(6-CHLORO-1-BENZOTHIEN-2-YL)SULFONYL]-2-OXOPIPERAZIN-1-YL}METHYL)BENZENECARBOXIMIDAMIDE,SmallMoleculeDrug,P00742,Coagulation factor X,F10,488.0
15297,DB08497,"(1S)-2-oxo-1-phenyl-2-[(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-5-yl)amino]ethyl acetate",SmallMoleculeDrug,P42574,Caspase-3,CASP3,277.0
15298,DB08498,"(1S)-1-(3-chlorophenyl)-2-oxo-2-[(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-5-yl)amino]ethyl acetate",SmallMoleculeDrug,P42574,Caspase-3,CASP3,277.0
15299,DB08499,"N-[3-(2-fluoroethoxy)phenyl]-N'-(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-6-yl)butanediamide",SmallMoleculeDrug,P42574,Caspase-3,CASP3,277.0
15300,DB08500,"(3S,5R,7R,8S,9S,10R)-7-(hydroxymethyl)-3-(2-naphthyl)-1,6-dioxa-2-azaspiro[4.5]decane-8,9,10-triol",SmallMoleculeDrug,P11217,"Glycogen phosphorylase, muscle form",PYGM,842.0
15303,DB08503,"(3S,5R,7R,8S,9S,10R)-7-(hydroxymethyl)-3-(4-methylphenyl)-1,6-dioxa-2-azaspiro[4.5]decane-8,9,10-triol",SmallMoleculeDrug,P11217,"Glycogen phosphorylase, muscle form",PYGM,842.0
15304,DB08504,"6-(4-{(1S,2S)-2-AMINO-1-[(DIMETHYLAMINO)CARBONYL]-3-[(3S)-3-FLUOROPYRROLIDIN-1-YL]-3-OXOPROPYL}PHENYL)-1H-[1,2,4]TRIAZOLO[1,5-A]PYRIDIN-4-IUM",SmallMoleculeDrug,P27487,Dipeptidyl peptidase 4,DPP4,766.0
15307,DB08507,N-[[2-METHYL-4-HYDROXYCARBAMOYL]BUT-4-YL-N]-BENZYL-P-[PHENYL]-P-[METHYL]PHOSPHINAMID,SmallMoleculeDrug,P08254,Stromelysin-1,MMP3,477.0
15310,DB08510,5-ALPHA-PREGNANE-3-BETA-OL-HEMISUCCINATE,SmallMoleculeDrug,P01859,Ig gamma-2 chain C region,IGHG2,326.0
15313,DB08513,[4-({5-(AMINOCARBONYL)-4-[(3-METHYLPHENYL)AMINO]PYRIMIDIN-2-YL}AMINO)PHENYL]ACETIC ACID,SmallMoleculeDrug,P28482,Mitogen-activated protein kinase 1,MAPK1,360.0
15314,DB08513,[4-({5-(AMINOCARBONYL)-4-[(3-METHYLPHENYL)AMINO]PYRIMIDIN-2-YL}AMINO)PHENYL]ACETIC ACID,SmallMoleculeDrug,P06213,Insulin receptor,INSR,1382.0
15315,DB08513,[4-({5-(AMINOCARBONYL)-4-[(3-METHYLPHENYL)AMINO]PYRIMIDIN-2-YL}AMINO)PHENYL]ACETIC ACID,SmallMoleculeDrug,P35568,Insulin receptor substrate 1,IRS1,1242.0
15317,DB08515,"(3AR,6R,6AS)-6-((S)-((S)-CYCLOHEX-2-ENYL)(HYDROXY)METHYL)-6A-METHYL-4-OXO-HEXAHYDRO-2H-FURO[3,2-C]PYRROLE-6-CARBALDEHYDE",SmallMoleculeDrug,P25786,Proteasome subunit alpha type-1,PSMA1,263.0
15318,DB08515,"(3AR,6R,6AS)-6-((S)-((S)-CYCLOHEX-2-ENYL)(HYDROXY)METHYL)-6A-METHYL-4-OXO-HEXAHYDRO-2H-FURO[3,2-C]PYRROLE-6-CARBALDEHYDE",SmallMoleculeDrug,P25787,Proteasome subunit alpha type-2,PSMA2,234.0
15319,DB08515,"(3AR,6R,6AS)-6-((S)-((S)-CYCLOHEX-2-ENYL)(HYDROXY)METHYL)-6A-METHYL-4-OXO-HEXAHYDRO-2H-FURO[3,2-C]PYRROLE-6-CARBALDEHYDE",SmallMoleculeDrug,P25788,Proteasome subunit alpha type-3,PSMA3,255.0
15320,DB08515,"(3AR,6R,6AS)-6-((S)-((S)-CYCLOHEX-2-ENYL)(HYDROXY)METHYL)-6A-METHYL-4-OXO-HEXAHYDRO-2H-FURO[3,2-C]PYRROLE-6-CARBALDEHYDE",SmallMoleculeDrug,P25789,Proteasome subunit alpha type-4,PSMA4,261.0
15321,DB08515,"(3AR,6R,6AS)-6-((S)-((S)-CYCLOHEX-2-ENYL)(HYDROXY)METHYL)-6A-METHYL-4-OXO-HEXAHYDRO-2H-FURO[3,2-C]PYRROLE-6-CARBALDEHYDE",SmallMoleculeDrug,P28066,Proteasome subunit alpha type-5,PSMA5,241.0
15322,DB08515,"(3AR,6R,6AS)-6-((S)-((S)-CYCLOHEX-2-ENYL)(HYDROXY)METHYL)-6A-METHYL-4-OXO-HEXAHYDRO-2H-FURO[3,2-C]PYRROLE-6-CARBALDEHYDE",SmallMoleculeDrug,P60900,Proteasome subunit alpha type-6,PSMA6,246.0
15323,DB08515,"(3AR,6R,6AS)-6-((S)-((S)-CYCLOHEX-2-ENYL)(HYDROXY)METHYL)-6A-METHYL-4-OXO-HEXAHYDRO-2H-FURO[3,2-C]PYRROLE-6-CARBALDEHYDE",SmallMoleculeDrug,O14818,Proteasome subunit alpha type-7,PSMA7,248.0
15324,DB08515,"(3AR,6R,6AS)-6-((S)-((S)-CYCLOHEX-2-ENYL)(HYDROXY)METHYL)-6A-METHYL-4-OXO-HEXAHYDRO-2H-FURO[3,2-C]PYRROLE-6-CARBALDEHYDE",SmallMoleculeDrug,P20618,Proteasome subunit beta type-1,PSMB1,241.0
15325,DB08515,"(3AR,6R,6AS)-6-((S)-((S)-CYCLOHEX-2-ENYL)(HYDROXY)METHYL)-6A-METHYL-4-OXO-HEXAHYDRO-2H-FURO[3,2-C]PYRROLE-6-CARBALDEHYDE",SmallMoleculeDrug,P49721,Proteasome subunit beta type-2,PSMB2,201.0
15326,DB08515,"(3AR,6R,6AS)-6-((S)-((S)-CYCLOHEX-2-ENYL)(HYDROXY)METHYL)-6A-METHYL-4-OXO-HEXAHYDRO-2H-FURO[3,2-C]PYRROLE-6-CARBALDEHYDE",SmallMoleculeDrug,P49720,Proteasome subunit beta type-3,PSMB3,205.0
15327,DB08515,"(3AR,6R,6AS)-6-((S)-((S)-CYCLOHEX-2-ENYL)(HYDROXY)METHYL)-6A-METHYL-4-OXO-HEXAHYDRO-2H-FURO[3,2-C]PYRROLE-6-CARBALDEHYDE",SmallMoleculeDrug,P28070,Proteasome subunit beta type-4,PSMB4,264.0
15328,DB08515,"(3AR,6R,6AS)-6-((S)-((S)-CYCLOHEX-2-ENYL)(HYDROXY)METHYL)-6A-METHYL-4-OXO-HEXAHYDRO-2H-FURO[3,2-C]PYRROLE-6-CARBALDEHYDE",SmallMoleculeDrug,P28074,Proteasome subunit beta type-5,PSMB5,263.0
15329,DB08515,"(3AR,6R,6AS)-6-((S)-((S)-CYCLOHEX-2-ENYL)(HYDROXY)METHYL)-6A-METHYL-4-OXO-HEXAHYDRO-2H-FURO[3,2-C]PYRROLE-6-CARBALDEHYDE",SmallMoleculeDrug,P28072,Proteasome subunit beta type-6,PSMB6,239.0
15330,DB08515,"(3AR,6R,6AS)-6-((S)-((S)-CYCLOHEX-2-ENYL)(HYDROXY)METHYL)-6A-METHYL-4-OXO-HEXAHYDRO-2H-FURO[3,2-C]PYRROLE-6-CARBALDEHYDE",SmallMoleculeDrug,Q99436,Proteasome subunit beta type-7,PSMB7,277.0
15331,DB08516,(S)-(+)-2-[4-(FLUOROBENZYLOXY-BENZYLAMINO)PROPIONAMIDE],SmallMoleculeDrug,P27338,Amine oxidase [flavin-containing] B,MAOB,520.0
15333,DB08519,"N~4~-(3-methyl-1H-indazol-6-yl)-N~2~-(3,4,5-trimethoxyphenyl)pyrimidine-2,4-diamine",SmallMoleculeDrug,P35968,Vascular endothelial growth factor receptor 2,KDR,1356.0
15334,DB08520,"(21S)-1AZA-4,4-DIMETHYL-6,19-DIOXA-2,3,7,20-TETRAOXOBICYCLO[19.4.0] PENTACOSANE",SmallMoleculeDrug,P62942,Peptidyl-prolyl cis-trans isomerase FKBP1A,FKBP1A,108.0
15335,DB08521,4-[5-(4-FLUORO-PHENYL)-2-(4-METHANESULFINYL-PHENYL)-3H-IMIDAZOL-4-YL]-PYRIDINE,SmallMoleculeDrug,Q16539,Mitogen-activated protein kinase 14,MAPK14,360.0
15336,DB08521,4-[5-(4-FLUORO-PHENYL)-2-(4-METHANESULFINYL-PHENYL)-3H-IMIDAZOL-4-YL]-PYRIDINE,SmallMoleculeDrug,P28482,Mitogen-activated protein kinase 1,MAPK1,360.0
15337,DB08522,4-(4-FLUOROPHENYL)-1-CYCLOROPROPYLMETHYL-5-(4-PYRIDYL)-IMIDAZOLE,SmallMoleculeDrug,Q16539,Mitogen-activated protein kinase 14,MAPK14,360.0
15342,DB08526,CARBOBENZYLOXY-(L)-LEUCINYL-(L)LEUCINYL METHOXYMETHYLKETONE,SmallMoleculeDrug,P09668,Pro-cathepsin H,CTSH,335.0
15343,DB08527,"1-[4-(AMINOSULFONYL)PHENYL]-1,6-DIHYDROPYRAZOLO[3,4-E]INDAZOLE-3-CARBOXAMIDE",SmallMoleculeDrug,P20248,Cyclin-A2,CCNA2,432.0
15344,DB08527,"1-[4-(AMINOSULFONYL)PHENYL]-1,6-DIHYDROPYRAZOLO[3,4-E]INDAZOLE-3-CARBOXAMIDE",SmallMoleculeDrug,P24941,Cyclin-dependent kinase 2,CDK2,298.0
15346,DB08529,"(6E,11E)-HEPTADECA-6,11-DIENE-9,9-DIYLBIS(PHOSPHONIC ACID)",SmallMoleculeDrug,O95749,Geranylgeranyl pyrophosphate synthase,GGPS1,300.0
15347,DB08530,"7-BENZYL-1,3-DIMETHYL-8-PIPERAZIN-1-YL-3,7-DIHYDRO-PURINE-2,6-DIONE",SmallMoleculeDrug,P27487,Dipeptidyl peptidase 4,DPP4,766.0
15348,DB08531,"5-(2,3-dichlorophenyl)-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine",SmallMoleculeDrug,P24941,Cyclin-dependent kinase 2,CDK2,298.0
15349,DB08532,"6-(2-fluorophenyl)-N-(pyridin-3-ylmethyl)imidazo[1,2-a]pyrazin-8-amine",SmallMoleculeDrug,P24941,Cyclin-dependent kinase 2,CDK2,298.0
15350,DB08533,"3-methyl-N-(pyridin-4-ylmethyl)imidazo[1,2-a]pyrazin-8-amine",SmallMoleculeDrug,P24941,Cyclin-dependent kinase 2,CDK2,298.0
15351,DB08534,"5-(2-fluorophenyl)-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine",SmallMoleculeDrug,P24941,Cyclin-dependent kinase 2,CDK2,298.0
15352,DB08535,"3-bromo-5-phenyl-N-(pyridin-3-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine",SmallMoleculeDrug,P24941,Cyclin-dependent kinase 2,CDK2,298.0
15353,DB08536,"3-bromo-5-phenyl-N-(pyrimidin-5-ylmethyl)pyrazolo[1,5-a]pyridin-7-amine",SmallMoleculeDrug,P24941,Cyclin-dependent kinase 2,CDK2,298.0
15354,DB08537,"3-bromo-6-phenyl-N-(pyrimidin-5-ylmethyl)imidazo[1,2-a]pyridin-8-amine",SmallMoleculeDrug,P24941,Cyclin-dependent kinase 2,CDK2,298.0
15355,DB08538,"N-((2-aminopyrimidin-5-yl)methyl)-5-(2,6-difluorophenyl)-3-ethylpyrazolo[1,5-a]pyrimidin-7-amine",SmallMoleculeDrug,P24941,Cyclin-dependent kinase 2,CDK2,298.0
15356,DB08539,"3-cyclopropyl-5-phenyl-N-(pyridin-3-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine",SmallMoleculeDrug,P24941,Cyclin-dependent kinase 2,CDK2,298.0
15362,DB08545,(1R)-1-PHENYLETHYL 4-(ACETYLAMINO)BENZYLPHOSPHONATE,SmallMoleculeDrug,Q6PYX1,Hepatitis B virus receptor binding protein,nan,348.0
15363,DB08546,"4-[(3AS,4R,7R,8AS,8BR)-2-(1,3-BENZODIOXOL-5-YLMETHYL)-7-HYDROXY-1,3-DIOXODECAHYDROPYRROLO[3,4-A]PYRROLIZIN-4-YL]BENZENECARBOXIMIDAMIDE",SmallMoleculeDrug,P00734,Prothrombin,F2,622.0
15364,DB08547,PROGESTERONE-11-ALPHA-OL-HEMISUCCINATE,SmallMoleculeDrug,P01859,Ig gamma-2 chain C region,IGHG2,326.0
15366,DB08549,"(3R)-METHYLCARBAMOYL-7-SULFOAMINO-3,4-DIHYDRO-1H-ISOQUINOLINE-2-CARBOXYLIC ACID BENZYL ESTER",SmallMoleculeDrug,P18031,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,435.0
15367,DB08550,"7,8-DICHLORO-1,2,3,4-TETRAHYDROISOQUINOLINE",SmallMoleculeDrug,P11086,Phenylethanolamine N-methyltransferase,PNMT,282.0
15372,DB08553,"(1E)-5-(1-piperidin-4-yl-3-pyridin-4-yl-1H-pyrazol-4-yl)-2,3-dihydro-1H-inden-1-one oxime",SmallMoleculeDrug,P15056,Serine/threonine-protein kinase B-raf,BRAF,766.0
15375,DB08555,"1-(3-bromophenyl)-7-chloro-6-methoxy-3,4-dihydroisoquinoline",SmallMoleculeDrug,P53779,Mitogen-activated protein kinase 10,MAPK10,464.0
15377,DB08557,"2-[(2-methoxyethyl)amino]-4-(4-oxo-1,2,3,4-tetrahydro-9H-carbazol-9-yl)benzamide",SmallMoleculeDrug,P07900,Heat shock protein HSP 90-alpha,HSP90AA1,732.0
15380,DB08558,"2-HYDROXYMETHYL-6-OCTYLSULFANYL-TETRAHYDRO-PYRAN-3,4,5-TRIOL",SmallMoleculeDrug,P08588,Beta-1 adrenergic receptor,ADRB1,477.0
15381,DB08558,"2-HYDROXYMETHYL-6-OCTYLSULFANYL-TETRAHYDRO-PYRAN-3,4,5-TRIOL",SmallMoleculeDrug,P09848,Lactase-phlorizin hydrolase,LCT,1927.0
15383,DB08560,3-FLUORO-N-[1-(4-FLUOROPHENYL)-3-(2-THIENYL)-1H-PYRAZOL-5-YL]BENZENESULFONAMIDE,SmallMoleculeDrug,P37231,Peroxisome proliferator-activated receptor gamma,PPARG,505.0
15384,DB08561,"BENZYL 6-BENZYL-5,7-DIOXO-6,7-DIHYDRO-5H-[1,3]THIAZOLO[3,2-C]PYRIMIDINE-2-CARBOXYLATE",SmallMoleculeDrug,P45452,Collagenase 3,MMP13,471.0
15385,DB08562,4-(4-STYRYL-PHENYLCARBAMOYL)-BUTYRIC ACID,SmallMoleculeDrug,P01834,Ig kappa chain C region,IGKC,107.0
15386,DB08562,4-(4-STYRYL-PHENYLCARBAMOYL)-BUTYRIC ACID,SmallMoleculeDrug,P01857,Ig gamma-1 chain C region,IGHG1,330.0
15388,DB08564,(2E)-N-{4-[(3-bromophenyl)amino]quinazolin-6-yl}-4-(dimethylamino)but-2-enamide,SmallMoleculeDrug,P12931,Proto-oncogene tyrosine-protein kinase Src,SRC,536.0
15389,DB08565,L-1-NAPHTHYL-2-ACETAMIDO-ETHANE BORONIC ACID,SmallMoleculeDrug,P17538,Chymotrypsinogen B,CTRB1,263.0
15390,DB08566,D-1-NAPHTHYL-2-ACETAMIDO-ETHANE BORONIC ACID,SmallMoleculeDrug,P17538,Chymotrypsinogen B,CTRB1,263.0
15392,DB08568,(2S)-1-{[5-(3-METHYL-1H-INDAZOL-5-YL)PYRIDIN-3-YL]OXY}-3-PHENYLPROPAN-2-AMINE,SmallMoleculeDrug,P17612,cAMP-dependent protein kinase catalytic subunit alpha,PRKACA,351.0
15393,DB08568,(2S)-1-{[5-(3-METHYL-1H-INDAZOL-5-YL)PYRIDIN-3-YL]OXY}-3-PHENYLPROPAN-2-AMINE,SmallMoleculeDrug,P61925,cAMP-dependent protein kinase inhibitor alpha,PKIA,76.0
15394,DB08569,"3-PYRIDIN-4-YL-2,4-DIHYDRO-INDENO[1,2-.C.] PYRAZOLE",SmallMoleculeDrug,P17612,cAMP-dependent protein kinase catalytic subunit alpha,PRKACA,351.0
15395,DB08569,"3-PYRIDIN-4-YL-2,4-DIHYDRO-INDENO[1,2-.C.] PYRAZOLE",SmallMoleculeDrug,P61925,cAMP-dependent protein kinase inhibitor alpha,PKIA,76.0
15399,DB08572,4-{[4-AMINO-6-(CYCLOHEXYLMETHOXY)-5-NITROSOPYRIMIDIN-2-YL]AMINO}BENZAMIDE,SmallMoleculeDrug,P20248,Cyclin-A2,CCNA2,432.0
15400,DB08572,4-{[4-AMINO-6-(CYCLOHEXYLMETHOXY)-5-NITROSOPYRIMIDIN-2-YL]AMINO}BENZAMIDE,SmallMoleculeDrug,P24941,Cyclin-dependent kinase 2,CDK2,298.0
15402,DB08574,"(5R)-2-SULFANYL-5-[4-(TRIFLUOROMETHYL)BENZYL]-1,3-THIAZOL-4-ONE",SmallMoleculeDrug,P55196,Afadin,AFDN,1824.0
15403,DB08575,"2-[(1S)-1-BENZYL-2-SULFANYLETHYL]-1H-IMIDAZO[4,5-C]PYRIDIN-5-IUM",SmallMoleculeDrug,P08473,Neprilysin,MME,750.0
15405,DB08577,3-[(3-(2-CARBOXYETHYL)-4-METHYLPYRROL-2-YL)METHYLENE]-2-INDOLINONE,SmallMoleculeDrug,P11362,Fibroblast growth factor receptor 1,FGFR1,822.0
15411,DB08583,"2-amino-5-[3-(1-ethyl-1H-pyrazol-5-yl)-1H-pyrrolo[2,3-b]pyridin-5-yl]-N,N-dimethylbenzamide",SmallMoleculeDrug,P00519,Tyrosine-protein kinase ABL1,ABL1,1130.0
15412,DB08584,"6-{[6-(1-methyl-1H-pyrazol-4-yl)[1,2,4]triazolo[4,3-b]pyridazin-3-yl]sulfanyl}quinoline",SmallMoleculeDrug,P08581,Hepatocyte growth factor receptor,MET,1390.0
15416,DB08588,2-({2-[(3R)-3-AMINOPIPERIDIN-1-YL]-4-OXOQUINAZOLIN-3(4H)-YL}METHYL)BENZONITRILE,SmallMoleculeDrug,P27487,Dipeptidyl peptidase 4,DPP4,766.0
15418,DB08590,1-(3-HYDROXYPROPYL)-2-[(3-NITROBENZOYL)AMINO]-1H-BENZIMIDAZOL-5-YL PIVALATE,SmallMoleculeDrug,Q9NWZ3,Interleukin-1 receptor-associated kinase 4,IRAK4,460.0
15419,DB08591,"5-(4-METHOXYBIPHENYL-3-YL)-1,2,5-THIADIAZOLIDIN-3-ONE 1,1-DIOXIDE",SmallMoleculeDrug,P18031,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,435.0
15420,DB08593,"1,2,5-THIADIAZOLIDIN-3-ONE-1,1-DIOXIDE",SmallMoleculeDrug,P18031,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,435.0
15421,DB08594,TERT-BUTYL 2-CYANO-2-METHYLHYDRAZINECARBOXYLATE,SmallMoleculeDrug,P43235,Cathepsin K,CTSK,329.0
15422,DB08595,"4-[(1S,2R,5S)-4,4,8-TRIMETHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL",SmallMoleculeDrug,P03372,Estrogen receptor,ESR1,595.0
15423,DB08595,"4-[(1S,2R,5S)-4,4,8-TRIMETHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL",SmallMoleculeDrug,Q15596,Nuclear receptor coactivator 2,NCOA2,1464.0
15424,DB08596,5'-deoxy-5'-piperidin-1-ylthymidine,SmallMoleculeDrug,P07998,Ribonuclease pancreatic,RNASE1,156.0
15425,DB08597,"6-[4-(2-piperidin-1-ylethoxy)phenyl]-3-pyridin-4-ylpyrazolo[1,5-a]pyrimidine",SmallMoleculeDrug,Q04771,Activin receptor type-1,ACVR1,509.0
15426,DB08597,"6-[4-(2-piperidin-1-ylethoxy)phenyl]-3-pyridin-4-ylpyrazolo[1,5-a]pyrimidine",SmallMoleculeDrug,P62942,Peptidyl-prolyl cis-trans isomerase FKBP1A,FKBP1A,108.0
15429,DB08599,N-[(4-methoxyphenyl)sulfonyl]-D-alanine,SmallMoleculeDrug,P39900,Macrophage metalloelastase,MMP12,470.0
15431,DB08601,tributylstannanyl,SmallMoleculeDrug,Q15596,Nuclear receptor coactivator 2,NCOA2,1464.0
15432,DB08601,tributylstannanyl,SmallMoleculeDrug,P19793,Retinoic acid receptor RXR-alpha,RXRA,462.0
15433,DB08602,"3-(2,6-difluorophenyl)-2-(methylthio)quinazolin-4(3H)-one",SmallMoleculeDrug,Q13946,"High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A",PDE7A,482.0
15440,DB08605,"6-METHYL-2(PROPANE-1-SULFONYL)-2H-THIENO[3,2-D][1,2,3]DIAZABORININ-1-OL",SmallMoleculeDrug,Q16698,"2,4-dienoyl-CoA reductase, mitochondrial",DECR1,335.0
15443,DB08607,"(5R)-5-(4-{[(2R)-6-HYDROXY-2,5,7,8-TETRAMETHYL-3,4-DIHYDRO-2H-CHROMEN-2-YL]METHOXY}BENZYL)-1,3-THIAZOLIDINE-2,4-DIONE",SmallMoleculeDrug,P10632,Cytochrome P450 2C8,CYP2C8,490.0
15444,DB08608,"4-({(2R,5S)-2,5-DIMETHYL-4-[(2R)-3,3,3-TRIFLUORO-2-HYDROXY-2-METHYLPROPANOYL]PIPERAZIN-1-YL}CARBONYL)BENZONITRILE",SmallMoleculeDrug,Q15119,"[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrial",PDK2,407.0
15445,DB08609,"(N-{4-[(ETHYLANILINO)SULFONYL]-2-METHYLPHENYL}-3,3,3-TRIFLUORO-2-HYDROXY-2-METHYLPROPANAMIDE",SmallMoleculeDrug,Q15119,"[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrial",PDK2,407.0
15446,DB08610,N-(2-AMINOETHYL)-2-{3-CHLORO-4-[(4-ISOPROPYLBENZYL)OXY]PHENYL} ACETAMIDE,SmallMoleculeDrug,Q15119,"[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrial",PDK2,407.0
15447,DB08611,"2-[(2',3',4'-TRIFLUOROBIPHENYL-2-YL)OXY]ETHANOL",SmallMoleculeDrug,P25774,Cathepsin S,CTSS,331.0
15448,DB08612,"1,1,1-TRIFLUORO-3-(OCTYLTHIO)ACETONE",SmallMoleculeDrug,Q9UKY3,Putative inactive carboxylesterase 4,CES1P1,287.0
15449,DB08613,"2,2,2-TRIFLUORO-1-{5-[(3-PHENYL-5,6-DIHYDROIMIDAZO[1,2-A]PYRAZIN-7(8H)-YL)CARBONYL]THIOPHEN-2-YL}ETHANE-1,1-DIOL",SmallMoleculeDrug,P56524,Histone deacetylase 4,HDAC4,1084.0
15450,DB08614,"3-[[(METHYLAMINO)SULFONYL]AMINO]-2-OXO-6-PHENYL-N-[3,3,3-TRIFLUORO-1-(1-METHYLETHYL)-2-OXOPHENYL]-1(2H)-PYRIDINE ACETAMIDE",SmallMoleculeDrug,Q9UNI1,Chymotrypsin-like elastase family member 1,CELA1,258.0
15451,DB08615,"2-[4-(DIMETHYLAMINO)PHENYL]-6-HYDROXY-3-METHYL-1,3-BENZOTHIAZOL-3-IUM",SmallMoleculeDrug,P22303,Acetylcholinesterase,ACHE,614.0
15452,DB08617,"4-(2,2,2-TRIFLUOROETHYL)-L-PHENYLALANINE",SmallMoleculeDrug,P54577,"Tyrosine--tRNA ligase, cytoplasmic",YARS,528.0
15453,DB08618,3-(HYDROXY-PHENYL-PHOSPHINOYLOXY)-8-METHYL-8-AZA-BICYCLO[3.2.1]OCTANE-2-CARBOXYLIC ACID METHYL ESTER,SmallMoleculeDrug,P01859,Ig gamma-2 chain C region,IGHG2,326.0
15455,DB08620,"{(2Z)-3-[(6-chloropyridin-3-yl)methyl]-1,3-thiazolidin-2-ylidene}cyanamide",SmallMoleculeDrug,Q494W8,CHRNA7-FAM7A fusion protein,CHRFAM7A,412.0
15459,DB08624,BENZOTHIAZOLE,SmallMoleculeDrug,P00734,Prothrombin,F2,622.0
15460,DB08626,Thiorphan,SmallMoleculeDrug,P08473,Neprilysin,MME,750.0
15463,DB08629,"N1-(2-AMINO-4-METHYLPENTYL)OCTAHYDRO-PYRROLO[1,2-A] PYRIMIDINE",SmallMoleculeDrug,P25705,"ATP synthase subunit alpha, mitochondrial",ATP5A1,553.0
15464,DB08629,"N1-(2-AMINO-4-METHYLPENTYL)OCTAHYDRO-PYRROLO[1,2-A] PYRIMIDINE",SmallMoleculeDrug,P06576,"ATP synthase subunit beta, mitochondrial",ATP5B,529.0
15465,DB08629,"N1-(2-AMINO-4-METHYLPENTYL)OCTAHYDRO-PYRROLO[1,2-A] PYRIMIDINE",SmallMoleculeDrug,P36542,"ATP synthase subunit gamma, mitochondrial",ATP5C1,298.0
15466,DB08631,"N-(4-CHLOROPHENYL)-1,2,3,4-TETRAHYDROISOQUINOLINE-7-SULFONAMIDE",SmallMoleculeDrug,P11086,Phenylethanolamine N-methyltransferase,PNMT,282.0
15467,DB08632,"1,3,5-BENZENETRICARBOXYLIC ACID",SmallMoleculeDrug,P69905,Hemoglobin subunit alpha,HBA1;,142.0
15468,DB08632,"1,3,5-BENZENETRICARBOXYLIC ACID",SmallMoleculeDrug,P68871,Hemoglobin subunit beta,HBB,147.0
15469,DB08633,"(CHLOROACETYL)CARBAMIC ACID (3R,4S,5S,5R)-5-METHOXY-4-[(2R,3R)-2-METHYL-3-(3-METHYL-2-BUTENYL)OXIRANYL]-1-OXASPIRO[2.5]OCT-6-YL ESTER",SmallMoleculeDrug,P50579,Methionine aminopeptidase 2,METAP2,478.0
15471,DB08635,N-(TRANS-4'-NITRO-4-STILBENYL)-N-METHYL-5-AMINO-PENTANOIC ACID,SmallMoleculeDrug,P01768,Ig heavy chain V-III region CAM,IGHV3-30,117.0
15476,DB08640,"(2S,3S)-3-FORMYL-2-({[(4-METHYLPHENYL)SULFONYL]AMINO}METHYL)PENTANOIC ACID",SmallMoleculeDrug,Q9UNI1,Chymotrypsin-like elastase family member 1,CELA1,258.0
15477,DB08641,"(2S,3S)-3-FORMYL-2-({[(4-NITROPHENYL)SULFONYL]AMINO}METHYL)PENTANOIC ACID",SmallMoleculeDrug,Q9UNI1,Chymotrypsin-like elastase family member 1,CELA1,258.0
15478,DB08642,"(2R,6S)-6-{[methyl(3,4,5-trimethoxyphenyl)amino]methyl}-1,2,5,6,7,8-hexahydroquinazoline-2,4-diamine",SmallMoleculeDrug,P00374,Dihydrofolate reductase,DHFR,187.0
15479,DB08643,2-(2-{2-[(BIPHENYL-4-YLMETHYL)-AMINO]-3-MERCAPTO-PENTANOYLAMINO}-ACETYLAMINO)-3-METHYL-BUTYRIC ACID METHYL ESTER,SmallMoleculeDrug,P08254,Stromelysin-1,MMP3,477.0
15481,DB08645,"6-CHLORO-3-(DICHLOROMETHYL)-3,4-DIHYDRO-2H-1,2,4-BENZOTHIADIAZINE-7-SULFONAMIDE 1,1-DIOXIDE",SmallMoleculeDrug,P00918,Carbonic anhydrase 2,CA2,260.0
15489,DB08647,TRAZEOLIDE,SmallMoleculeDrug,P01834,Ig kappa chain C region,IGKC,107.0
15498,DB08651,3'-THIO-THYMIDINE-5'-PHOSPHATE,SmallMoleculeDrug,Q02880,DNA topoisomerase 2-beta,TOP2B,1626.0
15503,DB08654,"TRANS-(1S,2S)-2-AMINO-1,2,3,4-TETRAHYDRONAPHTHALEN-1-OL",SmallMoleculeDrug,P11086,Phenylethanolamine N-methyltransferase,PNMT,282.0
15504,DB08655,"9-ACETYL-2,3,4,9-TETRAHYDRO-1H-CARBAZOL-1-ONE",SmallMoleculeDrug,Q92793,CREB-binding protein,CREBBP,2442.0
15507,DB08658,ETHYL HYDROGEN DIETHYLAMIDOPHOSPHATE,SmallMoleculeDrug,P06276,Cholinesterase,BCHE,602.0
15508,DB08659,2-(hydrazinocarbonyl)-3-phenyl-1H-indole-5-sulfonamide,SmallMoleculeDrug,P00918,Carbonic anhydrase 2,CA2,260.0
15509,DB08660,"1,2,5,8-tetrahydroxyanthracene-9,10-dione",SmallMoleculeDrug,P68400,Casein kinase II subunit alpha,CSNK2A1,391.0
15510,DB08661,"1-(2,5-dideoxy-5-pyrrolidin-1-yl-beta-L-erythro-pentofuranosyl)-5-methylpyrimidine-2,4(1H,3H)-dione",SmallMoleculeDrug,P07998,Ribonuclease pancreatic,RNASE1,156.0
15521,DB08672,4-[(3R)-3-{[2-(4-FLUOROPHENYL)-2-OXOETHYL]AMINO}BUTYL]BENZAMIDE,SmallMoleculeDrug,P27487,Dipeptidyl peptidase 4,DPP4,766.0
15522,DB08673,"4-[(5-ISOPROPYL-1,3-THIAZOL-2-YL)AMINO]BENZENESULFONAMIDE",SmallMoleculeDrug,P24941,Cyclin-dependent kinase 2,CDK2,298.0
15523,DB08674,"(20S)-19,20,21,22-TETRAHYDRO-19-OXO-5H-18,20-ETHANO-12,14-ETHENO-6,10-METHENO-18H-BENZ[D]IMIDAZO[4,3-K][1,6,9,12]OXATRIAZA-CYCLOOCTADECOSINE-9-CARBONITRILE",SmallMoleculeDrug,P49354,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,FNTA,379.0
15524,DB08674,"(20S)-19,20,21,22-TETRAHYDRO-19-OXO-5H-18,20-ETHANO-12,14-ETHENO-6,10-METHENO-18H-BENZ[D]IMIDAZO[4,3-K][1,6,9,12]OXATRIAZA-CYCLOOCTADECOSINE-9-CARBONITRILE",SmallMoleculeDrug,P49356,Protein farnesyltransferase subunit beta,FNTB,437.0
15525,DB08675,"(6E)-7-{6-[(1E)-OCT-1-ENYL]-2,3-DIAZABICYCLO[2.2.1]HEPT-2-EN-5-YL}HEPT-6-ENOIC ACID",SmallMoleculeDrug,Q16647,Prostacyclin synthase,PTGIS,500.0
15526,DB08676,"(20S)-19,20,22,23-TETRAHYDRO-19-OXO-5H,21H-18,20-ETHANO-12,14-ETHENO-6,10-METHENOBENZ[D]IMIDAZO[4,3-L][1,6,9,13]OXATRIAZACYCLONOADECOSINE-9-CARBONITRILE",SmallMoleculeDrug,P49354,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,FNTA,379.0
15527,DB08676,"(20S)-19,20,22,23-TETRAHYDRO-19-OXO-5H,21H-18,20-ETHANO-12,14-ETHENO-6,10-METHENOBENZ[D]IMIDAZO[4,3-L][1,6,9,13]OXATRIAZACYCLONOADECOSINE-9-CARBONITRILE",SmallMoleculeDrug,P49356,Protein farnesyltransferase subunit beta,FNTB,437.0
15528,DB08677,N-(5-ISOPROPYL-THIAZOL-2-YL)-2-PYRIDIN-3-YL-ACETAMIDE,SmallMoleculeDrug,P24941,Cyclin-dependent kinase 2,CDK2,298.0
15529,DB08678,(4-ETHYLPHENYL)SULFAMIC ACID,SmallMoleculeDrug,P23467,Receptor-type tyrosine-protein phosphatase beta,PTPRB,1997.0
15534,DB08683,"REL-(9R,12S)-9,10,11,12-TETRAHYDRO-9,12-EPOXY-1H-DIINDOLO[1,2,3-FG:3',2',1'-KL]PYRROLO[3,4-I][1,6]BENZODIAZOCINE-1,3(2H)-DIONE",SmallMoleculeDrug,O14757,Serine/threonine-protein kinase Chk1,CHEK1,476.0
15538,DB08687,N-[(1-CHLORO-4-HYDROXYISOQUINOLIN-3-YL)CARBONYL]GLYCINE,SmallMoleculeDrug,Q9GZT9,Egl nine homolog 1,EGLN1,426.0
15539,DB08687,N-[(1-CHLORO-4-HYDROXYISOQUINOLIN-3-YL)CARBONYL]GLYCINE,SmallMoleculeDrug,Q16665,Hypoxia-inducible factor 1-alpha,HIF1A,826.0
15540,DB08688,undecan-2-one,SmallMoleculeDrug,Q9NPJ3,Acyl-coenzyme A thioesterase 13,ACOT13,140.0
15545,DB08689,UBIQUINONE-1,SmallMoleculeDrug,P31040,"Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial",SDHA,664.0
15546,DB08689,UBIQUINONE-1,SmallMoleculeDrug,P21912,"Succinate dehydrogenase [ubiquinone] iron-sulfur subunit, mitochondrial",SDHB,280.0
15547,DB08689,UBIQUINONE-1,SmallMoleculeDrug,O14521,"Succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial",SDHD,159.0
15548,DB08689,UBIQUINONE-1,SmallMoleculeDrug,Q99643,"Succinate dehydrogenase cytochrome b560 subunit, mitochondrial",SDHC,169.0
15558,DB08690,UBIQUINONE-2,SmallMoleculeDrug,P08574,"Cytochrome c1, heme protein, mitochondrial",CYC1,325.0
15559,DB08690,UBIQUINONE-2,SmallMoleculeDrug,P00156,Cytochrome b,MT-CYB,380.0
15560,DB08690,UBIQUINONE-2,SmallMoleculeDrug,P31930,"Cytochrome b-c1 complex subunit 1, mitochondrial",UQCRC1,480.0
15561,DB08690,UBIQUINONE-2,SmallMoleculeDrug,P22695,"Cytochrome b-c1 complex subunit 2, mitochondrial",UQCRC2,453.0
15562,DB08690,UBIQUINONE-2,SmallMoleculeDrug,P07919,"Cytochrome b-c1 complex subunit 6, mitochondrial",UQCRH,91.0
15563,DB08690,UBIQUINONE-2,SmallMoleculeDrug,O14949,Cytochrome b-c1 complex subunit 8,UQCRQ,82.0
15564,DB08690,UBIQUINONE-2,SmallMoleculeDrug,P47985,"Cytochrome b-c1 complex subunit Rieske, mitochondrial",UQCRFS1,274.0
15565,DB08690,UBIQUINONE-2,SmallMoleculeDrug,O14957,Cytochrome b-c1 complex subunit 10,UQCR11,56.0
15566,DB08690,UBIQUINONE-2,SmallMoleculeDrug,P14927,Cytochrome b-c1 complex subunit 7,UQCRB,111.0
15567,DB08690,UBIQUINONE-2,SmallMoleculeDrug,Q9UDW1,Cytochrome b-c1 complex subunit 9,UQCR10,63.0
15579,DB08691,"ethyl 3-[(E)-2-amino-1-cyanoethenyl]-6,7-dichloro-1-methyl-1H-indole-2-carboxylate",SmallMoleculeDrug,P49759,Dual specificity protein kinase CLK1,CLK1,484.0
15580,DB08691,"ethyl 3-[(E)-2-amino-1-cyanoethenyl]-6,7-dichloro-1-methyl-1H-indole-2-carboxylate",SmallMoleculeDrug,P49761,Dual specificity protein kinase CLK3,CLK3,638.0
15581,DB08692,D-1-(4-CHLOROPHENYL)-2-(ACETAMIDO)ETHANE BORONIC ACID,SmallMoleculeDrug,P17538,Chymotrypsinogen B,CTRB1,263.0
15582,DB08693,L-1-(4-CHLOROPHENYL)-2-(ACETAMIDO)ETHANE BORONIC ACID,SmallMoleculeDrug,P17538,Chymotrypsinogen B,CTRB1,263.0
15583,DB08694,"9-amino-5-(2-aminopyrimidin-4-yl)pyrido[3',2':4,5]pyrrolo[1,2-c]pyrimidin-4-ol",SmallMoleculeDrug,P24941,Cyclin-dependent kinase 2,CDK2,298.0
15584,DB08694,"9-amino-5-(2-aminopyrimidin-4-yl)pyrido[3',2':4,5]pyrrolo[1,2-c]pyrimidin-4-ol",SmallMoleculeDrug,P20248,Cyclin-A2,CCNA2,432.0
15585,DB08695,3-(4-nitrophenyl)-1H-pyrazole,SmallMoleculeDrug,O60760,Hematopoietic prostaglandin D synthase,HPGDS,199.0
15586,DB08696,"5-{2-[1-(1-METHYL-PROPYL)-7A-METHYL-OCTAHYDRO-INDEN-4-YLIDENE]-ETHYLIDENE}-2-METHYLENE-CYCLOHEXANE-1,3-DIOL",SmallMoleculeDrug,Q15648,Mediator of RNA polymerase II transcription subunit 1,MED1,1581.0
15587,DB08696,"5-{2-[1-(1-METHYL-PROPYL)-7A-METHYL-OCTAHYDRO-INDEN-4-YLIDENE]-ETHYLIDENE}-2-METHYLENE-CYCLOHEXANE-1,3-DIOL",SmallMoleculeDrug,P11473,Vitamin D3 receptor,VDR,427.0
15588,DB08697,"4-(2-aminoethoxy)-N-(3-chloro-5-piperidin-1-ylphenyl)-3,5-dimethylbenzamide",SmallMoleculeDrug,P00749,Urokinase-type plasminogen activator,PLAU,431.0
15590,DB08699,"1-tert-butyl-3-(3-methylbenzyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine",SmallMoleculeDrug,Q13555,Calcium/calmodulin-dependent protein kinase type II subunit gamma,CAMK2G,558.0
15591,DB08700,"3-[(1R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy]-5-(1-piperidin-4-yl-1H-pyrazol-4-yl)pyridin-2-amine",SmallMoleculeDrug,P08581,Hepatocyte growth factor receptor,MET,1390.0
15595,DB08703,"12-(2-hydroxyethyl)-2-(1-methylethoxy)-13,14-dihydronaphtho[2,1-a]pyrrolo[3,4-c]carbazol-5(12H)-one",SmallMoleculeDrug,P80192,Mitogen-activated protein kinase kinase kinase 9,MAP3K9,1104.0
15597,DB08705,"6-(5-BROMO-2-HYDROXYPHENYL)-2-OXO-4-PHENYL-1,2-DIHYDROPYRIDINE-3-CARBONITRILE",SmallMoleculeDrug,P11309,Serine/threonine-protein kinase pim-1,PIM1,404.0
15599,DB08707,"4-[3-(4-chlorophenyl)-2,1-benzisoxazol-5-yl]pyrimidin-2-amine",SmallMoleculeDrug,P11309,Serine/threonine-protein kinase pim-1,PIM1,404.0
15600,DB08708,"N-cyclohexyl-3-[3-(trifluoromethyl)phenyl][1,2,4]triazolo[4,3-b]pyridazin-6-amine",SmallMoleculeDrug,P11309,Serine/threonine-protein kinase pim-1,PIM1,404.0
15601,DB08709,"2,3-diphenyl-1H-indole-7-carboxylic acid",SmallMoleculeDrug,P11309,Serine/threonine-protein kinase pim-1,PIM1,404.0
15624,DB08729,"5-ethoxy-4-(1-methyl-7-oxo-3-propyl-6,7-dihydro-1H-pyrazolo[4,3-d]pyrimidin-5-yl)thiophene-2-sulfonamide",SmallMoleculeDrug,O76074,"cGMP-specific 3',5'-cyclic phosphodiesterase",PDE5A,875.0
15625,DB08730,3-FLUORO-5-MORPHOLIN-4-YL-N-[1-(2-PYRIDIN-4-YLETHYL)-1H-INDOL-6-YL]BENZAMIDE,SmallMoleculeDrug,Q16539,Mitogen-activated protein kinase 14,MAPK14,360.0
15629,DB08733,"(2R,3R)-N^1^-[(1S)-2,2-DIMETHYL-1-(METHYLCARBAMOYL)PROPYL]-N^4^-HYDROXY-2-(2-METHYLPROPYL)-3-{[(1,3-THIAZOL-2-YLCARBONYL)AMINO]METHYL}BUTANEDIAMIDE",SmallMoleculeDrug,Q9UKQ2,Disintegrin and metalloproteinase domain-containing protein 28,ADAM28,775.0
15630,DB08734,"6,6-DIMETHYL-1-[3-(2,4,5-TRICHLOROPHENOXY)PROPOXY]-1,6-DIHYDRO-1,3,5-TRIAZINE-2,4-DIAMINE",SmallMoleculeDrug,P04818,Thymidylate synthase,TYMS,313.0
15631,DB08737,"(3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-9-OL",SmallMoleculeDrug,P03372,Estrogen receptor,ESR1,595.0
15632,DB08738,1-{3-oxo-3-[(2S)-2-(pyrrolidin-1-ylcarbonyl)pyrrolidin-1-yl]propyl}-3-phenylquinoxalin-2(1H)-one,SmallMoleculeDrug,P48147,Prolyl endopeptidase,PREP,710.0
15633,DB08739,"2-{3-[(2S)-4,4-difluoro-2-(pyrrolidin-1-ylcarbonyl)pyrrolidin-1-yl]-3-oxopropyl}-isoindole-1,3(2H)-dione",SmallMoleculeDrug,P48147,Prolyl endopeptidase,PREP,710.0
15634,DB08740,"CYCLOHEXYLMETHYL-2,3-DIHYDROXY-5-METHYL-HEXYLAMIDE",SmallMoleculeDrug,P07339,Cathepsin D,CTSD,412.0
15636,DB08742,"1,3-CYCLOHEXANEDIOL, 4-METHYLENE-5-[(2E)-[(1S,3AS,7AS)-OCTAHYDRO-1-(5-HYDROXY-5-METHYL-1,3-HEXADIYNYL)-7A-METHYL-4H-INDEN-4-YLIDENE]ETHYLIDENE]-, (1R,3S,5Z)",SmallMoleculeDrug,Q15788,Nuclear receptor coactivator 1,NCOA1,1441.0
15637,DB08742,"1,3-CYCLOHEXANEDIOL, 4-METHYLENE-5-[(2E)-[(1S,3AS,7AS)-OCTAHYDRO-1-(5-HYDROXY-5-METHYL-1,3-HEXADIYNYL)-7A-METHYL-4H-INDEN-4-YLIDENE]ETHYLIDENE]-, (1R,3S,5Z)",SmallMoleculeDrug,P11473,Vitamin D3 receptor,VDR,427.0
15638,DB08743,"2-({8-[(3R)-3-AMINOPIPERIDIN-1-YL]-1,3-DIMETHYL-2,6-DIOXO-1,2,3,6-TETRAHYDRO-7H-PURIN-7-YL}METHYL)BENZONITRILE",SmallMoleculeDrug,P27487,Dipeptidyl peptidase 4,DPP4,766.0
15639,DB08744,"6-methoxy-9-methyl[1,3]dioxolo[4,5-h]quinolin-8(9H)-one",SmallMoleculeDrug,P16083,Ribosyldihydronicotinamide dehydrogenase [quinone],NQO2,231.0
15640,DB08745,4-[[(1E)-2-(4-CHLOROPHENYL)ETHENYL]SULFONYL]-1-[[1-(4-PYRIDINYL)-4-PIPERIDINYL]METHYL]PIPERAZINONE,SmallMoleculeDrug,P00742,Coagulation factor X,F10,488.0
15641,DB08746,1-[[(1E)-2-(4-CHLOROPHENYL)ETHENYL]SULFONYL]-4-[[1-(4-PYRIDINYL)-4-PIPERIDINYL]METHYL]PIPERAZINE,SmallMoleculeDrug,P00742,Coagulation factor X,F10,488.0
15645,DB08749,3-(2-AMINO-6-BENZOYLQUINAZOLIN-3(4H)-YL)-N-CYCLOHEXYL-N-METHYLPROPANAMIDE,SmallMoleculeDrug,P56817,Beta-secretase 1,BACE1,501.0
15646,DB08750,"1-[4-(AMINOMETHYL)BENZOYL]-5'-FLUORO-1'H-SPIRO[PIPERIDINE-4,2'-QUINAZOLIN]-4'-AMINE",SmallMoleculeDrug,P35228,"Nitric oxide synthase, inducible",NOS2,1153.0
15647,DB08751,"N,N'-DIMETHYL-N-(ACETYL)-N'-(7-NITROBENZ-2-OXA-1,3-DIAZOL-4-YL)ETHYLENEDIAMINE",SmallMoleculeDrug,P01112,GTPase HRas,HRAS,189.0
15648,DB08752,N-[(1S)-2-[(4-cyano-1-methylpiperidin-4-yl)amino]-1-(cyclohexylmethyl)-2-oxoethyl]morpholine-4-carboxamide,SmallMoleculeDrug,P25774,Cathepsin S,CTSS,331.0
15651,DB08755,N-[(1S)-2-{[(1R)-2-(benzyloxy)-1-cyano-1-methylethyl]amino}-1-(cyclohexylmethyl)-2-oxoethyl]morpholine-4-carboxamide,SmallMoleculeDrug,P25774,Cathepsin S,CTSS,331.0
15652,DB08756,(R)-TRANS-4-(1-AMINOETHYL)-N-(4-PYRIDYL) CYCLOHEXANECARBOXAMIDE,SmallMoleculeDrug,P17612,cAMP-dependent protein kinase catalytic subunit alpha,PRKACA,351.0
15653,DB08756,(R)-TRANS-4-(1-AMINOETHYL)-N-(4-PYRIDYL) CYCLOHEXANECARBOXAMIDE,SmallMoleculeDrug,P61925,cAMP-dependent protein kinase inhibitor alpha,PKIA,76.0
15654,DB08756,(R)-TRANS-4-(1-AMINOETHYL)-N-(4-PYRIDYL) CYCLOHEXANECARBOXAMIDE,SmallMoleculeDrug,Q13464,Rho-associated protein kinase 1,ROCK1,1354.0
15655,DB08756,(R)-TRANS-4-(1-AMINOETHYL)-N-(4-PYRIDYL) CYCLOHEXANECARBOXAMIDE,SmallMoleculeDrug,O75116,Rho-associated protein kinase 2,ROCK2,1388.0
15659,DB08760,(2S)-2-(4-chlorophenoxy)-3-phenylpropanoic acid,SmallMoleculeDrug,P37231,Peroxisome proliferator-activated receptor gamma,PPARG,505.0
15661,DB08762,O-(((1R)-((N-PHENYLMETHOXYCARBONYL-L-ALANYL)AMINO)ETHYL)HYDROXYPHOSPHONO)-L-BENZYLACETIC ACID,SmallMoleculeDrug,P15085,Carboxypeptidase A1,CPA1,419.0
15662,DB08763,[N-(BENZYLOXYCARBONYL)AMINO](4-AMIDINOPHENYL)METHANE-PHOSPHONATE,SmallMoleculeDrug,P07477,Trypsin-1,PRSS1,247.0
15663,DB08764,4-BROMO-2-FLUORO-N-[(4E)-6-METHOXY-7-[(1-METHYLPIPERIDIN-4-YL)METHOXY]QUINAZOLIN-4(1H)-YLIDENE]ANILINE,SmallMoleculeDrug,P07949,Proto-oncogene tyrosine-protein kinase receptor Ret,RET,1114.0
15664,DB08765,"6-HYDROXY-1,3-BENZOTHIAZOLE-2-SULFONAMIDE",SmallMoleculeDrug,P00918,Carbonic anhydrase 2,CA2,260.0
15665,DB08765,"6-HYDROXY-1,3-BENZOTHIAZOLE-2-SULFONAMIDE",SmallMoleculeDrug,P14174,Macrophage migration inhibitory factor,MIF,115.0
15666,DB08766,"L-PROLINE, 1-[(2S)-3-MERCAPTO-2-METHYL-1-OXOPROPYL]-4-(PHENYLTHIO)-, 4S",SmallMoleculeDrug,P28838,Cytosol aminopeptidase,LAP3,519.0
15669,DB08768,N-(3-METHYLBUT-2-EN-1-YL)-9H-PURIN-6-AMINE,SmallMoleculeDrug,P24941,Cyclin-dependent kinase 2,CDK2,298.0
15670,DB08770,"4-{2-[(7-amino-2-furan-2-yl[1,2,4]triazolo[1,5-a][1,3,5]triazin-5-yl)amino]ethyl}phenol",SmallMoleculeDrug,P29274,Adenosine receptor A2a,ADORA2A,412.0
15671,DB08771,"(5R)-2-[(2-fluorophenyl)amino]-5-(1-methylethyl)-1,3-thiazol-4(5H)-one",SmallMoleculeDrug,P28845,Corticosteroid 11-beta-dehydrogenase isozyme 1,HSD11B1,292.0
15672,DB08772,"3,4-DIHYDRO-4-OXO-3-((5-TRIFLUOROMETHYL-2-BENZOTHIAZOLYL)METHYL)-1-PHTHALAZINE ACETIC ACID",SmallMoleculeDrug,O60218,Aldo-keto reductase family 1 member B10,AKR1B10,316.0
15673,DB08772,"3,4-DIHYDRO-4-OXO-3-((5-TRIFLUOROMETHYL-2-BENZOTHIAZOLYL)METHYL)-1-PHTHALAZINE ACETIC ACID",SmallMoleculeDrug,P15121,Aldose reductase,AKR1B1,316.0
15674,DB08773,RALOXIFENE CORE,SmallMoleculeDrug,P03372,Estrogen receptor,ESR1,595.0
15675,DB08773,RALOXIFENE CORE,SmallMoleculeDrug,Q15596,Nuclear receptor coactivator 2,NCOA2,1464.0
15676,DB08774,"1-[(2S)-4-(5-phenyl-1H-pyrazolo[3,4-b]pyridin-4-yl)morpholin-2-yl]methanamine",SmallMoleculeDrug,O14757,Serine/threonine-protein kinase Chk1,CHEK1,476.0
15677,DB08775,BENZOYL-TYROSINE-ALANINE-METHYL KETONE,SmallMoleculeDrug,Q9UBX1,Cathepsin F,CTSF,484.0
15678,DB08776,"N-(4-OXO-5,6,7,8-TETRAHYDRO-4H-[1,3]THIAZOLO[5,4-C]AZEPIN-2-YL)ACETAMIDE",SmallMoleculeDrug,O14757,Serine/threonine-protein kinase Chk1,CHEK1,476.0
15679,DB08777,"5,6,7,8-TETRAHYDRO[1]BENZOTHIENO[2,3-D]PYRIMIDIN-4(3H)-ONE",SmallMoleculeDrug,O14757,Serine/threonine-protein kinase Chk1,CHEK1,476.0
15680,DB08778,"[4-amino-2-(tert-butylamino)-1,3-thiazol-5-yl](phenyl)methanone",SmallMoleculeDrug,O14757,Serine/threonine-protein kinase Chk1,CHEK1,476.0
15681,DB08779,2-(methylsulfanyl)-5-(thiophen-2-ylmethyl)-1H-imidazol-4-ol,SmallMoleculeDrug,O14757,Serine/threonine-protein kinase Chk1,CHEK1,476.0
15682,DB08780,6-MORPHOLIN-4-YL-9H-PURINE,SmallMoleculeDrug,O14757,Serine/threonine-protein kinase Chk1,CHEK1,476.0
15683,DB08781,"1-[(2S)-4-(5-BROMO-1H-PYRAZOLO[3,4-B]PYRIDIN-4-YL)MORPHOLIN-2-YL]METHANAMINE",SmallMoleculeDrug,O14757,Serine/threonine-protein kinase Chk1,CHEK1,476.0
15684,DB08782,4-(2-AMINOETHYL)BENZENESULFONAMIDE,SmallMoleculeDrug,P00918,Carbonic anhydrase 2,CA2,260.0
15685,DB08783,(4-{(2S)-2-[(tert-butoxycarbonyl)amino]-3-methoxy-3-oxopropyl}phenyl)methaneseleninic acid,SmallMoleculeDrug,P18031,Tyrosine-protein phosphatase non-receptor type 1,PTPN1,435.0
15686,DB08784,2-(4-CHLORO-PHENYLAMINO)-NICOTINIC ACID,SmallMoleculeDrug,Q9HBL8,NmrA-like family domain-containing protein 1,NMRAL1,299.0
15688,DB08786,4-(2-methoxyethoxy)-6-methylpyrimidin-2-amine,SmallMoleculeDrug,P07900,Heat shock protein HSP 90-alpha,HSP90AA1,732.0
15689,DB08787,"4-(2,4-dichlorophenyl)-5-phenyldiazenyl-pyrimidin-2-amine",SmallMoleculeDrug,P07900,Heat shock protein HSP 90-alpha,HSP90AA1,732.0
15690,DB08788,"3,6-DIAMINO-5-CYANO-4-(4-ETHOXYPHENYL)THIENO[2,3-B]PYRIDINE-2-CARBOXAMIDE",SmallMoleculeDrug,P07900,Heat shock protein HSP 90-alpha,HSP90AA1,732.0
15691,DB08789,"2-AMINO-4-(2,4-DICHLOROPHENYL)-N-ETHYLTHIENO[2,3-D]PYRIMIDINE-6-CARBOXAMIDE",SmallMoleculeDrug,P07900,Heat shock protein HSP 90-alpha,HSP90AA1,732.0
15692,DB08790,1-PHENYL-1H-PYRAZOLE-4-CARBOXYLIC ACID,SmallMoleculeDrug,O60760,Hematopoietic prostaglandin D synthase,HPGDS,199.0
15693,DB08791,"1-[(2-NITROPHENYL)SULFONYL]-1H-PYRROLO[3,2-B]PYRIDINE-6-CARBOXAMIDE",SmallMoleculeDrug,P08581,Hepatocyte growth factor receptor,MET,1390.0
15700,DB08799,Antazoline,SmallMoleculeDrug,P35367,Histamine H1 receptor,HRH1,487.0
15701,DB08800,Chloropyramine,SmallMoleculeDrug,P35367,Histamine H1 receptor,HRH1,487.0
15702,DB08801,Dimetindene,SmallMoleculeDrug,P35367,Histamine H1 receptor,HRH1,487.0
15703,DB08801,Dimetindene,SmallMoleculeDrug,P08172,Muscarinic acetylcholine receptor M2,CHRM2,466.0
15704,DB08802,Isothipendyl,SmallMoleculeDrug,P35367,Histamine H1 receptor,HRH1,487.0
15705,DB08804,Nandrolone decanoate,SmallMoleculeDrug,P10275,Androgen receptor,AR,920.0
15706,DB08805,Metiamide,SmallMoleculeDrug,P25021,Histamine H2 receptor,HRH2,359.0
15707,DB08806,Roxatidine acetate,SmallMoleculeDrug,P25021,Histamine H2 receptor,HRH2,359.0
15708,DB08807,Bopindolol,SmallMoleculeDrug,P08588,Beta-1 adrenergic receptor,ADRB1,477.0
15709,DB08807,Bopindolol,SmallMoleculeDrug,P07550,Beta-2 adrenergic receptor,ADRB2,413.0
15710,DB08807,Bopindolol,SmallMoleculeDrug,P08908,5-hydroxytryptamine receptor 1A,HTR1A,422.0
15711,DB08807,Bopindolol,SmallMoleculeDrug,P28222,5-hydroxytryptamine receptor 1B,HTR1B,390.0
15712,DB08807,Bopindolol,SmallMoleculeDrug,P13945,Beta-3 adrenergic receptor,ADRB3,408.0
15713,DB08808,Bupranolol,SmallMoleculeDrug,P08588,Beta-1 adrenergic receptor,ADRB1,477.0
15714,DB08808,Bupranolol,SmallMoleculeDrug,P07550,Beta-2 adrenergic receptor,ADRB2,413.0
15715,DB08808,Bupranolol,SmallMoleculeDrug,P13945,Beta-3 adrenergic receptor,ADRB3,408.0
15716,DB08809,Dichloroacetic Acid,SmallMoleculeDrug,Q15118,"[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial",PDK1,436.0
15717,DB08810,Cinitapride,SmallMoleculeDrug,P08908,5-hydroxytryptamine receptor 1A,HTR1A,422.0
15718,DB08810,Cinitapride,SmallMoleculeDrug,P28223,5-hydroxytryptamine receptor 2A,HTR2A,471.0
15719,DB08810,Cinitapride,SmallMoleculeDrug,Q13639,5-hydroxytryptamine receptor 4,HTR4,388.0
15720,DB08811,Tofisopam,SmallMoleculeDrug,P27815,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A",PDE4A,886.0
15721,DB08811,Tofisopam,SmallMoleculeDrug,Q9Y233,"cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A",PDE10A,779.0
15722,DB08811,Tofisopam,SmallMoleculeDrug,Q14432,"cGMP-inhibited 3',5'-cyclic phosphodiesterase A",PDE3A,1141.0
15723,DB08811,Tofisopam,SmallMoleculeDrug,O00408,"cGMP-dependent 3',5'-cyclic phosphodiesterase",PDE2A,941.0
15724,DB08813,Nadroparin,SmallMoleculeDrug,P01008,Antithrombin-III,SERPINC1,464.0
15725,DB08813,Nadroparin,SmallMoleculeDrug,P16109,P-selectin,SELP,830.0
15726,DB08813,Nadroparin,SmallMoleculeDrug,P01100,Proto-oncogene c-Fos,FOS,380.0
15727,DB08813,Nadroparin,SmallMoleculeDrug,P01106,Myc proto-oncogene protein,MYC,439.0
15728,DB08814,Triflusal,SmallMoleculeDrug,P23219,Prostaglandin G/H synthase 1,PTGS1,599.0
15729,DB08814,Triflusal,SmallMoleculeDrug,P19838,Nuclear factor NF-kappa-B p105 subunit,NFKB1,968.0
15730,DB08814,Triflusal,SmallMoleculeDrug,P35228,"Nitric oxide synthase, inducible",NOS2,1153.0
15731,DB08814,Triflusal,SmallMoleculeDrug,Q9Y233,"cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A",PDE10A,779.0
15732,DB08815,Lurasidone,SmallMoleculeDrug,P14416,D(2) dopamine receptor,DRD2,443.0
15733,DB08815,Lurasidone,SmallMoleculeDrug,P28223,5-hydroxytryptamine receptor 2A,HTR2A,471.0
15734,DB08815,Lurasidone,SmallMoleculeDrug,P34969,5-hydroxytryptamine receptor 7,HTR7,479.0
15735,DB08815,Lurasidone,SmallMoleculeDrug,P08908,5-hydroxytryptamine receptor 1A,HTR1A,422.0
15736,DB08815,Lurasidone,SmallMoleculeDrug,P18825,Alpha-2C adrenergic receptor,ADRA2C,462.0
15737,DB08815,Lurasidone,SmallMoleculeDrug,P08913,Alpha-2A adrenergic receptor,ADRA2A,450.0
15738,DB08816,Ticagrelor,SmallMoleculeDrug,Q9H244,P2Y purinoceptor 12,P2RY12,342.0
15739,DB08818,Hyaluronic acid,SmallMoleculeDrug,P16070,CD44 antigen,CD44,742.0
15740,DB08818,Hyaluronic acid,SmallMoleculeDrug,P05362,Intercellular adhesion molecule 1,ICAM1,532.0
15741,DB08818,Hyaluronic acid,SmallMoleculeDrug,O75330,Hyaluronan mediated motility receptor,HMMR,724.0
15742,DB08818,Hyaluronic acid,SmallMoleculeDrug,O14594,Neurocan core protein,NCAN,1321.0
15743,DB08818,Hyaluronic acid,SmallMoleculeDrug,P13611,Versican core protein,VCAN,3396.0
15744,DB08818,Hyaluronic acid,SmallMoleculeDrug,Q07021,"Complement component 1 Q subcomponent-binding protein, mitochondrial",C1QBP,282.0
15745,DB08818,Hyaluronic acid,SmallMoleculeDrug,P10915,Hyaluronan and proteoglycan link protein 1,HAPLN1,354.0
15746,DB08818,Hyaluronic acid,SmallMoleculeDrug,Q96S86,Hyaluronan and proteoglycan link protein 3,HAPLN3,360.0
15747,DB08818,Hyaluronic acid,SmallMoleculeDrug,Q86UW8,Hyaluronan and proteoglycan link protein 4,HAPLN4,402.0
15748,DB08818,Hyaluronic acid,SmallMoleculeDrug,Q14520,Hyaluronan-binding protein 2,HABP2,560.0
15749,DB08818,Hyaluronic acid,SmallMoleculeDrug,Q6UX15,Layilin,LAYN,382.0
15750,DB08818,Hyaluronic acid,SmallMoleculeDrug,Q8WWQ8,Stabilin-2,STAB2,2551.0
15751,DB08818,Hyaluronic acid,SmallMoleculeDrug,P98066,Tumor necrosis factor-inducible gene 6 protein,TNFAIP6,277.0
15752,DB08818,Hyaluronic acid,SmallMoleculeDrug,Q9BZV3,Interphotoreceptor matrix proteoglycan 2,IMPG2,1241.0
15753,DB08818,Hyaluronic acid,SmallMoleculeDrug,Q5JVS0,Intracellular hyaluronan-binding protein 4,HABP4,413.0
15754,DB08819,Tafluprost,SmallMoleculeDrug,P43088,Prostaglandin F2-alpha receptor,PTGFR,359.0
15755,DB08820,Ivacaftor,SmallMoleculeDrug,P13569,Cystic fibrosis transmembrane conductance regulator,CFTR,1480.0
15756,DB08822,Azilsartan medoxomil,SmallMoleculeDrug,P30556,Type-1 angiotensin II receptor,AGTR1,359.0
15757,DB08827,Lomitapide,SmallMoleculeDrug,P55157,Microsomal triglyceride transfer protein large subunit,MTTP,894.0
15758,DB08828,Vismodegib,SmallMoleculeDrug,Q99835,Smoothened homolog,SMO,787.0
15759,DB08836,Temocapril,SmallMoleculeDrug,P12821,Angiotensin-converting enzyme,ACE,1306.0
15761,DB08837,Tetraethylammonium,SmallMoleculeDrug,Q9UGM1,Neuronal acetylcholine receptor subunit alpha-9,CHRNA9,479.0
15763,DB08838,Agmatine,SmallMoleculeDrug,P18825,Alpha-2C adrenergic receptor,ADRA2C,462.0
15764,DB08838,Agmatine,SmallMoleculeDrug,Q9Y2I1,Nischarin,NISCH,1504.0
15765,DB08838,Agmatine,SmallMoleculeDrug,P02708,Acetylcholine receptor subunit alpha,CHRNA1,482.0
15766,DB08838,Agmatine,SmallMoleculeDrug,Q05586,"Glutamate receptor ionotropic, NMDA 1",GRIN1,938.0
15767,DB08838,Agmatine,SmallMoleculeDrug,P48048,ATP-sensitive inward rectifier potassium channel 1,KCNJ1,391.0
15768,DB08838,Agmatine,SmallMoleculeDrug,Q00975,Voltage-dependent N-type calcium channel subunit alpha-1B,CACNA1B,2339.0
15769,DB08838,Agmatine,SmallMoleculeDrug,Q9UHC3,Acid-sensing ion channel 3,ASIC3,531.0
15770,DB08844,Uric Acid,SmallMoleculeDrug,P06737,"Glycogen phosphorylase, liver form",PYGL,847.0
15771,DB08846,Ellagic Acid,SmallMoleculeDrug,P00915,Carbonic anhydrase 1,CA1,261.0
15772,DB08846,Ellagic Acid,SmallMoleculeDrug,P00918,Carbonic anhydrase 2,CA2,260.0
15773,DB08846,Ellagic Acid,SmallMoleculeDrug,P07451,Carbonic anhydrase 3,CA3,260.0
15774,DB08846,Ellagic Acid,SmallMoleculeDrug,P22748,Carbonic anhydrase 4,CA4,312.0
15775,DB08846,Ellagic Acid,SmallMoleculeDrug,P35218,"Carbonic anhydrase 5A, mitochondrial",CA5A,305.0
15776,DB08846,Ellagic Acid,SmallMoleculeDrug,Q9Y2D0,"Carbonic anhydrase 5B, mitochondrial",CA5B,317.0
15777,DB08846,Ellagic Acid,SmallMoleculeDrug,P23280,Carbonic anhydrase 6,CA6,308.0
15778,DB08846,Ellagic Acid,SmallMoleculeDrug,P43166,Carbonic anhydrase 7,CA7,264.0
15779,DB08846,Ellagic Acid,SmallMoleculeDrug,Q16790,Carbonic anhydrase 9,CA9,459.0
15780,DB08846,Ellagic Acid,SmallMoleculeDrug,O43570,Carbonic anhydrase 12,CA12,354.0
15781,DB08846,Ellagic Acid,SmallMoleculeDrug,Q9ULX7,Carbonic anhydrase 14,CA14,337.0
15782,DB08846,Ellagic Acid,SmallMoleculeDrug,P68400,Casein kinase II subunit alpha,CSNK2A1,391.0
15783,DB08846,Ellagic Acid,SmallMoleculeDrug,P17612,cAMP-dependent protein kinase catalytic subunit alpha,PRKACA,351.0
15784,DB08846,Ellagic Acid,SmallMoleculeDrug,P17252,Protein kinase C alpha type,PRKCA,672.0
15785,DB08846,Ellagic Acid,SmallMoleculeDrug,P05771,Protein kinase C beta type,PRKCB,671.0
15786,DB08846,Ellagic Acid,SmallMoleculeDrug,P43405,Tyrosine-protein kinase SYK,SYK,635.0
15787,DB08846,Ellagic Acid,SmallMoleculeDrug,Q14534,Squalene monooxygenase,SQLE,574.0
15788,DB08848,Guvacine,SmallMoleculeDrug,Q9NSD5,Sodium- and chloride-dependent GABA transporter 2,SLC6A13,602.0
15789,DB08848,Guvacine,SmallMoleculeDrug,P30531,Sodium- and chloride-dependent GABA transporter 1,SLC6A1,599.0
15790,DB08848,Guvacine,SmallMoleculeDrug,P48066,Sodium- and chloride-dependent GABA transporter 3,SLC6A11,632.0
15791,DB08848,Guvacine,SmallMoleculeDrug,P48065,Sodium- and chloride-dependent betaine transporter,SLC6A12,614.0
15792,DB08860,Pitavastatin,SmallMoleculeDrug,P04035,3-hydroxy-3-methylglutaryl-coenzyme A reductase,HMGCR,888.0
15794,DB08864,Rilpivirine,SmallMoleculeDrug,O75469,Nuclear receptor subfamily 1 group I member 2,NR1I2,434.0
15795,DB08865,Crizotinib,SmallMoleculeDrug,Q9UM73,ALK tyrosine kinase receptor,ALK,1620.0
15796,DB08865,Crizotinib,SmallMoleculeDrug,P08581,Hepatocyte growth factor receptor,MET,1390.0
15797,DB08867,Ulipristal,SmallMoleculeDrug,P06401,Progesterone receptor,PGR,933.0
15798,DB08867,Ulipristal,SmallMoleculeDrug,P04150,Glucocorticoid receptor,NR3C1,777.0
15799,DB08867,Ulipristal,SmallMoleculeDrug,P10275,Androgen receptor,AR,920.0
15800,DB08868,Fingolimod,SmallMoleculeDrug,Q9H228,Sphingosine 1-phosphate receptor 5,S1PR5,398.0
15801,DB08869,Tesamorelin,SmallMoleculeDrug,Q02643,Growth hormone-releasing hormone receptor,GHRHR,423.0
15802,DB08870,Brentuximab vedotin,BiotechDrug,P28908,Tumor necrosis factor receptor superfamily member 8,TNFRSF8,595.0
15805,DB08875,Cabozantinib,SmallMoleculeDrug,P08581,Hepatocyte growth factor receptor,MET,1390.0
15806,DB08875,Cabozantinib,SmallMoleculeDrug,P35968,Vascular endothelial growth factor receptor 2,KDR,1356.0
15807,DB08875,Cabozantinib,SmallMoleculeDrug,P07949,Proto-oncogene tyrosine-protein kinase receptor Ret,RET,1114.0
15808,DB08877,Ruxolitinib,SmallMoleculeDrug,P23458,Tyrosine-protein kinase JAK1,JAK1,1154.0
15809,DB08877,Ruxolitinib,SmallMoleculeDrug,O60674,Tyrosine-protein kinase JAK2,JAK2,1132.0
15810,DB08879,Belimumab,BiotechDrug,Q9Y275,Tumor necrosis factor ligand superfamily member 13B,TNFSF13B,285.0
15811,DB08880,Teriflunomide,SmallMoleculeDrug,Q02127,"Dihydroorotate dehydrogenase (quinone), mitochondrial",DHODH,395.0
15812,DB08881,Vemurafenib,SmallMoleculeDrug,P15056,Serine/threonine-protein kinase B-raf,BRAF,766.0
15813,DB08882,Linagliptin,SmallMoleculeDrug,P27487,Dipeptidyl peptidase 4,DPP4,766.0
15814,DB08883,Perampanel,SmallMoleculeDrug,P42261,Glutamate receptor 1,GRIA1,906.0
15815,DB08885,Aflibercept,BiotechDrug,P15692,Vascular endothelial growth factor A,VEGFA,232.0
15816,DB08885,Aflibercept,BiotechDrug,P49763,Placenta growth factor,PGF,221.0
15817,DB08885,Aflibercept,BiotechDrug,P49765,Vascular endothelial growth factor B,VEGFB,207.0
15818,DB08888,Ocriplasmin,BiotechDrug,P02751,Fibronectin,FN1,2386.0
15819,DB08888,Ocriplasmin,BiotechDrug,P01023,Alpha-2-macroglobulin,A2M,1474.0
15820,DB08888,Ocriplasmin,BiotechDrug,P08697,Alpha-2-antiplasmin,SERPINF2,491.0
15821,DB08889,Carfilzomib,SmallMoleculeDrug,P28074,Proteasome subunit beta type-5,PSMB5,263.0
15822,DB08889,Carfilzomib,SmallMoleculeDrug,P28062,Proteasome subunit beta type-8,PSMB8,276.0
15823,DB08889,Carfilzomib,SmallMoleculeDrug,P20618,Proteasome subunit beta type-1,PSMB1,241.0
15824,DB08889,Carfilzomib,SmallMoleculeDrug,P28065,Proteasome subunit beta type-9,PSMB9,219.0
15825,DB08889,Carfilzomib,SmallMoleculeDrug,P49721,Proteasome subunit beta type-2,PSMB2,201.0
15826,DB08889,Carfilzomib,SmallMoleculeDrug,P40306,Proteasome subunit beta type-10,PSMB10,273.0
15827,DB08890,Linaclotide,SmallMoleculeDrug,P25092,Heat-stable enterotoxin receptor,GUCY2C,1073.0
15828,DB08891,Arbaclofen,SmallMoleculeDrug,Q9UBS5,Gamma-aminobutyric acid type B receptor subunit 1,GABBR1,961.0
15829,DB08891,Arbaclofen,SmallMoleculeDrug,O75899,Gamma-aminobutyric acid type B receptor subunit 2,GABBR2,941.0
15830,DB08892,Arbaclofen Placarbil,SmallMoleculeDrug,Q9UBS5,Gamma-aminobutyric acid type B receptor subunit 1,GABBR1,961.0
15831,DB08892,Arbaclofen Placarbil,SmallMoleculeDrug,O75899,Gamma-aminobutyric acid type B receptor subunit 2,GABBR2,941.0
15832,DB08893,Mirabegron,SmallMoleculeDrug,P13945,Beta-3 adrenergic receptor,ADRB3,408.0
15833,DB08894,Peginesatide,SmallMoleculeDrug,P19235,Erythropoietin receptor,EPOR,508.0
15834,DB08895,Tofacitinib,SmallMoleculeDrug,O60674,Tyrosine-protein kinase JAK2,JAK2,1132.0
15835,DB08895,Tofacitinib,SmallMoleculeDrug,P23458,Tyrosine-protein kinase JAK1,JAK1,1154.0
15836,DB08895,Tofacitinib,SmallMoleculeDrug,P52333,Tyrosine-protein kinase JAK3,JAK3,1124.0
15837,DB08896,Regorafenib,SmallMoleculeDrug,P17948,Vascular endothelial growth factor receptor 1,FLT1,1338.0
15838,DB08896,Regorafenib,SmallMoleculeDrug,P35968,Vascular endothelial growth factor receptor 2,KDR,1356.0
15839,DB08896,Regorafenib,SmallMoleculeDrug,P35916,Vascular endothelial growth factor receptor 3,FLT4,1363.0
15840,DB08896,Regorafenib,SmallMoleculeDrug,P10721,Mast/stem cell growth factor receptor Kit,KIT,976.0
15841,DB08896,Regorafenib,SmallMoleculeDrug,P16234,Platelet-derived growth factor receptor alpha,PDGFRA,1089.0
15842,DB08896,Regorafenib,SmallMoleculeDrug,P09619,Platelet-derived growth factor receptor beta,PDGFRB,1106.0
15843,DB08896,Regorafenib,SmallMoleculeDrug,P11362,Fibroblast growth factor receptor 1,FGFR1,822.0
15844,DB08896,Regorafenib,SmallMoleculeDrug,P21802,Fibroblast growth factor receptor 2,FGFR2,821.0
15845,DB08896,Regorafenib,SmallMoleculeDrug,Q02763,Angiopoietin-1 receptor,TEK,1124.0
15846,DB08896,Regorafenib,SmallMoleculeDrug,Q16832,Discoidin domain-containing receptor 2,DDR2,855.0
15847,DB08896,Regorafenib,SmallMoleculeDrug,P04629,High affinity nerve growth factor receptor,NTRK1,796.0
15848,DB08896,Regorafenib,SmallMoleculeDrug,P29317,Ephrin type-A receptor 2,EPHA2,976.0
15849,DB08896,Regorafenib,SmallMoleculeDrug,P04049,RAF proto-oncogene serine/threonine-protein kinase,RAF1,648.0
15850,DB08896,Regorafenib,SmallMoleculeDrug,P15056,Serine/threonine-protein kinase B-raf,BRAF,766.0
15851,DB08896,Regorafenib,SmallMoleculeDrug,Q15759,Mitogen-activated protein kinase 11,MAPK11,364.0
15852,DB08896,Regorafenib,SmallMoleculeDrug,P42685,Tyrosine-protein kinase FRK,FRK,505.0
15853,DB08896,Regorafenib,SmallMoleculeDrug,P00519,Tyrosine-protein kinase ABL1,ABL1,1130.0
15854,DB08896,Regorafenib,SmallMoleculeDrug,P07949,Proto-oncogene tyrosine-protein kinase receptor Ret,RET,1114.0
15855,DB08897,Aclidinium,SmallMoleculeDrug,P11229,Muscarinic acetylcholine receptor M1,CHRM1,460.0
15856,DB08897,Aclidinium,SmallMoleculeDrug,P08172,Muscarinic acetylcholine receptor M2,CHRM2,466.0
15857,DB08897,Aclidinium,SmallMoleculeDrug,P20309,Muscarinic acetylcholine receptor M3,CHRM3,590.0
15858,DB08897,Aclidinium,SmallMoleculeDrug,P08173,Muscarinic acetylcholine receptor M4,CHRM4,479.0
15859,DB08897,Aclidinium,SmallMoleculeDrug,P08912,Muscarinic acetylcholine receptor M5,CHRM5,532.0
15860,DB08899,Enzalutamide,SmallMoleculeDrug,P10275,Androgen receptor,AR,920.0
15861,DB08900,Teduglutide,BiotechDrug,O95838,Glucagon-like peptide 2 receptor,GLP2R,553.0
15862,DB08901,Ponatinib,SmallMoleculeDrug,P00519,Tyrosine-protein kinase ABL1,ABL1,1130.0
15863,DB08901,Ponatinib,SmallMoleculeDrug,P11274,Breakpoint cluster region protein,BCR,1271.0
15864,DB08901,Ponatinib,SmallMoleculeDrug,P10721,Mast/stem cell growth factor receptor Kit,KIT,976.0
15865,DB08901,Ponatinib,SmallMoleculeDrug,P07949,Proto-oncogene tyrosine-protein kinase receptor Ret,RET,1114.0
15866,DB08901,Ponatinib,SmallMoleculeDrug,Q02763,Angiopoietin-1 receptor,TEK,1124.0
15867,DB08901,Ponatinib,SmallMoleculeDrug,P36888,Receptor-type tyrosine-protein kinase FLT3,FLT3,993.0
15868,DB08901,Ponatinib,SmallMoleculeDrug,P11362,Fibroblast growth factor receptor 1,FGFR1,822.0
15869,DB08901,Ponatinib,SmallMoleculeDrug,P21802,Fibroblast growth factor receptor 2,FGFR2,821.0
15870,DB08901,Ponatinib,SmallMoleculeDrug,P22607,Fibroblast growth factor receptor 3,FGFR3,806.0
15871,DB08901,Ponatinib,SmallMoleculeDrug,P22455,Fibroblast growth factor receptor 4,FGFR4,802.0
15872,DB08901,Ponatinib,SmallMoleculeDrug,P06239,Tyrosine-protein kinase Lck,LCK,509.0
15873,DB08901,Ponatinib,SmallMoleculeDrug,P12931,Proto-oncogene tyrosine-protein kinase Src,SRC,536.0
15874,DB08901,Ponatinib,SmallMoleculeDrug,P07948,Tyrosine-protein kinase Lyn,LYN,512.0
15875,DB08901,Ponatinib,SmallMoleculeDrug,P35968,Vascular endothelial growth factor receptor 2,KDR,1356.0
15876,DB08901,Ponatinib,SmallMoleculeDrug,P16234,Platelet-derived growth factor receptor alpha,PDGFRA,1089.0
15879,DB08904,Certolizumab pegol,BiotechDrug,P01375,Tumor necrosis factor,TNF,233.0
15880,DB08906,Fluticasone furoate,SmallMoleculeDrug,P04150,Glucocorticoid receptor,NR3C1,777.0
15881,DB08907,Canagliflozin,SmallMoleculeDrug,P31639,Sodium/glucose cotransporter 2,SLC5A2,672.0
15882,DB08907,Canagliflozin,SmallMoleculeDrug,P13866,Sodium/glucose cotransporter 1,SLC5A1,664.0
15883,DB08908,Dimethyl fumarate,SmallMoleculeDrug,Q14145,Kelch-like ECH-associated protein 1,KEAP1,624.0
15884,DB08910,Pomalidomide,SmallMoleculeDrug,Q96SW2,Protein cereblon,CRBN,442.0
15885,DB08910,Pomalidomide,SmallMoleculeDrug,P01375,Tumor necrosis factor,TNF,233.0
15886,DB08910,Pomalidomide,SmallMoleculeDrug,P35354,Prostaglandin G/H synthase 2,PTGS2,604.0
15887,DB08911,Trametinib,SmallMoleculeDrug,Q02750,Dual specificity mitogen-activated protein kinase kinase 1,MAP2K1,393.0
15888,DB08911,Trametinib,SmallMoleculeDrug,P36507,Dual specificity mitogen-activated protein kinase kinase 2,MAP2K2,400.0
15889,DB08912,Dabrafenib,SmallMoleculeDrug,P15056,Serine/threonine-protein kinase B-raf,BRAF,766.0
15890,DB08912,Dabrafenib,SmallMoleculeDrug,P04049,RAF proto-oncogene serine/threonine-protein kinase,RAF1,648.0
15891,DB08912,Dabrafenib,SmallMoleculeDrug,P57059,Serine/threonine-protein kinase SIK1,SIK1,783.0
15892,DB08912,Dabrafenib,SmallMoleculeDrug,Q8NG66,Serine/threonine-protein kinase Nek11,NEK11,645.0
15893,DB08912,Dabrafenib,SmallMoleculeDrug,P53667,LIM domain kinase 1,LIMK1,647.0
15894,DB08915,Aleglitazar,SmallMoleculeDrug,Q07869,Peroxisome proliferator-activated receptor alpha,PPARA,468.0
15895,DB08915,Aleglitazar,SmallMoleculeDrug,P37231,Peroxisome proliferator-activated receptor gamma,PPARG,505.0
15896,DB08915,Aleglitazar,SmallMoleculeDrug,Q15788,Nuclear receptor coactivator 1,NCOA1,1441.0
15897,DB08916,Afatinib,SmallMoleculeDrug,P00533,Epidermal growth factor receptor,EGFR,1210.0
15898,DB08916,Afatinib,SmallMoleculeDrug,P04626,Receptor tyrosine-protein kinase erbB-2,ERBB2,1255.0
15899,DB08916,Afatinib,SmallMoleculeDrug,Q15303,Receptor tyrosine-protein kinase erbB-4,ERBB4,1308.0
15900,DB08918,Levomilnacipran,SmallMoleculeDrug,P31645,Sodium-dependent serotonin transporter,SLC6A4,630.0
15901,DB08918,Levomilnacipran,SmallMoleculeDrug,P23975,Sodium-dependent noradrenaline transporter,SLC6A2,617.0
15902,DB08923,Epoetin Zeta,BiotechDrug,P19235,Erythropoietin receptor,EPOR,508.0
15903,DB08927,Amperozide,SmallMoleculeDrug,P28223,5-hydroxytryptamine receptor 2A,HTR2A,471.0
15904,DB08929,MK-8931,SmallMoleculeDrug,P56817,Beta-secretase 1,BACE1,501.0
15906,DB08931,Riociguat,SmallMoleculeDrug,P33402,Guanylate cyclase soluble subunit alpha-2,GUCY1A2,732.0
15907,DB08932,Macitentan,SmallMoleculeDrug,P25101,Endothelin-1 receptor,EDNRA,427.0
15908,DB08932,Macitentan,SmallMoleculeDrug,P24530,Endothelin B receptor,EDNRB,442.0
15910,DB08935,Obinutuzumab,BiotechDrug,P11836,B-lymphocyte antigen CD20,MS4A1,297.0
15911,DB08936,Chlorcyclizine,SmallMoleculeDrug,P35367,Histamine H1 receptor,HRH1,487.0
15912,DB08954,Ifenprodil,SmallMoleculeDrug,Q05586,"Glutamate receptor ionotropic, NMDA 1",GRIN1,938.0
15913,DB08954,Ifenprodil,SmallMoleculeDrug,Q13224,"Glutamate receptor ionotropic, NMDA 2B",GRIN2B,1484.0
15914,DB08996,Dimetacrine,SmallMoleculeDrug,P22303,Acetylcholinesterase,ACHE,614.0
15915,DB09014,Captodiame,SmallMoleculeDrug,P28335,5-hydroxytryptamine receptor 2C,HTR2C,458.0
15916,DB09014,Captodiame,SmallMoleculeDrug,Q99720,Sigma non-opioid intracellular receptor 1,SIGMAR1,223.0
15917,DB09014,Captodiame,SmallMoleculeDrug,P35462,D(3) dopamine receptor,DRD3,400.0
15918,DB09016,Butriptyline,SmallMoleculeDrug,P31645,Sodium-dependent serotonin transporter,SLC6A4,630.0
15919,DB09016,Butriptyline,SmallMoleculeDrug,P35367,Histamine H1 receptor,HRH1,487.0
15920,DB09016,Butriptyline,SmallMoleculeDrug,P28223,5-hydroxytryptamine receptor 2A,HTR2A,471.0
15921,DB09018,Bromopride,SmallMoleculeDrug,P14416,D(2) dopamine receptor,DRD2,443.0
15922,DB09026,Aliskiren,SmallMoleculeDrug,P00797,Renin,REN,406.0
15924,DB09028,Cytisine,SmallMoleculeDrug,P43681,Neuronal acetylcholine receptor subunit alpha-4,CHRNA4,627.0
15925,DB09028,Cytisine,SmallMoleculeDrug,P36544,Neuronal acetylcholine receptor subunit alpha-7,CHRNA7,502.0
15926,DB09028,Cytisine,SmallMoleculeDrug,P32297,Neuronal acetylcholine receptor subunit alpha-3,CHRNA3,505.0
15927,DB09028,Cytisine,SmallMoleculeDrug,Q15825,Neuronal acetylcholine receptor subunit alpha-6,CHRNA6,494.0
15928,DB09029,Secukinumab,BiotechDrug,Q16552,Interleukin-17A,IL17A,155.0
15929,DB09030,Vorapaxar,SmallMoleculeDrug,P25116,Proteinase-activated receptor 1,F2R,425.0
15930,DB09033,Vedolizumab,BiotechDrug,P13612,Integrin alpha-4,ITGA4,1032.0
15931,DB09033,Vedolizumab,BiotechDrug,P26010,Integrin beta-7,ITGB7,798.0
15932,DB09034,Suvorexant,SmallMoleculeDrug,O43613,Orexin receptor type 1,HCRTR1,425.0
15933,DB09034,Suvorexant,SmallMoleculeDrug,O43614,Orexin receptor type 2,HCRTR2,444.0
15934,DB09035,Nivolumab,BiotechDrug,Q15116,Programmed cell death protein 1,PDCD1,288.0
15935,DB09036,Siltuximab,BiotechDrug,P05231,Interleukin-6,IL6,212.0
15936,DB09037,Pembrolizumab,BiotechDrug,Q15116,Programmed cell death protein 1,PDCD1,288.0
15937,DB09038,Empagliflozin,SmallMoleculeDrug,P31639,Sodium/glucose cotransporter 2,SLC5A2,672.0
15938,DB09039,Eliglustat,SmallMoleculeDrug,Q16739,Ceramide glucosyltransferase,UGCG,394.0
15941,DB09043,Albiglutide,BiotechDrug,P43220,Glucagon-like peptide 1 receptor,GLP1R,463.0
15942,DB09045,Dulaglutide,BiotechDrug,P43220,Glucagon-like peptide 1 receptor,GLP1R,463.0
15943,DB09046,Metreleptin,BiotechDrug,P48357,Leptin receptor,LEPR,1165.0
15946,DB09047,Finafloxacin,SmallMoleculeDrug,P11388,DNA topoisomerase 2-alpha,TOP2A,1531.0
15947,DB09048,Netupitant,SmallMoleculeDrug,P25103,Substance-P receptor,TACR1,407.0
15948,DB09049,Naloxegol,SmallMoleculeDrug,P35372,Mu-type opioid receptor,OPRM1,400.0
15951,DB09052,Blinatumomab,BiotechDrug,P15391,B-lymphocyte antigen CD19,CD19,556.0
15952,DB09052,Blinatumomab,BiotechDrug,P04234,T-cell surface glycoprotein CD3 delta chain,CD3D,171.0
15953,DB09053,Ibrutinib,SmallMoleculeDrug,Q06187,Tyrosine-protein kinase BTK,BTK,659.0
15965,DB09063,Ceritinib,SmallMoleculeDrug,Q9UM73,ALK tyrosine kinase receptor,ALK,1620.0
15966,DB09067,Corticorelin ovine triflutate,SmallMoleculeDrug,P34998,Corticotropin-releasing factor receptor 1,CRHR1,444.0
15967,DB09068,Vortioxetine,SmallMoleculeDrug,P31645,Sodium-dependent serotonin transporter,SLC6A4,630.0
15968,DB09068,Vortioxetine,SmallMoleculeDrug,P46098,5-hydroxytryptamine receptor 3A,HTR3A,478.0
15969,DB09068,Vortioxetine,SmallMoleculeDrug,P34969,5-hydroxytryptamine receptor 7,HTR7,479.0
15970,DB09068,Vortioxetine,SmallMoleculeDrug,P28222,5-hydroxytryptamine receptor 1B,HTR1B,390.0
15971,DB09068,Vortioxetine,SmallMoleculeDrug,P08908,5-hydroxytryptamine receptor 1A,HTR1A,422.0
15972,DB09068,Vortioxetine,SmallMoleculeDrug,P08588,Beta-1 adrenergic receptor,ADRB1,477.0
15973,DB09069,Trimetazidine,SmallMoleculeDrug,P09110,"3-ketoacyl-CoA thiolase, peroxisomal",ACAA1,424.0
15974,DB09070,Tibolone,SmallMoleculeDrug,P03372,Estrogen receptor,ESR1,595.0
15975,DB09071,Tasimelteon,SmallMoleculeDrug,P48039,Melatonin receptor type 1A,MTNR1A,350.0
15976,DB09071,Tasimelteon,SmallMoleculeDrug,P49286,Melatonin receptor type 1B,MTNR1B,362.0
15977,DB09073,Palbociclib,SmallMoleculeDrug,P11802,Cyclin-dependent kinase 4,CDK4,303.0
15978,DB09073,Palbociclib,SmallMoleculeDrug,Q00534,Cyclin-dependent kinase 6,CDK6,326.0
15979,DB09074,Olaparib,SmallMoleculeDrug,P09874,Poly [ADP-ribose] polymerase 1,PARP1,1014.0
15980,DB09074,Olaparib,SmallMoleculeDrug,Q9UGN5,Poly [ADP-ribose] polymerase 2,PARP2,583.0
15981,DB09074,Olaparib,SmallMoleculeDrug,Q9Y6F1,Poly [ADP-ribose] polymerase 3,PARP3,533.0
15982,DB09075,Edoxaban,SmallMoleculeDrug,P00742,Coagulation factor X,F10,488.0
15983,DB09076,Umeclidinium,SmallMoleculeDrug,P11229,Muscarinic acetylcholine receptor M1,CHRM1,460.0
15984,DB09076,Umeclidinium,SmallMoleculeDrug,P08172,Muscarinic acetylcholine receptor M2,CHRM2,466.0
15985,DB09076,Umeclidinium,SmallMoleculeDrug,P20309,Muscarinic acetylcholine receptor M3,CHRM3,590.0
15986,DB09076,Umeclidinium,SmallMoleculeDrug,P08173,Muscarinic acetylcholine receptor M4,CHRM4,479.0
15987,DB09076,Umeclidinium,SmallMoleculeDrug,P08912,Muscarinic acetylcholine receptor M5,CHRM5,532.0
15988,DB09078,Lenvatinib,SmallMoleculeDrug,P17948,Vascular endothelial growth factor receptor 1,FLT1,1338.0
15989,DB09078,Lenvatinib,SmallMoleculeDrug,P35968,Vascular endothelial growth factor receptor 2,KDR,1356.0
15990,DB09078,Lenvatinib,SmallMoleculeDrug,P35916,Vascular endothelial growth factor receptor 3,FLT4,1363.0
15991,DB09078,Lenvatinib,SmallMoleculeDrug,P11362,Fibroblast growth factor receptor 1,FGFR1,822.0
15992,DB09078,Lenvatinib,SmallMoleculeDrug,P21802,Fibroblast growth factor receptor 2,FGFR2,821.0
15993,DB09078,Lenvatinib,SmallMoleculeDrug,P22607,Fibroblast growth factor receptor 3,FGFR3,806.0
15994,DB09078,Lenvatinib,SmallMoleculeDrug,P22455,Fibroblast growth factor receptor 4,FGFR4,802.0
15995,DB09078,Lenvatinib,SmallMoleculeDrug,P10721,Mast/stem cell growth factor receptor Kit,KIT,976.0
15996,DB09079,Nintedanib,SmallMoleculeDrug,P17948,Vascular endothelial growth factor receptor 1,FLT1,1338.0
15997,DB09079,Nintedanib,SmallMoleculeDrug,P35968,Vascular endothelial growth factor receptor 2,KDR,1356.0
15998,DB09079,Nintedanib,SmallMoleculeDrug,P35916,Vascular endothelial growth factor receptor 3,FLT4,1363.0
15999,DB09079,Nintedanib,SmallMoleculeDrug,P11362,Fibroblast growth factor receptor 1,FGFR1,822.0
16000,DB09079,Nintedanib,SmallMoleculeDrug,P21802,Fibroblast growth factor receptor 2,FGFR2,821.0
16001,DB09079,Nintedanib,SmallMoleculeDrug,P22607,Fibroblast growth factor receptor 3,FGFR3,806.0
16002,DB09079,Nintedanib,SmallMoleculeDrug,P36888,Receptor-type tyrosine-protein kinase FLT3,FLT3,993.0
16003,DB09079,Nintedanib,SmallMoleculeDrug,P06239,Tyrosine-protein kinase Lck,LCK,509.0
16004,DB09079,Nintedanib,SmallMoleculeDrug,P07948,Tyrosine-protein kinase Lyn,LYN,512.0
16005,DB09079,Nintedanib,SmallMoleculeDrug,P12931,Proto-oncogene tyrosine-protein kinase Src,SRC,536.0
16006,DB09080,Olodaterol,SmallMoleculeDrug,P07550,Beta-2 adrenergic receptor,ADRB2,413.0
16007,DB09082,Vilanterol,SmallMoleculeDrug,P07550,Beta-2 adrenergic receptor,ADRB2,413.0
16008,DB09085,Tetracaine,SmallMoleculeDrug,P21817,Ryanodine receptor 1,RYR1,5038.0
16009,DB09085,Tetracaine,SmallMoleculeDrug,Q92736,Ryanodine receptor 2,RYR2,4967.0
16011,DB09105,Asfotase Alfa,BiotechDrug,P21453,Sphingosine 1-phosphate receptor 1,S1PR1,382.0
16012,DB09107,Methoxy polyethylene glycol-epoetin beta,BiotechDrug,P19235,Erythropoietin receptor,EPOR,508.0
16013,DB09119,Eslicarbazepine acetate,SmallMoleculeDrug,Q99571,P2X purinoceptor 4,P2RX4,388.0
16014,DB09126,Chorionic Gonadotropin (Human),BiotechDrug,P22888,Lutropin-choriogonadotropic hormone receptor,LHCGR,699.0
16015,DB09128,Brexpiprazole,SmallMoleculeDrug,P08908,5-hydroxytryptamine receptor 1A,HTR1A,422.0
16016,DB09128,Brexpiprazole,SmallMoleculeDrug,P14416,D(2) dopamine receptor,DRD2,443.0
16017,DB09128,Brexpiprazole,SmallMoleculeDrug,P28223,5-hydroxytryptamine receptor 2A,HTR2A,471.0
16018,DB09128,Brexpiprazole,SmallMoleculeDrug,P18825,Alpha-2C adrenergic receptor,ADRA2C,462.0
16019,DB09128,Brexpiprazole,SmallMoleculeDrug,P35368,Alpha-1B adrenergic receptor,ADRA1B,520.0
16020,DB09129,Chromic chloride,SmallMoleculeDrug,P06213,Insulin receptor,INSR,1382.0
16021,DB09143,Sonidegib,SmallMoleculeDrug,Q99835,Smoothened homolog,SMO,787.0
16022,DB09146,Iron saccharate,SmallMoleculeDrug,P69905,Hemoglobin subunit alpha,HBA1;,142.0
16023,DB09148,Florbetaben (18F),SmallMoleculeDrug,P05067,Amyloid beta A4 protein,APP,770.0
16024,DB09149,Florbetapir (18F),SmallMoleculeDrug,P05067,Amyloid beta A4 protein,APP,770.0
16025,DB09151,Flutemetamol (18F),SmallMoleculeDrug,P05067,Amyloid beta A4 protein,APP,770.0
16027,DB09202,Cirazoline,SmallMoleculeDrug,P35348,Alpha-1A adrenergic receptor,ADRA1A,466.0
16028,DB09202,Cirazoline,SmallMoleculeDrug,P35368,Alpha-1B adrenergic receptor,ADRA1B,520.0
16029,DB09202,Cirazoline,SmallMoleculeDrug,P25100,Alpha-1D adrenergic receptor,ADRA1D,572.0
16030,DB09202,Cirazoline,SmallMoleculeDrug,P08913,Alpha-2A adrenergic receptor,ADRA2A,450.0
16031,DB09202,Cirazoline,SmallMoleculeDrug,P18089,Alpha-2B adrenergic receptor,ADRA2B,450.0
16032,DB09202,Cirazoline,SmallMoleculeDrug,P18825,Alpha-2C adrenergic receptor,ADRA2C,462.0
16033,DB09207,AS-8112,SmallMoleculeDrug,P14416,D(2) dopamine receptor,DRD2,443.0
16034,DB09207,AS-8112,SmallMoleculeDrug,P35462,D(3) dopamine receptor,DRD3,400.0
16035,DB09207,AS-8112,SmallMoleculeDrug,Q9UE69,5HT3 serotonin receptor,nan,11.0
16036,DB09217,Firocoxib,SmallMoleculeDrug,P35354,Prostaglandin G/H synthase 2,PTGS2,604.0
16037,DB09228,C1 Esterase Inhibitor (Recombinant),BiotechDrug,P00736,Complement C1r subcomponent,C1R,705.0
16038,DB09228,C1 Esterase Inhibitor (Recombinant),BiotechDrug,P09871,Complement C1s subcomponent,C1S,688.0
16039,DB09228,C1 Esterase Inhibitor (Recombinant),BiotechDrug,P03952,Plasma kallikrein,KLKB1,638.0
16040,DB09228,C1 Esterase Inhibitor (Recombinant),BiotechDrug,P00748,Coagulation factor XII,F12,615.0
16041,DB09228,C1 Esterase Inhibitor (Recombinant),BiotechDrug,P00734,Prothrombin,F2,622.0
16042,DB09228,C1 Esterase Inhibitor (Recombinant),BiotechDrug,P03951,Coagulation factor XI,F11,625.0
16043,DB09228,C1 Esterase Inhibitor (Recombinant),BiotechDrug,P00750,Tissue-type plasminogen activator,PLAT,562.0
16044,DB09241,Methylene blue,SmallMoleculeDrug,P33402,Guanylate cyclase soluble subunit alpha-2,GUCY1A2,732.0
16045,DB09241,Methylene blue,SmallMoleculeDrug,P29475,"Nitric oxide synthase, brain",NOS1,1434.0
16046,DB09242,Moxonidine,SmallMoleculeDrug,Q9Y2I1,Nischarin,NISCH,1504.0
16047,DB09272,Eluxadoline,SmallMoleculeDrug,P35372,Mu-type opioid receptor,OPRM1,400.0
16048,DB09272,Eluxadoline,SmallMoleculeDrug,P41143,Delta-type opioid receptor,OPRD1,372.0
16049,DB09272,Eluxadoline,SmallMoleculeDrug,P41145,Kappa-type opioid receptor,OPRK1,380.0
16052,DB09278,Activated charcoal,SmallMoleculeDrug,P06858,Lipoprotein lipase,LPL,475.0
16053,DB09280,Lumacaftor,SmallMoleculeDrug,P13569,Cystic fibrosis transmembrane conductance regulator,CFTR,1480.0
16054,DB09292,Sacubitril,SmallMoleculeDrug,P08473,Neprilysin,MME,750.0
16058,DB09302,Alirocumab,BiotechDrug,Q8NBP7,Proprotein convertase subtilisin/kexin type 9,PCSK9,692.0
16059,DB09317,"Synthetic Conjugated Estrogens, A",SmallMoleculeDrug,P03372,Estrogen receptor,ESR1,595.0
16060,DB09318,"Synthetic Conjugated Estrogens, B",SmallMoleculeDrug,P03372,Estrogen receptor,ESR1,595.0
16064,DB09330,Osimertinib,SmallMoleculeDrug,P00533,Epidermal growth factor receptor,EGFR,1210.0
16065,DB09331,Daratumumab,BiotechDrug,P28907,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,CD38,300.0
16066,DB09357,Dexpanthenol,SmallMoleculeDrug,P20309,Muscarinic acetylcholine receptor M3,CHRM3,590.0
16067,DB09389,Norgestrel,SmallMoleculeDrug,P06401,Progesterone receptor,PGR,933.0
16068,DB09389,Norgestrel,SmallMoleculeDrug,P18405,3-oxo-5-alpha-steroid 4-dehydrogenase 1,SRD5A1,259.0
16069,DB09389,Norgestrel,SmallMoleculeDrug,P10275,Androgen receptor,AR,920.0
16070,DB09396,Propoxyphene napsylate,SmallMoleculeDrug,P35372,Mu-type opioid receptor,OPRM1,400.0
16071,DB09396,Propoxyphene napsylate,SmallMoleculeDrug,P41145,Kappa-type opioid receptor,OPRK1,380.0
16072,DB09396,Propoxyphene napsylate,SmallMoleculeDrug,P41143,Delta-type opioid receptor,OPRD1,372.0
16073,DB09421,Protirelin,SmallMoleculeDrug,P34981,Thyrotropin Releasing Hormone Receptor,TRHR,398.0
16074,DB09460,Sodium carbonate,SmallMoleculeDrug,P00915,Carbonic anhydrase 1,CA1,261.0
16075,DB09460,Sodium carbonate,SmallMoleculeDrug,P00918,Carbonic anhydrase 2,CA2,260.0
16076,DB09460,Sodium carbonate,SmallMoleculeDrug,P22748,Carbonic anhydrase 4,CA4,312.0
16077,DB09460,Sodium carbonate,SmallMoleculeDrug,Q16790,Carbonic anhydrase 9,CA9,459.0
16078,DB09462,Glycerin,SmallMoleculeDrug,Q03181,Peroxisome proliferator-activated receptor delta,PPARD,441.0
16079,DB09477,Enalaprilat,SmallMoleculeDrug,P12821,Angiotensin-converting enzyme,ACE,1306.0
16080,DB09488,Acrivastine,SmallMoleculeDrug,P35367,Histamine H1 receptor,HRH1,487.0
16083,DB09526,Hydroquinone,SmallMoleculeDrug,P14679,Tyrosinase,TYR,529.0
16084,DB09543,Methyl salicylate,SmallMoleculeDrug,P31645,Sodium-dependent serotonin transporter,SLC6A4,630.0
16085,DB09543,Methyl salicylate,SmallMoleculeDrug,Q01959,Sodium-dependent dopamine transporter,SLC6A3,620.0
16086,DB09555,Dexchlorpheniramine maleate,SmallMoleculeDrug,P35367,Histamine H1 receptor,HRH1,487.0
16087,DB09559,Necitumumab,BiotechDrug,P00533,Epidermal growth factor receptor,EGFR,1210.0
16088,DB09560,Filgrastim-sndz,BiotechDrug,Q99062,Granulocyte colony-stimulating factor receptor,CSF3R,836.0
16089,DB09564,Insulin Degludec,BiotechDrug,P06213,Insulin receptor,INSR,1382.0
16090,DB11120,Turpentine,SmallMoleculeDrug,P28482,Mitogen-activated protein kinase 1,MAPK1,360.0
16091,DB11256,Levomefolic acid,SmallMoleculeDrug,Q92887,Canalicular multispecific organic anion transporter 1,ABCC2,1545.0
16092,DB11362,Selexipag,SmallMoleculeDrug,P43119,Prostacyclin receptor,PTGIR,386.0
16093,DB11363,Alectinib,SmallMoleculeDrug,Q9UM73,ALK tyrosine kinase receptor,ALK,1620.0
16094,DB11560,Lesinurad,SmallMoleculeDrug,Q96S37,Solute carrier family 22 member 12,SLC22A12,553.0
16095,DB11560,Lesinurad,SmallMoleculeDrug,Q9NSA0,Solute carrier family 22 member 11,SLC22A11,550.0
16096,DB11569,Ixekizumab,BiotechDrug,Q16552,Interleukin-17A,IL17A,155.0
16098,DB11581,Venetoclax,SmallMoleculeDrug,P10415,Apoptosis regulator Bcl-2,BCL2,239.0
16099,DB11582,Thiocolchicoside,SmallMoleculeDrug,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,GABRA1,456.0
16100,DB11582,Thiocolchicoside,SmallMoleculeDrug,P47869,Gamma-aminobutyric acid receptor subunit alpha-2,GABRA2,451.0
16101,DB11582,Thiocolchicoside,SmallMoleculeDrug,P34903,Gamma-aminobutyric acid receptor subunit alpha-3,GABRA3,492.0
16102,DB11582,Thiocolchicoside,SmallMoleculeDrug,P48169,Gamma-aminobutyric acid receptor subunit alpha-4,GABRA4,554.0
16103,DB11582,Thiocolchicoside,SmallMoleculeDrug,P31644,Gamma-aminobutyric acid receptor subunit alpha-5,GABRA5,462.0
16104,DB11582,Thiocolchicoside,SmallMoleculeDrug,Q16445,Gamma-aminobutyric acid receptor subunit alpha-6,GABRA6,453.0
16105,DB11582,Thiocolchicoside,SmallMoleculeDrug,P18505,Gamma-aminobutyric acid receptor subunit beta-1,GABRB1,474.0
16106,DB11582,Thiocolchicoside,SmallMoleculeDrug,P47870,Gamma-aminobutyric acid receptor subunit beta-2,GABRB2,512.0
16107,DB11582,Thiocolchicoside,SmallMoleculeDrug,P28472,Gamma-aminobutyric acid receptor subunit beta-3,GABRB3,473.0
16108,DB11582,Thiocolchicoside,SmallMoleculeDrug,O14764,Gamma-aminobutyric acid receptor subunit delta,GABRD,452.0
16109,DB11582,Thiocolchicoside,SmallMoleculeDrug,P78334,Gamma-aminobutyric acid receptor subunit epsilon,GABRE,506.0
16110,DB11582,Thiocolchicoside,SmallMoleculeDrug,Q8N1C3,Gamma-aminobutyric acid receptor subunit gamma-1,GABRG1,465.0
16111,DB11582,Thiocolchicoside,SmallMoleculeDrug,P18507,Gamma-aminobutyric acid receptor subunit gamma-2,GABRG2,467.0
16112,DB11582,Thiocolchicoside,SmallMoleculeDrug,Q99928,Gamma-aminobutyric acid receptor subunit gamma-3,GABRG3,467.0
16113,DB11582,Thiocolchicoside,SmallMoleculeDrug,O00591,Gamma-aminobutyric acid receptor subunit pi,GABRP,440.0
16114,DB11582,Thiocolchicoside,SmallMoleculeDrug,Q9UN88,Gamma-aminobutyric acid receptor subunit theta,GABRQ,632.0
16115,DB11582,Thiocolchicoside,SmallMoleculeDrug,P23415,Glycine receptor subunit alpha-1,GLRA1,457.0
16116,DB11582,Thiocolchicoside,SmallMoleculeDrug,O14788,Tumor necrosis factor ligand superfamily member 11,TNFSF11,317.0
16117,DB11591,Bilastine,SmallMoleculeDrug,P35367,Histamine H1 receptor,HRH1,487.0
16118,DB11595,Atezolizumab,BiotechDrug,Q9NZQ7,Programmed cell death 1 ligand 1,CD274,290.0
16119,DB11598,Antithrombin III human,BiotechDrug,P01008,Antithrombin-III,SERPINC1,464.0
16120,DB11611,Lifitegrast,SmallMoleculeDrug,P20701,Integrin alpha-L,ITGAL,1170.0
16121,DB11623,Candoxatrilat,SmallMoleculeDrug,P08473,Neprilysin,MME,750.0
16122,DB11699,Tropisetron,SmallMoleculeDrug,P46098,5-hydroxytryptamine receptor 3A,HTR3A,478.0
16123,DB11730,Ribociclib,SmallMoleculeDrug,P11802,Cyclin-dependent kinase 4,CDK4,303.0
16124,DB11730,Ribociclib,SmallMoleculeDrug,Q00534,Cyclin-dependent kinase 6,CDK6,326.0
16125,DB11737,Icotinib,SmallMoleculeDrug,P00533,Epidermal growth factor receptor,EGFR,1210.0
16126,DB12095,Telotristat,SmallMoleculeDrug,Q8IWU9,Tryptophan 5-hydroxylase 2,TPH2,490.0
16127,DB12095,Telotristat,SmallMoleculeDrug,P17752,Tryptophan 5-hydroxylase 1,TPH1,444.0
16128,DB12323,Radotinib,SmallMoleculeDrug,P00519,Tyrosine-protein kinase ABL1,ABL1,1130.0
16129,DB12332,Rucaparib,SmallMoleculeDrug,P09874,Poly [ADP-ribose] polymerase 1,PARP1,1014.0
16130,DB12332,Rucaparib,SmallMoleculeDrug,Q9UGN5,Poly [ADP-ribose] polymerase 2,PARP2,583.0
16131,DB12332,Rucaparib,SmallMoleculeDrug,Q9Y6F1,Poly [ADP-ribose] polymerase 3,PARP3,533.0
16132,DB12865,Etelcalcetide,SmallMoleculeDrug,P41180,Extracellular calcium-sensing receptor,CASR,1078.0
16133,DB13025,Tiapride,SmallMoleculeDrug,P14416,D(2) dopamine receptor,DRD2,443.0
16134,DB13025,Tiapride,SmallMoleculeDrug,P35462,D(3) dopamine receptor,DRD3,400.0
16135,DB13025,Tiapride,SmallMoleculeDrug,P08908,5-hydroxytryptamine receptor 1A,HTR1A,422.0
16136,DB13025,Tiapride,SmallMoleculeDrug,P28222,5-hydroxytryptamine receptor 1B,HTR1B,390.0
16137,DB13025,Tiapride,SmallMoleculeDrug,P28221,5-hydroxytryptamine receptor 1D,HTR1D,377.0
16138,DB13025,Tiapride,SmallMoleculeDrug,P28566,5-hydroxytryptamine receptor 1E,HTR1E,365.0
16139,DB13025,Tiapride,SmallMoleculeDrug,P30939,5-hydroxytryptamine receptor 1F,HTR1F,366.0
16140,DB13025,Tiapride,SmallMoleculeDrug,P28223,5-hydroxytryptamine receptor 2A,HTR2A,471.0
16141,DB13025,Tiapride,SmallMoleculeDrug,P41595,5-hydroxytryptamine receptor 2B,HTR2B,481.0
16142,DB13025,Tiapride,SmallMoleculeDrug,P28335,5-hydroxytryptamine receptor 2C,HTR2C,458.0
16143,DB13025,Tiapride,SmallMoleculeDrug,P46098,5-hydroxytryptamine receptor 3A,HTR3A,478.0
16144,DB13025,Tiapride,SmallMoleculeDrug,O95264,5-hydroxytryptamine receptor 3B,HTR3B,441.0
16145,DB13025,Tiapride,SmallMoleculeDrug,Q8WXA8,5-hydroxytryptamine receptor 3C,HTR3C,447.0
16146,DB13025,Tiapride,SmallMoleculeDrug,Q70Z44,5-hydroxytryptamine receptor 3D,HTR3D,454.0
16147,DB13025,Tiapride,SmallMoleculeDrug,A5X5Y0,5-hydroxytryptamine receptor 3E,HTR3E,456.0
16148,DB13025,Tiapride,SmallMoleculeDrug,Q13639,5-hydroxytryptamine receptor 4,HTR4,388.0
16149,DB13025,Tiapride,SmallMoleculeDrug,P50406,5-hydroxytryptamine receptor 6,HTR6,440.0
16150,DB13025,Tiapride,SmallMoleculeDrug,P34969,5-hydroxytryptamine receptor 7,HTR7,479.0
16151,DB13025,Tiapride,SmallMoleculeDrug,P35348,Alpha-1A adrenergic receptor,ADRA1A,466.0
16152,DB13025,Tiapride,SmallMoleculeDrug,P35368,Alpha-1B adrenergic receptor,ADRA1B,520.0
16153,DB13025,Tiapride,SmallMoleculeDrug,P25100,Alpha-1D adrenergic receptor,ADRA1D,572.0
16154,DB13025,Tiapride,SmallMoleculeDrug,P08913,Alpha-2A adrenergic receptor,ADRA2A,450.0
16155,DB13025,Tiapride,SmallMoleculeDrug,P18089,Alpha-2B adrenergic receptor,ADRA2B,450.0
16156,DB13025,Tiapride,SmallMoleculeDrug,P18825,Alpha-2C adrenergic receptor,ADRA2C,462.0
16157,DB13025,Tiapride,SmallMoleculeDrug,P35367,Histamine H1 receptor,HRH1,487.0
16158,DB13139,Levosalbutamol,SmallMoleculeDrug,P07550,Beta-2 adrenergic receptor,ADRB2,413.0
16159,DB13144,Lenograstim,BiotechDrug,Q99062,Granulocyte colony-stimulating factor receptor,CSF3R,836.0
16160,DB13150,Coagulation factor VII human,BiotechDrug,P13726,Tissue factor,F3,295.0
16161,DB13150,Coagulation factor VII human,BiotechDrug,P00742,Coagulation factor X,F10,488.0
16162,DB13150,Coagulation factor VII human,BiotechDrug,P00740,Coagulation factor IX,F9,461.0
16163,DB13155,Esculin,SmallMoleculeDrug,P10275,Androgen receptor,AR,920.0
16164,DB13158,Clobetasone,SmallMoleculeDrug,P04150,Glucocorticoid receptor,NR3C1,777.0
16165,DB13164,Olmutinib,SmallMoleculeDrug,P00533,Epidermal growth factor receptor,EGFR,1210.0
16166,DB13166,Zofenopril,SmallMoleculeDrug,P12821,Angiotensin-converting enzyme,ACE,1306.0
16167,DB13170,Plecanatide,SmallMoleculeDrug,P33402,Guanylate cyclase soluble subunit alpha-2,GUCY1A2,732.0
